PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Larocque, D; Fragoso, G; Huang, JH; Mushynski, WE; Loignon, M; Richard, S; Almazan, G				Larocque, Daniel; Fragoso, Gabriela; Huang, Jinghan; Mushynski, Walter E.; Loignon, Martin; Richard, Stephane; Almazan, Guillermina			The QKI-6 and QKI-7 RNA Binding Proteins Block Proliferation and Promote Schwann Cell Myelination	PLOS ONE			English	Article							MESSENGER-RNAS; QUAKING; INHIBITOR; P27(KIP1); DIFFERENTIATION; EXPRESSION; PHOSPHORYLATION; DYSMYELINATION; ISOFORMS; SIGNALS	Background: The quaking viable (qk(v)) mice have uncompacted myelin in their central and peripheral nervous system (CNS, PNS). The qk gene encodes 3 major alternatively spliced isoforms that contain unique sequence at their C-terminus dictating their cellular localization. QKI-5 is a nuclear isoform, whereas QKI-6 and QKI-7 are cytoplasmic isoforms. The qk(v) mice harbor an enhancer/promoter deletion that prevents the expression of isoforms QKI-6 and QKI-7 in myelinating cells resulting in a dysmyelination phenotype. It was shown that QKI regulates the differentiation of oligodendrocytes, the myelinating cells of the CNS, however, little is known about the role of the QKI proteins, or RNA binding proteins in PNS myelination. Methodology/Principal Findings: To define the role of the QKI proteins in PNS myelination, we ectopically expressed QKI-6 and QKI-7 in primary rat Schwann cell/neuron from dorsal root ganglia cocultures. We show that the QKI isoforms blocked proliferation and promoted Schwann cell differentiation and myelination. In addition, these events were coordinated with elevated proteins levels of p27(KIP1) and myelin basic protein (MBP), markers of Schwann cell differentiation. QKI-6 and QKI-7 expressing co-cultures contained myelinated fibers that had directionality and contained significantly thicker myelin, as assessed by electron microscopy. Moreover, QKI-deficient Schwann cells had reduced levels of MBP, p27(KIP1) and Krox-20 mRNAs, as assessed by quantitative RT-PCR. Conclusions/Significance: Our findings suggest that the QKI-6 and QKI-7 RNA binding proteins are positive regulators of PNS myelination and show that the QKI RNA binding proteins play a key role in Schwann cell differentiation and myelination.			Larocque, D (corresponding author), GlaxoSmithKline Biol N Amer, Laval, PQ, Canada.	stephane.richard@mcgill.ca; guillermina.almazan@mcgill.ca						BERGER B, 1971, BRAIN RES, V25, P35, DOI 10.1016/0006-8993(71)90565-8; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Dyer CA, 2000, J NEUROSCI RES, V60, P412, DOI 10.1002/(SICI)1097-4547(20000501)60:3<412::AID-JNR16>3.3.CO;2-5; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Fragoso G, 2003, EXP NEUROL, V183, P34, DOI 10.1016/S0014-4886(03)00101-8; Friessen AJ, 1997, J NEUROSCI RES, V50, P373; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Heinen A, 2008, P NATL ACAD SCI USA, V105, P8748, DOI 10.1073/pnas.0802659105; Iacovelli J, 2007, GLIA, V55, P1638, DOI 10.1002/glia.20578; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee Min-Ho, 2006, WormBook, P1; Li ZH, 2003, DEV GROWTH DIFFER, V45, P449; Li ZZ, 2000, J NEUROSCI, V20, P4944; Lopez-Sanchez E, 2007, EUR J OPHTHALMOL, V17, P377, DOI 10.1177/112067210701700317; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mager GM, 2008, J BIOL CHEM, V283, P18187, DOI 10.1074/jbc.M803330200; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Parkinson DB, 2004, J CELL BIOL, V164, P385, DOI 10.1083/jcb.200307132; Parrinello S, 2008, GENE DEV, V22, P3335, DOI 10.1101/gad.490608; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; SAMORAJS.T, 1970, J NEUROPATH EXP NEUR, V29, P507, DOI 10.1097/00005072-197010000-00001; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SUZUKI K, 1976, BRAIN RES, V106, P146, DOI 10.1016/0006-8993(76)90079-2; Tikoo R, 2000, J NEUROSCI, V20, P4627, DOI 10.1523/JNEUROSCI.20-12-04627.2000; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; TRAPP BD, 1984, J CELL BIOL, V99, P594, DOI 10.1083/jcb.99.2.594; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Zhang YY, 2003, EMBO J, V22, P1801, DOI 10.1093/emboj/cdg171; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zorick TS, 1999, DEVELOPMENT, V126, P1397	48	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5867	10.1371/journal.pone.0005867	http://dx.doi.org/10.1371/journal.pone.0005867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517016	Green Published, Green Submitted, gold			2022-12-27	WOS:000266873100002
J	Sabbisetti, V; Di Napoli, A; Seeley, A; Amato, AM; O'Regan, E; Ghebremichael, M; Loda, M; Signoretti, S				Sabbisetti, Venkata; Di Napoli, Arianna; Seeley, Apryle; Amato, Angela M.; O'Regan, Esther; Ghebremichael, Musie; Loda, Massimo; Signoretti, Sabina			p63 Promotes Cell Survival through Fatty Acid Synthase (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							PROSTATE-CANCER; PHARMACOLOGICAL INHIBITION; INDUCED APOPTOSIS; DOWN-REGULATION; DIRECT TARGET; P53 HOMOLOG; EXPRESSION; GENE; ACTIVATION; OVEREXPRESSION	There is increasing evidence that p63, and specifically Delta Np63, plays a central role in both development and tumorigenesis by promoting epithelial cell survival. However, few studies have addressed the molecular mechanisms through which such important function is exerted. Fatty acid synthase (FASN), a key enzyme that synthesizes long-chain fatty acids and is involved in both embryogenesis and cancer, has been recently proposed as a direct target of p53 family members, including p63 and p73. Here we show that knockdown of either total or Delta N-specific p63 isoforms in squamous cell carcinoma (SCC9) or immortalized prostate epithelial (iPrEC) cells caused a decrease in cell viability by inducing apoptosis without affecting the cell cycle. p63 silencing significantly reduced both the expression and the activity of FASN. Importantly, stable overexpression of either FASN or myristoylated AKT (myr-AKT) was able to partially rescue cells from cell death induced by p63 silencing. FASN induced AKT phosphorylation and a significant reduction in cell viability was observed when FASN-overexpressing SCC9 cells were treated with an AKT inhibitor after p63 knockdown, indicating that AKT plays a major role in FASN-mediated survival. Activated AKT did not cause any alteration in the FASN protein levels but induced its activity, suggesting that the rescue from apoptosis documented in the p63-silenced cells expressing myr-AKT cells may be partially mediated by FASN. Finally, we demonstrated that p63 and FASN expression are positively associated in clinical squamous cell carcinoma samples as well as in the developing prostate. Taken together, our findings demonstrate that FASN is a functionally relevant target of p63 and is required for mediating its pro-survival effects.			Sabbisetti, V (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02115 USA.	ssignoretti@partners.org	Di Napoli, Arianna/AAB-3210-2022	Di Napoli, Arianna/0000-0002-3159-5380	NCI NIH HHS [R01 CA131945] Funding Source: Medline; NIDDK NIH HHS [R21 DK72152, R21 DK072152] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA131945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072152] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agostini M, 2004, ORAL ONCOL, V40, P728, DOI 10.1016/j.oraloncology.2004.01.011; Bandyopadhyay S, 2005, ONCOGENE, V24, P5389, DOI 10.1038/sj.onc.1208555; Barbieri CE, 2005, CANCER RES, V65, P2314, DOI 10.1158/0008-5472.CAN-04-3449; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLKER HI, 1956, J EXP MED, V103, P199, DOI 10.1084/jem.103.2.199; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Choi HR, 2002, HUM PATHOL, V33, P158, DOI 10.1053/hupa.2002.30722; D'Erchia AM, 2006, CELL CYCLE, V5, P750, DOI 10.4161/cc.5.7.2622; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; DiRenzo J, 2002, CANCER RES, V62, P89; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Furuya Y, 1997, ANTICANCER RES, V17, P4589; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Li JN, 2001, CANCER RES, V61, P1493; Liefer KM, 2000, CANCER RES, V60, P4016; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; Menendez JA, 2004, MOL CARCINOGEN, V41, P164, DOI 10.1002/mc.20054; Menendez JA, 2004, INT J ONCOL, V24, P1369; MIGITA T, J NATL CANC IN PRESS; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2006, CURR OPIN GENET DEV, V16, P38, DOI 10.1016/j.gde.2005.12.001; Ogawa E, 2008, ONCOGENE, V27, P848, DOI 10.1038/sj.onc.1210682; Ortt K, 2008, J CELL BIOCHEM, V104, P1204, DOI 10.1002/jcb.21700; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Oskouian B, 2000, CANCER LETT, V149, P43, DOI 10.1016/S0304-3835(99)00342-0; Park BJ, 2000, CANCER RES, V60, P3370; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pizer ES, 1998, CANCER RES, V58, P4611; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rossi S, 2006, J PATHOL, V209, P369, DOI 10.1002/path.1983; Rossi S, 2003, MOL CANCER RES, V1, P707; Scarpino S, 2007, J PATHOL, V212, P411, DOI 10.1002/path.2183; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Swinnen JV, 2000, ONCOGENE, V19, P5173, DOI 10.1038/sj.onc.1203889; Takahiro T, 2003, CLIN CANCER RES, V9, P2204; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Van de Sande T, 2005, J PATHOL, V206, P214, DOI 10.1002/path.1760; Van de Sande T, 2002, CANCER RES, V62, P642; Visca P, 2004, ANTICANCER RES, V24, P4169; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang HQ, 2005, ONCOGENE, V24, P3574, DOI 10.1038/sj.onc.1208463; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu GJ, 2005, CANCER RES, V65, P758; Yamaguchi K, 2000, INT J CANCER, V86, P684, DOI 10.1002/(SICI)1097-0215(20000601)86:5<684::AID-IJC13>3.0.CO;2-M; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600	65	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5877	10.1371/journal.pone.0005877	http://dx.doi.org/10.1371/journal.pone.0005877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517019	Green Published, gold, Green Submitted			2022-12-27	WOS:000266873100010
J	Carbonell, WS; Ansorge, O; Sibson, N; Muschel, R				Carbonell, W. Shawn; Ansorge, Olaf; Sibson, Nicola; Muschel, Ruth			The Vascular Basement Membrane as "Soil'' in Brain Metastasis	PLOS ONE			English	Article							BREAST-CANCER CELLS; TARGETED DISRUPTION; BETA(1) INTEGRIN; MELANOMA; GROWTH; MIGRATION; INVASION; BETA-1-INTEGRIN; DISSEMINATION; PROGRESSION	Brain-specific homing and direct interactions with the neural substance are prominent hypotheses for brain metastasis formation and a modern manifestation of Paget's "seed and soil'' concept. However, there is little direct evidence for this "neurotropic'' growth in vivo. In contrast, many experimental studies have anecdotally noted the propensity of metastatic cells to grow along the exterior of pre-existing vessels of the CNS, a process termed vascular cooption. These observations suggest the "soil'' for malignant cells in the CNS may well be vascular, rather than neuronal. We used in vivo experimental models of brain metastasis and analysis of human clinical specimens to test this hypothesis. Indeed, over 95% of early micrometastases examined demonstrated vascular cooption with little evidence for isolated neurotropic growth. This vessel interaction was adhesive in nature implicating the vascular basement membrane (VBM) as the active substrate for tumor cell growth in the brain. Accordingly, VBM promoted adhesion and invasion of malignant cells and was sufficient for tumor growth prior to any evidence of angiogenesis. Blockade or loss of the beta 1 integrin subunit in tumor cells prevented adhesion to VBM and attenuated metastasis establishment and growth in vivo. Our data establishes a new understanding of CNS metastasis formation and identifies the neurovasculature as the critical partner for such growth. Further, we have elucidated the mechanism of vascular cooption for the first time. These findings may help inform the design of effective molecular therapies for patients with fatal CNS malignancies.			Carbonell, WS (corresponding author), Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England.	bigaxon@bigaxon.com			NATIONAL CANCER INSTITUTE [R01CA046830] Funding Source: NIH RePORTER; Cancer Research UK Funding Source: Medline; Medical Research Council Funding Source: Medline; NCI NIH HHS [CA46830, R01 CA046830] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham S, 2008, CIRC RES, V102, P562, DOI 10.1161/CIRCRESAHA.107.167908; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BRUNSON KW, 1978, NATURE, V272, P543, DOI 10.1038/272543a0; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; CHAMMAS R, 1993, P NATL ACAD SCI USA, V90, P1795, DOI 10.1073/pnas.90.5.1795; Cheng X, 2007, CANCER METAST REV, V26, P635, DOI 10.1007/s10555-007-9083-x; Cordes N, 2007, INT J RADIAT BIOL, V83, P753, DOI 10.1080/09553000701639694; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; Fidler IJ, 2002, LANCET ONCOL, V3, P53, DOI 10.1016/S1470-2045(01)00622-2; FIDLER IJ, 2002, NATURE REV, V3, P1; Fitzgerald DP, 2008, CLIN EXP METASTAS, V25, P799, DOI 10.1007/s10585-008-9193-z; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Heckmann D, 2007, METHOD ENZYMOL, V426, P463, DOI 10.1016/S0076-6879(07)26020-3; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Kren A, 2007, EMBO J, V26, P2832, DOI 10.1038/sj.emboj.7601738; Kusters B, 2002, CANCER RES, V62, P341; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Leenders W, 2003, INT J CANCER, V105, P437, DOI 10.1002/ijc.11102; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Marchetti D, 2003, PATHOL ONCOL RES, V9, P147, DOI 10.1007/BF03033729; MCGRADY BJ, 1992, CLIN EXP METASTAS, V10, P387, DOI 10.1007/BF00133467; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Murry BP, 2006, J CELL BIOCHEM, V97, P217, DOI 10.1002/jcb.20714; Nathoo N, 2005, J CLIN PATHOL, V58, P237, DOI 10.1136/jcp.2003.013623; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; NICOLSON GL, 1978, CANCER RES, V38, P4105; NICOLSON GL, 1987, J NEURO-ONCOL, V4, P209, DOI 10.1007/BF00150612; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Perides G, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-56; Pulaski BA, 1998, CANCER RES, V58, P1486; Rice TW, 2006, ANN THORAC SURG, V82, P2042, DOI 10.1016/j.athoracsur.2006.06.089; SANTARELLI JG, 2007, NEUROSURG FOCUS, V3, pE1; SCHACKERT G, 1988, J NATL CANCER I, V80, P1027, DOI 10.1093/jnci/80.13.1027; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; SPERDUTO PW, 2005, INT J RADIAT ONCOL, V70, P510; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stroeken PJM, 1998, CANCER RES, V58, P1569; Tham YL, 2006, CANCER, V107, P696, DOI 10.1002/cncr.22041; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Yoshimi K, 2002, BRAIN RES, V956, P53, DOI 10.1016/S0006-8993(02)03479-0; Zhang M, 1997, J NEURO-ONCOL, V35, P81, DOI 10.1023/A:1005799805335	53	213	215	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5857	10.1371/journal.pone.0005857	http://dx.doi.org/10.1371/journal.pone.0005857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516901	gold, Green Submitted, Green Published			2022-12-27	WOS:000266872900008
J	Muslimovic, A; Nystrom, S; Gao, Y; Hammarsten, O				Muslimovic, Aida; Nystrom, Susanne; Gao, Yue; Hammarsten, Ola			Numerical Analysis of Etoposide Induced DNA Breaks	PLOS ONE			English	Article								Background: Etoposide is a cancer drug that induces strand breaks in cellular DNA by inhibiting topoisomerase II (topoII) religation of cleaved DNA molecules. Although DNA cleavage by topoisomerase II always produces topoisomerase II-linked DNA double-strand breaks (DSBs), the action of etoposide also results in single-strand breaks (SSBs), since religation of the two strands are independently inhibited by etoposide. In addition, recent studies indicate that topoisomerase II-linked DSBs remain undetected unless topoisomerase II is removed to produce free DSBs. Methodology/Principal Findings: To examine etoposide-induced DNA damage in more detail we compared the relative amount of SSBs and DSBs, survival and H2AX phosphorylation in cells treated with etoposide or calicheamicin, a drug that produces free DSBs and SSBs. With this combination of methods we found that only 3% of the DNA strand breaks induced by etoposide were DSBs. By comparing the level of DSBs, H2AX phosphorylation and toxicity induced by etoposide and calicheamicin, we found that only 10% of etoposide-induced DSBs resulted in histone H2AX phosphorylation and toxicity. There was a close match between toxicity and histone H2AX phosphorylation for calicheamicin and etoposide suggesting that the few etoposide-induced DSBs that activated H2AX phosphorylation were responsible for toxicity. Conclusions/Significance: These results show that only 0.3% of all strand breaks produced by etoposide activate H2AX phosphorylation and suggests that over 99% of the etoposide induced DNA damage does not contribute to its toxicity.			Muslimovic, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Chem & Transfus Med, Inst Biomed, Gothenburg, Sweden.	ola.hammarsten@clinchem.gu.se	Hammarsten, Ola/A-2791-2012					Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Banath JP, 2003, CANCER RES, V63, P4347; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BLOCHER D, 1990, INT J RADIAT BIOL, V58, P23, DOI 10.1080/09553009014551411; BODLEY AL, 1993, MOL CELL BIOL, V13, P6190, DOI 10.1128/MCB.13.10.6190; Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN CZ, 1989, ELECTROPHORESIS, V10, P318, DOI 10.1002/elps.1150100509; DARPA P, 1990, CANCER RES, V50, P6919; DEDON PC, 1993, BIOCHEMISTRY-US, V32, P3617, DOI 10.1021/bi00065a013; Desai SD, 2001, CANCER RES, V61, P5926; Elmroth K, 2003, DNA REPAIR, V2, P363, DOI 10.1016/S1568-7864(02)00235-5; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; He DM, 1996, MUTAT RES-DNA REPAIR, V363, P43, DOI 10.1016/0921-8777(95)00060-7; HSIANG YH, 1989, CANCER RES, V49, P5077; Ismail IH, 2005, J BIOL CHEM, V280, P4649, DOI 10.1074/jbc.M411588200; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Jin SF, 1998, CARCINOGENESIS, V19, P965, DOI 10.1093/carcin/19.6.965; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; LIU LF, 1983, J BIOL CHEM, V258, P5365; LONG BH, 1986, CANCER RES, V46, P3809; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Martensson S, 2003, RADIAT RES, V160, P291, DOI 10.1667/0033-7587(2003)160[0291:AOTDPK]2.0.CO;2; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Muslimovic A, 2008, NAT PROTOC, V3, P1187, DOI 10.1038/nprot.2008.93; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nias AHW, 1998, INTRO RADIOBIOLOGY; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Tounekti O, 2001, BRIT J CANCER, V84, P1272, DOI 10.1054/bjoc.2001.1786; WLODEK D, 1990, RADIAT RES, V124, P326, DOI 10.2307/3577846; WOZNIAK AJ, 1983, CANCER RES, V43, P120; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200	50	67	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5859	10.1371/journal.pone.0005859	http://dx.doi.org/10.1371/journal.pone.0005859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516899	Green Published, Green Submitted, gold			2022-12-27	WOS:000266872900010
J	Chhabra, R; Adlakha, YK; Hariharan, M; Scaria, V; Saini, N				Chhabra, Ravindresh; Adlakha, Yogita K.; Hariharan, Manoj; Scaria, Vinod; Saini, Neeru			Upregulation of miR-23a similar to 27a similar to 24-2 Cluster Induces Caspase-Dependent and -Independent Apoptosis in Human Embryonic Kidney Cells	PLOS ONE			English	Article								miRNAs have emerged as important players in the regulation of gene expression and their deregulation is a common feature in a variety of diseases, especially cancer. Currently, many efforts are focused on studying miRNA expression patterns, as well as miRNA target validation. Here, we show that the over expression of miR-23a similar to 27a similar to 24-2 cluster in HEK293T cells induces apoptosis by caspase-dependent as well as caspase-independent pathway as proved by the annexin assay, caspase activation, release of cytochrome-c and AIF (apoptosis inducing factor) from mitochondria. Furthermore, the over expressed cluster modulates the expression of a number of genes involved in apoptosis including FADD (Fas Associated protein with Death Domain). Bioinformatically, FADD is predicted to be the target of hsa-miR-27a and interestingly, FADD protein was found to be up regulated consistent with very less expression of hsa-miR-27a in HEK293T cells. This effect was direct, as hsa-miR-27a negatively regulated the expression of FADD 3'UTR based reporter construct. Moreover, we also showed that over expression of miR-23a similar to 27a similar to 24-2 sensitized HEK293T cells to TNF-alpha cytotoxicity. Taken together, our study demonstrates that enhanced TNF-alpha induced apoptosis in HEK293T cells by over expression of miR-23a similar to 27a similar to 24-2 cluster provides new insights in the development of novel therapeutics for cancer.			Chhabra, R (corresponding author), Inst Genom & Integrat Biol, Delhi, India.	nkhanna@igib.res.in	Chhabra, Ravindresh/X-5251-2018; Scaria, Vinod/AAS-3151-2021; Chhabra, Ravindresh/AAM-4994-2021; Scaria, Vinod/B-2819-2008; Hariharan, Manoj/N-2855-2015; Chhabra, Ravindresh/GSE-1747-2022	Hariharan, Manoj/0000-0002-1006-5372; Chhabra, Ravindresh/0000-0002-2734-7368; Scaria, Vinod/0000-0001-7644-7181				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dvorak Z, 2006, CHEM-BIOL INTERACT, V159, P117, DOI 10.1016/j.cbi.2005.10.105; Goel A, 2007, FEBS LETT, V581, P2447, DOI 10.1016/j.febslet.2007.04.052; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Inman GJ, 2000, J IMMUNOL, V165, P2500, DOI 10.4049/jimmunol.165.5.2500; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khanna N, 2004, LIFE SCI, V75, P179, DOI 10.1016/j.lfs.2003.11.026; Kim PKM, 1996, J IMMUNOL, V157, P5461; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ohara M, 2008, INFECT IMMUN, V76, P4783, DOI 10.1128/IAI.01612-07; Parreno M, 2008, CANCER RES, V68, P6313, DOI 10.1158/0008-5472.CAN-08-1054; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Radovic Nikola, 2008, Acta Medica Croatica, V62, P249; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Slack Frank J, 2006, Future Oncol, V2, P73, DOI 10.2217/14796694.2.1.73; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Tourneur L, 2004, CANCER RES, V64, P8101, DOI 10.1158/0008-5472.CAN-04-2361; Tourneur L, 2003, ONCOGENE, V22, P2795, DOI 10.1038/sj.onc.1206399; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yeh WC, 1999, IMMUNOL REV, V169, P283, DOI 10.1111/j.1600-065X.1999.tb01323.x; Zhang L, 2006, CELL CYCLE, V5, P2216, DOI 10.4161/cc.5.19.3319	53	124	132	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5848	10.1371/journal.pone.0005848	http://dx.doi.org/10.1371/journal.pone.0005848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513126	Green Published, gold, Green Submitted			2022-12-27	WOS:000267228800013
J	DeScioli, P; Kurzban, R				DeScioli, Peter; Kurzban, Robert			The Alliance Hypothesis for Human Friendship	PLOS ONE			English	Article							SOCIAL-RELATIONS; RECIPROCAL ALTRUISM; ELEMENTARY FORMS; 3RD PARTIES; EVOLUTION; EXCHANGE; INTELLIGENCE; AGGRESSION; CONFLICT; ERRORS	Background: Exploration of the cognitive systems underlying human friendship will be advanced by identifying the evolved functions these systems perform. Here we propose that human friendship is caused, in part, by cognitive mechanisms designed to assemble support groups for potential conflicts. We use game theory to identify computations about friends that can increase performance in multi-agent conflicts. This analysis suggests that people would benefit from: 1) ranking friends, 2) hiding friend-ranking, and 3) ranking friends according to their own position in partners' rankings. These possible tactics motivate the hypotheses that people possess egocentric and allocentric representations of the social world, that people are motivated to conceal this information, and that egocentric friend-ranking is determined by allocentric representations of partners' friend-rankings (more than others' traits). Methodology/Principal Findings: We report results from three studies that confirm predictions derived from the alliance hypothesis. Our main empirical finding, replicated in three studies, was that people's rankings of their ten closest friends were predicted by their own perceived rank among their partners' other friends. This relationship remained strong after controlling for a variety of factors such as perceived similarity, familiarity, and benefits. Conclusions/Significance: Our results suggest that the alliance hypothesis merits further attention as a candidate explanation for human friendship.			DeScioli, P (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	descioli@psych.upenn.edu		DeScioli, Peter/0000-0001-5915-8564				Archer J, 2005, PERS SOC PSYCHOL REV, V9, P212, DOI 10.1207/s15327957pspr0903_2; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bierstedt R., 1964, EXCHANGE POWER SOCIA; Black D., 1998, SOCIAL STRUCTURE RIG; Brehm SS, 2002, SOCIAL PSYCHOL; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Byrne R., 1988, MACHIAVELLIAN INTELL; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037/0022-3514.37.1.12; CLARK MS, 1984, J PERS SOC PSYCHOL, V47, P549, DOI 10.1037/0022-3514.47.3.549; CLARK MS, 1989, PERS SOC PSYCHOL B, V15, P533, DOI 10.1177/0146167289154007; CLARK MS, 1993, PERS SOC PSYCHOL B, V19, P684, DOI 10.1177/0146167293196003; Connor RC, 2007, PHILOS T R SOC B, V362, P587, DOI 10.1098/rstb.2006.1997; Dawkins R., 1982, pi; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Engh AL, 2005, ANIM BEHAV, V69, P209, DOI 10.1016/j.anbehav.2004.04.013; Festinger L., 1950, SOCIAL PRESSURES INF; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fiske A.P., 1991, STRUCTURES SOCIAL LI; Fiske A. P., 1995, J QUANTITATIVE ANTHR, V5, P305; FISKE AP, 1991, J PERS SOC PSYCHOL, V60, P656, DOI 10.1037/0022-3514.60.5.656; Fiske AP, 1997, POLIT PSYCHOL, V18, P255, DOI 10.1111/0162-895X.00058; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; FISKE AP, 1993, J CROSS CULT PSYCHOL, V24, P463, DOI 10.1177/0022022193244006; Fiske AP, 1997, EUR J SOC PSYCHOL, V27, P725, DOI 10.1002/(SICI)1099-0992(199711/12)27:6<725::AID-EJSP832>3.0.CO;2-A; Gould RV, 2002, AM J SOCIOL, V107, P1143, DOI 10.1086/341744; HASLAM N, 1992, J EXP SOC PSYCHOL, V28, P441, DOI 10.1016/0022-1031(92)90041-H; Holekamp KE, 2007, PHILOS T R SOC B, V362, P523, DOI 10.1098/rstb.2006.1993; HOMANS GC, 1958, AM J SOCIOL, V63, P597, DOI 10.1086/222355; Kelley H. H, 1978, INTERPERSONAL RELATI; Kenny D. A, 1994, INTERPERSONAL PERCEP; KENNY DA, 1993, PSYCHOL BULL, V114, P145, DOI 10.1037/0033-2909.114.1.145; Liska George, 1962, NATIONS ALLIANCE LIM; MAHAJAN V, 1982, J MARKETING RES, V19, P334, DOI 10.2307/3151567; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Oswald DL, 2003, PERS RELATIONSHIP, V10, P187, DOI 10.1111/1475-6811.00045; Phillips S, 2005, AM SOCIOL REV, V70, P334, DOI 10.1177/000312240507000207; Pinker S., 2007, STUFF THOUGHT LANGUA; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; Silk JB, 2003, DAHL WS ENV, P37; Snyder G., 1997, ALLIANCE POLITICS; SNYDER GH, 1984, WORLD POLIT, V36, P461, DOI 10.2307/2010183; Tesser A., 1988, ADV EXP SOC PSYCHOL, V21, P181, DOI 10.1016/S0065-2601(08)60227-0; Tooby J., 1996, P BRIT ACAD, P119, DOI DOI 10.1002/(SICI)1520-6300(1998)10:5<681::AID-; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; von Neumann J., 1947, THEORY GAMES EC BEHA, V2; VUCHINICH S, 1988, CHILD DEV, V59, P1293, DOI 10.2307/1130492; Whiten A., 1997, MACHIAVELLIAN INTELL, DOI [10.1017/CBO9780511525636, DOI 10.1017/CBO9780511525636]; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	49	105	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5802	10.1371/journal.pone.0005802	http://dx.doi.org/10.1371/journal.pone.0005802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453PV	19492066	Green Published, gold, Green Submitted			2022-12-27	WOS:000266624300023
J	Yang, LC; Calingasan, NY; Thomas, B; Chaturvedi, RK; Kiaei, M; Wille, EJ; Liby, KT; Williams, C; Royce, D; Risingsong, R; Musiek, ES; Morrow, JD; Sporn, M; Beal, MF				Yang, Lichuan; Calingasan, Noel Y.; Thomas, Bobby; Chaturvedi, Rajnish K.; Kiaei, Mahmoud; Wille, Elizabeth J.; Liby, Karen T.; Williams, Charlotte; Royce, Darlene; Risingsong, Renee; Musiek, Eric S.; Morrow, Jason D.; Sporn, Michael; Beal, M. Flint			Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; 3-NITROPROPIONIC ACID; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; IN-VIVO; MICE; MPTP; PROTECTION; INDUCTION; DISEASE	The NF-E2-related factor-2 (Nrf2)/antioxidant response element (ARE) signaling pathway regulates phase 2 detoxification genes, including a variety of antioxidative enzymes. We tested neuroprotective effects of the synthetic triterpenoid CDDO-MA, a potent activator of the Nrf2/ARE signaling. CDDO-MA treatment of neuroblastoma SH-SY5Y cells resulted in Nrf2 upregulation and translocation from cytosol to nucleus and subsequent activation of ARE pathway genes. CDDO-MA blocked t-butylhydroperoxide-induced production of reactive oxygen species (ROS) by activation of ARE genes only in wild type, but not Nrf2 knockout mouse embryonic fibroblasts. Oral administration of CDDO-MA resulted in significant protection against MPTP-induced nigrostriatal dopaminergic neurodegeneration, pathological alpha-synuclein accumulation and oxidative damage in mice. Additionally, CDDO-MA treatment in rats produced significant rescue against striatal lesions caused by the neurotoxin 3-NP, and associated increases in the oxidative damage markers malondialdehyde, F-2-Isoprostanes, 8-hydroxy-2-deoxyguanosine, 3-nitrotyrosine, and impaired glutathione homeostasis. Our results indicate that the CDDO-MA renders its neuroprotective effects through its potent activation of the Nrf2/ARE pathway, and suggest that triterpenoids may be beneficial for the treatment of neurodegenerative diseases like Parkinson's disease and Huntington's disease.			Yang, LC (corresponding author), Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Neurol & Neurosci, New York, NY 10021 USA.	fbeal@med.cornell.edu	Chaturvedi, Rajnish/AAZ-9955-2020; Chaturvedi, Dr. Rajnish/E-2803-2010	Liby, Karen/0000-0003-3317-3437; Musiek, Erik/0000-0002-8873-0360	NCI NIH HHS [R01 CA078814, CA78814] Funding Source: Medline; NINDS NIH HHS [NS39258, R01 NS039258] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039258] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agarwal R, 2002, J CHROMATOGR B, V775, P121, DOI 10.1016/S1570-0232(02)00273-8; BEAL MF, 1993, J NEUROSCI, V13, P4181; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Burton NC, 2006, NEUROTOXICOLOGY, V27, P1094, DOI 10.1016/j.neuro.2006.07.019; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; CALKINS MJ, 2008, ANTIOXID REDOX SIGNA; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Cleren C, 2005, NEUROBIOL DIS, V20, P701, DOI 10.1016/j.nbd.2005.05.022; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Dumont M, 2009, J NEUROCHEM, V109, P502, DOI 10.1111/j.1471-4159.2009.05970.x; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kiaei M, 2005, J NEUROCHEM, V93, P403, DOI 10.1111/j.1471-4159.2005.03024.x; Klivenyi P, 2004, J NEUROCHEM, V88, P576, DOI 10.1046/j.1471-4159.2003.02160.x; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Klivenyi P, 2000, J NEUROSCI, V20, P1; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Liberatore GT, 1999, NAT MED, V5, P1403; Liby K, 2005, CANCER RES, V65, P4789, DOI 10.1158/0008-5472.CAN-04-4539; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu GW, 2005, ANAL CHEM, V77, P6407, DOI 10.1021/ac050892r; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Montine TJ, 1999, NEUROLOGY, V52, P1104, DOI 10.1212/WNL.52.5.1104; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Ouary S, 2000, NEUROSCIENCE, V97, P521, DOI 10.1016/S0306-4522(00)00020-8; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Suh NJ, 1999, CANCER RES, V59, P336; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Thomas B, 2007, NEUROBIOL DIS, V26, P312, DOI 10.1016/j.nbd.2006.12.021; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yang LC, 2005, EXP NEUROL, V191, P86, DOI 10.1016/j.expneurol.2004.07.012; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823	60	136	147	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5757	10.1371/journal.pone.0005757	http://dx.doi.org/10.1371/journal.pone.0005757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484125	Green Published, gold, Green Submitted			2022-12-27	WOS:000266528200010
J	Agarwal, G; Rajavel, M; Gopal, B; Srinivasan, N				Agarwal, Garima; Rajavel, Malligarjunan; Gopal, Balasubramanian; Srinivasan, Narayanaswamy			Structure-Based Phylogeny as a Diagnostic for Functional Characterization of Proteins with a Cupin Fold	PLOS ONE			English	Article								Background: The members of cupin superfamily exhibit large variations in their sequences, functions, organization of domains, quaternary associations and the nature of bound metal ion, despite having a conserved beta-barrel structural scaffold. Here, an attempt has been made to understand structure-function relationships among the members of this diverse superfamily and identify the principles governing functional diversity. The cupin superfamily also contains proteins for which the structures are available through world-wide structural genomics initiatives but characterized as "hypothetical''. We have explored the feasibility of obtaining clues to functions of such proteins by means of comparative analysis with cupins of known structure and function. Methodology/Principal Findings: A 3-D structure-based phylogenetic approach was undertaken. Interestingly, a dendrogram generated solely on the basis of structural dissimilarity measure at the level of domain folds was found to cluster functionally similar members. This clustering also reflects an independent evolution of the two domains in bicupins. Close examination of structural superposition of members across various functional clusters reveals structural variations in regions that not only form the active site pocket but are also involved in interaction with another domain in the same polypeptide or in the oligomer. Conclusions/Significance: Structure-based phylogeny of cupins can influence identification of functions of proteins of yet unknown function with cupin fold. This approach can be extended to other proteins with a common fold that show high evolutionary divergence. This approach is expected to have an influence on the function annotation in structural genomics initiatives.			Agarwal, G (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in	Gopal, Balasubramanian/K-4566-2012; Gopal, Balasubramanian/ABG-3754-2021		Wellcome Trust [078994] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adachi M, 2003, P NATL ACAD SCI USA, V100, P7395, DOI 10.1073/pnas.0832158100; Adachi M, 2001, J MOL BIOL, V305, P291, DOI 10.1006/jmbi.2000.4310; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Balaji S, 2001, PROTEIN ENG, V14, P219, DOI 10.1093/protein/14.4.219; Christendat D, 2000, J BIOL CHEM, V275, P24608, DOI 10.1074/jbc.C000238200; Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; Crowther RL, 2005, PROTEINS, V61, P680, DOI 10.1002/prot.20598; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dong CJ, 2003, STRUCTURE, V11, P715, DOI 10.1016/S0969-2126(03)00098-4; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Felsenstein J, PHYLIP PHYLOGENY INF; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Giraud MF, 2000, NAT STRUCT BIOL, V7, P398; Gopal B, 2005, BIOCHEMISTRY-US, V44, P193, DOI 10.1021/bi0484421; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jaroszewski L, 2004, PROTEINS, V56, P611, DOI 10.1002/prot.20130; JOHNSON MS, 1990, J MOL EVOL, V30, P43, DOI 10.1007/BF02102452; Ko TP, 2000, ACTA CRYSTALLOGR D, V56, P411, DOI 10.1107/S0907444900002237; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Maruyama N, 2001, EUR J BIOCHEM, V268, P3595, DOI 10.1046/j.1432-1327.2001.02268.x; Maruyama Y, 2004, ACTA CRYSTALLOGR D, V60, P289, DOI 10.1107/S0907444903027367; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; McLuskey K, 2005, P NATL ACAD SCI USA, V102, P14221, DOI 10.1073/pnas.0504314102; McMullan D, 2004, PROTEINS, V56, P615, DOI 10.1002/prot.20139; Merkel AB, 2002, ACTA CRYSTALLOGR D, V58, P1226, DOI 10.1107/S0907444902007382; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Opaleye O, 2006, J BIOL CHEM, V281, P6428, DOI 10.1074/jbc.M510256200; Pang H, 2004, J BIOL CHEM, V279, P1491, DOI 10.1074/jbc.M310022200; Pochapsky TC, 2006, J BIOMOL NMR, V34, P117, DOI 10.1007/s10858-005-5735-8; Raymond S, 2005, PROTEINS, V61, P454, DOI 10.1002/prot.20537; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Swan MK, 2003, J BIOL CHEM, V278, P47261, DOI 10.1074/jbc.M308603200; Titus GP, 2000, NAT STRUCT BIOL, V7, P542; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Xu QP, 2006, PROTEINS, V64, P808, DOI 10.1002/prot.20947; ZHANG Y, 2005, STRUCTURAL STUDIES 3, P7632; Zhou CZ, 2005, PROTEIN SCI, V14, P209, DOI 10.1110/ps.041121305	44	50	50	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5736	10.1371/journal.pone.0005736	http://dx.doi.org/10.1371/journal.pone.0005736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478949	Green Published, gold			2022-12-27	WOS:000266490000012
J	Wanderley, JLM; da Silva, LHP; Deolindo, P; Soong, L; Borges, VM; Prates, DB; de Souza, APA; Barral, A; Balanco, JMD; do Nascimento, MTC; Saraiva, EM; Barcinski, MA				Mendes Wanderley, Joao Luiz; Pinto da Silva, Lucia Helena; Deolindo, Poliana; Soong, Lynn; Borges, Valeria Matos; Prates, Deboraci Brito; Almeida de Souza, Ana Paula; Barral, Aldina; de Freitas Balanco, Jose Mario; Cunha do Nascimento, Michelle Tanny; Saraiva, Elvira Maria; Barcinski, Marcello Andre			Cooperation between Apoptotic and Viable Metacyclics Enhances the Pathogenesis of Leishmaniasis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; EXPOSES PHOSPHATIDYLSERINE; L AMAZONENSIS; PUTATIVE ROLE; PROMASTIGOTES; DIFFERENTIATION; MIMICRY; METACASPASES; MECHANISMS; AUTOPHAGY	Mimicking mammalian apoptotic cells by exposing phosphatidylserine (PS) is a strategy used by virus and parasitic protozoa to escape host protective inflammatory responses. With Leishmania amazonensis (La), apoptotic mimicry is a prerogative of the intramacrophagic amastigote form of the parasite and is modulated by the host. Now we show that differently from what happens with amastigotes, promastigotes exposing PS are non-viable, non-infective cells, undergoing apoptotic death. As part of the normal metacyclogenic process occurring in axenic cultures and in the gut of sand fly vectors, a subpopulation of metacyclic promastigotes exposes PS. Apoptotic death of the purified PS-positive (PSPOS) sub-population was confirmed by TUNEL staining and DNA laddering. Transmission electron microscopy revealed morphological alterations in PSPOS metacyclics such as DNA condensation, cytoplasm degradation and mitochondrion and kinetoplast destruction, both in in vitro cultures and in sand fly guts. TUNELPOS promastigotes were detected only in the anterior midgut to foregut boundary of infected sand flies. Interestingly, caspase inhibitors modulated parasite death and PS exposure, when added to parasite cultures in a specific time window. Efficient in vitro macrophage infections and in vivo lesions only occur when PSPOS and PS-negative (PSNEG) parasites were simultaneously added to the cell culture or inoculated in the mammalian host. The viable PSNEG promastigote was the infective form, as shown by following the fate of fluorescently labeled parasites, while the PSPOS apoptotic sub-population inhibited host macrophage inflammatory response. PS exposure and macrophage inhibition by a subpopulation of promastigotes is a different mechanism than the one previously described with amastigotes, where the entire population exposes PS. Both mechanisms co-exist and play a role in the transmission and development of the disease in case of infection by La. Since both processes confer selective advantages to the infective microorganism they justify the occurrence of apoptotic features in a unicellular pathogen.			Wanderley, JLM (corresponding author), Natl Canc Inst, Div Expt Med, Rio De Janeiro, Brazil.	barcinsk@icb.usp.br	Pinto-da-Silva, Lucia/AAF-1318-2022; Balanco, Jose Mario F/P-5051-2015; Wanderley, Joao Luiz/J-6711-2014; Borges, Val/N-6647-2019; Balanco, José Mário de Freitas/AAD-9701-2022; Saraiva, Elvira M/L-2864-2017; nascimento, Michelle Tanny Cunha/O-7844-2018; Barral, Aldina/B-4191-2009; Pinto-da-Silva, Lucia/AFG-2678-2022; Borges, Valeria/G-2009-2014	Borges, Val/0000-0002-2775-5409; Saraiva, Elvira M/0000-0002-6388-5286; Barral, Aldina/0000-0002-7177-464X; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043003, R56AI043003] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43003, R01 AI043003, R56 AI043003] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P285; Araujo-Santos JM, 2003, BIOCHEM BIOPH RES CO, V306, P250, DOI 10.1016/S0006-291X(03)00947-1; Arnoult D, 2002, CELL DEATH DIFFER, V9, P65, DOI 10.1038/sj.cdd.4400951; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; Das M, 2001, J CELL SCI, V114, P2461; Debrabant Alain, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-7; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Freire-de-Lima CG, 2000, NATURE, V404, P904, DOI 10.1038/35009154; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Golstein P, 2005, CELL DEATH DIFFER, V12, P1490, DOI 10.1038/sj.cdd.4401607; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Holzmuller P, 2006, PARASITOLOGY, V132, pS19, DOI 10.1017/S0031182006000837; HOWARD MK, 1987, EXP PARASITOL, V64, P147, DOI 10.1016/0014-4894(87)90138-X; JAMES ER, 2002, TRENDS PARASITOL, V20, P280; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Kima PE, 2007, INT J PARASITOL, V37, P1087, DOI 10.1016/j.ijpara.2007.04.007; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Longo VD, 2005, NAT REV GENET, V6, DOI 10.1038/nrg1706; Mazzoni C, 2008, BBA-MOL CELL RES, V1783, P1320, DOI 10.1016/j.bbamcr.2008.02.015; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Moreira MEC, 2004, AN ACAD BRAS CIENC, V76, P93, DOI 10.1590/S0001-37652004000100009; Moreira MEC, 1996, J CELL PHYSIOL, V167, P305, DOI 10.1002/(SICI)1097-4652(199605)167:2&lt;305::AID-JCP15&gt;3.0.CO;2-6; Nguewa PA, 2004, TRENDS PARASITOL, V20, P375, DOI 10.1016/j.pt.2004.05.006; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Picot S, 1997, T ROY SOC TROP MED H, V91, P590, DOI 10.1016/S0035-9203(97)90039-0; PIMENTA PFP, 1991, EXP PARASITOL, V72, P191, DOI 10.1016/0014-4894(91)90137-L; Pinto-da-Silva LH, 2005, INT J PARASITOL, V35, P757, DOI 10.1016/j.ijpara.2005.03.004; Ridgley EL, 1999, BIOCHEM J, V340, P33, DOI 10.1042/0264-6021:3400033; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Saraiva EM, 2005, EXP PARASITOL, V110, P39, DOI 10.1016/j.exppara.2005.01.004; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tripathi A, 2003, MOL BIOCHEM PARASIT, V128, P1, DOI 10.1016/S0166-6851(03)00024-0; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; WALTERS LL, 1989, AM J TROP MED HYG, V41, P295, DOI 10.4269/ajtmh.1989.41.295; Wanderley JLM, 2005, BRAZ J MED BIOL RES, V38, P807, DOI 10.1590/S0100-879X2005000600001; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Welburn SC, 2006, PARASITOLOGY, V132, pS7, DOI 10.1017/S0031182006000825; Welburn SC, 1997, PARASITOL TODAY, V13, P22, DOI 10.1016/S0169-4758(96)10076-4; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x	53	66	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5733	10.1371/journal.pone.0005733	http://dx.doi.org/10.1371/journal.pone.0005733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478944	gold, Green Published, Green Submitted			2022-12-27	WOS:000266490000009
J	van Vonderen, MGA; van Agtmael, MA; Hassink, EAM; Milinkovic, A; Brinkman, K; Geerlings, SE; Ristola, M; van Eeden, A; Danner, SA; Reiss, P				van Vonderen, Marit G. A.; van Agtmael, Michiel A.; Hassink, Elly A. M.; Milinkovic, Ana; Brinkman, Kees; Geerlings, Suzanne E.; Ristola, Matti; van Eeden, Arne; Danner, Sven A.; Reiss, Peter		Mediclas Study Grp	Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss	PLOS ONE			English	Article								Background: Lipoatrophy is known to be associated with stavudine as part of the treatment for HIV infection, but it is less clear if this serious side effect is also related to other nucleoside reverse transcriptase inhibitors like zidovudine. We aimed to determine whether zidovudine-sparing first-line antiretroviral therapy would lead to less lipoatrophy and other metabolic changes than zidovudine-containing therapy. Methodology/Principal Findings: Fifty antiretroviral therapy-naive HIV-1 infected men with an indication to start antiretroviral therapy were included in a randomized single blinded clinical trial. Randomisation was between zidovudine-containing therapy (zidovudine/lamivudine+lopinavir/ritonavir) and zidovudine-sparing therapy (nevirapine+lopinavir/ritonavir). Main outcome measures were body composition assessed by computed tomography and dual-energy X-ray absorptiometry scan and lipid profile before and after 3, 12, 24 months of antiretroviral therapy. In the zidovudine/lamivudine+lopinavir/ritonavir group, from 3 months onward limb fat decreased progressively by 6846293 grams (estimated mean +/- standard error of the mean)(p=0.02) up to 24 months whereas abdominal fat increased, but exclusively in the visceral compartment (+21.9 +/- 8.1 cm(2), p=0.008)). In contrast, in the nevirapine+lopinavir/ritonavir group, a generalized increase in fat mass was observed. After 24 months no significant differences in high density lipoprotein and total/high density lipoprotein cholesterol ratio were found between both treatment groups, but total and low density lipoprotein cholesterol levels were higher in the nevirapine+lopinavir/ritonavir group (6.1 +/- 0.2 versus 5.3 +/- 0.2 and 3.6 +/- 0.1 versus 2.8 +/- 0.1 mmol/l respectively, p < 0.05). Virologic response and safety were comparable in both groups. Conclusions/Significance: Zidovudine/lamivudine+lopinavir/ritonavir, but not nevirapine+lopinavir/ritonavir in antiretroviral therapy-naive patients, is associated with lipoatrophy and greater relative intraabdominal lipohypertrophy, suggesting that zidovudine/lamivudine contributes to both these features of lipodystrophy. These findings support to no longer consider zidovudine/lamivudine as one of the preferred possible components of first-line antiretroviral therapy where alternative treatments are available.			van Vonderen, MGA (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands.	M.vVonderen@vumc.nl	Ristola, Matti/AAD-5092-2022	Milinkovic, Ana/0000-0002-7732-9168; Ristola, Matti/0000-0001-5115-2811				AACTG, 1992, TABL GRAD SEV AD ADV; Allavena C, 2005, JAIDS-J ACQ IMM DEF, V39, P300, DOI 10.1097/01.qai.0000165914.42827.bb; Blumer RME, 2008, AIDS, V22, P227, DOI 10.1097/QAD.0b013e3282f33557; Cameron DW, 2007, J ANTIMICROB CHEMOTH, V59, P957, DOI 10.1093/jac/dkm029; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Dube MP, 2007, JAIDS-J ACQ IMM DEF, V45, P508, DOI 10.1097/QAI.0b013e3181142d26; FISHER M, 2007, 11 EUR AIDS C EACS M; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; HARRIS M, 2005, 3 IAS C HIV PATH TRE; HAUBRICH RH, 2007, 14 C RETR OPP INF FE; Hugen PWH, 2002, THER DRUG MONIT, V24, P579, DOI 10.1097/00007691-200210000-00001; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; Moyle GJ, 2006, AIDS, V20, P2043, DOI 10.1097/01.aids.0000247574.33998.03; Nolan D, 2003, ANTIVIR THER, V8, P617; Podzamczer D, 2007, JAIDS-J ACQ IMM DEF, V44, P139, DOI 10.1097/QAI.0b013e31802bf122; Power R, 2003, SEX TRANSM INFECT, V79, P137, DOI 10.1136/sti.79.2.137; RIDDLER SA, 2006, 16 INT AIDS C AUG 13; Tebas P, 2007, JAIDS-J ACQ IMM DEF, V45, P193, DOI 10.1097/QAI.0b013e318042e204; van der Valk M, 2001, AIDS, V15, P2407, DOI 10.1097/00002030-200112070-00008	20	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5647	10.1371/journal.pone.0005647	http://dx.doi.org/10.1371/journal.pone.0005647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19479079	Green Published, gold			2022-12-27	WOS:000266331000006
J	Girgis, HS; Hottes, AK; Tavazoie, S				Girgis, Hany S.; Hottes, Alison K.; Tavazoie, Saeed			Genetic Architecture of Intrinsic Antibiotic Susceptibility	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; RCS PHOSPHORELAY; ANTIBACTERIAL RESISTANCE; PSEUDOMONAS-AERUGINOSA; MULTIDRUG-RESISTANCE; GENOME SEQUENCE; EFFLUX PUMP; WASTE-WATER; MECHANISMS; PROTEIN	Background: Antibiotic exposure rapidly selects for more resistant bacterial strains, and both a drug's chemical structure and a bacterium's cellular network affect the types of mutations acquired. Methodology/Principal Findings: To better characterize the genetic determinants of antibiotic susceptibility, we exposed a transposon-mutagenized library of Escherichia coli to each of 17 antibiotics that encompass a wide range of drug classes and mechanisms of action. Propagating the library for multiple generations with drug concentrations that moderately inhibited the growth of the isogenic parental strain caused the abundance of strains with even minor fitness advantages or disadvantages to change measurably and reproducibly. Using a microarray-based genetic footprinting strategy, we then determined the quantitative contribution of each gene to E. coli's intrinsic antibiotic susceptibility. We found both loci whose removal increased general antibiotic tolerance as well as pathways whose down-regulation increased tolerance to specific drugs and drug classes. The beneficial mutations identified span multiple pathways, and we identified pairs of mutations that individually provide only minor decreases in antibiotic susceptibility but that combine to provide higher tolerance. Conclusions/Significance: Our results illustrate that a wide-range of mutations can modulate the activity of many cellular resistance processes and demonstrate that E. coli has a large mutational target size for increasing antibiotic tolerance. Furthermore, the work suggests that clinical levels of antibiotic resistance might develop through the sequential accumulation of chromosomal mutations of small individual effect.			Girgis, HS (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	tavazoie@genomics.princeton.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003787] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AKIYAMA M, 1992, J BIOL CHEM, V267, P22556; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; ALPER MD, 1978, J BACTERIOL, V133, P149, DOI 10.1128/JB.133.1.149-157.1978; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Baba Tomoya, 2006, Mol Syst Biol, V2; Baquero F, 2001, DRUG RESIST UPDATE, V4, P93, DOI 10.1054/drup.2001.0196; Barua S, 2002, MOL MICROBIOL, V43, P629, DOI 10.1046/j.1365-2958.2002.02768.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Breidenstein EBM, 2008, ANTIMICROB AGENTS CH, V52, P4486, DOI 10.1128/AAC.00222-08; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Castanie-Cornet MP, 2006, J BACTERIOL, V188, P4264, DOI 10.1128/JB.00004-06; CAYLEY PJ, 1981, BIOCHEMISTRY-US, V20, P874, DOI 10.1021/bi00507a034; Chenia HY, 2006, J ANTIMICROB CHEMOTH, V58, P1274, DOI 10.1093/jac/dkl404; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El'Garch F, 2007, ANTIMICROB AGENTS CH, V51, P1016, DOI 10.1128/AAC.00704-06; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Fishman N, 2006, AM J MED, V119, pS62, DOI 10.1016/j.amjmed.2006.04.004; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Froelich JM, 2006, J BACTERIOL, V188, P1180, DOI 10.1128/JB.188.3.1180-1183.2006; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Giladi M, 2003, J BACTERIOL, V185, P7015, DOI 10.1128/JB.185.23.7015-7018.2003; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Gomez MJ, 2006, ANTIMICROB AGENTS CH, V50, P3562, DOI 10.1128/AAC.00579-06; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Harms C, 2001, MICROBIOL-SGM, V147, P2991, DOI 10.1099/00221287-147-11-2991; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; Haussmann C, 1997, J BACTERIOL, V179, P949, DOI 10.1128/jb.179.3.949-951.1997; Herrington MB, 1999, CAN J MICROBIOL, V45, P191, DOI 10.1139/cjm-45-3-191; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; HOLTJE JV, 1978, EUR J BIOCHEM, V86, P345, DOI 10.1111/j.1432-1033.1978.tb12316.x; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; Kishony R, 2003, J BIOL, V2, P14, DOI [DOI 10.1186/1475-4924-2-14, 10.1186/1475-4924-2-14]; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; LECLERCQ R, 2008, EXPERT RULES ANTIMIC; Lee W, 2002, BIOTECHNIQUES, V33, P1334, DOI 10.2144/02336bc04; Lenski RE, 2002, P NATL ACAD SCI USA, V99, P556, DOI 10.1073/pnas.022641999; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; LEWIS K, 1994, TRENDS BIOCHEM SCI, V19, P119, DOI 10.1016/0968-0004(94)90204-6; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2005, J BACTERIOL, V187, P6770, DOI 10.1128/JB.187.19.6770-6778.2005; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; MALINVERNI JC, 2009, P NATL ACAD IN PRESS; MANNEL D, 1978, EUR J BIOCHEM, V86, P361, DOI 10.1111/j.1432-1033.1978.tb12318.x; McKeegan KS, 2002, TRENDS MICROBIOL, V10, pS8, DOI 10.1016/S0966-842X(02)02429-0; Minagawa S, 2003, J BACTERIOL, V185, P3696, DOI 10.1128/JB.185.13.3696-3702.2003; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; NEWMAN EB, 1982, J BACTERIOL, V150, P710, DOI 10.1128/JB.150.2.710-715.1982; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Onan LJ, 2003, FEMS MICROBIOL LETT, V220, P15, DOI 10.1016/S0378-1097(03)00045-4; Patel OG, 2004, TRENDS PARASITOL, V20, P1, DOI 10.1016/j.pt.2003.10.009; Plumbridge J, 2002, CURR OPIN MICROBIOL, V5, P187, DOI 10.1016/S1369-5274(02)00296-5; RAINWATER S, 1990, J BACTERIOL, V172, P2456, DOI 10.1128/jb.172.5.2456-2461.1990; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Rybak MJ, 2006, AM J MED, V119, pS37, DOI 10.1016/j.amjmed.2006.04.001; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; Schurek KN, 2008, ANTIMICROB AGENTS CH, V52, P4213, DOI 10.1128/AAC.00507-08; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; SCOTT GM, 2001, HDB ESSENTIAL ANTIBI; Silhavy T.J., 1984, EXPT GENE FUSIONS; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stafford GP, 2005, MICROBIOL-SGM, V151, P1779, DOI 10.1099/mic.0.27879-0; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; THANASSI DG, 1995, J BACTERIOL, V177, P998, DOI 10.1128/jb.177.4.998-1007.1995; THEN RL, 1982, REV INFECT DIS, V4, P261; Thiele-Bruhn S, 2003, J PLANT NUTR SOIL SC, V166, P145, DOI 10.1002/jpln.200390023; TORRESCABASSA AS, 1987, J BACTERIOL, V169, P981, DOI 10.1128/jb.169.3.981-989.1987; Travisano M, 1996, GENETICS, V143, P15; VERKLIN RM, 1977, J LAB CLIN MED, V89, P65; vonRechenberg M, 1996, MICROB DRUG RESIST, V2, P155, DOI 10.1089/mdr.1996.2.155; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Walsh C., 2003, ANTIBIOTICS ACTIONS; Watkinson AJ, 2007, WATER RES, V41, P4164, DOI 10.1016/j.watres.2007.04.005; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Wright GD, 2003, CURR OPIN CHEM BIOL, V7, P563, DOI 10.1016/j.cbpa.2003.08.004	96	118	122	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5629	10.1371/journal.pone.0005629	http://dx.doi.org/10.1371/journal.pone.0005629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19462005	Green Submitted, Green Published, gold			2022-12-27	WOS:000266234700016
J	Bhat, UG; Halasi, M; Gartel, AL				Bhat, Uppoor G.; Halasi, Marianna; Gartel, Andrei L.			Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells	PLOS ONE			English	Article							M1 TRANSCRIPTION FACTOR; GENE-EXPRESSION PROFILES; GENOME-WIDE ANALYSIS; HEPATOCELLULAR CARCINOMAS; MICROARRAY ANALYSIS; CDNA MICROARRAY; TUMOR-CELLS; IDENTIFICATION; PROGRESSION; PROLIFERATION	Forkhead box M1 (FoxM1) oncogenic transcription factor represents an attractive therapeutic target in the fight against cancer, because it is overexpressed in a majority of human tumors. Recently, using a cell-based assay system we identified thiazole antibiotic Siomycin A as an inhibitor of FoxM1 transcriptional activity. Here, we report that structurally similar thiazole antibiotic, thiostrepton also inhibits the transcriptional activity of FoxM1. Furthermore, we found that these thiopeptides did not inhibit the transcriptional activity of other members of the Forkhead family or some non-related transcription factors. Further experiments revealed that thiazole antibiotics also inhibit FoxM1 expression, but not the expression of other members of the Forkhead box family. In addition, we found that the thiazole antibiotics efficiently inhibited the growth and induced potent apoptosis in human cancer cell lines of different origin. Thiopeptide-induced apoptosis correlated with the suppression of FoxM1 expression, while overexpression of FoxM1 partially protected cancer cells from the thiazole antibiotic-mediated cell death. These data suggest that Siomycin A and thiostrepton may specifically target FoxM1 to induce apoptosis in cancer cells and FoxM1 inhibitors/thiazole antibiotics could be potentially developed as novel anticancer drugs against human neoplasia.			Bhat, UG (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	agartel@uic.edu			NCI NIH HHS [R21 CA134615, 1R01CA1294414-01A1, 1R21CA134615-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA134615] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adami Guy R, 2007, Future Oncol, V3, P1, DOI 10.2217/14796694.3.1.1; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gartel AL, 2008, EXPERT OPIN THER TAR, V12, P663, DOI 10.1517/14728222.12.6.663 ; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; HALASI M, 2009, CELL CYCLE IN PRESS, V8; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lentzen G, 2003, CHEM BIOL, V10, P769, DOI 10.1016/S1074-5521(03)00173-X; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nicolaou KC, 2005, J AM CHEM SOC, V127, P15042, DOI 10.1021/ja0552803; Obama K, 2005, HEPATOLOGY, V41, P1339, DOI 10.1002/hep.20718; Okabe H, 2001, CANCER RES, V61, P2129; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Radhakrishnan Senthil K, 2008, Nat Rev Cancer, V8, pc2, DOI 10.1038/nrc2223-c1; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Teh MT, 2002, CANCER RES, V62, P4773; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626	35	162	176	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5592	10.1371/journal.pone.0005592	http://dx.doi.org/10.1371/journal.pone.0005592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440351	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107500020
J	Boselt, I; Rompler, H; Hermsdorf, T; Thor, D; Busch, W; Schulz, A; Schoneberg, T				Boeselt, Iris; Roempler, Holger; Hermsdorf, Thomas; Thor, Doreen; Busch, Wibke; Schulz, Angela; Schoeneberg, Torsten			Involvement of the V2 Vasopressin Receptor in Adaptation to Limited Water Supply	PLOS ONE			English	Article								Mammals adapted to a great variety of habitats with different accessibility to water. In addition to changes in kidney morphology, e. g. the length of the loops of Henle, several hormone systems are involved in adaptation to limited water supply, among them the renal-neurohypophysial vasopressin/vasopressin receptor system. Comparison of over 80 mammalian V2 vasopressin receptor (V2R) orthologs revealed high structural and functional conservation of this key component involved in renal water reabsorption. Although many mammalian species have unlimited access to water there is no evidence for complete loss of V2R function indicating an essential role of V2R activity for survival even of those species. In contrast, several marsupial V2R orthologs show a significant increase in basal receptor activity. An increased vasopressin-independent V2R activity can be interpreted as a shift in the set point of the renal-neurohypophysial hormone circuit to realize sufficient water reabsorption already at low hormone levels. As found in other desert mammals arid-adapted marsupials show high urine osmolalities. The gain of basal V2R function in several marsupials may contribute to the increased urine concentration abilities and, therefore, provide an advantage to maintain water and electrolyte homeostasis under limited water supply conditions.			Boselt, I (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Thor, Doreen/P-6778-2019; Busch, Wibke/I-9348-2012	Thor, Doreen/0000-0002-9522-5098; Busch, Wibke/0000-0002-5497-6266				Acher R, 1996, GEN COMP ENDOCR, V102, P157, DOI 10.1006/gcen.1996.0057; Acher R, 1999, J EXP ZOOL, V284, P475, DOI 10.1002/(SICI)1097-010X(19991001)284:5<475::AID-JEZ2>3.0.CO;2-9; Adan RAH, 2006, TRENDS PHARMACOL SCI, V27, P183, DOI 10.1016/j.tips.2006.02.002; Adan RAH, 2003, TRENDS PHARMACOL SCI, V24, P315, DOI 10.1016/S0165-6147(03)00130-5; Arthus MF, 2000, J AM SOC NEPHROL, V11, P1044, DOI 10.1681/ASN.V1161044; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BEUCHAT CA, 1990, AM J PHYSIOL, V258, pR298, DOI 10.1152/ajpregu.1990.258.2.R298; Beuchat CA, 1996, AM J PHYSIOL-REG I, V271, pR157, DOI 10.1152/ajpregu.1996.271.1.R157; Bichet DG, 2008, SEMIN NEPHROL, V28, P245, DOI 10.1016/j.semnephrol.2008.03.005; Bradshaw D, 2007, GEN COMP ENDOCR, V152, P125, DOI 10.1016/j.ygcen.2006.12.026; Bradshaw SD, 2001, J COMP PHYSIOL B, V171, P23, DOI 10.1007/s003600000144; BROWNFIELD MS, 1976, COMP BIOCHEM PHYS A, V55, P69, DOI 10.1016/0300-9629(76)90125-0; Dawson TJ, 2006, J COMP PHYSIOL B, V176, P45, DOI 10.1007/s00360-005-0030-2; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; FIRSOV D, 1994, PFLUG ARCH EUR J PHY, V429, P79, DOI 10.1007/BF02584033; Fujiwara TM, 2005, J AM SOC NEPHROL, V16, P2836, DOI 10.1681/ASN.2005040371; Gaeth AP, 1999, P NATL ACAD SCI USA, V96, P5555, DOI 10.1073/pnas.96.10.5555; Gwee PC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-93; Innamorati G, 1997, J BIOL CHEM, V272, P2486; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Kamperis K, 2000, PEDIATR NEPHROL, V15, P43, DOI 10.1007/s004670000431; King JM, 2008, GEN COMP ENDOCR, V155, P378, DOI 10.1016/j.ygcen.2007.07.004; Kleinau G, 2008, CELL MOL LIFE SCI, V65, P3664, DOI 10.1007/s00018-008-8450-2; Krause G, 2000, MOL PHARMACOL, V57, P232; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Liu AGSC, 2008, P NATL ACAD SCI USA, V105, P5786, DOI 10.1073/pnas.0800884105; LUZIUS H, 1992, J RECEPTOR RES, V12, P351, DOI 10.3109/10799899209074800; MBASSA GK, 1988, VET RES COMMUN, V12, P1, DOI 10.1007/BF00396399; McCormick SD, 2006, GEN COMP ENDOCR, V147, P3, DOI 10.1016/j.ygcen.2005.12.009; MURASAWA S, 1995, J BIOL CHEM, V270, P20042, DOI 10.1074/jbc.270.34.20042; Ortiz RM, 2001, J EXP BIOL, V204, P1831; PAN Y, 1994, J BIOL CHEM, V269, P31933; Pasel K, 2000, J CLIN ENDOCR METAB, V85, P1703, DOI 10.1210/jc.85.4.1703; PERROTT MN, 1993, GEN COMP ENDOCR, V89, P387, DOI 10.1006/gcen.1993.1046; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sangkuhl K, 2004, HUM MOL GENET, V13, P893, DOI 10.1093/hmg/ddh105; Sangkuhl Katrin, 2005, Hum Mutat, V25, P505, DOI 10.1002/humu.9337; Sarmiento JM, 2004, J BIOL CHEM, V279, P47017, DOI 10.1074/jbc.M410011200; SCHMI.B, 1961, AM J PHYSIOL, V200, P1119, DOI 10.1152/ajplegacy.1961.200.6.1119; Schon D, 2007, CLIN J AM SOC NEPHRO, V2, P268, DOI 10.2215/CJN.01880606; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schoneberg T, 1996, EMBO J, V15, P1283, DOI 10.1002/j.1460-2075.1996.tb00470.x; SCHOTT HC, 1993, J VET INTERN MED, V7, P68; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Schulein R, 1996, BIOCHEM J, V313, P611, DOI 10.1042/bj3130611; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Schulz A, 2002, J CLIN ENDOCR METAB, V87, P5247, DOI 10.1210/jc.2002-020286; SEIBOLD A, 1992, AM J HUM GENET, V51, P1078; Spanakis E, 2008, J CELL PHYSIOL, V217, P605, DOI 10.1002/jcp.21552; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; SUZUKI M, 1995, J MOL ENDOCRINOL, V14, P67, DOI 10.1677/jme.0.0140067; Takei Y, 2006, J EXP ZOOL PART A, V305A, P787, DOI 10.1002/jez.a.309; Wildin RS, 1998, KIDNEY INT, V54, P1909, DOI 10.1046/j.1523-1755.1998.00214.x; WILDIN RS, 1994, AM J HUM GENET, V55, P266; Wu S, 2008, ANAL CHEM, V80, P6034, DOI 10.1021/ac8008548; Yun J, 2000, J CLIN INVEST, V106, P1361, DOI 10.1172/JCI9154	57	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5573	10.1371/journal.pone.0005573	http://dx.doi.org/10.1371/journal.pone.0005573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440390	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107500005
J	Goulding, MQ				Goulding, Morgan Q.			Cell Lineage of the Ilyanassa Embryo: Evolutionary Acceleration of Regional Differentiation during Early Development	PLOS ONE			English	Article								Cell lineage studies in mollusk embryos have documented numerous variations on the lophotrochozoan theme of spiral cleavage. In the experimentally tractable embryo of the mud snail Ilyanassa, cell lineage has previously been described only up to the 29-cell stage. Here I provide a chronology of cell divisions in Ilyanassa to the stage of 84 cells (about 16 hours after first cleavage at 23 degrees C), and show spatial arrangements of identified nuclei at stages ranging from 27 to 84 cells. During this period the spiral cleavage pattern gives way to a bilaterally symmetric, dorsoventrally polarized pattern of mitotic timing and geometry. At the same time, the mesentoblast cell 4d rapidly proliferates to form twelve cells lying deep to the dorsal ectoderm. The onset of epiboly coincides with a period of mitotic quiescence throughout the ectoderm. As in other gastropod embryos, cell cycle lengths vary widely and predictably according to cell identity, and many of the longest cell cycles occur in small daughters of highly asymmetric divisions. While Ilyanassa shares many features of embryonic cell lineage with two other caenogastropod genera, Crepidula and Bithynia, it is distinguished by a general tendency toward earlier and more pronounced diversification of cell division pattern along axes of later differential growth.			Goulding, MQ (corresponding author), Univ Oregon, Dept Phys, Eugene, OR 97403 USA.	goulding@uoregon.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM049869] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackermann C, 2005, J MORPHOL, V266, P258, DOI 10.1002/jmor.10375; ARNOLDS WJA, 1983, ROUX ARCH DEV BIOL, V192, P75, DOI 10.1007/BF00848483; Casteel D. B., 1904, P ACAD NAT SCI PHILA, V56, P325; CATHER JN, 1963, CARYOLOGIA, V16, P663, DOI 10.1080/00087114.1963.10796106; Child CM, 1900, ARCH ENTWICKLUNG ORG, V9, P587, DOI 10.1007/BF02156195; CLEMENT AC, 1967, J EXP ZOOL, V166, P77, DOI 10.1002/jez.1401660109; CLEMENT AC, 1986, INT J INVER REP DEV, V9, P155, DOI 10.1080/01688170.1986.10510193; CLEMENT AC, 1962, J EXP ZOOL, V149, P193, DOI 10.1002/jez.1401490304; CLEMENT AC, 1986, INT J INVER REP DEV, V9, P139, DOI 10.1080/01688170.1986.10510192; CLEMENT AC, 1952, J EXP ZOOL, V121, P593, DOI 10.1002/jez.1401210310; Collier J.R., 1981, P217; Conklin E. G., 1907, P ACAD NAT SCI PHILA, V59, P320; Conklin Edwin G., 1902, Journal of the Academy of Natural Sciences of Philadelphia Ser 2, V12; Conklin EG, 1897, J MORPHOL, V13, P1, DOI DOI 10.1002/JMOR.1050130102; CONRAD GW, 1974, DEV BIOL, V36, P363, DOI 10.1016/0012-1606(74)90058-X; COSTELLO DP, 1945, J EXP ZOOL, V100, P19, DOI 10.1002/jez.1401000103; CRAIG MM, 1986, INT J INVER REP DEV, V9, P209, DOI 10.1080/01688170.1986.10510197; Crampton H.E., 1896, ARCH ENTWICKLUNGSMEC, V3, P1; Damen P, 1996, MECH DEVELOP, V56, P41, DOI 10.1016/0925-4773(96)00510-2; Dictus WJAG, 1997, MECH DEVELOP, V62, P213, DOI 10.1016/S0925-4773(97)00666-7; Dohle W, 1999, HYDROBIOLOGIA, V402, P267, DOI 10.1023/A:1003709129576; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eleath H., 1899, ZOOL JB ABT ANAT ONT, V12, P567; FREEMAN G, 1992, J EVOLUTION BIOL, V5, P205, DOI 10.1046/j.1420-9101.1992.5020205.x; Gonzales EE, 2007, DEV GENES EVOL, V217, P105, DOI 10.1007/s00427-006-0118-z; Goulding M, 2003, DEVELOPMENT, V130, P1181, DOI 10.1242/dev.00322; Hejnol A, 2007, DEV BIOL, V305, P63, DOI 10.1016/j.ydbio.2007.01.044; Henry JJ, 1999, HYDROBIOLOGIA, V402, P255, DOI 10.1023/A:1003756912738; Henry JQ, 2006, DEV BIOL, V297, P295, DOI 10.1016/j.ydbio.2006.04.441; Holmes SJ, 1900, J MORPHOL, V16, P369, DOI 10.1002/jmor.1050160205; Kingsley EP, 2007, EVOL DEV, V9, P527, DOI 10.1111/j.1525-142X.2007.00194.x; LABORDUS V, 1986, J EXP ZOOL, V239, P65, DOI 10.1002/jez.1402390109; Lambert JD, 2001, DEVELOPMENT, V128, P45; MARTINDALE MQ, 1986, INT J INVER REP DEV, V9, P229, DOI 10.1080/01688170.1986.10510198; Maslakova SA, 2004, DEV BIOL, V267, P342, DOI 10.1016/j.ydbio.2003.10.022; MEISENHEIMER J, 1901, Z WISS ZOOL ABT A, V4, P1; Morgan TH, 1933, J EXP ZOOL, V64, P433, DOI 10.1002/jez.1400640305; Page LR, 2003, J EXP ZOOL PART B, V297B, P11, DOI 10.1002/jez.b.00012; Ponder Winston F., 2008, P331; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Render J, 1997, DEV BIOL, V189, P301, DOI 10.1006/dbio.1997.8654; RENDER J, 1989, DEV BIOL, V132, P241, DOI 10.1016/0012-1606(89)90220-0; RENDER J, 1991, DEVELOPMENT, V113, P495; Robert H., 1902, ARCH ZOOL EXP GEN, V3, P18; Smirthwaite JJ, 2007, EVOL DEV, V9, P122, DOI 10.1111/j.1525-142X.2007.00143.x; Sweet HC, 1998, DEVELOPMENT, V125, P4033; TOMLINSON SG, 1987, INT J INVER REP DEV, V12, P253, DOI 10.1080/01688170.1987.10510325; VANDAM WI, 1986, J MORPHOL, V188, P289, DOI 10.1002/jmor.1051880304; vandenBiggelaar JAM, 1996, EVOLUTION, V50, P1520, DOI 10.1111/j.1558-5646.1996.tb03925.x; VANDENBIGGELAAR JAM, 1993, J MORPHOL, V216, P121, DOI 10.1002/jmor.1052160203; VANDENBIGGELAAR JAM, 1979, DEV BIOL, V68, P462, DOI 10.1016/0012-1606(79)90218-5; vandenBiggelaar JAM, 1996, DEV BIOL, V174, P423, DOI 10.1006/dbio.1996.0085; VANDENBIGGELAAR JAM, 1977, J MORPHOL, V154, P157, DOI 10.1002/jmor.1051540111; VANDONGEN CA, 1974, P K NED AKAD C BIOL, V77, P57; Watase S, 1891, J MORPHOL, V4, P247; Wierzejski A, 1905, Z WISS ZOOL ABT A, V83, P502; Wilson EB, 1892, J MORPHOL, V6, P361	57	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5506	10.1371/journal.pone.0005506	http://dx.doi.org/10.1371/journal.pone.0005506			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430530	Green Published, Green Submitted, gold			2022-12-27	WOS:000266009700011
J	Heg, D; Jutzeler, E; Mitchell, JS; Hamilton, IM				Heg, Dik; Jutzeler, Eva; Mitchell, Jeremy S.; Hamilton, Ian M.			Helpful Female Subordinate Cichlids Are More Likely to Reproduce	PLOS ONE			English	Article							SOCIAL-STATUS; HELPING-BEHAVIOR; DIRECT BENEFITS; MALE HELPERS; RELATEDNESS; EVOLUTION; FISH; RECIPROCITY; GROWTH; STAY	Background: In many cooperatively breeding vertebrates, subordinates assist a dominant pair to raise the dominants' offspring. Previously, it has been suggested that subordinates may help in payment for continued residency on the territory (the 'pay-to-stay hypothesis'), but payment might also be reciprocated or might allow subordinates access to reproductive opportunities. Methodology/Principal Findings: We measured dominant and subordinate female alloparental brood care and reproductive success in four separate experiments and show that unrelated female dominant and subordinate cichlid fish care for each other's broods (alloparental brood care), but that there is no evidence for reciprocal 'altruism' (no correlation between alloparental care received and given). Instead, subordinate females appear to pay with alloparental care for own direct reproduction. Conclusions/Significance: Our results suggest subordinate females pay with alloparental care to ensure access to the breeding substrate and thereby increase their opportunities to lay their own clutches. Subordinates' eggs are laid, on average, five days after the dominant female has produced her first brood. We suggest that immediate reproductive benefits need to be considered in tests of the pay-to-stay hypothesis.			Heg, D (corresponding author), Univ Bern, Dept Behav Ecol, Inst Ecol & Evolut, Hinterkappelen, Switzerland.	dik.heg@iee.unibe.ch	Hamilton, Ian Michael/A-4949-2012	Hamilton, Ian Michael/0000-0002-1198-3431; Heg, Dik/0000-0002-8766-7945				Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; Awata S, 2006, BEHAV ECOL, V17, P372, DOI 10.1093/beheco/arj043; Balshine-Earn S, 1998, BEHAV ECOL, V9, P432, DOI 10.1093/beheco/9.5.432; Bender N, 2006, HORM BEHAV, V50, P173, DOI 10.1016/j.yhbeh.2006.02.009; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bergmuller R, 2005, P ROY SOC B-BIOL SCI, V272, P325, DOI 10.1098/rspb.2004.2960; Bergmuller R, 2005, ANIM BEHAV, V69, P19, DOI 10.1016/j.anbehav.2004.05.009; Bshary R, 2002, ECOL LETT, V5, P130, DOI 10.1046/j.1461-0248.2002.00295.x; Canestrari D, 2005, BEHAV ECOL SOCIOBIOL, V57, P422, DOI 10.1007/s00265-004-0879-1; Dierkes P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1581, DOI 10.1007/s00265-008-0587-3; Dierkes P, 2005, ECOL LETT, V8, P968, DOI 10.1111/j.1461-0248.2005.00801.x; Field J, 2000, NATURE, V404, P869, DOI 10.1038/35009097; Fitzpatrick JL, 2006, BEHAV ECOL, V17, P25, DOI 10.1093/beheco/ari090; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Hamilton IM, 2008, J FISH BIOL, V72, P1079, DOI 10.1111/j.1095-8649.2007.01787.x; Hamilton IM, 2007, BEHAV ECOL, V18, P467, DOI 10.1093/beheco/arl108; Hamilton IM, 2005, BEHAVIOUR, V142, P1591, DOI 10.1163/156853905774831846; Hamilton IM, 2004, BEHAV ECOL, V15, P585, DOI 10.1093/beheco/arh047; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P445, DOI 10.1098/rspb.2004.2961; Heg D, 2006, BEHAV ECOL, V17, P419, DOI 10.1093/beheco/arj056; Heg D, 2005, BEHAVIOUR, V142, P1615, DOI 10.1163/156853905774831891; Heg D, 2005, ETHOLOGY, V111, P1017, DOI 10.1111/j.1439-0310.2005.01135.x; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, pS505, DOI 10.1098/rsbl.2004.0232; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Heg D, 2008, BIOL LETTERS, V4, P606, DOI 10.1098/rsbl.2008.0365; Heg D, 2008, MOL ECOL, V17, P4359, DOI 10.1111/j.1365-294X.2008.03920.x; Heg D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1249, DOI 10.1007/s00265-008-0553-0; Heg D, 2006, ENVIRON BIOL FISH, V76, P265, DOI 10.1007/s10641-006-9032-5; Hoeksema JD, 2003, P ROY SOC B-BIOL SCI, V270, P913, DOI 10.1098/rspb.2002.2312; Khan MZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P376, DOI 10.1007/s002650050680; Koenig W.D., 2004, ECOLOGY EVOLUTION CO; LIGON JD, 1983, ANIM BEHAV, V31, P480, DOI 10.1016/S0003-3472(83)80069-4; LIGON JD, 1978, NATURE, V276, P496, DOI 10.1038/276496a0; Manson JH, 2004, ANIM BEHAV, V67, P493, DOI 10.1016/j.anbehav.2003.05.009; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Norusis M.J, 2007, SPSS 15 0 ADV STAT P; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; RABENOLD KN, 1985, BEHAV ECOL SOCIOBIOL, V17, P1, DOI 10.1007/BF00299422; Richardson DS, 2002, EVOLUTION, V56, P2313; SCHURCH R, 2008, THESIS U BERN SWITZE; Seddon N, 2005, MOL ECOL, V14, P3573, DOI 10.1111/j.1365-294X.2005.02675.x; Solomon N. G., 1997, COOPERATIVE BREEDING; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; TABORSKY M, 1985, BEHAVIOUR, V95, P45, DOI 10.1163/156853985X00046; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Horn RC, 2004, MOL ECOL, V13, P449, DOI 10.1046/j.1365-294X.2003.02071.x; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; Werner NY, 2003, BEHAV ECOL, V14, P749, DOI 10.1093/beheco/arg067; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0	51	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5458	10.1371/journal.pone.0005458	http://dx.doi.org/10.1371/journal.pone.0005458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421320	Green Published, gold			2022-12-27	WOS:000265836900014
J	Marchetti, M; Resnick, L; Gamliel, E; Kesaraju, S; Weissbach, H; Binninger, D				Marchetti, Maria; Resnick, Lionel; Gamliel, Edna; Kesaraju, Shailaja; Weissbach, Herbert; Binninger, David			Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASES; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SULFIDE-INDUCED APOPTOSIS; CYCLOOXYGENASE-2 INHIBITORS; INDEPENDENT INDUCTION; HUMAN COLON; ASPIRIN; AGENTS	Background: Sulindac is an FDA-approved non-steroidal anti-inflammatory drug (NSAID) that affects prostaglandin production by inhibiting cyclooxygenases (COX) 1 and 2. Sulindac has also been of interest for more than decade as a chemopreventive for adenomatous colorectal polyps and colon cancer. Principal Findings: Pretreatment of human colon and lung cancer cells with sulindac enhances killing by an oxidizing agent such as tert-butyl hydroperoxide (TBHP) or hydrogen peroxide. This effect does not involve cyclooxygenase (COX) inhibition. However, under the conditions used, there is a significant increase in reactive oxygen species (ROS) within the cancer cells and a loss of mitochondrial membrane potential, suggesting that cell death is due to apoptosis, which was confirmed by Tunel assay. In contrast, this enhanced killing was not observed with normal lung or colon cells. Significance: These results indicate that normal and cancer cells handle oxidative stress in different ways and sulindac can enhance this difference. The combination of sulindac and an oxidizing agent could have therapeutic value.			Marchetti, M (corresponding author), Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA.	binninge@fau.edu			NATIONAL CANCER INSTITUTE [R15CA122001] Funding Source: NIH RePORTER; NCI NIH HHS [1 R15 CA 122001-01A1, R15 CA122001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi M, 2007, HISTOL HISTOPATHOL, V22, P437, DOI 10.14670/HH-22.437; Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Babbar N, 2003, J BIOL CHEM, V278, P47762, DOI 10.1074/jbc.M307265200; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Bonnesen C, 2001, CANCER RES, V61, P6120; Boolbol SK, 1996, CANCER RES, V56, P2556; Bottone FG, 2003, J BIOL CHEM, V278, P25790, DOI 10.1074/jbc.M301002200; DUGGAN DE, 1977, J PHARMACOL EXP THER, V201, P8; Etienne F, 2003, BIOCHEM BIOPH RES CO, V312, P1005, DOI 10.1016/j.bbrc.2003.10.203; Grosch S, 2001, FASEB J, V15, P2742, DOI 10.1096/fj.01-0299fje; Guldenschuh L, 2001, DIS COLON RECTUM, V44, P1090, DOI 10.1007/BF02234627; Gwyn K, 2002, AM J GASTROENTEROL, V97, P13, DOI 10.1111/j.1572-0241.2002.05435.x; Haanen C, 2001, Curr Opin Investig Drugs, V2, P677; Huang Y, 2001, CANCER RES, V61, P6918; Jiang TT, 2004, J EXP CLIN CANC RES, V23, P259; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Marchetti MA, 2005, INVEST OPHTH VIS SCI, V46, P2107, DOI 10.1167/iovs.05-0018; MEYSKENS FL, 2008, CANC PREVEN IN PRESS, V1; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Rao KVN, 1996, CARCINOGENESIS, V17, P1435, DOI 10.1093/carcin/17.7.1435; Ravi R, 2002, CANCER RES, V62, P1583; RESNICK L, 2009, J DRUGS DERMATOL, V8, P1241; Richter M, 2001, CARCINOGENESIS, V22, P17, DOI 10.1093/carcin/22.1.17; Rohnstock A, 2007, TOXICOL IN VITRO, V21, P1552, DOI 10.1016/j.tiv.2007.05.001; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Seo SK, 2007, APOPTOSIS, V12, P195, DOI 10.1007/s10495-006-0527-5; Taketo MM, 1998, JNCI-J NATL CANCER I, V90, P1609, DOI 10.1093/jnci/90.21.1609; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vogt T, 2001, MELANOMA RES, V11, P587, DOI 10.1097/00008390-200112000-00005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wick M, 2002, MOL PHARMACOL, V62, P1207, DOI 10.1124/mol.62.5.1207; Yamazaki R, 2002, FEBS LETT, V531, P278, DOI 10.1016/S0014-5793(02)03535-4; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100	39	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5804	10.1371/journal.pone.0005804	http://dx.doi.org/10.1371/journal.pone.0005804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503837	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717200001
J	Merl, D; Johnson, LR; Gramacy, RB; Mangel, M				Merl, Daniel; Johnson, Leah R.; Gramacy, Robert B.; Mangel, Marc			A Statistical Framework for the Adaptive Management of Epidemiological Interventions	PLOS ONE			English	Article							VACCINATION STRATEGIES; TRANSMISSION	Background: Epidemiological interventions aim to control the spread of infectious disease through various mechanisms, each carrying a different associated cost. Methodology: We describe a flexible statistical framework for generating optimal epidemiological interventions that are designed to minimize the total expected cost of an emerging epidemic while simultaneously propagating uncertainty regarding the underlying disease model parameters through to the decision process. The strategies produced through this framework are adaptive: vaccination schedules are iteratively adjusted to reflect the anticipated trajectory of the epidemic given the current population state and updated parameter estimates. Conclusions: Using simulation studies based on a classic influenza outbreak, we demonstrate the advantages of adaptive interventions over non-adaptive ones, in terms of cost and resource efficiency, and robustness to model misspecification.			Merl, D (corresponding author), Duke Univ, Dept Stat Sci, Durham, NC 27710 USA.	dan@stat.duke.edu		Johnson, Leah/0000-0002-9922-579X	Engineering and Physical Sciences Research Council [EP/C522702/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ANDERSON R M, 1991; Ball FG, 2002, MATH BIOSCI, V177, P333, DOI 10.1016/S0025-5564(01)00095-5; Clark CW, 2000, OX ECOL EV; Elderd BD, 2006, P NATL ACAD SCI USA, V103, P15693, DOI 10.1073/pnas.0600816103; Enserink M, 2001, SCIENCE, V294, P26, DOI 10.1126/science.294.5540.26; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Gamerman D, 2006, MARKOV CHAIN MONTE C; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Lloyd-Smith JO, 2003, P ROY SOC B-BIOL SCI, V270, P1979, DOI 10.1098/rspb.2003.2481; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; MERL D, 2008, AMEI ADAPTIVE MANAGE; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324	15	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5807	10.1371/journal.pone.0005807	http://dx.doi.org/10.1371/journal.pone.0005807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503812	gold, Green Published, Green Submitted			2022-12-27	WOS:000266717200004
J	Leischner, U; Zieglgansberger, W; Dodt, HU				Leischner, Ulrich; Zieglgaensberger, Walter; Dodt, Hans-Ulrich			Resolution of Ultramicroscopy and Field of View Analysis	PLOS ONE			English	Article								In a recent publication we described a microscopical technique called Ultramicroscopy, combined with a histological procedure that makes biological samples transparent. With this combination we can gather three-dimensional image data of large biological samples. Here we present the theoretical analysis of the z-resolution. By analyzing the cross-section of the illuminating sheet of light we derive resolution values according to the Rayleigh-criterion. Next we investigate the resolution adjacent to the focal point of the illumination beam, analyze throughout what extend the illumination beam is of acceptable sharpness and investigate the resolution improvements caused by the objective lens. Finally we conclude with a useful rule for the sampling rates. These findings are of practical importance for researchers working with Ultramicroscopy to decide on adequate sampling rates. They are also necessary to modify deconvolution techniques to gain further image improvements.			Leischner, U (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	Ulrich.Leischner@lrz.tum.de		Leischner, Ulrich/0000-0001-7771-2135				AMOS WB, 1995, HDB BIOL CONFOCAL MI; BIRAUD Y, 1969, ASTRON ASTROPHYS, V1, P124; BLUME M, IMAGE REGISTRATION M; BLUME M, 2007, THESIS TU MUNCHEN MU; Blume M, 2007, LECT NOTES COMPUT SC, V4791, P743; Born M, 2005, PRINCIPLES OPTICS, V7th edn; COX IJ, 1982, APPL OPTICS, V21, P778, DOI 10.1364/AO.21.000778; denDekker AJ, 1997, J OPT SOC AM A, V14, P547, DOI 10.1364/JOSAA.14.000547; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Engelbrecht CJ, 2006, OPT LETT, V31, P1477, DOI 10.1364/OL.31.001477; *FDN FS, 2007, FREE SOFT DEF; Fuchs E, 2002, OPT EXPRESS, V10, P145, DOI 10.1364/OE.10.000145; Hecht E, 2001, OPTIK; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; INGELSTAM E, 1956, PROBLEM CONT OPTICS, P128; Keller H. Ernst, 1995, P111; SCHELL AC, 1965, J I ELECTRON RAD ENG, V29, P21, DOI 10.1049/ree.1965.0004; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; SOMMERFELD A, 1950, VORLESUNGEN THEORETI, V4, P341; Spalteholz W., 1903, DURCHSICHTIGMACHEN M; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wein W, 2007, LECT NOTES COMPUT SC, V4792, P718; Wilson R.G., 1995, FOURIER SERIES OPTIC	23	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5785	10.1371/journal.pone.0005785	http://dx.doi.org/10.1371/journal.pone.0005785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492052	gold, Green Published, Green Submitted			2022-12-27	WOS:000266624300020
J	Modha, DS				Modha, Dharmendra S.			A Conceptual Cortical Surface Atlas	PLOS ONE			English	Article								Volumetric, slice-based, 3-D atlases are invaluable tools for understanding complex cortical convolutions. We present a simple scheme to convert a slice-based atlas to a conceptual surface atlas that is easier to visualize and understand. The key idea is to unfold each slice into a one-dimensional vector, and concatenate a succession of these vectors - while maintaining as much spatial contiguity as possible - into a 2-D matrix. We illustrate our methodology using a coronal slice-based atlas of the Rhesus Monkey cortex. The conceptual surface-based atlases provide a useful complement to slice-based atlases for the purposes of indexing and browsing.			Modha, DS (corresponding author), IBM Almaden Res Ctr, San Jose, CA USA.	dmodha@us.ibm.com			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306, F31ES027304] Funding Source: NIH RePORTER; NIEHS NIH HHS [27304C0002, 27306C0002] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Drury HA, 1996, J COGNITIVE NEUROSCI, V8, P1, DOI 10.1162/jocn.1996.8.1.1; Franklin K., 2007, MOUSE BRAIN STEREOTA; Harrower M, 2003, CARTOGR J, V40, P27, DOI 10.1179/000870403235002042; Ju LL, 2005, NEUROIMAGE, V28, P869, DOI 10.1016/j.neuroimage.2005.06.055; Mai JK., 2007, ATLAS HUMAN BRAIN; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Paxinos G., 2009, RHESUS MONKEY BRAIN; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; SHNEIDERMAN B, 2003, ACM C U US ACM PRESS, P1; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson P. M., 2002, Computing and Visualization in Science, V5, P13, DOI 10.1007/s00791-002-0084-6; Toga AW, 1999, BRAIN WARPING; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; VANESSEN DC, 1980, J COMP NEUROL, V191, P255, DOI 10.1002/cne.901910208; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561	17	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5693	10.1371/journal.pone.0005693	http://dx.doi.org/10.1371/journal.pone.0005693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453CI	19503613	Green Published, Green Submitted, gold			2022-12-27	WOS:000266587400002
J	Tubau, E; Lopez-Moliner, J				Tubau, Elisabet; Lopez-Moliner, Joan			Knowing What to Respond in the Future Does Not Cancel the Influence of Past Events	PLOS ONE			English	Article							2-CHOICE REACTION-TIME; CHOICE-REACTION-TIME; AUTOMATIC FACILITATION; EXPLICIT KNOWLEDGE; EXPECTANCY; SEQUENCE; TASKS; ACTIVATION	Everyday tasks seldom involve isolate actions but sequences of them. We can see whether previous actions influence the current one by exploring the response time to controlled sequences of stimuli. Specifically, depending on the response-stimulus temporal interval (RSI), different mechanisms have been proposed to explain sequential effects in two-choice serial response tasks. Whereas an automatic facilitation mechanism is thought to produce a benefit for response repetitions at short RSIs, subjective expectancies are considered to replace the automatic facilitation at longer RSIs, producing a cost-benefit pattern: repetitions are faster after other repetitions but they are slower after alternations. However, there is not direct evidence showing the impact of subjective expectancies on sequential effects. By using a fixed sequence, the results of the reported experiment showed that the repetition effect was enhanced in participants who acquired complete knowledge of the order. Nevertheless, a similar cost-benefit pattern was observed in all participants and in all learning blocks. Therefore, results of the experiment suggest that sequential effects, including the cost-benefit pattern, are the consequence of automatic mechanisms which operate independently of (and simultaneously with) explicit knowledge of the sequence or other subjective expectancies.			Tubau, E (corresponding author), Univ Barcelona, Fac Psicol, Dept Psicol Basica, Barcelona, Catalonia, Spain.	etubau@ub.edu	Tubau, Elisabet/C-6016-2011	Tubau, Elisabet/0000-0002-6632-3772; Lopez-Moliner, Joan/0000-0001-5040-8889				Ayton P, 2004, MEM COGNITION, V32, P1369, DOI 10.3758/BF03206327; BERTELSON P, 1965, NATURE, V206, P217, DOI 10.1038/206217a0; Eliassen JC, 2001, EXP BRAIN RES, V141, P269, DOI 10.1007/s002210100822; Fecteau JH, 2003, NAT REV NEUROSCI, V4, P435, DOI 10.1038/nrn1114; Fecteau JH, 2004, EXP BRAIN RES, V159, P84, DOI 10.1007/s00221-004-1935-9; Hoffmann J, 1997, PSYCHOL RES-PSYCH FO, V60, P87, DOI 10.1007/BF00419682; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Jentzsch I, 2002, ACTA PSYCHOL, V111, P265, DOI 10.1016/S0001-6918(02)00053-7; Jentzsch I, 2002, PERCEPT PSYCHOPHYS, V64, P1169, DOI 10.3758/BF03194765; KAHNEMAN D, 1982, VARIANTS UNCERTAINTY; KIRBY N, 1980, SEQUENTIAL EFFECTS C; KIRBY NH, 1976, J EXP PSYCHOL HUMAN, V2, P567, DOI 10.1037/0096-1523.2.4.567; MATT J, 1992, J EXP PSYCHOL LEARN, V18, P810, DOI 10.1037/0278-7393.18.4.810; Melis A, 2002, BRAIN COGNITION, V49, P420, DOI 10.1006/brcg.2001.1508; Perruchet P, 2006, J EXP PSYCHOL LEARN, V32, P955, DOI 10.1037/0278-7393.32.5.955; Smulders SFA, 2005, J EXP CHILD PSYCHOL, V90, P208, DOI 10.1016/j.jecp.2004.10.003; Soetens E, 2005, ACTA PSYCHOL, V119, P189, DOI 10.1016/j.actpsy.2005.01.003; Soetens E, 2004, PSYCHOL RES-PSYCH FO, V69, P124, DOI 10.1007/s00426-003-0163-4; Soetens E, 1998, J EXP PSYCHOL HUMAN, V24, P547, DOI 10.1037/0096-1523.24.2.547; SOETENS E, 1985, J EXP PSYCHOL HUMAN, V11, P598, DOI 10.1037/0096-1523.11.5.598; Tubau E, 2004, PSYCHOL RES-PSYCH FO, V68, P55, DOI 10.1007/s00426-003-0139-4; Tubau E, 2007, J EXP PSYCHOL GEN, V136, P43, DOI 10.1037/0096-3445.136.1.43; Whitwell RL, 2008, EXP BRAIN RES, V188, P603, DOI 10.1007/s00221-008-1395-8	23	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5607	10.1371/journal.pone.0005607	http://dx.doi.org/10.1371/journal.pone.0005607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	451SH	19478951	Green Submitted, Green Published, gold			2022-12-27	WOS:000266490000003
J	Watts, T; Haselkorn, TS; Moran, NA; Markow, TA				Watts, Thomas; Haselkorn, Tamara S.; Moran, Nancy A.; Markow, Therese A.			Variable Incidence of Spiroplasma Infections in Natural Populations of Drosophila Species	PLOS ONE			English	Article							MALE-KILLING SPIROPLASMA; CYTOPLASMIC INCOMPATIBILITY; VERTICAL TRANSMISSION; WOLBACHIA INFECTION; LOW-TEMPERATURES; ENDOSYMBIONT; DYNAMICS; DENSITY	Spiroplasma is widespread as a heritable bacterial symbiont in insects and some other invertebrates, in which it sometimes acts as a male-killer and causes female-biased sex ratios in hosts. Besides Wolbachia, it is the only heritable bacterium known from Drosophila, having been found in 16 of over 200 Drosophila species screened, based on samples of one or few individuals per species. To assess the extent to which Spiroplasma infection varies within and among species of Drosophila, intensive sampling consisting of 50-281 individuals per species was conducted for natural populations of 19 Drosophila species. Infection rates varied among species and among populations of the same species, and 12 of 19 species tested negative for all individuals. Spiroplasma infection never was fixed, and the highest infection rates were 60% in certain populations of D. hydei and 85% in certain populations of D. mojavensis. In infected species, infection rates were similar for males and females, indicating that these Spiroplasma infections do not confer a strong male-killing effect. These findings suggest that Spiroplasma has other effects on hosts that allow it to persist, and that environmental or host variation affects transmission or persistence leading to differences among populations in infection frequencies.			Watts, T (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	tmarkow@ucsd.edu	Moran, Nancy A/G-1591-2010					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anbutsu H, 2003, APPL ENVIRON MICROB, V69, P1428, DOI 10.1128/AEM.69.3.1428-1434.2003; Anbutsu H, 2008, APPL ENVIRON MICROB, V74, P6053, DOI 10.1128/AEM.01503-08; Bourtzis K, 1996, GENETICS, V144, P1063; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; EBBERT MA, 1991, EVOLUTION, V45, P971, DOI [10.2307/2409703, 10.1111/j.1558-5646.1991.tb04364.x]; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; Hoffmann AA, 1998, GENETICS, V148, P221; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hurst GDD, 2000, GENETICS, V156, P699; Kageyama D, 2006, APPL ENVIRON MICROB, V72, P6667, DOI 10.1128/AEM.00803-06; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; MALOGOLOWKIN C, 1959, GENETICS, V44, P59; Markow T.A., 2005, DROSOPHILA GUIDE SPE; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Montenegro H, 2006, J ZOOL SYST EVOL RES, V44, P130, DOI 10.1111/j.1439-0469.2006.00353.x; Montenegro H, 2005, INSECT MOL BIOL, V14, P281, DOI 10.1111/j.1365-2583.2005.00558.x; Montenegro H, 2004, J INVERTEBR PATHOL, V86, P50, DOI 10.1016/j.jip.2004.03.004; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Olsen K, 2001, HEREDITY, V86, P731, DOI 10.1046/j.1365-2540.2001.00892.x; Osaka R, 2008, CURR MICROBIOL, V57, P335, DOI 10.1007/s00284-008-9199-4; OTA T, 1979, J HERED, V70, P211, DOI 10.1093/oxfordjournals.jhered.a109235; Pool JE, 2006, HEREDITY, V97, P27, DOI 10.1038/sj.hdy.6800830; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; Williamson DL., 1979, MYCOPLASMAS, P175, DOI [10.1016/B978-0-12-078403-5.50012-8, DOI 10.1016/B978-0-12-078403-5.50012-8]; FLYENDO DROSOPHILA E	30	48	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5703	10.1371/journal.pone.0005703	http://dx.doi.org/10.1371/journal.pone.0005703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492088	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415100007
J	Jaiswal, BS; Janakiraman, V; Kljavin, NM; Eastham-Anderson, J; Cupp, JE; Liang, YX; Davis, DP; Hoeflich, KP; Seshagiri, S				Jaiswal, Bijay S.; Janakiraman, Vasantharajan; Kljavin, Noelyn M.; Eastham-Anderson, Jeffrey; Cupp, James E.; Liang, Yuxin; Davis, David P.; Hoeflich, Klaus P.; Seshagiri, Somasekar			Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors	PLOS ONE			English	Article								Background: Oncogenic RAS is a highly validated cancer target. Attempts at targeting RAS directly have so far not succeeded in the clinic. Understanding downstream RAS-effectors that mediate oncogenesis in a RAS mutant setting will help tailor treatments that use RAS-effector inhibitors either alone or in combination to target RAS-driven tumors. Methodology/Principal Findings: In this study, we have investigated the sufficiency of targeting RAS-effectors, RAF, MEK and PI3-Kinase either alone or in combination in RAS mutant lines, using an inducible shRNA in vivo mouse model system. We find that in colon cancer cells harboring a KRAS(G13D) mutant allele, knocking down KRAS alone or the RAFs in combination or the RAF effectors, MEK1 and MEK2, together is effective in delaying tumor growth in vivo. In melanoma cells harboring an NRAS(Q61L) or NRAS(Q61K) mutant allele, we find that targeting NRAS alone or both BRAF and CRAF in combination or both BRAF and PIK3CA together showed efficacy. Conclusion/Significance: Our data indicates that targeting oncogenic NRAS-driven melanomas require decrease in both pERK and pAKT downstream of RAS-effectors for efficacy. This can be achieved by either targeting both BRAF and CRAF or BRAF and PIK3CA simultaneously in NRAS mutant tumor cells.			Jaiswal, BS (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	sekar@gene.com		Seshagiri, Somasekar/0000-0003-4272-6443				Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Bedogni B, 2004, CANCER RES, V64, P2552, DOI 10.1158/0008-5472.CAN-03-3327; Bedogni B, 2006, MOL CANCER THER, V5, P3071, DOI 10.1158/1535-7163.MCT-06-0269; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Diaz-Flores E, 2007, GENE DEV, V21, P1989, DOI 10.1101/gad.1587907; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Gray DC, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-61; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Haluska F, 2007, SEMIN ONCOL, V34, P546, DOI 10.1053/j.seminoncol.2007.09.011; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Kratz CP, 2006, CELL CYCLE, V5, P1607, DOI 10.4161/cc.5.15.3128; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Lindsley CW, 2007, CURR TOP MED CHEM, V7, P1349; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Ollikainen M, 2007, INT J CANCER, V121, P915, DOI 10.1002/ijc.22768; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rossi DJ, 2006, CELL, V125, P229, DOI 10.1016/j.cell.2006.04.006; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Smalley KSM, 2009, ONCOGENE, V28, P85, DOI 10.1038/onc.2008.362; Smalley KSM, 2009, CANCER RES, V69, P3241, DOI 10.1158/0008-5472.CAN-08-4305; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Yu K, 2008, CANCER BIOL THER, V7, P307; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	35	88	103	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5717	10.1371/journal.pone.0005717	http://dx.doi.org/10.1371/journal.pone.0005717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492075	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415000024
J	Agherbi, H; Gaussmann-Wenger, A; Verthuy, C; Chasson, L; Serrano, M; Djabali, M				Agherbi, Hanane; Gaussmann-Wenger, Anne; Verthuy, Christophe; Chasson, Lionel; Serrano, Manuel; Djabali, Malek			Polycomb Mediated Epigenetic Silencing and Replication Timing at the INK4a/ARF Locus during Senescence	PLOS ONE			English	Article							METHYLTRANSFERASE ACTIVITY; MAMMALIAN TRITHORAX; DELAYED REPLICATION; CELLULAR SENESCENCE; GROUP GENE; HISTONE; METHYLATION; MLL; INACTIVATION; DOMAIN	Background: The INK4/ARF locus encodes three tumor suppressor genes (p15(Ink4b), Arf and p16(Ink4a)) and is frequently inactivated in a large number of human cancers. Mechanisms regulating INK4/ARF expression are not fully characterized. Principal Findings: Here we show that in young proliferating embryonic fibroblasts (MEFs) the Polycomb Repressive Complex 2 (PRC2) member EZH2 together with PRC1 members BMI1 and M33 are strongly expressed and localized at the INK4/ARF regulatory domain (RD) identified as a DNA replication origin. When cells enter senescence the binding to RD of both PRC1 and PRC2 complexes is lost leading to a decreased level of histone H3K27 trimethylation (H3K27me3). This loss is accompanied with an increased expression of the histone demethylase Jmjd3 and with the recruitment of the MLL1 protein, and correlates with the expression of the Ink4a/Arf genes. Moreover, we show that the Polycomb protein BMI1 interacts with CDC6, an essential regulator of DNA replication in eukaryotic cells. Finally, we demonstrate that Polycomb proteins and associated epigenetic marks are crucial for the control of the replication timing of the INK4a/ARF locus during senescence. Conclusions: We identified the replication licencing factor CDC6 as a new partner of the Polycomb group member BMI1. Our results suggest that in young cells Polycomb proteins are recruited to the INK4/ARF locus through CDC6 and the resulting silent locus is replicated during late S-phase. Upon senescence, Jmjd3 is overexpressed and the MLL1 protein is recruited to the locus provoking the dissociation of Polycomb from the INK4/ARF locus, its transcriptional activation and its replication during early S-phase. Together, these results provide a unified model that integrates replication, transcription and epigenetics at the INK4/ARF locus.			Agherbi, H (corresponding author), INSERM CNRS Marseille Luminy, Ctr Immunol, Marseille, France.	djabali@ciml.univ-mrs.fr	Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312				AGGER K, 2007, NATURE; Azuara V, 2006, NAT PROTOC, V1, P2171, DOI 10.1038/nprot.2006.353; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Campisi J, 2000, IN VIVO, V14, P183; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Core N, 2004, ONCOGENE, V23, P7660, DOI 10.1038/sj.onc.1207998; Core N, 1997, DEVELOPMENT, V124, P721; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; DIMRI GP, 1994, COLD SPRING HARB SYM, V59, P67, DOI 10.1101/SQB.1994.059.01.010; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Gonzalez AG, 2006, BIOSYSTEMS, V84, P91, DOI 10.1016/j.biosystems.2005.10.003; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; HAYASHI MT, 2009, NAT CELL BIOL; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lan F., 2007, NATURE; Matheu A, 2005, J BIOL CHEM, V280, P42433, DOI 10.1074/jbc.M508270200; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Perry P, 2004, CELL CYCLE, V3, P1645; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	53	106	112	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5622	10.1371/journal.pone.0005622	http://dx.doi.org/10.1371/journal.pone.0005622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19462008	Green Published, Green Submitted, gold			2022-12-27	WOS:000266234700009
J	Marinho, CRF; Neres, R; Epiphanio, S; Goncalves, LA; Catarino, MB; Penha-Goncalves, C				Marinho, Claudio R. F.; Neres, Rita; Epiphanio, Sabrina; Goncalves, Ligia A.; Catarino, Manuela Beirao; Penha-Goncalves, Carlos			Recrudescent Plasmodium berghei from Pregnant Mice Displays Enhanced Binding to the Placenta and Induces Protection in Multigravida	PLOS ONE			English	Article								Pregnancy-associated malaria (PAM) is associated with placenta pathology and poor pregnancy outcome but the mechanisms that control the malaria parasite expansion in pregnancy are still poorly understood and not amenable for study in human subjects. Here, we used a set of new tools to re-visit an experimental mouse model of pregnancy-induced malaria recrudescence, BALB/c with chronic Plasmodium berghei infection. During pregnancy 60% of the pre-exposed primiparous females showed pregnancy-induced malaria recrudescence and we demonstrated that the recrudescent P. berghei show an unexpected enhancement of the adherence to placenta tissue sections with a marked specificity for CSA. Furthermore, we showed that the intensity of parasitemia in primigravida was quantitatively correlated with the degree of thickening of the placental tissue and up-regulation of inflammation-related genes such as IL10. We also confirmed that the incidence of pregnancy-induced recrudescence, the intensity of the parasitemia peak and the impact on the pregnancy outcome decreased gradually from the first to the third pregnancy. Interestingly, placenta pathology and fetal impairment were also observed at low frequency among non-recrudescent females. Together, the data raise the hypothesis that recrudescent P. berghei displays selected specificity for the placenta tissue enabling on one hand, the triggering of the pathological process underlying PAM and on the other hand, the induction of PAM protection mechanisms that are revealed in subsequent pregnancies. Thus, by exploiting P. berghei pregnancy-induced recrudescence, this experimental system offers a mouse model to study the susceptibility to PAM and the mechanisms of disease protection in multigravida.			Marinho, CRF (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	cpenha@igc.gulbenkian.pt	Marinho, Claudio Romero Farias/F-7507-2012; Epiphanio, Sabrina/C-7572-2012; Penha-Goncalves, Carlos/F-4640-2012; Gonçalves, Lígia Antunes/F-6242-2014	Marinho, Claudio Romero Farias/0000-0002-1227-3845; Epiphanio, Sabrina/0000-0001-6094-9750; Gonçalves, Lígia Antunes/0000-0001-9804-6899; Neres, Rita/0000-0003-1794-4377; Penha-Goncalves, Carlos/0000-0001-7225-1907				Ahmed A, 2000, MOL MED, V6, P391, DOI 10.1007/BF03401783; [Anonymous], 2004, STRATEGIC FRAMEWORK; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Boeuf P, 2008, J INFECT DIS, V197, P757, DOI 10.1086/526521; Bourgeois C, 1997, J CLIN ENDOCR METAB, V82, P3116, DOI 10.1210/jc.82.9.3116; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Diouf I, 2004, J INFECT DIS, V189, P2235, DOI 10.1086/420791; Epiphanio S, 2008, CELL HOST MICROBE, V3, P331, DOI 10.1016/j.chom.2008.04.003; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Freyre A, 2006, EXP PARASITOL, V113, P154, DOI 10.1016/j.exppara.2005.12.019; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Janse CJ, 2006, NAT PROTOC, V1, P614, DOI 10.1038/nprot.2006.88; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1994, METHOD CELL BIOL, V42, P295; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Luty AJF, 2000, INFECT IMMUN, V68, P3909, DOI 10.1128/IAI.68.7.3909-3915.2000; MEGNEKOU R, 2009, INFECT IMMUN, V23, P23; Menendez C, 2006, CURR MOL MED, V6, P269, DOI 10.2174/156652406776055186; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Muthusamy A, 2004, AM J PATHOL, V164, P2013, DOI 10.1016/S0002-9440(10)63761-3; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Neres R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001608; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Othoro C, 2008, INFECT IMMUN, V76, P1678, DOI 10.1128/IAI.01420-07; Phillips RS, 1997, PARASITE IMMUNOL, V19, P427, DOI 10.1046/j.1365-3024.1997.d01-239.x; POELS LG, 1977, EXP PARASITOL, V43, P255, DOI 10.1016/0014-4894(77)90031-5; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Schofield L, 2007, IMMUNOL CELL BIOL, V85, P130, DOI 10.1038/sj.icb.7100040; Shulman CE, 2001, TROP MED INT HEALTH, V6, P770, DOI 10.1046/j.1365-3156.2001.00786.x; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; VANZON AAJC, 1980, TROPENMED PARASITOL, V31, P402; VANZON AAJC, 1980, INFECT IMMUN, V28, P630; VANZON AAJC, 1985, PARASITOLOGY, V91, P9, DOI 10.1017/S003118200005647X; WALTER PR, 1982, AM J PATHOL, V109, P330	49	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5630	10.1371/journal.pone.0005630	http://dx.doi.org/10.1371/journal.pone.0005630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461965	gold, Green Submitted, Green Published			2022-12-27	WOS:000266234700017
J	Mehling, WE; Gopisetty, V; Daubenmier, J; Price, CJ; Hecht, FM; Stewart, A				Mehling, Wolf E.; Gopisetty, Viranjini; Daubenmier, Jennifer; Price, Cynthia J.; Hecht, Frederick M.; Stewart, Anita			Body Awareness: Construct and Self-Report Measures	PLOS ONE			English	Review							IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; LOW-BACK-PAIN; INTEROCEPTIVE AWARENESS; MINDFULNESS MEDITATION; EMOTIONAL EXPERIENCE; SOMATOSENSORY AMPLIFICATION; CORTICAL REORGANIZATION; ATTENTIONAL STRATEGIES; PSYCHOLOGICAL STRESS	Objectives: Heightened body awareness can be adaptive and maladaptive. Improving body awareness has been suggested as an approach for treating patients with conditions such as chronic pain, obesity and post-traumatic stress disorder. We assessed the psychometric quality of selected self-report measures and examined their items for underlying definitions of the construct. Data sources: PubMed, PsychINFO, HaPI, Embase, Digital Dissertations Database. Review methods: Abstracts were screened; potentially relevant instruments were obtained and systematically reviewed. Instruments were excluded if they exclusively measured anxiety, covered emotions without related physical sensations, used observer ratings only, or were unobtainable. We restricted our study to the proprioceptive and interoceptive channels of body awareness. The psychometric properties of each scale were rated using a structured evaluation according to the method of McDowell. Following a working definition of the multi-dimensional construct, an inter-disciplinary team systematically examined the items of existing body awareness instruments, identified the dimensions queried and used an iterative qualitative process to refine the dimensions of the construct. Results: From 1,825 abstracts, 39 instruments were screened. 12 were included for psychometric evaluation. Only two were rated as high standard for reliability, four for validity. Four domains of body awareness with 11 sub-domains emerged. Neither a single nor a compilation of several instruments covered all dimensions. Key domains that might potentially differentiate adaptive and maladaptive aspects of body awareness were missing in the reviewed instruments. Conclusion: Existing self-report instruments do not address important domains of the construct of body awareness, are unable to discern between adaptive and maladaptive aspects of body awareness, or exhibit other psychometric limitations. Restricting the construct to its proprio-and interoceptive channels, we explore the current understanding of the multidimensional construct and suggest next steps for further research.			Mehling, WE (corresponding author), Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA.	mehlingw@ocim.ucsf.edu		Hecht, Frederick/0000-0002-5782-1171	NCCIH NIH HHS [5K23AT002298, K23 AT002298] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT002298] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Abramowitz JS, 2002, MAYO CLIN PROC, V77, P1323, DOI 10.4065/77.12.1323; Afrell M, 2007, SCAND J CARING SCI, V21, P291, DOI 10.1111/j.1471-6712.2007.00475.x; ANDERSON R, 2006, HUMANISTIC PSYCHOL, V34, P357; Arch JJ, 2006, BEHAV RES THER; Aronson KR, 2006, J PSYCHOSOM RES, V60, P521, DOI 10.1016/j.jpsychores.2005.09.001; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Astin JA, 2003, J AM BOARD FAM PRACT, V16, P131, DOI 10.3122/jabfm.16.2.131; Austin DW, 2006, J ANXIETY DISORD, V20, P237, DOI 10.1016/j.janxdis.2005.01.001; Baas Linda S, 2004, J Cardiovasc Nurs, V19, P32; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Bakal D, 2006, MED HYPOTHESES, V67, P1443, DOI 10.1016/j.mehy.2006.05.028; Bakal D, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-6; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Barnes Patricia M, 2004, Adv Data, P1; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; BARSKY AJ, 1990, J PSYCHIAT RES, V24, P323, DOI 10.1016/0022-3956(90)90004-A; Bechara A, 2004, NAT NEUROSCI, V7, P102, DOI 10.1038/nn0204-102; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bekker MHJ, 2008, J CLIN PSYCHOL, V64, P747, DOI 10.1002/jclp.20486; BERNET M, 1995, STYLES PERCEPTION AF; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Bogaerts K, 2008, J PSYCHOSOM RES, V65, P417, DOI 10.1016/j.jpsychores.2008.03.019; Brahler E, 2000, DIAGNOSTICA, V46, P156, DOI 10.1026//0012-1924.46.3.156; Brewer B., 1995, BODY SELF; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Burns JW, 2006, EMOTION, V6, P180, DOI 10.1037/1528-3542.6.2.180; Cameron O.G., 2002, VISCERAL SENSORY NEU; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Carruthers G, 2008, CONSCIOUS COGN, V17, P1302, DOI 10.1016/j.concog.2008.02.001; CHAMBLESS DL, 1984, J CONSULT CLIN PSYCH, V52, P1090, DOI 10.1037/0022-006X.52.6.1090; Christensen AJ, 1996, J CONSULT CLIN PSYCH, V64, P147, DOI 10.1037/0022-006X.64.1.147; CIOFFI D, 1991, PSYCHOL BULL, V109, P25, DOI 10.1037/0033-2909.109.1.25; CIOFFI D, 1993, J PERS SOC PSYCHOL, V64, P274, DOI 10.1037/0022-3514.64.2.274; Clark DM, 1997, J CONSULT CLIN PSYCH, V65, P203, DOI 10.1037/0022-006X.65.2.203; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, J COMP NEUROL, V477, P119, DOI 10.1002/cne.20240; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2002, NEUROIMAGE, V16, P909, DOI 10.1006/nimg.2002.1147; Dahme B, 1996, BIOL PSYCHOL, V42, P215, DOI 10.1016/0301-0511(95)05156-2; Damasio A, 2003, NATURE, V423, P227, DOI 10.1038/423227a; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2000, FEELING WHAT HAPPENS; Daubenmier JJ, 2005, PSYCHOL WOMEN QUART, V29, P207, DOI 10.1111/j.1471-6402.2005.00183.x; DAUBENMIER JJ, ANN BEHAV M IN PRESS; Davenport PW, 2007, J APPL PHYSIOL, V102, P276, DOI 10.1152/japplphysiol.01436.2005; Deusinger IM, 1998, FRANKFURTER KORPERKO; Drossman DA, 2003, GASTROENTEROLOGY, V124, P754, DOI 10.1053/gast.2003.50103; Eccleston C, 1997, PAIN, V72, P209, DOI 10.1016/S0304-3959(97)00030-4; Edelman G., 2004, WIDER SKY PHENOMENAL; ELERT J, 1999, ADV PHYSIOTHERAPY, V1, P83; Eriksson EM, 2007, WORLD J GASTROENTERO, V13, P3206, DOI 10.3748/wjg.v13.i23.3206; Ernst E, 2003, FORSCH KOMP KLAS NAT, V10, P325, DOI 10.1159/000075886; Fairclough SH, 2007, J PSYCHOSOM RES, V62, P289, DOI 10.1016/j.jpsychores.2006.10.017; FARB NAS, 2007, SCAN ADV ACCESS 0813, P1; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Feipel V, 2003, CLIN BIOMECH, V18, P612, DOI 10.1016/S0268-0033(03)00094-9; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Ferguson RJ, 1998, BEHAV RES THER, V36, P527, DOI 10.1016/S0005-7967(98)00048-5; FISHER S, 1966, PSYCHOL MONOGR, V80, P1; Flor H, 2002, APPL PSYCHOPHYS BIOF, V27, P215, DOI 10.1023/A:1016204029162; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; FORESTER CA, 2001, BODY AWARENESS ASPEC; FRANZOI SL, 1989, SEX ROLES, V21, P499, DOI 10.1007/BF00289100; Fredrickson BL, 1998, J PERS SOC PSYCHOL, V75, P269, DOI 10.1037/0022-3514.75.1.269; FRIIS S, 1989, PSYCHOTHER PSYCHOSOM, V51, P18, DOI 10.1159/000288129; Gallagher S., 2005, BODY SHAPES MIND; Gard G, 2005, DISABIL REHABIL, V27, P725, DOI 10.1080/09638280400009071; GARNER DM, 1991, EATING DISORDERS INV; GIUMMARRA MJ, 2007, NEUROSCI BIOBEHAV RE; Goubert L, 2004, PAIN, V110, P220, DOI 10.1016/j.pain.2004.03.034; Grossman P, 2008, J PSYCHOSOM RES, V64, P405, DOI 10.1016/j.jpsychores.2008.02.001; Grossman P, 2007, PSYCHOTHER PSYCHOSOM, V76, P226, DOI 10.1159/000101501; Gustafsson M, 2004, J REHABIL MED, V36, P97, DOI 10.1080/16501970310018314; Gyllensten AL, 2004, SCAND J CARING SCI, V18, P213, DOI 10.1111/j.1471-6712.2004.00272.x; Gyllensten AL, 1999, SCAND J CARING SCI, V13, P217, DOI 10.1080/02839319950162408; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HANSELL S, 1991, J GERONTOL, V46, pS151, DOI 10.1093/geronj/46.3.S151; HART EA, 1989, J SPORT EXERCISE PSY, V11, P94, DOI 10.1123/jsep.11.1.94; Haugstad GK, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.019; Haugstad GK, 2006, J PSYCHOSOM RES, V61, P637, DOI 10.1016/j.jpsychores.2006.05.003; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzl R, 1996, BIOL PSYCHOL, V42, P199, DOI 10.1016/0301-0511(95)05155-4; Hoyer J, 2000, DIAGNOSTICA, V46, P140, DOI 10.1026//0012-1924.46.3.140; Ives JC, 2003, RES Q EXERCISE SPORT, V74, P116, DOI 10.1080/02701367.2003.10609072; Johnson Malcolm H, 2005, Curr Pain Headache Rep, V9, P90, DOI 10.1007/s11916-005-0044-1; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KABATZINN J, 1985, J BEHAV MED, V8, P163, DOI 10.1007/BF00845519; KAHN J, 2007, MASSAGE CLIENTS PERC; KAWANO R, 1997, EFFECT EXERCISE BODY; Kearney DJ, 2008, NAT CLIN PRACT GASTR, V5, P624, DOI 10.1038/ncpgasthep1257; Kerr C, 2002, CULT MED PSYCHIAT, V26, P419, DOI 10.1023/A:1021772324119; Khalsa S S, 2008, INT J PSYCHOPHYSIOL; Khalsa SS, 2008, PSYCHOPHYSIOLOGY, V45, P671, DOI 10.1111/j.1469-8986.2008.00666.x; KHALSA SS, 2007, ANN SCI M AM PSYCH S; Kirmayer LJ, 2006, CURR OPIN PSYCHIATR, V19, P54, DOI 10.1097/01.yco.0000194810.76096.f2; Kolt G. S., 2000, J BODYWORK MOV THER, V4, P216, DOI [10.1054/jbmt.2000.0179, DOI 10.1054/JBMT.2000.0179]; Krisanaprakornkit T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004998.pub2; Kristeller J L, 1999, J Health Psychol, V4, P357, DOI 10.1177/135910539900400305; Lakoff George., 1999, PHILOS FLESH EMBODIE; Landsman-Dijkstra JJA, 2006, PATIENT EDUC COUNS, V60, P66, DOI 10.1016/j.pec.2004.12.003; Laskowski E R, 2000, Phys Med Rehabil Clin N Am, V11, P323; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Leder Drew, 1990, ABSENT BODY; Little P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a884; LOMBARDO C, 1995, B PSICOLOGIA APPL, V214, P45; LOREY B, 2009, EXP BRAIN RES; Mailloux J, 2002, PSYCHOSOM MED, V64, P353, DOI 10.1097/00006842-200203000-00020; MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5; MANDLER G, 1958, J ABNORM SOC PSYCH, V56, P367, DOI 10.1037/h0048083; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; McKinley NM, 1996, PSYCHOL WOMEN QUART, V20, P181, DOI 10.1111/j.1471-6402.1996.tb00467.x; Mehling WE, 2005, ALTERN THER HEALTH M, V11, P44, DOI 10.1111/j.1365-263X.2005.00605.x; Mehling WE, 2001, FORSCH KOMP KLAS NAT, V8, P359, DOI 10.1159/000057253; Mehling WE, 2005, J ALTERN COMPLEM MED, V11, P333, DOI 10.1089/acm.2005.11.333; MILLER LC, 1981, J PERS SOC PSYCHOL, V41, P397, DOI 10.1037/0022-3514.41.2.397; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; Morone NE, 2007, PAIN MED, V8, P359, DOI 10.1111/j.1526-4637.2007.00312.x; MORONE NE, 2007, PAIN; Murray CD, 2001, CYBERPSYCHOL BEHAV, V4, P365, DOI 10.1089/109493101300210268; Naliboff BD, 2006, GASTROENTEROLOGY, V131, P352, DOI 10.1053/j.gastro.2006.05.014; Naqvi N, 2006, CURR DIR PSYCHOL SCI, V15, P260, DOI 10.1111/j.1467-8721.2006.00448.x; NCCAM, 2004, US COMPL ALT MED US; Netz Y, 2003, J PSYCHOL, V137, P405, DOI 10.1080/00223980309600624; Nielsen L, 2006, EMOTION, V6, P392, DOI 10.1037/1528-3542.6.3.392; *NIH NCCAM, 2005, C BIOL MAN THER JUN; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; PAULUUS P, 1982, ERFAHRUNG EIGENEN KO; Pekala R. J., 1981, IMAGINATION COGNITIO, V1, P29; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Porges, 1993, BODY PERCEPTION QUES; Price C, 2005, ALTERN THER HEALTH M, V11, P46; PRICE CJ, 2006, J ALTERN COMPLEMENT; Price CJ, 2007, J ALTERN COMPLEM MED, V13, P945, DOI 10.1089/acm.2007.0537; Price CJ, 2007, ALTERN THER HEALTH M, V13, P32; ROHRER T, 2007, BODY LANGUA IN PRESS; ROXENDAL G, 1992, BAS SKALAN MED BAS H; RYDING C, 2002, ADV PHYSIOTHERAPY, V2, P176; Sacks O, 1984, LEG STAND; Schmidt NB, 1997, J CONSULT CLIN PSYCH, V65, P214, DOI 10.1037/0022-006X.65.2.214; Schneider A, 2005, J ALTERN COMPLEM MED, V11, P119, DOI 10.1089/acm.2005.11.119; Sechrest L, 2005, HEALTH SERV RES, V40, P1584, DOI 10.1111/j.1475-6773.2005.00443.x; Sephton SE, 2007, ARTHRIT RHEUM-ARTHR, V57, P77, DOI 10.1002/art.22478; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; SHIELDS SA, 1989, J PERS ASSESS, V53, P802, DOI 10.1207/s15327752jpa5304_16; Singer W, 2004, DEUT Z PHILOS, V52, P235; SKRINAR GS, 1986, PERCEPT MOTOR SKILL, V62, P483, DOI 10.2466/pms.1986.62.2.483; Smith MC, 1999, ALTERN THER HEALTH M, V5, P64; Snell WE, 1997, AM J HEALTH BEHAV, V21, P33; Spoor Sonja T P, 2005, Eat Disord, V13, P479, DOI 10.1080/10640260500297267; Steen E, 2001, PATIENT EDUC COUNS, V42, P35, DOI 10.1016/S0738-3991(00)00088-4; Stephan E, 2003, J GASTROINTEST SURG, V7, P740, DOI 10.1016/S1091-255X(03)00071-4; Steptoe A, 1997, BEHAV RES THER, V35, P901, DOI 10.1016/S0005-7967(97)00055-7; STERN RM, 1969, J PSYCHOSOM RES, V13, P77, DOI 10.1016/0022-3999(69)90022-1; Taylor-Piliae Ruth E, 2003, J Cardiopulm Rehabil, V23, P90; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; Uman LS, 2008, J PEDIATR PSYCHOL, V33, P842, DOI 10.1093/jpepsy/jsn031; Vaitl D, 1996, BIOL PSYCHOL, V42, P1, DOI 10.1016/0301-0511(95)05144-9; Van der Kolk BA, 2006, ANN NY ACAD SCI, V1071, P277, DOI 10.1196/annals.1364.022; van Dixhoorn J J, 1999, J Cardiopulm Rehabil, V19, P178, DOI 10.1097/00008483-199905000-00005; vanWijk CMTG, 1996, PERS INDIV DIFFER, V20, P55; Varela FJ, 2017, EMBODIED MIND COGNIT; Verhagen JV, 2007, BRAIN RES REV, V53, P271, DOI 10.1016/j.brainresrev.2006.09.002; Villien F, 2005, RESP PHYSIOL NEUROBI, V146, P85, DOI 10.1016/j.resp.2004.11.010; Watkins E, 2004, J AFFECT DISORDERS, V82, P1, DOI 10.1016/j.jad.2003.10.006; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Wu G, 2002, J AM GERIATR SOC, V50, P746, DOI 10.1046/j.1532-5415.2002.50173.x; Young Katharine, 1997, PRESENCE FLESH BODY; Zoellner LA, 1999, BEHAV RES THER, V37, P1141, DOI 10.1016/S0005-7967(98)00202-2	173	283	286	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5614	10.1371/journal.pone.0005614	http://dx.doi.org/10.1371/journal.pone.0005614			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	446ZK	19440300	Green Published, Green Submitted, gold			2022-12-27	WOS:000266161200015
J	Monkhorst, K; de Hoon, B; Jonkers, I; Achame, EM; Monkhorst, W; Hoogerbrugge, J; Rentmeester, E; Westerhoff, HV; Grosveld, F; Grootegoed, JA; Gribnau, J				Monkhorst, Kim; de Hoon, Bas; Jonkers, Iris; Achame, Eskeatnaf Mulugeta; Monkhorst, Wouter; Hoogerbrugge, Jos; Rentmeester, Eveline; Westerhoff, Hans V.; Grosveld, Frank; Grootegoed, J. Anton; Gribnau, Joost			The Probability to Initiate X Chromosome Inactivation Is Determined by the X to Autosomal Ratio and X Chromosome Specific Allelic Properties	PLOS ONE			English	Article							DNA-REPAIR ENZYME; RED-BLOOD-CELLS; ANTISENSE TRANSCRIPTION; EXTRAEMBRYONIC TISSUES; COUNTING PROCESS; NUCLEAR VOLUME; XIST GENE; TSIX; MICE; UBIQUITIN	Background: In female mammalian cells, random X chromosome inactivation (XCI) equalizes the dosage of X-encoded gene products to that in male cells. XCI is a stochastic process, in which each X chromosome has a probability to be inactivated. To obtain more insight in the factors setting up this probability, we studied the role of the X to autosome (X:A) ratio in initiation of XCI, and have used the experimental data in a computer simulation model to study the cellular population dynamics of XCI. Methodology/Principal Findings: To obtain more insight in the role of the X:A ratio in initiation of XCI, we generated triploid mouse ES cells by fusion of haploid round spermatids with diploid female and male ES cells. These fusion experiments resulted in only XXY triploid ES cells. XYY and XXX ES lines were absent, suggesting cell death related either to insufficient X-chromosomal gene dosage (XYY) or to inheritance of an epigenetically modified X chromosome (XXX). Analysis of active (Xa) and inactive (Xi) X chromosomes in the obtained triploid XXY lines indicated that the initiation frequency of XCI is low, resulting in a mixed population of XaXiY and XaXaY cells, in which the XaXiY cells have a small proliferative advantage. This result, and findings on XCI in diploid and tetraploid ES cell lines with different X:A ratios, provides evidence that the X:A ratio determines the probability for a given X chromosome to be inactivated. Furthermore, we found that the kinetics of the XCI process can be simulated using a probability for an X chromosome to be inactivated that is proportional to the X:A ratio. These simulation studies re-emphasize our hypothesis that the probability is a function of the concentration of an X-encoded activator of XCI, and of X chromosome specific allelic properties determining the threshold for this activator. Conclusions: The present findings reveal that the probability for an X chromosome to be inactivated is proportional to the X:A ratio. This finding supports the presence of an X-encoded activator of the XCI process.			Monkhorst, K (corresponding author), Univ Med Ctr, Dept Reprod & Dev, Erasmus MC, Rotterdam, Netherlands.	j.gribnau@erasmusmc.nl	Westerhoff, Hans V/I-5762-2012; Mulugeta, Eskeatnaf/H-2640-2016; Mulugeta, Eskeatnaf/AAZ-7471-2020	Westerhoff, Hans V/0000-0002-0443-6114; Mulugeta, Eskeatnaf/0000-0003-4045-4835; Mulugeta, Eskeatnaf/0000-0003-4045-4835	Biotechnology and Biological Sciences Research Council [BB/C008219/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Baarends WM, 2003, MOL CELL BIOL, V23, P1151, DOI 10.1128/MCB.23.4.1151-1162.2003; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; CATTANACH BM, 1967, GENETICS, V57, P331; Chadwick LH, 2006, GENETICS, V173, P2103, DOI 10.1534/genetics.105.054882; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; DUSART D, 1992, AM J MED GENET, V42, P156, DOI 10.1002/ajmg.1320420204; Gartler SM, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-41; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Heard E, 1999, MOL CELL BIOL, V19, P3156; HENDRIKSSON P, 1974, ACTA PAEDIATR SCAND, P447; HENERY CC, 1992, J EXP ZOOL, V261, P472, DOI 10.1002/jez.1402610414; HENERY CC, 1993, EUR J MORPHOL, V31, P237; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Iliopoulos D, 2005, GENET MOL RES, V4, P755; KAUFMAN MH, 1989, CYTOGENET CELL GENET, V50, P98, DOI 10.1159/000132732; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LEISTI J, 1970, SCAND J CLIN LAB INV, V25, P60; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MCMAHON A, 1983, GENET RES, V41, P69, DOI 10.1017/S0016672300021078; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ohhata T, 2008, DEVELOPMENT, V135, P227, DOI 10.1242/dev.008490; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Sado T, 2001, DEVELOPMENT, V128, P1275; Sado T, 2006, DEVELOPMENT, V133, P4925, DOI 10.1242/dev.02670; SPEIRS S, 1990, GENET RES, V56, P107, DOI 10.1017/S0016672300035175; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; TAKAGI N, 1983, CELL, V34, P1053, DOI 10.1016/0092-8674(83)90563-9; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; UCHIDA IA, 1985, AM J OBSTET GYNECOL, V151, P65, DOI 10.1016/0002-9378(85)90426-0; Ulrich HD, 2005, CHEMBIOCHEM, V6, P1735, DOI 10.1002/cbic.200500139; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; WEBB S, 1992, GENET RES, V59, P205, DOI 10.1017/S0016672300030494; WILLARD HF, 1977, AM J HUM GENET, V29; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001	53	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5616	10.1371/journal.pone.0005616	http://dx.doi.org/10.1371/journal.pone.0005616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440388	Green Published, gold			2022-12-27	WOS:000266161200016
J	Gao, J; Davidson, MK; Wahls, WP				Gao, Jun; Davidson, Mari K.; Wahls, Wayne P.			Phosphorylation-Independent Regulation of Atf1-Promoted Meiotic Recombination by Stress-Activated, p38 Kinase Spc1 of Fission Yeast	PLOS ONE			English	Article							ATF1 TRANSCRIPTION FACTOR; HOT-SPOT M26; SCHIZOSACCHAROMYCES-POMBE; PROTEIN-KINASE; HISTONE DEACETYLASE; SEXUAL DEVELOPMENT; MISMATCH REPAIR; DNA-SEQUENCE; MATING-TYPE; ADE6 GENE	Background: Stress-activated protein kinases regulate multiple cellular responses to a wide variety of intracellular and extracellular conditions. The conserved, multifunctional, ATF/CREB protein Atf1 (Mts1, Gad7) of fission yeast binds to CRE-like (M26) DNA sites. Atf1 is phosphorylated by the conserved, p38-family kinase Spc1 (Sty1, Phh1) and is required for many Spc1-dependent stress responses, efficient sexual differentiation, and activation of Rec12 (Spo11)-dependent meiotic recombination hotspots like ade6-M26. Methodology/Principal Findings: We sought to define mechanisms by which Spc1 regulates Atf1 function at the ade6-M26 hotspot. The Spc1 kinase was essential for hotspot activity, but dispensable for basal recombination. Unexpectedly, a protein lacking all eleven MAPK phospho-acceptor sites and detectable phosphorylation (Atf1-11M) was fully proficient for hotspot recombination. Furthermore, tethering of Atf1 to ade6 in the chromosome by a heterologous DNA binding domain bypassed the requirement for Spc1 in promoting recombination. Conclusions/Significance: The Spc1 protein kinase regulates the pathway of Atf1-promoted recombination at or before the point where Atf1 binds to chromosomes, and this pathway regulation is independent of the phosphorylation status of Atf1. Since basal recombination is Spc1-independent, the principal function of the Spc1 kinase in meiotic recombination is to correctly position Atf1-promoted recombination at hotspots along chromosomes. We also propose new hypotheses on regulatory mechanisms for shared (e. g., DNA binding) and distinct (e. g., osmoregulatory vs. recombinogenic) activities of multifunctional, stress-activated protein Atf1.			Gao, J (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	wahlswaynep@uams.edu	GAO, JUN/K-3981-2014		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081766, R01GM062244] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES013787, ES13787] Funding Source: Medline; NIGMS NIH HHS [R01 GM081766, R01 GM062244, GM81766, GM62244] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Davidson MK, 2004, J BIOL CHEM, V279, P50857, DOI 10.1074/jbc.M409079200; Davidson MK, 2004, NUCLEIC ACIDS RES, V32, P4400, DOI 10.1093/nar/gkh767; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Fox ME, 1997, P NATL ACAD SCI USA, V94, P7446, DOI 10.1073/pnas.94.14.7446; Fox ME, 2000, GENETICS, V156, P59; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gao J, 2008, NUCLEIC ACIDS RES, V36, P2838, DOI 10.1093/nar/gkn037; GUTZ H, 1971, GENETICS, V69, P331; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kon N, 1998, MOL CELL BIOL, V18, P7575, DOI 10.1128/MCB.18.12.7575; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Krawchuk MD, 1999, GENETICS, V153, P49; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Mizuno K, 2001, GENETICS, V159, P1467; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Nishant KT, 2006, BIOESSAYS, V28, P45, DOI 10.1002/bies.20349; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Paredes V, 2004, YEAST, V21, P593, DOI 10.1002/yea.1128; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; PONTICELLI AS, 1988, GENETICS, V119, P491; PONTICELLI AS, 1989, GENETICS, V123, P45; Pryce D. W., 2009, V5, P1, DOI 10.1159/000166614; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; Rudolph C, 1999, MOL CELL BIOL, V19, P241; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; SCHAR P, 1993, GENETICS, V133, P825; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; Sharif Wallace D, 2002, Cell Chromosome, V1, P1, DOI 10.1186/1475-9268-1-1; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; Steiner WW, 2005, MOL CELL BIOL, V25, P9054, DOI 10.1128/MCB.25.20.9054-9062.2005; SUNNERHAGEN P, 1993, BIOTECHNIQUES, V14, P18; SZANKASI P, 1988, J MOL BIOL, V204, P917, DOI 10.1016/0022-2836(88)90051-4; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Wahls WP, 1998, CURR TOP DEV BIOL, V37, P37; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yamaguchi Y, 2004, J BIOL CHEM, V279, P15630, DOI 10.1074/jbc.M400355200	57	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5533	10.1371/journal.pone.0005533	http://dx.doi.org/10.1371/journal.pone.0005533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436749	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107300003
J	Berthelemy, N; Kerdjoudj, H; Schaaf, P; Prin-Mathieu, C; Lacolley, P; Stoltz, JF; Voegel, JC; Menu, P				Berthelemy, Nicolas; Kerdjoudj, Halima; Schaaf, Pierre; Prin-Mathieu, Christine; Lacolley, Patrick; Stoltz, Jean-Francois; Voegel, Jean-Claude; Menu, Patrick			O-2 Level Controls Hematopoietic Circulating Progenitor Cells Differentiation into Endothelial or Smooth Muscle Cells	PLOS ONE			English	Article							ENGINEERED BLOOD-VESSELS; HUMAN UMBILICAL ARTERIES; PERIPHERAL-BLOOD; HYPOXIA; TRANSPLANTATION; EXPRESSION; CLONING; GRAFTS; GROWTH; MODEL	Background: Recent studies showed that progenitor cells could differentiate into mature vascular cells. The main physiological factors implicated in cell differentiation are specific growth factors. We hypothesized that simply by varying the oxygen content, progenitor cells can be differentiated either in mature endothelial cells (ECs) or contractile smooth muscle cells (SMCs) while keeping exactly the same culture medium. Methodology/Principal Findings: Mononuclear cells were isolated by density gradient were cultivated under hypoxic (5% O-2) or normoxic (21% O-2) environment. Differentiated cells characterization was performed by confocal microscopy examination and flow cytometry analyses. The phenotype stability over a longer time period was also performed. The morphological examination of the confluent obtained cells after several weeks (between 2 and 4 weeks) showed two distinct morphologies: cobblestone shape in normoxia and a spindle like shape in hypoxia. The cell characterization showed that cobblestone cells were positive to ECs markers while spindle like shape cells were positive to contractile SMCs markers. Moreover, after several further amplification (until 3(rd) passage) in hypoxic or normoxic conditions of the previously differentiated SMC, immunofluorescence studies showed that more than 80% cells continued to express SMCs markers whatever the cell environmental culture conditions with a higher contractile markers expression compared to control (aorta SMCs) signature of phenotype stability. Conclusion/Significance: We demonstrate in this paper that in vitro culture of peripheral blood mononuclear cells with specific angiogenic growth factors under hypoxic conditions leads to SMCs differentiation into a contractile phenotype, signature of their physiological state. Moreover after amplification, the differentiated SMC did not reverse and keep their contractile phenotype after the 3(rd) passage performed under hypoxic and normoxic conditions. These aspects are of the highest importance for tissue engineering strategies. These results highlight also the determinant role of the tissue environment in the differentiation process of vascular progenitor cells.			Berthelemy, N (corresponding author), UHP Nancy 1, Bioengn Grp, CNRS, Fac Med,UMR 7561, Vandoeuvre Les Nancy, France.	patrick.menu@medecine.uhp-nancy.fr	Lacolley, Patrick/G-3118-2013	KERDJOUDJ, Halima/0000-0002-8072-9728				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Babu GJ, 2004, AM J PHYSIOL-CELL PH, V287, pC723, DOI 10.1152/ajpcell.00029.2004; Bach AD, 2003, CLIN PLAST SURG, V30, P589, DOI 10.1016/S0094-1298(03)00077-4; Berthelemy N, 2008, ADV MATER, V20, P2674, DOI 10.1002/adma.200702418; BISSELL MJ, 1987, J CELL SCI, P327; Cha JM, 2006, ARTIF ORGANS, V30, P250, DOI 10.1111/j.1525-1594.2006.00212.x; Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Cramer T, 2004, OSTEOARTHR CARTILAGE, V12, P433, DOI 10.1016/j.joca.2004.02.003; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Davis MJ, 2001, AM J PHYSIOL-HEART C, V280, pH1427, DOI 10.1152/ajpheart.2001.280.4.H1427; FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126; Gerasimovskaya EV, 2008, ANGIOGENESIS, V11, P169, DOI 10.1007/s10456-007-9087-8; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; INGBER DE, 1994, INT REV CYTOL, V150, P173; Kerdjoudj H, 2008, J AM COLL CARDIOL, V52, P1589, DOI 10.1016/j.jacc.2008.08.009; Kerdjoudj H, 2007, ADV FUNCT MATER, V17, P2667, DOI 10.1002/adfm.200600795; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; Liu JY, 2007, CARDIOVASC RES, V75, P618, DOI 10.1016/j.cardiores.2007.04.018; Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417; Mellander S, 2005, EUR J VASC ENDOVASC, V30, P63, DOI 10.1016/j.ejvs.2005.02.051; MEYER D, 1991, MAYO CLIN PROC, V66, P516, DOI 10.1016/S0025-6196(12)62394-5; Muto A, 2007, J VASC SURG, V45, p15A, DOI 10.1016/j.jvs.2007.02.061; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; OWENS GK, 1995, PHYSIOL REV, V75, P487; Payne TR, 2007, J AM COLL CARDIOL, V50, P1677, DOI 10.1016/j.jacc.2007.04.100; Reusch P, 1996, CIRC RES, V79, P1046, DOI 10.1161/01.RES.79.5.1046; ROVNER AS, 1986, J BIOL CHEM, V261, P4740; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Xie SZ, 2008, J ZHEJIANG UNIV-SC B, V9, P923, DOI 10.1631/jzus.B0820257; Yeh ETH, 2003, CIRCULATION, V108, P2070, DOI 10.1161/01.CIR.0000099501.52718.70	38	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5514	10.1371/journal.pone.0005514	http://dx.doi.org/10.1371/journal.pone.0005514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436758	Green Submitted, gold, Green Published			2022-12-27	WOS:000266009900007
J	Tsolis, RM; Seshadri, R; Santos, RL; Sangari, FJ; Lobo, JMG; de Jong, MF; Ren, QH; Myers, G; Brinkac, LM; Nelson, WC; Deboy, RT; Angiuoli, S; Khouri, H; Dimitrov, G; Robinson, JR; Mulligan, S; Walker, RL; Elzer, PE; Hassan, KA; Paulsen, IT				Tsolis, Renee M.; Seshadri, Rekha; Santos, Renato L.; Sangari, Felix J.; Garcia Lobo, Juan M.; de Jong, Maarten F.; Ren, Qinghu; Myers, Garry; Brinkac, Lauren M.; Nelson, William C.; DeBoy, Robert T.; Angiuoli, Samuel; Khouri, Hoda; Dimitrov, George; Robinson, Jeffrey R.; Mulligan, Stephanie; Walker, Richard L.; Elzer, Philip E.; Hassan, Karl A.; Paulsen, Ian T.			Genome Degradation in Brucella ovis Corresponds with Narrowing of Its Host Range and Tissue Tropism	PLOS ONE			English	Article								Brucella ovis is a veterinary pathogen associated with epididymitis in sheep. Despite its genetic similarity to the zoonotic pathogens B. abortus, B. melitensis and B. suis, B. ovis does not cause zoonotic disease. Genomic analysis of the type strain ATCC25840 revealed a high percentage of pseudogenes and increased numbers of transposable elements compared to the zoonotic Brucella species, suggesting that genome degradation has occurred concomitant with narrowing of the host range of B. ovis. The absence of genomic island 2, encoding functions required for lipopolysaccharide biosynthesis, as well as inactivation of genes encoding urease, nutrient uptake and utilization, and outer membrane proteins may be factors contributing to the avirulence of B. ovis for humans. A 26.5 kb region of B. ovis ATCC25840 Chromosome II was absent from all the sequenced human pathogenic Brucella genomes, but was present in all of 17 B. ovis isolates tested and in three B. ceti isolates, suggesting that this DNA region may be of use for differentiating B. ovis from other Brucella spp. This is the first genomic analysis of a non-zoonotic Brucella species. The results suggest that inactivation of genes involved in nutrient acquisition and utilization, cell envelope structure and urease may have played a role in narrowing of the tissue tropism and host range of B. ovis.			Tsolis, RM (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	ipaulsen@cbms.mq.edu.au	Lobo, Juan M Garcia/K-2727-2014; de Lima Santos, Renato/A-1134-2008; Sangari, Félix J/K-9104-2014; Paulsen, Ian T/K-3832-2012; Angiuoli, Samuel V/H-7340-2014; brasileira, Inct Pecuaria/J-9542-2013; Nelson, William C/E-9263-2016; Myers, Garry/E-7708-2011; Hassan, Karl/B-2802-2013	Lobo, Juan M Garcia/0000-0002-9187-0671; de Lima Santos, Renato/0000-0002-4830-0470; Sangari, Félix J/0000-0002-3298-6076; Paulsen, Ian T/0000-0001-9015-9418; Nelson, William C/0000-0002-1873-3929; Angiuoli, Samuel/0000-0001-9525-4350; Myers, Garry/0000-0002-4756-4810; de jong, maarten/0000-0003-2278-286X; Tsolis, Renee/0000-0001-9131-6657; Hassan, Karl/0000-0003-2031-9679	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050553, U01AI049036] Funding Source: NIH RePORTER; NIAID NIH HHS [AI050553, R01 AI050553, 1U01AI49036-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcantara RB, 2004, INFECT IMMUN, V72, P4911, DOI 10.1128/IAI.72.8.4911-4917.2004; Allen CA, 1998, INFECT IMMUN, V66, P1008, DOI 10.1128/IAI.66.3.1008-1016.1998; ANDERSON JD, 1965, J GEN MICROBIOL, V38, P109, DOI 10.1099/00221287-38-1-109; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Bandara AB, 2005, VET MICROBIOL, V109, P95, DOI 10.1016/j.vetmic.2005.05.012; Bandara AB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-57; BIBERSTEIN EL, 1964, CORNELL VET, V54, P27; Blasco J. M., 1990, Animal brucellosis., P351; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Bosse JT, 2000, CAN J VET RES, V64, P145; Brew SD, 1999, VET REC, V144, P483; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; BROWN GM, 1973, CORNELL VET, V63, P29; BUDDLE M. B., 1956, JOUR HYG, V54, P351; BURGESS GW, 1982, VET MICROBIOL, V7, P551, DOI 10.1016/0378-1135(82)90049-9; CARPENTER TE, 1987, J AM VET MED ASSOC, V190, P977; Chain PSG, 2005, INFECT IMMUN, V73, P8353, DOI 10.1128/IAI.73.12.8353-8361.2005; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; DEJONG MF, 2008, MOL MICROBIOL; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Delrue RM, 2001, CELL MICROBIOL, V3, P487, DOI 10.1046/j.1462-5822.2001.00131.x; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; Essenberg RC, 1997, MICROBIOL-UK, V143, P1549, DOI 10.1099/00221287-143-5-1549; EWALT DR, 1994, J VET DIAGN INVEST, V6, P448, DOI 10.1177/104063879400600408; Ficapal A, 1998, SMALL RUMINANT RES, V29, P13, DOI 10.1016/S0921-4488(97)00108-9; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Freer E, 1999, INFECT IMMUN, V67, P6181, DOI 10.1128/IAI.67.11.6181-6186.1999; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Godfroid F, 1998, INFECT IMMUN, V66, P5485, DOI 10.1128/IAI.66.11.5485-5493.1998; Grillo MJ, 1999, VET REC, V144, P555, DOI 10.1136/vr.144.20.555; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; HALLING SM, 1994, MOL MICROBIOL, V14, P681, DOI 10.1111/j.1365-2958.1994.tb01306.x; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Halling SM, 2002, BBA-GENE STRUCT EXPR, V1574, P109, DOI 10.1016/S0167-4781(01)00352-9; Hayes CS, 2003, CELL, V112, P2, DOI 10.1016/S0092-8674(02)01282-5; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Izadjoo MJ, 2004, INFECT IMMUN, V72, P4031, DOI 10.1128/IAI.72.7.4031-4039.2004; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x; Lavigne JP, 2005, INFECT IMMUN, V73, P7779, DOI 10.1128/IAI.73.11.7779-7783.2005; Loisel-Meyer S, 2006, INFECT IMMUN, V74, P1973, DOI 10.1128/IAI.74.3.1973-1976.2006; MAGHALHAES A, 1996, PESQUISA VETERIINARI, V16, P75; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; MARQUIS H, 1993, INFECT IMMUN, V61, P3785, DOI 10.1128/IAI.61.9.3785-3790.1993; Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013; McQuiston JR, 1999, INFECT IMMUN, V67, P3830, DOI 10.1128/IAI.67.8.3830-3835.1999; MEYER ME, 1969, AM J VET RES, V30, P1757; MichauxCharachon S, 1997, J BACTERIOL, V179, P3244, DOI 10.1128/jb.179.10.3244-3249.1997; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; Monir Madkour M., 2001, MADKOURS BRUCELLOSIS; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Myers GSA, 2007, NAT BIOTECHNOL, V25, P569, DOI 10.1038/nbt1302; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; OUAHRANI S, 1993, J GEN MICROBIOL, V139, P3265, DOI 10.1099/00221287-139-12-3265; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004; Robles CA, 1998, VET RES COMMUN, V22, P435, DOI 10.1023/A:1006158514414; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Sangari FJ, 2007, INFECT IMMUN, V75, P774, DOI 10.1128/IAI.01244-06; Sangari FJ, 2000, MICROBIOL-UK, V146, P487, DOI 10.1099/00221287-146-2-487; SERGEANT ESG, 1994, NEW ZEAL VET J, V42, P97, DOI 10.1080/00480169.1994.35795; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; SMITH H, 1962, NATURE, V193, P47, DOI 10.1038/193047a0; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; SPERRY JF, 1975, J BACTERIOL, V124, P391, DOI 10.1128/JB.124.1.391-397.1975; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; TORRES EDN, 1997, VET MEXICO, V28, P241; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; VERGER JM, 1985, INT J SYST BACTERIOL, V35, P292, DOI 10.1099/00207713-35-3-292; Vizcaino N, 1996, INFECT IMMUN, V64, P3744; Vizcaino N, 2004, MICROBES INFECT, V6, P821, DOI 10.1016/j.micinf.2004.04.009; WALKER RL, 1986, J AM VET MED ASSOC, V188, P393; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; Yost CK, 2006, MICROBIOL-SGM, V152, P2061, DOI 10.1099/mic.0.28938-0	82	91	424	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5519	10.1371/journal.pone.0005519	http://dx.doi.org/10.1371/journal.pone.0005519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436743	Green Submitted, Green Published, gold			2022-12-27	WOS:000266009900012
J	Parnas, O; Zipin-Roitman, A; Mazor, Y; Liefshitz, B; Ben-Aroya, S; Kupiec, M				Parnas, Oren; Zipin-Roitman, Adi; Mazor, Yuval; Liefshitz, Batia; Ben-Aroya, Shay; Kupiec, Martin			The Elg1 Clamp Loader Plays a Role in Sister Chromatid Cohesion	PLOS ONE			English	Article								Mutations in the ELG1 gene of yeast lead to genomic instability, manifested in high levels of genetic recombination, chromosome loss, and gross chromosomal rearrangements. Elg1 shows similarity to the large subunit of the Replication Factor C clamp loader, and forms a RFC-like (RLC) complex in conjunction with the 4 small RFC subunits. Two additional RLCs exist in yeast: in one of them the large subunit is Ctf18, and in the other, Rad24. Ctf18 has been characterized as the RLC that functions in sister chromatid cohesion. Here we present evidence that the Elg1 RLC (but not Rad24) also plays an important role in this process. A genetic screen identified the cohesin subunit Mcd1/Scc1 and its loader Scc2 as suppressors of the synthetic lethality between elg1 and ctf4. We describe genetic interactions between ELG1 and genes encoding cohesin subunits and their accessory proteins. We also show that defects in Elg1 lead to higher precocious sister chromatid separation, and that Ctf18 and Elg1 affect cohesion via a joint pathway. Finally, we localize both Ctf18 and Elg1 to chromatin and show that Elg1 plays a role in the recruitment of Ctf18. Our results suggest that Elg1, Ctf4, and Ctf18 may coordinate the relative movement of the replication fork with respect to the cohesin ring.			Parnas, O (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel.	martin@post.tau.ac.il		Mazor, Yuval/0000-0001-5072-0928				Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402; Banerjee S, 2007, BIOCHEM BIOPH RES CO, V362, P546, DOI 10.1016/j.bbrc.2007.07.126; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Ben Aroya S, 2005, DNA REPAIR, V4, P409, DOI 10.1016/j.dnarep.2004.08.003; Ben-Aroya S, 2003, P NATL ACAD SCI USA, V100, P9906, DOI 10.1073/pnas.1633757100; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Hiraga S, 2006, EMBO J, V25, P1505, DOI 10.1038/sj.emboj.7601038; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kim J, 2005, NUCLEIC ACIDS RES, V33, P4078, DOI 10.1093/nar/gki728; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Koren A, 2003, CURR GENET, V43, P62, DOI 10.1007/s00294-003-0373-8; KOUPRINA N, 1994, GENETICS, V138, P1067; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; KOUPRINA NY, 1988, YEAST, V4, P257, DOI 10.1002/yea.320040404; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Liefshitz B, 1998, MUTAT RES-DNA REPAIR, V407, P135, DOI 10.1016/S0921-8777(97)00070-0; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Ogiwara H, 2007, NUCLEIC ACIDS RES, V35, P353, DOI 10.1093/nar/gkl1027; Scholes DT, 2001, GENETICS, V159, P1449; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; Smolikov S, 2004, P NATL ACAD SCI USA, V101, P1656, DOI 10.1073/pnas.0307796100; SPENCER F, 1990, GENETICS, V124, P237; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876	47	54	54	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5497	10.1371/journal.pone.0005497	http://dx.doi.org/10.1371/journal.pone.0005497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430531	Green Submitted, Green Published, gold			2022-12-27	WOS:000266009700003
J	Dalin, P; Kindvall, O; Bjorkman, C				Dalin, Peter; Kindvall, Oskar; Bjorkman, Christer			Reduced Population Control of an Insect Pest in Managed Willow Monocultures	PLOS ONE			English	Article								Background: There is a general belief that insect outbreak risk is higher in plant monocultures than in natural and more diverse habitats, although empirical studies investigating this relationship are lacking. In this study, using density data collected over seven years at 40 study sites, we compare the temporal population variability of the leaf beetle Phratora vulgatissima between willow plantations and natural willow habitats. Methodology/Principal Findings: The study was conducted in 1999-2005. The density of adult P. vulgatissima was estimated in the spring every year by a knock-down sampling technique. We used two measures of population variability, CV and PV, to compare temporal variations in leaf beetle density between plantation and natural habitat. Relationships between density and variability were also analyzed to discern potential underlying processes behind stability in the two systems. The results showed that the leaf beetle P. vulgatissima had a greater temporal population variability and outbreak risk in willow plantations than in natural willow habitats. We hypothesize that the greater population stability observed in the natural habitat was due to two separate processes operating at different levels of beetle density. First, stable low population equilibrium can be achieved by the relatively high density of generalist predators observed in natural stands. Second, stable equilibrium can also be imposed at higher beetle density due to competition, which occurs through depletion of resources (plant foliage) in the natural habitat. In willow plantations, competition is reduced mainly because plants grow close enough for beetle larvae to move to another plant when foliage is consumed. Conclusion/Significance: To our knowledge, this is the first empirical study confirming that insect pest outbreak risk is higher in monocultures. The study suggests that comparative studies of insect population dynamics in different habitats may improve our ability to predict insect pest outbreaks and could facilitate the development of sustainable pest control in managed systems.			Dalin, P (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	dalin@msi.ucsb.edu						Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Bjorkman C, 2006, AGR FOREST ENTOMOL, V8, P97, DOI 10.1111/j.1461-9555.2006.00288.x; Bjorkman C, 2004, ECOL APPL, V14, P1624, DOI 10.1890/03-5341; Bjorkman C, 2003, J INSECT BEHAV, V16, P747, DOI 10.1023/B:JOIR.0000018318.37306.a8; Bjorkman C., 2000, Agricultural and Forest Entomology, V2, P131, DOI 10.1046/j.1461-9563.2000.00058.x; Cumming GS, 2006, BIOL CONSERV, V131, P533, DOI 10.1016/j.biocon.2006.02.025; Dalin P, 2006, B ENTOMOL RES, V96, P629, DOI 10.1017/BER2006465; Dalin P, 2004, AGR FOREST ENTOMOL, V6, P105, DOI 10.1111/j.1461-9555.2004.00211.x; Dalin P, 2003, OECOLOGIA, V134, P112, DOI 10.1007/s00442-002-1093-3; DALIN P, 2004, THESIS SWEDISH U AGR; Dalin P, 2006, ANIM BEHAV, V72, P1025, DOI 10.1016/j.anbehav.2006.02.017; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; DWYER G, 1994, AM NAT, V143, P533, DOI 10.1086/285619; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Heath JP, 2006, OIKOS, V115, P573; JULKUNENTIITTO R, 1986, PHYTOCHEMISTRY, V25, P663, DOI 10.1016/0031-9422(86)88020-7; Lin BB, 2008, BIOSCIENCE, V58, P847, DOI 10.1641/B580911; Liu WC, 2007, THEOR POPUL BIOL, V72, P86, DOI 10.1016/j.tpb.2007.01.002; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Peacock L, 2001, ENTOMOL EXP APPL, V98, P195, DOI 10.1023/A:1018991802435; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roschewitz I, 2005, J APPL ECOL, V42, P873, DOI 10.1111/j.1365-2664.2005.01072.x; Sinclair ARE, 1996, OIKOS, V75, P164, DOI 10.2307/3546240; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Underwood N, 2002, AM NAT, V160, P20, DOI 10.1086/340602; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wilby A, 2002, ECOL LETT, V5, P353, DOI 10.1046/j.1461-0248.2002.00331.x	30	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5487	10.1371/journal.pone.0005487	http://dx.doi.org/10.1371/journal.pone.0005487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424439	Green Published, gold, Green Submitted			2022-12-27	WOS:000265933800017
J	Efeyan, A; Murga, M; Martinez-Pastor, B; Ortega-Molina, A; Soria, R; Collado, M; Fernandez-Capetillo, O; Serrano, M				Efeyan, Alejo; Murga, Matilde; Martinez-Pastor, Barbara; Ortega-Molina, Ana; Soria, Rebeca; Collado, Manuel; Fernandez-Capetillo, Oscar; Serrano, Manuel			Limited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; K-RAS ONCOGENE; ATAXIA-TELANGIECTASIA; P53; ACTIVATION; CANCER; GENE; MYC; TUMORIGENESIS; INDUCTION	Recent studies in human fibroblasts have provided a new general paradigm of tumor suppression according to which oncogenic signaling produces DNA damage and this, in turn, results in ATM/p53-dependent cellular senescence. Here, we have tested this model in a variety of murine experimental systems. Overexpression of oncogenic Ras in murine fibroblasts efficiently induced senescence but this occurred in the absence of detectable DNA damage signaling, thus suggesting a fundamental difference between human and murine cells. Moreover, lung adenomas initiated by endogenous levels of oncogenic K-Ras presented abundant senescent cells, but undetectable DNA damage signaling. Accordingly, K-Ras-driven adenomas were also senescent in Atm-null mice, and the tumorigenic progression of these lesions was only modestly accelerated by Atm-deficiency. Finally, we have examined chemically-induced fibrosarcomas, which possess a persistently activated DNA damage response and are highly sensitive to the activity of p53. We found that the absence of Atm favored genomic instability in the resulting tumors, but did not affect the persistent DNA damage response and did not impair p53-dependent tumor suppression. All together, we conclude that oncogene-induced senescence in mice may occur in the absence of a detectable DNA damage response. Regarding murine Atm, our data suggest that it plays a minor role in oncogene-induced senescence or in p53-dependent tumor suppression, being its tumor suppressive activity probably limited to the maintenance of genomic stability.			Efeyan, A (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid, Spain.	ofernandez@cnio.es; mserrano@cnio.es	Collado, Manuel/K-8140-2014; Serrano, Manuel/H-2634-2015; Efeyan, Alejo/J-8197-2016; Fernandez-Capetillo, Oscar/H-3508-2015; Murga, Matilde/B-3499-2018	Collado, Manuel/0000-0002-0330-0880; Serrano, Manuel/0000-0001-7177-9312; Efeyan, Alejo/0000-0002-3806-6799; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; ORTEGA-MOLINA, ANA/0000-0003-2782-8994	European Research Council [233270] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Bailey SL, 2008, MOL CANCER RES, V6, P1185, DOI 10.1158/1541-7786.MCR-07-2009; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bowen TJ, 2005, CANCER RES, V65, P8736, DOI 10.1158/0008-5472.CAN-05-1598; CARBONE G, 1991, INT J CANCER, V47, P619, DOI 10.1002/ijc.2910470423; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Efeyan A, 2007, CANCER RES, V67, P7350, DOI 10.1158/0008-5472.CAN-07-0200; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; EVA A, 1983, SCIENCE, V220, P955, DOI 10.1126/science.6302839; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Frappart PO, 2006, NEUROMOL MED, V8, P495, DOI 10.1385/NMM:8:4:495; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Kwong LN, 2008, ONCOGENE, V27, P1013, DOI 10.1038/sj.onc.1210708; Liao MJ, 1999, MOL CELL BIOL, V19, P3095; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lu S, 2006, CARCINOGENESIS, V27, P848, DOI 10.1093/carcin/bgi302; Maclean KH, 2007, MOL CANCER RES, V5, P705, DOI 10.1158/1541-7786.MCR-07-0058; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Mavrou A, 2008, ANTICANCER RES, V28, P401; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Shen KC, 2005, CANCER RES, V65, P8747, DOI 10.1158/0008-5472.CAN-05-1471; Shimokado K, 1998, JPN J CANCER RES, V89, P269, DOI 10.1111/j.1349-7006.1998.tb00558.x; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Umesako S, 2005, BREAST CANCER RES, V7, pR164, DOI 10.1186/bcr968; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Watanabe H, 1999, JPN J CANCER RES, V90, P40, DOI 10.1111/j.1349-7006.1999.tb00663.x; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	55	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5475	10.1371/journal.pone.0005475	http://dx.doi.org/10.1371/journal.pone.0005475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421407	Green Submitted, gold, Green Published			2022-12-27	WOS:000265837000009
J	Bayha, E; Jorgensen, MC; Serup, P; Grapin-Botton, A				Bayha, Elke; Jorgensen, Mette C.; Serup, Palle; Grapin-Botton, Anne			Retinoic Acid Signaling Organizes Endodermal Organ Specification along the Entire Antero-Posterior Axis	PLOS ONE			English	Article								Background: Endoderm organ primordia become specified between gastrulation and gut tube folding in Amniotes. Although the requirement for RA signaling for the development of a few individual endoderm organs has been established a systematic assessment of its activity along the entire antero-posterior axis has not been performed in this germ layer. Methodology/Principal Findings: RA is synthesized from gastrulation to somitogenesis in the mesoderm that is close to the developing gut tube. In the branchial arch region specific levels of RA signaling control organ boundaries. The most anterior endoderm forming the thyroid gland is specified in the absence of RA signaling. Increasing RA in anterior branchial arches results in thyroid primordium repression and the induction of more posterior markers such as branchial arch Hox genes. Conversely reducing RA signaling shifts Hox genes posteriorly in endoderm. These results imply that RA acts as a caudalizing factor in a graded manner in pharyngeal endoderm. Posterior foregut and midgut organ primordia also require RA, but exposing endoderm to additional RA is not sufficient to expand these primordia anteriorly. We show that in chick, in contrast to non-Amniotes, RA signaling is not only necessary during gastrulation, but also throughout gut tube folding during somitogenesis. Our results show that the induction of CdxA, a midgut marker, and pancreas induction require direct RA signaling in endoderm. Moreover, communication between CdxA(+) cells is necessary to maintain CdxA expression, therefore synchronizing the cells of the midgut primordium. We further show that the RA pathway acts synergistically with FGF4 in endoderm patterning rather than mediating FGF4 activity. Conclusions/Significance: Our work establishes that retinoic acid (RA) signaling coordinates the position of different endoderm organs along the antero-posterior axis in chick embryos and could serve as a basis for the differentiation of specific endodermal organs from ES cells.			Bayha, E (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland.	anne.grapin-botton@epfl.ch	Jørgensen, Mette/H-9828-2012; Serup, Palle/A-7407-2011	Serup, Palle/0000-0002-0858-590X; Grapin-Botton, Anne/0000-0002-1202-5235				Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Blentic A, 2003, DEV DYNAM, V227, P114, DOI 10.1002/dvdy.10292; Bleul CC, 2005, J IMMUNOL, V175, P5213, DOI 10.4049/jimmunol.175.8.5213; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Burns RC, 2004, DEV BIOL, V265, P61, DOI 10.1016/j.ydbio.2003.09.021; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Charite J, 1998, DEVELOPMENT, V125, P4349; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Couly G, 1998, DEVELOPMENT, V125, P3445; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; EICHELE G, 1987, J CELL BIOL, V105, P1917, DOI 10.1083/jcb.105.4.1917; FRUMKIN A, 1993, DEVELOPMENT, V118, P553; Grapin-Botton A, 2005, INT J DEV BIOL, V49, P335, DOI 10.1387/ijdb.041946ag; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Guris DL, 2006, DEV CELL, V10, P81, DOI 10.1016/j.devcel.2005.12.002; Halilagic A, 2003, DEVELOPMENT, V130, P2039, DOI 10.1242/dev.00423; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kimura W, 2006, DEV BIOL, V289, P283, DOI 10.1016/j.ydbio.2005.09.009; Kochhar DM, 1998, INT J DEV BIOL, V42, P601; Koyama E, 1999, DEV BIOL, V208, P375, DOI 10.1006/dbio.1999.9207; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lawson A, 2003, DEVELOPMENT, V130, P3491, DOI 10.1242/dev.00579; LEDOUARIN N, 1964, B BIOL FRANCE BELGIQ, V98, P543; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Matt N, 2003, DEVELOPMENT, V130, P2083, DOI 10.1242/dev.00428; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; MICHAILLE JJ, 1995, INT J DEV BIOL, V39, P587; MICHAILLE JJ, 1994, DEV DYNAM, V201, P334, DOI 10.1002/aja.1002010405; Min Q, 1998, TEACH LEARN MED, V10, P12, DOI 10.1207/S15328015TLM1001_3; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2003, DEVELOPMENT, V130, P2525, DOI 10.1242/dev.00463; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Pan FC, 2007, MECH DEVELOP, V124, P518, DOI 10.1016/j.mod.2007.06.003; Pera EM, 1998, DEV GENES EVOL, V208, P168, DOI 10.1007/s004270050170; Prinos P, 2001, DEV BIOL, V239, P257, DOI 10.1006/dbio.2001.0446; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Schubert M, 2005, DEVELOPMENT, V132, P61, DOI 10.1242/dev.01554; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wendling O, 2000, DEVELOPMENT, V127, P1553; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yanai M, 2005, DEV DYNAM, V233, P1116, DOI 10.1002/dvdy.20413; YASUGI S, 1993, DEV GROWTH DIFFER, V35, P1; Yatskievych TA, 1999, MECH DEVELOP, V80, P107, DOI 10.1016/S0925-4773(98)00204-4; Zeng X, 1998, J ANAT, V193, P399, DOI 10.1046/j.1469-7580.1998.19330399.x	74	87	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5845	10.1371/journal.pone.0005845	http://dx.doi.org/10.1371/journal.pone.0005845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516907	Green Published, gold, Green Submitted			2022-12-27	WOS:000266872900002
J	Beckman, RA				Beckman, Robert A.			Mutator Mutations Enhance Tumorigenic Efficiency across Fitness Landscapes	PLOS ONE			English	Article							SOMATIC MUTATIONS; HUMAN BREAST; CANCERS; INSTABILITY; SEQUENCES; SELECTION; EVOLUTION	Background: Tumorigenesis requires multiple genetic changes. Mutator mutations are mutations that increase genomic instability, and according to the mutator hypothesis, accelerate tumorigenesis by facilitating oncogenic mutations. Alternatively, repeated lineage selection and expansion without increased mutation frequency may explain observed cancer incidence. Mutator lineages also risk increased deleterious mutations, leading to extinction, thus providing another counterargument to the mutator hypothesis. Both selection and extinction involve changes in lineage fitness, which may be represented as "trajectories'' through a "fitness landscape'' defined by genetics and environment. Methodology/Principal Findings: Here I systematically analyze the relative efficiency of tumorigenesis with and without mutator mutations by evaluating archetypal fitness trajectories using deterministic and stochastic mathematical models. I hypothesize that tumorigenic mechanisms occur clinically in proportion to their relative efficiency. This work quantifies the relative importance of mutator pathways as a function of experimentally measurable parameters, demonstrating that mutator pathways generally enhance efficiency of tumorigenesis. An optimal mutation rate for tumor evolution is derived, and shown to differ from that for species evolution. Conclusions/Significance: The models address the major counterarguments to the mutator hypothesis, confirming that mutator mechanisms are generally more efficient routes to tumorigenesis than non-mutator mechanisms. Mutator mutations are more likely to occur early, and to occur when more oncogenic mutations are required to create a tumor. Mutator mutations likely occur in a minority of premalignant lesions, but these mutator premalignant lesions are disproportionately likely to develop into malignant tumors. Tumor heterogeneity due to mutator mutations may contribute to therapeutic resistance, and the degree of heterogeneity of tumors may need to be considered when therapeutic strategies are devised. The model explains and predicts important biological observations in bacterial and mouse systems, as well as clinical observations.			Beckman, RA (corresponding author), Inst Adv Study, Simons Ctr Syst Biol, Olden Lane, Princeton, NJ 08540 USA.	eniac1@snip.net						ALBERTINI RJ, 1990, ANNU REV GENET, V24, P305; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; BECKMAN RA, 1993, Q REV BIOPHYS, V26, P225, DOI 10.1017/S0033583500002869; Beckman RA, 2005, GENETICS, V171, P2123, DOI 10.1534/genetics.105.040840; Beckman RA, 2005, SEMIN CANCER BIOL, V15, P423, DOI 10.1016/j.semcancer.2005.06.007; Beckman RA, 2006, P NATL ACAD SCI USA, V103, P14140, DOI 10.1073/pnas.0606271103; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Camps M, 2003, P NATL ACAD SCI USA, V100, P9727, DOI 10.1073/pnas.1333928100; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; EIGEN M, 1993, VIRAL QUASISPECIES S, P42; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHER JC, 1958, NATURE, V181, P651, DOI 10.1038/181651b0; GOLDIE JH, 1998, DRUG RESISTANCE CANC; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Komarova NL, 2003, CANCER RES, V63, P6635; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; LOEB LA, 1974, ERRORS DNA REPLICATI, P2311; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Nowak M.A, 2006, EVOLUTIONARY DYNAMIC, P45; Nowak MA, 2004, P NATL ACAD SCI USA, V101, P10635, DOI 10.1073/pnas.0400747101; Nowak MA., 2000, VIRUS DYNAMICS MATH; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; Venkatesan RN, 2007, MOL CELL BIOL, V27, P7669, DOI 10.1128/MCB.00002-07; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	38	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5860	10.1371/journal.pone.0005860	http://dx.doi.org/10.1371/journal.pone.0005860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19517009	Green Submitted, Green Published, gold			2022-12-27	WOS:000266872900011
J	Muh, HC; Tong, JC; Tammi, MT				Muh, Hon Cheng; Tong, Joo Chuan; Tammi, Martti T.			AllerHunter: A SVM-Pairwise System for Assessment of Allergenicity and Allergic Cross-Reactivity in Proteins	PLOS ONE			English	Article								Allergy is a major health problem in industrialized countries. The number of transgenic food crops is growing rapidly creating the need for allergenicity assessment before they are introduced into human food chain. While existing bioinformatic methods have achieved good accuracies for highly conserved sequences, the discrimination of allergens and non-allergens from allergen-like non-allergen sequences remains difficult. We describe AllerHunter, a web-based computational system for the assessment of potential allergenicity and allergic cross-reactivity in proteins. It combines an iterative pairwise sequence similarity encoding scheme with SVM as the discriminating engine. The pairwise vectorization framework allows the system to model essential features in allergens that are involved in cross-reactivity, but not limited to distinct sets of physicochemical properties. The system was rigorously trained and tested using 1,356 known allergen and 13,449 putative non-allergen sequences. Extensive testing was performed for validation of the prediction models. The system is effective for distinguishing allergens and non-allergens from allergen-like non-allergen sequences. Testing results showed that AllerHunter, with a sensitivity of 83.4% and specificity of 96.4% (accuracy = 95.3%, area under the receiver operating characteristic curve AROC = 0.928 +/- 0.004 and Matthew's correlation coefficient MCC = 0.738), performs significantly better than a number of existing methods using an independent dataset of 1443 protein sequences. AllerHunter is available at http://tiger.dbs.nus.edu.sg/AllerHunter			Muh, HC (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	martti.tammi@ki.se						Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bjorklund AK, 2005, BIOINFORMATICS, V21, P39, DOI 10.1093/bioinformatics/bth477; Brusic V, 2003, ALLERGY, V58, P1083, DOI 10.1034/j.1398-9995.2003.00224.x; Casolaro V, 1996, CURR OPIN IMMUNOL, V8, P796, DOI 10.1016/S0952-7915(96)80007-0; Chang C. C., 2004, LIBSVM LIB SUPPORT V; Chua HN, 2005, P APBC, P11; Cox HE, 1999, CLIN GENETIC ASPECTS; Cui J, 2007, MOL IMMUNOL, V44, P514, DOI 10.1016/j.molimm.2006.02.010; DENNIS AB, 2005, NUCLEIC ACIDS RES, V33, pD34; FAO/WHO, 2003, COD PRINC GUID FOODS; Fiers MWEJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-133; Goodman RE, 2005, INT ARCH ALLERGY IMM, V137, P153, DOI 10.1159/000086314; Hileman RE, 2002, INT ARCH ALLERGY IMM, V128, P280, DOI 10.1159/000063861; Ivanciuc O, 2003, NUCLEIC ACIDS RES, V31, P359, DOI 10.1093/nar/gkg010; Joachims T., 1999, ADV KERNEL METHODS S, P42; KING TP, 1994, B WORLD HEALTH ORGAN, V72, P797; Lee YH, 2000, ADV DRUG DELIVER REV, V42, P225, DOI 10.1016/S0169-409X(00)00063-6; Li KB, 2004, BIOINFORMATICS, V20, P2572, DOI 10.1093/bioinformatics/bth286; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Mari A, 2005, J ALLERGY CLIN IMMUN, V115, pS87, DOI DOI 10.1016/j.jaci.2004.12.359; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Silvanovich A, 2006, TOXICOL SCI, V90, P252, DOI 10.1093/toxsci/kfj068; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soeria-Atmadja D, 2004, INT ARCH ALLERGY IMM, V133, P101, DOI 10.1159/000076382; Stadler MB, 2003, FASEB J, V17, P1141, DOI 10.1096/fj.02-1052fje; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Tong JC, 2008, FRONT BIOSCI-LANDMRK, V13, P4882, DOI 10.2741/3047; Vapnik V., 2013, NATURE STAT LAERNING; Vapnik V., 1998, STAT LEARNING THEORY; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Zhang ZH, 2006, CELL IMMUNOL, V244, P90, DOI 10.1016/j.cellimm.2007.01.007; Zorzet Anna, 2002, In Silico Biology, V2, P525	36	72	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5861	10.1371/journal.pone.0005861	http://dx.doi.org/10.1371/journal.pone.0005861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516900	gold, Green Published, Green Submitted			2022-12-27	WOS:000266872900012
J	Perez-Andino, J; Buck, CB; Ribbeck, K				Perez-Andino, Julio; Buck, Christopher B.; Ribbeck, Katharina			Adsorption of Human Papillomavirus 16 to Live Human Sperm	PLOS ONE			English	Article								Human Papillomaviruses (HPVs) are a diverse group of viruses that infect the skin and mucosal tissues of humans. A high-risk subgroup of HPVs is associated with virtually all cases of cervical cancer [1-3]. High-risk HPVs are transmitted sexually; however, the exact mechanisms by which sexual contact promotes virus infection remain uncertain. To study this question we asked whether capsids of HPV type 16 (a high-risk HPV) specifically interact with sperm cells. We tested if purified HPV16 virions directly adsorb to live human sperm cells in native semen and in conditions that resemble the female genital tract. We found that HPV16 capsids bind efficiently to two distinct sites at the equatorial region of the sperm head surface. Moreover, we observed that the interaction of virus with sperm can be reduced by two HPV infection inhibitors, heparin and carrageenan. Our findings suggest that 1) sperm cells may serve as motile carriers that promote virus dispersal and mucosal penetration, and 2) blocking interactions between HPV16 and sperm cells may be an important strategy for the development of antiviral therapies.			Perez-Andino, J (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	kribbeck@cgr.harvard.edu	Buck, Christopher/G-8358-2017	Buck, Christopher/0000-0003-3165-8094	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [P50 GM068763, P50 GM068763-06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aynaud O, 2002, INT J STD AIDS, V13, P547, DOI 10.1258/095646202760159666; BAGASRA O, 1988, J ACQ IMMUN DEF SYND, V1, P431; Bocharova E N, 2007, Dokl Biol Sci, V412, P82, DOI 10.1134/S0012496607010279; Bocharova E N, 2003, Dokl Biol Sci, V391, P379, DOI 10.1023/A:1025179307236; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2007, CURR PROTOC CELL BIO; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; CHAN PJ, 1994, FERTIL STERIL, V61, P982; CHAN PJ, 1995, FERTIL STERIL, V63, P1121, DOI 10.1016/S0015-0282(16)57560-8; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; KIESSLING AA, 1987, P NATL ACAD SCI USA, V84, P8667, DOI 10.1073/pnas.84.23.8667; Kotronias D, 1998, IN VIVO, V12, P391; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Lai YM, 1997, FERTIL STERIL, V67, P1152, DOI 10.1016/S0015-0282(97)81454-9; Lai YM, 1996, FERTIL STERIL, V65, P1026, DOI 10.1016/S0015-0282(16)58281-8; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LOWY DR, 1994, P NATL ACAD SCI USA, V91, P2436, DOI 10.1073/pnas.91.7.2436; MULCAHY D, 1984, SCIENCE, V225, P333, DOI 10.1126/science.6740314; Olatunbosun Olufemi A, 2004, Methods Mol Biol, V253, P95; OSTROW RS, 1986, SCIENCE, V231, P731, DOI 10.1126/science.3003908; Piomboni P, 2000, MOL REPROD DEV, V56, P238, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;238::AID-MRD5&gt;3.0.CO;2-1; Ribbeck K, 2007, CURR BIOL, V17, P230, DOI 10.1016/j.cub.2006.11.050; Sanders NN, 2000, J PHARM SCI-US, V89, P835, DOI 10.1002/1520-6017(200007)89:7<835::AID-JPS1>3.0.CO;2-6; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Schroter S, 1999, HUM REPROD UPDATE, V5, P302, DOI 10.1093/humupd/5.4.302; SCOFIELD V L, 1991, Archives of AIDS Research, V5, P11; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	34	51	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5847	10.1371/journal.pone.0005847	http://dx.doi.org/10.1371/journal.pone.0005847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513123	gold, Green Published, Green Submitted			2022-12-27	WOS:000267228800012
J	Bhowmick, S; Ali, N				Bhowmick, Sudipta; Ali, Nahid			Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis	PLOS ONE			English	Article							MEMBRANE-ASSOCIATED PROTEINS; SUSCEPTIBLE BALB/C MICE; T-CELLS; CUTANEOUS LEISHMANIASIS; EXPRESSION CLONING; MIXED TH1/TH2; DNA VACCINE; IMMUNITY; LIPOSOMES; RESPONSES	Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani is a major public health problem in the developing world. But there is no effective and safe vaccine approved for clinical use against any form of leishmaniasis. Through reactivity with kala-azar patient and cured sera, polypeptides ranging from 91 to 31-kDa from L. donovani promastigotes were previously identified as potential protective vaccine candidates. In this study four polypeptides 91(LD91), 72 (LD72), 51(LD51) and 31 (LD31)-kDa were purified using sodium dodecyl sulfate polyacrylamide gel electrophoresis followed by electroelution. We compared the vaccine efficacy of these antigens encapsulated in cationic liposomes in BALB/c mice against challenge infection with L. donovani. Our results demonstrated that liposomal LD31 (74%-77%) and LD51 (72%-75%) vaccination reduced parasite burden to the greatest degree followed by liposomal LD72 (65%-67%) and LD91 (46%-49%). Analysis of the cytokine responses in immunized mice revealed that all the vaccinated groups produced prechallenge interferon-gamma, interleukin-12 and interleukin-4. Interestingly, the degree of reduction in parasite load could be predicted by the magnitude of the cytokine responses which correlated inversely with the parasite burden both in liver and spleen. The 31, 51 and 72-kDa bands were identified as ATP synthase alpha chain, beta-tubulin and heat shock 70-related protein 1 precursor of L. major, respectively using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF/TOF) mass spectrometry. These three leishmanial antigens have not been described before as successful vaccine candidates examined against in vivo VL model. Thus, these antigens can be potential components of future antileishmaniasis vaccines.			Bhowmick, S (corresponding author), Indian Inst Chem Biol, Div Infect Dis & Immunol, Kolkata, W Bengal, India.	nali@iicb.res.in	bhattacharyya, Anirban/F-6067-2015					AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381; Afrin F, 1998, J PARASITOL, V84, P743, DOI 10.2307/3284581; Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Afrin F, 1997, INFECT IMMUN, V65, P2371, DOI 10.1128/IAI.65.6.2371-2377.1997; Aguilar-Be I, 2005, INFECT IMMUN, V73, P812, DOI 10.1128/IAI.73.2.812-819.2005; Alexander J, 2000, EUR J IMMUNOL, V30, P2935, DOI 10.1002/1521-4141(200010)30:10&lt;2935::AID-IMMU2935&gt;3.0.CO;2-Q; Ashton PD, 2001, TRENDS PARASITOL, V17, P198, DOI 10.1016/S1471-4922(00)01947-4; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhatia A, 1999, MOL BIOCHEM PARASIT, V102, P249, DOI 10.1016/S0166-6851(99)00098-5; Bhowmick S, 2008, EXPERT OPIN DRUG DEL, V5, P789, DOI [10.1517/17425247.5.7.789, 10.1517/17425247.5.7.789 ]; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Campbell M, 2003, INFECT IMMUN, V71, P6270, DOI 10.1128/IAI.71.11.6270-6278.2003; CAMPOSNETO A, 1995, J EXP MED, V182, P1423, DOI 10.1084/jem.182.5.1423; Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; Connolly JP, 2006, PROTEOMICS, V6, P3767, DOI 10.1002/pmic.200500730; DANDREA A, 1995, J EXP MED, V181, P537, DOI 10.1084/jem.181.2.537; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Engwerda CR, 1998, EUR J IMMUNOL, V28, P669, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;669::AID-IMMU669&gt;3.0.CO;2-N; Ghedin E, 1997, CLIN DIAGN LAB IMMUN, V4, P530, DOI 10.1128/CDLI.4.5.530-535.1997; Ghosh A, 2001, VACCINE, V20, P59, DOI 10.1016/S0264-410X(01)00322-X; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jones A, 2006, PROTEOMICS, V6, P259, DOI 10.1002/pmic.200500119; KAMOGAWA Y, 1993, CELL, V75, P985, DOI 10.1016/0092-8674(93)90542-X; KAYE PM, 1991, J IMMUNOL, V146, P2763; KEMP M, 1993, IMMUNOL CELL BIOL, V71, P583, DOI 10.1038/icb.1993.64; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malen H, 2008, PROTEOMICS, V8, P1859, DOI 10.1002/pmic.200700528; Martins DRA, 2006, INFECT IMMUN, V74, P6940, DOI 10.1128/IAI.02032-05; Mazumdar T, 2004, VACCINE, V22, P1162, DOI 10.1016/j.vaccine.2003.09.030; McMahon-Pratt D, 2004, IMMUNOL REV, V201, P206, DOI 10.1111/j.0105-2896.2004.00190.x; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; Mukhopadhyay S, 2000, CLIN DIAGN LAB IMMUN, V7, P233, DOI 10.1128/CDLI.7.2.233-240.2000; Murray HW, 1997, J EXP MED, V185, P867, DOI 10.1084/jem.185.5.867; PLATZER C, 1992, EUR J IMMUNOL, V22, P1179, DOI 10.1002/eji.1830220511; Probst P, 2001, J IMMUNOL, V166, P498, DOI 10.4049/jimmunol.166.1.498; Qazi KR, 2007, VACCINE, V25, P1096, DOI 10.1016/j.vaccine.2006.09.058; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; Rafati S, 2007, VACCINE, V25, P4159, DOI 10.1016/j.vaccine.2007.03.006; Ravindran R, 2004, INFECT IMMUN, V72, P863, DOI 10.1128/IAI.72.2.863-870.2004; Rosenkrands I, 1999, INFECT IMMUN, V67, P5552, DOI 10.1128/IAI.67.11.5552-5558.1999; Rosenzweig D, 2008, PROTEOMICS, V8, P1843, DOI 10.1002/pmic.200701043; SATOH M, 1995, LUPUS, V4, P63, DOI 10.1177/096120339500400113; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; SKEIKY YAW, 1995, INFECT IMMUN, V63, P4105, DOI 10.1128/IAI.63.10.4105-4114.1995; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; STAUBER LA, 1958, J PROTOZOOL, V5, P269, DOI 10.1111/j.1550-7408.1958.tb02565.x; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; Tabatabai LB, 2004, INFECT IMMUN, V72, P1195, DOI 10.1128/IAI.72.2.1195-1198.2004; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; Theinert SM, 2005, INFECT IMMUN, V73, P7018, DOI 10.1128/IAI.73.10.7018-7021.2005	58	44	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5820	10.1371/journal.pone.0005820	http://dx.doi.org/10.1371/journal.pone.0005820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503834	gold, Green Published, Green Submitted			2022-12-27	WOS:000266717200016
J	Laurila, JP; Laatikainen, LE; Castellone, MD; Laukkanen, MO				Laurila, Juha P.; Laatikainen, Lilja E.; Castellone, Maria D.; Laukkanen, Mikko O.			SOD3 Reduces Inflammatory Cell Migration by Regulating Adhesion Molecule and Cytokine Expression	PLOS ONE			English	Article								Inflammatory cell migration characteristic of ischemic damages has a dual role providing the tissue with factors needed for tissue injury recovery simultaneously causing deleterious development depending on the quality and the quantity of infiltrated cells. Extracellular superoxide dismutase (SOD3) has been shown to have an anti-inflammatory role in ischemic injuries where it increases the recovery process by activating mitogen signal transduction and increasing cell proliferation. However, SOD3 derived effects on inflammatory cytokine and adhesion molecule expression, which would explain reduced inflammation in vascular lesions, has not been properly characterized. In the present work the effect of SOD3 on the inflammatory cell extravasation was studied in vivo in rat hind limb ischemia and mouse peritonitis models by identifying the migrated cells and analyzing SOD3-derived response on inflammatory cytokine and adhesion molecule expression. SOD3 overexpression significantly reduced TNF alpha, IL1 alpha, IL6, MIP2, and MCP-1 cytokine and VCAM, ICAM, P-selectin, and E-selectin adhesion molecule expressions in injured tissues. Consequently the mononuclear cell, especially CD68+ monocyte and CD3+ T cell infiltration were significantly decreased whereas granulocyte migration was less affected. According to our data SOD3 has a selective anti-inflammatory role in ischemic damages preventing the migration of reactive oxygen producing monocyte/macrophages, which in excessive amounts could potentially further intensify the tissue injuries therefore suggesting potential for SOD3 in treatment of inflammatory disorders.			Laurila, JP (corresponding author), Univ Turku, Medicity Res Lab, Turku, Finland.	Mikko.Laukkanen@utu.fi	; Laukkanen, Mikko/K-5868-2016	CASTELLONE, MARIADOMENICA/0000-0003-0507-8037; Laukkanen, Mikko/0000-0002-1004-7131				Ali MH, 1999, AM J PHYSIOL-LUNG C, V277, pL1057, DOI 10.1152/ajplung.1999.277.5.L1057; Alom-Ruiz SP, 2008, ANTIOXID REDOX SIGN, V10, P1089, DOI 10.1089/ars.2007.2007; Azevedo LCP, 2000, CARDIOVASC RES, V47, P436, DOI 10.1016/S0008-6363(00)00091-2; Bal MP, 2008, J APPL PHYSIOL, V104, P446, DOI 10.1152/japplphysiol.00951.2007; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Brasen JH, 2007, J AM COLL CARDIOL, V50, P2249, DOI 10.1016/j.jacc.2007.08.038; BULKLEY BH, 1974, AM J MED, V56, P244, DOI 10.1016/0002-9343(74)90603-2; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Chen XL, 2003, J PHARMACOL EXP THER, V305, P573, DOI 10.1124/jpet.102.047894; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; El-Helou V, 2008, J APPL PHYSIOL, V104, P150, DOI 10.1152/japplphysiol.00663.2007; ENTMAN ML, 1992, J CLIN INVEST, V90, P1335, DOI 10.1172/JCI115999; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; EVANS N, 1994, ARCH DIS CHILD-FETAL, V70, pF25, DOI 10.1136/fn.70.1.F25; FAN R, 2002, ADV APPL STAT, V1, P277; Folz RJ, 1999, J CLIN INVEST, V103, P1055, DOI 10.1172/JCI3816; FREY RS, 2008, ANTIOXID REDOX SIGNA; Getting SJ, 1997, BRIT J PHARMACOL, V120, P1075, DOI 10.1038/sj.bjp.0701029; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gu Y, 2002, EXP CELL RES, V272, P62, DOI 10.1006/excr.2001.5404; Hayashi T, 2008, AM J PHYSIOL-HEART C, V294, pH2197, DOI 10.1152/ajpheart.91496.2007; He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001; JOLLY SR, 1986, AM HEART J, V112, P682, DOI 10.1016/0002-8703(86)90461-8; Kirton JP, 2006, CIRC RES, V98, P1264, DOI 10.1161/01.RES.0000223056.68892.8b; KORTHUIS RJ, 1988, AM J PHYSIOL, V254, pH823, DOI 10.1152/ajpheart.1988.254.5.H823; KOZARSKY KF, 1993, CURR OPIN GENET DEV, V3, P499, DOI 10.1016/0959-437X(93)90126-A; Laukkanen MO, 2000, GENE, V254, P173, DOI 10.1016/S0378-1119(00)00272-9; Laukkanen MO, 2002, CIRCULATION, V106, P1999, DOI 10.1161/01.CIR.0000031331.05368.9D; Laukkanen MO, 2001, J GENE MED, V3, P321, DOI 10.1002/jgm.194; Laurila JP, 2009, MOL THER, V17, P448, DOI 10.1038/mt.2008.282; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LIBERMAN R, 1990, DENT MATER, V6, P10, DOI 10.1016/0109-5641(90)90036-E; Lorne E, 2008, AM J PHYSIOL-CELL PH, V294, pC985, DOI 10.1152/ajpcell.00454.2007; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Nehme A, 2008, INVEST OPHTH VIS SCI, V49, P2030, DOI 10.1167/iovs.07-0273; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Paoni NF, 2002, PHYSIOL GENOMICS, V11, P263, DOI 10.1152/physiolgenomics.00110.2002; Patel SS, 1998, CIRCULATION, V97, P75, DOI 10.1161/01.CIR.97.1.75; PATERSON IS, 1989, SURGERY, V106, P224; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Ramos CL, 1999, CIRC RES, V84, P1237, DOI 10.1161/01.RES.84.11.1237; Rocksen D, 2000, CLIN EXP IMMUNOL, V122, P249, DOI 10.1046/j.1365-2249.2000.01373.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEEKAMP A, 1993, AGENT ACTION SUPPL, V41, P137; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; SICA A, 1990, J IMMUNOL, V144, P3034; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; van der Goes A, 2001, FASEB J, V15, P1852, DOI 10.1096/fj.00-0881fje; van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003; WARD PA, 1988, FREE RADICAL BIO MED, V5, P403, DOI 10.1016/0891-5849(88)90114-1; Wei ZH, 1999, CIRC RES, V85, P682, DOI 10.1161/01.RES.85.8.682; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; WIDMER U, 1993, J IMMUNOL, V150, P4996; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244	65	84	87	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5786	10.1371/journal.pone.0005786	http://dx.doi.org/10.1371/journal.pone.0005786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495415	Green Submitted, Green Published, gold			2022-12-27	WOS:000266716900001
J	Moustafa, A; Loram, JE; Hackett, JD; Anderson, DM; Plumley, FG; Bhattacharya, D				Moustafa, Ahmed; Loram, Jeannette E.; Hackett, Jeremiah D.; Anderson, Donald M.; Plumley, F. Gerald; Bhattacharya, Debashish			Origin of Saxitoxin Biosynthetic Genes in Cyanobacteria	PLOS ONE			English	Article							DATABASE; GENOMES; PROTEIN; IDENTIFICATION; PURIFICATION; PHYLOGENIES; SEQUENCES; STRAINS	Background: Paralytic shellfish poisoning (PSP) is a potentially fatal syndrome associated with the consumption of shellfish that have accumulated saxitoxin (STX). STX is produced by microscopic marine dinoflagellate algae. Little is known about the origin and spread of saxitoxin genes in these under-studied eukaryotes. Fortuitously, some freshwater cyanobacteria also produce STX, providing an ideal model for studying its biosynthesis. Here we focus on saxitoxin-producing cyanobacteria and their non-toxic sisters to elucidate the origin of genes involved in the putative STX biosynthetic pathway. Methodology/Principal Findings: We generated a draft genome assembly of the saxitoxin-producing (STX+) cyanobacterium Anabaena circinalis ACBU02 and searched for 26 candidate saxitoxin-genes (named sxtA to sxtZ) that were recently identified in the toxic strain Cylindrospermopsis raciborskii T3. We also generated a draft assembly of the nontoxic (STX2) sister Anabaena circinalis ACFR02 to aid the identification of saxitoxin-specific genes. Comparative phylogenomic analyses revealed that nine putative STX genes were horizontally transferred from non-cyanobacterial sources, whereas one key gene (sxtA) originated in STX+ cyanobacteria via two independent horizontal transfers followed by fusion. In total, of the 26 candidate saxitoxin-genes, 13 are of cyanobacterial provenance and are monophyletic among the STX+ taxa, four are shared amongst STX+ and STX-cyanobacteria, and the remaining nine genes are specific to STX+ cyanobacteria. Conclusions/Significance: Our results provide evidence that the assembly of STX genes in ACBU02 involved multiple HGT events from different sources followed presumably by coordination of the expression of foreign and native genes in the common ancestor of STX+ cyanobacteria. The ability to produce saxitoxin was subsequently lost multiple independent times resulting in a nested relationship of STX+ and STX2 strains among Anabaena circinalis strains.			Moustafa, A (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	debashi-bhattacharya@uiowa.edu	Moustafa, Ahmed/AAZ-3991-2020; Moustafa, Ahmed/C-5234-2009	Moustafa, Ahmed/0000-0002-0111-3555; Moustafa, Ahmed/0000-0002-0111-3555	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012742, R01ES013679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629, R01GM098629] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES013679-01A2, R01 ES013679, P50 ES012742] Funding Source: Medline; NIGMS NIH HHS [T32 GM98629, T32 GM008629, R01 GM098629] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Beltran EC, 2000, APPL ENVIRON MICROB, V66, P4468, DOI 10.1128/AEM.66.10.4468-4474.2000; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bolch CJS, 1996, J APPL PHYCOL, V8, P5, DOI 10.1007/BF02186215; Carmichael WW, 1997, APPL ENVIRON MICROB, V63, P3104, DOI 10.1128/AEM.63.8.3104-3110.1997; Chorus I., 1999, Toxic cyanobacteria in water: a guide to their public health consequences, monitoring and management; Christiansen G, 2008, MOL BIOL EVOL, V25, P1695, DOI 10.1093/molbev/msn120; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; HAWSER SP, 1991, TOXICON, V29, P277, DOI 10.1016/0041-0101(91)90231-F; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Kellmann R, 2007, J PHYCOL, V43, P497, DOI 10.1111/j.1529-8817.2007.00351.x; Kim JS, 1999, J PHYCOL, V35, P865, DOI 10.1046/j.1529-8817.1999.3540865.x; KROHN A, 2005, GENOME ANAL SAXITOXI; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; MOUSTAFA A, 2008, EASYCLUSTER SIMPLE P; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nguyen TT, 2008, BIOCHEMISTRY-US, V47, P1194, DOI 10.1021/bi7017738; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; Plumley FG, 2001, J PHYCOL, V37, P926; Pomati F, 2004, APPL ENVIRON MICROB, V70, P4711, DOI 10.1128/AEM.70.8.4711-4719.2004; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Sako Y, 2001, J PHYCOL, V37, P1044, DOI 10.1046/j.1529-8817.2001.00119.x; SHIMIZU Y, 1984, J AM CHEM SOC, V106, P6433, DOI 10.1021/ja00333a062; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Taroncher-Oldenburg G, 2000, APPL ENVIRON MICROB, V66, P2105, DOI 10.1128/AEM.66.5.2105-2112.2000; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; URIBE P, 2008, MAR BIOTECHNOL NY; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WILSON K, 1990, CURRENT PROTOCOLS MO; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306; RAPID ANNOTATION USI	40	95	97	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5758	10.1371/journal.pone.0005758	http://dx.doi.org/10.1371/journal.pone.0005758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484122	gold, Green Submitted, Green Published			2022-12-27	WOS:000266528200011
J	Wiswede, D; Munte, TF; Kramer, UM; Russeler, J				Wiswede, Daniel; Muente, Thomas F.; Kraemer, Ulrike M.; Ruesseler, Jascha			Embodied Emotion Modulates Neural Signature of Performance Monitoring	PLOS ONE			English	Article							FACIAL FEEDBACK HYPOTHESIS; ERROR-RELATED NEGATIVITY; POSITIVE AFFECT; COGNITIVE CONTROL; DOPAMINE NEURONS; FRONTAL-CORTEX; BRAIN ACTIVITY; REWARD; SYSTEM; PREDICTION	Background: Recent research on the "embodiment of emotion'' implies that experiencing an emotion may involve perceptual, somatovisceral, and motor feedback aspects. For example, manipulations of facial expression and posture appear to induce emotional states and influence how affective information is processed. The present study investigates whether performance monitoring, a cognitive process known to be under heavy control of the dopaminergic system, is modulated by induced facial expressions. In particular, we focused on the error-related negativity, an electrophysiological correlate of performance monitoring. Methods/Principal Findings: During a choice reaction task, participants held a Chinese chop stick either horizontally between the teeth ("smile'' condition) or, in different runs, vertically ("no smile'') with the upper lip. In a third control condition, no chop stick was used ("no stick''). It could be shown on a separate sample that the facial feedback procedure is feasible to induce mild changes in positive affect. In the ERP sample, the smile condition, hypothesized to lead to an increase in dopaminergic activity, was associated with a decrease of ERN amplitude relative to "no smile'' and "no stick'' conditions. Conclusion: Embodying emotions by induced facial expressions leads to a changes in the neural correlates of error detection. We suggest that this is due to the joint influence of the dopaminergic system on positive affect and performance monitoring.			Wiswede, D (corresponding author), Otto VonGuericke Univ Magdegurg, Dept Neuropsychol, D-39016 Magdeburg, Germany.	Thomas.Muente@med.ovgu.de	Krämer, Ulrike/AAF-2966-2020; Krämer, Ulrike M./A-8871-2019; Münte, Thomas/C-2077-2014	Krämer, Ulrike M./0000-0002-3841-1812; Wiswede, Daniel/0000-0002-2702-8316; Russeler, Jascha/0000-0002-5053-5914				Ashby F. G., 2002, EMOTIONAL COGNITION, P245, DOI [DOI 10.1075/AICR.44.11ASH, 10.1075/aicr.44.11ash]; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Ashby FG, 2003, NEURAL NETWORKS, V16, P973, DOI 10.1016/S0893-6080(03)00051-0; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Debus G., 1978, EIGENSCHAFTSWORTERLI; Dreisbach G, 2004, J EXP PSYCHOL LEARN, V30, P343, DOI 10.1037/0278-7393.30.2.343; Dreisbach G, 2006, BRAIN COGNITION, V60, P11, DOI 10.1016/j.bandc.2005.08.003; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8986.2005.00270.x; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Hajcak G, 2003, BIOL PSYCHOL, V64, P77, DOI 10.1016/S0301-0511(03)00103-0; Hajcak G, 2002, PSYCHIAT RES, V110, P63, DOI 10.1016/S0165-1781(02)00034-3; Havas DA, 2007, PSYCHON B REV, V14, P436, DOI 10.3758/BF03194085; HESS U, 1992, INT J PSYCHOPHYSIOL, V12, P251, DOI 10.1016/0167-8760(92)90064-I; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Isen AM, 2001, J CONSUM PSYCHOL, V11, P75, DOI 10.1207/S15327663JCP1102_01; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; JANKE W, 1996, INT SKALEN PSYCHIAT, P43; Johannes S, 2001, PSYCHOPHARMACOLOGY, V155, P100, DOI 10.1007/s002130100680; Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1111/j.1469-8986.2003.00141.x; Lange CG., 1912, CLASSICAL PSYCHOL, P672; Lee AY, 1999, J CONSUM RES, V26, P115, DOI 10.1086/209554; MATSUMOTO D, 1987, J PERS SOC PSYCHOL, V52, P769, DOI 10.1037/0022-3514.52.4.769; MCCANNE TR, 1987, J PERS SOC PSYCHOL, V52, P759, DOI 10.1037/0022-3514.52.4.759; McIntosh DN, 1996, MOTIV EMOTION, V20, P121, DOI 10.1007/BF02253868; Munte TF, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.011.2007; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; OHIRA H, 1993, PERCEPT MOTOR SKILL, V77, P1251, DOI 10.2466/pms.1993.77.3f.1251; Rabbit P.M.A., 1981, HUMAN SKILLS, P153; Rabbitt P, 2002, Q J EXP PSYCHOL-A, V55, P1081, DOI 10.1080/02724980244000080; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; SCHWARTZ GE, 1980, PSYCHOPHYSIOLOGY, V17, P75, DOI 10.1111/j.1469-8986.1980.tb02463.x; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; Tobler PN, 2003, J NEUROSCI, V23, P10402; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Weber CS, 2007, SCAND J PSYCHOL, V48, P459, DOI 10.1111/j.1467-9450.2007.00612.x; WISWEDE D, 2007, EMOTIONAL MODULATION; Wiswede D, 2009, NEUROPSYCHOLOGIA, V47, P83, DOI 10.1016/j.neuropsychologia.2008.08.016; ZUCKERMAN M, 1981, J PERS SOC PSYCHOL, V41, P929, DOI 10.1037/0022-3514.41.5.929	53	37	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5754	10.1371/journal.pone.0005754	http://dx.doi.org/10.1371/journal.pone.0005754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	452GL	19484132	Green Published, gold, Green Submitted			2022-12-27	WOS:000266528200007
J	Li, H; Wang, DM; Singh, LS; Berk, M; Tan, HY; Zhao, ZW; Steinmetz, R; Kirmani, K; Wei, G; Xu, Y				Li, Hui; Wang, Dongmei; Singh, Lisam Shanjukumar; Berk, Michael; Tan, Haiyan; Zhao, Zhenwen; Steinmetz, Rosemary; Kirmani, Kashif; Wei, Gang; Xu, Yan			Abnormalities in Osteoclastogenesis and Decreased Tumorigenesis in Mice Deficient for Ovarian Cancer G Protein-Coupled Receptor 1	PLOS ONE			English	Article								Ovarian cancer G protein-coupled receptor 1 (OGR1) has been shown to be a proton sensing receptor in vitro. We have shown that OGR1 functions as a tumor metastasis suppressor gene when it is over-expressed in human prostate cancer cells in vivo. To examine the physiological functions of OGR1, we generated conditional OGR1 deficient mice by homologous recombination. OGR1 deficient mice were viable and upon gross-inspection appeared normal. Consistent with in vitro studies showing that OGR1 is involved in osteoclastogenesis, reduced osteoclasts were detected in OGR1 deficient mice. A pH-dependent osteoclasts survival effect was also observed. However, overall abnormality in the bones of these animals was not observed. In addition, melanoma cell tumorigenesis was significantly inhibited in OGR1 deficient mice. OGR1 deficient mice in the mixed background produced significantly less peritoneal macrophages when stimulated with thioglycolate. These macrophages also showed altered extracellular signal-regulated kinases (ERK) activation and nitric oxide (NO) production in response to lipopolysaccharide. OGR1-dependent pH responses assessed by cAMP production and cell survival in macrophages or brown fat cells were not observed, presumably due to the presence of other proton sensing receptors in these cells. Our results indicate that OGR1's role in osteoclastogenesis is not strong enough to affect overall bone development and its role in tumorigenesis warrants further investigation. The mice generated can be potentially used for several disease models, including cancers or osteoclast-related diseases.			Li, H (corresponding author), Indiana Univ, Sch Med, Dept Obstet & Gynecol, Ctr Canc, Indianapolis, IN 46202 USA.	xu2@iupui.edu	Berk, Michael/M-3585-2019; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946	NATIONAL CANCER INSTITUTE [R01CA089228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068804] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA89228, R01 CA089228] Funding Source: Medline; NHLBI NIH HHS [R01 HL68804, R01 HL068804] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AN SZ, 1995, FEBS LETT, V375, P121, DOI 10.1016/0014-5793(95)01196-L; Bolick DT, 2007, CIRC RES, V100, P572, DOI 10.1161/01.RES.0000258877.57836.d2; Giordano Antonio, 2008, V456, P83, DOI 10.1007/978-1-59745-245-8_6; Im DS, 2005, ACTA PHARMACOL SIN, V26, P1435, DOI 10.1111/j.1745-7254.2005.00237.x; Im DS, 2001, J CELL BIOL, V153, P429, DOI 10.1083/jcb.153.2.429; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; IWAI K, 2007, J BONE MINER RES; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Johnson LE, 2008, HEPATOLOGY, V48, P1138, DOI 10.1002/hep.22433; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Mogi C, 2005, J PHARMACOL SCI, V99, P160, DOI 10.1254/jphs.FP0050599; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Nardin A, 2008, FRONT BIOSCI-LANDMRK, V13, P3494; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Parks BW, 2009, ARTERIOSCL THROM VAS, V29, P539, DOI 10.1161/ATVBAHA.108.179937; Parks BW, 2005, J LIPID RES, V46, P1405, DOI 10.1194/jlr.M500085-JLR200; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Radu CG, 2006, MOL CELL BIOL, V26, P668, DOI 10.1128/MCB.26.2.668-677.2006; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; SCHREIBER RD, 1982, J EXP MED, V156, P677, DOI 10.1084/jem.156.3.677; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Soler C, 2001, J BIOL CHEM, V276, P30043, DOI 10.1074/jbc.M101807200; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; TOMURA H, 2008, J BONE MINER RES; Tosa N, 2003, INT IMMUNOL, V15, P741, DOI 10.1093/intimm/dxg070; Valverde AM, 2005, MINI-REV MED CHEM, V5, P269, DOI 10.2174/1389557053175380; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Warden CH, 2004, MAMM GENOME, V15, P460, DOI 10.1007/s00335-004-2353-9; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Xu Y, 1996, GENOMICS, V35, P397, DOI 10.1006/geno.1996.0377; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200	37	61	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5705	10.1371/journal.pone.0005705	http://dx.doi.org/10.1371/journal.pone.0005705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479052	Green Published, gold			2022-12-27	WOS:000266415100008
J	Yordanova, J; Kolev, V; Wagner, U; Verleger, R				Yordanova, Juliana; Kolev, Vasil; Wagner, Ullrich; Verleger, Rolf			Covert Reorganization of Implicit Task Representations by Slow Wave Sleep	PLOS ONE			English	Article							LONG-TERM-MEMORY; LATE-NIGHT SLEEP; BRAIN POTENTIALS; CONSOLIDATION; INFORMATION; RETRIEVAL; HIPPOCAMPUS; AWARENESS; HUMANS; SYSTEM	Background: There is evidence that slow wave sleep (SWS) promotes the consolidation of memories that are subserved by mediotemporal- and hippocampo-cortical neural networks. In contrast to implicit memories, explicit memories are accompanied by conscious (attentive and controlled) processing. Awareness at pre-sleep encoding has been recognized as critical for the off-line memory consolidation. The present study elucidated the role of task-dependent cortical activation guided by attentional control at pre-sleep encoding for the consolidation of hippocampus-dependent memories during sleep. Methodology: A task with a hidden regularity was used (Number Reduction Task, NRT), in which the responses that can be implicitly predicted by the hidden regularity activate hippocampo-cortical networks more strongly than responses that cannot be predicted. Task performance was evaluated before and after early-night sleep, rich in SWS, and late-night sleep, rich in rapid eye movement (REM) sleep. In implicit conditions, slow cortical potentials (SPs) were analyzed to reflect the amount of controlled processing and the localization of activated neural task representations. Principal Findings: During implicit learning before sleep, the amount of controlled processing did not differ between unpredictable and predictable responses, nor between early-and late-night sleep groups. A topographic re-distribution of SPs indicating a spatial reorganization occurred only after early, not after late sleep, and only for predictable responses. These SP changes correlated with the amount of SWS and were covert because off-line RT decrease did not differentiate response types or sleep groups. Conclusions: It is concluded that SWS promotes the neural reorganization of task representations that rely on the hippocampal system despite absence of conscious access to these representations.			Yordanova, J (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	jyord@gmx.net	Yordanova, Juliana/I-4690-2014; Kolev, Vasil/B-4595-2008	Yordanova, Juliana/0000-0003-4500-1122; Kolev, Vasil/0000-0002-2694-2149; Lauwereyns, Jan/0000-0003-0551-2550				Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Drosopoulos S, 2005, LEARN MEMORY, V12, P44, DOI 10.1101/lm.83805; Elsner B, 2002, NEUROIMAGE, V17, P364, DOI 10.1006/nimg.2002.1162; Fischer S, 2006, J COGNITIVE NEUROSCI, V18, P311, DOI 10.1162/089892906775990598; Forkstam C, 2005, CURR OPIN NEUROL, V18, P435, DOI 10.1097/01.wco.0000171951.82995.c4; Frensch PA, 2002, ATTENTION IMPLICIT L, P335; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Greene AJ, 2007, HIPPOCAMPUS, V17, P429, DOI 10.1002/hipo.20296; Haider H, 2007, METHODS, V42, P49, DOI 10.1016/j.ymeth.2006.12.004; Heil M, 1997, NEUROSCI LETT, V222, P45, DOI 10.1016/S0304-3940(97)13338-9; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Khader P, 2005, NEUROIMAGE, V27, P805, DOI 10.1016/j.neuroimage.2005.05.006; Khader P, 2007, J COGNITIVE NEUROSCI, V19, P493, DOI 10.1162/jocn.2007.19.3.493; LANG S, 2006, J COGNITIVE NEUROSCI, V18, P1; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; REBER PJ, 1994, LEARN MEMORY, V1, P217; Rechtschaffen A, 1968, NIH PUBL, V204; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Rockstroh B., 1989, SLOW CORTICAL POTENT; Rose M, 2005, J COGNITIVE NEUROSCI, V17, P918, DOI 10.1162/0898929054021193; Rose M, 2004, LEARN MEMORY, V11, P145, DOI 10.1101/lm.67204; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; ROSLER F, 1995, J COGNITIVE NEUROSCI, V7, P51, DOI 10.1162/jocn.1995.7.1.51; Rosler F, 1997, BIOL PSYCHOL, V45, P109, DOI 10.1016/S0301-0511(96)05225-8; RUCHKIN DS, 1988, HUMAN EVENT RELATED, V3, P7; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Verleger R, 2008, BRAIN COGNITION, V68, P180, DOI 10.1016/j.bandc.2008.04.006; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Woltz DJ, 1996, J EXP PSYCHOL LEARN, V22, P438, DOI 10.1037/0278-7393.22.2.438; Yeshenko O, 2006, J SLEEP RES, V15, P11; Yordanova J, 2008, LEARN MEMORY, V15, P508, DOI 10.1101/lm.897908	53	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5675	10.1371/journal.pone.0005675	http://dx.doi.org/10.1371/journal.pone.0005675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	449LI	19479080	gold, Green Submitted, Green Published			2022-12-27	WOS:000266331700004
J	Israel, S; Lerer, E; Shalev, I; Uzefovsky, F; Riebold, M; Laiba, E; Bachner-Melman, R; Maril, A; Bornstein, G; Knafo, A; Ebstein, RP				Israel, Salomon; Lerer, Elad; Shalev, Idan; Uzefovsky, Florina; Riebold, Mathias; Laiba, Efrat; Bachner-Melman, Rachel; Maril, Anat; Bornstein, Gary; Knafo, Ariel; Ebstein, Richard P.			The Oxytocin Receptor (OXTR) Contributes to Prosocial Fund Allocations in the Dictator Game and the Social Value Orientations Task	PLOS ONE			English	Article							NEURAL CIRCUITRY; UNIFIED APPROACH; GENE OXTR; VASOPRESSIN; ASSOCIATION; BEHAVIOR; AUTISM; AVPR1A; TESTS; TRUST	Background: Economic games observe social decision making in the laboratory that involves real money payoffs. Previously we have shown that allocation of funds in the Dictator Game (DG), a paradigm that illustrates costly altruistic behavior, is partially determined by promoter-region repeat region variants in the arginine vasopressin 1a receptor gene (AVPR1a). In the current investigation, the gene encoding the related oxytocin receptor (OXTR) was tested for association with the DG and a related paradigm, the Social Values Orientation (SVO) task. Methodology/Principal Findings: Association (101 male and 102 female students) using a robust-family based test between 15 single tagging SNPs (htSNPs) across the OXTR was demonstrated with both the DG and SVO. Three htSNPs across the gene region showed significant association with both of the two games. The most significant association was observed with rs1042778 (p = 0.001). Haplotype analysis also showed significant associations for both DG and SVO. Following permutation test adjustment, significance was observed for 2-5 locus haplotypes (p < 0.05). A second sample of 98 female subjects was subsequently and independently recruited to play the dictator game and was genotyped for the three significant SNPs found in the first sample. The rs1042778 SNP was shown to be significant for the second sample as well (p = 0.004, Fisher's exact test). Conclusions: The demonstration that genetic polymorphisms for the OXTR are associated with human prosocial decision making converges with a large body of animal research showing that oxytocin is an important social hormone across vertebrates including Homo sapiens. Individual differences in prosocial behavior have been shown by twin studies to have a substantial genetic basis and the current investigation demonstrates that common variants in the oxytocin receptor gene, an important element of mammalian social circuitry, underlie such individual differences.			Israel, S (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	rpebstein@gmail.com	Bachner-Melman, Rachel/AAD-9411-2019; Shalev, Idan/H-1943-2011; Knafo-Noam, Ariel/E-8067-2011	Bachner-Melman, Rachel/0000-0002-8840-2914; Knafo-Noam, Ariel/0000-0003-0613-1960; Uzefovsky, Florina/0000-0003-4571-2514; Israel, Salomon/0000-0003-3629-2466; Ebstein, Richard/0000-0002-3626-541X				Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bachner-Melman R, 2005, MOL PSYCHIATR, V10, P333, DOI 10.1038/sj.mp.4001635; Bachner-Melman R, 2004, INT J EAT DISORDER, V36, P451, DOI 10.1002/eat.20049; Bachner-Melman R., 2005, J INDIVID DIFFER, V26, P2, DOI DOI 10.1027/1614-0001.26.1.2; Bales KL, 2004, HORM BEHAV, V45, P354, DOI 10.1016/j.yhbeh.2004.01.004; Barberis C, 1998, J ENDOCRINOL, V156, P223, DOI 10.1677/joe.0.1560223; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartz JA, 2006, HORM BEHAV, V50, P518, DOI 10.1016/j.yhbeh.2006.06.018; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; Blanks AM, 2007, SEMIN REPROD MED, V25, P52, DOI 10.1055/s-2006-956775; BOSSMAR T, 1995, BRIT J OBSTET GYNAEC, V102, P907, DOI 10.1111/j.1471-0528.1995.tb10880.x; Carter CS, 1998, PSYCHONEUROENDOCRINO, V23, P779; Carter CS, 2006, BEHAV BRAIN RES; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Domes G, 2006, BIOL PSYCHIAT; Domes G, 2007, BIOL PSYCHIAT, V62, P1187, DOI 10.1016/j.biopsych.2007.03.025; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Eckel CC, 1996, GAME ECON BEHAV, V16, P181, DOI 10.1006/game.1996.0081; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gordon I., 2008, PSYCHOPHYSIOLOGY; GRANOT R, 2007, EVOLUTION H IN PRESS; Guastella A.J., 2007, BIOL PSYCHIAT; Halldorsson BV, 2004, HUM HERED, V58, P190, DOI 10.1159/000083546; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hirasawa M, 2003, J NEUROSCI, V23, P4270; Hollander E, 2007, BIOL PSYCHIAT, V61, P498, DOI 10.1016/j.biopsych.2006.05.030; ISRAEL S, 2008, PROG BRAIN IN PRESS; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Knafo A, 2006, J PERS SOC PSYCHOL, V90, P147, DOI 10.1037/0022-3514.90.1.147; KNAFO A, ANN NEW YOR IN PRESS; KNAFO A, 2007, GENES BRAIN BEHAV; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Koeleman BPC, 2000, ANN HUM GENET, V64, P207, DOI 10.1017/S0003480000008095; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; LOEWENSTEIN G, 2007, ANN REV PSYCHOL; Meinlschmidt G, 2007, BIOL PSYCHIAT, V61, P1109, DOI 10.1016/j.biopsych.2006.09.007; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Pedersen CA, 2006, NEUROSCIENCE, V139, P843, DOI 10.1016/j.neuroscience.2006.01.002; PRICHARD ZM, 2007, ONLINE HUM MUTAT, V28, P1150; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Ragnauth AK, 2004, NEUROENDOCRINOLOGY, V80, P92, DOI 10.1159/000081844; Savaskan E., 2008, PSYCHONEUROENDOCRINO; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; STEEN KV, 2005, HUM GENOMICS, V2, P67; Storm EE, 2005, NEURON, V47, P483, DOI 10.1016/j.neuron.2005.08.004; Thompson R, 2004, PSYCHONEUROENDOCRINO, V29, P35, DOI 10.1016/S0306-4530(02)00133-6; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yirmiya N, 2006, MOL PSYCHIATR, V11, P488, DOI 10.1038/sj.mp.4001812; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zak PJ, 2006, ECON HUM BIOL, V4, P412, DOI 10.1016/j.ehb.2006.06.004; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	67	189	198	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5535	10.1371/journal.pone.0005535	http://dx.doi.org/10.1371/journal.pone.0005535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448AY	19461999	Green Published, gold, Green Submitted			2022-12-27	WOS:000266234700002
J	Long, EM; Millen, B; Kubes, P; Robbins, SM				Long, Elizabeth M.; Millen, Brandie; Kubes, Paul; Robbins, Stephen M.			Lipoteichoic Acid Induces Unique Inflammatory Responses when Compared to Other Toll-Like Receptor 2 Ligands	PLOS ONE			English	Article								Toll-like receptors (TLRs) recognize evolutionarily-conserved molecular patterns originating from invading microbes. In this study, we were interested in determining if microbial ligands, which use distinct TLR2-containing receptor complexes, represent unique signals to the cell and can thereby stimulate unique cellular responses. Using the TLR2 ligands, R-FSL1, S-FSL1, Pam2CSK4, Pam3CSK4, and lipoteichoic acid (LTA), we demonstrate that these ligands activate NF-kappa B and MAP Kinase pathways with ligand-specific differential kinetics in murine macrophages. Most strikingly, LTA stimulation of these pathways was substantially delayed when compared with the other TLR2 ligands. These kinetics differences were associated with a delay in the LTA-induced expression of a subset of genes as compared with another TLR2 ligand, R-FSL1. However, this did not translate to overall differences in gene expression patterns four hours following stimulation with different TLR2 ligands. We extended this study to evaluate the in vivo responses to distinct TLR2 ligands using a murine model of acute inflammation, which employs intravital microscopy to monitor leukocyte recruitment into the cremaster muscle. We found that, although R-FSL1, S-FSL1, Pam2CSK4, and Pam3CSK4 were all able to stimulate robust leukocyte recruitment in vivo, LTA remained functionally inert in this in vivo model. Therefore distinct TLR2 ligands elicit unique cellular responses, as evidenced by differences in the kinetic profiles of signaling and gene expression responses in vitro, as well as the physiologically relevant differences in the in vivo responses to these ligands.			Long, EM (corresponding author), Univ Calgary, Dept Oncol, Calgary, AB, Canada.	srobbins@ucalgary.ca		Robbins, Stephen/0000-0001-7475-1665				Albrecht I, 2004, EMBO REP, V5, P172, DOI 10.1038/sj.embor.7400078; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bisson SA, 2002, ONCOGENE, V21, P3677, DOI 10.1038/sj.onc.1205510; BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; Dessing MC, 2008, J INFECT DIS, V197, P245, DOI 10.1086/524873; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kanwar S, 1997, J EXP MED, V185, P1077, DOI 10.1084/jem.185.6.1077; Kruithof EKO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-148; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; O'Neill L A, 2000, Sci STKE, V2000, pre1; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Takeda K, 2002, J ENDOTOXIN RES, V8, P459, DOI 10.1179/096805102125001073; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Uematsu Satoshi, 2008, V183, P1; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Yipp BG, 2002, J IMMUNOL, V168, P4650, DOI 10.4049/jimmunol.168.9.4650	30	44	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5601	10.1371/journal.pone.0005601	http://dx.doi.org/10.1371/journal.pone.0005601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440307	Green Submitted, Green Published, gold			2022-12-27	WOS:000266161200004
J	Lu, JY; Jeong, H; Kong, N; Yang, YY; Carroll, J; Luo, HBR; Silberstein, LE; Ma, YP; Chai, L				Lu, Jiayun; Jeong, Hawon; Kong, Nikki; Yang, Youyang; Carroll, John; Luo, Hongbo R.; Silberstein, Leslie E.; Ma, Yupo; Chai, Li			Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex	PLOS ONE			English	Article								Background: The embryonic stem cell (ESC) factor, SALL4, plays an essential role in both development and leukemogenesis. It is a unique gene that is involved in self-renewal in ESC and leukemic stem cell (LSC). Methodology/Principal Findings: To understand the mechanism(s) of SALL4 function(s), we sought to identify SALL4-associated proteins by tandem mass spectrometry. Components of a transcription repressor Mi-2/Nucleosome Remodeling and Deacetylase (NuRD) complex were found in the SALL4-immunocomplexes with histone deacetylase (HDAC) activity in ESCs with endogenous SALL4 expression and 293T cells overexpressing SALL4. The SALL4-mediated transcriptional regulation was tested on two potential target genes: PTEN and SALL1. Both genes were confirmed as SALL4 downstream targets by chromatin-immunoprecipitation, and their expression levels, when tested by quantitative reverse transcription polymerase chain reaction (qRT-PCR), were decreased in 293T cells overexpressing SALL4. Moreover, SALL4 binding sites at the promoter regions of PTEN and SALL1 were co-occupied by NuRD components, suggesting that SALL4 represses the transcriptions of PTEN and SALL1 through its interactions with the Mi-2/NuRD complex. The in vivo repressive effect( s) of SALL4 were evaluated in SALL4 transgenic mice, where decreased expressions of PTEN and SALL1 were associated with myeloid leukemia and cystic kidneys, respectively. Conclusions/Significance: In summary, we are the first to demonstrate that stem cell protein SALL4 represses its target genes, PTEN and SALL1, through the epigenetic repressor Mi-2/NuRD complex. Our novel finding provides insight into the mechanism(s) of SALL4 functions in kidney development and leukemogenesis.			Lu, JY (corresponding author), Harvard Univ, Brigham & Womens Hosp, Childrens Hosp Boston, Sch Med,Dept Pathol,Joint Program Transfus Med, Boston, MA 02115 USA.	lchai@partners.org		Chai, Li/0000-0003-1937-4750	NATIONAL CANCER INSTITUTE [K08CA097185] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK063220] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA097185] Funding Source: Medline; NCRR NIH HHS [P20 RR016464] Funding Source: Medline; NHLBI NIH HHS [R01 HL092437] Funding Source: Medline; NIDDK NIH HHS [K08 DK063220] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Basson M, 1996, GENE DEV, V10, P1953, DOI 10.1101/gad.10.15.1953; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019505; Camp E, 2003, DEV GENES EVOL, V213, P35, DOI 10.1007/s00427-002-0284-6; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dong PDS, 2003, P NATL ACAD SCI USA, V100, P10293, DOI 10.1073/pnas.1836391100; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hollemann T, 1996, MECH DEVELOP, V55, P19, DOI 10.1016/0925-4773(95)00485-8; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Kim SK, 2005, CLIN CANCER RES, V11, P5965, DOI 10.1158/1078-0432.CCR-05-0371; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Kohlhase J, 1999, GENOMICS, V62, P216, DOI 10.1006/geno.1999.6005; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Kohlhase J, 2000, MAMM GENOME, V11, P64, DOI 10.1007/s003350010012; Koster R, 1997, DEVELOPMENT, V124, P3147; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lauberth SM, 2007, J BIOL CHEM, V282, P34858, DOI 10.1074/jbc.M703702200; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Ma Y, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730437; Ma YP, 2001, PEDIATR NEPHROL, V16, P701, DOI 10.1007/s004670100624; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Marlin S, 1999, HUM MUTAT, V14, P377, DOI 10.1002/(SICI)1098-1004(199911)14:5<377::AID-HUMU3>3.0.CO;2-A; McDonel P, 2009, INT J BIOCHEM CELL B, V41, P108, DOI 10.1016/j.biocel.2008.07.022; Neff AW, 2005, DEV DYNAM, V233, P356, DOI 10.1002/dvdy.20363; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Rossi DJ, 2006, CELL, V125, P229, DOI 10.1016/j.cell.2006.04.006; Sharov AA, 2007, CELL STEM CELL, V1, P237, DOI 10.1016/j.stem.2007.08.015; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Toker AS, 2003, DEVELOPMENT, V130, P3831, DOI 10.1242/dev.00398; Wong CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001955; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yilmaz OH, 2008, BLOOD CELL MOL DIS, V41, P73, DOI 10.1016/j.bcmd.2008.02.004; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	49	120	131	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5577	10.1371/journal.pone.0005577	http://dx.doi.org/10.1371/journal.pone.0005577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440552	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107500008
J	Grimsrud, A; Stein, DJ; Seedat, S; Williams, D; Myer, L				Grimsrud, Anna; Stein, Dan J.; Seedat, Soraya; Williams, David; Myer, Landon			The Association between Hypertension and Depression and Anxiety Disorders: Results from a Nationally-Representative Sample of South African Adults	PLOS ONE			English	Article							BLOOD-PRESSURE; PSYCHOSOCIAL PREDICTORS; GLOBAL BURDEN; YOUNG-ADULTS; SYMPTOMS; HEALTH; RISK; PREVALENCE; SEVERITY; DISTRESS	Objective: Growing evidence suggests high levels of comorbidity between hypertension and mental illness but there are few data from low-and middle-income countries. We examined the association between hypertension and depression and anxiety in South Africa. Methods: Data come from a nationally-representative survey of adults (n = 4351). The Composite International Diagnostic Interview was used to measure DSM-IV mental disorders during the previous 12-months. The relationships between self-reported hypertension and anxiety disorders, depressive disorders and comorbid anxiety-depression were assessed after adjustment for participant characteristics including experience of trauma and other chronic physical conditions. Results: Overall 16.7% reported a previous medical diagnosis of hypertension, and 8.1% and 4.9% were found to have a 12-month anxiety or depressive disorder, respectively. In adjusted analyses, hypertension diagnosis was associated with 12-month anxiety disorders [Odds ratio (OR) = 1.55, 95% Confidence interval (CI) = 1.10-2.18] but not 12-month depressive disorders or 12-month comorbid anxiety-depression. Hypertension in the absence of other chronic physical conditions was not associated with any of the 12-month mental health outcomes (p-values all, <0.05), while being diagnosed with both hypertension and another chronic physical condition were associated with 12-month anxiety disorders (OR = 2.25, 95% CI = 1.46-3.45), but not 12-month depressive disorders or comorbid anxiety-depression. Conclusions: These are the first population-based estimates to demonstrate an association between hypertension and mental disorders in sub-Saharan Africa. Further investigation is needed into role of traumatic life events in the aetiology of hypertension as well as the temporality of the association between hypertension and mental disorders.			Grimsrud, A (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	landon.myer@uct.ac.za	Stein, Dan/A-1752-2008; QQ, Simon/D-3888-2014	Stein, Dan/0000-0001-7218-7810; Seedat, Soraya/0000-0002-5118-786X	FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070884, R01MH069864, R13MH066849, R01MH059575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558] Funding Source: NIH RePORTER; FIC NIH HHS [R01-TW006481, R03 TW006481] Funding Source: Medline; NIDA NIH HHS [R01 DA016558] Funding Source: Medline; NIMH NIH HHS [R13 MH066849, R01 MH059575, R01 MH070884, R13-MH066849, R01-MH069864, R01-MH059575, R01MH070884, R01 MH069864] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alonso A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-94; ANDREWS G, 1998, SOC PSYCH PSYCH EPID, V33, P8; COELHO R, 1989, J PSYCHOSOM RES, V33, P187, DOI 10.1016/0022-3999(89)90046-9; Davidson K, 2000, ARCH INTERN MED, V160, P1495, DOI 10.1001/archinte.160.10.1495; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; *DEP HLTH S AFR, 1998, S AFR DEM HLTH SURV; Dorn T, 2007, AM J EPIDEMIOL, V165, P410, DOI 10.1093/aje/kwk029; Ellis CG, 2003, SAMJ S AFR MED J, V93, P342; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; HAROOO J, 2006, INT J METHODS PSYCHI, V13; Harter MC, 2003, EUR ARCH PSY CLIN N, V253, P313, DOI 10.1007/s00406-003-0449-y; Jonas BS, 1997, ARCH FAM MED, V6, P43, DOI 10.1001/archfami.6.1.43; Jones DR, 2004, PSYCHIAT SERV, V55, P1250, DOI 10.1176/appi.ps.55.11.1250; JonesWebb R, 1996, ALCOHOL CLIN EXP RES, V20, P420, DOI 10.1111/j.1530-0277.1996.tb01069.x; Kadam UT, 2005, J CLIN EPIDEMIOL, V58, P909, DOI 10.1016/j.jclinepi.2005.02.007; Levenstein S, 2001, ARCH INTERN MED, V161, P1341, DOI 10.1001/archinte.161.10.1341; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lowe B, 2004, PSYCHOSOM MED, V66, P831, DOI 10.1097/01.psy.0000145593.37594.39; MARKOVITZ JH, 1993, JAMA-J AM MED ASSOC, V270, P2439; *MED HSO, 2007, WORLD MENT HLTH SURV, V2005; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Myer L, 2004, EPIDEMIOL REV, V26, P112, DOI 10.1093/epirev/mxh004; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Paterniti S, 1999, PSYCHOSOM MED, V61, P77, DOI 10.1097/00006842-199901000-00013; Scherrer JF, 2003, PSYCHOSOM MED, V65, P548, DOI 10.1097/01.PSY.0000077507.29863.CB; SCOTT K, 2006, AUSTR NZ J PSYCHIAT, V40, P7; SCOTT KM, 2007, J AFFECTIVE IN PRESS; Shinn EH, 2001, AM J HYPERTENS, V14, P660, DOI 10.1016/S0895-7061(01)01304-8; Smit J, 2006, Afr Health Sci, V6, P215; SOMOVA LI, 1995, J HYPERTENS, V13, P193; Stein DJ, 2008, BRIT J PSYCHIAT, V192, P112, DOI 10.1192/bjp.bp.106.029280; Steyn K, 2001, J HYPERTENS, V19, P1717, DOI 10.1097/00004872-200110000-00004; Tormo MJ, 2000, J EPIDEMIOL COMMUN H, V54, P221, DOI 10.1136/jech.54.3.221; Ustun TB, 1999, AM J PUBLIC HEALTH, V89, P1315, DOI 10.2105/AJPH.89.9.1315; Wei TM, 2006, INT J PSYCHIAT MED, V36, P315, DOI 10.2190/5LX9-D3BH-FUA3-PQF0; Wiehe M, 2006, J HUM HYPERTENS, V20, P434, DOI 10.1038/sj.jhh.1002017; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; Williams DR, 2004, METAB BRAIN DIS, V19, P135, DOI 10.1023/B:MEBR.0000027424.86587.74; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138	41	73	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5552	10.1371/journal.pone.0005552	http://dx.doi.org/10.1371/journal.pone.0005552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	446FX	19440241	Green Submitted, gold, Green Published			2022-12-27	WOS:000266107300016
J	Pino, SC; O'Sullivan-Murphy, B; Lidstone, EA; Yang, C; Lipson, KL; Jurczyk, A; Dilorio, P; Brehm, MA; Mordes, JP; Greiner, DL; Rossini, AA; Bortell, R				Pino, Steven C.; O'Sullivan-Murphy, Bryan; Lidstone, Erich A.; Yang, Chaoxing; Lipson, Kathryn L.; Jurczyk, Agata; Dilorio, Philip; Brehm, Michael A.; Mordes, John P.; Greiner, Dale L.; Rossini, Aldo A.; Bortell, Rita			CHOP Mediates Endoplasmic Reticulum Stress-Induced Apoptosis in Gimap5-Deficient T Cells	PLOS ONE			English	Article								Gimap5 (GTPase of the immunity-associated protein 5) has been linked to the regulation of T cell survival, and polymorphisms in the human GIMAP5 gene associate with autoimmune disorders. The BioBreeding diabetes-prone (BBDP) rat has a mutation in the Gimap5 gene that leads to spontaneous apoptosis of peripheral T cells by an unknown mechanism. Because Gimap5 localizes to the endoplasmic reticulum (ER), we hypothesized that absence of functional Gimap5 protein initiates T cell death through disruptions in ER homeostasis. We observed increases in ER stress-associated chaperones in T cells but not thymocytes or B cells from Gimap5(-/-) BBDP rats. We then discovered that ER stress-induced apoptotic signaling through C/EBP-homologous protein (CHOP) occurs in Gimap5(-/-) T cells. Knockdown of CHOP by siRNA protected Gimap5(-/-) T cells from ER stress-induced apoptosis, thereby identifying a role for this cellular pathway in the T cell lymphopenia of the BBDP rat. These findings indicate a direct relationship between Gimap5 and the maintenance of ER homeostasis in the survival of T cells.			Pino, SC (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	rita.bortell@umassmed.edu		Brehm, Michael/0000-0001-6813-3262; O'Sullivan-Murphy, Bryan/0000-0002-1426-5013	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025306, P30DK032520, R01DK025306, R01DK066447, R01DK049106] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK049106, R01 DK025306, DK32520,, P30 DK032520, DK066447, R01 DK066447, DK49106, DK25306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Blankenhorn EP, 2005, DIABETES, V54, P1233, DOI 10.2337/diabetes.54.4.1233; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Daheron L, 2001, NUCLEIC ACIDS RES, V29, P1308, DOI 10.1093/nar/29.6.1308; Dalberg U, 2007, INT IMMUNOL, V19, P447, DOI 10.1093/intimm/dxm009; Faitova J, 2006, CELL MOL BIOL LETT, V11, P488, DOI 10.2478/s11658-006-0040-4; Gallegos AM, 2006, IMMUNOL REV, V209, P290, DOI 10.1111/j.0105-2896.2006.00348.x; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hellquist A, 2007, J MED GENET, V44, P314, DOI 10.1136/jmg.2006.046185; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Iwakoshi NN, 1998, J IMMUNOL, V160, P5838; Jung CC, 1999, IMMUNOLOGY, V98, P590, DOI 10.1046/j.1365-2567.1999.00907.x; KAABA SA, 1995, IMMUNOL LETT, V47, P209, DOI 10.1016/0165-2478(95)00088-5; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Keita M, 2007, BIOCHEM BIOPH RES CO, V361, P481, DOI 10.1016/j.bbrc.2007.07.048; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Lang JA, 2004, EUR J IMMUNOL, V34, P2396, DOI 10.1002/eji.200324751; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Michalkiewicz M, 2004, PHYSIOL GENOMICS, V19, P228, DOI 10.1152/physiolgenomics.00126.2004; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Mordes JP, 2002, DIABETES, V51, P3254, DOI 10.2337/diabetes.51.11.3254; MORDES JP, 2009, MAMM GENOME IN PRESS; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Pandarpurkar M, 2003, P NATL ACAD SCI USA, V100, P10382, DOI 10.1073/pnas.1832170100; Pino SC, 2008, CELL STRESS CHAPERON, V13, P421, DOI 10.1007/s12192-008-0038-0; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ramanathan S, 1998, J IMMUNOL, V160, P5757; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rigby MR, 1996, DIABETES, V45, P1419, DOI 10.2337/diabetes.45.10.1419; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rossini AA, 2004, DIABETES, V53, P267, DOI 10.2337/diabetes.53.2.267; Sandal T, 2003, MOL BIOL CELL, V14, P3292, DOI 10.1091/mbc.e02-10-0700; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Shin JH, 2007, GENES IMMUN, V8, P503, DOI 10.1038/sj.gene.6364413; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	52	42	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5468	10.1371/journal.pone.0005468	http://dx.doi.org/10.1371/journal.pone.0005468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424493	Green Published, Green Submitted, gold			2022-12-27	WOS:000265933800005
J	Schley, D; Gubbins, S; Paton, DJ				Schley, David; Gubbins, Simon; Paton, David J.			Quantifying the Risk of Localised Animal Movement Bans for Foot-and-Mouth Disease	PLOS ONE			English	Article							VACCINATION STRATEGIES; UK FOOT; EPIDEMIOLOGY; OUTBREAK; SPREAD	The maintenance of disease-free status from Foot-and-Mouth Disease is of significant socio-economic importance to countries such as the UK. The imposition of bans on the movement of susceptible livestock following the discovery of an outbreak is deemed necessary to prevent the spread of what is a highly contagious disease, but has a significant economic impact on the agricultural community in itself. Here we consider the risk of applying movement restrictions only in localised zones around outbreaks in order to help evaluate how quickly nation-wide restrictions could be lifted after notification. We show, with reference to the 2001 and 2007 UK outbreaks, that it would be practical to implement such a policy provided the basic reproduction ratio of known infected premises can be estimated. It is ultimately up to policy makers and stakeholders to determine the acceptable level of risk, involving a cost benefit analysis of the potential outcomes, but quantifying the risk of spread from different sized zones is a prerequisite for this. The approach outlined is relevant to the determination of control zones and vaccination policies and has the potential to be applied to future outbreaks of other diseases.			Schley, D (corresponding author), Inst Anim Hlth, Pirbright Lab, Surrey, England.	David.Schley@bbsrc.ac.uk		Gubbins, Simon/0000-0003-0538-4173	BBSRC [BBS/E/I/00001320] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [IAH1320, BBS/E/I/00001320] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Anderson I., 2002, FOOT MOUTH DIS 2001; Anderson I., 2008, FOOT MOUTH DIS 2007; BANKOWSKI BM, 2006, UNDERSTANDING FMDV T; Barnett PV, 1999, VET J, V158, P6, DOI 10.1053/tvjl.1998.0338; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; *DEFR, 2007, BLUET DIS CONT PLANS; *DEFR, 2007, REC FMD FREE STAT UK; *DEFR, 2007, FMD EP REP EV 30 SEP; DONALDSON AI, 1982, VET REC, V110, P53, DOI 10.1136/vr.110.3.53; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Kao RR, 2001, VET REC, V148, P746, DOI 10.1136/vr.148.24.746; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kitching RP, 2007, NATURE, V445, pE12, DOI 10.1038/nature05604; Risk Solutions, 2005, FMD CBA EP MOD SPEC; SPRATT B, 2007, CONTRIBUTION FOOT AN; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Wingfield A, 2006, VET REC, V158, P706, DOI 10.1136/vr.158.20.706-a; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; 2003, OFF J EUR UNION L, V306	22	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5481	10.1371/journal.pone.0005481	http://dx.doi.org/10.1371/journal.pone.0005481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424494	Green Published, gold, Green Submitted			2022-12-27	WOS:000265933800013
J	Heung, MMS; Jin, SN; Tsui, NBY; Ding, CM; Leung, TY; Lau, TK; Chiu, RWK; Lo, YMD				Heung, Macy M. S.; Jin, Shengnan; Tsui, Nancy B. Y.; Ding, Chunming; Leung, Tak Y.; Lau, Tze K.; Chiu, Rossa W. K.; Lo, Y. M. Dennis			Placenta-Derived Fetal Specific mRNA Is More Readily Detectable in Maternal Plasma than in Whole Blood	PLOS ONE			English	Article								Background: Placental mRNA was detected in maternal whole blood, raising the possibility of using maternal blood for noninvasive prenatal diagnosis. We investigated fetal mRNA detection in maternal whole blood and determined if it offered advantages over maternal plasma analysis. Methodology: The concentrations of placental expressed genes, CSH1, KISS1, PLAC4 and PLAC1 in plasma and whole blood from healthy pregnant and non-pregnant individuals were compared by real-time quantitative reverse-transcriptase polymerase chain reaction analysis. Their fetal specificity was investigated by comparing the transcript concentrations in pre-and post-delivery samples and through SNP genotyping by matrix-assisted laser-desorption and ionization time-of-flight mass spectrometry. The gene expression profiles of pregnant and non-pregnant whole blood were investigated by microarray analysis. Upregulated genes in pregnant whole blood were selected for further quantitative analysis. Principal Findings: The concentrations of the four transcripts were significantly higher in third trimester maternal whole blood than corresponding plasma without significant correlations. KISS1, PLAC4 and PLAC1 were detected in non-pregnant whole blood but not plasma. The transcripts remained detectable in some postpartum whole blood samples. The PLAC4 mRNA in maternal plasma showed fetal genotype while that in corresponding whole blood indicated both fetal and maternal contributions. Microarray analysis revealed upregulation of genes involved in neutrophil functions in pregnant whole blood including DEFA4, CEACAM8, OLFM4, ORM1, MMP8 and MPO. Though possibly pregnancy-related, they were not pregnancy-specific as suggested by the lack of post-delivery reduction in concentrations. Conclusions: Maternal plasma is preferred over maternal whole blood for placenta-derived fetal RNA detection. Most studied "placental' mRNA molecules in maternal whole blood were of maternal origin and might be derived from processes such as 'illegitimate transcription'.			Heung, MMS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Sha Tin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Lo, Yuk Ming Dennis/D-4468-2011; Jin, Shengnan/I-6264-2012; Ding, Chunming/B-2593-2008	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Jin, Shengnan/0000-0003-0467-6502; Ding, Chunming/0000-0002-2063-5594; Lau, Tze Kin/0000-0002-0242-1410				Adley BP, 2006, ARCH PATHOL LAB MED, V130, P1865; *AFF, 2003, GLOB RED PROT METH P, P1; Arechavaleta-Velasco F, 2004, AM J OBSTET GYNECOL, V190, P843, DOI 10.1016/j.ajog.2003.09.032; Banzola I, 2008, PRENATAL DIAG, V28, P1262, DOI 10.1002/pd.2163; Bianchi DW, 1999, BRIT J HAEMATOL, V105, P574, DOI 10.1046/j.1365-2141.1999.01383.x; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; BROWN E S, 1963, Br Med J, V1, P1000; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Concu M, 2005, FETAL DIAGN THER, V20, P27, DOI 10.1159/000081365; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farina A, 2005, CLIN CHEM, V51, P224; Farina A, 2004, CLIN CHEM, V50, P1851, DOI 10.1373/clinchem.2004.037713; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Gala JL, 1998, CLIN CHEM, V44, P472; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Go ATJI, 2007, CLIN CHEM, V53, P2223, DOI 10.1373/clinchem.2007.093146; Halicka HD, 2000, EXP CELL RES, V260, P248, DOI 10.1006/excr.2000.5027; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; Kimoto Y, 1998, MOL GEN GENET, V258, P233, DOI 10.1007/s004380050727; Kindzelskii AL, 2006, EUR J IMMUNOL, V36, P1619, DOI 10.1002/eji.200535391; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; Ko Y, 2000, ONCOLOGY-BASEL, V59, P81, DOI 10.1159/000012126; Koshida S, 2007, CANCER SCI, V98, P315, DOI 10.1111/j.1349-7006.2006.00383.x; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Kuhnert M, 1998, EUR J OBSTET GYN R B, V76, P147, DOI 10.1016/S0301-2115(97)00180-2; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Maron JL, 2007, J CLIN INVEST, V117, P3007, DOI 10.1172/JCI29959; Mavrou A, 2007, PRENATAL DIAG, V27, P150, DOI 10.1002/pd.1640; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Nien JK, 2006, AM J OBSTET GYNECOL, V195, P1025, DOI 10.1016/j.ajog.2006.06.054; Okazaki S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040634; PITKIN RM, 1979, JAMA-J AM MED ASSOC, V242, P2696, DOI 10.1001/jama.242.24.2696; Prikk K, 2001, J PATHOL, V194, P232, DOI 10.1002/path.849; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; THOMAS T, 1993, PLACENTA, V14, P417, DOI 10.1016/S0143-4004(05)80462-X; Tsui NBY, 2004, J MED GENET, V41, P461, DOI 10.1136/jmg.2003.016881; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Zhao LS, 2004, J IMMUNOL METHODS, V293, P207, DOI 10.1016/j.jim.2004.08.009	44	29	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5858	10.1371/journal.pone.0005858	http://dx.doi.org/10.1371/journal.pone.0005858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516908	Green Published, gold, Green Submitted			2022-12-27	WOS:000266872900009
J	Bhaskar, PB; Venkateshwaran, M; Wu, L; Ane, JM; Jiang, JM				Bhaskar, Pudota B.; Venkateshwaran, Muthusubramanian; Wu, Lei; Ane, Jean-Michel; Jiang, Jiming			Agrobacterium-Mediated Transient Gene Expression and Silencing: A Rapid Tool for Functional Gene Assay in Potato	PLOS ONE			English	Article							LATE BLIGHT RESISTANCE; BROAD-SPECTRUM RESISTANCE; PHYTOPHTHORA-INFESTANS; SOLANUM-BULBOCASTANUM; DISEASE-RESISTANCE; NICOTIANA-BENTHAMIANA; R-GENE; PROTEIN; PLANT; AGROINFILTRATION	Potato is the third most important food crop worldwide. However, genetic and genomic research of potato has lagged behind other major crops due to the autopolyploidy and highly heterozygous nature associated with the potato genome. Reliable and technically undemanding techniques are not available for functional gene assays in potato. Here we report the development of a transient gene expression and silencing system in potato. Gene expression or RNAi-based gene silencing constructs were delivered into potato leaf cells using Agrobacterium-mediated infiltration. Agroinfiltration of various gene constructs consistently resulted in potato cell transformation and spread of the transgenic cells around infiltration zones. The efficiency of agroinfiltration was affected by potato genotypes, concentration of Agrobacterium, and plant growth conditions. We demonstrated that the agroinfiltration-based transient gene expression can be used to detect potato proteins in sub-cellular compartments in living cells. We established a double agroinfiltration procedure that allows to test whether a specific gene is associated with potato late blight resistance pathway mediated by the resistance gene RB. This procedure provides a powerful approach for high throughput functional assay for a large number of candidate genes in potato late blight resistance.			Bhaskar, PB (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.	jjiang1@wisc.edu	pudota, bhaskar/C-5896-2011; Ané, Jean-Michel/G-5921-2010; Jiang, Jiming/V-6060-2019; Jiang, Jiming/A-9614-2009	Ané, Jean-Michel/0000-0002-3128-9439; Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Pudota, Bala/0000-0003-2576-101X; Venkateshwaran, Muthusubramanian/0000-0001-7023-1988				Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bhaskar PB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-8; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Chen S, 2008, PLANT CELL ENVIRON, V31, P165, DOI 10.1111/j.1365-3040.2007.01747.x; Chincinska IA, 2008, PLANT PHYSIOL, V146, P515, DOI 10.1104/pp.107.112334; Faivre-Rampant O, 2004, PLANT PHYSIOL, V134, P1308, DOI 10.1104/pp.103.037507; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Hofius D, 2004, PLANT PHYSIOL, V135, P1256, DOI 10.1104/pp.104.043927; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Huang SW, 2004, MOL PLANT MICROBE IN, V17, P428, DOI 10.1094/MPMI.2004.17.4.428; Joh LD, 2005, BIOTECHNOL BIOENG, V91, P861, DOI 10.1002/bit.20557; Kanneganti Thirumala-Devi, 2007, Methods Mol Biol, V354, P35; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim YS, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-36; Koscianska E, 2005, PLANT MOL BIOL, V59, P647, DOI 10.1007/s11103-005-0668-x; Kramer LC, 2009, MOL PLANT MICROBE IN, V22, P447, DOI 10.1094/MPMI-22-4-0447; Messinese E, 2007, MOL PLANT MICROBE IN, V20, P912, DOI 10.1094/MPMI-20-8-0912; Orzaez D, 2006, PLANT PHYSIOL, V140, P3, DOI 10.1104/pp.105.068221; PEREIRA A, 1992, NETH J PLANT PATHOL, V98, P215, DOI 10.1007/BF01974488; Regan S, 2006, CAN J PLANT PATHOL, V28, pS247, DOI 10.1080/07060660609507382; Riely BK, 2007, PLANT J, V49, P208, DOI 10.1111/j.1365-313X.2006.02957.x; Rommens CM, 2006, J AGR FOOD CHEM, V54, P9882, DOI 10.1021/jf062477l; Santos-Rosa M, 2008, PLANT CELL REP, V27, P1053, DOI 10.1007/s00299-008-0531-z; Serra O, 2009, PLANT PHYSIOL, V149, P1050, DOI 10.1104/pp.108.127183; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Van der Hoorn RAL, 2000, MOL PLANT MICROBE IN, V13, P439, DOI 10.1094/MPMI.2000.13.4.439; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; Van Eck J, 2007, AM J POTATO RES, V84, P331, DOI 10.1007/BF02986245; van Enckevort LJG, 2001, MOL BREEDING, V7, P117, DOI 10.1023/A:1011362323992; Vleeshouwers VGAA, 2006, MOL PLANT PATHOL, V7, P499, DOI 10.1111/j.1364-3703.2006.00355.X; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wachter A, 2005, PLANT J, V41, P15, DOI 10.1111/j.1365-313X.2004.02269.x; Wang YL, 2008, MOL PLANT MICROBE IN, V21, P294, DOI 10.1094/MPMI-21-3-0294; WEIGEL D, 2006, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.PR0T4668; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Zottini M, 2008, PLANT CELL REP, V27, P845, DOI 10.1007/s00299-008-0510-4	45	94	104	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5812	10.1371/journal.pone.0005812	http://dx.doi.org/10.1371/journal.pone.0005812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503835	gold, Green Published, Green Submitted			2022-12-27	WOS:000266717200008
J	Kramer, MC; van der Wal, AC; Koch, KT; Rittersma, SZ; Li, XF; Ploegmakers, HP; Henriques, JP; van der Schaaf, RJ; Baan, J; Vis, MM; Meesterman, MG; Piek, JJ; Tijssen, JG; de Winter, RJ				Kramer, Miranda C.; van der Wal, Allard C.; Koch, Karel T.; Rittersma, Saskia Z.; Li, Xiaofei; Ploegmakers, Hanneke P.; Henriques, Jose P.; van der Schaaf, Rene J.; Baan, Jan, Jr.; Vis, Marije M.; Meesterman, Martin G.; Piek, Jan J.; Tijssen, Jan G.; de Winter, Robbert J.			Histopathological Features of Aspirated Thrombi after Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							THROMBECTOMY; PROTECTION; RUPTURE	Background: Plaque disruption with superimposed thrombus is the predominant mechanism responsible for the onset of acute coronary syndromes. Studies have shown that plaque disruption and thrombotic occlusion are frequently separated in time. We established the histopathological characteristics of material aspirated during primary percutaneous coronary intervention (PCI) in a large consecutive ST-elevation myocardial infarction (STEMI) population. Methodology/Principal Findings: Thrombus aspiration during primary PCI was performed in 1,362 STEMI patients. Thrombus age was classified as fresh (<1 day), lytic (1-5 days), or organized (>5 day). Further, the presence of plaque was documented. The histopathological findings were related to the clinical, angiographic, and procedural characteristics. Material could be aspirated in 1,009 patients (74%). Components of plaque were found in 395 of these patients (39%). Fresh thrombus was found in 577 of 959 patients (60%) compared to 382 patients (40%) with lytic or organized thrombi. Distal embolization was present in 21% of patients with lytic thrombus compared to 12% and 15% of patients with fresh or organized thrombus. Conclusions/Significance: Material could be obtained in 74% of STEMI patients treated with thrombus aspiration during primary PCI. In 40% of patients thrombus age is older than 24 h, indicating that plaque disruption and thrombus formation occur significantly earlier than the onset of symptoms in many patients.			Kramer, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands.	r.j.dewinter@amc.uva.nl	Li, xiaofei/GXF-7187-2022	van der Wal, Allard/0000-0001-5590-3758				ARBUSTINI E, 1993, CORONARY ARTERY DIS, V4, P751, DOI 10.1097/00019501-199309000-00001; Burke AP, 2001, CIRCULATION, V103, P934; de Gouveia RH, 2002, EUR HEART J, V23, P1433, DOI 10.1053/euhj.2002.3159; Koch KT, 2007, REV CARDIOVASC MED, V8, P160; Kondo M, 1998, J AM COLL CARDIOL, V32, P898, DOI 10.1016/S0735-1097(98)00435-5; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Murakami T, 1998, AM J CARDIOL, V82, P839, DOI 10.1016/S0002-9149(98)00489-5; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4	11	42	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5817	10.1371/journal.pone.0005817	http://dx.doi.org/10.1371/journal.pone.0005817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503788	gold, Green Published, Green Submitted			2022-12-27	WOS:000266717200013
J	Espert, L; Varbanov, M; Robert-Hebmann, V; Sagnier, S; Robbins, I; Sanchez, F; Lafont, V; Biard-Piechaczyk, M				Espert, Lucile; Varbanov, Mihayl; Robert-Hebmann, Veronique; Sagnier, Sophie; Robbins, Ian; Sanchez, Francoise; Lafont, Virginie; Biard-Piechaczyk, Martine			Differential Role of Autophagy in CD4 T Cells and Macrophages during X4 and R5 HIV-1 Infection	PLOS ONE			English	Article								Background: HIV-1 can infect and replicate in both CD4 T cells and macrophages. In these cell types, HIV-1 entry is mediated by the binding of envelope glycoproteins (gp120 and gp41, Env) to the receptor CD4 and a coreceptor, principally CCR5 or CXCR4, depending on the viral strain (R5 or X4, respectively). Uninfected CD4 T cells undergo X4 Env-mediated autophagy, leading to their apoptosis, a mechanism now recognized as central to immunodeficiency. Methodology/Principal Findings: We demonstrate here that autophagy and cell death are also induced in the uninfected CD4 T cells by HIV-1 R5 Env, while autophagy is inhibited in productively X4 or R5-infected CD4 T cells. In contrast, uninfected macrophages, a preserved cell population during HIV-1 infection, do not undergo X4 or R5 Env-mediated autophagy. Autophagosomes, however, are present in macrophages exposed to infectious HIV-1 particles, independently of coreceptor use. Interestingly, we observed two populations of autophagic cells: one highly autophagic and the other weakly autophagic. Surprisingly, viruses could be detected in the weakly autophagic cells but not in the highly autophagic cells. In addition, we show that the triggering of autophagy in macrophages is necessary for viral replication but addition of Bafilomycin A1, which blocks the final stages of autophagy, strongly increases productive infection. Conclusions/Significance: Taken together, our data suggest that autophagy plays a complex, but essential, role in HIV pathology by regulating both viral replication and the fate of the target cells.			Espert, L (corresponding author), CNRS, CPBS, UM1, UM2,Inst Biol, 4 CS, F-69033 Montpellier, France.	martine.biard@univ-montp1.fr	Espert, Lucile/ABF-5614-2021; Lafont, Virginie/R-9356-2017	Lafont, Virginie/0000-0001-9612-3934; Varbanov, Mihayl/0000-0002-2515-3009				Berkowitz RD, 1998, J VIROL, V72, P10108, DOI 10.1128/JVI.72.12.10108-10117.1998; Blanco J, 1999, AIDS, V13, P909, DOI 10.1097/00002030-199905280-00006; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Bosch B, 2006, ANTIVIR RES, V69, P173, DOI 10.1016/j.antiviral.2005.12.004; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Callahan MA, 1998, J VIROL, V72, P5189, DOI 10.1128/JVI.72.6.5189-5197.1998; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Chiantia S, 2008, BBA-BIOMEMBRANES, V1778, P1356, DOI 10.1016/j.bbamem.2008.02.008; Colombo MI, 2005, CELL DEATH DIFFER, V12, P1481, DOI 10.1038/sj.cdd.4401767; DENIZOT M, 2008, AUTOPHAGY, V4; DENIZOT M, 2008, AUTOPHAGY; Espert L, 2007, J MOL MED, V85, P811, DOI 10.1007/s00109-007-0173-6; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Lee HK, 2008, CURR OPIN IMMUNOL, V20, P23, DOI 10.1016/j.coi.2008.01.001; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Marsh M, 2009, BIOCHEM SOC T, V37, P185, DOI 10.1042/BST0370185; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2005, J ALLERGY CLIN IMMUN, V116, P419, DOI 10.1016/j.jaci.2005.05.040; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; ORVEDAHL A, 2008, CELL DEATH DIFFER; Roggero R, 2001, J VIROL, V75, P7637, DOI 10.1128/JVI.75.16.7637-7650.2001; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schweighardt B, 2004, J VIROL, V78, P9164, DOI 10.1128/JVI.78.17.9164-9173.2004; Trujillo JR, 2007, P NATL ACAD SCI USA, V104, P5097, DOI 10.1073/pnas.0611263104; Tuttle DL, 1998, J VIROL, V72, P4962, DOI 10.1128/JVI.72.6.4962-4969.1998; Verani A, 2005, MOL IMMUNOL, V42, P195, DOI 10.1016/j.molimm.2004.06.020; Wahl SM, 2006, J LEUKOCYTE BIOL, V80, P973, DOI 10.1189/jlb.0306130; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	44	107	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5787	10.1371/journal.pone.0005787	http://dx.doi.org/10.1371/journal.pone.0005787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492063	Green Published, gold			2022-12-27	WOS:000266624300021
J	Fukui, T; Kimura, T; Kadota, K; Shimojo, S; Gomi, H				Fukui, Takao; Kimura, Toshitaka; Kadota, Koji; Shimojo, Shinsuke; Gomi, Hiroaki			Odd Sensation Induced by Moving-Phantom which Triggers Subconscious Motor Program	PLOS ONE			English	Article							PLATFORM; DISORIENTATION; CONSEQUENCES; ESCALATORS; INTENTION; BEHAVIOR; ILLUSION; WALKING; HUMANS; MODEL	Our motor actions are sometimes not properly performed despite our having complete understanding of the environmental situation with a suitable action intention. In most cases, insufficient skill for motor control can explain the improper performance. A notable exception is the action of stepping onto a stopped escalator, which causes clumsy movements accompanied by an odd sensation. Previous studies have examined short-term sensorimotor adaptations to treadmills and moving sleds, but the relationship between the odd sensation and behavioral properties in a real stopped-escalator situation has never been examined. Understanding this unique action-perception linkage would help us to assess the brain function connecting automatic motor controls and the conscious awareness of action. Here we directly pose a question: Does the odd sensation emerge because of the unfamiliar motor behavior itself toward the irregular step-height of a stopped escalator or as a consequence of an automatic habitual motor program cued by the escalator itself. We compared the properties of motor behavior toward a stopped escalator (SE) with those toward moving escalator and toward a wooden stairs (WS) that mimicked the stopped escalator, and analyzed the subjective feeling of the odd sensation in the SE and WS conditions. The results show that moving escalator-specific motor actions emerged after participants had stepped onto the stopped escalator despite their full awareness that it was stopped, as if the motor behavior was guided by a "phantom'' of a moving escalator. Additionally, statistical analysis reveals that postural forward sway that occurred after the stepping action is directly linked with the odd sensation. The results suggest a dissociation between conscious awareness and subconscious motor control: the former makes us perfectly aware of the current environmental situation, but the latter automatically emerges as a result of highly habituated visual input no matter how unsuitable the motor control is. This dissociation appears to yield an attribution conflict, resulting in the odd sensation.			Fukui, T (corresponding author), NTT Corp, NTT, Commun Sci Labs, Kanagawa, Japan.	gomi@idea.brl.ntt.co.jp	Gomi, Hiroaki/C-5269-2013; Gomi, Hiroaki/AEL-2645-2022	Lauwereyns, Jan/0000-0003-0551-2550; Gomi, Hiroaki/0000-0003-3541-2251				ANSTIS S, 1995, EXP BRAIN RES, V103, P476; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Blakemore SJ, 1998, J NEUROSCI, V18, P7511; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Bunday KL, 2006, EXP BRAIN RES, V174, P270, DOI 10.1007/s00221-006-0446-2; Bunday KL, 2008, J NEUROPHYSIOL, V99, P1354, DOI 10.1152/jn.01214.2007; Cavaco S, 2004, BRAIN, V127, P1853, DOI 10.1093/brain/awh208; COHN TE, 1990, PERCEPTION, V19, P573, DOI 10.1068/p190573; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; ESLINGER PJ, 1986, J NEUROSCI, V6, P3006; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Lacquaniti F, 1992, Curr Opin Neurobiol, V2, P807, DOI 10.1016/0959-4388(92)90138-B; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MUNCKFAIRWOOD RC, 1992, PERCEPTION, V21, P747, DOI 10.1068/p210747; NASHNER LM, 1980, J NEUROPHYSIOL, V44, P650, DOI 10.1152/jn.1980.44.4.650; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Norman D. A., 2000, COGNITIVE NEUROSCIEN, P376; Pelah A, 1996, NATURE, V381, P283, DOI 10.1038/381283a0; Reynolds RF, 2006, NEUROREPORT, V17, P1503, DOI 10.1097/01.wnr.0000234741.04700.3e; Reynolds RF, 2004, J NEUROPHYSIOL, V91, P92, DOI 10.1152/jn.00495.2003; Reynolds RF, 2003, EXP BRAIN RES, V151, P301, DOI 10.1007/s00221-003-1444-2; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Ullman J. B., 2004, HDB DATA ANAL, P431; WESTERMANN R, 1985, APPL PSYCH MEAS, V9, P265, DOI 10.1177/014662168500900304; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yamadori A, 1996, COGNITIVE BRAIN RES, V5, P49, DOI 10.1016/S0926-6410(96)00040-7	33	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5782	10.1371/journal.pone.0005782	http://dx.doi.org/10.1371/journal.pone.0005782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453PV	19492054	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000266624300018
J	van der Zwaag, B; Franke, L; Poot, M; Hochstenbach, R; Spierenburg, HA; Vorstman, JAS; van Daalen, E; de Jonge, MV; Verbeek, NE; Brilstra, EH; van't Slot, R; Ophoff, RA; van Es, MA; Blauw, HM; Veldink, JH; Buizer-Voskamp, JE; Beemer, FA; van den Berg, LH; Wijmenga, C; van Amstel, HKP; van Engeland, H; Burbach, JPH; Staal, WG				van der Zwaag, Bert; Franke, Lude; Poot, Martin; Hochstenbach, Ron; Spierenburg, Henk A.; Vorstman, Jacob A. S.; van Daalen, Emma; de Jonge, Maretha V.; Verbeek, Nienke E.; Brilstra, Eva H.; van't Slot, Ruben; Ophoff, Roel A.; van Es, Michael A.; Blauw, Hylke M.; Veldink, Jan H.; Buizer-Voskamp, Jacobine E.; Beemer, Frits A.; van den Berg, Leonard H.; Wijmenga, Cisca; van Amstel, Hans Kristian Ploos; van Engeland, Herman; Burbach, J. Peter H.; Staal, Wouter G.			Gene-Network Analysis Identifies Susceptibility Genes Related to Glycobiology in Autism	PLOS ONE			English	Article							CONGENITAL DISORDERS; GENOMEWIDE SCREEN; LINKAGE; SPECTRUM; PRIORITIZATION; GLYCOSYLATION; CHROMOSOMES; RESOLUTION; VARIANTS; TRAITS	The recent identification of copy-number variation in the human genome has opened up new avenues for the discovery of positional candidate genes underlying complex genetic disorders, especially in the field of psychiatric disease. One major challenge that remains is pinpointing the susceptibility genes in the multitude of disease-associated loci. This challenge may be tackled by reconstruction of functional gene-networks from the genes residing in these loci. We applied this approach to autism spectrum disorder (ASD), and identified the copy-number changes in the DNA of 105 ASD patients and 267 healthy individuals with Illumina Humanhap300 Beadchips. Subsequently, we used a human reconstructed gene-network, Prioritizer, to rank candidate genes in the segmental gains and losses in our autism cohort. This analysis highlighted several candidate genes already known to be mutated in cognitive and neuropsychiatric disorders, including RAI1, BRD1, and LARGE. In addition, the LARGE gene was part of a sub-network of seven genes functioning in glycobiology, present in seven copy-number changes specifically identified in autism patients with limited co-morbidity. Three of these seven copy-number changes were de novo in the patients. In autism patients with a complex phenotype and healthy controls no such sub-network was identified. An independent systematic analysis of 13 published autism susceptibility loci supports the involvement of genes related to glycobiology as we also identified the same or similar genes from those loci. Our findings suggest that the occurrence of genomic gains and losses of genes associated with glycobiology are important contributors to the development of ASD.			van der Zwaag, B (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	J.P.H.Burbach@Umcutrecht.nl; W.Staal@Umcutrecht.nl	Staal, W.G./L-4665-2015; Poot, Martin/F-9427-2010; Wijmenga, Cisca/AAE-7719-2019; van+Es, Michael/AAC-5772-2021; Staal, Wouter G/A-3099-2013; De Jonge, Maretha V/F-4942-2013; Brilstra, Eva/AAT-3092-2021; Wijmenga, Cisca/D-2173-2009; Franke, Lude/P-7036-2016	Wijmenga, Cisca/0000-0002-5635-1614; Franke, Lude/0000-0002-5159-8802; Veldink, Jan/0000-0001-5572-9657; van Es, Michael/0000-0002-7709-5883				Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Buxbaum JD, 2004, MOL PSYCHIATR, V9, P144, DOI 10.1038/sj.mp.4001465; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Palferman S, 2001, AM J HUM GENET, V69, P570; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Rozen S, 2000, Methods Mol Biol, V132, P365; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seranski P, 1999, GENOMICS, V56, P1, DOI 10.1006/geno.1998.5647; Seranski P, 2001, GENE, V270, P69, DOI 10.1016/S0378-1119(01)00415-2; Severinsen JE, 2006, MOL PSYCHIATR, V11, P1126, DOI 10.1038/sj.mp.4001885; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; van der Zwaag B, 2005, GENOMICS, V86, P55, DOI 10.1016/j.ygeno.2005.03.007; van Reeuwijk J, 2007, HUM GENET, V121, P685, DOI 10.1007/s00439-007-0362-y; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; WALSH T, 2008, SCIENCE; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	37	96	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5324	10.1371/journal.pone.0005324	http://dx.doi.org/10.1371/journal.pone.0005324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492091	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415100001
J	Diaz-San Segundo, F; Rodriguez-Calvo, T; de Avila, A; Sevilla, N				Diaz-San Segundo, Fayna; Rodriguez-Calvo, Teresa; de Avila, Ana; Sevilla, Noemi			Immunosuppression during Acute Infection with Foot-and-Mouth Disease Virus in Swine Is Mediated by IL-10	PLOS ONE			English	Article							DENDRITIC CELLS; ANTIGEN PRESENTATION; VIRAL PERSISTENCE; IMMUNE-RESPONSE; FMDV PEPTIDES; T-CELLS; INTERLEUKIN-10; INDUCTION; MATURATION; ANTIBODY	Foot-and-mouth disease virus (FMDV) is one of the most contagious animal viruses, causing a devastating disease in cloven-hoofed animals with enormous economic consequences. Identification of the different parameters involved in the immune response elicited against FMDV remains unclear, and it is fundamental the understanding of such parameters before effective control measures can be put in place. In the present study, we show that interleukin-10 (IL-10) production by dendritic cells (DCs) is drastically increased during acute infection with FMDV in swine. In vitro blockade of IL-10 with a neutralizing antibody against porcine IL-10 restores T cell activation by DCs. Additionally, we describe that FMDV infects DC precursors and interferes with DC maturation and antigen presentation capacity. Thus, we propose a new mechanism of virus immunity in which a non-persistent virus, FMDV, induces immunosuppression by an increment in the production of IL-10, which in turn, reduces T cell function. This reduction of T cell activity may result in a more potent induction of neutralizing antibody responses, clearing the viral infection.	[Diaz-San Segundo, Fayna; Rodriguez-Calvo, Teresa; Sevilla, Noemi] INIA, Ctr Invest Sanidad Anim, Madrid, Spain; [de Avila, Ana; Sevilla, Noemi] Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Diaz-San Segundo, F (corresponding author), ARS, Plum Isl Anim Dis Ctr, North Atlantic Area, USDA, Greenport, NY 11944 USA.	sevilla@inia.es	Sevilla, Noemi/K-8648-2014; Rodriguez-Calvo, Teresa/AAH-2365-2019; Rodriguez-Calvo, Teresa/A-6831-2010	Sevilla, Noemi/0000-0003-0118-0376; de Avila Lucas, Ana Isabel/0000-0002-9381-0963				Andrews DM, 2001, NAT IMMUNOL, V2, P1077, DOI 10.1038/ni724; Balabanian K, 2002, BLOOD, V99, P427, DOI 10.1182/blood.V99.2.427; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bautista EA, 2005, J VIROL, V79, P4838, DOI 10.1128/JVI.79.8.4838-4847.2005; Bautista EM, 2003, VET IMMUNOL IMMUNOP, V92, P61, DOI 10.1016/S0165-2427(03)00004-7; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Brady MT, 2003, EUR J IMMUNOL, V33, P3448, DOI 10.1002/eji.200324251; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Carbonneil C, 2004, J IMMUNOL, V172, P7832, DOI 10.4049/jimmunol.172.12.7832; Cebulla CM, 2002, J IMMUNOL, V169, P167, DOI 10.4049/jimmunol.169.1.167; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Collen T, 1998, VIRUS RES, V56, P125, DOI 10.1016/S0168-1702(98)00035-5; COLLEN T, 1989, J GEN VIROL, V70, P395, DOI 10.1099/0022-1317-70-2-395; DELATORRE JC, 1988, J VIROL, V62, P2050, DOI 10.1128/JVI.62.6.2050-2058.1988; delaTorre JC, 1996, ADV VIRUS RES, V46, P311; Ejrnaes M, 2006, CLIN DEV IMMUNOL, V13, P337, DOI 10.1080/17402520600800721; FugierVivier I, 1997, J EXP MED, V186, P813, DOI 10.1084/jem.186.6.813; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; GLASS EJ, 1994, IMMUNOLOGY, V82, P1; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Grubman MJ, 2008, FEMS IMMUNOL MED MIC, V53, P8, DOI 10.1111/j.1574-695X.2008.00409.x; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guzylack-Piriou L, 2006, EUR J IMMUNOL, V36, P1674, DOI 10.1002/eji.200635866; Harwood LJ, 2008, J VIROL, V82, P6379, DOI 10.1128/JVI.00021-08; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Ji JX, 2005, INT IMMUNOL, V17, P729, DOI 10.1093/intimm/dxh252; Knight SC, 1997, ANNU REV IMMUNOL, V15, P593, DOI 10.1146/annurev.immunol.15.1.593; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Marin-Serrano E, 2006, J VIRAL HEPATITIS, V13, P230, DOI 10.1111/j.1365-2893.2005.00679.x; Montes CL, 2006, EUR J IMMUNOL, V36, P1474, DOI 10.1002/eji.200535537; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; OLDSTONE MBA, 1989, J INFECT DIS, V159, P384, DOI 10.1093/infdis/159.3.384; Oldstone MBA, 2002, CURR TOP MICROBIOL, V263, P83; Orange JS, 2002, NAT IMMUNOL, V3, P1006, DOI 10.1038/ni1102-1006; Ostrowski M, 2005, J IMMUNOL, V175, P3971, DOI 10.4049/jimmunol.175.6.3971; Ostrowski M, 2007, J VIROL, V81, P9357, DOI 10.1128/JVI.00677-07; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; ROUSE BT, 1986, REV INFECT DIS, V8, P850; RUECKERT RR, 1984, J VIROL, V50, P957, DOI 10.1128/JVI.50.3.957-959.1984; Segundo FDS, 2006, J VIROL, V80, P2369, DOI 10.1128/JVI.80.5.2369-2379.2006; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; VANLIEROP MJC, 1992, IMMUNOLOGY, V75, P406; Weigel BJ, 2002, BLOOD, V100, P4169, DOI 10.1182/blood-2002-04-1063; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	59	43	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5659	10.1371/journal.pone.0005659	http://dx.doi.org/10.1371/journal.pone.0005659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19478852	Green Submitted, Green Published, gold			2022-12-27	WOS:000266331000017
J	Ellison, DW; Clark, TR; Sturdevant, DE; Virtaneva, K; Hackstadt, T				Ellison, Damon W.; Clark, Tina R.; Sturdevant, Daniel E.; Virtaneva, Kimmo; Hackstadt, Ted			Limited Transcriptional Responses of Rickettsia rickettsii Exposed to Environmental Stimuli	PLOS ONE			English	Article								Rickettsiae are strict obligate intracellular pathogens that alternate between arthropod and mammalian hosts in a zoonotic cycle. Typically, pathogenic bacteria that cycle between environmental sources and mammalian hosts adapt to the respective environments by coordinately regulating gene expression such that genes essential for survival and virulence are expressed only upon infection of mammals. Temperature is a common environmental signal for upregulation of virulence gene expression although other factors may also play a role. We examined the transcriptional responses of Rickettsia rickettsii, the agent of Rocky Mountain spotted fever, to a variety of environmental signals expected to be encountered during its life cycle. R. rickettsii exposed to differences in growth temperature (25 degrees C vs. 37 degrees C), iron limitation, and host cell species displayed nominal changes in gene expression under any of these conditions with only 0, 5, or 7 genes, respectively, changing more than 3-fold in expression levels. R. rickettsii is not totally devoid of ability to respond to temperature shifts as cold shock (37 degrees C vs. 4 degrees C) induced a change greater than 3-fold in up to 56 genes. Rickettsiae continuously occupy a relatively stable environment which is the cytosol of eukaryotic cells. Because of their obligate intracellular character, rickettsiae are believed to be undergoing reductive evolution to a minimal genome. We propose that their relatively constant environmental niche has led to a minimal requirement for R. rickettsii to respond to environmental changes with a consequent deletion of non-essential transcriptional response regulators. A minimal number of predicted transcriptional regulators in the R. rickettsii genome is consistent with this hypothesis.			Ellison, DW (corresponding author), NIAID, Rocky Mt Labs, Intracellular Parasites Lab, NIH, Hamilton, MT 59840 USA.	thackstadt@niaid.nih.gov		Hackstadt, Ted/0000-0003-1367-5528	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000977, ZIAAI000977] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDREWS DL, 1988, BIOCHEM J, V252, P199, DOI 10.1042/bj2520199; Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Blanc G, 2005, ANN NY ACAD SCI, V1063, P83, DOI 10.1196/annals.1355.012; Briggs HL, 2008, INFECT IMMUN, V76, P2189, DOI 10.1128/IAI.01609-07; Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209; BURGDORFER W, 1967, ANNU REV ENTOMOL, V12, P347, DOI 10.1146/annurev.en.12.010167.002023; BURGDORFER W, 1966, B WORLD HEALTH ORGAN, V35, P149; Chen LF, 2008, INFECT DIS CLIN N AM, V22, P415, DOI 10.1016/j.idc.2008.03.008; CORY J, 1974, APPL MICROBIOL, V27, P1157, DOI 10.1128/AEM.27.6.1157-1161.1974; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Dautel H, 1996, J COMP PHYSIOL B, V166, P517, DOI 10.1007/BF02338295; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Dumler JS, 2005, NEW ENGL J MED, V353, P551, DOI 10.1056/NEJMp058138; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Goodchild A, 2004, J PROTEOME RES, V3, P1164, DOI 10.1021/pr0498988; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Han YP, 2004, MICROBIOL IMMUNOL, V48, P791, DOI 10.1111/j.1348-0421.2004.tb03605.x; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Howe D, 1999, INFECT IMMUN, V67, P3236, DOI 10.1128/IAI.67.7.3236-3241.1999; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; Lacz NL, 2006, J EUR ACAD DERMATOL, V20, P411, DOI 10.1111/j.1468-3083.2006.01489.x; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; MCDADE JE, 1986, ANNU REV MICROBIOL, V40, P287, DOI 10.1146/annurev.mi.40.100186.001443; Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003; Miethke M, 2006, J BACTERIOL, V188, P8655, DOI 10.1128/JB.01049-06; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Muga A, 2008, CURR PROTEIN PEPT SC, V9, P552, DOI 10.2174/138920308786733903; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; OJCIUS DM, 1995, INFECT IMMUN, V63, P3069, DOI 10.1128/IAI.63.8.3069-3072.1995; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Policastro PF, 1997, J MED MICROBIOL, V46, P839, DOI 10.1099/00222615-46-10-839; PRICE WH, 1953, SCIENCE, V118, P49, DOI 10.1126/science.118.3054.49; Qin JH, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-51; Raulston JE, 1997, INFECT IMMUN, V65, P4539, DOI 10.1128/IAI.65.11.4539-4547.1997; Renesto P, 2005, FEMS MICROBIOL LETT, V245, P231, DOI 10.1016/j.femsle.2005.03.004; SCARLATO V, 1993, BIOESSAYS, V15, P99, DOI 10.1002/bies.950150205; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; SILVERMAN DJ, 1992, INFECT IMMUN, V60, P2733, DOI 10.1128/IAI.60.7.2733-2740.1992; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Spencer RR, 1923, PUBLIC HEALTH REP, V38, P333, DOI 10.2307/4576667; WALKER DH, 1989, CLIN MICROBIOL REV, V2, P227, DOI 10.1128/CMR.2.3.227-240.1989; Walker DH, 2001, AM J TROP MED HYG, V65, P936, DOI 10.4269/ajtmh.2001.65.936; WALKER DH, 1983, INFECT IMMUN, V40, P840, DOI 10.1128/IAI.40.2.840-842.1983; WEISS E, 1975, APPL MICROBIOL, V30, P456, DOI 10.1128/AEM.30.3.456-463.1975; Whitby PW, 2006, J BACTERIOL, V188, P5640, DOI 10.1128/JB.00417-06; WINKLER HH, 1990, ANNU REV MICROBIOL, V44, P131, DOI 10.1146/annurev.mi.44.100190.001023; WINKLER HH, 1989, INFECT IMMUN, V57, P36, DOI 10.1128/IAI.57.1.36-40.1989; WINKLER HH, 1980, INFECT IMMUN, V29, P316; Zhou DS, 2006, FEMS MICROBIOL LETT, V258, P9, DOI 10.1111/j.1574-6968.2006.00208.x	60	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5612	10.1371/journal.pone.0005612	http://dx.doi.org/10.1371/journal.pone.0005612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440298	gold, Green Submitted, Green Published			2022-12-27	WOS:000266161200013
J	Safdar, A; Abadi, A; Akhtar, M; Hettinga, BP; Tarnopolsky, MA				Safdar, Adeel; Abadi, Arkan; Akhtar, Mahmood; Hettinga, Bart P.; Tarnopolsky, Mark A.			miRNA in the Regulation of Skeletal Muscle Adaptation to Acute Endurance Exercise in C57Bl/6J Male Mice	PLOS ONE			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; PYRUVATE-DEHYDROGENASE COMPLEX; TRANSCRIPTIONAL COACTIVATOR; GENE-EXPRESSION; PPAR-ALPHA; MICRORNAS; PGC-1-ALPHA; METABOLISM; INCREASES; GLUCOSE	MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNA species involved in post-transcriptional gene regulation. In vitro studies have identified a small number of skeletal muscle-specific miRNAs which play a crucial role in myoblast proliferation and differentiation. In skeletal muscle, an acute bout of endurance exercise results in the upregulation of transcriptional networks that regulate mitochondrial biogenesis, glucose and fatty acid metabolism, and skeletal muscle remodelling. The purpose of this study was to assess the expressional profile of targeted miRNA species following an acute bout of endurance exercise and to determine relationships with previously established endurance exercise responsive transcriptional networks. C57Bl/6J wild-type male mice (N = 7/group) were randomly assigned to either sedentary or forced-endurance exercise (treadmill run @ 15 m/min for 90 min) group. The endurance exercise group was sacrificed three hours following a single bout of exercise. The expression of miR-181, 1, 133, 23, and 107, all of which have been predicted to regulate transcription factors and co-activators involved in the adaptive response to exercise, was measured in quadriceps femoris muscle. Endurance exercise significantly increased the expression of miR-181, miR-1, and miR-107 by 37%, 40%, and 56%, respectively, and reduced miR-23 expression by 84% (P <= 0.05 for all), with no change in miR-133. Importantly, decreased expression of miRNA-23, a putative negative regulator of PGC-1 alpha was consistent with increased expression of PGC-1 alpha mRNA and protein along with several downstream targets of PGC-1 alpha including ALAS, CS, and cytochrome c mRNA. PDK4 protein content remains unaltered despite an increase in its putative negative regulator, miR-107, and PDK4 mRNA expression. mRNA expression of miRNA processing machinery (Drosha, Dicer, and DGCR8) remained unchanged. We conclude that miRNA-mediated post-transcriptional regulation is potentially involved in the complex regulatory networks that govern skeletal muscle adaptation to endurance exercise in C57Bl/6J male mice.			Safdar, A (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	tarnopol@mcmaster.ca		Safdar, Adeel/0000-0003-2469-0467; Safdar, Adeel/0000-0002-7453-7770				Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Baar K, 2003, FASEB J, V17, P1666, DOI 10.1096/fj.03-0049com; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bonen A, 1999, AM J PHYSIOL-ENDOC M, V276, pE642, DOI 10.1152/ajpendo.1999.276.4.E642; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Carter SL, 2001, AM J PHYSIOL-ENDOC M, V280, pE898, DOI 10.1152/ajpendo.2001.280.6.E898; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; GOLLNICK PD, 1982, CLIN PHYSIOL, V2, P1, DOI 10.1111/j.1475-097X.1982.tb00001.x; Hamilton MT, 2000, J APPL PHYSIOL, V88, P327, DOI 10.1152/jappl.2000.88.1.327; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hawley JA, 2006, ESSAYS BIOCHEM, V42, P1, DOI 10.1042/bse0420001; Hildebrandt AL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1021, DOI 10.1152/ajpendo.00234.2003; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hoppeler H, 2007, ADV EXP MED BIOL, V618, P245; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Joseph AM, 2006, ESSAYS BIOCHEM, V42, P13, DOI 10.1042/bse0420013; Keller P, 2007, BIOCHEM SOC T, V35, P1306, DOI 10.1042/BST0351306; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Papagiannakopoulos T, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-15; Peters SJ, 2001, AM J PHYSIOL-REG I, V280, pR661, DOI 10.1152/ajpregu.2001.280.3.R661; Pilegaard H, 2002, J PHYSIOL-LONDON, V541, P261, DOI 10.1113/jphysiol.2002.016832; Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ramaswamy G, 2004, J LIPID RES, V45, P17, DOI 10.1194/jlr.M300279-JLR200; REN JM, 1994, J BIOL CHEM, V269, P14396; Rose AJ, 2005, J PHYSIOL-LONDON, V569, P223, DOI 10.1113/jphysiol.2005.097154; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Skrede S, 1997, BBA-LIPID LIPID MET, V1344, P115, DOI 10.1016/S0005-2760(96)00138-5; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vissing K, 2008, AM J PHYSIOL-ENDOC M, V294, pE408, DOI 10.1152/ajpendo.00403.2007; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	62	164	181	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5610	10.1371/journal.pone.0005610	http://dx.doi.org/10.1371/journal.pone.0005610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440340	Green Submitted, Green Published, gold			2022-12-27	WOS:000266161200012
J	Crow, A; Race, PR; Jubelin, G; Chavez, CV; Escoubas, JM; Oswald, E; Banfield, MJ				Crow, Allister; Race, Paul R.; Jubelin, Gregory; Chavez, Carolina Varela; Escoubas, Jean-Michel; Oswald, Eric; Banfield, Mark J.			Crystal Structures of Cif from Bacterial Pathogens Photorhabdus luminescens and Burkholderia pseudomallei	PLOS ONE			English	Article							HOST-CELL CYCLE; CYCLOMODULIN CIF; SECRETION; EFFECTOR; BLOCKS; DOMAIN	A pre-requisite for bacterial pathogenesis is the successful interaction of a pathogen with a host. One mechanism used by a broad range of Gram negative bacterial pathogens is to deliver effector proteins directly into host cells through a dedicated type III secretion system where they modulate host cell function. The cycle inhibiting factor (Cif) family of effector proteins, identified in a growing number of pathogens that harbour functional type III secretion systems and have a wide host range, arrest the eukaryotic cell cycle. Here, the crystal structures of Cifs from the insect pathogen/nematode symbiont Photorhabdus luminescens (a gamma-proteobacterium) and human pathogen Burkholderia pseudomallei (a beta-proteobacterium) are presented. Both of these proteins adopt an overall fold similar to the papain sub-family of cysteine proteases, as originally identified in the structure of a truncated form of Cif from Enteropathogenic E. coli (EPEC), despite sharing only limited sequence identity. The structure of an N-terminal region, referred to here as the 'tail-domain' (absent in the EPEC Cif structure), suggests a surface likely to be involved in host-cell substrate recognition. The conformation of the Cys-His-Gln catalytic triad is retained, and the essential cysteine is exposed to solvent and addressable by small molecule reagents. These structures and biochemical work contribute to the rapidly expanding literature on Cifs, and direct further studies to better understand the molecular details of the activity of these proteins.	[Crow, Allister; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Race, Paul R.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Jubelin, Gregory; Oswald, Eric] Univ Toulouse, INRA, ENVT, UMR 1225, Toulouse, France; [Chavez, Carolina Varela; Escoubas, Jean-Michel] INRA, Lab EMIP UMR1133, F-34095 Montpellier, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Newcastle University - UK; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE	Banfield, MJ (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England.	mark.banfield@bbsrc.ac.uk	ESCOUBAS, Jean-Michel/G-4027-2010; Crow, Allister/F-2147-2018; Banfield, Mark/C-7453-2013	ESCOUBAS, Jean-Michel/0000-0002-6138-1148; Crow, Allister/0000-0001-6856-5962; Banfield, Mark/0000-0001-8921-3835; Oswald, Eric/0000-0002-3017-0081; JUBELIN, Gregory/0000-0002-9902-0663	BBSRC [BB/F008732/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [F008732, BB/F008732/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hsu Y, 2008, J MOL BIOL, V384, P465, DOI 10.1016/j.jmb.2008.09.051; Jubelin G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004855; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; KLEYWEGT GJ, 2001, INT TABLES CRYSTALLO, VF; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Miranda JJL, 2003, PROTEIN SCI, V12, P73, DOI 10.1110/ps.0224203; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naktin J, 1999, CLIN LAB MED, V19, P523; Nougayrede JP, 2001, INFECT IMMUN, V69, P6785, DOI 10.1128/IAI.69.11.6785-6795.2001; REECE RJ, 1991, J BIOL CHEM, V266, P3540; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Stebbins CE, 2005, CELL MICROBIOL, V7, P1227, DOI 10.1111/j.1462-5822.2005.00564.x; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Taieb F, 2006, CELL MICROBIOL, V8, P1910, DOI 10.1111/j.1462-5822.2006.00757.x; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; YAO Q, 2009, P NATL ACAD SCI US; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	31	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5582	10.1371/journal.pone.0005582	http://dx.doi.org/10.1371/journal.pone.0005582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440549	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107500012
J	Mate, KS; Bennett, B; Mphatswe, W; Barker, P; Rollins, N				Mate, Kedar S.; Bennett, Brandon; Mphatswe, Wendy; Barker, Pierre; Rollins, Nigel			Challenges for Routine Health System Data Management in a Large Public Programme to Prevent Mother-to-Child HIV Transmission in South Africa	PLOS ONE			English	Article								Background: Recent changes to South Africa's prevention of mother-to-child transmission of HIV (PMTCT) guidelines have raised hope that the national goal of reducing perinatal HIV transmission rates to less than 5% can be attained. While programmatic efforts to reach this target are underway, obtaining complete and accurate data from clinical sites to track progress presents a major challenge. We assessed the completeness and accuracy of routine PMTCT data submitted to the district health information system (DHIS) in three districts of Kwazulu-Natal province, South Africa. Methodology/Principal Findings: We surveyed the completeness and accuracy of data reported for six key PMTCT data elements between January and December 2007 from all 316 clinics and hospitals in three districts. Through visits to randomly selected sites, we reconstructed reports for the same six PMTCT data elements from clinic registers and assessed accuracy of the monthly reports previously submitted to the DHIS. Data elements were reported only 50.3% of the time and were "accurate'' (i.e. within 10% of reconstructed values) 12.8% of the time. The data element "Antenatal Clients Tested for HIV'' was the most accurate data element (i.e. consistent with the reconstructed value) 19.8% of the time, while "HIV PCR testing of baby born to HIV positive mother'' was the least accurate with only 5.3% of clinics meeting the definition of accuracy. Conclusions/Significance: Data collected and reported in the public health system across three large, high HIV-prevalence Districts was neither complete nor accurate enough to track process performance or outcomes for PMTCT care. Systematic data evaluation can determine the magnitude of the data reporting failure and guide site-specific improvements in data management. Solutions are currently being developed and tested to improve data quality.			Mate, KS (corresponding author), Inst Healthcare Improvement, Cambridge, MA USA.	kmate@partners.org		Mate, Kedar/0000-0001-7579-6697				Boerma T, 2009, B WORLD HEALTH ORGAN, V87, P2, DOI 10.2471/BLT.08.061945; Burger EH, 2007, SAMJ S AFR MED J, V97, P1077; Campbell B, 1996, DATA DECISION MAKING; Clements CJ, 2008, VACCINE, V26, P1926, DOI 10.1016/j.vaccine.2008.02.032; Garrib A, 2008, SAMJ S AFR MED J, V98, P549; Makombe SD, 2008, B WORLD HEALTH ORGAN, V86, P310, DOI 10.2471/BLT.07.044685; Mavimbe JC, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-108; Otwombe KN, 2007, B WORLD HEALTH ORGAN, V85, P315, DOI 10.2471/BLT.06.033712; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Ronveaux O, 2005, B WORLD HEALTH ORGAN, V83, P503; *S AFR DEP HLTH, 2007, NAT STRAT PLAN HIV A; Shaw V, 2005, B WORLD HEALTH ORGAN, V83, P632; South African Department of Health, 2008, POL GUID IMPL PMTCT; The IATT on Prevention of HIV Infection in Pregnant Women MatC, 2007, GUID GLOB SCAL UP PR; Wilkins K, 2008, PUBLIC HEALTH, V122, P914, DOI 10.1016/j.puhe.2007.11.002; World Health Organization (WHO), 2008, TOOLK MON HLTH SYST	16	144	145	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2009	4	5							e5483	10.1371/journal.pone.0005483	http://dx.doi.org/10.1371/journal.pone.0005483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VZ	19434234	Green Published, gold			2022-12-27	WOS:000266009800004
J	Reigstad, CS; Lunden, GO; Felin, J; Backhed, F				Reigstad, Christopher S.; Lunden, Gunnel Ostergren; Felin, Jenny; Backhed, Fredrik			Regulation of Serum Amyloid A3 (SAA3) in Mouse Colonic Epithelium and Adipose Tissue by the Intestinal Microbiota	PLOS ONE			English	Article							DIET-INDUCED OBESITY; NF-KAPPA-B; INSULIN-RESISTANCE; GUT MICROBIOTA; GENE FAMILY; EXPRESSION; INFLAMMATION; ADIPOKINE	The gut microbiota has been proposed as an environmental factor that affects the development of metabolic and inflammatory diseases in mammals. Recent reports indicate that gut bacteria-derived lipopolysaccharide (LPS) can initiate obesity and insulin resistance in mice; however, the molecular interactions responsible for microbial regulation of host metabolism and mediators of inflammation have not been studied in detail. Hepatic serum amyloid A (SAA) proteins are markers and proposed mediators of inflammation that exhibit increased levels in serum of insulin-resistant mice. Adipose tissue-derived SAA3 displays monocyte chemotactic activity and may play a role in metabolic inflammation associated with obesity and insulin resistance. To investigate a potential mechanistic link between the intestinal microbiota and induction of proinflammatory host factors, we performed molecular analyses of germ-free, conventionally raised and genetically modified Myd88(-/-) mouse models. SAA3 expression was determined to be significantly augmented in adipose (9.9 +/- 1.9-fold; P<0.001) and colonic tissue (7.0 +/- 2.3-fold; P<0.05) by the presence of intestinal microbes. In the colon, we provided evidence that SAA3 is partially regulated through the Toll-like receptor (TLR)/MyD88/NF-kappaB signaling axis. We identified epithelial cells and macrophages as cellular sources of SAA3 in the colon and found that colonic epithelial expression of SAA3 may be part of an NF-kappaB-dependent response to LPS from gut bacteria. In vitro experiments showed that LPS treatments of both epithelial cells and macrophages induced SAA3 expression (27.1 +/- 2.5-fold vs. 1.6 +/- 0.1-fold, respectively). Our data suggest that LPS, and potentially other products of the indigenous gut microbiota, might elevate cytokine expression in tissues and thus exacerbate chronic low-grade inflammation observed in obesity.			Reigstad, CS (corresponding author), Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden.	fredrik.backhed@wlab.gu.se	Eckhardt, Erik/G-1567-2010; Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818				Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Bing ZY, 1999, J BIOL CHEM, V274, P24649, DOI 10.1074/jbc.274.35.24649; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; CHIBA T, 2009, J LIPID RES; DESPRES JP, 1992, MOL CELL BIOCHEM, V113, P151, DOI 10.1007/BF00231535; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCole DF, 2007, CURR OPIN GASTROEN, V23, P647, DOI 10.1097/MOG.0b013e3282f0153b; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Ogasawara K, 2004, ATHEROSCLEROSIS, V174, P349, DOI 10.1016/j.atherosclerosis.2004.01.030; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Reinhardt C, 2009, J PEDIATR GASTR NUTR, V48, P249, DOI 10.1097/MPG.0b013e318183187c; Roncon-Albuquerque R, 2008, LIFE SCI, V83, P502, DOI 10.1016/j.lfs.2008.07.021; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; SHIMIZU H, 1994, GENE, V149, P305; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Sommer G, 2008, J CELL BIOCHEM, V104, P2241, DOI 10.1002/jcb.21782; Son DS, 2004, ENDOCRINOLOGY, V145, P2245, DOI 10.1210/en.2003-1261; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Turnbaugh P.J., 2008, NATURE; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287	40	98	112	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5842	10.1371/journal.pone.0005842	http://dx.doi.org/10.1371/journal.pone.0005842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513118	Green Published, gold, Green Submitted			2022-12-27	WOS:000267228800008
J	Vera, PL; Wang, XH; Bucala, RJ; Meyer-Siegler, KL				Vera, Pedro L.; Wang, Xihai; Bucala, Richard J.; Meyer-Siegler, Katherine L.			Intraluminal Blockade of Cell-Surface CD74 and Glucose Regulated Protein 78 Prevents Substance P-Induced Bladder Inflammatory Changes in the Rat	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; EPITHELIAL-CELLS; UP-REGULATION; RECEPTOR; MIF; INDUCTION; RELEASE; BINDING	Background: Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine constitutively expressed by urothelial cells. During inflammatory stimuli, MIF is released into the lumen complexed to other proteins and these complexes can bind to urothelial cell-surface receptors to activate signaling pathways. Since MIF is complexed to alpha 1-inhibitor III (A1-I3; a member of the alpha 2-macroglubulin family) and glucose regulated protein 78 (GRP78) is a receptor for A1-I3 the goals of this study were to determine if substance P elicits urothelial cell-surface expression of GRP78 and to assess the functional role of CD74 (receptor for MIF) or GRP78 in substance P-induced bladder inflammatory changes. Methodology/Principal Findings: Anesthetized male Sprague-Dawley rats received either saline or substance P (s.c.), bladders were collected 1 hour after treatment and processed for histology or protein/mRNA. The expression of GRP78 at urothelial cell-surface was determined by performing in vivo biotinylation of urothelial cell-surface proteins. Finally, in order to determine the effects of receptor blockade on substance P-induced MIF release and inflammatory changes, rats received either intraluminal antibodies to CD74, GRP78, both, or non-specific IgG (as a control). GRP78 and MIF immunostaining was simultaneously visualized in umbrella cells only after substance P treatment. Immunoprecipitation studies showed GRP78-MIF complexes increased after substance P while in vivo biotinylation confirmed substance P-induced GRP78 cell-surface expression in urothelial cells. Intraluminal blockade of CD74 and/or GRP78 prevented substance P-induced changes, including bladder edema, intraluminal MIF release by urothelial cells and production of inflammatory cytokines by urothelial cells. Conclusions/Significance: GRP78 is expressed on the surface of urothelial cells after substance P treatment where it can bind MIF complexes. Blocking CD74 (receptor for MIF) and/or GRP78 prevented substance P-induced inflammatory changes in bladder and urothelium, indicating that these urothelial receptors are effective targets for disrupting MIF-mediated bladder inflammation.			Vera, PL (corresponding author), Bay Pines VA Healthcare Syst Res & Dev, Bay Pines, FL USA.	pvera@health.usf.edu	Vera, Pedro/AAE-1514-2021		NIAID NIH HHS [AI04230] Funding Source: Medline; NIDDK NIH HHS [DK075059, R21 DK075059] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075059] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Birder LA, 2004, SCAND J UROL NEPHROL, V38, P48, DOI 10.1080/03008880410015165; Boilard M, 2004, BIOL REPROD, V71, P1879, DOI 10.1095/biolreprod.103.026849; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Maitra A, 1999, NAT MED, V5, P459, DOI 10.1038/7458; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Meyer-Siegler KL, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/535348; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Meyer-Siegler KL, 2005, J UROLOGY, V173, P615, DOI 10.1097/01.ju.0000143188.02802.f3; Meyer-Siegler KL, 2004, J UROLOGY, V172, P1504, DOI 10.1097/01.ju.0000140213.54457.97; Meyer-Siegler KL, 2004, J UROLOGY, V171, P1698, DOI 10.1097/01.ju.0000115883.49365.1a; Meyer-Siegler KL, 2004, J INTERF CYTOK RES, V24, P55, DOI 10.1089/107999004772719918; Misra UK, 1996, J CELL BIOCHEM, V61, P61, DOI 10.1002/(SICI)1097-4644(19960401)61:1<61::AID-JCB8>3.3.CO;2-N; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Simmons DG, 2000, BIOL REPROD, V62, P1168, DOI 10.1095/biolreprod62.5.1168; Vera PL, 2008, J UROLOGY, V180, P373, DOI 10.1016/j.juro.2008.02.040; Vera Pedro L, 2006, BMC Urol, V6, P24, DOI 10.1186/1471-2490-6-24; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003898; Vera PL, 2005, J UROLOGY, V174, P338, DOI 10.1097/01.ju.0000161606.15696.79; Vera PL, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-17; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105	27	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5835	10.1371/journal.pone.0005835	http://dx.doi.org/10.1371/journal.pone.0005835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503733	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717400014
J	Liu, PT; Schenk, M; Walker, VP; Dempsey, PW; Kanchanapoomi, M; Wheelwright, M; Vazirnia, A; Zhang, XR; Steinmeyer, A; Zugel, U; Hollis, BW; Cheng, GH; Modlin, RL				Liu, Philip T.; Schenk, Mirjam; Walker, Valencia P.; Dempsey, Paul W.; Kanchanapoomi, Melissa; Wheelwright, Matthew; Vazirnia, Aria; Zhang, Xiaoran; Steinmeyer, Andreas; Zuegel, Ulrich; Hollis, Bruce W.; Cheng, Genhong; Modlin, Robert L.			Convergence of IL-1 beta and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses	PLOS ONE			English	Article								Antimicrobial effector mechanisms are central to the function of the innate immune response in host defense against microbial pathogens. In humans, activation of Toll-like receptor 2/1 (TLR2/1) on monocytes induces a vitamin D dependent antimicrobial activity against intracellular mycobacteria. Here, we report that TLR activation of monocytes triggers induction of the defensin beta 4 gene (DEFB4), requiring convergence of the IL-1 beta and vitamin D receptor (VDR) pathways. TLR2/1 activation triggered IL-1 beta activity, involving the upregulation of both IL-1 beta and IL-1 receptor, and downregulation of the IL-1 receptor antagonist. TLR2/1L induction of IL-1 beta was required for upregulation of DEFB4, but not cathelicidin, whereas VDR activation was required for expression of both antimicrobial genes. The differential requirements for induction of DEFB4 and cathelicidin were reflected by differences in their respective promoter regions; the DEFB4 promoter had one vitamin D response element (VDRE) and two NF-kappa B sites, whereas the cathelicidin promoter had three VDREs and no NF-kappa B sites. Transfection of NF-kappa B into primary monocytes synergized with 1,25D3 in the induction of DEFB4 expression. Knockdown of either DEFB4 or cathelicidin in primary monocytes resulted in the loss of TLR2/1-mediated antimicrobial activity against intracellular mycobacteria. Therefore, these data identify a novel mechanism of host defense requiring the induction of IL-1 beta in synergy with vitamin D activation, for the TLR-induced antimicrobial pathway against an intracellular pathogen.			Liu, PT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA.	philip@bruinphd.com	Modlin, Robert L/M-7941-2014; Zhang, Xiaoran/C-4979-2015; Liu, Philip/C-9638-2011	Modlin, Robert L/0000-0003-4720-031X; Schenk, Mirjam/0000-0002-1637-0730; Wheelwright, Matthew/0000-0001-8883-4453; Liu, Philip/0000-0002-6144-0304	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD034610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047868] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI047868] Funding Source: Medline; NICHD NIH HHS [K12 HD034610] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS JS, 1989, J CLIN ENDOCR METAB, V69, P457, DOI 10.1210/jcem-69-2-457; ANDERSSON J, 1992, EUR J IMMUNOL, V22, P2617, DOI 10.1002/eji.1830221022; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Carl VS, 2002, J BIOL CHEM, V277, P17448, DOI 10.1074/jbc.M111847200; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chang JM, 2004, J LAB CLIN MED, V143, P14, DOI 10.1016/j.lab.2003.08.002; CROWLE AJ, 1987, INFECT IMMUN, V55, P2945, DOI 10.1128/IAI.55.12.2945-2950.1987; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; FENTON MJ, 1987, J IMMUNOL, V138, P3972; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gamero AM, 2006, IMMUNITY, V24, P16, DOI 10.1016/j.immuni.2005.12.007; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; JANSON RW, 1991, J IMMUNOL, V147, P4218; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; LIAO ZH, 1985, J IMMUNOL, V134, P3882; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu PT, 2005, J IMMUNOL, V174, P2467, DOI 10.4049/jimmunol.174.5.2467; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Miller LS, 2005, J IMMUNOL, V174, P6137, DOI 10.4049/jimmunol.174.10.6137; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Morello S, 2006, J IMMUNOL, V177, P7173, DOI 10.4049/jimmunol.177.10.7173; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; ORINO E, 1992, J IMMUNOL, V149, P925; Rivas-Santiago B, 2005, INFECT IMMUN, V73, P4505, DOI 10.1128/IAI.73.8.4505-4511.2005; ROGERS HW, 1992, P NATL ACAD SCI USA, V89, P1011, DOI 10.1073/pnas.89.3.1011; ROGERS HW, 1994, J IMMUNOL, V153, P2093; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Shin JS, 2004, EXP MOL MED, V36, P204, DOI 10.1038/emm.2004.28; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; SONE S, 1994, EUR RESPIR J, V7, P657, DOI 10.1183/09031936.94.07040657; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; TURNER M, 1991, EUR J IMMUNOL, V21, P1635, DOI 10.1002/eji.1830210708; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WATSON RWG, 1994, J LEUKOCYTE BIOL, V56, P95, DOI 10.1002/jlb.56.1.95; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863	51	241	246	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5810	10.1371/journal.pone.0005810	http://dx.doi.org/10.1371/journal.pone.0005810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503839	gold, Green Published, Green Submitted			2022-12-27	WOS:000266717200006
J	Evensen, L; Micklem, DR; Blois, A; Berge, SV; Aarsaether, N; Littlewood-Evans, A; Wood, J; Lorens, JB				Evensen, Lasse; Micklem, David R.; Blois, Anna; Berge, Sissel Vik; Aarsaether, Niels; Littlewood-Evans, Amanda; Wood, Jeanette; Lorens, James B.			Mural Cell Associated VEGF Is Required for Organotypic Vessel Formation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; VASCULAR MORPHOGENESIS; BLOOD-VESSELS; MOLECULAR REGULATION; COCULTURE MODEL; FACTOR-BETA; ANGIOGENESIS; PERICYTE; TUMORS	Background: Blood vessels comprise endothelial cells, mural cells (pericytes/vascular smooth muscle cells) and basement membrane. During angiogenesis, mural cells are recruited to sprouting endothelial cells and define a stabilizing context, comprising cell-cell contacts, secreted growth factors and extracellular matrix components, that drives vessel maturation and resistance to anti-angiogenic therapeutics. Methods and Findings: To better understand the basis for mural cell regulation of angiogenesis, we conducted high content imaging analysis on a microtiter plate format in vitro organotypic blood vessel system comprising primary human endothelial cells co-cultured with primary human mural cells. We show that endothelial cells co-cultured with mural cells undergo an extensive series of phenotypic changes reflective of several facets of blood vessel formation and maturation: Loss of cell proliferation, pathfinding-like cell migration, branching morphogenesis, basement membrane extracellular matrix protein deposition, lumen formation, anastamosis and development of a stabilized capillary-like network. This phenotypic sequence required endothelial-mural cell-cell contact, mural cell-derived VEGF and endothelial VEGFR2 signaling. Inhibiting formation of adherens junctions or basement membrane structures abrogated network formation. Notably, inhibition of mural cell VEGF expression could not be rescued by exogenous VEGF. Conclusions: These results suggest a unique role for mural cell-associated VEGF in driving vessel formation and maturation.			Evensen, L (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	jim.lorens@biomed.uib.no	Lorens, James/B-9737-2017	Lorens, James/0000-0002-6782-3349; Micklem, David/0000-0003-2756-2591				Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Bryan BA, 2008, METHOD ENZYMOL, V443, P315, DOI 10.1016/S0076-6879(08)02016-8; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Ding RB, 2004, STEM CELLS DEV, V13, P509, DOI 10.1089/1547328042417336; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; GOTO F, 1993, LAB INVEST, V69, P508; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hall AP, 2006, TOXICOL PATHOL, V34, P763, DOI 10.1080/01926230600936290; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Kurzen H, 2002, J INVEST DERMATOL, V119, P143, DOI 10.1046/j.1523-1747.2002.01792.x; Lilly B, 2009, PHYSIOL GENOMICS, V36, P69, DOI 10.1152/physiolgenomics.90318.2008; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Lorens JB, 2000, MOL THER, V1, P438, DOI 10.1006/mthe.2000.0063; Lorens JB, 2004, J BIOCHEM BIOPH METH, V58, P101, DOI 10.1016/S0165-022X(03)00147-7; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Presta LG, 1997, CANCER RES, V57, P4593; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Wakui S, 2006, LAB INVEST, V86, P1172, DOI 10.1038/labinvest.3700476; Wilkinson-Berka JL, 2004, AM J PATHOL, V164, P1263, DOI 10.1016/S0002-9440(10)63214-2; Wood JM, 2000, CANCER RES, V60, P2178	42	106	110	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5798	10.1371/journal.pone.0005798	http://dx.doi.org/10.1371/journal.pone.0005798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495422	Green Submitted, Green Published, gold			2022-12-27	WOS:000266716900008
J	Irimia, M; Rukov, JL; Roy, SW				Irimia, Manuel; Rukov, Jakob Lewin; Roy, Scott William			Evolution of Alternative Splicing Regulation: Changes in Predicted Exonic Splicing Regulators Are Not Associated with Changes in Alternative Splicing Levels in Primates	PLOS ONE			English	Article							GENE; IDENTIFICATION; SEQUENCES; EXPRESSION; ENHANCERS; ELEMENTS; CONSERVATION; COMPLEXITY; DEFINITION; SELECTION	Alternative splicing is tightly regulated in a spatio-temporal and quantitative manner. This regulation is achieved by a complex interplay between spliceosomal ( trans) factors that bind to different sequence (cis) elements. cis-elements reside in both introns and exons and may either enhance or silence splicing. Differential combinations of cis-elements allows for a huge diversity of overall splicing signals, together comprising a complex 'splicing code'. Many cis-elements have been identified, and their effects on exon inclusion levels demonstrated in reporter systems. However, the impact of interspecific differences in these elements on the evolution of alternative splicing levels has not yet been investigated at genomic level. Here we study the effect of interspecific differences in predicted exonic splicing regulators (ESRs) on exon inclusion levels in human and chimpanzee. For this purpose, we compiled and studied comprehensive datasets of predicted ESRs, identified by several computational and experimental approaches, as well as microarray data for changes in alternative splicing levels between human and chimpanzee. Surprisingly, we found no association between changes in predicted ESRs and changes in alternative splicing levels. This observation holds across different ESR exon positions, exon lengths, and 59 splice site strengths. We suggest that this lack of association is mainly due to the great importance of context for ESR functionality: many ESR-like motifs in primates may have little or no effect on splicing, and thus interspecific changes at short-time scales may primarily occur in these effectively neutral ESRs. These results underscore the difficulties of using current computational ESR prediction algorithms to identify truly functionally important motifs, and provide a cautionary tale for studies of the effect of SNPs on splicing in human disease.			Irimia, M (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	mirimia@gmail.com; royscott@ncbi.nlm.nih.gov	Irimia, Manuel/E-3040-2010	Irimia, Manuel/0000-0002-2179-2567	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Artamonova II, 2007, CHEM REV, V107, P3407, DOI 10.1021/cr068304c; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Barberan-Soler S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000001; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Carlini DB, 2006, J MOL EVOL, V62, P89, DOI 10.1007/s00239-005-0055-x; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Irimia M, 2008, MOL BIOL EVOL, V25, P375, DOI 10.1093/molbev/msm262; Irimia M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-188; Irimia M, 2009, BIOESSAYS, V31, P40, DOI 10.1002/bies.080092; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Ke SD, 2008, GENOME RES, V18, P533, DOI 10.1101/gr.070268.107; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Parmley JL, 2007, MOL BIOL EVOL, V24, P1600, DOI 10.1093/molbev/msm104; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Roca X, 2005, RNA, V11, P683, DOI 10.1261/rna.2040605; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; Rukov JL, 2007, MOL BIOL EVOL, V24, P909, DOI 10.1093/molbev/msm023; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Shai O, 2006, BIOINFORMATICS, V22, P606, DOI 10.1093/bioinformatics/btk028; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stadler MB, 2006, PLOS GENET, V2, P1849, DOI 10.1371/journal.pgen.0020191; StallingsMann ML, 1996, P NATL ACAD SCI USA, V93, P12394, DOI 10.1073/pnas.93.22.12394; Stanton T, 2003, P NATL ACAD SCI USA, V100, P5997, DOI 10.1073/pnas.0931490100; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Warnecke T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r29; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang XHF, 2005, METHODS, V37, P292, DOI 10.1016/j.ymeth.2005.07.011; Zhang XHF, 2005, MOL CELL BIOL, V25, P7323, DOI 10.1128/MCB.25.16.7323-7332.2005; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng CL, 2005, RNA, V11, P1777, DOI 10.1261/rna.2660805	70	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5800	10.1371/journal.pone.0005800	http://dx.doi.org/10.1371/journal.pone.0005800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495418	gold, Green Submitted, Green Published			2022-12-27	WOS:000266716900010
J	DeLuca, I; Blachere, NE; Santomasso, B; Darnell, RB				DeLuca, Ilana; Blachere, Nathalie E.; Santomasso, Bianca; Darnell, Robert B.			Tolerance to the Neuron-Specific Paraneoplastic HuD Antigen	PLOS ONE			English	Article								Experiments dating back to the 1940's have led to the hypothesis that the brain is an immunologically privileged site, shielding its antigens from immune recognition. The paraneoplastic Hu syndrome provides a powerful paradigm for addressing this hypothesis; it is believed to develop because small cell lung cancers (SCLC) express the neuron-specific Hu protein. This leads to an Hu-specific tumor immune response that can develop into an autoimmune attack against neurons, presumably when immune privilege in the brain is breached. Interestingly, all SCLC express the onconeural HuD antigen, and clinically useful tumor immune responses can be detected in up to 20% of patients, yet the paraneoplastic neurologic syndrome is extremely rare. We found that HuD-specific CD8+ T cells are normally present in the mouse T cell repertoire, but are not expanded upon immunization, although they can be detected after in vitro expansion. In contrast, HuD-specific T cells could be directly activated in HuD null mice, without the need for in vitro expansion. Taken together, these results demonstrate robust tolerance to the neuronal HuD antigen in vivo, and suggest a re-evaluation of the current concept of immune privilege in the brain.			DeLuca, I (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088; Santomasso, Bianca/0000-0001-9423-4059	NATIONAL CANCER INSTITUTE [R01CA085784] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA85784, R01 CA085784] Funding Source: Medline; NCRR NIH HHS [UL1 RR024143] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; BANERJEE R, 1992, J NEUROCYTOL, V21, P235, DOI 10.1007/BF01224758; Benyahia B, 1999, ANN NEUROL, V45, P162, DOI 10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; DALMAU J, 1992, MEDICINE, V71, P59, DOI 10.1097/00005792-199203000-00001; DALMAU J, 1990, ANN NEUROL, V27, P544, DOI 10.1002/ana.410270515; Darnell JC, 2000, CANCER RES, V60, P2136; Darnell RB, 1996, P NATL ACAD SCI USA, V93, P4529, DOI 10.1073/pnas.93.10.4529; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; de Beukelaar JW, 2007, CANCER IMMUNOL IMMUN, V56, P1501, DOI 10.1007/s00262-007-0295-2; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Dyall R, 1996, J EXP MED, V184, P253, DOI 10.1084/jem.184.1.253; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Graus F, 1997, J CLIN ONCOL, V15, P2866, DOI 10.1200/JCO.1997.15.8.2866; Harling-Berg CJ, 1999, J NEUROIMMUNOL, V101, P111, DOI 10.1016/S0165-5728(99)00130-7; HARLINGBERG CJ, 1991, J NEUROIMMUNOL, V35, P45, DOI 10.1016/0165-5728(91)90160-9; Heath WR, 1998, J EXP MED, V187, P1549, DOI 10.1084/jem.187.10.1549; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JAECKLE K, 1983, ANN NEUROL, V111; JEAN WC, 1994, NEUROLOGY, V44, P140, DOI 10.1212/WNL.44.1.140; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; MANLEY GT, 1995, ANN NEUROL, V38, P102, DOI 10.1002/ana.410380117; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; Okano HJ, 1997, J NEUROSCI, V17, P3024; Plonquet A, 2003, J NEUROIMMUNOL, V142, P93, DOI 10.1016/S0165-5728(03)00269-8; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; ROBERTS WK, 2009, J CLIN INVE IN PRESS; Rousseau A, 2005, J NEURO-ONCOL, V71, P231, DOI 10.1007/s11060-004-1723-1; Santomasso BD, 2007, P NATL ACAD SCI USA, V104, P19073, DOI 10.1073/pnas.0704336104; Streilein JW, 2002, VISION RES, V42, P487, DOI 10.1016/S0042-6989(01)00185-7; Tanaka M, 2002, J NEUROL SCI, V201, P9, DOI 10.1016/S0022-510X(02)00157-0	38	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5739	10.1371/journal.pone.0005739	http://dx.doi.org/10.1371/journal.pone.0005739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492067	gold, Green Published, Green Submitted			2022-12-27	WOS:000266624300004
J	Walsh, MP; Chintakuntlawar, A; Robinson, CM; Madisch, I; Harrach, B; Hudson, NR; Schnurr, D; Heim, A; Chodosh, J; Seto, D; Jones, MS				Walsh, Michael P.; Chintakuntlawar, Ashish; Robinson, Christopher M.; Madisch, Ijad; Harrach, Balazs; Hudson, Nolan R.; Schnurr, David; Heim, Albert; Chodosh, James; Seto, Donald; Jones, Morris S.			Evidence of Molecular Evolution Driven by Recombination Events Influencing Tropism in a Novel Human Adenovirus that Causes Epidemic Keratoconjunctivitis	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISEASE; WORLD MONKEY ADENOVIRUS; BIOINFORMATICS ANALYSIS; GENOME SEQUENCE; DNA-REPLICATION; VIRUS TYPE-1; EXPRESSION; DEFICIENCY; POLYMERASE; REDUNDANT	In 2005, a human adenovirus strain (formerly known as HAdV-D22/H8 but renamed here HAdV-D53) was isolated from an outbreak of epidemic keratoconjunctititis (EKC), a disease that is usually caused by HAdV-D8, -D19, or -D37, not HAdV-D22. To date, a complete change of tropism compared to the prototype has never been observed, although apparent recombinant strains of other viruses from species Human adenovirus D (HAdV-D) have been described. The complete genome of HAdV-D53 was sequenced to elucidate recombination events that lead to the emergence of a viable and highly virulent virus with a modified tropism. Bioinformatic and phylogenetic analyses of this genome demonstrate that this adenovirus is a recombinant of HAdV-D8 (including the fiber gene encoding the primary cellular receptor binding site), HAdV-D22, (the e determinant of the hexon gene), HAdV-D37 (including the penton base gene encoding the secondary cellular receptor binding site), and at least one unknown or unsequenced HAdV-D strain. Bootscanning analysis of the complete genomic sequence of this novel adenovirus, which we have re-named HAdV-D53, indicated at least five recombination events between the aforementioned adenoviruses. Intrahexon recombination sites perfectly framed the epsilon neutralization determinant that was almost identical to the HAdV-D22 prototype. Additional bootscan analysis of all HAdV-D hexon genes revealed recombinations in identical locations in several other adenoviruses. In addition, HAdV-D53 but not HAdV-D22 induced corneal inflammation in a mouse model. Serological analysis confirmed previous results and demonstrated that HAdV-D53 has a neutralization profile representative of the e determinant of its hexon (HAdV-D22) and the fiber (HAdV-D8) proteins. Our recombinant hexon sequence is almost identical to the hexon sequences of the HAdV-D strain causing EKC outbreaks in Japan, suggesting that HAdV-D53 is pandemic as an emerging EKC agent. This documents the first genomic, bioinformatic, and biological descriptions of the molecular evolution events engendering an emerging pathogenic adenovirus.			Walsh, MP (corresponding author), George Mason Univ, Dept Bioinformat & Computat Biol, Manassas, VA USA.	drmorrisj@yahoo.com	Robinson, Christopher/FKL-4907-2022; Harrach, Balazs/AAC-2154-2020; Harrach, Balázs/A-3680-2008	Harrach, Balázs/0000-0002-1410-6469; Chintakuntlawar, Ashish/0000-0002-2907-6522	NATIONAL EYE INSTITUTE [R01EY013124] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adhikary AK, 2004, J CLIN PATHOL, V57, P411, DOI 10.1136/jcp.2003.012500; ALLARD A, 1990, J CLIN MICROBIOL, V28, P2659, DOI 10.1128/JCM.28.12.2659-2667.1990; Aoki K, 2008, J CLIN MICROBIOL, V46, P3259, DOI 10.1128/JCM.02354-07; Benko M, 2003, CURR TOP MICROBIOL, V272, P3; Benko M., 2005, VIRUS TAXONOMY 8 REP, P213; BOS A, 1978, BIOCHIM BIOPHYS ACTA, V525, P37, DOI 10.1016/0005-2744(78)90197-3; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Carr DJJ, 2008, J INTERF CYTOK RES, V28, P245, DOI 10.1089/jir.2007.0110; Chintakuntlawar AV, 2007, INVEST OPHTH VIS SCI, V48, P781, DOI 10.1167/iovs.06-1036; CRAWFORDMIKSZA LK, 1994, J CLIN MICROBIOL, V32, P2331, DOI 10.1128/JCM.32.9.2331-2334.1994; Dan A, 2001, VIRUS GENES, V22, P175, DOI 10.1023/A:1008125324346; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Del Rio L, 2001, J IMMUNOL, V167, P6503, DOI 10.4049/jimmunol.167.11.6503; Dhurandhar NV, 2000, INT J OBESITY, V24, P989, DOI 10.1038/sj.ijo.0801319; DINGLE JH, 1968, AM REV RESPIR DIS, V97, P1; Ebner K, 2005, J VIROL, V79, P12635, DOI 10.1128/JVI.79.20.12635-12642.2005; Engelmann I, 2006, CLIN INFECT DIS, V43, pE64, DOI 10.1086/507533; Evans J. D., 2002, ADENOVIRAL VECTORS G, P39; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginsberg HS, 1955, AM J PUBLIC HEALTH N, V45, P915, DOI 10.2105/AJPH.45.7.915; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon Y., 1996, OCULAR INFECT IMMUNI, P877; Harrach B., 1998, METH MOLEC MED, V21, P309; HATFIELD L, 1991, VIROLOGY, V184, P265, DOI 10.1016/0042-6822(91)90843-Z; HATFIELD L, 1993, J VIROL, V67, P3931, DOI 10.1128/JVI.67.7.3931-3939.1993; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; HESTDAL K, 1991, J IMMUNOL, V147, P22; HILLEMAN MR, 1954, P SOC EXP BIOL MED, V85, P183, DOI 10.3181/00379727-85-20825; HIRSCH S, 1981, J EXP MED, V154, P713, DOI 10.1084/jem.154.3.713; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kiss I, 1996, Acta Vet Hung, V44, P243; Kovacs GM, 2005, J GEN VIROL, V86, P1681, DOI 10.1099/vir.0.80757-0; Kovacs GM, 2004, J GEN VIROL, V85, P2799, DOI 10.1099/vir.0.80225-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauer KP, 2004, J GEN VIROL, V85, P2615, DOI 10.1099/vir.0.80118-0; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; MUL YM, 1990, J VIROL, V64, P5510, DOI 10.1128/JVI.64.11.5510-5518.1990; Purkayastha A, 2005, J CLIN MICROBIOL, V43, P3083, DOI 10.1128/JCM.43.7.3083-3094.2005; Purkayastha A, 2005, J VIROL, V79, P2559, DOI 10.1128/JVI.79.4.2559-2572.2005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-213; Robinson CM, 2009, VIRUS RES, V139, P122, DOI 10.1016/j.virusres.2008.10.001; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SHULTZ J, 1965, ARCH BIOCHEM BIOPHYS, V96, P465; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPERLEY SM, 1992, EMBO J, V11, P761, DOI 10.1002/j.1460-2075.1992.tb05109.x; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612	54	168	176	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5635	10.1371/journal.pone.0005635	http://dx.doi.org/10.1371/journal.pone.0005635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492050	Green Published, Green Submitted, gold			2022-12-27	WOS:000266624300002
J	Sui, HY; Zhao, GY; Huang, JD; Jin, DY; Yuen, KY; Zheng, BJ				Sui, Hong-Yan; Zhao, Guang-Yu; Huang, Jian-Dong; Jin, Dong-Yan; Yuen, Kwok-Yung; Zheng, Bo-Jian			Small Interfering RNA Targeting M2 Gene Induces Effective and Long Term Inhibition of Influenza A Virus Replication	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; LENTIVIRAL VECTORS; EXPRESSION; CELLS; MICE; RESISTANT; PROTEIN; SIRNA; DELIVERY; REQUIRES	RNA interference (RNAi) provides a powerful new means to inhibit viral infection specifically. However, the selection of siRNA-resistant viruses is a major concern in the use of RNAi as antiviral therapeutics. In this study, we conducted a lentiviral vector with a H1-short hairpin RNA (shRNA) expression cassette to deliver small interfering RNAs (siRNAs) into mammalian cells. Using this vector that also expresses enhanced green fluorescence protein (EGFP) as surrogate marker, stable shRNA-expressing cell lines were successfully established and the inhibition efficiencies of rationally designed siRNAs targeting to conserved regions of influenza A virus genome were assessed. The results showed that a siRNA targeting influenza M2 gene (siM2) potently inhibited viral replication. The siM2 was not only effective for H1N1 virus but also for highly pathogenic avian influenza virus H5N1. In addition to its M2 inhibition, the siM2 also inhibited NP mRNA accumulation and protein expression. A long term inhibition effect of the siM2 was demonstrated and the emergence of siRNA-resistant mutants in influenza quasispecies was not observed. Taken together, our study suggested that M2 gene might be an optimal RNAi target for antiviral therapy. These findings provide useful information for the development of RNAi-based prophylaxis and therapy for human influenza virus infection.			Sui, HY (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	bzheng@hkucc.hku.hk	Sui, Hongyan/M-1305-2013; /C-4277-2009	/0000-0001-7531-2816; Yuen, Kwok-yung/0000-0002-2083-1552				An DS, 2003, HUM GENE THER, V14, P1207, DOI 10.1089/104303403322168037; APPASANI K, 2004, RNA INTERFERENCE TEC, pR33; Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; BEATON AR, 1986, P NATL ACAD SCI USA, V83, P6282, DOI 10.1073/pnas.83.17.6282; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; DEGELAU J, 1992, ARCH INTERN MED, V152, P390, DOI 10.1001/archinte.152.2.390; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; ENGELKE DR, 2004, RNA INTERFERENCE, pR37; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; Garcia-Sastre A, 2002, MICROBES INFECT, V4, P647, DOI 10.1016/S1286-4579(02)01583-6; Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HOUCK P, 1995, ARCH INTERN MED, V155, P533, DOI 10.1001/archinte.155.5.533; Hui EKW, 2004, J GEN VIROL, V85, P1877, DOI 10.1099/vir.0.79906-0; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; KINCHINGTON D, 2000, ANTIVIRAL METHODS PR, pR14; Konishi M, 2006, J VIRAL HEPATITIS, V13, P756, DOI 10.1111/j.1365-2893.2006.00752.x; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Li YC, 2005, AVIAN DIS, V49, P562, DOI 10.1637/7365-041205R2.1; Moore MD, 2005, J GENE MED, V7, P918, DOI 10.1002/jgm.739; Scherr M, 2003, BLOOD, V101, P1566, DOI 10.1182/blood-2002-06-1685; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wohlbold L, 2003, BLOOD, V102, P2236, DOI 10.1182/blood-2002-12-3899; Yen HL, 2005, J INFECT DIS, V192, P665, DOI 10.1086/432008; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; ZHENG BJ, 1993, VACCINE, V11, P1191, DOI 10.1016/0264-410X(93)90042-V; Zheng BJ, 2001, INT J CANCER, V92, P421, DOI 10.1002/ijc.1198; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; ZHOU H, 2007, ANTIVIRAL RES	42	53	61	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5671	10.1371/journal.pone.0005671	http://dx.doi.org/10.1371/journal.pone.0005671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19479060	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331200008
J	Gyorffy, B; Molnar, B; Lage, H; Szallasi, Z; Eklund, AC				Gyorffy, Balazs; Molnar, Bela; Lage, Hermann; Szallasi, Zoltan; Eklund, Aron C.			Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples	PLOS ONE			English	Article							GENE-EXPRESSION MEASUREMENTS; BREAST-CANCER; NORMALIZATION; ARRAYS	Background: Several preprocessing algorithms for Affymetrix gene expression microarrays have been developed, and their performance on spike-in data sets has been evaluated previously. However, a comprehensive comparison of preprocessing algorithms on samples taken under research conditions has not been performed. Methodology/Principal Findings: We used TaqMan RT-PCR arrays as a reference to evaluate the accuracy of expression values from Affymetrix microarrays in two experimental data sets: one comprising 84 genes in 36 colon biopsies, and the other comprising 75 genes in 29 cancer cell lines. We evaluated consistency using the Pearson correlation between measurements obtained on the two platforms. Also, we introduce the log-ratio discrepancy as a more relevant measure of discordance between gene expression platforms. Of nine preprocessing algorithms tested, PLIER+16 produced expression values that were most consistent with RT-PCR measurements, although the difference in performance between most of the algorithms was not statistically significant. Conclusions/Significance: Our results support the choice of PLIER+16 for the preprocessing of clinical Affymetrix microarray data. However, other algorithms performed similarly and are probably also good choices.			Gyorffy, B (corresponding author), Hungarian Acad Sci, Budapest, Hungary.	eklund@cbs.dtu.dk	Gyorffy, Balazs/AAA-9135-2021	Gyorffy, Balazs/0000-0002-5772-3766; Szallasi, Zoltan/0000-0001-5395-7509; Eklund, Aron Charles/0000-0003-0861-1001	NCI NIH HHS [P50 CA089393, P50 CA89393] Funding Source: Medline; NLM NIH HHS [R21 LM008823, R21 LM008823-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM008823] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		*AFF, 2008, PLIER TECHN; *AFF, 2008, LAT SQUAR DAT; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carter SL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-107; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Eklund AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r26; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; MILLER CJ, 2008, PLIER; Okoniewski MJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040006; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pepper SD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-273; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tong WD, 2006, NAT BIOTECHNOL, V24, P1132, DOI 10.1038/nbt1237; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882	34	66	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5645	10.1371/journal.pone.0005645	http://dx.doi.org/10.1371/journal.pone.0005645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19461970	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000266331000004
J	Lee, HJ; Kim, MK; Kim, HJ; Kim, SU				Lee, Hong J.; Kim, Mi K.; Kim, Hee J.; Kim, Seung U.			Human Neural Stem Cells Genetically Modified to Overexpress Akt1 Provide Neuroprotection and Functional Improvement in Mouse Stroke Model	PLOS ONE			English	Article							BRAIN TRANSPLANTATION; NEURONAL SURVIVAL; GLIAL-CELLS; KINASE-B; RECOVERY; EXPRESSION; APOPTOSIS; RATS; PROLIFERATION; DIFFERENTIATE	In a previous study, we have shown that human neural stem cells (hNSCs) transplanted in brain of mouse intracerebral hemorrhage (ICH) stroke model selectively migrate to the ICH lesion and induce behavioral recovery. However, low survival rate of grafted hNSCs in the brain precludes long-term therapeutic effect. We hypothesized that hNSCs overexpressing Akt1 transplanted into the lesion site could provide long-term improved survival of hNSCs, and behavioral recovery in mouse ICH model. F3 hNSC was genetically modified with a mouse Akt1 gene using a retroviral vector. F3 hNSCs expressing Akt1 were found to be highly resistant to H2O2-induced cytotoxicity in vitro. Following transplantation in ICH mouse brain, F3. Akt1 hNSCs induced behavioral improvement and significantly increased cell survival (50-100% increase) at 2 and 8 weeks post-transplantation as compared to parental F3 hNSCs. Brain transplantation of hNSCs overexpressing Akt1 in ICH animals provided functional recovery, and survival and differentiation of grafted hNSCs. These results indicate that the F3. Akt1 human NSCs should be a great value as a cellular source for the cellular therapy in animal models of human neurological disorders including ICH.			Lee, HJ (corresponding author), Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada.	sukim@interchange.ubc.ca						Brognard J, 2001, CANCER RES, V61, P3986; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Chu K, 2004, NEUROSCI RES, V50, P459, DOI 10.1016/j.neures.2004.08.015; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gebel JM, 2000, NEUROL CLIN, V18, P419, DOI 10.1016/S0733-8619(05)70200-0; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; HWANG DH, 2008, GENE THER IN PRESS; Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kim Hyungchul, 2006, Journal of Electrical Engineering & Technology, V1, P129; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; KIM SU, 1986, J NEUROSCI RES, V15, P303, DOI 10.1002/jnr.490150303; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; KIM SU, 1985, J NEUROIMMUNOL, V8, P255, DOI 10.1016/S0165-5728(85)80066-7; LEE HJ, 2007, PLOS ONE, V2, P1; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Matsuzaki H, 1999, J NEUROCHEM, V73, P2037; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meng XL, 2003, J NEUROSCI RES, V74, P266, DOI 10.1002/jnr.10764; Morgenstern LB, 2005, STROKE, V36, pE23, DOI 10.1161/01.STR.0000155685.77775.4c; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Ryu JK, 2003, J NEUROSCI RES, V72, P352, DOI 10.1002/jnr.10507; Salinas M, 2004, FEBS LETT, V578, P90, DOI 10.1016/j.febslet.2004.10.077; Taylor JM, 2005, J NEUROCHEM, V92, P283, DOI 10.1111/j.1471-4159.2004.02863.x; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200	43	58	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5586	10.1371/journal.pone.0005586	http://dx.doi.org/10.1371/journal.pone.0005586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440551	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107500015
J	Banavali, NK; MacKerell, AD				Banavali, Nilesh K.; MacKerell, Alexander D., Jr.			Characterizing Structural Transitions Using Localized Free Energy Landscape Analysis	PLOS ONE			English	Article								Background: Structural changes in molecules are frequently observed during biological processes like replication, transcription and translation. These structural changes can usually be traced to specific distortions in the backbones of the macromolecules involved. Quantitative energetic characterization of such distortions can greatly advance the atomic-level understanding of the dynamic character of these biological processes. Methodology/Principal Findings: Molecular dynamics simulations combined with a variation of the Weighted Histogram Analysis Method for potential of mean force determination are applied to characterize localized structural changes for the test case of cytosine (underlined) base flipping in a GTCAG (C) under bar GCATGG DNA duplex. Free energy landscapes for backbone torsion and sugar pucker degrees of freedom in the DNA are used to understand their behavior in response to the base flipping perturbation. By simplifying the base flipping structural change into a two-state model, a free energy difference of upto 14 kcal/mol can be attributed to the flipped state relative to the stacked Watson-Crick base paired state. This two-state classification allows precise evaluation of the effect of base flipping on local backbone degrees of freedom. Conclusions/Significance: The calculated free energy landscapes of individual backbone and sugar degrees of freedom expectedly show the greatest change in the vicinity of the flipping base itself, but specific delocalized effects can be discerned upto four nucleotide positions away in both 59 and 39 directions. Free energy landscape analysis thus provides a quantitative method to pinpoint the determinants of structural change on the atomic scale and also delineate the extent of propagation of the perturbation along the molecule. In addition to nucleic acids, this methodology is anticipated to be useful for studying conformational changes in all macromolecules, including carbohydrates, lipids, and proteins.			Banavali, NK (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Genet, Lab Computat & Struct Biol, Albany, NY 12237 USA.	banavali@wadsworth.org; alex@outerbanks.umaryland.edu	MacKerell, Alex/Y-2469-2019; MacKerell, Alex/AAA-2560-2020	MacKerell, Alex/0000-0001-8287-6804; Banavali, Nilesh/0000-0003-2206-7049	NIGMS NIH HHS [R01 GM051501, GM51501, R29 GM051501] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051501, R01GM051501] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTONA C, 1972, J AM CHEM SOC, V94, P8205, DOI 10.1021/ja00778a043; Banavali NK, 2006, J PHYS CHEM B, V110, P10997, DOI 10.1021/jp0561322; Banavali NK, 2005, J AM CHEM SOC, V127, P6866, DOI 10.1021/ja050482k; Banavali NK, 2002, J MOL BIOL, V319, P141, DOI 10.1016/S0022-2836(02)00194-8; BEGLOV D, 1994, J CHEM PHYS, V98, P10089; Bernard D, 2007, J MED CHEM, V50, P1799, DOI 10.1021/jm0612463; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; BROOKS BR, 1983, J COMPUT CHEM, V21, P105; Chene P, 2008, DRUG DISCOV TODAY, V13, P522, DOI 10.1016/j.drudis.2008.03.023; Chipot C, 2002, MOL SIMULAT, V28, P1, DOI 10.1080/08927020211974; Crouzy S, 1999, J COMPUT CHEM, V20, P1644, DOI 10.1002/(SICI)1096-987X(19991130)20:15<1644::AID-JCC5>3.0.CO;2-Y; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dickerson RE, 1998, NUCLEIC ACIDS RES, V26, P1906, DOI 10.1093/nar/26.8.1906; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Edgell DR, 2003, CURR BIOL, V13, P973, DOI 10.1016/S0960-9822(03)00340-3; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Foloppe N, 1999, J PHYS CHEM B, V103, P10955, DOI 10.1021/jp992716q; Foloppe N, 1998, J PHYS CHEM B, V102, P6669, DOI 10.1021/jp9818683; Foster MP, 2007, BIOCHEMISTRY-US, V46, P331, DOI 10.1021/bi0621314; Gelbin A, 1996, J AM CHEM SOC, V118, P519, DOI 10.1021/ja9528846; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Gu B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.088104; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; Harrison SC, 2004, NAT STRUCT MOL BIOL, V11, P12, DOI 10.1038/nsmb0104-12; Horton JR, 2004, NUCLEIC ACIDS RES, V32, P3877, DOI 10.1093/nar/gkh701; Huang N, 2004, PHILOS T R SOC A, V362, P1439, DOI 10.1098/rsta.2004.1383; Huang N, 2003, P NATL ACAD SCI USA, V100, P68, DOI 10.1073/pnas.0135427100; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEROY JL, 1988, J MOL BIOL, V200, P223, DOI 10.1016/0022-2836(88)90236-7; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Marquez VE, 2004, J AM CHEM SOC, V126, P543, DOI 10.1021/ja037929e; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Priyakumar UD, 2006, CHEM REV, V106, P489, DOI 10.1021/cr040475z; Priyakumar UD, 2006, J CHEM THEORY COMPUT, V2, P187, DOI 10.1021/ct0501957; Priyakumar UD, 2006, J AM CHEM SOC, V128, P678, DOI 10.1021/ja056445a; Rauch C, 2003, J AM CHEM SOC, V125, P14990, DOI 10.1021/ja037218g; Saenger W., 1984, PRINCIPLES NUCL ACID; Schneider B, 1997, BIOPOLYMERS, V42, P113, DOI 10.1002/(SICI)1097-0282(199707)42:1<113::AID-BIP10>3.0.CO;2-O; Schneider TD, 2001, NUCLEIC ACIDS RES, V29, P4881, DOI 10.1093/nar/29.23.4881; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Sidorova NY, 2004, BIOPHYS J, V87, P2564, DOI 10.1529/biophysj.104.042390; Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Varnai P, 2004, J AM CHEM SOC, V126, P14659, DOI 10.1021/ja0470721; Varnai P, 2002, NUCLEIC ACIDS RES, V30, P5398, DOI 10.1093/nar/gkf680; Varnai P, 2002, J AM CHEM SOC, V124, P7272, DOI 10.1021/ja025980x; Wang PY, 2000, J AM CHEM SOC, V122, P12422, DOI 10.1021/ja001989s; Wery JP, 1997, CURR OPIN CHEM BIOL, V1, P365, DOI 10.1016/S1367-5931(97)80075-0	54	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5525	10.1371/journal.pone.0005525	http://dx.doi.org/10.1371/journal.pone.0005525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436759	Green Published, Green Submitted, gold			2022-12-27	WOS:000266009900017
J	Sadagopal, S; Braunstein, M; Hager, CC; Wei, J; Daniel, AK; Bochan, MR; Crozier, I; Smith, NE; Gates, HO; Barnett, L; Van Kaer, L; Price, JO; Blackwell, TS; Kalams, SA; Kernodle, DS				Sadagopal, Shanmugalakshmi; Braunstein, Miriam; Hager, Cynthia C.; Wei, Jie; Daniel, Alexandria K.; Bochan, Markian R.; Crozier, Ian; Smith, Nathaniel E.; Gates, Hiriam O.; Barnett, Louise; Van Kaer, Luc; Price, James O.; Blackwell, Timothy S.; Kalams, Spyros A.; Kernodle, Douglas S.			Reducing the Activity and Secretion of Microbial Antioxidants Enhances the Immunogenicity of BCG	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-TUBERCULOSIS INFECTION; CHRONIC GRANULOMATOUS-DISEASE; ALTERNATIVE SIGMA-FACTOR; CD8(+) T-CELLS; SUPEROXIDE-DISMUTASE; COMPARATIVE GENOMICS; ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; VACCINE EFFICACY	Background: In early clinical studies, the live tuberculosis vaccine Mycobacterium bovis BCG exhibited 80% protective efficacy against pulmonary tuberculosis ( TB). Although BCG still exhibits reliable protection against TB meningitis and miliary TB in early childhood it has become less reliable in protecting against pulmonary TB. During decades of in vitro cultivation BCG not only lost some genes due to deletions of regions of the chromosome but also underwent gene duplication and other mutations resulting in increased antioxidant production. Methodology/Principal Findings: To determine whether microbial antioxidants influence vaccine immunogenicity, we eliminated duplicated alleles encoding the oxidative stress sigma factor SigH in BCG Tice and reduced the activity and secretion of iron co-factored superoxide dismutase. We then used assays of gene expression and flow cytometry with intracellular cytokine staining to compare BCG-specific immune responses in mice after vaccination with BCG Tice or the modified BCG vaccine. Compared to BCG, the modified vaccine induced greater IL-12p40, RANTES, and IL-21 mRNA in the spleens of mice at three days post-immunization, more cytokine-producing CD8+ lymphocytes at the peak of the primary immune response, and more IL-2-producing CD4+ lymphocytes during the memory phase. The modified vaccine also induced stronger secondary CD4+ lymphocyte responses and greater clearance of challenge bacilli. Conclusions/Significance: We conclude that antioxidants produced by BCG suppress host immune responses. These findings challenge the hypothesis that the failure of extensively cultivated BCG vaccines to prevent pulmonary tuberculosis is due to over-attenuation and suggest instead a new model in which BCG evolved to produce more immunity-suppressing antioxidants. By targeting these antioxidants it may be possible to restore BCG's ability to protect against pulmonary TB.			Sadagopal, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.	doug.kernodle@vanderbilt.edu	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, T32AI007474, P30AI054999, R21AI051561, R01AI054540, R01AI051561] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-68518, R01 HL068518] Funding Source: Medline; NIAID NIH HHS [R21 AI051561, P30 AI-54999, AI-54540, U54 AI057157, P30 AI054999, AI-51561, R01 AI054540, T32 AI-007474, T32 AI007474, R01 AI051561, U54 AI 057157] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; ALAM MS, 2008, FEBS J; Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; ARONSON JD, 1958, ARCH INTERN MED, V101, P881, DOI 10.1001/archinte.1958.00260170037006; ARONSON JD, 1950, AM J PUBLIC HLTH, V40, P533; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; Bjartveit K, 2003, INT J TUBERC LUNG D, V7, P306; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Brandau S, 2007, BIOMED PHARMACOTHER, V61, P299, DOI 10.1016/j.biopha.2007.05.004; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Brosch R, 2000, YEAST, V17, P111, DOI 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; BUNCHCHR.K, 1970, B WORLD HEALTH ORGAN, V43, P65; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Carranza C, 2006, AM J RESP CRIT CARE, V173, P238, DOI 10.1164/rccm.200503-411OC; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; COLLINS FM, 1980, IMMUNOLOGY, V40, P529; COMSTOCK GW, 1988, AM REV RESPIR DIS, V138, P479, DOI 10.1164/ajrccm/138.2.479; COMSTOCK GW, 1994, EPIDEMIOL REV, V16, P77, DOI 10.1093/oxfordjournals.epirev.a036147; Comstock GW, 2000, CLIN INFECT DIS, V30, pS250, DOI 10.1086/313870; COOPER JB, 1995, J MOL BIOL, V246, P531, DOI 10.1006/jmbi.1994.0105; Corthay A, 2006, SCAND J IMMUNOL, V64, P93, DOI 10.1111/j.1365-3083.2006.01782.x; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; DUBOS R J, 1956, Am Rev Tuberc, V74, P683; DUBOS RJ, 1956, AM REV TUBERC PULM, V74, P699; DUBOS RJ, 1957, AM REV TUBERC PULM, V75, P692; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; FIALKOW L, 1993, J BIOL CHEM, V268, P17131; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Forman HJ, 2001, IUBMB LIFE, V51, P365; FRIMODTMOLLER J, 1968, INDIAN J TUBERC, V15, P40; Gagliardi MC, 2005, J LEUKOCYTE BIOL, V78, P106, DOI 10.1189/jlb.0105037; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; HASUI M, 1993, J INFECT DIS, V167, P983, DOI 10.1093/infdis/167.4.983; HEIJNEN CJ, 1986, CLIN EXP IMMUNOL, V66, P111; Herr HW, 2008, J UROLOGY, V179, P53, DOI 10.1016/j.juro.2007.08.122; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horwitz MA, 2009, VACCINE, V27, P441, DOI 10.1016/j.vaccine.2008.10.058; IRVINE KN, 1949, BCG VACCINATION THEO; Jaeger T, 2004, ARCH BIOCHEM BIOPHYS, V423, P182, DOI 10.1016/j.abb.2003.11.021; Kamath AB, 2005, INFECT IMMUN, V73, P6110, DOI 10.1128/IAI.73.9.6110-6118.2005; Kamath A, 2006, J IMMUNOL, V177, P6361, DOI 10.4049/jimmunol.177.9.6361; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kremer L, 1997, EUR J IMMUNOL, V27, P2450, DOI 10.1002/eji.1830270945; LADEFOGED A, 1976, B WORLD HEALTH ORGAN, V53, P435; LADEFOGED A, 1970, B WORLD HEALTH ORGAN, V43, P71; Lagranderie MRR, 1996, INFECT IMMUN, V64, P1; Lakey DL, 2000, INFECT IMMUN, V68, P233, DOI 10.1128/IAI.68.1.233-238.2000; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Mahomed H, 2006, PEDIATR INFECT DIS J, V25, P1167, DOI 10.1097/01.inf.0000243765.33880.54; Mak TK, 2008, LANCET, V372, P786, DOI 10.1016/S0140-6736(08)61318-5; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mostowy S, 2003, VACCINE, V21, P4270, DOI 10.1016/S0264-410X(03)00484-5; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Oettinger T., 1999, Tubercle and Lung Disease, V79, P243, DOI 10.1054/tuld.1999.0206; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SHER NA, 1973, INFECT IMMUN, V8, P736, DOI 10.1128/IAI.8.5.736-742.1973; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; SUTER WE, 1951, J EXP MED, V93, P559, DOI 10.1084/jem.93.6.559; TENDAM HG, 1993, TUBERCULOSIS COMPREH, P251; Tree JA, 2004, CLIN EXP IMMUNOL, V138, P405, DOI 10.1111/j.1365-2249.2004.02648.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tuberculosis Prevention Trial, 1979, B WORLD HEALTH ORGAN, V57, P819; van der Veen RC, 2004, J NEUROIMMUNOL, V153, P183, DOI 10.1016/j.jneuroim.2004.05.008; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Wilkinson RJ, 1998, IMMUNOLOGY, V95, P585, DOI 10.1046/j.1365-2567.1998.00648.x; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson T, 1998, MICROBIOL-UK, V144, P2687, DOI 10.1099/00221287-144-10-2687; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; World Health Organization, 2008, GLOB TUB CONTR SURV; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; [No title captured]	85	37	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5531	10.1371/journal.pone.0005531	http://dx.doi.org/10.1371/journal.pone.0005531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436730	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009900022
J	Petit-Paitel, A; Brau, F; Cazareth, J; Chabry, J				Petit-Paitel, Agnes; Brau, Frederic; Cazareth, Julie; Chabry, Joelle			Involvment of Cytosolic and Mitochondrial GSK-3 beta in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PERMEABILITY TRANSITION PORE; COMPLEX-I DEFICIENCY; PARKINSONS-DISEASE; PROTECTS NEURONS; CHRONIC LITHIUM; APOPTOSIS; INHIBITION; GSK3-BETA; KINASE	Aberrant mitochondrial function appears to play a central role in dopaminergic neuronal loss in Parkinson's disease (PD). 1-methyl-4-phenylpyridinium iodide (MPP+), the active metabolite of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), is a selective inhibitor of mitochondrial complex I and is widely used in rodent and cell models to elicit neurochemical alterations associated with PD. Recent findings suggest that Glycogen Synthase Kinase-3 beta (GSK-3 beta), a critical activator of neuronal apoptosis, is involved in the dopaminergic cell death. In this study, the role of GSK-3 beta in modulating MPP+-induced mitochondrial dysfunction and neuronal death was examined in vivo, and in two neuronal cell models namely primary cultured and immortalized neurons. In both cell models, MPTP/MPP+ treatment caused cell death associated with time- and concentration-dependent activation of GSK-3b, evidenced by the increased level of the active form of the kinase, i.e. GSK-3 beta phosphorylated at tyrosine 216 residue. Using immunocytochemistry and subcellular fractionation techniques, we showed that GSK-3 beta partially localized within mitochondria in both neuronal cell models. Moreover, MPP+ treatment induced a significant decrease of the specific phospho-Tyr216-GSK-3 beta labeling in mitochondria concomitantly with an increase into the cytosol. Using two distinct fluorescent probes, we showed that MPP+ induced cell death through the depolarization of mitochondrial membrane potential. Inhibition of GSK-3 beta activity using well-characterized inhibitors, LiCl and kenpaullone, and RNA interference, prevented MPP+-induced cell death by blocking mitochondrial membrane potential changes and subsequent caspase-9 and -3 activation. These results indicate that GSK-3 beta is a critical mediator of MPTP/MPP+-induced neurotoxicity through its ability to regulate mitochondrial functions. Inhibition of GSK-3 beta activity might provide protection against mitochondrial stress-induced cell death.			Petit-Paitel, A (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, 660 Route Lucioles, F-06560 Valbonne, France.	petit@ipmc.cnrs.fr	Chabry, Joelle/O-2101-2016	Petit-Paitel, Agnes/0000-0003-1138-9966				Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Avila Jesus, 2007, Expert Rev Neurother, V7, P1527, DOI 10.1586/14737175.7.11.1527; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bijur GN, 2000, J BIOL CHEM, V275, P7583, DOI 10.1074/jbc.275.11.7583; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chen J, 1999, ECON BOT, V53, P2, DOI 10.1007/BF02860785; Chuang DM, 2002, BIPOLAR DISORD, V4, P129, DOI 10.1034/j.1399-5618.2002.01179.x; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dirikoc S, 2007, J NEUROSCI, V27, P9537, DOI 10.1523/JNEUROSCI.1942-07.2007; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Feng JH, 2005, ANESTHESIOLOGY, V103, P987, DOI 10.1097/00000542-200511000-00013; Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hetman M, 2000, J NEUROSCI, V20, P2567; HOSHI M, 1995, J BIOCHEM-TOKYO, V118, P683, DOI 10.1093/oxfordjournals.jbchem.a124965; Iqbal K, 2008, J CELL MOL MED, V12, P38, DOI 10.1111/j.1582-4934.2008.00225.x; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; King TD, 2005, NEUROREPORT, V16, P597, DOI 10.1097/00001756-200504250-00016; Kunick C, 2004, BIOORG MED CHEM LETT, V14, P413, DOI 10.1016/j.bmcl.2003.10.062; Lai JS, 2006, EUR J PHARMACOL, V539, P18, DOI 10.1016/j.ejphar.2006.03.076; Lee KY, 2007, BRAIN RES, V1129, P89, DOI 10.1016/j.brainres.2006.10.055; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Li XH, 2004, NEUROPSYCHOPHARMACOL, V29, P1426, DOI 10.1038/sj.npp.1300439; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Maiese K, 2007, CURR MED CHEM, V14, P1729; Manji HK, 1999, J CLIN PSYCHIAT, V60, P27; Manji HK, 2002, MOL PSYCHIATR, V7, pS46, DOI 10.1038/sj.mp.4001018; MANJI HK, 1999, J CLIN PSYCHIAT S2, V60, P113; Martinez A, 2002, MED RES REV, V22, P373, DOI 10.1002/med.10011; MAURER F, 1906, HDB VERGLEICHENDEN 1, V3, P1; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Nonaka S, 1998, J PHARMACOL EXP THER, V286, P539; Obame FN, 2008, J PHARMACOL EXP THER, V326, P252, DOI 10.1124/jpet.108.138008; Ohori K, 2008, AM J PHYSIOL-HEART C, V295, pH2079, DOI 10.1152/ajpheart.00092.2008; Orth M, 2003, MOVEMENT DISORD, V18, P729, DOI 10.1002/mds.10447; Park SS, 2006, J MOL CELL CARDIOL, V40, P708, DOI 10.1016/j.yjmcc.2006.01.024; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Roucou X, 2001, CELL DEATH DIFFER, V8, P875, DOI 10.1038/sj.cdd.4400910; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Senatorov VV, 2004, MOL PSYCHIATR, V9, P371, DOI 10.1038/sj.mp.4001463; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Takadera T, 2004, EUR J PHARMACOL, V499, P239, DOI 10.1016/j.ejphar.2004.07.115; Takadera T, 2007, NEUROCHEM RES, V32, P1336, DOI 10.1007/s11064-007-9310-4; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang TE, 2007, ASIA-PAC J CLIN ONCO, V3, P52, DOI 10.1111/j.1743-7563.2006.00082.x; Watcharasit P, 2003, J BIOL CHEM, V278, P48872, DOI 10.1074/jbc.M305870200; Wu YM, 2007, BIOTECHNOL BIOPROC E, V12, P1, DOI 10.1007/BF02931796; Youdim MBH, 2004, NEUROPHARMACOLOGY, V46, P1130, DOI 10.1016/j.neuropharm.2004.02.005; Zhou KY, 2009, ALCOHOL ALCOHOLISM, V44, P20, DOI 10.1093/alcalc/agn098	71	94	96	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5491	10.1371/journal.pone.0005491	http://dx.doi.org/10.1371/journal.pone.0005491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430525	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009700001
J	Madjidian, JA; Lankinen, A				Madjidian, Josefin A.; Lankinen, Asa			Sexual Conflict and Sexually Antagonistic Coevolution in an Annual Plant	PLOS ONE			English	Article							COLLINSIA-HETEROPHYLLA PLANTAGINACEAE; MATING-SYSTEM; POPULATION CROSSES; POLLEN COMPETITION; STIGMA RECEPTIVITY; INBREEDING DEPRESSION; GENETIC-VARIABILITY; SELECTION; EVOLUTION; DIVERGENCE	Background: Sexual conflict theory predicts sexually antagonistic coevolution of reproductive traits driven by conflicting evolutionary interests of two reproducing individuals. Most studies of the evolutionary consequences of sexual conflicts have, however, to date collectively investigated only a few species. In this study we used the annual herb Collinsia heterophylla to experimentally test the existence and evolutionary consequences of a potential sexual conflict over onset of stigma receptivity. Methodology/Principal Findings: We conducted crosses within and between four greenhouse-grown populations originating from two regions. Our experimental setup allowed us to investigate male-female interactions at three levels of geographic distances between interacting individuals. Both recipient and pollen donor identity affected onset of stigma receptivity within populations, confirming previous results that some pollen donors can induce stigma receptivity. We also found that donors were generally better at inducing stigma receptivity following pollen deposition on stigmas of recipients from another population than their own, especially within a region. On the other hand, we found that donors did worse at inducing stigma receptivity in crosses between regions. Interestingly, recipient costs in terms of lowered seed number after early fertilisation followed the same pattern: the cost was apparent only if the pollen donor belonged to the same region as the recipient. Conclusion/Significance: Our results indicate that recipients are released from the cost of interacting with local pollen donors when crossed with donors from a more distant location, a pattern consistent with a history of sexually antagonistic coevolution within populations. Accordingly, sexual conflicts may have important evolutionary consequences also in plants.			Madjidian, JA (corresponding author), Lund Univ, Dept Plant Ecol & Systemat, Lund, Sweden.	josefin.madjidian@ekol.lu.se						Andersson Malte, 1994; Andres JA, 2001, P ROY SOC B-BIOL SCI, V268, P399, DOI 10.1098/rspb.2000.1392; Anthes N, 2007, BIOL LETTERS, V3, P121, DOI 10.1098/rsbl.2006.0596; Armbruster WS, 1996, J EVOLUTION BIOL, V9, P261, DOI 10.1046/j.1420-9101.1996.9030261.x; Armbruster WS, 2004, AM J BOT, V91, P1939, DOI 10.3732/ajb.91.11.1939; Armbruster WS, 2002, AM J BOT, V89, P37, DOI 10.3732/ajb.89.1.37; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G, 2004, EVOLUTION, V58, P1383; ARNQVIST G, 2005, SEXUAL CONFLICT, P230; ASHMAN TL, 1994, NATURE, V371, P788, DOI 10.1038/371788a0; Attia FA, 2004, EVOL ECOL RES, V6, P927; Bernasconi G, 2004, SCIENCE, V303, P971, DOI 10.1126/science.1092180; Brandvain Y, 2005, AM NAT, V166, P330, DOI 10.1086/432036; Brody AK, 1997, ECOLOGY, V78, P1624, DOI 10.1890/0012-9658(1997)078[1624:EOPHAS]2.0.CO;2; Burdon JJ, 1999, EVOLUTION, V53, P704, DOI [10.1111/j.1558-5646.1999.tb05365.x, 10.2307/2640711]; Burke J, 2001, ENTERTAIN DES, V35, P52; Calsbeek R, 2003, MOL ECOL, V12, P1021, DOI 10.1046/j.1365-294X.2003.01794.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHARLESWORTH D, 1995, AM J BOT, V82, P112, DOI 10.2307/2445793; CHARNOV EL, 1979, P NATL ACAD SCI USA, V76, P2480, DOI 10.1073/pnas.76.5.2480; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Fiebig A, 2004, P NATL ACAD SCI USA, V101, P3286, DOI 10.1073/pnas.0305448101; Fisher RA, 1930, GENETICAL THEORY NAT; Fricke C, 2004, J EVOLUTION BIOL, V17, P1345, DOI 10.1111/j.1420-9101.2004.00757.x; GALEN C, 1986, AM NAT, V127, P462, DOI 10.1086/284495; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Hardling R, 1999, OIKOS, V84, P27, DOI 10.2307/3546863; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; HOEKSTRA FA, 1975, PHYSIOL PLANTARUM, V34, P221, DOI 10.1111/j.1399-3054.1975.tb03825.x; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Jolivet C, 2007, J EVOLUTION BIOL, V20, P1361, DOI 10.1111/j.1420-9101.2007.01344.x; Kearns C. A., 1993, TECHNIQUES POLLINATI; Knowles LL, 2001, P NATL ACAD SCI USA, V98, P8692, DOI 10.1073/pnas.151123998; Koene JM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-25; LALONDE RG, 1989, AM J BOT, V76, P1107, DOI 10.2307/2444822; Lankinen A, 2007, J EVOLUTION BIOL, V20, P737, DOI 10.1111/j.1420-9101.2006.01233.x; LANKINEN A, 2007, EVOL ECOL IN PRESS; Lankinen A, 2007, AM NAT, V170, P854, DOI 10.1086/522839; Lankinen A, 2007, AM J BOT, V94, P1183, DOI 10.3732/ajb.94.7.1183; Lankinen A, 2006, EVOLUTION, V60, P2454, DOI 10.1111/j.0014-3820.2006.tb01881.x; Lankinen A, 2009, ANN BOT-LONDON, V103, P941, DOI 10.1093/aob/mcp014; Lapointe FJ, 2005, AM NAT, V166, P290, DOI 10.1086/431283; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Long TAF, 2006, PHILOS T R SOC B, V361, P363, DOI 10.1098/rstb.2005.1786; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Marshall DL, 1996, EVOLUTION, V50, P1842, DOI 10.1111/j.1558-5646.1996.tb03570.x; MAZER SJ, 1987, BIOL J LINN SOC, V30, P115, DOI 10.1111/j.1095-8312.1987.tb00293.x; Michiels NK, 2006, INTEGR COMP BIOL, V46, P473, DOI 10.1093/icb/icj043; Michiels NK, 1998, NATURE, V391, P647, DOI 10.1038/35527; NEESE EC, 1993, JEPSON MANUAL HIGHER; Newsom VM, 1929, BOT GAZ, V87, P260, DOI 10.1086/333934; Nilsson T, 2002, EVOLUTION, V56, P111, DOI 10.1111/j.0014-3820.2002.tb00853.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Parker G. A., 1979, SEXUAL SELECTION REP; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Pizzari T, 2004, EVOLUTION, V58, P1389; Pizzari T, 2003, EVOLUTION, V57, P1223, DOI 10.1111/j.0014-3820.2003.tb00331.x; Prasad NG, 2006, J GENET, V85, P161, DOI 10.1007/BF02935325; QUELLER DC, 1983, NATURE, V305, P706, DOI 10.1038/305706a0; QUELLER DC, 1984, EVOLUTION, V38, P1148, DOI 10.1111/j.1558-5646.1984.tb00383.x; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rowe L, 2003, P ROY SOC B-BIOL SCI, V270, P2009, DOI 10.1098/rspb.2003.2453; Rowe L, 2002, EVOLUTION, V56, P754; SERVICE PM, 1993, GENETICA, V91, P111, DOI 10.1007/BF01435992; Shaanker RU, 1997, CURR SCI INDIA, V72, P932; Skogsmyr I, 2002, BIOL REV, V77, P537, DOI 10.1017/S1464793102005973; Sokal R. R, 1981, BIOMETRY; *SPSS INC, 2005, SPSS 14 0 SYNT REF G; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; WEIL J, 1964, EVOLUTION, V18, P515, DOI 10.1111/j.1558-5646.1964.tb01668.x; Wright S, 1943, GENETICS, V28, P114; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	79	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5477	10.1371/journal.pone.0005477	http://dx.doi.org/10.1371/journal.pone.0005477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421402	Green Published, gold, Green Submitted			2022-12-27	WOS:000265837000011
J	Wise, JL; Crout, RJ; McNeil, DW; Weyant, RJ; Marazita, ML; Wenger, SL				Wise, Jasen L.; Crout, Richard J.; McNeil, Daniel W.; Weyant, Robert J.; Marazita, Mary L.; Wenger, Sharon L.			Cryptic Subtelomeric Rearrangements and X Chromosome Mosaicism: A Study of 565 Apparently Normal Individuals with Fluorescent In Situ Hybridization	PLOS ONE			English	Article								Five percent of patients with unexplained mental retardation have been attributed to cryptic unbalanced subtelomeric rearrangements. Half of these affected individuals have inherited the rearrangement from a parent who is a carrier for a balanced translocation. However, the frequency of carriers for cryptic balanced translocations is unknown. To determine this frequency, 565 phenotypically normal unrelated individuals were examined for balanced subtelomeric rearrangements using Fluorescent In Situ hybridization ( FISH) probes for all subtelomere regions. While no balanced subtelomeric rearrangements were identified, three females in this study were determined to be mosaic for the X chromosome. Mosaicism for XXX cell lines were observed in the lymphocyte cultures of 3 in 379 women (0.8%), which is a higher frequency than the 1 in 1000 (0.1%) reported for sex chromosome aneuploidies. Our findings suggest that numerical abnormalities of the X chromosome are more common in females than previously reported. Based on a review of the literature, the incidence of cryptic translocation carriers is estimated to be approximately 1/8,000, more than ten-fold higher than the frequency of visible reciprocal translocations.			Wise, JL (corresponding author), W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA.	jasenwise@gmail.com		Weyant, Robert/0000-0002-5252-9120	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899] Funding Source: NIH RePORTER; NIDCR NIH HHS [5 R01 DE 014899, R01 DE014899] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; Adeyinka A, 2005, AM J MED GENET A, V135A, P28, DOI 10.1002/ajmg.a.30675; Anderlid BM, 2002, AM J MED GENET, V107, P275, DOI 10.1002/ajmg.10029; Baker E, 2002, AM J MED GENET, V107, P285, DOI 10.1002/ajmg.10159; Bocian E, 2004, MED SCI MONITOR, V10, pCR143; Catalan J, 2000, MUTAGENESIS, V15, P251, DOI 10.1093/mutage/15.3.251; Estop AM, 1997, EUR J HUM GENET, V5, P78, DOI 10.1159/000484737; FITZGERALD PH, 1975, HUMANGENETIK, V28, P153, DOI 10.1007/BF00735748; Flint J, 1996, BRIT MED BULL, V52, P453; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; FORD JH, 1985, AM J HUM GENET, V37, P973; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; Helias-Rodzewicz Z, 2002, J Med Genet, V39, pe53, DOI 10.1136/jmg.39.9.e53; Hook EB, 1977, FREQUENCY CHROMOSOME, P63; Joyce CA, 2001, HUM GENET, V109, P440, DOI 10.1007/s004390100588; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Knight SJL, 1997, EUR J HUM GENET, V5, P1; Li R, 2004, CHINESE MED J-PEKING, V117, P1414; Mukherjee AB, 1996, MECH AGEING DEV, V90, P145, DOI 10.1016/0047-6374(96)01762-9; Polk Deborah E, 2008, BMC Oral Health, V8, P18, DOI 10.1186/1472-6831-8-18; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Russell LM, 2007, CYTOGENET GENOME RES, V116, P181, DOI 10.1159/000098184; van Karnebeek CDM, 2002, J MED GENET, V39, P546, DOI 10.1136/jmg.39.8.546; Walter S, 2004, AM J MED GENET A, V128A, P364, DOI 10.1002/ajmg.a.30160; WENGER SL, 1984, AM J MED GENET, V19, P715, DOI 10.1002/ajmg.1320190411	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5855	10.1371/journal.pone.0005855	http://dx.doi.org/10.1371/journal.pone.0005855			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516895	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000266872900006
J	Horii, T; Morita, S; Kimura, M; Hatada, I				Horii, Takuro; Morita, Sumiyo; Kimura, Mika; Hatada, Izuho			Epigenetic Regulation of Adipocyte Differentiation by a Rho Guanine Nucleotide Exchange Factor, WGEF	PLOS ONE			English	Article							DNA-METHYLATION; GTPASES; ADIPOGENESIS; MOUSE; DEMETHYLATION; MODULATION; PROMOTER; PROTEIN; FAMILY; OBESE	Epigenetic regulation, including DNA methylation, plays an important role in several differentiation processes and possibly in adipocyte differentiation. To search for genes that show methylation change during adipogenesis, genome-wide DNA methylation analysis in insulin-induced adipogenesis of 3T3-L1 preadipocyte cells was performed using a method called microarray-based integrated analysis of methylation by isoschizomers (MIAMI). The MIAMI revealed that Hpa II sites of exon 1 in a Rho guanine nucleotide exchange factor 19 (ARHGEF19; WGEF) gene were demethylated during adipocyte differentiation of 3T3-L1 cells. Deletion of the region containing cytosine-guanine (CpG) sites that showed methylation change suppressed transcriptional activity in the reporter assay, indicating that this region regulates WGEF transcription. WGEF expression in 3T3-L1 cells was reduced during adipocyte differentiation, and high-fat diet-induced obese mice also showed lower expression of WGEF gene than control mice in white adipose tissue. Additionally, forced expression of WGEF in 3T3-L1 cells down-regulated the expression of adipogenic marker genes and inhibited the adipogenic program. This study clarified that adipogenesis was regulated by WGEF expression through DNA methylation change.			Horii, T (corresponding author), Gunma Univ, Lab Genome Sci, Biosignal Genome Resource Ctr, Inst Mol & Cellular Regulat, Maebashi, Gunma 371, Japan.	ihatada@showa.gunma-u.ac.jp						ALEXANDER M, 1985, J BIOL CHEM, V260, P1978; Bryan BA, 2005, MOL CELL BIOL, V25, P11089, DOI 10.1128/MCB.25.24.11089-11101.2005; Bryan BA, 2005, CELL MOL LIFE SCI, V62, P1547, DOI 10.1007/s00018-005-5029-z; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cantrell DA, 2003, IMMUNOL REV, V192, P122, DOI 10.1034/j.1600-065X.2003.00028.x; Charrasse S, 2003, J MUSCLE RES CELL M, V24, P309; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Hatada I, 2008, J HUM GENET, V53, P185, DOI 10.1007/s10038-007-0228-0; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; KITAGAWA K, 1989, BIOCHIM BIOPHYS ACTA, V1014, P83, DOI 10.1016/0167-4889(89)90244-9; LEMONNIER D, 1975, DIABETES METAB, V1, P77; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miltenberger RJ, 1997, J NUTR, V127, pS1902, DOI 10.1093/jn/127.9.1902S; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang YH, 2004, BIOCHEM BIOPH RES CO, V324, P1053, DOI 10.1016/j.bbrc.2004.09.153; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	29	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5809	10.1371/journal.pone.0005809	http://dx.doi.org/10.1371/journal.pone.0005809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503838	Green Submitted, gold, Green Published			2022-12-27	WOS:000266717200005
J	Grochot-Przeczek, A; Lach, R; Mis, J; Skrzypek, K; Gozdecka, M; Sroczynska, P; Dubiel, M; Rutkowski, A; Kozakowska, M; Zagorska, A; Walczynski, J; Was, H; Kotlinowski, J; Drukala, J; Kurowski, K; Kieda, C; Herault, Y; Dulak, J; Jozkowicz, A				Grochot-Przeczek, Anna; Lach, Radoslaw; Mis, Jacek; Skrzypek, Klaudia; Gozdecka, Malgorzata; Sroczynska, Patrycja; Dubiel, Milena; Rutkowski, Andrzej; Kozakowska, Magdalena; Zagorska, Anna; Walczynski, Jacek; Was, Halina; Kotlinowski, Jerzy; Drukala, Justyna; Kurowski, Krzysztof; Kieda, Claudine; Herault, Yann; Dulak, Jozef; Jozkowicz, Alicja			Heme Oxygenase-1 Accelerates Cutaneous Wound Healing in Mice	PLOS ONE			English	Article								Heme oxygenase-1 (HO-1), a cytoprotective, pro-angiogenic and anti-inflammatory enzyme, is strongly induced in injured tissues. Our aim was to clarify its role in cutaneous wound healing. In wild type mice, maximal expression of HO-1 in the skin was observed on the 2(nd) and 3(rd) days after wounding. Inhibition of HO-1 by tin protoporphyrin-IX resulted in retardation of wound closure. Healing was also delayed in HO-1 deficient mice, where lack of HO-1 could lead to complete suppression of reepithelialization and to formation of extensive skin lesions, accompanied by impaired neovascularization. Experiments performed in transgenic mice bearing HO-1 under control of keratin 14 promoter showed that increased level of HO-1 in keratinocytes is enough to improve the neovascularization and hasten the closure of wounds. Importantly, induction of HO-1 in wounded skin was relatively weak and delayed in diabetic (db/db) mice, in which also angiogenesis and wound closure were impaired. In such animals local delivery of HO-1 transgene using adenoviral vectors accelerated the wound healing and increased the vascularization. In summary, induction of HO-1 is necessary for efficient wound closure and neovascularization. Impaired wound healing in diabetic mice may be associated with delayed HO-1 upregulation and can be improved by HO-1 gene transfer.	[Grochot-Przeczek, Anna; Lach, Radoslaw; Mis, Jacek; Skrzypek, Klaudia; Gozdecka, Malgorzata; Sroczynska, Patrycja; Dubiel, Milena; Rutkowski, Andrzej; Kozakowska, Magdalena; Zagorska, Anna; Walczynski, Jacek; Was, Halina; Kotlinowski, Jerzy; Dulak, Jozef; Jozkowicz, Alicja] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Drukala, Justyna] Jagiellonian Univ, Dept Cell Biol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Kurowski, Krzysztof] Adamed Ltd, R&D Div, Pienkow, Poland; [Kieda, Claudine] CNRS, Ctr Mol Biophys, Orleans, France; [Herault, Yann] CNRS, Ctr Transgen Anim, Orleans, France	Jagiellonian University; Jagiellonian University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Grochot-Przeczek, A (corresponding author), Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	alicja.jozkowicz@uj.edu.pl; jozef.dulak@uj.edu.pl	Herault, Yann/B-5500-2012; Longo, Kenneth A/A-5631-2010; Skrzypek, Klaudia/U-6462-2018; Kieda, Claudine/U-1361-2019	Herault, Yann/0000-0001-7049-6900; Skrzypek, Klaudia/0000-0002-3997-924X; Was, Halina/0000-0003-2743-0337; , Malgorzata/0000-0002-3134-1276; Drukala, Justyna/0000-0001-5573-2979; Grochot-Przeczek, Anna/0000-0003-0533-7254; Lach, Radoslaw/0000-0001-8513-6780	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham NG, 2004, AM J PHYSIOL-HEART C, V287, pH2468, DOI 10.1152/ajpheart.01187.2003; Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; Almolki A, 2008, AM J PATHOL, V173, P981, DOI 10.2353/ajpath.2008.070863; Altavilla D, 2005, SHOCK, V24, P85, DOI 10.1097/01.shk.0000168523.37796.89; Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667; Ashcroft GS, 2002, J CLIN INVEST, V110, P615, DOI 10.1172/JCI200215704; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Bloch W, 2000, FASEB J, V14, P2373; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Calabrese V, 2007, CELL STRESS CHAPERON, V12, P299, DOI 10.1379/CSC-270.1; Calzi SL, 2008, DIABETES, V57, P2488, DOI 10.2337/db08-0381; Cisowski J, 2005, BIOCHEM BIOPH RES CO, V326, P670, DOI 10.1016/j.bbrc.2004.11.083; Cosso L, 2001, FREE RADICAL RES, V34, P189, DOI 10.1080/10715760100300171; Cukiernik M, 2003, CURR EYE RES, V27, P301, DOI 10.1076/ceyr.27.5.301.17227; daSilva JL, 1997, CURR EYE RES, V16, P380, DOI 10.1076/ceyr.16.4.380.10695; Deshpande A, 2007, FOUND TRENDS DATABAS, V1, P1, DOI 10.1561/1900000001; Di Filippo C, 2005, DIABETES, V54, P803; Dickens S, 2008, TISSUE ENG PT A, V14, P19, DOI 10.1089/ten.a.2007.0060; Drukala J, 2001, CELL TRANSPLANT, V10, P765, DOI 10.3727/000000001783986251; Dulak J, 2002, ANTIOXID REDOX SIGN, V4, P229, DOI 10.1089/152308602753666280; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Farhangkhoee H, 2003, J MOL CELL CARDIOL, V35, P1439, DOI 10.1016/j.yjmcc.2003.09.007; Frank C, 2004, CAN FAM PHYSICIAN, V50, P1653; Galeano M, 2003, DIABETOLOGIA, V46, P546, DOI 10.1007/s00125-003-1064-1; Galeano M, 2003, CRIT CARE MED, V31, P1017, DOI 10.1097/01.CCM.0000059435.88283.C2; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gilliver SC, 2006, J CELL SCI, V119, P722, DOI 10.1242/jcs.02786; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Groves R W, 2000, Adv Skin Wound Care, V13, P107; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)90622-2; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Hayashi K, 2001, DIABETES RES CLIN PR, V52, P85, DOI 10.1016/S0168-8227(01)00218-2; Honorati MC, 2006, OSTEOARTHR CARTILAGE, V14, P345, DOI 10.1016/j.joca.2005.10.004; Howdieshell TR, 2001, J SURG RES, V96, P173, DOI 10.1006/jsre.2001.6089; Jazwa A, 2006, FREE RADICAL BIO MED, V40, P1250, DOI 10.1016/j.freeradbiomed.2005.11.016; Jozkowicz A, 2002, ANTIOXID REDOX SIGN, V4, P577, DOI 10.1089/15230860260220076; Jozkowicz A, 2003, ACTA BIOCHIM POL, V50, P69, DOI 10.18388/abp.2003_3715; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kampfer H, 2001, MOL MED, V7, P488, DOI 10.1007/BF03401854; Koya D, 2003, J AM SOC NEPHROL, V14, pS250, DOI 10.1097/01.ASN.0000077412.07578.44; Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Michaels J, 2005, WOUND REPAIR REGEN, V13, P506, DOI 10.1111/j.1067-1927.2005.00071.x; Minuzzo S, 2007, MOL ASPECTS MED, V28, P59, DOI 10.1016/j.mam.2006.12.008; Moreira TJTP, 2007, J CEREBR BLOOD F MET, V27, P1710, DOI 10.1038/sj.jcbfm.9600479; Moyer KE, 2002, J CELL PHYSIOL, V193, P173, DOI 10.1002/jcp.10160; NOLAN VG, 1997, BRIT J HAEMATOL, V133, P570; Ojha N, 2008, FREE RADICAL BIO MED, V44, P682, DOI 10.1016/j.freeradbiomed.2007.10.056; Oksala NKJ, 2007, ANTIOXID REDOX SIGN, V9, P497, DOI 10.1089/ars.2006.1450; Patil K, 2008, INVEST OPHTH VIS SCI, V49, P3379, DOI 10.1167/iovs.07-1515; Pittock ST, 2005, KIDNEY INT, V68, P611, DOI 10.1111/j.1523-1755.2005.00439.x; Platt JL, 1998, NAT MED, V4, P1364, DOI 10.1038/3947; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Quan S, 2004, BIOCHEM BIOPH RES CO, V315, P509, DOI 10.1016/j.bbrc.2004.01.086; Rossi S, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/60285; Rossiter H, 2004, CANCER RES, V64, P3508, DOI 10.1158/0008-5472.CAN-03-2581; Sambuceti G, 2009, STEM CELLS, V27, P399, DOI 10.1634/stemcells.2008-0800; Shukla A, 1997, FREE RADICAL RES, V26, P93, DOI 10.3109/10715769709097788; Singh H., 1992, Journal of Burn Care and Rehabilitation, V13, P617, DOI 10.1097/00004630-199211000-00002; Song FF, 2007, EUR J NUTR, V46, P61, DOI 10.1007/s00394-006-0632-9; Song J, 2009, ATHEROSCLEROSIS, V202, P573, DOI 10.1016/j.atherosclerosis.2008.05.057; Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4; Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Suzuki M, 2003, BIOCHEM BIOPH RES CO, V302, P138, DOI 10.1016/S0006-291X(03)00114-1; Theilla M, 2007, CLIN NUTR, V26, P752, DOI 10.1016/j.clnu.2007.06.015; Thomasson MA, 2005, MAR BIOL RES, V1, P107, DOI 10.1080/17451000510019051; Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248; Wu CC, 2008, NEPHROL DIAL TRANSPL, V23, P3082, DOI 10.1093/ndt/gfn247; Zhang F, 2003, BLOOD, V102, P2115, DOI 10.1182/blood-2003-01-0049; Zhao WX, 2008, J MOL MED, V86, P1127, DOI 10.1007/s00109-008-0372-9	77	99	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5803	10.1371/journal.pone.0005803	http://dx.doi.org/10.1371/journal.pone.0005803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495412	Green Published, Green Submitted, gold			2022-12-27	WOS:000266716900012
J	Donner, SD				Donner, Simon D.			Coping with Commitment: Projected Thermal Stress on Coral Reefs under Different Future Scenarios	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE-VARIATION; BLEACHING EVENT; BUILDING CORALS; FLEXIBILITY; RESILIENCE; ASSEMBLAGES; EXTINCTION; RECOVERY; IMPACTS	Background: Periods of anomalously warm ocean temperatures can lead to mass coral bleaching. Past studies have concluded that anthropogenic climate change may rapidly increase the frequency of these thermal stress events, leading to declines in coral cover, shifts in the composition of corals and other reef-dwelling organisms, and stress on the human populations who depend on coral reef ecosystems for food, income and shoreline protection. The ability of greenhouse gas mitigation to alter the near-term forecast for coral reefs is limited by the time lag between greenhouse gas emissions and the physical climate response. Methodology/Principal Findings: This study uses observed sea surface temperatures and the results of global climate model forced with five different future emissions scenarios to evaluate the "committed warming'' for coral reefs worldwide. The results show that the physical warming commitment from current accumulation of greenhouse gases in the atmosphere could cause over half of the world's coral reefs to experience harmfully frequent (p >= 0.2 year(-1)) thermal stress by 2080. An additional "societal'' warming commitment, caused by the time required to shift from a business-as-usual emissions trajectory to a 550 ppm CO2 stabilization trajectory, may cause over 80% of the world's coral reefs to experience harmfully frequent events by 2030. Thermal adaptation of 1.5 degrees C would delay the thermal stress forecast by 50-80 years. Conclusions/Significance: The results suggest that adaptation - via biological mechanisms, coral community shifts and/or management interventions - could provide time to change the trajectory of greenhouse gas emissions and possibly avoid the recurrence of harmfully frequent events at the majority (97%) of the world's coral reefs this century. Without any thermal adaptation, atmospheric CO2 concentrations may need to be stabilized below current levels to avoid the degradation of coral reef ecosystems from frequent thermal stress events.			Donner, SD (corresponding author), Univ British Columbia, Dept Geog, Vancouver, BC, Canada.	simon.donner@ubc.ca						Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baird AH, 2007, MAR ECOL PROG SER, V347, P307, DOI 10.3354/meps07220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cao L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035072; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; DONNER SD, 2008, CORAL BLEACHING PATT, P159; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Donner SD, 2007, BIOSCIENCE, V57, P214, DOI 10.1641/B570302; EAKIN CM, 2008, CORAL BLEACHING PATT, P41; Garpe KC, 2006, MAR ECOL PROG SER, V315, P237, DOI 10.3354/meps315237; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kayanne H, 2002, MAR ECOL PROG SER, V239, P93, DOI 10.3354/meps239093; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Marshall PA, 2006, REEF MANAGERS GUIDE; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; O'Neill BC, 2002, SCIENCE, V296, P1971, DOI 10.1126/science.1071238; Parry M. L., 2007, CLIMATE CHANGE 2007; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Randall DA., 2007, CLIMATE CHANGE 2007; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schuhmacher H, 2005, FACIES, V51, P80, DOI 10.1007/s10347-005-0020-6; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Skirving W, 2006, RE S D I PR, V9, P11, DOI 10.1007/1-4020-3968-9_2; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; VERON JEN, 2006, CORALS WORLD	52	156	158	2	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5712	10.1371/journal.pone.0005712	http://dx.doi.org/10.1371/journal.pone.0005712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492060	gold, Green Submitted, Green Published			2022-12-27	WOS:000266624300003
J	Antoine-Moussiaux, N; Cornet, A; Cornet, F; Glineur, S; Dermine, M; Desmecht, D				Antoine-Moussiaux, Nicolas; Cornet, Anne; Cornet, Francois; Glineur, Stephanie; Dermine, Martin; Desmecht, Daniel			A Non-Cytosolic Protein of Trypanosoma evansi Induces CD45-Dependent Lymphocyte Death	PLOS ONE			English	Article								In a recent study dealing with a mouse model of Trypanosoma evansi-associated disease, a remarkable synchrony between the parasitaemia peak and the white-blood-cell count nadir was noticed. The present study was designed to establish whether there is a direct causal link between the parasite load during its exponential phase of growth and the disappearance of peripheral blood leukocytes. In vitro experiments performed with trypanosomes and purified peripheral blood mononucleated cells revealed the existence of a lymphotoxin embedded in the T. evansi membrane: a protein sensitive to serine proteases, with a molecular mass of less than 30 kDa. Lymphocytes death induced by this protein was found to depend on the intervention of a lymphocytic protein tyrosine phosphatase. When lymphocytes were exposed to increasing quantities of a monoclonal antibody raised against the extracellular portion of CD45, a transmembrane protein tyrosine phosphatase covering over 10% of the lymphocyte surface, T. evansi membrane extracts showed a dose-dependent decrease in cytotoxicity. As the regulatory functions of CD45 concern not only the fate of lymphocytes but also the activation threshold of the TCR-dependent signal and the amplitude and nature of cytokinic effects, this demonstration of its involvement in T. evansi-dependent lymphotoxicity suggests that T. evansi might manipulate, via CD45, the host's cytokinic and adaptive responses.			Antoine-Moussiaux, N (corresponding author), Univ Liege, Fac Vet Med, Dept Pathol, Liege, Belgium.	daniel.desmecht@ulg.ac.be		Antoine-Moussiaux, Nicolas/0000-0003-1575-625X; Glineur, Stephanie/0000-0002-4053-0255				ADAH MI, 1993, VET PARASITOL, V47, P177, DOI 10.1016/0304-4017(93)90020-N; Antoine-Moussiaux N, 2008, ACTA TROP, V107, P139, DOI 10.1016/j.actatropica.2008.05.010; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chen JC, 2002, BLOOD, V99, P561, DOI 10.1182/blood.V99.2.561; DOSREIS G, 1995, PARASITOL TODAY, V11, P391; ESIEVO KAN, 1983, J COMP PATHOL, V93, P165, DOI 10.1016/0021-9975(83)90002-6; Fortin M, 2002, J IMMUNOL, V168, P6084, DOI 10.4049/jimmunol.168.12.6084; Goossens B, 1998, VET PARASITOL, V79, P283, DOI 10.1016/S0304-4017(98)00171-X; Gregori S, 2005, J EXP MED, V201, P1293, DOI 10.1084/jem.20040912; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HERRERA HM, 2008, PARASITOLOGY RES; IKEDE B O, 1977, Tropical Animal Health and Production, V9, P93, DOI 10.1007/BF02236387; JACKSON DG, 1985, BIOCHEM J, V230, P195, DOI 10.1042/bj2300195; Kim J, 2006, CLIN EXP ALLERGY, V36, P122, DOI 10.1111/j.1365-2222.2005.02407.x; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; Littell RC, 1998, J ANIM SCI, V76, P1216; Lopes MF, 1996, INFECT IMMUN, V64, P1559, DOI 10.1128/IAI.64.5.1559-1564.1996; MABBOTT N, 1995, INFECT IMMUN, V63, P1563, DOI 10.1128/IAI.63.4.1563-1566.1995; Mabbott NA, 1998, IMMUNOLOGY, V94, P476, DOI 10.1046/j.1365-2567.1998.00541.x; MACKENZIE PKI, 1978, RES VET SCI, V24, P4, DOI 10.1016/S0034-5288(18)33089-3; Magez S, 2004, J INFECT DIS, V189, P527, DOI 10.1086/381151; Magez S, 1998, J IMMUNOL, V160, P1949; MAXIE MG, 1979, TROPENMED PARASITOL, V30, P274; Onah DN, 1999, PARASITOL RES, V85, P263, DOI 10.1007/s004360050545; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Radwanska M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000078; Steff AM, 2003, CRIT REV IMMUNOL, V23, P421, DOI 10.1615/CritRevImmunol.v23.i56.40; Tchilian EZ, 2006, TRENDS IMMUNOL, V27, P146, DOI 10.1016/j.it.2006.01.001; Uzcanga GL, 2004, BIOCHEMISTRY-US, V43, P595, DOI 10.1021/bi0301946; WILLIAMS DJL, 1991, PARASITE IMMUNOL, V13, P171, DOI 10.1111/j.1365-3024.1991.tb00273.x; Zhang J, 1999, J MOL CELL CARDIOL, V31, P581, DOI 10.1006/jmcc.1998.0893	31	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5728	10.1371/journal.pone.0005728	http://dx.doi.org/10.1371/journal.pone.0005728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478957	Green Published, gold, Green Submitted			2022-12-27	WOS:000266490000006
J	Ragan, C; Cloonan, N; Grimmond, SM; Zuker, M; Ragan, MA				Ragan, Chikako; Cloonan, Nicole; Grimmond, Sean M.; Zuker, Michael; Ragan, Mark A.			Transcriptome-Wide Prediction of miRNA Targets in Human and Mouse Using FASTH	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MICRORNA; EXPRESSION; SEQUENCE; RNA; IMPACT; IDENTIFICATION; SPECIFICITY; APOPTOSIS; VARIANTS	Transcriptional regulation by microRNAs (miRNAs) involves complementary base-pairing at target sites on mRNAs, yielding complex secondary structures. Here we introduce an efficient computational approach and software (FASTH) for genome-scale prediction of miRNA target sites based on minimizing the free energy of duplex structure. We apply our approach to identify miRNA target sites in the human and mouse transcriptomes. Our results show that short sequence motifs in the 59 end of miRNAs frequently match mRNAs perfectly, not only at validated target sites but additionally at many other, energetically favourable sites. High-quality matching regions are abundant and occur at similar frequencies in all mRNA regions, not only the 3'UTR. About one-third of potential miRNA target sites are reassigned to different mRNA regions, or gained or lost altogether, among different transcript isoforms from the same gene. Many potential miRNA target sites predicted in human are not found in mouse, and vice-versa, but among those that do occur in orthologous human and mouse mRNAs most are situated in corresponding mRNA regions, i.e. these sites are themselves orthologous. Using a luciferase assay in HEK293 cells, we validate four of six predicted miRNA-mRNA interactions, with the mRNA level reduced by an average of 73%. We demonstrate that a thermodynamically based computational approach to prediction of miRNA binding sites on mRNAs can be scaled to analyse complete mammalian transcriptome datasets. These results confirm and extend the scope of miRNA-mediated species-and transcript-specific regulation in different cell types, tissues and developmental conditions.			Ragan, C (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	m.ragan@imb.uq.edu.au	Grimmond, Sean M/J-5304-2016; Cloonan, Nicole/B-5272-2008; Grimmond, Sean/K-3246-2019; Ragan, Mark A/A-9825-2014	Grimmond, Sean M/0000-0002-8102-7998; Cloonan, Nicole/0000-0001-7802-6647; Grimmond, Sean/0000-0002-8102-7998; Ragan, Mark A/0000-0003-1672-7020	NIGMS NIH HHS [R01 GM054250, GM54250] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054250] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; MANFIELD JH, 2004, NAT GENET, V36, P1079; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Saetrom O, 2005, RNA, V11, P995, DOI 10.1261/rna.7290705; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Takeda J, 2006, NUCLEIC ACIDS RES, V34, P3917, DOI 10.1093/nar/gkl507; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xiao JN, 2007, J CELL PHYSIOL, V212, P285, DOI 10.1002/jcp.21062; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoshinari K, 2004, NUCLEIC ACIDS RES, V32, P691, DOI 10.1093/nar/gkh221; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	62	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5745	10.1371/journal.pone.0005745	http://dx.doi.org/10.1371/journal.pone.0005745			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478946	Green Published, gold			2022-12-27	WOS:000266490000019
J	Yan, CG; Liu, DQ; He, Y; Zou, QH; Zhu, CZ; Zuo, XN; Long, XY; Zang, YF				Yan, Chaogan; Liu, Dongqiang; He, Yong; Zou, Qihong; Zhu, Chaozhe; Zuo, Xinian; Long, Xiangyu; Zang, Yufeng			Spontaneous Brain Activity in the Default Mode Network Is Sensitive to Different Resting-State Conditions with Limited Cognitive Load	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; BOLD SIGNAL FLUCTUATIONS; EMOTION-INDUCED CHANGES; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; WORKING-MEMORY; MOTOR CORTEX; BASE-LINE; FMRI; MRI	Background: Recent functional MRI (fMRI) studies have demonstrated that there is an intrinsically organized default mode network (DMN) in the resting brain, primarily made up of the posterior cingulate cortex (PCC) and the medial prefrontal cortex (MPFC). Several previous studies have found that the DMN is minimally disturbed during different resting-state conditions with limited cognitive demand. However, this conclusion was drawn from the visual inspection of the functional connectivity patterns within the DMN and no statistical comparison was performed. Methodology/Principal Findings: Four resting-state fMRI sessions were acquired: 1) eyes-closed (EC) (used to generate the DMN mask); 2) EC; 3) eyes-open with no fixation (EO); and 4) eyes-open with a fixation (EO-F). The 2-4 sessions were counterbalanced across participants (n = 20, 10 males). We examined the statistical differences in both functional connectivity and regional amplitude of low frequency fluctuation (ALFF) within the DMN among the 2-4 resting-state conditions (i.e., EC, EO, and EO-F). Although the connectivity patterns of the DMN were visually similar across these three different conditions, we observed significantly higher functional connectivity and ALFF in both the EO and the EO-F conditions as compared to the EC condition. In addition, the first and second resting EC conditions showed significant differences within the DMN, suggesting an order effect on the DMN activity. Conclusions/Significance: Our findings of the higher DMN connectivity and regional spontaneous activities in the resting state with the eyes open suggest that the participants might have more non-specific or non-goal-directed visual information gathering and evaluation, and mind wandering or daydreaming during the resting state with the eyes open as compared to that with the eyes closed, thus providing insights into the understanding of unconstrained mental activity within the DMN. Our results also suggest that it should be cautious when choosing the type of a resting condition and designating the order of the resting condition in multiple scanning sessions in experimental design.			Yan, CG (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zangyf@bnu.edu.cn	He, Yong/C-2161-2009; Yan, Chao-Gan/D-1713-2015; ZANG, Yu-Feng/J-1558-2012; He, Yong/Q-5756-2018; Zuo, Xi-Nian/A-7273-2009	Yan, Chao-Gan/0000-0003-3413-5977; ZANG, Yu-Feng/0000-0003-1833-8010; Zuo, Xi-Nian/0000-0001-9110-585X				Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2007, MAGN RESON IMAGING, V25, P1358, DOI 10.1016/j.mri.2007.03.022; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; CHEN S, 2008, BRAIN RES; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; HOROVITZ SG, 2007, HUM BRAIN MAPP; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1567, DOI 10.1016/j.neuroimage.2007.09.040; Kiviniemi V, 2000, MAGN RESON MED, V44, P373, DOI 10.1002/1522-2594(200009)44:3<373::AID-MRM5>3.0.CO;2-P; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Li SJ, 2000, MAGNET RESON MED, V43, P45, DOI 10.1002/(SICI)1522-2594(200001)43:1<45::AID-MRM6>3.0.CO;2-0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LONG XY, J NEUROSCI METHODS, V171, P349; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Pelled G, 2004, MAGN RESON MED, V52, P913, DOI 10.1002/mrm.20229; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wig GS, 2008, P NATL ACAD SCI USA, V105, P18555, DOI 10.1073/pnas.0804546105; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002	52	247	251	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5743	10.1371/journal.pone.0005743	http://dx.doi.org/10.1371/journal.pone.0005743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	451SH	19492040	Green Submitted, Green Published, gold			2022-12-27	WOS:000266490000017
J	Arnason, E; Hernandez, UB; Kristinsson, K				Arnason, Einar; Hernandez, Ubaldo Benitez; Kristinsson, Kristjan			Intense Habitat-Specific Fisheries-Induced Selection at the Molecular Pan I Locus Predicts Imminent Collapse of a Major Cod Fishery	PLOS ONE			English	Article							GADUS-MORHUA L.; ATLANTIC COD; NATURAL-SELECTION; GENETIC DIFFERENTIATION; ARCTIC POPULATIONS; NORTHERN NORWAY; REACTION NORMS; MATURATION; EVOLUTION; SIZE	Predation is a powerful agent in the ecology and evolution of predator and prey. Prey may select multiple habitats whereby different genotypes prefer different habitats. If the predator is also habitat-specific the prey may evolve different habitat occupancy. Drastic changes can occur in the relation of the predator to the evolved prey. Fisheries exert powerful predation and can be a potent evolutionary force. Fisheries-induced selection can lead to phenotypic changes that influence the collapse and recovery of the fishery. However, heritability of the phenotypic traits involved and selection intensities are low suggesting that fisheries-induced evolution occurs at moderate rates at decadal time scales. The Pantophysin I (Pan I) locus in Atlantic cod (Gadus morhua), representing an ancient balanced polymorphism predating the split of cod and its sister species, is under an unusual mix of balancing and directional selection including current selective sweeps. Here we show that Pan I alleles are highly correlated with depth with a gradient of 0.44% allele frequency change per meter. AA fish are shallow-water and BB deep-water adapted in accordance with behavioral studies using data storage tags showing habitat selection by Pan I genotype. AB fish are somewhat intermediate although closer to AA. Furthermore, using a sampling design covering space and time we detect intense habitat-specific fisheries-induced selection against the shallow-water adapted fish with an average 8% allele frequency change per year within year class. Genotypic fitness estimates (0.08, 0.27, 1.00 of AA, AB, and BB respectively) predict rapid disappearance of shallow-water adapted fish. Ecological and evolutionary time scales, therefore, are congruent. We hypothesize a potential collapse of the fishery. We find that probabilistic maturation reaction norms for Atlantic cod at Iceland show declining length and age at maturing comparable to changes that preceded the collapse of northern cod at Newfoundland, further supporting the hypothesis. We speculate that immediate establishment of large no-take reserves may help avert collapse.			Arnason, E (corresponding author), Univ Iceland, Inst Biol, Reykjavik, Iceland.	einararn@hi.is	Arnason, Einar/M-3090-2015	Arnason, Einar/0000-0003-3686-6407				Arnason E, 2004, GENETICS, V166, P1871, DOI 10.1534/genetics.166.4.1871; Barot S, 2004, ECOL APPL, V14, P1257, DOI 10.1890/03-5066; Barot S, 2004, EVOL ECOL RES, V6, P659; Begg GA, 2003, FISH RES, V59, P343, DOI 10.1016/S0165-7836(02)00025-5; BJORNSSON H, 2007, 131 HAFR MAR RES I; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; Case RAJ, 2005, MAR ECOL PROG SER, V301, P267, DOI 10.3354/meps301267; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Conover DO, 2007, NATURE, V450, P179, DOI 10.1038/450179a; Conover DO, 2000, MAR ECOL PROG SER, V208, P303; de Meeus T, 2007, INFECT GENET EVOL, V7, P731, DOI 10.1016/j.meegid.2007.07.005; Endler J.A., 1986, Monographs in Population Biology, pviii; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Fevolden SE, 1997, J FISH BIOL, V51, P895, DOI 10.1006/jfbi.1997.0491; Fisher R., 1970, STAT METHODS RES WOR; GALVANI AP, 2004, P ROY SOC LOND B BIO, V27, P171; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hedrick P.W., 2011, GENETICS POPULATIONS; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Hutchings JA, 2004, NATURE, V428, P899, DOI 10.1038/428899a; Hutchings JA, 1996, CAN J FISH AQUAT SCI, V53, P943, DOI 10.1139/f96-097; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; *ICES, 2008, 2008ACOM03 ICES; Johannesson K, 1997, EVOLUTION, V51, P402, DOI 10.1111/j.1558-5646.1997.tb02427.x; Jonsdottir IG, 2006, ICES J MAR SCI, V63, P1501, DOI 10.1016/j.icesjms.2006.05.006; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Karlsson S, 2003, MOL ECOL, V12, P3265, DOI 10.1046/j.1365-294X.2003.01993.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Kurlansky Mark, 1997, COD BIOGRAPHY FISH C; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; LEWONTIN RC, 1959, EVOLUTION, V13, P561, DOI 10.2307/2406136; Marteinsdottir G, 2000, ICES J MAR SCI, V57, P1182, DOI 10.1006/jmsc.2000.0880; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; Nielsen EE, 2006, MOL ECOL, V15, P3219, DOI 10.1111/j.1365-294X.2006.03025.x; Olsen E, 2005, CAN J FISH AQUAT SCI, V62, P811, DOI 10.1139/F05-065; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Palsson OK, 2003, CAN J FISH AQUAT SCI, V60, P1409, DOI 10.1139/F03-117; Pampoulie C, 2008, BEHAV GENET, V38, P76, DOI 10.1007/s10519-007-9175-y; Pampoulie C, 2006, CAN J FISH AQUAT SCI, V63, P2660, DOI 10.1139/F06-150; Pogson GH, 2003, MOL ECOL, V12, P63, DOI 10.1046/j.1365-294X.2003.01713.x; Pogson GH, 2004, MOL BIOL EVOL, V21, P65, DOI 10.1093/molbev/msg237; Pogson GH, 2001, GENETICS, V157, P317; PROUT T, 1965, EVOLUTION, V19, P546, DOI 10.2307/2406251; R Development Core Team, 2007, R LANG ENV STAT COMP; RIJNSDORP AD, 1993, OECOLOGIA, V96, P391, DOI 10.1007/BF00317510; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; ROBERTSON A, 1965, ANIM PROD, V7, P319, DOI 10.1017/S0003356100025770; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sarkar D., 2007, LATTICE LATTICE GRAP; Sarkar D, 2008, USE R, P1; Sarvas TH, 2005, FISH RES, V76, P307, DOI 10.1016/j.fishres.2005.07.013; Sarvas TH, 2005, J FISH BIOL, V67, P444, DOI 10.1111/j.0022-1112.2005.00738.x; SCHOPKA SA, 2007, 133 MAR RES I; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; SWAIN DP, 1994, ICES J MAR SCI, V51, P493, DOI 10.1006/jmsc.1994.1050; Venables WN., 2002, MODERN APPL STAT S 4; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WALLACE B, 1958, EVOLUTION, V12, P113, DOI 10.2307/2405911; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Westgaard JI, 2007, FISH RES, V85, P306, DOI 10.1016/j.fishres.2007.04.001; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x; 2001, 80 MAR RES I; 2007, 138 MAR RES I; 2000, 75 MAR RES I; 2007, 126 MAR RES I	74	50	51	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5529	10.1371/journal.pone.0005529	http://dx.doi.org/10.1371/journal.pone.0005529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479037	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415000001
J	Tickle, P; Nudds, R; Codd, J				Tickle, Peter; Nudds, Robert; Codd, Jonathan			Uncinate Process Length in Birds Scales with Resting Metabolic Rate	PLOS ONE			English	Article							BASAL; TEMPERATURE; MECHANICS; CAPACITY; ANATOMY; SYSTEM	A fundamental function of the respiratory system is the supply of oxygen to meet metabolic demand. Morphological constraints on the supply of oxygen, such as the structure of the lung, have previously been studied in birds. Recent research has shown that uncinate processes (UP) are important respiratory structures in birds, facilitating inspiratory and expiratory movements of the ribs and sternum. Uncinate process length (UPL) is important for determining the mechanical advantage for these respiratory movements. Here we report on the relationship between UPL, body size, metabolic demand and locomotor specialisation in birds. UPL was found to scale isometrically with body mass. Process length is greatest in specialist diving birds, shortest in walking birds and intermediate length in all others relative to body size. Examination of the interaction between the length of the UP and metabolic demand indicated that, relative to body size, species with high metabolic rates have corresponding elongated UP. We propose that elongated UP confer an advantage on the supply of oxygen, perhaps by improving the mechanical advantage and reducing the energetic cost of movements of the ribs and sternum.			Tickle, P (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	jonathan.codd@manchester.ac.uk		Codd, Jonathan/0000-0003-0211-1786	Biotechnology and Biological Sciences Research Council [G011338/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ASCHOFF J, 1970, FED PROC, V29, P1541; Aschoff J, 1970, J. Orn., Berl., V111, P38, DOI 10.1007/BF01668180; BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; Bishop CM, 1997, PHILOS T R SOC B, V352, P447, DOI 10.1098/rstb.1997.0032; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; BRACKENBURY JH, 1972, J EXP BIOL, V57, P543; BRACKENBURY JH, 1973, COMP BIOCHEM PHYSIOL, V44, P599, DOI 10.1016/0300-9629(73)90511-2; CARRIER DR, 1991, AM ZOOL, V31, P644; CARRIER DR, 1992, BIOL J LINN SOC, V47, P61, DOI 10.1111/j.1095-8312.1992.tb00656.x; Codd JR, 2008, P ROY SOC B-BIOL SCI, V275, P157, DOI 10.1098/rspb.2007.1233; Codd JR, 2005, J EXP BIOL, V208, P849, DOI 10.1242/jeb.01489; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; Dutenhoffer MS, 1996, PHYSIOL ZOOL, V69, P1232, DOI 10.1086/physzool.69.5.30164255; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Greenewalt C.H., 1962, SMITHSON MISC COLLNS, V144, P1, DOI DOI 10.1007/S00360-016-1016-Y; Jetz W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003261; KLEIBER MAX, 1932, HILGARDIA, V6, P315; LASIEWSKI RC, 1971, RESP PHYSIOL, V11, P152, DOI 10.1016/0034-5687(71)90020-X; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; McKechnie AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P502, DOI 10.1086/383511; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; Nassar PN, 2001, J EXP BIOL, V204, P1641; Parkes R, 2002, J EXP BIOL, V205, P3945; Powell F.L., 2000, P233, DOI 10.1016/B978-012747605-6/50011-0; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; RAYNER JMV, 1985, J ZOOL, V206, P415; Rezende EL, 2002, J EXP BIOL, V205, P101; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHUFELDT RW, 1890, MYOLOGY RAVEN, P300; Seymour RS, 2008, COMP BIOCHEM PHYS A, V150, P169, DOI 10.1016/j.cbpa.2006.03.018; Sokal R.R., 2012, BIOMETRY; TAYLOR CR, 1981, RESP PHYSIOL, V44, P1, DOI 10.1016/0034-5687(81)90073-6; Tickle PG, 2009, POULTRY SCI, V88, P179, DOI 10.3382/ps.2008-00349; Tickle PG, 2007, J EXP BIOL, V210, P3955, DOI 10.1242/jeb.008953; Walker WF, 1994, FUNCTIONAL ANATOMY V; Welty J.C., 1988, LIFE BIRDS, V4th edn; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; White CR, 2007, P ROY SOC B-BIOL SCI, V274, P287, DOI 10.1098/rspb.2006.3727; Wilson RP, 2003, J EXP BIOL, V206, P1751, DOI 10.1242/jeb.00341; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zimmer K., 1935, ZOOLOGICA, V88, P1	43	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5667	10.1371/journal.pone.0005667	http://dx.doi.org/10.1371/journal.pone.0005667			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479074	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415000005
J	Watanabe, S; Ito, T; Sasaki, T; Li, SS; Uchiyama, I; Kishii, K; Kikuchi, K; Skov, RL; Hiramatsu, K				Watanabe, Shinya; Ito, Teruyo; Sasaki, Takashi; Li, Shanshuang; Uchiyama, Ikuo; Kishii, Kozue; Kikuchi, Ken; Skov, Robert Leo; Hiramatsu, Keiichi			Genetic Diversity of Staphylocoagulase Genes (coa): Insight into the Evolution of Variable Chromosomal Virulence Factors in Staphylococcus aureus	PLOS ONE			English	Article								Background: The production of staphylocoagulase (SC) causing the plasma coagulation is one of the important characteristics of Staphylococcus aureus. Although SCs have been classified into 10 serotypes based on the differences in the antigenicity, genetic bases for their diversities and relatedness to chromosome types are poorly understood. Methodology/Principal Findings: We compared the nucleotide sequences of 105 SC genes (coa), 59 of which were determined in this study. D1 regions, which contain prothrombin-activating and -binding domains and are presumed to be the binding site of each type-specific antiserum, were classified into twelve clusters having more than 90% nucleotide identities, resulting to create two novel SC types, XI and XII, in addition to extant 10 types. Nine of the twelve SC types were further subdivided into subtypes based on the differences of the D2 or the central regions. The phylogenetical relations of the D1 regions did not correlate exactly with either one of agr types and multilocus sequence types (STs). In addition, genetic analysis showed that recombination events have occurred in and around coa. So far tested, STs of 126 S. aureus strains correspond to the combination of SC type and agr type except for the cases of CC1 and CC8, which contained two and three different SC types, respectively. Conclusion: The data suggested that the evolution of coa was not monophyletic in the species. Chromosomal recombination had occurred at coa and agr loci, resulting in the carriage of the combinations of allotypically different important virulence determinants in staphylococcal chromosome.			Watanabe, S (corresponding author), NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	teruybac@juntendo.ac.jp	Sasaki, Takashi/AAW-7641-2021; Watanabe, Shinya/B-7008-2009; Skov, Robert/ABB-3105-2020; Kikuchi, Ken/I-8398-2019; Sasaki, Takashi/AAD-1461-2019	Watanabe, Shinya/0000-0001-6542-6502; Skov, Robert/0000-0002-6079-5381; Kikuchi, Ken/0000-0002-3165-8206; Watanabe, Shinya/0000-0003-3932-8575; Uchiyama, Ikuo/0000-0002-9197-5000				Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BABA T, 2004, STAPHYLOCOCCUS AUREU, P66; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Berglund C, 2009, J ANTIMICROB CHEMOTH, V63, P32, DOI 10.1093/jac/dkn435; Devriese LA, 2005, INT J SYST EVOL MICR, V55, P1569, DOI 10.1099/ijs.0.63413-0; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzgerald J. Ross, 2008, P255; Foster G, 1997, INT J SYST BACTERIOL, V47, P724, DOI 10.1099/00207713-47-3-724; Freney J, 1999, INT J SYST BACTERIOL, V49, P489, DOI 10.1099/00207713-49-2-489; Friedrich R, 2006, J BIOL CHEM, V281, P1188, DOI 10.1074/jbc.M507957200; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; HEMKER HC, 1975, BIOCHIM BIOPHYS ACTA, V379, P180, DOI 10.1016/0005-2795(75)90020-3; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Hisata K, 2005, J CLIN MICROBIOL, V43, P3364, DOI 10.1128/JCM.43.7.3364-3372.2005; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; IGARASHI H, 1985, IMMUNOLOGICAL DIFFER; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kanemitsu K, 2001, MICROBIOL IMMUNOL, V45, P23, DOI 10.1111/j.1348-0421.2001.tb01270.x; KAWABATA S, 1986, J BIOL CHEM, V261, P1427; Kinoshita M, 2008, MICROBIOL IMMUNOL, V52, P334, DOI 10.1111/j.1348-0421.2008.00045.x; Kishii K, 2008, J ANTIMICROB CHEMOTH, V62, P324, DOI 10.1093/jac/dkn186; Komori Y, 2001, J NAT TOXINS, V10, P111; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Sakai F, 2008, J MICROBIOL METH, V75, P312, DOI 10.1016/j.mimet.2008.07.003; Sasaki T, 2007, J CLIN MICROBIOL, V45, P2770, DOI 10.1128/JCM.00360-07; SCOTT AC, 1969, J MED MICROBIOL, V2, P253, DOI 10.1099/00222615-2-3-253; Shopsin B, 2003, J CLIN MICROBIOL, V41, P456, DOI 10.1128/JCM.41.1.456-459.2003; SMITH JM, 1992, J MOL EVOL, V34, P126; STREITFELD MM, 1959, NATURE, V184, P1665, DOI 10.1038/1841665a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; USHIODA H, 1981, ZBL BAKT S, V10, P77; UTSUI Y, 1985, ANTIMICROB AGENTS CH, V28, P397, DOI 10.1128/AAC.28.3.397; Watanabe S, 2005, J BACTERIOL, V187, P3698, DOI 10.1128/JB.187.11.3698-3707.2005	55	49	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5714	10.1371/journal.pone.0005714	http://dx.doi.org/10.1371/journal.pone.0005714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492076	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415000021
J	Beed, PS; Salmen, B; Schmitz, D				Beed, Prateep S.; Salmen, Benedikt; Schmitz, Dietmar			GluK2-Mediated Excitability within the Superficial Layers of the Entorhinal Cortex	PLOS ONE			English	Article								Recent analysis of genetically modified mice deficient in different kainate receptor (KAR) subunits have strongly pointed to a role of the GluK2 subunit, mediating the vulnerability of the brain towards seizures. Research concerning this issue has focused mainly on the hippocampus. However, several studies point to a potential role of other parts of the hippocampal formation, in particular the entorhinal cortex, in the development of epileptic seizures. There is extensive cell death after such seizures in layer III of the medial entorhinal cortex (LIII mEC), making this region of special interest for investigation into related pathological conditions. We therefore characterized KAR mediated currents in LIII mEC pyramidal neurons by several different approaches. Using patch-clamp technique, in combination with glutamate uncaging in horizontal brain slices, we show that LIII mEC neurons exhibit KAR currents. Use of genetically modified mice reveal that these currents are mediated by GluK2 containing KARs. The IV curve indicates the predominant presence of a Ca(2+) impermeable and edited form of the KAR. Finally, we show that GluK2 containing kainate receptors are essential for kainate-induced gamma oscillations within the entorhinal cortex.			Beed, PS (corresponding author), Univ Med Berlin, Neurosci Res Ctr, Berlin, Germany.	dietmar.schmitz@charite.de		Schmitz, Dietmar/0000-0003-2741-5241				BAHN S, 1994, J NEUROSCI, V14, P5525; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BORLOTTO ZA, 2005, NEUROTOXICOLOGY, V25, P769; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Cunningham MO, 2006, J NEUROSCI, V26, P2767, DOI 10.1523/JNEUROSCI.5054-05.2006; Cunningham MO, 2003, J NEUROSCI, V23, P9761; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Dickson CT, 1997, NEUROSCIENCE, V81, P937, DOI 10.1016/S0306-4522(97)00263-7; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; Eder M, 2003, J NEUROSCI, V23, P6660; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P65, DOI 10.1113/jphysiol.2004.077388; Frerking M, 2002, J NEUROSCI, V22, P7434; Gloveli T, 1997, J NEUROPHYSIOL, V78, P3444, DOI 10.1152/jn.1997.78.6.3444; Gloveli T, 1997, NEUROSCIENCE, V77, P629, DOI 10.1016/S0306-4522(96)00494-0; Grigorenko EV, 1998, NEUROREPORT, V9, P2219, DOI 10.1097/00001756-199807130-00013; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Huxter JR, 2007, J NEUROSCI, V27, P2212, DOI 10.1523/JNEUROSCI.3954-06.2007; JARRARD LE, 1993, NEUROPATH APPL NEURO, V19, P381, DOI 10.1111/j.1365-2990.1993.tb00458.x; Kortenbruck G, 2000, EUR J NEUROSCI, V12, P107; Kortenbruck G, 2001, NEUROBIOL DIS, V8, P459, DOI 10.1006/nbdi.2001.0394; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; LOMELI H, 1992, FEBS LETT, V307, P139, DOI 10.1016/0014-5793(92)80753-4; MacGregor DG, 1997, EXP NEUROL, V148, P110, DOI 10.1006/exnr.1997.6625; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Musshoff U, 2002, KLIN NEUROPHYSIOL, V32, P178; Paschen W, 1996, J CEREBR BLOOD F MET, V16, P548, DOI 10.1097/00004647-199607000-00004; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Sailer A, 1999, J NEUROSCI, V19, P8757, DOI 10.1523/JNEUROSCI.19-20-08757.1999; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sprengel R, 1998, N-S ARCH PHARMACOL, V358, pR370; TOLLE TR, 1993, J NEUROSCI, V13, P5009, DOI 10.1523/JNEUROSCI.13-12-05009.1993; Tolner EA, 2005, EPILEPSIA, V46, P72, DOI 10.1111/j.1528-1167.2005.01012.x; Tolner EA, 2007, NEUROBIOL DIS, V26, P419, DOI 10.1016/j.nbd.2007.01.009; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vissel B, 2001, NEURON, V29, P217, DOI 10.1016/S0896-6273(01)00192-1; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; West PJ, 2007, NEUROSCIENCE, V146, P1000, DOI 10.1016/j.neuroscience.2007.02.035; West PJ, 2005, EPILEPSIA, V46, P128; Whittington MA, 2000, PHARMACOL THERAPEUT, V86, P171, DOI 10.1016/S0163-7258(00)00038-3; WISDEN W, 1993, J NEUROSCI, V13, P3582	47	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5576	10.1371/journal.pone.0005576	http://dx.doi.org/10.1371/journal.pone.0005576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440371	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000266107500007
J	Murphy, AJ; Guyre, PM; Wira, CR; Pioli, PA				Murphy, Amy J.; Guyre, Paul M.; Wira, Charles R.; Pioli, Patricia A.			Estradiol Regulates Expression of Estrogen Receptor ER alpha 46 in Human Macrophages	PLOS ONE			English	Article								Background: Monocytes and macrophages are key innate immune effector cells that produce cytokines and chemokines upon activation. We and others have shown that 17 beta-estradiol (E2) has a direct role in the modulation of monocyte and macrophage immune function. However, relatively little is known about the ability of E2 to regulate isoform expression of estrogen receptors (ERs) in these cells. Methodology/Principal Findings: In this study, we quantify expression of ER alpha and ER beta in human monocytes and macrophages. We also show for the first time that the N-terminal truncated ER alpha variant, ER alpha 46, is expressed in both cell types. Promoter utilization studies reveal that transcription of ER alpha in both cell types occurs from upstream promoters E and F. Treatment with E2 induces ER alpha expression in macrophages but has no effect on ER beta levels in either cell type. During monocyte-to-macrophage differentiation, ER alpha is upregulated in a time-dependent manner. Previous studies by our group demonstrated that E2 treatment attenuates production of the chemokine CXCL8 in an ER-dependent manner. We now show that ER alpha expression levels parallel the ability of E2 to suppress CXCL8 production. Conclusions/Significance: This work demonstrates for the first time that human macrophages predominantly express the truncated ER variant ER alpha p46, which is estradiol-inducible. This is mediated through usage of the ER alpha F promoter. Alternative promoter usage may account for tissue and cell type-specific differences in estradiol-induced effects on gene expression. These studies signify the importance of ER alpha expression and regulation in the ability of E2 to modulate innate immune responses.			Murphy, AJ (corresponding author), Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA.	pioli@dartmouth.edu			NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051547, P01AI051877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007576] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA023108] Funding Source: Medline; NIAID NIH HHS [P01 AI051877, AI51877, R01 AI051547, AI051547] Funding Source: Medline; NIAMS NIH HHS [T32 AR007576, T32AR007576] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adeyemo O, 1993, Afr J Med Med Sci, V22, P55; Angele Martin K., 2006, Clinics, V61, P479, DOI 10.1590/S1807-59322006000500017; Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288; BAIRD DT, 1974, J ENDOCRINOL, V63, P201, DOI 10.1677/joe.0.0630201; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Calippe B, 2008, J IMMUNOL, V180, P7980, DOI 10.4049/jimmunol.180.12.7980; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Chen JL, 1997, STEM CELLS, V15, P368, DOI 10.1002/stem.150368; Creekmore AL, 2007, MOL CELL ENDOCRINOL, V267, P106, DOI 10.1016/j.mce.2007.01.001; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Denger S, 2001, MOL CELL ENDOCRINOL, V178, P155, DOI 10.1016/S0303-7207(01)00417-8; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Donaghue C, 1999, MOL ENDOCRINOL, V13, P1934, DOI 10.1210/me.13.11.1934; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; GIRARD MT, 1987, J IMMUNOL, V138, P3235; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hersh D, 1998, CURR OPIN MICROBIOL, V1, P43, DOI 10.1016/S1369-5274(98)80141-0; Hsieh YC, 2007, AM J PHYSIOL-LUNG C, V292, pL1227, DOI 10.1152/ajplung.00479.2006; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Kato S, 1999, JPN J CLIN ONCOL, V29, P321, DOI 10.1093/jjco/29.7.321; Khan KN, 2005, HUM REPROD, V20, P2004, DOI 10.1093/humrep/deh897; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Kramer PR, 2002, J STEROID BIOCHEM, V81, P203, DOI 10.1016/S0960-0760(02)00065-1; Lambert KC, 2005, J IMMUNOL, V175, P5716, DOI 10.4049/jimmunol.175.9.5716; Lambert KC, 2004, J LEUKOCYTE BIOL, V75, P1166, DOI 10.1189/jlb.1103589; Lambertini E, 2003, BIOCHEM J, V372, P831, DOI 10.1042/BJ20021633; Lambertini E, 2008, J CELL PHYSIOL, V216, P101, DOI 10.1002/jcp.21379; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9; Messingham KAN, 2001, J LEUKOCYTE BIOL, V70, P887; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mor G, 2003, J IMMUNOL, V170, P114, DOI 10.4049/jimmunol.170.1.114; Nalbandian G, 2005, J IMMUNOL, V175, P2666, DOI 10.4049/jimmunol.175.4.2666; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Naz RK, 1996, AM J REPROD IMMUNOL, V35, P534; Penot G, 2005, ENDOCRINOLOGY, V146, P5474, DOI 10.1210/en.2005-0866; Pioli PA, 2006, J IMMUNOL, V176, P6647, DOI 10.4049/jimmunol.176.11.6647; Pioli PA, 2007, J IMMUNOL, V179, P6284, DOI 10.4049/jimmunol.179.9.6284; Reid G, 2002, CELL MOL LIFE SCI, V59, P821, DOI 10.1007/s00018-002-8470-2; Robertson JA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290125; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; SARDA IR, 1976, AM J OBSTET GYNECOL, V124, P234, DOI 10.1016/0002-9378(76)90149-6; SHEN L, 1986, CLIN EXP IMMUNOL, V65, P387; Soriano D, 2003, FERTIL STERIL, V79, P975, DOI 10.1016/S0015-0282(02)04853-7; Stevens TA, 2006, ONCOGENE, V25, P5426, DOI 10.1038/sj.onc.1209529; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Suzuki T, 2008, J CELL PHYSIOL, V214, P662, DOI 10.1002/jcp.21255; Suzuki T, 2007, AM J PHYSIOL-CELL PH, V293, pC978, DOI 10.1152/ajpcell.00092.2007; THIJSSEN JHH, 1984, J STEROID BIOCHEM, V20, P955, DOI 10.1016/0022-4731(84)90003-7; Treilleux I, 1997, MOL ENDOCRINOL, V11, P1319, DOI 10.1210/me.11.9.1319; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; ZHANG B, 2005, COMPUTER ENG APPL, V6, P7; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003	58	106	110	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5539	10.1371/journal.pone.0005539	http://dx.doi.org/10.1371/journal.pone.0005539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440537	gold, Green Published, Green Submitted			2022-12-27	WOS:000266107500001
J	Xilouri, M; Vogiatzi, T; Vekrellis, K; Park, D; Stefanis, L				Xilouri, Maria; Vogiatzi, Tereza; Vekrellis, Kostas; Park, David; Stefanis, Leonidas			Abberant alpha-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy	PLOS ONE			English	Article								Background: The mechanisms through which aberrant alpha-synuclein (ASYN) leads to neuronal death in Parkinson's disease (PD) are uncertain. In isolated liver lysosomes, mutant ASYNs impair Chaperone Mediated Autophagy (CMA), a targeted lysosomal degradation pathway; however, whether this occurs in a cellular context, and whether it mediates ASYN toxicity, is unknown. We have investigated presently the effects of WT or mutant ASYN on the lysosomal pathways of CMA and macroautophagy in neuronal cells and assessed their impact on ASYN-mediated toxicity. Methods and Findings: Novel inducible SH-SY5Y and PC12 cell lines expressing human WT and A53T ASYN, as well as two mutant forms that lack the CMA-targeting motif were generated. Such forms were also expressed in primary cortical neurons, using adenoviral transduction. In each case, effects on long-lived protein degradation, LC3 II levels (as a macroautophagy index), and cell death and survival were assessed. In both PC12 and SH-SY5Y cycling cells, induction of A53T ASYN evoked a significant decrease in lysosomal degradation, largely due to CMA impairment. In neuronally differentiated SH-SH5Y cells, both WT and A53T ASYN induction resulted in gradual toxicity, which was partly dependent on CMA impairment and compensatory macroautophagy induction. In primary neurons both WT and A53T ASYN were toxic, but only in the case of A53T ASYN did CMA dysfunction and compensatory macroautophagy induction occur and participate in death. Conclusions: Expression of mutant A53T, and, in some cases, WT ASYN in neuronal cells leads to CMA dysfunction, and this in turn leads to compensatory induction of macroautophagy. Inhibition of these lysosomal effects mitigates ASYN toxicity. Therefore, CMA dysfunction mediates aberrant ASYN toxicity, and may be a target for therapeutic intervention in PD and related disorders. Furthermore, macroautophagy induction in the context of ASYN over-expression, in contrast to other settings, appears to be a detrimental response, leading to neuronal death.			Xilouri, M (corresponding author), Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens, Greece.	lstefanis@bioacademy.gr	Stefanis, Leonidas/AAD-7192-2019	Park, David/0000-0002-4490-3784; Xilouri, Maria/0000-0001-7038-0780	NINDS NIH HHS [R21 NS055693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055693] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burke WJ, 2003, CNS NEUROL DISORD-DR, V2, P143, DOI 10.2174/1568007033482913; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dietrich P, 2003, MOL CELL NEUROSCI, V24, P430, DOI 10.1016/S1044-7431(03)00201-X; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; EMMANOUILIDOU E, 2008, NEUROBIOL AGING; Farinelli SE, 1998, J NEUROSCI, V18, P5112, DOI 10.1523/JNEUROSCI.18-14-05112.1998; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; KIM C, 2008, J NEUROCHEM; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Maguire-Zeiss KA, 2005, MOL BRAIN RES, V134, P18, DOI 10.1016/j.molbrainres.2004.09.014; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Mosharov EV, 2006, J NEUROSCI, V26, P9304, DOI 10.1523/JNEUROSCI.0519-06.2006; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 1997, J NEUROCHEM, V69, P1425; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Stefanis L, 1999, J NEUROSCI, V19, P6235; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Vekrellis K, 2004, MOL NEUROBIOL, V30, P1, DOI 10.1385/MN:30:1:001; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	64	263	271	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5515	10.1371/journal.pone.0005515	http://dx.doi.org/10.1371/journal.pone.0005515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436756	gold, Green Submitted, Green Published			2022-12-27	WOS:000266009900008
J	Egger, B; Steinke, D; Tarui, H; De Mulder, K; Arendt, D; Borgonie, G; Funayama, N; Gschwentner, R; Hartenstein, V; Hobmayer, B; Hooge, M; Hrouda, M; Ishida, S; Kobayashi, C; Kuales, G; Nishimura, O; Pfister, D; Rieger, R; Salvenmoser, W; Smith, J; Technau, U; Tyler, S; Agata, K; Salzburger, W; Ladurner, P				Egger, Bernhard; Steinke, Dirk; Tarui, Hiroshi; De Mulder, Katrien; Arendt, Detlev; Borgonie, Gaetan; Funayama, Noriko; Gschwentner, Robert; Hartenstein, Volker; Hobmayer, Bert; Hooge, Matthew; Hrouda, Martina; Ishida, Sachiko; Kobayashi, Chiyoko; Kuales, Georg; Nishimura, Osamu; Pfister, Daniela; Rieger, Reinhard; Salvenmoser, Willi; Smith, Julian, III; Technau, Ulrich; Tyler, Seth; Agata, Kiyokazu; Salzburger, Walter; Ladurner, Peter			To Be or Not to Be a Flatworm: The Acoel Controversy	PLOS ONE			English	Article							PLANARIAN STEM-CELLS; BASAL POSITION; ACOELOMORPH FLATWORMS; MITOCHONDRIAL GENOME; MACROSTOMUM-LIGNANO; BILATERIAN ANIMALS; S-PHASE; PLATYHELMINTHES; REGENERATION; SUPPORT	Since first described, acoels were considered members of the flatworms (Platyhelminthes). However, no clear synapomorphies among the three large flatworm taxa - the Catenulida, the Acoelomorpha and the Rhabditophora have been characterized to date. Molecular phylogenies, on the other hand, commonly positioned acoels separate from other flatworms. Accordingly, our own multi-locus phylogenetic analysis using 43 genes and 23 animal species places the acoel flatworm Isodiametra pulchra at the base of all Bilateria, distant from other flatworms. By contrast, novel data on the distribution and proliferation of stem cells and the specific mode of epidermal replacement constitute a strong synapomorphy for the Acoela plus the major group of flatworms, the Rhabditophora. The expression of a piwi-like gene not only in gonadal, but also in adult somatic stem cells is another unique feature among bilaterians. These two independent stem-cell-related characters put the Acoela into the Platyhelminthes-Lophotrochozoa clade and account for the most parsimonious evolutionary explanation of epidermal cell renewal in the Bilateria. Most available multigene analyses produce conflicting results regarding the position of the acoels in the tree of life. Given these phylogenomic conflicts and the contradiction of developmental and morphological data with phylogenomic results, the monophyly of the phylum Platyhelminthes and the position of the Acoela remain unresolved. By these data, both the inclusion of Acoela within Platyhelminthes, and their separation from flatworms as basal bilaterians are well-supported alternatives.			Egger, B (corresponding author), Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria.	styler@maine.edu; agata@mdb.biophys.kyoto-u.ac.jp; walter.salzburger@unibas.ch; peter.ladurner@uibk.ac.at	Steinke, Dirk/D-4700-2009; Nishimura, Osamu/AAC-1236-2020; Salzburger, Walter/G-1598-2011	Nishimura, Osamu/0000-0003-1969-2580; Salzburger, Walter/0000-0002-9988-1674; Ladurner, Peter/0000-0002-0323-9266; Technau, Ulrich/0000-0003-4472-8258; Steinke, Dirk/0000-0002-8992-575X; Funayama, Noriko/0000-0002-6253-9795; Egger, Bernhard/0000-0001-6353-9458; Agata, Kiyokazu/0000-0002-5195-2576				Baguna J, 2004, BIOESSAYS, V26, P1046, DOI 10.1002/bies.20113; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Baguna J, 2008, PHILOS T R SOC B, V363, P1481, DOI 10.1098/rstb.2007.2238; Bode A, 2006, CELL TISSUE RES, V325, P577, DOI 10.1007/s00441-006-0196-2; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; DROBYSHEVA IM, 1988, FORTSCHR ZOOL, V36, P97; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Egger B, 2006, DEV GENES EVOL, V216, P565, DOI 10.1007/s00427-006-0069-4; Ehlers U., 1992, Microfauna Marina, V7, P311; Ehlers U, 1985, PHYLOGENETISCHE SYST; Gschwentner R, 2001, CELL TISSUE RES, V304, P401, DOI 10.1007/s004410100375; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; GUSTAFSSON MKS, 1976, Z PARASITENKD, V50, P323, DOI 10.1007/BF02462976; Hanselmann R, 2000, BIOL BULL, V199, P199, DOI 10.2307/1542896; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Jimenez-Guri E, 2006, INT J DEV BIOL, V50, P675, DOI 10.1387/ijdb.062167ej; Karling T.G., 1974, P1; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Ladurner P, 2000, DEV BIOL, V226, P231, DOI 10.1006/dbio.2000.9867; Larsson K, 2008, ORG DIVERS EVOL, V8, P378, DOI 10.1016/j.ode.2008.09.002; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; MACKINNON BM, 1981, HYDROBIOLOGIA, V84, P241, DOI 10.1007/BF00026186; Muller WA, 2004, DEV BIOL, V275, P215, DOI 10.1016/j.ydbio.2004.08.006; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; OTT HN, 1892, J MORPHOL, V7, P263; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Paulus T, 2006, J MORPHOL, V267, P393, DOI 10.1002/jmor.10280; Pfister D, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-9; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; RIEGER R, 2006, SPEZIELLE ZOOLOGIE, V1, P209; Rossi L, 2006, DEV GENES EVOL, V216, P335, DOI 10.1007/s00427-006-0060-0; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Sempere LF, 2007, EVOL DEV, V9, P409, DOI 10.1111/j.1525-142X.2007.00180.x; SMITH JPS, 1986, HYDROBIOLOGIA, V132, P13, DOI 10.1007/BF00046223; SMITH JPS, 2009, NEOBLASTS NEMERTODER; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Toledo A, 1997, J PARASITOL, V83, P189, DOI 10.2307/3284437; Tyler S, 2004, CAN J ZOOL, V82, P194, DOI [10.1139/z03-222, 10.1139/Z03-222]	45	79	82	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5502	10.1371/journal.pone.0005502	http://dx.doi.org/10.1371/journal.pone.0005502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430533	Green Published, gold			2022-12-27	WOS:000266009700007
J	Miksa, M; Das, P; Zhou, M; Wu, RQ; Dong, WF; Ji, YX; Goyert, SM; Ravikumar, TS; Wang, P				Miksa, Michael; Das, Padmalaya; Zhou, Mian; Wu, Rongqian; Dong, Weifeng; Ji, Youxin; Goyert, Sanna M.; Ravikumar, Thanjavur S.; Wang, Ping			Pivotal Role of the alpha(2A)-Adrenoceptor in Producing Inflammation and Organ Injury in a Rat Model of Sepsis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEPATOCELLULAR DYSFUNCTION; TNF-ALPHA; RECEPTORS; STIMULATION; EXPRESSION; MECHANISM; CYTOKINES; RELEASE; INNATE	Background: Norepinephrine (NE) modulates the responsiveness of macrophages to proinflammatory stimuli through the activation of adrenergic receptors (ARs). Being part of the stress response, early increases of NE in sepsis sustain adverse systemic inflammatory responses. The intestine is an important source of NE release in the early stage of cecal ligation and puncture (CLP)-induced sepsis in rats, which then stimulates TNF-alpha production in Kupffer cells (KCs) through the activation of the alpha(2)-AR. It is important to know which of the three alpha(2)-AR subtypes (i.e., alpha(2A), alpha(2B) or alpha(2C)) is responsible for the upregulation of TNF-alpha production. The aim of this study was to determine the contribution of alpha(2A)-AR in this process. Methodology/Principal Findings: Adult male rats underwent CLP and KCs were isolated 2 h later. Gene expression of alpha(2A)-AR was determined. In additional experiments, cultured KCs were incubated with NE with or without BRL-44408 maleate, a specific alpha(2A)-AR antagonist, and intraportal infusion of NE for 2 h with or without BRL-44408 maleate was carried out in normal animals. Finally, the impact of alpha(2A)-AR activation by NE was investigated under inflammatory conditions (i.e., endotoxemia and CLP). Gene expression of the alpha(2A)-AR subtype was significantly upregulated after CLP. NE increased the release of TNF-alpha in cultured KCs, which was specifically inhibited by the alpha(2A)-AR antagonist BRL-44408. Equally, intraportal NE infusion increased TNF-alpha gene expression in KCs and plasma TNF-alpha which was also abrogated by co-administration of BRL-44408. NE also potentiated LPS-induced TNF-alpha release via the alpha(2A)-AR in vitro and in vivo. This potentiation of TNF-alpha release by NE was mediated through the alpha(2A)-AR coupled G alpha i protein and the activation of the p38 MAP kinase. Treatment of septic animals with BRL-44408 suppressed TNF-alpha, prevented multiple organ injury and significantly improved survival from 45% to 75%. Conclusions/Significance: Our novel finding is that hyperresponsiveness to alpha(2)-AR stimulation observed in sepsis is primarily due to an increase in alpha(2A)-AR expression in KCs. This appears to be in part responsible for the increased proinflammatory response and ensuing organ injury in sepsis. These findings provide important feasibility information for further developing the alpha(2A)-AR antagonist as a new therapy for sepsis.			Miksa, M (corresponding author), N Shore Univ Hosp, Feinstein Inst Med Res, Ctr Immunol & Inflammat, Dept Surg, Manhasset, NY USA.	pwang@nshs.edu	Wu, Rongqian/I-3614-2012; ji, youxin/F-3802-2014; Goyert, Sanna/P-8351-2017; ji, youxin/F-3802-2014	Wu, Rongqian/0000-0003-0993-4531; ji, youxin/0000-0003-2895-4730; Wang, Ping/0000-0002-1557-0394; Goyert, Sanna/0000-0002-0994-7757; ji, youxin/0000-0003-2303-8784	NIA NIH HHS [R01 AG028352] Funding Source: Medline; NIGMS NIH HHS [R01 GM053008, R01 GM057468] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057468, R01GM053008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028352] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bergmann M, 2002, WIEN KLIN WOCHENSCHR, V114, P752; Beutler B, 2001, CRIT CARE MED, V29, pS2, DOI 10.1097/00003246-200107001-00002; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Flugge G, 2003, EUR J NEUROSCI, V17, P917, DOI 10.1046/j.1460-9568.2003.02510.x; HAHN PY, 1995, SHOCK, V4, P269, DOI 10.1097/00024382-199510000-00007; Handy DE, 1998, HYPERTENSION, V32, P311, DOI 10.1161/01.HYP.32.2.311; Hasko G, 1998, BIOCHEM PHARMACOL, V56, P1079, DOI 10.1016/S0006-2952(98)00153-1; Ihalainen JA, 2002, EUR J NEUROSCI, V15, P1789, DOI 10.1046/j.1460-9568.2002.02014.x; Koo DJ, 1999, J SURG RES, V83, P151, DOI 10.1006/jsre.1999.5584; Kotanidou A, 1996, J APPL PHYSIOL, V81, P2304, DOI 10.1152/jappl.1996.81.5.2304; KOVARIK MF, 1987, CIRC SHOCK, V22, P281; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Vizi ES, 2000, PHARMACOL REV, V52, P63; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WANG P, 1994, AM J PHYSIOL, V267, pG52, DOI 10.1152/ajpgi.1994.267.1.G52; WANG P, 1991, AM J PHYSIOL, V261, pR1507, DOI 10.1152/ajpregu.1991.261.6.R1507; WANG P, 1993, AM J PHYSIOL, V265, pG126, DOI 10.1152/ajpgi.1993.265.1.G126; Wang P, 1996, AM J PHYSIOL-REG I, V270, pR927, DOI 10.1152/ajpregu.1996.270.5.R927; Wang P, 1997, ARCH SURG-CHICAGO, V132, P364; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Willems EW, 2001, BRIT J PHARMACOL, V132, P1292, DOI 10.1038/sj.bjp.0703915; Wu RQ, 2003, REGUL PEPTIDES, V112, P19, DOI 10.1016/S0167-0115(03)00018-1; Yang SL, 2000, AM J PHYSIOL-GASTR L, V279, pG1274, DOI 10.1152/ajpgi.2000.279.6.G1274; Yang SL, 2001, AM J PHYSIOL-GASTR L, V281, pG1014, DOI 10.1152/ajpgi.2001.281.4.G1014; Yang SL, 1999, J TRAUMA, V47, P706, DOI 10.1097/00005373-199910000-00015; Zhou M, 2001, BBA-MOL BASIS DIS, V1537, P49, DOI 10.1016/S0925-4439(01)00055-2	32	58	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5504	10.1371/journal.pone.0005504	http://dx.doi.org/10.1371/journal.pone.0005504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430535	Green Published, gold			2022-12-27	WOS:000266009700009
J	Dreyfus, DH				Dreyfus, David H.			Paleo-Immunology: Evidence Consistent with Insertion of a Primordial Herpes Virus-Like Element in the Origins of Acquired Immunity	PLOS ONE			English	Article								Background: The RAG encoded proteins, RAG-1 and RAG-2 regulate site-specific recombination events in somatic immune B-and T-lymphocytes to generate the acquired immune repertoire. Catalytic activities of the RAG proteins are related to the recombinase functions of a pre-existing mobile DNA element in the DDE recombinase/RNAse H family, sometimes termed the "RAG transposon''. Methodology/'Principal Findings: Novel to this work is the suggestion that the DDE recombinase responsible for the origins of acquired immunity was encoded by a primordial herpes virus, rather than a "RAG transposon.'' A subsequent "arms race'' between immunity to herpes infection and the immune system obscured primary amino acid similarities between herpes and immune system proteins but preserved regulatory, structural and functional similarities between the respective recombinase proteins. In support of this hypothesis, evidence is reviewed from previous published data that a modern herpes virus protein family with properties of a viral recombinase is co-regulated with both RAG-1 and RAG-2 by closely linked cis-acting co-regulatory sequences. Structural and functional similarity is also reviewed between the putative herpes recombinase and both DDE site of the RAG-1 protein and another DDE/RNAse H family nuclease, the Argonaute protein component of RISC (RNA induced silencing complex). Conclusions/Significance: A "co-regulatory'' model of the origins of V(D)J recombination and the acquired immune system can account for the observed linked genomic structure of RAG-1 and RAG-2 in non-vertebrate organisms such as the sea urchin that lack an acquired immune system and V(D)J recombination. Initially the regulated expression of a viral recombinase in immune cells may have been positively selected by its ability to stimulate innate immunity to herpes virus infection rather than V(D)J recombination Unlike the "RAG-transposon'' hypothesis, the proposed model can be readily tested by comparative functional analysis of herpes virus replication and V(D)J recombination.			Dreyfus, DH (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	dhdreyfus@pol.net			NIAID NIH HHS [T32 AI007365, T32-AI07365] Funding Source: Medline; NIGMS NIH HHS [T32 GM007288, T32-GM07288] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Balmelle N, 2004, J IMMUNOL, V173, P5054, DOI 10.4049/jimmunol.173.8.5054; Brandt VL, 2008, J IMMUNOL, V180, P3, DOI 10.4049/jimmunol.180.1.3; CAREY M, 1992, J VIROL, V66, P4803, DOI 10.1128/JVI.66.8.4803-4813.1992; Chatterji M, 2004, IMMUNOL REV, V200, P261, DOI 10.1111/j.0105-2896.2004.00167.x; Chen YM, 1996, VIROLOGY, V221, P281, DOI 10.1006/viro.1996.0377; CHOWDHURY SI, 1990, J VIROL, V64, P873, DOI 10.1128/JVI.64.2.873-880.1990; Dardari R, 2001, J CLIN MICROBIOL, V39, P3164, DOI 10.1128/JCM.39.9.3164-3170.2001; Delecluse HJ, 2000, J CLIN PATHOL-MOL PA, V53, P270, DOI 10.1136/mp.53.5.270; Dreyfus DH, 2006, ANN ALLERG ASTHMA IM, V97, P567, DOI 10.1016/S1081-1206(10)61083-6; Dreyfus DH, 1999, MED HYPOTHESES, V52, P545, DOI 10.1054/mehy.1997.0691; Dreyfus DH, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-12; DREYFUS DH, 1992, MOL IMMUNOL, V29, P807, DOI 10.1016/0161-5890(92)90191-Y; Dreyfus DH, 1999, MOL IMMUNOL, V36, P481, DOI 10.1016/S0161-5890(99)00034-6; Dreyfus DH, 1996, IMMUNOL REV, V152, P89, DOI 10.1111/j.1600-065X.1996.tb00912.x; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; FINKEL TH, 1991, IMMUNOL TODAY, V12, P79, DOI 10.1016/0167-5699(91)90162-M; Francis AL, 1997, J VIROL, V71, P3054, DOI 10.1128/JVI.71.4.3054-3061.1997; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Gladow M, 2004, EUR J IMMUNOL, V34, P1882, DOI 10.1002/eji.200425041; Hah C, 2005, J BIOCHEM MOL BIOL, V38, P334; HAMMERSCHMIDT W, 1990, MOL BIOL MED, V7, P45; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hung CH, 1999, J GEN VIROL, V80, P2747, DOI 10.1099/0022-1317-80-10-2747; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; Jones JM, 2001, STRUCTURE, V9, P881, DOI 10.1016/S0969-2126(01)00658-X; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; KOLMAN JL, 1992, P NATL ACAD SCI USA, V89, P7772, DOI 10.1073/pnas.89.16.7772; Kolman JL, 1996, J VIROL, V70, P1493, DOI 10.1128/JVI.70.3.1493-1504.1996; KOPS AD, 1994, J VIROL, V68, P3512; KUHNHALLEK I, 1995, BLOOD, V85, P1289, DOI 10.1182/blood.V85.5.1289.bloodjournal8551289; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu CP, 2008, NUCLEIC ACIDS RES, V36, P2864, DOI 10.1093/nar/gkn128; Lu CP, 2006, NAT STRUCT MOL BIOL, V13, P1010, DOI 10.1038/nsmb1154; Makhov AM, 2004, BBA-PROTEINS PROTEOM, V1701, P101, DOI 10.1016/j.bbapap.2004.06.006; Mapelli M, 2005, J BIOL CHEM, V280, P2990, DOI 10.1074/jbc.M406780200; Melek M, 2002, P NATL ACAD SCI USA, V99, P134, DOI 10.1073/pnas.012610699; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P9324, DOI 10.1073/pnas.87.23.9324; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Moody CA, 2003, J VIROL, V77, P8555, DOI 10.1128/JVI.77.15.8555-8561.2003; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; Paramita DK, 2007, J MED VIROL, V79, P1710, DOI 10.1002/jmv.20987; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; Schatz DG, 2004, SEMIN IMMUNOL, V16, P245, DOI 10.1016/j.smim.2004.08.004; Shih IH, 2002, EMBO J, V21, P6625, DOI 10.1093/emboj/cdf630; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Spain TA, 1997, VIROLOGY, V237, P137, DOI 10.1006/viro.1997.8770; Spanopoulou E, 1996, CELL, V87, P263, DOI 10.1016/S0092-8674(00)81344-6; SRINIVAS SK, 1995, J VIROL, V69, P8155, DOI 10.1128/JVI.69.12.8155-8158.1995; Srinivas SK, 1998, J INFECT DIS, V177, P1705, DOI 10.1086/517427; Sun R, 1997, J VIROL, V71, P6136, DOI 10.1128/JVI.71.8.6136-6143.1997; SWANSON DL, 2004, J ACAD ETHICS, V2, P1; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Taylor TJ, 2003, VIROLOGY, V309, P219, DOI 10.1016/S0042-6822(03)00108-9; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsai CL, 2003, EMBO J, V22, P1922, DOI 10.1093/emboj/cdg185; Uprichard SL, 2003, J VIROL, V77, P7467, DOI 10.1128/JVI.77.13.7467-7476.2003; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Verkoczy LK, 2004, CURR OPIN IMMUNOL, V16, P808, DOI 10.1016/j.coi.2004.09.017; Wagner HJ, 2004, J INFECT DIS, V190, P979, DOI 10.1086/423211; Zhou CH, 2002, J VIROL, V76, P5893, DOI 10.1128/JVI.76.12.5893-5904.2002; ZIMMERMANN J, 1995, J VIROL, V69, P3147, DOI 10.1128/JVI.69.5.3147-3155.1995	69	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5778	10.1371/journal.pone.0005778	http://dx.doi.org/10.1371/journal.pone.0005778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492059	Green Published, Green Submitted, gold			2022-12-27	WOS:000266624300014
J	Koyanagi, M; Iwasaki, M; Haendeler, J; Leitges, M; Zeiher, AM; Dimmeler, S				Koyanagi, Masamichi; Iwasaki, Masayoshi; Haendeler, Judith; Leitges, Michael; Zeiher, Andreas M.; Dimmeler, Stefanie			Wnt5a Increases Cardiac Gene Expressions of Cultured Human Circulating Progenitor Cells via a PKC Delta Activation	PLOS ONE			English	Article								Background: Wnt signaling controls the balance between stem cell proliferation and differentiation and body patterning throughout development. Previous data demonstrated that non-canonical Wnts (Wnt5a, Wnt11) increased cardiac gene expression of circulating endothelial progenitor cells (EPC) and bone marrow-derived stem cells cultured in vitro. Since previous studies suggested a contribution of the protein kinase C (PKC) family to the Wnt5a-induced signalling, we investigated which PKC isoforms are activated by non-canonical Wnt5a in human EPC. Methodology/Principal Findings: Immunoblot experiments demonstrated that Wnt5a selectively activated the novel PKC isoform, PKC delta, as evidenced by phosphorylation and translocation. In contrast, the classical Ca(2+)-dependent PKC isoforms, PKC alpha and beta2, and one of the other novel PKC isoforms, PKC epsilon, were not activated by Wnt5a. The PKC delta inhibitor rottlerin significantly blocked co-culture-induced cardiac differentiation in vitro, whereas inhibitors directed against the classical Ca(2+)-dependent PKC isoforms or a PKC epsilon-inhibitory peptide did not block cardiac differentiation. In accordance, EPC derived from PKC delta heterozygous mice exhibited a significant reduction of Wnt5a-induced cardiac gene expression compared to wild type mice derived EPC. Conclusions/Significance: These data indicate that Wnt5a enhances cardiac gene expressions of EPC via an activation of PKC delta.			Koyanagi, M (corresponding author), Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany.	dimmeler@em.uni-frankfurt.de	Leitges, Michael/AAN-1953-2021	Haendeler, Judith/0000-0001-8507-4540; Dimmeler, Stefanie/0000-0002-1045-2436; Leitges, Michael/0000-0003-4203-6995				Bedada FB, 2005, MOL CELL BIOL, V25, P9509, DOI 10.1128/MCB.25.21.9509-9519.2005; Brade T, 2006, CARDIOVASC RES, V72, P198, DOI 10.1016/j.cardiores.2006.06.025; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Gobbi G, 2007, STEM CELLS, V25, P2322, DOI 10.1634/stemcells.2006-0839; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Koyanagi M, 2005, J BIOL CHEM, V280, P16838, DOI 10.1074/jbc.M500323200; Leitges M, 2001, J CLIN INVEST, V108, P1505; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Palpant NJ, 2007, J MOL CELL CARDIOL, V43, P362, DOI 10.1016/j.yjmcc.2007.06.012; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Steinhart R, 2007, GLIA, V55, P224, DOI 10.1002/glia.20454; Zhou X, 2003, DEV BIOL, V255, P407, DOI 10.1016/S0012-1606(02)00080-5	24	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5765	10.1371/journal.pone.0005765	http://dx.doi.org/10.1371/journal.pone.0005765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19492056	Green Published, Green Submitted, gold			2022-12-27	WOS:000266587400008
J	Friedrich, R; Friederici, AD				Friedrich, Roland; Friederici, Angela D.			Mathematical Logic in the Human Brain: Syntax	PLOS ONE			English	Article							HIERARCHICAL ORGANIZATION; PREFRONTAL CORTEX; NEURAL BASIS; LANGUAGE	Theory predicts a close structural relation of formal languages with natural languages. Both share the aspect of an underlying grammar which either generates (hierarchically) structured expressions or allows us to decide whether a sentence is syntactically correct or not. The advantage of rule-based communication is commonly believed to be its efficiency and effectiveness. A particularly important class of formal languages are those underlying the mathematical syntax. Here we provide brain-imaging evidence that the syntactic processing of abstract mathematical formulae, written in a first order language, is, indeed efficient and effective as a rule-based generation and decision process. However, it is remarkable, that the neural network involved, consisting of intraparietal and prefrontal regions, only involves Broca's area in a surprisingly selective way. This seems to imply that despite structural analogies of common and current formal languages, at the neural level, mathematics and natural language are processed differently, in principal.			Friedrich, R (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	friedrich@cbs.mpg.de						Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Ben-Shachar M, 2003, PSYCHOL SCI, V14, P433, DOI 10.1111/1467-9280.01459; Butterworth B, 2005, J CHILD PSYCHOL PSYC, V46, P3, DOI 10.1111/j.1469-7610.2004.00374.x; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2006, CEREB CORTEX, V16, P1709, DOI 10.1093/cercor/bhj106; Goel V, 2007, TRENDS COGN SCI, V11, P435, DOI 10.1016/j.tics.2007.09.003; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Opitz B, 2007, HUM BRAIN MAPP, V28, P585, DOI 10.1002/hbm.20287; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Sanides F., 1962, ARCHITEKTONIK MENSCH, DOI [10.1007/978-3-642-86210-6, DOI 10.1007/978-3-642-86210-6]; SHAYWITZ BA, 1995, HUM BRAIN MAPP, V2, P149, DOI DOI 10.1002/HBM.460020304; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; Talairach J, 1988, CO PLANAR STEREOTAXI; Tettamanti M, 2002, NEUROIMAGE, V17, P700, DOI 10.1006/nimg.2002.1201; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Volz KG, 2004, NEUROIMAGE, V21, P848, DOI 10.1016/j.neuroimage.2003.10.028; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	29	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5599	10.1371/journal.pone.0005599	http://dx.doi.org/10.1371/journal.pone.0005599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	450QE	19478999	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415100002
J	Hallett, TB; Ghys, P; Barnighausen, T; Yan, P; Garnett, GP				Hallett, Timothy B.; Ghys, Peter; Baernighausen, Till; Yan, Ping; Garnett, Geoff P.			Errors in 'BED'-Derived Estimates of HIV Incidence Will Vary by Place, Time and Age	PLOS ONE			English	Article								Background: The BED Capture Enzyme Immunoassay, believed to distinguish recent HIV infections, is being used to estimate HIV incidence, although an important property of the test - how specificity changes with time since infection - has not been not measured. Methods: We construct hypothetical scenarios for the performance of BED test, consistent with current knowledge, and explore how this could influence errors in BED estimates of incidence using a mathematical model of six African countries. The model is also used to determine the conditions and the sample sizes required for the BED test to reliably detect trends in HIV incidence. Results: If the chance of misclassification by BED increases with time since infection, the overall proportion of individuals misclassified could vary widely between countries, over time, and across age-groups, in a manner determined by the historic course of the epidemic and the age-pattern of incidence. Under some circumstances, changes in BED estimates over time can approximately track actual changes in incidence, but large sample sizes (50,000+) will be required for recorded changes to be statistically significant. Conclusions: The relationship between BED test specificity and time since infection has not been fully measured, but, if it decreases, errors in estimates of incidence could vary by place, time and age-group. This means that post-assay adjustment procedures using parameters from different populations or at different times may not be valid. Further research is urgently needed into the properties of the BED test, and the rate of misclassification in a wide range of populations.			Hallett, TB (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	timothy.hallett@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008; Yan, Ping/AAD-2758-2019; Hallett, Timothy/A-2390-2011; Bärnighausen, Till/Y-2388-2019	Yan, Ping/0000-0001-6765-0735; Hallett, Timothy/0000-0002-9681-0424	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; Medical Research Council Funding Source: Medline; NICHD NIH HHS [1R01-HD058482-01, R01 HD058482] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome Trust)		Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; BARNIGHAUSEN T, 2008, PLOS ONE; BARNIGHAUSEN T, 2008, USING TEST RECENT IN; BARNIGHAUSEN T, WORLDWIDE APPL UNPUB; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Cheluget B, 2006, SEX TRANSM INFECT, V82, pI21, DOI 10.1136/sti.2005.015990; Ghys PD, 2006, SEX TRANSM INFECT, V82, pI52, DOI 10.1136/sti.2005.016428; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; HLADIK W, 2007, EFFECT ANTIRETROVIRA; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; KIM A, 2007, 14 C RETR OPP INF; Kirkwood BR, 2003, ESSENTIAL MED STAT; LAEYENDECKER O, 2009, SESS 2 MEAS NEW HIV; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Low-Beer D, 2007, PLOS MED, V4, P1308, DOI 10.1371/journal.pmed.0040219; MARINDA ET, 2009, AIDS UNPUB; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; *MIN HLTH KEN NAT, 2008, KEN AIDS IND SURV 20; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; RABOUD JM, 1995, J ACQ IMMUN DEF SYND, V10, pS67; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Ross A, 2004, AIDS, V18, P799, DOI 10.1097/00002030-200403260-00012; Rutstein SO, 2006, GUIDE DHS STAT; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; *SURV SURV LAB WOR, 2006, INT REC US BED CAPT; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; *UNAIDS, 2006, WKLY EPIDEMIOL REC, V81, P40; UNAIDS, 2008, REP GLOB AIDS EP; WELTE T, 2009, USING TESTS RE UNPUB; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Bank, 1991, WORLD DEV REP 1991; YAN P, STAT OBSERVATI UNPUB; ZABA B, 2008, DIVERSE AGE PATTERNS	41	47	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5720	10.1371/journal.pone.0005720	http://dx.doi.org/10.1371/journal.pone.0005720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479050	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415100013
J	Kvam, E; Nannenga, BL; Wang, MS; Jia, ZJ; Sierks, MR; Messer, A				Kvam, Erik; Nannenga, Brent L.; Wang, Min S.; Jia, Zongjian; Sierks, Michael R.; Messer, Anne			Conformational Targeting of Fibrillar Polyglutamine Proteins in Live Cells Escalates Aggregation and Cytotoxicity	PLOS ONE			English	Article								Background: Misfolding- and aggregation-prone proteins underlying Parkinson's, Huntington's and Machado-Joseph diseases, namely a-synuclein, huntingtin, and ataxin-3 respectively, adopt numerous intracellular conformations during pathogenesis, including globular intermediates and insoluble amyloid-like fibrils. Such conformational diversity has complicated research into amyloid-associated intracellular dysfunction and neurodegeneration. To this end, recombinant single-chain Fv antibodies (scFvs) are compelling molecular tools that can be selected against specific protein conformations, and expressed inside cells as intrabodies, for investigative and therapeutic purposes. Methodology/Principal Findings: Using atomic force microscopy (AFM) and live-cell fluorescence microscopy, we report that a human scFv selected against the fibrillar form of a-synuclein targets isomorphic conformations of misfolded polyglutamine proteins. When expressed in the cytoplasm of striatal cells, this conformation-specific intrabody co-localizes with intracellular aggregates of misfolded ataxin-3 and a pathological fragment of huntingtin, and enhances the aggregation propensity of both disease-linked polyglutamine proteins. Using this intrabody as a tool for modulating the kinetics of amyloidogenesis, we show that escalating aggregate formation of a pathologic huntingtin fragment is not cytoprotective in striatal cells, but rather heightens oxidative stress and cell death as detected by flow cytometry. Instead, cellular protection is achieved by suppressing aggregation using a previously described intrabody that binds to the amyloidogenic N-terminus of huntingtin. Analogous cytotoxic results are observed following conformational targeting of normal or polyglutamine-expanded human ataxin-3, which partially aggregate through non-polyglutamine domains. Conclusions/Significance: These findings validate that the rate of aggregation modulates polyglutamine-mediated intracellular dysfunction, and caution that molecules designed to specifically hasten aggregation may be detrimental as therapies for polyglutamine disorders. Moreover, our findings introduce a novel antibody-based tool that, as a consequence of its general specificity for fibrillar conformations and its ability to function intracellularly, offers broad research potential for a variety of human amyloid diseases.			Kvam, E (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA.	messer@wadsworth.org	; Wang, Min Sze/C-6495-2009	Nannenga, Brent/0000-0001-6859-3429; Wang, Min Sze/0000-0002-8978-4918	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053912, R21NS061257] Funding Source: NIH RePORTER; NINDS NIH HHS [NS061257, R01 NS053912, R01 NS053912-04, NS053912, R21 NS061257] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrigo AP, 2005, METHODS, V35, P126, DOI 10.1016/j.ymeth.2004.08.003; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Barkhordarian H, 2006, PROTEIN ENG DES SEL, V19, P497, DOI 10.1093/protein/gzl036; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Bodner RA, 2006, CELL CYCLE, V5, P1477, DOI 10.4161/cc.5.14.2929; Cattaneo A, 1999, TRENDS BIOTECHNOL, V17, P115, DOI 10.1016/S0167-7799(98)01268-2; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Charvin D, 2005, P NATL ACAD SCI USA, V102, P12218, DOI 10.1073/pnas.0502698102; Colby DW, 2006, NAT CHEM BIOL, V2, P319, DOI 10.1038/nchembio792; Cong SY, 2006, EXP NEUROL, V199, P257, DOI 10.1016/j.expneurol.2005.11.008; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Dahlgren PR, 2005, NANOMED-NANOTECHNOL, V1, P52, DOI 10.1016/j.nano.2004.11.004; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Emadi S, 2007, J MOL BIOL, V368, P1132, DOI 10.1016/j.jmb.2007.02.089; Firdaus WJJ, 2006, FEBS J, V273, P5428, DOI 10.1111/j.1742-4658.2006.05537.x; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gong B, 2008, BRAIN RES BULL, V75, P146, DOI 10.1016/j.brainresbull.2007.08.005; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hazeki N, 1999, BIOCHEM BIOPH RES CO, V256, P361, DOI 10.1006/bbrc.1999.0337; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; HU X, 2008, YEAST SURFACE 2 HYBR; Huang DG, 2006, APPL ENVIRON MICROB, V72, P7748, DOI 10.1128/AEM.01403-06; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; King MA, 2008, J NEUROSCI, V28, P14401, DOI 10.1523/JNEUROSCI.4751-08.2008; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; Lee KJ, 2007, J CELL SCI, V120, P2663, DOI 10.1242/jcs.004598; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin-Aparicio E, 2002, EUR J NEUROSCI, V16, P355, DOI 10.1046/j.1460-9568.2002.02075.x; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; MCLEAR JA, 2008, FASEB J; Miller TW, 2005, NEUROBIOL DIS, V19, P47, DOI 10.1016/j.nbd.2004.11.003; Murphy RC, 2004, MOL BRAIN RES, V121, P141, DOI 10.1016/j.molbrainres.2003.11.011; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nannenga BL, 2008, FEBS LETT, V582, P517, DOI 10.1016/j.febslet.2008.01.014; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Omi K, 2008, NEUROSCI LETT, V431, P45, DOI 10.1016/j.neulet.2007.11.018; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Peipp M, 2004, J IMMUNOL METHODS, V285, P265, DOI 10.1016/j.jim.2003.12.001; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; RATOVITSKI T, 2009, J BIOL CHEM IN PRESS; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Reiner A, 2007, J COMP NEUROL, V505, P603, DOI 10.1002/cne.21515; Rochet Jean-Christophe, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000385; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Scappini E, 2007, HUM MOL GENET, V16, P1862, DOI 10.1093/hmg/ddm134; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stochaj U, 2000, FASEB J, V14, P2130, DOI 10.1096/fj.99-0751fje; Sugaya K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000635; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Uversky VN, 2007, NANOMEDICINE-UK, V2, P615, DOI 10.2217/17435889.2.5.615; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang MS, 2009, LANGMUIR, V25, P912, DOI 10.1021/la8025914; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164; Zhou C, 2004, MOL THER, V10, P1023, DOI 10.1016/j.ymthe.2004.08.019	79	49	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5727	10.1371/journal.pone.0005727	http://dx.doi.org/10.1371/journal.pone.0005727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492089	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415100017
J	Han, L; Garcia, HG; Blumberg, S; Towles, KB; Beausang, JF; Nelson, PC; Phillips, R				Han, Lin; Garcia, Hernan G.; Blumberg, Seth; Towles, Kevin B.; Beausang, John F.; Nelson, Philip C.; Phillips, Rob			Concentration and Length Dependence of DNA Looping in Transcriptional Regulation	PLOS ONE			English	Article								In many cases, transcriptional regulation involves the binding of transcription factors at sites on the DNA that are not immediately adjacent to the promoter of interest. This action at a distance is often mediated by the formation of DNA loops: Binding at two or more sites on the DNA results in the formation of a loop, which can bring the transcription factor into the immediate neighborhood of the relevant promoter. These processes are important in settings ranging from the historic bacterial examples (bacterial metabolism and the lytic-lysogeny decision in bacteriophage), to the modern concept of gene regulation to regulatory processes central to pattern formation during development of multicellular organisms. Though there have been a variety of insights into the combinatorial aspects of transcriptional control, the mechanism of DNA looping as an agent of combinatorial control in both prokaryotes and eukaryotes remains unclear. We use single-molecule techniques to dissect DNA looping in the lac operon. In particular, we measure the propensity for DNA looping by the Lac repressor as a function of the concentration of repressor protein and as a function of the distance between repressor binding sites. As with earlier single-molecule studies, we find (at least) two distinct looped states and demonstrate that the presence of these two states depends both upon the concentration of repressor protein and the distance between the two repressor binding sites. We find that loops form even at interoperator spacings considerably shorter than the DNA persistence length, without the intervention of any other proteins to prebend the DNA. The concentration measurements also permit us to use a simple statistical mechanical model of DNA loop formation to determine the free energy of DNA looping, or equivalently, the J-factor for looping.	[Han, Lin; Blumberg, Seth; Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Garcia, Hernan G.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Towles, Kevin B.; Beausang, John F.; Nelson, Philip C.] Univ Penn, Dept Phys & Astron, Philadelphia, PA USA	California Institute of Technology; California Institute of Technology; University of Pennsylvania	Han, L (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu	Nelson, Philip C/I-6251-2015	Nelson, Philip C/0000-0002-1782-3076; Garcia, Hernan G./0000-0002-5212-3649	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000217] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; ADHYA S, 1989, ANNU REV GENET, V23, P227, DOI 10.1146/annurev.genet.23.1.227; Balaeff A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031919; BARKLEY MD, 1981, BIOCHEMISTRY-US, V20, P3833, DOI 10.1021/bi00516a026; Barry JK, 1999, BIOCHEMISTRY-US, V38, P6520, DOI 10.1021/bi9900727; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Becker NA, 2007, NUCLEIC ACIDS RES, V35, P3988, DOI 10.1093/nar/gkm419; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Blumberg S, 2005, BIOPHYS J, V88, P1692, DOI 10.1529/biophysj.104.054486; BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; Colquhoun David, 1995, P483; Czapla L, 2006, J CHEM THEORY COMPUT, V2, P685, DOI 10.1021/ct060025+; DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4777, DOI 10.1021/bi00641a003; Du Q, 2005, P NATL ACAD SCI USA, V102, P5397, DOI 10.1073/pnas.0500983102; DUNN TM, 1984, P NATL ACAD SCI-BIOL, V81, P5017, DOI 10.1073/pnas.81.16.5017; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; Falcon CM, 1999, J BIOL CHEM, V274, P30849, DOI 10.1074/jbc.274.43.30849; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; Frank DE, 1997, J MOL BIOL, V267, P1186, DOI 10.1006/jmbi.1997.0920; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; GOEDDEL DV, 1977, P NATL ACAD SCI USA, V74, P3292, DOI 10.1073/pnas.74.8.3292; Guerra RF, 2007, BIOPHYS J, V93, P176, DOI 10.1529/biophysj.106.099929; Horton N, 1997, J MOL BIOL, V265, P1, DOI 10.1006/jmbi.1996.0706; HSIEH WT, 1987, J BIOL CHEM, V262, P14583; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; KRAMER H, 1988, EMBO J, V7, P547, DOI 10.1002/j.1460-2075.1988.tb02844.x; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; LAW SM, 1993, J MOL BIOL, V230, P161, DOI 10.1006/jmbi.1993.1133; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Levandoski MM, 1996, J MOL BIOL, V260, P697, DOI 10.1006/jmbi.1996.0431; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Mehta RA, 1999, J MOL BIOL, V294, P67, DOI 10.1006/jmbi.1999.3244; Morgan MA, 2005, BIOPHYS J, V89, P2588, DOI 10.1529/biophysj.105.067728; Moroz JD, 1998, MACROMOLECULES, V31, P6333, DOI 10.1021/ma971804a; MOSSING MC, 1985, J MOL BIOL, V186, P295, DOI 10.1016/0022-2836(85)90106-8; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Nelson PC, 2007, CURR OPIN COLLOID IN, V12, P307, DOI 10.1016/j.cocis.2007.07.015; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; Normanno D, 2008, NUCLEIC ACIDS RES, V36, P2505, DOI 10.1093/nar/gkn071; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; OGORMAN RB, 1980, J BIOL CHEM, V255, P100; Pouget N, 2006, NUCLEIC ACIDS RES, V34, P4313, DOI 10.1093/nar/gkl420; Pouget N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh073; Ptashne M, 2004, GENETIC SWITCH PHAGE; RECORD MT, 1981, ANNU REV BIOCHEM, V50, P997, DOI 10.1146/annurev.bi.50.070181.005025; RECORD MT, 1977, BIOCHEMISTRY-US, V16, P4791, DOI 10.1021/bi00641a005; REVZIN A, 1977, BIOCHEMISTRY-US, V16, P4769, DOI 10.1021/bi00641a002; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Ruben GC, 1997, MICROSC RES TECHNIQ, V36, P400, DOI 10.1002/(SICI)1097-0029(19970301)36:5<400::AID-JEMT10>3.0.CO;2-W; Saiz L, 2005, P NATL ACAD SCI USA, V102, P17642, DOI 10.1073/pnas.0505693102; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segall DE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088306; Semsey S, 2004, GENE DEV, V18, P1898, DOI 10.1101/gad.1209404; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; Strick T, 2000, PROG BIOPHYS MOL BIO, V74, P115, DOI 10.1016/S0079-6107(00)00018-3; Strick TR, 1998, P NATL ACAD SCI USA, V95, P10579, DOI 10.1073/pnas.95.18.10579; Swigon D, 2006, P NATL ACAD SCI USA, V103, P9879, DOI 10.1073/pnas.0603557103; Tolic-Norrelykke SF, 2006, BIOPHYS J, V90, P3694, DOI 10.1529/biophysj.105.074856; TOWLES K, 2009, PHYS BIOL IN PRESS; van den Broek B, 2006, NUCLEIC ACIDS RES, V34, P167, DOI 10.1093/nar/gkj432; Vanzi F, 2003, RNA, V9, P1174, DOI 10.1261/rna.5800303; Vanzi F, 2006, NUCLEIC ACIDS RES, V34, P3409, DOI 10.1093/nar/gkl393; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; WANG AC, 1977, NUCLEIC ACIDS RES, V4, P1579, DOI 10.1093/nar/4.5.1579; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; WHITSON PA, 1987, J BIOL CHEM, V262, P14592; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0; ZELLER RW, 1995, P NATL ACAD SCI USA, V92, P2989, DOI 10.1073/pnas.92.7.2989; ZHANG XL, 1993, BIOCHEMISTRY-US, V32, P11374, DOI 10.1021/bi00093a014; Zhang Y, 2006, BIOPHYS J, V90, P1903, DOI 10.1529/biophysj.105.070490; Zhang YL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000136; Zurla C, 2006, J PHYS-CONDENS MAT, V18, pS225, DOI 10.1088/0953-8984/18/14/S07; Zurla C, 2007, BIOPHYS CHEM, V128, P245, DOI 10.1016/j.bpc.2007.04.012	92	72	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5621	10.1371/journal.pone.0005621	http://dx.doi.org/10.1371/journal.pone.0005621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479049	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000266331700002
J	Casas, F; Pessemesse, L; Grandemange, S; Seyer, P; Baris, O; Gueguen, N; Ramonatxo, C; Perrin, F; Fouret, G; Lepourry, L; Cabello, G; Wrutniak-Cabello, C				Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Baris, Olivier; Gueguen, Naig; Ramonatxo, Christelle; Perrin, Florence; Fouret, Gilles; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal			Overexpression of the Mitochondrial T3 Receptor Induces Skeletal Muscle Atrophy during Aging	PLOS ONE			English	Article								In previous studies, we characterized a new hormonal pathway involving a mitochondrial T3 receptor (p43) acting as a mitochondrial transcription factor. In in vitro and in vivo studies, we have shown that p43 increases mitochondrial transcription and mitochondrial biogenesis. In addition, p43 overexpression in skeletal muscle stimulates mitochondrial respiration and induces a shift in metabolic and contractile features of muscle fibers which became more oxidative. Here we have studied the influence of p43 overexpression in skeletal muscle of mice during aging. We report that p43 overexpression initially increased mitochondrial mass. However, after the early rise in mitochondrial DNA occurring at 2 months of age in transgenic mice, we observed a progressive decrease of mitochondrial DNA content which became 2-fold lower at 23 months of age relatively to control animals. Moreover, p43 overexpression induced an oxidative stress characterized by a strong increase of lipid peroxidation and protein oxidation in quadriceps muscle, although antioxidant enzyme activities (catalase and superoxide dismutase) were stimulated. In addition, muscle atrophy became detectable at 6 months of age, probably through a stimulation of the ubiquitin proteasome pathway via two muscle-specific ubiquitin ligases E3, Atrogin-1/MAFbx and MuRF1. Taken together, these results demonstrate that a prolonged stimulation of mitochondrial activity induces muscle atrophy. In addition, these data underline the importance of a tight control of p43 expression and suggest that a deregulation of the direct T3 mitochondrial pathway could be one of the parameters involved in the occurrence of sarcopenia.	[Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Baris, Olivier; Gueguen, Naig; Ramonatxo, Christelle; Fouret, Gilles; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal] INRA, UMR866 Differenciat Cellulaire & Croissance, F-34060 Montpellier, France; [Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Baris, Olivier; Gueguen, Naig; Ramonatxo, Christelle; Fouret, Gilles; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal] Univ Montpellier 1 & 2, Montpellier, France; [Perrin, Florence] Univ Montpellier 1 & 2, INSERM, U583 Inst Neurosci Montpellier, Montpellier, France	INRAE; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Casas, F (corresponding author), INRA, UMR866 Differenciat Cellulaire & Croissance, F-34060 Montpellier, France.	casasf@supagro.inra.fr	Grandemange, Stéphanie/G-7928-2015; Ramonatxo, Christelle/B-2929-2017; Baris, Olivier R/L-3463-2016	Ramonatxo, Christelle/0000-0001-6112-0864; Baris, Olivier R/0000-0003-0974-6856; PERRIN, Florence/0000-0002-7630-0515; Francois, Casas/0000-0002-5535-8195				Argiles JM, 2002, BIOCHEM BIOPH RES CO, V293, P1145, DOI 10.1016/S0006-291X(02)00355-8; BERGMEYER HU, 1963, ENZYMES BIOL REAGENT, V1, P443; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; Busquets S, 2005, FEBS LETT, V579, P717, DOI 10.1016/j.febslet.2004.12.050; BUTLERBROWNE GS, 1984, FEBS LETT, V166, P71, DOI 10.1016/0014-5793(84)80047-2; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002501; Criswell DS, 1997, RESP PHYSIOL, V107, P149, DOI 10.1016/S0034-5687(96)02509-1; FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; Gueguen N, 2005, COMP BIOCHEM PHYS B, V140, P287, DOI 10.1016/j.cbpc.2004.10.014; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; JOCELYN PC, 1987, METHOD ENZYMOL, V143, P44; KING DB, 1987, J EXP ZOOL, P291; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lunde PK, 2001, CIRC RES, V88, P1299, DOI 10.1161/hh1201.092041; Lynch GS, 2000, EXP PHYSIOL, V85, P295, DOI 10.1111/j.1469-445X.2000.02018.x; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; Ryall JG, 2002, AM J PHYSIOL-REG I, V283, pR1386, DOI 10.1152/ajpregu.00324.2002; Sanchis D, 1998, FEBS LETT, V436, P415, DOI 10.1016/S0014-5793(98)01178-8; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; SUGIE H, 1985, MUSCLE NERVE, V8, P654, DOI 10.1002/mus.880080805; SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wharton DC., 1967, METHOD ENZYMOL, P245; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067	36	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5631	10.1371/journal.pone.0005631	http://dx.doi.org/10.1371/journal.pone.0005631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19462004	Green Published, Green Submitted, gold			2022-12-27	WOS:000266234700018
J	Schoolmeesters, A; Eklund, T; Leake, D; Vermeulen, A; Smith, Q; Aldred, SF; Fedorov, Y				Schoolmeesters, Angela; Eklund, Teresa; Leake, Devin; Vermeulen, Annaleen; Smith, Queta; Aldred, Shelley Force; Fedorov, Yuriy			Functional Profiling Reveals Critical Role for miRNA in Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; OSTEOGENIC DIFFERENTIATION; MICRORNAS; EXPRESSION; GRANCALCIN; CHORDIN; CLONING	Background: Mesenchymal stem (MS) cells are excellent candidates for cell-based therapeutic strategies to regenerate injured tissue. Although human MS cells can be isolated from bone marrow and directed to differentiate by means of an osteogenic pathway, the regulation of cell-fate determination is not well understood. Recent reports identify critical roles for microRNAs (miRNAs), regulators of gene expression either by inhibiting the translation or by stimulating the degradation of target mRNAs. Methodology/Principal Findings: In this study, we employed a library of miRNA inhibitors to evaluate the role of miRNAs in early osteogenic differentiation of human MS cells. We discovered that miR-148b, -27a and -489 are essential for the regulation of osteogenesis: miR-27a and miR-489 down-regulate while miR-148b up-regulates differentiation. Modulation of these miRNAs induced osteogenesis in the absence of other external differentiation cues and restored osteogenic potential in high passage number human MS cells. Conclusions/Significance: Overall, we have demonstrated the utility of the functional profiling strategy for unraveling complex miRNA pathways. Our findings indicate that miRNAs regulate early osteogenic differentiation in human MS cells: miR-148b, -27a, and -489 were found to play a critical role in osteogenesis.			Schoolmeesters, A (corresponding author), Thermo Fisher Sci, Lafayette, CO USA.	Yuriy.Fedorov@thermofisher.com						Bentwich I, 2008, CURR TOP MICROBIOL, V320, P257; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BOYHAN A, 1992, J BIOL CHEM, V267, P2928; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; Foshay Kara M, 2007, Curr Stem Cell Res Ther, V2, P264, DOI 10.2174/157488807782793781; FRIEDENSTEIN A, 1971, TRANSPLANTATION, V12, P99, DOI 10.1097/00007890-197108000-00001; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Palmieri A, 2008, BIO-MED MATER ENG, V18, P91, DOI 10.3233/BME-2008-0512; Palmieri A, 2007, J BIOMED SCI, V14, P777, DOI 10.1007/s11373-007-9193-z; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402; TANABE S, 2008, J BIOCH; TEAHAN CG, 1992, BIOCHEM J, V286, P549, DOI 10.1042/bj2860549; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wall ME, 2007, TISSUE ENG, V13, P1291, DOI 10.1089/ten.2006.0275; Zhang DH, 2002, J BONE MINER RES, V17, P293, DOI 10.1359/jbmr.2002.17.2.293	30	141	154	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5605	10.1371/journal.pone.0005605	http://dx.doi.org/10.1371/journal.pone.0005605			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440384	gold, Green Published, Green Submitted			2022-12-27	WOS:000266161200008
J	Sato, F; Tsuchiya, S; Terasawa, K; Tsujimoto, G				Sato, Fumiaki; Tsuchiya, Soken; Terasawa, Kazuya; Tsujimoto, Gozoh			Intra-Platform Repeatability and Inter-Platform Comparability of MicroRNA Microarray Technology	PLOS ONE			English	Article								Over the last decade, DNA microarray technology has provided a great contribution to the life sciences. The MicroArray Quality Control (MAQC) project demonstrated the way to analyze the expression microarray. Recently, microarray technology has been utilized to analyze a comprehensive microRNA expression profiling. Currently, several platforms of microRNA microarray chips are commercially available. Thus, we compared repeatability and comparability of five different microRNA microarray platforms (Agilent, Ambion, Exiqon, Invitrogen and Toray) using 309 microRNAs probes, and the Taqman microRNA system using 142 microRNA probes. This study demonstrated that microRNA microarray has high intra-platform repeatability and comparability to quantitative RT-PCR of microRNA. Among the five platforms, Agilent and Toray array showed relatively better performances than the others. However, the current lineup of commercially available microRNA microarray systems fails to show good inter-platform concordance, probably because of lack of an adequate normalization method and severe divergence in stringency of detection call criteria between different platforms. This study provided the basic information about the performance and the problems specific to the current microRNA microarray systems.			Sato, F (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan.	fsato@pharm.kyoto-u.ac.jp						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nakahara K, 2004, CURR OPIN CELL BIOL, V16, P127, DOI 10.1016/j.ceb.2004.02.006; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shippy R, 2006, NAT BIOTECHNOL, V24, P1123, DOI 10.1038/nbt1241; Tong WD, 2006, NAT BIOTECHNOL, V24, P1132, DOI 10.1038/nbt1237; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	21	156	164	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5540	10.1371/journal.pone.0005540	http://dx.doi.org/10.1371/journal.pone.0005540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436744	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107300006
J	Gunther, S; Matuschewski, K; Muller, S				Guenther, Svenja; Matuschewski, Kai; Mueller, Sylke			Knockout Studies Reveal an Important Role of Plasmodium Lipoic Acid Protein Ligase A1 for Asexual Blood Stage Parasite Survival	PLOS ONE			English	Article								Lipoic acid (LA) is a dithiol-containing cofactor that is essential for the function of alpha-keto acid dehydrogenase complexes. LA acts as a reversible acyl group acceptor and 'swinging arm' during acyl-coenzyme A formation. The cofactor is post-translationally attached to the acyl-transferase subunits of the multienzyme complexes through the action of octanoyl (lipoyl): N-octanoyl (lipoyl) transferase (LipB) or lipoic acid protein ligases (LplA). Remarkably, apicomplexan parasites possess LA biosynthesis as well as scavenging pathways and the two pathways are distributed between mitochondrion and a vestigial organelle, the apicoplast. The apicoplast-specific LipB is dispensable for parasite growth due to functional redundancy of the parasite's lipoic acid/octanoic acid ligases/transferases. In this study, we show that LplA1 plays a pivotal role during the development of the erythrocytic stages of the malaria parasite. Gene disruptions in the human malaria parasite P. falciparum consistently were unsuccessful while in the rodent malaria model parasite P. berghei the LplA1 gene locus was targeted by knock-in and knockout constructs. However, the LplA1((-)) mutant could not be cloned suggesting a critical role of LplA1 for asexual parasite growth in vitro and in vivo. These experimental genetics data suggest that lipoylation during expansion in red blood cells largely occurs through salvage from the host erythrocytes and subsequent ligation of LA to the target proteins of the malaria parasite.			Gunther, S (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	s.muller@bio.gla.ac.uk		Matuschewski, Kai/0000-0001-6147-8591	Wellcome Trust [WT061173MA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allary M, 2007, MOL MICROBIOL, V63, P1331, DOI 10.1111/j.1365-2958.2007.05592.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Crawford MJ, 2006, EMBO J, V25, P3214, DOI 10.1038/sj.emboj.7601189; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016; Gunther S, 2007, PLOS PATHOG, V3, P1938, DOI 10.1371/journal.ppat.0030189; Gunther S, 2005, BIOCHEM SOC T, V33, P977, DOI 10.1042/BST20050977; Gunther S, 2009, INT J BIOCHEM CELL B, V41, P748, DOI 10.1016/j.biocel.2008.10.028; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Keeney KM, 2007, MOL MICROBIOL, V66, P758, DOI 10.1111/j.1365-2958.2007.05956.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; McMillan PJ, 2005, MOL MICROBIOL, V55, P27, DOI 10.1111/j.1365-2958.2004.04398.x; Mooney BP, 2002, ANNU REV PLANT BIOL, V53, P357, DOI 10.1146/annurev.arplant.53.100301.135251; O'Riordan M, 2003, SCIENCE, V302, P462, DOI 10.1126/science.1088170; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; REED LJ, 1990, J BIOL CHEM, V265, P8971; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; Thathy Vandana, 2002, Methods Mol Med, V72, P317, DOI 10.1385/1-59259-271-6:317; Thomsen-Zieger N, 2003, FEBS LETT, V547, P80, DOI 10.1016/S0014-5793(03)00673-2; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UMLAS J, 1971, AM J TROP MED HYG, V20, P527, DOI 10.4269/ajtmh.1971.20.527; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Wrenger C, 2004, MOL MICROBIOL, V53, P103, DOI 10.1111/j.1365-2958.2004.04112.x; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; Yasuno R, 2002, FEBS LETT, V517, P110, DOI 10.1016/S0014-5793(02)02589-9	34	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2009	4	5							e5510	10.1371/journal.pone.0005510	http://dx.doi.org/10.1371/journal.pone.0005510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VZ	19434237	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000266009800008
J	Byrnes, EJ; Li, W; Lewit, Y; Perfect, JR; Carter, DA; Cox, GM; Heitman, J				Byrnes, Edmond J., III; Li, Wenjun; Lewit, Yonathan; Perfect, John R.; Carter, Dee A.; Cox, Gary M.; Heitman, Joseph			First Reported Case of Cryptococcus gattii in the Southeastern USA: Implications for Travel-Associated Acquisition of an Emerging Pathogen	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; VANCOUVER-ISLAND; BRITISH-COLUMBIA; GENETIC DIVERSITY; HUMAN INFECTION; SEXUAL CYCLE; VIRULENCE; RECOMBINATION; POPULATIONS; OUTBREAK	In 2007, the first confirmed case of Cryptococcus gattii was reported in the state of North Carolina, USA. An otherwise healthy HIV negative male patient presented with a large upper thigh cryptococcoma in February, which was surgically removed and the patient was started on long-term high-dose fluconazole treatment. In May of 2007, the patient presented to the Duke University hospital emergency room with seizures. Magnetic resonance imaging revealed two large CNS lesions found to be cryptococcomas based on brain biopsy. Prior chest CT imaging had revealed small lung nodules indicating that C. gattii spores or desiccated yeast were likely inhaled into the lungs and dissemination occurred to both the leg and CNS. The patient's travel history included a visit throughout the San Francisco, CA region in September through October of 2006, consistent with acquisition during this time period. Cultures from both the leg and brain biopsies were subjected to analysis. Based on phenotypic and molecular methods, both isolates were C. gattii, VGI molecular type, and distinct from the Vancouver Island outbreak isolates. Based on multilocus sequence typing of coding and noncoding regions and virulence in a heterologous host model, the leg and brain isolates are identical, but the two differed in mating fertility. Two clinical isolates, one from a transplant recipient in San Francisco and the other from Australia, were identical to the North Carolina clinical isolate at all markers tested. Closely related isolates that differ at only one or a few noncoding markers are present in the Australian environment. Taken together, these findings support a model in which C. gattii VGI was transferred from Australia to California, possibly though an association with its common host plant E. camaldulensis, and the patient was exposed in San Francisco and returned to present with disease in North Carolina.			Byrnes, EJ (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021; Carter, Dee/C-1331-2010	Carter, Dee/0000-0002-4638-0059	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039115] Funding Source: NIH RePORTER; Howard Hughes Medical Institute [55000640] Funding Source: Medline; NIAID NIH HHS [R37 AI039115, R01 AI039115, R01 AI39115] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartlett Karen H, 2008, Curr Infect Dis Rep, V10, P58, DOI 10.1007/s11908-008-0011-1; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blankenship JR, 2005, J CLIN MICROBIOL, V43, P464, DOI 10.1128/JCM.43.1.464-467.2005; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; BRISSE S, 2009, EUKARYOT CELL; Byrnes EJ, 2009, J VET DIAGN INVEST, V21, P133, DOI 10.1177/104063870902100122; BYRNES EJ, 2009, J INF DIS; Campbell LT, 2006, FEMS YEAST RES, V6, P588, DOI 10.1111/j.1567-1364.2006.00087.x; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chambers C, 2008, EMERG INFECT DIS, V14, P1781, DOI 10.3201/eid1411.080532; Chaturvedi S, 2005, EMERG INFECT DIS, V11, P1686, DOI 10.3201/eid1111.040875; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; DATTA K, 2009, EMERG INFECT D UNPUB; Fan W, 2007, INFECT IMMUN, V75, P3394, DOI 10.1128/IAI.01977-06; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Fuchs BB, 2006, CURR OPIN MICROBIOL, V9, P346, DOI 10.1016/j.mib.2006.06.004; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Halliday CL, 2003, J CLIN MICROBIOL, V41, P703, DOI 10.1128/JCM.41.2.703-711.2003; Heitman J, 2006, CURR BIOL, V16, pR711, DOI 10.1016/j.cub.2006.07.064; IDNURM A, 2009, EUKARYOT CELL; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kidd SE, 2003, MED MYCOL, V41, P171, DOI 10.1080/714858208; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Kwon-Chung KJ, 2006, FEMS YEAST RES, V6, P574, DOI 10.1111/j.1567-1364.2006.00088.x; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WJ, 2008, MICROBIOL-SGM, V154, P521, DOI 10.1099/mic.0.2007/011668-0; Li WJ, 2007, EMERG INFECT DIS, V13, P1178, DOI 10.3201/eid1308.070085; Lim S, 2004, FUNGAL GENET BIOL, V41, P1025, DOI 10.1016/j.fgb.2004.08.004; Lindberg J, 2007, EMERG INFECT DIS, V13, P178, DOI 10.3201/eid1301.060945; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Litvintseva AP, 2005, J INFECT DIS, V192, P888, DOI 10.1086/432486; Litvintseva AP, 2005, J CLIN MICROBIOL, V43, P556, DOI 10.1128/JCM.43.2.556-564.2005; London R, 2006, FEMS YEAST RES, V6, P567, DOI 10.1111/j.1567-1364.2006.00056.x; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Miller WG, 2002, J CLIN MICROBIOL, V40, P721, DOI 10.1128/JCM.40.2.721-724.2002; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Perfect J R, 1989, Infect Dis Clin North Am, V3, P77; PERFECT JR, 2006, MOL PRINCIPALS FUNGA; PFEIFFER T, 1991, J INFECT DIS, V163, P929, DOI 10.1093/infdis/163.4.929; Raboin LM, 2007, FUNGAL GENET BIOL, V44, P64, DOI 10.1016/j.fgb.2006.07.004; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Sorrell TC, 1996, J CLIN MICROBIOL, V34, P1253, DOI 10.1128/JCM.34.5.1253-1260.1996; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Stephen C, 2002, CAN VET J, V43, P792; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Upton A, 2007, J CLIN MICROBIOL, V45, P3086, DOI 10.1128/JCM.00593-07; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005	59	64	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5851	10.1371/journal.pone.0005851	http://dx.doi.org/10.1371/journal.pone.0005851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516904	Green Published, gold, Green Submitted			2022-12-27	WOS:000266872900003
J	Macedo-Ribeiro, S; Cortes, L; Maciel, P; Carvalho, AL				Macedo-Ribeiro, Sandra; Cortes, Luisa; Maciel, Patricia; Carvalho, Ana Luisa			Nucleocytoplasmic Shuttling Activity of Ataxin-3	PLOS ONE			English	Article								Spinocerebellar ataxia type-3, also known as Machado-Joseph Disease (MJD), is one of many inherited neurodegenerative disorders caused by polyglutamine-encoding CAG repeat expansions in otherwise unrelated genes. Disease protein misfolding and aggregation, often within the nucleus of affected neurons, characterize polyglutamine disorders. Several evidences have implicated the nucleus as the primary site of pathogenesis for MJD. However, the molecular determinants for the nucleocytoplasmic transport of human ataxin-3 (Atx3), the protein which is mutated in patients with MJD, are not characterized. In order to characterize the nuclear shuttling activity of Atx3, we performed yeast nuclear import assays and found that Atx3 is actively imported into the nucleus, by means of a classical nuclear localizing sequence formed by a cluster of lysine and arginine residues. On the other hand, when active nuclear export was inhibited using leptomycin B, a specific inhibitor of the nuclear export receptor CRM1, both endogenous Atx3 and transfected GFP-Atx3 accumulated inside the nucleus of a subpopulation of COS-7 cells, whereas both proteins are normally predominant in the cytoplasm. Additionally, using a Rev(1.4)-GFP nuclear export assay, we performed an extensive analysis of six putative aliphatic nuclear export motifs identified in Atx3 amino acid sequence. Although none of the tested peptide sequences were found to drive nuclear export when isolated, we have successfully mapped the region of Atx3 responsible for its CRM1-independent nuclear export activity. Curiously, the N-terminal Josephin domain alone is exported into the cytoplasm, but the nuclear export activity of Atx3 is significantly enhanced in a longer construct that is truncated after the two ubiquitin interaction motifs, upstream from the polyQ tract. Our data show that Atx3 is actively imported to and exported from the cell nucleus, and that its nuclear export activity is dependent on a motif located at its N-terminal region. Since pathological Atx3 aggregates in the nucleus of affected neurons in MJD, and there is in vivo evidence that nuclear localization of Atx3 is required for the manifestation of symptoms in MJD, defects in the nucleocytoplasmic shuttling activity of the protein may be involved in the nuclear accumulation and aggregation of expanded Atx3.			Macedo-Ribeiro, S (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	sribeiro@ibmc.up.pt; alc@cnc.cj.uc.pt	Maciel, Patrícia/B-5989-2009; Maciel, Patricia/AAH-2102-2020; Cortes, Luisa/F-7349-2014; Carvalho, Ana Luisa/K-6367-2013; Macedo-Ribeiro, Sandra/D-9258-2011	Maciel, Patrícia/0000-0002-0920-6350; Maciel, Patricia/0000-0002-0920-6350; Cortes, Luisa/0000-0001-5292-4369; Carvalho, Ana Luisa/0000-0001-8368-6666; Macedo-Ribeiro, Sandra/0000-0002-7698-1170				Alves S, 2008, HUM MOL GENET, V17, P2071, DOI 10.1093/hmg/ddn106; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chen X, 2008, J NEUROSCI, V28, P12713, DOI 10.1523/JNEUROSCI.3909-08.2008; Chow MKM, 2004, J MOL BIOL, V335, P333, DOI 10.1016/j.jmb.2003.08.064; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; DiFiglia M, 2002, MOL CELL, V10, P224, DOI 10.1016/S1097-2765(02)00609-3; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Eulalio A, 2006, J VIROL, V80, P1393, DOI 10.1128/JVI.80.3.1393-1404.2006; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Giannini A, 2004, EXP CELL RES, V295, P150, DOI 10.1016/j.yexcr.2003.12.012; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Jackson WS, 2003, HUM MOL GENET, V12, P1621, DOI 10.1093/hmg/ddg163; Kaiser C., 1994, METHODS YEAST GENETI; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; LIM J, 2008, NATURE; Maciel P, 2001, ARCH NEUROL-CHICAGO, V58, P1821, DOI 10.1001/archneur.58.11.1821; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; Orr HT, 2001, NEURON, V31, P875, DOI 10.1016/S0896-6273(01)00435-4; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Paulson H, 2003, NAT MED, V9, P825, DOI 10.1038/nm0703-825; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Perez MK, 1999, HUM MOL GENET, V8, P2377, DOI 10.1093/hmg/8.13.2377; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Rhee Y, 2000, NAT BIOTECHNOL, V18, P433, DOI 10.1038/74500; Ross CA, 1999, PHILOS T ROY SOC B, V354, P1005, DOI 10.1098/rstb.1999.0452; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Schmidt T, 1998, BRAIN PATHOL, V8, P669, DOI 10.1111/j.1750-3639.1998.tb00193.x; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; SEQUEIROS J, 1993, ADV NEUROL, V61, P139; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; STACHEL SE, 1985, EMBO J, V4, P891, DOI 10.1002/j.1460-2075.1985.tb03715.x; Sun J, 2007, J NEUROSCI RES, V85, P2306, DOI 10.1002/jnr.21369; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; Taylor J, 2006, J BIOL CHEM, V281, P2730, DOI 10.1074/jbc.M506751200; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Trottier Y, 1998, NEUROBIOL DIS, V5, P335, DOI 10.1006/nbdi.1998.0208; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Yang YH, 2004, J BIOL CHEM, V279, P38820, DOI 10.1074/jbc.M401663200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	68	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5834	10.1371/journal.pone.0005834	http://dx.doi.org/10.1371/journal.pone.0005834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503814	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717400013
J	Zhang, DP; Xiong, HL; Mennigen, JA; Popesku, JT; Marlatt, VL; Martyniuk, CJ; Crump, K; Cossins, AR; Xia, X; Trudeau, VL				Zhang, Dapeng; Xiong, Huiling; Mennigen, Jan A.; Popesku, Jason T.; Marlatt, Vicki L.; Martyniuk, Christopher J.; Crump, Kate; Cossins, Andrew R.; Xia, Xuhua; Trudeau, Vance L.			Defining Global Neuroendocrine Gene Expression Patterns Associated with Reproductive Seasonality in Fish	PLOS ONE			English	Article							GOLDFISH CARASSIUS-AURATUS; GONADOTROPIN-RELEASING-HORMONE; MESSENGER-RNA EXPRESSION; BASS DICENTRARCHUS-LABRAX; RAINBOW-TROUT; AROMATASE-ACTIVITY; SEX STEROIDS; MELATONIN RECEPTORS; BRAIN AROMATASE; MICROARRAY DATA	Background: Many vertebrates, including the goldfish, exhibit seasonal reproductive rhythms, which are a result of interactions between external environmental stimuli and internal endocrine systems in the hypothalamo-pituitary-gonadal axis. While it is long believed that differential expression of neuroendocrine genes contributes to establishing seasonal reproductive rhythms, no systems-level investigation has yet been conducted. Methodology/Principal Findings: In the present study, by analyzing multiple female goldfish brain microarray datasets, we have characterized global gene expression patterns for a seasonal cycle. A core set of genes (873 genes) in the hypothalamus were identified to be differentially expressed between May, August and December, which correspond to physiologically distinct stages that are sexually mature (prespawning), sexual regression, and early gonadal redevelopment, respectively. Expression changes of these genes are also shared by another brain region, the telencephalon, as revealed by multivariate analysis. More importantly, by examining one dataset obtained from fish in October who were kept under long-day-length photoperiod (16 h) typical of the springtime breeding season (May), we observed that the expression of identified genes appears regulated by photoperiod, a major factor controlling vertebrate reproductive cyclicity. Gene ontology analysis revealed that hormone genes and genes functionally involved in G-protein coupled receptor signaling pathway and transmission of nerve impulses are significantly enriched in an expression pattern, whose transition is located between prespawning and sexually regressed stages. The existence of seasonal expression patterns was verified for several genes including isotocin, ependymin II, GABA(A) gamma2 receptor, calmodulin, and aromatase b by independent samplings of goldfish brains from six seasonal time points and real-time PCR assays. Conclusions/Significance: Using both theoretical and experimental strategies, we report for the first time global gene expression patterns throughout a breeding season which may account for dynamic neuroendocrine regulation of seasonal reproductive development.			Zhang, DP (corresponding author), Univ Ottawa, Dept Biol, CAREG, Ottawa, ON, Canada.	trudeauv@uottawa.ca	Popesku, Jason/E-3603-2010; Trudeau, Vance L./P-5542-2019; Xia, Xuhua/E-5264-2010	Trudeau, Vance L./0000-0002-0845-9444; Xia, Xuhua/0000-0002-3092-7566; Werry, Kate/0000-0003-3997-2379; Martyniuk, Christopher J./0000-0003-0921-4796; Zhang, Dapeng/0000-0001-8535-7620; Cossins, Andrew/0000-0002-0813-5212	NERC [NBAF010002] Funding Source: UKRI; Natural Environment Research Council [NBAF010002] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andersson E, 2001, COMP BIOCHEM PHYS B, V129, P551, DOI 10.1016/S1096-4959(01)00363-3; Barrell GK, 2000, BIOL REPROD, V63, P769, DOI 10.1095/biolreprod63.3.769; Basilevsky A.T., 1994, STAT FACTOR ANAL REL; Bayarri MJ, 2004, GEN COMP ENDOCR, V136, P72, DOI 10.1016/j.ygcen.2003.12.004; Blazquez M, 1998, COMP BIOCHEM PHYS C, V119, P345, DOI 10.1016/S0742-8413(98)00023-1; Bluthgen Nils, 2005, Genome Inform, V16, P106; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROMAGE NR, 1982, GEN COMP ENDOCR, V47, P366, DOI 10.1016/0016-6480(82)90246-5; CALLARD GV, 1995, ENVIRON HEALTH PERSP, V103, P51, DOI 10.2307/3432508; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darrow J.M., 1986, Journal of Biological Rhythms, V1, P39, DOI 10.1177/074873048600100106; DAVIES B, 1994, GEN COMP ENDOCR, V96, P19, DOI 10.1006/gcen.1994.1155; Davis SJ, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-3-reviews1008; Dupre SM, 2008, ENDOCRINOLOGY, V149, P5527, DOI 10.1210/en.2008-0834; DUSTON J, 1987, GEN COMP ENDOCR, V65, P373, DOI 10.1016/0016-6480(87)90122-5; EKSTROM P, 1992, NEUROENDOCRINOLOGY, V55, P529, DOI 10.1159/000126166; Evans JJ, 1996, J ENDOCRINOL, V151, P169, DOI 10.1677/joe.0.1510169; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Forlano PM, 2005, J NEUROBIOL, V65, P37, DOI 10.1002/neu.20179; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Gelinas D, 1998, MOL CELL ENDOCRINOL, V138, P81, DOI 10.1016/S0303-7207(98)00015-X; Gonzalez A, 2003, GEN COMP ENDOCR, V132, P223, DOI 10.1016/S0016-6480(03)00086-8; Goodson JL, 2000, J COMP NEUROL, V422, P363, DOI 10.1002/1096-9861(20000703)422:3<363::AID-CNE4>3.0.CO;2-8; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; HONTELA A, 1983, J EXP ZOOL, V228, P543, DOI 10.1002/jez.1402280314; Jodo A, 2005, ZOOL SCI, V22, P1331, DOI 10.2108/zsj.22.1331; Jones S, 2008, BRAIN RES BULL, V76, P536, DOI 10.1016/j.brainresbull.2008.03.008; Joy KP, 1999, COMP BIOCHEM PHYS A, V123, P369, DOI 10.1016/S1095-6433(99)00075-6; Koger CS, 1999, BIOL REPROD, V61, P1287, DOI 10.1095/biolreprod61.5.1287; Lariviere K, 2005, MOL BRAIN RES, V141, P1, DOI 10.1016/j.molbrainres.2005.06.005; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Li GL, 2007, ANIM REPROD SCI, V99, P156, DOI 10.1016/j.anireprosci.2006.05.015; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Lincoln GA, 1998, COMP BIOCHEM PHYS C, V119, P283, DOI 10.1016/S0742-8413(98)00017-6; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Martyniuk CJ, 2006, PHYSIOL GENOMICS, V27, P328, DOI 10.1152/physiolgenomics.00090.2006; Mazurais D, 1999, J COMP NEUROL, V409, P313, DOI 10.1002/(SICI)1096-9861(19990628)409:2<313::AID-CNE11>3.0.CO;2-1; MCNULTY JA, 1982, REPROD NUTR DEV, V22, P1061, DOI 10.1051/rnd:19820716; Mennigen JA, 2008, PHYSIOL GENOMICS, V35, P273, DOI 10.1152/physiolgenomics.90263.2008; MUNKITTRICK KR, 1984, J FISH BIOL, V24, P75, DOI 10.1111/j.1095-8649.1984.tb04778.x; Okuzawa K, 2003, GEN COMP ENDOCR, V130, P324, DOI 10.1016/S0016-6480(02)00629-9; Orlando EF, 2007, GEN COMP ENDOCR, V151, P318, DOI 10.1016/j.ygcen.2007.01.032; PASMANIK M, 1988, ENDOCRINOLOGY, V122, P1349, DOI 10.1210/endo-122-4-1349; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; PETER RE, 1979, ANNU REV PHYSIOL, V41, P323, DOI 10.1146/annurev.ph.41.030179.001543; PETER RE, 1986, RECENT PROG HORM RES, V42, P513; Peyon P, 1999, MOL BRAIN RES, V74, P190, DOI 10.1016/S0169-328X(99)00282-X; Peyon P, 2000, PEPTIDES, V21, P225, DOI 10.1016/S0196-9781(99)00190-4; Popesku JT, 2008, MOL CELL ENDOCRINOL, V293, P43, DOI 10.1016/j.mce.2008.06.017; Prendergast BJ, 2002, P NATL ACAD SCI USA, V99, P16291, DOI 10.1073/pnas.232490799; RAZANI H, 1987, EXP BIOL, V47, P89; Rettori V, 1997, P NATL ACAD SCI USA, V94, P2741, DOI 10.1073/pnas.94.6.2741; Ripperger Jurgen A, 2007, Genome Biol, V8, P313, DOI 10.1186/gb-2007-8-8-313; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samia M, 2004, GEN COMP ENDOCR, V139, P198, DOI 10.1016/j.ygcen.2004.09.004; SHASHOUA VE, 1991, ANN NY ACAD SCI, V627, P94; Sherlock G, 2001, Brief Bioinform, V2, P350, DOI 10.1093/bib/2.4.350; Sigel Erwin, 2002, Current Topics in Medicinal Chemistry, V2, P833, DOI 10.2174/1568026023393444; Sohn YC, 1999, GEN COMP ENDOCR, V113, P436, DOI 10.1006/gcen.1998.7224; Somoza GM, 2002, CELL MOL NEUROBIOL, V22, P589, DOI 10.1023/A:1021888420271; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Storey JD, 2007, BIOSTATISTICS, V8, P414, DOI 10.1093/biostatistics/kxl019; Thiery JC, 2002, DOMEST ANIM ENDOCRIN, V23, P87, DOI 10.1016/S0739-7240(02)00148-0; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; Trudeau V L, 1997, Rev Reprod, V2, P55, DOI 10.1530/ror.0.0020055; TRUDEAU VL, 1991, BIOL REPROD, V44, P951, DOI 10.1095/biolreprod44.6.951; Trudeau VL, 2000, BIOCHEM CELL BIOL, V78, P241, DOI 10.1139/bcb-78-3-241; TRUDEAU VL, 1993, AM J PHYSIOL, V265, pR348, DOI 10.1152/ajpregu.1993.265.2.R348; Vernadakis AJ, 1998, GEN COMP ENDOCR, V110, P67, DOI 10.1006/gcen.1997.7042; Westring CG, 2008, GEN COMP ENDOCR, V155, P126, DOI 10.1016/j.ygcen.2007.03.013; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zhang J, 2004, J NEUROSCI RES, V75, P361, DOI 10.1002/jnr.10850	76	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5816	10.1371/journal.pone.0005816	http://dx.doi.org/10.1371/journal.pone.0005816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503831	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717200012
J	Riazi, AM; Takeuchi, JK; Hornberger, LK; Zaidi, SH; Amini, F; Coles, J; Bruneau, BG; Van Arsdell, GS				Riazi, Ali M.; Takeuchi, Jun K.; Hornberger, Lisa K.; Zaidi, Syed Hassan; Amini, Fariba; Coles, John; Bruneau, Benoit G.; Van Arsdell, Glen S.			NKX2-5 Regulates the Expression of beta-Catenin and GATA4 in Ventricular Myocytes	PLOS ONE			English	Article								Background: The molecular pathway that controls cardiogenesis is temporally and spatially regulated by master transcriptional regulators such as NKX2-5, Isl1, MEF2C, GATA4, and beta-catenin. The interplay between these factors and their downstream targets are not completely understood. Here, we studied regulation of beta-catenin and GATA4 by NKX2-5 in human fetal cardiac myocytes. Methodology/Principal Findings: Using antisense inhibition we disrupted the expression of NKX2-5 and studied changes in expression of cardiac-associated genes. Down-regulation of NKX2-5 resulted in increased beta-catenin while GATA4 was decreased. We demonstrated that this regulation was conferred by binding of NKX2-5 to specific elements (NKEs) in the promoter region of the beta-catenin and GATA4 genes. Using promoter-luciferase reporter assay combined with mutational analysis of the NKEs we demonstrated that the identified NKX2-5 binding sites were essential for the suppression of beta-catenin, and upregulation of GATA4 by NKX2-5. Conclusions: This study suggests that NKX2-5 modulates the beta-catenin and GATA4 transcriptional activities in developing human cardiac myocytes.			Riazi, AM (corresponding author), Hosp Sick Children, Labatt Family Heart Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ali.riazi@sickkids.ca		Bruneau, Benoit/0000-0002-0804-7597				Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Brewer AC, 2005, STEM CELLS DEV, V14, P425, DOI 10.1089/scd.2005.14.425; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; CHEN WS, 1995, ONCOL REP, V2, P5; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Harvey RP, 2002, COLD SPRING HARB SYM, V67, P107, DOI 10.1101/sqb.2002.67.107; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kasahara H, 2003, J MOL CELL CARDIOL, V35, P243, DOI 10.1016/S0022-2828(03)00002-6; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Kwon C, 2008, CELL CYCLE, V7, P3815, DOI 10.4161/cc.7.24.7189; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Montgomery Mary K, 2004, Methods Mol Biol, V265, P3; Nollet F, 1996, GENOMICS, V32, P413, DOI 10.1006/geno.1996.0136; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Riazi AM, 2005, J BIOL CHEM, V280, P10716, DOI 10.1074/jbc.M500028200; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Skerjanc IS, 1998, J BIOL CHEM, V273, P34904, DOI 10.1074/jbc.273.52.34904; Smagulova FO, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-67; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van der Heyden MAG, 1998, J CELL SCI, V111, P1741; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; ZAIDI SHE, 1995, J BIOL CHEM, V270, P17292, DOI 10.1074/jbc.270.29.17292; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769	31	35	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5698	10.1371/journal.pone.0005698	http://dx.doi.org/10.1371/journal.pone.0005698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479054	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415100006
J	Yuan, XH; Ta, TC; Lin, M; Evans, JR; Dong, YC; Bolotin, E; Sherman, MA; Forman, BM; Sladek, FM				Yuan, Xiaohui; Ta, Tuong Chi; Lin, Min; Evans, Jane R.; Dong, Yinchen; Bolotin, Eugene; Sherman, Mark A.; Forman, Barry M.; Sladek, Frances M.			Identification of an Endogenous Ligand Bound to a Native Orphan Nuclear Receptor	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; X-RAY-STRUCTURE; REV-ERB-ALPHA; TRANSCRIPTION FACTOR; ESTROGEN-RECEPTOR; STEROID-RECEPTORS; GENE-EXPRESSION; BINDING DOMAIN; CENTRAL REGULATOR; CRYSTAL-STRUCTURE	Orphan nuclear receptors have been instrumental in identifying novel signaling pathways and therapeutic targets. However, identification of ligands for these receptors has often been based on random compound screens or other biased approaches. As a result, it remains unclear in many cases if the reported ligands are the true endogenous ligands, -i.e., the ligand that is bound to the receptor in an unperturbed in vivo setting. Technical limitations have limited our ability to identify ligands based on this rigorous definition. The orphan receptor hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a key regulator of many metabolic pathways and linked to several diseases including diabetes, atherosclerosis, hemophilia and cancer. Here we utilize an affinity isolation/mass-spectrometry (AIMS) approach to demonstrate that HNF4 alpha is selectively occupied by linoleic acid (LA, C18:2 omega 6) in mammalian cells and in the liver of fed mice. Receptor occupancy is dramatically reduced in the fasted state and in a receptor carrying a mutation derived from patients with Maturity Onset Diabetes of the Young 1 (MODY1). Interestingly, however, ligand occupancy does not appear to have a significant effect on HNF4 alpha transcriptional activity, as evidenced by genome-wide expression profiling in cells derived from human colon. We also use AIMS to show that LA binding is reversible in intact cells, indicating that HNF4 alpha could be a viable drug target. This study establishes a general method to identify true endogenous ligands for nuclear receptors (and other lipid binding proteins), independent of transcriptional function, and to track in vivo receptor occupancy under physiologically relevant conditions.			Yuan, XH (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Gene Regulat & Drug Discovery, Gonda Diabet Res Ctr, Duarte, CA 91010 USA.	bmforman@earthlink.net; frances.sladek@ucr.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072020, R01DK053892, U19DK062434, R56DK053892] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK053892, R56 DK053892, DK053892, U19 DK062434, DK072020, DK62434, R21 DK072020] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALMOGHRABI S, 1995, J COMP PHYSIOL B, V165, P183; [Anonymous], 2001, NUCL RECEPTORS GENET; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; BOLOTIN E, 2008, TRANSCRIPTION FACTOR; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; CRONAN JE, 1994, J BACTERIOL, V176, P3069, DOI 10.1128/JB.176.10.3069-3071.1994; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; EDELMAN IS, 1963, P NATL ACAD SCI USA, V50, P1169, DOI 10.1073/pnas.50.6.1169; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Grasso LC, 2001, MOL PHYLOGENET EVOL, V21, P93, DOI 10.1006/mpev.2001.0994; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Guido EC, 1996, MOL ENDOCRINOL, V10, P1178, DOI 10.1210/me.10.10.1178; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Ingraham HA, 2005, CURR OPIN STRUC BIOL, V15, P708, DOI 10.1016/j.sbi.2005.10.009; Ismail A, 2005, IUBMB LIFE, V57, P483, DOI 10.1080/15216540500147163; JENSEN E, 1996, FATE STEROID ESTROGE, P161; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Moller AM, 1997, DIABETOLOGIA, V40, P980, DOI 10.1007/s001250050778; Navas MA, 1999, DIABETES, V48, P1459, DOI 10.2337/diabetes.48.7.1459; Norman AW, 2004, NAT REV DRUG DISCOV, V3, P27, DOI 10.1038/nrd1283; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Paris M, 2008, DEV GENES EVOL, V218, P667, DOI 10.1007/s00427-008-0255-7; Paris M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-219; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potier N, 2003, PROTEIN SCI, V12, P725, DOI 10.1110/ps.0232503; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; Schulman IG, 2004, CHEM BIOL, V11, P639, DOI 10.1016/j.chembiol.2003.12.021; Sladek FM, 2002, MOL CELL, V10, P219, DOI 10.1016/S1097-2765(02)00605-6; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Stehlin C, 2001, EMBO J, V20, P5822, DOI 10.1093/emboj/20.21.5822; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; van den Bemd GJCM, 2002, J BIOL CHEM, V277, P14539, DOI 10.1074/jbc.M111224200; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yuan Xiaohui, 2005, Nucl Recept Signal, V3, pe002	63	150	156	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5609	10.1371/journal.pone.0005609	http://dx.doi.org/10.1371/journal.pone.0005609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440305	Green Submitted, Green Published, gold			2022-12-27	WOS:000266161200011
J	Boria, S; Fabbri-Destro, M; Cattaneo, L; Sparaci, L; Sinigaglia, C; Santelli, E; Cossu, G; Rizzolatti, G				Boria, Sonia; Fabbri-Destro, Maddalena; Cattaneo, Luigi; Sparaci, Laura; Sinigaglia, Corrado; Santelli, Erica; Cossu, Giuseppe; Rizzolatti, Giacomo			Intention Understanding in Autism	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; SPECTRUM-DISORDERS; SOCIAL COGNITION; CORTICAL ACTIVATION; ASPERGERS-SYNDROME; IMITATION; CORTEX; CHILDREN; MRI; ABNORMALITIES	When we observe a motor act (e. g. grasping a cup) done by another individual, we extract, according to how the motor act is performed and its context, two types of information: the goal (grasping) and the intention underlying it (e.g. grasping for drinking). Here we examined whether children with autistic spectrum disorder (ASD) are able to understand these two aspects of motor acts. Two experiments were carried out. In the first, one group of high-functioning children with ASD and one of typically developing (TD) children were presented with pictures showing hand-object interactions and asked what the individual was doing and why. In half of the "why'' trials the observed grip was congruent with the function of the object ("why-use'' trials), in the other half it corresponded to the grip typically used to move that object ("why-place'' trials). The results showed that children with ASD have no difficulties in reporting the goals of individual motor acts. In contrast they made several errors in the why task with all errors occurring in the "why-place'' trials. In the second experiment the same two groups of children saw pictures showing a hand-grip congruent with the object use, but within a context suggesting either the use of the object or its placement into a container. Here children with ASD performed as TD children, correctly indicating the agent's intention. In conclusion, our data show that understanding others' intentions can occur in two ways: by relying on motor information derived from the hand-object interaction, and by using functional information derived from the object's standard use. Children with ASD have no deficit in the second type of understanding, while they have difficulties in understanding others' intentions when they have to rely exclusively on motor cues.			Boria, S (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	giacomo.rizzolatti@unipr.it	SINIGAGLIA, CORRADO/AGY-7196-2022; sinigaglia, corrado/AAI-2220-2021; Fabbri-Destro, Maddalena/J-4988-2018; Cattaneo, Luigi/E-3690-2010	SINIGAGLIA, CORRADO/0000-0002-3365-7522; Cattaneo, Luigi/0000-0001-8905-7529; Fabbri Destro, Maddalena/0000-0001-8321-4634				Akshoomoff N, 2002, DEV PSYCHOPATHOL, V14, P613, DOI 10.1017/S0954579402003115; ALTSCHULER EL, 1997, 27 ANN M SOC NEUR NE; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Courchesne E, 1997, CURR OPIN NEUROBIOL, V7, P269, DOI 10.1016/S0959-4388(97)80016-5; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Dunn L.M., 2007, PEABODY PICTURE VOCA; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frith U., 2003, AUTISM EXPLAINING EN; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hamilton AFD, 2007, NEUROPSYCHOLOGIA, V45, P1859, DOI 10.1016/j.neuropsychologia.2006.11.022; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Hobson R, 1993, AUTISM DEV MIND; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jou R. J., 2008, PSYCHOL MED, V24, P1; Kanner L, 1943, NERV CHILD, V2, P217; Leighton J, 2008, NEUROPSYCHOLOGIA, V46, P1041, DOI 10.1016/j.neuropsychologia.2007.11.013; Liepelt R, 2008, NEUROIMAGE, V43, P784, DOI 10.1016/j.neuroimage.2008.08.007; Lord C., 2005, AUTISM DIAGNOSTIC OB; Martineau J, 2008, INT J PSYCHOPHYSIOL, V68, P35, DOI 10.1016/j.ijpsycho.2008.01.002; McAlonan GM, 2008, J CHILD PSYCHOL PSYC, V49, P1287, DOI 10.1111/j.1469-7610.2008.01933.x; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Muller RA, 2003, AM J PSYCHIAT, V160, P1847, DOI 10.1176/appi.ajp.160.10.1847; Nishitani N, 2004, ANN NEUROL, V55, P558, DOI 10.1002/ana.20031; Oberman LM, 2008, NEUROPSYCHOLOGIA, V46, P1558, DOI 10.1016/j.neuropsychologia.2008.01.010; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; PERRETT DI, 1989, J EXP BIOL, V146, P87; RAVEN JC, 1984, COLOURED PROGR MATRI; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rubini V, 1986, WECHSLER INTELLIGENC; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Southgate V, 2008, TRENDS COGN SCI, V12, P225, DOI 10.1016/j.tics.2008.03.005; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	51	102	104	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5596	10.1371/journal.pone.0005596	http://dx.doi.org/10.1371/journal.pone.0005596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	446FZ	19440332	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107500023
J	Losito, O; Szijgyarto, Z; Resnick, AC; Saiardi, A				Losito, Oriana; Szijgyarto, Zsolt; Resnick, Adam Cain; Saiardi, Adolfo			Inositol Pyrophosphates and Their Unique Metabolic Complexity: Analysis by Gel Electrophoresis	PLOS ONE			English	Article								Background: Inositol pyrophosphates are a recently characterized cell signalling molecules responsible for the pyrophosphorylation of protein substrates. Though likely involved in a wide range of cellular functions, the study of inositol pyrophosphates has suffered from a lack of readily available methods for their analysis. Principal Finding: We describe a novel, sensitive and rapid polyacrylamide gel electrophoresis (PAGE)-based method for the analysis of inositol pyrophosphates. Using 4',6-diamidino-2-phenylindole (DAPI) and Toluidine Blue we demonstrate the unequivocal detection of various inositol pyrophosphate species. Conclusion: The use of the PAGE-based method reveals the likely underestimation of inositol pyrophosphates and their signalling contribution in cells when measured via traditional HPLC-based techniques. PAGE-based analyses also reveals the existence of a number of additional, previously uncharacterised pyrophosphorylated inositol reaction products, defining a more complex metabolism associated with the catalytically flexible kinase class responsible for the production of these highly energetic cell signalling molecules.				dmcbado@ucl.ac.uk			NATIONAL CANCER INSTITUTE [K99CA134914] Funding Source: NIH RePORTER; MRC [MC_U122680443] Funding Source: UKRI; Medical Research Council [MC_U122680443] Funding Source: Medline; NCI NIH HHS [1K99CA134914, K99 CA134914] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; BURTON A, 2009, J CELL PHYSL; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Huang CF, 1998, BIOCHEMISTRY-US, V37, P14998, DOI 10.1021/bi981920l; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Lin HY, 2009, J BIOL CHEM, V284, P1863, DOI 10.1074/jbc.M805686200; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Morrison BH, 2002, ONCOGENE, V21, P1882, DOI 10.1038/sj.onc.1205265; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; TIJSSEN JPF, 1982, BIOCHIM BIOPHYS ACTA, V721, P394, DOI 10.1016/0167-4889(82)90094-5; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305	28	88	91	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5580	10.1371/journal.pone.0005580	http://dx.doi.org/10.1371/journal.pone.0005580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440344	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107500011
J	Yanamandra, K; Alexeyev, O; Zamotin, V; Srivastava, V; Shchukarev, A; Brorsson, AC; Tartaglia, GG; Vogl, T; Kayed, R; Wingsle, G; Olsson, J; Dobson, CM; Bergh, A; Elgh, F; Morozova-Roche, LA				Yanamandra, Kiran; Alexeyev, Oleg; Zamotin, Vladimir; Srivastava, Vaibhav; Shchukarev, Andrei; Brorsson, Ann-Christin; Tartaglia, Gian Gaetano; Vogl, Thomas; Kayed, Rakez; Wingsle, Gunnar; Olsson, Jan; Dobson, Christopher M.; Bergh, Anders; Elgh, Fredrik; Morozova-Roche, Ludmilla A.			Amyloid Formation by the Pro-Inflammatory S100A8/A9 Proteins in the Ageing Prostate	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; ESCHERICHIA-COLI STRAINS; CORPORA-AMYLACEA; S100 PROTEINS; ALZHEIMERS-DISEASE; AGGREGATION-PRONE; FIBRIL FORMATION; EQUINE LYSOZYME; CANCER REGISTER; OLIGOMERS	Background: The conversion of soluble peptides and proteins into polymeric amyloid structures is a hallmark of many age-related degenerative disorders, including Alzheimer's disease, type II diabetes and a variety of systemic amyloidoses. We report here that amyloid formation is linked to another major age-related phenomenon 2 prostate tissue remodelling in middle-aged and elderly men. Methodology/Principal Findings: By using multidisciplinary analysis of corpora amylacea inclusions in prostate glands of patients diagnosed with prostate cancer we have revealed that their major components are the amyloid forms of S100A8 and S100A9 proteins associated with numerous inflammatory conditions and types of cancer. In prostate protease rich environment the amyloids are stabilized by dystrophic calcification and lateral thickening. We have demonstrated that material closely resembling CA can be produced from S100A8/A9 in vitro under native and acidic conditions and shows the characters of amyloids. This process is facilitated by calcium or zinc, both of which are abundant in ex vivo inclusions. These observations were supported by computational analysis of the S100A8/A9 calcium-dependent aggregation propensity profiles. We found DNA and proteins from Escherichia coli in CA bodies, suggesting that their formation is likely to be associated with bacterial infection. CA inclusions were also accompanied by the activation of macrophages and by an increase in the concentration of S100A8/A9 in the surrounding tissues, indicating inflammatory reactions. Conclusions/Significance: These findings, taken together, suggest a link between bacterial infection, inflammation and amyloid deposition of pro-inflammatory proteins S100A8/A9 in the prostate gland, such that a self-perpetuating cycle can be triggered and may increase the risk of malignancy in the ageing prostate. The results provide strong support for the prediction that the generic ability of polypeptide chains to convert into amyloids could lead to their involvement in an increasing number of otherwise apparently unrelated diseases, particularly those associated with ageing.			Yanamandra, K (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	ludmilla.morozova-roche@medchem.umu.se	Morozova-Roche, Ludmilla/AAV-9983-2021; Srivastava, Vaibhav/H-1320-2015; Yanamandra, Kiran/M-4037-2014; Morozova-Roche, Ludmilla A./AAU-9044-2021; Tartaglia, Gian Gaetano/K-1229-2014	Morozova-Roche, Ludmilla/0000-0001-5886-2023; Srivastava, Vaibhav/0000-0003-1877-4154; Yanamandra, Kiran/0000-0002-4908-5848; Olsson, Jan/0000-0001-9094-319X; Tartaglia, Gian Gaetano/0000-0001-7524-6310; Zamotin, Vladimir/0000-0002-3661-8772	Medical Research Council [G0700990] Funding Source: Medline; MRC [G0700990] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Andreu A, 1997, J INFECT DIS, V176, P464, DOI 10.1086/514065; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Bergh J, 2007, EUR UROL, V51, P457, DOI 10.1016/j.eururo.2006.06.008; BOSTWICK DG, 1993, HUM PATHOL, V24, P298, DOI 10.1016/0046-8177(93)90041-E; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Christian JD, 2005, MODERN PATHOL, V18, P36, DOI 10.1038/modpathol.3800250; Chung MH, 1996, J NEUROPATH EXP NEUR, V55, P403, DOI 10.1097/00005072-199604000-00002; CISSE S, 1993, ACTA NEUROPATHOL, V85, P233; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; CROSS PA, 1992, J CLIN PATHOL, V45, P894, DOI 10.1136/jcp.45.10.894; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DRACH GW, 1978, J UROLOGY, V120, P266, DOI 10.1016/S0022-5347(17)57135-9; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Emberley ED, 2004, BIOCHEM CELL BIOL, V82, P508, DOI 10.1139/O04-052; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Fung KYC, 2004, PROSTATE, V61, P171, DOI 10.1002/pros.20089; Gati Istvan, 2001, Pathology and Oncology Research, V7, P140; Gebhardt C, 2002, ONCOGENE, V21, P4266, DOI 10.1038/sj.onc.1205521; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gueft B, 1972, Acta Pathol Microbiol Scand Suppl, V233, P132; GUEVARA J, 1985, CANCER RES, V45, P1766; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Heizmann C. W., 2007, V45, P93; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; Higurashi T, 2005, J MOL BIOL, V351, P1057, DOI 10.1016/j.jmb.2005.07.006; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; Itzhaki RF, 2008, J NEUROVIROL, V14, P1, DOI 10.1080/13550280701802543; Jager GJ, 1997, EUR RADIOL, V7, P552, DOI 10.1007/s003300050202; Jun SY, 2003, J KOREAN MED SCI, V18, P447, DOI 10.3346/jkms.2003.18.3.447; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; KLIMAS R, 1985, PROSTATE, V7, P91, DOI 10.1002/pros.2990070110; Leone L, 2006, SURF INTERFACE ANAL, V38, P202, DOI 10.1002/sia.2184; Leukert N, 2005, BIOL CHEM, V386, P429, DOI 10.1515/BC.2005.051; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Malisauskas M, 2005, J BIOL CHEM, V280, P6269, DOI 10.1074/jbc.M407273200; Malisauskas M, 2003, J MOL BIOL, V330, P879, DOI 10.1016/S0022-2836(03)00551-5; MARX AJ, 1965, ARCH PATHOL, V80, P487; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Morozova-Roche LA, 2004, BIOCHEMISTRY-US, V43, P9610, DOI 10.1021/bi0494121; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nacken W, 2007, FEBS LETT, V581, P5127, DOI 10.1016/j.febslet.2007.09.060; NELSON SR, 1991, BIOCHEM J, V275, P67, DOI 10.1042/bj2750067; Ott HW, 2003, CANCER RES, V63, P7507; Otzen D, 2008, CELL MOL LIFE SCI, V65, P910, DOI 10.1007/s00018-007-7404-4; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Rocken C, 1996, PATHOL RES PRACT, V192, P998; ROODVELDT C, 2008, J CELL MOL MED; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shintaku M, 2005, NEUROPATHOLOGY, V25, P175, DOI 10.1111/j.1440-1789.2005.00613.x; Singh SK, 2005, INT UROL NEPHROL, V37, P495, DOI 10.1007/s11255-005-2088-x; SINGHRAO SK, 1993, NEUROPATH APPL NEURO, V19, P269, DOI 10.1111/j.1365-2990.1993.tb00437.x; Solomon A, 2008, ARCH PATHOL LAB MED, V132, P14, DOI 10.1043/1543-2165(2008)132[14b:IR]2.0.CO;2; Soto SM, 2007, J UROLOGY, V177, P365, DOI 10.1016/j.juro.2006.08.081; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Thomas BA, 1927, J UROLOGY, V18, P470, DOI 10.1016/S0022-5347(17)73300-9; TOKUTAKE S, 1995, NEUROPATH APPL NEURO, V21, P269, DOI 10.1111/j.1365-2990.1995.tb01059.x; Untergasser G, 2005, EXP GERONTOL, V40, P121, DOI 10.1016/j.exger.2004.12.008; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; van den Bos C, 1998, PROTEIN EXPRES PURIF, V13, P313, DOI 10.1006/prep.1998.0917; Varenhorst E, 2005, SCAND J UROL NEPHROL, V39, P117, DOI 10.1080/00365590510007793; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	77	77	79	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5562	10.1371/journal.pone.0005562	http://dx.doi.org/10.1371/journal.pone.0005562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440546	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107400006
J	Tian, CH; Murrin, LC; Zheng, JLC				Tian, Changhai; Murrin, L. Charles; Zheng, Jialin C.			Mitochondrial Fragmentation Is Involved in Methamphetamine-Induced Cell Death in Rat Hippocampal Neural Progenitor Cells	PLOS ONE			English	Article								Methamphetamine (METH) induces neurodegeneration through damage and apoptosis of dopaminergic nerve terminals and striatal cells, presumably via cross-talk between the endoplasmic reticulum and mitochondria-dependent death cascades. However, the effects of METH on neural progenitor cells (NPC), an important reservoir for replacing neurons and glia during development and injury, remain elusive. Using a rat hippocampal NPC (rhNPC) culture, we characterized the METH-induced mitochondrial fragmentation, apoptosis, and its related signaling mechanism through immunocytochemistry, flow cytometry, and Western blotting. We observed that METH induced rhNPC mitochondrial fragmentation, apoptosis, and inhibited cell proliferation. The mitochondrial fission protein dynamin-related protein 1 (Drp1) and reactive oxygen species (ROS), but not calcium (Ca2+) influx, were involved in the regulation of METH-induced mitochondrial fragmentation. Furthermore, our results indicated that dysregulation of ROS contributed to the oligomerization and translocation of Drp1, resulting in mitochondrial fragmentation in rhNPC. Taken together, our data demonstrate that METH-mediated ROS generation results in the dysregulation of Drp1, which leads to mitochondrial fragmentation and subsequent apoptosis in rhNPC. This provides a potential mechanism for METH-related neurodegenerative disorders, and also provides insight into therapeutic strategies for the neurodegenerative effects of METH.			Tian, CH (corresponding author), Univ Nebraska Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Lab Neurotoxicol, Omaha, NE USA.	jzheng@unmc.edu	Tian, Changhai/AAD-4856-2019		NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061642, P01NS043985, R01NS041858] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR015635, P20 RR15635-01] Funding Source: Medline; NIMH NIH HHS [R21 MH083525, R21 MH 083525-01] Funding Source: Medline; NINDS NIH HHS [R01 NS041858, R01 NS061642, R01 NS 41858-01, P01NS043985, P01 NS043985, R01 NS 061642-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Capano M, 2002, BIOCHEM J, V367, P169, DOI 10.1042/BJ20020805; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Chen Q, 1997, ONCOGENE, V15, P2249, DOI 10.1038/sj.onc.1201371; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Copp J, 2005, AM J PHYSIOL-CELL PH, V288, pC403, DOI 10.1152/ajpcell.00095.2004; Costantini P, 2000, ONCOGENE, V19, P307, DOI 10.1038/sj.onc.1203299; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Dawirs RR, 2001, ACTA PSYCHIAT SCAND, V104, P10, DOI 10.1034/j.1600-0447.2001.104s408010.x; Deng XL, 2000, MOL BRAIN RES, V83, P121, DOI 10.1016/S0169-328X(00)00169-8; Deng XL, 2002, MOL PHARMACOL, V62, P993, DOI 10.1124/mol.62.5.993; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; Eisch AJ, 2006, HIPPOCAMPUS, V16, P271, DOI 10.1002/hipo.20161; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fontana X, 2006, CEREB CORTEX, V16, P301, DOI 10.1093/cercor/bhi120; FRANCIS B, 2001, SEX ED, V1, P1; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Hanson GR, 2004, NEUROPHARMACOLOGY, V47, P92, DOI 10.1016/j.neuropharm.2004.06.004; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hendrickson H, 2006, AAPS J, V8, pE709, DOI 10.1208/aapsj080480; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jayanthi S, 2001, FASEB J, V15, P1745, DOI 10.1096/fj.01-0025com; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee CT, 2008, PLOS MED, V5, P987, DOI 10.1371/journal.pmed.0050117; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Liao XD, 2003, BIOCHEM BIOPH RES CO, V310, P405, DOI 10.1016/j.bbrc.2003.09.023; Maeda K, 2007, J PHARMACOL SCI, V103, P299, DOI 10.1254/jphs.FP0061424; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meredith CW, 2005, HARVARD REV PSYCHIAT, V13, P141, DOI 10.1080/10673220591003605; Miyatake M, 2005, EUR J NEUROSCI, V22, P1476, DOI 10.1111/j.1460-9568.2005.04325.x; MUNSCH T, 1995, J NEUROSCI METH, V57, P195, DOI 10.1016/0165-0270(94)00149-B; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; PARRA V, 2007, CHANGES MITOCHONDRIA; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Pubill D, 2003, N-S ARCH PHARMACOL, V367, P490, DOI 10.1007/s00210-003-0747-y; Raudensky J, 2007, BRAIN RES, V1135, P129, DOI 10.1016/j.brainres.2006.12.002; Riddle EL, 2006, AAPS J, V8, pE413, DOI 10.1007/BF02854914; Sever S, 2002, CURR OPIN CELL BIOL, V14, P463, DOI 10.1016/S0955-0674(02)00347-2; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Shimazu K, 2006, LEARN MEMORY, V13, P307, DOI 10.1101/lm.76006; Simoes PF, 2007, NEUROSCIENCE, V150, P433, DOI 10.1016/j.neuroscience.2007.09.044; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; STANFIELD BB, 1988, EXP BRAIN RES, V72, P399; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tian CH, 2008, J NEUROCHEM, V105, P994, DOI 10.1111/j.1471-4159.2007.05197.x; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Volz TJ, 2007, J NEUROCHEM, V101, P883, DOI 10.1111/j.1471-4159.2006.04419.x; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	81	62	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5546	10.1371/journal.pone.0005546	http://dx.doi.org/10.1371/journal.pone.0005546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436752	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107300011
J	Choi, DY; Liu, M; Hunter, RL; Cass, WA; Pandya, JD; Sullivan, PG; Shin, EJ; Kim, HC; Gash, DM; Bing, GY				Choi, Dong-Young; Liu, Mei; Hunter, Randy L.; Cass, Wayne A.; Pandya, Jignesh D.; Sullivan, Patrick G.; Shin, Eun-Joo; Kim, Hyoung-Chun; Gash, Don M.; Bing, Guoying			Striatal Neuroinflammation Promotes Parkinsonism in Rats	PLOS ONE			English	Article								Background: Sporadic Parkinson's disease (PD) is a progressive neurodegenerative disorder with unknown cause, but it has been suggested that neuroinflammation may play a role in pathogenesis of the disease. Neuroinflammatory component in process of PD neurodegeneration was proposed by postmortem, epidemiological and animal model studies. However, it remains unclear how neuroinflammatory factors contribute to dopaminergic neuronal death in PD. Findings: In this study, we analyzed the relationship among inducible nitric oxide synthase (iNOS)-derived NO, mitochondrial dysfunction and dopaminergic neurodegeneration to examine the possibility that microglial neuroinflammation may induce dopaminergic neuronal loss in the substantia nigra. Unilateral injection of lipopolysaccharide (LPS) into the striatum of rat was followed by immunocytochemical, histological, neurochemical and biochemical analyses. In addition, behavioral assessments including cylinder test and amphetamine-induced rotational behavior test were employed to validate ipsilateral damage to the dopamine nigrostriatal pathway. LPS injection caused progressive degeneration of the dopamine nigrostriatal system, which was accompanied by motor impairments including asymmetric usage of forelimbs and amphetamine-induced turning behavior in animals. Interestingly, some of the remaining nigral dopaminergic neurons had intracytoplasmic accumulation of alpha-synuclein and ubiquitin. Furthermore, defect in the mitochondrial respiratory chain, and extensive S-nitrosylation/nitration of mitochondrial complex I were detected prior to the dopaminergic neuronal loss. The mitochondrial injury was prevented by treatment with L-N-6-(l-iminoethyl)-lysine, an iNOS inhibitor, suggesting that iNOS-derived NO is associated with the mitochondrial impairment. Conclusions: These results implicate neuroinflammation-induced S-nitrosylation/nitration of mitochondrial complex I in mitochondrial malfunction and subsequent degeneration of the nigral dopamine neurons.			Choi, DY (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA.	gbing@uky.edu		Bing, Guoying/0000-0003-0609-8152	NINDS NIH HHS [R01 NS044157, NS39345, NS044157] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039345, R01NS044157] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antunes F, 2002, BBA-BIOENERGETICS, V1556, P233, DOI 10.1016/S0005-2728(02)00365-1; Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Arimoto T, 2003, NEUROBIOL DIS, V12, P35, DOI 10.1016/S0969-9961(02)00017-7; Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Banati RB, 1998, MOVEMENT DISORD, V13, P221, DOI 10.1002/mds.870130205; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Cass WA, 2003, BRAIN RES, V984, P133, DOI 10.1016/S0006-8993(03)03122-6; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cohen G, 1999, J NEUROCHEM, V73, P2310, DOI 10.1046/j.1471-4159.1999.0732310.x; COSTALL B, 1985, BRIT J PHARMACOL, V85, P943, DOI 10.1111/j.1476-5381.1985.tb11095.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Gash DM, 2008, ANN NEUROL, V63, P184, DOI 10.1002/ana.21288; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Georgievska B, 2004, EUR J NEUROSCI, V20, P3121, DOI 10.1111/j.1460-9568.2004.03770.x; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Herrera AJ, 2000, NEUROBIOL DIS, V7, P429, DOI 10.1006/nbdi.2000.0289; Hsieh PF, 2002, NEUROREPORT, V13, P277, DOI 10.1097/00001756-200203040-00006; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; HUNTER RL, 2009, J NEUROSCI RES; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Liberatore GT, 1999, NAT MED, V5, P1403; Liu M, 2008, J NEUROSCI RES, V86, P2792, DOI 10.1002/jnr.21725; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Tangpong J, 2007, J NEUROCHEM, V100, P191, DOI 10.1111/j.1471-4159.2006.04179.x; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Yagami T, 2004, NEUROBIOL DIS, V16, P481, DOI 10.1016/j.nbd.2004.04.013; Zhang J, 2005, NEUROSCIENCE, V135, P829, DOI 10.1016/j.neuroscience.2005.06.049; ZIGMOND MJ, 1990, TRENDS NEUROSCI, V13, P290, DOI 10.1016/0166-2236(90)90112-N	59	93	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5482	10.1371/journal.pone.0005482	http://dx.doi.org/10.1371/journal.pone.0005482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424495	Green Published, gold, Green Submitted			2022-12-27	WOS:000265933800014
J	Anderson, DD; Stover, PJ				Anderson, Donald D.; Stover, Patrick J.			SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis	PLOS ONE			English	Article								The three enzymes that constitute the de novo thymidylate synthesis pathway in mammals, cytoplasmic serine hydroxymethyltransferase (SHMT1), thymidylate synthase (TYMS) and dihydrofolate reductase (DHFR) undergo sumoylation and nuclear import during S-phase. In this study, we demonstrate that purified intact mouse liver nuclei convert dUMP to dTMP in the presence of NADPH and serine. Neither nuclear extracts nor intact nuclei exposed to aminomethylphosphonate, a SHMT inhibitor, exhibit thymidylate synthesis activity. Nuclei isolated from Shmt1(-/-) mouse livers retained 25% of thymidylate synthesis activity exhibited by nuclei isolated from wild type mice. This residual activity was due to the presence of a cytoplasmic/nuclear isozyme of SHMT encoded by Shmt2. Shmt2 is shown to encode two transcripts, one which encodes a protein that localizes exclusively to the mitochondria (SHMT2), and a second transcript that lacks exon 1 and encodes a protein that localizes to the cytoplasm and nucleus during S-phase (SHMT2 alpha). The ability of Shmt2 to encode a cytoplasmic isozyme of SHMT may account for the viability of Shmt1(-/-) mice and provide redundancy that permitted the expansion of the human SHMT1 L474F polymorphism that impairs SHMT1 sumoylation and nuclear translocation.			Anderson, DD (corresponding author), Cornell Univ, Grad Field Biochem Mol & Cellular Biol, Ithaca, NY 14850 USA.	pjs13@cornell.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK058144, R37 DK058144, DK58144] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bissoon-Haqqani S, 2006, J HISTOCHEM CYTOCHEM, V54, P19, DOI 10.1369/jhc.5A6642.2005; BOORSTEIN RJ, 1983, BIOCHEM BIOPH RES CO, V117, P30, DOI 10.1016/0006-291X(83)91536-X; Chang WN, 2007, DRUG METAB DISPOS, V35, P2127, DOI 10.1124/dmd.107.016840; Cowin GJ, 1996, BBA-MOL CELL RES, V1310, P32, DOI 10.1016/0167-4889(95)00142-5; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Graham JM, 2001, CURRENT PROTOCOLS CE; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu XW, 2001, BIOCHEMISTRY-US, V40, P4932, DOI 10.1021/bi002598t; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Perry C, 2007, ARCH BIOCHEM BIOPHYS, V462, P21, DOI 10.1016/j.abb.2007.04.005; POTTER H, 2003, CURRENT PROTOCOLS CE; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; SHIN YS, 1976, BIOCHIM BIOPHYS ACTA, V444, P794; STOVER P, 1991, J BIOL CHEM, V266, P1543; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Zanetti KA, 2003, J BIOL CHEM, V278, P10142, DOI 10.1074/jbc.M211569200	27	139	142	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5839	10.1371/journal.pone.0005839	http://dx.doi.org/10.1371/journal.pone.0005839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513116	gold, Green Submitted, Green Published			2022-12-27	WOS:000267228800005
J	Leemans, JC; Butter, LM; Pulskens, WPC; Teske, GJD; Claessen, N; van der Poll, T; Florquin, S				Leemans, Jaklien C.; Butter, Loes M.; Pulskens, Wilco P. C.; Teske, Gwendoline J. D.; Claessen, Nike; van der Poll, Tom; Florquin, Sandrine			The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury	PLOS ONE			English	Article								Tissue fibrosis and chronic inflammation are common causes of progressive organ damage, including progressive renal disease, leading to loss of physiological functions. Recently, it was shown that Toll-like receptor 2 (TLR2) is expressed in the kidney and activated by endogenous danger signals. The expression and function of TLR2 during renal fibrosis and chronic inflammation has however not yet been elucidated. Therefore, we studied TLR2 expression in human and murine progressive renal diseases and explored its role by inducing obstructive nephropathy in TLR2(-/-) or TLR2(+/+) mice. We found that TLR2 is markedly upregulated on tubular and tubulointerstitial cells in patients with chronic renal injury. In mice with obstructive nephropathy, renal injury was associated with a marked upregulation and change in distribution of TLR2 and upregulation of murine TLR2 danger ligands Gp96, biglycan, and HMGB1. Notably, TLR2 enhanced inflammation as reflected by a significantly reduced influx of neutrophils and production of chemokines and TGF-beta in kidneys of TLR2(-/-) mice compared with TLR2(+/+) animals. Although, the obstructed kidneys of TLR2(-/-) mice had less interstitial myofibroblasts in the later phase of obstructive nephropathy, tubular injury and renal matrix accumulation was similar in both mouse strains. Together, these data demonstrate that TLR2 can initiate renal inflammation during progressive renal injury and that the absence of TLR2 does not affect the development of chronic renal injury and fibrosis.			Leemans, JC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	j.c.leemans@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020; Pulskens, Wilco/P-6023-2015; Florquin, Sandrine/B-8242-2012	Pulskens, Wilco/0000-0001-9697-3189; Florquin, Sandrine/0000-0002-9676-1722				Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Duymelinck C, 2000, KIDNEY INT, V58, P1186, DOI 10.1046/j.1523-1755.2000.00274.x; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; El-Achkar TM, 2006, NAT CLIN PRACT NEPHR, V2, P568, DOI 10.1038/ncpneph0300; Elass E, 2005, INFECT IMMUN, V73, P7064, DOI 10.1128/IAI.73.10.7064-7068.2005; Florquin S, 2002, AM J KIDNEY DIS, V39, P407, DOI 10.1053/ajkd.2002.30563; Gebbia JA, 2004, J INFECT DIS, V189, P113, DOI 10.1086/380414; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Hasan UA, 2005, J BIOL CHEM, V280, P20620, DOI 10.1074/jbc.M500877200; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Johnson GB, 2003, TRENDS IMMUNOL, V24, P19, DOI 10.1016/S1471-4906(02)00014-5; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kuroda M, 2004, CLIN NEPHROL, V61, P7; Lang A, 2005, J AM SOC NEPHROL, V16, P383, DOI 10.1681/ASN.2004040276; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; McCoy CE, 2008, FRONT BIOSCI-LANDMRK, V13, P62, DOI 10.2741/2660; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Mueller T, 2003, PEDIATR NEPHROL, V18, P97, DOI 10.1007/s00467-002-1037-5; Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; SEE WA, 2008, BJU INT; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Stokman G, 2008, NEPHROL DIAL TRANSPL, V23, P483, DOI 10.1093/ndt/gfm607; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Valles P, 2003, PEDIATR NEPHROL, V18, P527, DOI 10.1007/s00467-003-1096-2; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	54	96	104	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5704	10.1371/journal.pone.0005704	http://dx.doi.org/10.1371/journal.pone.0005704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479087	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415000015
J	Marsh, AA; Yu, HH; Schechter, JC; Blair, RJR				Marsh, Abigail A.; Yu, Henry H.; Schechter, Julia C.; Blair, R. J. R.			Larger than Life: Humans' Nonverbal Status Cues Alter Perceived Size	PLOS ONE			English	Article							BODY-SIZE; REPRODUCTIVE SUCCESS; TRAIT IMPRESSIONS; DOMINANCE RANK; HEIGHT; BEHAVIOR; GENDER; ASSOCIATION; EXPRESSION; EVOLUTION	Background: Social dominance and physical size are closely linked. Nonverbal dominance displays in many non-human species are known to increase the displayer's apparent size. Humans also employ a variety of nonverbal cues that increase apparent status, but it is not yet known whether these cues function via a similar mechanism: by increasing the displayer's apparent size. Methodology/Principal Finding: We generated stimuli in which actors displayed high status, neutral, or low status cues that were drawn from the findings of a recent meta-analysis. We then conducted four studies that indicated that nonverbal cues that increase apparent status do so by increasing the perceived size of the displayer. Experiment 1 demonstrated that nonverbal status cues affect perceivers' judgments of physical size. The results of Experiment 2 showed that altering simple perceptual cues can affect judgments of both size and perceived status. Experiment 3 used objective measurements to demonstrate that status cues change targets' apparent size in the two-dimensional plane visible to a perceiver, and Experiment 4 showed that changes in perceived size mediate changes in perceived status, and that the cue most associated with this phenomenon is postural openness. Conclusions/Significance: We conclude that nonverbal cues associated with social dominance also affect the perceived size of the displayer. This suggests that certain nonverbal dominance cues in humans may function as they do in other species: by creating the appearance of changes in physical size.			Marsh, AA (corresponding author), Georgetown Univ, Dept Psychol, Washington, DC 20057 USA.	aam72@georgetown.edu	Blair, Robert James/ABH-7982-2020	Blair, Robert James/0000-0002-6377-2361; Yu, Henry/0000-0003-3789-5250	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allen JM, 1997, COPEIA, P195, DOI 10.2307/1447858; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; CHANCE MRA, 1967, MAN, V2, P503, DOI 10.2307/2799336; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; de Waal Frans, 2005, OUR INNER APE; DEAUX K, 1984, J PERS SOC PSYCHOL, V46, P991, DOI 10.1037/0022-3514.46.5.991; DOVIDIO JF, 1988, J PERS SOC PSYCHOL, V54, P233, DOI 10.1037/0022-3514.54.2.233; Eibl-Eibesfeldt Irenaus, 1996, LOVE HATE NATURAL HI; EIBLEIBESFELDT I, 1961, SCI AM, V205, P112, DOI 10.1038/scientificamerican1261-112; French AR, 2005, BIOTROPICA, V37, P96, DOI 10.1111/j.1744-7429.2005.04051.x; FRIEZE IH, 1990, J APPL SOC PSYCHOL, V20, P46, DOI 10.1111/j.1559-1816.1990.tb00377.x; Gladwell M., 2005, BLINK POWER THINKING; Hall JA, 2005, PSYCHOL BULL, V131, P898, DOI 10.1037/0033-2909.131.6.898; Hall JA, 2001, SEX ROLES, V44, P677, DOI 10.1023/A:1012298230455; Harrington Fred H., 2003, P66; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; HIGHAM PA, 1992, CAN J BEHAV SCI, V24, P404, DOI 10.1037/h0078723; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Langkilde T, 2004, OECOLOGIA, V140, P684, DOI 10.1007/s00442-004-1640-1; Liaw Jim-Shih, 1993, Adaptive Behavior, V1, P227, DOI 10.1177/105971239300100301; Lorenz K., 1966, AGGRESSION; Mackey WC, 2003, SOC BIOL, V50, P42; Marsh AA, 2005, PERS SOC PSYCHOL B, V31, P73, DOI 10.1177/0146167204271306; Marsh AA, 2009, J COGNITIVE NEUROSCI, V21, P713, DOI 10.1162/jocn.2009.21052; Martin Robert D., 1994, P159; Mast MS, 2004, J NONVERBAL BEHAV, V28, P145, DOI 10.1023/B:JONB.0000039647.94190.21; MATHAI AM, 1999, STAT DISTRIBUT MOD A, V1, P1; MAZUR A, 1985, SOC FORCES, V64, P377; MONTEPARE JM, 1995, J NONVERBAL BEHAV, V19, P31, DOI 10.1007/BF02173411; Nedeljkovic A, 2009, INT J SPORTS MED, V30, P100, DOI 10.1055/s-2008-1038886; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Pierce CA, 1996, SOC BEHAV PERSONAL, V24, P143, DOI 10.2224/sbp.1996.24.2.143; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; RUMP EE, 1973, J PERS SOC PSYCHOL, V28, P343, DOI 10.1037/h0035117; SCHWARTZ B, 1982, SOC PSYCHOL QUART, V45, P114, DOI 10.2307/3033934; Silventoinen K, 2006, GENES BRAIN BEHAV, V5, P585, DOI 10.1111/j.1601-183X.2006.00208.x; SMITH DG, 1993, PRIMATES, V34, P471, DOI 10.1007/BF02382658; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; STECKEL RH, 1982, NBER WORK PAP SER, V880, P1; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; Tracy JL, 2008, P NATL ACAD SCI USA, V105, P11655, DOI 10.1073/pnas.0802686105; Tracy JL, 2004, PSYCHOL SCI, V15, P194, DOI 10.1111/j.0956-7976.2004.01503008.x; Van Dyk DA, 2008, BEHAV ECOL, V19, P895, DOI 10.1093/beheco/arn052; WILSON PR, 1968, J SOC PSYCHOL, V74, P97, DOI 10.1080/00224545.1968.9919806; Zebrowitz LA, 2003, PERS SOC PSYCHOL REV, V7, P194, DOI 10.1207/S15327957PSPR0703_01; Zebrowitz LA, 2007, PERS SOC PSYCHOL B, V33, P648, DOI 10.1177/0146167206297399	47	44	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5707	10.1371/journal.pone.0005707	http://dx.doi.org/10.1371/journal.pone.0005707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	450QD	19479082	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415000017
J	Pandey, KC; Barkan, DT; Sali, A; Rosenthal, PJ				Pandey, Kailash C.; Barkan, David T.; Sali, Andrej; Rosenthal, Philip J.			Regulatory Elements within the Prodomain of Falcipain-2, a Cysteine Protease of the Malaria Parasite Plasmodium falciparum	PLOS ONE			English	Article							STRUCTURAL BASIS; PROCATHEPSIN B; INHIBITION; HEMOGLOBIN; MOTIF; SUBSTRATE; BINDING; PEPTIDE	Falcipain-2, a papain family cysteine protease of the malaria parasite Plasmodium falciparum, plays a key role in parasite hydrolysis of hemoglobin and is a potential chemotherapeutic target. As with many proteases, falcipain-2 is synthesized as a zymogen, and the prodomain inhibits activity of the mature enzyme. To investigate the mechanism of regulation of falcipain-2 by its prodomain, we expressed constructs encoding different portions of the prodomain and tested their ability to inhibit recombinant mature falcipain-2. We identified a C-terminal segment (Leu(155)-Asp(243)) of the prodomain, including two motifs (ERFNIN and GNFD) that are conserved in cathepsin L sub-family papain family proteases, as the mediator of prodomain inhibitory activity. Circular dichroism analysis showed that the prodomain including the C-terminal segment, but not constructs lacking this segment, was rich in secondary structure, suggesting that the segment plays a crucial role in protein folding. The falcipain-2 prodomain also efficiently inhibited other papain family proteases, including cathepsin K, cathepsin L, cathepsin B, and cruzain, but it did not inhibit cathepsin C or tested proteases of other classes. A structural model of pro-falcipain-2 was constructed by homology modeling based on crystallographic structures of mature falcipain-2, procathepsin K, procathepsin L, and procaricain, offering insights into the nature of the interaction between the prodomain and mature domain of falcipain-2 as well as into the broad specificity of inhibitory activity of the falcipain-2 prodomain.			Pandey, KC (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	prosenthal@medsfgh.ucsf.edu	Pandey, Kailash/H-5048-2011		NIAID NIH HHS [R56 AI035800, P01 AI035707, R01 AI035800, R29 AI035800] Funding Source: Medline; NIGMS NIH HHS [R01 GM054762, P01 GM071790, R29 GM054762] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; Groves MR, 1998, PROTEINS, V32, P504, DOI 10.1002/(SICI)1097-0134(19980901)32:4<504::AID-PROT8>3.0.CO;2-F; Guay J, 2000, EUR J BIOCHEM, V267, P6311, DOI 10.1046/j.1432-1327.2000.01730.x; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Korde R, 2008, J MED CHEM, V51, P3116, DOI 10.1021/jm070735f; Kreusch S, 2000, EUR J BIOCHEM, V267, P2965; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; Pandey KC, 2006, PLOS PATHOG, V2, P1031, DOI 10.1371/journal.ppat.0020117; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Pandey KC, 2004, J BIOL CHEM, V279, P3484, DOI 10.1074/jbc.M310536200; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081	28	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5694	10.1371/journal.pone.0005694	http://dx.doi.org/10.1371/journal.pone.0005694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479029	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415000007
J	Robbins, G; Tripathy, VM; Misra, VN; Mohanty, RK; Shinde, VS; Gray, KM; Schug, MD				Robbins, Gwen; Tripathy, V. Mushrif; Misra, V. N.; Mohanty, R. K.; Shinde, V. S.; Gray, Kelsey M.; Schug, Malcolm D.			Ancient Skeletal Evidence for Leprosy in India (2000 BC)	PLOS ONE			English	Article							TUBERCULOSIS	Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae that affects almost 250,000 people worldwide. The timing of first infection, geographic origin, and pattern of transmission of the disease are still under investigation. Comparative genomics research has suggested M. leprae evolved either in East Africa or South Asia during the Late Pleistocene before spreading to Europe and the rest of the World. The earliest widely accepted evidence for leprosy is in Asian texts dated to 600 B.C. Methodology/Principal Findings: We report an analysis of pathological conditions in skeletal remains from the second millennium B. C. in India. A middle aged adult male skeleton demonstrates pathological changes in the rhinomaxillary region, degenerative joint disease, infectious involvement of the tibia (periostitis), and injury to the peripheral skeleton. The presence and patterning of lesions was subject to a process of differential diagnosis for leprosy including treponemal disease, leishmaniasis, tuberculosis, osteomyelitis, and non-specific infection. Conclusions/Significance: Results indicate that lepromatous leprosy was present in India by 2000 B. C. This evidence represents the oldest documented skeletal evidence for the disease. Our results indicate that Vedic burial traditions in cases of leprosy were present in northwest India prior to the first millennium B. C. Our results also support translations of early Vedic scriptures as the first textual reference to leprosy. The presence of leprosy in skeletal material dated to the post-urban phase of the Indus Age suggests that if M. leprae evolved in Africa, the disease migrated to India before the Late Holocene, possibly during the third millennium B. C. at a time when there was substantial interaction among the Indus Civilization, Mesopotamia, and Egypt. This evidence should be impetus to look for additional skeletal and molecular evidence of leprosy in India and Africa to confirm the African origin of the disease.			Robbins, G (corresponding author), Appalachian State Univ, Dept Anthropol, Boone, NC 28608 USA.	Robbinsgm@appstate.edu	SCHUG, GWEN ROBBINS/AAN-8980-2020	SCHUG, GWEN ROBBINS/0000-0002-3928-9230; Mushrif-Tripathy, Veena/0000-0002-4749-1316	NICHD NIH HHS [R15 HD057570, 1R15HD057570-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD057570] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andersen J.G., 1992, INT J OSTEOARCHAEOL, V2, P121, DOI [10.1002/oa.1390020204, DOI 10.1002/OA.1390020204]; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P293; Auferheide AC, 1998, CAMBRIDGE ENCY HUMAN; Belcastro M. G., 2005, INT J OSTEOARCHAEOL, V15, P16, DOI DOI 10.1002/0A.799; Blau S, 2005, AM J PHYS ANTHROPOL, V126, P150, DOI 10.1002/ajpa.20121; Bloomfield M., HYMNS ATHARVA VEDA; Brothwell D.R., 1981, DIGGING BONES EXCAVA; Bryant Edwin, 2004, QUEST ORIGINS VEDIC; Buikstra J. E., 1994, STANDARDS DATA COLLE; COOK D, 2002, PRESENT LEPROSY ARCH, P78; Cust R. N., 1881, PICTURES INDIAN LIFE; Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966; DZIERZYKRAYROGALSKI T, 1980, J HUM EVOL, V9, P71, DOI 10.1016/0047-2484(80)90044-5; Elliot-Smith G, 1924, EGYPTIAN MUMMIES; FARLEY M, 1989, MEDIEV ARCHAEOL, V32, P82, DOI DOI 10.1080/00766097.1989.11735520; Gibson S., 2002, ANCIENT BIOMOL, V4, P134; HULSE EV, 1972, LANCET, V2, P1024; Hutchinson J., 1906, LEPROSY FISH EATING; Jain M, 2003, CURR SCI INDIA, V84, P1048; JAIN M, 2000, THESIS U DELHI INDIA; Johansen PG, 2004, J ANTHROPOL ARCHAEOL, V23, P309, DOI 10.1016/j.jaa.2004.05.003; Judd MA, 1998, AM J PHYS ANTHROPOL, V105, P43, DOI 10.1002/(SICI)1096-8644(199801)105:1<43::AID-AJPA5>3.0.CO;2-E; KALE VS, 1987, NATURE, V325, P612, DOI 10.1038/325612a0; Likovsky J, 2006, J ARCHAEOL SCI, V33, P1276, DOI 10.1016/j.jas.2006.01.001; LUKACS JR, 1995, INT J OSTEOARCHAEOL, V5, P151, DOI 10.1002/oa.1390050207; Manchester, 2002, PRESENT LEPROSY ARCH; Manchester K., 2002, PAST PRESENT LEPROSY, V1054, P69; Marcsik Antonia, 2002, Acta Biologica Szegediensis, V46, P95; Mariotti V, 2005, INT J OSTEOARCHAEOL, V15, P311, DOI 10.1002/oa.775; MCKERN TW, 1957, SKELETAL AGE CHANGES, P179; MCLEOD KCD, 1981, HARVARD J ASIAT STUD, V41, P111, DOI 10.2307/2719003; Misra V. N., 2005, MAN ENV, V30, P54; Misra V.N., 1997, S ASIAN STUDIES, V13, P251; Moller-Christensen V., 1961, BONE CHANGES LEPROSY; MOLTO JE, 2002, PRESENT LEPROSY ARCH, P186; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; ORTNER D, 2002, PRESENT LEPROSY ARCH, P73; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Paddayya K., 2001, B DECCAN COLL POSTGR, V60-61, P189; Palfi G, 1991, INT J OSTEOARCHAEOL, V1, P99, DOI DOI 10.1002/0A.1390010205; Phadtare NR, 2000, QUATERNARY RES, V53, P122, DOI 10.1006/qres.1999.2108; Pinhasi R, 2006, SCIENCE, V312, P846; Possehl Gregory L., 2002, INDUS CIVILIZATION C; Rawcliffe C., 2006, LEPROSY MEDIEVAL ENG; ROBBINS G, 2007, MAN ENV, V31, P50; Roberts C.A., 2003, BIOARCHAEOLOGY TUBER; ROBERTS CA, INT SERIES 2002 BRIT, P213; Roberts CA, 1999, ARCHAEOLOGICAL REV C, V15, P79; Roberts Charlotte, 2005, ARCHAEOLOGY DIS; Roberts CA, 2007, AM J PHYS ANTHROPOL, V133, P792, DOI 10.1002/ajpa.20601; SHINDE V, 2000, B INDOPACIFIC PREHIS, V19, P115; Steele D.G., 1988, ANATOMY BIOL HUMAN S; Tayles N, 2004, AM J PHYS ANTHROPOL, V125, P239, DOI 10.1002/ajpa.10378; Taylor GM, 2000, J ARCHAEOL SCI, V27, P1133, DOI 10.1006/jasc.1999.0532; Ubelaker D.H., 1994, HUMAN SKELETAL REMAI; *WHO, 2005, CDS CPE CEE; ZIAS J, 2002, PRESENT LEPROSY ARCH, P259; Zysk Kenneth., 1992, RELIG MED HIST EVOLU	58	87	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5669	10.1371/journal.pone.0005669	http://dx.doi.org/10.1371/journal.pone.0005669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	450QD	19479078	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415000006
J	Wong, KKL; Kelso, RM; Worthley, SG; Sanders, P; Mazumdar, J; Abbott, D				Wong, Kelvin Kian Loong; Kelso, Richard Malcolm; Worthley, Stephen Grant; Sanders, Prashanthan; Mazumdar, Jagannath; Abbott, Derek			Noninvasive Cardiac Flow Assessment Using High Speed Magnetic Resonance Fluid Motion Tracking	PLOS ONE			English	Article							HEART	Cardiovascular diseases can be diagnosed by assessing abnormal flow behavior in the heart. We introduce, for the first time, a magnetic resonance imaging-based diagnostic that produces sectional flow maps of cardiac chambers, and presents cardiac analysis based on the flow information. Using steady-state free precession magnetic resonance images of blood, we demonstrate intensity contrast between asynchronous and synchronous proton spins. Turbulent blood flow in cardiac chambers contains asynchronous blood proton spins whose concentration affects the signal intensities that are registered onto the magnetic resonance images. Application of intensity flow tracking based on their non-uniform signal concentrations provides a flow field map of the blood motion. We verify this theory in a patient with an atrial septal defect whose chamber blood flow vortices vary in speed of rotation before and after septal occlusion. Based on the measurement of cardiac flow vorticity in our implementation, we establish a relationship between atrial vorticity and septal defect. The developed system has the potential to be used as a prognostic and investigative tool for assessment of cardiac abnormalities, and can be exploited in parallel to examining myocardial defects using steady-state free precession magnetic resonance images of the heart.			Wong, KKL (corresponding author), Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia.	kelvin.wong@adelaide.edu.au	Sanders, Prashanthan/D-7641-2013; Wong, Kelvin/AAL-8636-2021; Wong, Kelvin Kian Loong/ABA-3915-2021; Abbott, Derek/E-8352-2011	Sanders, Prashanthan/0000-0003-3803-8429; Wong, Kelvin Kian Loong/0000-0002-8600-1105; Abbott, Derek/0000-0002-0945-2674				Alsop D, 2007, United States Patent Application, Patent No. [US 2007/0132452 A1, 20070132452]; BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; BELLHOUSE BJ, 1969, NATURE, V224, P615, DOI 10.1038/224615a0; Bohrnstedt G.W., 1983, MEASUREMENT HDB SURV; Bouguet J.-Y., 2000, PYRAMIDAL IMPLEMENTA; BRANDT E, 2001, P INT SOC MAG RESON, V9, P1838; Chen MC, 2003, CHEST, V124, P1663, DOI 10.1378/chest.124.5.1663; Durongpisitkul K, 2004, PEDIATR CARDIOL, V25, P124, DOI 10.1007/s00246-003-0481-8; Edelman RR, 2004, RADIOLOGY, V232, P653, DOI 10.1148/radiol.2323031558; Eggers J, 1999, STROKE, V30, P1977, DOI 10.1161/01.STR.30.9.1974c; Fyrenius A, 2001, HEART, V86, P448, DOI 10.1136/heart.86.4.448; Gatehouse PD, 2005, EUR RADIOL, V15, P2172, DOI 10.1007/s00330-005-2829-3; Gladden LF, 1996, MEAS SCI TECHNOL, V7, P423, DOI 10.1088/0957-0233/7/3/026; GLADDEN LF, 1994, CHEM ENG SCI, V49, P3339, DOI 10.1016/0009-2509(94)00129-4; GLOBITS S, 1995, AM HEART J, V129, P369, DOI 10.1016/0002-8703(95)90020-9; HARTIALA JJ, 1993, AM HEART J, V125, P1054, DOI 10.1016/0002-8703(93)90114-O; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Kilner PJ, 2000, NATURE, V404, P759, DOI 10.1038/35008075; KILNER PJ, 1998, THESIS U LONDON; KUETHE DO, 1989, PHYS REV A, V40, P4542, DOI 10.1103/PhysRevA.40.4542; Lauerma K, 2000, RADIOLOGY, V217, P729, DOI 10.1148/radiology.217.3.r00dc18729; Malik M., 2004, DYNAMIC ELECTROCARDI; Markl M, 2007, J MAGN RESON IMAGING, V25, P824, DOI 10.1002/jmri.20871; Martinez E, 2007, AIDS REV, V9, P63; Plein S, 2001, J MAGN RESON IMAGING, V14, P230, DOI 10.1002/jmri.1178; Podrid PJ., 2001, CARDIAC ARRHYTHMIA M, V2; Potter M., 1997, MECH FLUIDS, Vsecond; Raffel M., 1998, EXP FLUID MECH; Rehwald WG, 2004, NAT MED, V10, P545, DOI 10.1038/nm1027; Ruhnau P, 2005, EXP FLUIDS, V38, P21, DOI 10.1007/s00348-004-0880-5; Shan K, 2004, CIRCULATION, V109, P1328, DOI 10.1161/01.CIR.0000120294.67948.E3; SMITH RL, 1972, J APPL PHYSIOL, V32, P261, DOI 10.1152/jappl.1972.32.2.261; STAHLBERG F, 1995, ACTA PAEDIATR, V84, P49, DOI 10.1111/j.1651-2227.1995.tb13844.x; STEIN PD, 1974, CIRC RES, V35, P608, DOI 10.1161/01.RES.35.4.608; Webb G, 2006, CIRCULATION, V114, P1645, DOI 10.1161/CIRCULATIONAHA.105.592055; Wong KKL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004747	36	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5688	10.1371/journal.pone.0005688	http://dx.doi.org/10.1371/journal.pone.0005688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479033	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331700015
J	Ramirez, O; Gigli, E; Bover, P; Alcover, JA; Bertranpetit, J; Castresana, J; Lalueza-Fox, C				Ramirez, Oscar; Gigli, Elena; Bover, Pere; Antoni Alcover, Josep; Bertranpetit, Jaume; Castresana, Jose; Lalueza-Fox, Carles			Paleogenomics in a Temperate Environment: Shotgun Sequencing from an Extinct Mediterranean Caprine	PLOS ONE			English	Article							MYOTRAGUS-BALEARICUS BATE; MITOCHONDRIAL GENOME; DNA-SEQUENCES; EVOLUTION; AMPLIFICATION; ARTIODACTYLA; ALIGNMENT	Background: Numerous endemic mammals, including dwarf elephants, goats, hippos and deers, evolved in isolation in the Mediterranean islands during the Pliocene and Pleistocene. Most of them subsequently became extinct during the Holocene. Recently developed high-throughput sequencing technologies could provide a unique tool for retrieving genomic data from these extinct species, making it possible to study their evolutionary history and the genetic bases underlying their particular, sometimes unique, adaptations. Methodology/Principals Findings: A DNA extraction of similar to 6,000 year-old bone sample from an extinct caprine (Myotragus balearicus) from the Balearic Islands in the Western Mediterranean, has been subjected to shotgun sequencing with the GS FLX 454 platform. Only 0.27% of the resulting sequences, identified from alignments with the cow genome and comprising 15,832 nucleotides, with an average length of 60 nucleotides, proved to be endogenous. Conclusions: A phylogenetic tree generated with Myotragus sequences and those from other artiodactyls displays an identical topology to that generated from mitochondrial DNA data. Despite being in an unfavourable thermal environment, which explains the low yield of endogenous sequences, our study demonstrates that it is possible to obtain genomic data from extinct species from temperate regions.	[Ramirez, Oscar; Gigli, Elena; Bertranpetit, Jaume; Castresana, Jose; Lalueza-Fox, Carles] UPF, CSIC, Inst Evolutionary Biol, Barcelona, Spain; [Bover, Pere; Antoni Alcover, Josep] CSIC UIB, Inst Mediterrani Estudis Avancats, Esporles, Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Lalueza-Fox, C (corresponding author), UPF, CSIC, Inst Evolutionary Biol, Barcelona, Spain.	carles.lalueza@upf.edu	LALUEZA-FOX, CARLES/AAG-5341-2020; Castresana, Jose/K-3437-2014; Ramirez, Oscar/E-7293-2012; Bertranpetit, Jaume/F-8550-2012; Alcover, Josep Antoni/Y-3796-2018	LALUEZA-FOX, CARLES/0000-0002-1730-5914; Castresana, Jose/0000-0002-9391-8050; Ramirez, Oscar/0000-0001-5164-6790; Bertranpetit, Jaume/0000-0003-0100-0590; Bover Arbos, Pedro/0000-0003-2942-2840; Alcover, Josep Antoni/0000-0001-9905-2588				Alcover J. A., 1981, QUIMERES PASSAT ELS; Alcover JA, 2008, J WORLD PREHIST, V21, P19, DOI 10.1007/s10963-008-9010-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews CW, 1915, PHILOS T R SOC LON B, V206, P281, DOI 10.1098/rstb.1915.0006; Bate D. M. A., 1909, GEOL MAG, V543, P385, DOI [10.1017/S0016756800124665, DOI 10.1017/S0016756800124665]; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Bover P, 1999, BIOL J LINN SOC, V68, P401; Bover P, 2003, J BIOGEOGR, V30, P771, DOI 10.1046/j.1365-2699.2003.00872.x; Bover P, 2008, QUATERN INT, V182, P135, DOI 10.1016/j.quaint.2007.06.039; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Encinas Jose Antonio, 1997, Endins, V21, P83; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2005, J ARCHAEOL SCI, V32, P785, DOI 10.1016/j.jas.2004.12.008; GILBERT MTP, 2008, NEXT GENERATION GENO, P183; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hassanin A, 1999, MOL PHYLOGENET EVOL, V13, P227, DOI 10.1006/mpev.1999.0619; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hofreiter M, 2008, CR PALEVOL, V7, P113, DOI 10.1016/j.crpv.2007.12.005; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kohler M, 2004, BRAIN BEHAV EVOLUT, V63, P125, DOI 10.1159/000076239; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Lalueza-Fox C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-70; Lalueza-Fox C, 2002, MOL PHYLOGENET EVOL, V25, P501, DOI 10.1016/S1055-7903(02)00290-7; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; LALUEZAFOX C, 2008, J EXP ZOOL PART B, V288, P56; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; POINAR HN, 2006, DNA SCI, V311, P392; RAMIS D, 2005, P INT S INS VERT EV, P309; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; SPOOR CF, 1988, P K NED AKAD B PHYS, V91, P285; SPOOR CF, 1988, P K NED AKAD B PHYS, V91, P295; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175	45	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5670	10.1371/journal.pone.0005670	http://dx.doi.org/10.1371/journal.pone.0005670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	449LD	19461892	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331200007
J	Correia, DV; d'Orey, F; Cardoso, BA; Lanca, T; Grosso, AR; deBarros, A; Martins, LR; Barata, JT; Silva-Santos, B				Correia, Daniel V.; d'Orey, Francisco; Cardoso, Bruno A.; Lanca, Telma; Grosso, Ana R.; deBarros, Ana; Martins, Leila R.; Barata, Joao T.; Silva-Santos, Bruno			Highly Active Microbial Phosphoantigen Induces Rapid yet Sustained MEK/Erk- and PI-3K/Akt-Mediated Signal Transduction in Anti-Tumor Human gamma delta T-Cells	PLOS ONE			English	Article								Background: The unique responsiveness of V gamma 9V delta 2 T-cells, the major gamma delta subset of human peripheral blood, to non-peptidic prenyl pyrophosphate antigens constitutes the basis of current gamma delta T-cell-based cancer immunotherapy strategies. However, the molecular mechanisms responsible for phosphoantigen-mediated activation of human gamma delta T-cells remain unclear. In particular, previous reports have described a very slow kinetics of activation of T-cell receptor (TCR)-associated signal transduction pathways by isopentenyl pyrophosphate and bromohydrin pyrophosphate, seemingly incompatible with direct binding of these antigens to the V gamma 9V delta 2 TCR. Here we have studied the most potent natural phosphoantigen yet identified, (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP), produced by Eubacteria and Protozoa, and examined its gamma delta T-cell activation and anti-tumor properties. Methodology/Principal Findings: We have performed a comparative study between HMB-PP and the anti-CD3 epsilon monoclonal antibody OKT3, used as a reference inducer of bona fide TCR signaling, and followed multiple cellular and molecular gamma delta T-cell activation events. We show that HMB-PP activates MEK/Erk and PI-3K/Akt pathways as rapidly as OKT3, and induces an almost identical transcriptional profile in V gamma 9(+) T-cells. Moreover, MEK/Erk and PI-3K/Akt activities are indispensable for the cellular effects of HMB-PP, including gamma delta T-cell activation, proliferation and anti-tumor cytotoxicity, which are also abolished upon antibody blockade of the V gamma 9(+) TCR Surprisingly, HMB-PP treatment does not induce down-modulation of surface TCR levels, and thereby sustains gamma delta T-cell activation upon re-stimulation. This ultimately translates in potent human gamma delta T-cell anti-tumor function both in vitro and in vivo upon transplantation of human leukemia cells into lymphopenic mice, Conclusions/Significance: The development of efficient cancer immunotherapy strategies critically depends on our capacity to maximize anti-tumor effector T-cell responses. By characterizing the intracellular mechanisms of HMB-PP-mediated activation of the highly cytotoxic V gamma 9(+) T-cell subset, our data strongly support the usage of this microbial antigen in novel cancer clinical trials.			Correia, DV (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Mol Immunol Unit, P-1699 Lisbon, Portugal.	bsilvasantos@gmail.com	Barata, João T./D-9181-2015; Grosso, Ana Rita/I-6656-2013	Barata, João T./0000-0002-4826-8976; Grosso, Ana Rita/0000-0001-6974-4209; Correia, Daniel/0000-0002-0784-0307; Cardoso, Bruno/0000-0002-6521-7257; de Barros, Ana/0000-0002-6493-4676; Silva-Santos, Bruno/0000-0003-4141-9302; Martins, Leila/0000-0002-5887-4734				Ali Z, 2007, J IMMUNOL, V179, P8287, DOI 10.4049/jimmunol.179.12.8287; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Bukowski JF, 1998, J IMMUNOL, V161, P286; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Casetti R, 2005, J IMMUNOL, V175, P1593, DOI 10.4049/jimmunol.175.3.1593; Chen Y, 2008, BLOOD, V111, P4220, DOI 10.1182/blood-2007-07-101691; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Corvaisier M, 2005, J IMMUNOL, V175, P5481, DOI 10.4049/jimmunol.175.8.5481; Devilder MC, 2006, J IMMUNOL, V176, P1386, DOI 10.4049/jimmunol.176.3.1386; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dietrich J, 2002, J IMMUNOL, V168, P5434, DOI 10.4049/jimmunol.168.11.5434; Eberl M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000308; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Gomes AQ, 2007, EMBO REP, V8, P1024, DOI 10.1038/sj.embor.7401090; Ismaili J, 2002, CLIN IMMUNOL, V103, P296, DOI 10.1006/clim.2002.5218; Kabelitz D, 2004, J IMMUNOL, V173, P6767, DOI 10.4049/jimmunol.173.11.6767; Kunzmann V, 2005, LEUKEMIA LYMPHOMA, V46, P671, DOI 10.1080/10428190500051893; Lafont V, 2001, J BIOL CHEM, V276, P15961, DOI 10.1074/jbc.M008684200; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Pennington DJ, 2005, ADV IMMUNOL, V87, P27, DOI 10.1016/S0065-2776(05)87002-6; Shu ST, 2007, CANCER RES, V67, P11859, DOI 10.1158/0008-5472.CAN-07-1701; Sireci G, 2001, EUR J IMMUNOL, V31, P1628, DOI 10.1002/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T; Stagg J, 2007, IMMUNOL REV, V220, P82, DOI 10.1111/j.1600-065X.2007.00566.x; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Yamashita S, 2005, BIOCHEM BIOPH RES CO, V334, P349, DOI 10.1016/j.bbrc.2005.06.100	33	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5657	10.1371/journal.pone.0005657	http://dx.doi.org/10.1371/journal.pone.0005657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19479075	gold, Green Published, Green Submitted			2022-12-27	WOS:000266331000015
J	Schyns, PG; Petro, LS; Smith, ML				Schyns, Philippe G.; Petro, Lucy S.; Smith, Marie L.			Transmission of Facial Expressions of Emotion Co-Evolved with Their Efficient Decoding in the Brain: Behavioral and Brain Evidence	PLOS ONE			English	Article							VISUAL RECOGNITION; SPATIAL SCALES; ERP EVIDENCE; FACE; INFORMATION; AMYGDALA; PERCEPTION; RESPONSES; OBJECTS; DISCRIMINATION	Competent social organisms will read the social signals of their peers. In primates, the face has evolved to transmit the organism's internal emotional state. Adaptive action suggests that the brain of the receiver has co-evolved to efficiently decode expression signals. Here, we review and integrate the evidence for this hypothesis. With a computational approach, we co-examined facial expressions as signals for data transmission and the brain as receiver and decoder of these signals. First, we show in a model observer that facial expressions form a lowly correlated signal set. Second, using time-resolved EEG data, we show how the brain uses spatial frequency information impinging on the retina to decorrelate expression categories. Between 140 to 200 ms following stimulus onset, independently in the left and right hemispheres, an information processing mechanism starts locally with encoding the eye, irrespective of expression, followed by a zooming out to processing the entire face, followed by a zooming back in to diagnostic features (e.g. the opened eyes in "fear'', the mouth in "happy''). A model categorizer demonstrates that at 200 ms, the left and right brain have represented enough information to predict behavioral categorization performance.			Schyns, PG (corresponding author), Univ Glasgow, CCNi, Glasgow, Lanark, Scotland.	philippe@psy.gla.ac.uk	Smith, Marie/N-8491-2013; Schyns, Philippe/C-8127-2009; Schyns, Philippe/AAT-6989-2020	Schyns, Philippe/0000-0002-8542-7489; Petro, Lucy/0000-0002-8255-5776	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 1996, J NEUROSCI, V16, P7678; BACKUS GE, 1967, GEOPHYS J ROY ASTR S, V13, P247, DOI 10.1111/j.1365-246X.1967.tb02159.x; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BARLOW H, 1989, COMP NEUR S, P54; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 2007, NAT NEUROSCI, V10, P801, DOI 10.1038/nn0707-801; BERSON DM, 1988, PROG BRAIN RES, V75, P17; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bonnar L, 2002, PERCEPTION, V31, P683, DOI 10.1068/p3276; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Dailey M., 2001, CALIFORNIA FAC UNPUB; Dailey MN, 1999, NEURAL NETWORKS, V12, P1053, DOI 10.1016/S0893-6080(99)00050-7; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davidson RJ, 2004, P NATL ACAD SCI USA, V101, P11915, DOI 10.1073/pnas.0404264101; de Haan M, 1998, DEV NEUROPSYCHOL, V14, P495, DOI 10.1080/87565649809540725; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 2003, UNMASKING FACE GUIDE; Ekman P., 2002, FACIAL ACTION CODING; Ekman P., 1999, HDB COGN EMOT, V98, P16; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Gerson AD, 2005, NEUROIMAGE, V28, P342, DOI 10.1016/j.neuroimage.2005.06.026; Goffaux V, 2003, COGNITIVE BRAIN RES, V16, P416, DOI 10.1016/S0926-6410(03)00056-9; Goffaux V, 2003, COGNITIVE SCI, V27, P313, DOI 10.1016/S0364-0213(03)00002-8; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gosselin F, 2002, TRENDS COGN SCI, V6, P70, DOI 10.1016/S1364-6613(00)01838-6; HARMON LD, 1973, SCI AM, V229, P70, DOI 10.1038/scientificamerican1173-70; HARMON LD, 1973, SCIENCE, V180, P1194, DOI 10.1126/science.180.4091.1194; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEDOUX JE, 1985, J COMP NEUROL, V242, P182, DOI 10.1002/cne.902420204; LEVENTHAL AG, 1985, J COMP NEUROL, V237, P216, DOI 10.1002/cne.902370206; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Morrison DJ, 2001, PSYCHON B REV, V8, P454, DOI 10.3758/BF03196180; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Ohman A., 1992, HDB EMOTIONS, P511; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725, DOI 10.1001/archneurpsyc.1937.02260220069003; Pizzagalli D, 1999, NEUROREPORT, V10, P2691, DOI 10.1097/00001756-199909090-00001; ROLLS ET, 1999, BRAIN EMOTION; Rousselet GA, 2004, TRENDS COGN SCI, V8, P363, DOI 10.1016/j.tics.2004.06.003; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Schyns PG, 1998, COGNITION, V67, P147, DOI 10.1016/S0010-0277(98)00016-X; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Schyns PG, 2003, NEUROREPORT, V14, P1665, DOI 10.1097/00001756-200309150-00002; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; SMITH F, 2009, PSYCHOL SCI IN PRESS; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Smith ML, 2006, P NATL ACAD SCI USA, V103, P5626, DOI 10.1073/pnas.0508972103; Sowden PT, 2006, TRENDS COGN SCI, V10, P538, DOI 10.1016/j.tics.2006.10.007; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Taylor MJ, 2001, NEUROREPORT, V12, P1671, DOI 10.1097/00001756-200106130-00031; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; Ullman S., 1996, HIGH LEVEL VISION OB; VANRIJSBERGEN N, 2009, DYNAMICS REPRE UNPUB; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Whalen PJ, 1998, J NEUROSCI, V18, P411; Winston JS, 2003, CURR BIOL, V13, P1824, DOI 10.1016/j.cub.2003.09.038	65	81	83	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5625	10.1371/journal.pone.0005625	http://dx.doi.org/10.1371/journal.pone.0005625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448AY	19462006	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000266234700012
J	Bondareva, A; Downey, CM; Ayres, F; Liu, W; Boyd, SK; Hallgrimsson, B; Jirik, FR				Bondareva, Alla; Downey, Charlene M.; Ayres, Fabio; Liu, Wei; Boyd, Steven K.; Hallgrimsson, Benedikt; Jirik, Frank R.			The Lysyl Oxidase Inhibitor, beta-Aminopropionitrile, Diminishes the Metastatic Colonization Potential of Circulating Breast Cancer Cells	PLOS ONE			English	Article								Lysyl oxidase (LOX), an extracellular matrix remodeling enzyme, appears to have a role in promoting breast cancer cell motility and invasiveness. In addition, increased LOX expression has been correlated with decreases in both metastases-free, and overall survival in breast cancer patients. With this background, we studied the ability of beta-aminopropionitrile (BAPN), an irreversible inhibitor of LOX, to regulate the metastatic colonization potential of the human breast cancer cell line, MDA-MB-231. BAPN was administered daily to mice starting either 1 day prior, on the same day as, or 7 days after intracardiac injection of luciferase expressing MDA-MB-231-Luc2 cells. Development of metastases was monitored by in vivo bioluminescence imaging, and tumor-induced osteolysis was assessed by micro-computed tomography (mu CT). We found that BAPN administration was able to reduce the frequency of metastases. Thus, when BAPN treatment was initiated the day before, or on the same day as the intra-cardiac injection of tumor cells, the number of metastases was decreased by 44%, and 27%, and whole-body photon emission rates (reflective of total tumor burden) were diminished by 78%, and 45%, respectively. In contrast, BAPN had no effect on the growth of established metastases. Our findings suggest that LOX activity is required during extravasation and/or initial tissue colonization by circulating MDA-MB-231 cells, lending support to the idea that LOX inhibition might be useful in metastasis prevention.			Bondareva, A (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	jirik@ucalgary.ca	Boyd, Steven K/E-9595-2010; Hallgrimsson, Benedikt/A-9616-2008	Boyd, Steven K/0000-0002-2930-5997; Hallgrimsson, Benedikt/0000-0002-7192-9103				AMER MH, 1982, J SURG ONCOL, V19, P101, DOI 10.1002/jso.2930190212; Ben Mahdi MH, 2000, IUBMB LIFE, V50, P291, DOI 10.1080/15216540051081038; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Carbajal JM, 1998, BIOCHEM BIOPH RES CO, V249, P461, DOI 10.1006/bbrc.1998.9172; CASEY T, 2008, BREAST CANC RES TREA; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Choy A, 1996, BRIT J CANCER, V73, P79, DOI 10.1038/bjc.1996.14; Cowey S, 2007, CLIN EXP METASTAS, V24, P389, DOI 10.1007/s10585-007-9076-8; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Di Donato A, 1997, FEBS LETT, V419, P63, DOI 10.1016/S0014-5793(97)01420-8; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; Earley S, 2008, BIOCHEM BIOPH RES CO, V366, P476, DOI 10.1016/j.bbrc.2007.11.181; Erler JT, 2006, CANCER RES, V66, P10238, DOI 10.1158/0008-5472.CAN-06-3197; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Galan M, 2002, ANTICANCER RES, V22, P2877; Giampuzzi M, 2000, J BIOL CHEM, V275, P36341, DOI 10.1074/jbc.M003362200; Giampuzzi M, 2003, BBA-PROTEINS PROTEOM, V1647, P239, DOI 10.1016/S1570-9639(03)00058-X; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1940, DOI 10.1152/ajpcell.2001.281.6.C1940; Kirschmann DA, 1999, BREAST CANCER RES TR, V55, P127; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Lazarus HM, 1995, MATRIX BIOL, V14, P727, DOI 10.1016/S0945-053X(05)80015-0; Lee KC, 2007, CLIN CANCER RES, V13, P1839, DOI 10.1158/1078-0432.CCR-06-1657; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; LEVENE CI, 1989, BRIT J EXP PATHOL, V70, P621; Li WD, 2000, J CELL BIOCHEM, V78, P550, DOI 10.1002/1097-4644(20000915)78:4<550::AID-JCB4>3.3.CO;2-#; Li XM, 2002, CLIN EXP METASTAS, V19, P347, DOI 10.1023/A:1015510207431; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Manders K, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-179; MELLO MLS, 1995, EXP CELL RES, V220, P374, DOI 10.1006/excr.1995.1328; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Morris VL, 1997, INVAS METAST, V17, P281; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Naumov GN, 1999, J CELL SCI, V112, P1835; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Phadke PA, 2006, CLIN CANCER RES, V12, P1431, DOI 10.1158/1078-0432.CCR-05-1806; Postovit LM, 2008, J CELL BIOCHEM, V103, P1369, DOI 10.1002/jcb.21517; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Schluter K, 2006, AM J PATHOL, V169, P1064, DOI 10.2353/ajpath.2006.050566; Usatyuk PV, 2005, AM J PHYSIOL-LUNG C, V289, pL999, DOI 10.1152/ajplung.00211.2005; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wu M, 2007, CELLS TISSUES ORGANS, V185, P100, DOI 10.1159/000101309; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	59	110	115	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5620	10.1371/journal.pone.0005620	http://dx.doi.org/10.1371/journal.pone.0005620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440335	gold, Green Submitted, Green Published			2022-12-27	WOS:000266161200020
J	Ahrne, K; Bengtsson, J; Elmqvist, T				Ahrne, Karin; Bengtsson, Jan; Elmqvist, Thomas			Bumble Bees (Bombus spp) along a Gradient of Increasing Urbanization	PLOS ONE			English	Article							FORAGING RANGE; LANDSCAPE CONTEXT; CROP POLLINATION; HYMENOPTERA; CONSERVATION; DECLINES; RARITY; SCALE; COMMUNITIES; CONSTANCY	Background: Bumble bees and other wild bees are important pollinators of wild flowers and several cultivated crop plants, and have declined in diversity and abundance during the last decades. The main cause of the decline is believed to be habitat destruction and fragmentation associated with urbanization and agricultural intensification. Urbanization is a process that involves dramatic and persistent changes of the landscape, increasing the amount of built-up areas while decreasing the amount of green areas. However, urban green areas can also provide suitable alternative habitats for wild bees. Methodology/Principal Findings: We studied bumble bees in allotment gardens, i.e. intensively managed flower rich green areas, along a gradient of urbanization from the inner city of Stockholm towards more rural (periurban) areas. Keeping habitat quality similar along the urbanization gradient allowed us to separate the effect of landscape change (e.g. proportion impervious surface) from variation in habitat quality. Bumble bee diversity (after rarefaction to 25 individuals) decreased with increasing urbanization, from around eight species on sites in more rural areas to between five and six species in urban allotment gardens. Bumble bee abundance and species composition were most affected by qualities related to the management of the allotment areas, such as local flower abundance. The variability in bumble bee visits between allotment gardens was higher in an urban than in a periurban context, particularly among small and long-tongued bumble bee species. Conclusions/Significance: Our results suggest that allotment gardens and other urban green areas can serve as important alternatives to natural habitats for many bumble bee species, but that the surrounding urban landscape influences how many species that will be present. The higher variability in abundance of certain species in the most urban areas may indicate a weaker reliability of the ecosystem service pollination in areas strongly influenced by human activity.			Ahrne, K (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	karin.ahrne@ekol.slu.se	Bengtsson, Jan/AAF-2325-2021; Elmqvist, Thomas/AAY-6344-2021	Elmqvist, Thomas/0000-0002-4617-6197				Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Andersson E, 2007, ECOL APPL, V17, P1267, DOI 10.1890/06-1116.1; Benton T., 2006, BUMBLEBEES NATURAL H; Bhattacharya M, 2003, BIOL CONSERV, V109, P37, DOI 10.1016/S0006-3207(02)00130-1; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Buchmann SL, 1996, FORGOTTEN POLLINATOR; CANE JH, 2001, CONSERV ECOL, V0005; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Darvill B, 2004, OIKOS, V107, P471, DOI 10.1111/j.0030-1299.2004.13510.x; Dramstad WE, 2003, AGR ECOSYST ENVIRON, V95, P349, DOI 10.1016/S0167-8809(02)00043-9; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; FUSSELL M, 1992, J APPL ECOL, V29, P451, DOI 10.2307/2404513; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Gotelli NJ, 2006, ECOSIM NULL MODELS S; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; GOULSON D, 2003, BUMBLE BEES BEHAV EC; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; HEINRICH B, 1976, ECOLOGY, V57, P874, DOI 10.2307/1941054; Heinrich B., 1979, BUMBLEBEE EC; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kells AR, 2001, J INSECT CONSERV, V5, P283, DOI 10.1023/A:1013307822575; Kells AR, 2003, BIOL CONSERV, V109, P165, DOI 10.1016/S0006-3207(02)00131-3; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; Lewontin RC, 1966, SYST ZOOL, V15, P141, DOI DOI 10.2307/2411632; LOKEN A, 1973, NORSK ENTOMOL TIDSSK, V20, P1; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MANSSON L, 2002, PERENNER DIN TRADGAR; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2001, AGR ECOSYST ENVIRON, V83, P129, DOI 10.1016/S0167-8809(00)00262-0; RANTA E, 1981, OIKOS, V36, P28, DOI 10.2307/3544375; RISBERG J, 2004, THESIS SWEDISH U AGR; Saure Christoph, 1996, Linnean Society Symposium Series, V18, P47; Saville NM, 1997, AGR ECOSYST ENVIRON, V61, P145, DOI 10.1016/S0167-8809(96)01100-0; *SCB, 2006, STAT YB SWED STAT SW; SOKAL RR, 1980, SYST ZOOL, V29, P50, DOI 10.2307/2412626; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Stenberg L., 1992, NORDISKA FLORAN; Svensson B, 2000, AGR ECOSYST ENVIRON, V77, P247, DOI 10.1016/S0167-8809(99)00106-1; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tommasi D, 2004, CAN ENTOMOL, V136, P851; Walther-Hellwig K, 2000, J INSECT BEHAV, V13, P239, DOI 10.1023/A:1007740315207; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Williams P, 2005, BIOL CONSERV, V122, P33, DOI 10.1016/j.biocon.2004.06.019; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003	56	187	198	5	266	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5574	10.1371/journal.pone.0005574	http://dx.doi.org/10.1371/journal.pone.0005574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440367	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107400016
J	Chan, LK; Ko, FCF; Ng, IOL; Yam, JWP				Chan, Lo-Kong; Ko, Frankie Chi Fat; Ng, Irene Oi-Lin; Yam, Judy Wai Ping			Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function	PLOS ONE			English	Article								Background: Deleted in liver cancer 1 (DLC1) is a Rho GTPase-activating protein (RhoGAP) frequently deleted and underexpressed in hepatocellular carcinoma (HCC) as well as in other cancers. Recent independent studies have shown interaction of DLC1 with members of the tensin focal adhesion protein family in a Src Homology 2 (SH2) domain-dependent mechanism. DLC1 and tensins interact and co-localize to punctate structures at focal adhesions. However, the mechanisms underlying the interaction between DLC1 and various tensins remain controversial. Methodology/Principal Findings: We used a co-immunoprecipitation assay to identify a previously undocumented binding site at 375-385 of DLC1 that predominantly interacted with the phosphotyrosine binding (PTB) domain of tensin2. DLC1-tensin2 interaction is completely abolished in a DLC1 mutant lacking this novel PTB binding site (DLC1 Delta PTB). However, as demonstrated by immunofluorescence and co-immunoprecipitation, neither the focal adhesion localization nor the interaction with tensin1 and C-terminal tensin-like (cten) were affected. Interestingly, the functional significance of this novel site was exhibited by the partial reduction of the RhoGAP activity, which, in turn, attenuated the growth-suppressive activity of DLC1 upon its removal from DLC1. Conclusions/Significance: This study has provided new evidence that DLC1 also interacts with tensin2 in a PTB domain-dependent manner. In addition to properly localizing focal adhesions and preserving RhoGAP activity, DLC1 interaction with tensin2 through this novel focal adhesion binding site contributes to the growth-suppressive activity of DLC1.			Chan, LK (corresponding author), Univ Hong Kong, Dept Pathol, Liver Canc & Hepatitis Res Lab, Pokfulam, Hong Kong, Peoples R China.	judyyam@pathology.hku.hk	Kong, Chan Lo/AAI-9300-2020; Ko, Frankie Chi Fat/C-4759-2009; Yam, Judy Wai Ping/C-4454-2009	Kong, Chan Lo/0000-0003-3082-1013; Ko, Frankie Chi Fat/0000-0002-0393-9668; Yam, Judy Wai Ping/0000-0002-5637-121X; Ng, Irene Oi-lin/0000-0001-7532-2029				Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Hers I, 2006, J BIOL CHEM, V281, P4762, DOI 10.1074/jbc.M511008200; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2003, BJU INT, V91, P234, DOI 10.1046/j.1464-410X.2003.03063.x; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Kim TY, 2003, ONCOGENE, V22, P3943, DOI 10.1038/sj.onc.1206573; KIM TY, 2008, J BIOL CHEM; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Liao YC, 2008, CANCER RES, V68, P7718, DOI 10.1158/0008-5472.CAN-08-2042; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Ng IOL, 2000, CANCER RES, V60, P6581; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Peng D, 2006, ACTA BIOCH BIOPH SIN, V38, P349, DOI 10.1111/j.1745-7270.2006.00164.x; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Ying JM, 2007, EPIGENETICS-US, V2, P15, DOI 10.4161/epi.2.1.3883; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhang Q, 2007, CANCER LETT, V249, P220, DOI 10.1016/j.canlet.2006.08.019; Zhou X, 2008, INT J ONCOL, V32, P1285; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	43	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5572	10.1371/journal.pone.0005572	http://dx.doi.org/10.1371/journal.pone.0005572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440389	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107400015
J	Dong, SM; Qutob, D; Tedman-Jones, J; Kuflu, K; Wang, YC; Tyler, BM; Gijzen, M				Dong, Suomeng; Qutob, Dinah; Tedman-Jones, Jennifer; Kuflu, Kuflom; Wang, Yuanchao; Tyler, Brett M.; Gijzen, Mark			The Phytophthora sojae Avirulence Locus Avr3c Encodes a Multi-Copy RXLR Effector with Sequence Polymorphisms among Pathogen Strains	PLOS ONE			English	Article								Root and stem rot disease of soybean is caused by the oomycete Phytophthora sojae. The avirulence (Avr) genes of P. sojae control race-cultivar compatibility. In this study, we identify the P. sojae Avr3c gene and show that it encodes a predicted RXLR effector protein of 220 amino acids. Sequence and transcriptional data were compared for predicted RXLR effectors occurring in the vicinity of Avr4/6, as genetic linkage of Avr3c and Avr4/6 was previously suggested. Mapping of DNA markers in a F(2) population was performed to determine whether selected RXLR effector genes co-segregate with the Avr3c phenotype. The results pointed to one RXLR candidate gene as likely to encode Avr3c. This was verified by testing selected genes by a co-bombardment assay on soybean plants with Rps3c, thus demonstrating functionality and confirming the identity of Avr3c. The Avr3c gene together with eight other predicted genes are part of a repetitive segment of 33.7 kb. Three near-identical copies of this segment occur in a tandem array. In P. sojae strain P6497, two identical copies of Avr3c occur within the repeated segments whereas the third copy of this RXLR effector has diverged in sequence. The Avr3c gene is expressed during the early stages of infection in all P. sojae strains examined. Virulent alleles of Avr3c that differ in amino acid sequence were identified in other strains of P. sojae. Gain of virulence was acquired through mutation and subsequent sequence exchanges between the two copies of Avr3c. The results illustrate the importance of segmental duplications and RXLR effector evolution in the control of race-cultivar compatibility in the P. sojae and soybean interaction.			Dong, SM (corresponding author), Agr & Agri Food Canada, London, ON, Canada.	mark.gijzen@agr.gc.ca	Gijzen, Mark/C-6284-2011; wang, yuanchao/G-9667-2011	Gijzen, Mark/0000-0002-3715-6389; wang, yuanchao/0000-0001-5803-5343				Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bhattacharyya MK, 2005, THEOR APPL GENET, V111, P75, DOI 10.1007/s00122-005-1993-9; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Gao H, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-29; Gijzen M, 1996, CAN J BOT, V74, P800, DOI 10.1139/b96-100; Govers F, 2006, MOL PLANT MICROBE IN, V19, P1295, DOI 10.1094/MPMI-19-1295; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jiang RHY, 2006, GENOME RES, V16, P827, DOI 10.1101/gr.5193806; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; MacGregor T, 2002, GENETICS, V160, P949; May KJ, 2002, FUNGAL GENET BIOL, V37, P1, DOI 10.1016/S1087-1845(02)00027-0; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Qutob D, 2000, PLANT PHYSIOL, V123, P243, DOI 10.1104/pp.123.1.243; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Qutob D, 2006, PLANT CELL, V18, P3721, DOI 10.1105/tpc.106.044180; Qutob D, 2006, TRENDS MICROBIOL, V14, P470, DOI 10.1016/j.tim.2006.09.004; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Torto-Alalibo TA, 2007, MOL PLANT MICROBE IN, V20, P781, DOI 10.1094/MPMI-20-7-0781; TYLER BM, 1995, MOL PLANT MICROBE IN, V8, P515, DOI 10.1094/MPMI-8-0515; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van der Lee T, 2001, GENETICS, V157, P949; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; WARD EWB, 1979, PHYTOPATHOLOGY, V69, P951, DOI 10.1094/Phyto-69-951; WHISSON SC, 1994, CURR GENET, V27, P77, DOI 10.1007/BF00326582; Whisson SC, 2004, FUNGAL GENET BIOL, V41, P62, DOI 10.1016/j.fgb.2003.08.007; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037	39	75	82	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5556	10.1371/journal.pone.0005556	http://dx.doi.org/10.1371/journal.pone.0005556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440541	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107400002
J	Duan, WR; Gao, L; Wu, X; Hade, EM; Gao, JX; Ding, HM; Barsky, SH; Otterson, GA; Villalona-Calero, MA				Duan, Wenrui; Gao, Li; Wu, Xin; Hade, Erinn M.; Gao, Jian-Xin; Ding, Haiming; Barsky, Sanford H.; Otterson, Gregory A.; Villalona-Calero, Miguel A.			Expression of a Mutant p53 Results in an Age-Related Demographic Shift in Spontaneous Lung Tumor Formation in Transgenic Mice	PLOS ONE			English	Article								Background: Mutations in the P53 gene are among the most common genetic abnormalities in human lung cancer. Codon 273 in the sequence-specific DNA binding domain is one of the most frequently mutated sites. Methodology: To investigate the role of mutant p53 in lung tumorigenesis, a lung specific p53(273H) transgenic mouse model was developed. Rates of lung cancer formation in the transgenic animals and their littermates were evaluated by necropsy studies performed in progressive age cohorts ranging from 4 to 24 months. In order to establish the influence of other common genetic abnormalities in lung tumor formation in the animals, K-Ras gene mutation and p16INK4a (p16) promoter methylation were evaluated in a total of 281 transgenic mice and 189 non-transgenic littermates. Principal Findings: At the age extremes of 4-12 and 22-24 months no differences were observed, with very low prevalence of tumors in animals younger than 12 months, and a relatively high prevalence at age 22 months or older. However, the transgenic mice had a significant higher lung tumor rate than their non-transgenic counterparts during the age of 13-21 months, suggesting an age-related shift in lung tumor formation induced by the lung-specific expression of the human mutant p53. Histopathology suggested a more aggressive nature for the transgenic tumors. Older mice (>13 months) had a significantly higher rate of p16 promoter methylation (17% v 82%). In addition, an age related effect was observed for K-Ras codons 12 or 13 mutations, but not for codon 61 mutations. Conclusions/Significance: These results would suggest that the mutant p53(273H) contributes to an acceleration in the development of spontaneous lung tumors in these mice. Combination with other genetic and epigenetic alterations occurring after the age of 13 months is intimately linked to its oncogenic potential.			Duan, WR (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Coll Med & Publ Hlth, Columbus, OH 43210 USA.	Wenrui.duan@osumc.edu; miguel.villalona@osumc.edu	Wu, Xin/B-2244-2010	duan, wenrui/0000-0001-6512-7350; Hade, Erinn/0000-0001-8977-6443	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016058, CA76970, P30CA16058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; Albor A, 1998, CANCER RES, V58, P2091; Anders CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001373; Atwal GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001951; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARGONETTI J, 1992, GENE DEV, V6, P1886, DOI 10.1101/gad.6.10.1886; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Busuttil R, 2007, NEUROSCIENCE, V145, P1341, DOI 10.1016/j.neuroscience.2006.09.060; Chen JD, 1996, MOL CELL BIOL, V16, P2445; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CHUMAKOV AM, 1993, ONCOGENE, V8, P3005; DAMICO D, 1992, ONCOGENE, V7, P339; DAVIDOFF AM, 1991, P NATL ACAD SCI USA, V88, P5006, DOI 10.1073/pnas.88.11.5006; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Duan W, 2002, BIOTECHNIQUES, V33, P58, DOI 10.2144/02331st02; Duan WR, 2008, TRANSGENIC RES, V17, P355, DOI 10.1007/s11248-007-9154-3; Duan WR, 2004, JNCI-J NATL CANCER I, V96, P1718, DOI 10.1093/jnci/djh292; Duan WR, 2002, ONCOGENE, V21, P7831, DOI 10.1038/sj.onc.1205909; El-Hizawi S, 2002, CANCER RES, V62, P3264; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; Hernandez-Boussard TM, 1998, ENVIRON HEALTH PERSP, V106, P385, DOI 10.2307/3434065; HOLM S, 1979, SCAND J STAT, V6, P65; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kawamura M, 1996, ONCOGENE, V12, P2361; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Liu Y, 2003, CARCINOGENESIS, V24, P1897, DOI 10.1093/carcin/bgg169; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; MAZARS R, 1992, CANCER RES, V52, P3918; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MULLIGAN LM, 1990, P NATL ACAD SCI USA, V87, P5863, DOI 10.1073/pnas.87.15.5863; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; OTTERSON GA, 1995, ONCOGENE, V11, P1211; Ozols RF, 2007, J CLIN ONCOL, V25, P146, DOI 10.1200/JCO.2006.09.7030; PARK DJ, 1994, ONCOGENE, V9, P1899; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; RODENHUIS S, 1988, CANCER RES, V48, P5738; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sigal A, 2000, CANCER RES, V60, P6788; StataCorp L, 2007, STAT DAT AN STAT SOF; Takahashi T, 2002, ONCOGENE, V21, P6868, DOI 10.1038/sj.onc.1205830; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang YA, 2005, ONCOGENE, V24, P3042, DOI 10.1038/sj.onc.1208390; Wijnhoven SWP, 2007, CANCER RES, V67, P4648, DOI 10.1158/0008-5472.CAN-06-4681; WU L, 1995, MOL CELL BIOL, V15, P497, DOI 10.1128/MCB.15.1.497; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; ZHANG W, 1993, ONCOGENE, V8, P2555	67	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5563	10.1371/journal.pone.0005563	http://dx.doi.org/10.1371/journal.pone.0005563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440353	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107400007
J	Teran, E; Branscomb, AD; Seeling, JM				Teran, Evelyn; Branscomb, Aron D.; Seeling, Joni M.			Dpr Acts as a Molecular Switch, Inhibiting Wnt Signaling when Unphosphorylated, but Promoting Wnt Signaling when Phosphorylated by Casein Kinase I delta/epsilon	PLOS ONE			English	Article								The Wnt pathway is a key regulator of development and tumorigenesis. Dpr (Dact/Frodo) influences Wnt signaling in part through the interaction of its PDZ-B domain with Dsh's PDZ domain. Studies have shown that XDpr1a and its close relative, Frodo, are involved in multiple steps of the Wnt pathway in either inhibitory or activating roles. We found that XDpr1a is phosphorylated by casein kinase I delta/epsilon (CK1 delta/epsilon), an activator of Wnt signaling, in the presence of XDsh. Abrogating XDpr1a's ability to bind XDsh through mutation of XDpr1a's PDZ-B domain blocks CK1 delta/epsilon's phosphorylation of XDpr1a. Conversely, XDsh possessing a mutation in its PDZ domain that is unable to bind XDpr1a does not promote XDpr1a phosphorylation. Phosphorylation of XDpr1a and XDsh by CKI delta/epsilon decreases their interaction. Moreover, the phosphorylation of XDpr1a by CKI delta/epsilon not only abrogates XDpr1a's promotion of beta-catenin degradation but blocks beta-catenin degradation. Our data suggest that XDpr1a phosphorylation by CKI delta/epsilon is dependent on the interaction of XDpr1a's PDZ-B domain with XDsh's PDZ domain, and that the phosphorylation state of XDpr1a determines whether it inhibits or activates Wnt signaling.			Seeling, JM (corresponding author), CUNY, Queens Coll, Dept Biol, Flushing, NY USA.	joni.seeling@qc.cuny.edu			NCI NIH HHS [R15 CA127974, R15CA127974] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R15CA127974] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arce C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000098; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; GAO X, 2008, J BIOL CHEM; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang L, 2006, DEV BIOL, V299, P221, DOI 10.1016/j.ydbio.2006.07.025	30	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5522	10.1371/journal.pone.0005522	http://dx.doi.org/10.1371/journal.pone.0005522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440376	Green Published, gold			2022-12-27	WOS:000266107400001
J	Le Verche, V; Kaindl, AM; Verney, C; Csaba, Z; Peineau, S; Olivier, P; Adle-Biassette, H; Leterrier, C; Vitalis, T; Renaud, J; Dargent, B; Gressens, P; Dournaud, P				Le Verche, Virginia; Kaindl, Angela M.; Verney, Catherine; Csaba, Zsolt; Peineau, Stephane; Olivier, Paul; Adle-Biassette, Homa; Leterrier, Christophe; Vitalis, Tania; Renaud, Julie; Dargent, Benedicte; Gressens, Pierre; Dournaud, Pascal			The Somatostatin 2A Receptor Is Enriched in Migrating Neurons during Rat and Human Brain Development and Stimulates Migration and Axonal Outgrowth	PLOS ONE			English	Article								The neuropeptide somatostatin has been suggested to play an important role during neuronal development in addition to its established modulatory impact on neuroendocrine, motor and cognitive functions in adults. Although six somatostatin G protein-coupled receptors have been discovered, little is known about their distribution and function in the developing mammalian brain. In this study, we have first characterized the developmental expression of the somatostatin receptor sst2A, the subtype found most prominently in the adult rat and human nervous system. In the rat, the sst2A receptor expression appears as early as E12 and is restricted to post-mitotic neuronal populations leaving the ventricular zone. From E12 on, migrating neuronal populations immunopositive for the receptor were observed in numerous developing regions including the cerebral cortex, hippocampus and ganglionic eminences. Intense but transient immunoreactive signals were detected in the deep part of the external granular layer of the cerebellum, the rostral migratory stream and in tyrosine hydroxylase- and serotonin-positive neurons and axons. Activation of the sst2A receptor in vitro in rat cerebellar microexplants and primary hippocampal neurons revealed stimulatory effects on neuronal migration and axonal growth, respectively. In the human cortex, receptor immunoreactivity was located in the preplate at early development stages (8 gestational weeks) and was enriched to the outer part of the germinal zone at later stages. In the cerebellum, the deep part of the external granular layer was strongly immunoreactive at 19 gestational weeks, similar to the finding in rodents. In addition, migrating granule cells in the internal granular layer were also receptor-positive. Together, theses results strongly suggest that the somatostatin sst2A receptor participates in the development and maturation of specific neuronal populations during rat and human brain ontogenesis.			Le Verche, V (corresponding author), INSERM, U676, Unite Mixte Rech, Paris, France.	pascal.dournaud@inserm.fr	Adle-Biassette, Homa/AAG-2751-2019; De Granzial, Nadine-Tania Vitalis/K-8485-2017; Leterrier, Christophe/G-6975-2011; gressens, pierre/M-7557-2017	De Granzial, Nadine-Tania Vitalis/0000-0002-5531-3771; Leterrier, Christophe/0000-0002-2957-2032; gressens, pierre/0000-0002-0909-4221; Peineau, Stephane/0000-0002-4721-6795; Csaba, Zsolt/0000-0002-3392-2605; Kaindl, Angela/0000-0001-9454-206X	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderton F, 1998, BRIT J PHARMACOL, V125, P1630, DOI 10.1038/sj.bjp.0702282; Bassant MH, 2005, J NEUROSCI, V25, P2032, DOI 10.1523/JNEUROSCI.4619-04.2005; Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; BODENANT C, 1991, NEUROSCIENCE, V41, P595, DOI 10.1016/0306-4522(91)90352-O; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Charrier C, 2006, NEUROSCIENCE, V138, P5, DOI 10.1016/j.neuroscience.2005.10.046; Coskun V, 2002, J NEUROSCI RES, V69, P795, DOI 10.1002/jnr.10336; Csaba Z, 2005, J NEUROPATH EXP NEUR, V64, P956, DOI 10.1097/01.jnen.0000186923.50215.50; Csaba Z, 2004, EUR J NEUROSCI, V19, P2531, DOI 10.1111/j.0953-816X.2004.03361.x; Csaba Z, 2003, ENDOCRINOLOGY, V144, P1564, DOI 10.1210/en.2002-221090; Csaba Z, 2002, J COMP NEUROL, V454, P192, DOI 10.1002/cne.10430; Csaba Z, 2001, MOL CELL NEUROSCI, V17, P646, DOI 10.1006/mcne.2000.0958; Csaba Z, 2001, NEUROPEPTIDES, V35, P1, DOI 10.1054/npep.2001.0848; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; DAIKOKU S, 1983, CELL TISSUE RES, V233, P347; de Lecea L, 2006, NAT CLIN PRACT ENDOC, V2, P356, DOI 10.1038/ncpendmet0219; deLecea L, 1997, J NEUROSCI, V17, P5868; EADIE LA, 1987, J NEUROCYTOL, V16, P445, DOI 10.1007/BF01668499; Englund C, 2006, J NEUROSCI, V26, P9184, DOI 10.1523/JNEUROSCI.1610-06.2006; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Falluel-Morel A, 2005, P NATL ACAD SCI USA, V102, P2637, DOI 10.1073/pnas.0409681102; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; GONZALEZ BJ, 1988, DEV BRAIN RES, V40, P154, DOI 10.1016/0165-3806(88)90018-1; GONZALEZ BJ, 1991, J COMP NEUROL, V305, P177, DOI 10.1002/cne.903050202; GONZALEZ BJ, 1990, J NEUROCHEM, V55, P729, DOI 10.1111/j.1471-4159.1990.tb04552.x; GONZALEZ BJ, 1989, NEUROSCIENCE, V29, P629, DOI 10.1016/0306-4522(89)90136-X; Goodyer CG, 2004, NEUROSCIENCE, V125, P441, DOI 10.1016/j.neuroscience.2004.02.001; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Gutierrez-Mecinas M, 2005, EUR J NEUROSCI, V22, P1357, DOI 10.1111/j.1460-9568.2005.04328.x; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Helboe L, 1997, MOL BRAIN RES, V49, P82, DOI 10.1016/S0169-328X(97)00127-7; INAGAKI S, 1982, DEV BRAIN RES, V3, P509, DOI 10.1016/0165-3806(82)90051-7; Kalinichenko S G, 2005, Neurosci Behav Physiol, V35, P21, DOI 10.1023/B:NEAB.0000049648.20702.ad; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kramer D, 2005, J NEUROCHEM, V94, P1374, DOI 10.1111/j.1471-4159.2005.03285.x; KUBBUTAT MHG, 1994, J CLIN PATHOL, V47, P524, DOI 10.1136/jcp.47.6.524; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; MACMILLAN FM, 1986, NEUROHISTOCHEMISTRY, P49; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; MAUBERT E, 1994, NEUROSCIENCE, V62, P317, DOI 10.1016/0306-4522(94)90335-2; MCDONALD JK, 1982, J NEUROCYTOL, V11, P809, DOI 10.1007/BF01153520; Monier A, 2007, J NEUROPATH EXP NEUR, V66, P372, DOI 10.1097/nen.0b013e3180517b46; Mor-Vaknin N, 2006, MOL CELL BIOL, V26, P9484, DOI 10.1128/MCB.01030-06; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Pujol F, 2005, J CELL SCI, V118, P1071, DOI 10.1242/jcs.01694; Pyronnet S, 2008, MOL CELL ENDOCRINOL, V286, P230, DOI 10.1016/j.mce.2008.02.002; Rauca C, 1999, N-S ARCH PHARMACOL, V360, P633, DOI 10.1007/s002109900136; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Salmaso N, 2006, HORM BEHAV, V50, P448, DOI 10.1016/j.yhbeh.2006.05.006; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; Schindler M, 1998, BRIT J PHARMACOL, V125, P209, DOI 10.1038/sj.bjp.0702064; Schindler M, 1998, NEUROREPORT, V9, P521, DOI 10.1097/00001756-199802160-00027; Schwaller B, 1999, J NEUROSCI METH, V92, P137, DOI 10.1016/S0165-0270(99)00106-5; SHIOSAKA S, 1981, J COMP NEUROL, V203, P173, DOI 10.1002/cne.902030203; SHIOSAKA S, 1982, J COMP NEUROL, V204, P211, DOI 10.1002/cne.902040302; Stanic D, 2009, BRAIN RES, V1249, P101, DOI 10.1016/j.brainres.2008.10.024; Stewart R, 2003, STEM CELLS, V21, P248, DOI 10.1634/stemcells.21-3-248; Stumm RK, 2004, J NEUROSCI, V24, P11404, DOI 10.1523/JNEUROSCI.3834-04.2004; Susini C, 2006, ANN ONCOL, V17, P1733, DOI 10.1093/annonc/mdl105; TSALIKIAN E, 1984, PEDIATR RES, V18, P953, DOI 10.1203/00006450-198418100-00009; Varea E, 2005, NEUROSCIENCE, V136, P435, DOI 10.1016/j.neuroscience.2005.08.009; Varea E, 2007, J CHEM NEUROANAT, V33, P202, DOI 10.1016/j.jchemneu.2007.03.006; Vezzani A, 1999, EUR J NEUROSCI, V11, P3767, DOI 10.1046/j.1460-9568.1999.00838.x; Viollet C, 2008, MOL CELL ENDOCRINOL, V286, P75, DOI 10.1016/j.mce.2007.09.007; Wang JM, 2005, J NEUROSCI, V25, P4706, DOI 10.1523/JNEUROSCI.4520-04.2005; Wong CH, 2005, ENDOCRINOLOGY, V146, P1192, DOI 10.1210/en.2004-1275; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; ZECEVIC N, 1995, J COMP NEUROL, V351, P509, DOI 10.1002/cne.903510404	76	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2009	4	5							e5509	10.1371/journal.pone.0005509	http://dx.doi.org/10.1371/journal.pone.0005509			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VZ	19434240	Green Published, gold			2022-12-27	WOS:000266009800007
J	Li, L; Oropeza, CE; Sainz, B; Uprichard, SL; Gonzalez, FJ; McLachlan, A				Li, Lie; Oropeza, Claudia E.; Sainz, Bruno, Jr.; Uprichard, Susan L.; Gonzalez, Frank J.; McLachlan, Alan			Developmental Regulation of Hepatitis B Virus Biosynthesis by Hepatocyte Nuclear Factor 4 alpha	PLOS ONE			English	Article								The host cellular factors that promote persistent viral infections in vivo are, in general, poorly understood. Utilizing the hepatitis B virus (HBV) transgenic mouse model of chronic infection, we demonstrate that the nuclear receptor, hepatocyte nuclear factor 4 alpha (HNF4 alpha, NR2A1), is essential for viral biosynthesis in the liver. The dependency of HBV transcription on HNF4 alpha links viral biosynthesis and persistence to a developmentally regulated transcription factor essential for host viability.			Li, L (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	mclach@uic.edu	Anding, Bruno Sainz/ABH-5365-2020; McLachlan, Alan/AAR-9194-2020	Anding, Bruno Sainz/0000-0003-4829-7651; McLachlan, Alan/0000-0002-4168-2365	NATIONAL CANCER INSTITUTE [ZIABC005561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI30070, R01AI030070, N01AI030070] Funding Source: NIH RePORTER; NIAID NIH HHS [N01AI30070, R01 AI030070] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson AL, 2005, J VIROL, V79, P11045, DOI 10.1128/JVI.79.17.11045-11052.2005; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; DELCANHO R, 1994, VACCINE, V12, P1323, DOI 10.1016/S0264-410X(94)80059-9; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; FENECH FF, 1967, BMJ-BRIT MED J, V3, P155, DOI 10.1136/bmj.3.5558.155; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guidotti LG, 1999, J VIROL, V73, P10377, DOI 10.1128/JVI.73.12.10377-10386.1999; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; Sambrook J., 2002, MOL CLONING LAB MANU; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Shlomai A, 2006, P NATL ACAD SCI USA, V103, P16003, DOI 10.1073/pnas.0607837103; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Tang H, 2001, DRUG NEWS PERSPECT, V14, P325; WILL H, 1987, J VIROL, V61, P904, DOI 10.1128/JVI.61.3.904-911.1987; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	30	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5489	10.1371/journal.pone.0005489	http://dx.doi.org/10.1371/journal.pone.0005489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424486	Green Published, gold, Green Submitted			2022-12-27	WOS:000265933800019
J	Lapebie, P; Gazave, E; Ereskovsky, A; Derelle, R; Bezac, C; Renard, E; Houliston, E; Borchiellini, C				Lapebie, Pascal; Gazave, Eve; Ereskovsky, Alexander; Derelle, Romain; Bezac, Chantal; Renard, Emmanuelle; Houliston, Evelyn; Borchiellini, Carole			WNT/beta-Catenin Signalling and Epithelial Patterning in the Homoscleromorph Sponge Oscarella	PLOS ONE			English	Article								Sponges branch basally in the metazoan phylogenetic tree and are thus well positioned to provide insights into the evolution of mechanisms controlling animal development, likely to remain active in adult sponges. Of the four sponge clades, the Homoscleromorpha are of particular interest as they alone show the "true" epithelial organization seen in other metazoan phyla (the Eumetazoa). We have examined the deployment in sponges of Wnt signalling pathway components, since this pathway is an important regulator of many developmental patterning processes. We identified a reduced repertoire of three divergent Wnt ligand genes in the recently-sequenced Amphimedon queenslandica (demosponge) genome and two Wnts from our EST collection from the homoscleromorph Oscarella lobularis, along with well-conserved genes for intracellular pathway components (beta-catenin, GSK3 beta). Remarkably, the two O. lobularis Wnt genes showed complementary expression patterns in relation to the evenly spaced ostia (canal openings) of the exopinacoderm (ectoderm), highly reminiscent of Wnt expression during skin appendage formation in vertebrates. Furthermore, experimental activation of the Wnt/beta-catenin pathway using GSK3 beta inhibitors provoked formation of ectopic ostia, as has been shown for epithelial appendages in Eumetazoa. We thus suggest that deployment of Wnt signalling is a common and perhaps ancient feature of metazoan epithelial patterning and morphogenesis.			Lapebie, P (corresponding author), Aix Marseille Univ, Ctr Oceanol Marseille, CNRS, Marine Endoume Stn,UMR 6540, Marseille, France.	pascal.lapebie@univmed.fr	Ereskovsky, Alexander/W-1504-2019; Gazave, Eve/F-2665-2010; Ereskovsky, Alexander/B-3136-2013	Ereskovsky, Alexander/0000-0003-1079-7204; Houliston, Evelyn/0000-0001-9264-2585; Renard, Emmanuelle/0000-0002-4184-5507; Gazave, Eve/0000-0002-4647-6640; Lapebie, Pascal/0000-0003-4073-0633				Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adell T, 2007, CELL BIOL INT, V31, P939, DOI 10.1016/j.cellbi.2007.03.003; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Boury-Esnault N, 2003, INVERTEBR BIOL, V122, P187, DOI 10.1111/j.1744-7410.2003.tb00084.x; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Chang CH, 2004, MECH DEVELOP, V121, P157, DOI 10.1016/j.mod.2003.12.004; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; ERESKOVSKY A, 2008, BIOESSAYS IN PRESS; Ereskovsky AV, 2007, J MORPHOL, V268, P518, DOI 10.1002/jmor.10506; Ereskovsky AV, 2007, MAR BIOL, V151, P425, DOI 10.1007/s00227-006-0439-5; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Gazave E, 2008, DEV GENES EVOL, V218, P479, DOI 10.1007/s00427-008-0242-z; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; He XC, 2005, ANN NY ACAD SCI, V1049, P28, DOI 10.1196/annals.1334.005; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Magie CR, 2008, BIOL BULL-US, V214, P218, DOI 10.2307/25470665; Maldonado M, 2004, INVERTEBR BIOL, V123, P1; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mikkola ML, 2006, J MAMMARY GLAND BIOL, V11, P187, DOI 10.1007/s10911-006-9029-x; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Narhi K, 2008, DEVELOPMENT, V135, P1019, DOI 10.1242/dev.016550; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; Noramly S, 1999, DEVELOPMENT, V126, P3509; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; Ruiz-Trillo I, 2008, MOL BIOL EVOL, V25, P664, DOI 10.1093/molbev/msn006; Sperling EA, 2007, GEOL SOC SPEC PUBL, V286, P355, DOI 10.1144/SP286.25; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Tyler S, 2003, INTEGR COMP BIOL, V43, P55, DOI 10.1093/icb/43.1.55; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	50	64	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5823	10.1371/journal.pone.0005823	http://dx.doi.org/10.1371/journal.pone.0005823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503791	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717400003
J	Wolfs, TGAM; Buurman, WA; Zoer, B; Moonen, RMJ; Derikx, JPM; Thuijls, G; Villamor, E; Gantert, M; Garnier, Y; Zimmermann, LJI; Kramer, BW				Wolfs, Tim G. A. M.; Buurman, Wim A.; Zoer, Bea; Moonen, Rob M. J.; Derikx, Joep P. M.; Thuijls, Geertje; Villamor, Eduardo; Gantert, Markus; Garnier, Yves; Zimmermann, Luc J. I.; Kramer, Boris W.			Endotoxin Induced Chorioamnionitis Prevents Intestinal Development during Gestation in Fetal Sheep	PLOS ONE			English	Article							INTRAAMNIOTIC ENDOTOXIN; PREMATURE-INFANTS; LUNG MATURATION; INNATE IMMUNITY; PRETERM; INFLAMMATION; MECHANISMS; PULMONARY; ARGININE; INJURY	Chorioamnionitis is the most significant source of prenatal inflammation and preterm delivery. Prematurity and prenatal inflammation are associated with compromised postnatal developmental outcomes, of the intestinal immune defence, gut barrier function and the vascular system. We developed a sheep model to study how the antenatal development of the gut was affected by gestation and/or by endotoxin induced chorioamnionitis. Chorioamnionitis was induced at different gestational ages (GA). Animals were sacrificed at low GA after 2d or 14d exposure to chorioamnionitis. Long term effects of 30d exposure to chorioamnionitis were studied in near term animals after induction of chorioamnionitis. The cellular distribution of tight junction protein ZO-1 was shown to be underdeveloped at low GA whereas endotoxin induced chorioamnionitis prevented the maturation of tight junctions during later gestation. Endotoxin induced chorioamnionitis did not induce an early (2d) inflammatory response in the gut in preterm animals. However, 14d after endotoxin administration preterm animals had increased numbers of T-lymphocytes, myeloperoxidase-positive cells and gammadelta T-cells which lasted till 30d after induction of chorioamnionitis in then near term animals. At early GA, low intestinal TLR-4 and MD-2 mRNA levels were detected which were further down regulated during endotoxin-induced chorioamnionitis. Predisposition to organ injury by ischemia was assessed by the vascular function of third-generation mesenteric arteries. Endotoxin-exposed animals of low GA had increased contractile response to the thromboxane A2 mimetic U46619 and reduced endothelium-dependent relaxation in responses to acetylcholine. The administration of a nitric oxide (NO) donor completely restored endothelial dysfunction suggesting reduced NO bioavailability which was not due to low expression of endothelial nitric oxide synthase. Our results indicate that the distribution of the tight junctional protein ZO-1, the immune defence and vascular function are immature at low GA and are further compromised by endotoxin-induced chorioamnionitis. This study suggests that both prematurity and inflammation in utero disturb fetal gut development, potentially predisposing to postnatal intestinal pathology.			Wolfs, TGAM (corresponding author), Maastricht Univ Med Ctr, Dept Surg, NUTRIM, Maastricht, Netherlands.	b.kramer@mumc.nl	Kramer, Boris/AAO-3183-2021; Villamor, Eduardo/E-6520-2011	Villamor, Eduardo/0000-0003-1949-9123; derikx, joep/0000-0003-0694-7679; Wolfs, Tim/0000-0003-4417-4144				Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Been JV, 2008, NEW ENGL J MED, V359, P1523; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Boston VE, 2006, PEDIATR SURG INT, V22, P477, DOI 10.1007/s00383-006-1697-5; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Hillman NH, 2008, PEDIATR RES, V63, P388, DOI 10.1203/PDR.0b013e3181647b3a; Jobe Alan H, 2003, Semin Neonatol, V8, P9, DOI 10.1016/S1084-2756(02)00188-4; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2007, J IMMUNOL, V179, P8491, DOI 10.4049/jimmunol.179.12.8491; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kawase Y, 2006, PEDIATR INT, V48, P599, DOI 10.1111/j.1442-200X.2006.02282.x; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kramer BW, 2009, INNATE IMMUN-LONDON, V15, P101, DOI 10.1177/1753425908100455; Kramer BW, 2005, AM J RESP CRIT CARE, V171, P73, DOI 10.1164/rccm.200406-745OC; Kramer BW, 2002, AM J PHYSIOL-LUNG C, V283, pL452, DOI 10.1152/ajplung.00407.2001; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Moonen RMJ, 2007, PEDIATR RES, V62, P188, DOI 10.1203/PDR.0b013e3180a0324e; Moss TJM, 2002, AM J OBSTET GYNECOL, V187, P1059, DOI 10.1067/mob.2002.126296; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nusrat A, 2000, J CELL SCI, V113, P1771; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Philpott DJ, 1996, AM J PHYSIOL-GASTR L, V270, pG634, DOI 10.1152/ajpgi.1996.270.4.G634; Richir MC, 2007, BRIT J NUTR, V97, P906, DOI 10.1017/S0007114507669268; Rouwet EV, 2002, PEDIATR RES, V51, P64, DOI 10.1203/00006450-200201000-00012; Saji F, 2000, J REPROD IMMUNOL, V47, P185, DOI 10.1016/S0165-0378(00)00064-4; SHAUL PW, 1992, AM J PHYSIOL, V262, pH355, DOI 10.1152/ajpheart.1992.262.2.H355; SPITZ J, 1995, AM J PHYSIOL-GASTR L, V268, pG374, DOI 10.1152/ajpgi.1995.268.2.G374; Srinivasan PS, 2008, CLIN PERINATOL, V35, P251, DOI 10.1016/j.clp.2007.11.009; Villamor E, 2003, PEDIATR RES, V54, P372, DOI 10.1203/01.PDR.0000077481.15081.C8; Viswanathan VK, 2000, CURR OPIN GASTROEN, V16, P546, DOI 10.1097/00001574-200011000-00015; WOLFS TG, 2009, INFLAMM BOW IN PRESS; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Zamora SA, 1997, J PEDIATR-US, V131, P226, DOI 10.1016/S0022-3476(97)70158-6	38	66	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5837	10.1371/journal.pone.0005837	http://dx.doi.org/10.1371/journal.pone.0005837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503810	gold, Green Published			2022-12-27	WOS:000266717400016
J	Anderson, I; Ulrich, LE; Lupa, B; Susanti, D; Porat, I; Hooper, SD; Lykidis, A; Sieprawska-Lupa, M; Dharmarajan, L; Goltsman, E; Lapidus, A; Saunders, E; Han, C; Land, M; Lucas, S; Mukhopadhyay, B; Whitman, WB; Woese, C; Bristow, J; Kyrpides, N				Anderson, Iain; Ulrich, Luke E.; Lupa, Boguslaw; Susanti, Dwi; Porat, Iris; Hooper, Sean D.; Lykidis, Athanasios; Sieprawska-Lupa, Magdalena; Dharmarajan, Lakshmi; Goltsman, Eugene; Lapidus, Alla; Saunders, Elizabeth; Han, Cliff; Land, Miriam; Lucas, Susan; Mukhopadhyay, Biswarup; Whitman, William B.; Woese, Carl; Bristow, James; Kyrpides, Nikos			Genomic Characterization of Methanomicrobiales Reveals Three Classes of Methanogens	PLOS ONE			English	Article								Background: Methanomicrobiales is the least studied order of methanogens. While these organisms appear to be more closely related to the Methanosarcinales in ribosomal-based phylogenetic analyses, they are metabolically more similar to Class I methanogens. Methodology/Principal Findings: In order to improve our understanding of this lineage, we have completely sequenced the genomes of two members of this order, Methanocorpusculum labreanum Z and Methanoculleus marisnigri JR1, and compared them with the genome of a third, Methanospirillum hungatei JF-1. Similar to Class I methanogens, Methanomicrobiales use a partial reductive citric acid cycle for 2-oxoglutarate biosynthesis, and they have the Eha energy-converting hydrogenase. In common with Methanosarcinales, Methanomicrobiales possess the Ech hydrogenase and at least some of them may couple formylmethanofuran formation and heterodisulfide reduction to transmembrane ion gradients. Uniquely, M. labreanum and M. hungatei contain hydrogenases similar to the Pyrococcus furiosus Mbh hydrogenase, and all three Methanomicrobiales have anti-sigma factor and anti-anti-sigma factor regulatory proteins not found in other methanogens. Phylogenetic analysis based on seven core proteins of methanogenesis and cofactor biosynthesis places the Methanomicrobiales equidistant from Class I methanogens and Methanosarcinales. Conclusions/Significance: Our results indicate that Methanomicrobiales, rather than being similar to Class I methanogens or Methanomicrobiales, share some features of both and have some unique properties. We find that there are three distinct classes of methanogens: the Class I methanogens, the Methanomicrobiales (Class II), and the Methanosarcinales (Class III).			Anderson, I (corresponding author), Joint Genome Inst, Walnut Creek, CA USA.	IJAnderson@lbl.gov	Land, Miriam L/A-6200-2011; Lapidus, Alla L/I-4348-2013; Whitman, William/AAC-5896-2020; Susanti, Dwi/GQB-4050-2022; Kyrpides, Nikos C./A-6305-2014	Land, Miriam L/0000-0001-7102-0031; Lapidus, Alla L/0000-0003-0427-8731; Kyrpides, Nikos C./0000-0002-6131-0462; Han, Cliff/0000-0003-1972-0692; Mukhopadhyay, Biswarup/0000-0003-0736-0298; Whitman, William/0000-0003-1229-0423	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072285] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072285, GM72285] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aufhammer SW, 2004, STRUCTURE, V12, P361, DOI 10.1016/j.str.2004.02.010; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Bapteste Eric, 2005, Archaea, V1, P353, DOI 10.1155/2005/859728; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; BLEICHER K, 1991, EUR J BIOCHEM, V200, P43, DOI 10.1111/j.1432-1033.1991.tb21046.x; Brewer ML, 2007, J CHEM INF MODEL, V47, P1727, DOI 10.1021/ci600565r; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Decatur AL, 1996, GENE DEV, V10, P2348, DOI 10.1101/gad.10.18.2348; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferry JG, 1997, SCIENCE, V278, P1413, DOI 10.1126/science.278.5342.1413; FERRY JG, 1974, INT J SYST BACTERIOL, V24, P465, DOI 10.1099/00207713-24-4-465; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; GARCIA JL, 2006, PROKARYOTES, V3, P208, DOI DOI 10.1007/0-387-30743-5_10; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kyrpides NC, 1997, J MOL EVOL, V45, P706; Lupa B, 2008, APPL ENVIRON MICROB, V74, P6584, DOI 10.1128/AEM.01455-08; Makarova KS, 2003, FEMS MICROBIOL LETT, V227, P17, DOI 10.1016/S0378-1097(03)00596-2; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Meuer J, 2002, P NATL ACAD SCI USA, V99, P5632, DOI 10.1073/pnas.072615499; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Porat I, 2006, J BACTERIOL, V188, P1373, DOI 10.1128/JB.188.4.1373-1380.2006; ROMESSER JA, 1979, ARCH MICROBIOL, V121, P147, DOI 10.1007/BF00689979; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; SIOUD M, 1988, J BACTERIOL, V170, P946, DOI 10.1128/jb.170.2.946-953.1988; Stojanowic A, 2003, ARCH MICROBIOL, V180, P194, DOI 10.1007/s00203-003-0577-9; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verhees CH, 2001, J BACTERIOL, V183, P7145, DOI 10.1128/JB.183.24.7145-7153.2001; WHITMAN WB, 1986, SYST APPL MICROBIOL, V7, P235; WIDDEL F, 1988, ARCH MICROBIOL, V150, P477, DOI 10.1007/BF00422290; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; ZELLNER G, 1987, FEMS MICROBIOL LETT, V44, P323, DOI 10.1016/0378-1097(87)90343-0; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-251; ZHAO YZ, 1989, INT J SYST BACTERIOL, V39, P10, DOI 10.1099/00207713-39-1-10	46	68	71	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5797	10.1371/journal.pone.0005797	http://dx.doi.org/10.1371/journal.pone.0005797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495416	Green Submitted, Green Published, gold			2022-12-27	WOS:000266716900007
J	Swart, M; Kortekaas, R; Aleman, A				Swart, Marte; Kortekaas, Rudie; Aleman, Andre			Dealing with Feelings: Characterization of Trait Alexithymia on Emotion Regulation Strategies and Cognitive-Emotional Processing	PLOS ONE			English	Article							MIND; SCHIZOPHRENIA; RECOGNITION; RELIABILITY; VALIDITY; SCALE; QUESTIONNAIRE; PREVALENCE; VALIDATION; EXPRESSION	Background: Alexithymia, or "no words for feelings'', is a personality trait which is associated with difficulties in emotion recognition and regulation. It is unknown whether this deficit is due primarily to regulation, perception, or mentalizing of emotions. In order to shed light on the core deficit, we tested our subjects on a wide range of emotional tasks. We expected the high alexithymics to underperform on all tasks. Method: Two groups of healthy individuals, high and low scoring on the cognitive component of the Bermond-Vorst Alexithymia Questionnaire, completed questionnaires of emotion regulation and performed several emotion processing tasks including a micro expression recognition task, recognition of emotional prosody and semantics in spoken sentences, an emotional and identity learning task and a conflicting beliefs and emotions task (emotional mentalizing). Results: The two groups differed on the Emotion Regulation Questionnaire, Berkeley Expressivity Questionnaire and Empathy Quotient. Specifically, the Emotion Regulation Quotient showed that alexithymic individuals used more suppressive and less reappraisal strategies. On the behavioral tasks, as expected, alexithymics performed worse on recognition of micro expressions and emotional mentalizing. Surprisingly, groups did not differ on tasks of emotional semantics and prosody and associative emotional-learning. Conclusion: Individuals scoring high on the cognitive component of alexithymia are more prone to suppressive emotion regulation strategies rather than reappraisal strategies. Regarding emotional information processing, alexithymia is associated with reduced performance on measures of early processing as well as higher order mentalizing. However, difficulties in the processing of emotional language were not a core deficit in our alexithymic group.			Swart, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, NeuroImaging Ctr, Groningen, Netherlands.	m.swart@med.umcg.nl	Aleman, Andre/E-1341-2012					Aleman A, 2005, TRENDS COGN SCI, V9, P553, DOI 10.1016/j.tics.2005.10.002; Bagby R.M., 1997, DISORDERS AFFECT REG; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bermond B, 2007, COGNITION EMOTION, V21, P1125, DOI 10.1080/02699930601056989; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; Berthoz S., 2000, EUROPEAN REV APPL PS, V50, P359; Berthoz S, 2007, J PSYCHOSOM RES, V62, P341, DOI 10.1016/j.jpsychores.2006.10.008; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; EKMAN P, 2003, EXPRESSION TRAINING; Ekman P., 1976, PICTURES FACIAL AFFE; Exner C, 2004, SCHIZOPHR RES, V71, P493, DOI 10.1016/j.schres.2004.02.023; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Greenberg L., 2002, EMOTION FOCUSED THER; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1997, J PERS SOC PSYCHOL, V72, P435, DOI 10.1037/0022-3514.72.2.435; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Guttman H, 2002, COMPR PSYCHIAT, V43, P448, DOI 10.1053/comp.2002.35905; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; KIRMAYER LJ, 1993, PSYCHOSOMATICS, V34, P41, DOI 10.1016/S0033-3182(93)71926-X; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Lane RD, 1997, BIOL PSYCHIAT, V42, P834, DOI 10.1016/S0006-3223(97)00050-4; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; LAZARUS RS, 1964, J ABNORM SOC PSYCH, V69, P195, DOI 10.1037/h0044635; Luminet O, 2006, J RES PERS, V40, P713, DOI 10.1016/j.jrp.2005.09.001; Mattila AK, 2007, PSYCHOSOMATICS, V48, P523, DOI 10.1176/appi.psy.48.6.523; Moriguchi Y, 2006, NEUROIMAGE, V32, P1472, DOI 10.1016/j.neuroimage.2006.04.186; NEMIAH JC, 1970, PSYCHOTHER PSYCHOSOM, V18, P154, DOI 10.1159/000286074; NEWTON TL, 1994, PSYCHOSOM MED, V56, P457, DOI 10.1097/00006842-199409000-00011; *NOR, 2002, STAT PACK SOC SCI SP; PILOWSKY I, 1983, INT J PSYCHIAT MED, V13, P11; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Schneider W., 2002, E PRIME USERS GUIDE; Schoeman-Malan MC, 2007, PSYCHOL MED, V10, P24; Shaw P, 2004, BRAIN, V127, P1535, DOI 10.1093/brain/awh168; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Suslow T, 1998, EUR J PERSONALITY, V12, P433, DOI 10.1002/(SICI)1099-0984(199811/12)12:6<433::AID-PER320>3.0.CO;2-O; Taylor G.J., 1997, DISORDERS AFFECT REG; Taylor GJ, 2004, PSYCHOTHER PSYCHOSOM, V73, P68, DOI 10.1159/000075537; van Rijn S, 2007, J INT NEUROPSYCH SOC, V13, P1065, DOI 10.1017/S1355617707071044; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Vermeulen N, 2006, COGNITION EMOTION, V20, P64, DOI 10.1080/02699930500304654; Vermeulen N, 2008, COGNITION EMOTION; Vingerhoets G, 2003, NEUROPSYCHOLOGY, V17, P93, DOI 10.1037/0894-4105.17.1.93; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Wastell CA, 2002, SOC BEHAV PERSONAL, V30, P141, DOI 10.2224/sbp.2002.30.2.141; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zech E, 1999, EUR J PERSONALITY, V13, P511	50	203	217	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5751	10.1371/journal.pone.0005751	http://dx.doi.org/10.1371/journal.pone.0005751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453PV	19492045	Green Submitted, gold, Green Published			2022-12-27	WOS:000266624300007
J	Carpio, RVD; Silverstein, TD; Lone, S; Swan, MK; Choudhury, JR; Johnson, RE; Prakash, S; Prakash, L; Aggarwal, AK				Carpio, Rodrigo Vasquez-Del; Silverstein, Timothy D.; Lone, Samer; Swan, Michael K.; Choudhury, Jayati R.; Johnson, Robert E.; Prakash, Satya; Prakash, Louise; Aggarwal, Aneel K.			Structure of Human DNA Polymerase kappa Inserting dATP Opposite an 8-OxoG DNA Lesion	PLOS ONE			English	Article								Background: Oxygen-free radicals formed during normal aerobic cellular metabolism attack bases in DNA and 7,8-dihydro-8-oxoguanine (8-oxoG) is one of the major lesions formed. It is amongst the most mutagenic lesions in cells because of its dual coding potential, wherein 8-oxoG(syn) can pair with an A in addition to normal base pairing of 8-oxoG(anti) with a C. Human DNA polymerase kappa (Pol kappa) is a member of the newly discovered Y-family of DNA polymerases that possess the ability to replicate through DNA lesions. To understand the basis of Pol kappa's preference for insertion of an A opposite 8-oxoG lesion, we have solved the structure of Pol kappa in ternary complex with a template-primer presenting 8-oxoG in the active site and with dATP as the incoming nucleotide. Methodology and Principal Findings: We show that the Pol kappa active site is well-adapted to accommodate 8-oxoG in the syn conformation. That is, the polymerase and the bound template-primer are almost identical in their conformations to that in the ternary complex with undamaged DNA. There is no steric hindrance to accommodating 8-oxoG in the syn conformation for Hoogsteen base-paring with incoming dATP. Conclusions and Significance: The structure we present here is the first for a eukaryotic translesion synthesis (TLS) DNA polymerase with an 8-oxoG: A base pair in the active site. The structure shows why Pol kappa is more efficient at inserting an A opposite the 8-oxoG lesion than a C. The structure also provides a basis for why Pol kappa is more efficient at inserting an A opposite the lesion than other Y-family DNA polymerases.			Carpio, RVD (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA.	aneel.aggarwal@mssm.edu	Prakash, Satya/C-6420-2013; Prakash, Louise/C-7891-2012	Silverstein, Timothy/0000-0003-0931-6274; Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016666] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES016666, R01 ES016666] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Brieba LG, 2005, STRUCTURE, V13, P1653, DOI 10.1016/j.str.2005.07.020; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR A, V47, P110; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Uijon SN, 2004, STRUCTURE, V12, P1395, DOI 10.1016/j.str.2004.05.011; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 2002, P NATL ACAD SCI USA, V99, P1910, DOI 10.1073/pnas.032594399; Wolfle WT, 2006, MOL CELL BIOL, V26, P381, DOI 10.1128/MCB.26.1.381-386.2006; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	44	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5766	10.1371/journal.pone.0005766	http://dx.doi.org/10.1371/journal.pone.0005766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19492058	gold, Green Published, Green Submitted			2022-12-27	WOS:000266587400009
J	de la Torre-Barcena, JE; Kolokotronis, SO; Lee, EK; Stevenson, DW; Brenner, ED; Katari, MS; Coruzzi, GM; DeSalle, R				de la Torre-Barcena, Jose Eduardo; Kolokotronis, Sergios-Orestis; Lee, Ernest K.; Stevenson, Dennis Wm.; Brenner, Eric D.; Katari, Manpreet S.; Coruzzi, Gloria M.; DeSalle, Rob			The Impact of Outgroup Choice and Missing Data on Major Seed Plant Phylogenetics Using Genome-Wide EST Data	PLOS ONE			English	Article							MADS-BOX GENES; EXTANT GYMNOSPERMS; DRAFT SEQUENCE; INCONGRUENCE; EVOLUTION; SUPPORT; PHYLOGENOMICS; ANGIOSPERMS; GNETALES; ORIGIN	Background: Genome level analyses have enhanced our view of phylogenetics in many areas of the tree of life. With the production of whole genome DNA sequences of hundreds of organisms and large-scale EST databases a large number of candidate genes for inclusion into phylogenetic analysis have become available. In this work, we exploit the burgeoning genomic data being generated for plant genomes to address one of the more important plant phylogenetic questions concerning the hierarchical relationships of the several major seed plant lineages (angiosperms, Cycadales, Gingkoales, Gnetales, and Coniferales), which continues to be a work in progress, despite numerous studies using single, few or several genes and morphology datasets. Although most recent studies support the notion that gymnosperms and angiosperms are monophyletic and sister groups, they differ on the topological arrangements within each major group. Methodology: We exploited the EST database to construct a supermatrix of DNA sequences (over 1,200 concatenated orthologous gene partitions for 17 taxa) to examine non-flowering seed plant relationships. This analysis employed programs that offer rapid and robust orthology determination of novel, short sequences from plant ESTs based on reference seed plant genomes. Our phylogenetic analysis retrieved an unbiased (with respect to gene choice), well-resolved and highly supported phylogenetic hypothesis that was robust to various outgroup combinations. Conclusions: We evaluated character support and the relative contribution of numerous variables (e. g. gene number, missing data, partitioning schemes, taxon sampling and outgroup choice) on tree topology, stability and support metrics. Our results indicate that while missing characters and order of addition of genes to an analysis do not influence branch support, inadequate taxon sampling and limited choice of outgroup(s) can lead to spurious inference of phylogeny when dealing with phylogenomic scale data sets. As expected, support and resolution increases significantly as more informative characters are added, until reaching a threshold, beyond which support metrics stabilize, and the effect of adding conflicting characters is minimized.			de la Torre-Barcena, JE (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	desalle@amnh.org	Coruzzi, Gloria/GWM-5852-2022; Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Katari, Manpreet/0000-0002-3377-063X; Lee, Ernest/0000-0002-0974-7763				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALBERT VA, 1994, ANN MO BOT GARD, V81, P534, DOI 10.2307/2399902; Albert VA, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-5; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Chiu JC, 2006, BIOINFORMATICS, V22, P699, DOI 10.1093/bioinformatics/btk040; CRANE PR, 1993, NATURE, V366, P631, DOI 10.1038/366631a0; CRANE PR, 1985, ANN MO BOT GARD, V72, P716, DOI 10.2307/2399221; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; de la Torre JEB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-48; DeSalle R, 2005, METHOD ENZYMOL, V395, P104, DOI 10.1016/S0076-6879(05)95008-8; Dolphin K, 2000, MOL PHYLOGENET EVOL, V17, P401, DOI 10.1006/mpev.2000.0845; Donoghue MJ, 2000, CURR BIOL, V10, pR106, DOI 10.1016/S0960-9822(00)00304-3; DOYLE JA, 1986, BOT REV, V52, P321, DOI 10.1007/BF02861082; Doyle JA, 1998, MOL PHYLOGENET EVOL, V9, P448, DOI 10.1006/mpev.1998.0506; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Frohlich MW, 2000, SYST BOT, V25, P155, DOI 10.2307/2666635; Gatesy J, 1999, CLADISTICS, V15, P271, DOI 10.1111/j.1096-0031.1999.tb00268.x; Gatesy J, 2005, SYST BIOL, V54, P483, DOI 10.1080/10635150590945368; Gatesy J, 2007, SYSTEMATIC BIOL, V56, P355, DOI 10.1080/10635150701294733; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Goremykin V, 1996, MOL BIOL EVOL, V13, P383, DOI 10.1093/oxfordjournals.molbev.a025597; HASEBE M, 1992, BOT MAG TOKYO, V105, P673, DOI 10.1007/BF02489441; Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lockhart PJ, 2005, TRENDS PLANT SCI, V10, P201, DOI 10.1016/j.tplants.2005.03.006; LOCONTE H, 1990, BRITTONIA, V42, P197, DOI 10.2307/2807216; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Mathews S, 2002, ANAL PHYTOCHROME DAT; Mathews S, 2009, AM J BOT, V96, P228, DOI 10.3732/ajb.0800178; Mayer K, 2002, CURR OPIN PLANT BIOL, V5, P173, DOI 10.1016/S1369-5266(02)00235-2; NIXON KC, 1994, ANN MO BOT GARD, V81, P484, DOI 10.2307/2399901; OTT M, 2007, P IEEE ACM SUP C SC2; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Planet PJ, 2003, NAT GENET, V34, P193, DOI 10.1038/ng1154; Poultney CS, 2007, BIOINFORMATICS, V23, P259, DOI 10.1093/bioinformatics/btl496; ROHLF FJ, 1990, EVOLUTION, V44, P1671, DOI 10.1111/j.1558-5646.1990.tb03855.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; ROTHWELL GW, 1994, SYST BOT, V19, P443, DOI 10.2307/2419767; Samigullin TK, 1999, J MOL EVOL, V49, P310, DOI 10.1007/PL00006553; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Sarkar IN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-103; Schmidt M, 2002, J MOL EVOL, V54, P715, DOI 10.1007/s00239-001-0042-9; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Soltis DE, 2002, AM J BOT, V89, P1670, DOI 10.3732/ajb.89.10.1670; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Soltis PS, 1999, MOL BIOL EVOL, V16, P1774, DOI 10.1093/oxfordjournals.molbev.a026089; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P8, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Stamatakis A, 2008, LECT N BIOINFORMAT, V5265, P424, DOI 10.1007/978-3-540-88436-1_36; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; WHEELER WC, 1990, CLADISTICS, V6, P363, DOI 10.1111/j.1096-0031.1990.tb00550.x; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Winter KU, 1999, P NATL ACAD SCI USA, V96, P7342, DOI 10.1073/pnas.96.13.7342; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	67	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5764	10.1371/journal.pone.0005764	http://dx.doi.org/10.1371/journal.pone.0005764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503618	Green Published, Green Submitted, gold			2022-12-27	WOS:000266587400007
J	Kabeer, BSA; Sikhamani, R; Swaminathan, S; Perumal, V; Paramasivam, P; Raja, A				Kabeer, Basirudeen Syed Ahamed; Sikhamani, Rajasekaran; Swaminathan, Sowmya; Perumal, Venkatesan; Paramasivam, Paulkumaran; Raja, Alamelu			Role of Interferon Gamma Release Assay in Active TB Diagnosis among HIV Infected Individuals	PLOS ONE			English	Article								Background: A rapid and specific test is urgently needed for tuberculosis (TB) diagnosis especially among human immunodeficiency virus (HIV) infected individuals. In this study, we assessed the sensitivity of Interferon gamma release assay (IGRA) in active tuberculosis patients who were positive for HIV infection and compared it with that of tuberculin skin test (TST). Methodology/Principal Findings: A total of 105 HIV-TB patients who were naive for anti tuberculosis and anti retroviral therapy were included for this study out of which 53 (50%) were culture positive. Of 105 tested, QuantiFERON-TB Gold in-tube (QFT-G) was positive in 65% (95% CI: 56% to 74%), negative in 18% (95% CI: 11% to 25%) and indeterminate in 17% (95% CI: 10% to 24%) of patients. The sensitivity of QFT-G remained similar in pulmonary TB and extra-pulmonary TB patients. The QFT-G positivity was not affected by low CD4 count, but it often gave indeterminate results especially in individuals with CD4 count <200 cells/mu l. All of the QFT-G indeterminate patients whose sputum culture were positive, showed <= 0.25IU/ml of IFN-gamma response to phytohemagglutinin (PHA). TST was performed in all the 105 patients and yielded the sensitivity of 31% (95% CI: 40% to 22%). All the TST positives were QFT-G positives. The sensitivity of TST was decreased, when CD4 cell counts declined. Conclusions/Significance: Our study shows neither QFT-G alone or in combination with TST can be used to exclude the suspicion of active TB disease. However, unlike TST, QFT-G yielded fewer false negative results even in individuals with low CD4 count. The low PHA cut-off point for indeterminate results suggested in this study (<= 0.25 IU/ml) may improve the proportion of valid QFT-G results.				alameluraja@gmail.com	Kabeer, Basirudeen Syed Ahamed/AAQ-7599-2020	Kabeer, Basirudeen Syed Ahamed/0000-0002-7287-1636	NIAID NIH HHS [R03 AI064055-01, R03 AI064055] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI064055] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balcells ME, 2008, INT J INFECT DIS, V12, P645, DOI 10.1016/j.ijid.2008.03.005; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Goletti D, 2006, CLIN MICROBIOL INFEC, V12, P544, DOI 10.1111/j.1469-0691.2006.01391.x; Hanson C A, 1989, Semin Respir Infect, V4, P182; Harada Nobuyuki, 2004, Kekkaku, V79, P725; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Janssens JP, 2007, EUR RESPIR J, V30, P722, DOI 10.1183/09031936.00028507; Janssens JP, 2007, EUR RESPIR J, V30, P183, DOI 10.1183/09031936.00042807; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; Karam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001441; Kobashi Y, 2006, CLIN INFECT DIS, V43, P1540, DOI 10.1086/509327; Lagrange Philippe H, 2008, Open Respir Med J, V2, P52, DOI 10.2174/1874306400802010052; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; *MIN HLTH FAM WELF, 1998, REV NAT TUB CONTR PR; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; SHARP V, 1993, 9 INT C AIDS; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; Swaminathan S, 2008, INT J TUBERC LUNG D, V12, P168; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; WHO, 2008, GLOBAL TUBERCULOSIS	32	61	61	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5718	10.1371/journal.pone.0005718	http://dx.doi.org/10.1371/journal.pone.0005718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479058	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000266415100011
J	Mineri, R; Pavelka, N; Fernandez-Vizarra, E; Ricciardi-Castagnoli, P; Zeviani, M; Tiranti, V				Mineri, Rossana; Pavelka, Norman; Fernandez-Vizarra, Erika; Ricciardi-Castagnoli, Paola; Zeviani, Massimo; Tiranti, Valeria			How Do Human Cells React to the Absence of Mitochondrial DNA?	PLOS ONE			English	Article								Background: Mitochondrial biogenesis is under the control of two different genetic systems: the nuclear genome (nDNA) and the mitochondrial genome (mtDNA). The mtDNA is a circular genome of 16.6 kb encoding 13 of the approximately 90 subunits that form the respiratory chain, the remaining ones being encoded by the nDNA. Eukaryotic cells are able to monitor and respond to changes in mitochondrial function through alterations in nuclear gene expression, a phenomenon first defined in yeast and known as retrograde regulation. To investigate how the cellular transcriptome is modified in response to the absence of mtDNA, we used Affymetrix HG-U133A GeneChip arrays to study the gene expression profile of two human cell lines, 143BTK(-) and A549, which had been entirely depleted of mtDNA (rho degrees cells), and compared it with that of corresponding undepleted parental cells (rho(+) cells). Results: Our data indicate that absence of mtDNA is associated with: i) a down-regulation of cell cycle control genes and a reduction of cell replication rate, ii) a down-regulation of nuclear-encoded subunits of complex III of the respiratory chain and iii) a down-regulation of a gene described as the human homolog of ELAC2 of E. coli, which encodes a protein that we show to also target to the mitochondrial compartment. Conclusions: Our results indicate a strong correlation between mitochondrial biogenesis and cell cycle control and suggest that some proteins could have a double role: for instance in controlling both cell cycle progression and mitochondrial functions. In addition, the finding that ELAC2 and maybe other transcripts that are located into mitochondria, are downregulated in rho degrees cells, make them good candidates for human disorders associated with defective replication and expression of mtDNA.			Mineri, R (corresponding author), IRCCS Fdn Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Milan, Italy.	tiranti@istituto-besta.it	Zeviani, Massimo/K-2891-2014; Tiranti, Valeria/J-8233-2016; Castagnoli, Paola/E-8288-2010; Fernandez-Vizarra, Erika/AAE-5600-2020; Pavelka, Norman/G-4577-2018; Tiranti, Valeria/AFN-5783-2022; Zeviani, Massimo/AAU-2632-2021	Tiranti, Valeria/0000-0002-3584-7338; Pavelka, Norman/0000-0003-4542-9970; Tiranti, Valeria/0000-0002-3584-7338; Zeviani, Massimo/0000-0002-9067-5508; Fernandez-Vizarra, Erika/0000-0002-2469-142X	Telethon [GGP07019] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Behan A, 2005, MITOCHONDRION, V5, P173, DOI 10.1016/j.mito.2005.03.002; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson BW, 2005, INT J BIOCHEM CELL B, V37, P927, DOI 10.1016/j.biocel.2004.11.013; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Magda D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-521; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Majumdar M, 2002, BIOCHEM BIOPH RES CO, V291, P829, DOI 10.1006/bbrc.2002.6491; MERKWIRTH C, 2008, BIOCHIM BIOPHYS ACTA, V1793, P27; Miceli MV, 2005, EXP CELL RES, V302, P270, DOI 10.1016/j.yexcr.2004.09.006; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Patterson M K Jr, 1979, Methods Enzymol, V58, P141; Pavelka N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-203; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y; Schauen M, 2006, J CELL PHYSIOL, V209, P103, DOI 10.1002/jcp.20711; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Singh KK, 2005, GENE, V354, P140, DOI 10.1016/j.gene.2005.03.027; Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Stryer L., 1988, BIOCHEMISTRY-US; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Yu CA, 1999, J BIOENERG BIOMEMBR, V31, P191, DOI 10.1023/A:1005411510913	54	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5713	10.1371/journal.pone.0005713	http://dx.doi.org/10.1371/journal.pone.0005713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492094	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415100010
J	Elgass, K; Caesar, K; Schleifenbaum, F; Stierhof, YD; Meixner, AJ; Harter, K				Elgass, Kirstin; Caesar, Katharina; Schleifenbaum, Frank; Stierhof, York-Dieter; Meixner, Alfred J.; Harter, Klaus			Novel Application of Fluorescence Lifetime and Fluorescence Microscopy Enables Quantitative Access to Subcellular Dynamics in Plant Cells	PLOS ONE			English	Article							CORRELATION SPECTROSCOPY; SINGLE MOLECULES; SYSTEMS BIOLOGY; RECEPTOR; PROTEIN; KINASE; ARABIDOPSIS; BRI1; BRASSINOSTEROIDS; GFP	Background: Optical and spectroscopic technologies working at subcellular resolution with quantitative output are required for a deeper understanding of molecular processes and mechanisms in living cells. Such technologies are prerequisite for the realisation of predictive biology at cellular and subcellular level. However, although established in the physical sciences, these techniques are rarely applied to cell biology in the plant sciences. Principal Findings: Here, we present a combined application of one-chromophore fluorescence lifetime microscopy and wavelength-selective fluorescence microscopy to analyse the function of a GFP fusion of the Brassinosteroid Insensitive 1 Receptor (BRI1-GFP) with high spatial and temporal resolution in living Arabidopsis cells in their tissue environment. We show a rapid, brassinolide-induced cell wall expansion and a fast BR-regulated change in the BRI1-GFP fluorescence lifetime in the plasmamembrane in vivo. Both cell wall expansion and changes in fluorescence lifetime reflect early BR-induced and BRI1-dependent physiological or signalling processes. Our experiments also show the potential of one-chromophore fluorescence lifetime microscopy for the in vivo monitoring of the biochemical and biophysical subcellular environment using GFP fusion proteins as probes. Significance: One-chromophore fluorescence lifetime microscopy, combined with wavelength-specific fluorescence microscopy, opens up new frontiers for in vivo dynamic and quantitative analysis of cellular processes at high resolution which are not addressable by pure imaging technologies or transmission electron microscopy.			Elgass, K (corresponding author), Univ Tubingen, Inst Phys & Theoret Chem, Morgenstelle 8, D-7400 Tubingen, Germany.	alfred.meixner@uni-tuebingen.de; klaus.harter@zmbp.uni-tuebingen.de	Meixner, Alfred J./C-1826-2014; Meixner, Alfred J./P-3260-2019	Meixner, Alfred J./0000-0002-0187-2906				Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blum C, 2001, J PHYS CHEM A, V105, P6983, DOI 10.1021/jp0031092; Bose G, 2004, BIOPHYS J, V87, P2013, DOI 10.1529/biophysj.103.038521; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Haubrick LL, 2006, PHYSIOL PLANTARUM, V128, P134, DOI 10.1111/j.1399-3054.2006.00708.x; Haubrick LL, 2006, PLANT CELL ENVIRON, V29, P446, DOI 10.1111/j.1365-3040.2005.01481.x; Heinlein T, 2005, CHEMPHYSCHEM, V6, P949, DOI 10.1002/cphc.200400622; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Lakowicz JR., 1999, PRINCIPLES FLUORESCE, P25; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu ET, 2005, CELL, V121, P505, DOI 10.1016/j.cell.2005.04.021; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Martini J, 2007, J STRUCT BIOL, V158, P401, DOI 10.1016/j.jsb.2006.12.012; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Muto Hideki, 2009, V479, P203, DOI 10.1007/978-1-59745-289-2_13; Nakabayashi T, 2008, PHOTOCH PHOTOBIO SCI, V7, P668, DOI 10.1039/b800391b; Ries J, 2008, PHYS CHEM CHEM PHYS, V10, P3487, DOI 10.1039/b718132a; Robert S, 2008, P NATL ACAD SCI USA, V105, P8464, DOI 10.1073/pnas.0711650105; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Schleifenbaum F, 2008, J PHYS CHEM B, V112, P7669, DOI 10.1021/jp7114753; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Slaughter BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001931; Striker G, 1999, J PHYS CHEM B, V103, P8612, DOI 10.1021/jp991425e; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vale RD, 2008, CELL, V135, P779, DOI 10.1016/j.cell.2008.11.009; van Manen HJ, 2008, BIOPHYS J, V94, pL67, DOI 10.1529/biophysj.107.127837; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Zander C, 1996, APPL PHYS B-LASERS O, V63, P517	37	27	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5716	10.1371/journal.pone.0005716	http://dx.doi.org/10.1371/journal.pone.0005716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492078	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415000023
J	Smidt, K; Jessen, N; Petersen, AB; Larsen, A; Magnusson, N; Jeppesen, JB; Stoltenberg, M; Culvenor, JG; Tsatsanis, A; Brock, B; Schmitz, O; Wogensen, L; Bush, AI; Rungby, J				Smidt, Kamille; Jessen, Niels; Petersen, Andreas Bronden; Larsen, Agnete; Magnusson, Nils; Jeppesen, Johanne Bruun; Stoltenberg, Meredin; Culvenor, Janetta G.; Tsatsanis, Andrew; Brock, Birgitte; Schmitz, Ole; Wogensen, Lise; Bush, Ashley I.; Rungby, Jorgen			SLC30A3 Responds to Glucose- and Zinc Variations in beta-Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During beta-Cell Stress	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK LOCI; SYNAPTIC VESICLES; TRANSPORTER GENES; PANCREATIC-ISLETS; GLUCAGON-RELEASE; TRANSGENIC MICE; FAMILY GENES; MOUSE-BRAIN; DEATH	Background: Ion transporters of the Slc30A-(ZnT-) family regulate zinc fluxes into sub-cellular compartments. beta-cells depend on zinc for both insulin crystallization and regulation of cell mass. Methodology/Principal Findings: This study examined: the effect of glucose and zinc chelation on ZnT gene and protein levels and apoptosis in beta-cells and pancreatic islets, the effects of ZnT-3 knock-down on insulin secretion in a beta-cell line and ZnT-3 knock-out on glucose metabolism in mice during streptozotocin-induced beta-cell stress. In INS-1E cells 2 mM glucose down-regulated ZnT-3 and up-regulated ZnT-5 expression relative to 5 mM. 16 mM glucose increased ZnT-3 and decreased ZnT-8 expression. Zinc chelation by DEDTC lowered INS-1E insulin content and insulin expression. Furthermore, zinc depletion increased ZnT-3- and decreased ZnT-8 gene expression whereas the amount of ZnT-3 protein in the cells was decreased. Zinc depletion and high glucose induced apoptosis and necrosis in INS-1E cells. The most responsive zinc transporter, ZnT-3, was investigated further; by immunohistochemistry and western blotting ZnT-3 was demonstrated in INS-1E cells. 44% knock-down of ZnT-3 by siRNA transfection in INS-1E cells decreased insulin expression and secretion. Streptozotocin-treated mice had higher glucose levels after ZnT-3 knock-out, particularly in overt diabetic animals. Conclusion/Significance: Zinc transporting proteins in beta-cells respond to variations in glucose and zinc levels. ZnT-3, which is pivotal in the development of cellular changes as also seen in type 2 diabetes (e. g. amyloidosis in Alzheimer's disease) but not previously described in beta-cells, is present in this cell type, up-regulated by glucose in a concentration dependent manner and up-regulated by zinc depletion which by contrast decreased ZnT-3 protein levels. Knock-down of the ZnT-3 gene lowers insulin secretion in vitro and affects in vivo glucose metabolism after streptozotocin treatment.			Smidt, K (corresponding author), Aarhus Univ, Dept Pharmacol, Aarhus, Denmark.	jr@farm.au.dk	Rungby, Jørgen/AAQ-4332-2021; Bush, Ashley I/A-1186-2007; Jessen, Niels/E-1731-2011; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Larsen, Agnete/0000-0001-8765-8443; Jessen, Niels/0000-0001-5613-7274; Magnusson, Nils Erik/0000-0002-9614-0133				Ackland ML, 2007, IMMUNOL CELL BIOL, V85, P617, DOI 10.1038/sj.icb.7100109; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; Chang I, 2003, DIABETOLOGIA, V46, P1220, DOI 10.1007/s00125-003-1171-z; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Clifford KS, 2000, DIABETES RES CLIN PR, V49, P77, DOI 10.1016/S0168-8227(00)00141-8; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; KADOTA I, 1951, J LAB CLIN MED, V38, P671; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kim BJ, 2000, DIABETES, V49, P367, DOI 10.2337/diabetes.49.3.367; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; KURAHASHI M, 1993, DIABETES RES CLIN PR, V19, P39, DOI 10.1016/0168-8227(93)90143-S; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lee JY, 2000, J NEUROSCI, V20; Lee JY, 2004, J BIOL CHEM, V279, P8602, DOI 10.1074/jbc.M309730200; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Priel T, 2007, EUR J PHARMACOL, V565, P232, DOI 10.1016/j.ejphar.2007.02.064; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smidt K, 2006, HORM METAB RES, V38, P8, DOI 10.1055/s-2006-924968; Smidt K, 2007, MOL CELL ENDOCRINOL, V264, P68, DOI 10.1016/j.mce.2006.10.010; Sondergaard LG, 2005, HORM METAB RES, V37, P133, DOI 10.1055/s-2005-861290; Sondergaard LG, 2003, APMIS, V111, P1147, DOI 10.1111/j.1600-0463.2003.apm1111211.x; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wall MJ, 2005, CEREBELLUM, V4, P224, DOI 10.1080/14734220500242084; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	69	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5684	10.1371/journal.pone.0005684	http://dx.doi.org/10.1371/journal.pone.0005684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19492079	Green Published, gold			2022-12-27	WOS:000266331700012
J	Stuart-Fox, D; Godinho, R; de Bellocq, JG; Irwin, NR; Brito, JC; Moussalli, A; Siroky, P; Hugall, AF; Baird, SJE				Stuart-Fox, Devi; Godinho, Raquel; de Bellocq, Joelle Gouey; Irwin, Nancy R.; Brito, Jose Carlos; Moussalli, Adnan; Siroky, Pavel; Hugall, Andrew F.; Baird, Stuart J. E.			Variation in Phenotype, Parasite Load and Male Competitive Ability across a Cryptic Hybrid Zone	PLOS ONE			English	Article							LIZARD LACERTA-SCHREIBERI; SEXUAL SELECTION; MITOCHONDRIAL-DNA; MATING SUCCESS; FEMALE CHOICE; MATE CHOICE; PHYLOGEOGRAPHY; EVOLUTION; PLUMAGE; HYBRIDIZATION	Background: Molecular genetic studies are revealing an increasing number of cryptic lineages or species, which are highly genetically divergent but apparently cannot be distinguished morphologically. This observation gives rise to three important questions: 1) have these cryptic lineages diverged in phenotypic traits that may not be obvious to humans; 2) when cryptic lineages come into secondary contact, what are the evolutionary consequences: stable co-existence, replacement, admixture or differentiation and 3) what processes influence the evolutionary dynamics of these secondary contact zones? Methodology/Principal Findings: To address these questions, we first tested whether males of the Iberian lizard Lacerta schreiberi from two highly genetically divergent, yet morphologically cryptic lineages on either side of an east-west secondary contact could be differentiated based on detailed analysis of morphology, coloration and parasite load. Next, we tested whether these differences could be driven by pre-copulatory intra-sexual selection (male-male competition). Compared to eastern males, western males had fewer parasites, were in better body condition and were more intensely coloured. Although subtle environmental variation across the hybrid zone could explain the differences in parasite load and body condition, these were uncorrelated with colour expression, suggesting that the differences in coloration reflect heritable divergence. The lineages did not differ in their aggressive behaviour or competitive ability. However, body size, which predicted male aggressiveness, was positively correlated with the colour traits that differed between genetic backgrounds. Conclusions/Significance: Our study confirms that these cryptic lineages differ in several aspects that are likely to influence fitness. Although there were no clear differences in male competitive ability, our results suggest a potential indirect role for intra-sexual selection. Specifically, if lizards use the colour traits that differ between genetic backgrounds to assess the size of potential rivals or mates, the resulting fitness differential favouring western males could result in net male-mediated gene flow from west to east across the current hybrid zone.			Stuart-Fox, D (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	devis@unimelb.edu.au	Brito, José C./A-7831-2010; Baird, Stuart J. E./B-3872-2011; Irwin, Nancy R./G-3818-2015; Široký, Pavel/H-1674-2014; Godinho, Raquel/L-6804-2013; Gouy de Bellocq, Joelle/J-4733-2013	Brito, José C./0000-0001-5444-8132; Irwin, Nancy R./0000-0002-9384-0134; Godinho, Raquel/0000-0002-4260-4799; Gouy de Bellocq, Joelle/0000-0001-5831-6284; Stuart-Fox, Devi/0000-0003-3362-1412				Andersson Malte, 1994; Andersson S., 2006, BIRD COLORATION, P76; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Brito JC, 1998, HERPETOL J, V8, P187; Bronson CL, 2003, ANIM BEHAV, V65, P489, DOI 10.1006/anbe.2003.2103; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; DESSER SS, 1993, PARASITIC PROTOZOA, V4, P247; Estrada-Pena A, 2005, EXP APPL ACAROL, V37, P257, DOI 10.1007/s10493-005-3271-6; Fritz RS, 1999, ANNU REV ECOL SYST, V30, P565, DOI 10.1146/annurev.ecolsys.30.1.565; Godinho R, 2008, MOL ECOL, V17, P4670, DOI 10.1111/j.1365-294X.2008.03929.x; Godinho R, 2006, HEREDITY, V96, P454, DOI 10.1038/sj.hdy.6800823; Godinho R, 2003, HERPETOL J, V13, P35; Harrison RG, 1993, HYBRID ZONES EVOLUTI; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; HEWS DK, 1990, EVOLUTION, V44, P1956, DOI 10.1111/j.1558-5646.1990.tb04302.x; Hill GE, 2005, ANIM BEHAV, V69, P387, DOI 10.1016/j.anbehav.2004.03.013; Hoskin CJ, 2005, NATURE, V437, P1353, DOI 10.1038/nature04004; Hoskin CJ, 2007, BIOL J LINN SOC, V92, P593, DOI 10.1111/j.1095-8312.2007.00862.x; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; JOHN JL, 1995, OIKOS, V72, P395, DOI 10.2307/3546125; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; Lailvaux SP, 2004, P ROY SOC B-BIOL SCI, V271, P2501, DOI 10.1098/rspb.2004.2891; Lappin AK, 2005, AM NAT, V166, P426, DOI 10.1086/432564; Leache AD, 2007, MOL ECOL, V16, P1035, DOI 10.1111/j.1365-294X.2006.03194.x; LEVINE N. D., 1988, PROTOZOAN PHYLUM API, VI; Lopez P, 2004, ETHOLOGY, V110, P543, DOI 10.1111/j.1439-0310.2004.00996.x; LOSOS JB, 1985, COPEIA, P905, DOI 10.2307/1445240; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Marco A, 1999, ETHOL ECOL EVOL, V11, P279, DOI 10.1080/08927014.1999.9522828; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; Martin J, 1999, ETHOLOGY, V105, P439, DOI 10.1046/j.1439-0310.1999.00418.x; Martin J, 2007, BIOL LETTERS, V3, P125, DOI 10.1098/rsbl.2006.0589; McDonald DB, 2001, EVOLUTION, V55, P1443; Moller AP, 1998, J EVOLUTION BIOL, V11, P703, DOI 10.1007/s000360050114; MORAZA ML, ZOOTAXA IN PRESS; Moulia C, 1999, ECOLOGY, V80, P392, DOI 10.1890/0012-9658(1999)080[0392:POPAAH]2.0.CO;2; O'Connor DE, 2004, ANIM BEHAV, V68, P1361, DOI 10.1016/j.anbehav.2004.02.014; OLSSON M, 1995, BEHAV ECOL SOCIOBIOL, V36, P179, DOI 10.1007/BF00177794; Ord TJ, 2001, P ROY SOC B-BIOL SCI, V268, P737, DOI 10.1098/rspb.2000.1417; Orr HA, 2007, J HERED, V98, P103, DOI 10.1093/jhered/esl060; PARSONS TJ, 1993, SCIENCE, V260, P1643, DOI 10.1126/science.260.5114.1643; Paulo OS, 2001, P ROY SOC B-BIOL SCI, V268, P1625, DOI 10.1098/rspb.2001.1706; Pearson SF, 2000, BEHAV ECOL, V11, P93, DOI 10.1093/beheco/11.1.93; PEREIRA R, 2005, THESIS U PORTO PORTO; Perry G, 2004, ANIM BEHAV, V67, P37, DOI 10.1016/j.anbehav.2003.02.003; Phillips BL, 2004, EVOLUTION, V58, P1536; Reichenow, 1913, ARB KAISERL GESUNDH, V45, P317; Reudink MW, 2006, BEHAV ECOL, V17, P56, DOI 10.1093/beheco/ari098; Reullier J, 2006, MOL ECOL, V15, P753, DOI 10.1111/j.1365-294X.2005.02826.x; Rohwer S, 2001, EVOLUTION, V55, P405; Schall JJ, 1997, OECOLOGIA, V111, P543, DOI 10.1007/s004420050269; Siroky P, 2007, FOLIA PARASIT, V54, P13, DOI 10.14411/fp.2007.002; Sorci G, 1997, TRENDS ECOL EVOL, V12, P196, DOI 10.1016/S0169-5347(97)01056-2; Stein AC, 2006, EVOLUTION, V60, P1476, DOI 10.1111/j.0014-3820.2006.tb01226.x; Stuart-Fox DM, 2005, BEHAVIOUR, V142, P329, DOI 10.1163/1568539053778265; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; Svahn K., 1975, Norwegian J Zool, V23, P277; TOKARZ RR, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P17, DOI 10.2307/1466994; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Walther BA, 1999, OIKOS, V87, P157, DOI 10.2307/3547006; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018; Whiting MJ, 2003, LIZARD SOCIAL BEHAVIOR, P47; Whiting MJ, 1999, BEHAV ECOL SOCIOBIOL, V46, P210, DOI 10.1007/s002650050611; Wolinska J, 2008, TRENDS PARASITOL, V24, P121, DOI 10.1016/j.pt.2007.11.010	66	17	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5677	10.1371/journal.pone.0005677	http://dx.doi.org/10.1371/journal.pone.0005677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479073	Green Published, gold			2022-12-27	WOS:000266331700005
J	Haston, KM; Tung, JY; Pera, RAR				Haston, Kelly M.; Tung, Joyce Y.; Pera, Renee A. Reijo			Dazl Functions in Maintenance of Pluripotency and Genetic and Epigenetic Programs of Differentiation in Mouse Primordial Germ Cells In Vivo and In Vitro	PLOS ONE			English	Article								Background: Mammalian germ cells progress through a unique developmental program that encompasses proliferation and migration of the nascent primordial germ cell (PGC) population, reprogramming of nuclear DNA to reset imprinted gene expression, and differentiation of mature gametes. Little is known of the genes that regulate quantitative and qualitative aspects of early mammalian germ cell development both in vivo, and during differentiation of germ cells from mouse embryonic stem cells (mESCs) in vitro. Methodology and Principal Findings: We used a transgenic mouse system that enabled isolation of small numbers of Oct4 Delta PE:GFP-positive germ cells in vivo, and following differentiation from mESCs in vitro, to uncover quantitate and qualitative phenotypes associated with the disruption of a single translational regulator, Dazl. We demonstrate that disruption of Dazl results in a post-migratory, pre-meiotic reduction in PGC number accompanied by aberrant expression of pluripotency genes and failure to erase and re-establish genomic imprints in isolated male and female PGCs, as well as subsequent defect in progression through meiosis. Moreover, the phenotypes observed in vivo were mirrored by those in vitro, with inability of isolated mutant PGCs to establish pluripotent EG (embryonic germ) cell lines and few residual Oct-4-expressing cells remaining after somatic differentiation of mESCs carrying a Dazl null mutation. Finally, we observed that even within undifferentiated mESCs, a nascent germ cell subpopulation exists that was effectively eliminated with ablation of Dazl. Conclusions and Significance: This report establishes the translational regulator Dazl as a component of pluripotency, genetic, and epigenetic programs at multiple time points of germ cell development in vivo and in vitro, and validates use of the ESC system to model and explore germ cell biology.			Haston, KM (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Obstet & Gynecol, Palo Alto, CA 94304 USA.	reneer@stanford.edu		Reijo Pera, Renee/0000-0002-6487-1329	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055764] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD055764, R01 HD047221, 5U54HD055764-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Anderson R, 1999, DEVELOPMENT, V126, P1655; Bendsen E, 2003, HUM REPROD, V18, P13, DOI 10.1093/humrep/deg057; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Cao F, 2007, STEM CELLS DEV, V16, P883, DOI 10.1089/scd.2007.0160; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; De Miguel MP, 2003, METHOD ENZYMOL, V365, P353; DOETSCHMAN T, 2009, METHOD MOL BIOL, V530, P1; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Eisener-Dorman AF, 2009, BRAIN BEHAV IMMUN, V23, P318, DOI 10.1016/j.bbi.2008.09.001; Ensenat-Waser R, 2006, IN VITRO CELL DEV-AN, V42, P115, DOI 10.1290/0509063.1; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; GOMPERTS M, 1994, DEVELOPMENT, V120, P135; Gonsalves J, 2005, REPRODUCTION, V130, P223, DOI 10.1530/rep.1.00641; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hasegawa E, 2006, DEV BIOL, V295, P689, DOI 10.1016/j.ydbio.2006.04.002; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Houston DW, 2000, CURR TOP DEV BIOL, V50, P155, DOI 10.1016/S0070-2153(00)50008-8; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Molyneaux KA, 2003, DEVELOPMENT, V130, P4287, DOI 10.1242/dev.00650; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Moore FL, 2004, GENOMICS, V83, P834, DOI 10.1016/j.ygeno.2003.11.005; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okamura D, 2005, MOL REPROD DEV, V70, P20, DOI 10.1002/mrd.20136; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Swain A, 2006, CURR BIOL, V16, pR507, DOI 10.1016/j.cub.2006.06.009; Teramura T, 2007, CLONING STEM CELLS, V9, P144, DOI 10.1089/clo.2006.0070; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Tung JY, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-40; Tung JY, 2006, HUM GENET, V118, P730, DOI 10.1007/s00439-005-0098-5; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wang R, 2008, DIFFERENTIATION, V76, P931, DOI 10.1111/j.1432-0436.2008.00272.x; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yen PH, 1996, HUM MOL GENET, V5, P2013, DOI 10.1093/hmg/5.12.2013; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	67	85	91	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5654	10.1371/journal.pone.0005654	http://dx.doi.org/10.1371/journal.pone.0005654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19468308	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331000012
J	Franzen, JL; Gingerich, PD; Habersetzer, J; Hurum, JH; von Koenigswald, W; Smith, BH				Franzen, Jens L.; Gingerich, Philip D.; Habersetzer, Joerg; Hurum, Jorn H.; von Koenigswald, Wighart; Smith, B. Holly			Complete Primate Skeleton from the Middle Eocene of Messel in Germany: Morphology and Paleobiology	PLOS ONE			English	Article							LIFE-HISTORY; SEXUAL DIMORPHISM; SAIMIRI-SCIUREUS; EVOLUTION; GROWTH; ADAPTATIONS; NOTHARCTUS; PHYLOGENY; DENTITION; ADAPIDAE	Background: The best European locality for complete Eocene mammal skeletons is Grube Messel, near Darmstadt, Germany. Although the site was surrounded by a para-tropical rain forest in the Eocene, primates are remarkably rare there, and only eight fragmentary specimens were known until now. Messel has now yielded a full primate skeleton. The specimen has an unusual history: it was privately collected and sold in two parts, with only the lesser part previously known. The second part, which has just come to light, shows the skeleton to be the most complete primate known in the fossil record. Methodology/Principal Findings: We describe the morphology and investigate the paleobiology of the skeleton. The specimen is described as Darwinius masillae n.gen. n.sp. belonging to the Cercamoniinae. Because the skeleton is lightly crushed and bones cannot be handled individually, imaging studies are of particular importance. Skull radiography shows a host of teeth developing within the juvenile face. Investigation of growth and proportion suggest that the individual was a weaned and independent-feeding female that died in her first year of life, and might have attained a body weight of 650-900 g had she lived to adulthood. She was an agile, nail-bearing, generalized arboreal quadruped living above the floor of the Messel rain forest. Conclusions/Significance: Darwinius masillae represents the most complete fossil primate ever found, including both skeleton, soft body outline and contents of the digestive tract. Study of all these features allows a fairly complete reconstruction of life history, locomotion, and diet. Any future study of Eocene-Oligocene primates should benefit from information preserved in the Darwinius holotype. Of particular importance to phylogenetic studies, the absence of a toilet claw and a toothcomb demonstrates that Darwinius masillae is not simply a fossil lemur, but part of a larger group of primates, Adapoidea, representative of the early haplorhine diversification.			Franzen, JL (corresponding author), Forschungsinst Senckenberg, Frankfurt, Germany.	j.h.hurum@nhm.uio.no	Gingerich, Philip D/A-6903-2008; Smith, B. Holly/C-4984-2008	Gingerich, Philip D/0000-0002-1550-2674; Smith, B. Holly/0000-0001-5126-5445				Asher RJ, 1998, AM J PHYS ANTHROPOL, V105, P355, DOI 10.1002/(SICI)1096-8644(199803)105:3<355::AID-AJPA5>3.0.CO;2-Q; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P11093, DOI 10.1073/pnas.0804159105; BEARD KC, 1988, INT J PRIMATOL, V9, P83, DOI 10.1007/BF02735730; DAGOSTO M, 1992, INT J PRIMATOL, V13, P307, DOI 10.1007/BF02547818; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; Dean MC, 2008, J HUM EVOL, V54, P258, DOI 10.1016/j.jhevol.2007.09.021; Decker R.L., 1974, P261; DIXON AF, 1987, AM J PRIMATOL, V13, P51; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Franzen J.L., 1987, Courier Forschungsinstitut Senckenberg, V91, P151; Franzen J.L., 1993, P379; Franzen J.L., 1988, Courier Forschungsinstitut Senckenberg, V107, P275; Franzen Jens Lorenz, 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V3, P113; Franzen Jens Lorenz, 2005, Annales de Paleontologie, V91, P329, DOI 10.1016/j.annpal.2005.04.002; Franzen Jens Lorenz, 2000, Senckenbergiana Lethaea, V80, P289; Franzen Jens Lorenz, 1994, Natur und Museum (Frankfurt am Main), V124, P91; Franzen Jens Lorenz, 1994, P99; Franzen Jens Lorenz, 2000, Senckenbergiana Lethaea, V80, P275; Franzen Jens Lorenz, 1997, Natur und Museum (Frankfurt am Main), V127, P46; Franzen Jens Lorenz, 2007, Schweizerische Palaeontologische Abhandlungen, V127, P1; Franzen JL, 2003, J HUM EVOL, V44, P373, DOI 10.1016/S0047-2484(02)00204-X; FRANZEN JL, 1983, PALAONTOLOGISCHE GES, V53; GEBO DL, 1986, J HUM EVOL, V15, P421, DOI 10.1016/S0047-2484(86)80025-2; Geoffroy Saint-Hilaire E., 1812, ANN MUS HIST NAT, V19, P156; GINGERICH P D, 1975, Contributions from the Museum of Paleontology University of Michigan, V24, P163; GINGERICH P D, 1990, Contributions from the Museum of Paleontology University of Michigan, V28, P79; Gingerich P. D., 1977, Geobios Lyon Memoire Special, VNo. 1, P165; GINGERICH PD, 1982, AM J PHYS ANTHROPOL, V58, P81, DOI 10.1002/ajpa.1330580110; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; GINGERICH PD, 1979, J PALEONTOL, V53, P153; GINGERICH PD, 1981, AM J PHYS ANTHROPOL, V56, P217, DOI 10.1002/ajpa.1330560303; GINGERICH PD, 1986, NATURE, V320, P319; Godinot M, 1998, FOLIA PRIMATOL, V69, P218, DOI 10.1159/000052715; Godinot M., 1993, P335; Godinot M., 1992, Human Evolution, V6, P307, DOI 10.1007/BF02437255; GODINOT M, 1992, J HUM EVOL, V22, P267, DOI 10.1016/0047-2484(92)90059-I; GODINOT M, 1983, ACT S PAL, P221; Godinot Marc, 2008, P285, DOI 10.1007/978-1-4020-6997-0_12; Gregory W. K., 1920, Memoirs from the American Museum of Natural History New York NS, V3, P49; Gregory WK, 1915, BULL GEOL SOC AM, V26, P419; Gruber G., 2007, MESSEL TREASURES EOC; GUNNELL GF, 1995, AM J PHYS ANTHROPOL, V98, P447, DOI 10.1002/ajpa.1330980406; Hamrick Mark W., 1996, American Museum Novitates, V3182, P1; HARTENBERGER J.-L., 1970, B SOC GEOL FRANCE, V12, P886; Hill W.C.O., 1955, PRIMATES COMP ANATOM; HUBRECHT AAW, 1897, LECT DELIVERED OCCAS; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Kelley J, 2003, J HUM EVOL, V44, P307, DOI 10.1016/S0047-2484(03)00005-8; KOENIGSWALD W, 1979, PALAEONTOL Z, V53, P63; Koenigswald W. v, 1985, CAROLINEA, V42, P145; Koenigswald W. von, 1998, MESSEL POMPEJI PALAO; Koenigswald Wv, 2004, PALAEONTOL Z, V78, P345; LONG JO, 1968, SQUIRREL MONKEY, P169; MACPHEE RDE, 1987, AM J PHYS ANTHROPOL, V74, P233; MANOCHA SL, 1979, EXPERIENTIA, V35, P96, DOI 10.1007/BF01917901; Marivaux L, 2005, P NATL ACAD SCI USA, V102, P8436, DOI 10.1073/pnas.0503469102; Marivaux L, 2003, P NATL ACAD SCI USA, V100, P13173, DOI 10.1073/pnas.2332542100; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Mertz D.F., 2005, COUR FORSCH I SENCKE, V255, P67; Osman Hill WC, 1953, PRIMATES COMP ANATOM; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; POCOCK RI, 1918, P ZOOL SOC LOND, V3, P19; Pucciarelli HM, 2000, AM J PHYS ANTHROPOL, V112, P57, DOI 10.1002/(SICI)1096-8644(200005)112:1<57::AID-AJPA7>3.3.CO;2-H; RASMUSSEN DT, 1990, INT J PRIMATOL, V11, P439, DOI 10.1007/BF02196131; Richter G., 1980, Natur und Museum (Frankfurt am Main), V110, P353; ROSENBERGER AL, 1985, FOLIA PRIMATOL, V44, P15, DOI 10.1159/000156195; Rowe N, 1996, PICTORIAL GUIDE LIVI; Rutimeyer L., 1862, NEUE DENKSCHRIFTEN A, V19, P1; Schaal S., 1992, MESSEL INSIGHT HIST; Schaefer MS, 2007, AM J PRIMATOL, V69, P103, DOI 10.1002/ajp.20330; Schaller O., 2007, ILLUSTRATED VET ANAT, P614; Schmitz J, 2001, GENETICS, V157, P777; SCHULTZ AH, 1971, HUMAN GROWTH, V3, P1; Schwartz GT, 2002, P NATL ACAD SCI USA, V99, P6124, DOI 10.1073/pnas.092685099; SHIGEHARA N, 1980, Primates, V21, P1, DOI 10.1007/BF02383820; Simons EL, 1972, PRIMATE EVOLUTION IN; SIMONS ELWYN L., 1962, BULL BRIT MUS [NAT HIST] GEOL, V7, P1; Sirianni J. E., 1985, GROWTH DEV PIGTAILED; Smith B. H., 1991, AM J PHYS ANTHR S, V12, P163; Smith B. Holly, 1994, Yearbook of Physical Anthropology, V37, P177; Smith B. Holly, 2000, P212, DOI 10.1017/CBO9780511542626.015; SMITH BH, 1989, EVOLUTION, V43, P683, DOI 10.1111/j.1558-5646.1989.tb04266.x; SMITH GE, 1919, P ZOOL SOC LOND, V1919, P465; Soligo C, 2006, AM J PHYS ANTHROPOL, V130, P283, DOI 10.1002/ajpa.20298; Szalay FS, 1976, B AM MUS NAT HIST, V156, P159; TAPPEN NC, 1971, FOLIA PRIMATOL, V15, P293, DOI 10.1159/000155387; Thalmann Urs, 1994, Courier Forschungsinstitut Senckenberg, V175, P1; WUTTKE M, 1983, Senckenbergiana Lethaea, V64, P509; YOUNG JW, 2008, THESIS STATE U NEW Y	89	94	121	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5723	10.1371/journal.pone.0005723	http://dx.doi.org/10.1371/journal.pone.0005723			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	446ZK	19492084	Green Published, gold, Green Submitted			2022-12-27	WOS:000266161200021
J	Parcellier, A; Tintignac, LA; Zhuravleva, E; Dummler, B; Brazil, DP; Hynx, D; Cron, P; Schenk, S; Olivieri, V; Hemmings, BA				Parcellier, Arnaud; Tintignac, Lionel A.; Zhuravleva, Elena; Dummler, Bettina; Brazil, Derek P.; Hynx, Debby; Cron, Peter; Schenk, Susanne; Olivieri, Vesna; Hemmings, Brian A.			The Carboxy-Terminal Modulator Protein (CTMP) Regulates Mitochondrial Dynamics	PLOS ONE			English	Article								Background: Mitochondria are central to the metabolism of cells and participate in many regulatory and signaling events. They are looked upon as dynamic tubular networks. We showed recently that the Carboxy-Terminal Modulator Protein (CTMP) is a mitochondrial protein that may be released into the cytosol under apoptotic conditions. Methodology/Principal Findings: Here we report an unexpected function of CTMP in mitochondrial homeostasis. In this study, both full length CTMP, and a CTMP mutant refractory to N-terminal cleavage and leading to an immature protein promote clustering of spherical mitochondria, suggesting a role for CTMP in the fission process. Indeed, cellular depletion of CTMP led to accumulation of swollen and interconnected mitochondria, without affecting the mitochondrial fusion process. Importantly, in vivo results support the relevance of these findings, as mitochondria from livers of adult CTMP knockout mice had a similar phenotype to cells depleted of CTMP. Conclusions/Significance: Together, these results lead us to propose that CTMP has a major function in mitochondrial dynamics and could be involved in the regulation of mitochondrial functions.			Parcellier, A (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	brian.hemmings@fmi.ch		Tintignac, Lionel/0000-0001-5902-1138; Brazil, Derek/0000-0003-1375-1076				Ahmad N, 2006, AM J PHYSIOL-HEART C, V290, pH2402, DOI 10.1152/ajpheart.00737.2005; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delivani P, 2006, MOL CELL, V21, P761, DOI 10.1016/j.molcel.2006.01.034; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Knobbe CB, 2004, J NATL CANCER I, V96, P483, DOI 10.1093/jnci/djh064; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; PARCELLIER A, 2009, CELL SIGNAL; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; PIAO L, 2009, CELL SIGNAL; Rojo M, 2002, J CELL SCI, V115, P1663; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Tintignac LAJ, 2004, MOL CELL BIOL, V24, P1809, DOI 10.1128/MCB.24.4.1809-1821.2004; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wright GL, 2008, FASEB J, V22, P3264, DOI 10.1096/fj.08-106468; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Youle RJ, 2005, DEV CELL, V8, P298, DOI 10.1016/j.devcel.2005.02.003; Zollino M, 2003, AM J HUM GENET, V72, P590, DOI 10.1086/367925	45	13	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5471	10.1371/journal.pone.0005471	http://dx.doi.org/10.1371/journal.pone.0005471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421406	Green Submitted, gold, Green Published			2022-12-27	WOS:000265837000007
J	Rathcke, CN; Holmkvist, J; Jorgensen, T; Borch-Johnsen, K; Hansen, T; Pedersen, OB; Vestergaard, H				Rathcke, Camilla Noelle; Holmkvist, Johan; Jorgensen, Torben; Borch-Johnsen, Knut; Hansen, Torben; Pedersen, Oluf Borbye; Vestergaard, Henrik			Variation in CHI3LI in Relation to Type 2 Diabetes and Related Quantitative Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SMOOTH-MUSCLE-CELLS; HEPARIN-BINDING GLYCOPROTEIN; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION; SERUM-LEVELS; YKL-40; INFLAMMATION	Background: CHI3LI encoding the inflammatory glycoprotein YKL-40 is located on chromosome 1q32.1. YKL-40 is involved in inflammatory processes and patients with Type 2 Diabetes (T2D) have elevated circulating YKL-40 levels which correlate with their level of insulin resistance. Interestingly, it has been reported that rs10399931 (-329 G/A) of CHI3LI contributes to the inter-individual plasma YKL-40 levels in patients with sarcoidosis, and that rs4950928 (-131 C/G) is a susceptibility polymorphism for asthma and a decline in lung function. We hypothesized that single nucleotide polymorphisms (SNPs) or haplotypes thereof the CHI3LI locus might influence risk of T2D. The aim of the present study was to investigate the putative association between SNPs and haplotype blocks of CHI3LI and T2D and T2D related quantitative traits. Methods/Principal Findings: Eleven SNPs of CHI3LI were genotyped in 6514 individuals from the Inter99 cohort and 2924 individuals from the outpatient clinic at Steno Diabetes Center. In cas-control studies a total of 2345 T2D patients and 5302 individuals with a normal glucose tolerance test were examined. We found no association between rs10399931 (OR, 0.98 (CI, 0.88-1.10), p = 0.76), rs4950928 (0.98 (0.87-1.10), p = 0.68) or any of the other SNPs with T2D. Similarly, we found no significant association between any of the 11 tgSNPs and T2D related quantitative traits, all p>0.14. None of the identified haplotype blocks of CHI3LI showed any association with T2D, all p>0.16. Conclusions/Significance: None of the examined SNPs or haplotype blocks of CHI3LI showed any association with T2D or T2D related quantitative traits. Estimates of insulin resistance and dysregulated glucose homeostasis in T2D do not seem to be accounted for by the examined variations of CHI3LI.			Rathcke, CN (corresponding author), Univ Copenhagen, Dept Endocrinol, Herlev Hosp, Copenhagen, Denmark.	cnr@dadlnet.dk	Pedersen, Oluf/AAG-8015-2020; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019	Pedersen, Oluf/0000-0002-3321-3972; Jorgensen, Torben/0000-0001-9453-2830; Vestergaard, Henrik/0000-0003-3090-269X				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dupuis J, 2005, ATHEROSCLEROSIS, V182, P307, DOI 10.1016/j.atherosclerosis.2005.02.015; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Festa A, 2003, CIRCULATION, V108, P1822, DOI 10.1161/01.CIR.0000091339.70120.53; Ingelsson E, 2008, EUR J CLIN INVEST, V38, P502, DOI 10.1111/j.1365-2362.2008.01962.x; Johansen JS, 2006, DAN MED BULL, V53, P172; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Langefeld CD, 2004, DIABETES, V53, P1170, DOI 10.2337/diabetes.53.4.1170; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; McCarthy MI, 2007, TRENDS PHARMACOL SCI, V28, P598, DOI 10.1016/j.tips.2007.10.008; McCarthy Mark I, 2006, Curr Diab Rep, V6, P147, DOI 10.1007/s11892-006-0026-7; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; MILLIS AJT, 1986, J CELL PHYSIOL, V127, P366, DOI 10.1002/jcp.1041270304; Nojgaard C, 2008, CORONARY ARTERY DIS, V19, P257, DOI 10.1097/MCA.0b013e3282f40dd5; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Pantsulaia I, 2002, CYTOKINE, V19, P138, DOI 10.1006/cyto.2002.1959; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Rathcke CN, 2006, INFLAMM RES, V55, P53, DOI 10.1007/s00011-005-0010-8; RATHCKE CN, 2009, DIABETES CA IN PRESS; RATHCKE CN, 2009, INT J CARDI IN PRESS; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5469	10.1371/journal.pone.0005469	http://dx.doi.org/10.1371/journal.pone.0005469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421404	Green Submitted, gold, Green Published			2022-12-27	WOS:000265837000005
J	Defourny, I; Minetti, A; Harczi, G; Doyon, S; Shepherd, S; Tectonidis, M; Bradol, JH; Golden, M				Defourny, Isabelle; Minetti, Andrea; Harczi, Geza; Doyon, Stephane; Shepherd, Susan; Tectonidis, Milton; Bradol, Jean-Herve; Golden, Michael			A Large-Scale Distribution of Milk-Based Fortified Spreads: Evidence for a New Approach in Regions with High Burden of Acute Malnutrition	PLOS ONE			English	Article								Background: There are 146 million underweight children in the developing world, which contribute to up to half of the world's child deaths. In high burden regions for malnutrition, the treatment of individual children is limited by available resources. Here, we evaluate a large-scale distribution of a nutritional supplement on the prevention of wasting. Methods and Findings: A new ready-to-use food (RUF) was developed as a diet supplement for children under three. The intervention consisted of six monthly distributions of RUF during the 2007 hunger gap in a district of Maradi region, Niger, for approximately 60,000 children (length: 60-85 cm). At each distribution, all children over 65 cm had their Mid-Upper Arm Circumference (MUAC) recorded. Admission trends for severe wasting (WFH, 70% NCHS) in Maradi, 2002-2005 show an increase every year during the hunger gap. In contrast, in 2007, throughout the period of the distribution, the incidence of severe acute malnutrition (MUAC, 110 mm) remained at extremely low levels. Comparison of year-over-year admissions to the therapeutic feeding program shows that the 2007 blanket distribution had essentially the same flattening effect on the seasonal rise in admissions as the 2006 individualized treatment of almost 60,000 children moderately wasted. Conclusions: These results demonstrate the potential for distribution of fortified spreads to reduce the incidence of severe wasting in large population of children 6-36 months of age. Although further information is needed on the cost-effectiveness of such distributions, these results highlight the importance of re-evaluating current nutritional strategies and international recommendations for high burden areas of childhood malnutrition.			Defourny, I (corresponding author), Med Sans Frontieres, Paris, France.	andrea.minetti@epicentre.msf.org	Golden, Michael/AAB-8989-2020	Golden, Michael/0000-0002-4039-7538				Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Attama S, 1998, ENQUETE DEMOGRAPHIQU; Beaton G., 1993, EFFECTIVENESS VITAMI; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Dale NM, 2009, ARCH PEDIAT ADOL MED, V163, P126, DOI 10.1001/archpediatrics.2008.540; Defourny I, 2006, FIELD EXCHANGE, V28, P2; Defourny I, 2007, FIELD EXCHANGE, V31, P2; Delpeuch F., 2006, EVALUATION DISPOSITI; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; *FEWS, 2008, FEWS NET W AFR FOOD; Flax VL, 2008, MATERN CHILD NUTR, V4, P65, DOI 10.1111/j.1740-8709.2007.00098.x; Galpin L, 2007, J NUTR, V137, P1828, DOI 10.1093/jn/137.7.1828; GOLDEN MHN, 1991, ACTA PAEDIATR SCAND, P95; *INS NIG MACR INT, 2007, DEM HLTH SURV MULT I; Isanaka S, 2009, PEDIATRICS, V123, pE54, DOI 10.1542/peds.2008-1375; KOURGUENI IA, 1992, ENQUETE DEMOGRAPHIQU; Kuusipalo H, 2006, J PEDIATR GASTR NUTR, V43, P525, DOI 10.1097/01.mpg.0000235981.26700.d3; Lapidus N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000039; Lopriore C, 2004, AM J CLIN NUTR, V80, P973, DOI 10.1093/ajcn/80.4.973; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; NAVARROCOLORADO C, 2007, RETROSPECTIVE STUDY; Ndekha MJ, 2005, ACTA PAEDIATR, V94, P222, DOI 10.1080/08035250410022503; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Phuka JC, 2008, ARCH PEDIAT ADOL MED, V162, P619, DOI 10.1001/archpedi.162.7.619; Phuka JC, 2009, AM J CLIN NUTR, V89, P382, DOI 10.3945/ajcn.2008.26483; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Ruel MT, 2008, LANCET, V371, P588, DOI 10.1016/S0140-6736(08)60271-8; Sadler K, 2007, PUBLIC HEALTH NUTR, V10, P907, DOI 10.1017/S1368980007711035; Tectonidis M, 2006, NEW ENGL J MED, V354, P224, DOI 10.1056/NEJMp058240; *UN CHILDR FUND, 2006, 4 UN CHILDR FUND; UN Millennium Project, 2005, HALV HUNG IT CAN BE; United Nations Children's Fund, STAT WORLDS CHILDR 2; YIP R, 1994, J NUTR, V124, pS2043	35	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5455	10.1371/journal.pone.0005455	http://dx.doi.org/10.1371/journal.pone.0005455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421316	gold, Green Published, Green Submitted			2022-12-27	WOS:000265836900011
J	Gao, K; Zhou, H; Zhang, L; Lee, JW; Zhou, Q; Hu, S; Wolinsky, LE; Farrell, J; Eibl, G; Wong, DT				Gao, Kai; Zhou, Hui; Zhang, Lei; Lee, Jin Wook; Zhou, Qing; Hu, Shen; Wolinsky, Lawrence E.; Farrell, James; Eibl, Guido; Wong, David T.			Systemic Disease-Induced Salivary Biomarker Profiles in Mouse Models of Melanoma and Non-Small Cell Lung Cancer	PLOS ONE			English	Article								Background: Saliva (oral fluids) is an emerging biofluid poised for detection of clinical diseases. Although the rationale for oral diseases applications (e. g. oral cancer) is intuitive, the rationale and relationship between systemic diseases and saliva biomarkers are unclear. Methodology/Principal Findings: In this study, we used mouse models of melanoma and non-small cell lung cancer and compared the transcriptome biomarker profiles of tumor-bearing mice to those of control mice. Microarray analysis showed that salivary transcriptomes were significantly altered in tumor-bearing mice vs. controls. Significant overlapping among transcriptomes of mouse tumors, serum, salivary glands and saliva suggests that salivary biomarkers have multiple origins. Furthermore, we identified that the expression of two groups of significantly altered transcription factors (TFs) Runx1, Mixipi, Trim30 and Egr1, Tbx1, Nr1d1 in salivary gland tissue of melanoma-bearing mice can potentially be responsible for 82.6% of the up-regulated gene expression and 62.5% of the down-regulated gene expression, respectively, in the saliva of melanoma-bearing mice. We also showed that the ectopic production of nerve growth factor (NGF) in the melanoma tumor tissue as a tumor-released mediator can induce expression of the TF Egr-1 in the salivary gland. Conclusions: Taken together, our data support the conclusion that upon systemic disease development, significant changes can occur in the salivary biomarker profile. Although the origins of the disease-induced salivary biomarkers may be both systemic and local, stimulation of salivary gland by mediators released from remote tumors plays an important role in regulating the salivary surrogate biomarker profiles.			Gao, K (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	dtww@ucla.edu	Hu, Steve/B-3799-2011		NATIONAL CANCER INSTITUTE [R21CA126733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017170] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA126733] Funding Source: Medline; NIDCR NIH HHS [R01 DE017170] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Boffa DJ, 2004, CLIN CANCER RES, V10, P293, DOI 10.1158/1078-0432.CCR-0629-3; Bogenmann E, 1998, ONCOGENE, V17, P2367, DOI 10.1038/sj.onc.1202160; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De Vicente JC, 1998, ANN ANAT, V180, P157, DOI 10.1016/S0940-9602(98)80016-2; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Fleischhacker M, 2006, ANN NY ACAD SCI, V1075, P40, DOI 10.1196/annals.1368.005; Gao K, 2008, INT J ONCOL, V32, P1343; Gao K, 2006, CANCER RES, V66, P8382, DOI 10.1158/0008-5472.CAN-05-4402; Holder G, 2006, METH MOL B, V324, P141; HU S, 2008, CLIN CANC R IN PRESS; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; HU Z, 2008, CLIN CHEM; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Iles RK, 2007, MOL CELL ENDOCRINOL, V260, P264, DOI 10.1016/j.mce.2006.02.019; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kelly K, 2008, J THORAC ONCOL, V3, P664, DOI 10.1097/JTO.0b013e3181758141; Koyanagi K, 2006, CANCER RES, V66, P6111, DOI 10.1158/0008-5472.CAN-05-4198; KUJUBU DA, 1993, J NEUROSCI RES, V36, P58, DOI 10.1002/jnr.490360107; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2006, J CLIN ONCOL, V24, P1754, DOI 10.1200/JCO.2005.03.7598; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303; Nagler RM, 2001, ARCH ORAL BIOL, V46, P487, DOI 10.1016/S0003-9969(01)00008-5; Palanisamy V, 2008, J DENT RES, V87, P772, DOI 10.1177/154405910808700803; Park NJ, 2007, ARCH ORAL BIOL, V52, P30, DOI 10.1016/j.archoralbio.2006.08.014; Park NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/clinchem.2005.063206; Perrotta C, 2007, CANCER RES, V67, P7559, DOI 10.1158/0008-5472.CAN-07-0309; Roeb W, 2007, P NATL ACAD SCI USA, V104, P18085, DOI 10.1073/pnas.0708910104; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Seynhaeve ALB, 2008, FRONT BIOSCI-LANDMRK, V13, P3034, DOI 10.2741/2908; Shooter EM, 2001, ANNU REV NEUROSCI, V24, P601, DOI 10.1146/annurev.neuro.24.1.601; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Teicher BA, 2001, CANCER METAST REV, V20, P133, DOI 10.1023/A:1013177011767; Truzzi F, 2008, J INVEST DERMATOL, V128, P2031, DOI 10.1038/jid.2008.21; Yamano S, 1999, CLIN IMMUNOL, V92, P265, DOI 10.1006/clim.1999.4759; Yao CJ, 2005, IMMUNOLOGY, V116, P213, DOI 10.1111/j.1365-2567.2005.02212.x; Zimmermann BG, 2008, ORAL ONCOL, V44, P425, DOI 10.1016/j.oraloncology.2007.09.009; Zimmermann BG, 2007, ANN NY ACAD SCI, V1098, P184, DOI 10.1196/annals.1384.002	41	53	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5875	10.1371/journal.pone.0005875	http://dx.doi.org/10.1371/journal.pone.0005875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517020	gold, Green Submitted, Green Published			2022-12-27	WOS:000266873100008
J	Lindvall, C; Zylstra, CR; Evans, N; West, RA; Dykema, K; Furge, KA; Williams, BO				Lindvall, Charlotta; Zylstra, Cassandra R.; Evans, Nicole; West, Richard A.; Dykema, Karl; Furge, Kyle A.; Williams, Bart O.			The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; BREAST CARCINOMAS; EXPRESSION; CANCER; GENE; MICE; INITIATION; MUTATIONS; RECEPTORS	Canonical Wnt signals are transduced through a Frizzled receptor and either the LRP5 or LRP6 co-receptor; such signals play central roles during development and in disease. We have previously shown that Lrp5 is required for ductal stem cell activity and that loss of Lrp5 delays normal mammary development and Wnt1-induced tumorigenesis. Here we show that canonical Wnt signals through the Lrp6 co-receptor are also required for normal mouse mammary gland development. Loss of Lrp6 compromises Wnt/beta-catenin signaling and interferes with mammary placode, fat pad, and branching development during embryogenesis. Heterozygosity for an inactivating mutation in Lrp6 is associated with a reduced number of terminal end buds and branches during postnatal development. While Lrp6 is expressed in both the basal and luminal mammary epithelium during embryogenesis, Lrp6 expression later becomes restricted to cells residing in the basal epithelial layer. Interestingly, these cells also express mammary stem cell markers. In humans, increased Lrp6 expression is associated with basal-like breast cancer. Taken together, our results suggest both overlapping and specific functions for Lrp5 and Lrp6 in the mammary gland.			Lindvall, C (corresponding author), Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI USA.	Charlotta.Lindvall@vai.org; Bart.Williams@vai.org	Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301; Diegel, Cassandra/0000-0002-6526-9372; West, Richard/0000-0003-1459-0825				Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ip M. M., 2000, METHODS MAMMARY GLAN; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Patel MS, 2002, NEW ENGL J MED, V346, P1572, DOI 10.1056/NEJM200205163462011; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Slusarski DC, 2007, DEV BIOL, V307, P1, DOI 10.1016/j.ydbio.2007.04.043; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smith GH, 2003, CELL PROLIFERAT, V36, P3, DOI 10.1046/j.1365-2184.36.s.1.2.x; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Tung CH, 2004, CANCER RES, V64, P1579, DOI 10.1158/0008-5472.CAN-03-3226; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Veltmaat JM, 2003, DIFFERENTIATION, V71, P1, DOI 10.1046/j.1432-0436.2003.700601.x; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047	54	108	111	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5813	10.1371/journal.pone.0005813	http://dx.doi.org/10.1371/journal.pone.0005813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503830	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717200009
J	Brinkhof, MWG; Pujades-Rodriguez, M; Egger, M				Brinkhof, Martin W. G.; Pujades-Rodriguez, Mar; Egger, Matthias			Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SCALE-UP; THERAPY; ADHERENCE; HIV; OUTCOMES; HAART; CHALLENGES; BARRIERS; DISTRICT; SURVIVAL	Background: The retention of patients in antiretroviral therapy ( ART) programmes is an important issue in resource-limited settings. Loss to follow up can be substantial, but it is unclear what the outcomes are in patients who are lost to programmes. Methods and Findings: We searched the PubMed, EMBASE, Latin American and Caribbean Health Sciences Literature (LILACS), Indian Medlars Centre (IndMed) and African Index Medicus (AIM) databases and the abstracts of three conferences for studies that traced patients lost to follow up to ascertain their vital status. Main outcomes were the proportion of patients traced, the proportion found to be alive and the proportion that had died. Where available, we also examined the reasons why some patients could not be traced, why patients found to be alive did not return to the clinic, and the causes of death. We combined mortality data from several studies using random-effects meta-analysis. Seventeen studies were eligible. All were from sub-Saharan Africa, except one study from India, and none were conducted in children. A total of 6420 patients (range 44 to 1343 patients) were included. Patients were traced using telephone calls, home visits and through social networks. Overall the vital status of 4021 patients could be ascertained (63%, range across studies: 45% to 86%); 1602 patients had died. The combined mortality was 40% (95% confidence interval 33%-48%), with substantial heterogeneity between studies (P < 0.0001). Mortality in African programmes ranged from 12% to 87% of patients lost to follow-up. Mortality was inversely associated with the rate of loss to follow up in the programme: it declined from around 60% to 20% as the percentage of patients lost to the programme increased from 5% to 50%. Among patients not found, telephone numbers and addresses were frequently incorrect or missing. Common reasons for not returning to the clinic were transfer to another programme, financial problems and improving or deteriorating health. Causes of death were available for 47 deaths: 29 (62%) died of an AIDS defining illness. Conclusions: In ART programmes in resource-limited settings a substantial minority of adults lost to follow up cannot be traced, and among those traced 20% to 60% had died. Our findings have implications both for patient care and the monitoring and evaluation of programmes.			Brinkhof, MWG (corresponding author), Univ Bern, Div Int & Environm Hlth, Inst Social & Prevent Med, Bern, Switzerland.	brinkhof@ispm.unibe.ch	Pujades-Rodriguez, Mar/T-1129-2018; Franzeck, Fabian C/B-5055-2011; Pujades-Rodriguez, Mar/G-4388-2014	Pujades-Rodriguez, Mar/0000-0002-1375-1028; Pujades-Rodriguez, Mar/0000-0002-7778-3520; Brinkhof, Martin/0000-0002-9319-665X; Egger, Matthias/0000-0001-7462-5132				Ammassari A, 2002, JAIDS-J ACQ IMM DEF, V31, pS140, DOI 10.1097/00126334-200212153-00011; Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; An MW, 2009, BIOMETRICS, V65, P301, DOI 10.1111/j.1541-0420.2008.01043.x; BILLY A, 2007, 4 IAS C HIV PATH TRE; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; BRINKHOF MW, 2008, B WORLD HEALTH ORGAN, V86, P497; DAHAB M, 2008, AIDS 2008 17 INT AID; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; HOCHGESANG M, 2006, AIDS 2006 16 INT AID; IVE P, 2005, 3 IAS C HIV PATH TRE; JOSHI K, 2008, AIDS 2008 17 INT AID; Krebs DW, 2008, AIDS CARE, V20, P311, DOI 10.1080/09540120701594776; LURTON G, 2008, AIDS 2008 17 INT AID; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; MCGUIRE M, 2009, 16 C RETR OPP INF MO; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; MUWANGA A, 2008, 15 C RETR OPP INF BO; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; World Health Organization, 2008, UN ACC SCAL PRIOR HI; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121; C RETR OPP INF ABSTR	37	358	360	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5790	10.1371/journal.pone.0005790	http://dx.doi.org/10.1371/journal.pone.0005790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495419	Green Published, gold			2022-12-27	WOS:000266716900003
J	Segarra, C; Lehmann, S; Coste, J				Segarra, Christiane; Lehmann, Sylvain; Coste, Joliette			Prion Protein Expression and Processing in Human Mononuclear Cells: The Impact of the Codon 129 Prion Gene Polymorphism	PLOS ONE			English	Article								Background: So far, all clinical cases of new variant Creutzfeldt-Jakob disease (vCJD), thought to result from the Bovine Spongiform Encephalopathy (BSE) prion agent, have shown Methionine-Methionine (M/M) homozygosity at the M129V polymorphism of the PRNP gene. Although established, this relationship is still not understood. In both vCJD and experimental BSE models prion agents do reach the bloodstream, raising concerns regarding disease transmission through blood transfusion. Methodology/Principal Findings: We investigated the impact of the M129V polymorphism on the expression and processing of the prion protein in human peripheral blood mononuclear cells (PBMCs) from three blood donor populations with Methionine-Methionine (M/M), Valine-Valine (V/V) and M/V genotypes. Using real-time PCR, ELISA and immunoblot assays we were unable to find differences in prion protein expression and processing relating to the M129V polymorphism. Conclusions/Significance: These results suggest that in PBMCs, the M129V PrP polymorphism has no significant impact on PrP expression, processing and the apparent glycoform distribution. Prion propagation should be investigated further in other cell types or tissues.			Segarra, C (corresponding author), Etab Francais Sang Pyrenees Mediterranee, Montpellier, France.	joliette.coste@efs.sante.fr	Lehmann, Sylvain/P-1301-2017	Lehmann, Sylvain/0000-0001-6117-562X				Alonso DOV, 2001, P NATL ACAD SCI USA, V98, P2985, DOI 10.1073/pnas.061555898; Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Barclay GR, 2002, TRANSFUSION, V42, P517, DOI 10.1046/j.1537-2995.2002.00095.x; Barclay GR, 1999, BRIT J HAEMATOL, V107, P804, DOI 10.1046/j.1365-2141.1999.01789.x; Brandel JP, 2003, LANCET, V362, P128, DOI 10.1016/S0140-6736(03)13867-6; Caughey B, 2001, ADV PROTEIN CHEM, V57, P139; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; d'Aignaux JH, 1999, NEUROLOGY, V53, P1197, DOI 10.1212/WNL.53.6.1197; Dodelet VC, 1998, BLOOD, V91, P1556, DOI 10.1182/blood.V91.5.1556.1556_1556_1561; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Halliday S, 2005, J GEN VIROL, V86, P1571, DOI 10.1099/vir.0.80561-0; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Lee SC, 2000, J CLIN MICROBIOL, V38, P4171, DOI 10.1128/JCM.38.11.4171-4179.2000; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Lucotte Gerard, 2005, Infection Genetics and Evolution, V5, P141, DOI 10.1016/j.meegid.2004.08.002; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2005, J VIROL, V79, P934, DOI 10.1128/JVI.79.2.934-943.2005; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Pincock S, 2004, LANCET, V363, P43, DOI 10.1016/S0140-6736(03)15247-6; Pincock Stephen, 2004, BMJ, V329, P251, DOI 10.1136/bmj.329.7460.251-a; POCCHIARI M, 1994, MOL ASPECTS MED, V15, P195, DOI 10.1016/0098-2997(94)90042-6; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; PRUSINER SB, 1993, ARCH NEUROL-CHICAGO, V50, P1129, DOI 10.1001/archneur.1993.00540110011002; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Shamsir MS, 2005, PROTEINS, V59, P275, DOI 10.1002/prot.20401; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Teupser D, 2002, J NEUROSCI METH, V115, P93, DOI 10.1016/S0165-0270(02)00008-0; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Turner ML, 2009, BRIT J HAEMATOL, V144, P14, DOI 10.1111/j.1365-2141.2008.07376.x; Vega A, 2001, CLIN CHEM, V47, P1874; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004	58	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5796	10.1371/journal.pone.0005796	http://dx.doi.org/10.1371/journal.pone.0005796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495414	Green Published, Green Submitted, gold			2022-12-27	WOS:000266716900006
J	Rodriguez, S; Hall, AJ; Granell, R; McLean, WHI; Irvine, AD; Palmer, CNA; Smith, GD; Henderson, J; Day, INM				Rodriguez, Santiago; Hall, Amanda J.; Granell, Raquel; McLean, W. H. Irwin; Irvine, Alan D.; Palmer, Colin N. A.; Smith, George Davey; Henderson, John; Day, Ian N. M.			Carrier Status for the Common R501X and 2282del4 Filaggrin Mutations Is Not Associated with Hearing Phenotypes in 5377 Children from the ALSPAC Cohort	PLOS ONE			English	Article								Background: Filaggrin is a major protein in the epidermis. Several mutations in the filaggrin gene (FLG) have been associated with a number of conditions. Filaggrin is expressed in the tympanic membrane and could alter its mechanical properties, but the relationship between genetic variation in FLG and hearing has not yet been tested. Methodology/Principal Findings: We examined whether loss-of function mutations R501X and 2282del4 in the FLG gene affected hearing in children. Twenty eight hearing variables representing five different aspects of hearing at age nine years in 5,377 children from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort were tested for association with these mutations. No evidence of association was found between R501X or 2282del4 (or overall FLG mutation carrier status) and any of the hearing phenotypes analysed. Conclusions/Significance: In conclusion, carrier status for common filaggrin mutations does not affect hearing in children.			Rodriguez, S (corresponding author), Univ Bristol, Dept Social Med, BGEL, Bristol, Avon, England.	santi.rodriguez@bristol.ac.uk	Irvine, Alan D/A-3982-2008; Granell, Raquel/AAB-5256-2022; Palmer, Colin NA/C-7053-2008; Hall, Amanda/AAB-7570-2022; Granell, Raquel/AAY-4846-2020; Davey Smith, George/A-7407-2013; McLean, William HI/C-6352-2009	Irvine, Alan D/0000-0002-9048-2044; Granell, Raquel/0000-0002-4890-4012; Palmer, Colin NA/0000-0002-6415-6560; Davey Smith, George/0000-0002-1407-8314; Rodriguez, Santiago/0000-0001-6551-932X; Hall, Amanda/0000-0001-8520-6005; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; McLean, William Henry Irwin/0000-0001-5539-5757	Medical Research Council [G0700314, G9815508, G0600705] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Chief Scientist Office Funding Source: Medline; MRC [G0700314, G0600705] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Broekaert D., 1995, Acta Oto-Rhino-Laryngologica Belgica, V49, P127; CHAO WY, 1989, ACTA OTO-LARYNGOL, V107, P249, DOI 10.3109/00016488909127505; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gruber R, 2007, EUR J HUM GENET, V15, P179, DOI 10.1038/sj.ejhg.5201742; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Jones RW, 2000, EUR J HUM GENET, V8, P653, DOI 10.1038/sj.ejhg.5200502; KINLEYGRANT LJ, 1989, P NATL ACAD SCI USA, V86, P4848; McGrath JA, 2008, AUSTRALAS J DERMATOL, V49, P67, DOI 10.1111/j.1440-0960.2008.00443.x; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; STAMMBERGER M, 1995, AM J OTOL, V16, P527	14	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5784	10.1371/journal.pone.0005784	http://dx.doi.org/10.1371/journal.pone.0005784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492053	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000266624300019
J	Perez, SI; Bernal, V; Gonzalez, PN; Sardi, M; Politis, GG				Ivan Perez, S.; Bernal, Valeria; Gonzalez, Paula N.; Sardi, Marina; Politis, Gustavo G.			Discrepancy between Cranial and DNA Data of Early Americans: Implications for American Peopling	PLOS ONE			English	Article							DEL-FUEGO-PATAGONIA; HUMAN SKELETAL REMAINS; NEW-WORLD; MITOCHONDRIAL-DNA; MODERN HUMANS; GEOMETRIC MORPHOMETRICS; CRANIOFACIAL MORPHOLOGY; EXTINCT ABORIGINES; HUMAN-POPULATIONS; DENTAL VARIATION	Currently, one of the major debates about the American peopling focuses on the number of populations that originated the biological diversity found in the continent during the Holocene. The studies of craniometric variation in American human remains dating from that period have shown morphological differences between the earliest settlers of the continent and some of the later Amerindian populations. This led some investigators to suggest that these groups-known as Paleomericans and Amerindians respectively-may have arisen from two biologically different populations. On the other hand, most DNA studies performed over extant and ancient populations suggest a single migration of a population from Northeast Asia. Comparing craniometric and mtDNA data of diachronic samples from East Central Argentina dated from 8,000 to 400 years BP, we show here that even when the oldest individuals display traits attributable to Paleoamerican crania, they present the same mtDNA haplogroups as later populations with Amerindian morphology. A possible explanation for these results could be that the craniofacial differentiation was a local phenomenon resulting from random (i.e. genetic drift) and non-random factors (e.g. selection and plasticity). Local processes of morphological differentiation in America are a probable scenario if we take into consideration the rapid peopling and the great ecological diversity of this continent; nevertheless we will discuss alternative explanations as well.			Perez, SI (corresponding author), Univ Nacl La Plata, Fac Ciencias Nat & Museo, Div Antropol, CONICET, Buenos Aires, DF, Argentina.			Sardi, Marina L./0000-0003-3614-8341				Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BERBERIAN EE, 2001, HIST ARGENTINA PREHI; Bernal V, 2008, MAGALLANIA, V36, P175, DOI 10.4067/S0718-22442008000200013; Borrero LA, 1999, J WORLD PREHIST, V13, P321, DOI 10.1023/A:1022341730119; Brace CL, 2001, P NATL ACAD SCI USA, V98, P10017, DOI 10.1073/pnas.171305898; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Buikstra J.E., 1994, STANDARDS DATA COLLE, DOI 10.1002/ajhb.1310070519; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Correal Urrego G., 1977, INVESTIGACIONES ARQU; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dillehay T., 2000, SETTLEMENT AM NEW PR; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Figueiro G, 2007, REV ARG ANTROP BIOL, V9, P78; Garcia-Bour J, 2004, AM J PHYS ANTHROPOL, V123, P361, DOI 10.1002/ajpa.10337; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez-Jose RG, 2003, NATURE, V425, P62, DOI 10.1038/nature01816; GREENBERG J, 1986, CURR ANTHROPOL, V4, P477; Hanihara T, 2000, AM J PHYS ANTHROPOL, V111, P105, DOI 10.1002/(SICI)1096-8644(200001)111:1<105::AID-AJPA7>3.0.CO;2-O; HOWELLS WW, 1989, SKULL SHAPE MAP PAPE; Hrdlicka A., 1912, BUREAU AM ETHNOLOGY, V52; Imbelloni J., 1938, TABLA CLASIFICATORIA; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Lalueza C, 1997, HUM MOL GENET, V6, P41, DOI 10.1093/hmg/6.1.41; Malhi RS, 2007, J ARCHAEOL SCI, V34, P642, DOI 10.1016/j.jas.2006.07.004; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Neves Walter A., 1989, Ciencia e Cultura (Sao Paulo), V41, P566; Neves WA, 2005, P NATL ACAD SCI USA, V102, P18309, DOI 10.1073/pnas.0507185102; Neves WA, 2003, J HUM EVOL, V45, P19, DOI 10.1016/S0047-2484(03)00081-2; Neves WA, 2007, AM J PHYS ANTHROPOL, V133, P1080, DOI 10.1002/ajpa.20637; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Perez SI, 2007, AM J PHYS ANTHROPOL, V133, P1067, DOI 10.1002/ajpa.20633; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Perez SI, 2009, EVOLUTION, V63, P978, DOI 10.1111/j.1558-5646.2008.00539.x; POLITIS G, 2009, SERIE MONOG IN PRESS, V5; POLITIS G, 2009, PRIMEROS AM HIST ARQ; Powell JF, 1999, YEARB PHYS ANTHROPOL, V42, P153; Price TD, 2009, P NATL ACAD SCI USA, V106, P6427, DOI 10.1073/pnas.0902617106; R Core Team, 2018, R LANG ENV STAT COMP; Rohlf FJ, 2008, TPS SERIE SOFTWARES; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sardi ML, 2006, AM J PHYS ANTHROPOL, V130, P333, DOI 10.1002/ajpa.20379; SARDI ML, 2001, REV ARG ANTROP BIOL, V3, P96; SARDI ML, 2004, ANTHROPOL ANZ, V62, P120; SCABUZZO C, 2007, CURR RES PLEISTOCENE, V23, P64; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Sheets H. D., 2003, IMP INTEGRATED MORPH, V14208; Larsen CS, 2006, QUATERN INT, V150, P12, DOI 10.1016/j.quaint.2006.01.004; Steele J, 2009, J ARCHAEOL SCI, V36, P419, DOI 10.1016/j.jas.2008.09.024; Stynder DD, 2007, AM J PHYS ANTHROPOL, V134, P489, DOI 10.1002/ajpa.20696; Sun C, 2007, GENOMICS, V89, P338, DOI 10.1016/j.ygeno.2006.11.005; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Turner C G 2nd, 1984, Acta Anthropogenet, V8, P23; TURNER CG, 1987, AM J PHYS ANTHROPOL, V73, P305, DOI 10.1002/ajpa.1330730304; van Vark GN, 2003, AM J PHYS ANTHROPOL, V121, P181, DOI 10.1002/ajpa.10176; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	61	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5746	10.1371/journal.pone.0005746	http://dx.doi.org/10.1371/journal.pone.0005746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	451SH	19478947	Green Published, Green Submitted, gold			2022-12-27	WOS:000266490000020
J	Baranov, PV; Venin, M; Provan, G				Baranov, Pavel V.; Venin, Maxime; Provan, Gregory			Codon Size Reduction as the Origin of the Triplet Genetic Code	PLOS ONE			English	Article							TRANSFER-RNA; ANTICODON LOOP; PROTEIN-SYNTHESIS; FROZEN ACCIDENT; AMINO-ACIDS; RIBOSOME; EVOLUTION; SELECTION; REASSIGNMENT; SUPPRESSORS	The genetic code appears to be optimized in its robustness to missense errors and frameshift errors. In addition, the genetic code is near-optimal in terms of its ability to carry information in addition to the sequences of encoded proteins. As evolution has no foresight, optimality of the modern genetic code suggests that it evolved from less optimal code variants. The length of codons in the genetic code is also optimal, as three is the minimal nucleotide combination that can encode the twenty standard amino acids. The apparent impossibility of transitions between codon sizes in a discontinuous manner during evolution has resulted in an unbending view that the genetic code was always triplet. Yet, recent experimental evidence on quadruplet decoding, as well as the discovery of organisms with ambiguous and dual decoding, suggest that the possibility of the evolution of triplet decoding from living systems with non-triplet decoding merits reconsideration and further exploration. To explore this possibility we designed a mathematical model of the evolution of primitive digital coding systems which can decode nucleotide sequences into protein sequences. These coding systems can evolve their nucleotide sequences via genetic events of Darwinian evolution, such as point-mutations. The replication rates of such coding systems depend on the accuracy of the generated protein sequences. Computer simulations based on our model show that decoding systems with codons of length greater than three spontaneously evolve into predominantly triplet decoding systems. Our findings suggest a plausible scenario for the evolution of the triplet genetic code in a continuous manner. This scenario suggests an explanation of how protein synthesis could be accomplished by means of long RNA-RNA interactions prior to the emergence of the complex decoding machinery, such as the ribosome, that is required for stabilization and discrimination of otherwise weak triplet codon-anticodon interactions.			Baranov, PV (corresponding author), Univ Coll Cork, Dept Biochem, Cork, Ireland.	p.baranov@ucc.ie	Baranov, Pavel/A-2782-2011	Baranov, Pavel/0000-0001-9017-0270; Provan, Gregory/0000-0003-3678-046X				Abascal F, 2006, PLOS BIOL, V4, P711, DOI 10.1371/journal.pbio.0040127; Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Anderson JC, 2002, CHEM BIOL, V9, P237, DOI 10.1016/S1074-5521(02)00094-7; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Bernhardt HS, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-53; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Di Giulio M, 2005, BIOSYSTEMS, V80, P175, DOI 10.1016/j.biosystems.2004.11.005; Di Giulio M, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-37; Di Giulio Massimo, 2008, V1, P59; Dunham CM, 2007, RNA, V13, P817, DOI 10.1261/rna.367307; Freeland SJ, 2000, MOL BIOL EVOL, V17, P511, DOI 10.1093/oxfordjournals.molbev.a026331; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Freeland SJ, 2000, TRENDS BIOCHEM SCI, V25, P44, DOI 10.1016/S0968-0004(99)01531-5; Gilis D, 2001, GENOME BIOL, V2; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hohsaka T, 1999, Nucleic Acids Symp Ser, P79; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Klobutcher LA, 2005, EUKARYOT CELL, V4, P2098, DOI 10.1128/EC.4.12.2098-2105.2005; Klobutcher LA, 2002, CELL, V111, P763, DOI 10.1016/S0092-8674(02)01138-8; Knight RD, 2000, CELL, V101, P569, DOI 10.1016/S0092-8674(00)80866-1; Knight RD, 1999, TRENDS BIOCHEM SCI, V24, P241, DOI 10.1016/S0968-0004(99)01392-4; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; KOONIN EV, 2008, IUBMB LIFE; Korostelev A, 2007, TRENDS BIOCHEM SCI, V32, P434, DOI 10.1016/j.tibs.2007.08.002; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Li JN, 1997, J MOL BIOL, V271, P209, DOI 10.1006/jmbi.1997.1176; Maeshiro T, 1998, P NATL ACAD SCI USA, V95, P5088, DOI 10.1073/pnas.95.9.5088; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; Miranda I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000996; Moore B, 2000, J MOL BIOL, V298, P195, DOI 10.1006/jmbi.2000.3658; NieseltStruwe K, 1997, J THEOR BIOL, V187, P1, DOI 10.1006/jtbi.1997.0404; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; ORGEL LE, 1989, J MOL EVOL, V29, P465, DOI 10.1007/BF02602917; OSAWA S, 1989, J MOL EVOL, V28, P271, DOI 10.1007/BF02103422; Patel A, 2005, J THEOR BIOL, V233, P527, DOI 10.1016/j.jtbi.2004.10.029; Ramakrishnan V, 2008, BIOCHEM SOC T, V36, P567, DOI 10.1042/BST0360567; RIDDLE DL, 1973, NATURE-NEW BIOL, V242, P230, DOI 10.1038/newbio242230a0; Rodriguez EA, 2006, P NATL ACAD SCI USA, V103, P8650, DOI 10.1073/pnas.0510817103; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Schultz DW, 1996, J MOL EVOL, V42, P597, DOI 10.1007/BF02352290; Seligmann H, 2004, DNA CELL BIOL, V23, P701, DOI 10.1089/1044549042476910; Sella G, 2002, J MOL EVOL, V54, P638, DOI 10.1007/s00239-001-0060-7; Sella G, 2006, J MOL EVOL, V63, P297, DOI 10.1007/s00239-004-0176-7; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta S, 2005, GENETICS, V170, P831, DOI 10.1534/genetics.104.037887; SROGA GE, 1992, NUCLEIC ACIDS RES, V20, P3463, DOI 10.1093/nar/20.13.3463; Steitz TA, 2003, TRENDS BIOCHEM SCI, V28, P411, DOI 10.1016/S0968-0004(03)00169-5; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Tamas I, 2008, P NATL ACAD SCI USA, V105, P14934, DOI 10.1073/pnas.0806554105; Tlusty T, 2008, P NATL ACAD SCI USA, V105, P8238, DOI 10.1073/pnas.0710274105; TUOHY TMF, 1992, J MOL BIOL, V228, P1042, DOI 10.1016/0022-2836(92)90313-9; Turanov AA, 2009, SCIENCE, V323, P259, DOI 10.1126/science.1164748; Wilhelm T, 2004, J MOL EVOL, V59, P598, DOI 10.1007/s00239-004-2650-7; Wills PR, 2009, J THEOR BIOL, V257, P345, DOI 10.1016/j.jtbi.2008.12.030; WOESE CR, 1965, P NATL ACAD SCI USA, V54, P71, DOI 10.1073/pnas.54.1.71; Wolf YI, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-14; WONG JTF, 1991, ORIGINS LIFE EVOL B, V21, P165, DOI 10.1007/BF01809445; Wu HL, 2005, J MOL EVOL, V61, P54, DOI 10.1007/s00239-004-0224-3; Yarus M, 2005, ANNU REV BIOCHEM, V74, P179, DOI 10.1146/annurev.biochem.74.082803.133119	63	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5708	10.1371/journal.pone.0005708	http://dx.doi.org/10.1371/journal.pone.0005708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479032	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415000018
J	Korsten, H; Ziel-van Der Made, A; Ma, XQ; van der Kwast, T; Trapman, J				Korsten, Hanneke; Ziel-van der Made, Angelique; Ma, Xiaoqian; van der Kwast, Theo; Trapman, Jan			Accumulating Progenitor Cells in the Luminal Epithelial Cell Layer Are Candidate Tumor Initiating Cells in a Pten Knockout Mouse Prostate Cancer Model	PLOS ONE			English	Article								The PSA-Cre;Pten-loxP/loxP mouse prostate cancer model displays clearly defined stages of hyperplasia and cancer. Here, the initial stages of hyperplasia development are studied. Immunohistochemical staining showed that accumulated pAkt(+) hyperplastic cells overexpress luminal epithelial cell marker CK8, and progenitor cell markers CK19 and Sca-1, but not basal epithelial cell markers. By expression profiling we identified novel hyperplastic cell markers, including Tacstd2 and Clu. Further we showed that at young age prostates of targeted Pten knockout mice contained in the luminal epithelial cell layer single pAkt(+)cells, which overexpressed CK8, Sca-1, Tacstd2 and Clu; basal epithelial cells were always pAkt(-). Importantly, in the luminal epithelial cell layer of normal prostates we detected rare Clu(+)Tacstd2(+)Sca-1(+)progenitor cells. These novel cells are candidate tumor initiating cells in Pten knockout mice. Remarkably, all luminal epithelial cells in the proximal region of normal prostates were Clu(+)Tacstd2(+)Sca-1(+). However, in PSA-Cre; Pten-loxP/loxP mice, the proximal prostate does not contain hyperplastic foci. Small hyperplastic foci in prostates of PSA-Cre; Pten-loxP/+ mice found at old age, showed complete Pten inactivation and a progenitor marker profile. Finally, we present a novel model of prostate development and renewal, including lineage-specific luminal epithelial progenitor cells. It is proposed that Pten deficiency induces a shift in the balance of differentiation to proliferation in these cells.			Korsten, H (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands.	j.trapman@erasmusmc.nl		Van der Kwast, Theodorus/0000-0001-8640-5786				Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; AKALA OO, 2006, CURR OPIN GENET DEV; Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Bonkhoff H, 1996, PROSTATE, V28, P98; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P1256, DOI 10.1210/me.11.9.1256; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Hermans KG, 2008, CANCER RES, V68, P3094, DOI 10.1158/0008-5472.CAN-08-0198; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim MJ, 2002, CANCER RES, V62, P2999; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lam JS, 2006, UROL ONCOL-SEMIN ORI, V24, P131, DOI 10.1016/j.urolonc.2005.11.038; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Maddison LA, 2004, CANCER RES, V64, P6018, DOI 10.1158/0008-5472.CAN-03-2509; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Marino S, 2002, DEVELOPMENT, V129, P3513; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parsons JK, 2001, UROLOGY, V58, P619, DOI 10.1016/S0090-4295(01)01311-5; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizzo S, 2005, CELL PROLIFERAT, V38, P363, DOI 10.1111/j.1365-2184.2005.00356.x; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2006, CELL, V125, P229, DOI 10.1016/j.cell.2006.04.006; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768	65	51	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5662	10.1371/journal.pone.0005662	http://dx.doi.org/10.1371/journal.pone.0005662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19461893	Green Submitted, gold, Green Published			2022-12-27	WOS:000266331200002
J	Beecham, R; Reeve, RA; Wilson, SJ				Beecham, Rowena; Reeve, Robert A.; Wilson, Sarah J.			Spatial Representations Are Specific to Different Domains of Knowledge	PLOS ONE			English	Article							NUMBER MAGNITUDE; SPACE; SIMON; PITCH	There is evidence that many abstract concepts are represented cognitively in a spatial format. However, it is unknown whether similar spatial processes are employed in different knowledge domains, or whether individuals exhibit similar spatial profiles within and across domains. This research investigated similarities in spatial representation in two knowledge domains-mathematics and music. Sixty-one adults completed analogous number magnitude and pitch discrimination tasks: the Spatial-Numerical Association of Response Codes and Spatial-Musical Association of Response Codes tasks. Subgroups of individuals with different response patterns were identified through cluster analyses. For both the mathematical and musical tasks, approximately half of the participants showed the expected spatial judgment effect when explicitly cued to focus on the spatial properties of the stimuli. Despite this, performances on the two tasks were largely independent. Consistent with previous research, the study provides evidence for the spatial representation of number and pitch in the majority of individuals. However, there was little evidence to support the claim that the same spatial representation processes underpin mathematical and musical judgments.			Beecham, R (corresponding author), Univ Melbourne, Dept Psychol, Sch Behav Sci, Melbourne, Vic, Australia.	rowena.beecham@gmail.com		Wilson, Professor Sarah/0000-0002-2678-1576				Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; Bull R, 2005, LEARN INDIVID DIFFER, V15, P223, DOI 10.1016/j.lindif.2005.01.004; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Cheek JM, 1999, ADOLESCENCE, V34, P759; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Colom R, 2004, PERS INDIV DIFFER, V37, P1289, DOI 10.1016/j.paid.2003.12.014; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Gardiner MF, 1996, NATURE, V381, P284, DOI 10.1038/381284a0; Gevers W, 2005, EUR J COGN PSYCHOL, V17, P659, DOI 10.1080/09541440540000112; Graziano AB, 1999, NEUROL RES, V21, P139, DOI 10.1080/01616412.1999.11740910; James J., 1993, MUSIC SPHERES MUSIC; Keus IM, 2005, COGNITIVE BRAIN RES, V24, P48, DOI 10.1016/j.cogbrainres.2004.12.005; Krumhansl CL, 2000, PSYCHOL BULL, V126, P159, DOI 10.1037/0033-2909.126.1.159; Levinson S. C., 2003, SPACE LANGUAGE COGNI; Mapelli D, 2003, COGNITION, V88, pB1, DOI 10.1016/S0010-0277(03)00042-8; Nuerk HC, 2005, EXP PSYCHOL, V52, P187, DOI 10.1027/1618-3169.52.3.187; PHILLIPS K, 2003, J CULT EVOL PSYCHOL, V1, P53; Rueckert L, 1996, NEUROIMAGE, V3, P97, DOI 10.1006/nimg.1996.0011; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; SHUTER R, 1968, PSYCHOL MUSIC ABILIT	23	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5543	10.1371/journal.pone.0005543	http://dx.doi.org/10.1371/journal.pone.0005543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448AY	19461994	Green Published, gold			2022-12-27	WOS:000266234700004
J	Osborne, A; Reis, AH; Bach, L; Wangh, LJ				Osborne, Adam; Reis, Arthur H., Jr.; Bach, Loren; Wangh, Lawrence J.			Single-Molecule LATE-PCR Analysis of Human Mitochondrial Genomic Sequence Variations	PLOS ONE			English	Article							THE-EXPONENTIAL (LATE)-PCR; POINT MUTATIONS; DNA; QUANTIFICATION; HETEROPLASMY	It is thought that changes in mitochondrial DNA are associated with many degenerative diseases, including Alzheimer's and diabetes. Much of the evidence, however, depends on correlating disease states with changing levels of heteroplasmy within populations of mitochondrial genomes, rather than individual mitochondrial genomes. Thus these measurements are likely to either overestimate the extent of heteroplasmy due to technical artifacts, or underestimate the actual level of heteroplasmy because only the most abundant changes are observable. In contrast, Single Molecule (SM) LATE-PCR analysis achieves efficient amplification of single-stranded amplicons from single target molecules. The product molecules, in turn, can be accurately sequenced using a convenient Dilute-'N'-Go protocol, as shown here. Using these novel technologies we have rigorously analyzed levels of mitochondrial genome heteroplasmy found in single hair shafts of healthy adult individuals. Two of the single molecule sequences (7% of the samples) were found to contain mutations. Most of the mtDNA sequence changes, however, were due to the presence of laboratory contaminants. Amplification and sequencing errors did not result in mis-identification of mutations. We conclude that SM-LATE-PCR in combination with Dilute-'N'-Go Sequencing are convenient technologies for detecting infrequent mutations in mitochondrial genomes, provided great care is taken to control and document contamination. We plan to use these technologies in the future to look for age, drug, and disease related mitochondrial genome changes in model systems and clinical samples.			Osborne, A (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	Wangh@brandeis.edu						ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ANTONIO S, 2005, PLOS MED, V2, P1158; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Bandelt HJ, 2006, J HUM GENET, V51, P1073, DOI 10.1007/s10038-006-0066-5; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; Budowle B, 2002, FORENSIC SCI INT, V126, P30, DOI 10.1016/S0379-0738(02)00019-1; Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949; Cavelier L, 2000, HUM GENET, V107, P45, DOI 10.1007/s004390050009; Chen JJZ, 2004, J ENVIRON SCI HEAL C, V22, P1, DOI 10.1081/GNC-120037931; Chen TJ, 1999, CLIN CHEM, V45, P1162; Divne AM, 2005, J FORENSIC SCI, V50, P548; DOUGLAS CW, 1994, P NATL ACAD SCI USA, V91, P8739; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; HILARY AC, 2002, ANN NY ACAD SCI, V959, P434; JOHN ER, 2007, NATURE PROTOCOLS, V2, P2429; KENNETH EP, 2000, MOL HUM REPROD, V6, P1155; Lee HY, 2004, ELECTROPHORESIS, V25, P28, DOI 10.1002/elps.200305681; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; MARK S, 2000, AM J HUM GENET, V67, P1029; Pierce KE, 2005, P NATL ACAD SCI USA, V102, P8609, DOI 10.1073/pnas.0501946102; Pierce KE, 2002, BIOTECHNIQUES, V32, P1106, DOI 10.2144/02325pf01; Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207; Sanchez JA, 2004, P NATL ACAD SCI USA, V101, P1933, DOI 10.1073/pnas.0305476101; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; VANDENBOSCH BJ, 2000, NUCLEIC ACIDS RES, V28, P1; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008; Wilson MR, 1997, HUM GENET, V100, P167, DOI 10.1007/s004390050485; Yao YG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000681; YEVGENYA K, 2004, ANAL SOMATIC MUTATIO, P97; YEVGENYA K, 2005, EXPERT REV MOL DIAGN, V5, P809	33	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5636	10.1371/journal.pone.0005636	http://dx.doi.org/10.1371/journal.pone.0005636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461959	Green Submitted, Green Published, gold			2022-12-27	WOS:000266234700022
J	Lovelock, CE; Ball, MC; Martin, KC; Feller, IC				Lovelock, Catherine E.; Ball, Marilyn C.; Martin, Katherine C.; Feller, Ilka C.			Nutrient Enrichment Increases Mortality of Mangroves	PLOS ONE			English	Article							RHIZOPHORA-MANGLE; AVICENNIA-MARINA; HYDRAULIC CONDUCTANCE; PUERTO-RICO; WATER-USE; GROWTH; NITROGEN; PHOSPHORUS; SALINITY; PHOTOSYNTHESIS	Nutrient enrichment of the coastal zone places intense pressure on marine communities. Previous studies have shown that growth of intertidal mangrove forests is accelerated with enhanced nutrient availability. However, nutrient enrichment favours growth of shoots relative to roots, thus enhancing growth rates but increasing vulnerability to environmental stresses that adversely affect plant water relations. Two such stresses are high salinity and low humidity, both of which require greater investment in roots to meet the demands for water by the shoots. Here we present data from a global network of sites that documents enhanced mortality of mangroves with experimental nutrient enrichment at sites where high sediment salinity was coincident with low rainfall and low humidity. Thus the benefits of increased mangrove growth in response to coastal eutrophication is offset by the costs of decreased resilience due to mortality during drought, with mortality increasing with soil water salinity along climatic gradients.			Lovelock, CE (corresponding author), Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia.	c.lovelock@uq.edu.au	Ball, Marilyn/D-1180-2009; Lovelock, Catherine E/G-7370-2012; Lovelock, Catherine E./AAF-7294-2020	Ball, Marilyn/0000-0001-9170-940X; Lovelock, Catherine E/0000-0002-2219-6855; Lovelock, Catherine E./0000-0002-2219-6855; Feller, Ilka/0000-0002-6391-1608				Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; [Anonymous], 2001, PLANT STRATEGIES VEG; ARMENTANO TV, 1995, ANAL PATTERN POSSIBL; Atwell BJ, 2009, PLANT CELL ENVIRON, V32, P553, DOI 10.1111/j.1365-3040.2009.01949.x; BALL MC, 1988, AUST J PLANT PHYSIOL, V15, P447, DOI 10.1071/PP9880447; Ball MC, 1997, PLANT CELL ENVIRON, V20, P1158, DOI 10.1046/j.1365-3040.1997.d01-144.x; BOTO KG, 1983, MAR ECOL PROG SER, V11, P63, DOI 10.3354/meps011063; CHAPIN FS, 1991, BIOSCIENCE, V41, P29, DOI 10.2307/1311538; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; CINTRON G, 1978, BIOTROPICA, V10, P110, DOI 10.2307/2388013; Clarkson DT, 2000, J EXP BOT, V51, P61, DOI 10.1093/jexbot/51.342.61; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Clough B.F., 1983, BIOL ECOLOGY MANGROV, V8, P151, DOI [10.1007/978-94-017-0914-9_17, DOI 10.1007/978-94-017-0914-9_17, DOI 10.1007/978-94-017-0914-9_]; Downing JA, 1999, BIOGEOCHEMISTRY, V46, P109, DOI 10.1007/BF01007576; Duke NC, 2005, MAR POLLUT BULL, V51, P308, DOI 10.1016/j.marpolbul.2004.10.040; Feller IC, 2003, OECOLOGIA, V134, P405, DOI 10.1007/s00442-002-1117-z; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; FELLER IC, 1995, ECOL MONOGR, V65, P477, DOI 10.2307/2963499; Fosberg F. R., 1961, US GEOL SOC PROF P D, V424-D, P216; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jupiter Stacy D., 2007, Wetlands Ecology and Management, V15, P51, DOI 10.1007/s11273-006-9011-9; Koch MS, 1997, BIOTROPICA, V29, P427, DOI 10.1111/j.1744-7429.1997.tb00037.x; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Levine JM, 1998, J ECOL, V86, P285, DOI 10.1046/j.1365-2745.1998.00253.x; LIN G, 1992, AUST J PLANT PHYSIOL, V19, P509, DOI 10.1071/PP9920509; LINDER S, 1987, CAN J FOREST RES, V17, P1157, DOI 10.1139/x87-179; Lovelock CE, 2007, ECOL LETT, V10, P1154, DOI 10.1111/j.1461-0248.2007.01112.x; Lovelock CE, 2007, OECOLOGIA, V153, P633, DOI 10.1007/s00442-007-0750-y; Lovelock CE, 2006, NEW PHYTOL, V172, P514, DOI 10.1111/j.1469-8137.2006.01851.x; Lovelock CE, 2006, PLANT CELL ENVIRON, V29, P793, DOI 10.1111/j.1365-3040.2005.01446.x; Lovelock CE, 2004, FUNCT ECOL, V18, P25, DOI 10.1046/j.0269-8463.2004.00805.x; Lovelock CE, 2003, OECOLOGIA, V134, P455, DOI 10.1007/s00442-002-1118-y; MARTIN KC, 2007, THESIS AUSTR NATL U; McCarthy HR, 2006, P NATL ACAD SCI USA, V103, P19356, DOI 10.1073/pnas.0609448103; NAIDOO G, 1987, NEW PHYTOL, V107, P317, DOI 10.1111/j.1469-8137.1987.tb00183.x; Naidoo G, 2009, AQUAT BOT, V90, P184, DOI 10.1016/j.aquabot.2008.10.001; Paerl HW, 1997, LIMNOL OCEANOGR, V42, P1154, DOI 10.4319/lo.1997.42.5_part_2.1154; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; ROBERTSON AI, 1995, HYDROBIOLOGIA, V295, P311, DOI 10.1007/BF00029138; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; TILMAN D, 1991, AM NAT, V138, P1269, DOI 10.1086/285283; Wier AM, 2000, BIOTROPICA, V32, P299, DOI 10.1646/0006-3606(2000)032[0299:DORMRM]2.0.CO;2; Wong YS, 1997, HYDROBIOLOGIA, V352, P49, DOI 10.1023/A:1003040920173	44	121	129	6	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5600	10.1371/journal.pone.0005600	http://dx.doi.org/10.1371/journal.pone.0005600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440554	Green Published, gold, Green Submitted			2022-12-27	WOS:000266161200003
J	Wares, JP; Pankey, MS; Pitombo, F; Daglio, LG; Achituv, Y				Wares, John P.; Pankey, M. Sabrina; Pitombo, Fabio; Daglio, Liza Gomez; Achituv, Yair			A "Shallow Phylogeny" of Shallow Barnacles (Chthamalus)	PLOS ONE			English	Article							TROPICAL EASTERN PACIFIC; CIRRIPEDIA; DNA; SPECIATION; BIOGEOGRAPHY; INCONGRUENCE; CRUSTACEA; AMPLIFICATION; SUBSTITUTION; SYSTEMATICS	Background: We present a multi-locus phylogenetic analysis of the shallow water (high intertidal) barnacle genus Chthamalus, focusing on member species in the western hemisphere. Understanding the phylogeny of this group improves interpretation of classical ecological work on competition, distributional changes associated with climate change, and the morphological evolution of complex cirripede phenotypes. Methodology and Findings: We use traditional and Bayesian phylogenetic and 'deep coalescent' approaches to identify a phylogeny that supports the monophyly of the mostly American 'fissus group' of Chthamalus, but that also supports a need for taxonomic revision of Chthamalus and Microeuraphia. Two deep phylogeographic breaks were also found within the range of two tropical American taxa (C. angustitergum and C. southwardorum) as well. Conclusions: Our data, which include two novel gene regions for phylogenetic analysis of cirripedes, suggest that much more evaluation of the morphological evolutionary history and taxonomy of Chthamalid barnacles is necessary. These data and associated analyses also indicate that the radiation of species in the late Pliocene and Pleistocene was very rapid, and may provide new insights toward speciation via transient allopatry or ecological barriers.			Wares, JP (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	jpwares@uga.edu	Pitombo, Fabio B/G-1778-2012	Wares, John/0000-0003-1827-0669; Pankey, M Sabrina/0000-0002-7061-9613				Avise JC, 2008, SYST BIOL, V57, P503, DOI 10.1080/10635150802164587; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Belfiore NM, 2008, SYST BIOL, V57, P294, DOI 10.1080/10635150802044011; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; BURROWS MT, 1992, J EXP MAR BIOL ECOL, V160, P229, DOI 10.1016/0022-0981(92)90240-B; Carling MD, 2008, GENETICS, V178, P363, DOI 10.1534/genetics.107.076422; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; DANDO PR, 1980, J MAR BIOL ASSOC UK, V60, P787, DOI 10.1017/S0025315400040455; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; Darwin C., 1854, MONOGRAPH SUBCLASS C; Degnan JH, 2005, EVOLUTION, V59, P24; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fisher T, 2004, BIOL J LINN SOC, V83, P39, DOI 10.1111/j.1095-8312.2004.00371.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hastings PA, 2000, ZOOL J LINN SOC-LOND, V128, P319, DOI 10.1006/zjls.1998.0196; HEDGECOCK D, 1979, MAR BIOL, V54, P207; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; KUO CH, 2008, MOL BIOL EVOL; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Newman W.A., 1976, Memoirs of the San Diego Society of Natural History, VNo. 9, P1; Nilsson-Cantell CA, 1921, ZOOL BIDR UPPS, V7, P75; Nylander J. A. A., 2004, MRMODELTEST V2; Palumbi Stephen R., 1996, P205; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pilsbry HA., 1916, B US NATN MUS, V93, P1, DOI DOI 10.5479/SI.03629236.93.1; Pitombo FB, 2007, ZOOTAXA, P1; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Poltarukha O., 1997, J ZOOL, V1, P463; POPE ELIZABETH C., 1965, PROC LINN SOC NEW SWALES, V90, P10; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Power AM, 1999, MAR ECOL PROG SER, V191, P251, DOI 10.3354/meps191251; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Southward A.J., 1977, FAO FISHERIES REPORT, V200, P407; SOUTHWARD AJ, 1991, J MAR BIOL ASSOC UK, V71, P495, DOI 10.1017/S002531540005311X; Southward AJ, 2003, J MAR BIOL ASSOC UK, V83, P797, DOI 10.1017/S0025315403007835h; STANLEY SM, 1980, PALEOBIOLOGY, V6, P173, DOI 10.1017/S0094837300006734; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Towle DW, 2001, J EXP BIOL, V204, P4005; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; Wares JP, 2005, J MAR BIOL ASSOC UK, V85, P327, DOI 10.1017/S0025315405011227h; Wares JP, 2001, MOL PHYLOGENET EVOL, V18, P104, DOI 10.1006/mpev.2000.0857; Wethey DS, 2002, INTEGR COMP BIOL, V42, P872, DOI 10.1093/icb/42.4.872; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yan Y, 2004, J CRUSTACEAN BIOL, V24, P519, DOI 10.1651/C-2491; Zardus JD, 2005, MOL ECOL, V14, P3719, DOI 10.1111/j.1365-294X.2005.02701.x; ZULLO VA, 1963, 16 INT C ZOOL, V1, P190	56	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5567	10.1371/journal.pone.0005567	http://dx.doi.org/10.1371/journal.pone.0005567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440543	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107400011
J	Aliverti, A; Bovio, D; Fullin, I; Dellaca, RL; Lo Mauro, A; Pedotti, A; Macklem, PT				Aliverti, Andrea; Bovio, Dario; Fullin, Irene; Dellaca, Raffaele L.; Lo Mauro, Antonella; Pedotti, Antonio; Macklem, Peter T.			The Abdominal Circulatory Pump	PLOS ONE			English	Article								Blood in the splanchnic vasculature can be transferred to the extremities. We quantified such blood shifts in normal subjects by measuring trunk volume by optoelectronic plethysmography, simultaneously with changes in body volume by whole body plethysmography during contractions of the diaphragm and abdominal muscles. Trunk volume changes with blood shifts, but body volume does not so that the blood volume shifted between trunk and extremities (Vbs) is the difference between changes in trunk and body volume. This is so because both trunk and body volume change identically with breathing and gas expansion or compression. During tidal breathing Vbs was 50-75 ml with an ejection fraction of 4-6% and an output of 750-1500 ml/min. Step increases in abdominal pressure resulted in rapid emptying presumably from the liver with a time constant of 0.61+/-0.1SE sec. followed by slower flow from non-hepatic viscera. The filling time constant was 0.57+/-0.09SE sec. Splanchnic emptying shifted up to 650 ml blood. With emptying, the increased hepatic vein flow increases the blood pressure at its entry into the inferior vena cava (IVC) and abolishes the pressure gradient producing flow between the femoral vein and the IVC inducing blood pooling in the legs. The findings are important for exercise because the larger the Vbs the greater the perfusion of locomotor muscles. During asystolic cardiac arrest we calculate that appropriate timing of abdominal compression could produce an output of 6 L/min. so that the abdominal circulatory pump might act as an auxiliary heart.			Aliverti, A (corresponding author), Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy.	andrea.aliverti@polimi.it	Andrea, Aliverti/A-3901-2015; Dellaca', Raffaele/AAF-7078-2019	Andrea, Aliverti/0000-0002-2950-0231; Dellaca', Raffaele/0000-0002-3672-4591; LoMauro, Antonella/0000-0002-1408-6971; Bovio, Dario/0000-0002-2654-9734				Aliverti A, 2005, EUR J APPL PHYSIOL, V95, P229, DOI 10.1007/s00421-005-1386-4; Aliverti A, 2002, J APPL PHYSIOL, V92, P1953, DOI 10.1152/japplphysiol.01222.2000; Aliverti A, 1997, J APPL PHYSIOL, V83, P1256, DOI 10.1152/jappl.1997.83.4.1256; BARRANCO F, 1990, RESUSCITATION, V20, P67, DOI 10.1016/0300-9572(90)90088-V; BERRYMAN CR, 1984, ANN EMERG MED, V13, P226, DOI 10.1016/S0196-0644(84)80467-9; BRIENZA N, 1995, AM J RESP CRIT CARE, V152, P511, DOI 10.1164/ajrccm.152.2.7633700; BRIENZA N, 1995, AM J RESP CRIT CARE, V152, P504, DOI 10.1164/ajrccm.152.2.7633699; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; CRILEY JM, 1976, JAMA-J AM MED ASSOC, V236, P1246, DOI 10.1001/jama.236.11.1246; DECRAMER M, 1984, J APPL PHYSIOL, V57, P1682, DOI 10.1152/jappl.1984.57.6.1682; EINAGLE V, 1988, CHEST, V93, P1206, DOI 10.1378/chest.93.6.1206; FROELICH JW, 1988, J NUCL MED, V29, P1714; GREENWAY CV, 1986, CAN J PHYSIOL PHARM, V64, P383, DOI 10.1139/y86-062; GUYTON AC, 1955, AM J PHYSIOL, V180, P463, DOI 10.1152/ajplegacy.1955.180.3.463; HOWARD M, 1987, ANN EMERG MED, V16, P253, DOI 10.1016/S0196-0644(87)80169-5; HYATT RE, 1958, J APPL PHYSIOL, V13, P331, DOI 10.1152/jappl.1958.13.3.331; Iandelli I, 2002, J APPL PHYSIOL, V92, P1943, DOI 10.1152/japplphysiol.00393.2000; JOHNSTONE FRC, 1956, AM J PHYSIOL, V185, P450, DOI 10.1152/ajplegacy.1956.185.3.450; MaassMoreno R, 1997, AM J PHYSIOL-HEART C, V272, pH2826, DOI 10.1152/ajpheart.1997.272.6.H2826; MATEER JR, 1985, AM J EMERG MED, V3, P143, DOI 10.1016/0735-6757(85)90038-5; MEAD J, 1967, J APPL PHYSIOL, V22, P95, DOI 10.1152/jappl.1967.22.1.95; Miller JD, 2005, J APPL PHYSIOL, V99, P1802, DOI 10.1152/japplphysiol.00278.2005; Miller JD, 2005, J PHYSIOL-LONDON, V563, P925, DOI 10.1113/jphysiol.2004.076422; MORENO AH, 1967, AM J PHYSIOL, V213, P455, DOI 10.1152/ajplegacy.1967.213.2.455; NIEMANN JT, 1980, CRIT CARE MED, V8, P141, DOI 10.1097/00003246-198003000-00011; PERMUTT S, 1963, J APPL PHYSIOL, V18, P924, DOI 10.1152/jappl.1963.18.5.924; RALSTON SH, 1982, ANESTH ANALG, V61, P645; RISOE C, 1991, J APPL PHYSIOL, V70, P818, DOI 10.1152/jappl.1991.70.2.818; Rothe CF, 2006, J APPL PHYSIOL, V101, P1262, DOI 10.1152/japplphysiol.00561.2006; ROTHE CF, 1983, PHYSIOL REV, V63, P1281, DOI 10.1152/physrev.1983.63.4.1281; ROWELL LB, 1990, J NUCL MED, V31, P160; SACK J B, 1992, Journal of the American Medical Association, V267, P379, DOI 10.1001/jama.267.3.379; SYLVESTER JT, 1981, CIRC RES, V49, P980, DOI 10.1161/01.RES.49.4.980; TAKATA M, 1992, J APPL PHYSIOL, V72, P597, DOI 10.1152/jappl.1992.72.2.597; TAKATA M, 1992, AM J PHYSIOL, V262, pH763, DOI 10.1152/ajpheart.1992.262.3.H763; TAKATA M, 1990, J APPL PHYSIOL, V69, P1961, DOI 10.1152/jappl.1990.69.6.1961; Tang WC, 1997, CIRCULATION, V95, P1335; WADE OL, 1956, CLIN SCI, V15, P457; WARD KR, 1989, ANN EMERG MED, V18, P831, DOI 10.1016/S0196-0644(89)80206-9; WEST JB, 1964, J APPL PHYSIOL, V19, P713, DOI 10.1152/jappl.1964.19.4.713; [No title captured]	41	38	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5550	10.1371/journal.pone.0005550	http://dx.doi.org/10.1371/journal.pone.0005550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19440240	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107300014
J	Qiu, XG; Fernando, L; Alimonti, JB; Melito, PL; Feldmann, F; Dick, D; Stroher, U; Feldmann, H; Jones, SM				Qiu, Xiangguo; Fernando, Lisa; Alimonti, Judie B.; Melito, P. Leno; Feldmann, Friedericke; Dick, Daryl; Stroeher, Ute; Feldmann, Heinz; Jones, Steven M.			Mucosal Immunization of Cynomolgus Macaques with the VSV Delta G/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses	PLOS ONE			English	Article							PROTECTS NONHUMAN-PRIMATES; HEMORRHAGIC-FEVER; VIRUS INFECTION; RHESUS-MONKEYS; MOUSE MODEL; IN-VITRO; MARBURG; GLYCOPROTEINS; MICE; TRANSMISSION	Background: Zaire ebolavirus (ZEBOV) produces a lethal viral hemorrhagic fever in humans and non-human primates. Methodology/Principal Findings: We demonstrate that the VSVDG/ZEBOVGP vaccine given 28 days pre-challenge either intranasally (IN), orally (OR), or intramuscularly (IM) protects non-human primates against a lethal systemic challenge of ZEBOV, and induces cellular and humoral immune responses. We demonstrated that ZEBOVGP-specific T-cell and humoral responses induced in the IN and OR groups, following an immunization and challenge, produced the most IFN-gamma and IL-2 secreting cells, and long term memory responses. Conclusions/Significance: We have shown conclusively that mucosal immunization can protect from systemic ZEBOV challenge and that mucosal delivery, particularly IN immunization, seems to be more potent than IM injection in the immune parameters we have tested. Mucosal immunization would be a huge benefit in any emergency mass vaccination campaign during a natural outbreak, or following intentional release, or for mucosal immunization of great apes in the wild.			Qiu, XG (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB, Canada.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Bradfute SB, 2007, J INFECT DIS, V196, pS296, DOI 10.1086/520602; Bukreyev A, 2009, VIROLOGY, V383, P348, DOI 10.1016/j.virol.2008.09.030; Bukreyev A, 2007, J VIROL, V81, P6379, DOI 10.1128/JVI.00105-07; CHEPURNOV AA, 1995, VOP VIRUSOL+, V40, P74; Daddario-DiCaprio KM, 2006, J VIROL, V80, P9659, DOI 10.1128/JVI.00959-06; Ebihara H, 2007, J INFECT DIS, V196, pS313, DOI 10.1086/520590; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082; Geisbert TW, 2000, LAB INVEST, V80, P171, DOI 10.1038/labinvest.3780021; Geisbert TW, 2005, PLOS MED, V2, P537, DOI 10.1371/journal.pmed.0020183; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001; Gupta M, 2001, VIROLOGY, V284, P20, DOI 10.1006/viro.2001.0836; Gupta M, 2007, VIROLOGY, V364, P45, DOI 10.1016/j.virol.2007.02.017; Ignatyev GM, 1996, J BIOTECHNOL, V44, P111, DOI 10.1016/0168-1656(95)00104-2; Jaax N, 1995, LANCET, V346, P1669, DOI 10.1016/S0140-6736(95)92841-3; Jaax NK, 1996, ARCH PATHOL LAB MED, V120, P140; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Jones SM, 2007, J INFECT DIS, V196, pS404, DOI 10.1086/520591; Leffel EK, 2004, BIOSECUR BIOTERROR, V2, P186, DOI 10.1089/bsp.2004.2.186; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Mason C, 2008, CAN MED ASSOC J, V178, P1266, DOI 10.1503/cmaj.080524; Peters C.J., 1996, FIELDS VIROLOGY, P1161; Pushko P, 2000, VACCINE, V19, P142, DOI 10.1016/S0264-410X(00)00113-4; Rao M, 2002, J VIROL, V76, P9176, DOI 10.1128/JVI.76.18.9176-9185.2002; Reed DS, 2004, VIRAL IMMUNOL, V17, P390, DOI 10.1089/vim.2004.17.390; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Stroher U, 2001, J VIROL, V75, P11025, DOI 10.1128/JVI.75.22.11025-11033.2001; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Swenson DL, 2008, CLIN VACCINE IMMUNOL, V15, P460, DOI 10.1128/CVI.00431-07; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Vanderzanden L, 1998, VIROLOGY, V246, P134, DOI 10.1006/viro.1998.9176; Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI.79.4.2413-2419.2005; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; World Health Organization, 2008, Weekly Epidemiological Record, V83, P89	46	110	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5547	10.1371/journal.pone.0005547	http://dx.doi.org/10.1371/journal.pone.0005547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19440245	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107300012
J	Caccamo, N; Guggino, G; Meraviglia, S; Gelsomino, G; Di Carlo, P; Titone, L; Bocchino, M; Galati, D; Matarese, A; Nouta, J; Klein, MR; Salerno, A; Sanduzzi, A; Dieli, F; Ottenhoff, THM				Caccamo, Nadia; Guggino, Giuliana; Meraviglia, Serena; Gelsomino, Giuseppe; Di Carlo, Paola; Titone, Lucina; Bocchino, Marialuisa; Galati, Domenico; Matarese, Alessandro; Nouta, Jan; Klein, Michel R.; Salerno, Alfredo; Sanduzzi, Alessandro; Dieli, Francesco; Ottenhoff, Tom H. M.			Analysis of Mycobacterium tuberculosis-Specific CD8 T-Cells in Patients with Active Tuberculosis and in Individuals with Latent Infection	PLOS ONE			English	Article								CD8 T-cells contribute to control of Mycobacterium tuberculosis infection, but little is known about the quality of the CD8 T-cell response in subjects with latent infection and in patients with active tuberculosis disease. CD8 T-cells recognizing epitopes from 6 different proteins of Mycobacterium tuberculosis were detected by tetramer staining. Intracellular cytokines staining for specific production of IFN-gamma and IL-2 was performed, complemented by phenotyping of memory markers on antigen-specific CD8 T-cells. The ex-vivo frequencies of tetramer-specific CD8 T-cells in tuberculous patients before therapy were lower than in subjects with latent infection, but increased at four months after therapy to comparable percentages detected in subjects with latent infection. The majority of CD8 T-cells from subjects with latent infection expressed a terminally-differentiated phenotype (CD45RA(+)CCR7(-)). In contrast, tuberculous patients had only 35% of antigen-specific CD8 T-cells expressing this phenotype, while containing higher proportions of cells with an effector memory-and a central memory-like phenotype, and which did not change significantly after therapy. CD8 T-cells from subjects with latent infection showed a codominance of IL-2(+)/IFN-gamma(+) and IL-2(-)/IFN-gamma(+) T-cell populations; interestingly, only the IL-2(+)/IFN-gamma(+) population was reduced or absent in tuberculous patients, highly suggestive of a restricted functional profile of Mycobacterium tuberculosis-specific CD8 T-cells during active disease. These results suggest distinct Mycobacterium tuberculosis specific CD8 T-cell phenotypic and functional signatures between subjects which control infection (subjects with latent infection) and those who do not (patients with active disease).			Caccamo, N (corresponding author), Univ Palermo, Dipartimento Biopatol & Metodol Biomed, Palermo, Italy.	caccamo@unipa.it	Di Carlo, Paola/I-2123-2019; Di Carlo, Paola/S-2456-2017; Caccamo, Nadia/J-6808-2018; Meraviglia, Serena/K-5164-2016	Di Carlo, Paola/0000-0003-4418-5855; Di Carlo, Paola/0000-0003-4418-5855; GUGGINO, Giuliana/0000-0003-2479-6958; Galati, Domenico/0000-0001-5613-9149; CACCAMO, Nadia Rosalia/0000-0002-1018-5710; Dieli, Francesco/0000-0002-6685-352X				Caccamo N, 2006, J IMMUNOL, V177, P1780, DOI 10.4049/jimmunol.177.3.1780; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; DAMARO J, 1995, HUM IMMUNOL, V43, P13, DOI 10.1016/0198-8859(94)00153-H; Di Liberto D, 2007, TUBERCULOSIS, V87, P322, DOI 10.1016/j.tube.2007.01.003; Dieli F, 2000, SCAND J IMMUNOL, V52, P96; Dieli F, 1999, J INFECT DIS, V180, P225, DOI 10.1086/314852; Dieli F, 2002, J INFECT DIS, V186, P1835, DOI 10.1086/345766; Dunne PJ, 2005, BLOOD, V106, P558, DOI 10.1182/blood-2004-11-4469; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; GAMBONDEZA F, 1995, INFECT IMMUN, V63, P1235; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577; Geluk A, 2000, J IMMUNOL, V165, P6463, DOI 10.4049/jimmunol.165.11.6463; GELUK A, 1995, MOL IMMUNOL, V32, P975, DOI 10.1016/0161-5890(95)00058-M; Hammond AS, 2005, CLIN EXP IMMUNOL, V140, P109, DOI 10.1111/j.1365-2249.2005.02751.x; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Klein MR, 2002, INFECT IMMUN, V70, P981, DOI 10.1128/IAI.70.2.981-984.2002; Klein MR, 2001, ARCH IMMUNOL THER EX, V49, P379; KOGA T, 1989, SCIENCE, V245, P1112, DOI 10.1126/science.2788923; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Liebana E, 1999, INFECT IMMUN, V67, P1034; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; OTTENHOFF THM, 2008, HDB TUBERCULOSIS IMM; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Teixeira A, 2002, PROTEIN PEPTIDE LETT, V9, P379, DOI 10.2174/0929866023408481; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; World Health Organization, 2008, GLOB TUB CONTR SURV; 1999, AM J RESP CRIT CARE, V161	39	86	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5528	10.1371/journal.pone.0005528	http://dx.doi.org/10.1371/journal.pone.0005528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436760	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009900020
J	Mohamad, K; Olsson, M; van Tol, HTA; Mikko, S; Vlamings, BH; Andersson, G; Rodriguez-Martinez, H; Purwantara, B; Paling, RW; Colenbrander, B; Lenstra, JA				Mohamad, Kusdiantoro; Olsson, Mia; van Tol, Helena T. A.; Mikko, Sofia; Vlamings, Bart H.; Andersson, Goeran; Rodriguez-Martinez, Heriberto; Purwantara, Bambang; Paling, Robert W.; Colenbrander, Ben; Lenstra, Johannes A.			On the Origin of Indonesian Cattle	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; DIVERSITY; AFRICAN; HYBRIDIZATION; ADMIXTURE; MARKERS; BANTENG; EAST	Background: Two bovine species contribute to the Indonesian livestock, zebu (Bos indicus) and banteng (Bos javanicus), respectively. Although male hybrid offspring of these species is not fertile, Indonesian cattle breeds are supposed to be of mixed species origin. However, this has not been documented and is so far only supported by preliminary molecular analysis. Methods and Findings: Analysis of mitochondrial, Y-chromosomal and microsatellite DNA showed a banteng introgression of 10-16% in Indonesian zebu breeds. East-Javanese Madura and Galekan cattle have higher levels of autosomal banteng introgression (20-30%) and combine a zebu paternal lineage with a predominant (Madura) or even complete (Galekan) maternal banteng origin. Two Madura bulls carried taurine Y-chromosomal haplotypes, presumably of French Limousin origin. In contrast, we did not find evidence for zebu introgression in five populations of the Bali cattle, a domestic form of the banteng. Conclusions: Because of their unique species composition Indonesian cattle represent a valuable genetic resource, which potentially may also be exploited in other tropical regions.			Mohamad, K (corresponding author), Bogor Agr Univ, Fac Vet Med, Bogor, Indonesia.	J.A.Lenstra@uu.nl	Andersson, Goran/AAK-6564-2020; Mikko, Sofia/F-1347-2017; Rodriguez, Heriberto/G-2675-2012; Lenstra, Johannes A./H-2988-2019; Rodriguez-Martinez, Heriberto/AAG-4076-2020; Mohamad, Kusdiantoro/GPG-3156-2022	Andersson, Goran/0000-0001-5131-3144; Mikko, Sofia/0000-0002-6375-1376; Rodriguez, Heriberto/0000-0002-5194-2124; Lenstra, Johannes A./0000-0003-1745-7739; Rodriguez-Martinez, Heriberto/0000-0002-5194-2124; Mohamad, Kusdiantoro/0000-0002-7143-168X				BARWEGEN M, 2005, GOUDEN HOORNS GESCHI; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Bradshaw CJA, 2006, CONSERV BIOL, V20, P1306, DOI 10.1111/j.1523-1739.2006.00428.x; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; FELIUS M, 1995, CATTLE BREEDS ENCY M; Freeman AR, 2004, MOL ECOL, V13, P3477, DOI 10.1111/j.1365-294X.2004.02311.x; GINJA C, 2008, J HERED; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Hall S.J.G., 2004, LIVESTOCK BIODIVERSI; Kikkawa Y, 2003, ANIM GENET, V34, P96, DOI 10.1046/j.1365-2052.2003.00956.x; KIKKAWA Y, 1995, BIOCHEM GENET, V33, P51, DOI 10.1007/BF00554558; KREDIET G, 1913, RUNDVEEFOKKERIJ JAVA; Kumar P, 2003, HEREDITY, V91, P43, DOI 10.1038/sj.hdy.6800277; Lenstra JA, 1999, GENETICS OF CATTLE, P1; LOFTUS RT, 1994, ANIM GENET, V25, P265, DOI 10.1111/j.1365-2052.1994.tb00203.x; MCCOOL C, 1992, TROP ANIM HEALTH PRO, V24, P165, DOI 10.1007/BF02359609; NAMIKAWA T, 1978, Japanese Journal of Zootechnical Science, V49, P817; NAMIKAWA T, 1981, Z TIERZ ZUCHTUNGSBIO, V98, P151; Nijman IJ, 2003, HEREDITY, V90, P10, DOI 10.1038/sj.hdy.6800174; Nijman IJ, 2008, CLADISTICS, V24, P723, DOI 10.1111/j.1096-0031.2008.00201.x; PAYNE W J A, 1976, Zeitschrift fuer Tierzuechtung und Zuechtungsbiologie, V93, P89; PAYNE WJA, 1973, WLD ANIM REV, V7, P13; Pritchard JK, 2000, GENETICS, V155, P945; ROLLINSON DHL, 1994, EVOLUTION DOMESTIC A; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; ROWLINSON P, 2008, LIVESTOCK GLOBAL CLI; Sambrook J, 1989, MOL CLONING; THOEN H, 1919, VEERASSEN VEETEELT N; Verkaar ELC, 2003, HEREDITY, V91, P565, DOI 10.1038/sj.hdy.6800359; Verkaar ELC, 2002, MEAT SCI, V60, P365, DOI 10.1016/S0309-1740(01)00144-9; Yu Y, 1999, ANIM GENET, V30, P245, DOI 10.1046/j.1365-2052.1999.00483.x	32	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5490	10.1371/journal.pone.0005490	http://dx.doi.org/10.1371/journal.pone.0005490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436739	gold, Green Published, Green Submitted			2022-12-27	WOS:000266009900003
J	James, CE; Mahendran, KR; Molitor, A; Bolla, JM; Bessonov, AN; Winterhalter, M; Page, JM				James, Chloe E.; Mahendran, Kozhinjampara R.; Molitor, Alexander; Bolla, Jean-Michel; Bessonov, Andrey N.; Winterhalter, Mathias; Page, Jean-Marie			How beta-Lactam Antibiotics Enter Bacteria: A Dialogue with the Porins	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; OUTER-MEMBRANE PERMEABILITY; ESCHERICHIA-COLI; ENTEROBACTER-AEROGENES; KLEBSIELLA-PNEUMONIAE; OMPF CHANNEL; MOLECULAR-BASIS; RESISTANCE; ERTAPENEM; EFFLUX	Background: Multi-drug resistant (MDR) infections have become a major concern in hospitals worldwide. This study investigates membrane translocation, which is the first step required for drug action on internal bacterial targets. beta-lactams, a major antibiotic class, use porins to pass through the outer membrane barrier of Gram-negative bacteria. Clinical reports have linked the MDR phenotype to altered membrane permeability including porin modification and efflux pump expression. Methodology/Principal Findings: Here influx of beta-lactams through the major Enterobacter aerogenes porin Omp36 is characterized. Conductance measurements through a single Omp36 trimer reconstituted into a planar lipid bilayer allowed us to count the passage of single beta-lactam molecules. Statistical analysis of each transport event yielded the kinetic parameters of antibiotic travel through Omp36 and distinguishable translocation properties of beta-lactams were quantified for ertapenem and cefepime. Expression of Omp36 in an otherwise porin-null bacterial strain is shown to confer increases in the killing rate of these antibiotics and in the corresponding bacterial susceptibility. Conclusions/Significance: We propose the idea of a molecular "passport'' that allows rapid transport of substrates through porins. Deciphering antibiotic translocation provides new insights for the design of novel drugs that may be highly effective at passing through the porin constriction zone. Such data may hold the key for the next generation of antibiotics capable of rapid intracellular accumulation to circumvent the further development MDR infections.			James, CE (corresponding author), Univ Aix Marseille 2, UMR MD 1, Fac Med, IFR 88, Marseille, France.	Jean-Marie.PAGES@univmed.fr	James, Chloe/G-2371-2010; Bolla, Jean Michel/D-3885-2014; Pages, Jean-Marie/F-2555-2013	Bolla, Jean Michel/0000-0003-3892-4340; Winterhalter, Mathias/0000-0002-1604-3318; Pages, Jean-Marie/0000-0001-7092-7977; James, Chloe/0000-0002-0131-7988				Ardanuy C, 1998, ANTIMICROB AGENTS CH, V42, P1636, DOI 10.1128/AAC.42.7.1636; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Berezhkovskii AM, 2005, BIOPHYS J, V88, pL17, DOI 10.1529/biophysj.104.057588; Blot S, 2007, CURR OPIN INFECT DIS, V20, P391, DOI 10.1097/QCO.0b013e32818be6f7; Bolla Jean Michel, 2003, Methods Mol Biol, V228, P131, DOI 10.1385/1-59259-400-X:131; Bornet C, 2004, ANTIMICROB AGENTS CH, V48, P2153, DOI 10.1128/AAC.48.6.2153-2158.2004; Bornet C, 2000, J CLIN MICROBIOL, V38, P1048, DOI 10.1128/JCM.38.3.1048-1052.2000; Bredin J, 2002, BIOCHEM J, V363, P521, DOI 10.1042/0264-6021:3630521; Bryskier A, 2005, ANTIMICROBIAL AGENTS: ANTIBACTERIALS AND ANTIFUNGALS, P1; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Danelon C, 2006, BIOPHYS J, V90, P1617, DOI 10.1529/biophysj.105.075192; Danelon C, 2003, BIOPHYS CHEM, V104, P591, DOI 10.1016/S0301-4622(03)00062-0; Davin-Regli A, 2008, CURR DRUG TARGETS, V9, P750, DOI 10.2174/138945008785747824; De E, 2001, MOL MICROBIOL, V41, P189, DOI 10.1046/j.1365-2958.2001.02501.x; Domenech-Sanchez A, 2003, ANTIMICROB AGENTS CH, V47, P3332, DOI 10.1128/AAC.47.10.3332-3335.2003; Elliott E, 2006, CLIN INFECT DIS, V42, pE95, DOI 10.1086/503264; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Gayet S, 2003, ANTIMICROB AGENTS CH, V47, P1555, DOI 10.1128/AAC.47.5.1555-1559.2003; Hammond ML, 2004, J ANTIMICROB CHEMOTH, V53, P7, DOI 10.1093/jac/dkh203; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Iyer R, 2000, J MOL BIOL, V297, P933, DOI 10.1006/jmbi.2000.3599; Jacoby GA, 2004, ANTIMICROB AGENTS CH, V48, P3203, DOI 10.1128/AAC.48.8.3203-3206.2004; JEANTEUR D, 1994, P NATL ACAD SCI USA, V91, P10675, DOI 10.1073/pnas.91.22.10675; KARSHIKOFF A, 1994, J MOL BIOL, V240, P372, DOI 10.1006/jmbi.1994.1451; Liu NZ, 1997, BBA-BIOMEMBRANES, V1326, P201, DOI 10.1016/S0005-2736(97)00024-2; Livermore DM, 2003, J ANTIMICROB CHEMOTH, V52, P331, DOI 10.1093/jac/dkg375; Mach T, 2008, J AM CHEM SOC, V130, P13301, DOI 10.1021/ja803188c; Mallea M, 1998, MICROBIOL-UK, V144, P3003, DOI 10.1099/00221287-144-11-3003; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; NEKOLLA S, 1994, BIOPHYS J, V66, P1388, DOI 10.1016/S0006-3495(94)80929-4; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Rice LB, 2006, BIOCHEM PHARMACOL, V71, P991, DOI 10.1016/j.bcp.2005.09.018; Saier MH, 2007, J MOL MICROB BIOTECH, V12, P161, DOI 10.1159/000099638; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Simonet V, 2000, ANTIMICROB AGENTS CH, V44, P311, DOI 10.1128/AAC.44.2.311-315.2000; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Vidal S, 2005, J MED CHEM, V48, P1395, DOI 10.1021/jm049652e; Weingart H, 2008, CURR DRUG TARGETS, V9, P789, DOI 10.2174/138945008785747752; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; Zakharian E, 2003, FEBS LETT, V555, P229, DOI 10.1016/S0014-5793(03)01236-5	47	75	75	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2009	4	5							e5453	10.1371/journal.pone.0005453	http://dx.doi.org/10.1371/journal.pone.0005453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VZ	19434239	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000266009800002
J	Guidicelli, G; Chaigne-Delalande, B; Dilhuydy, MS; Pinson, B; Mahfouf, W; Pasquet, JM; Mahon, FX; Pourquier, P; Moreau, JF; Legembre, P				Guidicelli, Gwendaline; Chaigne-Delalande, Benjamin; Dilhuydy, Marie-Sarah; Pinson, Benoit; Mahfouf, Walid; Pasquet, Jean-Max; Mahon, Francois-Xavier; Pourquier, Philippe; Moreau, Jean-Francois; Legembre, Patrick			The Necrotic Signal Induced by Mycophenolic Acid Overcomes Apoptosis-Resistance in Tumor Cells	PLOS ONE			English	Article								Background: The amount of inosine monophosphate dehydrogenase (IMPDH), a pivotal enzyme for the biosynthesis of the guanosine tri-phosphate (GTP), is frequently increased in tumor cells. The anti-viral agent ribavirin and the immunosuppressant mycophenolic acid (MPA) are potent inhibitors of IMPDH. We recently showed that IMPDH inhibition led to a necrotic signal requiring the activation of Cdc42. Methodology/Principal Findings: Herein, we strengthened the essential role played by this small GTPase in the necrotic signal by silencing Cdc42 and by the ectopic expression of a constitutive active mutant of Cdc42. Since resistance to apoptosis is an essential step for the tumorigenesis process, we next examined the effect of the MPA-mediated necrotic signal on different tumor cells demonstrating various mechanisms of resistance to apoptosis (Bcl2-, HSP70-, Lyn-, BCR-ABL-overexpressing cells). All tested cells remained sensitive to MPA-mediated necrotic signal. Furthermore, inhibition of IMPDH activity in Chronic Lymphocytic Leukemia cells was significantly more efficient at eliminating malignant cells than apoptotic inducers. Conclusions/Significance: These findings indicate that necrosis and apoptosis are split signals that share few if any common hub of signaling. In addition, the necrotic signaling pathway induced by depletion of the cellular amount of GTP/GDP would be of great interest to eliminate apoptotic-resistant tumor cells.			Guidicelli, G (corresponding author), CNRS, UMR 5164, Bordeaux, France.	patrick.legembre@inserm.fr	PASQUET, JEAN-MAX/I-9702-2014; PASQUET, JEAN-MAX/T-4906-2019; Pourquier, Philippe/O-8030-2018; Legembre, Patrick/U-1882-2019; legembre, patrick/L-3475-2016	PASQUET, JEAN-MAX/0000-0002-1345-3776; Pourquier, Philippe/0000-0001-5326-3005; Legembre, Patrick/0000-0001-6649-8049; legembre, patrick/0000-0001-6649-8049; Pinson, Benoit/0000-0003-2936-9058				Ahn JH, 1999, MOL CELLS, V9, P200; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Beneteau M, 2007, CANCER RES, V67, P108, DOI 10.1158/0008-5472.CAN-06-1415; Buell JF, 2005, TRANSPLANTATION, V80, pS254, DOI 10.1097/01.tp.0000186382.81130.ba; BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; Chaigne-Delalande B, 2008, J IMMUNOL, V181, P7630, DOI 10.4049/jimmunol.181.11.7630; Chen LQ, 2007, CURR OPIN DRUG DISC, V10, P403; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; Danilov AV, 2006, CURR MOL MED, V6, P665, DOI 10.2174/156652406778195008; Dyer MJS, 2007, J CLIN ONCOL, V25, P4505, DOI 10.1200/JCO.2007.13.1011; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haessler J, 2007, CLIN CANCER RES, V13, P7073, DOI 10.1158/1078-0432.CCR-07-0527; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Henson ES, 2008, LEUKEMIA LYMPHOMA, V49, P27, DOI 10.1080/10428190701713655; Holland GN, 2000, OCUL IMMUNOL INFLAMM, V8, P1, DOI 10.1076/0927-3948(200003)8:1;1-S;FT001; Inoue S, 2004, CELL DEATH DIFFER, V11, pS193, DOI 10.1038/sj.cdd.4401535; Koehl GE, 2007, TRANSPLANTATION, V83, P607, DOI 10.1097/01.tp.0000253756.69243.65; Legembre P, 2005, MOL CELL BIOL, V25, P6811, DOI 10.1128/MCB.25.15.6811-6820.2005; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; Luciano F, 2003, FASEB J, V17, P711, DOI 10.1096/fj.02-0716fje; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Mateo W, 2002, BLOOD, V100, P2882, DOI 10.1182/blood-2001-12-0217; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; NAGAI M, 1991, CANCER RES, V51, P3886; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Pocaly M, 2007, LEUKEMIA, V21, P93, DOI 10.1038/sj.leu.2404463; Robson R, 2005, AM J TRANSPLANT, V5, P2954, DOI 10.1111/j.1600-6143.2005.01125.x; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VELASQUEZ WS, 1994, J CLIN ONCOL, V12, P1169, DOI 10.1200/JCO.1994.12.6.1169	40	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5493	10.1371/journal.pone.0005493	http://dx.doi.org/10.1371/journal.pone.0005493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430526	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009700002
J	Shim, E; Galvani, AP				Shim, Eunha; Galvani, Alison P.			Evolutionary Repercussions of Avian Culling on Host Resistance and Influenza Virulence	PLOS ONE			English	Article							A H5N1; HUMAN-DISEASE; GENETICS; MALARIA; VIRUS; EMERGENCE; MORTALITY; THAILAND; PROTEIN; MX	Background: Keeping pandemic influenza at bay is a global health priority. Of particular concern is the continued spread ofthe influenza subtype H5N1 in avian populations and the increasing frequency of transmission to humans. To decrease this threat, mass culling is the principal strategy for eradicating influenza in avian populations. Although culling has a crucial short-term epidemiological benefit, evolutionary repercussions on reservoir hosts and on the viral population have not been considered. Methods and Findings: To explore the epidemiological and evolutionary repercussions of mass avian culling, we combine population genetics and epidemiological influenza dynamics in a mathematical model parameterized by clinical, epidemiological, and poultry data. We model the virulence level of influenza and the selection on a dominant allele that confers resistance against influenza [ 1,2] in a poultry population. Our findings indicate that culling impedes the evolution of avian host resistance against influenza. On the pathogen side of the coevolutionary race between pathogen and host, culling selects for heightened virulence and transmissibility of influenza. Conclusions: Mass culling achieves a short-term benefit at the expense of long-term detriments: a more genetically susceptible host population, ultimately greater mortality, and elevated influenza virulence.			Shim, E (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.	eunha.shim@yale.edu						Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Bacon PA, 2005, NEW ENGL J MED, V352, P330, DOI 10.1056/NEJMp048338; BARD CW, 1998, AVIAN INFLUENZA FORE, P73; BEAN WJ, 1985, J VIROL, V54, P151, DOI 10.1128/JVI.54.1.151-160.1985; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; *CHICK FARM NOV SO, 2002, IS CHICK RAIS; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; DOLAN RB, 1987, PARASITOL TODAY, V3, P137, DOI 10.1016/0169-4758(87)90197-9; DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; *FAO, 2004, FAO WORKSH SOC EC IM; *FAO, 2005, AV INFL DIS CARD; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; Galvani AP, 2003, TRENDS ECOL EVOL, V18, P132, DOI 10.1016/S0169-5347(02)00050-2; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; GARBER EA, 1991, VIROLOGY, V180, P754, DOI 10.1016/0042-6822(91)90088-S; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; GILCHRIST MA, 2005, THEORETICAL POPULATI, V69, P145; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Landes M., 2004, INDIAS POULTRY SECTO; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; MARSHALL I. D., 1958, JOUR HYGIENE, V56, P288; Matthews L, 1999, P ROY SOC B-BIOL SCI, V266, P1085, DOI 10.1098/rspb.1999.0747; MATTHEWS L, 2003, P ROY SOC LOND B BIO, V270, P1679; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; *OFF INT EP, 2005, DIS INF PUBL 18 MONT; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Porco TC, 2005, J THEOR BIOL, V233, P91, DOI 10.1016/j.jtbi.2004.09.009; Qiao CL, 2009, ANTIVIR RES, V81, P234, DOI 10.1016/j.antiviral.2008.12.002; *SASK AGR FOOD, 2005, EGG PROD CHICK; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; STAEHELI P, 1986, J VIROL, V58, P967, DOI 10.1128/JVI.58.3.967-969.1986; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Webster RG, 2004, REV SCI TECH OIE, V23, P453, DOI 10.20506/rst.23.2.1493; *WHO, 2007, CUM NUMB CONF HUM CA; Williams PD, 2001, P ROY SOC B-BIOL SCI, V268, P2331, DOI 10.1098/rspb.2001.1795; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zeitlin Gary Adam, 2005, Curr Infect Dis Rep, V7, P193, DOI 10.1007/s11908-005-0034-9	54	27	27	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5503	10.1371/journal.pone.0005503	http://dx.doi.org/10.1371/journal.pone.0005503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430529	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009700008
J	Sheth, BR; Nguyen, N; Janvelyan, D				Sheth, Bhavin R.; Nguyen, Ngan; Janvelyan, Davit			Does Sleep Really Influence Face Recognition Memory?	PLOS ONE			English	Article							DECLARATIVE MEMORY; CONSOLIDATION; AREA	Mounting evidence implicates sleep in the consolidation of various kinds of memories. We investigated the effect of sleep on memory for face identity, a declarative form of memory that is indispensable for nearly all social interaction. In the acquisition phase, observers viewed faces that they were required to remember over a variable retention period (0-36 hours). In the test phase, observers viewed intermixed old and new faces and judged seeing each before. Participants were classified according to acquisition and test times into seven groups. Memory strength (d') and response bias (c) were evaluated. Substantial time spent awake (12 hours or more) during the retention period impaired face recognition memory evaluated at test, whereas sleep per se during the retention period did little to enhance the memory. Wakefulness during retention also led to a tightening of the decision criterion. Our findings suggest that sleep passively and transiently shelters face recognition memory from waking interference (exposure) but does not actively aid in its long-term consolidation.			Sheth, BR (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA.	brsheth@uh.edu						CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Sheth BR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003190; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 1998, J COGNITIVE NEUROSCI, V10, P77; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wagner U, 2007, NEUROBIOL LEARN MEM, V87, P679, DOI 10.1016/j.nlm.2007.01.004; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2004, SLEEP, V27, P406; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2003, SLEEP, V26, pA441; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	28	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5496	10.1371/journal.pone.0005496	http://dx.doi.org/10.1371/journal.pone.0005496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	443TN	19424440	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000265933800023
J	Kaur, D; Pham, H; Larrouy-Maumus, G; Riviere, M; Vissa, V; Guerin, ME; Puzo, G; Brennan, PJ; Jackson, M				Kaur, Devinder; Pham, Ha; Larrouy-Maumus, Gerald; Riviere, Michel; Vissa, Varalakshmi; Guerin, Marcelo E.; Puzo, Germain; Brennan, Patrick J.; Jackson, Mary			Initiation of Methylglucose Lipopolysaccharide Biosynthesis in Mycobacteria	PLOS ONE			English	Article							TUBERCULOSIS; POLYSACCHARIDE; GROWTH	Background: Mycobacteria produce two unique families of cytoplasmic polymethylated polysaccharides - the methylglucose lipopolysaccharides ( MGLPs) and the methylmannose polysaccharides ( MMPs) - the physiological functions of which are still poorly defined. Towards defining the roles of these polysaccharides in mycobacterial physiology, we generated knock-out mutations of genes in their putative biosynthetic pathways. Methodology/Principal Findings: We report here on the characterization of the Rv1208 protein of Mycobacterium tuberculosis and its ortholog in Mycobacterium smegmatis (MSMEG_5084) as the enzymes responsible for the transfer of the first glucose residue of MGLPs. Disruption of MSMEG_5084 in M. smegmatis resulted in a dramatic decrease in MGLP synthesis directly attributable to the almost complete abolition of glucosyl-3-phosphoglycerate synthase activity in this strain. Synthesis of MGLPs in the mutant was restored upon complementation with wild-type copies of the Rv1208 gene from M. tuberculosis or MSMEG_5084 from M. smegmatis. Conclusions/Significance: This is the first evidence linking Rv1208 to MGLP biosynthesis. Thus, the first step in the initiation of MGLP biosynthesis in mycobacteria has been defined, and subsequent steps can be inferred.			Kaur, D (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu	Guerin, Marcelo M/N-7245-2016; Jackson, Mary/D-5345-2017	Guerin, Marcelo M/0000-0001-9524-3184; Jackson, Mary/0000-0002-9212-0258; Larrouy-Maumus, Gerald/0000-0001-6614-8698	NIAID NIH HHS [R01 AI064798] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Pereira PJB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003748; BLOCH K, 1977, ADV ENZYMOLOGY, P1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; FORSBERG LS, 1982, J BIOL CHEM, V257, P3555; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Gest P, 2008, ACTA CRYSTALLOGR F, V64, P1121, DOI 10.1107/S1744309108032892; GRAY GR, 1971, J BIOL CHEM, V246, P6835; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; LEE YC, 1966, J BIOL CHEM, V241, P1899; LEE YC, 1964, J BIOL CHEM, V239; MAITRA SK, 1977, J BIOL CHEM, V252, P2459; MALONEY DH, 1980, J BACTERIOL, V141, P1217, DOI 10.1128/JB.141.3.1217-1221.1980; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; YABUSAKI KK, 1979, J BIOL CHEM, V254, P2314	20	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5447	10.1371/journal.pone.0005447	http://dx.doi.org/10.1371/journal.pone.0005447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421329	Green Submitted, Green Published, gold			2022-12-27	WOS:000265837000001
J	Skoglund, A; Backhed, HK; Nilsson, C; Bjorkholm, B; Normark, S; Engstrand, L				Skoglund, Anna; Backhed, Helene Kling; Nilsson, Christina; Bjorkholm, Britta; Normark, Staffan; Engstrand, Lars			A Changing Gastric Environment Leads to Adaptation of Lipopolysaccharide Variants in Helicobacter pylori Populations during Colonization	PLOS ONE			English	Article							LEWIS ANTIGEN-EXPRESSION; COMPLETE GENOME SEQUENCE; BLOOD-GROUP ANTIGENS; PHASE VARIATION; MOLECULAR MIMICRY; EPITHELIAL-CELLS; STRAINS; DISEASE; CAGA; DIVERSITY	The human gastric pathogen Helicobacter pylori colonizes the stomachs of half of the human population, and causes development of peptic ulcer disease and gastric adenocarcinoma. H. pylori-associated chronic atrophic gastritis (ChAG) with loss of the acid-producing parietal cells, is correlated with an increased risk for development of gastric adenocarinoma. The majority of H. pylori isolates produce lipopolysaccharides (LPS) decorated with human-related Lewis epitopes, which have been shown to phase-vary in response to different environmental conditions. We have characterized the adaptations of H. pylori LPS and Lewis antigen expression to varying gastric conditions; in H. pylori isolates from mice with low or high gastric pH, respectively; in 482 clinical isolates from healthy individuals and from individuals with ChAG obtained at two time points with a four-year interval between endoscopies; and finally in isolates grown at different pH in vitro. Here we show that the gastric environment can contribute to a switch in Lewis phenotype in the two experimental mouse models. The clinical isolates from different human individuals showed that intra-individual isolates varied in Lewis antigen expression although the LPS diversity was relatively stable within each individual over time. Moreover, the isolates demonstrated considerable diversity in the levels of glycosylation and in the sizes of fucosylated O-antigen chains both within and between individuals. Thus our data suggest that different LPS variants exist in the colonizing H. pylori population, which can adapt to changes in the gastric environment and provide a means to regulate the inflammatory response of the host during disease progression.			Skoglund, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	lars.engstrand@smi.se			NIDDK NIH HHS [DK058529, R01 DK058529] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058529] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Appelmelk BJ, 1998, INFECT IMMUN, V66, P70, DOI 10.1128/IAI.66.1.70-76.1998; Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bjorkholm B, 2001, INFECT IMMUN, V69, P7832, DOI 10.1128/IAI.69.12.7832-7838.2001; Broutet N, 2002, J INFECT DIS, V185, P503, DOI 10.1086/339016; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Correa P, 2005, J SURG ONCOL, V90, P134, DOI 10.1002/jso.20216; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; Enroth H, 2000, CANCER EPIDEM BIOMAR, V9, P981; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Heneghan MA, 2000, INFECT IMMUN, V68, P937, DOI 10.1128/IAI.68.2.937-941.2000; Keenan JI, 2008, INNATE IMMUN, V14, P279, DOI 10.1177/1753425908096857; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kuipers EJ, 2000, J INFECT DIS, V181, P273, DOI 10.1086/315173; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Marshall DG, 1999, FEMS IMMUNOL MED MIC, V24, P79, DOI 10.1111/j.1574-695X.1999.tb01268.x; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; Monteiro MA, 2000, EUR J BIOCHEM, V267, P305, DOI 10.1046/j.1432-1327.2000.01007.x; Monteiro MA, 1998, J BIOL CHEM, V273, P11533, DOI 10.1074/jbc.273.19.11533; Monteiro MA, 2000, GLYCOBIOLOGY, V10, P701, DOI 10.1093/glycob/10.7.701; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Moran AP, 2002, J BIOL CHEM, V277, P5785, DOI 10.1074/jbc.M108574200; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Nilsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003811; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Rasko DA, 2000, J INFECT DIS, V181, P1089, DOI 10.1086/315354; Rasko DA, 2001, J INFECT DIS, V184, P315, DOI 10.1086/322025; SimoonsSmit IM, 1996, J CLIN MICROBIOL, V34, P2196, DOI 10.1128/JCM.34.9.2196-2200.1996; Storskrubb T, 2005, SCAND J GASTROENTERO, V40, P302, DOI 10.1080/00365520410010625; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Taylor DE, 1998, GASTROENTEROLOGY, V115, P1113, DOI 10.1016/S0016-5085(98)70082-4; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Wirth HP, 2006, FASEB J, V20, P1534, DOI 10.1096/fj.05-5529fje; Wirth HP, 1997, GASTROENTEROLOGY, V113, P1091, DOI 10.1053/gast.1997.v113.pm9322503; Wirth HP, 1996, INFECT IMMUN, V64, P4598, DOI 10.1128/IAI.64.11.4598-4605.1996	44	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5885	10.1371/journal.pone.0005885	http://dx.doi.org/10.1371/journal.pone.0005885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517017	Green Published, Green Submitted, gold			2022-12-27	WOS:000266873100014
J	Hatjimihail, AT				Hatjimihail, Aristides T.			Estimation of the Optimal Statistical Quality Control Sampling Time Intervals Using a Residual Risk Measure	PLOS ONE			English	Article								Background: An open problem in clinical chemistry is the estimation of the optimal sampling time intervals for the application of statistical quality control (QC) procedures that are based on the measurement of control materials. This is a probabilistic risk assessment problem that requires reliability analysis of the analytical system, and the estimation of the risk caused by the measurement error. Methodology/Principal Findings: Assuming that the states of the analytical system are the reliability state, the maintenance state, the critical-failure modes and their combinations, we can define risk functions based on the mean time of the states, their measurement error and the medically acceptable measurement error. Consequently, a residual risk measure rr can be defined for each sampling time interval. The rr depends on the state probability vectors of the analytical system, the state transition probability matrices before and after each application of the QC procedure and the state mean time matrices. As optimal sampling time intervals can be defined those minimizing a QC related cost measure while the rr is acceptable. I developed an algorithm that estimates the rr for any QC sampling time interval of a QC procedure applied to analytical systems with an arbitrary number of critical-failure modes, assuming any failure time and measurement error probability density function for each mode. Furthermore, given the acceptable rr, it can estimate the optimal QC sampling time intervals. Conclusions/Significance: It is possible to rationally estimate the optimal QC sampling time intervals of an analytical system to sustain an acceptable residual risk with the minimum QC related cost. For the optimization the reliability analysis of the analytical system and the risk analysis of the measurement error are needed.			Hatjimihail, AT (corresponding author), Hellen Complex Syst Lab, Drama, Greece.	ath@hcsl.com	Hatjimihail, Aristides T./C-5584-2008	Hatjimihail, Aristides T./0000-0002-0502-7996				BANERJEE PK, 1988, TECHNOMETRICS, V30, P407, DOI 10.2307/1269803; Chen J, 1997, COMPUT CHEM ENG, V21, P593, DOI 10.1016/S0098-1354(96)00295-5; *DEP HLTH HUM SERV, 2003, MED MED CLIA PROGR L, P3640; DHILON BS, 2000, MED DEVICE RELIABILI; DUNCAN AJ, 1956, J AM STAT ASSOC, V51, P228, DOI 10.2307/2281343; Ferson S., 2004, SAND20043072, P1; FERSON S, 2002, SAND20024015, P1; HATJIMIHAIL AT, 1992, CLIN CHEM, V38, P204; HATJIMIHAIL AT, 1993, CLIN CHEM, V39, P1972; HATJIMIHAIL AT, 1992, CLIN CHEM, V38, P2360; HATJIMIHAIL AT, 1994, CLIN CHEM, V40, P2672; *ISO, 2007, MED DEV  APPL RISK M, P1; Leger MN, 2005, CHEMOMETR INTELL LAB, V77, P181, DOI 10.1016/j.chemolab.2004.09.017; Liebscher E, 2008, J MULTIVARIATE ANAL, V99, P2234, DOI 10.1016/j.jmva.2008.02.025; Linderman K, 2005, EUR J OPER RES, V164, P324, DOI 10.1016/j.ejor.2003.11.026; LINNET K, 1989, CLIN CHEM, V35, P284; Morad K, 1999, COMPUT CHEM ENG, V23, P889, DOI 10.1016/S0098-1354(99)00259-8; Panagiotidou S, 2009, RELIAB ENG SYST SAFE, V94, P732, DOI 10.1016/j.ress.2008.07.003; Parvin CA, 1997, CLIN CHEM, V43, P2149; Parvin CA, 2007, CLIN CHEM, V53, P575, DOI 10.1373/clinchem.2006.083311; Parvin CA, 2008, CLIN CHEM, V54, P2049, DOI 10.1373/clinchem.2008.113639; Smith DJ, 2001, RELIABILITY MAINTAIN; Stametelatos M., 2002, FAULT TREE HDB AEROS, P1; WESTGARD JO, 1992, CLIN CHEM, V38, P1226; WESTGARD JO, 1990, CLIN CHEM, V36, P1760	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5770	10.1371/journal.pone.0005770	http://dx.doi.org/10.1371/journal.pone.0005770			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513124	Green Published, Green Submitted, gold			2022-12-27	WOS:000267228800002
J	Stie, J; Bruni, G; Fox, D				Stie, Jamal; Bruni, Gillian; Fox, Deborah			Surface-Associated Plasminogen Binding of Cryptococcus neoformans Promotes Extracellular Matrix Invasion	PLOS ONE			English	Article							CANDIDA-ALBICANS ENOLASE; CELL-WALL; STREPTOCOCCUS-PNEUMONIAE; ALPHA-ENOLASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BORRELIA-BURGDORFERI; IN-VITRO; PROTEINS; IDENTIFICATION; VIRULENCE	Background: The fungal pathogen Cryptococcus neoformans is a leading cause of illness and death in persons with predisposing factors, including: malignancies, solid organ transplants, and corticosteroid use. C. neoformans is ubiquitous in the environment and enters into the lungs via inhalation, where it can disseminate through the bloodstream and penetrate the central nervous system (CNS), resulting in a difficult to treat and often-fatal infection of the brain, called meningoencephalitis. Plasminogen is a highly abundant protein found in the plasma component of blood and is necessary for the degradation of fibrin, collagen, and other structural components of tissues. This fibrinolytic system is utilized by cancer cells during metastasis and several pathogenic species of bacteria have been found to manipulate the host plasminogen system to facilitate invasion of tissues during infection by modifying the activation of this process through the binding of plasminogen at their surface. Methodology: The invasion of the brain and the central nervous system by penetration of the protective blood-brain barrier is a prerequisite to the establishment of meningoencephalitis by the opportunistic fungal pathogen C. neoformans. In this study, we examined the ability of C. neoformans to subvert the host plasminogen system to facilitate tissue barrier invasion. Through a combination of biochemical, cell biology, and proteomic approaches, we have shown that C. neoformans utilizes the host plasminogen system to cross tissue barriers, providing support for the hypothesis that plasminogen-binding may contribute to the invasion of the blood-brain barrier by penetration of the brain endothelial cells and underlying matrix. In addition, we have identified the cell wall-associated proteins that serve as plasminogen receptors and characterized both the plasminogen-binding and plasmin-activation potential for this significant human pathogen. Conclusions: The results of this study provide evidence for the cooperative role of multiple virulence determinants in C. neoformans pathogenesis and suggest new avenues for the development of anti-infective agents in the prevention of fungal tissue invasion.			Stie, J (corresponding author), Louisiana State Univ, Childrens Hosp, Hlth Sci Ctr, Res Inst Children, New Orleans, LA USA.	dfox@chnola-research.org		Bruni, Gillian/0000-0002-5856-3274	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI055302] Funding Source: NIH RePORTER; NIAID NIH HHS [K22 AI055302, AI055302] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andronicos NM, 1997, BBA-PROTEIN STRUCT M, V1337, P27, DOI 10.1016/S0167-4838(96)00146-X; Angiolella L, 1996, J INFECT DIS, V173, P684, DOI 10.1093/infdis/173.3.684; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; BULMER GS, 1967, J BACTERIOL, V94, P1475, DOI 10.1128/JB.94.5.1475-1479.1967; Castillo L, 2008, PROTEOMICS, V8, P3871, DOI 10.1002/pmic.200800110; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chin C S, 1989, Med J Malaysia, V44, P194; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; DEVOS AM, 1992, BIOCHEMISTRY-US, V31, P270, DOI 10.1021/bi00116a037; Eigenheer RA, 2007, FEMS YEAST RES, V7, P499, DOI 10.1111/j.1567-1364.2006.00198.x; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eroles P, 1997, MICROBIOL-SGM, V143, P313, DOI 10.1099/00221287-143-2-313; Foster AJ, 2007, J APPL MICROBIOL, V103, P390, DOI 10.1111/j.1365-2672.2006.03259.x; Fox D, 2001, MED MYCOL, V39, P495, DOI 10.1080/714031070; Fox DS, 2001, MOL MICROBIOL, V39, P835, DOI 10.1046/j.1365-2958.2001.02295.x; FRANKLYN KM, 1994, FEMS MICROBIOL LETT, V118, P219, DOI 10.1111/j.1574-6968.1994.tb06831.x; FROMTLING RA, 1982, MYCOPATHOLOGIA, V79, P23, DOI 10.1007/BF00636177; Gancedo C, 2008, MICROBIOL MOL BIOL R, V72, P197, DOI 10.1128/MMBR.00036-07; Gates MA, 2004, MOL MICROBIOL, V52, P13, DOI 10.1111/j.1365-2958.2003.03957.x; GOLDMAN D, 1994, INFECT IMMUN, V62, P4755, DOI 10.1128/IAI.62.11.4755-4761.1994; Goldman DL, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e66; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; HADLEY S, 1995, INFECT DIS CLIN N AM, V9, P1045; Huang C, 2002, INFECT IMMUN, V70, P5485, DOI 10.1128/IAI.70.10.5485-5493.2002; Huang SH, 2001, CELL MICROBIOL, V3, P277, DOI 10.1046/j.1462-5822.2001.00116.x; IBRAHIM AS, 1995, INFECT IMMUN, V63, P4368, DOI 10.1128/IAI.63.11.4368-4374.1995; Ikeda R, 2003, MICROBIOL IMMUNOL, V47, P271, DOI 10.1111/j.1348-0421.2003.tb03395.x; Jong A, 2007, EUKARYOT CELL, V6, P1486, DOI 10.1128/EC.00120-07; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Kakeya H, 1999, CLIN EXP IMMUNOL, V115, P485; Kakeya H, 1997, INFECT IMMUN, V65, P1653, DOI 10.1128/IAI.65.5.1653-1658.1997; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Knaust A, 2007, J BACTERIOL, V189, P3246, DOI 10.1128/JB.01966-06; Kolberg J, 2006, MICROBIOL-SGM, V152, P1307, DOI 10.1099/mic.0.28747-0; KOZEL TR, 1982, J IMMUNOL, V129, P1675; KWONCHUNG KJ, 1986, INFECT IMMUN, V51, P218, DOI 10.1128/IAI.51.1.218-223.1986; Lahteenmaki K, 2000, METHODS, V21, P125, DOI 10.1006/meth.2000.0983; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lai HY, 2002, INT ARCH ALLERGY IMM, V127, P181, DOI 10.1159/000053862; LEVITZ SM, 1989, J IMMUNOL, V142, P659; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Liu Zheng-Yin, 2003, Zhonghua Yi Xue Za Zhi, V83, P399; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479; Maligie MA, 2005, ANTIMICROB AGENTS CH, V49, P2851, DOI 10.1128/AAC.49.7.2851-2856.2005; Mansour MK, 2004, INFECT IMMUN, V72, P1746, DOI 10.1128/IAI.72.3.1746-1754.2004; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; MILES LA, 1986, BIOCHEMISTRY-US, V25, P6926, DOI 10.1021/bi00370a028; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; MURPHY JW, 1988, INFECT IMMUN, V56, P424, DOI 10.1128/IAI.56.2.424-431.1988; NOVOKHATNY VV, 1984, J MOL BIOL, V179, P215, DOI 10.1016/0022-2836(84)90466-2; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Orendi JM, 1997, CLIN EXP IMMUNOL, V107, P293, DOI 10.1111/j.1365-2249.1997.283-ce1169.x; Perfect JR, 1999, DRUG RESIST UPDATE, V2, P259, DOI 10.1054/drup.1999.0090; PERFECT JR, 1983, MEDICINE, V62, P98, DOI 10.1097/00005792-198303000-00003; Pietrella D, 2001, INFECT IMMUN, V69, P2808, DOI 10.1128/IAI.69.5.2808-2814.2001; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Pitzurra L, 1997, J MED VET MYCOL, V35, P299; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2003, MICROB PATHOGENESIS, V34, P65, DOI 10.1016/S0882-4010(02)00195-X; Santos J, 1998, An Med Interna, V15, P523; Sar B, 2004, J ANTIMICROB CHEMOTH, V54, P563, DOI 10.1093/jac/dkh361; Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781; Steen BR, 2002, GENOME RES, V12, P1386, DOI 10.1101/gr.80202; STGEORGIEV V, 1993, MED RES REV, V13, P493, DOI 10.1002/med.2610130405; van Duin D, 2002, ANTIMICROB AGENTS CH, V46, P3394, DOI 10.1128/AAC.46.11.3394-3400.2002; VARTIVARIAN SE, 1989, J BACTERIOL, V171, P6850, DOI 10.1128/jb.171.12.6850-6852.1989; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; Wang CY, 2005, NEW ENGL J MED, V352, P1271, DOI 10.1056/NEJM200503243521225; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Zaas AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000101	89	54	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5780	10.1371/journal.pone.0005780	http://dx.doi.org/10.1371/journal.pone.0005780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492051	Green Published, gold, Green Submitted			2022-12-27	WOS:000266624300016
J	Kosmider, O; Buet, D; Gallais, I; Denis, N; Moreau-Gachelin, F				Kosmider, Olivier; Buet, Dorothee; Gallais, Isabelle; Denis, Nicole; Moreau-Gachelin, Francoise			Erythropoietin Down-Regulates Stem Cell Factor Receptor (Kit) Expression in the Leukemic Proerythroblast: Role of Lyn Kinase	PLOS ONE			English	Article							ERYTHROID PROGENITOR CELLS; C-KIT; INDUCED DIFFERENTIATION; SIGNALING PATHWAYS; TYROSINE KINASE; MUTANT MICE; DNA-BINDING; PROTEIN; STAT5; GENE	Overexpression of the transcription factor Spi-1/PU.1 by transgenesis in mice induces a maturation arrest at the proerythroblastic stage of differentiation. We have previously isolated a panel of spi-1 transgenic erythroleukemic cell lines that proliferated in the presence of either erythropoietin (Epo) or stem cell factor (SCF). Using these cell lines, we observed that EpoR stimulation by Epo down-regulated expression of the SCF receptor Kit and induced expression of the Src kinase Lyn. Furthermore, enforced expression of Lyn in the cell lines increased cell proliferation in response to Epo, but reduced cell growth in response to SCF in accordance with Lyn ability to down-regulate Kit expression. Together, the data suggest that Epo-R/Lyn signaling pathway is essential for extinction of SCF signaling leading the proerythroblast to strict Epo dependency. These results highlight a new role for Lyn as an effector of EpoR in controlling Kit expression. They suggest that Lyn may play a central role in during erythroid differentiation at the switch between proliferation and maturation.			Kosmider, O (corresponding author), INSERM, U830, Paris, France.	framoreau@curie.fr		Selimoglu-Buet, Dorothee/0000-0002-3565-2709; KOSMIDER, olivier/0000-0002-6021-4057				Arcasoy MO, 2005, BRIT J HAEMATOL, V130, P121, DOI 10.1111/j.1365-2141.2005.05580.x; Barnache S, 2001, BLOOD, V98, P2372, DOI 10.1182/blood.V98.8.2372; Brizzi MF, 1999, J BIOL CHEM, V274, P16965, DOI 10.1074/jbc.274.24.16965; Broudy VC, 1999, BLOOD, V94, P1979; Casteran N, 2003, ONCOGENE, V22, P4710, DOI 10.1038/sj.onc.1206587; Chin H, 1998, BLOOD, V91, P3734; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; FRASER JK, 1988, EXP HEMATOL, V16, P836; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GOUILLEUX F, 1995, EMBO J, V14, P2005, DOI 10.1002/j.1460-2075.1995.tb07192.x; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; JacobsHelber SM, 1997, J BIOL CHEM, V272, P6850, DOI 10.1074/jbc.272.11.6850; Jahn T, 2002, ONCOGENE, V21, P4508, DOI 10.1038/sj.onc.1205559; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Kapur R, 2001, J BIOL CHEM, V276, P1099, DOI 10.1074/jbc.M007442200; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; KATAYAMA N, 1993, BLOOD, V82, P2353; Kosmider O, 2005, CANCER CELL, V8, P467, DOI 10.1016/j.ccr.2005.11.009; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Kubota Y, 2001, EMBO J, V20, P5666, DOI 10.1093/emboj/20.20.5666; Li K, 2003, J BIOL CHEM, V278, P40702, DOI 10.1074/jbc.M307182200; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; MIYAZAWA K, 1994, BLOOD, V83, P137; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; Okutani Y, 2001, ONCOGENE, V20, P6643, DOI 10.1038/sj.onc.1204807; Panterne B, 1996, J CELL SCI, V109, P1795; Panzenbock B, 1998, BLOOD, V92, P3658, DOI 10.1182/blood.V92.10.3658.422k18_3658_3668; Penta K, 1995, J BIOL CHEM, V270, P31282, DOI 10.1074/jbc.270.52.31282; Pircher TJ, 2001, J BIOL CHEM, V276, P8995, DOI 10.1074/jbc.M007473200; Rimmele P, 2007, BLOOD, V109, P3007, DOI 10.1182/blood-2006-03-006718; Sato T, 1998, J BIOL CHEM, V273, P16921, DOI 10.1074/jbc.273.27.16921; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; Tan BL, 2003, J BIOL CHEM, V278, P11686, DOI 10.1074/jbc.M207068200; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; Tilbrook PA, 2001, CANCER RES, V61, P2453; UOSHIMA N, 1995, BRIT J HAEMATOL, V91, P30, DOI 10.1111/j.1365-2141.1995.tb05240.x; Vitelli L, 2000, MOL CELL BIOL, V20, P5330, DOI 10.1128/MCB.20.14.5330-5342.2000; von Lindern M, 1999, BLOOD, V94, P550, DOI 10.1182/blood.V94.2.550.414k39_550_559; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; WOGNUM AW, 1990, BLOOD, V76, P697; Wu H, 1997, P NATL ACAD SCI USA, V94, P1806, DOI 10.1073/pnas.94.5.1806; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YEE NS, 1994, J BIOL CHEM, V269, P31991	54	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5721	10.1371/journal.pone.0005721	http://dx.doi.org/10.1371/journal.pone.0005721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492092	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415100014
J	Zhang, ZH; Zhang, JZ				Zhang, Zhihua; Zhang, Jianzhi			A Big World Inside Small-World Networks	PLOS ONE			English	Article								Real networks, including biological networks, are known to have the small-world property, characterized by a small "diameter'', which is defined as the average minimal path length between all pairs of nodes in a network. Because random networks also have short diameters, one may predict that the diameter of a real network should be even shorter than its random expectation, because having shorter diameters potentially increases the network efficiency such as minimizing transition times between metabolic states in the context of metabolic networks. Contrary to this expectation, we here report that the observed diameter is greater than the random expectation in every real network examined, including biological, social, technological, and linguistic networks. Simulations show that a modest enlargement of the diameter beyond its expectation allows a substantial increase of the network modularity, which is present in all real networks examined. Hence, short diameters appear to be sacrificed for high modularities, suggesting a tradeoff between network efficiency and advantages offered by modularity (e. g., multi-functionality, robustness, and/or evolvability).			Zhang, ZH (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	jianzhi@umich.edu	zhang, zh/GWV-4677-2022					Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Baldwin CY, 2000, DESIGN RULES POWER M, V1; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; CHEN X, 2006, ARXIVPHYS0609239; COHEN R, 2002, CONDMAT0205476; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; Dorogovtsev SN, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066122; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Krapivsky PL, 2001, PHYS REV LETT, V86, P5401, DOI 10.1103/PhysRevLett.86.5401; Kumar R, 2000, ANN IEEE SYMP FOUND, P57, DOI 10.1109/SFCS.2000.892065; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Milo R, 2004, ARXIVCONDMAT0312028V; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Selby RW, 2005, IEEE T SOFTWARE ENG, V31, P495, DOI 10.1109/TSE.2005.69; Variano EA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.188701; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2004, NUCLEIC ACIDS RES, V32, P328, DOI 10.1093/nar/gkh164	31	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5686	10.1371/journal.pone.0005686	http://dx.doi.org/10.1371/journal.pone.0005686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479083	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331700013
J	Perkins, JM; Khan, KT; Subramanian, SV				Perkins, Jessica M.; Khan, Kashif T.; Subramanian, S. V.			Patterns and Distribution of HIV among Adult Men and Women in India	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOCIOECONOMIC-STATUS; SOUTH-INDIA; HIV/AIDS; INFECTION; POVERTY; PREVALENCE; EPIDEMIC; WEALTH; PEOPLE	Background: While the estimated prevalence of HIV in India experienced a downward revision in 2007, the patterning and distribution of HIV in the population remains unclear. We examined the individual and state-level socioeconomic patterning of individual HIV status among adult men and women in India as well as the patterning of other individual demographic and behavioral determinants of HIV status. Methodology/Principal Findings: We conducted logistic regression models accounting for the survey design using nationally representative, cross-sectional data on 100,030 women and men from the 2005-2006 India National Family Health survey which, for the first time, provided objective assessments of HIV seroprevalence. Although there was a weak relationship between household wealth and risk of being HIV-positive, there was a clear negative relationship between individual education attainment and risk of being HIV-positive among both men and women. A 1000 Rupee change in the per capita net state domestic product was associated with a 4% and 5% increase in the risk for positive HIV status among men and women, respectively. State-level income inequality was associated with increased risk of HIV for men. Marital status and selected sexual behavior indicators were significant predictors of HIV status among women whereas the age effect was the most dominant predictor of HIV infection among men. Conclusions/Significance: Although the prevalence of HIV in India is low, the lack of strong wealth patterning in the risk of HIV suggests a more generalized distribution of HIV risk than some of India's high-risk group HIV prevention policies have assumed. The positive association between state economic development and individual risk for HIV is intriguing and requires further scrutiny.			Perkins, JM (corresponding author), Harvard Univ, Dept Hlth Policy, Cambridge, MA 02138 USA.	svsubram@hsph.harvard.edu	Perkins, Jessica M./ABG-2467-2020	Perkins, Jessica M./0000-0002-5475-8816	NHLBI NIH HHS [K25 HL081275] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barnard JMR, 2007, INVESTIG BIBLIOTECOL, V21, P7; Becker ML, 2007, AIDS, V21, P739, DOI 10.1097/QAD.0b013e328012b885; Buve A, 2001, AIDS, V15, pS117, DOI 10.1097/00002030-200108004-00013; Carter MW, 2007, AIDS BEHAV, V11, P822, DOI 10.1007/s10461-006-9203-6; Chu C, 2008, AIDS READ, V18, P144; Claeson M, 2008, HEALTH AFFAIR, V27, P1091, DOI 10.1377/hlthaff.27.4.1091; Cohen J, 2007, SCIENCE, V317, P179, DOI 10.1126/science.317.5835.179; Dandona L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-308; Dandona L, 2007, LANCET, V370, P1811, DOI 10.1016/S0140-6736(07)61756-5; Dev S.M., 2007, ECON POLIT WEEKLY, V42, P509; Farmer P., 1999, INFECT INEQUALITIES; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fortson JG, 2008, DEMOGRAPHY, V45, P303, DOI 10.1353/dem.0.0006; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; HARGREAVES J, 2006, GIRL POWER IMPACT GI; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; IBRAHIM F, 2008, SOCIAL EC HARDSHIP P; *ICHAP I CCAP, 2004, HIDD EP HIV AIDS KAR; IIPS and Macro International, 2007, NAT FAM HLTH SURV NF, V1; *INT HFPSIAM, 2007, NAT FAM HLTH SURV NF, V2; *INT HFPSIAM, 2007, NAT FAM HLTH SURV NF, V1; *JLINT UN PROGR HI, 2007, 978929173621B978929; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; Majumdar D, 2006, Indian J Public Health, V50, P28; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; *NIHFW NACON, 2007, ANN HIV SENT SURV CO; *ORCMACRO, 2005, AN HIV TEST FIELD MA; *ORCMACRO, 2005, HIV TEST LAB MAN DEM; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Rao JVRP, 2004, LANCET, V364, P1296, DOI 10.1016/S0140-6736(04)17205-X; RODRIGUES JJ, 1995, BRIT MED J, V311, P283, DOI 10.1136/bmj.311.7000.283; *SCI IFPSI INT M, 2007, NAT FAM HLTH SURV NF, V2; *SCI IFPSI INT M, 2007, NAT FAM HLTH SURV NF, V1; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; Steinbrook R, 2008, NEW ENGL J MED, V358, P107, DOI 10.1056/NEJMp0708474; *UN BUDG EC SURV M, 2007, EC SURV 2007 2008; Whiteside A, 2002, THIRD WORLD Q, V23, P313, DOI 10.1080/01436590220126667; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Zaba B, 2004, SEX TRANSM INFECT, V80, P28, DOI 10.1136/sti.2004.012674	43	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5648	10.1371/journal.pone.0005648	http://dx.doi.org/10.1371/journal.pone.0005648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	449LB	19462003	gold, Green Published, Green Submitted			2022-12-27	WOS:000266331000007
J	Markel, G; Seidman, R; Besser, MJ; Zabari, N; Ortenberg, R; Shapira, R; Treves, AJ; Loewenthal, R; Orenstein, A; Nagler, A; Schachter, J				Markel, Gal; Seidman, Rachel; Besser, Michal J.; Zabari, Naama; Ortenberg, Rona; Shapira, Ronnie; Treves, Avraham J.; Loewenthal, Ron; Orenstein, Arie; Nagler, Arnon; Schachter, Jacob			Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells	PLOS ONE			English	Article							INHIBITORY RECEPTORS; IMMUNOGLOBULIN SUPERFAMILY; SELF-MHC; MELANOMA; LIGANDS; MEMBER; TRANSPLANTATION; HEMAGGLUTININS; ALLOREACTIVITY; CYTOTOXICITY	Background: NK cells are key players in anti tumor immune response, which can be employed in cell-based therapeutic modalities. One of the suggested ways to amplify their anti tumor effect, especially in the field of stem cell transplantation, is by selecting donor/recipient mismatches in specific HLA, to reduce the inhibitory effect of killer Ig-like receptors (KIRs). Here we suggest an alternative approach for augmentation of anti tumor effect of allogeneic NK cells, which is founded on profile matching of donor NK lysis receptors (NKLR) phenotype with tumor lysis-ligands. Methodology/Principal Findings: We show that an NKLR-mediated killing directly correlates with the NKLR expression intensity on NK cells. Considerable donor variability in the expression of CD16, NKp46, NKG2D and NKp30 on circulating NK cells, combined with the stability of phenotype in several independently performed tests over two months, indicates that NKLR-guided selection of donors is feasible. As a proof of concept, we show that melanoma cells are dominantly recognized by three NKLRs: NKG2D, NKp30 and NKp44. Notably, the expression of NKp30 on circulating NK cells among metastatic melanoma patients was significantly decreased, which diminishes their ability to kill melanoma cells. Ex vivo expansion of NK cells results not only in increased amount of cells but also in a consistently superior and predictable expression of NKG2D, NKp30 and NKp44. Moreover, expanded NK cultures with high expression of NKG2D or NKp30 were mostly derived from the corresponding NKG2D(high) or NK30(high) donors. These NK cultures subsequently displayed an improved cytotoxic activity against melanoma in a HLA/KIR-ligand mismatched setup, which was NKLR-dependent, as demonstrated with blocking anti-NKG2D antibodies. Conclusions/Significance: NKLR/NKLR-ligand matching reproducibly elicits enhanced NK anti-tumor response. Common NKLR recognition patterns of tumors, as demonstrated here in melanoma, would allow implementation of this approach in solid malignancies and potentially in hematological malignancies, either independently or in adjunction to other modalities.			Markel, G (corresponding author), Sheba Med Ctr, Canc Res Ctr, Ella Inst Melanoma, Ramat Gan, Israel.	markel@post.tau.ac.il						Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2007, SEMIN ONCOL, V34, P524, DOI 10.1053/j.seminoncol.2007.09.002; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Frohn C, 2000, J IMMUNOTHER, V23, P499, DOI 10.1097/00002371-200007000-00014; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Igarashi T, 2004, BLOOD, V104, P170, DOI 10.1182/blood-2003-12-4438; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LAW TM, 1995, CANCER-AM CANCER SOC, V76, P824, DOI 10.1002/1097-0142(19950901)76:5<824::AID-CNCR2820760517>3.0.CO;2-N; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Markel G, 2006, J IMMUNOL, V177, P6062, DOI 10.4049/jimmunol.177.9.6062; Markel G, 2009, IMMUNOLOGY, V126, P186, DOI 10.1111/j.1365-2567.2008.02888.x; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585; Parham P, 2006, IMMUNOL REV, V214, P155, DOI 10.1111/j.1600-065X.2006.00462.x; Pascal V, 2004, EUR J IMMUNOL, V34, P2930, DOI 10.1002/eji.200425146; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Schwartz RN, 2002, ONCOLOGY-NY, V16, P11; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; VANDEGRIEND RJ, 1987, J IMMUNOL, V138, P3137; Vitale C, 2005, MOL IMMUNOL, V42, P405, DOI 10.1016/j.molimm.2004.07.019; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yano Hiroshi, 1999, Gastric Cancer, V2, P26, DOI 10.1007/s101200050017	41	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5597	10.1371/journal.pone.0005597	http://dx.doi.org/10.1371/journal.pone.0005597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440333	Green Published, Green Submitted, gold			2022-12-27	WOS:000266161200001
J	Molfetta, R; Gasparrini, F; Peruzzi, G; Vian, L; Piccoli, M; Frati, L; Santoni, A; Paolini, R				Molfetta, Rosa; Gasparrini, Francesca; Peruzzi, Giovanna; Vian, Laura; Piccoli, Mario; Frati, Luigi; Santoni, Angela; Paolini, Rossella			Lipid Raft-Dependent Fc epsilon RI Ubiquitination Regulates Receptor Endocytosis through the Action of Ubiquitin Binding Adaptors	PLOS ONE			English	Article							IMMUNOGLOBULIN-E RECEPTOR; GROWTH-FACTOR RECEPTOR; AFFINITY IGE RECEPTOR; CLATHRIN-COATED PITS; MAST-CELL ACTIVATION; ENDOSOMAL TRAFFICKING; SIGNAL-TRANSDUCTION; MEMBRANE DOMAINS; TYROSINE KINASE; RBL-2H3 CELLS	The best characterized role for ubiquitination of membrane receptors is to negatively regulate signaling by targeting receptors for lysosomal degradation. The high affinity receptor for IgE (Fc epsilon RI) expressed on mast cells and basophils is rapidly ubiquitinated upon antigen stimulation. However, the nature and the role of this covalent modification are still largelly unknown. Here, we show that Fc epsilon RI subunits are preferentially ubiquitinated at multiple sites upon stimulation, and provide evidence for a role of ubiquitin as an internalization signal: under conditions of impaired receptor ubiquitination a decrease of receptor entry is observed by FACS analysis and fluorescence microscopy. We also used biochemical approaches combined with fluorescence microscopy, to demonstrate that receptor endocytosis requires the integrity of specific membrane domains, namely lipid rafts. Additionally, by RNA interference we demonstrate the involvement of ubiquitin-binding endocytic adaptors in Fc epsilon RI internalization and sorting. Notably, the triple depletion of Eps15, Eps15R and Epsin1 negatively affects the early steps of Ag-induced receptor endocytosis, whereas Hrs depletion retains ubiquitinated receptors into early endosomes and partially prevents their sorting into lysosomes for degradation. Our results are compatible with a scenario in which the accumulation of engaged receptor subunits into lipid rafts is required for receptor ubiquitination, a prerequisite for efficient receptor internalization, sorting and delivery to a lysosomal compartment.			Molfetta, R (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy.	rossella.paolini@uniroma1.it	Molfetta, Rosa/N-4529-2015; santoni, angela/K-8997-2016; Frati, Luigi/ABI-7437-2020	Molfetta, Rosa/0000-0003-2904-6371; santoni, angela/0000-0003-1206-7731; PAOLINI, Rossella/0000-0001-7605-1531; Peruzzi, Giovanna/0000-0002-6517-9107	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Carbone R, 1997, CANCER RES, V57, P5498; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Ciechanover A, 2000, J CELL BIOCHEM, P40; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Fattakhova G, 2006, TRAFFIC, V7, P673, DOI 10.1111/j.1600-0854.2006.00423.x; Fattakhova GV, 2009, MOL IMMUNOL, V46, P793, DOI 10.1016/j.molimm.2008.09.002; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Fujimuro M, 2005, METHOD ENZYMOL, V399, P75, DOI 10.1016/S0076-6879(05)99006-X; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Kovarova M, 2006, J EXP MED, V203, P1161, DOI 10.1084/jem.20051701; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lafont F, 2001, P NATL ACAD SCI USA, V98, P3180, DOI 10.1073/pnas.051003498; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Molfetta R, 2005, J IMMUNOL, V175, P4208, DOI 10.4049/jimmunol.175.7.4208; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Murai S, 2000, BIOCHEM BIOPH RES CO, V277, P752, DOI 10.1006/bbrc.2000.3749; Oliver C, 2007, J HISTOCHEM CYTOCHEM, V55, P315, DOI 10.1369/jhc.6A7037.2006; PAOLINI R, 1993, EMBO J, V12, P779, DOI 10.1002/j.1460-2075.1993.tb05712.x; Paolini R, 2002, J BIOL CHEM, V277, P36940, DOI 10.1074/jbc.M204948200; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Santini F, 1996, J CELL BIOL, V132, P1025, DOI 10.1083/jcb.132.6.1025; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Yamasaki S, 2005, CHEM IMMUNOL ALLERGY, V87, P22, DOI 10.1159/000087568; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	45	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5604	10.1371/journal.pone.0005604	http://dx.doi.org/10.1371/journal.pone.0005604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440386	Green Published, Green Submitted, gold			2022-12-27	WOS:000266161200007
J	Zhang, WP; Lv, ZB; Nie, ZM; Chen, GG; Chen, J; Sheng, Q; Yu, W; Jin, YF; Wu, XF; Zhang, YZ				Zhang, Wenping; Lv, Zhengbing; Nie, Zuoming; Chen, Guogang; Chen, Jian; Sheng, Qing; Yu, Wei; Jin, Yongfeng; Wu, Xiangfu; Zhang, Yaozhou			Bioavailability of Orally Administered rhGM-CSF: A Single-Dose, Randomized, Open-Label, Two-Period Crossover Trial	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BOMBYX-MORI; SILKWORM; PURIFICATION; EXPRESSION; INHIBITOR; PROTEIN; DELIVERY	Background: Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) is usually administered by injection, and its oral administration in a clinical setting has been not yet reported. Here we demonstrate the bioavailability of orally administered rhGM-CSF in healthy volunteers. The rhGM-CSF was expressed in Bombyx mori expression system (BmrhGM-CSF). Methods and Findings: Using a single-dose, randomized, open-label, two-period crossover clinical trial design, 19 healthy volunteers were orally administered with BmrhGM-CSF (8 mu g/kg) and subcutaneously injected with rhGM- CSF (3.75 mu g/kg) respectively. Serum samples were drawn at 0.0h, 0.5h, 0.75h, 1.0h, 1.5h, 2.0h, 3.0h, 4.0h, 5.0h, 6.0h, 8.0h, 10.0h and 12.0h after administrations. The hGM-CSF serum concentrations were determined by ELISA. The AUC was calculated using the trapezoid method. The relative bioavailability of BmrhGM-CSF was determined according to the AUC ratio of both orally administered and subcutaneously injected rhGM- CSF. Three volunteers were randomly selected from 15 orally administrated subjects with ELISA detectable values. Their serum samples at the 0.0h, 1.0h, 2.0h, 3.0h and 4.0h after the administrations were analyzed by Q-Trap MS/MS TOF. The different peaks were revealed by the spectrogram profile comparison of the 1.0h, 2.0h, 3.0h and 4.0h samples with that of the 0.0h sample, and further analyzed using both Enhanced Product Ion (EPI) scanning and Peptide Mass Fingerprinting Analysis. The rhGM- CSF was detected in the serum samples from 15 of 19 volunteers administrated with BmrhGM-CSF. Its bioavailability was observed at an average of 1.0%, with the highest of 3.1%. The rhGM- CSF peptide sequences in the serum samples were detected by MS analysis, and their sizes ranging from 2,039 to 7,336 Da. Conclusions: The results demonstrated that the oral administered BmrhGM-CSF was absorbed into the blood. This study provides an approach for an oral administration of rhGM- CSF protein in clinical settings. Trial Registration: www.chictr.orgChiCTR-TRC-00000107			Zhang, WP (corresponding author), Zhejiang Univ, Inst Biochem, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yaozhou@chinagene.com						ANTMAN KS, 1988, NEW ENGL J MED, V319, P593, DOI 10.1056/NEJM198809083191001; BADARO R, 1994, J INFECT DIS, V170, P413, DOI 10.1093/infdis/170.2.413; Chalasani KB, 2007, J CONTROL RELEASE, V117, P421, DOI 10.1016/j.jconrel.2006.12.003; Chen J, 2007, APPL BIOCHEM BIOTECH, V141, P149, DOI 10.1007/s12010-007-9217-1; Chen J, 2006, J BIOTECHNOL, V123, P236, DOI 10.1016/j.jbiotec.2005.11.015; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; Gersting JA, 2003, PHARMACOL RES, V48, P643, DOI 10.1016/S1043-6618(03)00249-4; Gong ZH, 2005, J BIOTECHNOL, V119, P93, DOI 10.1016/j.jbiotec.2005.05.027; HARDY D, 1994, EUR J CLIN MICROBIOL, V13, pS34, DOI 10.1007/BF01973600; He N, 2003, BBA-GENE STRUCT EXPR, V1628, P71, DOI 10.1016/S0167-4781(03)00118-0; HORD JD, 1995, J PEDIAT HEMATOL ONC, V17, P140, DOI 10.1097/00043426-199505000-00007; Hussein A M, 1995, Eur J Haematol, V55, P348; KRUMWIEH D, 1988, BEHRING I MITT, V83, P250; Lee SY, 2001, CLIN IMMUNOL, V101, P220, DOI 10.1006/clim.2001.5122; LESZEK J, 2002, MED SCI MONITOR, V8, P193; Leszek Jerzy, 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P377; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Marinaro M, 1997, J EXP MED, V185, P415, DOI 10.1084/jem.185.3.415; Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; Naylor PH, 1999, J INTERF CYTOK RES, V19, P953, DOI 10.1089/107999099313505; Pauletti GM, 1997, ADV DRUG DELIVER REV, V27, P235, DOI 10.1016/S0169-409X(97)00045-8; SASAKI T, 1978, J BIOCHEM, V84, P267, DOI 10.1093/oxfordjournals.jbchem.a132127; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Shiba HJ, 2001, ARCH BIOCHEM BIOPHYS, V390, P28, DOI 10.1006/abbi.2001.2343; Shirai K, 2000, INSECT BIOCHEM MOLEC, V30, P363, DOI 10.1016/S0965-1748(00)00003-5; Shrivastava B, 2003, INSECT BIOCHEM MOLEC, V33, P1025, DOI 10.1016/S0965-1748(03)00117-6; VADHANRAJ S, 1987, NEW ENGL J MED, V317, P1545, DOI 10.1056/NEJM198712173172501; Wuolle K, 2007, INT DAIRY J, V17, P1216, DOI 10.1016/j.idairyj.2007.02.004; Yamamoto Y, 1999, FEBS LETT, V448, P257, DOI 10.1016/S0014-5793(99)00382-8; Zhang W, 2006, CHAOS SOLITON FRACT, V29, P223, DOI 10.1016/j.chaos.2005.08.020	31	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2009	4	5							e5353	10.1371/journal.pone.0005353	http://dx.doi.org/10.1371/journal.pone.0005353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VZ	19434235	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009800001
J	Kadzhaev, K; Zingmark, C; Golovliov, I; Bolanowski, M; Shen, H; Conlan, W; Sjostedt, A				Kadzhaev, Konstantin; Zingmark, Carl; Golovliov, Igor; Bolanowski, Mark; Shen, Hua; Conlan, Wayne; Sjostedt, Anders			Identification of Genes Contributing to the Virulence of Francisella tularensis SCHU S4 in a Mouse Intradermal Infection Model	PLOS ONE			English	Article							LIVE VACCINE STRAIN; MOLECULAR-CLONING; O-ANTIGEN; PROTECTIVE IMMUNITY; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; ACID TRANSFERASE; MUTANT; DELETION; PROTEIN	Background: Francisella tularensis is a highly virulent human pathogen. The most virulent strains belong to subspecies tularensis and these strains cause a sometimes fatal disease. Despite an intense recent research effort, there is very limited information available that explains the unique features of subspecies tularensis strains that distinguish them from other F. tularensis strains and that explain their high virulence. Here we report the use of targeted mutagenesis to investigate the roles of various genes or pathways for the virulence of strain SCHU S4, the type strain of subspecies tularensis. Methodology/Principal Findings: The virulence of SCHU S4 mutants was assessed by following the outcome of infection after intradermal administration of graded doses of bacteria. By this route, the LD50 of the SCHU S4 strain is one CFU. The virulence of 20 in-frame deletion mutants and 37 transposon mutants was assessed. A majority of the mutants did not show increased prolonged time to death, among them notably Delta pyrB and Delta recA. Of the remaining, mutations in six unique targets, tolC, rep, FTT0609, FTT1149c, ahpC, and hfq resulted in significantly prolonged time to death and mutations in nine targets, rplA, wbtI, iglB, iglD, purL, purF, ggt, kdtA, and glpX, led to marked attenuation with an LD50 of >10(3) CFU. In fact, the latter seven mutants showed very marked attenuation with an LD50 of >= 10(7) CFU. Conclusions/Significance: The results demonstrate that the characterization of targeted mutants yielded important information about essential virulence determinants that will help to identify the so far little understood extreme virulence of F. tularensis subspecies tularensis.			Kadzhaev, K (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	anders.sjostedt@climi.umu.se	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	NIAID NIH HHS [AI60689, R01 AI060689] Funding Source: Medline; PHS HHS [HHSN26620050041C] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060689] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcantara RB, 2004, INFECT IMMUN, V72, P4911, DOI 10.1128/IAI.72.8.4911-4917.2004; Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; Ancuta P, 1996, INFECT IMMUN, V64, P2041, DOI 10.1128/IAI.64.6.2041-2046.1996; BERG JM, 1992, INFECT IMMUN, V60, P690, DOI 10.1128/IAI.60.2.690-693.1992; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Broekhuijsen M, 2003, J CLIN MICROBIOL, V41, P2924, DOI 10.1128/JCM.41.7.2924-2931.2003; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan JW, 2002, MICROB PATHOGENESIS, V32, P127, DOI 10.1006/mpat.2001.0489; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; FRIESEN JD, 1974, P NATL ACAD SCI USA, V71, P3465, DOI 10.1073/pnas.71.9.3465; Fuller JR, 2008, INFECT IMMUN, V76, P4934, DOI 10.1128/IAI.00475-08; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gil H, 2004, INFECT IMMUN, V72, P3042, DOI 10.1128/IAI.72.5.3042-3047.2004; Gil H, 2006, P NATL ACAD SCI USA, V103, P12897, DOI 10.1073/pnas.0602582103; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; KANG WK, 1989, MOL GEN GENET, V217, P281, DOI 10.1007/BF02464894; Kawula TH, 2004, APPL ENVIRON MICROB, V70, P6901, DOI 10.1128/AEM.70.11.6901-6904.2004; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; KISS K, 2008, FEMS MICROBIOL LETT; Kosuge T, 1997, FEMS MICROBIOL LETT, V157, P73, DOI 10.1016/S0378-1097(97)00456-4; Kotloff KL, 2004, J INFECT DIS, V190, P1745, DOI 10.1086/424680; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Langer RC, 2001, TRENDS PARASITOL, V17, P269, DOI 10.1016/S1471-4922(01)01918-3; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; LOBAU S, 1995, MOL MICROBIOL, V18, P391, DOI 10.1111/j.1365-2958.1995.mmi_18030391.x; McGovern KJ, 2001, INFECT IMMUN, V69, P4168, DOI 10.1128/IAI.69.6.4168-4173.2001; MEDINA V, 1990, J BACTERIOL, V172, P7151, DOI 10.1128/jb.172.12.7151-7156.1990; MEIBOM KL, 2009, HFQ NOVEL PLEIOTROPI; Morel F, 1999, MICROBIOL-UK, V145, P437, DOI 10.1099/13500872-145-2-437; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; NORTH RJ, 1981, J IMMUNOL, V127, P342; OLSUFJEV NG, 1970, J HYG EPID MICROB IM, V14, P67; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Peng DX, 2005, INFECT IMMUN, V73, P4222, DOI 10.1128/IAI.73.7.4222-4230.2005; Qin AP, 2008, INFECT IMMUN, V76, P3086, DOI 10.1128/IAI.00363-08; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Quarry JE, 2007, VACCINE, V25, P2011, DOI 10.1016/j.vaccine.2006.11.054; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Sander P, 2001, INFECT IMMUN, V69, P3562, DOI 10.1128/IAI.69.6.3562-3568.2001; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Shen H, 2004, VACCINE, V22, P2116, DOI 10.1016/j.vaccine.2003.12.003; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; SJOSTEDT AB, 2005, PROTEOBACTERIA B, V2, P200; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Tarnvik A, 2003, EUR RESPIR J, V21, P361, DOI 10.1183/09031936.03.00088903; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Wang JY, 2001, INFECT IMMUN, V69, P4734, DOI 10.1128/IAI.69.8.4734-4741.2001; Wehmeier L, 2001, MICROBIOL-UK, V147, P691, DOI 10.1099/00221287-147-3-691; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; WOOD WB, 1980, MICROBIOLOGY, P551; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006; Zogaj X, 2008, MICROBIOL-SGM, V154, P2139, DOI 10.1099/mic.0.2008/018077-0	78	87	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5463	10.1371/journal.pone.0005463	http://dx.doi.org/10.1371/journal.pone.0005463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424499	Green Published, gold, Green Submitted			2022-12-27	WOS:000265933800002
J	Rosell, R; Perez-Roca, L; Sanchez, JJ; Cobo, M; Moran, T; Chaib, I; Provencio, M; Domine, M; Sala, MA; Jimenez, U; Diz, P; Barneto, I; Macias, JA; de las Penas, R; Catot, S; Isla, D; Sanchez, JM; Ibeas, R; Lopez-Vivanco, G; Oramas, J; Mendez, P; Reguart, N; Blanco, R; Taron, M				Rosell, Rafael; Perez-Roca, Laia; Javier Sanchez, Jose; Cobo, Manuel; Moran, Teresa; Chaib, Imane; Provencio, Mariano; Domine, Manuel; Angeles Sala, Maria; Jimenez, Ulpiano; Diz, Pilar; Barneto, Isidoro; Antonio Macias, Jose; de las Penas, Ramon; Catot, Silvia; Isla, Dolores; Miguel Sanchez, Jose; Ibeas, Rafael; Lopez-Vivanco, Guillermo; Oramas, Juana; Mendez, Pedro; Reguart, Noemi; Blanco, Remei; Taron, Miquel			Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-III; ACTIVATING MUTATIONS; CLINICAL-RESPONSE; DOWN-REGULATION; GEFITINIB; CISPLATIN; SURVIVAL; CHEMORESISTANCE; INACTIVATION	Background: Median survival is 10 months and 2-year survival is 20% in metastatic non-small-cell lung cancer (NSCLC) treated with platinum-based chemotherapy. A small fraction of non-squamous cell lung cancers harbor EGFR mutations, with improved outcome to gefitinib and erlotinib. Experimental evidence suggests that BRCA1 overexpression enhances sensitivity to docetaxel and resistance to cisplatin. RAP80 and Abraxas are interacting proteins that form complexes with BRCA1 and could modulate the effect of BRCA1. In order to further examine the effect of EGFR mutations and BRCA1 mRNA levels on outcome in advanced NSCLC, we performed a prospective non-randomized phase II clinical trial, testing the hypothesis that customized therapy would confer improved outcome over non-customized therapy. In an exploratory analysis, we also examined the effect of RAP80 and Abraxas mRNA levels. Methodology/Principal Findings: We treated 123 metastatic non-squamous cell lung carcinoma patients using a customized approach. RNA and DNA were isolated from microdissected specimens from paraffin-embedded tumor tissue. Patients with EGFR mutations received erlotinib, and those without EGFR mutations received chemotherapy with or without cisplatin based on their BRCA1 mRNA levels: low, cisplatin plus gemcitabine; intermediate, cisplatin plus docetaxel; high, docetaxel alone. An exploratory analysis examined RAP80 and Abraxas expression. Median survival exceeded 28 months for 12 patients with EGFR mutations, and was 11 months for 38 patients with low BRCA1, 9 months for 40 patients with intermediate BRCA1, and 11 months for 33 patients with high BRCA1. Two-year survival was 73.3%, 41.2%, 15.6% and 0%, respectively. Median survival was influenced by RAP80 expression in the three BRCA1 groups. For example, for patients with both low BRCA1 and low RAP80, median survival exceeded 26 months. RAP80 was a significant factor for survival in patients treated according to BRCA1 levels (hazard ratio, 1.3 [95% CI, 1-1.7]; P = 0.05). Conclusions/Significance: Chemotherapy customized according to BRCA1 expression levels is associated with excellent median and 2-year survival for some subsets of NSCLC patients, and RAP80 could play a crucial modulating effect on this model of customized chemotherapy.			Rosell, R (corresponding author), Catalan Inst Oncol, Badalona, Spain.	rrosell@ico.scs.es	Lopez, Guillermo/F-3435-2012; Provencio, Mariano/ABE-8586-2020	Provencio, Mariano/0000-0001-9053-9197; Provencio Pulla, Mariano/0000-0001-6315-7919; Isla, Dolores/0000-0002-2483-198X				Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Boukovinas I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003695; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Costa DB, 2007, LUNG CANCER, V58, P95, DOI 10.1016/j.lungcan.2007.05.017; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Husain A, 1998, CANCER RES, V58, P1120; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Quinn JE, 2003, CANCER RES, V63, P6221; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Taron M, 2005, CLIN CANCER RES, V11, P5878, DOI 10.1158/1078-0432.CCR-04-2618; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924	36	122	136	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5133	10.1371/journal.pone.0005133	http://dx.doi.org/10.1371/journal.pone.0005133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415121	gold, Green Submitted, Green Published			2022-12-27	WOS:000265836700001
J	Goel, N; Banks, S; Mignot, E; Dinges, DF				Goel, Namni; Banks, Siobhan; Mignot, Emmanuel; Dinges, David F.			PER3 Polymorphism Predicts Cumulative Sleep Homeostatic but Not Neurobehavioral Changes to Chronic Partial Sleep Deprivation	PLOS ONE			English	Article							INTERINDIVIDUAL DIFFERENCES; INDIVIDUAL-DIFFERENCES; LENGTH POLYMORPHISM; PERFORMANCE; RESTRICTION; GENE; ASSOCIATION; WAKEFULNESS; PHYSIOLOGY; DISSOCIATION	Background: The variable number tandem repeat (VNTR) polymorphism 5-repeat allele of the circadian gene PERIOD3 (PER3(5/5)) has been associated with cognitive decline at a specific circadian phase in response to a night of total sleep deprivation (TSD), relative to the 4-repeat allele (PER3(4/4)). PER3(5/5) has also been related to higher sleep homeostasis, which is thought to underlie this cognitive vulnerability. To date, no study has used a candidate gene approach to investigate the response to chronic partial sleep deprivation (PSD), a condition distinct from TSD and one commonly experienced by millions of people on a daily and persistent basis. We evaluated whether the PER3 VNTR polymorphism contributed to cumulative neurobehavioral deficits and sleep homeostatic responses during PSD. Methodology/Principal Findings: PER3(5/5) (n = 14), PER3(4/5) (n = 63) and PER3(4/4) (n = 52) healthy adults (aged 22-45 y) demonstrated large, but equivalent cumulative decreases in cognitive performance and physiological alertness, and cumulative increases in sleepiness across 5 nights of sleep restricted to 4 h per night. Such effects were accompanied by increasing daily inter-subject variability in all groups. The PER3 genotypes did not differ significantly at baseline in habitual sleep, physiological sleep structure, circadian phase, physiological sleepiness, cognitive performance, or subjective sleepiness, although during PSD, PER3(5/5) subjects had slightly but reliably elevated sleep homeostatic pressure as measured physiologically by EEG slow-wave energy in non-rapid eye movement sleep compared with PER3(4/4) subjects. PER3 genotypic and allelic frequencies did not differ significantly between Caucasians and African Americans. Conclusions/Significance: The PER3 VNTR polymorphism was not associated with individual differences in neurobehavioral responses to PSD, although it was related to one marker of sleep homoeostatic response during PSD. The comparability of PER3 genotypes at baseline and their equivalent inter-individual vulnerability to sleep restriction indicate that PER3 does not contribute to the neurobehavioral effects of chronic sleep loss.			Goel, N (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA.	goel@mail.med.upenn.edu	Dinges, David/P-7183-2019; Banks, Siobhan/L-2149-2013	Banks, Siobhan/0000-0002-7489-0929; Goel, Namni/0000-0003-2602-1996	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023724, P50NS023724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004281] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [UL1 RR024134] Funding Source: Medline; NINDS NIH HHS [P50 NS023724, NS-23724] Funding Source: Medline; NINR NIH HHS [NR004281, R01 NR004281] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Banks S, 2007, J CLIN SLEEP MED, V3, P519; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benton AL, 1976, MULTILINGUAL APHASIA; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Bliese PD, 2006, J SLEEP RES, V15, P376, DOI 10.1111/j.1365-2869.2006.00557.x; Bodenmann S, 2009, CLIN PHARMACOL THER, V85, P296, DOI 10.1038/clpt.2008.222; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; Collette F, 2001, NEUROIMAGE, V14, P258, DOI 10.1006/nimg.2001.0846; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; CULBERTSON WC, 2001, TOWER LONDON; Dinges D.F., 2005, PRINCIPLES PRACTICE, V4th ed., P67, DOI DOI 10.1016/B0-72-160797-7/50013-6; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dorrian J., 2005, THESIS, P39; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Drake CL, 2001, PSYCHOPHYSIOLOGY, V38, P979, DOI 10.1111/1469-8986.3860979; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; Galliaudi E, 2008, J SLEEP RES, V17, P11, DOI 10.1111/j.1365-2869.2008.00629.x; GOEL N, 2009, SEMIN NEURO IN PRESS; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Groeger JA, 2008, SLEEP, V31, P1159; Jones KHS, 2007, J SLEEP RES, V16, P12, DOI 10.1111/j.1365-2869.2007.00561.x; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Landolt HP, 2008, CURR PHARM DESIGN, V14, P3396, DOI 10.2174/138161208786549344; Leproult R, 2003, AM J PHYSIOL-REG I, V284, pR280, DOI 10.1152/ajpregu.00197.2002; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; MITLER MM, 1982, ELECTROEN CLIN NEURO, V53, P658, DOI 10.1016/0013-4694(82)90142-0; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Nadkarni NA, 2005, J BIOL RHYTHM, V20, P490, DOI 10.1177/0748730405281332; National Sleep Foundation, 2008, 2008 SLEEP AM POLL; Perez-Calatayud J, 2005, MED PHYS, V32, P28, DOI 10.1118/1.1834835; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rogers NL, 2003, FRONT BIOSCI-LANDMRK, V8, pS1056, DOI 10.2741/1174; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tucker AM, 2007, J SLEEP RES, V16, P170, DOI 10.1111/j.1365-2869.2007.00594.x; Unterrainer JM, 2004, J CLIN EXP NEUROPSYC, V26, P846, DOI 10.1080/13803390490509574; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2005, CLIN SPORT MED, V24, P237, DOI 10.1016/j.csm.2004.12.007; Van Dongen HPA, 2005, SLEEP, V28, P479, DOI 10.1093/sleep/28.4.479; Van Dongen HPA, 2004, AVIAT SPACE ENVIR MD, V75, pA147; Van Dongen HPA, 2004, SLEEP, V27, P423; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Wood AG, 2001, NEUROIMAGE, V14, P162, DOI 10.1006/nimg.2001.0778	53	115	117	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5874	10.1371/journal.pone.0005874	http://dx.doi.org/10.1371/journal.pone.0005874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456TJ	19516903	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000266873100007
J	Mann, EE; Rice, KC; Boles, BR; Endres, JL; Ranjit, D; Chandramohan, L; Tsang, LH; Smeltzer, MS; Horswill, AR; Bayles, KW				Mann, Ethan E.; Rice, Kelly C.; Boles, Blaise R.; Endres, Jennifer L.; Ranjit, Dev; Chandramohan, Lakshmi; Tsang, Laura H.; Smeltzer, Mark S.; Horswill, Alexander R.; Bayles, Kenneth W.			Modulation of eDNA Release and Degradation Affects Staphylococcus aureus Biofilm Maturation	PLOS ONE			English	Article							MUREIN HYDROLASE ACTIVITY; EXTRACELLULAR DNA; CELL-DEATH; BACTERIAL BIOFILMS; GENE; REGULATOR; EXPRESSION; POLYSACCHARIDE; IDENTIFICATION; METABOLISM	Recent studies have demonstrated a role for Staphylococcus aureus cidA-mediated cell lysis and genomic DNA release in biofilm adherence. The current study extends these findings by examining both temporal and additional genetic factors involved in the control of genomic DNA release and degradation during biofilm maturation. Cell lysis and DNA release were found to be critical for biofilm attachment during the initial stages of development and the released DNA (eDNA) remained an important matrix component during biofilm maturation. This study also revealed that an lrgAB mutant exhibits increased biofilm adherence and matrix-associated eDNA consistent with its proposed role as an inhibitor of cidA-mediated lysis. In flow-cell assays, both cid and lrg mutations had dramatic effects on biofilm maturation and tower formation. Finally, staphylococcal thermonuclease was shown to be involved in biofilm development as a nuc mutant formed a thicker biofilm containing increased levels of matrix-associated eDNA. Together, these findings suggest a model in which the opposing activities of the cid and lrg gene products control cell lysis and genomic DNA release during biofilm development, while staphylococcal thermonuclease functions to degrade the eDNA, possibly as a means to promote biofilm dispersal.			Mann, EE (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.	kbayles@unmc.edu	Smeltzer, Mark/M-2009-2018	Smeltzer, Mark/0000-0002-0878-0692	NIAID NIH HHS [R01 AI038901, R01AI038901] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038901] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Bayles KW, 2003, TRENDS MICROBIOL, V11, P306, DOI 10.1016/S0966-842X(03)00144-6; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; BRUNSKILL E, 1995, INVESTIGATION ANAL L; Brunskill EW, 1996, J BACTERIOL, V178, P5810, DOI 10.1128/jb.178.19.5810-5812.1996; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Costerton JW, 2004, MICROBIAL BIOFILMS, P4; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lasa I, 2006, RES MICROBIOL, V157, P99, DOI 10.1016/j.resmic.2005.11.003; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Ogris M, 2000, BBA-GEN SUBJECTS, V1474, P237, DOI 10.1016/S0304-4165(00)00018-0; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Patton TG, 2006, MOL MICROBIOL, V59, P1395, DOI 10.1111/j.1365-2958.2006.05034.x; Patton TG, 2005, MOL MICROBIOL, V56, P1664, DOI 10.1111/j.1365-2958.2005.04653.x; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rice KC, 2004, J BACTERIOL, V186, P3029, DOI 10.1128/JB.186.10.3029-3037.2004; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; SHAFER WM, 1979, INFECT IMMUN, V25, P902, DOI 10.1128/IAI.25.3.902-911.1979; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Stewart PS, 2007, LETT APPL MICROBIOL, V44, P454, DOI 10.1111/j.1472-765X.2007.02112.x; THOMAS VC, 2008, J BACTERIOL; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Vuong Cuong, 2008, V431, P97; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; WECKE J, 1986, ARCH MICROBIOL, V144, P110, DOI 10.1007/BF00414719; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; YABU K, 1995, CURR MICROBIOL, V30, P299, DOI 10.1007/BF00295505; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x; Yang SJ, 2005, J BACTERIOL, V187, P5893, DOI 10.1128/JB.187.17.5893-5900.2005; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	53	347	369	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5822	10.1371/journal.pone.0005822	http://dx.doi.org/10.1371/journal.pone.0005822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513119	Green Published, gold, Green Submitted			2022-12-27	WOS:000267228800003
J	Westmoreland, TJ; Wickramasekara, SM; Guo, AY; Selim, AL; Winsor, TS; Greenleaf, AL; Blackwell, KL; Olson, JA; Marks, JR; Bennett, CB				Westmoreland, Tammy J.; Wickramasekara, Sajith M.; Guo, Andrew Y.; Selim, Alice L.; Winsor, Tiffany S.; Greenleaf, Arno L.; Blackwell, Kimberly L.; Olson, John A., Jr.; Marks, Jeffrey R.; Bennett, Craig B.			Comparative Genome-Wide Screening Identifies a Conserved Doxorubicin Repair Network That Is Diploid Specific in Saccharomyces cerevisiae	PLOS ONE			English	Article							DNA TOPOISOMERASE-II; DOUBLE-STRAND BREAKS; TRANSCRIPTION-ASSOCIATED RECOMBINATION; KLUYVEROMYCES-LACTIS ZYMOCIN; MESSENGER-RNA EXPORT; G1 CHECKPOINT ARREST; MATING-TYPE; BUDDING YEAST; CELL-CYCLE; MITOTIC RECOMBINATION	The chemotherapeutic doxorubicin (DOX) induces DNA double-strand break (DSB) damage. In order to identify conserved genes that mediate DOX resistance, we screened the Saccharomyces cerevisiae diploid deletion collection and identified 376 deletion strains in which exposure to DOX was lethal or severely reduced growth fitness. This diploid screen identified 5-fold more DOX resistance genes than a comparable screen using the isogenic haploid derivative. Since DSB damage is repaired primarily by homologous recombination in yeast, and haploid cells lack an available DNA homolog in G1 and early S phase, this suggests that our diploid screen may have detected the loss of repair functions in G1 or early S phase prior to complete DNA replication. To test this, we compared the relative DOX sensitivity of 30 diploid deletion mutants identified under our screening conditions to their isogenic haploid counterpart, most of which (n = 26) were not detected in the haploid screen. For six mutants (bem1 Delta, ctf4 Delta, ctk1 Delta, hfi1 Delta, nup133 Delta, tho2 Delta) DOX-induced lethality was absent or greatly reduced in the haploid as compared to the isogenic diploid derivative. Moreover, unlike WT, all six diploid mutants displayed severe G1/S phase cell cycle progression defects when exposed to DOX and some were significantly enhanced (ctk1 Delta and hfi1 Delta) or deficient (tho2 Delta) for recombination. Using these and other "THO2-like" hypo-recombinogenic, diploid-specific DOX sensitive mutants (mft1 Delta, thp1 Delta, thp2 Delta) we utilized known genetic/proteomic interactions to construct an interactive functional genomic network which predicted additional DOX resistance genes not detected in the primary screen. Most (76%) of the DOX resistance genes detected in this diploid yeast screen are evolutionarily conserved suggesting the human orthologs are candidates for mediating DOX resistance by impacting on checkpoint and recombination functions in G1 and/or early S phases.			Westmoreland, TJ (corresponding author), Duke Univ, Dept Surg Sci, Med Ctr, Durham, NC 27710 USA.	bennett048@yahoo.com						ABE H, 1994, ANTICANCER RES, V14, P1807; AGUILERA A, 1988, GENETICS, V119, P779; AGUILERA A, 1989, GENETICS, V122, P503; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; Aylon Y, 2005, CELL CYCLE, V4, P259; Barbour L, 2006, MOL MICROBIOL, V59, P637, DOI 10.1111/j.1365-2958.2005.04965.x; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bennett CB, 2001, MOL CELL BIOL, V21, P5359, DOI 10.1128/MCB.21.16.5359-5373.2001; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Binaschi M, 1998, CANCER RES, V58, P1886; BODLEY A, 1989, CANCER RES, V49, P5969; Borst P, 2007, CELL CYCLE, V6, P2782, DOI 10.4161/cc.6.22.4936; Buschini A, 2003, MUTAGENESIS, V18, P25, DOI 10.1093/mutage/18.1.25; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Cutts SM, 1996, J BIOL CHEM, V271, P5422, DOI 10.1074/jbc.271.10.5422; Di Nicolantonio F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-78; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Duan ZF, 2008, MOL CANCER THER, V7, P2377, DOI 10.1158/1535-7163.MCT-08-0316; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; Durant ST, 1999, CURR BIOL, V9, P51, DOI 10.1016/S0960-9822(99)80047-5; FASULLO M, 1994, MOL GEN GENET, V243, P63, DOI 10.1007/BF00283877; Fong CS, 2008, FEMS YEAST RES, V8, P386, DOI 10.1111/j.1567-1364.2007.00349.x; Friesen C., 2008, MOL BIOL CELL; Furuchi T, 2004, BIOCHEM BIOPH RES CO, V314, P844, DOI 10.1016/j.bbrc.2003.12.160; Furuchi T, 2004, NUCLEIC ACIDS RES, V32, P2578, DOI 10.1093/nar/gkh582; Gallardo M, 2001, GENETICS, V157, P79; Game JC, 2000, MUTAT RES-FUND MOL M, V451, P277, DOI 10.1016/S0027-5107(00)00055-5; Garcia-Rubio M, 2003, GENETICS, V165, P457; Gerald JNF, 2002, J CELL SCI, V115, P1749; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Grenetier S, 2006, NUCLEIC ACIDS RES, V34, P4996, DOI 10.1093/nar/gkl493; Guano F, 1999, MOL PHARMACOL, V56, P77, DOI 10.1124/mol.56.1.77; Guo SC, 2005, CANCER RES, V65, P3011, DOI 10.1158/0008-5472.CAN-04-3624; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; HEUDE M, 1993, GENETICS, V133, P489; HIXON SC, 1980, ANTIMICROB AGENTS CH, V17, P443, DOI 10.1128/AAC.17.3.443; Huang RY, 2007, CANCER RES, V67, P765, DOI 10.1158/0008-5472.CAN-06-2839; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Ivanov EL, 1996, GENETICS, V142, P693; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Jordan PW, 2007, PLOS GENET, V3, P2368, DOI 10.1371/journal.pgen.0030222; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Kitamoto HK, 2002, MOL GENET GENOMICS, V268, P49, DOI 10.1007/s00438-002-0720-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LEE JM, 1991, GENE EXPRESSION, V1, P149; Lee JM, 1997, J BIOL CHEM, V272, P10990; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; LOVETT ST, 1987, GENETICS, V116, P547; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Meczes EL, 1997, CANCER CHEMOTH PHARM, V39, P367, DOI 10.1007/s002800050585; Mehlgarten C, 2003, MOL GENET GENOMICS, V269, P188, DOI 10.1007/s00438-003-0807-5; Moro S, 2004, BIOCHEMISTRY-US, V43, P7503, DOI 10.1021/bi0361665; Mulder KW, 2005, NUCLEIC ACIDS RES, V33, P6384, DOI 10.1093/nar/gki938; Muller I, 1998, INT J MOL MED, V1, P491; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Ostapenko D, 2003, EUKARYOT CELL, V2, P274, DOI 10.1128/EC.2.2.274-283.2003; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Patel S, 1997, MOL PHARMACOL, V52, P658, DOI 10.1124/mol.52.4.658; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; SAGULENKO V, 2008, CARCINOGENESIS; Schenk PW, 2002, MOL PHARMACOL, V61, P659, DOI 10.1124/mol.61.3.659; Schenk PW, 2003, MOL PHARMACOL, V64, P259, DOI 10.1124/mol.64.2.259; Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; SIEDE W, 1994, GENETICS, V138, P271; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; SKLADANOWSKI A, 1994, BIOCHEM PHARMACOL, V47, P2269, DOI 10.1016/0006-2952(94)90265-8; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Souid AK, 2006, GENETICS, V173, P1919, DOI 10.1534/genetics.106.057596; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Takahashi T, 2005, J CELL PHYSIOL, V202, P100, DOI 10.1002/jcp.20082; Takahashi T, 2006, CANCER RES, V66, P11932, DOI 10.1158/0008-5472.CAN-06-3220; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Traven A, 2005, GENETICS, V169, P65, DOI 10.1534/genetics.104.030940; Valencia-Burton M, 2006, GENETICS, V174, P41, DOI 10.1534/genetics.106.058685; van Hille B, 1998, CANCER CHEMOTH PHARM, V42, P345, DOI 10.1007/s002800050828; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Westmoreland TJ, 2004, EUKARYOT CELL, V3, P430, DOI 10.1128/EC.3.2.430-446.2004; Westmoreland TJ, 2003, J SURG RES, V113, P62, DOI 10.1016/S0022-4804(03)00155-0; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; Xia L, 2007, CANCER RES, V67, P11411, DOI 10.1158/0008-5472.CAN-07-2399; YAN YX, 1995, CURR GENET, V28, P12, DOI 10.1007/BF00311876; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2	109	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5830	10.1371/journal.pone.0005830	http://dx.doi.org/10.1371/journal.pone.0005830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503795	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717400010
J	Ushizawa, K; Takahashi, T; Hosoe, M; Kizaki, K; Hashizume, K				Ushizawa, Koichi; Takahashi, Toru; Hosoe, Misa; Kizaki, Keiichiro; Hashizume, Kazuyoshi			Characterization and Expression Analysis of SOLD1, a Novel Member of the Retrotransposon-Derived Ly-6 Superfamily, in Bovine Placental Villi	PLOS ONE			English	Article								Background: Ly-6 superfamily members have a conserved Ly-6 domain that is defined by a distinct disulfide bonding pattern between eight or ten cysteine residues. These members are divided into membrane-type and secretory-type proteins. In the present study, we report the identification of a novel Ly-6 domain protein, secreted protein of Ly-6 domain 1 (SOLD1), from bovine placenta. Principal Findings: SOLD1 mRNA was expressed in trophoblast mononucleate cells and the protein was secreted into and localized in the extracellular matrix of the mesenchyme in cotyledonary villi. SOLD1 bound mainly with type I collagen telopeptide. We confirmed secretion of SOLD1 from the basolateral surface of a bovine trophoblast cell line (BT-1). It may be related to the organization of the extra-cellular matrix in the mesenchyme of fetal villi. Since trophoblast mononucleate cells are epithelial cells, their polar organization is expected to have a crucial role in the SOLD1 secretion system. We established that SOLD1 is an intronless bovine gene containing the Alu retrotransposon, which was integrated via cytoplasmic reverse transcription. Conclusion: We identified a novel retrotransposon-like Ly-6 domain protein in bovine placenta. SOLD1 is a crucial secreted protein that is involved in the organization of the mesenchyme of the cotyledonary villi. Furthermore, the gene encoding SOLD1 has an interesting genomic structure.			Ushizawa, K (corresponding author), Natl Inst Agrobiol Sci, Div Anim Sci, Reprod Biol Res Unit, Tsukuba, Ibaraki, Japan.	tatoru@affrc.go.jp						Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; ALON R, 1994, J IMMUNOL, V152, P1304; Ariel A, 1997, EUR J IMMUNOL, V27, P2562, DOI 10.1002/eji.1830271015; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Bera TK, 2002, P NATL ACAD SCI USA, V99, P3058, DOI 10.1073/pnas.052713699; Boos A, 2003, CELLS TISSUES ORGANS, V174, P170, DOI 10.1159/000072720; BRAKENHOFF RH, 1995, J CELL BIOL, V129, P1677, DOI 10.1083/jcb.129.6.1677; Brakenhoff RH, 1997, J IMMUNOL, V159, P4879; CASEY JR, 1994, BLOOD, V84, P1151; CHANG CP, 1994, J BIOL CHEM, V269, P26424; Coonrod SA, 1996, J REPROD FERTIL, V107, P287, DOI 10.1530/jrf.0.1070287; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; Eshel R, 2002, INT J CANCER, V98, P803, DOI 10.1002/ijc.10301; FREEMERMAN AJ, 1993, MOL REPROD DEV, V34, P140, DOI 10.1002/mrd.1080340205; GODKIN JD, 1982, J REPROD FERTIL, V65, P141, DOI 10.1530/jrf.0.0650141; Gootwine E, 2004, ANIM REPROD SCI, V82-3, P551, DOI 10.1016/j.anireprosci.2004.04.008; Green JA, 2000, BIOL REPROD, V62, P1624, DOI 10.1095/biolreprod62.6.1624; Hashizume K, 2007, REPROD FERT DEVELOP, V19, P79, DOI 10.1071/RD06118; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; KELLY JL, 1993, J CELL BIOL, V121, P1153, DOI 10.1083/jcb.121.5.1153; Kizaki K, 2003, PLACENTA, V24, P424, DOI 10.1053/plac.2002.0909; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; La Bonnardiere C, 2002, PLACENTA, V23, P716, DOI 10.1053/plac.2002.0848; Levitin F, 2008, J BIOL CHEM, V283, P16928, DOI 10.1074/jbc.M801454200; Li SH, 2006, REPRODUCTION, V132, P493, DOI 10.1530/rep.1.01183; MacLean JA, 2004, BIOL REPROD, V71, P455, DOI 10.1095/biolreprod.103.025908; Maclean JA, 2003, MOL REPROD DEV, V65, P30, DOI 10.1002/mrd.10262; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; MOORADIAN DL, 1989, J CELL BIOCHEM, V41, P189, DOI 10.1002/jcb.240410404; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Palfree RGE, 1996, TISSUE ANTIGENS, V48, P71, DOI 10.1111/j.1399-0039.1996.tb02610.x; PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D; Pfarrer C, 2003, PLACENTA, V24, P588, DOI 10.1016/S0143-4004(03)00059-6; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; PLOUG M, 1993, J BIOL CHEM, V268, P17539; REDDI PP, 1995, BIOL REPROD, V53, P873, DOI 10.1095/biolreprod53.4.873; ROBERTS RM, 1992, ENDOCR REV, V13, P432, DOI 10.1210/er.13.3.432; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawicki G, 2000, BIOL REPROD, V63, P1390, DOI 10.1095/biolreprod63.5.1390; SCHULER LA, 1988, BIOCHEMISTRY-US, V27, P8443, DOI 10.1021/bi00422a022; Schuppan D, 1998, GASTROENTEROLOGY, V114, P139, DOI 10.1016/S0016-5085(98)70642-0; Shimada A, 2001, PLACENTA, V22, P652, DOI 10.1053/plac.2001.0702; Soler-Garcia AA, 2005, REPRODUCTION, V129, P515, DOI 10.1530/rep.1.00576; Somasundaram R, 1996, J BIOL CHEM, V271, P26884, DOI 10.1074/jbc.271.43.26884; Somasundaram R, 2000, J BIOL CHEM, V275, P38170, DOI 10.1074/jbc.M006616200; Somasundaram R, 2002, J BIOL CHEM, V277, P3242, DOI 10.1074/jbc.M110011200; Song G, 2007, PLACENTA, V28, P1091, DOI 10.1016/j.placenta.2007.04.004; Southan C, 2002, PROTEOMICS, V2, P187, DOI 10.1002/1615-9861(200202)2:2<187::AID-PROT187>3.0.CO;2-A; Takahashi T, 2006, ANIM SCI J, V77, P10, DOI 10.1111/j.1740-0929.2006.00314.x; Takahashi T, 2008, J ENDOCRINOL, V196, P225, DOI 10.1677/JOE-07-0069; Tsuji H, 2003, GENOMICS, V81, P26, DOI 10.1016/S0888-7543(02)00025-3; Uekita T, 2004, PLACENTA, V25, P810, DOI 10.1016/j.placenta.2004.03.007; Ushizawa K, 2006, ANIM SCI J, V77, P18, DOI 10.1111/j.1740-0929.2006.00315.x; Ushizawa K, 2006, BIOL REPROD, V74, P344, DOI 10.1095/biolreprod.105.042655; Ushizawa K, 2005, J REPROD DEVELOP, V51, P211, DOI 10.1262/jrd.16072; Ushizawa Koichi, 2004, Reprod Biol Endocrinol, V2, P77; VALLET JL, 1988, J ENDOCRINOL, V117, pR5, DOI 10.1677/joe.0.117R005; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wooding FBP, 1996, PLACENTA, V17, P75, DOI 10.1016/S0143-4004(05)80646-0; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; WRIGHT RM, 1990, BIOL REPROD, V42, P693, DOI 10.1095/biolreprod42.4.693; Wyrwoll CS, 2005, MOL CELL ENDOCRINOL, V241, P73, DOI 10.1016/j.mce.2005.05.003	65	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5814	10.1371/journal.pone.0005814	http://dx.doi.org/10.1371/journal.pone.0005814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503832	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717200010
J	Fonseca, NA; Vieira, CP; Vieira, J				Fonseca, Nuno A.; Vieira, Cristina P.; Vieira, Jorge			Gene Classification Based on Amino Acid Motifs and Residues: The DLX (distal-less) Test Case	PLOS ONE			English	Article								Background: Comparative studies using hundreds of sequences can give a detailed picture of the evolution of a given gene family. Nevertheless, retrieving only the sequences of interest from public databases can be difficult, in particular, when working with highly divergent sequences. The difficulty increases substantially when one wants to include in the study sequences from many (or less well studied) species whose genomes are non-annotated or incompletely annotated. Methodology/Principal Findings: In this work we evaluate the usefulness of different approaches of gene retrieval and classification, using the distal-less (DLX) gene family as a test case. Furthermore, we evaluate whether the use of a large number of gene sequences from a wide range of animal species, the use of multiple alternative alignments, and the use of amino acids aligned with high confidence only, is enough to recover the accepted DLX evolutionary history. Conclusions/Significance: The canonical DLX homeobox gene sequence here derived, together with the characteristic amino acid variants here identified in the DLX homeodomain region, can be used to retrieve and classify DLX genes in a simple and efficient way. A program is made available that allows the easy retrieval of synteny information that can be used to classify gene sequences. Maximum likelihood trees using hundreds of sequences can be used for gene identification. Nevertheless, for the DLX case, the proposed DLX evolutionary is not recovered even when multiple alignment algorithms are used.			Fonseca, NA (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jbvieira@ibmc.up.pt	Vieira, Cristina P./K-1775-2013; Fonseca, Nuno A./B-7801-2009; INESC-TEC, CRACS/F-7527-2012; Vieira, Jorge/J-7477-2013	Vieira, Cristina P./0000-0002-7139-2107; Fonseca, Nuno A./0000-0003-4832-578X; Vieira, Jorge/0000-0001-7032-5220				Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Essoussi N, 2008, BIOINFORMATION, V2, P452; Fonseca NA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-200; Golubchik T, 2007, MOL BIOL EVOL, V24, P2433, DOI 10.1093/molbev/msm176; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Irvine SQ, 2007, J EXP ZOOL PART B, V308B, P428, DOI 10.1002/jez.b.21169; Kaiserman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-167; Monteiro AS, 2006, EVOL DEV, V8, P174, DOI 10.1111/j.1525-142X.2006.00087.x; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Stock DW, 2005, GENETICS, V169, P807, DOI 10.1534/genetics.104.031831; Sumiyama Kenta, 2003, Journal of Structural and Functional Genomics, V3, P151, DOI 10.1023/A:1022682505914; Sundstrom G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-254; Vieira J, 2008, J MOL EVOL, V67, P179, DOI 10.1007/s00239-008-9137-x; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Zwickl DJ., 2006, THESIS	20	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5748	10.1371/journal.pone.0005748	http://dx.doi.org/10.1371/journal.pone.0005748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484130	gold, Green Published, Green Submitted			2022-12-27	WOS:000266528200004
J	Habayeb, MS; Ekstrom, JO; Hultmark, D				Habayeb, Mazen S.; Ekstrom, Jens-Ola; Hultmark, Dan			Nora Virus Persistent Infections Are Not Affected by the RNAi Machinery	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; ANTIVIRAL IMMUNITY; DISTINCT ROLES; DICER-2; DEFENSE; PATHWAY	Drosophila melanogaster is widely used to decipher the innate immune system in response to various pathogens. The innate immune response towards persistent virus infections is among the least studied in this model system. We recently discovered a picorna-like virus, the Nora virus which gives rise to persistent and essentially symptom-free infections in Drosophila melanogaster. Here, we have used this virus to study the interaction with its host and with some of the known Drosophila antiviral immune pathways. First, we find a striking variability in the course of the infection, even between flies of the same inbred stock. Some flies are able to clear the Nora virus but not others. This phenomenon seems to be threshold-dependent; flies with a high-titer infection establish stable persistent infections, whereas flies with a lower level of infection are able to clear the virus. Surprisingly, we find that both the clearance of low-level Nora virus infections and the stability of persistent infections are unaffected by mutations in the RNAi pathways. Nora virus infections are also unaffected by mutations in the Toll and Jak-Stat pathways. In these respects, the Nora virus differs from other studied Drosophila RNA viruses.			Habayeb, MS (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	dan.hultmark@ucmp.umu.se	Hultmark, Dan/C-5058-2013	Hultmark, Dan/0000-0002-6506-5855				ANDERSON KV, 1984, NATURE, V311, P223, DOI 10.1038/311223a0; BRUN G, 1980, GENET BIOL DROSOPHIL, P625; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; GOMARIZZILBER E, 1995, J INVERTEBR PATHOL, V65, P243, DOI 10.1006/jipa.1995.1037; Habayeb MS, 2006, J GEN VIROL, V87, P3045, DOI 10.1099/vir.0.81997-0; Habayeb MS, 2009, J INVERTEBR PATHOL, V101, P29, DOI 10.1016/j.jip.2009.02.003; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; JOUSSET FX, 1975, ANN INST PASTEUR MIC, VB126, P231; Kavi HH, 2008, CURR TOP MICROBIOL, V320, P37; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; TENINGES D, 1979, J GEN VIROL, V42, P241, DOI 10.1099/0022-1317-42-2-241; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zamore PD, 2007, NATURE, V446, P864, DOI 10.1038/446864a	26	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5731	10.1371/journal.pone.0005731	http://dx.doi.org/10.1371/journal.pone.0005731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478998	Green Submitted, gold, Green Published			2022-12-27	WOS:000266490000008
J	Vidali, L; Rounds, CM; Hepler, PK; Bezanilla, M				Vidali, Luis; Rounds, Caleb M.; Hepler, Peter K.; Bezanilla, Magdalena			Lifeact-mEGFP Reveals a Dynamic Apical F-Actin Network in Tip Growing Plant Cells	PLOS ONE			English	Article								Background: Actin is essential for tip growth in plants. However, imaging actin in live plant cells has heretofore presented challenges. In previous studies, fluorescent probes derived from actin-binding proteins often alter growth, cause actin bundling and fail to resolve actin microfilaments. Methodology/Principal Findings: In this report we use Lifeact-mEGFP, an actin probe that does not affect the dynamics of actin, to visualize actin in the moss Physcomitrella patens and pollen tubes from Lilium formosanum and Nicotiana tobaccum. Lifeact-mEGFP robustly labels actin microfilaments, particularly in the apex, in both moss protonemata and pollen tubes. Lifeact-mEGFP also labels filamentous actin structures in other moss cell types, including cells of the gametophore. Conclusions/Significance: Lifeact-mEGFP, when expressed at optimal levels does not alter moss protonemal or pollen tube growth. We suggest that Lifeact-mEGFP represents an exciting new versatile probe for further studies of actin's role in tip growing plant cells.			Vidali, L (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	bezanilla@bio.umass.edu	Vidali, Luis/F-6931-2014	Vidali, Luis/0000-0002-5835-4587	Div Of Molecular and Cellular Bioscience [0747231] Funding Source: National Science Foundation	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Augustine RC, 2008, PLANT J, V54, P863, DOI 10.1111/j.1365-313X.2008.03451.x; Bezanilla M, 2005, PLANT BIOLOGY, V7, P251, DOI 10.1055/s-2005-837597; Bezanilla M, 2003, PLANT PHYSIOL, V133, P470, DOI 10.1104/pp.103.024901; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chen CY, 2002, PLANT CELL, V14, P2175, DOI 10.1105/tpc.003038; Cheung AY, 2008, MOL PLANT, V1, P686, DOI 10.1093/mp/ssn026; Cheung AY, 2004, PLANT CELL, V16, P257, DOI 10.1105/tpc.016550; Deeks MJ, 2005, NEW PHYTOL, V168, P529, DOI 10.1111/j.1469-8137.2005.01582.x; Fan XX, 2004, PLANT PHYSIOL, V136, P3979, DOI 10.1104/pp.104.046326; Finka A, 2008, CELL MOTIL CYTOSKEL, V65, P769, DOI 10.1002/cm.20298; Finka A, 2007, NEW PHYTOL, V174, P63, DOI 10.1111/j.1469-8137.2007.01989.x; Foissner I, 2002, PROTOPLASMA, V220, P1, DOI 10.1007/s00709-002-0032-9; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Gu Y, 2003, J EXP BOT, V54, P93, DOI 10.1093/jxb/54.380.93; Hamilton DA, 1998, PLANT MOL BIOL, V38, P663, DOI 10.1023/A:1006083725102; Harries PA, 2005, PLANT CELL, V17, P2327, DOI 10.1105/tpc.105.033266; Hwang JU, 2005, MOL BIOL CELL, V16, P5385, DOI 10.1091/mbc.E05-05-0409; Ketelaar T, 2004, PLANT PHYSIOL, V136, P3990, DOI 10.1104/pp.104.050799; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Li HB, 2008, NAT CELL BIOL, V10, P1301, DOI 10.1038/ncb1788; Li Y, 2001, PLANTA, V213, P722, DOI 10.1007/s004250100543; Lovy-Wheeler A, 2005, PLANTA, V221, P95, DOI 10.1007/s00425-004-1423-2; McKenna ST, 2004, PLANTA, V218, P906, DOI 10.1007/s00425-003-1174-5; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; MESKE V, 1995, PROTOPLASMA, V188, P59, DOI 10.1007/BF01276796; Miller DD, 1996, PROTOPLASMA, V195, P123, DOI 10.1007/BF01279191; Perroud PF, 2006, CELL MOTIL CYTOSKEL, V63, P162, DOI 10.1002/cm.20114; Raudaskoski M, 2001, J PLANT GROWTH REGUL, V20, P113, DOI 10.1007/s003440010015; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Staiger CJ, 2009, J CELL BIOL, V184, P269, DOI 10.1083/jcb.200806185; TANG XJ, 1989, CELL MOTIL CYTOSKEL, V12, P216, DOI 10.1002/cm.970120404; TIWARI SC, 1988, PROTOPLASMA, V147, P5, DOI 10.1007/BF01403873; TWELL D, 1990, DEVELOPMENT, V109, P705; Vidali L, 2001, MOL BIOL CELL, V12, P2534, DOI 10.1091/mbc.12.8.2534; Vidali L, 2007, PLANT CELL, V19, P3705, DOI 10.1105/tpc.107.053413; Walker LM, 1995, PROTOPLASMA, V189, P229, DOI 10.1007/BF01280177; Wilsen KL, 2006, SEX PLANT REPROD, V19, P51, DOI 10.1007/s00497-006-0021-9; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413	40	161	166	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5744	10.1371/journal.pone.0005744	http://dx.doi.org/10.1371/journal.pone.0005744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478943	Green Published, gold, Green Submitted			2022-12-27	WOS:000266490000018
J	Conti, AC; Maas, JW; Moulder, KL; Jiang, XP; Dave, BA; Mennerick, S; Muglia, LJ				Conti, Alana C.; Maas, James W., Jr.; Moulder, Krista L.; Jiang, Xiaoping; Dave, Bhumy A.; Mennerick, Steven; Muglia, Louis J.			Adenylyl Cyclases 1 and 8 Initiate a Presynaptic Homeostatic Response to Ethanol Treatment	PLOS ONE			English	Article								Background: Although ethanol exerts widespread action in the brain, only recently has progress been made in understanding the specific events occurring at the synapse during ethanol exposure. Mice deficient in the calcium-stimulated adenylyl cyclases, AC1 and AC8 (DKO), demonstrate increased sedation duration and impaired phosphorylation by protein kinase A (PKA) following acute ethanol treatment. While not direct targets for ethanol, we hypothesize that these cyclases initiate a homeostatic presynaptic response by PKA to reactivate neurons from ethanol-mediated inhibition. Methodology/Principal Findings: Here, we have used phosphoproteomic techniques and identified several presynaptic proteins that are phosphorylated in the brains of wild type mice (WT) after ethanol exposure, including synapsin, a known PKA target. Phosphorylation of synapsins I and II, as well as phosphorylation of non-PKA targets, such as, eukaryotic elongation factor-2 (eEF-2) and dynamin is significantly impaired in the brains of DKO mice. This deficit is primarily driven by AC1, as AC1-deficient, but not AC8-deficient mice also demonstrate significant reductions in phosphorylation of synapsin and eEF-2 in cortical and hippocampal tissues. DKO mice have a reduced pool of functional recycling vesicles and fewer active terminals as measured by FM1-43 uptake compared to WT controls, which may be a contributing factor to the impaired presynaptic response to ethanol treatment. Conclusions/Significance: These data demonstrate that calcium-stimulated AC-dependent PKA activation in the presynaptic terminal, primarily driven by AC1, is a critical event in the reactivation of neurons following ethanol-induced activity blockade.			Conti, AC (corresponding author), Washington Univ, Dept Pediat, St Louis, MO 63130 USA.	contia@psychiatry.wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054174, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012957, R01AA012952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA018109] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA12952, R01 AA012952, R01 AA012957, AA12957] Funding Source: Medline; NICHD NIH HHS [HD049305, T32 HD049305] Funding Source: Medline; NIDA NIH HHS [DA018109, K01 DA018109] Funding Source: Medline; NIMH NIH HHS [R01 MH078823, MH78823] Funding Source: Medline; NINDS NIH HHS [R01 NS054174, NS54174, P30NS057105, P30 NS057105] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Carpenter-Hyland EP, 2006, EUR J NEUROSCI, V24, P3496, DOI 10.1111/j.1460-9568.2006.05247.x; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Constantinescu A, 2004, J BIOL CHEM, V279, P43321, DOI 10.1074/jbc.M406994200; Constantinescu A, 2002, J BIOL CHEM, V277, P18810, DOI 10.1074/jbc.M112107200; Constantinescu A, 1999, J BIOL CHEM, V274, P26985, DOI 10.1074/jbc.274.38.26985; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Evans GJO, 2003, BIOCHEM SOC T, V31, P824, DOI 10.1042/bst0310824; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fujita K, 2006, FEMS YEAST RES, V6, P744, DOI 10.1111/j.1567-1364.2006.00040.x; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Hong-Brown LQ, 2007, J BIOL CHEM, V282, P3702, DOI 10.1074/jbc.M606593200; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Lu HC, 2006, J NEUROSCI, V26, P2692, DOI 10.1523/JNEUROSCI.3956-05.2006; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Smillie KJ, 2005, BIOCHEM SOC SYMP, V72, P87, DOI 10.1042/bss0720087; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Sun JY, 2006, P NATL ACAD SCI USA, V103, P2880, DOI 10.1073/pnas.0511300103; TANG WJ, 1991, J BIOL CHEM, V266, P8595; Torok N, 1997, GASTROENTEROLOGY, V113, P1938, DOI 10.1016/S0016-5085(97)70014-3; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; Villacres EC, 1998, J NEUROSCI, V18, P3186; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wand G, 2001, J NEUROSCI, V21, P5297, DOI 10.1523/JNEUROSCI.21-14-05297.2001; Wang HB, 2003, J NEUROSCI, V23, P9710; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Yang XJ, 1996, J PHARMACOL EXP THER, V278, P338	41	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5697	10.1371/journal.pone.0005697	http://dx.doi.org/10.1371/journal.pone.0005697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479030	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415000010
J	Konno, H; Yamamoto, T; Yamazaki, K; Gohda, J; Akiyama, T; Semba, K; Goto, H; Kato, A; Yujiri, T; Imai, T; Kawaguchi, Y; Su, B; Takeuchi, O; Akira, S; Tsunetsugu-Yokota, Y; Inoue, J				Konno, Hiroyasu; Yamamoto, Takuya; Yamazaki, Kohsuke; Gohda, Jin; Akiyama, Taishin; Semba, Kentaro; Goto, Hideo; Kato, Atsushi; Yujiri, Toshiaki; Imai, Takahiko; Kawaguchi, Yasushi; Su, Bing; Takeuchi, Osamu; Akira, Shizuo; Tsunetsugu-Yokota, Yasuko; Inoue, Jun-ichiro			TRAF6 Establishes Innate Immune Responses by Activating NF-kappa B and IRF7 upon Sensing Cytosolic Viral RNA and DNA	PLOS ONE			English	Article								Background: In response to viral infection, the innate immune system recognizes viral nucleic acids and then induces production of proinflammatory cytokines and type I interferons (IFNs). Toll-like receptor 7 (TLR7) and TLR9 detect viral RNA and DNA, respectively, in endosomal compartments, leading to the activation of nuclear factor kappa B (NF-kappa B) and IFN regulatory factors (IRFs) in plasmacytoid dendritic cells. During such TLR signaling, TNF receptor-associated factor 6 (TRAF6) is essential for the activation of NF-kappa B and the production of type I IFN. In contrast, RIG-like helicases (RLHs), cytosolic RNA sensors, are indispensable for antiviral responses in conventional dendritic cells, macrophages, and fibroblasts. However, the contribution of TRAF6 to the detection of cytosolic viral nucleic acids has been controversial, and the involvement of TRAF6 in IRF activation has not been adequately addressed. Principal Findings: Here we first show that TRAF6 plays a critical role in RLH signaling. The absence of TRAF6 resulted in enhanced viral replication and a significant reduction in the production of IL-6 and type I IFNs after infection with RNA virus. Activation of NF-kappa B and IRF7, but not that of IRF3, was significantly impaired during RLH signaling in the absence of TRAF6. TGF beta-activated kinase 1 (TAK1) and MEKK3, whose activation by TRAF6 during TLR signaling is involved in NF-kappa B activation, were not essential for RLH-mediated NF-kappa B activation. We also demonstrate that TRAF6-deficiency impaired cytosolic DNA-induced antiviral responses, and this impairment was due to defective activation of NF-kappa B and IRF7. Conclusions/Significance: Thus, TRAF6 mediates antiviral responses triggered by cytosolic viral DNA and RNA in a way that differs from that associated with TLR signaling. Given its essential role in signaling by various receptors involved in the acquired immune system, TRAF6 represents a key molecule in innate and antigen-specific immune responses against viral infection.			Konno, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Cellular & Mol Biol, Tokyo, Japan.	jun-i@ims.u-tokyo.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011; Akira, Shizuo/C-3134-2009; Yamamoto, Takuya/L-2642-2013; Yujiri, Toshiaki/AAY-8150-2020	Takeuchi, Osamu/0000-0002-1260-6232; Yamamoto, Takuya/0000-0003-3753-1211; Yujiri, Toshiaki/0000-0001-6838-3456; Kawaguchi, Yasushi/0000-0001-8232-6925; Akiyama, Taishin/0000-0002-0341-6154				Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kitamura T, 1998, INT J HEMATOL, V67, P351; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Nomura F, 2000, GENES CELLS, V5, P191; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prakash A, 2006, BIOCHEM BIOPH RES CO, V342, P50, DOI 10.1016/j.bbrc.2006.01.122; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tanaka M, 2003, J VIROL, V77, P1382, DOI 10.1128/JVI.77.2.1382-1391.2003; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang XY, 2007, J IMMUNOL, V178, P6770, DOI 10.4049/jimmunol.178.11.6770; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Yujiri T, 2003, J BIOL CHEM, V278, P3846, DOI 10.1074/jbc.M206087200; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	73	78	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5674	10.1371/journal.pone.0005674	http://dx.doi.org/10.1371/journal.pone.0005674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479062	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331700003
J	Watts, SW; Priestley, JRC; Thompson, JM				Watts, Stephanie W.; Priestley, Jessica R. C.; Thompson, Janice M.			Serotonylation of Vascular Proteins Important to Contraction	PLOS ONE			English	Article								Background: Serotonin (5-hydroxytryptamine, 5-HT) was named for its source (sero-) and ability to modify smooth muscle tone (tonin). The biological effects of 5-HT are believed to be carried out by stimulation of serotonin receptors at the plasma membrane. Serotonin has recently been shown to be synthesized in vascular smooth muscle and taken up from external sources, placing 5-HT inside the cell. The enzyme transglutaminase uses primary amines such as 5-HT to covalently modify proteins on glutamine residues. We tested the hypothesis that 5-HT is a substrate for transglutaminase in arterial vascular smooth muscle, with protein serotonylation having physiological function. Methodology/Principal Findings: The model was the rat aorta and cultured aortic smooth muscle cells. Western analysis demonstrated that transglutaminase II was present in vascular tissue, and transglutaminase activity was observed as a cystamine-inhibitable incorporation of the free amine pentylamine-biotin into arterial proteins. Serotonin-biotin was incorporated into alpha-actin, beta-actin, gamma-actin, myosin heavy chain and filamin A as shown through tandem mass spectrometry. Using antibodies directed against biotin or 5-HT, immunoprecipitation and immunocytochemistry confirmed serotonylation of smooth muscle alpha-actin. Importantly, the alpha-actin-dependent process of arterial isometric contraction to 5-HT was reduced by cystamine. Conclusions: 5-HT covalently modifies proteins integral to contractility and the cytoskeleton. These findings suggest new mechanisms of action for 5-HT in vascular smooth muscle and consideration for intracellular effects of primary amines.			Watts, SW (corresponding author), Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA.	wattss@msu.edu	Priestley, Jessica/AAF-1665-2022; Priestley, Jessica/AFG-7149-2022; Priestley, Jessica/AAE-5410-2022	Priestley, Jessica/0000-0001-5457-7188	NHLBI NIH HHS [R01 HL081115, HL81115] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081115] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDER JS, 1987, BIOCHEM BIOPH RES CO, V143, P152, DOI 10.1016/0006-291X(87)90643-7; Bakker ENTP, 2005, CIRC RES, V96, P119, DOI 10.1161/01.RES.0000151333.56089.66; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bernassola F, 1999, ANN NY ACAD SCI, V887, P83, DOI 10.1111/j.1749-6632.1999.tb07924.x; Candi E, 2004, BIOCHEM J, V381, P313, DOI 10.1042/BJ20031474; Chowdhury ZA, 1997, EXP CELL RES, V231, P38, DOI 10.1006/excr.1996.3448; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; Dempsie Y, 2008, BRIT J PHARMACOL, V155, P455, DOI 10.1038/bjp.2008.241; Eddahibi S, 2006, ARCH MAL COEUR VAISS, V99, P621; Esposito C, 2007, CURR MED CHEM, V14, P2572, DOI 10.2174/092986707782023343; Fanburg BL, 1997, AM J PHYSIOL-LUNG C, V272, pL795, DOI 10.1152/ajplung.1997.272.5.L795; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Gupta M, 2007, J VASC RES, V44, P339, DOI 10.1159/000102277; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; IISMAA SE, 2006, SCI STKE, V353, pPE34; Jeitner TM, 2005, BIOCHEM PHARMACOL, V69, P961, DOI 10.1016/j.bcp.2004.12.011; Johnson TS, 1997, J CLIN INVEST, V99, P2950, DOI 10.1172/JCI119490; Kang SK, 2004, J BIOL CHEM, V279, P36593, DOI 10.1074/jbc.M402084200; KAUMANN AJ, 2006, PHARMACOL THERAPEUT, V111, P67; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Lai TS, 2007, FASEB J, V21, P4131, DOI 10.1096/fj.06-7598com; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; LINDER AE, 2008, J PHARMACOL EXP THER, V325, P1031; Miyazaki M, 2007, J CARDIOVASC PHARM, V49, P221, DOI 10.1097/FJC.0b013e3180325af3; NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674; Nguelefack TB, 2005, PHYTOTHER RES, V19, P207, DOI 10.1002/ptr.1646; Ni W, 2008, BRIT J PHARMACOL, V154, P663, DOI 10.1038/bjp.2008.111; Ni W, 2004, J CARDIOVASC PHARM, V43, P770, DOI 10.1097/00005344-200406000-00006; Ogden K, 2006, AM J PHYSIOL-HEART C, V291, pH2857, DOI 10.1152/ajpheart.00229.2006; Ou HS, 2000, CIRC RES, V87, P881, DOI 10.1161/01.RES.87.10.881; Pardin C, 2008, J ORG CHEM, V73, P5766, DOI 10.1021/jo8004843; Pistea A, 2008, J VASC RES, V45, P10, DOI 10.1159/000109073; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; SMALL DH, 1984, P NATL ACAD SCI-BIOL, V81, P959, DOI 10.1073/pnas.81.3.959; Szasz R, 2002, BLOOD, V100, P2827, DOI 10.1182/blood-2002-02-0354; Villalon CM, 2007, N-S ARCH PHARMACOL, V376, P45, DOI 10.1007/s00210-007-0179-1; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Watts SW, 2005, CLIN SCI, V108, P399, DOI 10.1042/CS20040364; Woo CH, 2006, BIOCHEM BIOPH RES CO, V351, P972, DOI 10.1016/j.bbrc.2006.10.154; Yildiz O, 1998, LIFE SCI, V62, P1723, DOI 10.1016/S0024-3205(97)01166-1	43	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5682	10.1371/journal.pone.0005682	http://dx.doi.org/10.1371/journal.pone.0005682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479059	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331700010
J	Prabakaran, M; Prabhu, N; He, F; Hongliang, Q; Ho, HT; Qiang, J; Meng, T; Goutama, M; Kwang, J				Prabakaran, Mookkan; Prabhu, Nayana; He, Fang; Hongliang, Qian; Ho, Hui-Ting; Qiang, Jia; Meng, Tao; Goutama, Michael; Kwang, Jimmy			Combination Therapy Using Chimeric Monoclonal Antibodies Protects Mice from Lethal H5N1 Infection and Prevents Formation of Escape Mutants	PLOS ONE			English	Article							AVIAN INFLUENZA; VIRUS; HEMAGGLUTININ; NEUTRALIZATION; EFFICACY; IMMUNITY; ELISA	Background: Given that there is a possibility of a human H5N1 pandemic and the fact that the recent H5N1 viruses are resistant to the anti-viral drugs, newer strategies for effective therapy are warranted. Previous studies show that single mAbs in immune prophylaxis can be protective against H5N1 infection. But a single mAb may not be effective in neutralization of a broad range of different strains of H5N1 and control of potential neutralization escape mutants. Methods/Principal Findings: We selected two mAbs which recognized different epitopes on the hemagglutinin molecule. These two mAbs could each neutralize in vitro escape mutants to the other and in combination could effectively neutralize viruses from clades 0, 1, 2.1, 2.2, 2.3, 4, 7 and 8 of influenza A H5N1 viruses. This combination of chimeric mAbs when administered passively, pre or post challenge with 10 MLD50 (50% mouse lethal dose) HPAI H5N1 influenza A viruses could protect 100% of the mice from two different clades of viruses (clades 1 and 2.1). We also tested the efficacy of a single dose of the combination of mAbs versus two doses. Two doses of the combination therapy not only affected early clearance of the virus from the lung but could completely prevent lung pathology of the H5N1 infected mice. No escape variants were detected after therapy. Conclusions/Significance: Our studies provide proof of concept that the synergistic action of two or more mAbs in combination is required for preventing the generation of escape mutants and also to enhance the therapeutic efficacy of passive therapy against H5N1 infection. Combination therapy may allow for a lower dose of antibody to be administered for passive therapy of influenza infection and hence can be made available at reduced economic costs during an outbreak.			Prabakaran, M (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	kwang@tll.org.sg		Prabakaran, Mookkan/0000-0002-9816-5908; Prabhu, Nayana/0000-0002-2350-6552				Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; de Kruif J, 2007, ANNU REV MED, V58, P359, DOI 10.1146/annurev.med.58.061705.145053; Eren R, 2006, J VIROL, V80, P2654, DOI 10.1128/JVI.80.6.2654-2664.2006; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; He QG, 2007, CLIN VACCINE IMMUNOL, V14, P617, DOI 10.1128/CVI.00444-06; Jostock T, 2004, J IMMUNOL METHODS, V289, P65, DOI 10.1016/j.jim.2004.03.014; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Li A, 1998, J VIROL, V72, P3235, DOI 10.1128/JVI.72.4.3235-3240.1998; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Prabakaran M, 2008, VIROLOGY, V380, P412, DOI 10.1016/j.virol.2008.08.002; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; REED LJ, 1938, AM J HYG, V27; Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X; SHAWLER DL, 1985, J IMMUNOL, V135, P1530; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; *US CDCP, 1999, BIOS MICR BIOM LAB; Veits J, 2008, VACCINE, V26, P1688, DOI 10.1016/j.vaccine.2008.01.016; Velumani S, 2008, J VIROL METHODS, V147, P219, DOI 10.1016/j.jviromet.2007.09.004; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; World Health Organization, 2004, LAB BIOS MAN, V3rd; Xu WD, 2002, VACCINE, V20, P1956, DOI 10.1016/S0264-410X(02)00077-4; YOKOYAMA WM, 2004, CURRENT PROTOCOLS IM; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001; 1995, ANN 1 SUPER SANITA, V31, P1	33	44	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5672	10.1371/journal.pone.0005672	http://dx.doi.org/10.1371/journal.pone.0005672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19478856	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331200009
J	Daley, P; Michael, JS; Kalaiselvan, S; Latha, A; Mathai, D; John, KR; Pai, M				Daley, Peter; Michael, Joy Sarojini; Kalaiselvan, S.; Latha, Asha; Mathai, Dilip; John, K. R.; Pai, Madhukar			A Pilot Study of Short-Duration Sputum Pretreatment Procedures for Optimizing Smear Microscopy for Tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSIS; CULTURE; SENSITIVITY; METHODOLOGY; PCR	Background: Direct sputum smear microscopy for tuberculosis (TB) lacks sensitivity for the detection of acid fast bacilli. Sputum pretreatment procedures may enhance sensitivity. We did a pilot study to compare the diagnostic accuracy and incremental yield of two short-duration (< 1 hour) sputum pretreatment procedures to optimize direct smears among patients with suspected TB at a referral hospital in India. Methodology/Findings: Blinded laboratory comparison of bleach and universal sediment processing (USP) pretreated centrifuged auramine smears to direct Ziehl-Neelsen (ZN) and direct auramine smears and to solid (Loweinstein-Jensen (LJ)) and liquid (BACTEC 460) culture. 178 pulmonary and extrapulmonary TB suspects were prospectively recruited during a one year period. Thirty six (20.2%) were positive by either solid or liquid culture. Direct ZN smear detected 22 of 36 cases and direct auramine smears detected 26 of 36 cases. Bleach and USP centrifugation detected 24 cases each, providing no incremental yield beyond direct smears. When compared to combined culture, pretreated smears were not more sensitive than direct smears (66.6% vs 61.1 (ZN) or 72.2 (auramine)), and were not more specific (92.3% vs 93.0 (ZN) or 97.2 (auramine). Conclusions/Significance: Short duration sputum pretreatment with bleach and USP centrifugation did not increase yield as compared to direct sputum smears. Further work is needed to confirm this in a larger study and also determine if longer duration pre-treatment might be effective in optimizing smear microscopy for TB.			Daley, P (corresponding author), Christian Med Coll Vellore, Dept Med, Vellore, Tamil Nadu, India.	madhukar.pai@mcgill.ca	Daley, Peter/J-8908-2017; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	Daley, Peter/0000-0001-7068-8056; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536	CIHR [89918] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Angeby KAK, 2004, INT J TUBERC LUNG D, V8, P806; Bonnet M, 2008, CLIN INFECT DIS, V46, P1710, DOI 10.1086/587891; Bossuyt PM, 2003, CLIN CHEM LAB MED, V41, P68, DOI 10.1515/CCLM.2003.012; Cattamanchi A, 2008, J CLIN MICROBIOL, V46, P3325, DOI 10.1128/JCM.01175-08; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P2703, DOI 10.1128/JCM.43.6.2703-2708.2005; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P2697, DOI 10.1128/JCM.43.6.2697-2702.2005; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P4357, DOI 10.1128/JCM.43.9.4357-4362.2005; den Hertog AL, 2009, INT J TUBERC LUNG D, V13, P466; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Frais S, 2001, INT ENDOD J, V34, P206, DOI 10.1046/j.1365-2591.2001.00371.x; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Lawson L, 2007, TUBERCULOSIS, V87, P368, DOI 10.1016/j.tube.2007.02.002; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Merid Y, 2009, INT J TUBERC LUNG D, V13, P136; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P509, DOI 10.1586/14737159.6.4.509; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2006, INT J TUBERC LUNG D, V10, P256; SIDDIQI SH, 1984, AM REV RESPIR DIS, V130, P634; SLOSAREK M, 1977, J HYG EPID MICROB IM, V21, P7; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; Warren JR, 2000, AM J RESP CRIT CARE, V161, P1559, DOI 10.1164/ajrccm.161.5.9908063; *WHO, 2005, IMPR DIAGN TUB OPT S; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2006, GLOB PLAN STOP TB 20	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5626	10.1371/journal.pone.0005626	http://dx.doi.org/10.1371/journal.pone.0005626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461963	gold, Green Published, Green Submitted			2022-12-27	WOS:000266234700013
J	Watson, A; Ramirez, CV; Salud, E				Watson, Andrew; Ramirez, Cesar V.; Salud, Ellen			Predicting Visibility of Aircraft	PLOS ONE			English	Article							CONTRAST-SENSITIVITY; VISION RESEARCH; PERFORMANCE; QUEST	Visual detection of aircraft by human observers is an important element of aviation safety. To assess and ensure safety, it would be useful to be able to be able to predict the visibility, to a human observer, of an aircraft of specified size, shape, distance, and coloration. Examples include assuring safe separation among aircraft and between aircraft and unmanned vehicles, design of airport control towers, and efforts to enhance or suppress the visibility of military and rescue vehicles. We have recently developed a simple metric of pattern visibility, the Spatial Standard Observer (SSO). In this report we examine whether the SSO can predict visibility of simulated aircraft images. We constructed a set of aircraft images from three-dimensional computer graphic models, and measured the luminance contrast threshold for each image from three human observers. The data were well predicted by the SSO. Finally, we show how to use the SSO to predict visibility range for aircraft of arbitrary size, shape, distance, and coloration.			Watson, A (corresponding author), NASA, Ames Res Ctr, Moffett Field, VA USA.	Andrew.b.watson@nasa.gov						Ahumada A., 2007, J VISION, V7, P337, DOI [10.1167/7.9.337, DOI 10.1167/7.9.337]; Andrews J.W., 1977, AIR TO AIR VISUAL AC; ANDREWS JW, 1991, UNALERTED AIR TO AIR; Carney T, 2000, P SOC PHOTO-OPT INS, V3959, P140, DOI 10.1117/12.387150; COLVIN K, 2005, P 13 INT S AV, V13, P104; DUNTLEY SQ, 1964, APPL OPTICS, V3, P549, DOI 10.1364/AO.3.000549; Ginsburg A. P., 1983, Proceedings of the Human Factors Society 27th Annual Meeting, P269; GINSBURG AP, 1982, AM J OPTOM PHYS OPT, V59, P105; GRAHAM W, 1970, PR INST ELECTR ELECT, V58, P337, DOI 10.1109/PROC.1970.7639; HARRIS JL, 1973, VISUAL ASPECTS AIR C, P26; Howell W.D., 1957, DETERMINATION DAYTIM; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; ROHALY AM, 1993, J OPT SOC AM A, V10, P1591, DOI 10.1364/JOSAA.10.001591; Rosenkrans W., 2008, AEROSAFETY WORLD, P34; Vollmerhausen RH, 2004, OPT ENG, V43, P2806, DOI 10.1117/1.1799111; Watson AB, 1999, PERCEPTION, V28, P45; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Watson AB, 2005, J VISION, V5, P717, DOI 10.1167/5.9.6; Watson AB, 2005, PROC SPIE, V5666, P1, DOI 10.1117/12.601935; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; WATSON AB, 1986, BEHAV RES METH INSTR, V18, P587, DOI 10.3758/BF03201433; Watson AB, 1997, SPATIAL VISION, V10, P447, DOI 10.1163/156856897X00384; WATSON AB, 2000, SHOWTIME WEB SITE; Watson AB, 2008, J VISION, V8, DOI 10.1167/8.4.17; Wolfram S., 2003, MATH BOOK	25	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5594	10.1371/journal.pone.0005594	http://dx.doi.org/10.1371/journal.pone.0005594			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19462007	Green Published, gold, Green Submitted			2022-12-27	WOS:000266234700007
J	Al-Balas, Q; Anthony, NG; Al-Jaidi, B; Alnimr, A; Abbott, G; Brown, AK; Taylor, RC; Besra, GS; McHugh, TD; Gillespie, SH; Johnston, BF; Mackay, SP; Coxon, GD				Al-Balas, Qosay; Anthony, Nahoum G.; Al-Jaidi, Bilal; Alnimr, Amani; Abbott, Grainne; Brown, Alistair K.; Taylor, Rebecca C.; Besra, Gurdyal S.; McHugh, Timothy D.; Gillespie, Stephen H.; Johnston, Blair F.; Mackay, Simon P.; Coxon, Geoffrey D.			Identification of 2-Aminothiazole-4-Carboxylate Derivatives Active against Mycobacterium tuberculosis H37Rv and the beta-Ketoacyl-ACP Synthase mtFabH	PLOS ONE			English	Article								Background: Tuberculosis (TB) is a disease which kills two million people every year and infects approximately over one-third of the world's population. The difficulty in managing tuberculosis is the prolonged treatment duration, the emergence of drug resistance and co-infection with HIV/AIDS. Tuberculosis control requires new drugs that act at novel drug targets to help combat resistant forms of Mycobacterium tuberculosis and reduce treatment duration. Methodology/Principal Findings: Our approach was to modify the naturally occurring and synthetically challenging antibiotic thiolactomycin (TLM) to the more tractable 2-aminothiazole-4-carboxylate scaffold to generate compounds that mimic TLM's novel mode of action. We report here the identification of a series of compounds possessing excellent activity against M. tuberculosis H37Rv and, dissociatively, against the beta-ketoacyl synthase enzyme mtFabH which is targeted by TLM. Specifically, methyl 2-amino-5-benzylthiazole-4-carboxylate was found to inhibit M. tuberculosis H37Rv with an MIC of 0.06 mu g/ml (240 nM), but showed no activity against mtFabH, whereas methyl 2-(2-bromoacetamido)-5-(3-chlorophenyl)thiazole-4-carboxylate inhibited mtFabH with an IC50 of 0.95 +/- 0.05 mu g/ml (2.43 +/- 0.13 mu M) but was not active against the whole cell organism. Conclusions/Significance: These findings clearly identify the 2-aminothiazole-4-carboxylate scaffold as a promising new template towards the discovery of a new class of anti-tubercular agents.			Al-Balas, Q (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	geoff.coxon@strath.ac.uk	McHugh, Timothy D/AAF-7231-2020; Alnimr, Amani/AAJ-3067-2020; Alnimr, Amani/A-4531-2015; Al-Balas, Qosay/AAG-4877-2020; Anthony, Nahoum/G-5121-2011; Johnston, Blair/X-3569-2019; McHugh, Timothy/O-3683-2019	McHugh, Timothy D/0000-0003-4658-8594; Johnston, Blair/0000-0001-9785-6822; Besra, Gurdyal/0000-0002-5605-0395; , Amani/0000-0001-5105-6002	Medical Research Council [G0802079, G0500590] Funding Source: Medline; MRC [G0802079, G0500590] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashek A, 2006, BIOORGAN MED CHEM, V14, P1474, DOI 10.1016/j.bmc.2005.10.001; BARTON A, 1982, J CHEM SOC PERK T 1, P159, DOI 10.1039/p19820000159; Bhowruth V, 2007, BIOORG MED CHEM LETT, V17, P5643, DOI 10.1016/j.bmcl.2007.07.082; Bloom BR, 1998, NEW ENGL J MED, V338, P677, DOI 10.1056/NEJM199803053381008; Brown AK, 2005, J BIOL CHEM, V280, P32539, DOI 10.1074/jbc.M413216200; Choi KH, 2000, J BIOL CHEM, V275, P28201; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kamal A, 2005, BIOORG MED CHEM LETT, V15, P1927, DOI 10.1016/j.bmcl.2005.01.084; Kim P, 2006, J MED CHEM, V49, P159, DOI 10.1021/jm050825p; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; KREMER L, 2000, GENETICS MYCOLIC ACI; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitchison DA, 2004, FRONT BIOSCI-LANDMRK, V9, P1059, DOI 10.2741/1293; NOTO T, 1982, J ANTIBIOT, V35, P401, DOI 10.7164/antibiotics.35.401; OISHI H, 1982, J ANTIBIOT, V35, P391, DOI 10.7164/antibiotics.35.391; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; SELWYN PA, 1992, JAMA-J AM MED ASSOC, V268, P504, DOI 10.1001/jama.268.4.504; Senior SJ, 2004, BIOORG MED CHEM LETT, V14, P373, DOI 10.1016/j.bmcl.2003.10.061; Senior SJ, 2003, BIOORG MED CHEM LETT, V13, P3685, DOI 10.1016/j.bmcl.2003.08.015; Slayden RA, 1996, ANTIMICROB AGENTS CH, V40, P2813, DOI 10.1128/AAC.40.12.2813; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630	29	43	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5617	10.1371/journal.pone.0005617	http://dx.doi.org/10.1371/journal.pone.0005617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440303	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000266161200017
J	Hughes, JN; Washington, JM; Zheng, ZQ; Lau, XWK; Yap, C; Rathjen, PD; Rathjen, J				Hughes, James N.; Washington, Jennifer M.; Zheng, Zhiqiang; Lau, Xiuwen K.; Yap, Charlotte; Rathjen, Peter D.; Rathjen, Joy			Manipulation of Cell:Cell Contacts and Mesoderm Suppressing Activity Direct Lineage Choice from Pluripotent Primitive Ectoderm-Like Cells in Culture	PLOS ONE			English	Article								In the mammal, the pluripotent cells of embryo differentiate and commit to either the mesoderm/endoderm lineages or the ectoderm lineage during gastrulation. In culture, the ability to direct lineage choice from pluripotent cells into the mesoderm/endoderm or ectoderm lineages will enable the development of technologies for the formation of highly enriched or homogenous populations of cells. Here we show that manipulation of cell: cell contact and a mesoderm suppressing activity in culture affects the outcome of pluripotent cell differentiation and when both variables are manipulated appropriately they can direct differentiation to either the mesoderm or ectoderm lineage. The disruption of cell: cell contacts and removal of a mesoderm suppressor activity results in the differentiation of pluripotent, primitive ectoderm-like cells to the mesoderm lineage, while maintenance of cell: cell contacts and inclusion, within the culture medium, of a mesoderm suppressing activity results in the formation of near homogenous populations of ectoderm. Understanding the contribution of these variables in lineage choice provides a framework for the development of directed differentiation protocols that result in the formation of specific cell populations from pluripotent cells in culture.			Hughes, JN (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	jrathjen@unimelb.edu.au	Washington, Jennifer/C-1199-2008	, Jennifer/0000-0002-5551-9913; Zheng, Zhiqiang/0000-0003-1028-3246				Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; CONLON FL, 1994, DEVELOPMENT, V120, P1919; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DICKSON MC, 1993, DEVELOPMENT, V117, P625; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Edgar D, 2004, PEDIATR SURG INT, V20, P737, DOI 10.1007/s00383-004-1288-2; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fu YX, 2003, BIOCHEM BIOPH RES CO, V310, P391, DOI 10.1016/j.bbrc.2003.09.021; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; JOHANSSON MW, 1995, TECHNIQUES FISH IMMU, V4, P141; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Lake JA, 2000, J CELL SCI, V113, P555; Larue L, 1996, DEVELOPMENT, V122, P3185; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; NIETO MA, 1992, DEVELOPMENT, V116, P227; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Pappano WN, 1998, GENOMICS, V52, P236, DOI 10.1006/geno.1998.5474; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Pelton TA, 2002, J CELL SCI, V115, P329; Pelton TA, 1998, REPROD FERT DEVELOP, V10, P535, DOI 10.1071/RD98084; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Rathjen J, 1999, J CELL SCI, V112, P601; Rathjen J, 2003, METHOD ENZYMOL, V365, P3; Rathjen J, 2003, BIOL REPROD, V69, P1863, DOI 10.1095/biolreprod.103.017384; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Rathjen J, 2001, REPROD FERT DEVELOP, V13, P15, DOI 10.1071/RD00079; Rathjen J, 2001, CURR OPIN GENET DEV, V11, P587, DOI 10.1016/S0959-437X(00)00237-9; Rodda SJ, 2002, INT J DEV BIOL, V46, P449; Rozen S, 2000, Methods Mol Biol, V132, P365; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; SMITH DE, 1992, DEVELOPMENT, V116, P1033; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 2004, CURR BIOL, V14, pR239, DOI 10.1016/j.cub.2004.02.056; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5579	10.1371/journal.pone.0005579	http://dx.doi.org/10.1371/journal.pone.0005579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440553	Green Published, gold			2022-12-27	WOS:000266107500010
J	Heinemann, L; Kleinschmidt, A; Muller, NG				Heinemann, Linda; Kleinschmidt, Andreas; Mueller, Notger G.			Exploring BOLD Changes during Spatial Attention in Non-Stimulated Visual Cortex	PLOS ONE			English	Article								Blood oxygen level-dependent (BOLD) responses were measured in parts of primary visual cortex that represented unstimulated visual field regions at different distances from a stimulated central target location. The composition of the visual scene varied by the presence or absence of additional peripheral distracter stimuli. Bottom-up effects were assessed by comparing peripheral activity during central stimulation vs. no stimulation. Top-down effects were assessed by comparing active vs. passive conditions. In passive conditions subjects simply watched the central letter stimuli and in active conditions they had to report occurrence of pre-defined targets in a rapid serial letter stream. Onset of the central letter stream enhanced activity in V1 representations of the stimulated region. Within representations of the periphery activation decreased and finally turned into deactivation with increasing distance from the stimulated location. This pattern was most pronounced in the active conditions and during the presence of peripheral stimuli. Active search for a target did not lead to additional enhancement at areas representing the attentional focus but to a stronger deactivation in the vicinity. Suppressed neuronal activity was also found in the non distracter condition suggesting a top-down attention driven effect. Our observations suggest that BOLD signal decreases in primary visual cortex are modulated by bottom-up sensory-driven factors such as the presence of distracters in the visual field as well as by top-down attentional processes.			Heinemann, L (corresponding author), Univ Frankfurt, Neurol Clin, Cognit Neurol Unit, Frankfurt, Germany.	heinemann@med.uni-frankfurt.de		Mueller, Notger/0000-0002-5483-6423				Baier B, 2006, J NEUROSCI, V26, P12260, DOI 10.1523/JNEUROSCI.1457-06.2006; Beard BL, 1997, VISION RES, V37, P325, DOI 10.1016/S0042-6989(96)00109-5; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Bressler D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000410; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Hopf JM, 2006, P NATL ACAD SCI USA, V103, P1053, DOI 10.1073/pnas.0507746103; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller NG, 2008, NEUROIMAGE, V40, P818, DOI 10.1016/j.neuroimage.2007.11.060; Muller NG, 2005, VISION RES, V45, P1129, DOI 10.1016/j.visres.2004.11.003; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Ohtani Y, 2002, VISION RES, V42, P1825, DOI 10.1016/S0042-6989(02)00103-7; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Slotnick SD, 2001, CLIN NEUROPHYSIOL, V112, P1349, DOI 10.1016/S1388-2457(01)00561-2; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Vanduffel W, 2000, CEREB CORTEX, V10, P109, DOI 10.1093/cercor/10.2.109	28	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5560	10.1371/journal.pone.0005560	http://dx.doi.org/10.1371/journal.pone.0005560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440362	Green Published, gold			2022-12-27	WOS:000266107400004
J	Zochowska, M; Paca, A; Schoehn, G; Andrieu, JP; Chroboczek, J; Dublet, B; Szolajska, E				Zochowska, Monika; Paca, Agnieszka; Schoehn, Guy; Andrieu, Jean-Pierre; Chroboczek, Jadwiga; Dublet, Bernard; Szolajska, Ewa			Adenovirus Dodecahedron, as a Drug Delivery Vector	PLOS ONE			English	Article								Background: Bleomycin (BLM) is an anticancer antibiotic used in many cancer regimens. Its utility is limited by systemic toxicity and dose-dependent pneumonitis able to progress to lung fibrosis. The latter can affect up to nearly 50% of the total patient population, out of which 3% will die. We propose to improve BLM delivery by tethering it to an efficient delivery vector. Adenovirus (Ad) dodecahedron base (DB) is a particulate vector composed of 12 copies of a pentameric viral protein responsible for virus penetration. The vector efficiently penetrates the plasma membrane, is liberated in the cytoplasmand has a propensity to concentrate around the nucleus; up to 300000 particles can be observed in one cell in vitro. Principal Findings: Dodecahedron (Dd) structure is preserved at up to about 50 degrees C at pH 7-8 and during dialysis, freezing and drying in the speed-vac in the presence of 150 mM ammonium sulfate, as well as during lyophilization in the presence of cryoprotectants. The vector is also stable in human serum for 2 h at 37 degrees C. We prepared a Dd-BLM conjugate which upon penetration induced death of transformed cells. Similarly to free bleomycin, Dd-BLM caused dsDNA breaks. Significantly, effective cytotoxic concentration of BLM delivered with Dd was 100 times lower than that of free bleomycin. Conclusions/Significance: Stability studies show that Dds can be conveniently stored and transported, and can potentially be used for therapeutic purposes under various climates. Successful BLM delivery by Ad Dds demonstrates that the use of virus like particle (VLP) results in significantly improved drug bioavailability. These experiments open new vistas for delivery of non-permeant labile drugs.			Zochowska, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	wisia@ibs.fr; ewasz@ibb.waw.pl	Chroboczek, Jadwiga/M-6554-2014	Szolajska, Ewa/0000-0002-7400-4333; Schoehn, Guy/0000-0002-1459-3201; Zochowska, Monika/0000-0002-3824-4962	PHS HHS [2P04B02329] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arndt D, 2001, DRUG DELIV, V8, P1; Balakireva L, 2003, J VIROL, V77, P4858, DOI 10.1128/JVI.77.8.4858-4866.2003; Berg K, 2005, CLIN CANCER RES, V11, P8476, DOI 10.1158/1078-0432.CCR-05-1245; BRADY JN, 1977, J VIROL, V23, P717, DOI 10.1128/JVI.23.3.717-724.1977; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Chen PL, 2001, FEBS LETT, V500, P109, DOI 10.1016/S0014-5793(01)02598-4; Cobbold SP, 2006, IMMUNOL REV, V213, P239, DOI 10.1111/j.1600-065X.2006.00428.x; DEMARCQ C, 1994, CELL GROWTH DIFFER, V5, P983; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2005, VIROLOGY, V340, P167, DOI 10.1016/j.virol.2005.06.030; Fender P, 2008, VIROLOGY, V371, P155, DOI 10.1016/j.virol.2007.09.026; GABIZON A, 1990, CANCER RES, V50, P6371; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Garcel A, 2006, J GENE MED, V8, P524, DOI 10.1002/jgm.862; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; HECHT SM, 1994, BIOCONJUGATE CHEM, V5, P513, DOI 10.1021/bc00030a006; Horiuchi A, 2000, INT J CANCER, V88, P640, DOI 10.1002/1097-0215(20001115)88:4<640::AID-IJC19>3.0.CO;2-K; Ishizu KI, 2001, J VIROL, V75, P61, DOI 10.1128/JVI.75.1.61-72.2001; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Larkin JO, 2008, ULTRASOUND MED BIOL, V34, P406, DOI 10.1016/j.ultrasmedbio.2007.09.005; LEHANE DE, 1975, CANCER RES, V35, P2724; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Li TC, 2003, VIROLOGY, V311, P115, DOI 10.1016/S0042-6822(03)00141-7; LOCK RB, 1994, CANCER RES, V54, P4933; Lock RB, 1996, CANCER RES, V56, P4006; McCarthy MP, 1998, J VIROL, V72, P32, DOI 10.1128/JVI.72.1.32-41.1998; Mir LM, 1996, GEN PHARMACOL-VASC S, V27, P745, DOI 10.1016/0306-3623(95)02101-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; NORRBY E, 1968, J GEN VIROL, V2, P135, DOI 10.1099/0022-1317-2-1-135; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; PODDEVIN B, 1991, BIOCHEM PHARMACOL, V42, pS67, DOI 10.1016/0006-2952(91)90394-K; Pron G, 1999, BIOCHEM PHARMACOL, V57, P45, DOI 10.1016/S0006-2952(98)00282-2; Puig PE, 2008, CELL BIOL INT, V32, P1031, DOI 10.1016/j.cellbi.2008.04.021; Rexroad J, 2006, J PHARM SCI-US, V95, P237, DOI 10.1002/jps.20496; SEBTI SM, 1991, CANCER RES, V51, P227; SEBTI SM, 1988, PHARMACOL THERAPEUT, V38, P321, DOI 10.1016/0163-7258(88)90009-5; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377; Sleijfer S, 2001, CHEST, V120, P617, DOI 10.1378/chest.120.2.617; SLIWINSKA MA, 2008, MECH AGEING DEV; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Sonoda S, 2007, CANCER BIOL THER, V6, P1276; TAKESHITA M, 1978, P NATL ACAD SCI USA, V75, P5983, DOI 10.1073/pnas.75.12.5983; Vives RR, 2004, VIROLOGY, V321, P332, DOI 10.1016/j.virol.2004.01.015; Wang CG, 2008, INT J PHARMACEUT, V351, P219, DOI 10.1016/j.ijpharm.2007.09.045; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yanai H, 2002, BJU INT, V89, P438, DOI 10.1046/j.1464-4096.2001.01836.x; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	52	47	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5569	10.1371/journal.pone.0005569	http://dx.doi.org/10.1371/journal.pone.0005569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440379	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107400013
J	Wang, XJ; Zhang, DD				Wang, Xiao-Jun; Zhang, Donna D.			Ectodermal-Neural Cortex 1 Down-Regulates Nrf2 at the Translational Level	PLOS ONE			English	Article								The transcription factor Nrf2 is the master regulator of a cellular defense mechanism against environmental insults. The Nrf2-mediated antioxidant response is accomplished by the transcription of a battery of genes that encode phase II detoxifying enzymes, xenobiotic transporters, and antioxidants. Coordinated expression of these genes is critical in protecting cells from toxic and carcinogenic insults and in maintaining cellular redox homeostasis. Activation of the Nrf2 pathway is primarily controlled by Kelch-like ECH-associated protein 1 (Keap1), which is a molecular switch that turns on or off the Nrf2 signaling pathway according to intracellular redox conditions. Here we report our finding of a novel Nrf2 suppressor ectodermal-neural cortex 1 (ENC1), which is a BTB-Kelch protein and belongs to the same family as Keap1. Transient expression of ENC1 reduced steady-state levels of Nrf2 and its downstream gene expression. Although ENC1 interacted with Keap1 indirectly, the ENC1-mediated down-regulation of Nrf2 was independent of Keap1. The negative effect of ENC1 on Nrf2 was not due to a change in the stability of Nrf2 because neither proteasomal nor lysosomal inhibitors had any effects. Overexpression of ENC1 did not result in a change in the level of Nrf2 mRNA, rather, it caused a decrease in the rate of Nrf2 protein synthesis. These results demonstrate that ENC1 functions as a negative regulator of Nrf2 through suppressing Nrf2 protein translation, which adds another level of complexity in controlling the Nrf2 signaling pathway.			Wang, XJ (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	dzhang@pharmacy.arizona.edu	Zhang, Donna/B-1015-2012		NIEHS NIH HHS [ES015010, R01 ES015010, ES006694, P30 ES006694] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015010, P30ES006694] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Du Y, 2008, ENVIRON HEALTH PERSP, V116, P1154, DOI 10.1289/ehp.11464; Frohlich DA, 2008, ONCOGENE, V27, P4353, DOI 10.1038/onc.2008.79; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hammarsund M, 2004, HUM MOL GENET, V13, P2925, DOI 10.1093/hmg/ddh315; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hernandez MC, 1998, EXP CELL RES, V242, P470, DOI 10.1006/excr.1998.4109; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kim TA, 2000, GENE, V255, P105, DOI 10.1016/S0378-1119(00)00297-3; Kim TA, 1998, J CELL BIOL, V141, P553, DOI 10.1083/jcb.141.3.553; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Laezza F, 2008, NEUROPHARMACOLOGY, V55, P1131, DOI 10.1016/j.neuropharm.2008.07.021; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lefebvre S, 1998, HUM MOL GENET, V7, P1531, DOI 10.1093/hmg/7.10.1531; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Liang XQ, 2004, ONCOGENE, V23, P5890, DOI 10.1038/sj.onc.1207776; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; MEIJERMAN I, 2008, CANC TREAT REV; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Purdom-Dickinson SE, 2007, MOL PHARMACOL, V72, P1074, DOI 10.1124/mol.107.035360; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Seng S, 2009, ONCOGENE, V28, P378, DOI 10.1038/onc.2008.396; Seng S, 2007, CANCER RES, V67, P8596, DOI 10.1158/0008-5472.CAN-06-3785; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; SUN Z, 2009, MOL CELL BIOL; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhao L, 2000, J BIOL CHEM, V275, P16845, DOI 10.1074/jbc.275.22.16845; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	53	21	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5492	10.1371/journal.pone.0005492	http://dx.doi.org/10.1371/journal.pone.0005492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424503	Green Submitted, gold, Green Published			2022-12-27	WOS:000265933800020
J	Gatti, G; Maresca, G; Natoli, M; Florenzano, F; Nicolin, A; Felsani, A; D'Agnano, I				Gatti, Giuliana; Maresca, Giovanna; Natoli, Manuela; Florenzano, Fulvio; Nicolin, Angelo; Felsani, Armando; D'Agnano, Igea			Myc Prevents Apoptosis and Enhances Endoreduplication Induced by Paclitaxel	PLOS ONE			English	Article								Background: The role of the MYC oncogene in the apoptotic pathways is not fully understood. MYC has been reported to protect cells from apoptosis activation but also to sensitize cells to apoptotic stimuli. We have previously demonstrated that the down-regulation of Myc protein activates apoptosis in melanoma cells and increases the susceptibility of cells to various antitumoral treatments. Beyond the well-known role in the G1 -> S transition, MYC is also involved in the G2-M cell cycle phases regulation. Methodology/Principal Findings: In this study we have investigated how MYC could influence cell survival signalling during G2 and M phases. We used the microtubules damaging agent paclitaxel (PTX), to arrest the cells in the M phase, in a p53 mutated melanoma cell line with modulated Myc level and activity. An overexpression of Myc protein is able to increase endoreduplication favoring the survival of cells exposed to antimitotic poisoning. The PTX-induced endoreduplication is associated in Myc overexpressing cells with a reduced expression of MAD2, essential component of the molecular core of the spindle assembly checkpoint (SAC), indicating an impairment of this checkpoint. In addition, for the first time we have localized Myc protein at the spindle poles (centrosomes) during pro-metaphase in different cell lines. Conclusions: The presence of Myc at the poles during the prometaphase could be necessary for the Myc-mediated attenuation of the SAC and the subsequent induction of endoreduplication. In addition, our data strongly suggest that the use of taxane in antitumor therapeutic strategies should be rationally based on the molecular profile of the individual tumor by specifically analyzing Myc expression levels.			Gatti, G (corresponding author), Univ Milan, Dept Pharmacol, Milan, Italy.	armando.felsani@inmm.cnr.it; igea.dagnano@inmm.cnr.it	D'Agnano, Igea/AAR-7282-2020; Felsani, Armando/D-1784-2010	Felsani, Armando/0000-0001-8851-6295; D'Agnano, Igea/0000-0002-2646-9224; Gatti, Giuliana/0000-0001-8844-4543				Abal M, 2003, CURR CANCER DRUG TAR, V3, P193, DOI 10.2174/1568009033481967; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Asnaghi L, 2004, ONCOGENE, V23, P5781, DOI 10.1038/sj.onc.1207698; Ayala-Torres S, 1999, EXP CELL RES, V246, P193, DOI 10.1006/excr.1998.4308; Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Beckman RA, 2005, SEMIN CANCER BIOL, V15, P423, DOI 10.1016/j.semcancer.2005.06.007; Biroccio A, 2001, MOL PHARMACOL, V60, P174, DOI 10.1124/mol.60.1.174; Bucci B, 2005, CLIN CANCER RES, V11, P2756, DOI 10.1158/1078-0432.CCR-04-1582; Chow JM, 2008, EXP HEMATOL, V36, P140, DOI 10.1016/j.exphem.2007.10.004; Citro G, 1998, CANCER RES, V58, P283; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; CRESCENZI M, 1994, J CELL BIOL, V125, P1137, DOI 10.1083/jcb.125.5.1137; D'Agnano I, 2001, ONCOGENE, V20, P2814, DOI 10.1038/sj.onc.1204392; D'Agnano I, 2007, J CELL PHYSIOL, V210, P72, DOI 10.1002/jcp.20810; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Greco C, 2006, INT J IMMUNOPATH PH, V19, P67; HANSON KD, 1994, MOL CELL BIOL, V14, P5748, DOI 10.1128/MCB.14.9.5748; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; LEVY N, 1993, MOL CELL BIOL, V13, P7942, DOI 10.1128/MCB.13.12.7942; Li Q, 1999, MOL CELL BIOL, V19, P5339; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Ryan KM, 1996, BIOCHEM J, V314, P713, DOI 10.1042/bj3140713; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sheen JH, 2003, BRIT J CANCER, V89, P1479, DOI 10.1038/sj.bjc.6601307; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wade M, 2006, CURR TOP MICROBIOL, V302, P169; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298; Zhang P, 2006, J NEURO-ONCOL, V80, P123, DOI 10.1007/s11060-006-9172-7; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	52	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5442	10.1371/journal.pone.0005442	http://dx.doi.org/10.1371/journal.pone.0005442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421315	Green Published, Green Submitted, gold			2022-12-27	WOS:000265836900004
J	Haskell, DG; Adhikari, A				Haskell, David G.; Adhikari, Anupam			Darwin's Manufactory Hypothesis Is Confirmed and Predicts the Extinction Risk of Extant Birds	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; SPECIES RICHNESS; HIGHER TAXA; EVOLUTIONARY; DIVERSITY; AVES; DIVERGENCE; SURROGATES; PATTERNS; NUCLEAR	In the Origin of Species Darwin hypothesized that the "manufactory'' of species operates at different rates in different lineages and that the richness of taxonomic units is autocorrelated across levels of the taxonomic hierarchy. We confirm the manufactory hypothesis using a database of all the world's extant avian subspecies, species and genera. The hypothesis is confirmed both in correlations across all genera and in paired comparisons controlling for phylogeny. We also find that the modern risk of extinction, as measured by "Red List'' classifications, differs across the different categories of genera identified by Darwin. Specifically, species in "manufactory'' genera are less likely to be threatened, endangered or recently extinct than are "weak manufactory'' genera. Therefore, although Darwin used his hypothesis to investigate past evolutionary processes, we find that the hypothesis also foreshadows future changes to the evolutionary tree.			Haskell, DG (corresponding author), Univ South, Dept Biol, Sewanee, TN 37375 USA.	dhaskell@sewanee.edu		Haskell, David G./0000-0003-1580-9438				Baillie J.E.M., 2004, IUCN RED LIST THREAT; Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; Baldi A, 2003, BASIC APPL ECOL, V4, P589, DOI 10.1078/1439-1791-00193; Benz BW, 2006, MOL PHYLOGENET EVOL, V40, P389, DOI 10.1016/j.ympev.2006.02.021; Cade B.S., 2005, USER MANUAL BLOSSOM; Cardillo M, 2003, ANIM CONSERV, V6, P63, DOI 10.1017/S1367943003003093; Darwin C, 1859, ORIGIN SPECIES MEANS; Dickinson EC., 2003, HOWARD MOORE COMPLET; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Griffiths CS, 2007, J AVIAN BIOL, V38, P587, DOI 10.1111/j.2007.0908-8857.03971.x; Heino J, 2007, BIOL CONSERV, V137, P78, DOI 10.1016/j.biocon.2007.01.017; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Keller RA, 2003, BOT REV, V69, P93, DOI 10.1663/0006-8101(2003)069[0093:TIBOPN]2.0.CO;2; Kotiaho JS, 2005, P NATL ACAD SCI USA, V102, P1963, DOI 10.1073/pnas.0406718102; Lerner HRL, 2008, AUK, V125, P304, DOI 10.1525/auk.2008.06161; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Lovette IJ, 2002, AUK, V119, P695, DOI 10.1642/0004-8038(2002)119[0695:WIAWWM]2.0.CO;2; Lovette IJ, 2007, MOL PHYLOGENET EVOL, V44, P1031, DOI 10.1016/j.ympev.2007.03.017; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mielke P. W., 2001, PERMUTATION METHODS; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Nee S, 2005, CONSERV BIOL SER, V8, P387; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Ohlson JI, 2007, MOL PHYLOGENET EVOL, V42, P25, DOI 10.1016/j.ympev.2006.05.041; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Phillimore AB, 2007, EVOLUTION, V61, P942, DOI 10.1111/j.1558-5646.2007.00068.x; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Schuh RT, 2003, BOT REV, V69, P59, DOI 10.1663/0006-8101(2003)069[0059:TLSAIY]2.0.CO;2; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2006, EVOLUTION, V60, P842; Wlodarska-Kowalczuk M, 2007, MAR ECOL PROG SER, V351, P53, DOI 10.3354/meps07127; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	43	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5460	10.1371/journal.pone.0005460	http://dx.doi.org/10.1371/journal.pone.0005460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421332	Green Published, Green Submitted, gold			2022-12-27	WOS:000265836900015
J	Bais, M; McLean, J; Sebastiani, P; Young, M; Wigner, N; Smith, T; Kotton, DN; Einhorn, TA; Gerstenfeld, LC				Bais, Manish; McLean, Jody; Sebastiani, Paola; Young, Megan; Wigner, Nathan; Smith, Temple; Kotton, Darrell N.; Einhorn, Thomas A.; Gerstenfeld, Louis C.			Transcriptional Analysis of Fracture Healing and the Induction of Embryonic Stem Cell-Related Genes	PLOS ONE			English	Article							SINGLE PERCUTANEOUS INJECTION; BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST-GROWTH-FACTOR; TEMPORAL EXPRESSION; TNF-ALPHA; MARROW; DIFFERENTIATION; ADULT; CHONDROGENESIS; SPECIFICATION	Fractures are among the most common human traumas. Fracture healing represents a unique temporarily definable postnatal process in which to study the complex interactions of multiple molecular events that regulate endochondral skeletal tissue formation. Because of the regenerative nature of fracture healing, it is hypothesized that large numbers of post-natal stem cells are recruited and contribute to formation of the multiple cell lineages that contribute to this process. Bayesian modeling was used to generate the temporal profiles of the transcriptome during fracture healing. The temporal relationships between ontologies that are associated with various biologic, metabolic, and regulatory pathways were identified and related to developmental processes associated with skeletogenesis, vasculogenesis, and neurogenesis. The complement of all the expressed BMPs, Wnts, FGFs, and their receptors were related to the subsets of transcription factors that were concurrently expressed during fracture healing. We further defined during fracture healing the temporal patterns of expression for 174 of the 193 genes known to be associated with human genetic skeletal disorders. In order to identify the common regulatory features that might be present in stem cells that are recruited during fracture healing to other types of stem cells, we queried the transcriptome of fracture healing against that seen in embryonic stem cells ( ESCs) and mesenchymal stem cells ( MSCs). Approximately 300 known genes that are preferentially expressed in ESCs and,350 of the known genes that are preferentially expressed in MSCs showed induction during fracture healing. Nanog, one of the central epigenetic regulators associated with ESC stem cell maintenance, was shown to be associated in multiple forms or bone repair as well as MSC differentiation. In summary, these data present the first temporal analysis of the transcriptome of an endochondral bone formation process that takes place during fracture healing. They show that neurogenesis as well as vasculogenesis are predominant components of skeletal tissue formation and suggest common pathways are shared between post-natal stem cells and those seen in ESCs.			Gerstenfeld, LC (corresponding author), Boston Univ, Sch Med, Orthopaed Res Lab, Boston, MA 02118 USA.	lgersten@bu.edu		/0000-0002-0477-1211; Kotton, Darrell/0000-0002-9604-8476; sebastiani, paola/0000-0001-6419-1545; Einhorn, Thomas/0000-0002-5075-4885; Bais, Manish/0000-0003-4198-7377	NIAMS NIH HHS [P01 AR049920, R01 AR044927, R29 AR044927, R56 AR044927, AR044927] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR044927, P01AR049920, R01AR044927, R29AR044927] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Buckwalter JA., 2001, ROCKWOOD GREENS FRAC, P245; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; CALVO W, 1969, AM J ANAT, V126, P355, DOI 10.1002/aja.1001260308; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chang WY, 2006, BIOCHEM CELL BIOL, V84, P257, DOI 10.1139/O06-036; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Chen YM, 2006, J BIOL CHEM, V281, P5726, DOI 10.1074/jbc.M510945200; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Denes A, 2005, NEUROSCIENCE, V134, P947, DOI 10.1016/j.neuroscience.2005.03.060; Desai BJ, 2003, J ORTHOP TRAUMA, V17, P689, DOI 10.1097/00005131-200311000-00005; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P1425, DOI 10.2106/00004623-200308000-00002; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Iversen PO, 2000, BLOOD, V96, P2081; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jepsen KJ, 2008, J BONE MINER RES, V23, P1204, DOI 10.1359/JBMR.080317; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kochupurakkal BS, 2008, BIOCHEM BIOPH RES CO, V365, P846, DOI 10.1016/j.bbrc.2007.11.073; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lehmann W, 2005, BONE, V36, P300, DOI 10.1016/j.bone.2004.10.010; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Maestroni GJM, 2000, ANN NY ACAD SCI, V917, P29; Meyer MH, 2007, J ORTHOP RES, V25, P488, DOI 10.1002/jor.20334; MICHALSKA AE, 2007, CURRENT PROTOCOLS ST; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakajima A, 2001, BONE, V29, P458, DOI 10.1016/S8756-3282(01)00604-4; Nakajima F, 2007, CALCIFIED TISSUE INT, V81, P132, DOI 10.1007/s00223-007-9048-7; NORK SE, 2006, ROCKWOOD GREENS FRAC, P1845; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Ota S, 2007, DEVELOPMENT, V134, P1583, DOI 10.1242/dev.000703; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Rundle CH, 2006, BONE, V38, P521, DOI 10.1016/j.bone.2005.09.015; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; SUVA LJ, 1993, J BONE MINER RES, V8, P379; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tabarowski Z, 1996, ACTA HISTOCHEM, V98, P453, DOI 10.1016/S0065-1281(96)80013-4; Takeda S, 2008, J NEUROENDOCRINOL, V20, P802, DOI 10.1111/j.1365-2826.2008.01732.x; Takeda S, 2008, BONE, V42, P837, DOI 10.1016/j.bone.2008.01.005; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Wang K, 2006, MATRIX BIOL, V25, P271, DOI 10.1016/j.matbio.2006.02.001; Wang L, 2006, LECT NOTES COMPUT SC, V3909, P60; Wang L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-147; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680	74	74	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5393	10.1371/journal.pone.0005393	http://dx.doi.org/10.1371/journal.pone.0005393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415118	gold, Green Published, Green Submitted			2022-12-27	WOS:000265836700004
J	Mehta, N; Trzmielina, S; Nonyane, BAS; Eliot, MN; Lin, RH; Foulkes, AS; McNeal, K; Ammann, A; Eulalievyolo, V; Sullivan, JL; Luzuriaga, K; Somasundaran, M; Somasundaran, M				Mehta, Nishaki; Trzmielina, Sonia; Nonyane, Bareng A. S.; Eliot, Melissa N.; Lin, Rongheng; Foulkes, Andrea S.; McNeal, Kristina; Ammann, Arthur; Eulalievyolo, Vindu; Sullivan, John L.; Luzuriaga, Katherine; Somasundaran, Mohan; Somasundaran, Mohan			Low-Cost HIV-1 Diagnosis and Quantification in Dried Blood Spots by Real Time PCR	PLOS ONE			English	Article								Background: Rapid and cost-effective methods for HIV-1 diagnosis and viral load monitoring would greatly enhance the clinical management of HIV-1 infected adults and children in limited-resource settings. Recent recommendations to treat perinatally infected infants within the first year of life are feasible only if early diagnosis is routinely available. Dried blood spots (DBS) on filter paper are an easy and convenient way to collect and transport blood samples. A rapid and cost effective method to diagnose and quantify HIV-1 from DBS is urgently needed to facilitate early diagnosis of HIV-1 infection and monitoring of antiretroviral therapy. Methods and Findings: We have developed a real-time LightCycler (rtLC) PCR assay to detect and quantify HIV-1 from DBS. HIV-1 RNA extracted from DBS was amplified in a one-step, single-tube system using primers specific for long-terminal repeat sequences that are conserved across all HIV-1 clades. SYBR Green dye was used to quantify PCR amplicons and HIV-1 RNA copy numbers were determined from a standard curve generated using serially diluted known copies of HIV-1 RNA. This assay detected samples across clades, has a dynamic range of 5 log(10), and %CV <8% up to 4 log(10) dilution. Plasma HIV-1 RNA copy numbers obtained using this method correlated well with the Roche Ultrasensitive (r=0.91) and branched DNA (r=0.89) assays. The lower limit of detection (95%) was estimated to be 136 copies. The rtLC DBS assay was 2.5 fold rapid as well as 40-fold cheaper when compared to commercial assays. Adaptation of the assay into other real-time systems demonstrated similar performance. Conclusions: The accuracy, reliability, genotype inclusivity and affordability, along with the small volumes of blood required for the assay suggest that the rtLC DBS assay will be useful for early diagnosis and monitoring of pediatric HIV-1 infection in resource-limited settings.			Mehta, N (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA.	mohan.somasundaran@umassmed.edu	Nonyane, Bareng A.S./AAC-8118-2020	Nonyane, Bareng A.S./0000-0001-5633-7487	NIAID NIH HHS [R01 AI032391, P30 AI042845, P30-AI042845, AI32391] Funding Source: Medline; NICHD NIH HHS [HD01489, K24 HD001489] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, R01AI032391] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvarez-Munoz MT, 2005, ARCH MED RES, V36, P382, DOI 10.1016/j.arcmed.2005.03.010; AMMANN A, 2007, EARLY DIAGNOSIS HIV; Bacon DJ, 2007, ANTIMICROB AGENTS CH, V51, P1172, DOI 10.1128/AAC.01313-06; Bertagnolio S, 2007, ANTIVIR THER, V12, P107; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Buckton AJ, 2008, J ANTIMICROB CHEMOTH, V62, P1191, DOI 10.1093/jac/dkn412; Buckton AJ, 2008, CURR OPIN INFECT DIS, V21, P653, DOI 10.1097/QCO.0b013e3283186d1a; Creek TL, 2007, AM J OBSTET GYNECOL, V197, pS64, DOI 10.1016/j.ajog.2007.03.002; Delamare C, 1997, J ACQ IMMUN DEF SYND, V15, P121, DOI 10.1097/00042560-199706010-00004; Driver GA, 2007, J VIROL METHODS, V146, P397, DOI 10.1016/j.jviromet.2007.07.024; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Escutenaire S, 2007, ARCH VIROL, V152, P41, DOI 10.1007/s00705-006-0840-x; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Fischer M, 1999, J CLIN MICROBIOL, V37, P1260, DOI 10.1128/JCM.37.5.1260-1264.1999; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Gomes-Ruiz AC, 2006, J MED VIROL, V78, P760, DOI 10.1002/jmv.20620; GUTHRIE R, 1980, NEONATAL SCREENING I, P259; Imlach S, 2001, J VIROL, V75, P11555, DOI 10.1128/JVI.75.23.11555-11564.2001; Jacob SM, 2008, INDIAN J MED MICROBI, V26, P71; Kane CT, 2008, J VIROL METHODS, V148, P291, DOI 10.1016/j.jviromet.2007.11.011; Karlsson H, 2003, CLIN CHEM, V49, P979, DOI 10.1373/49.6.979; Katz S, 2003, J AGING STUD, V17, P3, DOI 10.1016/S0890-4065(02)00086-5; KERR RJ, 2008, J CLIN MICROBIOL; Kuhn L, 1997, AIDS, V11, P429, DOI 10.1097/00002030-199704000-00005; Lambert JS, 2003, JAIDS-J ACQ IMM DEF, V34, P512, DOI 10.1097/00126334-200312150-00011; LEELAWIWAT W, 2008, J VIROL METHODS; Li CC, 2005, J CLIN MICROBIOL, V43, P3901, DOI 10.1128/JCM.43.8.3901-3905.2005; Luo W, 2005, J CLIN MICROBIOL, V43, P1851, DOI 10.1128/JCM.43.4.1851-1857.2005; Luzuriaga K, 2004, NEW ENGL J MED, V350, P2471, DOI 10.1056/NEJMoa032706; Luzuriaga K, 1997, NEW ENGL J MED, V336, P1343, DOI 10.1056/NEJM199705083361902; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mofenson LM, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.6.e88; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Mwaba P, 2003, LANCET, V362, P2067, DOI 10.1016/S0140-6736(03)15103-3; NGOGIANGHUONG N, 2008, J ACQUIR IMMUNE DEFI; Nielsen K, 2000, PEDIATR CLIN N AM, V47, P39, DOI 10.1016/S0031-3955(05)70194-2; *NIH, 1996, TECHN UT HIV BLOOD E, P17; O'Shea S, 1999, AIDS, V13, P630, DOI 10.1097/00002030-199904010-00019; Panther KU, 1999, POLISH STUD, V1, P37; Papin JF, 2004, J CLIN MICROBIOL, V42, P1511, DOI 10.1128/JCM.42.4.1511-1518.2004; *PATHF INT KEN PRE, 2007, EARL DIAGN HIV DRIED; Patton JC, 2008, CLIN VACCINE IMMUNOL, V15, P388, DOI 10.1128/CVI.00265-07; Patton JC, 2007, CLIN VACCINE IMMUNOL, V14, P201, DOI 10.1128/CVI.00223-06; Rason MA, 2008, T ROY SOC TROP MED H, V102, P346, DOI 10.1016/j.trstmh.2008.01.021; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rouet F, 2007, CLIN LAB, V53, P135; Saag MS, 1996, NAT MED, V2, P625, DOI 10.1038/nm0696-625; Santhosh SR, 2007, J CLIN VIROL, V39, P188, DOI 10.1016/j.jcv.2007.04.015; Scipioni A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-94; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; Steketee RW, 1997, J INFECT DIS, V175, P707, DOI 10.1093/infdis/175.3.707; Stevens W, 2008, J CLIN MICROBIOL, V46, P3941, DOI 10.1128/JCM.00754-08; Therrell BL, 1996, BIOCHEM MOL MED, V57, P116, DOI 10.1006/bmme.1996.0017; UNAIDS, 2007, AIDS EP UPD GLOB SUM; VIOLARI A, 2007, WESS103 ANTIRETROVIA; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Watanabe M, 2005, PEDIATR INT, V47, P286, DOI 10.1111/j.1442-200x.2005.02057.x; WHO Technical Reference Group, 2008, PAED HIV ART CAR GUI; Zhang Q, 2008, J CLIN MICROBIOL, V46, P721, DOI 10.1128/JCM.01539-07	65	36	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5819	10.1371/journal.pone.0005819	http://dx.doi.org/10.1371/journal.pone.0005819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503790	Green Accepted, Green Published, gold			2022-12-27	WOS:000266717200015
J	Gohli, J; Hogstedt, G				Gohli, Jostein; Hogstedt, Goran			Explaining the Evolution of Warning Coloration: Secreted Secondary Defence Chemicals May Facilitate the Evolution of Visual Aposematic Signals	PLOS ONE			English	Article								Several pathways have been postulated to explain the evolution of warning coloration, which is a perplexing phenomenon. Many of these attempt to circumvent the problem of naive predators by inferring kin selection or neophobia. Through a stochastic model, we show that a secreted secondary defence chemical can provide selective pressure, on the individual level, towards developing warning coloration. Our fundamental assumption is that increased conspicuousness will result in longer assessment periods and divergence from the predators' searching image, thus reducing the probability of a predator making mistakes. We conclude that strong olfactory signaling by means of chemical secretions can lead to the evolution of warning coloration.			Gohli, J (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	Jostein.Gohli@gmail.com	Gohli, Jostein/A-1145-2013					Cott H.B., 1940, ADAPTIVE COLORATION; EISNER T, 1981, SCIENCE, V213, P476, DOI 10.1126/science.7244647; Eisner T., 2005, SECRET WEAPONS DEFEN; Fisher RA, 1930, GENETICAL THEORY NAT; Gamberale-Stille G, 2000, ANIM BEHAV, V60, P95, DOI 10.1006/anbe.2000.1435; HARVEY PH, 1981, OIKOS, V37, P391, DOI 10.2307/3544135; HARVEY PH, 1982, AM NAT, V119, P710, DOI 10.1086/283944; Malakoff D, 1999, SCIENCE, V286, P704, DOI 10.1126/science.286.5440.704; Merilaita S, 2007, J THEOR BIOL, V245, P268, DOI 10.1016/j.jtbi.2006.10.022; Prudic KL, 2008, J CHEM ECOL, V34, P734, DOI 10.1007/s10886-008-9480-9; Rothschild M., 1961, Transactions of the Royal Entomological Society of London, V113, P101; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Rowe C, 1999, EVOL ECOL, V13, P655, DOI 10.1023/A:1011021630244; Skelhorn J, 2006, BIOL LETT-UK, V2, P348, DOI 10.1098/rsbl.2006.0483; Speed MP, 2005, EVOLUTION, V59, P2499; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; WALLACE AR, 1867, P ENT SOC LOND 4 MAR	17	13	13	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5779	10.1371/journal.pone.0005779	http://dx.doi.org/10.1371/journal.pone.0005779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492013	Green Published, Green Submitted, gold			2022-12-27	WOS:000266624300015
J	Lehmann, J; Cibils, M; Libchaber, A				Lehmann, Jean; Cibils, Michel; Libchaber, Albert			Emergence of a Code in the Polymerization of Amino Acids along RNA Templates	PLOS ONE			English	Article							GENETIC-CODE; SELF-ORGANIZATION; PROTEIN-SYNTHESIS; ORIGIN; RIBOSOME; EFFICIENCY; ENTROPY	The origin of the genetic code in the context of an RNA world is a major problem in the field of biophysical chemistry. In this paper, we describe how the polymerization of amino acids along RNA templates can be affected by the properties of both molecules. Considering a system without enzymes, in which the tRNAs (the translation adaptors) are not loaded selectively with amino acids, we show that an elementary translation governed by a Michaelis-Menten type of kinetics can follow different polymerization regimes: random polymerization, homopolymerization and coded polymerization. The regime under which the system is running is set by the relative concentrations of the amino acids and the kinetic constants involved. We point out that the coding regime can naturally occur under prebiotic conditions. It generates partially coded proteins through a mechanism which is remarkably robust against non-specific interactions (mismatches) between the adaptors and the RNA template. Features of the genetic code support the existence of this early translation system.			Lehmann, J (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	jlehmann@rockefeller.edu		Lehmann, Jean/0000-0002-9887-8123				Agmon F, 2005, BIOL CHEM, V386, P833, DOI 10.1515/BC.2005.098; Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; Armstrong AA, 2003, J AM CHEM SOC, V125, P14596, DOI 10.1021/ja0344359; Auffinger P, 2001, RNA, V7, P334, DOI 10.1017/S1355838201002382; BERG P, 1961, J BIOL CHEM, V236, P1726; Delarue M, 2007, RNA, V13, P161, DOI 10.1261/rna.257607; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P341, DOI 10.1007/BF00439699; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; GROSJEAN HJ, 1978, P NATL ACAD SCI USA, V75, P610, DOI 10.1073/pnas.75.2.610; Ikehara K, 2002, J MOL EVOL, V54, P530, DOI 10.1007/s00239-001-0053-6; Illangasekare M, 1999, RNA, V5, P1482, DOI 10.1017/S1355838299991264; Jung ME, 2005, CHEM REV, V105, P1735, DOI 10.1021/cr940337h; LACEY JC, 1992, ORIGINS LIFE EVOL B, V22, P243, DOI 10.1007/BF01810856; LACEY JC, 1983, ORIGINS LIFE EVOL B, V13, P3, DOI 10.1007/BF00928761; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Lehmann J, 2004, J THEOR BIOL, V227, P381, DOI 10.1016/j.jtbi.2003.11.015; Lehmann J, 2000, J THEOR BIOL, V202, P129, DOI 10.1006/jtbi.1999.1045; Lehmann J, 2007, RNA, V13, P1191, DOI 10.1261/rna.500907; Lightstone FC, 1996, J AM CHEM SOC, V118, P2595, DOI 10.1021/ja952589l; MATTHAEI JH, 1966, COLD SPRING HARB SYM, V31, P25, DOI 10.1101/SQB.1966.031.01.009; MILLER SL, 1987, COLD SPRING HARB SYM, V52, P17, DOI 10.1101/SQB.1987.052.01.005; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Olejniczak M, 2005, NAT STRUCT MOL BIOL, V12, P788, DOI 10.1038/nsmb978; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; TURNER DH, 1987, COLD SPRING HARB SYM, V52, P123, DOI 10.1101/SQB.1987.052.01.017; WOESE CR, 1966, P NATL ACAD SCI USA, V55, P966, DOI 10.1073/pnas.55.4.966; WOESE CR, 1965, P NATL ACAD SCI USA, V54, P71, DOI 10.1073/pnas.54.1.71	29	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5773	10.1371/journal.pone.0005773	http://dx.doi.org/10.1371/journal.pone.0005773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492048	Green Published, Green Submitted, gold			2022-12-27	WOS:000266624300010
J	Montero-Balaguer, M; Swirsding, K; Orsenigo, F; Cotelli, F; Mione, M; Dejana, E				Montero-Balaguer, Mercedes; Swirsding, Kendra; Orsenigo, Fabrizio; Cotelli, Franco; Mione, Marina; Dejana, Elisabetta			Stable Vascular Connections and Remodeling Require Full Expression of VE-Cadherin in Zebrafish Embryos	PLOS ONE			English	Article								Background: VE-cadherin is an endothelial specific, transmembrane protein, that clusters at adherens junctions where it promotes homotypic cell-cell adhesion. VE-cadherin null mutation in the mouse results in early fetal lethality due to altered vascular development. However, the mechanism of action of VE-cadherin is complex and, in the mouse embryo, it is difficult to define the specific steps of vascular development in which this protein is involved. Methodology and Principal Findings: In order to study the role VE-cadherin in the development of the vascular system in a more suitable model, we knocked down the expression of the coding gene in zebrafish. The novel findings reported here are: 1) partial reduction of VE-cadherin expression using low doses of morpholinos causes vascular fragility, head hemorrhages and increase in permeability; this has not been described before and suggests that the total amount of the protein expressed is an important determinant of vascular stability; 2) concentrations of morpholinos which abrogate VE-cadherin expression prevent vessels to establish successful reciprocal contacts and, as a consequence, vascular sprouting activity is not inhibited. This likely explains the observed vascular hyper-sprouting and the presence of several small, collapsing vessels; 3) the common cardinal vein lacks a correct connection with the endocardium leaving the heart separated from the rest of the circulatory system. The lack of closure of the circulatory loop has never been described before and may explain some downstream defects of the phenotype such as the lack of a correct vascular remodeling. Conclusions and Significance: Our observations identify several steps of vascular development in which VE-cadherin plays an essential role. While it does not appear to regulate vascular patterning it is implicated in vascular connection and inhibition of sprouting activity. These processes require stable cell-cell junctions which are defective in absence of VE-cadherin. Notably, also partial modifications in VE-cadherin expression prevent the formation of a stable vasculature. This suggests that partial internalization or change of function of this protein may strongly affect vascular stability and organization.			Montero-Balaguer, M (corresponding author), FIRC Inst Mol Oncol, Milan, Italy.	elisabetta.dejana@ifom-ieo-campus.it	Mione, Maria Caterina/I-3073-2013; Mione, Maria Caterina/ABG-9926-2021	DEJANA, ELISABETTA/0000-0002-0007-0426; Orsenigo, Fabrizio/0000-0001-9135-8478; Mione, Maria Caterina/0000-0002-9040-3705	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		ABRAHAM S, 2009, CURR BIOL IN PRESS; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Cha Young Ryun, 2007, Birth Defects Research, V81, P286, DOI 10.1002/bdrc.20103; Chico TJA, 2008, TRENDS CARDIOVAS MED, V18, P150, DOI 10.1016/j.tcm.2008.04.002; Crosby CV, 2005, BLOOD, V105, P2771, DOI 10.1182/blood-2004-06-2244; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; DEJANA E, 2009, DEV CELL IN PRESS; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu J, 2007, P NATL ACAD SCI USA, V104, P13990, DOI 10.1073/pnas.0700825104; Lundkvist Andrea, 2007, Novartis Found Symp, V283, P194; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Nyqvist D, 2008, EMBO REP, V9, P742, DOI 10.1038/embor.2008.123; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; THISSE C, 1993, DEVELOPMENT, V119, P1203; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Warga RM, 2007, DEV BIOL, V310, P211, DOI 10.1016/j.ydbio.2007.06.023; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005	45	89	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5772	10.1371/journal.pone.0005772	http://dx.doi.org/10.1371/journal.pone.0005772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19503615	Green Submitted, Green Published, gold			2022-12-27	WOS:000266624300009
J	Santos, AA; Carvalho, CM; Florentino, LH; Ramos, HJO; Fontes, EPB				Santos, Anesia A.; Carvalho, Claudine M.; Florentino, Lilian H.; Ramos, Humberto J. O.; Fontes, Elizabeth P. B.			Conserved Threonine Residues within the A-Loop of the Receptor NIK Differentially Regulate the Kinase Function Required for Antiviral Signaling	PLOS ONE			English	Article							NUCLEAR SHUTTLE PROTEIN; ACTIVATION-LOOP; CRYSTAL-STRUCTURE; GENE ENCODES; GEMINIVIRUS; INTERACTS; COMPLEX; DOMAIN; IDENTIFICATION; TRAFFICKING	NSP-interacting kinase (NIK1) is a receptor-like kinase identified as a virulence target of the begomovirus nuclear shuttle protein (NSP). We found that NIK1 undergoes a stepwise pattern of phosphorylation within its activation-loop domain (A-loop) with distinct roles for different threonine residues. Mutations at Thr-474 or Thr-468 impaired autophosphorylation and were defective for kinase activation. In contrast, a mutation at Thr-469 did not impact autophosphorylation and increased substrate phosphorylation, suggesting an inhibitory role for Thr-469 in kinase function. To dissect the functional significance of these results, we used NSP-expressing virus infection as a mechanism to interfere with wild type and mutant NIK1 action in plants. The NIK1 knockout mutant shows enhanced susceptibility to virus infections, a phenotype that could be complemented with ectopic expression of a 35S-NIK1 or 35S-T469A NIK1 transgenes. However, ectopic expression of an inactive kinase or the 35S-T474A NIK1 mutant did not reverse the enhanced susceptibility phenotype of knockout lines, demonstrating that Thr-474 autophosphorylation was needed to transduce a defense response to geminiviruses. Furthermore, mutations at Thr-474 and Thr-469 residues antagonistically affected NIK-mediated nuclear relocation of the downstream effector rpL10. These results establish that NIK1 functions as an authentic defense receptor as it requires activation to elicit a defense response. Our data also suggest a model whereby phosphorylation-dependent activation of a plant receptor-like kinase enables the A-loop to control differentially auto-and substrate phosphorylation.			Santos, AA (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol BIOAGRO, Vicosa, MG, Brazil.	bbfontes@ufv.br	Carvalho, Claudine/J-6347-2014; Fontes, Elizabeth/K-3159-2012	Fontes, Elizabeth/0000-0002-7986-1369; HASEGAWA FLORENTINO, LILIAN/0000-0002-5910-132X				Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Carvalho CM, 2008, PLANT SIGNAL BEHAV, V3, P752, DOI 10.4161/psb.3.9.6641; Carvalho CM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000247; Cascardo JCM, 2000, J BIOL CHEM, V275, P14494, DOI 10.1074/jbc.275.19.14494; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Costa MDL, 2008, J BIOL CHEM, V283, P20209, DOI 10.1074/jbc.M802654200; Delu-Filho N, 2000, PLANT PHYSIOL BIOCH, V38, P353, DOI 10.1016/S0981-9428(00)00752-X; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Florentino LH, 2006, J VIROL, V80, P6648, DOI 10.1128/JVI.00173-06; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Gafni Y, 2002, PHYSIOL MOL PLANT P, V60, P231, DOI 10.1006/pmpp.2002.0402; Galvao RM, 2003, J GEN VIROL, V84, P715, DOI 10.1099/vir.0.18783-0; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gong DM, 2002, J BIOL CHEM, V277, P28340, DOI 10.1074/jbc.M107719200; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; Jinn TL, 2000, GENE DEV, V14, P108; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lazarowitz SG, 1999, PLANT CELL, V11, P535, DOI 10.1105/tpc.11.4.535; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Mariano AC, 2004, VIROLOGY, V318, P24, DOI 10.1016/j.virol.2003.09.038; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; ORR JW, 1994, J BIOL CHEM, V269, P27715; Rocha CS, 2008, VIROLOGY, V380, P165, DOI 10.1016/j.virol.2008.08.005; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; ROJAS MR, 1993, PLANT DIS, V77, P340, DOI 10.1094/PD-77-0340; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Santos Anesia A., 2008, V451, P563, DOI 10.1007/978-1-59745-102-4_39; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Vanitharani R, 2005, TRENDS PLANT SCI, V10, P144, DOI 10.1016/j.tplants.2005.01.005; Wang H, 2005, J VIROL, V79, P7410, DOI 10.1128/JVI.79.12.7410-7418.2005; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhang XRS, 2006, J MOL EVOL, V63, P612, DOI 10.1007/s00239-005-0187-z; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	53	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5781	10.1371/journal.pone.0005781	http://dx.doi.org/10.1371/journal.pone.0005781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492062	Green Published, gold, Green Submitted			2022-12-27	WOS:000266624300017
J	Hirai, T; Subramaniam, S				Hirai, Teruhisa; Subramaniam, Sriram			Protein Conformational Changes in the Bacteriorhodopsin Photocycle: Comparison of Findings from Electron and X-Ray Crystallographic Analyses	PLOS ONE			English	Article							STRUCTURAL-CHANGES; PROTON TRANSLOCATION; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; PURPLE MEMBRANE; L-PHOTOINTERMEDIATE; EARLY INTERMEDIATE; K-INTERMEDIATE; N INTERMEDIATE; SCHIFF-BASE	Light-driven conformational changes in the membrane protein bacteriorhodopsin have been studied extensively using Xray and electron crystallography, resulting in the deposition of >30 sets of coordinates describing structural changes at various stages of proton transport. Using projection difference Fourier maps, we show that coordinates reported by different groups for the same photocycle intermediates vary considerably in the extent and nature of conformational changes. The different structures reported for the same intermediate cannot be reconciled in terms of differing extents of change on a single conformational trajectory. New measurements of image phases obtained by cryo-electron microscopy of the D96G/F171C/F219L triple mutant provide independent validation for the description of the large protein conformational change derived at 3.2 angstrom resolution by electron crystallography of 2D crystals, but do not support atomic models for light-driven conformational changes derived using X-ray crystallography of 3D crystals. Our findings suggest that independent determination of phase information from 2D crystals can be an important tool for testing the accuracy of atomic models for membrane protein conformational changes.			Hirai, T (corresponding author), RIKEN SPring 8 Ctr, Dimens Microscopy Res Team 3, Sayo, Hyogo, Japan.	thirai@spring8.or.jp; ss1@nih.gov	Hirai, Teruhisa/G-2105-2015	Hirai, Teruhisa/0000-0002-2114-8149; Subramaniam, Sriram/0000-0003-4231-4115	NATIONAL CANCER INSTITUTE [ZIABC010826, ZIABC010824, ZIABC010825, Z01BC010824, ZIABC010278] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; BROWN LS, 1994, BIOCHEMISTRY-US, V33, P12001, DOI 10.1021/bi00206a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulllough PA, 1999, J MOL BIOL, V286, P1663, DOI 10.1006/jmbi.1999.2570; Cartailler JP, 2003, ANNU REV BIOPH BIOM, V32, P285, DOI 10.1146/annurev.biophys.32.110601.142516; CESKA TA, 1990, J MOL BIOL, V213, P539, DOI 10.1016/S0022-2836(05)80214-1; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DENCHER NA, 1989, P NATL ACAD SCI USA, V86, P7876, DOI 10.1073/pnas.86.20.7876; Ebrey T.G., 1993, THERMODYNAMICS MEMBR, P353; Edman K, 2004, J BIOL CHEM, V279, P2147, DOI 10.1074/jbc.M300709200; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; Facciotti MT, 2001, BIOPHYS J, V81, P3442, DOI 10.1016/S0006-3495(01)75976-0; Faruqi AR, 2000, Q REV BIOPHYS, V33, P1, DOI 10.1017/S0033583500003577; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; HAYWARD SB, 1979, ULTRAMICROSCOPY, V4, P201, DOI 10.1016/S0304-3991(79)90211-0; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Hirai T, 2003, FEBS LETT, V545, P2, DOI 10.1016/S0014-5793(03)00386-7; Kamikubo H, 1997, BIOCHEMISTRY-US, V36, P12282, DOI 10.1021/bi9712302; Kamikubo H, 1996, P NATL ACAD SCI USA, V93, P1386, DOI 10.1073/pnas.93.4.1386; KHORANA HG, 1988, J BIOL CHEM, V263, P7439; Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323; Kleywegt GJ, 1994, CCP4 ESF EACBM NEWSL, P9; KOCH MHJ, 1991, EMBO J, V10, P521, DOI 10.1002/j.1460-2075.1991.tb07978.x; Kouyama T, 2004, J MOL BIOL, V335, P531, DOI 10.1016/j.jmb.2003.10.068; Lanyi JK, 2007, J MOL BIOL, V365, P1379, DOI 10.1016/j.jmb.2006.11.016; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lanyi JK, 2004, BBA-BIOENERGETICS, V1658, P14, DOI 10.1016/j.bbabio.2004.03.018; Lanyi JK, 2004, BIOCHEMISTRY-US, V43, P3, DOI 10.1021/bi035843s; Lanyi JK, 2003, J MOL BIOL, V328, P439, DOI 10.1016/S0022-2836(03)00263-8; Lanyi JK, 2002, J MOL BIOL, V321, P727, DOI 10.1016/S0022-2836(02)00682-4; LANYI JK, 1993, BIOCHIM BIOPHYS ACTA, V1183, P241, DOI 10.1016/0005-2728(93)90226-6; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; NAKASAKO M, 1991, FEBS LETT, V292, P73, DOI 10.1016/0014-5793(91)80837-S; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Oka T, 1999, BIOPHYS J, V76, P1018, DOI 10.1016/S0006-3495(99)77266-8; Okumura H, 2005, J MOL BIOL, V351, P481, DOI 10.1016/j.jmb.2005.06.026; Radzwill N, 2001, BIOPHYS J, V80, P2856, DOI 10.1016/S0006-3495(01)76252-2; Rouhani S, 2001, J MOL BIOL, V313, P615, DOI 10.1006/jmbi.2001.5066; Royant A, 2000, NATURE, V406, P645, DOI 10.1038/35020599; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Schobert B, 2003, J MOL BIOL, V330, P553, DOI 10.1016/S0022-2836(03)00576-X; Schobert B, 2002, J MOL BIOL, V321, P715, DOI 10.1016/S0022-2836(02)00681-2; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Subramaniam S, 1997, P NATL ACAD SCI USA, V94, P1767, DOI 10.1073/pnas.94.5.1767; Subramaniam S, 2002, PHILOS T ROY SOC A, V360, P859, DOI 10.1098/rsta.2001.0971; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Takeda K, 2004, J MOL BIOL, V341, P1023, DOI 10.1016/j.jmb.2004.06.080; Vonck J, 2000, EMBO J, V19, P2152, DOI 10.1093/emboj/19.10.2152	59	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5769	10.1371/journal.pone.0005769	http://dx.doi.org/10.1371/journal.pone.0005769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19488399	Green Submitted, Green Published, gold			2022-12-27	WOS:000266587400012
J	Benn, CL; Butler, R; Mariner, L; Nixon, J; Moffitt, H; Mielcarek, M; Woodman, B; Bates, GP				Benn, Caroline L.; Butler, Rachel; Mariner, Lydia; Nixon, Jude; Moffitt, Hilary; Mielcarek, Michal; Woodman, Ben; Bates, Gillian P.			Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article								Huntington's disease (HD) is an inherited, progressive neurological disorder caused by a CAG/polyglutamine repeat expansion, for which there is no effective disease modifying therapy. In recent years, transcriptional dysregulation has emerged as a pathogenic process that appears early in disease progression. Administration of histone deacetylase (HDAC) inhibitors such as suberoylanilide hydroxamic acid (SAHA) have consistently shown therapeutic potential in models of HD, at least partly through increasing the association of acetylated histones with down-regulated genes and by correcting mRNA abnormalities. The HDAC enzyme through which SAHA mediates its beneficial effects in the R6/2 mouse model of HD is not known. Therefore, we have embarked on a series of genetic studies to uncover the HDAC target that is relevant to therapeutic development for HD. HDAC7 is of interest in this context because SAHA has been shown to decrease HDAC7 expression in cell culture systems in addition to inhibiting enzyme activity. After confirming that expression levels of Hdac7 are decreased in the brains of wild type and R6/2 mice after SAHA administration, we performed a genetic cross to determine whether genetic reduction of Hdac7 would alleviate phenotypes in the R6/2 mice. We found no improvement in a number of physiological or behavioral phenotypes. Similarly, the dysregulated expression levels of a number of genes of interest were not improved suggesting that reduction in Hdac7 does not alleviate the R6/2 HD-related transcriptional dysregulation. Therefore, we conclude that the beneficial effects of HDAC inhibitors are not predominantly mediated through the inhibition of HDAC7.			Benn, CL (corresponding author), Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Mielcarek, Michal/M-6302-2018; Longo, Kenneth A/A-5631-2010; Bates, Gillian P/E-1146-2012	Mielcarek, Michal/0000-0002-9874-6753; Bates, Gillian P/0000-0002-4041-6305	Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; CODD R, 2008, INT J BIOCH CELL BIO; Cong SY, 2005, MOL CELL NEUROSCI, V30, P560, DOI 10.1016/j.mcn.2005.10.015; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gao CZ, 2006, FEBS LETT, V580, P5096, DOI 10.1016/j.febslet.2006.08.038; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Ha CH, 2008, ARTERIOSCL THROM VAS, V28, P1782, DOI 10.1161/ATVBAHA.108.172528; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2000, GENE DEV, V14, P55; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lione LA, 1999, J NEUROSCI, V19, P10428; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Richon VM, 2001, BLOOD CELL MOL DIS, V27, P260, DOI 10.1006/bcmd.2000.0376; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sadri-Vakili Ghazaleh, 2006, Current Alzheimer Research, V3, P403, DOI 10.2174/156720506778249407; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang YJ, 2008, CURR MED CHEM, V15, P2840, DOI 10.2174/092986708786242796	62	57	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5747	10.1371/journal.pone.0005747	http://dx.doi.org/10.1371/journal.pone.0005747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484127	Green Published, gold, Green Submitted			2022-12-27	WOS:000266528200003
J	Lindstrom, LS; Hall, P; Hartman, M; Wiklund, F; Czene, K				Lindstrom, Linda S.; Hall, Per; Hartman, Mikael; Wiklund, Fredrik; Czene, Kamila			Is Genetic Background Important in Lung Cancer Survival?	PLOS ONE			English	Article							IMPORTANT DETERMINANT; SMOKING-HABITS; FAMILY; POLYMORPHISMS; PROGRESSION; CHROMOSOME; HAPLOTYPES; BEHAVIOR; RISK	Background: In lung cancer, a patient's survival is poor with a wide variation in survival within the stage of disease. The aim of this study was to investigate the familial concordance in lung cancer survival by means of analyses of pairs with different degrees of familial relationships. Methods: Our population-based Swedish family database included three million families and over 58 100 lung cancer patients. We modelled the proband (parent, sibling, spouse) survival utilizing a multivariate proportional hazard (Cox) model adjusting for possible confounders of survival. Subsequently, the survival in proband's relative (child, sibling, spouse) was analysed with a Cox model. Findings: By use of Cox modelling with 5 years follow-up, we noted a decreased hazard ratio for death in children with good parental survival (Hazard Ratio [HR] = 0.71, 95% CI = 0.51 to 0.99), compared to those with poor parental survival. Also for siblings, a very strong protective effect was seen (HR = 0.14, 95% CI = 0.030 to 0.65). Finally, in spouses no correlation in survival was found. Interpretation: Our findings suggest that genetic factors are important in lung cancer survival. In a clinical setting, information on prognosis in a relative may be vital in foreseeing the survival in an individual newly diagnosed with lung cancer. Future molecular studies enhancing the understanding of the underlying mechanisms and pathways are needed.			Lindstrom, LS (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Linda.Lindstrom@ki.se	Lindstrom, Linda LS/J-3215-2012; Hartman, Mikael/B-4324-2011	Lindstrom, Linda Sofie/0000-0002-7722-7532; Hartman, Mikael/0000-0001-5726-9965; Czene, Kamila/0000-0002-3233-5695				Bermejo JL, 2005, CANCER EPIDEM BIOMAR, V14, P1738, DOI 10.1158/1055-9965.EPI-05-0201; BLOTH B, 1976, ACTA MED SCAND, V200, P281; Bricker JB, 2006, ADDICTION, V101, P128, DOI 10.1111/j.1360-0443.2005.01297.x; *CANC SIFFR, 2005, POP FAKT CANC; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Clark AE, 2006, J HEALTH ECON, V25, P958, DOI 10.1016/j.jhealeco.2006.02.002; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; *CTR EP CANC INC S, 2002, NAT BOARD HLTH WELF; Dubey S, 2006, J THORAC ONCOL, V1, P406, DOI 10.1097/01243894-200606000-00005; Ebbert JO, 2005, LUNG CANCER-J IASLC, V47, P165, DOI 10.1016/j.lungcan.2004.07.045; Griesbach D, 2003, SOC SCI MED, V56, P41, DOI 10.1016/S0277-9536(02)00014-X; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hunter K, 2003, NAT GENET, V34, P23, DOI 10.1038/ng0503-23b; Hunter KW, 2003, CANCER LETT, V200, P97, DOI 10.1016/S0304-3835(03)00420-8; Isla D, 2004, ANN ONCOL, V15, P1194, DOI 10.1093/annonc/mdh319; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Larsson L G, 1996, J Med Screen, V3, P129; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Lindstrom LS, 2007, LANCET ONCOL, V8, P1001, DOI 10.1016/S1470-2045(07)70282-6; Liu G, 2005, SEMIN RESP CRIT CARE, V26, P265, DOI 10.1055/s-2005-871983; MACINTYRE S, 1991, LANCET, V338, P869, DOI 10.1016/0140-6736(91)91513-T; Matakidou A, 2007, HUM MOL GENET, V16, P2333, DOI 10.1093/hmg/ddm190; Pine SR, 2007, J NATL CANCER I, V99, P1401, DOI 10.1093/jnci/djm128; PRICE RA, 1980, BEHAV GENET, V10, P59, DOI 10.1007/BF01067319; RUTQVIST LE, 1985, ACTA RADIOL ONCOL, V24, P385, DOI 10.3109/02841868509134405; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; SUTTON GC, 1980, ANN HUM BIOL, V7, P449, DOI 10.1080/03014468000004561; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; Tammemagi CM, 2004, CHEST, V125, P27, DOI 10.1378/chest.125.1.27; Welch DR, 2003, J NATL CANCER I, V95, P839, DOI 10.1093/jnci/95.12.839; West P, 1999, ADDICTION, V94, P1397, DOI 10.1046/j.1360-0443.1999.949139711.x; Yang P, 2002, LUNG CANCER, V35, P221, DOI 10.1016/S0169-5002(01)00426-3; Yoon SM, 2005, INT J RADIAT ONCOL, V63, P885, DOI 10.1016/j.ijrobp.2005.07.951; Yoshino I, 2007, SURG TODAY, V37, P725, DOI 10.1007/s00595-007-3516-6; Zhou W, 2006, LUNG CANCER-J IASLC, V53, P375, DOI 10.1016/j.lungcan.2006.05.017	37	78	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5588	10.1371/journal.pone.0005588	http://dx.doi.org/10.1371/journal.pone.0005588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	451SH	19478952	gold, Green Submitted, Green Published			2022-12-27	WOS:000266490000002
J	Miller, HB; Saunders, KO; Tomaras, GD; Garcia-Blanco, MA				Miller, Heather B.; Saunders, Kevin O.; Tomaras, Georgia D.; Garcia-Blanco, Mariano A.			Tat-SF1 Is Not Required for Tat Transactivation but Does Regulate the Relative Levels of Unspliced and Spliced HIV-1 RNAs	PLOS ONE			English	Article								Background: HIV-1 relies on several host proteins for productive viral transcription. HIV-1 Tat-specific factor 1 (Tat-SF1) is among these cofactors that were identified by in vitro reconstituted transcription reactions with immunodepleted nuclear extracts. At the onset of this work, the prevailing hypothesis was that Tat-SF1 was a required cofactor for the viral regulatory protein, Tat; however, this had not previously been formally tested in vivo. Methodology/Principal Findings: To directly address the involvement of Tat-SF1 in HIV-1 gene expression, we depleted Tat-SF1 in HeLa cells by conventional expression of shRNAs and in T-Rex-293 cells containing tetracycline-inducible shRNAs targeting Tat-SF1. We achieved efficient depletion of Tat-SF1 and demonstrated that this did not affect cell viability. HIV-1 infectivity decreased in Tat-SF1-depleted cells, but only when multiple rounds of infection occurred. Neither Tat-dependent nor basal transcription from the HIV-1 LTR was affected by Tat-SF1 depletion, suggesting that the decrease in infectivity was due to a deficiency at a later step in the viral lifecycle. Finally, Tat-SF1 depletion resulted in an increase in the ratio of unspliced to spliced viral transcripts. Conclusions/Significance: Tat-SF1 is not required for regulating HIV-1 transcription, but is required for maintaining the ratios of different classes of HIV-1 transcripts. These new findings highlight a novel, post-transcriptional role for Tat-SF1 in the HIV-1 life cycle.			Miller, HB (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	garci001@mc.duke.edu	Miller, Heather B./M-1540-2019; Miller, Heather/R-4812-2019; Tomaras, Georgia/J-5041-2016	Miller, Heather/0000-0003-1400-7716; 	NIAID NIH HHS [R01-AI052779, R01 AI052779, P30 AI064518, P30 AI 64518, UC6 AI058607] Funding Source: Medline; NIGMS NIH HHS [R01 GM071037, R01-GM071037] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, UC6AI058607, R01AI052779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071037] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARRIGO SJ, 1989, J VIROL, V63, P4875, DOI 10.1128/JVI.63.11.4875-4881.1989; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bieniasz PD, 1999, P NATL ACAD SCI USA, V96, P7791, DOI 10.1073/pnas.96.14.7791; Bonano VI, 2007, NAT PROTOC, V2, P2166, DOI 10.1038/nprot.2007.292; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; CHEN CH, 1993, AIDS RES HUM RETROV, V9, P1079, DOI 10.1089/aid.1993.9.1079; CULLEN BR, 1992, MICROBIOL REV, V56, P375, DOI 10.1128/MMBR.56.3.375-394.1992; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Exline CM, 2008, J VIROL, V82, P3921, DOI 10.1128/JVI.01558-07; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gorry PR, 1999, J VIROL, V73, P352, DOI 10.1128/JVI.73.1.352-361.1999; HERRMANN CH, 1993, VIROLOGY, V197, P601, DOI 10.1006/viro.1993.1634; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Isel C, 1999, J MOL BIOL, V290, P929, DOI 10.1006/jmbi.1999.2933; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim JB, 1999, MOL CELL BIOL, V19, P5960; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Misse D, 2005, AIDS, V19, P897, DOI 10.1097/01.aids.0000171403.07995.92; Naito T, 2007, P NATL ACAD SCI USA, V104, P18235, DOI 10.1073/pnas.0705856104; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; Overman R Glenn, 2007, Open Virol J, V1, P1, DOI 10.2174/1874357900701010001; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Ping Yueh-Hsin, 2004, Retrovirology, V1, P46, DOI 10.1186/1742-4690-1-46; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Sonza S, 2002, J VIROL, V76, P12611, DOI 10.1128/JVI.76.24.12611-12621.2002; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Taube R, 1999, VIROLOGY, V264, P245, DOI 10.1006/viro.1999.9944; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Wu-Baer F, 1998, J MOL BIOL, V277, P179, DOI 10.1006/jmbi.1997.1601; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou MS, 2004, J VIROL, V78, P13522, DOI 10.1128/JVI.78.24.13522-13533.2004; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605	58	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5710	10.1371/journal.pone.0005710	http://dx.doi.org/10.1371/journal.pone.0005710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479034	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415000019
J	Chen, K; Maaskola, J; Siegal, ML; Rajewsky, N				Chen, Kevin; Maaskola, Jonas; Siegal, Mark L.; Rajewsky, Nikolaus			Reexamining microRNA Site Accessibility in Drosophila: A Population Genomics Study	PLOS ONE			English	Article							SYSTEMATIC DISCOVERY; BINDING-SITES; GENES; POLYMORPHISM; PREDICTION; EVOLUTION; DATABASE; TARGETS; UPDATE; MOTIFS	Kertesz et al. (Nature Genetics 2008) described PITA, a miRNA target prediction algorithm based on hybridization energy and site accessibility. In this note, we used a population genomics approach to reexamine their data and found that the PITA algorithm had lower specificity than methods based on evolutionary conservation at comparable levels of sensitivity. We also showed that deeply conserved miRNAs tend to have stronger hybridization energies to their targets than do other miRNAs. Although PITA had higher specificity in predicting targets than a naive seed-match method, this signal was primarily due to the use of a single cutoff score for all miRNAs and to the observed correlation between conservation and hybridization energy. Overall, our results clarify the accuracy of different miRNA target prediction algorithms in Drosophila and the role of site accessibility in miRNA target prediction.			Chen, K (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	kc1111@nyu.edu		Rajewsky, Nikolaus/0000-0002-4785-4332; Siegal, Mark/0000-0001-6930-2988				Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Boffelli D, 2004, GENOME RES, V14, P2406, DOI 10.1101/gr.3199704; Chen K, 2006, COLD SH Q B, V71, P149; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2008, MOL BIOL EVOL, V25, P929, DOI 10.1093/molbev/msn040; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Rabani M, 2008, P NATL ACAD SCI USA, V105, P14885, DOI 10.1073/pnas.0803169105; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Singh ND, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-37; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5681	10.1371/journal.pone.0005681	http://dx.doi.org/10.1371/journal.pone.0005681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19478854	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000266331700009
J	Rotunno, M; Yu, K; Lubin, JH; Consonni, D; Pesatori, AC; Goldstein, AM; Goldin, LR; Wacholder, S; Welch, R; Burdette, L; Chanock, SJ; Bertazzi, PA; Tucker, MA; Caporaso, NE; Chatterjee, N; Bergen, AW; Landi, MT				Rotunno, Melissa; Yu, Kai; Lubin, Jay H.; Consonni, Dario; Pesatori, Angela C.; Goldstein, Alisa M.; Goldin, Lynn R.; Wacholder, Sholom; Welch, Robert; Burdette, Laurie; Chanock, Stephen J.; Bertazzi, Pier Alberto; Tucker, Margaret A.; Caporaso, Neil E.; Chatterjee, Nilanjan; Bergen, Andrew W.; Landi, Maria Teresa			Phase I Metabolic Genes and Risk of Lung Cancer: Multiple Polymorphisms and mRNA Expression	PLOS ONE			English	Article							MICROSOMAL EPOXIDE HYDROLASE; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; POLYCYCLIC AROMATIC-HYDROCARBONS; HUMAN CYP1A1; SUSCEPTIBILITY LOCUS; NICOTINE METABOLISM; CYTOCHROME P4501B1; CIGARETTE-SMOKING; DNA-ADDUCTS; CYP2A6	Polymorphisms in genes coding for enzymes that activate tobacco lung carcinogens may generate inter-individual differences in lung cancer risk. Previous studies had limited sample sizes, poor exposure characterization, and a few single nucleotide polymorphisms (SNPs) tested in candidate genes. We analyzed 25 SNPs (some previously untested) in 2101 primary lung cancer cases and 2120 population controls from the Environment And Genetics in Lung cancer Etiology (EAGLE) study from six phase I metabolic genes, including cytochrome P450s, microsomal epoxide hydrolase, and myeloperoxidase. We evaluated the main genotype effects and genotype-smoking interactions in lung cancer risk overall and in the major histology subtypes. We tested the combined effect of multiple SNPs on lung cancer risk and on gene expression. Findings were prioritized based on significance thresholds and consistency across different analyses, and accounted for multiple testing and prior knowledge. Two haplotypes in EPHX1 were significantly associated with lung cancer risk in the overall population. In addition, CYP1B1 and CYP2A6 polymorphisms were inversely associated with adenocarcinoma and squamous cell carcinoma risk, respectively. Moreover, the association between CYP1A1 rs2606345 genotype and lung cancer was significantly modified by intensity of cigarette smoking, suggesting an underling dose-response mechanism. Finally, increasing number of variants at CYP1A1/A2 genes revealed significant protection in never smokers and risk in ever smokers. Results were supported by differential gene expression in non-tumor lung tissue samples with down-regulation of CYP1A1 in never smokers and up-regulation in smokers from CYP1A1/A2 SNPs. The significant haplotype associations emphasize that the effect of multiple SNPs may be important despite null single SNP-associations, and warrants consideration in genome-wide association studies (GWAS). Our findings emphasize the necessity of post-GWAS fine mapping and SNP functional assessment to further elucidate cancer risk associations.			Rotunno, M (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	landim@mail.nih.gov	Consonni, Dario/AAM-2947-2020; bertazzi, pietro alberto/D-5039-2017; Wang, Weili/D-1546-2011; Tucker, Margaret A/B-4297-2015; pesatori, angela/K-5742-2016	Consonni, Dario/0000-0002-8935-3843; bertazzi, pietro alberto/0000-0003-3475-2449; pesatori, angela/0000-0002-0261-3252; Bergen, Andrew/0000-0002-1237-7644	NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDA NIH HHS [U01 DA020830] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aklillu E, 2005, CANCER RES, V65, P5105, DOI 10.1158/0008-5472.CAN-05-0113; Alexandrov K, 2002, CARCINOGENESIS, V23, P1969, DOI 10.1093/carcin/23.12.1969; Ariyoshi N, 2002, CANCER EPIDEM BIOMAR, V11, P890; Cascorbi I, 1996, CANCER RES, V56, P4965; Coller JK, 2001, HISTOCHEM J, V33, P329, DOI 10.1023/A:1012414806166; Cote ML, 2007, LUNG CANCER, V55, P255, DOI 10.1016/j.lungcan.2006.11.002; Feyler A, 2002, CANCER EPIDEM BIOMAR, V11, P1550; Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6; GRAZIANO C, 2008, LUNG CANC; Gresner P, 2007, LUNG CANCER, V57, P1, DOI 10.1016/j.lungcan.2007.02.002; Hanna IH, 2000, CANCER RES, V60, P3440; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; Houlston RS, 2000, PHARMACOGENETICS, V10, P105, DOI 10.1097/00008571-200003000-00002; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; KADLUBAR FF, 1992, ENVIRON HEALTH PERSP, V98, P69, DOI 10.2307/3431249; Kamataki T, 2005, BIOCHEM BIOPH RES CO, V338, P306, DOI 10.1016/j.bbrc.2005.08.268; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; Kiyohara C, 2006, EPIDEMIOLOGY, V17, P89, DOI 10.1097/01.ede.0000187627.70026.23; Kiyohara Chikako, 2007, Future Oncol, V3, P617, DOI 10.2217/14796694.3.6.617; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Landi MT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-203; LE ML, 2003, CANC CAUSES CONT5ROL, V14, P339; Lewis DFV, 1999, TOXICOLOGY, V133, P1, DOI 10.1016/S0300-483X(98)00149-8; Liang GY, 2005, CANCER LETT, V223, P265, DOI 10.1016/j.canlet.2004.12.042; London SJ, 1999, LANCET, V353, P898, DOI 10.1016/S0140-6736(98)04984-8; Lubin JH, 2007, INT J EPIDEMIOL, V36, P236, DOI 10.1093/ije/dym043; MALLET WG, 1991, CARCINOGENESIS, V12, P521, DOI 10.1093/carcin/12.3.521; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Nakajima M, 2006, CLIN PHARMACOL THER, V80, P282, DOI 10.1016/j.clpt.2006.05.012; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; OESCH F, 1973, XENOBIOTICA, V3, P305, DOI 10.3109/00498257309151525; Pianezza ML, 1998, NATURE, V393, P750, DOI 10.1038/31623; Raaka S, 1998, CARCINOGENESIS, V19, P387, DOI 10.1093/carcin/19.3.387; Schmekel B, 2000, RESP MED, V94, P564, DOI 10.1053/rmed.2000.0776; SCHOTTENFELD D, 1996, CANC EPIDEMIOLOGY PR, P641; SEIDEGARD J, 1983, BIOCHIM BIOPHYS ACTA, V695, P251, DOI 10.1016/0304-419X(83)90014-8; Shah PP, 2008, MUTAT RES-FUND MOL M, V643, P4, DOI 10.1016/j.mrfmmm.2008.05.001; Shah PP, 2008, MUTAT RES-FUND MOL M, V639, P1, DOI 10.1016/j.mrfmmm.2007.10.006; Shields PG, 1999, ANN ONCOL, V10, P7, DOI 10.1023/A:1008331616378; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Sorensen M, 2005, CANCER LETT, V221, P185, DOI 10.1016/j.canlet.2004.11.012; Spink DC, 1998, CARCINOGENESIS, V19, P291, DOI 10.1093/carcin/19.2.291; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Spivack SD, 2003, CLIN CANCER RES, V9, P6002; TEFRE T, 1991, PHARMACOGENETICS, V1, P20, DOI 10.1097/00008571-199110000-00004; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; To-Figueras J, 2001, CANCER LETT, V173, P155, DOI 10.1016/S0304-3835(01)00626-7; TRUSH MA, 1985, P NATL ACAD SCI USA, V82, P5194, DOI 10.1073/pnas.82.15.5194; Ueda R, 2006, MOL PHARMACOL, V69, P1924, DOI 10.1124/mol.105.021220; Van Schooten FJ, 2004, CANCER EPIDEM BIOMAR, V13, P828; Voho A, 2006, CANCER LETT, V237, P102, DOI 10.1016/j.canlet.2005.05.029; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang S, 2008, CANCER EPIDEM BIOMAR, V17, P405, DOI 10.1158/1055-9965.EPI-07-0695; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Watanabe J, 2000, PHARMACOGENETICS, V10, P25, DOI 10.1097/00008571-200002000-00004; Wright GS, 2000, CURR OPIN ONCOL, V12, P143, DOI 10.1097/00001622-200003000-00008; Xu LL, 2002, CANCER EPIDEM BIOMAR, V11, P1555; Zhu QS, 2003, BBA-MOL BASIS DIS, V1638, P208, DOI 10.1016/S0925-4439(03)00085-1; Zienolddiny S, 2008, CARCINOGENESIS, V29, P1164, DOI 10.1093/carcin/bgn020	61	69	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5652	10.1371/journal.pone.0005652	http://dx.doi.org/10.1371/journal.pone.0005652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19479063	Green Submitted, Green Published, gold			2022-12-27	WOS:000266331000011
J	Hurford, A				Hurford, Amy			GPS Measurement Error Gives Rise to Spurious 180 degrees Turning Angles and Strong Directional Biases in Animal Movement Data	PLOS ONE			English	Article							COLLAR PERFORMANCE; MARINE PREDATOR; TRACKING; HABITAT; CARIBOU; TELEMETRY; ACCURACY; MODELS; SITES	Background: Movement data are frequently collected using Global Positioning System (GPS) receivers, but recorded GPS locations are subject to errors. While past studies have suggested methods to improve location accuracy, mechanistic movement models utilize distributions of turning angles and directional biases and these data present a new challenge in recognizing and reducing the effect of measurement error. Methods: I collected locations from a stationary GPS collar, analyzed a probabilistic model and used Monte Carlo simulations to understand how measurement error affects measured turning angles and directional biases. Results: Results from each of the three methods were in complete agreement: measurement error gives rise to a systematic bias where a stationary animal is most likely to be measured as turning 180 degrees or moving towards a fixed point in space. These spurious effects occur in GPS data when the measured distance between locations is < 20 meters. Conclusions: Measurement error must be considered as a possible cause of 180 degrees turning angles in GPS data. Consequences of failing to account for measurement error are predicting overly tortuous movement, numerous returns to previously visited locations, inaccurately predicting species range, core areas, and the frequency of crossing linear features. By understanding the effect of GPS measurement error, ecologists are able to disregard false signals to more accurately design conservation plans for endangered wildlife.			Hurford, A (corresponding author), Univ Alberta, Ctr Math Biol, Dept Biol Sci, Kingston, ON, Canada.	ahurford@mast.queensu.ca						Adrados C, 2003, WILDLIFE SOC B, V31, P544; Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; Bergman CM, 2000, OECOLOGIA, V123, P364, DOI 10.1007/s004420051023; BISHOP J, 1995, INT J REMOTE SENS, V16, P1943, DOI 10.1080/01431169508954531; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; BULLOCK JB, 2006, UNDERSTANDING GPS PR, P391; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; Dussault C, 2001, WILDLIFE SOC B, V29, P171; Dyer SJ, 2002, CAN J ZOOL, V80, P839, DOI [10.1139/z02-060, 10.1139/Z02-060]; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Franke A, 2004, ECOL MODEL, V173, P259, DOI 10.1016/j.ecolmodel.2003.06.004; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; Ganskopp DC, 2007, RANGELAND ECOL MANAG, V60, P350, DOI 10.2111/1551-5028(2007)60[350:GEISAA]2.0.CO;2; Gudbjornsson S, 2004, SEA TECHNOL, V45, P23; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378; Iglay RB, 2006, WILDLIFE SOC B, V34, P208, DOI 10.2193/0091-7648(2006)34[208:ACOTMF]2.0.CO;2; Jerde CL, 2005, ECOL APPL, V15, P806, DOI 10.1890/04-0895; Johnson CE, 2004, FRONT ECOL ENVIRON, V2, P475, DOI 10.2307/3868336; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; KEATING KA, 1991, J WILDLIFE MANAGE, V55, P160, DOI 10.2307/3809254; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; McKenzie HW, 2009, ENVIRON ECOL STAT, V16, P531, DOI 10.1007/s10651-008-0095-7; Moen R, 1997, J WILDLIFE MANAGE, V61, P530, DOI 10.2307/3802612; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; MOORCROFT P, 2005, HOME RANGE PATTERNS; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Noss R. F., 1994, SAVING NATURES LEGAC; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pepin D, 2004, J MAMMAL, V85, P774, DOI 10.1644/BER-022; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Rondinini C, 2006, BIOL CONSERV, V133, P358, DOI 10.1016/j.biocon.2006.06.013; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; SOLOW AR, 1990, J MATH BIOL, V29, P189, DOI 10.1007/BF00168178; TURCHIN P, 1991, ECOLOGY, V72, P1253, DOI 10.2307/1941099; Turchin Peter, 1998; TURNER MG, 1993, ECOL MODEL, V69, P163, DOI 10.1016/0304-3800(93)90026-O; Visscher DR, 2006, ECOGRAPHY, V29, P458; Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Yasuda T, 2005, ZOOL SCI, V22, P547, DOI 10.2108/zsj.22.547; ZAR JH, 1998, BIOSTAT ANAL, P929	49	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5632	10.1371/journal.pone.0005632	http://dx.doi.org/10.1371/journal.pone.0005632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19479067	Green Published, Green Submitted, gold			2022-12-27	WOS:000266234700019
J	Tamburini, BA; Trapp, S; Phang, TL; Schappa, JT; Hunter, LE; Modiano, JF				Tamburini, Beth A.; Trapp, Susan; Phang, Tzu Lip; Schappa, Jill T.; Hunter, Lawrence E.; Modiano, Jaime F.			Gene Expression Profiles of Sporadic Canine Hemangiosarcoma Are Uniquely Associated with Breed	PLOS ONE			English	Article							TUMOR-GROWTH; AFRICAN-AMERICAN; DOGS; CELLS; THROMBOSPONDIN-1; CANCER; VEGF; ANGIOGENESIS; PREVALENCE; RECEPTOR-2	The role an individual's genetic background plays on phenotype and biological behavior of sporadic tumors remains incompletely understood. We showed previously that lymphomas from Golden Retrievers harbor defined, recurrent chromosomal aberrations that occur less frequently in lymphomas from other dog breeds, suggesting spontaneous canine tumors provide suitable models to define how heritable traits influence cancer genotypes. Here, we report a complementary approach using gene expression profiling in a naturally occurring endothelial sarcoma of dogs (hemangiosarcoma). Naturally occurring hemangiosarcomas of Golden Retrievers clustered separately from those of non-Golden Retrievers, with contributions from transcription factors, survival factors, and from pro-inflammatory and angiogenic genes, and which were exclusively present in hemangiosarcoma and not in other tumors or normal cells (i.e., they were not due simply to variation in these genes among breeds). Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) was among genes preferentially enriched within known pathways derived from gene set enrichment analysis when characterizing tumors from Golden Retrievers versus other breeds. Heightened VEGFR1 expression in these tumors also was apparent at the protein level and targeted inhibition of VEGFR1 increased proliferation of hemangiosarcoma cells derived from tumors of Golden Retrievers, but not from other breeds. Our results suggest heritable factors mold gene expression phenotypes, and consequently biological behavior in sporadic, naturally occurring tumors.			Tamburini, BA (corresponding author), Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA.	modiano@umn.edu	Fiumefreddo, Andrea/T-2977-2019; MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648; Hunter, Lawrence/0000-0003-1455-3370	NATIONAL CANCER INSTITUTE [P30CA077598, P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007405] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM008111] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA077598, P30 CA046934] Funding Source: Medline; NIAID NIH HHS [T32 AI007405] Funding Source: Medline; NLM NIH HHS [R01 LM008111-07, R01 LM008111] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Akhtar N, 2004, NEOPLASIA, V6, P106, DOI 10.1593/neo.03334; APPLEBY EC, 1978, VET REC, V102, P449, DOI 10.1136/vr.102.20.449-b; BROWN NO, 1985, J AM VET MED ASSOC, V186, P56; Burton-Wurster N, 2005, J HERED, V96, P821, DOI 10.1093/jhered/esi105; Chen H, 1996, FEBS LETT, V387, P36, DOI 10.1016/0014-5793(96)00460-7; Clifford CA, 2001, J VET INTERN MED, V15, P131, DOI 10.1892/0891-6640(2001)015&lt;0131:PVEGFC&gt;2.3.CO;2; Dickerson EB, 2005, VET PATHOL, V42, P618, DOI 10.1354/vp.42-5-618; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferguson SE, 2006, GYNECOL ONCOL, V101, P209, DOI 10.1016/j.ygyno.2005.11.028; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferreira JA, 2006, STAT APPL GENET MOL, V5; Fosmire SP, 2004, LAB INVEST, V84, P562, DOI 10.1038/labinvest.3700080; Glickman L, 2000, GOLDEN RETRIEVER CLU; GLICKMAN LT, 2003, IRISH SETTER CLUB AM; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; Hiratsuka S, 2005, MOL CELL BIOL, V25, P355, DOI 10.1128/MCB.25.1.355-363.2005; Hogan C, 2007, MUTAT RES-FUND MOL M, V618, P41, DOI 10.1016/j.mrfmmm.2006.07.010; Irizarry RA., 2003, STAT APPL GENET MOL, V2, pArticl; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jubala CM, 2005, VET PATHOL, V42, P468, DOI 10.1354/vp.42-4-468; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Lamerato-Kozicki AR, 2006, EXP HEMATOL, V34, P870, DOI 10.1016/j.exphem.2006.04.013; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MODIANO JF, 1991, J BIOL CHEM, V266, P10552; MODIANO JF, 1994, J BIOL CHEM, V269, P32972; Modiano JF, 2005, CANCER RES, V65, P5654, DOI 10.1158/0008-5472.CAN-04-4613; Modiano JF, 1999, DNA CELL BIOL, V18, P357, DOI 10.1089/104454999315259; Ostrander EA, 2000, TRENDS GENET, V16, P117, DOI 10.1016/S0168-9525(99)01958-7; Page GP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-84; Peterson MR, 2000, J VET INTERN MED, V14, P140, DOI 10.1892/0891-6640(2000)014&lt;0140:ASOTLO&gt;2.3.CO;2; Priester W A, 1980, Natl Cancer Inst Monogr, P1; PRYMAK C, 1988, J AM VET MED ASSOC, V193, P706; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rusk A, 2006, CLIN CANCER RES, V12, P7444, DOI 10.1158/1078-0432.CCR-06-0109; Selzner M, 2001, CANCER RES, V61, P1233; Shibuya M, 2003, CANCER SCI, V94, P751, DOI 10.1111/j.1349-7006.2003.tb01514.x; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; SPANGLER WL, 1992, J AM VET MED ASSOC, V200, P829; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Tate G, 2007, CANCER GENET CYTOGEN, V178, P160, DOI 10.1016/j.cancergencyto.2007.07.017; Thamm DH, 2006, RES VET SCI, V81, P76, DOI 10.1016/j.rvsc.2005.09.005; Thomson SAM, 2005, VET PATHOL, V42, P550, DOI 10.1354/vp.42-5-550; Tschoep K, 2007, CRIT REV ONCOL HEMAT, V63, P111, DOI 10.1016/j.critrevonc.2007.04.001; U'Ren LW, 2007, J VET INTERN MED, V21, P113, DOI 10.1892/0891-6640(2007)21[113:EOANTV]2.0.CO;2; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Volpert OV, 2003, CANCER CELL, V3, P199, DOI 10.1016/S1535-6108(03)00056-4; Wagner JL, 1999, J HERED, V90, P35, DOI 10.1093/jhered/90.1.35; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	53	60	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5549	10.1371/journal.pone.0005549	http://dx.doi.org/10.1371/journal.pone.0005549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461996	Green Published, gold			2022-12-27	WOS:000266234700005
J	Moresi, V; Garcia-Alvarez, G; Pristera, A; Rizzuto, E; Albertini, MC; Rocchi, M; Marazzi, G; Sassoon, D; Adamo, S; Coletti, D				Moresi, Viviana; Garcia-Alvarez, Gisela; Pristera, Alessandro; Rizzuto, Emanuele; Albertini, Maria C.; Rocchi, Marco; Marazzi, Giovanna; Sassoon, David; Adamo, Sergio; Coletti, Dario			Modulation of Caspase Activity Regulates Skeletal Muscle Regeneration and Function in Response to Vasopressin and Tumor Necrosis Factor	PLOS ONE			English	Article								Muscle homeostasis involves de novo myogenesis, as observed in conditions of acute or chronic muscle damage. Tumor Necrosis Factor (TNF) triggers skeletal muscle wasting in several pathological conditions and inhibits muscle regeneration. We show that intramuscular treatment with the myogenic factor Arg(8)-vasopressin (AVP) enhanced skeletal muscle regeneration and rescued the inhibitory effects of TNF on muscle regeneration. The functional analysis of regenerating muscle performance following TNF or AVP treatments revealed that these factors exerted opposite effects on muscle function. Principal component analysis showed that TNF and AVP mainly affect muscle tetanic force and fatigue. Importantly, AVP counteracted the effects of TNF on muscle function when delivered in combination with the latter. Muscle regeneration is, at least in part, regulated by caspase activation, and AVP abrogated TNF-dependent caspase activation. The contrasting effects of AVP and TNF in vivo are recapitulated in myogenic cell cultures, which express both PW1, a caspase activator, and Hsp70, a caspase inhibitor. We identified PW1 as a potential Hsp70 partner by screening for proteins interacting with PW1. Hsp70 and PW1 co-immunoprecipitated and co-localized in muscle cells. In vivo Hsp70 protein level was upregulated by AVP, and Hsp70 overexpression counteracted the TNF block of muscle regeneration. Our results show that AVP counteracts the effects of TNF through cross-talk at the Hsp70 level. Therefore, muscle regeneration, both in the absence and in the presence of cytokines may be enhanced by increasing Hsp70 expression.			Moresi, V (corresponding author), Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy.	sergio.adamo@uniroma1.it	Moresi, Viviana/N-7977-2013; Coletti, Dario/U-2219-2018; Coletti, Dario/CAG-9308-2022; Rizzuto, Emanuele/K-9437-2016; Adamo, Sergio/E-9058-2012; Albertini, Maria Cristina/AAG-6980-2019; Rocchi, Marco BL/AAK-5926-2021; SASSOON, David A/G-2502-2013	Rizzuto, Emanuele/0000-0003-2314-6128; Adamo, Sergio/0000-0002-1409-0452; Albertini, Maria Cristina/0000-0003-4549-1475; SASSOON, David A/0000-0001-6074-048X; Rocchi, marco/0000-0002-0056-5795; Moresi, viviana/0000-0003-1912-0339; Marazzi, giovanna/0000-0002-5388-1038; Coletti, Dario/0000-0001-7373-1953	NCI NIH HHS [P01 CA080058] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertini MC, 2006, CYTOM PART A, V69A, P260, DOI 10.1002/cyto.a.20263; Albertini MC, 2003, CYTOM PART A, V52A, P12, DOI 10.1002/cyto.a.10019; ALEXANDER SL, 1991, ENDOCRINOLOGY, V128, P65, DOI 10.1210/endo-128-1-65; Alvisi M, 2008, DIFFERENTIATION, V76, P371, DOI 10.1111/j.1432-0436.2007.00231.x; Anderson TW, 1984, INTRO MULTIVARIATE S; Breton C, 2002, J CLIN ENDOCR METAB, V87, P1415, DOI 10.1210/jc.87.3.1415; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; COLETTI D, 2008, BASIC APPL MYOL, V18, P109; Coletti D, 2007, CYTOM PART A, V71A, P846, DOI 10.1002/cyto.a.20447; CONVERTINO VA, 1983, J APPL PHYSIOL, V54, P508, DOI 10.1152/jappl.1983.54.2.508; Costelli P, 2006, AM J PHYSIOL-REG I, V291, pR674, DOI 10.1152/ajpregu.00104.2006; De Arcangelis V, 2003, MOL BIOL CELL, V14, P1392, DOI 10.1091/mbc.E02-03-0156; Decramer M, 2001, Verh K Acad Geneeskd Belg, V63, P577; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; DEL PZ, 2008, ANN BIOMED ENG, V36, P1281; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Denti MA, 2008, HUM GENE THER, V19, P601, DOI 10.1089/hum.2008.012; Duguez S, 2003, AM J PHYSIOL-ENDOC M, V285, pE206, DOI 10.1152/ajpendo.00331.2002; Frost RA, 2003, ENDOCRINOLOGY, V144, P1770, DOI 10.1210/en.2002-220808; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Graupe D, 2008, NEUROL RES, V30, P123, DOI 10.1179/174313208X281136; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Irintchev A, 1997, NEUROMUSCULAR DISORD, V7, P117, DOI 10.1016/S0960-8966(96)00422-1; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; Kayani AC, 2008, REJUV RES, V11, P1021, DOI 10.1089/rej.2008.0795; Kojima A, 2007, J ORTHOP SCI, V12, P74, DOI 10.1007/s00776-006-1083-0; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Layne MD, 1999, EXP CELL RES, V249, P177, DOI 10.1006/excr.1999.4465; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; McArdle A, 2003, FASEB J, V17, P355, DOI 10.1096/fj.03-0395fje; MELIN B, 1980, EUR J APPL PHYSIOL O, V44, P141, DOI 10.1007/BF00421092; Minotti S, 1998, CELL GROWTH DIFFER, V9, P155; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Miyabara EH, 2006, AM J PHYSIOL-CELL PH, V290, pC1128, DOI 10.1152/ajpcell.00399.2005; Moresi V, 2008, STEM CELLS, V26, P997, DOI 10.1634/stemcells.2007-0493; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Naro F, 2003, J BIOL CHEM, V278, P49308, DOI 10.1074/jbc.M306941200; NERVI C, 1995, CELL GROWTH DIFFER, V6, P81; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Ostrovsky O, 2003, J BIOL CHEM, V278, P21221, DOI 10.1074/jbc.M211357200; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Perniconi B, 2008, BASIC APPL MYOL, V18, P105; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Reid MB, 2002, AM J RESP CRIT CARE, V166, P479, DOI 10.1164/rccm.2202005; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Riederer I, 2008, TRANSPL P, V40, P624, DOI 10.1016/j.transproceed.2008.01.026; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Scicchitano BM, 2005, MOL BIOL CELL, V16, P3632, DOI 10.1091/mbc.E05-01-0055; Scicchitano BM, 2002, MOL ENDOCRINOL, V16, P1407, DOI 10.1210/me.16.6.1407; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Setsuta K, 2008, CIRC J, V72, P569; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Supinski GS, 2006, J APPL PHYSIOL, V100, P1770, DOI 10.1152/japplphysiol.01288.2005; TETI A, 1993, AM J PHYSIOL, V265, pC113, DOI 10.1152/ajpcell.1993.265.1.C113; Thibonnier M, 1996, GENOMICS, V31, P327, DOI 10.1006/geno.1996.0055; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	74	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5570	10.1371/journal.pone.0005570	http://dx.doi.org/10.1371/journal.pone.0005570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440308	gold, Green Submitted, Green Published			2022-12-27	WOS:000266107500004
J	Sirchia, SM; Tabano, S; Monti, L; Recalcati, MP; Gariboldi, M; Grati, FR; Porta, G; Finelli, P; Radice, P; Miozzo, M				Sirchia, Silvia M.; Tabano, Silvia; Monti, Laura; Recalcati, Maria P.; Gariboldi, Manuela; Grati, Francesca R.; Porta, Giovanni; Finelli, Palma; Radice, Paolo; Miozzo, Monica			Misbehaviour of XIST RNA in Breast Cancer Cells	PLOS ONE			English	Article								A role of X chromosome inactivation process in the development of breast cancer have been suggested. In particular, the relationship between the breast cancer predisposing gene BRCA1 and XIST, the main mediator of X chromosome inactivation, has been intensely investigated, but still remains controversial. We investigated this topic by assessing XIST behaviour in different groups of breast carcinomas and in a panel of breast cancer cell lines both BRCA1 mutant and wild type. In addition, we evaluated the occurrence of broader defects of heterochromatin in relation to BRCA1 status in breast cancer cells. We provide evidence that in breast cancer cells BRCA1 is involved in XIST regulation on the active X chromosome, but not in its localization as previously suggested, and that XIST can be unusually expressed by an active X and can decorate it. This indicates that the detection of XIST cloud in cancer cell is not synonymous of the presence of an inactive X chromosome. Moreover, we show that global heterochromatin defects observed in breast tumor cells are independent of BRCA1 status. Our observations sheds light on a possible previously uncharacterized mechanism of breast carcinogenesis mediated by XIST misbehaviour, particularly in BRCA1-related cancers. Moreover, the significant higher levels of XIST-RNA detected in BRCA1-associated respect to sporadic basal-like cancers, opens the possibility to use XIST expression as a marker to discriminate between the two groups of tumors.			Sirchia, SM (corresponding author), Univ Milan, Dept Med Surg & Dent, Med Genet Unit, Milan, Italy.	silvia.sirchia@unimi.it	Tabano, Silvia/P-1498-2017; Miozzo, Monica Rosa/AAC-6401-2022; Sirchia, Silvia/AAB-2620-2019; Finelli, Palma/A-3578-2016; Grati, Francesca Romana/H-7397-2019; RECALCATI, MARIA PAOLA/AAA-2215-2020; Radice, Paolo/O-3119-2013; Gariboldi, Manuela/K-4744-2016	Miozzo, Monica Rosa/0000-0002-6523-4575; Finelli, Palma/0000-0001-8464-6906; Radice, Paolo/0000-0001-6298-4111; Gariboldi, Manuela/0000-0001-8406-165X; Tabano, Silvia Maria/0000-0002-5260-6691; porta, giovanni/0000-0001-5260-2415; Sirchia, Silvia/0000-0002-6106-3721; Recalcati, Maria Paola/0000-0003-1780-9837	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		BALAZS M, 1991, CANCER GENET CYTOGEN, V57, P93, DOI 10.1016/0165-4608(91)90194-Y; Beever CL, 2003, AM J HUM GENET, V72, P399, DOI 10.1086/346119; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CAMARGO M, 1980, HUM GENET, V55, P81, DOI 10.1007/BF00329131; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Colombo M, 2008, MODERN PATHOL, V21, P1262, DOI 10.1038/modpathol.2008.43; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Deng CX, 2000, BIOESSAYS, V22, P728; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Ganesan S, 2002, CELL, V111, P393, DOI 10.1016/S0092-8674(02)01052-8; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Honrado E, 2006, ONCOGENE, V25, P5837, DOI 10.1038/sj.onc.1209875; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Ogilvie CM, 2005, J HISTOCHEM CYTOCHEM, V53, P285, DOI 10.1369/jhc.4B6409.2005; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Pageau GJ, 2007, J CELL BIOCHEM, V100, P835, DOI 10.1002/jcb.21188; Palacios J, 2005, BREAST CANCER RES TR, V90, P5, DOI 10.1007/s10549-004-1536-0; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Silver DP, 2007, CELL, V128, P991, DOI 10.1016/j.cell.2007.02.025; Sirchia SM, 2005, CANCER RES, V65, P2139, DOI 10.1158/0008-5472.CAN-04-3465; Song MA, 2007, ELECTROPHORESIS, V28, P2379, DOI 10.1002/elps.200600852; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Squire JA, 2000, GENOMICS, V65, P234, DOI 10.1006/geno.2000.6155; Takagi N, 2003, SEMIN CELL DEV BIOL, V14, P319, DOI 10.1016/j.semcdb.2003.09.027; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Vincent-Salomon A, 2007, CANCER RES, V67, P5134, DOI 10.1158/0008-5472.CAN-07-0465; WOLMAN SR, 1995, MODERN PATHOL, V8, P239; Xiao CY, 2007, CELL, V128, P977, DOI 10.1016/j.cell.2007.01.034; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049	41	51	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5559	10.1371/journal.pone.0005559	http://dx.doi.org/10.1371/journal.pone.0005559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440381	gold, Green Published, Green Submitted			2022-12-27	WOS:000266107400003
J	Tetteh, KKA; Stewart, LB; Ochola, LI; Amambua-Ngwa, A; Thomas, AW; Marsh, K; Weedall, GD; Conway, DJ				Tetteh, Kevin K. A.; Stewart, Lindsay B.; Ochola, Lynette Isabella; Amambua-Ngwa, Alfred; Thomas, Alan W.; Marsh, Kevin; Weedall, Gareth D.; Conway, David J.			Prospective Identification of Malaria Parasite Genes under Balancing Selection	PLOS ONE			English	Article								Background: Endemic human pathogens are subject to strong immune selection, and interrogation of pathogen genome variation for signatures of balancing selection can identify important target antigens. Several major antigen genes in the malaria parasite Plasmodium falciparum have shown such signatures in polymorphism-versus-divergence indices (comparing with the chimpanzee parasite P. reichenowi), and in allele frequency based indices. Methodology/Principal Findings: To compare methods for prospective identification of genes under balancing selection, 26 additional genes known or predicted to encode surface-exposed proteins of the invasive blood stage merozoite were first sequenced from a panel of 14 independent P. falciparum cultured lines and P. reichenowi. Six genes at the positive extremes of one or both of the Hudson-Kreitman-Aguade (HKA) and McDonald-Kreitman (MK) indices were identified. Allele frequency based analysis was then performed on a Gambian P. falciparum population sample for these six genes and three others as controls. Tajima's D (TjD) index was most highly positive for the msp3/6-like PF10_0348 (TjD = 1.96) as well as the positive control ama1 antigen gene (TjD = 1.22). Across the genes there was a strong correlation between population TjD values and the relative HKA indices (whether derived from the population or the panel of cultured laboratory isolates), but no correlation with the MK indices. Conclusions/Significance: Although few individual parasite genes show significant evidence of balancing selection, analysis of population genomic and comparative sequence data with the HKA and TjD indices should discriminate those that do, and thereby identify likely targets of immunity.			Tetteh, KKA (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	dconway@mrc.gm	Amambua-Ngwa, Alfred/AHD-7882-2022; Tetteh, Kevin/GYQ-9704-2022; Amambua-Ngwa, Alfred/HGU-8062-2022; Amambua-Ngwa, Alfred/ABA-7305-2020	Amambua-Ngwa, Alfred/0000-0003-4478-3601; Tetteh, Kevin/0000-0003-2733-0037; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Weedall, Gareth/0000-0002-8927-1063; Conway, David/0000-0002-8711-3037; Ochola-Oyier, Lynette/0000-0003-4393-0470	MRC [MC_U190081993] Funding Source: UKRI; Medical Research Council [MC_U190081993] Funding Source: Medline; Wellcome Trust [074695/Z/04/B] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Baum J, 2003, GENETICS, V163, P1327; Bethke LL, 2006, MOL BIOCHEM PARASIT, V150, P10, DOI 10.1016/j.molbiopara.2006.06.004; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Charlesworth J, 2008, MOL BIOL EVOL, V25, P1007, DOI 10.1093/molbev/msn005; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Conway DJ, 2002, PARASITOLOGY, V125, pS3, DOI 10.1017/S0031182002002214; Cortes A, 2005, INT J PARASITOL, V35, P125, DOI 10.1016/j.ijpara.2004.11.004; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; DIECKMANN U, 2002, PURSUIT VIRULENCE MA; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Escalante AA, 1998, GENETICS, V149, P189; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; FU YX, 1993, GENETICS, V133, P693; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; HUDSON RR, 1987, GENETICS, V116, P153; HUGHES MK, 1995, MOL BIOCHEM PARASIT, V71, P99, DOI 10.1016/0166-6851(95)00037-2; Innan H, 2006, GENETICS, V173, P1725, DOI 10.1534/genetics.106.056242; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nachman MW, 1996, GENETICS, V142, P953; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2001, GENETICS, V158, P1505; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sam-Yellowe TY, 2004, J PROTEOME RES, V3, P995, DOI 10.1021/pr049926m; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Verra F, 2006, MOL BIOCHEM PARASIT, V149, P182, DOI 10.1016/j.molbiopara.2006.05.010; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; Weedall GD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002281; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231	53	62	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5568	10.1371/journal.pone.0005568	http://dx.doi.org/10.1371/journal.pone.0005568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440377	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000266107400012
J	Engler, C; Gruetzner, R; Kandzia, R; Marillonnet, S				Engler, Carola; Gruetzner, Ramona; Kandzia, Romy; Marillonnet, Sylvestre			Golden Gate Shuffling: A One-Pot DNA Shuffling Method Based on Type IIs Restriction Enzymes	PLOS ONE			English	Article								We have developed a protocol to assemble in one step and one tube at least nine separate DNA fragments together into an acceptor vector, with 90% of recombinant clones obtained containing the desired construct. This protocol is based on the use of type IIs restriction enzymes and is performed by simply subjecting a mix of 10 undigested input plasmids (nine insert plasmids and the acceptor vector) to a restriction-ligation and transforming the resulting mix in competent cells. The efficiency of this protocol allows generating libraries of recombinant genes by combining in one reaction several fragment sets prepared from different parental templates. As an example, we have applied this strategy for shuffling of trypsinogen from three parental templates (bovine cationic trypsinogen, bovine anionic trypsinogen and human cationic trypsinogen) each divided in 9 separate modules. We show that one round of shuffling using the 27 trypsinogen entry plasmids can easily produce the 19,683 different possible combinations in one single restriction-ligation and that expression screening of a subset of the library allows identification of variants that can lead to higher expression levels of trypsin activity. This protocol, that we call 'Golden Gate shuffling', is robust, simple and efficient, can be performed with templates that have no homology, and can be combined with other shuffling protocols in order to introduce any variation in any part of a given gene.			Engler, C (corresponding author), Icon Genet GmbH, Biozentrum, Halle, Germany.	marillonnet@icongenetics.de						Bolchi A, 2005, BIOTECHNOL APPL BIOC, V42, P205, DOI 10.1042/BA20050050; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Coco WM, 2002, NAT BIOTECHNOL, V20, P1246, DOI 10.1038/nbt757; Coco WM, 2001, NAT BIOTECHNOL, V19, P354, DOI 10.1038/86744; Cost GJ, 2007, NAT PROTOC, V2, P2198, DOI 10.1038/nprot.2007.325; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Eggert T, 2005, CHEMBIOCHEM, V6, P1062, DOI 10.1002/cbic.200400417; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Hiraga K, 2003, J MOL BIOL, V330, P287, DOI 10.1016/S0022-2836(03)00590-4; Jezequel L, 2008, BIOTECHNIQUES, V45, P523, DOI 10.2144/000112954; Kotera I, 2008, J BIOTECHNOL, V137, P1, DOI 10.1016/j.jbiotec.2008.07.1816; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lutz S, 2004, CURR OPIN BIOTECH, V15, P291, DOI 10.1016/j.copbio.2004.05.004; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; MEYER MM, 2006, CURR PROTOC PROTEIN, pCH26; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Ostermeier M, 1999, NAT BIOTECHNOL, V17, P1205, DOI 10.1038/70754; Richardson TH, 2002, J BIOL CHEM, V277, P26501, DOI 10.1074/jbc.M203183200; Sen S, 2007, APPL BIOCHEM BIOTECH, V143, P212, DOI 10.1007/s12010-007-8003-4; Sieber V, 2001, NAT BIOTECHNOL, V19, P456, DOI 10.1038/88129; Silverman J, 2005, NAT BIOTECHNOL, V23, P1556, DOI 10.1038/nbt1166; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Trefzer A, 2007, APPL ENVIRON MICROB, V73, P4317, DOI 10.1128/AEM.02676-06; VOLKOV AA, 1999, NUCL ACIDS RES; Wang TW, 2006, MOL BIOTECHNOL, V34, P55, DOI 10.1385/MB:34:1:55; Woodard SL, 2003, BIOTECHNOL APPL BIOC, V38, P123, DOI 10.1042/BA20030026; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	28	602	726	11	211	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5553	10.1371/journal.pone.0005553	http://dx.doi.org/10.1371/journal.pone.0005553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436741	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107300017
J	Schmid, MC; Panagiotaropoulos, T; Augath, MA; Logothetis, NK; Smirnakis, SM				Schmid, Michael C.; Panagiotaropoulos, Theofanis; Augath, Mark A.; Logothetis, Nikos K.; Smirnakis, Stelios M.			Visually Driven Activation in Macaque Areas V2 and V3 without Input from the Primary Visual Cortex	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; MONKEY SUPERIOR COLLICULUS; TEMPORAL POLYSENSORY AREA; STRIATE CORTEX; REVERSIBLE INACTIVATION; RESPONSE PROPERTIES; RETINOTOPIC ORGANIZATION; PRESTRIATE CORTEX; NEURONAL-ACTIVITY; AFFERENT BASIS	Creating focal lesions in primary visual cortex (V1) provides an opportunity to study the role of extra-geniculo-striate pathways for activating extrastriate visual cortex. Previous studies have shown that more than 95% of neurons in macaque area V2 and V3 stop firing after reversibly cooling V1 [1,2,3]. However, no studies on long term recovery in areas V2, V3 following permanent V1 lesions have been reported in the macaque. Here we use macaque fMRI to study area V2, V3 activity patterns from 1 to 22 months after lesioning area V1. We find that visually driven BOLD responses persist inside the V1-lesion projection zones (LPZ) of areas V2 and V3, but are reduced in strength by similar to 70%, on average, compared to prelesion levels. Monitoring the LPZ activity over time starting one month following the V1 lesion did not reveal systematic changes in BOLD signal amplitude. Surprisingly, the retinotopic organization inside the LPZ of areas V2, V3 remained similar to that of the non-lesioned hemisphere, suggesting that LPZ activation in V2, V3 is not the result of input arising from nearby (non-lesioned) V1 cortex. Electrophysiology recordings of multi-unit activity corroborated the BOLD observations: visually driven multi-unit responses could be elicited inside the V2 LPZ, even when the visual stimulus was entirely contained within the scotoma induced by the V1 lesion. Restricting the stimulus to the intact visual hemi-field produced no significant BOLD modulation inside the V2, V3 LPZs. We conclude that the observed activity patterns are largely mediated by parallel, V1-bypassing, subcortical pathways that can activate areas V2 and V3 in the absence of V1 input. Such pathways may contribute to the behavioral phenomenon of blindsight.			Schmid, MC (corresponding author), Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany.	schmidmicha@gmail.com; ssmirnakis@cns.bcm.edu	Panagiotaropoulos, Theofanis/A-6053-2013; Schmid, Michael Christoph/AAH-4835-2020; Logothetis, Nikos/U-9282-2019; Schmid, Michael C./G-1867-2010	Panagiotaropoulos, Theofanis/0000-0002-4621-1183; Schmid, Michael Christoph/0000-0003-1424-130X; Schmid, Michael C./0000-0003-1424-130X	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY019272] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abel PL, 2000, J COMP NEUROL, V428, P278, DOI 10.1002/1096-9861(20001211)428:2<278::AID-CNE7>3.0.CO;2-R; Adams MM, 2000, J COMP NEUROL, V419, P377, DOI 10.1002/(SICI)1096-9861(20000410)419:3<377::AID-CNE9>3.0.CO;2-E; Anderson JC, 2006, J COMP NEUROL, V495, P709, DOI 10.1002/cne.20914; Azzopardi P, 2003, NEUROPSYCHOLOGIA, V41, P1738, DOI 10.1016/S0028-3932(03)00176-3; BARBUR JL, 1980, BRAIN, V103, P905, DOI 10.1093/brain/103.4.905; BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; Baseler HA, 1999, J NEUROSCI, V19, P2619; BENDER DB, 1981, J NEUROPHYSIOL, V46, P672, DOI 10.1152/jn.1981.46.3.672; Berman RA, 2008, PROG BRAIN RES, V171, P467, DOI 10.1016/S0079-6123(08)00668-7; Brewer AA, 2002, J NEUROSCI, V22, P10416; BRUCE CJ, 1986, J NEUROPHYSIOL, V55, P1057, DOI 10.1152/jn.1986.55.5.1057; BULLIER J, 1983, EXP BRAIN RES, V53, P168; Collins CE, 2005, P NATL ACAD SCI USA, V102, P5594, DOI 10.1073/pnas.0501762102; Collins CE, 2003, J NEUROSCI, V23, P2251; COWEY A, 1962, NATURE, V193, P302, DOI 10.1038/193302a0; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ffytche DH, 1996, BRAIN, V119, P1971, DOI 10.1093/brain/119.6.1971; FRIES W, 1981, PROC R SOC SER B-BIO, V213, P73, DOI 10.1098/rspb.1981.0054; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GIRARD P, 1991, J NEUROPHYSIOL, V66, P1493, DOI 10.1152/jn.1991.66.5.1493; GIRARD P, 1992, J NEUROPHYSIOL, V67, P1437, DOI 10.1152/jn.1992.67.6.1437; GIRARD P, 1991, NEUROREPORT, V2, P81, DOI 10.1097/00001756-199102000-00004; GIRARD P, 1989, J NEUROPHYSIOL, V62, P1287, DOI 10.1152/jn.1989.62.6.1287; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; GROSS CG, 1991, NEUROPSYCHOLOGIA, V29, P497, DOI 10.1016/0028-3932(91)90007-U; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; HARTING JK, 1980, J COMP NEUROL, V192, P853, DOI 10.1002/cne.901920414; HUMPHREY NK, 1967, NATURE, V215, P595, DOI 10.1038/215595a0; KAAS JH, 1992, VISUAL NEUROSCI, V9, P399, DOI 10.1017/S0952523800010804; KENNEDY H, 1985, J NEUROSCI, V5, P2815; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MCKINNON GC, 1993, MAGNET RESON MED, V30, P609, DOI 10.1002/mrm.1910300512; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; PERRY VH, 1984, NEUROSCIENCE, V12, P1125, DOI 10.1016/0306-4522(84)90007-1; Riddoch G, 1917, BRAIN, V40, P15, DOI 10.1093/brain/40.1.15; ROCHAMIRANDA CE, 1975, J NEUROPHYSIOL, V38, P475, DOI 10.1152/jn.1975.38.3.475; Rockland KS, 1999, J COMP NEUROL, V406, P221, DOI 10.1002/(SICI)1096-9861(19990405)406:2<221::AID-CNE7>3.0.CO;2-K; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; Rosa MGP, 2000, J NEUROSCI, V20, P5552, DOI 10.1523/JNEUROSCI.20-14-05552.2000; SCHILLER PH, 1977, BRAIN RES, V126, P366, DOI 10.1016/0006-8993(77)90734-X; SCHILLER PH, 1974, J NEUROPHYSIOL, V37, P181, DOI 10.1152/jn.1974.37.1.181; SHIPP S, 1989, EUR J NEUROSCI, V1, P333, DOI 10.1111/j.1460-9568.1989.tb00799.x; Shipp S, 2001, J COMP NEUROL, V439, P469, DOI 10.1002/cne.1363; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; SMIRNAKIS SM, 2007, J CEREB BLOOD FLOW M; Soares JGM, 2004, CLIN EXP PHARMACOL P, V31, P580, DOI 10.1111/j.1440-1681.2004.04051.x; Stoerig P, 2002, CEREB CORTEX, V12, P565, DOI 10.1093/cercor/12.6.565; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; VANESSEN DC, 1982, J NEUROSCI, V2, P265; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Weiskrantz L, 2003, PROG BRAIN RES, V144, P229, DOI 10.1016/S0079-6123(03)14401-6; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; YUKIE M, 1981, J COMP NEUROL, V201, P81, DOI 10.1002/cne.902010107; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; ZEKI S, 1989, EUR J NEUROSCI, V1, P494, DOI 10.1111/j.1460-9568.1989.tb00356.x; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P245, DOI 10.1113/jphysiol.1978.sp012271	73	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5527	10.1371/journal.pone.0005527	http://dx.doi.org/10.1371/journal.pone.0005527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436733	Green Published, gold			2022-12-27	WOS:000266009900019
J	Won, KJ; Agarwal, S; Shen, L; Shoemaker, R; Ren, B; Wang, W				Won, Kyoung-Jae; Agarwal, Saurabh; Shen, Li; Shoemaker, Robert; Ren, Bing; Wang, Wei			An Integrated Approach to Identifying Cis-Regulatory Modules in the Human Genome	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; CLUSTERS; PREDICTION; DISCOVERY; PROMOTERS; MOTIFS	In eukaryotic genomes, it is challenging to accurately determine target sites of transcription factors (TFs) by only using sequence information. Previous efforts were made to tackle this task by considering the fact that TF binding sites tend to be more conserved than other functional sites and the binding sites of several TFs are often clustered. Recently, ChIP-chip and ChIP-sequencing experiments have been accumulated to identify TF binding sites as well as survey the chromatin modification patterns at the regulatory elements such as promoters and enhancers. We propose here a hidden Markov model (HMM) to incorporate sequence motif information, TF-DNA interaction data and chromatin modification patterns to precisely identify cis-regulatory modules (CRMs). We conducted ChIP-chip experiments on four TFs, CREB, E2F1, MAX, and YY1 in 1% of the human genome. We then trained a hidden Markov model (HMM) to identify the labels of the CRMs by incorporating the sequence motifs recognized by these TFs and the ChIP-chip ratio. Chromatin modification data was used to predict the functional sites and to further remove false positives. Cross-validation showed that our integrated HMM had a performance superior to other existing methods on predicting CRMs. Incorporating histone signature information successfully penalized false prediction and improved the whole performance. The dataset we used and the software are available at http://nash.ucsd.edu/CIS/.			Won, KJ (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	biren@ucsd.edu; wei-wang@ucsd.edu	Hu, Ruogu/B-2203-2008; Shen, Li/B-3562-2008	Shen, Li/0000-0002-5190-2851; Won, Kyoung Jae/0000-0002-2924-9630				Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bulyk ML, 2004, GENOME BIOL, V5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Durbin R., 1998, BIOL SEQUENCE ANAL P; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Frith MC, 2002, NUCLEIC ACIDS RES, V30, P3214, DOI 10.1093/nar/gkf438; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Gupta M, 2005, P NATL ACAD SCI USA, V102, P7079, DOI 10.1073/pnas.0408743102; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JI H, 2006, NUCL ACIDS RES E, V146, P1188; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Krogh A, 2000, GENOME RES, V10, P523, DOI 10.1101/gr.10.4.523; KROGH A, 1997, 2 METHODS IMPROVING, P179; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Rokas A, 2007, CURR BIOL, V17, pR626, DOI 10.1016/j.cub.2007.06.025; SHEN L, 2008, REWIRING YY1 T UNPUB; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Won KJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-547; Xie D, 2008, GENOME RES, V18, P1325, DOI 10.1101/gr.072769.107; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101; Zhou Q, 2007, ANN APPL STAT, V1, P36, DOI 10.1214/07-AOAS103	30	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2009	4	5							e5501	10.1371/journal.pone.0005501	http://dx.doi.org/10.1371/journal.pone.0005501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VZ	19434238	Green Submitted, Green Published, gold			2022-12-27	WOS:000266009800005
J	Brunert, D; Kurtenbach, S; Isik, S; Benecke, H; Gisselmann, G; Schuhmann, W; Hatt, H; Wetzel, CH				Brunert, Daniela; Kurtenbach, Stefan; Isik, Sonnur; Benecke, Heike; Gisselmann, Guenter; Schuhmann, Wolfgang; Hatt, Hanns; Wetzel, Christian H.			Odorant-Dependent Generation of Nitric Oxide in Mammalian Olfactory Sensory Neurons	PLOS ONE			English	Article								The gaseous signalling molecule nitric oxide (NO) is involved in various physiological processes including regulation of blood pressure, immunocytotoxicity and neurotransmission. In the mammalian olfactory bulb (OB), NO plays a role in the formation of olfactory memory evoked by pheromones as well as conventional odorants. While NO generated by the neuronal isoform of NO synthase (nNOS) regulates neurogenesis in the olfactory epithelium, NO has not been implicated in olfactory signal transduction. We now show the expression and function of the endothelial isoform of NO synthase (eNOS) in mature olfactory sensory neurons (OSNs) of adult mice. Using NO-sensitive micro electrodes, we show that stimulation liberates NO from isolated wild-type OSNs, but not from OSNs of eNOS deficient mice. Integrated electrophysiological recordings (electro-olfactograms or EOGs) from the olfactory epithelium of these mice show that NO plays a significant role in modulating adaptation. Evidence for the presence of eNOS in mature mammalian OSNs and its involvement in odorant adaptation implicates NO as an important new element involved in olfactory signal transduction. As a diffusible messenger, NO could also have additional functions related to cross adaptation, regeneration, and maintenance of MOE homeostasis.			Brunert, D (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Bochum, Germany.	christian.wetzel@rub.de	Wetzel, Christian/F-1366-2018; Schuhmann, Wolfgang/S-2626-2016; Kurtenbach, Stefan/H-3786-2019; Wetzel, Christian H/N-9880-2017; Wetzel, Christian/C-2501-2009	Schuhmann, Wolfgang/0000-0003-2916-5223; Kurtenbach, Stefan/0000-0002-7445-596X; Wetzel, Christian H/0000-0002-5762-0003; Wetzel, Christian/0000-0002-5762-0003				Arnhold S, 1997, NEUROSCI LETT, V229, P165, DOI 10.1016/S0304-3940(97)00457-6; BARTSCH S, 1992, J NEUROSCI, V12, P736; Bedioui F, 1997, BIOSENS BIOELECTRON, V12, P205, DOI 10.1016/S0956-5663(97)85338-9; BREER H, 1992, NEUROREPORT, V3, P1030, DOI 10.1097/00001756-199211000-00022; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Chang SC, 2005, BIOSENS BIOELECTRON, V21, P917, DOI 10.1016/j.bios.2005.02.015; Cometto-Muniz JE, 1998, PHARMACOL BIOCHEM BE, V60, P765, DOI 10.1016/S0091-3057(98)00054-9; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Godecke A, 1998, CIRC RES, V82, P186; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Ingi T, 1995, J NEUROSCI, V15, P8214; Isik S, 2006, ANGEW CHEM INT EDIT, V45, P7451, DOI 10.1002/anie.200601708; Kosaka T, 2007, NEUROSCI RES, V57, P165, DOI 10.1016/j.neures.2006.10.005; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; LEIBOWITZ MD, 1986, J GEN PHYSIOL, V87, P25, DOI 10.1085/jgp.87.1.25; Lucero MT, 1998, BRAIN RES, V807, P234, DOI 10.1016/S0006-8993(98)00825-7; Lynch JW, 1998, J MEMBRANE BIOL, V165, P227, DOI 10.1007/s002329900436; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Moon C, 2005, J NEUROCHEM, V95, P200, DOI 10.1111/j.1471-4159.2005.03356.x; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; ROSKAMS AJ, 1994, NEURON, V13, P289; Schmachtenberg O, 2003, BRAIN RES, V980, P146, DOI 10.1016/S0006-8993(03)02990-1; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Weiler E, 1997, J NEUROSCI, V17, P3610; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; Zufall F, 1998, ANN NY ACAD SCI, V855, P199, DOI 10.1111/j.1749-6632.1998.tb10566.x	29	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5499	10.1371/journal.pone.0005499	http://dx.doi.org/10.1371/journal.pone.0005499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430528	Green Submitted, gold, Green Published			2022-12-27	WOS:000266009700005
J	Beste, DJV; Espasa, M; Bonde, B; Kierzek, AM; Stewart, GR; McFadden, J				Beste, Dany J. V.; Espasa, Mateus; Bonde, Bhushan; Kierzek, Andrzej M.; Stewart, Graham R.; McFadden, Johnjoe			The Genetic Requirements for Fast and Slow Growth in Mycobacteria	PLOS ONE			English	Article								Mycobacterium tuberculosis infects a third of the world's population. Primary tuberculosis involving active fast bacterial replication is often followed by asymptomatic latent tuberculosis, which is characterised by slow or non-replicating bacteria. Reactivation of the latent infection involving a switch back to active bacterial replication can lead to post-primary transmissible tuberculosis. Mycobacterial mechanisms involved in slow growth or switching growth rate provide rational targets for the development of new drugs against persistent mycobacterial infection. Using chemostat culture to control growth rate, we screened a transposon mutant library by Transposon site hybridization (TraSH) selection to define the genetic requirements for slow and fast growth of Mycobacterium bovis (BCG) and for the requirements of switching growth rate. We identified 84 genes that are exclusively required for slow growth (69 hours doubling time) and 256 genes required for switching from slow to fast growth. To validate these findings we performed experiments using individual M. tuberculosis and M. bovis BCG knock out mutants. We have demonstrated that growth rate control is a carefully orchestrated process which requires a distinct set of genes encoding several virulence determinants, gene regulators, and metabolic enzymes. The mce1 locus appears to be a component of the switch to slow growth rate, which is consistent with the proposed role in virulence of M. tuberculosis. These results suggest novel perspectives for unravelling the mechanisms involved in the switch between acute and persistent TB infections and provide a means to study aspects of this important phenomenon in vitro.			Beste, DJV (corresponding author), Univ Surrey, FHMS, Guildford GU2 5XH, Surrey, England.	j.mcfadden@surrey.ac.uk	ESPASA, MATEU/L-4587-2014	ESPASA, MATEU/0000-0003-4822-1024; Kierzek, Andrzej/0000-0002-2605-9057; McFadden, Johnjoe/0000-0003-2145-0046; Beste, Dany/0000-0001-6579-1366; Stewart, Graham/0000-0002-6867-6248	Biotechnology and Biological Sciences Research Council [BB/D007208/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline; BBSRC [BB/D007208/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; Beste DJV, 2007, J BACTERIOL, V189, P3969, DOI 10.1128/JB.01787-06; Beste DJV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r89; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chan K, 2005, INFECT IMMUN, V73, P5438, DOI 10.1128/IAI.73.9.5438-5449.2005; Chen P, 2000, INFECT IMMUN, V68, P5575, DOI 10.1128/IAI.68.10.5575-5580.2000; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Downing KJ, 2004, TUBERCULOSIS, V84, P167, DOI 10.1016/j.tube.2003.12.004; El Hajji M, 2009, MATH BIOSCI, V218, P33, DOI 10.1016/j.mbs.2008.12.003; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; GOLDMAN DS, 1963, J BACTERIOL, V86, P30, DOI 10.1128/JB.86.1.30-37.1963; Gu XL, 2006, BIOCHEM BIOPH RES CO, V339, P897, DOI 10.1016/j.bbrc.2005.11.088; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hu YM, 2004, FEMS MICROBIOL LETT, V237, P415, DOI 10.1016/j.femsle.2004.07.005; Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Karls RK, 2006, MICROBIOL-SGM, V152, P1591, DOI 10.1099/mic.0.28591-0; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Lima P, 2007, MICROBES INFECT, V9, P1285, DOI 10.1016/j.micinf.2007.05.020; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; Lobry C, 2006, CR BIOL, V329, P40, DOI 10.1016/j.crvi.2005.10.004; Movahedzadeh F, 2004, MICROBIOL-SGM, V150, P3499, DOI 10.1099/mic.0.27204-0; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; R Development Core Team, 2006, R LANG ENV STAT COMP; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rickman L, 2004, BIOCHEM BIOPH RES CO, V314, P259, DOI 10.1016/j.bbrc.2003.12.082; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Rousseau C, 2004, CELL MICROBIOL, V6, P277, DOI 10.1046/j.1462-5822.2004.00368.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Uchida Y, 2007, CELL MICROBIOL, V9, P1275, DOI 10.1111/j.1462-5822.2006.00870.x; Vulic M, 2001, GENETICS, V158, P519; *WHO, 2008, TUB FACT SHEET; Williams EP, 2007, J BACTERIOL, V189, P4234, DOI 10.1128/JB.00201-07; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198	54	85	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2009	4	4							e5349	10.1371/journal.pone.0005349	http://dx.doi.org/10.1371/journal.pone.0005349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VL	19479006	Green Published, Green Submitted, gold			2022-12-27	WOS:000265514900012
J	Wagner, W; Bork, S; Horn, P; Krunic, D; Walenda, T; Diehlmann, A; Benes, V; Blake, J; Huber, FX; Eckstein, V; Boukamp, P; Ho, AD				Wagner, Wolfgang; Bork, Simone; Horn, Patrick; Krunic, Damir; Walenda, Thomas; Diehlmann, Anke; Benes, Vladimir; Blake, Jonathon; Huber, Franz-Xaver; Eckstein, Volker; Boukamp, Petra; Ho, Anthony D.			Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; BONE-MARROW; LIFE-SPAN; TELOMERASE ACTIVITY; IN-VIVO; INTERNATIONAL-SOCIETY; SELF-RENEWAL; AGE; DIFFERENTIATION; EXPRESSION	The regenerative potential diminishes with age and this has been ascribed to functional impairments of adult stem cells. Cells in culture undergo senescence after a certain number of cell divisions whereby the cells enlarge and finally stop proliferation. This observation of replicative senescence has been extrapolated to somatic stem cells in vivo and might reflect the aging process of the whole organism. In this study we have analyzed the effect of aging on gene expression profiles of human mesenchymal stromal cells (MSC) and human hematopoietic progenitor cells (HPC). MSC were isolated from bone marrow of donors between 21 and 92 years old. 67 genes were age-induced and 60 were age-repressed. HPC were isolated from cord blood or from mobilized peripheral blood of donors between 27 and 73 years and 432 genes were age-induced and 495 were age-repressed. The overlap of age-associated differential gene expression in HPC and MSC was moderate. However, it was striking that several age-related gene expression changes in both MSC and HPC were also differentially expressed upon replicative senescence of MSC in vitro. Especially genes involved in genomic integrity and regulation of transcription were age-repressed. Although telomerase activity and telomere length varied in HPC particularly from older donors, an age-dependent decline was not significant arguing against telomere exhaustion as being causal for the aging phenotype. These studies have demonstrated that aging causes gene expression changes in human MSC and HPC that vary between the two different cell types. Changes upon aging of MSC and HPC are related to those of replicative senescence of MSC in vitro and this indicates that our stem and progenitor cells undergo a similar process also in vivo.			Wagner, W (corresponding author), Heidelberg Univ, Dept Med 5, Heidelberg, Germany.	wwagner@ukaachen.de		Ho, Anthony D./0000-0002-1656-0833; Benes, Vladimir/0000-0002-0352-2547; Wagner, Wolfgang/0000-0002-1971-3217				Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Assounga AG, 2004, IMMUNOLOGY, V113, P378, DOI 10.1111/j.1365-2567.2004.01967.x; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Blake J, 2006, BIOINFORMATICS, V22, P765, DOI 10.1093/bioinformatics/btk022; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Cerezo A, 2003, J INVEST DERMATOL, V121, P110, DOI 10.1046/j.1523-1747.2003.12304.x; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; DEHAAN G, 2007, EPIGENETIC CONTROL H; Di Donna S, 2003, MOL CANCER RES, V1, P643; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Dykstra B, 2008, CELL TISSUE RES, V331, P91, DOI 10.1007/s00441-007-0529-9; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Gazit R, 2008, SEMIN HEMATOL, V45, P218, DOI 10.1053/j.seminhematol.2008.07.010; Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x; GOLDSTEIN S, 1978, SCIENCE, V199, P781, DOI 10.1126/science.622567; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Ho AD, 2005, EMBO REP, V6, pS35, DOI 10.1038/sj.embor.7400436; Horn P, 2008, CYTOTHERAPY, V10, P676, DOI 10.1080/14653240802398845; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; JANICKBUCKNER D, 1991, GROWTH DEVELOP AGING, V55, P53; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kamminga LM, 2006, STEM CELLS, V24, P1143, DOI 10.1634/stemcells.2005-0345; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kirkwood TBL, 2008, J INTERN MED, V263, P117, DOI 10.1111/j.1365-2796.2007.01901.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Krunic D, 2009, BBA-MOL BASIS DIS, V1792, P297, DOI 10.1016/j.bbadis.2009.02.005; Lee HS, 2003, STEM CELLS, V21, P190, DOI 10.1634/stemcells.21-2-190; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7; Nalapareddy K, 2008, EXP GERONTOL, V43, P998, DOI 10.1016/j.exger.2008.09.002; Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prall WC, 2007, MECH AGEING DEV, V128, P503, DOI 10.1016/j.mad.2007.06.008; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wagner W, 2004, BLOOD, V104, P675, DOI 10.1182/blood-2003-10-3423; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; WALENDA T, 2009, J CELL MOL IN PRESS; Weng NP, 2001, J LEUKOCYTE BIOL, V70, P861; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zimmermann S, 2004, STEM CELLS, V22, P741, DOI 10.1634/stemcells.22-5-741	75	350	360	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5846	10.1371/journal.pone.0005846	http://dx.doi.org/10.1371/journal.pone.0005846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513108	gold, Green Published, Green Submitted			2022-12-27	WOS:000267228800011
J	Tokumasu, F; Nardone, GA; Ostera, GR; Fairhurst, RM; Beaudry, SD; Hayakawa, E; Dvorak, JA				Tokumasu, Fuyuki; Nardone, Glenn A.; Ostera, Graciela R.; Fairhurst, Rick M.; Beaudry, Steven D.; Hayakawa, Eri; Dvorak, James A.			Altered Membrane Structure and Surface Potential in Homozygous Hemoglobin C Erythrocytes	PLOS ONE			English	Article								Background: Hemoglobin C differs from normal hemoglobin A by a glutamate-to-lysine substitution at position 6 of beta globin and is oxidatively unstable. Compared to homozygous AA erythrocytes, homozygous CC erythrocytes contain higher levels of membrane-associated hemichromes and more extensively clustered band 3 proteins. These findings suggest that CC erythrocytes have a different membrane matrix than AA erythrocytes. Methodology and Findings: We found that AA and CC erythrocytes differ in their membrane lipid composition, and that a subset of CC erythrocytes expresses increased levels of externalized phosphatidylserine. Detergent membrane analyses for raft marker proteins indicated that CC erythrocyte membranes are more resistant to detergent solubilization. These data suggest that membrane raft organization is modified in CC erythrocytes. In addition, the average zeta potential (a measure of surface electrochemical potential) of CC erythrocytes was approximate to 2 mV lower than that of AA erythrocytes, indicating that substantial rearrangements occur in the membrane matrix of CC erythrocytes. We were able to recapitulate this low zeta potential phenotype in AA erythrocytes by treating them with NaNO(2) to oxidize hemoglobin A molecules and increase levels of membrane-associated hemichromes. Conclusion: Our data support the possibility that increased hemichrome deposition and altered lipid composition induce molecular rearrangements in CC erythrocyte membranes, resulting in a unique membrane structure.			Tokumasu, F (corresponding author), NIAID, Biophys & Biochem Parasitol Sect, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ftokumasu@niaid.nih.gov	Tokumasu, Fuyuki/GQP-4413-2022	Tokumasu, Fuyuki/0000-0003-2790-1071; Hayakawa, Eri/0000-0001-5067-2161	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000099, Z01AI001000, Z01AI000099, ZIAAI001000] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876; BATINA P, 1990, FOOD ADDIT CONTAM, V7, pS145, DOI 10.1080/02652039009373868; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; Brittain NJ, 2007, BRIT J HAEMATOL, V136, P491, DOI 10.1111/j.1365-2141.2006.06446.x; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; BRUNORI M, 1975, EUR J BIOCHEM, V53, P99, DOI 10.1111/j.1432-1033.1975.tb04046.x; CARRELL RW, 1975, BRIT J HAEMATOL, V30, P259, DOI 10.1111/j.1365-2141.1975.tb00540.x; CHIU D, 1989, SEMIN HEMATOL, V26, P128; Ciana A, 2005, J BIOSCIENCES, V30, P317, DOI 10.1007/BF02703669; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Daugas E, 2001, CELL DEATH DIFFER, V8, P1131, DOI 10.1038/sj.cdd.4400953; Duranton C, 2002, J PHYSIOL-LONDON, V539, P847, DOI 10.1113/jphysiol.2001.013040; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; FABRY ME, 1981, J CLIN INVEST, V67, P1284, DOI 10.1172/JCI110156; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; FLYNN TP, 1983, J CLIN INVEST, V71, P1215, DOI 10.1172/JCI110870; FRENCH CL, 1995, J APPL TOXICOL, V15, P167, DOI 10.1002/jat.2550150306; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; GUTHRIE N, 1995, MOL CELL BIOCHEM, V144, P117, DOI 10.1007/BF00944390; HASTED JB, 1948, J CHEM PHYS, V16, P1, DOI 10.1063/1.1746645; HEBBEL RP, 1985, CLIN HAEMATOL, V14, P129; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; HIRSCH RE, 1985, BLOOD, V66, P775; JAN KM, 1973, J GEN PHYSIOL, V61, P638, DOI 10.1085/jgp.61.5.638; KOSAKA H, 1982, BIOCHIM BIOPHYS ACTA, V702, P237; Kusumi A, 2005, SEMIN IMMUNOL, V17, P3, DOI 10.1016/j.smim.2004.09.004; Kuypers FA, 2004, CELL MOL BIOL, V50, P147; Kuypers FA, 1998, BLOOD, V91, P3044, DOI 10.1182/blood.V91.8.3044.3044_3044_3051; Lang F, 2004, PFLUG ARCH EUR J PHY, V448, P319, DOI 10.1007/s00424-004-1254-9; Lang PA, 2005, N-S ARCH PHARMACOL, V372, P228, DOI 10.1007/s00210-005-0009-2; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; LUTZ HU, 1984, J IMMUNOL, V133, P2610; Murphy SC, 2006, MOL MEMBR BIOL, V23, P81, DOI 10.1080/09687860500473440; Murphy SC, 2004, BLOOD, V103, P1920, DOI 10.1182/blood-2003-09-3165; Nagababu E, 2008, BLOOD CELL MOL DIS, V41, P60, DOI 10.1016/j.bcmd.2007.12.003; Nagao E, 2002, EXP PARASITOL, V102, P57, DOI 10.1016/S0014-4894(02)00143-1; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Patton G M, 1998, Methods Mol Biol, V110, P193; RACHMILEWITZ EA, 1974, SEMIN HEMATOL, V11, P441; REISS GH, 1982, J CLIN INVEST, V70, P946, DOI 10.1172/JCI110706; REPKA T, 1993, BLOOD, V82, P3204; RICEEVANS C, 1987, BIOCHEM J, V244, P191, DOI 10.1042/bj2440191; RICEEVANS C, 1986, BIOCHEM J, V237, P265, DOI 10.1042/bj2370265; RIFKIND JM, 1994, METHOD ENZYMOL, V231, P449; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; SHINAR E, 1990, SEMIN HEMATOL, V27, P70; SHUKLA SD, 1982, ARCH BIOCHEM BIOPHYS, V214, P335, DOI 10.1016/0003-9861(82)90038-8; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMITH EW, 1959, B JOHNS HOPKINS HOSP, V104, P17; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tokumasu F, 2005, J CELL SCI, V118, P1091, DOI 10.1242/jcs.01662; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; Wahid ST, 2001, DIABETES CARE, V24, P2001, DOI 10.2337/diacare.24.11.2001-a; WANG WQ, 1994, ACTA CHEM SCAND, V48, P753, DOI 10.3891/acta.chem.scand.48-0753; WAUGH SM, 1985, BIOCHEMISTRY-US, V24, P34, DOI 10.1021/bi00322a006; WINTERBOURN CC, 1974, J CLIN INVEST, V54, P678, DOI 10.1172/JCI107806; Winterbourn CC, 1985, CRC HDB METHODS OXYG, P137; Zhang DC, 2000, BLOOD, V96, P2925	64	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5828	10.1371/journal.pone.0005828	http://dx.doi.org/10.1371/journal.pone.0005828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503809	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717400008
J	Kamath, AT; Rochat, AF; Christensen, D; Agger, EM; Andersen, P; Lambert, PH; Siegrist, CA				Kamath, Arun T.; Rochat, Anne-Francoise; Christensen, Dennis; Agger, Else Marie; Andersen, Peter; Lambert, Paul-Henri; Siegrist, Claire-Anne			A Liposome-Based Mycobacterial Vaccine Induces Potent Adult and Neonatal Multifunctional T Cells through the Exquisite Targeting of Dendritic Cells	PLOS ONE			English	Article								Background: In the search for more potent and safer tuberculosis vaccines, CAF01 was identified as a remarkable formulation. Based on cationic liposomes and including a synthetic mycobacterial glycolipid as TLR-independent immunomodulator, it induces strong and protective T helper-1 and T helper-17 adult murine responses to Ag85B-ESAT-6, a major mycobacterial fusion protein. Here, we assessed whether these properties extend to early life and how CAF01 mediates its adjuvant properties in vivo. Methods/Findings: Following adult or neonatal murine immunization, Ag85B-ESAT-6/CAF01 similarly reduced the post-challenge bacterial growth of M. bovis BCG, whereas no protection was observed using Alum as control. This protection was mediated by the induction of similarly strong Th1 and Th17 responses in both age groups. Multifunctional Th1 cells were already elicited after a single vaccine dose and persisted at high levels for at least 6 months even after neonatal priming. Unexpectedly, this potent adjuvanticity was not mediated by a massive targeting/activation of dendritic cells: in contrast, very few DCs in the draining lymph nodes were bearing the labeled antigen/adjuvant. The increased expression of the CD40 and CD86 activation markers was restricted to the minute portion of adjuvant-bearing DCs. However, vaccine-associated activated DCs were recovered several days after immunization. Conclusion: The potent adult and neonatal adjuvanticity of CAF01 is associated in vivo with an exquisite but prolonged DC uptake and activation, fulfilling the preclinical requirements for novel tuberculosis vaccines to be used in early life.			Kamath, AT (corresponding author), Univ Geneva, Fac Med, Collaborating Ctr Vaccinol & Neonatal Immunol, WHO,Dept Pathol Immunol, Geneva, Switzerland.	Claire-Anne.Siegrist@unige.ch	Christensen, Dennis/C-6378-2008	Christensen, Dennis/0000-0003-2382-8639; Andersen, Peter/0000-0002-5869-2551				Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Barrios C, 1996, EUR J IMMUNOL, V26, P2666, DOI 10.1002/eji.1830261118; Baumann S, 2006, CURR OPIN IMMUNOL, V18, P438, DOI 10.1016/j.coi.2006.05.016; Cendron D, 2007, EUR J IMMUNOL, V37, P549, DOI 10.1002/eji.200636343; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Dadaglio G, 2002, J IMMUNOL, V168, P2219, DOI 10.4049/jimmunol.168.5.2219; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; de Jong R, 1998, SCIENCE, V280, P1435; GILLIS S, 1978, J IMMUNOL, V120, P2027; Giri PK, 2008, EXPERT OPIN BIOL TH, V8, P1759, DOI [10.1517/14712598.8.11.1759, 10.1517/14712598.8.11.1759 ]; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3; Holten-Andersen L, 2004, INFECT IMMUN, V72, P1608, DOI 10.1128/IAI.72.3.1608-1617.2004; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kaufmann SHE, 2008, SCAND J INFECT DIS, V40, P595, DOI 10.1080/00365540802032759; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Knuf M, 2008, J PEDIATR-US, V152, P655, DOI 10.1016/j.jpeds.2007.09.034; KORSHOLM KS, 2007, IMMUNOLOGY; Kovarik J, 2000, VIROLOGY, V268, P122, DOI 10.1006/viro.1999.0159; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Mandalakas Anna M, 2005, Semin Pediatr Infect Dis, V16, P93, DOI 10.1053/j.spid.2005.01.001; Martin GH, 2003, LIBRARY, V4, P428, DOI 10.1093/library/4.4.428; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miles DJC, 2008, CLIN VACCINE IMMUNOL, V15, P995, DOI 10.1128/CVI.00037-08; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Regner M, 2004, J IMMUNOL, V173, P2669, DOI 10.4049/jimmunol.173.4.2669; Reichenbach J, 2001, CURR OPIN ALLERGY CL, V1, P503, DOI 10.1097/00130832-200112000-00003; Riedl K, 2008, VACCINE, V26, P3461, DOI 10.1016/j.vaccine.2008.04.029; Roduit C, 2002, INFECT IMMUN, V70, P3521, DOI 10.1128/IAI.70.7.3521-3528.2002; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Teoh D, 2009, J IMMUNOL, V182, P2425, DOI 10.4049/jimmunol.0803661; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vekemans J, 2001, EUR J IMMUNOL, V31, P1531, DOI 10.1002/1521-4141(200105)31:5<1531::AID-IMMU1531>3.0.CO;2-1; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V32, P65, DOI 10.1016/S0928-8244(01)00267-X; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; WHO, 2007, WKLY EPIDEMIOL REC, V82, P18; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336	52	72	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5771	10.1371/journal.pone.0005771	http://dx.doi.org/10.1371/journal.pone.0005771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492047	Green Published, gold, Green Submitted			2022-12-27	WOS:000266624300008
J	Kelso, JAS; de Guzman, GC; Reveley, C; Tognoli, E				Kelso, J. A. Scott; de Guzman, Gonzalo C.; Reveley, Colin; Tognoli, Emmanuelle			Virtual Partner Interaction (VPI): Exploring Novel Behaviors via Coordination Dynamics	PLOS ONE			English	Article							PHASE-TRANSITIONS; HUMAN BRAIN; SYNCHRONIZATION; NETWORKS; MODEL; CLAMP; INTERFACES; EXCITATOR; COMPLEX; ROBOTS	Inspired by the dynamic clamp of cellular neuroscience, this paper introduces VPI-Virtual Partner Interaction-a coupled dynamical system for studying real time interaction between a human and a machine. In this proof of concept study, human subjects coordinate hand movements with a virtual partner, an avatar of a hand whose movements are driven by a computerized version of the Haken-Kelso-Bunz (HKB) equations that have been shown to govern basic forms of human coordination. As a surrogate system for human social coordination, VPI allows one to examine regions of the parameter space not typically explored during live interactions. A number of novel behaviors never previously observed are uncovered and accounted for. Having its basis in an empirically derived theory of human coordination, VPI offers a principled approach to human-machine interaction and opens up new ways to understand how humans interact with human-like machines including identification of underlying neural mechanisms.			Kelso, JAS (corresponding author), Florida Atlantic Univ, Human Brain & Behav Lab, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.	kelso@ccs.fau.edu		Tognoli, Emmanuelle/0000-0003-3674-504X	NIMH NIH HHS [R01 MH042900, MH 42900, R01 MH080838, MH 80038, R37 MH042900] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042900, R37MH042900, R01MH080838] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aramaki Y, 2006, CEREB CORTEX, V16, P1338, DOI 10.1093/cercor/bhj075; Barakova E., 2007, P 6 INT C INT DES CH, P73; Bartos M, 1999, J NEUROSCI, V19, P6650; Billard A, 2003, ROBOT AUTON SYST, V42, P259, DOI 10.1016/S0921-8890(02)00380-9; Braha D., 2006, COMPLEX ENG SYSTEMS; BREAZEAL M, 2002, INT J EXPT ROBOTICS, V11, P883; DAUTENHAHN K, 1999, SPRINGER LECT NOTES, V1562, P102; Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004; EDSINGER A, 2007, IEEE INT S ROBOT HUM, V16, P1167; Fink PW, 2009, J MOTOR BEHAV, V41, P147, DOI 10.3200/JMBR.41.2.147-157; Fisher NI, 1995, STAT ANAL CIRCULAR D; Forlizzi J, 2004, HUM-COMPUT INTERACT, V19, P25, DOI 10.1207/s15327051hci1901&2_3; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Fuchs A., 2009, ENCY COMPLEXITY SYST; Fuchs A, 2008, UNDERST COMPLEX SYST, P327, DOI 10.1007/978-3-540-74479-5_16; GEYER W, 2001, P 2001 INT ACM SIGGR; Gibson J.J., 1977, PERCEIVING ACTING KN, P67; Goaillard JM, 2006, PHYSIOLOGY, V21, P197, DOI 10.1152/physiol.00063.2005; Goodman PH, 2008, FRONT NEUROSCI-SWITZ, V2, P123, DOI 10.3389/neuro.01.007.2008; Grillner S, 1999, CURR OPIN NEUROBIOL, V9, P663, DOI 10.1016/S0959-4388(99)00036-7; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hoc JM, 2000, ERGONOMICS, V43, P833, DOI 10.1080/001401300409044; HOLLAN J, 2000, ACM T COMPUT-HUM INT, V7, P75; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Inamura T, 2001, IEEE ASME INT C ADV, P159, DOI 10.1109/AIM.2001.936447; Jantzen KJ, 2004, P NATL ACAD SCI USA, V101, P6815, DOI 10.1073/pnas.0401300101; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; Kaplan F, 2008, FRONT NEUROSCI-SWITZ, V2, P22, DOI 10.3389/neuro.01.023.2008; Kath WL, 2007, SCIENCE, V316, P1857, DOI 10.1126/science.1145111; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; KAZEROONI H, 1990, IEEE T SYST MAN CYB, V20, P450, DOI 10.1109/21.52555; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1987, PHYS SCRIPTA, V35, P79, DOI 10.1088/0031-8949/35/1/020; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; KELSO JAS, 1992, PHYS LETT A, V169, P134, DOI 10.1016/0375-9601(92)90583-8; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; KRAMER NC, HUMAN COMMU IN PRESS; Kuniyoshi Y, 2004, LECT NOTES ARTIF INT, V3139, P202; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Mayville JM, 1999, EXP BRAIN RES, V127, P371, DOI 10.1007/s002210050805; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Nowotny T, 2003, J NEUROSCI, V23, P9776; Oprisan SA, 2004, BIOPHYS J, V87, P2283, DOI 10.1529/biophysj.104.046193; Oullier O, 2009, ENCY COMPLEXITY SYST; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Park DC, 2007, J GERONTOL B-PSYCHOL, V62, P45, DOI 10.1093/geronb/62.special_issue_1.45; Patil PG, 2008, NEUROTHERAPEUTICS, V5, P137, DOI 10.1016/j.nurt.2007.11.002; PEPER CE, 2003, HUM MOVEMENT SCI, V18, P263; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Preiss DD, 2005, EDUC PSYCHO, P183; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; REGER BD, 2006, ARTIF LIFE, V6, P307; Repp BH, 2008, HUM MOVEMENT SCI, V27, P423, DOI 10.1016/j.humov.2008.02.016; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roy David M, 1994, C COMP HUM FACT COMP C COMP HUM FACT COMP, P313; SALVINI P, 2007, P 2007 IEEE INT C RO; SCHMIDT RC, 1994, BIOL CYBERN, V70, P369, DOI 10.1007/BF00200334; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; SCHOLTZ J, 2003, 36 ANN HAW INT C SYS, P125; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; Tognoli E, 2008, UNDERST COMPLEX SYST, P309, DOI 10.1007/978-3-540-74479-5_15; Wegner P, 1997, COMMUN ACM, V40, P80, DOI 10.1145/253769.253801; West R. L., 2001, Cognitive Systems Research, V1, P221, DOI 10.1016/S1389-0417(00)00014-0; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220; Zlatev J, 2001, MIND MACH, V11, P155, DOI 10.1023/A:1011218919464	75	77	77	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5749	10.1371/journal.pone.0005749	http://dx.doi.org/10.1371/journal.pone.0005749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453PV	19492044	gold, Green Published			2022-12-27	WOS:000266624300005
J	Kashuba, VI; Pavlova, TV; Grigorieva, EV; Kutsenko, A; Yenamandra, SP; Li, JF; Wang, FL; Protopopov, AI; Zabarovska, VI; Senchenko, V; Haraldson, K; Eshchenko, T; Kobliakova, J; Vorontsova, O; Kuzmin, I; Braga, E; Blinov, VM; Kisselev, LL; Zeng, YX; Ernberg, I; Lerman, MI; Klein, G; Zabarovsky, ER				Kashuba, Vladimir I.; Pavlova, Tatiana V.; Grigorieva, Elvira V.; Kutsenko, Alexey; Yenamandra, Surya Pavan; Li, Jingfeng; Wang, Fuli; Protopopov, Alexei I.; Zabarovska, Veronika I.; Senchenko, Vera; Haraldson, Klas; Eshchenko, Tatiana; Kobliakova, Julia; Vorontsova, Olga; Kuzmin, Igor; Braga, Eleonora; Blinov, Vladimir M.; Kisselev, Lev L.; Zeng, Yi-Xin; Ernberg, Ingemar; Lerman, Michael I.; Klein, George; Zabarovsky, Eugene R.			High Mutability of the Tumor Suppressor Genes RASSF1 and RBSP3 (CTDSPL) in Cancer	PLOS ONE			English	Article								Background: Many different genetic alterations are observed in cancer cells. Individual cancer genes display point mutations such as base changes, insertions and deletions that initiate and promote cancer growth and spread. Somatic hypermutation is a powerful mechanism for generation of different mutations. It was shown previously that somatic hypermutability of proto-oncogenes can induce development of lymphomas. Methodology/Principal Findings: We found an exceptionally high incidence of single-base mutations in the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) both located in 3p21.3 regions, LUCA and AP20 respectively. These regions contain clusters of tumor suppressor genes involved in multiple cancer types such as lung, kidney, breast, cervical, head and neck, nasopharyngeal, prostate and other carcinomas. Altogether in 144 sequenced RASSF1A clones (exons 1-2), 129 mutations were detected (mutation frequency, MF = 0.23 per 100 bp) and in 98 clones of exons 3-5 we found 146 mutations (MF = 0.29). In 85 sequenced RBSP3 clones, 89 mutations were found (MF = 0.10). The mutations were not cytidine-specific, as would be expected from alterations generated by AID/APOBEC family enzymes, and appeared de novo during cell proliferation. They diminished the ability of corresponding transgenes to suppress cell and tumor growth implying a loss of function. These high levels of somatic mutations were found both in cancer biopsies and cancer cell lines. Conclusions/Significance: This is the first report of high frequencies of somatic mutations in RASSF1 and RBSP3 in different cancers suggesting it may underlay the mutator phenotype of cancer. Somatic hypermutations in tumor suppressor genes involved in major human malignancies offer a novel insight in cancer development, progression and spread.			Kashuba, VI (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	lermanmi@gmail.com	Senchenko, Vera N/C-8992-2014; Grigorieva, Elvira/A-4937-2010; Kashuba, Vladimir/AAO-7742-2020; Kashuba, Vladimir I/N-3732-2017; Braga, Eleonora A./P-5574-2016	Senchenko, Vera N/0000-0002-3119-515X; Grigorieva, Elvira/0000-0003-2457-9179; Kashuba, Vladimir I/0000-0001-9416-8282; Braga, Eleonora/0000-0001-5188-4094; Pavlova, Tatiana/0000-0002-2857-5696	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alimov A, 2000, ONCOGENE, V19, P1392, DOI 10.1038/sj.onc.1203449; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; Braga E, 2002, INT J CANCER, V100, P534, DOI 10.1002/ijc.10511; Brulliard M, 2007, P NATL ACAD SCI USA, V104, P7522, DOI 10.1073/pnas.0611076104; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; CHUMAKOV IM, 1982, GENE, V17, P19, DOI 10.1016/0378-1119(82)90097-X; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2003, HISTOL HISTOPATHOL, V18, P665, DOI 10.14670/HH-18.665; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Gearhart PJ, 2001, NAT REV IMMUNOL, V1, P187, DOI 10.1038/35105009; Imreh S, 2003, GENE CHROMOSOME CANC, V38, P307, DOI 10.1002/gcc.10271; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kuzmin I, 2002, CANCER RES, V62, P3498; Lerman MI, 2000, CANCER RES, V60, P6116; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Li JF, 2004, ONCOGENE, V23, P5941, DOI 10.1038/sj.onc.1207789; Li JF, 2002, P NATL ACAD SCI USA, V99, P10724, DOI 10.1073/pnas.132271699; Li JF, 1999, FEBS LETT, V451, P289, DOI 10.1016/S0014-5793(99)00598-0; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Pan ZG, 2005, CANCER BIOL THER, V4, P1116, DOI 10.4161/cbt.4.10.2023; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Protopopov A, 2003, CANCER RES, V63, P404; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Senchenko V, 2003, ONCOGENE, V22, P2984, DOI 10.1038/sj.onc.1206429; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; SPANDIDOS DA, 1986, BIOSCIENCE REP, V6, P691, DOI 10.1007/BF01116536; Strauss BS, 2000, MUTAT RES-FUND MOL M, V457, P93, DOI 10.1016/S0027-5107(00)00135-4; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	36	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5231	10.1371/journal.pone.0005231	http://dx.doi.org/10.1371/journal.pone.0005231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478941	Green Published, Green Submitted, gold			2022-12-27	WOS:000266490000001
J	Namdar, M; Schepis, T; Koepfli, P; Gaemperli, O; Siegrist, PT; Grathwohl, R; Valenta, I; Delaloye, R; Klainguti, M; Wyss, CA; Luscher, TF; Kaufmann, PA				Namdar, Mehdi; Schepis, Tiziano; Koepfli, Pascal; Gaemperli, Oliver; Siegrist, Patrick T.; Grathwohl, Renate; Valenta, Ines; Delaloye, Raphael; Klainguti, Michael; Wyss, Christophe A.; Luescher, Thomas F.; Kaufmann, Philipp A.			Caffeine Impairs Myocardial Blood Flow Response to Physical Exercise in Patients with Coronary Artery Disease as well as in Age-Matched Controls	PLOS ONE			English	Article								Background: Caffeine is one of the most widely consumed pharmacologically active substances. Its acute effect on myocardial blood flow is widely unknown. Our aim was to assess the acute effect of caffeine in a dose corresponding to two cups of coffee on myocardial blood flow (MBF) in coronary artery disease (CAD). Methodology/Principal Findings: MBF was measured with O-15-labelled H2O and Positron Emission Tomography (PET) at rest and after supine bicycle exercise in controls (n = 15, mean age 58 +/- 13 years) and in CAD patients (n = 15, mean age 61 +/- 9 years). In the latter, regional MBF was assessed in segments subtended by stenotic and remote coronary arteries. All measurements were repeated fifty minutes after oral caffeine ingestion (200 mg). Myocardial perfusion reserve (MPR) was calculated as ratio of MBF during bicycle stress divided by MBF at rest. Resting MBF was not affected by caffeine in both groups. Exercise-induced MBF response decreased significantly after caffeine in controls (2.26 +/- 0.56 vs. 2.02 +/- 0.56, P<0.005), remote (2.40 +/- 0.70 vs. 1.78 +/- 0.46, P<0.001) and in stenotic segments (1.90 +/- 0.41 vs. 1.38 +/- 0.30, P<0.001). Caffeine decreased MPR significantly by 14% in controls (P<0.05 vs. baseline). In CAD patients MPR decreased by 18% (P<0.05 vs. baseline) in remote and by 25% in stenotic segments (P<0.01 vs. baseline). Conclusions: We conclude that caffeine impairs exercise-induced hyperaemic MBF response in patients with CAD to a greater degree than age-matched controls.			Namdar, M (corresponding author), Univ Zurich Hosp, CH-8091 Zurich, Switzerland.	pak@usz.ch		Kaufmann, Philipp/0000-0002-9451-5210; Namdar, Mehdi/0000-0002-5779-7431				BARDENHEUER H, 1986, AM J PHYSIOL, V250, pH173, DOI 10.1152/ajpheart.1986.250.2.H173; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; Baylin A, 2006, EPIDEMIOLOGY, V17, P506, DOI 10.1097/01.ede.0000229444.55718.96; Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; GROBBEE DE, 1990, NEW ENGL J MED, V323, P1026, DOI 10.1056/NEJM199010113231504; Happonen P, 2004, J NUTR, V134, P2381, DOI 10.1093/jn/134.9.2381; Headrick JP, 2003, AM J PHYSIOL-HEART C, V285, pH1797, DOI 10.1152/ajpheart.00407.2003; HEADRICK JP, 1993, AM J PHYSIOL, V264, pH61, DOI 10.1152/ajpheart.1993.264.1.H61; Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647; Kaufmann PA, 2000, J AM COLL CARDIOL, V36, P103, DOI 10.1016/S0735-1097(00)00697-5; Kaufmann PA, 2000, CIRCULATION, V102, P1233, DOI 10.1161/01.CIR.102.11.1233; Kaufmann PA, 1999, J NUCL MED, V40, P1848; Koepfli P, 2004, J NUCL MED, V45, P1626; Koepfli P, 2004, J NUCL MED, V45, P537; LACROIX AZ, 1986, NEW ENGL J MED, V315, P977, DOI 10.1056/NEJM198610163151601; MACDONALD TM, 1991, BRIT MED J, V303, P1235, DOI 10.1136/bmj.303.6812.1235; MINAMINO T, 1995, CIRCULATION, V92, P1254, DOI 10.1161/01.CIR.92.5.1254; Morrison RR, 2000, AM J PHYSIOL-HEART C, V279, pH1071, DOI 10.1152/ajpheart.2000.279.3.H1071; Namdar M, 2006, J AM COLL CARDIOL, V47, P405, DOI 10.1016/j.jacc.2005.08.064; PERITI M, 1987, CLIN SCI, V72, P443, DOI 10.1042/cs0720443; SHI J, 1993, CLIN PHARMACOL THER, V53, P6, DOI 10.1038/clpt.1993.3; Shryock JC, 1998, CIRCULATION, V98, P711, DOI 10.1161/01.CIR.98.7.711; SMOLENSKI RT, 1991, AM J PHYSIOL, V260, pC708, DOI 10.1152/ajpcell.1991.260.4.C708; Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481; Wyss CA, 2003, CIRCULATION, V108, P1202, DOI 10.1161/01.CIR.0000087432.63671.2E; Wyss CA, 2003, J NUCL MED, V44, P146	27	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5665	10.1371/journal.pone.0005665	http://dx.doi.org/10.1371/journal.pone.0005665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19479069	gold, Green Published, Green Submitted			2022-12-27	WOS:000266331200004
J	Cailotto, C; Lei, J; van der Vliet, J; van Heijningen, C; van Eden, CG; Kalsbeek, A; Pevet, P; Buijs, RM				Cailotto, Cathy; Lei, Jun; van der Vliet, Jan; van Heijningen, Caroline; van Eden, Corbert G.; Kalsbeek, Andries; Pevet, Paul; Buijs, Ruud M.			Effects of Nocturnal Light on (Clock) Gene Expression in Peripheral Organs: A Role for the Autonomic Innervation of the Liver	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; PLASMA-GLUCOSE; DIFFERENTIAL CONTROL; N-ACETYLTRANSFERASE; MELATONIN SYNTHESIS; INDUCED INHIBITION; NERVOUS-SYSTEM; ADRENAL-GLAND; RAT	Background: The biological clock, located in the hypothalamic suprachiasmatic nucleus (SCN), controls the daily rhythms in physiology and behavior. Early studies demonstrated that light exposure not only affects the phase of the SCN but also the functional activity of peripheral organs. More recently it was shown that the same light stimulus induces immediate changes in clock gene expression in the pineal and adrenal, suggesting a role of peripheral clocks in the organ-specific output. In the present study, we further investigated the immediate effect of nocturnal light exposure on clock genes and metabolism-related genes in different organs of the rat. In addition, we investigated the role of the autonomic nervous system as a possible output pathway of the SCN to modify the activity of the liver after light exposure. Methodology and Principal Findings: First, we demonstrated that light, applied at different circadian times, affects clock gene expression in a different manner, depending on the time of day and the organ. However, the changes in clock gene expression did not correlate in a consistent manner with those of the output genes (i.e., genes involved in the functional output of an organ). Then, by selectively removing the autonomic innervation to the liver, we demonstrated that light affects liver gene expression not only via the hormonal pathway but also via the autonomic input. Conclusion: Nocturnal light immediately affects peripheral clock gene expression but without a clear correlation with organ-specific output genes, raising the question whether the peripheral clock plays a "decisive" role in the immediate (functional) response of an organ to nocturnal light exposure. Interestingly, the autonomic innervation of the liver is essential to transmit the light information from the SCN, indicating that the autonomic nervous system is an important gateway for the SCN to cause an immediate resetting of peripheral physiology after phase-shift inducing light exposures.			Cailotto, C (corresponding author), Netherlands Inst Neurosci, Amsterdam, Netherlands.	c.cailotto@amc.uva.nl	Buijs, Rudolf/AAD-5707-2020; Kalsbeek, Andries/H-3076-2019; Jansen, Heiko T./A-5770-2008	Kalsbeek, Andries/0000-0001-9606-8453; Jansen, Heiko T./0000-0003-0178-396X				Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Bando H, 2007, J NEUROSCI, V27, P4359, DOI 10.1523/JNEUROSCI.4131-06.2007; BOS NPA, 1990, BRAIN RES, V511, P158, DOI 10.1016/0006-8993(90)90235-4; Buijs RM, 1998, PROG BRAIN RES, V119, P365; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cailotto C, 2008, ENDOCRINOLOGY, V149, P1914, DOI 10.1210/en.2007-0816; Chansard M, 2005, MOL BRAIN RES, V139, P333, DOI 10.1016/j.molbrainres.2005.06.004; Colle I, 2004, ANAT REC PART A, V280A, P924, DOI 10.1002/ar.a.20097; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x; DELAIGLESIA HO, 1995, NEUROREPORT, V6, P1715, DOI 10.1097/00001756-199509000-00004; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Drijfhout WJ, 1996, NEUROSCI LETT, V202, P185, DOI 10.1016/0304-3940(95)12245-1; Engeland WC, 2005, ENDOCRINE, V28, P325, DOI 10.1385/ENDO:28:3:325; Foulkes NS, 1997, BIOL CELL, V89, P487, DOI 10.1016/S0248-4900(98)80004-X; Fukuhara C, 2004, MOL BRAIN RES, V130, P109, DOI 10.1016/j.molbrainres.2004.07.014; Gerendai I, 2000, EXP CLIN ENDOCR DIAB, V108, P389, DOI 10.1055/s-2000-8134; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; HOLMES SW, 1976, BRIT J PHARMACOL, V56, pP360; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kalsbeek A, 2000, EUR J NEUROSCI, V12, P3146, DOI 10.1046/j.1460-9568.2000.00202.x; Kalsbeek A, 1999, NEUROSCIENCE, V91, P453, DOI 10.1016/S0306-4522(98)00635-6; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kalsbeek A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003194; KAMINSKY YG, 1987, COMP BIOCHEM PHYS B, V86, P763, DOI 10.1016/0305-0491(87)90224-0; KANEKO M, 1981, ENDOCRINOLOGY, V109, P70, DOI 10.1210/endo-109-1-70; Kennaway DJ, 2002, AM J PHYSIOL-REG I, V282, pR358, DOI 10.1152/ajpregu.00360.2001; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; Klieverik LP, 2008, AM J PHYSIOL-ENDOC M, V294, pE513, DOI 10.1152/ajpendo.00659.2007; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; la Fleur SE, 2003, DIABETES, V52, P2321, DOI 10.2337/diabetes.52.9.2321; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Larsen PJ, 1998, EUR J NEUROSCI, V10, P128; Lee CC, 2006, CANCER CAUSE CONTROL, V17, P525, DOI 10.1007/s10552-005-9003-8; LOH DH, 2008, NEUROENDOCRINOLOGY; Meijer JH, 1998, J NEUROSCI, V18, P9078; Meyer-Bernstein EL, 1999, ENDOCRINOLOGY, V140, P207, DOI 10.1210/en.140.1.207; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; Nagai K, 1996, PROG BRAIN RES, V111, P253, DOI 10.1016/S0079-6123(08)60413-6; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nishide S, 2006, GENES CELLS, V11, P1173, DOI 10.1111/j.1365-2443.2006.01015.x; NISHINO H, 1976, BRAIN RES, V112, P45, DOI 10.1016/0006-8993(76)90333-4; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; PERET J, 1978, J NUTR, V108, P265, DOI 10.1093/jn/108.2.265; Perreau-Lenz S, 2004, EUR J NEUROSCI, V19, P318, DOI 10.1111/j.0953-816X.2003.03132.x; Perreau-Lenz S, 2003, EUR J NEUROSCI, V17, P221, DOI 10.1046/j.1460-9568.2003.02442.x; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Radziuk J, 2001, DIABETES-METAB RES, V17, P250, DOI 10.1002/dmrr.217; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Scheer FAJL, 2005, NEUROSCIENCE, V132, P465, DOI 10.1016/j.neuroscience.2004.12.012; Scheer FAJL, 2001, AM J PHYSIOL-HEART C, V280, pH1391, DOI 10.1152/ajpheart.2001.280.3.H1391; Schibler U, 2005, CELL METAB, V2, P278, DOI 10.1016/j.cmet.2005.10.001; Schioth HB, 2003, GENOMICS, V81, P504, DOI 10.1016/S0888-7543(03)00028-4; Simonneaux V, 2004, MOL BRAIN RES, V120, P164, DOI 10.1016/j.molbrainres.2003.10.019; Slotten HA, 2000, BRAIN RES, V876, P10, DOI 10.1016/S0006-8993(00)02590-7; STEFFENS AB, 1969, PHYSIOL BEHAV, V4, P833, DOI 10.1016/0031-9384(69)90126-7; Sujino M, 2007, EUR J NEUROSCI, V26, P2731, DOI 10.1111/j.1460-9568.2007.05926.x; Teclemariam-Mesbah R, 1999, J COMP NEUROL, V406, P171, DOI 10.1002/(SICI)1096-9861(19990405)406:2<171::AID-CNE3>3.0.CO;2-U; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; VUJOVIC N, 2008, AM J PHYSL REGUL INT; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; YOO SH, 2004, P NATL ACAD SCI US; Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504; Young ME, 2001, CIRC RES, V88, P1142, DOI 10.1161/hh1101.091190	76	85	87	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5650	10.1371/journal.pone.0005650	http://dx.doi.org/10.1371/journal.pone.0005650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19478857	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331000009
J	Omelon, S; Georgiou, J; Henneman, ZJ; Wise, LM; Sukhu, B; Hunt, T; Wynnyckyj, C; Holmyard, D; Bielecki, R; Grynpas, MD				Omelon, Sidney; Georgiou, John; Henneman, Zachary J.; Wise, Lisa M.; Sukhu, Balram; Hunt, Tanya; Wynnyckyj, Chrystia; Holmyard, Douglas; Bielecki, Ryszard; Grynpas, Marc D.			Control of Vertebrate Skeletal Mineralization by Polyphosphates	PLOS ONE			English	Article								Background: Skeletons are formed in a wide variety of shapes, sizes, and compositions of organic and mineral components. Many invertebrate skeletons are constructed from carbonate or silicate minerals, whereas vertebrate skeletons are instead composed of a calcium phosphate mineral known as apatite. No one yet knows why the dynamic vertebrate skeleton, which is continually rebuilt, repaired, and resorbed during growth and normal remodeling, is composed of apatite. Nor is the control of bone and calcifying cartilage mineralization well understood, though it is thought to be associated with phosphate-cleaving proteins. Researchers have assumed that skeletal mineralization is also associated with non-crystalline, calcium- and phosphate-containing electron-dense granules that have been detected in vertebrate skeletal tissue prepared under non-aqueous conditions. Again, however, the role of these granules remains poorly understood. Here, we review bone and growth plate mineralization before showing that polymers of phosphate ions (polyphosphates: (PO(3)(-))(n)) are co-located with mineralizing cartilage and resorbing bone. We propose that the electron-dense granules contain polyphosphates, and explain how these polyphosphates may play an important role in apatite biomineralization. Principal Findings/Methodology: The enzymatic formation (condensation) and destruction (hydrolytic degradation) of polyphosphates offers a simple mechanism for enzymatic control of phosphate accumulation and the relative saturation of apatite. Under circumstances in which apatite mineral formation is undesirable, such as within cartilage tissue or during bone resorption, the production of polyphosphates reduces the free orthophosphate (PO(4)(3-)) concentration while permitting the accumulation of a high total PO(4)(3-) concentration. Sequestering calcium into amorphous calcium polyphosphate complexes can reduce the concentration of free calcium. The resulting reduction of both free PO(4)(3-) and free calcium lowers the relative apatite saturation, preventing formation of apatite crystals. Identified in situ within resorbing bone and mineralizing cartilage by the fluorescent reporter DAPI (4',6-diamidino-2-phenylindole), polyphosphate formation prevents apatite crystal precipitation while accumulating high local concentrations of total calcium and phosphate. When mineralization is required, tissue non-specific alkaline phosphatase, an enzyme associated with skeletal and cartilage mineralization, cleaves orthophosphates from polyphosphates. The hydrolytic degradation of polyphosphates in the calcium- polyphosphate complex increases orthophosphate and calcium concentrations and thereby favors apatite mineral formation. The correlation of alkaline phosphatase with this process may be explained by the destruction of polyphosphates in calcifying cartilage and areas of bone formation. Conclusions/Significance: We hypothesize that polyphosphate formation and hydrolytic degradation constitute a simple mechanism for phosphate accumulation and enzymatic control of biological apatite saturation. This enzymatic control of calcified tissue mineralization may have permitted the development of a phosphate-based, mineralized endoskeleton that can be continually remodeled.			Omelon, S (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	grynpas@lunenfeld.ca	Grynpas, Marc/ABG-7096-2020; Omelon, Sidney/GSE-4134-2022; Georgiou, John/E-9873-2013; Grynpas, Marc/E-4576-2013; Georgiou, John/ABA-1687-2020	Georgiou, John/0000-0003-4503-6384; Georgiou, John/0000-0003-4503-6384				Aaron J. E., 1978, Vitamin D, P201; ALLAN RA, 1980, CAN J MICROBIOL, V26, P912, DOI 10.1139/m80-158; ANDERSON HC, 1989, LAB INVEST, V60, P320; ARSENAULT AL, 1983, P NATL ACAD SCI-BIOL, V80, P1322, DOI 10.1073/pnas.80.5.1322; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Aubin Jane E., 1996, P51; BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; BEAUVOIT B, 1989, FEBS LETT, V252, P17, DOI 10.1016/0014-5793(89)80882-8; BENNETT RM, 1975, J CLIN INVEST, V56, P1571, DOI 10.1172/JCI108239; BONAR LC, 1983, CALCIFIED TISSUE INT, V35, P202, DOI 10.1007/BF02405032; BOOTHROYD B, 1964, J CELL BIOL, V20, P165, DOI 10.1083/jcb.20.1.165; BRIGHTON CT, 1994, BONE FORMATION REPAI; BROWN BE, 1982, BIOL REV, V57, P621, DOI 10.1111/j.1469-185X.1982.tb00375.x; Carter DH, 1997, HISTOCHEM J, V29, P783, DOI 10.1023/A:1026425404169; CH'UAN CHANG HUI, 1931, ANAT REC, V49, P397, DOI 10.1002/ar.1090490408; Das S, 1997, P NATL ACAD SCI USA, V94, P9075, DOI 10.1073/pnas.94.17.9075; de Jong WF, 1926, RECL TRAV CHIM PAY-B, V45, P445; EBRAHIMPOUR A, 1990, KINETICS DISSOLUTION; Eppell SJ, 2001, J ORTHOPAED RES, V19, P1027, DOI 10.1016/S0736-0266(01)00034-1; Eriksen EF., 1994, BONE HISTOMORPHOMETR; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; Fleisch H, 1999, Prog Mol Subcell Biol, V23, P197; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; FLEISH H, 1961, AM J PHYSIOL, V200, P1296, DOI 10.1152/ajplegacy.1961.200.6.1296; FORTUNA R, 1979, BIOCHIM BIOPHYS ACTA, V570, P291, DOI 10.1016/0005-2744(79)90149-9; FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664; Glimcher MJ, 2006, REV MINERAL GEOCHEM, V64, P223, DOI 10.2138/rmg.2006.64.8; GREENAWALT JW, 1964, J CELL BIOL, V23, P21, DOI 10.1083/jcb.23.1.21; Griffith E.J., 1995, PHOSPHATE FIBERS; Grynpas MD, 2007, BONE, V41, P162, DOI 10.1016/j.bone.2007.04.176; HAROLD FM, 1966, BACTERIOL REV, V30, P772, DOI 10.1128/MMBR.30.4.772-794.1966; HEARN PR, 1980, ANN RHEUM DIS, V39, P222, DOI 10.1136/ard.39.3.222; HEERSCHE JNM, 1990, ROLE CELLS CALCIFICA, P69; HIRSCHMA.A, 1969, CALC TISS RES, V4, P260, DOI 10.1007/BF02279129; HIRSCHMAN A, 1967, HISTOCHEMISTRY, V10, P369, DOI 10.1007/BF00304320; HUFFMAN EO, 1960, J PHYS CHEM-US, V64, P240, DOI 10.1021/j100831a014; KASHIWA HK, 1970, ANAT REC, V170, P119; Klauth P, 2006, APPL MICROBIOL BIOT, V72, P1099, DOI 10.1007/s00253-006-0562-8; Korn-berg A, 2008, MICROBE, V3, P119; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kulaev IS, 2004, BIOCH INORGANIC POLY, P1; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; LANDIS WJ, 1978, J ULTRA MOL STRUCT R, V63, P188, DOI 10.1016/S0022-5320(78)80074-4; LANDIS WJ, 1982, J ULTRA MOL STRUCT R, V78, P227, DOI 10.1016/S0022-5320(82)80001-4; LANDIS WJ, 1977, J ULTRA MOL STRUCT R, V59, P1, DOI 10.1016/S0022-5320(77)80025-7; LeGeros RZ., 1991, MON ORAL SCI, V15, P109, DOI [10.1159/000419238, DOI 10.1159/000419238]; LEHNINGER A L, 1970, Biochemical Journal, V119, P129; LEHNINGER AL, 1963, BIOCHEM BIOPH RES CO, V10, P444, DOI 10.1016/0006-291X(63)90377-2; LEITAO JM, 1995, MAR ECOL PROG SER, V121, P279, DOI 10.3354/meps121279; Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803; LORENZ B, 1994, J BIOL CHEM, V269, P22198; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; LOWENSTAM H. A., 1989, BIOMINERALISATION, P1; LYNN WS, 1963, BIOCHEM BIOPH RES CO, V11, P367, DOI 10.1016/0006-291X(63)90124-4; MARTIN JH, 1969, CALC TISS RES, V3, P184, DOI 10.1007/BF02058661; McConnell D, 1940, AM MINERAL, V25, P157; McConnell D., 1973, APATITE ITS CRYSTAL; MCCULLOUGH JF, 1956, J AM CHEM SOC, V78, P4528, DOI 10.1021/ja01599a006; Michelmore A, 2000, PHYS CHEM CHEM PHYS, V2, P2985, DOI 10.1039/b001213k; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Mullan A, 2002, ANAL BIOCHEM, V308, P294, DOI 10.1016/S0003-2697(02)00249-X; Mundy G. R., 1995, BONE REMODELING ITS; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Neu TR, 2002, APPL ENVIRON MICROB, V68, P901, DOI 10.1128/AEM.68.2.901-909.2002; NEUMAN WF, 1958, CHEMICAL DYNAMICS BO, P1; OMELON S, 2007, ELECTROPHORESIS, V28; Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527; Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97; Pestov NA, 2004, FEMS YEAST RES, V4, P643, DOI 10.1016/j.femsyr.2003.12.008; ROBISON R, 1991, CLIN ORTHOP RELAT R, P2; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; SCHWARZENBACH G, 1955, ANALYST, V80, P713, DOI 10.1039/an9558000713; SHAPIRO IM, 1969, CALC TISS RES, V3, P100, DOI 10.1007/BF02058651; SHAPIRO IM, 1984, METAB BONE DIS RELAT, V5, P317, DOI 10.1016/0221-8747(84)90019-5; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Taylor NW, 1929, J BIOL CHEM, V81, P479; TOMSON MB, 1977, ATOM ABSORPT NEWSL, V16, P177; Van Wazer J.R., 1958, PHOSPHORUS ITS COMPO; VANWAZER JR, 1950, J AM CHEM SOC, V72, P655; VANWAZER JR, 1950, J AM CHEM SOC, V72, P647; VANWAZER JR, 1950, J AM CHEM SOC, V72, P639; Weiner S, 2006, BONE, V39, P431, DOI 10.1016/j.bone.2006.02.058; WIDRA A, 1959, J BACTERIOL, V78, P664, DOI 10.1128/JB.78.5.664-670.1959	86	137	143	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5634	10.1371/journal.pone.0005634	http://dx.doi.org/10.1371/journal.pone.0005634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19492083	gold, Green Published, Green Submitted			2022-12-27	WOS:000266234700021
J	Carlsson, B; Kindberg, E; Buesa, J; Rydell, GE; Lidon, MF; Montava, R; Abu Mallouh, R; Grahn, A; Rodriguez-Diaz, J; Bellido, J; Arnedo, A; Larson, G; Svensson, L				Carlsson, Beatrice; Kindberg, Elin; Buesa, Javier; Rydell, Gustaf E.; Lidon, Marta Fos; Montava, Rebeca; Abu Mallouh, Reem; Grahn, Ammi; Rodriguez-Diaz, Jesus; Bellido, Juan; Arnedo, Alberto; Larson, Goran; Svensson, Lennart			The G428A Nonsense Mutation in FUT2 Provides Strong but Not Absolute Protection against Symptomatic GII.4 Norovirus Infection	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; ROUND-STRUCTURED VIRUSES; ACUTE GASTROENTERITIS; UNITED-STATES; P2 DOMAIN; SECRETOR FUT2; OUTBREAKS; SUSCEPTIBILITY; RESISTANCE; BINDING	In November 2004, 116 individuals in an elderly nursing home in El Grao de Castellon, Spain were symptomatically infected with genogroup II.4 (GII.4) norovirus. The global attack rate was 54.2%. Genotyping of 34 symptomatic individuals regarding the FUT2 gene revealed that one patient was, surprisingly, a non-secretor, hence indicating secretor-independent infection. Lewis genotyping revealed that Lewis-positive and negative individuals were susceptible to symptomatic norovirus infection indicating that Lewis status did not predict susceptibility. Saliva based ELISA assays were used to determine binding of the outbreak virus to saliva samples. Saliva from a secretor-negative individual bound the authentic outbreak GII.4 Valencia/2004/Es virus, but did not in contrast to secretor-positive saliva bind VLP of other strains including the GII.4 Dijon strain. Amino acid comparison of antigenic A and B sites located on the external loops of the P2 domain revealed distinct differences between the Valencia/2004/Es and Dijon strains. All three aa in each antigenic site as well as 10/11 recently identified evolutionary hot spots, were unique in the Valencia/2004/Es strain compared to the Dijon strain. To the best of our knowledge, this is the first example of symptomatic GII.4 norovirus infection of a Le(a+b-) individual homozygous for the G428A nonsense mutation in FUT2. Taken together, our study provides new insights into the host genetic susceptibility to norovirus infections and evolution of the globally dominating GII.4 viruses.			Carlsson, B (corresponding author), Linkoping Univ, Div Mol Virol, Linkoping, Sweden.	lennart.t.svensson@liu.se	Rodriguez-Diaz, Jesus/B-2091-2012; Larson, Göran/AAF-3404-2019; svensson, lennart/K-6163-2019; Buesa, Javier/D-8927-2014	Rodriguez-Diaz, Jesus/0000-0002-9698-7684; Buesa, Javier/0000-0002-3328-3428				Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Bucardo F, 2009, J MED VIROL, V81, P728, DOI 10.1002/jmv.21426; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Chakravarty S, 2005, J VIROL, V79, P554, DOI 10.1128/JVI.79.1.554-568.2005; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; DOLIN R, 1972, P SOC EXP BIOL MED, V140, P578, DOI 10.3181/00379727-140-36508; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Gallimore CI, 2004, J CLIN MICROBIOL, V42, P1396, DOI 10.1128/JCM.42.4.1396-1401.2004; GARY GW, 1987, J CLIN MICROBIOL, V25, P2001, DOI 10.1128/JCM.25.10.2001-2003.1987; Glass RI, 2000, J INFECT DIS, V181, pS254, DOI 10.1086/315588; Grahn A, 2001, Hum Mutat, V18, P358, DOI 10.1002/humu.1204; GREEN K, 2001, HUMAN CALICIVIRUSES, P841; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Henry S, 1996, VOX SANG, V70, P21, DOI 10.1111/j.1423-0410.1996.tb00991.x; Henry S, 1996, GLYCOCONJUGATE J, V13, P985, DOI 10.1007/BF01053194; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Johansson PJH, 2002, J CLIN MICROBIOL, V40, P794, DOI 10.1128/JCM.40.3.794-798.2002; JOHNSON PC, 1990, J INFECT DIS, V161, P18, DOI 10.1093/infdis/161.1.18; KELLEY WN, 1995, NAT MED, V1, P2, DOI 10.1038/nm0195-2a; Kindberg E, 2006, AIDS, V20, P685, DOI 10.1097/01.aids.0000216368.23325.bc; Kindberg E, 2007, J CLIN MICROBIOL, V45, P2720, DOI 10.1128/JCM.00162-07; Koda Y, 2001, Leg Med (Tokyo), V3, P2, DOI 10.1016/S1344-6223(01)00005-0; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Larson G, 1999, VOX SANG, V77, P227, DOI 10.1046/j.1423-0410.1999.7740227.x; Larsson MM, 2006, J INFECT DIS, V194, P1422, DOI 10.1086/508430; Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009; Lindesmith L, 2005, J VIROL, V79, P2900, DOI 10.1128/JVI.79.5.2900-2909.2005; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Liu YH, 1998, HUM GENET, V103, P204, DOI 10.1007/s004390050808; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; Nilsson M, 2003, J VIROL, V77, P13117, DOI 10.1128/JVI.77.24.13117-13124.2003; Noel JS, 1997, J MED VIROL, V53, P372, DOI 10.1002/(SICI)1096-9071(199712)53:4&lt;372::AID-JMV10&gt;3.0.CO;2-H; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Pezzlo M, 1992, CLIN MICROBIOLOGY PR; Rockx BHG, 2005, J INFECT DIS, V191, P749, DOI 10.1086/427779; Rydell GE, 2009, GLYCOBIOLOGY, V19, P309, DOI 10.1093/glycob/cwn139; Sdiri-Loulizi K, 2009, J CLIN MICROBIOL, V47, P421, DOI 10.1128/JCM.01852-08; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Tamura M, 2004, J VIROL, V78, P3817, DOI 10.1128/JVI.78.8.3817-3826.2004; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, J INFECT DIS, V198, P940, DOI 10.1086/589810; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; TAUBE S, 2009, J VIROL; Thorven M, 2005, J VIROL, V79, P15351, DOI 10.1128/JVI.79.24.15351-15355.2005; Vinje J, 1996, J INFECT DIS, V174, P610, DOI 10.1093/infdis/174.3.610; WYATT RG, 1974, J INFECT DIS, V129, P709, DOI 10.1093/infdis/129.6.709	52	107	112	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5593	10.1371/journal.pone.0005593	http://dx.doi.org/10.1371/journal.pone.0005593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440360	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107500021
J	Murph, MM; Liu, WB; Yu, SX; Lu, YL; Hall, H; Hennessy, BT; Lahad, J; Schaner, M; Helland, A; Kristensen, G; Borresen-Dale, AL; Mills, GB				Murph, Mandi M.; Liu, Wenbin; Yu, Shuangxing; Lu, Yiling; Hall, Hassan; Hennessy, Bryan T.; Lahad, John; Schaner, Marci; Helland, Aslaug; Kristensen, Gunnar; Borresen-Dale, Anne-Lise; Mills, Gordon B.			Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis	PLOS ONE			English	Article							EXPRESSION ANALYSIS; CANCER; TARGET; LPA; LYSOPHOSPHOLIPIDS; METASTASIS; EFFUSIONS; SECRETION; DISCOVERY; PATHWAYS	Background: Lysophosphatidic acid (LPA) governs a number of physiologic and pathophysiological processes. Malignant ascites fluid is rich in LPA, and LPA receptors are aberrantly expressed by ovarian cancer cells, implicating LPA in the initiation and progression of ovarian cancer. However, there is an absence of systematic data critically analyzing the transcriptional changes induced by LPA in ovarian cancer. Methodology and Principal Findings: In this study, gene expression profiling was used to examine LPA-mediated transcription by exogenously adding LPA to human epithelial ovarian cancer cells for 24 h to mimic long-term stimulation in the tumor microenvironment. The resultant transcriptional profile comprised a 39-gene signature that closely correlated to serous epithelial ovarian carcinoma. Hierarchical clustering of ovarian cancer patient specimens demonstrated that the signature is associated with worsened prognosis. Patients with LPA-signature-positive ovarian tumors have reduced disease-specific and progression-free survival times. They have a higher frequency of stage IIIc serous carcinoma and a greater proportion is deceased. Among the 39-gene signature, a group of seven genes associated with cell adhesion recapitulated the results. Out of those seven, claudin-1, an adhesion molecule and phenotypic epithelial marker, is the only independent biomarker of serous epithelial ovarian carcinoma. Knockdown of claudin-1 expression in ovarian cancer cells reduces LPA-mediated cellular adhesion, enhances suspended cells and reduces LPA-mediated migration. Conclusions: The data suggest that transcriptional events mediated by LPA in the tumor microenvironment influence tumor progression through modulation of cell adhesion molecules like claudin-1 and, for the first time, report an LPA-mediated expression signature in ovarian cancer that predicts a worse prognosis.			Murph, MM (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	mmurph@rx.uga.edu	Helland, Åslaug/H-3910-2015; liu, wen/HGE-3071-2022	Helland, Åslaug/0000-0002-5520-0275; Hennessy, Bryan/0000-0002-7871-6477	NATIONAL CANCER INSTITUTE [P50CA098258, P01CA099031, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016672, P50 CA098258, P01 CA099031] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Bignotti E, 2007, AM J OBSTET GYNECOL, V196, P245, DOI 10.1016/j.ajog.2006.10.874; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; CHECOVICH WJ, 1993, ARTERIOSCLER THROMB, V13, P1662, DOI 10.1161/01.ATV.13.11.1662; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; DiSaia PJ, 2007, CLIN GYNECOLOGIC ONC; Eder AM, 2000, CLIN CANCER RES, V6, P2482; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Hasegawa Y, 2008, MOL ONCOL, V2, P54, DOI 10.1016/j.molonc.2008.03.009; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hennessy BT, 2008, ADV EXP MED BIOL, V617, P23, DOI 10.1007/978-0-387-69080-3_3; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kleinberg L, 2008, HUM PATHOL, V39, P747, DOI 10.1016/j.humpath.2007.10.002; Kleinberg L, 2007, AM J CLIN PATHOL, V127, P928, DOI 10.1309/V025QRN3R9CJGNPX; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Murph Mandi, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000476; Murph MM, 2008, BBA-MOL CELL BIOL L, V1781, P547, DOI 10.1016/j.bbalip.2008.04.007; MURPH MM, 2008, BIOCH BIOPHYS ACTA; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Partheen K, 2006, EUR J CANCER, V42, P2846, DOI 10.1016/j.ejca.2006.06.026; Pustilnik TB, 1999, CLIN CANCER RES, V5, P3704; Reiser COA, 1998, BIOCHEM J, V330, P1107; Sakamoto S, 2004, ENDOCRINOLOGY, V145, P2929, DOI 10.1210/en.2003-1350; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Seidman JD, 2003, HEMATOL ONCOL CLIN N, V17, P909, DOI 10.1016/S0889-8588(03)00061-3; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Sobel G, 2006, GYNECOL ONCOL, V103, P591, DOI 10.1016/j.ygyno.2006.04.005; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tanyi JL, 2003, CANCER RES, V63, P1073; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umezu-Goto M, 2004, J CELL BIOCHEM, V92, P1115, DOI 10.1002/jcb.20113; Valenick LV, 2006, MATRIX BIOL, V25, P223, DOI 10.1016/j.matbio.2006.01.002; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Weinberg RA, 2007, BIOL CANC; Westermann AM, 1998, ANN ONCOL, V9, P437, DOI 10.1023/A:1008217129273; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378	46	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5583	10.1371/journal.pone.0005583	http://dx.doi.org/10.1371/journal.pone.0005583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440550	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107400018
J	Retamal, P; Castillo-Ruiz, M; Mora, GC				Retamal, Patricio; Castillo-Ruiz, Mario; Mora, Guido C.			Characterization of MgtC, a Virulence Factor of Salmonella enterica Serovar Typhi	PLOS ONE			English	Article								The MgtC is a virulence factor in Salmonella Typhimurium that is required for growth at low-Mg(2+) concentrations and intramacrophage survival. This gene is codified in a conserved region of the Salmonella pathogenicity island 3 (SPI-3), and is also present in the chromosome of other Salmonella serovars. In this study we characterized the MgtC factor in S. Typhi, a human specific pathogen, by using mgtC and SPI-3 mutant strains. We found that MgtC is the most important factor codified in the SPI-3 of S. Typhi for growth in low-Mg(2+) media and survival within human cells. In addition, by using reporter genes we determined that the low-Mg(2+) concentration, acidic media and PhoP regulator induce mgtC expression in S. Typhi. We suggest that MgtC is the most important virulence factor codified in the SPI-3 of S. Typhi.			Retamal, P (corresponding author), Univ Andres Bello, Dept Ciencias Biol, Santiago, Chile.	gmora@unab.cl	Retamal, Patricio/G-3054-2013	Retamal, Patricio/0000-0001-8597-9550; Castillo-Ruiz, Mario/0000-0002-0005-408X				Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Alix E, 2007, TRENDS MICROBIOL, V15, P252, DOI 10.1016/j.tim.2007.03.007; Amavisit P, 2003, J BACTERIOL, V185, P3624, DOI 10.1128/JB.185.12.3624-3635.2003; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Bucarey SA, 2005, INFECT IMMUN, V73, P6210, DOI 10.1128/IAI.73.10.6210-6219.2005; Bucarey SA, 2006, GENETICS, V173, P25, DOI 10.1534/genetics.105.054700; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chamnongpol S, 2002, MOL MICROBIOL, V44, P561, DOI 10.1046/j.1365-2958.2002.02917.x; Chaudhuri RR, 2004, NUCLEIC ACIDS RES, V32, pD296, DOI 10.1093/nar/gkh031; Contreras I, 1997, MICROBIOL-UK, V143, P2665, DOI 10.1099/00221287-143-8-2665; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorsey CW, 2005, MOL MICROBIOL, V57, P196, DOI 10.1111/j.1365-2958.2005.04666.x; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gunzel D, 2006, J BACTERIOL, V188, P5586, DOI 10.1128/JB.00296-06; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; MILLER FD, 1984, GENE, V29, P247, DOI 10.1016/0378-1119(84)90185-9; Moncrief MBC, 1998, INFECT IMMUN, V66, P3802, DOI 10.1128/IAI.66.8.3802-3809.1998; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; Rang C, 2007, MOL MICROBIOL, V63, P605, DOI 10.1111/j.1365-2958.2006.05542.x; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Smith RL, 1998, MICROBIOL-SGM, V144, P1835, DOI 10.1099/00221287-144-7-1835; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Spinelli SV, 2008, FEMS MICROBIOL LETT, V280, P226, DOI 10.1111/j.1574-6968.2008.01065.x; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; TUKEL C, 2007, J BACTERIOL; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198	35	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5551	10.1371/journal.pone.0005551	http://dx.doi.org/10.1371/journal.pone.0005551			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436747	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107300015
J	Dugan, LL; Ali, SS; Shekhtman, G; Roberts, AJ; Lucero, J; Quick, KL; Behrens, MM				Dugan, Laura L.; Ali, Sameh S.; Shekhtman, Grigoriy; Roberts, Amanda J.; Lucero, Jacinta; Quick, Kevin L.; Behrens, M. Margarita			IL-6 Mediated Degeneration of Forebrain GABAergic Interneurons and Cognitive Impairment in Aged Mice through Activation of Neuronal NADPH Oxidase	PLOS ONE			English	Article							INTERLEUKIN-6 GENE-EXPRESSION; FACTOR-KAPPA-B; SYNAPTIC PLASTICITY; WORKING-MEMORY; SUPEROXIDE-DISMUTASE; HIPPOCAMPAL MEMORY; PATTERN SEPARATION; DENTATE GYRUS; DISEASE; BRAIN	Background: Multiple studies have shown that plasma levels of the pro-inflammatory cytokine interleukin-6 (IL-6) are elevated in patients with important and prevalent adverse health conditions, including atherosclerosis, diabetes, obesity, obstructive sleep apnea, hypertension, and frailty. Higher plasma levels of IL-6, in turn, increase the risk of many conditions associated with aging including age-related cognitive decline. However, the mechanisms underlying this association between IL-6 and cognitive vulnerability remain unclear. Methods and Findings: We investigated the role of IL-6 in brain aging in young (4 mo) and aged (24 mo) wild-type C57BL6 and genetically-matched IL-6(-/-) mice, and determined that IL-6 was necessary and sufficient for increased neuronal expression of the superoxide-producing immune enzyme, NADPH-oxidase, and this was mediated by non-canonical NFkB signaling. Furthermore, superoxide production by NADPH-oxidase was directly responsible for age-related loss of parvalbumin (PV)-expressing GABAergic interneurons, neurons essential for normal information processing, encoding, and retrieval in hippocampus and cortex. Targeted deletion of IL-6 or elimination of superoxide by chronic treatment with a superoxide-dismutase mimetic prevented age-related loss of PV-interneurons and reversed age-related cognitive deficits on three standard tests of spatial learning and recall. Conclusions: Present results indicate that IL-6 mediates age-related loss of critical PV-expressing GABAergic interneurons through increased neuronal NADPH-oxidase-derived superoxide production, and that rescue of these interneurons preserves cognitive performance in aging mice, suggesting that elevated peripheral IL-6 levels may be directly and mechanistically linked to long-lasting cognitive deficits in even normal older individuals. Further, because PV-interneurons are also selectively affected by commonly used anesthetic agents and drugs, our findings imply that IL-6 levels may predict adverse CNS effects in older patients exposed to these compounds through specific derangements in inhibitory interneurons, and that therapies directed at lowering IL-6 may have cognitive benefits clinically.			Dugan, LL (corresponding author), Univ Calif San Diego, Dept Med, Div Geriatr Med, La Jolla, CA 92093 USA.	ladugan@ucsd.edu	Behrens, M. Margarita/K-2576-2014	Ali, Sameh Saad/0000-0002-0339-6106	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG026379, R21AG030320] Funding Source: NIH RePORTER; NIA NIH HHS [K25 AG026379, AG030320, R21 AG030320] Funding Source: Medline; NINDS NIH HHS [NS057096, P30 NS057096] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x; Bai L, 2004, NEUROBIOL AGING, V25, P201, DOI 10.1016/S0197-4580(03)00091-5; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Benice TS, 2008, J NEUROSCI METH, V168, P422, DOI 10.1016/j.jneumeth.2007.11.002; Bermejo P, 2008, IMMUNOL LETT, V117, P198, DOI 10.1016/j.imlet.2008.02.002; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bu J, 2003, EXP NEUROL, V182, P220, DOI 10.1016/S0014-4886(03)00094-3; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cartmell T, 2000, J PHYSIOL-LONDON, V526, P653, DOI 10.1111/j.1469-7793.2000.00653.x; Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005; DAYNES RA, 1993, J IMMUNOL, V150, P5219; de Erausquin GA, 2003, MOL PHARMACOL, V63, P784, DOI 10.1124/mol.63.4.784; Driscoll I, 2005, HORM BEHAV, V47, P326, DOI 10.1016/j.yhbeh.2004.11.013; ERSHLER WB, 1993, J AM GERIATR SOC, V41, P176, DOI 10.1111/j.1532-5415.1993.tb02054.x; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; EVERSE J, 2007, NEURODEGENERATION PE; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gilbert PE, 2006, BEHAV BRAIN RES, V169, P142, DOI 10.1016/j.bbr.2006.01.002; Giuliani N, 2001, EXP GERONTOL, V36, P547, DOI 10.1016/S0531-5565(00)00220-5; HALL D, 2009, IN VIVO OPTICAL IMAG; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hu DY, 2007, ANTIOXID REDOX SIGN, V9, P201, DOI 10.1089/ars.2007.9.201; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P699, DOI 10.1002/hipo.20429; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Kausler D. H., 1994, LEARNING MEMORY NORM; Keller Evan T., 1996, Frontiers in Bioscience (online), V1, pD340; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kishida KT, 2007, ANTIOXID REDOX SIGN, V9, P233, DOI 10.1089/ars.2007.9.233; Kishida KT, 2006, MOL CELL BIOL, V26, P5908, DOI 10.1128/MCB.00269-06; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Luebke JI, 2003, J COMP NEUROL, V460, P573, DOI 10.1002/cne.10668; Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575; Magnusson KR, 2003, BEHAV NEUROSCI, V117, P485, DOI 10.1037/0735-7044.117.3.485; Maki RA, 2009, J BIOL CHEM, V284, P3158, DOI 10.1074/jbc.M807731200; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Moffat SD, 2001, NEUROBIOL AGING, V22, P787, DOI 10.1016/S0197-4580(01)00251-2; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Prut L, 2007, BEHAV BRAIN RES, V179, P107, DOI 10.1016/j.bbr.2007.01.017; Pugliese M, 2004, J NEUROSCI RES, V77, P913, DOI 10.1002/jnr.20223; Qiu ZH, 2003, J NEUROIMMUNOL, V139, P51, DOI 10.1016/S0165-5728(03)00158-9; Quick KL, 2008, NEUROBIOL AGING, V29, P117, DOI 10.1016/j.neurobiolaging.2006.09.014; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Sarkisian CA, 2008, J AM GERIATR SOC, V56, P2292, DOI 10.1111/j.1532-5415.2008.02041.x; SERRANDER L, 2007, BIOCH J; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Thiels E, 2002, PHYSIOL BEHAV, V77, P601, DOI 10.1016/S0031-9384(02)00900-9; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Vela J, 2003, J NEUROCHEM, V85, P368, DOI 10.1046/j.1471-4159.2003.01681.x; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Wilson IA, 2006, TRENDS NEUROSCI, V29, P662, DOI 10.1016/j.tins.2006.10.002; YANG J, 2007, GENES DEV; Ye SM, 2001, J NEUROIMMUNOL, V117, P87, DOI 10.1016/S0165-5728(01)00316-2	65	111	114	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5518	10.1371/journal.pone.0005518	http://dx.doi.org/10.1371/journal.pone.0005518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	444WA	19436757	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009900011
J	DeSantis, LRG; Feranec, RS; MacFadden, BJ				DeSantis, Larisa R. G.; Feranec, Robert S.; MacFadden, Bruce J.			Effects of Global Warming on Ancient Mammalian Communities and Their Environments	PLOS ONE			English	Article							STABLE-ISOTOPES; CLIMATE-CHANGE; HORSE EQUUS; NORTH-AMERICA; BISON BISON; CARBON; FORESTS; ENAMEL; RECORD; TEETH	Background: Current global warming affects the composition and dynamics of mammalian communities and can increase extinction risk; however, long-term effects of warming on mammals are less understood. Dietary reconstructions inferred from stable isotopes of fossil herbivorous mammalian tooth enamel document environmental and climatic changes in ancient ecosystems, including C-3/C-4 transitions and relative seasonality. Methodology/Principal Findings: Here, we use stable carbon and oxygen isotopes preserved in fossil teeth to document the magnitude of mammalian dietary shifts and ancient floral change during geologically documented glacial and interglacial periods during the Pliocene (similar to 1.9 million years ago) and Pleistocene (similar to 1.3 million years ago) in Florida. Stable isotope data demonstrate increased aridity, increased C-4 grass consumption, inter-faunal dietary partitioning, increased isotopic niche breadth of mixed feeders, niche partitioning of phylogenetically similar taxa, and differences in relative seasonality with warming. Conclusion/Significance: Our data show that global warming resulted in dramatic vegetation and dietary changes even at lower latitudes (similar to 28 degrees N). Our results also question the use of models that predict the long term decline and extinction of species based on the assumption that niches are conserved over time. These findings have immediate relevance to clarifying possible biotic responses to current global warming in modern ecosystems.			DeSantis, LRG (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	larisa.desantis@gmail.com		DeSantis, Larisa/0000-0003-1159-9154				Barnosky AD, 2004, P NATL ACAD SCI USA, V101, P9297, DOI 10.1073/pnas.0402592101; Bell Christopher J., 2004, P232; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; DANSGAARD W, 1964, TELLUS, V16, P273; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DeSantis LRG, 2008, PALAEOGEOGR PALAEOCL, V266, P59, DOI 10.1016/j.palaeo.2008.03.032; DeSantis LRG, 2007, COUR FOR SEKENBG, V258, P147; EASLEY M C, 1990, Castanea, V55, P142; Ehleringer JR, 2002, PLANT BIOLOGY, V4, P181, DOI 10.1055/s-2002-25733; Feranec Robert S., 2004, P327; Feranec RS, 2009, PALAEOGEOGR PALAEOCL, V271, P153, DOI 10.1016/j.palaeo.2008.10.005; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; GRIMM EC, 1993, SCIENCE, V261, P198, DOI 10.1126/science.261.5118.198; Higgins P, 2004, PALAEOGEOGR PALAEOCL, V206, P337, DOI 10.1016/j.palaeo.2004.01.011; Hoppe KA, 2004, PALAEOGEOGR PALAEOCL, V206, P355, DOI 10.1016/j.palaeo.2004.01.012; Huffman Jean M., 1998, Castanea, V63, P25; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Koch PL, 1998, CHEM GEOL, V152, P119, DOI 10.1016/S0009-2541(98)00101-6; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; LEVINSKY I, 2007, BIODIVERS CONSERV, V11, P453; MacFadden BJ, 1999, GLOBAL ECOL BIOGEOGR, V8, P137, DOI 10.1046/j.1466-822X.1999.00127.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Morgan Gary S., 1995, Bulletin of the Florida Museum of Natural History, V37, P1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Passey BH, 2005, GEOCHIM COSMOCHIM AC, V69, P4101, DOI 10.1016/j.gca.2004.12.002; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Post E, 2004, P NATL ACAD SCI USA, V101, P9286, DOI 10.1073/pnas.0305029101; STOWE LG, 1978, AM NAT, V112, P609, DOI 10.1086/283301; TEERI JA, 1978, CAN J BOT, V56, P1750, DOI 10.1139/b78-208; TEERI JA, 1976, OECOLOGIA, V23, P1, DOI 10.1007/BF00351210; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P281, DOI 10.1016/0031-0182(94)90100-7	41	54	57	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5750	10.1371/journal.pone.0005750	http://dx.doi.org/10.1371/journal.pone.0005750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	453PV	19492043	Green Published, Green Submitted, gold			2022-12-27	WOS:000266624300006
J	Jacobi, AM; Zhang, J; Mackay, M; Aranow, C; Diamond, B				Jacobi, Annett M.; Zhang, Jie; Mackay, Meggan; Aranow, Cynthia; Diamond, Betty			Phenotypic Characterization of Autoreactive B Cells - Checkpoints of B Cell Tolerance in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article								DNA-reactive B cells play a central role in systemic lupus erythematosus (SLE); DNA antibodies precede clinical disease and in established disease correlate with renal inflammation and contribute to dendritic cell activation and high levels of type 1 interferon. A number of central and peripheral B cell tolerance mechanisms designed to control the survival, differentiation and activation of autoreactive B cells are thought to be disturbed in patients with SLE. The characterization of DNA-reactive B cells has, however, been limited by their low frequency in peripheral blood. Using a tetrameric configuration of a peptide mimetope of DNA bound by pathogenic anti-DNA antibodies, we can identify B cells producing potentially pathogenic DNA-reactive antibodies. We, therefore, characterized the maturation and differentiation states of peptide, (ds) double stranded DNA cross-reactive B cells in the peripheral blood of lupus patients and correlated these with clinical disease activity. Flow cytometric analysis demonstrated a significantly higher frequency of tetramer-binding B cells in SLE patients compared to healthy controls. We demonstrated the existence of a novel tolerance checkpoint at the transition of antigen-naive to antigen-experienced. We further demonstrate that patients with moderately active disease have more autoreactive B cells in both the antigen-naive and antigen-experienced compartments consistent with greater impairment in B cell tolerance in both early and late checkpoints in these patients than in patients with quiescent disease. This methodology enables us to gain insight into the development and fate of DNA-reactive B cells in individual patients with SLE and paves the way ultimately to permit better and more customized therapies.			Jacobi, AM (corresponding author), N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA.	bdiamond@nshs.edu						Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Borrero M, 2002, J IMMUNOL, V168, P13, DOI 10.4049/jimmunol.168.1.13; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Culton DA, 2006, J IMMUNOL, V176, P790, DOI 10.4049/jimmunol.176.2.790; Fukuyama H, 2005, NAT IMMUNOL, V6, P99, DOI 10.1038/ni1151; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Gaynor B, 1997, P NATL ACAD SCI USA, V94, P1955, DOI 10.1073/pnas.94.5.1955; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873; Grimaldi CM, 2001, J IMMUNOL, V167, P1886, DOI 10.4049/jimmunol.167.4.1886; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Huerta PT, 2006, P NATL ACAD SCI USA, V103, P678, DOI 10.1073/pnas.0510055103; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kuo P, 1999, EUR J IMMUNOL, V29, P3168, DOI 10.1002/(SICI)1521-4141(199910)29:10<3168::AID-IMMU3168>3.0.CO;2-H; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay M, 2006, J EXP MED, V203, P2157, DOI 10.1084/jem.20051503; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; Newman J, 2003, J IMMUNOL METHODS, V272, P177, DOI 10.1016/S0022-1759(02)00499-4; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Paul E, 2007, INT IMMUNOL, V19, P365, DOI 10.1093/intimm/dxm002; Peeva E, 2003, J CLIN INVEST, V111, P275, DOI 10.1172/JCI200316530; Pene J, 2004, J IMMUNOL, V172, P5154, DOI 10.4049/jimmunol.172.9.5154; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Pugh-Bernard AE, 2001, J CLIN INVEST, V108, P1061, DOI 10.1172/JCI12462; Putterman C, 1998, J EXP MED, V188, P29, DOI 10.1084/jem.188.1.29; Qian Y, 2001, J IMMUNOL, V166, P2412, DOI 10.4049/jimmunol.166.4.2412; Rahman ZSM, 2007, J IMMUNOL, V178, P897, DOI 10.4049/jimmunol.178.2.897; Rice JS, 2005, P NATL ACAD SCI USA, V102, P1608, DOI 10.1073/pnas.0409217102; ROARK JH, 1995, J EXP MED, V181, P1157, DOI 10.1084/jem.181.3.1157; Santulli-Marotto S, 2001, J IMMUNOL, V166, P5292, DOI 10.4049/jimmunol.166.8.5292; Schmidt KN, 1998, J EXP MED, V187, P929, DOI 10.1084/jem.187.6.929; Sharma A, 2003, RHEUMATOLOGY, V42, P453, DOI 10.1093/rheumatology/keg161; TAN EM, 1991, CELL, V67, P841, DOI 10.1016/0092-8674(91)90356-4; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; VLAHAKOS DV, 1992, KIDNEY INT, V41, P1690, DOI 10.1038/ki.1992.242; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; William J, 2005, J IMMUNOL, V174, P6872, DOI 10.4049/jimmunol.174.11.6872; XIANG Z, 2007, NAT IMMUNOL; Yoshio T, 2006, ARTHRITIS RHEUM, V54, P675, DOI 10.1002/art.21547; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446; Zhang J, 2008, J IMMUNOL METHODS, V338, P79, DOI 10.1016/j.jim.2008.07.015	49	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5776	10.1371/journal.pone.0005776	http://dx.doi.org/10.1371/journal.pone.0005776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19488401	Green Published, gold, Green Submitted			2022-12-27	WOS:000266587400013
J	Sharma, A; Singh, P				Sharma, Abhay; Singh, Priyanka			Detection of Transgenerational Spermatogenic Inheritance of Adult Male Acquired CNS Gene Expression Characteristics Using a Drosophila Systems Model	PLOS ONE			English	Article								Available instances of inheritance of epigenetic transgenerational phenotype are limited to environmental exposures during embryonic and adult gonadal development. Adult exposures can also affect gametogenesis and thereby potentially result in reprogramming of the germline. Although examples of epigenetic effects on gametogenesis exist, it is notable that transgenerational inheritance of environment-induced adult phenotype has not yet been reported. Epigenetic codes are considered to be critical in neural plasticity. A Drosophila systems model of pentylenetetrazole (PTZ) induced long-term brain plasticity has recently been described. In this model, chronic PTZ treatment of adult males causes alterations in CNS transcriptome. Here, we describe our search for transgenerational spermatogenic inheritance of PTZ induced gene expression phenotype acquired by adult Drosophila males. We generated CNS transcriptomic profiles of F-1 adults after treating F-0 adult males with PTZ and of F-2 adults resulting from a cross between F-1 males and normal females. Surprisingly, microarray clustering showed F-1 male profile as closest to F-1 female and F-0 male profile closest to F-2 male. Differentially expressed genes in F-1 males, F-1 females and F-2 males showed significant overlap with those caused by PTZ. Interestingly, microarray evidence also led to the identification of upregulated rRNA in F-2 males. Next, we generated microarray expression profiles of adult testis from F-0 and F-1 males. Further surprising, clustering of CNS and testis profiles and matching of differentially expressed genes in them provided evidence of a spermatogenic mechanism in the transgenerational effect observed. To our knowledge, we report for the first time detection of transgenerational spermatogenic inheritance of adult acquired somatic gene expression characteristic. The Drosophila systems model offers an excellent opportunity to understand the epigenetic mechanisms underlying the phenomenon. The finding that adult acquired transcriptomic alteration in soma is spermatogenically inherited across generations has potential implications in human health and evolution.			Sharma, A (corresponding author), CSIR, Inst Genom & Integrat Biol, Delhi, India.	abhaysharma@igib.res.in	Singh, Priyanka/GRF-6098-2022	Sharma, Abhay/0000-0003-1306-1497				Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; BOWNES M, 1987, DEVELOPMENT, V101, P931; CASTRILLON DH, 1993, GENETICS, V135, P489; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Darboux I, 1998, J BIOL CHEM, V273, P9424, DOI 10.1074/jbc.273.16.9424; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; DOREN MV, 2003, DEVELOPMENT, V130, P2355; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Graff J, 2008, BEHAV BRAIN RES, V192, P70, DOI 10.1016/j.bbr.2008.01.021; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Grummt I, 2008, CELL, V133, P577, DOI 10.1016/j.cell.2008.04.026; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hewes RS, 1998, J NEUROSCI, V18, P7138; JAYARAMAIAH R, 2005, MOL CELL BIOL, V25, P6165; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; McCarrey JR, 2005, ANN NY ACAD SCI, V1061, P226, DOI 10.1196/annals.1336.025; Mohammad F, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-11; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rongo C, 1997, COLD SPRING HARB SYM, V62, P1; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Trasler JM, 1998, SEMIN CELL DEV BIOL, V9, P467, DOI 10.1006/scdb.1998.0225; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; YOSHIKAWA K, 1998, BIOCHEM BIOPH RES CO, V151, P664	42	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5763	10.1371/journal.pone.0005763	http://dx.doi.org/10.1371/journal.pone.0005763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503609	gold, Green Published, Green Submitted			2022-12-27	WOS:000266587400006
J	Hong, QY; Sze, CI; Lin, SR; Lee, MH; He, RY; Schultz, L; Chang, JY; Chen, SJ; Boackle, RJ; Hsu, LJ; Chang, NS				Hong, Qunying; Sze, Chun-I; Lin, Sing-Ru; Lee, Ming-Hui; He, Ruei-Yu; Schultz, Lori; Chang, Jean-Yun; Chen, Shean-Jen; Boackle, Robert J.; Hsu, Li-Jin; Chang, Nan-Shan			Complement C1q Activates Tumor Suppressor WWOX to Induce Apoptosis in Prostate Cancer Cells	PLOS ONE			English	Article								Background: Tissue exudates contain low levels of serum complement proteins, and their regulatory effects on prostate cancer progression are largely unknown. We examined specific serum complement components in coordinating the activation of tumor suppressors p53 and WWOX (also named FOR or WOX1) and kinases ERK, JNK1 and STAT3 in human prostate DU145 cells. Methodology/Principal Findings: DU145 cells were cultured overnight in 1% normal human serum, or in human serum depleted of an indicated complement protein. Under complement C1q- or C6-free conditions, WOX1 and ERK were mainly present in the cytoplasm without phosphorylation, whereas phosphorylated JNK1 was greatly accumulated in the nuclei. Exogenous C1q rapidly restored the WOX1 activation (with Tyr33 phosphorylation) in less than 2 hr. Without serum complement C9, p53 became activated, and hyaluronan (HA) reversed the effect. Under C6-free conditions, HA induced activation of STAT3, an enhancer of metastasis. Notably, exogenous C1q significantly induced apoptosis of WOX1-overexpressing DU145 cells, but not vehicle-expressing cells. A dominant negative and Y33R mutant of WOX1 blocked the apoptotic effect. C1q did not enhance p53-mediated apoptosis. By total internal reflection fluorescence (TIRF) microscopy, it was determined that C1q destabilized adherence of WOX1-expressing DU145 cells by partial detaching and inducing formation of clustered microvilli for focal adhesion particularly in between cells. These cells then underwent shrinkage, membrane blebbing and death. Remarkably, as determined by immunostaining, benign prostatic hyperplasia and prostate cancer were shown to have a significantly reduced expression of tissue C1q, compared to age-matched normal prostate tissues. Conclusions/Significance: We conclude that complement C1q may induce apoptosis of prostate cancer cells by activating WOX1 and destabilizing cell adhesion. Downregulation of C1q enhances prostate hyperplasia and cancerous formation due to failure of WOX1 activation.			Hong, QY (corresponding author), Guthrie Res Inst, Lab Mol Immunol, Sayre, PA USA.	lijin.hsu@gmail.com; changns@mail.ncku.edu.tw	Hsu, Li-Jin/G-7822-2011					Ajona D, 2004, CANCER RES, V64, P6310, DOI 10.1158/0008-5472.CAN-03-2328; ALMEDA S, 1983, J BIOL CHEM, V258, P785; Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Bajgelman MC, 2006, PROSTATE, V66, P1455, DOI 10.1002/pros.20462; Bhole D, 2004, IMMUNOBIOLOGY, V209, P559, DOI 10.1016/j.imbio.2004.08.001; Bogoyevitch MA, 2006, BIOESSAYS, V28, P923, DOI 10.1002/bies.20458; Buras JA, 2004, IMMUNOBIOLOGY, V209, P629, DOI 10.1016/j.imbio.2004.09.004; Caragine TA, 2002, CANCER RES, V62, P1110; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; CHANG NS, 1985, MOL IMMUNOL, V22, P843; Chang NS, 2003, BIOCHEM PHARMACOL, V66, P1347, DOI 10.1016/S0006-2952(03)00484-2; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; CHANG NS, 1985, MOL IMMUNOL, V22, P391; Chang NS, 2002, J BIOL CHEM, V277, P10323, DOI 10.1074/jbc.M106607200; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chen JG, 2005, CANCER RES, V65, P4614, DOI 10.1158/0008-5472.CAN-04-2253; Chen ST, 2005, NEUROSCIENCE, V130, P397, DOI 10.1016/j.neuroscience.2004.07.054; D'Andrea Michael R, 2005, Am J Alzheimers Dis Other Demen, V20, P144, DOI 10.1177/153331750502000303; DEMESSIAS IT, 1994, J INVEST ALLERG CLIN, V4, P172; Eikelenboom P, 2008, NEURODEGENER DIS, V5, P190, DOI 10.1159/000113699; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; He RY, 2006, OPT EXPRESS, V14, P9307, DOI 10.1364/OE.14.009307; He RY, 2009, OPT EXPRESS, V17, P5987, DOI 10.1364/OE.17.005987; Hong QY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-50; Hong QY, 2007, INT J MOL MED, V19, P173; Horinaga M, 2005, UROLOGY, V66, P671, DOI 10.1016/j.urology.2005.03.066; HSU LJ, 2009, J BIOL CHEM IN PRESS; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Lee MH, 2006, SEMIN CANCER BIOL, V16, P225, DOI 10.1016/j.semcancer.2006.03.009; Lisignoli G, 2006, J CELL PHYSIOL, V207, P364, DOI 10.1002/jcp.20572; Lo CP, 2008, EUR J NEUROSCI, V27, P1634, DOI 10.1111/j.1460-9568.2008.06139.x; Lokeshwar V, 1999, PROSTATE CANCER P D, V2, pS21, DOI 10.1038/sj.pcan.4500346; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Oka R, 2001, EUR J CANCER, V37, P1158, DOI 10.1016/S0959-8049(01)00089-2; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Racila E, 2006, IMMUNOGENETICS, V58, P1, DOI 10.1007/s00251-005-0077-y; Rozanov DV, 2004, J BIOL CHEM, V279, P50321, DOI 10.1074/jbc.M409174200; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Takami A, 2006, CANCER SCI, V97, P80, DOI 10.1111/j.1349-7006.2006.00138.x; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Waggoner SN, 2005, J IMMUNOL, V175, P4706, DOI 10.4049/jimmunol.175.7.4706; Watanabe A, 2003, CANCER RES, V63, P8629; Wuillemin WA, 1997, J IMMUNOL, V159, P1953; Yamada M, 2004, EUR J IMMUNOL, V34, P221, DOI 10.1002/eji.200324026; Yen HT, 1996, ARCH DERMATOL RES, V288, P157, DOI 10.1007/BF02505826; Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhou W, 2006, BRIT J CANCER, V95, P164, DOI 10.1038/sj.bjc.6603234	57	77	80	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5755	10.1371/journal.pone.0005755	http://dx.doi.org/10.1371/journal.pone.0005755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484134	Green Published, gold, Green Submitted			2022-12-27	WOS:000266528200008
J	Ayles, H; Schaap, A; Nota, A; Sismanidis, C; Tembwe, R; De Haas, P; Muyoyeta, M; Beyers, N; Godfrey-Faussett, P				Ayles, Helen; Schaap, Albertus; Nota, Amos; Sismanidis, Charalambos; Tembwe, Ruth; De Haas, Petra; Muyoyeta, Monde; Beyers, Nulda; Godfrey-Faussett, Peter		ZAMSTAR Study Team	Prevalence of Tuberculosis, HIV and Respiratory Symptoms in Two Zambian Communities: Implications for Tuberculosis Control in the Era of HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; UNDIAGNOSED TUBERCULOSIS; OUTPATIENTS; DIAGNOSIS; IMPACT	Background: The Stop TB Partnership target for tuberculosis is to have reduced the prevalence of tuberculosis by 50% comparing 2015 to 1990. This target is challenging as few prevalence surveys have been conducted, especially in high burden tuberculosis and HIV countries. Current tuberculosis control strategies in high HIV prevalent settings are therefore based on limited epidemiological evidence and more evidence is needed from community-based surveys to inform improved policy formulation. Methods and Findings: 8044 adults were sampled from 2 sub-districts (wards) in Lusaka province, Zambia. Questionnaires were used to screen for symptoms, respiratory samples were obtained for culture and oral secretions collected for HIV testing. 79 individuals were found to have Mycobacterium tuberculosis in their sputum, giving an adjusted overall prevalence of tuberculosis of 870/100,000 (95% CI 570-1160/100,000). The adjusted overall prevalence of HIV was 28.61% (95% CI 26.04-31.19). HIV-infection was significantly associated with prevalent tuberculosis (Adj OR 2.3, 95% CI 1.42-3.74) and the population attributable fraction of HIV for prevalent tuberculosis was 36%. Symptoms such as prolonged cough (adj OR 12.72, 95% CI 7.05-22.94) and fever (Adj OR 2.04, 95% CI 1.23-3.39), were associated with prevalent tuberculosis, but 8 (10%) individuals with prevalent tuberculosis denied having any symptoms at all and only 34 (43%) would have been classified as a TB suspect by current guidelines. Conclusions: Undiagnosed tuberculosis is a challenge for tuberculosis control and new approaches are needed if we are to reach international targets. Epidemiological studies can inform screening algorithms for both detection and prevention of active tuberculosis.			Ayles, H (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	Helen@zambart.org.zm		Ayles, Helen/0000-0003-4108-2842	Medical Research Council [G0700837] Funding Source: Medline; MRC [G0700837] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALUOCH JA, 1982, T ROY SOC TROP MED H, V76, P679, DOI 10.1016/0035-9203(82)90240-1; ALUOCH JA, 1983, E AFR MED J, V60, P360; ALUOCH JA, 1978, TUBERCLE, V59, P233, DOI 10.1016/0041-3879(78)90001-6; ALUOCH JA, 1984, AM REV RESPIR DIS, V129, P915; ALUOCH JA, 1985, TUBERCLE, V66, P237, DOI 10.1016/0041-3879(85)90061-3; ALUOCH JA, 1983, E AFR MED J, V60, P542; Ayles H, 2006, TROP DOCT, V36, P83, DOI 10.1258/004947506776593521; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; den Boon S, 2007, EMERG INFECT DIS, V13, P1189, DOI 10.3201/eid1308.051327; DYE C, 2008, LANCET INFECT D 0116; ELLIOTT AM, 1993, AIDS, V7, P981, DOI 10.1097/00002030-199307000-00012; Godfrey-Faussett P, 2003, TUBERCULOSIS, V83, P68, DOI 10.1016/S1472-9792(02)00083-5; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KLAUSNER JD, 1993, J INFECT DIS, V168, P106, DOI 10.1093/infdis/168.1.106; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Sonnenberg P, 2004, AIDS, V18, P657, DOI 10.1097/00002030-200403050-00010; *STOP TB PARTN WHO, 2006, WHOHTMSTB200635 STOP; Styblo K, 2001, INT J TUBERC LUNG D, V5, P103; United Nations, 2000, MILL DEV GOALS; van Soolingen D, 2001, Methods Mol Med, V54, P165, DOI 10.1385/1-59259-147-7:165; *WHO, 2008, TB HIV FACT SHEET; WHO, 2008, GLOBAL TUBERCULOSIS; WHO, 2004, INT POL COLL TB HIV; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2008, EP COUNTR PROF HIV A; World Health Organization, 2007, ASS TB PREV POP BAS; World Health Organization, 2006, WHOHTMTB2006362	33	99	100	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5602	10.1371/journal.pone.0005602	http://dx.doi.org/10.1371/journal.pone.0005602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440346	Green Published, gold, Green Accepted			2022-12-27	WOS:000266161200005
J	Ruvinsky, I; Katz, M; Dreazen, A; Gielchinsky, Y; Saada, A; Freedman, N; Mishani, E; Zimmerman, G; Kasir, J; Meyuhas, O				Ruvinsky, Igor; Katz, Maximiliano; Dreazen, Avigail; Gielchinsky, Yuval; Saada, Ann; Freedman, Nanette; Mishani, Eyal; Zimmerman, Gabriel; Kasir, Judith; Meyuhas, Oded			Mice Deficient in Ribosomal Protein S6 Phosphorylation Suffer from Muscle Weakness that Reflects a Growth Defect and Energy Deficit	PLOS ONE			English	Article							SKELETAL-MUSCLE; CELL-SIZE; MOUSE PHENOTYPE; KINASE; CONTRACTION; METABOLISM; ACTIVATION; INCREASES; DELETION; REVEALS	Background: Mice, whose ribosomal protein S6 cannot be phosphorylated due to replacement of all five phosphorylatable serine residues by alanines (rpS6(P-/-)), are viable and fertile. However, phenotypic characterization of these mice and embryo fibroblasts derived from them, has established the role of these modifications in the regulation of the size of several cell types, as well as pancreatic beta-cell function and glucose homeostasis. A relatively passive behavior of these mice has raised the possibility that they suffer from muscle weakness, which has, indeed, been confirmed by a variety of physical performance tests. Methodology/Principal Findings: A large variety of experimental methodologies, including morphometric measurements of histological preparations, high throughput proteomic analysis, positron emission tomography (PET) and numerous biochemical assays, were used in an attempt to establish the mechanism underlying the relative weakness of rpS6(P-/-) muscles. Collectively, these experiments have demonstrated that the physical inferiority appears to result from two defects: a) a decrease in total muscle mass that reflects impaired growth, rather than aberrant differentiation of myofibers, as well as a diminished abundance of contractile proteins; and b) a reduced content of ATP and phosphocreatine, two readily available energy sources. The abundance of three mitochondrial proteins has been shown to diminish in the knockin mouse. However, the apparent energy deficiency in this genotype does not result from a lower mitochondrial mass or compromised activity of enzymes of the oxidative phosphorylation, nor does it reflect a decline in insulin-dependent glucose uptake, or diminution in storage of glycogen or triacylglycerol (TG) in the muscle. Conclusions/Significance: This study establishes rpS6 phosphorylation as a determinant of muscle strength through its role in regulation of myofiber growth and energy content. Interestingly, a similar role has been assigned for ribosomal protein S6 kinase 1, even though it regulates myoblast growth in an rpS6 phosphorylation-independent fashion.			Ruvinsky, I (corresponding author), Novamed Ltd, Jerusalem, Israel.	meyuhas@cc.huji.ac.il	Ruvinsky, Igal/AAC-3348-2021; Saada, Ann/J-6864-2017	Ruvinsky, Igal/0000-0002-9741-0457; Saada, Ann/0000-0003-2951-0656				Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; GRESSNER AM, 1974, J BIOL CHEM, V249, P6917; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; HEINZ F, 1985, METHOD ENZYMAT AN, P507; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Huijing PA, 2005, SCAND J MED SCI SPOR, V15, P349, DOI 10.1111/j.1600-0838.2005.00457.x; Isfort RJ, 2000, ELECTROPHORESIS, V21, P2228, DOI 10.1002/1522-2683(20000601)21:11<2228::AID-ELPS2228>3.0.CO;2-V; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; Kim YB, 2005, MOL CELL BIOL, V25, P9713, DOI 10.1128/MCB.25.21.9713-9723.2005; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malicdan MCV, 2008, PHYSIOL GENOMICS, V35, P106, DOI 10.1152/physiolgenomics.90219.2008; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Richardson MK, 2004, EVOL DEV, V6, P1, DOI 10.1111/j.1525-142X.2004.04008.x; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V291, pE1031, DOI 10.1152/ajpendo.00204.2006; Schumacher AM, 2006, BIOCHEMISTRY-US, V45, P13614, DOI 10.1021/bi060413y; Shearer J, 2005, AM J PHYSIOL-ENDOC M, V289, pE508, DOI 10.1152/ajpendo.00100.2005; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Trautschold I., 1985, METHODS ENZYMATIC AN, V3rd, P346; TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6; Watchko JF, 1996, PEDIATR RES, V40, P53, DOI 10.1203/00006450-199607000-00010; Wijers SLJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001777; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	47	69	69	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5618	10.1371/journal.pone.0005618	http://dx.doi.org/10.1371/journal.pone.0005618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19479038	Green Published, Green Submitted, gold			2022-12-27	WOS:000266161200018
J	Montero, JC; Ocana, A; Abad, M; Ortiz-Ruiz, MJ; Pandiella, A; Esparis-Ogando, A				Carlos Montero, Juan; Ocana, Alberto; Abad, Mar; Jesus Ortiz-Ruiz, Maria; Pandiella, Atanasio; Esparis-Ogando, Azucena			Expression of Erk5 in Early Stage Breast Cancer and Association with Disease Free Survival Identifies this Kinase as a Potential Therapeutic Target	PLOS ONE			English	Article								Background: Breast cancer is the most common neoplasia in women. Even though advances in its treatment have improved disease outcome, some patients relapse. Therefore, attempts to better define the molecular determinants that drive breast cancer cell proliferation may help in defining potential therapeutic targets. Mitogen-activated protein kinases (MAPK) play important roles in tumorigenesis. One of them, Erk5, has been linked to the proliferation of breast cancer cells in vitro. Here we have investigated the expression and prognostic value of Erk5 in human breast cancer. Methodology/Principal Findings: Animal and cellular models were used to study Erk5 expression and function in breast cancer. In 84 human breast tumours the expression of Erk5 was analyzed by immunohistochemistry. Active Erk5 (pErk5) was studied by Western blotting. Correlation of Erk5 with clinicopathological parameters and with disease-free survival in early stage breast cancer patients was analyzed. Expression of Erk5 was detected in most patients, and overexpression was found in 20%. Active Erk5 was present in a substantial number of samples, as well as in tumours from an animal breast cancer model. Overexpression of Erk5 was associated with a decrease in disease-free survival time, which was independent of other clinicopathological parameters of prognosis. Transient transfection of a short hairpin RNA (shRNA) targeting Erk5, and a stable cell line expressing a dominant negative form of Erk5 (Erk5(AEF)), were used to investigate the influence of Erk5 on drugs used in the clinic to treat breast tumours. We found that inhibition of Erk5 decreased cancer cell proliferation and also sensitized these cells to the action of anti-HER2 therapies. Conclusions/Significance: Overexpression of Erk5 is an independent predictor of disease-free survival in breast cancer, and may represent a future therapeutic target.			Montero, JC (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain.	esparis@usal.es	2009, Secribsal/A-1266-2012; Esparís-Ogando, Aucena/O-5326-2017; Pandiella, Atanasio/O-5180-2014; Montero, Juan Carlos/AAO-1780-2020	Esparís-Ogando, Aucena/0000-0003-4550-4192; Pandiella, Atanasio/0000-0002-4704-8971; Montero, Juan Carlos/0000-0003-4773-053X; Ocana, Alberto/0000-0002-1067-9630				Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; AMERICAN CANCER SOCIETY, 2007, CANC FACTS FIG; Baselga J, 2006, ONCOLOGIST, V11, P4, DOI 10.1634/theoncologist.11-90001-4; Cabrera N, 1996, J CELL BIOL, V132, P427, DOI 10.1083/jcb.132.3.427; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; de Alava E, 2007, J CLIN ONCOL, V25, P2656, DOI 10.1200/JCO.2006.08.6850; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Garaude J, 2006, J IMMUNOL, V177, P7607, DOI 10.4049/jimmunol.177.11.7607; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Hayashi M, 2005, CANCER RES, V65, P7699, DOI 10.1158/0008-5472.CAN-04-4540; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Ocana A, 2008, CLIN CANCER RES, V14, P961, DOI 10.1158/1078-0432.CCR-07-1630; Oshima RG, 2004, CANCER RES, V64, P169, DOI 10.1158/0008-5472.CAN-03-1944; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	21	74	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5565	10.1371/journal.pone.0005565	http://dx.doi.org/10.1371/journal.pone.0005565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440538	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107400009
J	Perales, C; Agudo, R; Domingo, E				Perales, Celia; Agudo, Ruben; Domingo, Esteban			Counteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic Treatment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MOUTH-DISEASE VIRUS; DEPENDENT RNA-POLYMERASE; HUMAN-IMMUNODEFICIENCY-VIRUS; VIRAL-RNA; ERROR CATASTROPHE; LETHAL MUTAGENESIS; ANTIVIRAL ACTIVITY; DRUG-RESISTANCE; INCREASED FIDELITY	Background: Lethal mutagenesis, or virus extinction promoted by mutagen-induced elevation of mutation rates of viruses, may meet with the problem of selection of mutagen-resistant variants, as extensively documented for standard, non-mutagenic antiviral inhibitors. Previously, we characterized a mutant of foot-and-mouth disease virus that included in its RNA-dependent RNA polymerase replacement M296I that decreased the sensitivity of the virus to the mutagenic nucleoside analogue ribavirin. Methodology and Principal Findings: Replacement M296I in the viral polymerase impedes the extinction of the mutant foot-and-mouth disease virus by elevated concentrations of ribavirin. In contrast, wild type virus was extinguished by the same ribavirin treatment and, interestingly, no mutants resistant to ribavirin were selected from the wild type populations. Decreases of infectivity and viral load of the ribavirin-resistant M296I mutant were attained with a combination of the mutagen 5-fluorouracil and the non-mutagenic inhibitor guanidine hydrocloride. However, extinction was achieved with a sequential treatment, first with ribavirin, and then with a minimal dose of 5-fluorouracil in combination with guanidine hydrochloride. Both, wild type and ribavirin-resistant mutant M296I exhibited equal sensitivity to this combination, indicating that replacement M296I in the polymerase did not confer a significant cross-resistance to 5-fluorouracil. We discuss these results in relation to antiviral designs based on lethal mutagenesis. Conclusions: (i) When dominant in the population, a mutation that confers partial resistance to a mutagenic agent can jeopardize virus extinction by elevated doses of the same mutagen. (ii)A wild type virus, subjected to identical high mutagenic treatment, need not select a mutagen-resistant variant, and the population can be extinguished. (iii) Extinction of the mutagen-resistant variant can be achieved by a sequential treatment of a high dose of the same mutagen, followed by a combination of another mutagen with an antiviral inhibitor.			Perales, C (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Campus Cantoblanco, Madrid, Spain.	edomingo@cbm.uam.es	Agudo Torres, Rubén/K-9173-2017; Domingo, Esteban/K-3937-2014	Domingo, Esteban/0000-0002-0573-1676; Perales Viejo, Celia Belen/0000-0003-1618-1937; Agudo Torres, Ruben/0000-0002-4784-3318				Agudo R, 2008, J MOL BIOL, V382, P652, DOI 10.1016/j.jmb.2008.07.033; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Anderson JP, 2004, ANNU REV MICROBIOL, V58, P183, DOI 10.1146/annurev.micro.58.030603.123649; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Asahina Y, 2005, J HEPATOL, V43, P623, DOI 10.1016/j.jhep.2005.05.032; Belsham GJ, 2008, J GEN VIROL, V89, P485, DOI 10.1099/vir.0.83385-0; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; Bull JJ, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P207, DOI 10.1016/B978-0-12-374153-0.00009-6; Castro C, 2005, VIRUS RES, V107, P141, DOI 10.1016/j.virusres.2004.11.004; Chevaliez S, 2007, J VIROL, V81, P7732, DOI 10.1128/JVI.00382-07; CONNOR E, 1993, ANTIMICROB AGENTS CH, V37, P532, DOI 10.1128/AAC.37.3.532; *CONS PAN, 2002, HEPATOLOGY, V36, pS3; Contreras AM, 2002, J VIROL, V76, P8505, DOI 10.1128/JVI.76.17.8505-8517.2002; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; DELATORRE JC, 1987, J VIROL, V61, P233, DOI 10.1128/JVI.61.1.233-235.1987; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Domingo E, 2005, VIRUS RES, V107, P115, DOI 10.1016/j.virusres.2004.11.001; Domingo E, 2005, VIRUS RES, V107, P129, DOI 10.1016/j.virusres.2004.11.003; DOMINGO E, 1980, GENE, V11, P333, DOI 10.1016/0378-1119(80)90073-6; Domingo E, 1989, Prog Drug Res, V33, P93; Domingo E., 2006, CURRENT TOPICS MICRO, VVolume 299; Domingo E, 2008, EXPERT OPIN BIOL TH, V8, P1455, DOI 10.1517/14712598.8.10.1455 ; Domingo E, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P87, DOI 10.1016/B978-0-12-374153-0.00004-7; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Escarmis C, 1999, J MOL BIOL, V285, P495, DOI 10.1006/jmbi.1998.2366; Escarmis C, 2002, J MOL BIOL, V315, P647, DOI 10.1006/jmbi.2001.5259; Escarmis C, 1996, J MOL BIOL, V264, P255, DOI 10.1006/jmbi.1996.0639; Escarmis C, 2008, J MOL BIOL, V376, P367, DOI 10.1016/j.jmb.2007.11.042; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Figlerowicz M, 2003, MED RES REV, V23, P488, DOI 10.1002/med.10045; Freistadt MS, 2004, DRUG RESIST UPDATE, V7, P19, DOI 10.1016/j.drup.2003.12.003; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Garcia-Arriaza J, 2006, J MOL BIOL, V360, P558, DOI 10.1016/j.jmb.2006.05.027; Ghoshal K, 1997, BIOCHEM PHARMACOL, V53, P1569, DOI 10.1016/S0006-2952(97)00040-3; GILBERT BE, 1986, ANTIMICROB AGENTS CH, V30, P201, DOI 10.1128/AAC.30.2.201; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Gonzalez-Lopez Claudia, 2005, Infection Genetics and Evolution, V5, P366, DOI 10.1016/j.meegid.2005.05.001; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Graci JD, 2002, VIROLOGY, V298, P175, DOI 10.1006/viro.2002.1487; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; HANLEY KH, 2008, ORIGIN EVOLUTION VIR; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; Hong Z, 2003, HEPATOLOGY, V38, P807, DOI 10.1053/jhep.2003.50464; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kanda T, 2004, J VIRAL HEPATITIS, V11, P479, DOI 10.1111/j.1365-2893.2004.00531.x; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lanford RE, 2001, J VIROL, V75, P8074, DOI 10.1128/JVI.75.17.8074-8081.2001; LE MV, 2002, AIDS, V16, P21; Lutchman G, 2007, GASTROENTEROLOGY, V132, P1757, DOI 10.1053/j.gastro.2007.03.035; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Meng XJ, 2000, VET MICROBIOL, V74, P309, DOI 10.1016/S0378-1135(00)00196-6; Muller V, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P279, DOI 10.1016/B978-0-12-374153-0.00014-X; NAJERA I, 1994, AIDS RES HUM RETROV, V10, P1479, DOI 10.1089/aid.1994.10.1479; NAJERA I, 1995, J VIROL, V69, P23; Nijhuis M., 2009, V189, P299, DOI 10.1007/978-3-540-79086-0_11; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; OGLE JW, 1989, J INFECT DIS, V159, P748, DOI 10.1093/infdis/159.4.748; PAGE T, 1990, INT J BIOCHEM, V22, P379, DOI 10.1016/0020-711X(90)90140-X; Pariente N, 2005, VIRUS RES, V107, P183, DOI 10.1016/j.virusres.2004.11.008; Pariente N, 2003, J VIROL, V77, P7131, DOI 10.1128/JVI.77.12.7131-7138.2003; Pariente N, 2001, J VIROL, V75, P9723, DOI 10.1128/JVI.75.20.9723-9730.2001; PARK JH, 1990, INT J GERIATR PSYCH, V5, P381, DOI 10.1002/gps.930050606; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Perales C, 2007, J MOL BIOL, V369, P985, DOI 10.1016/j.jmb.2007.03.074; Perelson AS, 2007, GASTROENTEROLOGY, V132, P2050, DOI 10.1053/j.gastro.2007.03.077; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; PINCUS SE, 1986, J VIROL, V60, P793, DOI 10.1128/JVI.60.2.793-796.1986; Quer J, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P303, DOI 10.1016/B978-0-12-374153-0.00015-1; Sanz-Ramos M, 2008, J VIROL, V82, P10465, DOI 10.1128/JVI.00825-08; SCHEIDEL LM, 1987, VIROLOGY, V158, P1, DOI 10.1016/0042-6822(87)90230-3; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000; Smidansky ED, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P135, DOI 10.1016/B978-0-12-374153-0.00006-0; Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; Van Vaerenbergh K, 2002, AIDS RES HUM RETROV, V18, P419, DOI 10.1089/088922202753614182; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Villarreal LP, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P477, DOI 10.1016/B978-0-12-374153-0.00021-7; Vo NV, 2003, BIOCHEMISTRY-US, V42, P10462, DOI 10.1021/bi0344681; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	93	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5554	10.1371/journal.pone.0005554	http://dx.doi.org/10.1371/journal.pone.0005554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436746	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107300018
J	Allan, LM; Ballard, CG; Rowan, EN; Kenny, RA				Allan, Louise M.; Ballard, Clive G.; Rowan, Elise N.; Kenny, Rose Anne			Incidence and Prediction of Falls in Dementia: A Prospective Study in Older People	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; LEWY BODIES; ALZHEIMERS-DISEASE; INTERNATIONAL WORKSHOP; COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; CORNELL SCALE; RISK-FACTORS; DIAGNOSIS; CONSENSUS	Background: Falls are a major cause of morbidity and mortality in dementia, but there have been no prospective studies of risk factors for falling specific to this patient population, and no successful falls intervention/ prevention trials. This prospective study aimed to identify modifiable risk factors for falling in older people with mild to moderate dementia. Methods and Findings: 179 participants aged over 65 years were recruited from outpatient clinics in the UK ( 38 Alzheimer's disease (AD), 32 Vascular dementia (VAD), 30 Dementia with Lewy bodies (DLB), 40 Parkinson's disease with dementia (PDD), 39 healthy controls). A multifactorial assessment of baseline risk factors was performed and fall diaries were completed prospectively for 12 months. Dementia participants experienced nearly 8 times more incident falls (9118/1000 person-years) than controls (1023/1000 person-years; incidence density ratio: 7.58, 3.11-18.5). In dementia, significant univariate predictors of sustaining at least one fall included diagnosis of Lewy body disorder (proportional hazard ratio (HR) adjusted for age and sex: 3.33, 2.11-5.26), and history of falls in the preceding 12 months (HR: 2.52, 1.52-4.17). In multivariate analyses, significant potentially modifiable predictors were symptomatic orthostatic hypotension (HR: 2.13, 1.19-3.80), autonomic symptom score (HR per point 0-36: 1.055, 1.012-1.099), and Cornell depression score (HR per point 0-40: 1.053, 1.01-1.099). Higher levels of physical activity were protective (HR per point 0-9: 0.827, 0.716-0.956). Conclusions: The management of symptomatic orthostatic hypotension, autonomic symptoms and depression, and the encouragement of physical activity may provide the core elements for the most fruitful strategy to reduce falls in people with dementia. Randomised controlled trials to assess such a strategy are a priority.			Allan, LM (corresponding author), Newcastle Gen Hosp, Wolfson Res Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	louise.allan@ncl.ac.uk	Allan, Louise M/A-2918-2009	Allan, Louise M/0000-0002-8912-4901; Ballard, Clive/0000-0003-0022-5632; Kenny, Rose Anne/0000-0002-9336-8124	MRC [G0500247, G0502157, G0400074] Funding Source: UKRI; Medical Research Council [G0500247, G0400074, G0502157] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALEXOPOULOS GS, 1988, J AM GERIATR SOC, V36, P230, DOI 10.1111/j.1532-5415.1988.tb01806.x; ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Asada T, 1996, AGE AGEING, V25, P22, DOI 10.1093/ageing/25.1.22; Ballard CG, 1999, DEMENT GERIATR COGN, V10, P97, DOI 10.1159/000017108; Baloh RW, 2003, ARCH NEUROL-CHICAGO, V60, P835, DOI 10.1001/archneur.60.6.835; Brierley EJ, 1996, QJM-MON J ASSOC PHYS, V89, P251; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Bueno-Cavanillas A, 2000, EUR J EPIDEMIOL, V16, P849, DOI 10.1023/A:1007636531965; Camicioli R, 2004, ALZ DIS ASSOC DIS, V18, P214; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Fahn S., 1987, RECENT DEV PARKINSON, P153; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIBB WRG, 1987, BRAIN, V110, P1131, DOI 10.1093/brain/110.5.1131; Holmes C, 1999, BRIT J PSYCHIAT, V174, P45, DOI 10.1192/bjp.174.1.45; Horikawa E, 2005, INTERNAL MED, V44, P717, DOI 10.2169/internalmedicine.44.717; Katz IR, 2004, AM J GERIAT PSYCHIAT, V12, P499; Kenny RA, 2004, J NEUROL NEUROSUR PS, V75, P966, DOI 10.1136/jnnp.2003.023812; McKeith IG, 1998, NEUROLOGY, V50, pA181; McKeith IG, 2000, NEUROLOGY, V54, P1050, DOI 10.1212/WNL.54.5.1050; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1987, J GERONTOL, V42, P412, DOI 10.1093/geronj/42.4.412; Oliver D, 2007, BRIT MED J, V334, P82, DOI 10.1136/bmj.39049.706493.55; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Shaw FE, 2002, CLIN GERIATR MED, V18, P159, DOI 10.1016/S0749-0690(02)00003-4; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; Wood B, 2001, AGE AGEING, V30, P423, DOI 10.1093/ageing/30.5.423; [No title captured]	40	286	290	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5521	10.1371/journal.pone.0005521	http://dx.doi.org/10.1371/journal.pone.0005521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	444WA	19436724	Green Published, gold			2022-12-27	WOS:000266009900014
J	Albergotti, LC; Hamlin, HJ; Mccoy, MW; Guillette, LJ				Albergotti, Lori C.; Hamlin, Heather J.; McCoy, Michael W.; Guillette, Louis J., Jr.			Endocrine Activity of Extraembryonic Membranes Extends beyond Placental Amniotes	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR ISOFORMS; EMBRYONIC-DEVELOPMENT; POSSIBLE MECHANISM; STEROID-HORMONES; FETAL MEMBRANES; ESTROGEN; CHICKEN; EXPRESSION; WITHDRAWAL; PREGNANCY	Background: During development, all amniotes (mammals, reptiles, and birds) form extraembryonic membranes, which regulate gas and water exchange, remove metabolic wastes, provide shock absorption, and transfer maternally derived nutrients. In viviparous (live-bearing) amniotes, both extraembryonic membranes and maternal uterine tissues contribute to the placenta, an endocrine organ that synthesizes, transports, and metabolizes hormones essential for development. Historically, endocrine properties of the placenta have been viewed as an innovation of placental amniotes. However, an endocrine role of extraembryonic membranes has not been investigated in oviparous (egg-laying) amniotes despite similarities in their basic structure, function, and shared evolutionary ancestry. In this study, we ask whether the oviparous chorioallantoic membrane (CAM) of chicken (Gallus gallus) has the capability to synthesize and receive signaling of progesterone, a major placental steroid hormone. Methodology/Principal Findings: We quantified mRNA expression of key steroidogenic enzymes involved in progesterone synthesis and found that 3 beta-hydroxysteroid dehydrogenase, which converts pregnenolone to progesterone exhibited a 464 fold increase in the CAM from day 8 to day 18 of embryonic development (F-5,F- 68 = 89.282, p<0.0001). To further investigate progesterone synthesis, we performed explant culture and found that the CAM synthesizes progesterone in vitro in the presence of a steroid precursor. Finally, we quantified mRNA expression and performed protein immunolocalization of the progesterone receptor in the CAM. Conclusions/Significance: Collectively, our data indicate that the chick CAM is steroidogenic and has the capability to both synthesize progesterone and receive progesterone signaling. These findings represent a paradigm shift in evolutionary reproductive biology by suggesting that endocrine activity of extraembryonic membranes is not a novel characteristic of placental amniotes. Rather, we hypothesize that these membranes may share an additional unifying characteristic, steroidogenesis, across amniotes at large.			Albergotti, LC (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	ljg@zoology.ufl.edu	Hamlin, Heather/K-6235-2019	Hamlin, Heather/0000-0002-9042-5509; McCoy, Michael/0000-0002-7993-6236	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Blackburn DG, 1999, HERPETOLOGICA, V55, P556; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; CROSS JC, 2003, GENES DEV EVOLUTION, P123; Cudeville C, 2000, BIOL REPROD, V62, P759, DOI 10.1095/biolreprod62.3.759; Elf PK, 2002, J EXP ZOOL, V293, P594, DOI 10.1002/jez.10169; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Giannoulias D, 2005, PLACENTA, V26, P289, DOI 10.1016/j.placenta.2004.07.005; Girling JE, 2007, ENDOCRINOLOGY, V148, P5433, DOI 10.1210/en.2007-0856; Girling JE, 2003, GEN COMP ENDOCR, V133, P100, DOI 10.1016/S0016-6480(03)00147-3; Goldman S, 2005, MOL HUM REPROD, V11, P269, DOI 10.1093/molehr/gah161; Gonzalez-Moran G, 2003, LIFE SCI, V73, P871, DOI 10.1016/S0024-3205(03)00353-9; Gonzalez-Moran G, 2002, COMP BIOCHEM PHYS A, V132, P519, DOI 10.1016/S1095-6433(02)00096-X; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Griffin C, 1999, MOL ENDOCRINOL, V13, P1571, DOI 10.1210/me.13.9.1571; Guarino FM, 1998, GEN COMP ENDOCR, V111, P261, DOI 10.1006/gcen.1998.7098; GUILLETTE LJ, 1993, BIOSCIENCE, V43, P742, DOI 10.2307/1312318; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Henson MC, 1998, HUM REPROD UPDATE, V4, P389, DOI 10.1093/humupd/4.4.389; Jojovic M, 1998, ANAT EMBRYOL, V198, P133, DOI 10.1007/s004290050171; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; King SR, 2004, J MOL ENDOCRINOL, V32, P507, DOI 10.1677/jme.0.0320507; Kluge A. G., 1977, CHORDATE STRUCTURE F, V2nd; Mark PJ, 2006, PLACENTA, V27, P208, DOI 10.1016/j.placenta.2005.01.004; MCCOY KA, 2008, ENV HLTH PERSPECT, V7, P116; MCEWEN RS, 1957, VERTEBRATE EMBRYOLOG; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Norris D. O., 1997, VERTEBRATE ENDOCRINO; OGLE TF, 1990, BIOL REPROD, V43, P276, DOI 10.1095/biolreprod43.2.276; OMAR HA, 1995, J CLIN ENDOCR METAB, V80, P370, DOI 10.1210/jc.80.2.370; Painter DL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P364, DOI 10.1086/430222; Pasanen S, 1997, MOL CELL ENDOCRINOL, V135, P79, DOI 10.1016/S0303-7207(97)00192-5; Pasqualini JR, 2005, J STEROID BIOCHEM, V97, P401, DOI 10.1016/j.jsbmb.2005.08.004; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Petraglia F, 1996, ENDOCR REV, V17, P156, DOI 10.1210/er.17.2.156; Pinheiro J, 2001, MIXED EFFECTS MODELS; ROSEN S, 2000, PRIMER3 WWW GEN USER, P365; Team RDC, 2019, R LANG ENV STAT COMP; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walter LM, 2005, REPRODUCTION, V129, P765, DOI 10.1530/rep.1.00625	42	29	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5452	10.1371/journal.pone.0005452	http://dx.doi.org/10.1371/journal.pone.0005452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424488	Green Published, gold, Green Submitted			2022-12-27	WOS:000265933800001
J	Garber, DA; O'Mara, LA; Zhao, J; Gangadhara, S; An, I; Feinberg, MB				Garber, David A.; O'Mara, Leigh A.; Zhao, Jun; Gangadhara, Sailaja; An, InChul; Feinberg, Mark B.			Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies	PLOS ONE			English	Article							URACIL-DNA GLYCOSYLASE; SIMIAN IMMUNODEFICIENCY VIRUS; ATTENUATED MVA STRAIN; CD8(+) T-CELLS; HOST-RANGE; PROTECTIVE IMMUNITY; DOMINANT SELECTION; SELECTABLE MARKER; REPLICATION; IMMUNOGENICITY	Background: Modified Vaccinia virus Ankara (MVA) is a safe, highly attenuated orthopoxvirus that is being developed as a recombinant vaccine vector for immunization against a number of infectious diseases and cancers. However, the expression by MVA vectors of large numbers of poxvirus antigens, which display immunodominance over vectored antigens-of-interest for the priming of T cell responses, and the induction of vector-neutralizing antibodies, which curtail the efficacy of subsequent booster immunizations, remain as significant impediments to the overall utility of such vaccines. Thus, genetic approaches that enable the derivation of MVA vectors that are antigenically less complex may allow for rational improvement of MVA-based vaccines. Principal Findings: We have developed a genetic complementation system that enables the deletion of essential viral genes from the MVA genome, thereby allowing us to generate MVA vaccine vectors that are antigenically less complex. Using this system, we deleted the essential uracil-DNA-glycosylase (udg) gene from MVA and propagated this otherwise replication-defective variant on a complementing cell line that constitutively expresses the poxvirus udg gene and that was derived from a newly identified continuous cell line that is permissive for growth of wild type MVA. The resulting virus, MVA Delta udg, does not replicate its DNA genome or express late viral gene products during infection of non-complementing cells in culture. As proof-of-concept for immunological 'focusing', we demonstrate that immunization of mice with MVA Delta udg elicits CD8+ T cell responses that are directed against a restricted repertoire of vector antigens, as compared to immunization with parental MVA. Immunization of rhesus macaques with MVA Delta udg-gag, a udg 2 recombinant virus that expresses an HIV subtype-B consensus gag transgene, elicited significantly higher frequencies of Gag-specific CD8 and CD4 T cells following both primary (2-4-fold) and booster (2-fold) immunizations as compared to the udg(+) control virus MVA-gag, as determined by intracellular cytokine assay. In contrast, levels of HIV Gag-specific antibodies were elicited similarly in macaques following immunization with MVA Delta udg-gag and MVA-gag. Furthermore, both udg 2 and udg+ MVA vectors induced comparatively similar titers of MVA-specific neutralizing antibody responses following immunization of mice (over a 4-log range: 10(4)-10(8) PFU) and rhesus macaques. These results suggest that the generation of MVA-specific neutralizing antibody responses are largely driven by input MVA antigens, rather than those that are synthesized de novo during infection, and that the processes governing the generation of antiviral antibody responses are more readily saturated by viral antigen than are those that elicit CD8+ T cell responses. Significance: Our identification of a spontaneously-immortalized (but not transformed) chicken embryo fibroblast cell line (DF-1) that is fully permissive for MVA growth and that can be engineered to stably express MVA genes provides the basis for a genetic system for MVA. DF-1 cells (and derivatives thereof) constitute viable alternatives, for the manufacture of MVA-based vaccines, to primary CEFs-the conventional cell substrate for MVA vaccines that is not amenable to genetic complementation strategies due to these cells' finite lifespan in culture. The establishment of a genetic system for MVA, as illustrated here to allow udg deletion, enables the generation of novel replication-defective MVA mutants and expands the repertoire of genetic viral variants that can now be explored as improved vaccine vectors.			Garber, DA (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	david.garber@emory.edu			NIAID NIH HHS [P01 AI046007, U19 AI061728] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Ausubel F., 1999, CURRENT PROTOCOLS MO; Basta S, 2002, J IMMUNOL, V168, P5403, DOI 10.4049/jimmunol.168.11.5403; BERDY J, 1980, AMINO ACID PEPTIDE A, P459; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; BORY JPL, 2006, PHASE 2 STUDY HPV16; Brockman MA, 2002, J VIROL, V76, P3678, DOI 10.1128/JVI.76.8.3678-3687.2002; CALMELS T, 1991, CURR GENET, V20, P309, DOI 10.1007/BF00318520; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; CARROLL MW, 1995, BIOTECHNIQUES, V19, P352; Casimiro DR, 2004, J VIROL, V78, P11434, DOI 10.1128/JVI.78.20.11434-11438.2004; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Coulibaly S, 2005, VIROLOGY, V341, P91, DOI 10.1016/j.virol.2005.06.043; Da Costa XJ, 2001, VIROLOGY, V288, P256, DOI 10.1006/viro.2001.1094; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Ellison KS, 1996, J VIROL, V70, P7965, DOI 10.1128/JVI.70.11.7965-7973.1996; ENGRAM J, VACCINE INDUCE UNPUB; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; FARRELL HE, 1994, J VIROL, V68, P927, DOI 10.1128/JVI.68.2.927-932.1994; Fischer MA, 2007, J GEN VIROL, V88, P2378, DOI 10.1099/vir.0.83107-0; FRANKE CA, 1985, MOL CELL BIOL, V5, P1918, DOI 10.1128/MCB.5.8.1918; Garg S, 2004, J IMMUNOL, V173, P550, DOI 10.4049/jimmunol.173.1.550; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; GOEPFERT PHC, 2007, HIV 1 DNA PRIME FOLL; GUIMARAESWALKER A, 2004, PRIMING CANDIDATE HI; Gutierrez CMC, 2004, HUM GENE THER, V15, P421, DOI 10.1089/10430340460745757; Hansen SG, 2002, BIOTECHNIQUES, V32, P1178, DOI 10.2144/02325dd08; HARRER THJ, 2007, THERAPEUTIC VACCINAT; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Hirsch VM, 1996, J VIROL, V70, P3741, DOI 10.1128/JVI.70.6.3741-3752.1996; Holzer GW, 1998, VIROLOGY, V249, P160, DOI 10.1006/viro.1998.9307; Holzer GW, 1999, J VIROL, V73, P4536, DOI 10.1128/JVI.73.6.4536-4542.1999; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; JAOKO W, 2004, SAFETY IMMUNOGENICIT; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; KEEFER MCE, 2007, SAFETY IMMUNOGENICIT; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lauvau G, 2004, EUR J IMMUNOL, V34, P913, DOI 10.1002/eji.200424944; Manischewitz J, 2003, J INFECT DIS, V188, P440, DOI 10.1086/376557; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Mayr A., 1975, INFECTION, V3, P6, DOI [10.1007/BF01641272, DOI 10.1007/BF01641272]; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Murphy CG, 2000, J VIROL, V74, P7745, DOI 10.1128/JVI.74.17.7745-7754.2000; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; NGUYEN LH, 1992, J VIROL, V66, P7067, DOI 10.1128/JVI.66.12.7067-7072.1992; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Ober BT, 2002, J VIROL, V76, P7713, DOI 10.1128/JVI.76.15.7713-7723.2002; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; Sanchez-Puig JM, 2000, GENE, V257, P57, DOI 10.1016/S0378-1119(00)00398-X; SANDSTROM EWB, 2007, IMPROVED MODES DELIV; Schaefer-Klein J, 1998, VIROLOGY, V248, P305, DOI 10.1006/viro.1998.9291; Shen XF, 2002, J IMMUNOL, V169, P4222, DOI 10.4049/jimmunol.169.8.4222; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Smith CL, 2005, J IMMUNOL, V175, P8431, DOI 10.4049/jimmunol.175.12.8431; Smith CL, 2005, INT J CANCER, V113, P259, DOI 10.1002/ijc.20569; SNAITH MR, 1995, GENE, V166, P173, DOI 10.1016/0378-1119(95)00579-8; Stittelaar KJ, 2001, VACCINE, V19, P3700, DOI 10.1016/S0264-410X(01)00075-5; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; SUTTER G, 1994, VACCINE, V12, P1032, DOI 10.1016/0264-410X(94)90341-7; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; VASAN S, 2007, CELLULAR HUMORAL IMM; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	76	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5445	10.1371/journal.pone.0005445	http://dx.doi.org/10.1371/journal.pone.0005445			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421328	Green Submitted, Green Published, gold			2022-12-27	WOS:000265836900006
J	Williams, DC; Novick, PJ				Williams, Daniel C.; Novick, Peter J.			Analysis of SEC9 Suppression Reveals a Relationship of SNARE Function to Cell Physiology	PLOS ONE			English	Article								Background: Growth and division of Saccharomyces cerevisiae is dependent on the action of SNARE proteins that are required for membrane fusion. SNAREs are regulated, through a poorly understood mechanism, to ensure membrane fusion at the correct time and place within a cell. Although fusion of secretory vesicles with the plasma membrane is important for yeast cell growth, the relationship between exocytic SNAREs and cell physiology has not been established. Methodology/Principal Findings: Using genetic analysis, we identified several influences on the function of exocytic SNAREs. Genetic disruption of the V-ATPase, but not vacuolar proteolysis, can suppress two different temperature-sensitive mutations in SEC9. Suppression is unlikely due to increased SNARE complex formation because increasing SNARE complex formation, through overexpression of SRO7, does not result in suppression. We also observed suppression of sec9 mutations by growth on alkaline media or on a non-fermentable carbon source, conditions associated with a reduced growth rate of wild-type cells and decreased SNARE complex formation. Conclusions/Significance: Three main conclusions arise from our results. First, there is a genetic interaction between SEC9 and the V-ATPase, although it is unlikely that this interaction has functional significance with respect to membrane fusion or SNAREs. Second, Sro7p acts to promote SNARE complex formation. Finally, Sec9p function and SNARE complex formation are tightly coupled to the physiological state of the cell.			Williams, DC (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	pnovick@ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035370, R01GM082861, R01GM035370] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM035370, GM082861, R01 GM082861, GM35370, R37 GM035370] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; FIELD C, 1980, J CELL BIOL, V86, P123, DOI 10.1083/jcb.86.1.123; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Grote E, 1999, MOL BIOL CELL, V10, P4149, DOI 10.1091/mbc.10.12.4149; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; HIRATA R, 1990, J BIOL CHEM, V265, P6726; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kagami M, 1998, GENETICS, V149, P1717; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MATSUI Y, 1992, MOL CELL BIOL, V12, P5690, DOI 10.1128/MCB.12.12.5690; Munson M, 2002, J BIOL CHEM, V277, P9375, DOI 10.1074/jbc.M111729200; Munson M, 2000, NAT STRUCT BIOL, V7, P894; NEBES VL, 1991, J BIOL CHEM, V266, P22851; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Prelich G, 1999, TRENDS GENET, V15, P261, DOI 10.1016/S0168-9525(99)01749-7; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SORENSEN SO, 1994, EUR J BIOCHEM, V220, P19, DOI 10.1111/j.1432-1033.1994.tb18594.x; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; ZUBENKO GS, 1983, P NATL ACAD SCI-BIOL, V80, P510, DOI 10.1073/pnas.80.2.510	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5449	10.1371/journal.pone.0005449	http://dx.doi.org/10.1371/journal.pone.0005449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421331	Green Published, Green Submitted, gold			2022-12-27	WOS:000265836900008
J	Forero, MG; Pennack, JA; Learte, AR; Hidalgo, A				Forero, Manuel G.; Pennack, Jenny A.; Learte, Anabel R.; Hidalgo, Alicia			DeadEasy Caspase: Automatic Counting of Apoptotic Cells in Drosophila	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; NUCLEI; COMPENSATION; SEGMENTATION; ATTENUATION; INTENSITY; SURVIVAL; DEATH	Development, cancer, neurodegenerative and demyelinating diseases, injury, and stem cell manipulations are characterised by alterations in cell number. Research into development, disease, and the effects of drugs require cell number counts. These are generally indirect estimates, because counting cells in an animal or organ is paradoxically difficult, as well as being tedious and unmanageable. Drosophila is a powerful model organism used to investigate the genetic bases of development and disease. There are Drosophila models for multiple neurodegenerative diseases, characterised by an increase in cell death. However, a fast, reliable, and accurate way to count the number of dying cells in vivo is not available. Here, we present a method based on image filtering and mathematical morphology techniques, to count automatically the number of dying cells in intact fruit-fly embryos. We call the resulting programme DeadEasy Caspase. It has been validated for Drosophila and we present examples of its power to address biological questions. Quantification is automatic, accurate, objective, and very fast. DeadEasy Caspase will be freely available as an ImageJ plug-in, and it can be modified for use in other sample types. It is of interest to the Drosophila and wider biomedical communities. DeadEasy Caspase is a powerful tool for the analysis of cell survival and cell death in development and in disease, such as neurodegenerative diseases and ageing. Combined with the power of Drosophila genetics, DeadEasy expands the tools that enable the use of Drosophila to analyse gene function, model disease and test drugs in the intact nervous system and whole animal.			Hidalgo, A (corresponding author), Univ Birmingham, Sch Biosci, NeuroDev Grp, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	Hidalgo, Alicia/F-5930-2015	Hidalgo, Alicia/0000-0001-8041-5764; Forero, Manuel/0000-0001-9972-8621	MRC [G0200140] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0200140] Funding Source: Medline; Wellcome Trust [073228] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adiga PSU, 2001, MICRON, V32, P363, DOI 10.1016/S0968-4328(00)00046-9; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Booth GE, 2000, DEVELOPMENT, V127, P237; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Burne JF, 1996, J NEUROSCI, V16, P2064; Can A, 2003, J MICROSC-OXFORD, V211, P67, DOI 10.1046/j.1365-2818.2003.01195.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Colombani J, 2006, CURR BIOL, V16, P1453, DOI 10.1016/j.cub.2006.05.059; CONCHELLO JA, 1995, P 1995 IS T SPIE S E, P138; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Forero MG, 2006, J MICROSC-OXFORD, V223, P120, DOI 10.1111/j.1365-2818.2006.01610.x; Griffiths RL, 2004, EMBO J, V23, P2440, DOI 10.1038/sj.emboj.7600258; Guan YQ, 2008, MICROSC RES TECHNIQ, V71, P146, DOI 10.1002/jemt.20536; Gue M, 2005, CYTOM PART A, V67A, P18, DOI 10.1002/cyto.a.20170; Kervrann C, 2004, J MICROSC-OXFORD, V214, P297, DOI 10.1111/j.0022-2720.2004.01333.x; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Ragone G, 2003, DEV BIOL, V255, P138, DOI 10.1016/S0012-1606(02)00081-7; ROERDINK JBT, 1993, J MICROSCOPY, V169, P233; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Shimada T, 2005, PHYSICA A, V350, P144, DOI 10.1016/j.physa.2004.11.033; Soustelle L, 2007, DEVELOPMENT, V134, P625, DOI 10.1242/dev.02750; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wahlby C., 2003, ALGORITHMS APPL DIGI; Wu HX, 2005, J MICROSC-OXFORD, V220, P9, DOI 10.1111/j.1365-2818.2005.01508.x; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5441	10.1371/journal.pone.0005441	http://dx.doi.org/10.1371/journal.pone.0005441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415123	Green Published, gold, Green Submitted			2022-12-27	WOS:000265836700013
J	Iqbal, M; Yaqub, T; Reddy, K; McCauley, JW				Iqbal, Munir; Yaqub, Tahir; Reddy, Kolli; McCauley, John W.			Novel Genotypes of H9N2 Influenza A Viruses Isolated from Poultry in Pakistan Containing NS Genes Similar to Highly Pathogenic H7N3 and H5N1 Viruses	PLOS ONE			English	Article							AVIAN INFLUENZA; HUMAN INFECTION; SOUTHERN CHINA; SUBTYPE H9N2; HOST-RANGE; EVOLUTION; PROTEIN; HEMAGGLUTININ; TRANSMISSION; REPLICATION	The impact of avian influenza caused by H9N2 viruses in Pakistan is now significantly more severe than in previous years. Since all gene segments contribute towards the virulence of avian influenza virus, it was imperative to investigate the molecular features and genetic relationships of H9N2 viruses prevalent in this region. Analysis of the gene sequences of all eight RNA segments from 12 viruses isolated between 2005 and 2008 was undertaken. The hemagglutinin (HA) sequences of all isolates were closely related to H9N2 viruses isolated from Iran between 2004 and 2007 and contained leucine instead of glutamine at position 226 in the receptor binding pocket, a recognised marker for the recognition of sialic acids linked alpha 2-6 to galactose. The neuraminidase (NA) of two isolates contained a unique five residue deletion in the stalk (from residues 80 to 84), a possible indication of greater adaptation of these viruses to the chicken host. The HA, NA, nucleoprotein (NP), and matrix (M) genes showed close identity with H9N2 viruses isolated during 1999 in Pakistan and clustered in the A/Quail/Hong Kong/G1/97 virus lineage. In contrast, the polymerase genes clustered with H9N2 viruses from India, Iran and Dubai. The NS gene segment showed greater genetic diversity and shared a high level of similarity with NS genes from either H5 or H7 subtypes rather than with established H9N2 Eurasian lineages. These results indicate that during recent years the H9N2 viruses have undergone extensive genetic reassortment which has led to the generation of H9N2 viruses of novel genotypes in the Indian sub-continent. The novel genotypes of H9N2 viruses may play a role in the increased problems observed by H9N2 to poultry and reinforce the continued need to monitor H9N2 infections for their zoonotic potential.			Iqbal, M (corresponding author), AFRC, Inst Anim Hlth, Compton Lab, Div Microbiol, Newbury RG16 0NN, Berks, England.	munir.iqbal@bbsrc.ac.uk	Yaqub, Tahir/U-1021-2019	Yaqub, Tahir/0000-0001-8698-3818; Iqbal, Munir/0000-0001-5165-5339	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001025, BBS/E/I/00001422] Funding Source: researchfish; Medical Research Council [MC_U117585868] Funding Source: researchfish; BBSRC [BBS/E/I/00001422] Funding Source: UKRI; MRC [MC_U117585868] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ALEXANDER DJ, 1981, AVIAN PATHOL, V10, P281, DOI 10.1080/03079458108418477; ALEXANDER DJ, 2004, MANUAL DIAGNOSTIC TE, P258; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Bano S, 2003, AVIAN DIS, V47, P817, DOI 10.1637/0005-2086-47.s3.817; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Campitelli L, 2008, J GEN VIROL, V89, P48, DOI 10.1099/vir.0.83111-0; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Cong YL, 2008, VIRUS GENES, V36, P461, DOI 10.1007/s11262-008-0227-z; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Dundon WG, 2006, VIRUS RES, V119, P171, DOI 10.1016/j.virusres.2006.01.005; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gambaryan A, 2002, ARCH VIROL, V147, P1197, DOI 10.1007/s00705-002-0796-4; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Golender N, 2008, VIRUS GENES, V37, P289, DOI 10.1007/s11262-008-0272-7; GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; GUO YJ, 1992, J GEN VIROL, V73, P383, DOI 10.1099/0022-1317-73-2-383; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kishida N, 2004, ARCH VIROL, V149, P2095, DOI 10.1007/s00705-004-0372-1; Kobasa D, 1997, J VIROL, V71, P6706, DOI 10.1128/JVI.71.9.6706-6713.1997; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; LI XS, 1992, J GEN VIROL, V73, P1329, DOI 10.1099/0022-1317-73-6-1329; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu HQ, 2003, AVIAN DIS, V47, P116, DOI 10.1637/0005-2086(2003)047[0116:PAOTHG]2.0.CO;2; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Macken CA, 2006, J GEN VIROL, V87, P2803, DOI 10.1099/vir.0.81454-0; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Mase M, 2001, J VIROL, V75, P3490, DOI 10.1128/JVI.75.7.3490-3494.2001; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich Mikhail N., 2008, V27, P134; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Monne I, 2008, J GEN VIROL, V89, P2691, DOI 10.1099/vir.0.2008/004259-0; Monne I, 2007, AVIAN DIS, V51, P451, DOI 10.1637/7563-033106R.1; Naeem K, 2007, AVIAN DIS, V51, P189, DOI 10.1637/7617-042506R.1; Naeem K, 2006, DEV BIOLOGICALS, V124, P145; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shi WF, 2008, ARCH VIROL, V153, P211, DOI 10.1007/s00705-007-1083-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tosh C, 2008, ARCH VIROL, V153, P1433, DOI 10.1007/s00705-008-0131-9; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Webster RG, 1997, FEMS IMMUNOL MED MIC, V18, P275, DOI 10.1016/S0928-8244(97)00058-8; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2008, AV INFL SIT PAK UPD; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06; Yao YX, 2001, J VIROL, V75, P5410, DOI 10.1128/JVI.75.11.5410-5415.2001; YOUNG JF, 1979, P NATL ACAD SCI USA, V76, P6547, DOI 10.1073/pnas.76.12.6547; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	76	128	136	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5788	10.1371/journal.pone.0005788	http://dx.doi.org/10.1371/journal.pone.0005788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517011	gold, Green Published, Green Submitted			2022-12-27	WOS:000266873100001
J	Kirk, SL; Samuelsson, AM; Argenton, M; Dhonye, H; Kalamatianos, T; Poston, L; Taylor, PD; Coen, CW				Kirk, Shona L.; Samuelsson, Anne-Maj; Argenton, Marco; Dhonye, Hannah; Kalamatianos, Theodosis; Poston, Lucilla; Taylor, Paul D.; Coen, Clive W.			Maternal Obesity Induced by Diet in Rats Permanently Influences Central Processes Regulating Food Intake in Offspring	PLOS ONE			English	Article								Hypothalamic systems which regulate appetite may be permanently modified during early development. We have previously reported hyperphagia and increased adiposity in the adult offspring of rodents fed an obesogenic diet prior to and throughout pregnancy and lactation. We now report that offspring of obese (OffOb) rats display an amplified and prolonged neonatal leptin surge, which is accompanied by elevated leptin mRNA expression in their abdominal white adipose tissue. At postnatal Day 30, before the onset of hyperphagia in these animals, serum leptin is normal, but leptin-induced appetite suppression and phosphorylation of STAT3 in the arcuate nucleus (ARC) are attenuated; the level of AgRP-immunoreactivity in the hypothalamic paraventricular nucleus (PVH), which derives from neurones in the ARC and is developmentally dependent on leptin, is also diminished. We hypothesise that prolonged release of abnormally high levels of leptin by neonatal OffOb rats leads to leptin resistance and permanently affects hypothalamic functions involving the ARC and PVH. Such effects may underlie the developmental programming of hyperphagia and obesity in these rats.			Kirk, SL (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London WC2R 2LS, England.	paul.taylor@kcl.ac.uk		Taylor, Paul David/0000-0002-4740-4307; Coen, Clive/0000-0003-1303-216X; Kalamatianos, Theodosis/0000-0003-4634-2965	Biotechnology and Biological Sciences Research Council [BBD5231861] Funding Source: Medline; British Heart Foundation [PG/06/067] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)		Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; ARMITAGE JA, 2005, J PHYSL; BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Barker DJP, 1994, FETAL MATERNAL MED R, V6, P71, DOI DOI 10.1017/S0965539500001005; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cripps RL, 2005, CLIN SCI, V109, P1, DOI 10.1042/CS20040367; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Passos MCF, 2009, BRIT J NUTR, V101, P250, DOI 10.1017/S0007114508006521; Ghebremeskel K, 1999, BRIT J NUTR, V81, P395, DOI 10.1017/S0007114599000689; GREEN MH, 1981, J NUTR, V111, P276, DOI 10.1093/jn/111.2.276; Grove KL, 2003, PHYSIOL BEHAV, V79, P47, DOI 10.1016/S0031-9384(03)00104-5; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Harvey NC, 2007, J CLIN ENDOCR METAB, V92, P523, DOI 10.1210/jc.2006-0456; Horvath TL, 2006, NAT MED, V12, P52, DOI 10.1038/nm0106-52; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Irani BG, 2007, ENDOCRINOLOGY, V148, P310, DOI 10.1210/en.2006-1126; JOSEPH SA, 1988, PEPTIDES, V9, P193, DOI 10.1016/0196-9781(88)90027-7; Keesey RE, 1997, J NUTR, V127, pS1875, DOI 10.1093/jn/127.9.1875S; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Korotkova M, 2005, AM J PHYSIOL-REG I, V288, pR575, DOI 10.1152/ajpregu.00342.2004; Koukkou E, 1998, CIRCULATION, V98, P2899, DOI 10.1161/01.CIR.98.25.2899; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; LEPAGE G, 1986, J LIPID RES, V27, P114; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Levin BE, 1998, AM J PHYSIOL-REG I, V274, pR412, DOI 10.1152/ajpregu.1998.274.2.R412; Levin BE, 2003, AM J PHYSIOL-ENDOC M, V285, pE949, DOI 10.1152/ajpendo.00186.2003; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mistry AM, 1999, AM J PHYSIOL-REG I, V277, pR742, DOI 10.1152/ajpregu.1999.277.3.R742; Morgan DA, 2008, AM J PHYSIOL-REG I, V295, pR1730, DOI 10.1152/ajpregu.90324.2008; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Muhlhausler BS, 2005, J PHYSIOL-LONDON, V565, P185, DOI 10.1113/jphysiol.2004.079079; Neary NM, 2004, CLIN ENDOCRINOL, V60, P153, DOI 10.1046/j.1365-2265.2003.01839.x; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; OKEN E, 2008, EPIDEMIOLOGY; Paxinos G, 1989, RAT BRAIN STEREOTAXI; PILCHER WH, 1986, PEPTIDES, V7, P783, DOI 10.1016/0196-9781(86)90096-3; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plagemann A, 2005, PHYSIOL BEHAV, V86, P661, DOI 10.1016/j.physbeh.2005.08.065; Plagemann A, 1999, BRAIN RES, V818, P160, DOI 10.1016/S0006-8993(98)01264-5; Plagemann A, 2008, BR J NUTR, P1; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; SAWCHENKO PE, 1983, J COMP NEUROL, V218, P121, DOI 10.1002/cne.902180202; Schmidt I, 2001, INT J OBESITY, V25, P1168, DOI 10.1038/sj.ijo.0801669; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V290, pE129, DOI 10.1152/ajpendo.00248.2005; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhang JL, 2005, AM J PHYSIOL-REG I, V288, pR112, DOI 10.1152/ajpregu.00351.2004	73	271	280	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5870	10.1371/journal.pone.0005870	http://dx.doi.org/10.1371/journal.pone.0005870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19516909	Green Published, gold, Green Submitted			2022-12-27	WOS:000266873100003
J	Comstedt, P; Asokliene, L; Eliasson, I; Olsen, B; Wallensten, A; Bunikis, J; Bergstrom, S				Comstedt, Par; Asokliene, Loreta; Eliasson, Ingvar; Olsen, Bjorn; Wallensten, Anders; Bunikis, Jonas; Bergstrom, Sven			Complex Population Structure of Lyme Borreliosis Group Spirochete Borrelia garinii in Subarctic Eurasia	PLOS ONE			English	Article								Borrelia garinii, a causative agent of Lyme borreliosis in Europe and Asia, is naturally maintained in marine and terrestrial enzootic cycles, which primarily involve birds, including seabirds and migratory passerines. These bird groups associate with, correspondingly, Ixodes uriae and Ixodes ricinus ticks, of which the latter species may bite and transmit the infection to humans. Studies of the overlap between these two natural cycles of B. garinii have been limited, in part due to the absence of representative collections of this spirochete's samples, as well as of the lack of reliable measure of the genetic heterogeneity of its strains. As a prerequisite for understanding the epidemiological correlates of the complex maintenance of B. garinii, the present study sought to assess the diversity and phylogenetic relationships of this species' strains from its natural hosts and patients with Lyme borreliosis from subarctic Eurasia. We used sequence typing of the partial rrs-rrl intergenic spacer (IGS) of archived and prospective samples of B. garinii from I. uriae ticks collected predominantly on Commander Islands in North Pacific, as well as on the islands in northern Sweden and arctic Norway. We also typed B. garinii samples from patients with Lyme borreliosis and I. ricinus ticks infesting migratory birds in southern Sweden, or found questing in selected sites on the islands in the Baltic Sea and Lithuania. Fifty-two (68%) of 77 B. garinii samples representing wide geographical range and associated with I. ricinus and infection of humans contributed 12 (60%) of total 20 identified IGS variants. In contrast, the remaining 25 (32%) samples recovered from I. uriae ticks from a few islands accounted for as many as 10 (50%) IGS types, suggesting greater local diversity of B. garinii maintained by seabirds and their ticks. Two IGS variants of the spirochete in common for both tick species were found in I. ricinus larvae from migratory birds, an indication that B. garinii strains are exchanged between different ecological niches. Notably, B. garinii variants associated with I. uriae ticks were found in each of the six clusters, representing two phylogenetic lineages of this species identified among the studied samples. Our findings suggest that B. garinii in subarctic Eurasia comprises two partially overlapping populations with different levels of genetic heterogeneity, presumably, due to distinctive selective pressures on the spirochete in its marine and terrestrial enzootic cycles.			Bergstrom, S (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	sven.bergstrom@molbiol.umu.se		Olsen, Bjorn/0000-0002-4646-691X				BENNET L, 2005, THESIS LUND U MALMO; BERGSTROM S, 1992, SCAND J INFECT DIS, V24, P181, DOI 10.3109/00365549209052610; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Bunikis J, 2004, EMERG INFECT DIS, V10, P1661, DOI 10.3201/eid1009.040236; Bunikis J, 1996, J CLIN MICROBIOL, V34, P364, DOI 10.1128/JCM.34.2.364-368.1996; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Busch U, 1996, J CLIN MICROBIOL, V34, P1072, DOI 10.1128/JCM.34.5.1072-1078.1996; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Glockner G, 2004, NUCLEIC ACIDS RES, V32, P6038, DOI 10.1093/nar/gkh953; GOSLER A, 2006, BIRDS WORLD; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; Gylfe A, 1999, J CLIN MICROBIOL, V37, P890; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; LARSSON C, 2007, VECTOR BORNE ZOONOTI; OLSEN B, 1995, J CLIN MICROBIOL, V33, P3270, DOI 10.1128/JCM.33.12.3270-3274.1995; OLSEN B, 1993, NATURE, V362, P340, DOI 10.1038/362340a0; Olsen B, 1996, MICROB PATHOGENESIS, V20, P319, DOI 10.1006/mpat.1996.0030; Ornstein K, 2001, J CLIN MICROBIOL, V39, P1294, DOI 10.1128/JCM.39.4.1294-1298.2001; Piesman J, 1996, AM J TROP MED HYG, V54, P294, DOI 10.4269/ajtmh.1996.54.294; Qiu WG, 1997, HEREDITAS, V127, P203, DOI 10.1111/j.1601-5223.1997.00203.x; Richter D, 2000, EMERG INFECT DIS, V6, P133, DOI 10.3201/eid0602.000205; Roessler D, 1997, J CLIN MICROBIOL, V35, P2752, DOI 10.1128/JCM.35.11.2752-2758.1997; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Smith RP, 2006, EMERG INFECT DIS, V12, P1909; SONENSHINE DE, BIOL TICKS; SPIELMAN A, 1994, ANN NY ACAD SCI, V740, P146, DOI 10.1111/j.1749-6632.1994.tb19865.x; STEELE GM, 1990, ACAROLOGIA, V31, P125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Wang GQ, 1998, J CLIN MICROBIOL, V36, P768, DOI 10.1128/JCM.36.3.768-776.1998; WILL G, 1995, MED MICROBIOL IMMUN, V184, P73, DOI 10.1007/BF00221390; WILSKE B, 1993, J CLIN MICROBIOL, V31, P340, DOI 10.1128/JCM.31.2.340-350.1993	38	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5841	10.1371/journal.pone.0005841	http://dx.doi.org/10.1371/journal.pone.0005841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513109	gold, Green Published, Green Submitted			2022-12-27	WOS:000267228800007
J	Trazzi, S; Perini, G; Bernardoni, R; Zoli, M; Reese, JC; Musacchio, A; Della Valle, G				Trazzi, Stefania; Perini, Giovanni; Bernardoni, Roberto; Zoli, Monica; Reese, Joseph C.; Musacchio, Andrea; Della Valle, Giuliano			The C-Terminal Domain of CENP-C Displays Multiple and Critical Functions for Mammalian Centromere Formation	PLOS ONE			English	Article								CENP-C is a fundamental component of functional centromeres. The elucidation of its structure-function relationship with centromeric DNA and other kinetochore proteins is critical to the understanding of centromere assembly. CENP-C carries two regions, the central and the C-terminal domains, both of which are important for the ability of CENP-C to associate with the centromeric DNA. However, while the central region is largely divergent in CENP-C homologues, the C-terminal moiety contains two regions that are highly conserved from yeast to humans, named Mif2p homology domains (blocks II and III). The activity of these two domains in human CENP-C is not well defined. In this study we performed a functional dissection of C-terminal CENP-C region analyzing the role of single Mif2p homology domains through in vivo and in vitro assays. By immunofluorescence and Chromatin immunoprecipitation assay (ChIP) we were able to elucidate the ability of the Mif2p homology domain II to target centromere and contact alpha satellite DNA. We also investigate the interactions with other conserved inner kinetochore proteins by means of coimmunoprecipitation and bimolecular fluorescence complementation on cell nuclei. We found that the C-terminal region of CENP-C (Mif2p homology domain III) displays multiple activities ranging from the ability to form higher order structures like homo-dimers and homo-oligomers, to mediate interaction with CENP-A and histone H3. Overall, our findings support a model in which the Mif2p homology domains of CENP-C, by virtue of their ability to establish multiple contacts with DNA and centromere proteins, play a critical role in the structuring of kinethocore chromatin.			Trazzi, S (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy.	giuliano.dellavalle@unibo.it	Bernardoni, Roberto/F-2845-2012	Trazzi, Stefania/0000-0003-2623-2769; Musacchio, Andrea/0000-0003-2362-8784	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058672] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058672-11, R01 GM058672] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; ARCHIDIACONO N, 1995, GENOMICS, V25, P477, DOI 10.1016/0888-7543(95)80048-Q; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; BROWN MT, 1995, GENE, V160, P111, DOI 10.1016/0378-1119(95)00163-Z; Burkin DJ, 1996, CYTOGENET CELL GENET, V74, P86, DOI 10.1159/000134388; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; Chueh AC, 2005, HUM MOL GENET, V14, P85, DOI 10.1093/hmg/ddi008; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; COOKE CA, 1990, J CELL BIOL, V110, P1475, DOI 10.1083/jcb.110.5.1475; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Durand-Dubief M, 2008, BIOESSAYS, V30, P526, DOI 10.1002/bies.20763; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 1997, HUM MOL GENET, V6, P2301, DOI 10.1093/hmg/6.13.2301; Fukagawa T, 2001, NUCLEIC ACIDS RES, V29, P3796, DOI 10.1093/nar/29.18.3796; Goldberg IG, 1996, MOL CELL BIOL, V16, P5156; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; JELINEK WR, 1980, P NATL ACAD SCI-BIOL, V77, P1398, DOI 10.1073/pnas.77.3.1398; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Loyter A, 2005, PLANT PHYSIOL, V138, P1318, DOI 10.1104/pp.105.062547; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; Politi V, 2002, J CELL SCI, V115, P2317; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Sugimoto K, 1997, CHROMOSOME RES, V5, P132, DOI 10.1023/A:1018422325569; SUGIMOTO K, 1994, DNA IMMUNOPRECIPITAT, P335; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Suzuki N, 2004, J BIOL CHEM, V279, P5934, DOI 10.1074/jbc.M306477200; Talbert Paul B, 2004, J Biol, V3, P18, DOI 10.1186/jbiol11; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Trazzi S, 2002, J STRUCT BIOL, V140, P39, DOI 10.1016/S1047-8477(02)00506-3; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Voullaire L, 1999, AM J MED GENET, V85, P403, DOI 10.1002/(SICI)1096-8628(19990806)85:4<403::AID-AJMG18>3.3.CO;2-I; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Yang CH, 1996, MOL CELL BIOL, V16, P3576	66	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5832	10.1371/journal.pone.0005832	http://dx.doi.org/10.1371/journal.pone.0005832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503796	Green Submitted, Green Published, gold			2022-12-27	WOS:000266717400011
J	Eswarappa, SM; Karnam, G; Nagarajan, AG; Chakraborty, S; Chakravortty, D				Eswarappa, Sandeepa M.; Karnam, Guruswamy; Nagarajan, Arvindhan G.; Chakraborty, Sangeeta; Chakravortty, Dipshikha			lac Repressor Is an Antivirulence Factor of Salmonella enterica: Its Role in the Evolution of Virulence in Salmonella	PLOS ONE			English	Article								The genus Salmonella includes many pathogens of great medical and veterinary importance. Bacteria belonging to this genus are very closely related to those belonging to the genus Escherichia. lacZYA operon and lacI are present in Escherichia coli, but not in Salmonella enterica. It has been proposed that Salmonella has lost lacZYA operon and lacI during evolution. In this study, we have investigated the physiological and evolutionary significance of the absence of lacI in Salmonella enterica. Using murine model of typhoid fever, we show that the expression of Lacl causes a remarkable reduction in the virulence of Salmonella enterica. Lacl also suppresses the ability of Salmonella enterica to proliferate inside murine macrophages. Microarray analysis revealed that Lacl interferes with the expression of virulence genes of Salmonella pathogenicity island 2. This effect was confirmed by RT-PCR and Western blot analysis. Interestingly, we found that SBG0326 of Salmonella bongori is homologous to lacI of Escherichia coli. Salmonella bongori is the only other species of the genus Salmonella and it lacks the virulence genes of Salmonella pathogenicity island 2. Overall, our results demonstrate that Lacl is an antivirulence factor of Salmonella enterica and suggest that absence of lacI has facilitated the acquisition of virulence genes of Salmonella pathogenicity island 2 in Salmonella enterica making it a successful systemic pathogen.			Eswarappa, SM (corresponding author), Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	chakravortty, dipshikha/A-9492-2009; Eswarappa, Sandeep/AFG-1997-2022; Chakravortty, Dipshikha/AAI-4448-2020	Chakravortty, Dipshikha/0000-0002-7838-5145; Muthanegere Eswarappa, Sandeepa/0000-0003-4479-5354				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; ANDREWS KJ, 1976, J MOL EVOL, V8, P317, DOI 10.1007/BF01739257; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; COHEN SL, 1987, J CLIN MICROBIOL, V25, P1516, DOI 10.1128/JCM.25.8.1516-1518.1987; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Eswarappa SM, 2008, MICROBIOL-SGM, V154, P666, DOI 10.1099/mic.0.2007/011114-0; FALCAO DP, 1975, J CLIN MICROBIOL, V2, P349; Falcon CM, 1999, J BIOL CHEM, V274, P30849, DOI 10.1074/jbc.274.43.30849; FALKOW S, 1962, J BACTERIOL, V84, P581, DOI 10.1128/JB.84.3.581-589.1962; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Ho TD, 2001, J BACTERIOL, V183, P611, DOI 10.1128/JB.183.2.611-620.2001; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; KOHBATA S, 1983, J CLIN MICROBIOL, V18, P920, DOI 10.1128/JCM.18.4.920-925.1983; KUNZ LJ, 1965, J BACTERIOL, V89, P1629, DOI 10.1128/JB.89.6.1629-1629.1965; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Mouslim C, 2002, MOL MICROBIOL, V45, P1019, DOI 10.1046/j.1365-2958.2002.03070.x; NAKATA N, 1993, MOL MICROBIOL, V9, P459, DOI 10.1111/j.1365-2958.1993.tb01707.x; RIGGS AD, 1970, J MOL BIOL, V51, P303, DOI 10.1016/0022-2836(70)90144-0; Russell DW., 2001, PLASMIDS THEIR USEFU; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; Stoebel DM, 2005, MOL BIOL EVOL, V22, P683, DOI 10.1093/molbev/msi056; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z	43	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5789	10.1371/journal.pone.0005789	http://dx.doi.org/10.1371/journal.pone.0005789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495420	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000266716900002
J	Romanish, MT; Nakamura, H; Lai, CB; Wang, YZ; Mager, DL				Romanish, Mark T.; Nakamura, Hisae; Lai, C. Benjamin; Wang, Yuzhuo; Mager, Dixie L.			A Novel Protein Isoform of the Multicopy Human NAIP Gene Derives from Intragenic Alu SINE Promoters	PLOS ONE			English	Article								The human neuronal apoptosis inhibitory protein (NAIP) gene is no longer principally considered a member of the Inhibitor of Apoptosis Protein (IAP) family, as its domain structure and functions in innate immunity also warrant inclusion in the Nod-Like Receptor (NLR) superfamily. NAIP is located in a region of copy number variation, with one full length and four partly deleted copies in the reference human genome. We demonstrate that several of the NAIP paralogues are expressed, and that novel transcripts arise from both internal and upstream transcription start sites. Remarkably, two internal start sites initiate within Alu short interspersed element (SINE) retrotransposons, and a third novel transcription start site exists within the final intron of the GUSBP1 gene, upstream of only two NAIP copies. One Alu functions alone as a promoter in transient assays, while the other likely combines with upstream L1 sequences to form a composite promoter. The novel transcripts encode shortened open reading frames and we show that corresponding proteins are translated in a number of cell lines and primary tissues, in some cases above the level of full length NAIP. Interestingly, some NAIP isoforms lack their caspase-sequestering motifs, suggesting that they have novel functions. Moreover, given that human and mouse NAIP have previously been shown to employ endogenous retroviral long terminal repeats as promoters, exaptation of Alu repeats as additional promoters provides a fascinating illustration of regulatory innovations adopted by a single gene.			Romanish, MT (corresponding author), BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada.	dmager@bccrc.ca		Mager, Dixie/0000-0002-5955-2550; Lai, Chieh Min Benjamin/0000-0002-4130-9413; Wang, Yuzhuo/0000-0002-9749-8591				ARCOT SS, 1995, GENOMICS, V29, P136, DOI 10.1006/geno.1995.1224; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Chen QF, 1998, GENOMICS, V48, P121, DOI 10.1006/geno.1997.5141; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Davoodi J, 2004, J BIOL CHEM, V279, P40622, DOI 10.1074/jbc.M405963200; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hasler J, 2007, CELL MOL LIFE SCI, V64, P1793, DOI 10.1007/s00018-007-7084-0; Hebb ALO, 2008, MULT SCLER J, V14, P577, DOI 10.1177/1352458507087468; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LAI CB, NUCLEIC ACI IN PRESS; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langemeijer SMC, 2008, EXPERT OPIN THER TAR, V12, P981, DOI 10.1517/14728222.12.8.981 ; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000225; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; Maier JKX, 2007, J HISTOCHEM CYTOCHEM, V55, P911, DOI 10.1369/jhc.6A7144.2007; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; MCCLINTOCK B, 1953, GENETICS, V38, P579; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Seidl R, 1999, J NEURAL TRANSM-SUPP, P283; Shankar R, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-37; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singer SS, 2004, J MOL BIOL, V341, P883, DOI 10.1016/j.jmb.2004.06.070; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Tomilin NV, 2008, BIOESSAYS, V30, P338, DOI 10.1002/bies.20741; Tran VK, 2008, PEDIATR INT, V50, P346, DOI 10.1111/j.1442-200X.2008.02590.x; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xu M, 2002, BBA-GENE STRUCT EXPR, V1574, P35, DOI 10.1016/S0167-4781(01)00343-8; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	65	41	41	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5761	10.1371/journal.pone.0005761	http://dx.doi.org/10.1371/journal.pone.0005761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19488400	gold, Green Submitted, Green Published			2022-12-27	WOS:000266587400004
J	Myers, BR; Sigal, YM; Julius, D				Myers, Benjamin R.; Sigal, Yaron M.; Julius, David			Evolution of Thermal Response Properties in a Cold-Activated TRP Channel	PLOS ONE			English	Article								Animals sense changes in ambient temperature irrespective of whether core body temperature is internally maintained (homeotherms) or subject to environmental variation (poikilotherms). Here we show that a cold-sensitive ion channel, TRPM8, displays dramatically different thermal activation ranges in frogs versus mammals or birds, consistent with variations in these species' cutaneous and core body temperatures. Thus, somatosensory receptors are not static through evolution, but show functional diversity reflecting the characteristics of an organism's ecological niche.			Myers, BR (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu						BANKER G, 1998, CULTURING NERVE CELL; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; CASTERLIN ME, 1980, HYDROBIOLOGIA, V75, P3; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius David, 2005, Harvey Lect, V101, P89; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Lin H, 2005, POULTRY SCI, V84, P1166, DOI 10.1093/ps/84.8.1166; LOUMONT C, 1984, REV SUISSE ZOOL, V91, P725, DOI 10.5962/bhl.part.81578; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Seebacher F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000281; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; YOCHIM JM, 1976, AM J PHYSIOL, V231, P361, DOI 10.1152/ajplegacy.1976.231.2.361	25	52	52	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5741	10.1371/journal.pone.0005741	http://dx.doi.org/10.1371/journal.pone.0005741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19492038	gold, Green Published, Green Submitted			2022-12-27	WOS:000266490000015
J	Ticini, LF; Klose, U; Nagele, T; Karnath, HO				Ticini, Luca Francesco; Klose, Uwe; Naegele, Thomas; Karnath, Hans-Otto			Perfusion Imaging in Pusher Syndrome to Investigate the Neural Substrates Involved in Controlling Upright Body Position	PLOS ONE			English	Article								Brain damage may induce a dysfunction of upright body position termed "pusher syndrome''. Patients with such disorder suffer from an alteration of their sense of body verticality. They experience their body as oriented upright when actually tilted nearly 20 degrees to the ipsilesional side. Pusher syndrome typically is associated with posterior thalamic stroke; less frequently with extra-thalamic lesions. This argued for a fundamental role of these structures in our control of upright body posture. Here we investigated whether such patients may show additional functional or metabolic abnormalities outside the areas of brain lesion. We investigated 19 stroke patients with thalamic or with extra-thalamic lesions showing versus not showing misperception of body orientation. We measured fluid-attenuated inversion-recovery (FLAIR) imaging, diffusion-weighted imaging (DWI), and perfusion-weighted imaging (PWI). This allowed us to determine the structural damage as well as to identify the malperfused but structural intact tissue. Pusher patients with thalamic lesions did not show dysfunctional brain areas in addition to the ones found to be structurally damaged. In the pusher patients with extra-thalamic lesions, the thalamus was neither structurally damaged nor malperfused. Rather, these patients showed small regions of abnormal perfusion in the structurally intact inferior frontal gyrus, middle temporal gyrus, inferior parietal lobule, and parietal white matter. The results indicate that these extra-thalamic brain areas contribute to the network controlling upright body posture. The data also suggest that damage of the neural tissue in the posterior thalamus itself rather than additional malperfusion in distant cortical areas is associated with pusher syndrome. Hence, it seems as if the normal functioning of both extra-thalamic as well as posterior thalamic structures is integral to perceiving gravity and controlling upright body orientation in humans.			Ticini, LF (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Ctr Neurol, Sect Neuropsychol, Tubingen, Germany.	Karnath@uni-tuebingen.de	Klose, Uwe/M-7110-2013; Ticini, Luca/D-2532-2014	Klose, Uwe/0000-0001-5236-3450; Ticini, Luca/0000-0002-4967-2460				Aubert-Broche B, 2003, PHYS MED BIOL, V48, P1505, DOI 10.1088/0031-9155/48/11/302; BARON JC, 1986, BRAIN, V109, P1243, DOI 10.1093/brain/109.6.1243; BARON JC, 1992, J NEUROL NEUROSUR PS, V55, P935, DOI 10.1136/jnnp.55.10.935; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BELLIVEAU JW, 1990, MAGNET RESON MED, V14, P538, DOI 10.1002/mrm.1910140311; Bisdorff AR, 1996, BRAIN, V119, P1523, DOI 10.1093/brain/119.5.1523; Bohning DE, 2001, INVEST RADIOL, V36, P470, DOI 10.1097/00004424-200108000-00006; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; BrantZawadzki M, 1996, STROKE, V27, P1187, DOI 10.1161/01.STR.27.7.1187; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Calamante F, 2002, STROKE, V33, P1146, DOI 10.1161/01.STR.0000014208.05597.33; Cappe C, 2007, NEUROSCIENCE, V146, P1371, DOI 10.1016/j.neuroscience.2007.02.033; Chae JH, 2003, J PSYCHIATR RES, V37, P443, DOI 10.1016/S0022-3956(03)00074-8; Dieterich M, 2005, BRAIN, V128, P2052, DOI 10.1093/brain/awh551; DIETERICH M, 1993, NEUROLOGY, V43, P1732, DOI 10.1212/WNL.43.9.1732; Dieterich M, 2007, BRAIN, V130, P2108, DOI 10.1093/brain/awm130; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Engelborghs S, 1998, ACTA NEUROL BELG, V98, P252; Fasold O, 2002, NEUROIMAGE, V17, P1384, DOI 10.1006/nimg.2002.1241; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Fruhmann-Berger M, 2005, J NEUROL, V252, P1194, DOI 10.1007/s00415-005-0831-y; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Hillis AE, 2001, ANN NEUROL, V50, P561, DOI 10.1002/ana.1265; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Johannsen L, 2006, J NEUROL, V253, P455, DOI 10.1007/s00415-005-0025-7; Johannsen L, 2004, J CLIN EXP NEUROPSYC, V26, P251, DOI 10.1076/jcen.26.2.251.28085; Johannsen L, 2006, J NEUROL, V253, P1367, DOI 10.1007/s00415-006-0216-x; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jones EG, 1995, THALAMUS; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Karnath HO, 2007, NEUROREHAB NEURAL RE, V21, P370, DOI 10.1177/1545968307300702; Karnath HO, 2007, J NEUROL, V254, P415, DOI 10.1007/s00415-006-0341-6; Karnath HO, 2005, NEUROLOGY, V64, P1014, DOI 10.1212/01.WNL.0000154527.72841.4A; Karnath HO, 2003, PHYS THER, V83, P1119, DOI 10.1093/ptj/83.12.1119; Karnath HO, 2005, BRAIN, V128, P2462, DOI 10.1093/brain/awh629; Karnath HO, 2000, NEUROLOGY, V55, P1298, DOI 10.1212/WNL.55.9.1298; Karnath HO, 2000, P NATL ACAD SCI USA, V97, P13931, DOI 10.1073/pnas.240279997; Klose U, 1999, ROFO-FORTSCHR RONTG, V170, P474, DOI 10.1055/s-2007-1011076; Liu YJ, 2002, J NEUROIMAGING, V12, P330, DOI 10.1111/j.1552-6569.2002.tb00141.x; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Mittelstaedt H., 1964, Symposia of the Society for Experimental Biology, V18, P365; Mittelstaedt H, 1998, NEUROSCI BIOBEHAV R, V22, P473, DOI 10.1016/S0149-7634(97)00032-8; Mullins ME, 2002, RADIOLOGY, V224, P353, DOI 10.1148/radiol.2242010873; Narayanan JT, 2002, EPILEPSIA, V43, P1509, DOI 10.1046/j.1528-1157.2002.16102.x; Neumann-Haefelin T, 1999, STROKE, V30, P1591, DOI 10.1161/01.STR.30.8.1591; Noguchi K, 1997, NEURORADIOLOGY, V39, P406, DOI 10.1007/s002340050433; Padberg J, 2006, J COMP NEUROL, V497, P416, DOI 10.1002/cne.21005; Palmer E, 1996, NEUROLOGY, V46, P471, DOI 10.1212/WNL.46.2.471; Ricci PE, 1999, AM J NEURORADIOL, V20, P1535; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Santos-Pontelli TEG, 2004, J NEUROL, V251, P1324, DOI 10.1007/s00415-004-0532-y; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Schlindwein P, 2008, NEUROIMAGE, V39, P19, DOI 10.1016/j.neuroimage.2007.08.016; Spinazzola L, 2003, BRAIN, V126, P2656, DOI 10.1093/brain/awg266; Thijs VN, 2004, STROKE, V35, P94, DOI 10.1161/01.STR.0000106136.15163.73; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weintraub S., 1985, PRINCIPLES BEHAV NEU, P71; Yamada K, 2002, STROKE, V33, P87, DOI 10.1161/hs0102.101893	61	38	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5737	10.1371/journal.pone.0005737	http://dx.doi.org/10.1371/journal.pone.0005737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478939	Green Published, Green Submitted, gold			2022-12-27	WOS:000266490000013
J	Lu, J; Fiala, JC; Lichtman, JW				Lu, Ju; Fiala, John C.; Lichtman, Jeff W.			Semi-Automated Reconstruction of Neural Processes from Large Numbers of Fluorescence Images	PLOS ONE			English	Article								We introduce a method for large scale reconstruction of complex bundles of neural processes from fluorescent image stacks. We imaged yellow fluorescent protein labeled axons that innervated a whole muscle, as well as dendrites in cerebral cortex, in transgenic mice, at the diffraction limit with a confocal microscope. Each image stack was digitally re-sampled along an orientation such that the majority of axons appeared in cross-section. A region growing algorithm was implemented in the open-source Reconstruct software and applied to the semi-automatic tracing of individual axons in three dimensions. The progression of region growing is constrained by user-specified criteria based on pixel values and object sizes, and the user has full control over the segmentation process. A full montage of reconstructed axons was assembled from the similar to 200 individually reconstructed stacks. Average reconstruction speed is similar to 0.5 mm per hour. We found an error rate in the automatic tracing mode of similar to 1 error per 250 um of axonal length. We demonstrated the capacity of the program by reconstructing the connectome of motor axons in a small mouse muscle.			Lu, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	jeff@mcb.harvard.edu						Al-Kofahi KA, 2003, IEEE T INF TECHNOL B, V7, P302, DOI 10.1109/TITB.2003.816564; Al-Kofahi KA, 2002, IEEE T INF TECHNOL B, V6, P171, DOI 10.1109/TITB.2002.1006304; Cai HM, 2006, NEUROIMAGE, V32, P1608, DOI 10.1016/j.neuroimage.2006.05.036; Castleman K. R., 1996, DIGITAL IMAGE PROCES; CONCHELLO JA, 1994, APPL OPTICS, V33, P3740, DOI 10.1364/AO.33.003740; Dima A, 2002, IEEE T IMAGE PROCESS, V11, P790, DOI 10.1109/TIP.2002.800888; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; HALL DH, 1991, J NEUROSCI, V11, P1; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu J, 2009, PLOS BIOL, V7, P265, DOI 10.1371/journal.pbio.1000032; Macke JH, 2008, J NEUROSCI METH, V167, P349, DOI 10.1016/j.jneumeth.2007.07.021; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	18	48	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5655	10.1371/journal.pone.0005655	http://dx.doi.org/10.1371/journal.pone.0005655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19479070	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331000013
J	Shroff, EH; Snyder, CM; Budinger, GRS; Jain, M; Chew, TL; Khuon, S; Perlman, H; Chandel, NS				Shroff, Emelyn H.; Snyder, Colleen M.; Budinger, G. R. Scott; Jain, Manu; Chew, Teng-Leong; Khuon, Satya; Perlman, Harris; Chandel, Navdeep S.			BH3 Peptides Induce Mitochondrial Fission and Cell Death Independent of BAX/BAK	PLOS ONE			English	Article								BH3 only proteins trigger cell death by interacting with pro- and anti-apoptotic members of the BCL-2 family of proteins. Here we report that BH3 peptides corresponding to the death domain of BH3-only proteins, which bind all the pro-survival BCL-2 family proteins, induce cell death in the absence of BAX and BAK. The BH3 peptides did not cause the release of cytochrome c from isolated mitochondria or from mitochondria in cells. However, the BH3 peptides did cause a decrease in mitochondrial membrane potential but did not induce the opening of the mitochondrial permeability transition pore. Interestingly, the BH3 peptides induced mitochondria to undergo fission in the absence of BAX and BAK. The binding of BCL-XL with dynamin-related protein 1 (DRP1), a GTPase known to regulate mitochondrial fission, increased in the presence of BH3 peptides. These results suggest that pro-survival BCL-2 proteins regulate mitochondrial fission and cell death in the absence of BAX and BAK.			Shroff, EH (corresponding author), Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA.	nav@northwestern.edu			NHLBI NIH HHS [P01 HL071643, HL071643-06A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; Breckenridge DG, 2008, MOL CELL, V31, P586, DOI 10.1016/j.molcel.2008.07.015; Brunelle JK, 2007, MOL CELL BIOL, V27, P1222, DOI 10.1128/MCB.01535-06; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cepero E, 2005, ONCOGENE, V24, P6354, DOI 10.1038/sj.onc.1208793; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; FRANCIS B, 2001, SEX ED, V1, P1; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; James DI, 2008, DEV CELL, V15, P341, DOI 10.1016/j.devcel.2008.08.011; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Rinkenberger JL, 2000, GENE DEV, V14, P23; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	40	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5646	10.1371/journal.pone.0005646	http://dx.doi.org/10.1371/journal.pone.0005646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19468307	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331000005
J	Deguchi, A; Miyamoto, K; Kuwahara, T; Miki, Y; Kaneko, I; Li, JH; McClane, BA; Akimoto, S				Deguchi, Agi; Miyamoto, Kazuaki; Kuwahara, Tomomi; Miki, Yasuhiro; Kaneko, Ikuko; Li, Jihong; McClane, Bruce A.; Akimoto, Shigeru			Genetic Characterization of Type A Enterotoxigenic Clostridium perfringens Strains	PLOS ONE			English	Article								Clostridium perfringens type A, is both a ubiquitous environmental bacterium and a major cause of human gastrointestinal disease, which usually involves strains producing C. perfringens enterotoxin (CPE). The gene (cpe) encoding this toxin can be carried on the chromosome or a large plasmid. Interestingly, strains carrying cpe on the chromosome and strains carrying cpe on a plasmid often exhibit different biological characteristics, such as resistance properties against heat. In this study, we investigated the genetic properties of C. perfringens by PCR-surveying 21 housekeeping genes and genes on representative plasmids and then confirmed those results by Southern blot assay (SB) of five genes. Furthermore, sequencing analysis of eight housekeeping genes and multilocus sequence typing (MLST) analysis were also performed. Fifty-eight C. perfringens strains were examined, including isolates from: food poisoning cases, human gastrointestinal disease cases, foods in Japan or the USA, or feces of healthy humans. In the PCR survey, eight of eleven housekeeping genes amplified positive reactions in all strains tested. However, by PCR survey and SB assay, one representative virulence gene, pfoA, was not detected in any strains carrying cpe on the chromosome. Genes involved in conjugative transfer of the cpe plasmid were also absent from almost all chromosomal cpe strains. MLST showed that, regardless of their geographic origin, date of isolation, or isolation source, chromosomal cpe isolates, i) assemble into one definitive cluster ii) lack pfoA and iii) lack a plasmid related to the cpe plasmid. Similarly, independent of their origin, strains carrying a cpe plasmid also appear to be related, but are more variable than chromosomal cpe strains, possibly because of the instability of cpe-borne plasmid(s) and/or the conjugative transfer of cpe-plasmid(s) into unrelated C. perfringens strains.			Deguchi, A (corresponding author), Wakayama Med Univ, Dept Microbiol, Sch Med, Wakayama, Japan.	kazuaki@wakayama-med.ac.jp			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019844] Funding Source: NIH RePORTER; NIAID NIH HHS [R37AI19844, R37 AI019844] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Brynestad S, 1999, FEMS MICROBIOL LETT, V170, P281, DOI 10.1016/S0378-1097(98)00557-6; Brynestad S, 2001, INFECT IMMUN, V69, P3483, DOI 10.1128/IAI.69.5.3483-3487.2001; Chalmers G, 2008, J CLIN MICROBIOL, V46, P3957, DOI 10.1128/JCM.01548-08; Collie RE, 1998, J CLIN MICROBIOL, V36, P30, DOI 10.1128/JCM.36.1.30-36.1998; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; GARNIER T, 1988, PLASMID, V19, P134, DOI 10.1016/0147-619X(88)90052-2; Harry KH, 2009, J BACTERIOL, V191, P2728, DOI 10.1128/JB.01839-08; Johansson A, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-47; Jost BH, 2006, VET MICROBIOL, V116, P158, DOI 10.1016/j.vetmic.2006.03.025; KAWAI T, 1998, OSAKA FURITU KOSHU E, V36, P191; Lahti P, 2008, J CLIN MICROBIOL, V46, P371, DOI 10.1128/JCM.01650-07; Li JH, 2007, APPL ENVIRON MICROB, V73, P7218, DOI 10.1128/AEM.01075-07; Li JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000056; Li JH, 2006, APPL ENVIRON MICROB, V72, P4561, DOI 10.1128/AEM.00177-06; Li JH, 2006, APPL ENVIRON MICROB, V72, P7620, DOI 10.1128/AEM.01911-06; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MATCHES JR, 1974, APPL MICROBIOL, V28, P655, DOI 10.1128/AEM.28.4.655-660.1974; McClane Bruce A., 2005, P385, DOI 10.1201/9780203489819.ch18; MEREDITH L, 2007, J BACTERIOL, V189, P7531; Miki Y, 2008, APPL ENVIRON MICROB, V74, P5366, DOI 10.1128/AEM.00783-08; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Miyamoto K, 2002, INFECT IMMUN, V70, P4261, DOI 10.1128/IAI.70.8.4261-4272.2002; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Parsons JA, 2007, J BACTERIOL, V189, P7782, DOI 10.1128/JB.00783-07; Rooney AP, 2006, GENETICS, V172, P2081, DOI 10.1534/genetics.105.054601; Sarker MR, 2000, APPL ENVIRON MICROB, V66, P3234, DOI 10.1128/AEM.66.8.3234-3240.2000; Sayeed S, 2008, MOL MICROBIOL, V67, P15, DOI 10.1111/j.1365-2958.2007.06007.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; SUTTON RGA, 1965, J HYG CAMB, V66, P135; Tanaka D, 2003, JPN J INFECT DIS, V56, P137; Tanaka D, 2007, JPN J INFECT DIS, V60, P68; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Wen QY, 2004, APPL ENVIRON MICROB, V70, P2685, DOI 10.1128/AEM.70.5.2685-2691.2004; YAMAGISHI T, 1983, MICROBIOL IMMUNOL, V27, P291, DOI 10.1111/j.1348-0421.1983.tb03591.x	36	59	60	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5598	10.1371/journal.pone.0005598	http://dx.doi.org/10.1371/journal.pone.0005598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19479065	gold, Green Published, Green Accepted			2022-12-27	WOS:000266161200002
J	Agouni, A; Lagrue-Lak-Hal, AH; Mostefai, HA; Tesse, A; Mulder, P; Rouet, P; Desmoulin, F; Heymes, C; Martinez, MC; Andriantsitohaina, R				Agouni, Abdelali; Lagrue-Lak-Hal, Anne-Helene; Mostefai, Hadj Ahmed; Tesse, Angela; Mulder, Paul; Rouet, Philippe; Desmoulin, Franck; Heymes, Christophe; Martinez, Maria Carmen; Andriantsitohaina, Ramaroson			Red Wine Polyphenols Prevent Metabolic and Cardiovascular Alterations Associated with Obesity in Zucker Fatty Rats (Fa/Fa)	PLOS ONE			English	Article							PORCINE CORONARY-ARTERIES; EDHF-MEDIATED RELAXATIONS; INSULIN-RESISTANCE; ENDOTHELIAL DYSFUNCTION; BLOOD-PRESSURE; GRAPE JUICE; HYPERTENSION; MODEL; SUSCEPTIBILITY; CONSUMPTION	Background: Obesity is associated with increased risks for development of cardiovascular diseases. Epidemiological studies report an inverse association between dietary flavonoid consumption and mortality from cardiovascular diseases. We studied the potential beneficial effects of dietary supplementation of red wine polyphenol extract, Provinols (TM), on obesity-associated alterations with respect to metabolic disturbances and cardiovascular functions in Zucker fatty (ZF) rats. Methodology/Principal Findings: ZF rats or their lean littermates received normal diet or supplemented with Provinols (TM) for 8 weeks. Provinols (TM) improved glucose metabolism by reducing plasma glucose and fructosamine in ZF rats. Moreover, it reduced circulating triglycerides and total cholesterol as well as LDL-cholesterol in ZF rats. Echocardiography measurements demonstrated that Provinols (TM) improved cardiac performance as evidenced by an increase in left ventricular fractional shortening and cardiac output associated with decreased peripheral arterial resistances in ZF rats. Regarding vascular function, Provinols (TM) corrected endothelial dysfunction in aortas from ZF rats by improving endothelium-dependent relaxation in response to acetylcholine (Ach). Provinols (TM) enhanced NO bioavailability resulting from increased nitric oxide (NO) production through enhanced endothelial NO-synthase (eNOS) activity and reduced superoxide anion release via decreased expression of NADPH oxidase membrane sub-unit, Nox-1. In small mesenteric arteries, although Provinols (TM) did not affect the endothelium-dependent response to Ach; it enhanced the endothelial-derived hyperpolarizing factor component of the response. Conclusions/Significance: Use of red wine polyphenols may be a potential mechanism for prevention of cardiovascular and metabolic alterations associated with obesity.			Agouni, A (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	ramaroson.andriantsitohaina@univ-angers.fr	Heymes, Christophe/Y-9368-2019; DESMOULIN, Franck/O-1895-2018; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; Agouni, Abdelali/AAP-5298-2020; desmoulin, franck/AAU-4544-2020; Tesse, Angela/D-4803-2015	Heymes, Christophe/0000-0002-6666-6193; DESMOULIN, Franck/0000-0003-0560-6266; Agouni, Abdelali/0000-0002-8363-1582; desmoulin, franck/0000-0003-0560-6266; Tesse, Angela/0000-0002-2153-4357; andriantsitohaina, ramaroson/0000-0002-4770-3585; Martinez, M Carmen/0000-0003-3897-7397; Rouet, Philippe/0000-0001-6204-2079; Mulder, Paul/0000-0002-5936-5704				Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Bernatova I, 2002, AM J PHYSIOL-HEART C, V282, pH942, DOI 10.1152/ajpheart.00724.2001; Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; Curin Y., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P277, DOI 10.2174/187152506778520691; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2006, ATHEROSCLEROSIS SUPP, V7, P11, DOI 10.1016/j.atherosclerosissup.2006.05.002; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; Fornoni A, 2005, CURR HYPERTENS REP, V7, P88, DOI 10.1007/s11906-005-0080-6; Galisteo M, 2005, J NUTR, V135, P2399, DOI 10.1093/jn/135.10.2399; Hsueh WA, 2004, AM J MED, V117, P109, DOI 10.1016/j.amjmed.2004.02.042; Iida M, 1996, BIOCHEM BIOPH RES CO, V222, P19, DOI 10.1006/bbrc.1996.0691; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KURTZ TW, 1989, HYPERTENSION, V13, P896, DOI 10.1161/01.HYP.13.6.896; Lee SD, 2008, J APPL PHYSIOL, V104, P1144, DOI 10.1152/japplphysiol.00152.2007; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Leslie EM, 2001, MOL PHARMACOL, V59, P1171, DOI 10.1124/mol.59.5.1171; Middleton E, 2000, PHARMACOL REV, V52, P673; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Napoli R, 2005, METABOLISM, V54, P306, DOI 10.1016/j.metabol.2004.09.010; Ndiaye M, 2004, BRIT J PHARMACOL, V142, P1131, DOI 10.1038/sj.bjp.0705774; Ndiaye M, 2003, BIOCHEM BIOPH RES CO, V310, P371, DOI 10.1016/j.bbrc.2003.09.028; Nigdikar SV, 1998, AM J CLIN NUTR, V68, P258, DOI 10.1093/ajcn/68.2.258; Ohlmann P, 1997, BRIT J PHARMACOL, V121, P657, DOI 10.1038/sj.bjp.0701169; Pechanova O, 2006, PHYSIOL RES, V55, pS17, DOI 10.33549/physiolres.930000.55.S1.17; Pechanova O, 2004, J HYPERTENS, V22, P1551, DOI 10.1097/01.hjh.0000133734.32125.c7; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Puzserova A, 2006, PHYSIOL RES, V55, pS39, DOI 10.33549/physiolres.930000.55.S1.39; Ranaivo HR, 2004, BRIT J PHARMACOL, V142, P671, DOI 10.1038/sj.bjp.0705833; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Ritz MF, 2008, J NUTR, V138, P519, DOI 10.1093/jn/138.3.519; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Stein JH, 1999, CIRCULATION, V100, P1050, DOI 10.1161/01.CIR.100.10.1050; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; STURM W, 2009, OBESITY SILVER SPRIN; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Subramanian R, 2003, EUR J PHARMACOL, V477, P143, DOI 10.1016/j.ejphar.2003.08.003; TERRETTAZ J, 1986, ENDOCRINOLOGY, V118, P674, DOI 10.1210/endo-118-2-674; Vinson JA, 2001, ATHEROSCLEROSIS, V156, P67, DOI 10.1016/S0021-9150(00)00625-0; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320	43	90	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5557	10.1371/journal.pone.0005557	http://dx.doi.org/10.1371/journal.pone.0005557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440378	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107500003
J	Schuck, SD; Mueller, H; Kunitz, F; Neher, A; Hoffmann, H; Franken, KLCM; Repsilber, D; Ottenhoff, THM; Kaufmann, SHE; Jacobsen, M				Schuck, Sebastian D.; Mueller, Henrik; Kunitz, Frank; Neher, Albert; Hoffmann, Harald; Franken, Kees L. C. M.; Repsilber, Dirk; Ottenhoff, Tom H. M.; Kaufmann, Stefan H. E.; Jacobsen, Marc			Identification of T-Cell Antigens Specific for Latent Mycobacterium Tuberculosis Infection	PLOS ONE			English	Article							DORMANCY REGULON; PROTEINS; VACCINATION; PROTECTION; RESPONSES; ASSAY; REACTIVITY; DISEASE; GENES	Background: T-cell responses against dormancy-, resuscitation-, and reactivation-associated antigens of Mycobacterium tuberculosis are candidate biomarkers of latent infection in humans. Methodology/Principal Findings: We established an assay based on two rounds of in vitro restimulation and intracellular cytokine analysis that detects T-cell responses to antigens expressed during latent M. tuberculosis infection. Comparison between active pulmonary tuberculosis (TB) patients and healthy latently M. tuberculosis-infected donors (LTBI) revealed significantly higher T-cell responses against 7 of 35 tested M. tuberculosis latency-associated antigens in LTBI. Notably, T cells specific for Rv3407 were exclusively detected in LTBI but not in TB patients. The T-cell IFN gamma response against Rv3407 in individual donors was the most influential factor in discrimination analysis that classified TB patients and LTBI with 83% accuracy using cross-validation. Rv3407 peptide pool stimulations revealed distinct candidate epitopes in four LTBI. Conclusions: Our findings further support the hypothesis that the latency-associated antigens can be exploited as biomarkers for LTBI.			Schuck, SD (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Franken, Kees/ABA-7095-2021; Kaufmann, Stefan HE/I-5454-2014	Franken, Kees/0000-0002-4747-6060; Kaufmann, Stefan HE/0000-0001-9866-8268; Jacobsen, Marc/0000-0002-4703-5652				Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Biketov S, 2000, FEMS IMMUNOL MED MIC, V29, P233, DOI 10.1016/S0928-8244(00)00210-8; Brahmbhatt S, 2006, CLIN EXP IMMUNOL, V146, P243, DOI 10.1111/j.1365-2249.2006.03211.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Downing KJ, 2004, TUBERCULOSIS, V84, P167, DOI 10.1016/j.tube.2003.12.004; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; JACOBSEN M, 2008, BIOL CHEM; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Leyten EMS, 2007, CLIN VACCINE IMMUNOL, V14, P880, DOI 10.1128/CVI.00132-07; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Mattow J, 2001, ELECTROPHORESIS, V22, P2936, DOI 10.1002/1522-2683(200108)22:14<2936::AID-ELPS2936>3.0.CO;2-S; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mollenkopf HJ, 2004, INFECT IMMUN, V72, P6471, DOI 10.1128/IAI.72.11.6471-6479.2004; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Ottenhoff THM, 2002, NAT GENET, V32, P97, DOI 10.1038/ng0902-97; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Regner M, 2001, IMMUNOL CELL BIOL, V79, P91, DOI 10.1046/j.1440-1711.2001.00994.x; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Weir RE, 1999, CLIN EXP IMMUNOL, V116, P263; Yeremeev VV, 2003, INFECT IMMUN, V71, P4789, DOI 10.1128/IAI.71.8.4789-4794.2003	30	116	125	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5590	10.1371/journal.pone.0005590	http://dx.doi.org/10.1371/journal.pone.0005590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440342	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107500018
J	van 't Wout, M; van Rijn, S; Jellema, T; Kahn, RS; Aleman, A				van 't Wout, Mascha; van Rijn, Sophie; Jellema, Tjeerd; Kahn, Rene S.; Aleman, Andre			Deficits in Implicit Attention to Social Signals in Schizophrenia and High Risk Groups: Behavioural Evidence from a New Illusion	PLOS ONE			English	Article							EMOTION-RECOGNITION DEFICIT; NEUROCOGNITIVE DEFICITS; KLINEFELTER-SYNDROME; FACIAL EMOTIONS; CUE PERCEPTION; VISUAL CONTEXT; NEURAL BASIS; CINGULATE; RELATIVES; SYMPTOMATOLOGY	Background: An increasing body of evidence suggests that the apparent social impairments observed in schizophrenia may arise from deficits in social cognitive processing capacities. The ability to process basic social cues, such as gaze direction and biological motion, effortlessly and implicitly is thought to be a prerequisite for establishing successful social interactions and for construing a sense of "social intuition." However, studies that address the ability to effortlessly process basic social cues in schizophrenia are lacking. Because social cognitive processing deficits may be part of the genetic vulnerability for schizophrenia, we also investigated two groups that have been shown to be at increased risk of developing schizophrenia-spectrum pathology: first-degree relatives of schizophrenia patients and men with Klinefelter syndrome (47, XXY). Results: We compared 28 patients with schizophrenia, 29 siblings of patients with schizophrenia, and 29 individuals with Klinefelter syndrome with 46 matched healthy control subjects on a new paradigm. This paradigm measures one's susceptibility for a bias in distance estimation between two agents that is induced by the implicit processing of gaze direction and biological motion conveyed by these agents. Compared to control subjects, patients with schizophrenia, as well as siblings of patients and Klinefelter men, showed a lack of influence of social cues on their distance judgments. Conclusions: We suggest that the insensitivity for social cues is a cognitive aspect of schizophrenia that may be seen as an endophenotype as it appears to be present both in relatives who are at increased genetic risk and in a genetic disorder at risk for schizophrenia-spectrum psychopathology. These social cue-processing deficits could contribute, in part, to the difficulties in higher order social cognitive tasks and, hence, to decreased social competence that has been observed in these groups.			van 't Wout, M (corresponding author), Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands.	maschavantwout@gmail.com	van 't Wout, Mascha/AAO-5710-2021; Aleman, Andre/E-1341-2012	van 't Wout, Mascha/0000-0002-1497-1989; van rijn, sophie/0000-0002-9179-7515				Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; APA, 1994, DIAGN STAT MAN MENT; Argyle M., 1976, GAZE MUTUAL GAZE; Ashton L, 1999, BEHAV NEUROL, V12, P93, DOI 10.1155/2000/913731; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BAUM KM, 1995, SCHIZOPHR RES, V16, P111, DOI 10.1016/0920-9964(94)00071-F; BELLACK AS, 1990, BRIT J PSYCHIAT, V156, P809, DOI 10.1192/bjp.156.6.809; Bolte S, 2007, J AUTISM DEV DISORD, V37, P243, DOI 10.1007/s10803-006-0165-3; Bojesen A, 2006, J CLIN ENDOCR METAB, V91, P1254, DOI 10.1210/jc.2005-0697; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Boks MPM, 2007, SCHIZOPHR RES, V93, P399, DOI 10.1016/j.schres.2007.03.015; Bruner J. S., 1960, PROCESS ED, DOI 10.1002/BS.3830090108; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; CORRIGAN PW, 1993, AM J PSYCHIAT, V150, P589; CORRIGAN PW, 1995, SCHIZOPHRENIA BULL, V21, P395, DOI 10.1093/schbul/21.3.395; CORRIGAN PW, 1994, SCHIZOPHR RES, V13, P73, DOI 10.1016/0920-9964(94)90062-0; CORRIGAN PW, 1994, PSYCHIAT RES, V53, P141, DOI 10.1016/0165-1781(94)90105-8; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; DeLisi LE, 2005, AM J MED GENET B, V135B, P15, DOI 10.1002/ajmg.b.30163; DELISI LE, 1994, SCHIZOPHRENIA BULL, V20, P495, DOI 10.1093/schbul/20.3.495; Dickerson F, 1999, SCHIZOPHR RES, V37, P13, DOI 10.1016/S0920-9964(98)00134-0; Dickerson F, 1996, SCHIZOPHR RES, V21, P75, DOI 10.1016/0920-9964(96)00040-0; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; DOLAN RJ, 1995, NATURE, V378, P180, DOI 10.1038/378180a0; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Fletcher P, 1999, NEUROIMAGE, V9, P337, DOI 10.1006/nimg.1998.0411; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; HANS SL, 1992, PSYCHIATRY, V55, P314; Jellema T, 2005, COGNITIVE NEUROSCIENCE OF SOCIAL BEHAVIOUR, P81, DOI 10.4324/9780203311875_chapter_4; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kohler CG, 2004, CURR OPIN PSYCHIATR, V17, P81, DOI 10.1097/00001504-200403000-00003; Kohler CG, 2000, BIOL PSYCHIAT, V48, P127, DOI 10.1016/S0006-3223(00)00847-7; KOZLOWSKI LT, 1977, PERCEPTION PSYCHOPHY, V21; Leitman DI, 2005, BIOL PSYCHIAT, V58, P56, DOI 10.1016/j.biopsych.2005.02.034; Lenzenweger MF, 1996, BRIT J PSYCHIAT, V168, P432, DOI 10.1192/bjp.168.4.432; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Loughland CM, 2004, SCHIZOPHR RES, V67, P11, DOI 10.1016/S0920-9964(03)00094-X; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Mandal MK, 1999, PSYCHIAT RES, V87, P39, DOI 10.1016/S0165-1781(99)00047-5; Martin F, 2005, PSYCHIAT RES, V134, P43, DOI 10.1016/j.psychres.2003.12.031; Mitelman SA, 2005, SCHIZOPHR RES, V72, P91, DOI 10.1016/j.schres.2004.02.011; Perrett DI, 1999, DESIGN OF ANIMAL COMMUNICATION, P159; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Rajarethinam RP, 2000, SCHIZOPHR RES, V41, P303, DOI 10.1016/S0920-9964(99)00083-3; Raven J. C, 1993, MANUAL RAVENS PROGRE; Russell TA, 2006, SCHIZOPHR RES, V81, P101, DOI 10.1016/j.schres.2005.10.002; Schmand B, 1991, Tijdschr Gerontol Geriatr, V22, P15; SCHNEIDER F, 1995, SCHIZOPHR RES, V17, P67, DOI 10.1016/0920-9964(95)00031-G; Scholten MRM, 2005, SCHIZOPHR RES, V78, P61, DOI 10.1016/j.schres.2005.06.019; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shen DG, 2004, NEUROIMAGE, V23, P648, DOI 10.1016/j.neuroimage.2004.08.018; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sitskoom MM, 2004, SCHIZOPHR RES, V71, P285, DOI 10.1016/j.schres.2004.03.007; Skuse D, 2003, NOVART FDN SYMP, V251, P84; Skuse DH, 2005, BRAIN, V128, P2084, DOI 10.1093/brain/awh562; SUMI S, 1984, PERCEPTION, V13, P283, DOI 10.1068/p130283; Takahashi H, 2004, NEUROIMAGE, V22, P1247, DOI 10.1016/j.neuroimage.2004.03.028; Toomey R, 1999, SCHIZOPHR RES, V40, P121, DOI 10.1016/S0920-9964(99)00036-5; Uhlhaas PJ, 2004, SCHIZOPHR RES, V68, P249, DOI 10.1016/s0920-9964(03)00184-1; van Rijn S, 2006, SCHIZOPHR RES, V84, P194, DOI 10.1016/j.schres.2006.02.020; van Rijn S, 2008, J AUTISM DEV DISORD, V38, P1634, DOI 10.1007/s10803-008-0542-1; van Rijn S, 2007, J INT NEUROPSYCH SOC, V13, P1065, DOI 10.1017/S1355617707071044; Van Rijn S, 2006, BRIT J PSYCHIAT, V189, P459, DOI 10.1192/bjp.bp.105.008961; VanderDoes AJW, 1996, SCHIZOPHR RES, V19, P61, DOI 10.1016/0920-9964(95)00046-1; WALKER EF, 1994, SCHIZOPHRENIA BULL, V20, P453, DOI 10.1093/schbul/20.3.453; van t'wout M, 2007, PSYCHIAT RES, V150, P227, DOI 10.1016/j.psychres.2006.03.010	72	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5581	10.1371/journal.pone.0005581	http://dx.doi.org/10.1371/journal.pone.0005581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	446FY	19440352	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107400017
J	Du, J; Sun, B; Chen, K; Zhang, L; Liu, SB; Gu, QQ; Fan, L; Zhao, NM; Wang, Z				Du, Jing; Sun, Bing; Chen, Kui; Zhang, Lang; Liu, Shubo; Gu, Qingquan; Fan, Li; Zhao, Nanming; Wang, Zhao			Metabolites of Cerebellar Neurons and Hippocampal Neurons Play Opposite Roles in Pathogenesis of Alzheimer's Disease	PLOS ONE			English	Article								Metabolites of neural cells, is known to have a significant effect on the normal physiology and function of neurons in brain. However, whether they play a role in pathogenesis of neurodegenerative diseases is unknown. Here, we show that metabolites of neurons play essential role in the pathogenesis of Alzheimer's disease (AD). Firstly, in vivo and in vitro metabolites of cerebellar neurons both significantly induced the expression of A beta-degrading enzymes in the hippocampus and cerebral cortex and promoted Ab clearance. Moreover, metabolites of cerebellar neurons significantly reduced brain Ab levels and reversed cognitive impairments and other AD-like phenotypes of APP/PS1 transgenic mice, in both early and late stages of AD pathology. On the other hand, metabolites of hippocampal neurons reduced the expression of A beta-degrading enzymes in the cerebellum and caused cerebellar neurodegeneration in APP/PS1 transgenic mice. Thus, we report, for the first time, that metabolites of neurons not only are required for maintaining the normal physiology of neurons but also play essential role in the pathogenesis of AD and may be responsible for the regional-specificity of Ab deposition and AD pathology.			Du, J (corresponding author), Tsinghua Univ, Sch Med, Dept Biol Sci & Biotechnol, Minist Educ,Prot Sci Key Lab, Beijing 100084, Peoples R China.	zwang@tsinghua.edu.cn	Sun, Bing/AAB-4304-2020	Sun, Bing/0000-0002-1992-3767; Du, Jing/0000-0003-1142-0433				Bobinski M, 1998, BRAIN RES, V805, P267, DOI 10.1016/S0006-8993(98)00759-8; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Du J, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-3; Giannakopoulos P, 1997, BRAIN RES REV, V25, P217, DOI 10.1016/S0165-0173(97)00023-4; Greene JDW, 1996, NEUROPSYCHOLOGIA, V34, P537, DOI 10.1016/0028-3932(95)00151-4; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Hempstead Barbara L., 2006, Current Alzheimer Research, V3, P19, DOI 10.2174/156720506775697061; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Janus C, 2000, NEUROBIOL AGING, V21, P541, DOI 10.1016/S0197-4580(00)00107-X; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kelly PH, 2003, NEUROBIOL AGING, V24, P365, DOI 10.1016/S0197-4580(02)00098-2; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; LI YT, 1994, NEUROBIOL AGING, V15, P1, DOI 10.1016/0197-4580(94)90139-2; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Miyan JA, 2003, CAN J PHYSIOL PHARM, V81, P317, DOI 10.1139/Y03-027; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; PILLON B, 1993, ARCH NEUROL-CHICAGO, V50, P374, DOI 10.1001/archneur.1993.00540040036010; Qu HY, 2008, EUR J PHARMACOL, V594, P93, DOI 10.1016/j.ejphar.2008.06.109; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shimizu E, 2008, J IMMUNOL, V181, P6503, DOI 10.4049/jimmunol.181.9.6503; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; SMITH QR, 1981, J NEUROCHEM, V37, P107, DOI 10.1111/j.1471-4159.1981.tb05297.x; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; VENABLE N, 1990, PSYCHOPHARMACOLOGY, V100, P215, DOI 10.1007/BF02244409; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	35	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5530	10.1371/journal.pone.0005530	http://dx.doi.org/10.1371/journal.pone.0005530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436731	Green Submitted, Green Published, gold			2022-12-27	WOS:000266009900021
J	Ruschke, K; Ebelt, H; Kloeting, N; Boettger, T; Raum, K; Bluher, M; Braun, T				Ruschke, Karen; Ebelt, Henning; Kloeting, Nora; Boettger, Thomas; Raum, Kay; Blueher, Matthias; Braun, Thomas			Defective Peripheral Nerve Development Is Linked to Abnormal Architecture and Metabolic Activity of Adipose Tissue in Nscl-2 Mutant Mice	PLOS ONE			English	Article								Background: In mammals the interplay between the peripheral nervous system (PNS) and adipose tissue is widely unexplored. We have employed mice, which develop an adult onset of obesity due to the lack the neuronal specific transcription factor Nscl-2 to investigate the interplay between the nervous system and white adipose tissue (WAT). Methodology: Changes in the architecture and innervation of WAT were compared between wildtype, Nscl22/2, ob/ob and Nscl-/-//ob/ob mice using morphological methods, immunohistochemistry and flow cytometry. Metabolic alterations in mutant mice and in isolated cells were investigated under basal and stimulated conditions. Principal Findings: We found that Nscl-2 mutant mice show a massive reduction of innervation of white epididymal and paired subcutaneous inguinal fat tissue including sensory and autonomic nerves as demonstrated by peripherin and neurofilament staining. Reduction of innervation went along with defects in the formation of the microvasculature, accumulation of cells of the macrophage/preadipocyte lineage, a bimodal distribution of the size of fat cells, and metabolic defects of isolated adipocytes. Despite a relative insulin resistance of white adipose tissue and isolated Nscl-2 mutant adipocytes the serum level of insulin in Nscl-2 mutant mice was only slightly increased. Conclusions: We conclude that the reduction of the innervation and vascularization of WAT in Nscl-2 mutant mice leads to the increase of preadipocyte/macrophage-like cells, a bimodal distribution of the size of adipocytes in WAT and an altered metabolic activity of adipocytes.			Ruschke, K (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, Halle, Germany.	thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008; Raum, Kay/A-5576-2013; Ruschke, Karen/E-6320-2014; Boettger, Thomas/E-3406-2012	Raum, Kay/0000-0003-0573-1622; Ruschke, Karen/0000-0001-5285-9675; Boettger, Thomas/0000-0003-4280-8449; Braun, Thomas/0000-0002-6165-4804				Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Blagoev B, 2002, J BIOL CHEM, V277, P42011, DOI 10.1074/jbc.M206975200; Bluher M, 2005, BEST PRACT RES CL EN, V19, P605, DOI 10.1016/j.beem.2005.07.006; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Caprio M, 2001, TRENDS ENDOCRIN MET, V12, P65, DOI 10.1016/S1043-2760(00)00352-0; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Coyle CA, 2002, PHYSIOL BEHAV, V77, P387, DOI 10.1016/S0031-9384(02)00885-5; CUSHMAN SW, 1978, J LIPID RES, V19, P269; Dodt C, 2003, ACTA PHYSIOL SCAND, V177, P351, DOI 10.1046/j.1365-201X.2003.01077.x; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Fornaro M, 2008, NEUROSCIENCE, V153, P1153, DOI 10.1016/j.neuroscience.2008.02.080; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Good DJ, 1997, NAT GENET, V15, P397, DOI 10.1038/ng0497-397; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; JANSSON PA, 1994, J CLIN INVEST, V93, P240, DOI 10.1172/JCI116951; Jing EX, 2004, ENDOCRINOLOGY, V145, P1503, DOI 10.1210/en.2003-0834; Jobst EE, 2006, ENDOCRINE, V29, P33, DOI 10.1385/ENDO:29:1:33; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kosacka J, 2006, J NEUROSCI RES, V83, P1160, DOI 10.1002/jnr.20811; Kruger M, 2006, EUR J NEUROSCI, V24, P1581, DOI 10.1111/j.1460-9568.2006.05051.x; Kruger M, 2004, EMBO J, V23, P4353, DOI 10.1038/sj.emboj.7600431; Kruger M, 2002, MOL CELL BIOL, V22, P792, DOI 10.1128/MCB.22.3.792-800.2002; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; NELSON JF, 1990, BIOL REPROD, V42, P649, DOI 10.1095/biolreprod42.4.649; Nilaweera KN, 2002, EUR J NEUROSCI, V15, P644, DOI 10.1046/j.1460-9568.2002.01894.x; Schmid T, 2007, J NEUROCHEM, V102, P2061, DOI 10.1111/j.1471-4159.2007.04694.x; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Torii I, 2003, J CELL PHYSIOL, V197, P42, DOI 10.1002/jcp.10326; Turtzo LC, 2001, P NATL ACAD SCI USA, V98, P12385, DOI 10.1073/pnas.231478898; Villena JA, 2002, HORM METAB RES, V34, P664, DOI 10.1055/s-2002-38244; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Zacchigna S, 2008, CURR TOP DEV BIOL, V80, P1, DOI 10.1016/S0070-2153(07)80001-9	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5516	10.1371/journal.pone.0005516	http://dx.doi.org/10.1371/journal.pone.0005516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436734	gold, Green Submitted, Green Published			2022-12-27	WOS:000266009900009
J	Thakkar, KN; Brugger, P; Park, S				Thakkar, Katharine N.; Brugger, Peter; Park, Sohee			Exploring Empathic Space: Correlates of Perspective Transformation Ability and Biases in Spatial Attention	PLOS ONE			English	Article							OUT-OF-BODY; SEX-DIFFERENCES; TEMPOROPARIETAL JUNCTION; HEMISPHERIC ASYMMETRIES; INDIVIDUAL-DIFFERENCES; WILLIAMS-SYNDROME; SOCIAL EMOTIONS; SELF; COGNITION; BRAIN	Separate lines of research have noted recruitment of parietal cortex during tasks involving visuo-spatial processes and empathy. To explore the relationship between these two functions, a self-other perspective transformation task and a task of spatial attention (line bisection) were administered to 40 healthy participants (19 women). Performance on these tasks was examined in relation to self-reported empathy. Rightward biases in line bisection correlated positively with trait-level self-reported empathic concern, suggesting a left hemisphere mediation of this prosocial personality trait. Unexpectedly, speed of perspective taking in the self-other transformation task correlated negatively with empathic concern, but only in women, which we interpret in light of gender differences in empathy and strategies for egocentric mental transformations. Together, the findings partially support the commonalities in visuo-spatial attention, perspective-taking and empathy. More broadly, they shed additional light on the relationship between basic cognitive functions and complex social constructs.			Thakkar, KN (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	katy.thakkar@vanderbilt.edu		Park, Sohee/0000-0003-3797-4776; Thakkar, Katharine/0000-0002-0026-2030	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073028, F31MH085405] Funding Source: NIH RePORTER; NIMH NIH HHS [F31 MH085405, R01 MH073028, MH073028] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Ames DL, 2008, PSYCHOL SCI, V19, P642, DOI 10.1111/j.1467-9280.2008.02135.x; Amorim MA, 2003, VIS COGN, V10, P157, DOI 10.1080/13506280244000078; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buck R, 1999, PSYCHOL REV, V106, P301, DOI 10.1037/0033-295X.106.2.301; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Compton RJ, 2000, NEUROPSYCHOLOGY, V14, P254, DOI 10.1037//0894-4105.14.2.254; Creem-Regehr SH, 2007, NEUROIMAGE, V35, P916, DOI 10.1016/j.neuroimage.2006.11.057; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; Davidson Richard J., 1995, P361; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Drake RA, 2006, COGNITION EMOTION, V20, P608, DOI 10.1080/02699930500368105; ELIOT TS, 1916, KNOWLEDGE EXPERIENCE; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; GUR RC, 1995, SCIENCE, V267, P528, DOI 10.1126/science.7824953; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; HEISTER G, 1986, PERCEPT PSYCHOPHYS, V40, P271, DOI 10.3758/BF03211507; Heller W, 1998, CURR DIR PSYCHOL SCI, V7, P26, DOI 10.1111/1467-8721.ep11521823; Heller W., 1993, NEUROPSYCHOLOGY, V7, P476, DOI [10.1037/0894-4105.7.4.476, DOI 10.1037/0894-4105.7.4.476]; Hoffman M L, 1977, Nebr Symp Motiv, V25, P169; HOFFMAN ML, 1977, PSYCHOL BULL, V84, P712, DOI 10.1037/0033-2909.84.4.712; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kaiser S, 2008, NEUROPSYCHOLOGIA, V46, P2524, DOI 10.1016/j.neuropsychologia.2008.04.013; KATZ AN, 1981, CAN J PSYCHOL, V35, P63, DOI 10.1037/h0081120; Kuhnen U, 2002, J EXP SOC PSYCHOL, V38, P492, DOI 10.1016/S0022-1031(02)00011-2; Leuthard J, 2005, COGN BEHAV NEUROL, V18, P173, DOI 10.1097/01.wnn.0000179114.06312.36; Macleans P. D., 1993, HDB EMOTIONS, P67; Marshall JC, 2001, NEUROIMAGE, V14, pS2, DOI 10.1006/nimg.2001.0834; McIsaac HK, 2002, PSYCHON B REV, V9, P146, DOI 10.3758/BF03196271; Mohr C, 2003, J NEUROPSYCH CLIN N, V15, P168, DOI 10.1176/appi.neuropsych.15.2.168; Morris C. A., 1999, HDB NEURODEVELOPMENT; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Nummenmaa L, NEUROIMAGE; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; PAULUS C, 1992, EMPATHIE KOMPETENZ A; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; REUTERLORENZ PA, 1990, BRAIN COGNITION, V12, P240, DOI 10.1016/0278-2626(90)90018-J; ROBERTSON IH, SPATIAL NEGLECT CLIN; ROSS ED, 1994, NEUROPSY NEUROPSY BE, V7, P1; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; SACKEIM HA, 1978, SCIENCE, V202, P434, DOI 10.1126/science.705335; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Tager-Flusberg H, 2000, COGNITION, V76, P59, DOI 10.1016/S0010-0277(00)00069-X; Vallar G., 1987, NEUROPHYSIOLOGICAL N, V45, P235; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3	60	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5864	10.1371/journal.pone.0005864	http://dx.doi.org/10.1371/journal.pone.0005864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456TI	19516894	Green Published, Green Submitted, gold			2022-12-27	WOS:000266872900015
J	Bouzaffour, M; Dufourcq, P; Lecaudey, V; Haas, P; Vriz, S				Bouzaffour, Mohamed; Dufourcq, Pascale; Lecaudey, Virginie; Haas, Petra; Vriz, Sophie			Fgf and Sdf-1 Pathways Interact during Zebrafish Fin Regeneration	PLOS ONE			English	Article								The chemokine stromal cell-derived factor-1 (SDF1) was originally identified as a pre-B cell stimulatory factor but has been recently implicated in several other key steps in differentiation and morphogenesis. In addition, SDF1 as well as FGF signalling pathways have recently been shown to be involved in the control of epimorphic regeneration. In this report, we address the question of a possible interaction between the two signalling pathways during adult fin regeneration in zebrafish. Using a combination of pharmaceutical and genetic tools, we show that during epimorphic regeneration, expression of sdf1, as well as of its cognate receptors, cxcr4a, cxcr4b and cxcr7 are controlled by FGF signalling. We further show that, Sdf1a negatively regulates the expression of fgf20a. Together, these results lead us to propose that: 1) the function of Fgf in blastema formation is, at least in part, relayed by the chemokine Sdf1a, and that 2) Sdf1 exerts negative feedback on the Fgf pathway, which contributes to a transient expression of Fgf20a downstream genes at the beginning of regeneration. However this feedback control can be bypassed since the Sdf1 null mutants regenerate their fin, though slower. Very few mutants for the regeneration process were isolated so far, illustrating the difficulty in identifying genes that are indispensable for regeneration. This observation supports the idea that the regeneration process involves a delicate balance between multiple pathways.			Bouzaffour, M (corresponding author), Univ Paris Diderot, Paris, France.	vriz@univ-paris-diderot.fr	Lecaudey, Virginie/A-8696-2013	/0000-0002-9058-9378; /0000-0003-2029-5750				Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Chong SW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-54; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Dufourcq P, 2006, DEV GENES EVOL, V216, P635, DOI 10.1007/s00427-006-0066-7; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Green PJ, 1996, BIOESSAYS, V18, P639, DOI 10.1002/bies.950180807; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Luo YQ, 2006, NEUROSCI LETT, V398, P291, DOI 10.1016/j.neulet.2006.01.024; Macdonald D, 2002, ACTA HAEMATOL-BASEL, V107, P101, DOI 10.1159/000046639; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Nakayama T, 2007, BLOOD, V109, P1363, DOI 10.1182/blood-2006-06-028217; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Sanders VJ, 2000, J NEUROSCI RES, V59, P671, DOI 10.1002/(SICI)1097-4547(20000301)59:5<671::AID-JNR10>3.0.CO;2-B; SLACK J, 1994, MOL REPROD DEV, V39, P118, DOI 10.1002/mrd.1080390118; SLACK J, 1994, MOL REPROD DEV, V39, P124; SLACK JMW, 1992, DEVELOPMENT, V114, P285; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tawk M, 2002, GENESIS, V32, P27, DOI 10.1002/gene.10025; TAYLOR GP, 1994, DEV BIOL, V163, P282, DOI 10.1006/dbio.1994.1144; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Xu XL, 1999, CELL TISSUE RES, V296, P33, DOI 10.1007/s004410051264; Yokoyama H, 2001, DEV BIOL, V233, P72, DOI 10.1006/dbio.2001.0180	43	36	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5824	10.1371/journal.pone.0005824	http://dx.doi.org/10.1371/journal.pone.0005824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503807	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717400004
J	Rasgon, JL				Rasgon, Jason L.			Multi-Locus Assortment (MLA) for Transgene Dispersal and Elimination in Mosquito Populations	PLOS ONE			English	Article							GENE DRIVE SYSTEMS; GLOBAL DISTRIBUTION; MALARIA VECTOR; AEDES-AEGYPTI; PEST-CONTROL; DENGUE; FITNESS; INSECTS; STRAIN; RISK	Background: Replacement of wild-type mosquito populations with genetically modified versions is being explored as a potential strategy to control vector-borne diseases. Due to lower expected relative fitness of transgenic individuals, transgenes must be driven into populations for these scenarios to be successful. Several gene drive mechanisms exist in a theoretical sense but none are currently workable in mosquitoes. Even if strategies were workable, it would be very difficult to recall released transgenes in the event of unforeseen consequences. What is needed is a way to test transgenes in the field for feasibility, efficacy and safety prior to releasing an active drive mechanism. Methodology/Principal Findings: We outline a method, termed Multi-locus assortment (MLA), to spread transgenes into vector populations by the release of genetically-modified mosquitoes carrying multiple stable transgene inserts. Simulations indicate that [1] insects do not have to carry transgenes at more than 4 loci, [2] transgenes can be maintained at high levels by sequential small releases, the frequency of which depends on the construct fitness cost, and [3] in the case of unforeseen negative non-target effects, transgenes can be eliminated from the population by halting transgenic releases and/or mass releases of wild-type insects. We also discuss potential methods to create MLA mosquito strains in the laboratory. Conclusions/Significance: While not as efficient as active drive mechanisms, MLA has other advantages: [1] MLA strains can be constructed for some mosquito species with currently-available technology, [2] MLA will allow the ecological components of transgenic mosquito releases to be tested before actual gene drive mechanisms are ready to be deployed, [3] since MLA is not self-propagating, the risk of an accidental premature release into nature is minimized, and [4] in the case that active gene drive mechanisms prove impossible to develop, the MLA approach can be used as a back-up transgene dispersal mechanism for disease control efforts in some systems.			Rasgon, JL (corresponding author), Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	jrasgon@jhsph.edu		Rasgon, Jason/0000-0002-4050-8429				Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Balakathiresan NS, 2007, AM J TROP MED HYG, V77, P270; Boete Christopher, 2002, Malaria Journal, V1, pUnpaginated; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; CLEMENTS NA, 1992, BIOL MOSQUITOES, V1; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gorrochotegui-Escalante N, 2000, AM J TROP MED HYG, V62, P200, DOI 10.4269/ajtmh.2000.62.200; Hahn MW, 2004, CURR BIOL, V14, pR264, DOI 10.1016/j.cub.2004.03.018; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Jin CY, 2009, APPL ENVIRON MICROB, V75, P3373, DOI 10.1128/AEM.00207-09; Knols Bart G.J., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-19; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; MACKAY TFC, 1989, GENOME, V31, P284, DOI 10.1139/g89-046; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; PAL R, 1974, ANNU REV ENTOMOL, V19, P269, DOI 10.1146/annurev.en.19.010174.001413; Rasgon JL, 2005, INSECT MOL BIOL, V14, P493, DOI 10.1111/j.1365-2583.2005.00580.x; RASGON JL, 2008, INSECT SYMBIOSIS, V3, P321; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1543, DOI 10.1603/0022-0493-93.6.1543; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1566, DOI 10.1603/0022-0493-93.6.1566; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor C, 2001, GENETICS, V157, P743; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; UNION BIOMETRICS COP	32	29	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5833	10.1371/journal.pone.0005833	http://dx.doi.org/10.1371/journal.pone.0005833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503813	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717400012
J	McDonald, RE; Fleming, RI; Beeley, JG; Bovell, DL; Lu, JR; Zhao, XB; Cooper, A; Kennedy, MW				McDonald, Rhona E.; Fleming, Rachel I.; Beeley, John G.; Bovell, Douglas L.; Lu, Jian R.; Zhao, Xiubo; Cooper, Alan; Kennedy, Malcolm W.			Latherin: A Surfactant Protein of Horse Sweat and Saliva	PLOS ONE			English	Article								Horses are unusual in producing protein-rich sweat for thermoregulation, a major component of which is latherin, a highly surface-active, non-glycosylated protein. The amino acid sequence of latherin, determined from cDNA analysis, is highly conserved across four geographically dispersed equid species (horse, zebra, onager, ass), and is similar to a family of proteins only found previously in the oral cavity and associated tissues of mammals. Latherin produces a significant reduction in water surface tension at low concentrations (<= 1 mg ml(-1)), and therefore probably acts as a wetting agent to facilitate evaporative cooling through a waterproofed pelt. Neutron reflection experiments indicate that this detergent-like activity is associated with the formation of a dense protein layer, about 10 A thick, at the air-water interface. However, biophysical characterization (circular dichroism, differential scanning calorimetry) in solution shows that latherin behaves like a typical globular protein, although with unusual intrinsic fluorescence characteristics, suggesting that significant conformational change or unfolding of the protein is required for assembly of the air-water interfacial layer. RT-PCR screening revealed latherin transcripts in horse skin and salivary gland but in no other tissues. Recombinant latherin produced in bacteria was also found to be the target of IgE antibody from horse-allergic subjects. Equids therefore may have adapted an oral/salivary mucosal protein for two purposes peculiar to their lifestyle, namely their need for rapid and efficient heat dissipation and their specialisation for masticating and processing large quantities of dry food material.			McDonald, RE (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland.	malcolm.kennedy@bio.gla.ac.uk	Cooper, Alan/F-7813-2011; Zhao, Xiubo/A-1690-2011; Zhao, Xiubo/AAZ-9058-2021	Cooper, Alan/0000-0001-6709-7343; Zhao, Xiubo/0000-0002-4620-2893; Zhao, Xiubo/0000-0002-4620-2893; Yu, Hai/0000-0002-6386-9761	Wellcome Trust [GR070994MA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alston RW, 2008, BIOPHYS J, V94, P2280, DOI 10.1529/biophysj.107.116921; Alston RW, 2008, BIOPHYS J, V94, P2288, DOI 10.1529/biophysj.107.116954; Beamer LJ, 1998, PROTEIN SCI, V7, P906; BEELEY JG, 1986, BIOCHEM J, V235, P645, DOI 10.1042/bj2350645; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bingle CD, 2004, INT J BIOCHEM CELL B, V36, P2144, DOI 10.1016/j.biocel.2004.05.002; Bingle CD, 2004, TRENDS IMMUNOL, V25, P53, DOI 10.1016/j.it.2003.11.007; Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Bingle L, 2004, J PATHOL, V204, p45A; Botros HG, 2001, EUR J BIOCHEM, V268, P3126, DOI 10.1046/j.1432-1327.2001.02217.x; Cameotra SS, 2004, CURR OPIN MICROBIOL, V7, P262, DOI 10.1016/j.mib.2004.04.006; Clarkson JR, 1999, J COLLOID INTERF SCI, V215, P333, DOI 10.1006/jcis.1999.6256; Cooper A, 2005, BIOPHYS J, V88, P2114, DOI 10.1529/biophysj.104.046268; D'Innocenzo B, 2006, BIOCHEMISTRY-US, V45, P13418, DOI 10.1021/bi061409p; DAYHOFF MO, 1979, ATLAS PROTEIN SEQUEN; EFTINK MR, 1977, BIOCHEMISTRY-US, V16, P5546, DOI 10.1021/bi00644a024; EFTINK MR, 1984, BIOCHEMISTRY-US, V23, P3891, DOI 10.1021/bi00312a016; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Egland KA, 2003, P NATL ACAD SCI USA, V100, P1099, DOI 10.1073/pnas.0337425100; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; FLEMING RI, 2009, P ROYAL S B IN PRESS; FOLK GE, 1991, INT J BIOMETEOROL, V35, P180, DOI 10.1007/BF01049065; Gregoire C, 1996, J BIOL CHEM, V271, P32951, DOI 10.1074/jbc.271.51.32951; Hakanpaa J, 2006, ACTA CRYSTALLOGR D, V62, P356, DOI 10.1107/S0907444906000862; Hakanpaa J, 2004, J BIOL CHEM, V279, P534, DOI 10.1074/jbc.M309650200; Hakanpaa J, 2006, PROTEIN SCI, V15, P2129, DOI 10.1110/ps.062326706; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jenkinson DM, 2006, VET DERMATOL, V17, P361, DOI 10.1111/j.1365-3164.2006.00545.x; Kankavi O, 2006, CROAT MED J, V47, P155; Kankavi O, 2007, ANIM REPROD SCI, V98, P259, DOI 10.1016/j.anireprosci.2006.03.009; Kennedy MW, 2000, CELL MOL LIFE SCI, V57, P1379, DOI 10.1007/PL00000623; Kim JK, 2007, AM J PHYSIOL-LUNG C, V292, pL879, DOI 10.1152/ajplung.00156.2006; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; LeClair EE, 2001, BIOCHEM BIOPH RES CO, V284, P792, DOI 10.1006/bbrc.2001.5024; Lu JR, 2007, CURR OPIN COLLOID IN, V12, P9, DOI 10.1016/j.cocis.2007.02.001; Lu JR, 2000, ADV COLLOID INTERFAC, V84, P143, DOI 10.1016/S0001-8686(99)00019-6; Lu JR, 1998, J CHEM SOC FARADAY T, V94, P3279, DOI 10.1039/a805731a; Lu JR, 1999, J COLLOID INTERF SCI, V213, P426, DOI 10.1006/jcis.1999.6157; Lu JR, 1998, J CHEM SOC FARADAY T, V94, P995, DOI 10.1039/a707853f; Lu JR, 2003, J AM CHEM SOC, V125, P3751, DOI 10.1021/ja0292290; Lu JR, 1999, LANGMUIR, V15, P6975, DOI 10.1021/la990131h; MACKENZIE CD, 2009, BIOPHYSICAL IN PRESS; McGuire JF, 2002, INT J PEDIATR OTORHI, V66, P1, DOI 10.1016/S0165-5876(02)00203-3; MONTGOMERY I, 1982, J ANAT, V135, P13; Mulero JJ, 2002, IMMUNOGENETICS, V54, P293, DOI 10.1007/s00251-002-0467-3; Porter AMW, 2001, J ROY SOC MED, V94, P236, DOI 10.1177/014107680109400509; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	53	63	65	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5726	10.1371/journal.pone.0005726	http://dx.doi.org/10.1371/journal.pone.0005726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478940	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000266490000005
J	Figge, MT				Figge, Marc Thilo			Optimization of Immunoglobulin Substitution Therapy by a Stochastic Immune Response Model	PLOS ONE			English	Article								Background: The immune system is a complex adaptive system of cells and molecules that are interwoven in a highly organized communication network. Primary immune deficiencies are disorders in which essential parts of the immune system are absent or do not function according to plan. X-linked agammaglobulinemia is a B-lymphocyte maturation disorder in which the production of immunoglobulin is prohibited by a genetic defect. Patients have to be put on life-long immunoglobulin substitution therapy in order to prevent recurrent and persistent opportunistic infections. Methodology: We formulate an immune response model in terms of stochastic differential equations and perform a systematic analysis of empirical therapy protocols that differ in the treatment frequency. The model accounts for the immunoglobulin reduction by natural degradation and by antigenic consumption, as well as for the periodic immunoglobulin replenishment that gives rise to an inhomogeneous distribution of immunoglobulin specificities in the shape space. Results are obtained from computer simulations and from analytical calculations within the framework of the Fokker-Planck formalism, which enables us to derive closed expressions for undetermined model parameters such as the infection clearance rate. Conclusions: We find that the critical value of the clearance rate, below which a chronic infection develops, is strongly dependent on the strength of fluctuations in the administered immunoglobulin dose per treatment and is an increasing function of the treatment frequency. The comparative analysis of therapy protocols with regard to the treatment frequency yields quantitative predictions of therapeutic relevance, where the choice of the optimal treatment frequency reveals a conflict of competing interests: In order to diminish immunomodulatory effects and to make good economic sense, therapeutic immunoglobulin levels should be kept close to physiological levels, implying high treatment frequencies. However, clearing infections without additional medication is more reliably achieved by substitution therapies with low treatment frequencies. Our immune response model predicts that the compromise solution of immunoglobulin substitution therapy has a treatment frequency in the range from one infusion per week to one infusion per two weeks.			Figge, MT (corresponding author), Univ Frankfurt, FIAS, Frankfurt, Germany.	figge@fias.uni-frankfurt.de	Figge, Marc Thilo/J-7547-2017	Figge, Marc Thilo/0000-0002-4044-9166				Andersson J, 1996, CLIN EXP IMMUNOL, V104, P10, DOI 10.1111/cei.1996.104.s1.10; AUKRUST P, 1994, BLOOD, V84, P2136; Bayry J, 2003, BLOOD, V101, P758, DOI 10.1182/blood-2002-05-1447; Bayry J, 2007, NAT CLIN PRACT NEURO, V3, P120, DOI 10.1038/ncpneuro0429; Berger M, 2008, IMMUNOL ALLERGY CLIN, V28, P413, DOI 10.1016/j.iac.2008.01.008; BRUTON OC, 1952, PEDIATRICS, V9, P722; Buckley RH, 1998, PEDIATRICS, V102, P213; Eibl MM, 2008, IMMUNOL ALLERGY CLIN, V28, P737, DOI 10.1016/j.iac.2008.06.004; Figge MT, 2008, J EXP MED, V205, P3019, DOI 10.1084/jem.20081160; Figge MT, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061901; Frank T, 1996, FOKKER PLANCK EQUATI; Fujikawa H, 2004, J FOOD HYG SOC JPN, V45, P250, DOI 10.3358/shokueishi.45.250; Gardulf A, 2007, BIODRUGS, V21, P105, DOI 10.2165/00063030-200721020-00005; Gaspar HB, 2000, CLIN EXP IMMUNOL, V119, P383, DOI 10.1046/j.1365-2249.2000.01192.x; Hurez V, 1994, Ther Immunol, V1, P269; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; JUNGI TW, 1990, CLIN EXP IMMUNOL, V82, P163; Kaveri S, 1996, J CLIN INVEST, V97, P865, DOI 10.1172/JCI118488; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kirmse J, 2006, J INFUSION NURS, V29, P15; MACGREGOR AG, 1951, BRIT HEART J, V13, P80; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; Marodi L, 2007, NAT REV IMMUNOL, V7, P851, DOI 10.1038/nri2195; Meyer-Hermann M, 2009, TRENDS IMMUNOL, V30, P157, DOI 10.1016/j.it.2009.01.005; Milgrom H, 1998, ANN ALLERG ASTHMA IM, V81, P97, DOI 10.1016/S1081-1206(10)62792-5; Mix E, 2006, J NEUROL, V253, P9, DOI 10.1007/s00415-006-5002-2; Moore ML, 2008, ANN ALLERG ASTHMA IM, V101, P114, DOI 10.1016/S1081-1206(10)60197-4; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Peleg M, 2007, FOOD RES INT, V40, P808, DOI 10.1016/j.foodres.2007.01.012; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Prasad NKA, 1998, J IMMUNOL, V161, P3781; Stangel M, 2000, J NEUROIMMUNOL, V106, P137, DOI 10.1016/S0165-5728(00)00210-1; Stangel M, 2006, J NEUROL, V253, P18, DOI 10.1007/s00415-006-5003-1; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Tha-In T, 2008, TRENDS IMMUNOL, V29, P608, DOI 10.1016/j.it.2008.08.004; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Van Impe JF, 2005, INT J FOOD MICROBIOL, V100, P97, DOI 10.1016/j.ijfoodmicro.2004.10.007; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0	40	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5685	10.1371/journal.pone.0005685	http://dx.doi.org/10.1371/journal.pone.0005685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479057	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415100003
J	Krueger, KAD; Tsuji, S; Fukuda, Y; Takahashi, Y; Goto, J; Mitsui, J; Ishiura, H; Dalton, JC; Miller, MB; Day, JW; Ranum, LPW				Krueger, Katherine A. Dick; Tsuji, Shoji; Fukuda, Yoko; Takahashi, Yuji; Goto, Jun; Mitsui, Jun; Ishiura, Hiroyuki; Dalton, Joline C.; Miller, Michael B.; Day, John W.; Ranum, Laura P. W.			SNP Haplotype Mapping in a Small ALS Family	PLOS ONE			English	Article								The identification of genes for monogenic disorders has proven to be highly effective for understanding disease mechanisms, pathways and gene function in humans. Nevertheless, while thousands of Mendelian disorders have not yet been mapped there has been a trend away from studying single-gene disorders. In part, this is due to the fact that many of the remaining single-gene families are not large enough to map the disease locus to a single site in the genome. New tools and approaches are needed to allow researchers to effectively tap into this genetic gold-mine. Towards this goal, we have used haploid cell lines to experimentally validate the use of high-density single nucleotide polymorphism (SNP) arrays to define genome-wide haplotypes and candidate regions, using a small amyotrophic lateral sclerosis (ALS) family as a prototype. Specifically, we used haploid-cell lines to determine if high-density SNP arrays accurately predict haplotypes across entire chromosomes and show that haplotype information significantly enhances the genetic information in small families. Panels of haploid-cell lines were generated and a 5 centimorgan (cM) short tandem repeat polymorphism (STRP) genome scan was performed. Experimentally derived haplotypes for entire chromosomes were used to directly identify regions of the genome identical-by-descent in 5 affected individuals. Comparisons between experimentally determined and in silico haplotypes predicted from SNP arrays demonstrate that SNP analysis of diploid DNA accurately predicted chromosomal haplotypes. These methods precisely identified 12 candidate intervals, which are shared by all 5 affected individuals. Our study illustrates how genetic information can be maximized using readily available tools as a first step in mapping single-gene disorders in small families.			Krueger, KAD (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	ranum001@umn.edu	Mitsui, Jun/B-5455-2012	Mitsui, Jun/0000-0001-7425-4765; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820; Day, John/0000-0002-0086-9529	NHLBI NIH HHS [N01HV48141] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antonarakis SE, 2006, NAT REV GENET, V7, P277, DOI 10.1038/nrg1826; Battistini S, 2005, J NEUROL, V252, P782, DOI 10.1007/s00415-005-0742-y; Berger MM, 2000, NEUROLOGY, V54, P20, DOI 10.1212/WNL.54.1.20; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; *J HOPK U I GEN ME, 2008, ONL MEND INH MAN OMI; Jackson M, 1997, ANN NEUROL, V42, P803, DOI 10.1002/ana.410420518; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Nishimura AL, 2004, J MED GENET, V41, P315, DOI 10.1136/jmg.2003.013029; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Ropers HH, 2007, AM J HUM GENET, V81, P199, DOI 10.1086/520679; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Shaw CE, 1998, ANN NEUROL, V43, P390, DOI 10.1002/ana.410430319; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; YAN J, 2006, 58 ANN M AM AC NEUR	27	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5687	10.1371/journal.pone.0005687	http://dx.doi.org/10.1371/journal.pone.0005687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479031	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331700014
J	Olsen, I; Tollefsen, S; Aagaard, C; Reitan, LJ; Bannantine, JP; Andersen, P; Sollid, LM; Lundin, KEA				Olsen, Ingrid; Tollefsen, Stig; Aagaard, Claus; Reitan, Liv J.; Bannantine, John P.; Andersen, Peter; Sollid, Ludvig M.; Lundin, Knut E. A.			Isolation of Mycobacterium avium Subspecies paratuberculosis Reactive CD4 T Cells from Intestinal Biopsies of Crohn's Disease Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; IDENTIFICATION; AUTOPHAGY; TUBERCULOSIS; ANTIGENS; SEQUENCE; GENE; NOD2; ENTEROBACTERIA	Background: Crohn's disease (CD) is a chronic granulomatous inflammation of the intestine. The etiology is unknown, but an excessive immune response to bacteria in genetically susceptible individuals is probably involved. The response is characterized by a strong Th1/Th17 response, but the relative importance of the various bacteria is not known. Methodology/Principal Findings: In an attempt to address this issue, we made T-cell lines from intestinal biopsies of patients with CD (n = 11), ulcerative colitis (UC) (n = 13) and controls (n = 10). The T-cell lines were tested for responses to various bacteria. A majority of the CD patients with active disease had a dominant response to Mycobacterium avium subspecies paratuberculosis (MAP). The T cells from CD patients also showed higher proliferation in response to MAP compared to UC patients (p<0.025). MAP reactive CD4 T-cell clones (n = 28) were isolated from four CD patients. The T-cell clones produced IL-17 and/or IFN-gamma, while minimal amounts of IL-4 were detected. To further characterize the specificity, the responses to antigen preparations from different mycobacterial species were tested. One T-cell clone responded only to MAP and the very closely related M. avium subspecies avium (MAA) while another responded to MAP, MAA and Mycobacterium intracellulare. A more broadly reactive T-cell clone reacted to MAP1508 which belongs to the esx protein family. Conclusions/Significance: The presence of MAP reactive T cells with a Th1 or Th1/Th17 phenotype may suggest a possible role of mycobacteria in the inflammation seen in CD. The isolation of intestinal T cells followed by characterization of their specificity is a valuable tool to study the relative importance of different bacteria in CD.			Olsen, I (corresponding author), Natl Vet Inst, Dept Anim Hlth, Oslo, Norway.	ingrid.olsen@vetinst.no	Lundin, Knut E. A./AAW-9519-2021; Sollid, Ludvig/N-9691-2015	Lundin, Knut E. A./0000-0003-1713-5545; Sollid, Ludvig/0000-0001-8860-704X; Bannantine, John/0000-0002-5692-7898; Andersen, Peter/0000-0002-5869-2551				Abubakar I, 2008, INFLAMM BOWEL DIS, V14, P401, DOI 10.1002/ibd.20276; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; AZUMA I, 1970, BIOCHIM BIOPHYS ACTA, V208, P444, DOI 10.1016/0304-4165(70)90217-5; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Coler RN, 2009, VACCINE, V27, P223, DOI 10.1016/j.vaccine.2008.10.056; DALTON HR, 1992, GUT, V33, P324, DOI 10.1136/gut.33.3.324; Duchmann R, 1996, SCAND J IMMUNOL, V44, P71, DOI 10.1046/j.1365-3083.1996.d01-273.x; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hemmer B, 1999, NAT MED, V5, P1375; Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Molberg O, 2003, GASTROENTEROLOGY, V125, P337, DOI 10.1016/S0016-5085(03)00890-4; MOLBERG O, 2000, CELIAC DIS METHODS P, P105; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olsen I, 2000, INFECT IMMUN, V68, P801, DOI 10.1128/IAI.68.2.801-808.2000; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pinedo PJ, 2009, VET MICROBIOL, V134, P346, DOI 10.1016/j.vetmic.2008.09.052; Raymond JB, 2005, J BIOL CHEM, V280, P326, DOI 10.1074/jbc.M411006200; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; SELDENRIJK CA, 1990, GUT, V31, P529, DOI 10.1136/gut.31.5.529; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000	36	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5641	10.1371/journal.pone.0005641	http://dx.doi.org/10.1371/journal.pone.0005641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19479064	Green Submitted, Green Published, gold			2022-12-27	WOS:000266331200001
J	Raychaudhuri, S; Dey, S; Bhattacharyya, NP; Mukhopadhyay, D				Raychaudhuri, Swasti; Dey, Sucharita; Bhattacharyya, Nitai P.; Mukhopadhyay, Debashis			The Role of Intrinsically Unstructured Proteins in Neurodegenerative Diseases	PLOS ONE			English	Article							DISORDERED PROTEINS; TOPOLOGICAL FEATURES; INTERACTION DATASETS; INTERACTION NETWORKS; HUNTINGTONS-DISEASE; STRUCTURAL DISORDER; ALPHA-SYNUCLEIN; ENERGY CONTENT; SEQUENCE; POLYGLUTAMINE	The number and importance of intrinsically disordered proteins (IUP), known to be involved in various human disorders, are growing rapidly. To test for the generalized implications of intrinsic disorders in proteins involved in Neurodegenerative diseases, disorder prediction tools have been applied to three datasets comprising of proteins involved in Huntington Disease (HD), Parkinson's disease (PD), Alzheimer's disease (AD). Results show, in general, proteins in disease datasets possess significantly enhanced intrinsic unstructuredness. Most of these disordered proteins in the disease datasets are found to be involved in neuronal activities, signal transduction, apoptosis, intracellular traffic, cell differentiation etc. Also these proteins are found to have more number of interactors and hence as the proportion of disorderedness (i.e., the length of the unfolded stretch) increased, the size of the interaction network simultaneously increased. All these observations reflect that, "Moonlighting" i.e. the contextual acquisition of different structural conformations (transient), eventually may allow these disordered proteins to act as network "hubs" and thus they may have crucial influences in the pathogenecity of neurodegenerative diseases.			Raychaudhuri, S (corresponding author), Saha Inst Nucl Phys, Struct Genom Sect, Kolkata, India.	debashis.mukhopadhyay@saha.ac.in	Raychaudhuri, Swasti/AAZ-2748-2020	Dey, Sucharita/0000-0003-0605-2576				Agorogiannis EI, 2004, NEUROPATH APPL NEURO, V30, P215, DOI 10.1111/j.1365-2990.2004.00558.x; BAXENDALE S, 1995, NAT GENET, V10, P67, DOI 10.1038/ng0595-67; Bordoli L, 2007, PROTEINS, V69, P129, DOI 10.1002/prot.21671; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Crocker SF, 2006, BRAIN RES, V1088, P176, DOI 10.1016/j.brainres.2006.02.102; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2000, P WORKSH GEN INF, V11, P161; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; JONSSON PF, BIOINFORMATICS, V22, P2291; Kaltenbach L., 2007, PLOS GENET; Kransnoslobodtsev AV, 2005, NANOMED-NANOTECHNOL, V1, P300, DOI 10.1016/j.nano.2005.10.005; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Raychaudhuri S, 2008, PROTEINS, V71, P1686, DOI 10.1002/prot.21856; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Skrabana R, 2006, CELL MOL NEUROBIOL, V26, P1085, DOI 10.1007/s10571-006-9083-3; SPIEGEL MR, 2000, THEORY PROBLEMS PROB, P241; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; XU J, BIOINFORMATICS, V22, P2800; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534	52	50	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5566	10.1371/journal.pone.0005566	http://dx.doi.org/10.1371/journal.pone.0005566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440375	Green Submitted, gold, Green Published			2022-12-27	WOS:000266107400010
J	Schweiger, MR; Kerick, M; Timmermann, B; Albrecht, MW; Borodina, T; Parkhomchuk, D; Zatloukal, K; Lehrach, H				Schweiger, Michal R.; Kerick, Martin; Timmermann, Bernd; Albrecht, Marcus W.; Borodina, Tatjana; Parkhomchuk, Dmitri; Zatloukal, Kurt; Lehrach, Hans			Genome-Wide Massively Parallel Sequencing of Formaldehyde Fixed-Paraffin Embedded (FFPE) Tumor Tissues for Copy-Number- and Mutation-Analysis	PLOS ONE			English	Article								Background: Cancer re-sequencing programs rely on DNA isolated from fresh snap frozen tissues, the preparation of which is combined with additional preservation efforts. Tissue samples at pathology departments are routinely stored as formalin-fixed and paraffin-embedded (FFPE) samples and their use would open up access to a variety of clinical trials. However, FFPE preparation is incompatible with many down-stream molecular biology techniques such as PCR based amplification methods and gene expression studies. Methodology/Principal Findings: Here we investigated the sample quality requirements of FFPE tissues for massively parallel short-read sequencing approaches. We evaluated key variables of pre-fixation, fixation related and post-fixation processes that occur in routine medical service (e. g. degree of autolysis, duration of fixation and of storage). We also investigated the influence of tissue storage time on sequencing quality by using material that was up to 18 years old. Finally, we analyzed normal and tumor breast tissues using the Sequencing by Synthesis technique (Illumina Genome Analyzer, Solexa) to simultaneously localize genome-wide copy number alterations and to detect genomic variations such as substitutions and point-deletions and/or insertions in FFPE tissue samples. Conclusions/Significance: The application of second generation sequencing techniques on small amounts of FFPE material opens up the possibility to analyze tissue samples which have been collected during routine clinical work as well as in the context of clinical trials. This is in particular important since FFPE samples are amply available from surgical tumor resections and histopathological diagnosis, and comprise tissue from precursor lesions, primary tumors, lymphogenic and/or hematogenic metastases. Large-scale studies using this tissue material will result in a better prediction of the prognosis of cancer patients and the early identification of patients which will respond to therapy.			Schweiger, MR (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Berlin, Germany.	mschweig@molgen.mpg.de	Kerick, Martin/AAD-8303-2022; Ferron, Gwenael/P-6193-2014; Schweiger, Michal R/H-5270-2015; ALEXANDRE, JEROME/O-8350-2017	Ferron, Gwenael/0000-0002-8545-4700; Schweiger, Michal R/0000-0002-4672-0623; Borodina, Tatiana/0000-0002-6978-016X; Kerick, Martin/0000-0002-6298-4514				Asslaber M, 2007, PATHOBIOLOGY, V74, P251, DOI 10.1159/000104453; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Tourneau C, 2008, DRUG RESIST UPDATE, V11, P99, DOI 10.1016/j.drup.2008.04.001; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Velculescu VE, 2007, NAT BIOTECHNOL, V25, P878, DOI 10.1038/nbt0807-878; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	18	128	178	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5548	10.1371/journal.pone.0005548	http://dx.doi.org/10.1371/journal.pone.0005548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19440246	Green Published, gold			2022-12-27	WOS:000266107300013
J	Maddocks, ODK; Short, AJ; Donnenberg, MS; Bader, S; Harrison, DJ				Maddocks, Oliver D. K.; Short, Abigail J.; Donnenberg, Michael S.; Bader, Scott; Harrison, David J.			Attaching and Effacing Escherichia coli Downregulate DNA Mismatch Repair Protein In Vitro and Are Associated with Colorectal Adenocarcinomas in Humans	PLOS ONE			English	Article								Background: Mucosa-associated Escherichia coli are frequently found in the colonic mucosa of patients with colorectal adenocarcinoma, but rarely in healthy controls. Chronic mucosal E. coli infection has therefore been linked to colonic tumourigenesis. E. coli strains carrying eae (encoding the bacterial adhesion protein intimin) attach intimately to the intestinal mucosa and are classed as attaching and effacing E. coli (AEEC). Enteropathogenic Escherichia coli (EPEC) are the most common form of AEEC identified in man. EPEC utilise a type III secretion system to translocate effector proteins into host cells and infection induces wide-ranging effects on the host cell proteome. We hypothesised that EPEC infection could influence molecular pathways involved in colorectal tumourigenesis. Methodology/Principal Findings: When co-cultured with human colorectal cell lines, EPEC dramatically downregulated the expression of key DNA mismatch repair proteins MSH2 and MLH1 in an attachment specific manner. Cytochrome c staining and TUNEL analysis confirmed that this effect was not a consequence of apoptosis/necrosis. Ex vivo human colonic mucosa was co-cultured with EPEC and probed by immunofluorescence to locate adherent bacteria. EPEC entered 10% of colonic crypts and adhered to crypt epithelial cells, often in the proliferative compartment. Adenocarcinoma and normal colonic mucosa from colorectal cancer patients (n = 20) was probed by immunofluorescence and PCR for AEEC. Mucosa-associated E. coli were found on 10/20 (50%) adenocarcinomas and 3/20 (15%) normal mucosa samples (P < 0.05). AEEC were detected on 5/20 (25%) adenocarcinomas, but not normal mucosa samples (P < 0.05). Significance/Conclusions: The ability of EPEC to downregulate DNA mismatch repair proteins represents a novel gene-environment interaction that could increase the susceptibility of colonic epithelial cells to mutations and therefore promote colonic tumourigenesis. The potential role of AEEC in colorectal tumourigenesis warrants further investigation.			Maddocks, ODK (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Div Pathol, Edinburgh, Midlothian, Scotland.	olivermaddocks@yahoo.co.uk	Maddocks, Oliver/K-5410-2012	Maddocks, Oliver/0000-0002-5551-9091; harrison, david/0000-0001-9041-9988; Donnenberg, Michael/0000-0002-8818-3184	NATIONAL CANCER INSTITUTE [R21CA141038] Funding Source: NIH RePORTER; Cancer Research UK [C505/A7328, 617SUR R40245] Funding Source: Medline; Medical Research Council [MRCDTGG122/5] Funding Source: Medline; NCI NIH HHS [R21 CA141038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afset JE, 2004, J MED MICROBIOL, V53, P1137, DOI 10.1099/jmm.0.45719-0; Baranovskaya S, 2001, P NATL ACAD SCI USA, V98, P15107, DOI 10.1073/pnas.251234498; BARTHOLD SW, 1977, CANCER RES, V37, P4352; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Beutin L, 2003, INFECT IMMUN, V71, P3995, DOI 10.1128/IAI.71.7.3995-4002.2003; BLASER MJ, 1995, CANCER RES, V55, P2111; Blasi MF, 2006, CANCER RES, V66, P9036, DOI 10.1158/0008-5472.CAN-06-1896; BROWNING TH, 1969, J CLIN INVEST, V48, P1423, DOI 10.1172/JCI106108; Castedo M, 2002, J IMMUNOL METHODS, V265, P39, DOI 10.1016/S0022-1759(02)00069-8; CHANTRET I, 1988, CANCER RES, V48, P1936; Clarke SC, 2003, CLIN MICROBIOL REV, V16, P365, DOI 10.1128/CMR.16.3.365-378.2003; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Crane JK, 1997, INFECT IMMUN, V65, P3277, DOI 10.1128/IAI.65.8.3277-3285.1997; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; DONNENBERG MS, 1993, J BACTERIOL, V175, P4670, DOI 10.1128/JB.175.15.4670-4680.1993; ETZLER ME, 1974, J CELL BIOL, V62, P329, DOI 10.1083/jcb.62.2.329; Giovannucci E, 2005, JNCI-J NATL CANCER I, V97, P1317, DOI 10.1093/jnci/dji305; Glaab WE, 1999, MUTAT RES-FUND MOL M, V427, P67, DOI 10.1016/S0027-5107(99)00091-3; Goosney DL, 2001, INFECT IMMUN, V69, P3315, DOI 10.1128/IAI.69.5.3315-3322.2001; HAKOMORI S, 1985, CANCER RES, V45, P2405; Hardwidge PR, 2004, J BIOL CHEM, V279, P20127, DOI 10.1074/jbc.M401228200; Hernandez-Pigeon H, 2004, FEBS LETT, V562, P40, DOI 10.1016/S0014-5793(04)00181-4; Hicks S, 1998, INFECT IMMUN, V66, P1570, DOI 10.1128/IAI.66.4.1570-1578.1998; Hyland RM, 2006, INFECT IMMUN, V74, P5419, DOI 10.1128/IAI.00739-06; Kane MF, 1997, CANCER RES, V57, P808; Kenny B, 1997, INFECT IMMUN, V65, P2528, DOI 10.1128/IAI.65.7.2528-2536.1997; Kim JJ, 2002, GASTROENTEROLOGY, V123, P542, DOI 10.1053/gast.2002.34751; KIM YS, 1971, J BIOL CHEM, V246, P5466; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; Lei XF, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh098; LEVINE MM, 1984, EPIDEMIOL REV, V6, P31, DOI 10.1093/oxfordjournals.epirev.a036274; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Malladi V, 2004, MICROBES INFECT, V6, P38, DOI 10.1016/j.micinf.2003.09.022; Marti TM, 2003, DNA REPAIR, V2, P571, DOI 10.1016/S1568-7864(03)00023-5; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pabst WL, 2003, J CLIN MICROBIOL, V41, P2289, DOI 10.1128/JCM.41.6.2289-2293.2003; Phillips AD, 2000, J INFECT DIS, V181, P1496, DOI 10.1086/315404; Robins-Browne RM, 2004, EMERG INFECT DIS, V10, P1797, DOI 10.3201/eid1010.031086; Rosenshine I, 1996, INFECT IMMUN, V64, P966, DOI 10.1128/IAI.64.3.966-973.1996; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Samowitz WS, 2007, MOL CANCER RES, V5, P165, DOI 10.1158/1541-7786.MCR-06-0398; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; SCHAUER DB, 1995, J CLIN MICROBIOL, V33, P2064, DOI 10.1128/JCM.33.8.2064-2068.1995; Schuller S, 2007, CELL MICROBIOL, V9, P1352, DOI 10.1111/j.1462-5822.2006.00879.x; Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259; Shifrin Y, 2002, CELL MICROBIOL, V4, P235, DOI 10.1046/j.1462-5822.2002.00188.x; SMOOT DT, 1993, INFECT IMMUN, V61, P350, DOI 10.1128/IAI.61.1.350-355.1993; Sohn KJ, 2003, CARCINOGENESIS, V24, P217, DOI 10.1093/carcin/24.2.217; Stewart BW, 2003, WORLD CANC REPORT, P198; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; WEISER MM, 1973, J BIOL CHEM, V248, P2542; Youn CK, 2005, NAT CELL BIOL, V7, P137, DOI 10.1038/ncb1215; Zhang SL, 2002, ENVIRON MOL MUTAGEN, V40, P243, DOI 10.1002/em.10113; Zhu WB, 1998, MUTAT RES-FUND MOL M, V398, P93, DOI 10.1016/S0027-5107(97)00244-3	64	87	91	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5517	10.1371/journal.pone.0005517	http://dx.doi.org/10.1371/journal.pone.0005517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436735	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000266009900010
J	SanGiovanni, JP; Arking, DE; Iyengar, SK; Elashoff, M; Clemons, TE; Reed, GF; Henning, AK; Sivakumaran, TA; Xu, XM; Dewan, A; Agron, E; Rochtchina, E; Sue, CM; Wang, JJ; Mitchell, P; Hoh, J; Francis, PJ; Klein, ML; Chew, EY; Chakravarti, A				SanGiovanni, John Paul; Arking, Dan E.; Iyengar, Sudha K.; Elashoff, Michael; Clemons, Traci E.; Reed, George F.; Henning, Alice K.; Sivakumaran, Theru A.; Xu, Xuming; DeWan, Andrew; Agron, Elvira; Rochtchina, Elena; Sue, Carolyn M.; Wang, Jie Jin; Mitchell, Paul; Hoh, Josephine; Francis, Peter J.; Klein, Michael L.; Chew, Emily Y.; Chakravarti, Aravinda			Mitochondrial DNA Variants of Respiratory Complex I that Uniquely Characterize Haplogroup T2 Are Associated with Increased Risk of Age-Related Macular Degeneration	PLOS ONE			English	Article								Background: Age-related macular degeneration (AMD), a chronic neurodegenerative and neovascular retinal disease, is the leading cause of blindness in elderly people of western European origin. While structural and functional alterations in mitochondria (mt) and their metabolites have been implicated in the pathogenesis of chronic neurodegenerative and vascular diseases, the relationship of inherited variants in the mitochondrial genome and mt haplogroup subtypes with advanced AMD has not been reported in large prospective cohorts. Methodology/Prinicipal Findings: We examined the relationship of inherited mtDNA variants with advanced AMD in 1168 people using a three-stage design on samples from 12-year and 10-year prospective studies on the natural history of age-related eye disease. In Stage I we resequenced the entire genome in 99 elderly AMD-free controls and 215 people with advanced AMD from the 12-year study. A consistent association with AMD in 14 of 17 SNPs characterizing the mtDNA T haplogroup emerged. Further analysis revealed these associations were driven entirely by the T2 haplogroup, and characterized by two variants in Complex I genes (A11812G of MT-ND4 and A14233G of MT-ND6). We genotyped T haplogroups in an independent sample of 490 cases and 61 controls from the same study (Stage II) and in 56 cases and 246 controls from the 10-year study (Stage III). People in the T2 haplogroup were approximately 2.5 times more likely to have advanced AMD than their peers (odds ratio [OR] = 2.54, 95%CI 1.36-4.80, P <= 0.004) after considering the totality of evidence. Findings persisted after considering the impact of AMD-associated variants A69S and Y402H (OR = 5.19, 95%CI 1.19-22.69, P <= 0.029). Conclusion: Loci defining the mtDNA T2 haplogroup and Complex I are reasonable targets for novel functional analyses and therapeutic research in AMD.			SanGiovanni, JP (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	jpsangio@post.harvard.edu	Wang, Jie Jin/P-1499-2014; SanGiovanni, John Paul/AAU-3895-2020; wang, jie/GRS-0942-2022; Mitchell, Paul/P-1498-2014; /S-1190-2019	Wang, Jie Jin/0000-0001-9491-4898; /0000-0001-7488-250X; DeWan, Andrew/0000-0002-7679-8704	Intramural NIH HHS [Z99 EY999999, ZIA EY000489-01] Funding Source: Medline; NEI NIH HHS [EY015810, 01-EY-0-2127, R01 EY015771, R01EY015771, R01 EY012203, R01-EY12203, R01 EY015810] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012203, R01EY015810, ZIAEY000489, ZIEEY000487, N01EY002127] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		*AREDS RES GROUP, 2008, DEF FIN AG REL MAC D; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; La Morgia C, 2008, NEUROLOGY, V70, P762, DOI 10.1212/01.wnl.0000295505.74234.d0; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448	30	71	76	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2009	4	5							e5508	10.1371/journal.pone.0005508	http://dx.doi.org/10.1371/journal.pone.0005508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VZ	19434233	Green Submitted, gold, Green Published			2022-12-27	WOS:000266009800006
J	Taniguchi, K; Sasaki, K; Watari, K; Yasukawa, H; Imaizumi, T; Ayada, T; Okamoto, F; Ishizaki, T; Kato, R; Kohno, RI; Kimura, H; Sato, Y; Ono, M; Yonemitsu, Y; Yoshimura, A				Taniguchi, Koji; Sasaki, Ken-ichiro; Watari, Kousuke; Yasukawa, Hideo; Imaizumi, Tsutomu; Ayada, Toranoshin; Okamoto, Fuyuki; Ishizaki, Takuma; Kato, Reiko; Kohno, Ri-ichiro; Kimura, Hiroshi; Sato, Yasufumi; Ono, Mayumi; Yonemitsu, Yoshikazu; Yoshimura, Akihiko			Suppression of Sproutys Has a Therapeutic Effect for a Mouse Model of Ischemia by Enhancing Angiogenesis	PLOS ONE			English	Article								Sprouty proteins (Sproutys) inhibit receptor tyrosine kinase signaling and control various aspects of branching morphogenesis. In this study, we examined the physiological function of Sproutys in angiogenesis, using gene targeting and short-hairpin RNA (shRNA) knockdown strategies. Sprouty2 and Sprouty4 double knockout (KO) (DKO) mice were embryonic-lethal around E12.5 due to cardiovascular defects. The number of peripheral blood vessels, but not that of lymphatic vessels, was increased in Sprouty4 KO mice compared with wild-type (WT) mice. Sprouty4 KO mice were more resistant to hind limb ischemia and soft tissue ischemia than WT mice were, because Sprouty4 deficiency causes accelerated neovascularization. Moreover, suppression of Sprouty2 and Sprouty4 expression in vivo by shRNA targeting accelerated angiogenesis and has a therapeutic effect in a mouse model of hind limb ischemia. These data suggest that Sproutys are physiologically important negative regulators of angiogenesis in vivo and novel therapeutic targets for treating peripheral ischemic diseases.			Taniguchi, K (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 812, Japan.	yoshimura@a6.keio.jp	Kimura, Hiroshi/B-9524-2015; Sato, Yasufumi/AAF-3367-2019; Yoshimura, Akihiko/K-5515-2013	Kimura, Hiroshi/0000-0003-0854-083X; Watari, Kosuke/0000-0003-0260-2323				Antoine M, 2005, GROWTH FACTORS, V23, P87, DOI 10.1080/08977190500096004; Ayada T, 2009, ONCOGENE, V28, P1076, DOI 10.1038/onc.2008.464; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; DAMATO R, 1993, MICROVASC RES, V46, P135, DOI 10.1006/mvre.1993.1042; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; KIMURA H, 2009, BLOOD IN PRESS; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Masaki I, 2002, CIRC RES, V90, P966, DOI 10.1161/01.RES.0000019540.41697.60; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nishinakamura H, 2007, INT IMMUNOL, V19, P609, DOI 10.1093/intimm/dxm026; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Schalch P, 2004, J THORAC CARDIOV SUR, V128, P595, DOI 10.1016/j.jtcvs.2004.02.036; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Sugano M, 2007, ATHEROSCLEROSIS, V191, P33, DOI 10.1016/j.atherosclerosis.2006.04.021; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Takeshita S, 1996, LAB INVEST, V74, P1061; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002	40	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5467	10.1371/journal.pone.0005467	http://dx.doi.org/10.1371/journal.pone.0005467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424491	Green Published, gold, Green Submitted			2022-12-27	WOS:000265933800004
J	Proverbio, AM; Riva, F; Zani, A				Proverbio, Alice Mado; Riva, Federica; Zani, Alberto			Observation of Static Pictures of Dynamic Actions Enhances the Activity of Movement-Related Brain Areas	PLOS ONE			English	Article								Background: Physiological studies of perfectly still observers have shown interesting correlations between increasing effortfulness of observed actions and increases in heart and respiration rates. Not much is known about the cortical response induced by observing effortful actions. The aim of this study was to investigate the time course and neural correlates of perception of implied motion, by presenting 260 pictures of human actions differing in degrees of dynamism and muscular exertion. ERPs were recorded from 128 sites in young male and female adults engaged in a secondary perceptual task. Principal Findings: Our results indicate that even when the stimulus shows no explicit motion, observation of static photographs of human actions with implied motion produces a clear increase in cortical activation, manifest in a long-lasting positivity (LP) between 350-600 ms that is much greater to dynamic than less dynamic actions, especially in men. A swLORETA linear inverse solution computed on the dynamic-minus-static difference wave in the time window 380-430 ms showed that a series of regions was activated, including the right V5/MT, left EBA, left STS (BA38), left premotor (BA6) and motor (BA4) areas, cingulate and IF cortex. Conclusions and Significance: Overall, the data suggest that corresponding mirror neurons respond more strongly to implied dynamic than to less dynamic actions. The sex difference might be partially cultural and reflect a preference of young adult males for highly dynamic actions depicting intense muscular activity, or a sporty context.			Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABG-8894-2020; Zani, Alberto/ABI-3498-2020	Zani, Alberto/0000-0002-3906-7988; Proverbio, Alice Mado/0000-0002-5138-1523				Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; DECETY J, 1993, J PHYSIOL-LONDON, V461, P549, DOI 10.1113/jphysiol.1993.sp019528; DECETY J, 1991, BEHAV BRAIN RES, V51, P1; DECETY J, 1994, MAPPING MOTOR REPRES, P600; Dinstein I, 2008, CURR BIOL, V18, pR13, DOI 10.1016/j.cub.2007.11.004; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; GAZZOLA V, 2008, CEREB CORTEX; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hautzel H, 2001, BRAIN RES, V892, P281, DOI 10.1016/S0006-8993(00)03224-8; Holz EM, 2008, BRAIN TOPOGR, V21, P93, DOI 10.1007/s10548-008-0066-1; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Paccalin C, 2000, BRAIN RES, V862, P194, DOI 10.1016/S0006-8993(00)02145-4; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Proverbio AM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-56; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Uusitalo MA, 1997, NEUROIMAGE, V5, P241, DOI 10.1006/nimg.1997.0266	31	71	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5389	10.1371/journal.pone.0005389	http://dx.doi.org/10.1371/journal.pone.0005389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421311	Green Submitted, gold, Green Published			2022-12-27	WOS:000265836900003
J	Holmkvist, J; Banasik, K; Andersen, G; Unoki, H; Jensen, TS; Pisinger, C; Borch-Johnsen, K; Sandbaek, A; Lauritzen, T; Brunak, S; Maeda, S; Hansen, T; Pedersen, O				Holmkvist, Johan; Banasik, Karina; Andersen, Gitte; Unoki, Hiroyuki; Jensen, Thomas Skot; Pisinger, Charlotta; Borch-Johnsen, Knut; Sandbaek, Annelli; Lauritzen, Torsten; Brunak, Soeren; Maeda, Shiro; Hansen, Torben; Pedersen, Oluf			The Type 2 Diabetes Associated Minor Allele of rs2237895 KCNQ1 Associates with Reduced Insulin Release Following an Oral Glucose Load	PLOS ONE			English	Article								Background: Polymorphisms in the potassium channel, voltage-gated, KQT-like subfamily, member 1 (KCNQ1) have recently been reported to associate with type 2 diabetes. The primary aim of the present study was to investigate the putative impact of these KCNQ1 polymorphisms (rs2283228, rs2237892, rs2237895, and rs2237897) on estimates of glucose stimulated insulin release. Methodology/Principal Findings: Genotypes were examined for associations with serum insulin levels following an oral glucose tolerance test (OGTT) in a population-based sample of 6,039 middle-aged and treatment-naive individuals. Insulin release indices estimated from the OGTT and the interplay between insulin sensitivity and insulin release were investigated using linear regression and Hotelling T2 analyses. Applying an additive genetic model the minor C-allele of rs2237895 was associated with reduced serum insulin levels 30 min (mean +/- SD: (CC) 277 +/- 160 vs. (AC) 280 +/- 164 vs. (AA) 299 +/- 200 pmol/l, p = 0.008) after an oral glucose load, insulinogenic index (29.6 +/- 17.4 vs. 30.2 +/- 18.7vs. 32.2 +/- 22.1, p = 0.007), incremental area under the insulin curve (20,477 +/- 12,491 vs. 20,503 +/- 12,386 vs. 21,810 +/- 14,685, p = 0.02) among the 4,568 individuals who were glucose tolerant. Adjustment for the degree of insulin sensitivity had no effect on the measures of reduced insulin release. The rs2237895 genotype had a similar impact in the total sample of treatment-naive individuals. No association with measures of insulin release were identified for the less common diabetes risk alleles of rs2237892, rs2237897, or rs2283228. Conclusion: The minor C-allele of rs2237895 of KCNQ1, which has a prevalence of about 42% among Caucasians was associated with reduced measures of insulin release following an oral glucose load suggesting that the increased risk of type 2 diabetes, previously reported for this variant, likely is mediated through an impaired beta cell function.			Holmkvist, J (corresponding author), Hagedorn Res Lab, DK-2820 Gentofte, Denmark.	oluf@hagedorn.dk	Banasik, Karina/G-1728-2013; Unoki-Kubota, Hiroyuki/H-7268-2019; Pedersen, Oluf/AAG-8015-2020; Banasik, Karina/S-3475-2019; Pedersen, Oluf/Z-1731-2019; Brunak, Soren/O-6621-2016	Unoki-Kubota, Hiroyuki/0000-0003-4827-8805; Banasik, Karina/0000-0003-2489-2499; Pedersen, Oluf/0000-0002-3321-3972; Pisinger, Charlotta/0000-0002-7970-3168; Brunak, Soren/0000-0003-0316-5866				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Jacobson DA, 2007, DIABETES OBES METAB, V9, P89, DOI 10.1111/j.1463-1326.2007.00784.x; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kanno T, 2002, J PHYSIOL-LONDON, V545, P501, DOI 10.1113/jphysiol.2002.031344; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Nielsen EMD, 2005, J MOL MED, V83, P353, DOI 10.1007/s00109-005-0647-3; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; TAN JT, 2009, DIABETES        0227; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Veglio M, 2004, J ENDOCRINOL INVEST, V27, P175, DOI 10.1007/BF03346265; YASUDA K, 2008, NAT GENET IN PRESS; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang M, 2005, J GEN PHYSIOL, V126, P353, DOI 10.1085/jgp.200509312	37	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5872	10.1371/journal.pone.0005872	http://dx.doi.org/10.1371/journal.pone.0005872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19516902	Green Published, gold, Green Submitted			2022-12-27	WOS:000266873100005
J	Hooshmand, MJ; Sontag, CJ; Uchida, N; Tamaki, S; Anderson, AJ; Cummings, BJ				Hooshmand, Mitra J.; Sontag, Christopher J.; Uchida, Nobuko; Tamaki, Stan; Anderson, Aileen J.; Cummings, Brian J.			Analysis of Host-Mediated Repair Mechanisms after Human CNS-Stem Cell Transplantation for Spinal Cord Injury: Correlation of Engraftment with Recovery	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; OLFACTORY ENSHEATHING CELLS; PROMOTE LOCOMOTOR RECOVERY; FUNCTIONAL RECOVERY; DELAYED TRANSPLANTATION; CORTICOSPINAL TRACT; AXON GROWTH; PRECURSOR CELLS; GRAFT-SURVIVAL; CONTUSION	Background: Human central nervous system-stem cells grown as neurospheres (hCNS-SCns) self-renew, are multipotent, and have potential therapeutic applications following trauma to the spinal cord. We have previously shown locomotor recovery in immunodeficient mice that received a moderate contusion spinal cord injury (SCI) and hCNS-SCns transplantation 9 days post-injury (dpi). Engrafted hCNS-SCns exhibited terminal differentiation to myelinating oligodendrocytes and synapse-forming neurons. Further, selective ablation of human cells using Diphtheria toxin (DT) abolished locomotor recovery in this paradigm, suggesting integration of human cells within the mouse host as a possible mechanism for the locomotor improvement. However, the hypothesis that hCNS-SCns could alter the host microenvironment as an additional or alternative mechanism of recovery remained unexplored; we tested that hypothesis in the present study. Methods and Findings: Stereological quantification of human cells using a human-specific cytoplasmic marker demonstrated successful cell engraftment, survival, migration and limited proliferation in all hCNS-SCns transplanted animals. DT administration at 16 weeks post-transplant ablated 80.5% of hCNS-SCns. Stereological quantification for lesion volume, tissue sparing, descending serotonergic host fiber sprouting, chondroitin sulfate proteoglycan deposition, glial scarring, and angiogenesis demonstrated no evidence of host modification within the mouse spinal cord as a result of hCNS-SCns transplantation. Biochemical analyses supplemented stereological data supporting the absence of neural stem-cell mediated host repair. However, linear regression analysis of the number of engrafted hCNS-SCns vs. the number of errors on a horizontal ladder beam task revealed a strong correlation between these variables (r = -0.78, p<0.05), suggesting that survival and engraftment were directly related to a quantitative measure of recovery. Conclusions: Altogether, the data suggest that the locomotor improvements associated with hCNS-SCns transplantation were not due to modifications within the host microenvironment, supporting the hypothesis that human cell integration within the host circuitry mediates functional recovery following a 9 day delayed transplant.			Hooshmand, MJ (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	cummings@uci.edu	Anderson, Aileen J/H-5926-2012; Cummings, Brian J/C-9180-2012; Waldvogel, Henry/D-6691-2012	Cummings, Brian J/0000-0003-3628-5290; Waldvogel, Henry/0000-0003-2165-8568	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS046975, R01NS049885] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Asher R A, 2001, Prog Brain Res, V132, P611; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belegu V, 2007, NEUROSURG CLIN N AM, V18, P143, DOI 10.1016/j.nec.2006.10.012; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Chen ZJ, 2002, MOL CELL NEUROSCI, V20, P125, DOI 10.1006/mcne.2002.1102; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Cummings BJ, 2007, BEHAV BRAIN RES, V177, P232, DOI 10.1016/j.bbr.2006.11.042; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davis LE, 2006, LANCET NEUROL, V5, P7, DOI 10.1016/S1474-4422(05)70259-3; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Glaser J, 2004, J NEUROSCI RES, V77, P701, DOI 10.1002/jnr.20204; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hasegawa K, 2005, EXP NEUROL, V193, P394, DOI 10.1016/j.expneurol.2004.12.024; Heine W, 2004, EXP NEUROL, V189, P231, DOI 10.1016/j.expneurol.2004.06.014; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Ikegami T, 2005, EUR J NEUROSCI, V22, P3036, DOI 10.1111/j.1460-9568.2005.04492.x; Inman DM, 2003, J NEUROTRAUM, V20, P33, DOI 10.1089/08977150360517164; Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Jelsing J, 2005, NEUROIMAGE, V26, P57, DOI 10.1016/j.neuroimage.2005.01.005; Joelving FC, 2006, HIPPOCAMPUS, V16, P826, DOI 10.1002/hipo.20212; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kim BG, 2006, J COMP NEUROL, V497, P182, DOI 10.1002/cne.20980; Kim D, 2001, EXP NEUROL, V169, P496, DOI 10.1006/exnr.2001.7660; Kim DH, 1999, J NEUROSCI, V19, P6213, DOI 10.1523/JNEUROSCI.19-14-06213.1999; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Liu Y, 1999, J NEUROSCI, V19, P4370; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Marsala M, 2004, EUR J NEUROSCI, V20, P2401, DOI 10.1111/j.1460-9568.2004.03702.x; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; MURPHY KR, STAT POWER ANAL SIMP; Murray M, 2002, BRAIN RES REV, V40, P292, DOI 10.1016/S0165-0173(02)00211-4; NGUYEN HX, 2008, QUANTATIVE ANA UNPUB; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Nothias JM, 2005, NEUROREHAB NEURAL RE, V19, P296, DOI 10.1177/1545968305281209; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Palmer TD, 1999, J NEUROSCI, V19, P8487; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; PAPPENHEIMER AM, 1982, J INFECT DIS, V145, P94, DOI 10.1093/infdis/145.1.94; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2006, NEUROL RES, V28, P488, DOI 10.1179/016164106X115134; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Sasaki M, 2006, GLIA, V53, P352, DOI 10.1002/glia.20285; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Serkova N, 2004, MOL INTERV, V4, P97, DOI 10.1124/mi.4.2.7; Shi EY, 2007, J THORAC CARDIOV SUR, V133, P942, DOI 10.1016/j.jtcvs.2006.12.017; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Siegenthaler MM, 2007, J NEUROTRAUM, V24, P1631, DOI 10.1089/neu.2007.0302; Stokes BT, 2002, SPINAL CORD, V40, P101, DOI 10.1038/sj.sc.3101254; Swanger SA, 2005, CELL TRANSPLANT, V14, P775, DOI 10.3727/000000005783982594; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; von Euler M, 1998, J COMP NEUROL, V400, P441; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wijdicks EFM, 2001, LIVER TRANSPLANT, V7, P937, DOI 10.1053/jlts.2001.27475; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Young W, 2002, PROG BRAIN RES, V137, P231; Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	105	89	91	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5871	10.1371/journal.pone.0005871	http://dx.doi.org/10.1371/journal.pone.0005871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517014	Green Published, gold			2022-12-27	WOS:000266873100004
J	Khoshnan, A; Ko, J; Tescu, S; Brundin, P; Patterson, PH				Khoshnan, Ali; Ko, Jan; Tescu, Simona; Brundin, Patrick; Patterson, Paul H.			IKK alpha and IKK beta Regulation of DNA Damage-Induced Cleavage of Huntingtin	PLOS ONE			English	Article							NF-KAPPA-B; MUTANT HUNTINGTIN; WILD-TYPE; MOUSE MODEL; ACTIVATION; DISEASE; KINASE; PHOSPHORYLATION; INHIBITION; SURVIVAL	Background: Proteolysis of huntingtin (Htt) plays a key role in the pathogenesis of Huntington's disease (HD). However, the environmental cues and signaling pathways that regulate Htt proteolysis are poorly understood. One stimulus may be the DNA damage that accumulates in neurons over time, and the subsequent activation of signaling pathways such as those regulated by I kappa B kinase (IKK), which can influence neurodegeneration in HD. Methodology/Principal Findings: We asked whether DNA damage induces the proteolysis of Htt and if activation of IKK plays a role. We report that treatment of neurons with the DNA damaging agent etoposide or gamma-irradiation promotes cleavage of wild type (WT) and mutant Htt, generating N-terminal fragments of 80-90 kDa. This event requires IKK beta and is suppressed by IKK alpha. Elevated levels of IKK alpha, or inhibition of IKK beta expression by a specific small hairpin RNA (shRNA) or its activity by sodium salicylate, prevents Htt proteolysis and increases neuronal resistance to DNA damage. Moreover, IKK beta phosphorylates the anti-apoptotic protein Bcl-xL, a modification known to reduce Bcl-xL levels, and activates caspases that can cleave Htt. When IKK beta expression is blocked, etoposide treatment does not decrease Bcl-xL and activation of caspases is diminished. Similar to silencing of IKK beta, increasing the level of Bcl-xL in neurons prevents etoposide-induced caspase activation and Htt proteolysis. Conclusions/Significance: These results indicate that DNA damage triggers cleavage of Htt and identify IKK beta as a prominent regulator. Moreover, IKK beta-dependent reduction of Bcl-xL is important in this process. Thus, inhibition of IKK beta may promote neuronal survival in HD as well as other DNA damage-induced neurodegenerative disorders.	[Khoshnan, Ali; Ko, Jan; Tescu, Simona; Patterson, Paul H.] CALTECH, Biol Div 216 76, Pasadena, CA 91125 USA; [Brundin, Patrick] Wallenberg Neurosci Ctr, Neuronal Survival Unit, Dept Expt Med Sci, Lund, Sweden	California Institute of Technology	Khoshnan, A (corresponding author), CALTECH, Biol Div 216 76, Pasadena, CA 91125 USA.	khoshnan@caltech.edu			NINDS [5RO1NS55298]; Hereditary Disease Foundation (HDF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055298] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hereditary Disease Foundation (HDF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NINDS 5RO1NS55298 and Hereditary Disease Foundation (HDF)(www.hdfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Cittelly DM, 2007, J NEUROSCI RES, V85, P1894, DOI 10.1002/jnr.21313; De Luca G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000266; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Enokido Y, 2008, BIOCHEM BIOPH RES CO, V376, P128, DOI 10.1016/j.bbrc.2008.08.108; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Jonas E, 2006, MOL INTERV, V6, P208, DOI 10.1124/mi.6.4.7; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Kuo LJ, 2008, IN VIVO, V22, P305; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; Lee ST, 2006, BRAIN RES, V1118, P199, DOI 10.1016/j.brainres.2006.08.035; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Politis M, 2008, BRAIN, V131, P2860, DOI 10.1093/brain/awn244; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	46	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5768	10.1371/journal.pone.0005768	http://dx.doi.org/10.1371/journal.pone.0005768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19488402	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000266587400011
J	Randhawa, HS; Mutti, JS; Kidwell, K; Morris, CF; Chen, XM; Gill, KS				Randhawa, Harpinder S.; Mutti, Jasdeep S.; Kidwell, Kim; Morris, Craig F.; Chen, Xianming; Gill, Kulvinder S.			Rapid and Targeted Introgression of Genes into Popular Wheat Cultivars Using Marker-Assisted Background Selection	PLOS ONE			English	Article							RUST PUCCINIA-STRIIFORMIS; RESISTANCE; SEGMENTS; SIZE	A marker-assisted background selection (MABS)-based gene introgression approach in wheat (Triticum aestivum L.) was optimized, where 97% or more of a recurrent parent genome (RPG) can be recovered in just two backcross (BC) generations. A four-step MABS method was developed based on 'Plabsim' computer simulations and wheat genome structure information. During empirical optimization of this method, double recombinants around the target gene were selected in a step-wise fashion during the two BC cycles followed by selection for recurrent parent genotype on non-carrier chromosomes. The average spacing between carrier chromosome markers was <4 cM. For non-carrier chromosome markers that flanked each of the 48 wheat gene-rich regions, this distance was similar to 12 cM. Employed to introgress seedling stripe rust (Puccinia striiformis f. sp. tritici) resistance gene Yr15 into the spring wheat cultivar 'Zak', marker analysis of 2,187 backcross-derived progeny resulted in the recovery of a BC2F2:3 plant with 97% of the recurrent parent genome. In contrast, only 82% of the recurrent parent genome was recovered in phenotypically selected BC4F7 plants developed without MABS. Field evaluation results from 17 locations indicated that the MABS-derived line was either equal or superior to the recurrent parent for the tested agronomic characteristics. Based on these results, MABS is recommended as a strategy for rapidly introgressing a targeted gene into a wheat genotype in just two backcross generations while recovering 97% or more of the recurrent parent genotype.			Randhawa, HS (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ksgill@wsu.edu	Randhawa, Harpinder/AAQ-7207-2021	Morris, Craig/0000-0003-0311-2449				Allard R.W., 1999, PRINCIPLES PLANT BRE; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P1428, DOI 10.1094/Phyto-82-1428; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Frisch M, 2000, J HERED, V91, P86, DOI 10.1093/jhered/91.1.86; Frisch M, 1999, CROP SCI, V39, P1295, DOI 10.2135/cropsci1999.3951295x; GRAMA A, 1974, EUPHYTICA, V23, P393, DOI 10.1007/BF00035884; Hospital F, 2001, GENETICS, V158, P1363; Hospital F, 2002, J HERED, V93, P383, DOI 10.1093/jhered/93.5.383; Kidwell KK, 2002, CROP SCI, V42, P661, DOI 10.2135/cropsci2002.661a; Prigge V, 2008, THEOR APPL GENET, V116, P739, DOI 10.1007/s00122-007-0707-x; RAGOT M, 1995, COLLOQ INRA, P45; Sidhu D., 2004, Plant Cell, Tissue and Organ Culture, V79, P257, DOI 10.1007/s11240-005-2487-9; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; YOUNG ND, 1989, THEOR APPL GENET, V77, P353, DOI 10.1007/BF00305828	16	56	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5752	10.1371/journal.pone.0005752	http://dx.doi.org/10.1371/journal.pone.0005752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484121	gold, Green Published, Green Submitted			2022-12-27	WOS:000266528200005
J	Goldhaber-Fiebert, JD; Denny, LA; De Souza, M; Kuhn, L; Goldie, SJ				Goldhaber-Fiebert, Jeremy D.; Denny, Lynette A.; De Souza, Michelle; Kuhn, Louise; Goldie, Sue J.			Program Spending to Increase Adherence: South African Cervical Cancer Screening	PLOS ONE			English	Article							LOW-RESOURCE SETTINGS; INTERVENTIONS; PREVENTION	Background: Adherence is crucial for public health program effectiveness, though the benefits of increasing adherence must ultimately be weighed against the associated costs. We sought to determine the relationship between investment in community health worker (CHW) home visits and increased attendance at cervical cancer screening appointments in Cape Town, South Africa. Methodology/Principal Findings: We conducted an observational study of 5,258 CHW home visits made in 2003-4 as part of a community-based screening program. We estimated the functional relationship between spending on these visits and increased appointment attendance (adherence). Increased adherence was noted after each subsequent CHW visit. The costs of making the CHW visits was based on resource use including both personnel time and vehicle-related expenses valued in 2004 Rand. The CHW program cost R194,018, with 1,576 additional appointments attended. Adherence increased from 74% to 90%; 55% to 87%; 48% to 77%; and 56% to 80% for 6-, 12-, 24-, and 36-month appointments. Average per-woman costs increased by R14-R47. The majority of this increase occurred with the first 2 CHW visits (90%, 83%, 74%, and 77%; additional cost: R12-R26). Conclusions/Significance: We found that study data can be used for program planning, identifying spending levels that achieve adherence targets given budgetary constraints. The results, derived from a single disease program, are retrospective, and should be prospectively replicated.			Goldhaber-Fiebert, JD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Program Hlth Decis Sci, Boston, MA 02115 USA.	jeremygf@stanford.edu		Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	NATIONAL CANCER INSTITUTE [R01CA093435] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA93435, R01 CA093435] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Cleemput I, 2002, LANCET, V359, P2129, DOI 10.1016/S0140-6736(02)09114-6; Denny L, 2006, INT J GYNECOL OBSTET, V95, pS211, DOI 10.1016/S0020-7292(06)60036-2; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Denny L, 2006, VACCINE S3, V24, pS3/71; *DEP SOC SERV POV, 2005, POP REG UPD KHAYEL 2; Department of Health Republic of South Africa, NAT GUID CERV CANC S; Goldhaber-Fiebert Jeremy D, 2005, Cost Eff Resour Alloc, V3, P11, DOI 10.1186/1478-7547-3-11; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Kitchener HC, 2006, VACCINE S3, V24, pS3/63; KOUTSKY LA, 2006, VACCINE S3, V24; Liu Q, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006594.pub2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, VACCINE S3, V24, pS3/11; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; SHACKLETON SJ, 2007, RAPID ASSESSMENT CEL; Stirratt Michael J, 2008, Curr HIV/AIDS Rep, V5, P186, DOI 10.1007/s11904-008-0027-z; van Dulmen S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-55; Volmink J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000010; World Bank, 2005, WORLD DEV IND; Yabroff KR, 2000, PREV MED, V31, P429, DOI 10.1006/pmed.2000.0722; 2001, CENSUS 2001; [No title captured]; 2008, BICYCLILNG BIKE TOWN	28	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5691	10.1371/journal.pone.0005691	http://dx.doi.org/10.1371/journal.pone.0005691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492097	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415100005
J	Di Giuseppe, M; Gambelli, F; Hoyle, GW; Lungarella, G; Studer, SM; Richards, T; Yousem, S; McCurry, K; Dauber, J; Kaminski, N; Leikauf, G; Ortiz, LA				Di Giuseppe, Michelangelo; Gambelli, Federica; Hoyle, Gary W.; Lungarella, Giuseppe; Studer, Sean M.; Richards, Thomas; Yousem, Sam; McCurry, Ken; Dauber, James; Kaminski, Naftali; Leikauf, George; Ortiz, Luis A.			Systemic Inhibition of NF-kappa B Activation Protects from Silicosis	PLOS ONE			English	Article								Background: Silicosis is a complex lung disease for which no successful treatment is available and therefore lung transplantation is a potential alternative. Tumor necrosis factor alpha (TNF alpha) plays a central role in the pathogenesis of silicosis. TNF alpha signaling is mediated by the transcription factor, Nuclear Factor (NF)-kappa B, which regulates genes controlling several physiological processes including the innate immune responses, cell death, and inflammation. Therefore, inhibition of NF-kappa B activation represents a potential therapeutic strategy for silicosis. Methods/Findings: In the present work we evaluated the lung transplant database (May 1986-July 2007) at the University of Pittsburgh to study the efficacy of lung transplantation in patients with silicosis (n = 11). We contrasted the overall survival and rate of graft rejection in these patients to that of patients with idiopathic pulmonary fibrosis (IPF, n = 79) that was selected as a control group because survival benefit of lung transplantation has been identified for these patients. At the time of lung transplantation, we found the lungs of silica-exposed subjects to contain multiple foci of inflammatory cells and silicotic nodules with proximal TNF alpha expressing macrophage and NF-kappa B activation in epithelial cells. Patients with silicosis had poor survival (median survival 2.4 yr; confidence interval (CI): 0.16-7.88 yr) compared to IPF patients (5.3 yr; CI: 2.8-15 yr; p = 0.07), and experienced early rejection of their lung grafts (0.9 yr; CI: 0.22-0.9 yr) following lung transplantation (2.4 yr; CI: 1.5-3.6 yr; p<0.05). Using a mouse experimental model in which the endotracheal instillation of silica reproduces the silica-induced lung injury observed in humans we found that systemic inhibition of NF-kappa B activation with a pharmacologic inhibitor (BAY 11-7085) of IkB alpha phosphorylation decreased silica-induced inflammation and collagen deposition. In contrast, transgenic mice expressing a dominant negative IkB alpha mutant protein under the control of epithelial cell specific promoters demonstrate enhanced apoptosis and collagen deposition in their lungs in response to silica. Conclusions: Although limited by its size, our data support that patients with silicosis appear to have poor outcome following lung transplantation. Experimental data indicate that while the systemic inhibition of NF-kappa B protects from silica-induced lung injury, epithelial cell specific NF-kappa B inhibition appears to aggravate the outcome of experimental silicosis.			Di Giuseppe, M (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, Div Occupat & Environm Med, Pittsburgh, PA 15260 USA.	lao1@pitt.edu	ortiz, luis a/H-9851-2013	ortiz, luis a/0000-0003-4510-7066; Kaminski, Naftali/0000-0001-5917-4601; LUNGARELLA, Giuseppe/0000-0002-3796-7317; Leikauf, George/0000-0002-4514-7060	NHLBI NIH HHS [HL073745, R01 HL085655, R01 HL077763, R01 HL073745, HL071953, R01 HL065612, R01 HL071953] Funding Source: Medline; NIEHS NIH HHS [ES10859, R01 ES010859, U01 ES015675, R01 ES010562] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085655, R01HL071953, R01HL073745, R01HL077763, R01HL065612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010859, U01ES015675, R01ES010562] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], 2005, MORBIDITY MORTALITY, V54; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Beckett W, 1997, AM J RESP CRIT CARE, V155, P761, DOI 10.1164/ajrccm.155.2.9032226; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; Borges VM, 2001, J EXP MED, V194, P155, DOI 10.1084/jem.194.2.155; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Burton CM, 2005, J HEART LUNG TRANSPL, V24, P1834, DOI 10.1016/j.healun.2005.03.001; Cavarra E, 2001, EUR RESPIR J, V17, P474, DOI 10.1183/09031936.01.17304740; Chen F, 2002, MOL CELL BIOCHEM, V234, P169, DOI 10.1023/A:1015915000265; Cherla RP, 2001, J IMMUNOL, V166, P3067, DOI 10.4049/jimmunol.166.5.3067; Corbett EL, 2002, AM J RESP CRIT CARE, V165, P690, DOI 10.1164/ajrccm.165.5.2010050; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; FULOP GM, 1983, CELL IMMUNOL, V75, P91, DOI 10.1016/0008-8749(83)90308-8; Gambelli F, 2004, J BIOL CHEM, V279, P2020, DOI 10.1074/jbc.M309763200; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Goodwin SS, 2003, AM J IND MED, V44, P304, DOI 10.1002/ajim.10260; Gozal E, 2002, AM J RESP CELL MOL, V27, P91, DOI 10.1165/ajrcmb.27.1.4790; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoyle GW, 1998, AM J RESP CELL MOL, V18, P149, DOI 10.1165/ajrcmb.18.2.2803m; Hubbard AK, 2002, AM J PHYSIOL-LUNG C, V282, pL968, DOI 10.1152/ajplung.00327.2001; Kang JL, 2000, TOXICOL APPL PHARM, V169, P59, DOI 10.1006/taap.2000.9039; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Langley RJ, 2004, AM J RESP CELL MOL, V30, P823, DOI 10.1165/rcmb.2003-0284OC; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Ortiz LA, 1999, AM J RESP CELL MOL, V20, P825, DOI 10.1165/ajrcmb.20.4.3193; Ortiz LA, 2001, AM J RESP CRIT CARE, V163, P244, DOI 10.1164/ajrccm.163.1.2002123; OSHA, 2003, FED REG, V68, P30583; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; PIGUET PF, 1994, EUR RESPIR J, V7, P515, DOI 10.1183/09031936.94.07030515; PIGUET PF, 1990, NATURE, V344, P245, DOI 10.1038/344245a0; Porter DW, 2004, TOXICOL SCI, V79, P370, DOI 10.1093/toxsci/kfh110; Porter DW, 2002, INHAL TOXICOL, V14, P349, DOI 10.1080/08958370252870998; RICH IN, 1980, BLUT, V40, P297; Rosenman KD, 2003, AM J IND MED, V44, P141, DOI 10.1002/ajim.10243; Sacks M, 1998, BIOCHEM BIOPH RES CO, V253, P181, DOI 10.1006/bbrc.1998.9763; Schins RPF, 2000, TOXICOL APPL PHARM, V167, P107, DOI 10.1006/taap.2000.8982; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; THALBUT G, 2003, J THORACIC CARDIOVAS, V126, P469; VERMEIRE P, 1972, AM REV RESPIR DIS, V106, P515, DOI 10.1164/arrd.1972.106.4.515; Warshamana GS, 2001, EXP MOL PATHOL, V71, P13, DOI 10.1006/exmp.2001.2376; *WHO, 2000, 238 WHO; Yassin A, 2005, ENVIRON HEALTH PERSP, V113, P255, DOI 10.1289/ehp.7384; Yatera K, 2001, ENVIRON HEALTH PERSP, V109, P795, DOI 10.2307/3454821	50	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5689	10.1371/journal.pone.0005689	http://dx.doi.org/10.1371/journal.pone.0005689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479048	Green Published, Green Accepted, gold			2022-12-27	WOS:000266331700016
J	Tsibris, AMN; Korber, B; Arnaout, R; Russ, C; Lo, CC; Leitner, T; Gaschen, B; Theiler, J; Paredes, R; Su, ZH; Hughes, MD; Gulick, RM; Greaves, W; Coakley, E; Flexner, C; Nusbaum, C; Kuritzkes, DR				Tsibris, Athe M. N.; Korber, Bette; Arnaout, Ramy; Russ, Carsten; Lo, Chien-Chi; Leitner, Thomas; Gaschen, Brian; Theiler, James; Paredes, Roger; Su, Zhaohui; Hughes, Michael D.; Gulick, Roy M.; Greaves, Wayne; Coakley, Eoin; Flexner, Charles; Nusbaum, Chad; Kuritzkes, Daniel R.			Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SYNCYTIUM-INDUCING PHENOTYPE; V3 LOOP; TYPE-1; CORECEPTOR; PROGRESSION; VICRIVIROC; RESISTANCE; MARAVIROC; DISEASE	High-throughput sequencing platforms provide an approach for detecting rare HIV-1 variants and documenting more fully quasispecies diversity. We applied this technology to the V3 loop-coding region of env in samples collected from 4 chronically HIV-infected subjects in whom CCR5 antagonist (vicriviroc [VVC]) therapy failed. Between 25,000-140,000 amplified sequences were obtained per sample. Profound baseline V3 loop sequence heterogeneity existed; predicted CXCR4-using populations were identified in a largely CCR5-using population. The V3 loop forms associated with subsequent virologic failure, either through CXCR4 use or the emergence of high-level VVC resistance, were present as minor variants at 0.8-2.8% of baseline samples. Extreme, rapid shifts in population frequencies toward these forms occurred, and deep sequencing provided a detailed view of the rapid evolutionary impact of VVC selection. Greater V3 diversity was observed post-selection. This previously unreported degree of V3 loop sequence diversity has implications for viral pathogenesis, vaccine design, and the optimal use of HIV-1 CCR5 antagonists.			Tsibris, AMN (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	dkuritzkes@partners.org	Su, Zhaohui/HIK-0448-2022	Su, Zhaohui/0000-0003-2005-9504; Korber, Bette/0000-0002-2026-5757	NCRR NIH HHS [K24 RR016482] Funding Source: Medline; NIAID NIH HHS [T32 AI007387, K08 AI081547, U01 AI069472, R37 AI553537, U01 AI067854, P30 AI060354] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR016482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, K08AI081547, U01AI069472, P30AI060354, T32AI007387] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; BROCKMAN W, 2008, GENOME RES; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gulick RM, 2007, J INFECT DIS, V196, P304, DOI 10.1086/518797; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Low AJ, 2007, AIDS, V21, pF19, DOI 10.1097/QAD.0b013e3282ef81ea; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Ribeiro RM, 2000, P NATL ACAD SCI USA, V97, P7681, DOI 10.1073/pnas.97.14.7681; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tsibris AMN, 2008, J VIROL, V82, P8210, DOI 10.1128/JVI.00444-08; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; WOOD N, 2008, PLOS COMPUT IN PRESS	32	185	189	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5683	10.1371/journal.pone.0005683	http://dx.doi.org/10.1371/journal.pone.0005683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479085	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331700011
J	Morrhaye, G; Kermani, H; Legros, JJ; Baron, F; Beguin, Y; Moutschen, M; Cheynier, R; Martens, HJ; Geenen, V				Morrhaye, Gabriel; Kermani, Hamid; Legros, Jean-Jacques; Baron, Frederic; Beguin, Yves; Moutschen, Michel; Cheynier, Remi; Martens, Henri J.; Geenen, Vincent			Impact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients	PLOS ONE			English	Article								Background: Despite age-related adipose involution, T cell generation in the thymus (thymopoiesis) is maintained beyond puberty in adults. In rodents, growth hormone (GH), insulin-like growth factor-1 (IGF-1), and GH secretagogues reverse age-related changes in thymus cytoarchitecture and increase thymopoiesis. GH administration also enhances thymic mass and function in HIV-infected patients. Until now, thymic function has not been investigated in adult GH deficiency (AGHD). The objective of this clinical study was to evaluate thymic function in AGHD, as well as the repercussion upon thymopoiesis of GH treatment for restoration of GH/IGF-1 physiological levels. Methodology/Principal Findings: Twenty-two patients with documented AGHD were enrolled in this study. The following parameters were measured: plasma IGF-1 concentrations, signal-joint T-cell receptor excision circle (sjTREC) frequency, and sj/beta TREC ratio. Analyses were performed at three time points: firstly on GH treatment at maintenance dose, secondly one month after GH withdrawal, and thirdly one month after GH resumption. After 1-month interruption of GH treatment, both plasma IGF-1 concentrations and sjTREC frequency were decreased (p<0.001). Decreases in IGF-1 and sjTREC levels were correlated (r = 0.61, p<0.01). There was also a decrease in intrathymic T cell proliferation as indicated by the reduced sj/beta TREC ratio (p<0.01). One month after reintroduction of GH treatment, IGF-1 concentration and sjTREC frequency regained a level equivalent to the one before GH withdrawal. The sj/beta TREC ratio also increased with GH resumption, but did not return to the level measured before GH withdrawal. Conclusions: In patients with AGHD under GH treatment, GH withdrawal decreases thymic T cell output, as well as intrathymic T cell proliferation. These parameters of thymus function are completely or partially restored one month after GH resumption. These data indicate that the functional integrity of the somatotrope GH/IGF-1 axis is important for the maintenance of a normal thymus function in human adults. Trial Registration: ClinicalTrials.gov NTC00601419			Morrhaye, G (corresponding author), Univ Liege, Ctr Immunol, Lab Immunoendocrinol, Inst Pathol, CHU-B23, Liege, Belgium.	hmartens@ulg.ac.be	Cheynier, Remi/E-9921-2010	Cheynier, Remi/0000-0003-1146-660X; Geenen, Vincent/0000-0002-8733-7284; Martens, Henri/0000-0003-4713-8982; Moutschen, Michel/0000-0002-6405-1785				ARKINS S, 1993, ENDOCRINOLOGY, V133, P2334, DOI 10.1210/en.133.5.2334; BINZ K, 1990, P NATL ACAD SCI USA, V87, P3690, DOI 10.1073/pnas.87.10.3690; Castermans E, 2008, HAEMATOLOGICA, V93, P240, DOI 10.3324/haematol.11708; Chu YW, 2008, BLOOD, V112, P2836, DOI 10.1182/blood-2008-04-149435; Clark R, 1997, ENDOCR REV, V18, P157, DOI 10.1210/er.18.2.157; Coelho VDM, 2002, NEUROENDOCRINOLOGY, V75, P139, DOI 10.1159/000048230; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Dorshkind K, 2000, ENDOCR REV, V21, P292, DOI 10.1210/er.21.3.292; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dulude G, 2008, J IMMUNOL, V181, P7818, DOI 10.4049/jimmunol.181.11.7818; Foster MP, 2000, CLIN IMMUNOL, V96, P140, DOI 10.1006/clim.2000.4889; Geenen V, 2003, J ENDOCRINOL, V176, P305, DOI 10.1677/joe.0.1760305; GEENEN V, 1993, THYMUS, V21, P115; Geenen V, 2004, IMMUNOENDOCRINOLOGY, P337; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hinton PS, 1998, AM J PHYSIOL-REG I, V274, pR912, DOI 10.1152/ajpregu.1998.274.4.R912; Kecha O, 2000, ENDOCRINOLOGY, V141, P1209, DOI 10.1210/en.141.3.1209; Kecha O, 1999, J NEUROENDOCRINOL, V11, P435; KELLEY KW, 1986, P NATL ACAD SCI USA, V83, P5663, DOI 10.1073/pnas.83.15.5663; Kong FK, 2002, J IMMUNOL, V168, P6500, DOI 10.4049/jimmunol.168.12.6500; Kong FK, 1998, IMMUNITY, V8, P97, DOI 10.1016/S1074-7613(00)80462-8; KOOIJMAN R, 1995, J ENDOCRINOL, V147, P203, DOI 10.1677/joe.0.1470203; LEONARD WJ, 2003, FUNDAMENTAL IMMUNOLO, P701; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Montecino-Rodriguez E, 1998, ENDOCRINOLOGY, V139, P4120, DOI 10.1210/en.139.10.4120; MURPHY WJ, 1993, J EXP MED, V178, P231, DOI 10.1084/jem.178.1.231; Napolitano LA, 2002, AIDS, V16, P1103, DOI 10.1097/00002030-200205240-00003; Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830; PIERPAOLI W, 1968, J IMMUNOL, V101, P1036; Poulin JF, 1999, J EXP MED, V190, P479, DOI 10.1084/jem.190.4.479; Redelman D, 2008, CELL IMMUNOL, V252, P111, DOI 10.1016/j.cellimm.2007.12.003; Savino W, 2002, SCAND J IMMUNOL, V55, P442, DOI 10.1046/j.1365-3083.2002.01077.x; Savino W, 2000, ENDOCR REV, V21, P412, DOI 10.1210/er.21.4.412; Smith PE, 1930, ANAT REC, V47, P119, DOI 10.1002/ar.1090470110; Sneppen SB, 2002, CLIN ENDOCRINOL, V57, P787, DOI 10.1046/j.1365-2265.2002.01670.x; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; TAUB DD, 1994, J CLIN INVEST, V94, P293, DOI 10.1172/JCI117320; van den Dool C, 2006, J IMMUNOL, V177, P4391, DOI 10.4049/jimmunol.177.7.4391	41	39	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5668	10.1371/journal.pone.0005668	http://dx.doi.org/10.1371/journal.pone.0005668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19479077	Green Published, gold			2022-12-27	WOS:000266331200006
J	Uusitupa, M; Peltonen, M; Lindstrom, J; Aunola, S; Ilanne-Parikka, P; Keinanen-Kiukaanniemi, S; Valle, TT; Eriksson, JG; Tuomilehto, J				Uusitupa, Matti; Peltonen, Markku; Lindstrom, Jaana; Aunola, Sirkka; Ilanne-Parikka, Pirjo; Keinanen-Kiukaanniemi, Sirkka; Valle, Timo T.; Eriksson, Johan G.; Tuomilehto, Jaakko		Finnish Diabet Prevention Study	Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study-Secondary Analysis of the Randomized Trial	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; CORONARY-HEART-DISEASE; FOLLOW-UP; MELLITUS; VALIDITY; FINLAND; DIET; IGT	Background: The Finnish Diabetes Prevention Study (DPS) was a randomized controlled trial, which showed that it is possible to prevent type 2 diabetes by lifestyle changes. The aim of the present study was to examine whether the lifestyle intervention had an effect on the ten-year mortality and cardiovascular morbidity in the DPS participants originally randomized either into an intervention or control group. Furthermore, we compared these results with a population-based cohort comprising individuals of varying glucose tolerance states. Methods and Findings: Middle-aged, overweight people with IGT (n=522) were randomized into intensive intervention (including physical activity, weight reduction and dietary counseling), or control "mini-intervention" group. Median length of the intervention period was 4 years and the mean follow-up was 10.6 years. The population-based reference study cohort included 1881 individuals (1570 with normal glucose tolerance, 183 with IGT, 59 with screen-detected type 2 diabetes, 69 with previously known type 2 diabetes) with the mean follow-up of 13.8 years. Mortality and cardiovascular morbidity data were collected from the national Hospital Discharge Register and Causes of Death Register. Among the DPS participants who consented for register linkage (n=505), total mortality (2.2 vs. 3.8 per 1000 person years, hazard ratio HR=0.57, 95% CI 0.21-1.58) and cardiovascular morbidity (22.9 vs. 22.0 per 1000 person years, HR=1.04, 95% CI 0.72-1.51) did not differ significantly between the intervention and control groups. Compared with the population-based cohort with impaired glucose tolerance, adjusted HRs were 0.21 (95% CI 0.09-0.52) and 0.39 (95% CI 0.20-0.79) for total mortality, and 0.89 (95% CI 0.62-1.27) and 0.87 (0.60-1.27) for cardiovascular morbidity in the intervention and control groups of the DPS, respectively. The risk of death in DPS combined cohort was markedly lower than in FINRISK IGT cohort (adjusted HR 0.30, 95% CI 0.17-0.54), but there was no significant difference in the risk of CVD (adjusted HR 0.88, 95% CI 0.64-1.21). Conclusions: Lifestyle intervention among persons with IGT did not decrease cardiovascular morbidity during the first 10 years of follow-up. However, the statistical power may not be sufficient to detect small differences between the intervention and control groups. Low total mortality among participants of the DPS compared with individuals with IGT in the general population could be ascribed to a lower cardiovascular risk profile at baseline and regular follow-up.			Uusitupa, M (corresponding author), Univ Kuopio, Food & Hlth Res Ctr, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland.	Matti.Uusitupa@uku.fi	Peltonen, Markku/F-3037-2015; Uusitupa, Matti Ilmari Julius/AAX-4929-2020	Peltonen, Markku/0000-0002-3767-4223; Aunola, Sirkka/0000-0003-2681-1541; Lindstrom, Jaana/0000-0001-9255-020X				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 1997, DIABETIC MED, V14, pS25, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S25::AID-DIA441>3.3.CO;2-T; Ilanne-Parikka P, 2008, DIABETES CARE, V31, P805, DOI 10.2337/dc07-1117; Juutilainen A, 2005, DIABETES CARE, V28, P2901, DOI 10.2337/diacare.28.12.2901; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Mahonen M, 1999, J CLIN EPIDEMIOL, V52, P157, DOI 10.1016/S0895-4356(98)00145-0; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; StataCorp, 2005, STAT STAT SOFTW REL; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; UUSITUPA MIJ, 1993, DIABETOLOGIA, V36, P1175, DOI 10.1007/BF00401063; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; *WHO, 1985, TECHN REP SER, V727	26	141	144	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5656	10.1371/journal.pone.0005656	http://dx.doi.org/10.1371/journal.pone.0005656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19479072	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331000014
J	Dye, MWG; Hauser, PC; Bavelier, D				Dye, Matthew W. G.; Hauser, Peter C.; Bavelier, Daphne			Is Visual Selective Attention in Deaf Individuals Enhanced or Deficient? The Case of the Useful Field of View	PLOS ONE			English	Article							MOVEMENT DETECTION TASK; NORMAL-HEARING ADULTS; CONGENITALLY DEAF; SPATIAL-DISTRIBUTION; AUDITORY DEPRIVATION; SIGN-LANGUAGE; SEARCH; SPACE; AUDITION; PEOPLE	Background: Early deafness leads to enhanced attention in the visual periphery. Yet, whether this enhancement confers advantages in everyday life remains unknown, as deaf individuals have been shown to be more distracted by irrelevant information in the periphery than their hearing peers. Here, we show that, in a complex attentional task, a performance advantage results for deaf individuals. Methodology/Principal Findings: We employed the Useful Field of View (UFOV) which requires central target identification concurrent with peripheral target localization in the presence of distractors - a divided, selective attention task. First, the comparison of deaf and hearing adults with or without sign language skills establishes that deafness and not sign language use drives UFOV enhancement. Second, UFOV performance was enhanced in deaf children, but only after 11 years of age. Conclusions/Significance: This work demonstrates that, following early auditory deprivation, visual attention resources toward the periphery slowly get augmented to eventually result in a clear behavioral advantage by pre-adolescence on a selective visual attention task.			Dye, MWG (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	mdye@bcs.rochester.edu	Dye, Matthew William Geoffrey/AAW-1407-2020	Dye, Matthew/0000-0001-6260-641X; Bavelier, Daphne/0000-0002-5904-1240				BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bosworth RG, 2002, BRAIN COGNITION, V49, P170, DOI 10.1006/brcg.2001.1498; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; Chen Q, 2006, BRAIN RES, V1109, P117, DOI 10.1016/j.brainres.2006.06.043; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Dye M., 2008, DEAF COGNITION FDN O, P250, DOI [10.1093/acprof:oso/9780195368673.003.0009, DOI 10.1093/ACPROF:OSO/9780195368673.003.0009]; Dye MWG, 2007, NEUROPSYCHOLOGIA, V45, P1801, DOI 10.1016/j.neuropsychologia.2006.12.019; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; ENNS JT, 1989, CHILD DEV, V60, P1188, DOI 10.1111/j.1467-8624.1989.tb03549.x; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Forster S, 2007, PSYCHOL SCI, V18, P377, DOI 10.1111/j.1467-9280.2007.01908.x; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; LOKE WH, 1991, B PSYCHONOMIC SOC, V29, P437; Maurer D, 2007, DEVELOPMENTAL SCI, V10, P40, DOI 10.1111/j.1467-7687.2007.00562.x; Mitchell TV, 1996, J CLIN CHILD PSYCHOL, V25, P83, DOI 10.1207/s15374424jccp2501_10; Nava E, 2008, EXP BRAIN RES, V190, P179, DOI 10.1007/s00221-008-1459-9; NEVILLE HJ, 1987, BRAIN RES, V405, P253, DOI 10.1016/0006-8993(87)90295-2; NEVILLE HJ, 1987, BRAIN RES, V405, P284, DOI 10.1016/0006-8993(87)90297-6; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; NEVILLE HJ, 1983, BRAIN RES, V266, P127, DOI 10.1016/0006-8993(83)91314-8; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; QUITTNER AL, 1994, PSYCHOL SCI, V5, P347, DOI 10.1111/j.1467-9280.1994.tb00284.x; Rettenbach R, 1999, J COGNITIVE NEUROSCI, V11, P560, DOI 10.1162/089892999563616; Sladen DP, 2005, J SPEECH LANG HEAR R, V48, P1529, DOI 10.1044/1092-4388(2005/106); Smith LB, 1998, DEV PSYCHOL, V34, P840, DOI 10.1037/0012-1649.34.5.840; Stevens C, 2006, J COGNITIVE NEUROSCI, V18, P701, DOI 10.1162/jocn.2006.18.5.701; Stivalet P, 1998, COGNITIVE BRAIN RES, V6, P227, DOI 10.1016/S0926-6410(97)00026-8	32	105	110	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5640	10.1371/journal.pone.0005640	http://dx.doi.org/10.1371/journal.pone.0005640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448AY	19462009	Green Published, Green Submitted, gold			2022-12-27	WOS:000266234700025
J	Kumamoto, Y; Denda-Nagai, K; Aida, S; Higashi, N; Irimura, T				Kumamoto, Yosuke; Denda-Nagai, Kaori; Aida, Satoshi; Higashi, Nobuaki; Irimura, Tatsuro			MGL2(+) Dermal Dendritic Cells Are Sufficient to Initiate Contact Hypersensitivity In Vivo	PLOS ONE			English	Article								Background: Dendritic cells (DCs) are the most potent antigen-presenting cells in the mammalian immune system. In the skin, epidermal Langerhans cells (LCs) and dermal dendritic cells (DDCs) survey for invasive pathogens and present antigens to T cells after migration to the cutaneous lymph nodes (LNs). So far, functional and phenotypic differences between these two DC subsets remain unclear due to lack of markers to identify DDCs. Methodology/Principal Findings: In the present report, we demonstrated that macrophage galactose-type C-type lectin (MGL) 2 was exclusively expressed in the DDC subset in the skin-to-LN immune system. In the skin, MGL2 was expressed on the majority (about 88%) of MHCII(+)CD11c(+) cells in the dermis. In the cutaneous LN, MGL2 expression was restricted to B220(-)CD8 alpha(lo)CD11b(+)CD11c(+)MHCII(hi) tissue-derived DC. MGL2(+)DDC migrated from the dermis into the draining LNs within 24 h after skin sensitization with FITC. Distinct from LCs, MGL2(+)DDCs localized near the high endothelial venules in the outer T cell cortex. In FITC-induced contact hypersensitivity (CHS), adoptive transfer of FITC(+)MGL2(+)DDCs, but not FITC(+)MGL2(-)DCs into naive mice resulted in the induction of FITC-specific ear swelling, indicating that DDCs played a key role in initiation of immune responses in the skin. Conclusions/Significance: These results demonstrated the availability of MGL2 as a novel marker for DDCs and suggested the contribution of MGL2(+) DDCs for initiating CHS.			Kumamoto, Y (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	irimura@mol.f.u-tokyo.ac.jp		Kumamoto, Yosuke/0000-0001-9369-4934; Denda-Nagai, Kaori/0000-0001-8325-3289				Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bennett CL, 2005, J CELL BIOL, V169, P569, DOI 10.1083/jcb.200501071; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; BURSCH LS, 2007, J EXP MED; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; Douillard P, 2005, J INVEST DERMATOL, V125, P983, DOI 10.1111/j.0022-202X.2005.23951.x; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; GINHOUX F, 2007, J EXP MED; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Kimber I, 1998, CURR OPIN IMMUNOL, V10, P614, DOI 10.1016/S0952-7915(98)80078-2; KIMURA T, 1995, J BIOL CHEM, V270, P16056, DOI 10.1074/jbc.270.27.16056; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Leon B, 2008, BLOOD, V111, P3126, DOI 10.1182/blood-2007-07-100610; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Onami TM, 2002, MOL CELL BIOL, V22, P5173, DOI 10.1128/MCB.22.14.5173-5181.2002; POULIN LF, 2007, J EXP MED; Qu CF, 2004, J EXP MED, V200, P1231, DOI 10.1084/jem.20032152; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Sato K, 2005, BLOOD, V106, P207, DOI 10.1182/blood-2004-12-4943; Sato K, 2005, INT IMMUNOL, V17, P559, DOI 10.1093/intimm/dxh235; Sato K, 1998, J IMMUNOL, V161, P6835; SHELLEY WB, 1976, NATURE, V261, P46, DOI 10.1038/261046a0; SILBERBERGSINAKIN I, 1976, CELL IMMUNOL, V25, P137, DOI 10.1016/0008-8749(76)90105-2; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; TOEWS GB, 1980, J IMMUNOL, V124, P445; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2002, J IMMUNOL, V168, P782, DOI 10.4049/jimmunol.168.2.782; Vremec D, 1997, J IMMUNOL, V159, P565; WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110	55	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5619	10.1371/journal.pone.0005619	http://dx.doi.org/10.1371/journal.pone.0005619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440334	Green Published, Green Submitted, gold			2022-12-27	WOS:000266161200019
J	Zolopa, AR; Andersen, J; Komarow, L; Sanne, I; Sanchez, A; Hogg, E; Suckow, C; Powderly, W				Zolopa, Andrew R.; Andersen, Janet; Komarow, Lauren; Sanne, Ian; Sanchez, Alejandro; Hogg, Evelyn; Suckow, Carol; Powderly, William		ACTG A5164 Study Team	Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESTORATION DISEASE; RISK-FACTORS; LATE DIAGNOSIS; HIV-INFECTION; ERA; PREVALENCE; INDINAVIR; MORTALITY; ADULTS	Background: Optimal timing of ART initiation for individuals presenting with AIDS-related OIs has not been defined. Methods and Findings: A5164 was a randomized strategy trial of "early ART'' - given within 14 days of starting acute OI treatment versus "deferred ART'' - given after acute OI treatment is completed. Randomization was stratified by presenting OI and entry CD4 count. The primary week 48 endpoint was 3-level ordered categorical variable: 1. Death/AIDS progression; 2. No progression with incomplete viral suppression (ie HIV viral load (VL) >= 50 copies/ml); 3. No progression with optimal viral suppression (ie HIV VL,50 copies/ml). Secondary endpoints included: AIDS progression/death; plasma HIV RNA and CD4 responses and safety parameters including IRIS. 282 subjects were evaluable; 141 per arm. Entry OIs included Pneumocytis jirovecii pneumonia 63%, cryptococcal meningitis 12%, and bacterial infections 12%. The early and deferred arms started ART a median of 12 and 45 days after start of OI treatment, respectively. The difference in the primary endpoint did not reach statistical significance: AIDS progression/death was seen in 20 (14%) vs. 34 (24%); whereas no progression but with incomplete viral suppression was seen in 54 (38%) vs. 44 (31%); and no progression with optimal viral suppression in 67 (48%) vs 63 (45%) in the early vs. deferred arm, respectively (p = 0.22). However, the early ART arm had fewer AIDS progression/deaths (OR = 0.51; 95% CI = 0.27-0.94) and a longer time to AIDS progression/death (stratified HR = 0.53; 95% CI = 0.30-0.92). The early ART had shorter time to achieving a CD4 count above 50 cells/mL (p<0.001) and no increase in adverse events. Conclusions: Early ART resulted in less AIDS progression/death with no increase in adverse events or loss of virologic response compared to deferred ART. These results support the early initiation of ART in patients presenting with acute AIDS-related OIs, absent major contraindications. Trial Registration: ClinicalTrials.gov NCT00055120			Zolopa, AR (corresponding author), Stanford Univ, AIDS Clin Trials Unit, Stanford, CA 94305 USA.	azolopa@stanford.edu	Sanne, Ian/ABH-2231-2020	Powderly, William/0000-0001-7808-3086	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068634, UM1AI068636, UM1AI068634, U01AI038858, U01AI068636] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38858, AI68634, UM1 AI068634, UM1 AI068636, U01 AI038858, AI68636, U01 AI068636, U01 AI068634] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hirsch M, 1999, J INFECT DIS, V180, P659, DOI 10.1086/314948; Jevtovic D, 2005, HIV MED, V6, P140, DOI 10.1111/j.1468-1293.2005.00277.x; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Manabe YC, 2007, JAIDS-J ACQ IMM DEF, V46, P456, DOI 10.1097/QAI.0b013e3181594c8c; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Schwarcz S, 2006, JAIDS-J ACQ IMM DEF, V43, P491, DOI 10.1097/01.qai.0000243114.37035.de; Shelburne SA, 2006, J ANTIMICROB CHEMOTH, V57, P167, DOI 10.1093/jac/dki444; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Sterne JAC, 2007, JAIDS-J ACQ IMM DEF, V46, P607, DOI 10.1097/QAI.0b013e31815b7dba	18	341	355	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5575	10.1371/journal.pone.0005575	http://dx.doi.org/10.1371/journal.pone.0005575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440326	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107500006
J	Prieur, A; Nacerddine, K; van Lohuizen, M; Peeper, DS				Prieur, Alexandre; Nacerddine, Karim; van Lohuizen, Maarten; Peeper, Daniel S.			SUMOylation of DRIL1 Directs Its Transcriptional Activity Towards Leukocyte Lineage-Specific Genes	PLOS ONE			English	Article								DRIL1 is an ARID family transcription factor that can immortalize primary mouse fibroblasts, bypass RAS(V12)-induced cellular senescence and collaborate with RAS(V12) or MYC in mediating oncogenic transformation. It also activates immunoglobulin heavy chain transcription and engages in heterodimer formation with E2F to stimulate E2F-dependent transcription. Little, however, is known about the regulation of DRIL1 activity. Recently, DRIL1 was found to interact with the SUMO-conjugating enzyme Ubc9, but the functional relevance of this association has not been assessed. Here, we show that DRIL1 is sumoylated both in vitro and in vivo at lysine 398. Moreover, we provide evidence that PIASy functions as a specific SUMO E3-ligase for DRIL1 and promotes its sumoylation both in vitro and in vivo. Furthermore, consistent with the subnuclear localization of PIASy in the Matrix-Associated Region (MAR), SUMO-modified DRIL1 species are found exclusively in the MAR fraction. This post-translational modification interferes neither with the subcellular localization nor the DNA-binding activity of the protein. In contrast, DRIL1 sumoylation impairs its interaction with E2F1 in vitro and modifies its transcriptional activity in vivo, driving transcription of subset of genes regulating leukocyte fate. Taken together, these results identify sumoylation as a novel post-translational modification of DRIL1 that represents an important mechanism for targeting and modulating DRIL1 transcriptional activity.			Prieur, A (corresponding author), Inst Genom Fonct, Equipe Plasticite Genome & Vieillissement, Montpellier, France.	d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020					Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Callery EM, 2005, DEV BIOL, V278, P542, DOI 10.1016/j.ydbio.2004.11.017; Fukuyo Y, 2004, CELL DEATH DIFFER, V11, P747, DOI 10.1038/sj.cdd.4401412; Gao HW, 2002, J BIOL CHEM, V277, P38827, DOI 10.1074/jbc.M206224200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gregory SL, 1996, MOL CELL BIOL, V16, P792; Kim D, 2006, MOL CELL BIOL, V26, P2187, DOI 10.1128/MCB.26.6.2187-2201.2006; Kim D, 2007, J BIOL CHEM, V282, P15768, DOI 10.1074/jbc.M700397200; Kortschak RD, 1998, GENOMICS, V51, P288, DOI 10.1006/geno.1998.5259; Liu B, 2008, CURR OPIN CELL BIOL, V20, P288, DOI 10.1016/j.ceb.2008.03.014; Lopez-Soto A, 2006, J BIOL CHEM, V281, P30419, DOI 10.1074/jbc.M604868200; Ma KW, 2003, MOL CANCER RES, V1, P438; Nixon JC, 2004, J BIOL CHEM, V279, P52465, DOI 10.1074/jbc.M403028200; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schymeinsky J, 2007, THROMB HAEMOSTASIS, V98, P262, DOI 10.1160/TH07-02-0156; Shandala T, 2002, INT J DEV BIOL, V46, P423; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Suzuki M, 1998, ONCOGENE, V17, P853, DOI 10.1038/sj.onc.1202163; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; WEBB CF, 1991, MOL CELL BIOL, V11, P5206, DOI 10.1128/MCB.11.10.5206; Webb CF, 2000, J IMMUNOL, V165, P6956, DOI 10.4049/jimmunol.165.12.6956; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	29	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5542	10.1371/journal.pone.0005542	http://dx.doi.org/10.1371/journal.pone.0005542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436740	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107300008
J	Ben-Tzvi, O; Kiflawi, M; Polak, O; Abelson, A				Ben-Tzvi, Ofer; Kiflawi, Moshe; Polak, Omer; Abelson, Avigdor			The Effect of Adult Aggression on Habitat Selection by Settlers of Two Coral-Dwelling Damselfishes	PLOS ONE			English	Article								Coral-reef fishes experience a major challenge when facing settlement in a multi-threat environment, within which, using settlement cues, they need to select a suitable site. Studies in laboratories and artificial setups have shown that the presence of conspecific adults often serves as a positive settlement cue, whose value is explained by the increased survival of juveniles in an already proven fit environment. However, settlement in already inhabited corals may expose the recruits to adult aggression. Daily observations and manipulation experiments were used in the present study, which was conducted in the natural reef. We revealed differential strategies of settlers, which do not necessarily join conspecific adults. Dascyllus aruanus prefer to settle near (not with) their aggressive adults, and to join them only after gaining in size; whereas Dascyllus marginatus settlers in densely populated reefs settle independently of their adult distribution. Our results present different solutions to the challenges faced by fish recruits while selecting their microhabitat, and emphasize the complexity of habitat selection by the naive settlers. Although laboratory experiments are important to the understanding of fish habitat selection, further studies in natural habitats are essential in order to elucidate the actual patterns of settlement and habitat selection, which are crucial for the survival of coral-reef fish populations.			Ben-Tzvi, O (corresponding author), Interuniv Inst Marine Sci Eilat, Elat, Israel.	obentzvi@gmail.com	KIFLAWI, MOSHE/AAH-7991-2021	Kiflawi, Moshe/0000-0002-9705-6486				Almany GR, 2004, ECOLOGY, V85, P2872, DOI 10.1890/03-3166; Almany GR, 2003, ECOLOGY, V84, P1920, DOI 10.1890/0012-9658(2003)084[1920:PEICRF]2.0.CO;2; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Bednekoff PA, 1998, TRENDS ECOL EVOL, V13, P284, DOI 10.1016/S0169-5347(98)01327-5; Bednekoff PA, 2003, BEHAV PROCESS, V63, P135, DOI 10.1016/S0376-6357(03)00008-1; Ben-Tzvi O, 2008, J FISH BIOL, V73, P1005, DOI 10.1111/j.1095-8649.2008.02003.x; Ben-Tzvi O, 2007, LIMNOL OCEANOGR, V52, P2618, DOI 10.4319/lo.2007.52.6.2618; Bertram B.C.R., 1978, P64; BOOTH DJ, 1992, J EXP MAR BIOL ECOL, V155, P85, DOI 10.1016/0022-0981(92)90029-A; Booth DJ, 2004, ECOLOGY, V85, P2881, DOI 10.1890/03-0535; BOOTH DJ, 1995, ECOLOGY, V76, P91, DOI 10.2307/1940634; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; COATES D, 1980, J ANIM ECOL, V49, P335, DOI 10.2307/4292; COATES D, 1980, Z TIERPSYCHOL, V52, P347; COATES D, 1980, Z TIERPSYCHOL, V52, P355; Doherty Peter J., 2002, P327, DOI 10.1016/B978-012615185-5/50019-0; DUFOUR V, 1993, MAR ECOL PROG SER, V102, P143, DOI 10.3354/meps102143; ELLIOTT JK, 1995, MAR BIOL, V122, P377, DOI 10.1007/BF00350870; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; FORRESTER GE, 1990, ECOLOGY, V71, P1666, DOI 10.2307/1937576; FRICKE HW, 1974, NATURWISSENSCHAFTEN, V61, P367, DOI 10.1007/BF00600312; FRICKE HW, 1977, HELGOLAND WISS MEER, V30, P412, DOI 10.1007/BF02207851; FRICKE HW, 1980, ANIM BEHAV, V28, P561, DOI 10.1016/S0003-3472(80)80065-0; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Jones G.P., 1991, P294; Karplus I, 2006, MAR ECOL PROG SER, V319, P215, DOI 10.3354/meps319215; KATZIR G, 1981, ANIM BEHAV, V29, P835, DOI 10.1016/S0003-3472(81)80018-8; Lecchini D, 2007, J EXP MAR BIOL ECOL, V341, P85, DOI 10.1016/j.jembe.2006.10.006; Lecchini D, 2005, BEHAV ECOL SOCIOBIOL, V58, P18, DOI 10.1007/s00265-004-0905-3; Lecchini D, 2005, OECOLOGIA, V143, P326, DOI 10.1007/s00442-004-1805-y; McCormick MI, 1997, MAR ECOL PROG SER, V153, P247, DOI 10.3354/meps153247; Motro R, 2005, CORAL REEFS, V24, P95, DOI 10.1007/s00338-004-0451-5; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Myrberg Arthur A. Jr, 2002, P123, DOI 10.1016/B978-012615185-5/50009-8; Pulliam HR., 1984, BEHAVIOURAL ECOLOGY, P122; Sandin SA, 2005, ECOLOGY, V86, P1520, DOI 10.1890/03-0654; Shima JS, 2001, ECOLOGY, V82, P2190, DOI 10.2307/2680225; SHPIGEL M, 1986, ENVIRON BIOL FISH, V17, P253, DOI 10.1007/BF00001492; Sponaugle S, 1996, MAR FRESHWATER RES, V47, P433, DOI 10.1071/MF9960433; Stamps J, 2005, ECOLOGY, V86, P2860, DOI 10.1890/05-0290; SWEATMAN H, 1988, J EXP MAR BIOL ECOL, V124, P163, DOI 10.1016/0022-0981(88)90170-0; SWEATMAN HPA, 1983, MAR BIOL, V75, P225, DOI 10.1007/BF00406006; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; SWEATMAN HPA, 1985, 5TH P INT COR REEF C, V5, P367; White JW, 2007, ECOLOGY, V88, P3044, DOI 10.1890/06-1949.1; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z	48	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5511	10.1371/journal.pone.0005511	http://dx.doi.org/10.1371/journal.pone.0005511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436725	Green Published, Green Submitted, gold			2022-12-27	WOS:000266009900004
J	Sun, YR; Kong, WQ; Falk, A; Hu, J; Zhou, LF; Pollard, S; Smith, A				Sun, Yirui; Kong, Weiqing; Falk, Anna; Hu, Jin; Zhou, Liangfu; Pollard, Steve; Smith, Austin			CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent	PLOS ONE			English	Article								Background: CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the assumption that CD133 is expressed constitutively in neural precursor cells has not been examined. Methodology/Principal Findings: In this study, we demonstrate that CD133 and a second marker CD15 are expressed heterogeneously in uniformly undifferentiated human neural stem (NS) cell cultures. After fractionation by flow cytometry, clonogenic tripotent cells are found in populations negative or positive for either marker. We further show that CD133 is down-regulated at the mRNA level in cells lacking CD133 immunoreactivity. Cell cycle profiling reveals that CD133 negative cells largely reside in G1/G0, while CD133 positive cells are predominantly in S, G2, or M phase. A similar pattern is apparent in mouse NS cell lines. Compared to mouse NS cells, however, human NS cell cultures harbour an increased proportion of CD133 negative cells and display a longer doubling time. This may in part reflect a sub-population of slow- or non-cycling cells amongst human NS cells because we find that around 5% of cells do not take up BrdU over a 14-day labelling period. Non-proliferating NS cells remain undifferentiated and at least some of them are capable of re-entry into the cell cycle and subsequent continuous expansion. Conclusions: The finding that a significant fraction of clonogenic neural stem cells lack the established markers CD133 and CD15, and that some of these cells may be dormant or slow- cycling, has implications for approaches to identify and isolate neural stem cells and brain cancer stem cells. Our data also suggest the possibility that CD133 may be specifically down-regulated during G0/G1, and this should be considered when this marker is used to identify and isolate other tissue and cancer stem cells.			Sun, YR (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	austin.smith@cscr.cam.ac.uk	Falk, Anna/GWV-1616-2022; Pollard, Steven/B-7966-2010	Smith, Austin/0000-0002-3029-4682; Pollard, Steven/0000-0001-6428-0492; Falk, Anna/0000-0003-1634-8610	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0800784, G9806702] Funding Source: Medline; MRC [G0800784, G9806702] Funding Source: UKRI; Medical Research Council [G0800784B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ARNDTJOVIN DJ, 1989, METHOD CELL BIOL, V30, P417; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Azuma A, 2001, MOL PHARMACOL, V59, P725, DOI 10.1124/mol.59.4.725; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Frey D, 2008, CANCER BIOTHER RADIO, V23, P65, DOI 10.1089/cbr.2007.0407; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Ladd AC, 1997, BLOOD, V90, P658, DOI 10.1182/blood.V90.2.658.658_658_668; LATT SA, 1976, J HISTOCHEM CYTOCHEM, V24, P24, DOI 10.1177/24.1.943439; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; POLLARD SM, 2009, CELL STEM C IN PRESS; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Roy NS, 2000, NAT MED, V6, P271; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; SHAPIRO HM, 1981, CYTOMETRY, V2, P143, DOI 10.1002/cyto.990020302; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; WARING MJ, 1965, J MOL BIOL, V13, P269, DOI 10.1016/S0022-2836(65)80096-1; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zappone MV, 2000, DEVELOPMENT, V127, P2367	44	97	101	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5498	10.1371/journal.pone.0005498	http://dx.doi.org/10.1371/journal.pone.0005498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430532	Green Submitted, Green Published, gold			2022-12-27	WOS:000266009700004
J	Sun, LN; Lu, XH; Li, C; Wang, M; Liu, QZ; Li, Z; Hu, XF; Li, JD; Liu, F; Li, Q; Belser, JA; Hancock, K; Shu, YL; Katz, JM; Liang, MF; Li, DX				Sun, Lina; Lu, Xiuhua; Li, Chuan; Wang, Min; Liu, Qinzhi; Li, Zi; Hu, Xiaofen; Li, Jiandong; Liu, Feng; Li, Qun; Belser, Jessica A.; Hancock, Kathy; Shu, Yuelong; Katz, Jacqueline M.; Liang, Mifang; Li, Dexin			Generation, Characterization and Epitope Mapping of Two Neutralizing and Protective Human Recombinant Antibodies against Influenza A H5N1 Viruses	PLOS ONE			English	Article								Background: The development of new therapeutic targets and strategies to control highly pathogenic avian influenza (HPAI) H5N1 virus infection in humans is urgently needed. Broadly cross-neutralizing recombinant human antibodies obtained from the survivors of H5N1 avian influenza provide an important role in immunotherapy for human H5N1 virus infection and definition of the critical epitopes for vaccine development. Methodology/Principal Findings: We have characterized two recombinant baculovirus-expressed human antibodies (rhAbs), AVFluIgG01 and AVFluIgG03, generated by screening a Fab antibody phage library derived from a patient recovered from infection with a highly pathogenic avian influenza A H5N1 clade 2.3 virus. AVFluIgG01 cross-neutralized the most of clade 0, clade 1, and clade 2 viruses tested, in contrast, AVFluIgG03 only neutralized clade 2 viruses. Passive immunization of mice with either AVFluIgG01 or AVFluIgG03 antibody resulted in protection from a lethal H5N1 clade 2.3 virus infection. Furthermore, through epitope mapping, we identify two distinct epitopes on H5 HA molecule recognized by these rhAbs and demonstrate their potential to protect against a lethal H5N1 virus infection in a mouse model. Conclusions/Significance: Importantly, localization of the epitopes recognized by these two neutralizing and protective antibodies has provided, for the first time, insight into the human antibody responses to H5N1 viruses which contribute to the H5 immunity in the recovered patient. These results highlight the potential of a rhAbs treatment strategy for human H5N1 virus infection and provide new insight for the development of effective H5N1 pandemic vaccines.			Sun, LN (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China.	mifangl@vip.sina.com; lidx@chinacdc.cn						Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ASSAAD FA, 1980, B WORLD HEALTH ORGAN, V58, P585; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Barbas CF, 1996, TRENDS BIOTECHNOL, V14, P230, DOI 10.1016/0167-7799(96)10029-9; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Bayry J, 2004, TRENDS PHARMACOL SCI, V25, P306, DOI 10.1016/j.tips.2004.04.002; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; COX NJ, 1996, OPTIONS CONTROL INFL, V3, P591; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Kendal AP, 1982, CONCEPTS PROCEDURES; Kong L K, 2006, Hong Kong Med J, V12, P489; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Liang MF, 2001, J IMMUNOL METHODS, V247, P119, DOI 10.1016/S0022-1759(00)00322-7; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Mozdzanowska K, 2003, J VIROL, V77, P8322, DOI 10.1128/JVI.77.15.8322-8328.2003; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; REED LJ, 1938, AM J HYG, V27; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Tsuchiya E, 2001, J GEN VIROL, V82, P2475, DOI 10.1099/0022-1317-82-10-2475; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; *WHO, 2008, WHO CUM NUMB CONF HU; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	46	69	74	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5476	10.1371/journal.pone.0005476	http://dx.doi.org/10.1371/journal.pone.0005476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421326	gold, Green Published			2022-12-27	WOS:000265837000010
J	Berry, B; Deddouche, S; Kirschner, D; Imler, JL; Antoniewski, C				Berry, Bassam; Deddouche, Safia; Kirschner, Doris; Imler, Jean-Luc; Antoniewski, Christophe			Viral Suppressors of RNA Silencing Hinder Exogenous and Endogenous Small RNA Pathways in Drosophila	PLOS ONE			English	Article								Background: In plants and insects, RNA interference (RNAi) is the main responder against viruses and shapes the basis of antiviral immunity. Viruses counter this defense by expressing viral suppressors of RNAi (VSRs). While VSRs in Drosophila melanogaster were shown to inhibit RNAi through different modes of action, whether they act on other silencing pathways remained unexplored. Methodology/Principal Findings: Here we show that expression of various plant and insect VSRs in transgenic flies does not perturb the Drosophila microRNA (miRNA) pathway; but in contrast, inhibits antiviral RNAi and the RNA silencing response triggered by inverted repeat transcripts, and injection of dsRNA or siRNA. Strikingly, these VSRs also suppressed transposon silencing by endogenous siRNAs (endo-siRNAs). Conclusions/Significance: Our findings identify VSRs as tools to unravel small RNA pathways in insects and suggest a cosuppression of antiviral RNAi and endo-siRNA silencing by viruses during fly infections.			Berry, B (corresponding author), Inst Pasteur, CNRS, URA2578, Paris, France.	christophe.antoniewski@pasteur.fr	Imler, Jean-Luc/GXH-4323-2022; Antoniewski, Christophe/G-4519-2011	Antoniewski, Christophe/0000-0001-7709-2116	NIAID NIH HHS [P01 AI070167] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Bortolamiol D, 2007, CURR BIOL, V17, P1615, DOI 10.1016/j.cub.2007.07.061; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Forsyth D, 1907, Q J MED, V1, P287; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Merai Z, 2005, J VIROL, V79, P7217, DOI 10.1128/JVI.79.11.7217-7226.2005; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Reavy B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-18; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yu B, 2006, FEBS LETT, V580, P3117, DOI 10.1016/j.febslet.2006.04.063; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Ziegler-Graff Veronique, 2008, V451, P81, DOI 10.1007/978-1-59745-102-4_6	43	56	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5866	10.1371/journal.pone.0005866	http://dx.doi.org/10.1371/journal.pone.0005866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516905	gold, Green Submitted, Green Published			2022-12-27	WOS:000266872900017
J	Ngamskulrungroj, P; Gilgado, F; Faganello, J; Litvintseva, AP; Leal, AL; Tsui, KM; Mitchell, TG; Vainstein, MH; Meyer, W				Ngamskulrungroj, Popchai; Gilgado, Felix; Faganello, Josiane; Litvintseva, Anastasia P.; Leal, Ana Lusia; Tsui, Kin Ming; Mitchell, Thomas G.; Vainstein, Marilene Henning; Meyer, Wieland			Genetic Diversity of the Cryptococcus Species Complex Suggests that Cryptococcus gattii Deserves to Have Varieties	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; MATING-TYPE; VANCOUVER-ISLAND; SEROTYPE-A; MOLECULAR EPIDEMIOLOGY; BRITISH-COLUMBIA; POLYMORPHIC DNA; STRAINS; POPULATION; ALPHA	The Cryptococcus species complex contains two sibling taxa, Cryptococcus neoformans and Cryptococcus gattii. Both species are basidiomycetous yeasts and major pathogens of humans and other mammals. Genotyping methods have identified major haploid molecular types of C. neoformans (VNI, VNII, VNB and VNIV) and of C. gattii (VGI, VGII, VGIII and VGIV). To investigate the phylogenetic relationships among these haploid genotypes, we selected 73 strains from 2000 globally collected isolates investigated in our previous typing studies, representing each of these genotypes and carried out multigene sequence analyses using four genetically unlinked nuclear loci, ACT1, IDE, PLB1 and URA5. The separate or combined sequence analyses of all four loci revealed seven clades with significant support for each molecular type. However, three strains of each species revealed some incongruence between the original molecular type and the sequence-based type obtained here. The topology of the individual gene trees was identical for each clade of C. neoformans but incongruent for the clades of C. gattii indicating recent recombination events within C. gattii. There was strong evidence of recombination in the global VGII population. Both parsimony and likelihood analyses supported three major clades of C. neoformans (VNI/VNB, VNII and VNIV) and four major clades of C. gattii ( VGI, VGII, VGIII and VGIV). The sequence variation between VGI, VGIII and VGIV was similar to that between VNI/VNB and VNII. MATa was for the first time identified for VGIV. The VNIV and VGII clades are basal to the C. neoformans or the C. gattii clade, respectively. Divergence times among the seven haploid monophyletic lineages in the Cryptococcus species complex were estimated by applying the hypothesis of the molecular clock. The genetic variation found among all of these haploid monophyletic lineages indicates that they warrant varietal status.			Ngamskulrungroj, P (corresponding author), Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Mol Mycol Res Lab,Westmead Millennium Inst, Westmead, NSW 2145, Australia.	w.meyer@usyd.edu.au	Ngamskulrungroj, Popchai/ABE-7699-2021; Meyer, Wieland/G-1204-2015; Ngamskulrungroj, Popchai/N-8545-2019; Mitchell, Thomas G./A-2356-2008; Leal, Ana Lusia/H-7527-2012; Tsui, Clement/F-6416-2013; Vainstein, Marilene H/J-5452-2014	Meyer, Wieland/0000-0001-9933-8340; Ngamskulrungroj, Popchai/0000-0001-5162-5498; Tsui, Clement/0000-0001-5129-1037; Vainstein, Marilene H/0000-0002-3914-2300; Leal, Ana Lusia/0000-0002-9175-0864				Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; AUTHIER F, 1995, P NATL ACAD SCI USA, V92, P3859, DOI 10.1073/pnas.92.9.3859; Boekhout T, 1997, CURR GENET, V32, P203, DOI 10.1007/s002940050267; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Butler MI, 2005, FUNGAL GENET BIOL, V42, P452, DOI 10.1016/j.fgb.2005.01.011; Campbell LT, 2006, FEMS YEAST RES, V6, P588, DOI 10.1111/j.1567-1364.2006.00087.x; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; Campbell LT, 2005, EUKARYOT CELL, V4, P1410, DOI 10.1128/EC.4.8.1410-1419.2005; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; Cogliati M, 2006, FEMS YEAST RES, V6, P608, DOI 10.1111/j.1567-1364.2006.00085.x; COX GM, 1995, J MED VET MYCOL, V33, P261; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Diaz MR, 2005, FEMS YEAST RES, V5, P1129, DOI 10.1016/j.femsyr.2005.05.005; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Escandon P, 2007, BIOMEDICA, V27, P308, DOI 10.7705/biomedica.v27i2.227; Escandon P, 2006, FEMS YEAST RES, V6, P625, DOI 10.1111/j.1567-1364.2006.00055.x; ESPINELINGROFF A, 1992, J CLIN MICROBIOL, V30, P3138, DOI 10.1128/JCM.30.12.3138-3145.1992; ESTABROOK G F, 1975, Taxon, V24, P609, DOI 10.2307/1220730; FAGANELLO J, 2009, MED MYCOL, V47, P584, DOI DOI 10.1080/13693780802272148; Farris JS, 1995, CLADISTICS, V11, P377, DOI 10.1111/j.1096-0031.1995.tb00096.x; Franzot SP, 1998, J CLIN MICROBIOL, V36, P2200, DOI 10.1128/JCM.36.8.2200-2204.1998; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; GARCIA JV, 1989, J CELL BIOL, V109, P1301, DOI 10.1083/jcb.109.3.1301; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Halliday CL, 1999, J CLIN MICROBIOL, V37, P2920, DOI 10.1128/JCM.37.9.2920-2926.1999; Halliday CL, 2003, J CLIN MICROBIOL, V41, P703, DOI 10.1128/JCM.41.2.703-711.2003; Huelsenbeck J. P., 2001, MRBAYES BAYESIAN INF, P754; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Igreja RP, 2004, MED MYCOL, V42, P229, DOI 10.1080/13693780310001644743; Katsu M, 2004, FEMS YEAST RES, V4, P377, DOI 10.1016/S1567-1356(03)00176-4; KIDD S, 2003, MOL EPIDEMIOLOGY CHA; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; KOOIMAN P, 1963, ANTON VAN LEE J M S, V29, P169, DOI 10.1007/BF02046049; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Latouche GN, 2003, APPL ENVIRON MICROB, V69, P2080, DOI 10.1128/AEM.69.4.2080-2086.2003; Lengeler KB, 2001, INFECT IMMUN, V69, P115, DOI 10.1128/IAI.69.1.115-122.2001; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Litvintseva AP, 2003, EUKARYOT CELL, V2, P1162, DOI 10.1128/EC.2.6.1162-1168.2003; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Mayden R. L., 1997, V54, P381; MAYNARDSMITH JM, 1993, CLONAL ARE BACTERIA; Mayr E., 1942, P1; McClelland CM, 2004, TRENDS MICROBIOL, V12, P208, DOI 10.1016/j.tim.2004.03.003; Meyer W, 1999, ELECTROPHORESIS, V20, P1790, DOI 10.1002/(SICI)1522-2683(19990101)20:8&lt;1790::AID-ELPS1790&gt;3.0.CO;2-2; Meyer W, 2003, EMERG INFECT DIS, V9, P189; MEYER W, 1993, EXS, V67, P311; Ngamskulrungroj P, 2008, MED MYCOL, V46, P665, DOI 10.1080/13693780802210734; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; SAMSON RA, 1983, A VAN LEEUW J MICROB, V49, P447; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Sharpton TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r24; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Sriburee P, 2004, MYCOPATHOLOGIA, V158, P25, DOI 10.1023/B:MYCO.0000038435.14281.f4; STEPHENS JC, 1985, J MOL EVOL, V22, P289; Sukroongreung S, 1996, MYCOPATHOLOGIA, V135, P75, DOI 10.1007/BF00436454; SWOFFORD DL, 2001, PAUP PHYLOGENETIC US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trilles L, 2003, MED MYCOL, V41, P383, DOI 10.1080/1369378031000137206; Varma A, 1998, CURR GENET, V34, P60, DOI 10.1007/s002940050366; Velegraki A, 2001, MED MYCOL, V39, P419, DOI 10.1080/mmy.39.5.419.422; WICKES BL, 1994, MICROBIOL-SGM, V140, P543, DOI 10.1099/00221287-140-3-543; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Xu JP, 2003, MICROBIOL-SGM, V149, P2147, DOI 10.1099/mic.0.26180-0	82	129	131	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5862	10.1371/journal.pone.0005862	http://dx.doi.org/10.1371/journal.pone.0005862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19517012	Green Published, gold			2022-12-27	WOS:000266872900013
J	Ren, Y; Zhang, ZH; Liu, JH; Staub, JE; Han, YH; Cheng, ZC; Li, XF; Lu, JY; Miao, H; Kang, HX; Xie, BY; Gu, XF; Wang, XW; Du, YC; Jin, WW; Huang, SW				Ren, Yi; Zhang, Zhonghua; Liu, Jinhua; Staub, Jack E.; Han, Yonghua; Cheng, Zhouchao; Li, Xuefeng; Lu, Jingyuan; Miao, Han; Kang, Houxiang; Xie, Bingyan; Gu, Xingfang; Wang, Xiaowu; Du, Yongchen; Jin, Weiwei; Huang, Sanwen			Integrated Genetic and Cytogenetic Map of the Cucumber Genome	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; SATIVUS L.; LINKAGE MAP; MICROSATELLITES; HYBRIDIZATION; CONSTRUCTION; RESISTANCE; KARYOTYPE; SEQUENCES; TRAITS	The Cucurbitaceae includes important crops such as cucumber, melon, watermelon, squash and pumpkin. However, few genetic and genomic resources are available for plant improvement. Some cucurbit species such as cucumber have a narrow genetic base, which impedes construction of saturated molecular linkage maps. We report herein the development of highly polymorphic simple sequence repeat (SSR) markers originated from whole genome shotgun sequencing and the subsequent construction of a high-density genetic linkage map. This map includes 995 SSRs in seven linkage groups which spans in total 573 cM, and defines similar to 680 recombination breakpoints with an average of 0.58 cM between two markers. These linkage groups were then assigned to seven corresponding chromosomes using fluorescent in situ hybridization (FISH). FISH assays also revealed a chromosomal inversion between Cucumis subspecies [C. sativus var. sativus L. and var. hardwickii (R.) Alef], which resulted in marker clustering on the genetic map. A quarter of the mapped markers showed relatively high polymorphism levels among 11 inbred lines of cucumber. Among the 995 markers, 49%, 26% and 22% were conserved in melon, watermelon and pumpkin, respectively. This map will facilitate whole genome sequencing, positional cloning, and molecular breeding in cucumber, and enable the integration of knowledge of gene and trait in cucurbits.			Ren, Y (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Sino Dutch Joint Lab Hort Genom, Opening Lab Genet Improvement Agr Crops,Minist Ag, Beijing, Peoples R China.	weiweijin@cau.edu.cn; huangsanwen@caas.net.cn	Wang, Xiaowu/L-2579-2019; Huang, Sanwen/ABE-9053-2020	Huang, Sanwen/0000-0002-8547-5309; Ren, Yi/0000-0003-3770-6093; zhang, zhonghua/0000-0002-1034-227X				Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bradeen JM, 2001, GENOME, V44, P111, DOI 10.1139/gen-44-1-111; Chen JF, 1998, GENET RESOUR CROP EV, V45, P301, DOI 10.1023/A:1008603608879; Chung SM, 2006, GENOME, V49, P219, DOI 10.1139/G05-101; Danin-Poleg Y, 2000, GENOME, V43, P963, DOI 10.1139/gen-43-6-963; DEAKIN JR, 1971, ECON BOT, V25, P195, DOI 10.1007/BF02860080; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fan ZC, 2006, THEOR APPL GENET, V112, P843, DOI 10.1007/s00122-005-0186-x; Fazio G, 2003, THEOR APPL GENET, V107, P864, DOI 10.1007/s00122-003-1277-1; Fazio G, 2003, THEOR APPL GENET, V107, P875, DOI 10.1007/s00122-003-1313-1; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; HORST EK, 1978, 5 CUC GEN COOP; JIANG JM, 1995, P NATL ACAD SCI USA, V92, P4487, DOI 10.1073/pnas.92.10.4487; KEIM P, 1992, THEOR APPL GENET, V85, P205, DOI 10.1007/BF00222861; KENNARD WC, 1994, THEOR APPL GENET, V89, P42, DOI 10.1007/BF00226980; Kong Q, 2006, MOL ECOL NOTES, V6, P1234, DOI 10.1111/j.1471-8286.2006.01500.x; Koo DH, 2005, GENOME, V48, P534, DOI 10.1139/G04-128; LANDER E S, 1988, Genomics, V2, P231; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Munshi AD, 2008, EUPHYTICA, V164, P501, DOI 10.1007/s10681-008-9741-2; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NAYAR NM, 1998, CUCURBITS ENFIELD; Rieseberg LH, 2003, SCIENCE, V300, P267, DOI 10.1126/science.1084192; ROBBINS MD, 2009, THEOR APPL IN PRESS; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; Sharma BD, 1996, GENET RESOUR CROP EV, V43, P7, DOI 10.1007/BF00126935; Staub Jack E., 2008, V1, P241; Staub JE, 2000, ACTA HORTIC, P357, DOI 10.17660/ActaHortic.2000.510.57; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; VanOoijen J. W., 2001, JOINMAP3 0 SOFTWARE; WALTERS SA, 1993, HORTSCIENCE, V28, P151, DOI 10.21273/HORTSCI.28.2.151; Watcharawongpaiboon N, 2008, PLANT BREEDING, V127, P74, DOI 10.1111/j.1439-0523.2007.01425.x; Yuan XJ, 2008, PLANT BREEDING, V127, P180, DOI 10.1111/j.1439-0523.2007.01426.x; Zhang ZH, 2007, DNA RES, V14, P37, DOI 10.1093/dnares/dsm005	39	203	248	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5795	10.1371/journal.pone.0005795	http://dx.doi.org/10.1371/journal.pone.0005795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495411	gold, Green Published, Green Submitted			2022-12-27	WOS:000266716900005
J	de Nooijer, S; Holland, BR; Penny, D				de Nooijer, Silvester; Holland, Barbara R.; Penny, David			The Emergence of Predators in Early Life: There was No Garden of Eden	PLOS ONE			English	Article							COPES RULE; EVOLUTION; ORIGIN; CELLS; CLASSIFICATION; MITOCHONDRIA; HYPOTHESIS; SIZE	Background: Eukaryote cells are suggested to arise somewhere between 0.85 similar to 2.7 billion years ago. However, in the present world of unicellular organisms, cells that derive their food and metabolic energy from larger cells engulfing smaller cells (phagocytosis) are almost exclusively eukaryotic. Combining these propositions, that eukaryotes were the first phagocytotic predators and that they arose only 0.85 similar to 2.7 billion years ago, leads to an unexpected prediction of a long period (similar to 1-3 billion years) with no phagocytotes - a veritable Garden of Eden. Methodology: We test whether such a long period is reasonable by simulating a population of very simple unicellular organisms - given only basic physical, biological and ecological principles. Under a wide range of initial conditions, cellular specialization occurs early in evolution; we find a range of cell types from small specialized primary producers to larger opportunistic or specialized predators. Conclusions: Both strategies, specialized smaller cells and phagocytotic larger cells are apparently fundamental biological strategies that are expected to arise early in cellular evolution. Such early predators could have been 'prokaryotes', but if the earliest cells on the eukaryote lineage were predators then this explains most of their characteristic features.			de Nooijer, S (corresponding author), Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	d.penny@massey.ac.nz	Holland, Barbara/G-1646-2013; Penny, David/E-9410-2011	Holland, Barbara/0000-0002-4628-7938; 				Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; Burtsev M, 2006, NATURE, V440, P1041, DOI 10.1038/nature04470; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Ceulemans H, 2006, BIOESSAYS, V28, P316, DOI 10.1002/bies.20373; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Collins LJ, 2009, TRENDS GENET, V25, P120, DOI 10.1016/j.tig.2008.12.003; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Forde SE, 2008, NATURE, V455, P220, DOI 10.1038/nature07152; Forterre P, 2006, P NATL ACAD SCI USA, V103, P3669, DOI 10.1073/pnas.0510333103; Gardner PP, 2003, P ROY SOC B-BIOL SCI, V270, P1177, DOI 10.1098/rspb.2003.2355; Guillard RR, 1977, BIOL DIATOMS, V13, P372; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; JURKEVITCH E, 2007, MICROBE, V2, P67; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Martin W, 1999, P ROY SOC B-BIOL SCI, V266, P1387, DOI 10.1098/rspb.1999.0792; MOROWITZ HJ, 1968, ENERGY FLOW BIOL BIO, DOI DOI 10.1126/SCIENCE.164.3880.683-A; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Penny D, 1999, CURR OPIN GENET DEV, V9, P672, DOI 10.1016/S0959-437X(99)00020-9; PENNY D, 1982, J THEOR BIOL, V96, P129, DOI 10.1016/0022-5193(82)90216-8; Poole AM, 2003, BIOSYSTEMS, V69, P163, DOI 10.1016/S0303-2647(02)00131-4; Poole AM, 2007, BIOESSAYS, V29, P74, DOI 10.1002/bies.20516; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; Woodhams MD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S13	40	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5507	10.1371/journal.pone.0005507	http://dx.doi.org/10.1371/journal.pone.0005507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492046	Green Published, Green Submitted, gold			2022-12-27	WOS:000266624300001
J	Karaulanov, E; Bottcher, RT; Stannek, P; Wu, W; Rau, M; Ogata, S; Cho, KWY; Niehrs, C				Karaulanov, Emil; Boettcher, Ralph T.; Stannek, Peter; Wu, Wei; Rau, Marlene; Ogata, Souichi; Cho, Ken W. Y.; Niehrs, Christof			Unc5B Interacts with FLRT3 and Rnd1 to Modulate Cell Adhesion in Xenopus Embryos	PLOS ONE			English	Article								The FLRT family of transmembrane proteins has been implicated in the regulation of FGF signalling, neurite outgrowth, homotypic cell sorting and cadherin-mediated adhesion. In an expression screen we identified the Netrin receptors Unc5B and Unc5D as high-affinity FLRT3 interactors. Upon overexpression, Unc5B phenocopies FLRT3 and both proteins synergize in inducing cell deadhesion in Xenopus embryos. Morpholino knock-downs of Unc5B and FLRT3 synergistically affect Xenopus development and induce morphogenetic defects. The small GTPase Rnd1, which transmits FLRT3 deadhesion activity, physically and functionally interacts with Unc5B, and mediates its effect on cell adhesion. The results suggest that FLRT3, Unc5B and Rnd1 proteins interact to modulate cell adhesion in early Xenopus development.			Karaulanov, E (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Mol Embryol, D-6900 Heidelberg, Germany.	niehrs@dkfz-heidelberg.de						Aoki J, 2000, BIOCHEM BIOPH RES CO, V278, P604, DOI 10.1006/bbrc.2000.3842; Arakawa H, 2005, CELL DEATH DIFFER, V12, P1057, DOI 10.1038/sj.cdd.4401601; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Egea J, 2008, GENE DEV, V22, P3349, DOI 10.1101/gad.486708; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kamachi Y, 2008, GENESIS, V46, P1, DOI 10.1002/dvg.20361; Karaulanov EE, 2006, EMBO REP, V7, P283, DOI 10.1038/sj.embor.7400614; Kuhl M, 1996, DEV DYNAM, V207, P121, DOI 10.1002/(SICI)1097-0177(199610)207:2<121::AID-AJA1>3.0.CO;2-J; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Maretto S, 2008, DEV BIOL, V318, P184, DOI 10.1016/j.ydbio.2008.03.021; Navankasattusas S, 2008, DEVELOPMENT, V135, P659, DOI 10.1242/dev.013623; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Robinson M, 2004, MOL CELL NEUROSCI, V27, P202, DOI 10.1016/j.mcn.2004.06.008; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Tsuji L, 2004, BIOCHEM BIOPH RES CO, V313, P1086, DOI 10.1016/j.bbrc.2003.12.047	24	40	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5742	10.1371/journal.pone.0005742	http://dx.doi.org/10.1371/journal.pone.0005742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19492039	Green Submitted, gold, Green Published			2022-12-27	WOS:000266490000016
J	Alipour, M; Suntres, ZE; Halwani, M; Azghani, AO; Omri, A				Alipour, Misagh; Suntres, Zacharias E.; Halwani, Majed; Azghani, Ali O.; Omri, Abdelwahab			Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis	PLOS ONE			English	Article								Background: To compare the effectiveness of liposomal tobramycin or polymyxin B against Pseudomonas aeruginosa in the Cystic Fibrosis (CF) sputum and its inhibition by common polyanionic components such as DNA, F-actin, lipopolysaccharides (LPS), and lipoteichoic acid (LTA). Methodology: Liposomal formulations were prepared from a mixture of 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC) or 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC) and Cholesterol (Chol), respectively. Stability of the formulations in different biological milieus and antibacterial activities compared to conventional forms in the presence of the aforementioned inhibitory factors or CF sputum were evaluated. Results: The formulations were stable in all conditions tested with no significant differences compared to the controls. Inhibition of antibiotic formulations by DNA/F-actin and LPS/LTA was concentration dependent. DNA/F-actin (125 to 1000 mg/L) and LPS/LTA (1 to 1000 mg/L) inhibited conventional tobramycin bioactivity, whereas, liposome-entrapped tobramycin was inhibited at higher concentrations - DNA/F-actin (500 to 1000 mg/L) and LPS/LTA (100 to 1000 mg/L). Neither polymyxin B formulation was inactivated by DNA/F-actin, but LPS/LTA (1 to 1000 mg/L) inhibited the drug in conventional form completely and higher concentrations of the inhibitors (100 to 1000 mg/L) was required to inhibit the liposome-entrapped polymyxin B. Co-incubation with inhibitory factors (1000 mg/L) increased conventional (16-fold) and liposomal (4-fold) tobramycin minimum bactericidal concentrations (MBCs), while both polymyxin B formulations were inhibited 64-fold. Conclusions: Liposome-entrapment reduced antibiotic inhibition up to 100-fold and the CFU of endogenous P. aeruginosa in sputum by 4-fold compared to the conventional antibiotic, suggesting their potential applications in CF lung infections.			Alipour, M (corresponding author), Laurentian Univ, Dept Chem & Biochem, Novel Drug & Vaccine Delivery Syst Facil, Sudbury, ON P3E 2C6, Canada.	aomri@laurentian.ca	Azghani, Ali/GNW-5689-2022; Omri, Abdelwahab/G-3172-2010	Azghani, Ali/0000-0002-7626-5967; Omri, Abdelwahab/0000-0002-4093-5762; Halwani, Majed/0000-0002-2192-3264				Alipour M, 2008, INT J PHARM, V355, P293, DOI 10.1016/j.ijpharm.2007.11.035; Allison SD, 2007, J INFUS MURS, V30, P89, DOI 10.1097/01.NAN.0000264712.26219.67; BATAILLON V, 1992, J ANTIMICROB CHEMOTH, V29, P499, DOI 10.1093/jac/29.5.499; Boyle MP, 2007, JAMA-J AM MED ASSOC, V298, P1787, DOI 10.1001/jama.298.15.1787; Broughton-Head VJ, 2007, PULM PHARMACOL THER, V20, P708, DOI 10.1016/j.pupt.2006.08.008; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Bucki R, 2007, J ANTIMICROB CHEMOTH, V60, P535, DOI 10.1093/jac/dkm218; Cannella CA, 2006, AM J HEALTH-SYST PH, V63, P1858, DOI 10.2146/ajhp060196; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Chuchalin Alexander, 2007, Paediatr Drugs, V9 Suppl 1, P21, DOI 10.2165/00148581-200709001-00004; Courtney J M, 2004, J Cyst Fibros, V3, P223, DOI 10.1016/j.jcf.2004.06.006; Davies JC, 2007, SEMIN RESP CRIT CARE, V28, P312, DOI 10.1055/s-2007-981652; DAVIES M, 1978, BIOCHIM BIOPHYS ACTA, V508, P260, DOI 10.1016/0005-2736(78)90329-2; DAVIS SD, 1978, AM REV RESPIR DIS, V117, P176; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Eisenberg J, 1997, CHEST, V111, P955, DOI 10.1378/chest.111.4.955; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Fernandes B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006682.pub2; Geller DE, 2007, PEDIATR PULM, V42, P307, DOI 10.1002/ppul.20594; Govan J, 2002, HOSP MED, V63, P421, DOI 10.12968/hosp.2002.63.7.1987; Halwani M, 2007, J ANTIMICROB CHEMOTH, V60, P760, DOI 10.1093/jac/dkm289; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hodson ME, 2002, EUR RESPIR J, V20, P658, DOI 10.1183/09031936.02.00248102; Horianopoulou M, 2005, J CHEMOTHERAPY, V17, P536, DOI 10.1179/joc.2005.17.5.536; HUNT BE, 1995, ANTIMICROB AGENTS CH, V39, P34, DOI 10.1128/AAC.39.1.34; Iredell JR, 2007, SEMIN RESP CRIT CARE, V28, P656, DOI 10.1055/s-2007-996412; Kater A, 2007, ANN NY ACAD SCI, V1112, P140, DOI 10.1196/annals.1415.006; Kaye D, 2004, INFECT DIS CLIN N AM, V18, P669, DOI 10.1016/j.idc.2004.04.007; Kharitonov Sergei A., 2007, V14, P83, DOI 10.1159/000107056; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Lahiri T, 2007, CLIN CHEST MED, V28, P307, DOI 10.1016/j.ccm.2007.02.003; Landry RM, 2006, MOL MICROBIOL, V59, P142, DOI 10.1111/j.1365-2958.2005.04941.x; Lenoir Gerard, 2007, Paediatr Drugs, V9 Suppl 1, P11, DOI 10.2165/00148581-200709001-00003; LETHEM MI, 1990, EUR RESPIR J, V3, P19; LEVY J, 1983, J INFECT DIS, V148, P1069, DOI 10.1093/infdis/148.6.1069; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; MARSHALL AJH, 1994, J ANTIMICROB CHEMOTH, V34, P465, DOI 10.1093/jac/34.4.465; Meers P, 2008, J ANTIMICROB CHEMOTH, V61, P859, DOI 10.1093/jac/dkn059; Merlo CA, 2007, CHEST, V132, P562, DOI 10.1378/chest.06-2888; Mozafari MR, 2006, J SCI FOOD AGR, V86, P2038, DOI 10.1002/jsfa.2576; Mozafari MR, 2008, J LIPOSOME RES, V18, P309, DOI [10.1080/08982100802465941 , 10.1080/08982100802465941]; Mugabe C, 2006, INT J PHARMACEUT, V307, P244, DOI 10.1016/j.ijpharm.2005.10.005; Mugabe C, 2006, ANTIMICROB AGENTS CH, V50, P2016, DOI 10.1128/AAC.01547-05; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; NICAS TI, 1980, J BACTERIOL, V143, P872, DOI 10.1128/JB.143.2.872-878.1980; Omri A, 2002, BIOCHEM PHARMACOL, V64, P1407, DOI 10.1016/S0006-2952(02)01346-1; POTTER JL, 1965, PEDIATRICS, V36, P714; RAMPHAL R, 1988, J ANTIMICROB CHEMOTH, V22, P483, DOI 10.1093/jac/22.4.483; Remmington T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005405; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; Sagel Scott D, 2007, Proc Am Thorac Soc, V4, P406, DOI 10.1513/pats.200703-044BR; Sanders NN, 2000, AM J RESP CRIT CARE, V162, P1905, DOI 10.1164/ajrccm.162.5.9909009; Sanders NN, 2002, PHARMACEUT RES, V19, P451, DOI 10.1023/A:1015139527747; Sanders NN, 2001, AM J RESP CRIT CARE, V164, P486, DOI 10.1164/ajrccm.164.3.2011041; Schiffelers R, 2001, J ANTIMICROB CHEMOTH, V48, P333, DOI 10.1093/jac/48.3.333; Sobieszczyk ME, 2004, J ANTIMICROB CHEMOTH, V54, P566, DOI 10.1093/jac/dkh369; SOMEYA A, 1979, J ANTIBIOT, V32, P156, DOI 10.7164/antibiotics.32.156; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Stern M, 1998, GENE THER, V5, P91, DOI 10.1038/sj.gt.3300556; Swan SK, 1997, SEMIN NEPHROL, V17, P27; Tang JX, 2005, AM J PHYSIOL-LUNG C, V289, pL599, DOI 10.1152/ajplung.00061.2005; Touw DJ, 2007, J CYST FIBROS, V6, P327, DOI 10.1016/j.jcf.2006.12.007; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; Westerman EM, 2007, J CYST FIBROS, V6, P284, DOI 10.1016/j.jcf.2006.10.010; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	70	52	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5724	10.1371/journal.pone.0005724	http://dx.doi.org/10.1371/journal.pone.0005724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479000	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415100015
J	Newman, SH; Iverson, SA; Takekawa, JY; Gilbert, M; Prosser, DJ; Batbayar, N; Natsagdorj, T; Douglas, DC				Newman, Scott H.; Iverson, Samuel A.; Takekawa, John Y.; Gilbert, Martin; Prosser, Diann J.; Batbayar, Nyambyar; Natsagdorj, Tseveenmyadag; Douglas, David C.			Migration of Whooper Swans and Outbreaks of Highly Pathogenic Avian Influenza H5N1 Virus in Eastern Asia	PLOS ONE			English	Article							BIRDS; INFECTION; DUCKS	Evaluating the potential involvement of wild avifauna in the emergence of highly pathogenic avian influenza H5N1 (hereafter H5N1) requires detailed analyses of temporal and spatial relationships between wild bird movements and disease emergence. The death of wild swans (Cygnus spp.) has been the first indicator of the presence of H5N1 in various Asian and European countries; however their role in the geographic spread of the disease remains poorly understood. We marked 10 whooper swans (Cygnus cygnus) with GPS transmitters in northeastern Mongolia during autumn 2006 and tracked their migratory movements in relation to H5N1 outbreaks. The prevalence of H5N1 outbreaks among poultry in eastern Asia during 2003-2007 peaked during winter, concurrent with whooper swan movements into regions of high poultry density. However outbreaks involving poultry were detected year round, indicating disease perpetuation independent of migratory waterbird presence. In contrast, H5N1 outbreaks involving whooper swans, as well as other migratory waterbirds that succumbed to the disease in eastern Asia, tended to occur during seasons (late spring and summer) and in habitats (areas of natural vegetation) where their potential for contact with poultry is very low to nonexistent. Given what is known about the susceptibility of swans to H5N1, and on the basis of the chronology and rates of whooper swan migration movements, we conclude that although there is broad spatial overlap between whooper swan distributions and H5N1 outbreak locations in eastern Asia, the likelihood of direct transmission between these groups is extremely low. Thus, our data support the hypothesis that swans are best viewed as sentinel species, and moreover, that in eastern Asia, it is most likely that their infections occurred through contact with asymptomatic migratory hosts (e. g., wild ducks) at or near their breeding grounds.			Newman, SH (corresponding author), Food & Agr Org United Nations, Anim Prod & Hlth Div, Emergency Ctr Transboundary Anim Dis, EMPRES Wildlife Unit,Infect Dis Grp, Rome, Italy.	scott.newman@fao.org	Batbayar, Nyambayar/N-7066-2015; Batbayar, Nyambayar/N-3761-2019; Douglas, David C./AAU-1087-2021	Batbayar, Nyambayar/0000-0002-9138-9626; Batbayar, Nyambayar/0000-0002-9138-9626; Douglas, David C./0000-0003-0186-1104; Prosser, Diann/0000-0002-5251-1799; Gilbert, Martin/0000-0002-9930-4383				Albertsen JO, 2002, WATERBIRDS, V25, P74; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; *FAO, 2008, FAO EMPRES I DAT; *FAO, 2006, EMPRES WATCH EV HIGH; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Lee YJ, 2008, EMERG INFECT DIS, V14, P487, DOI 10.3201/eid1403.070767; Liu CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000191; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Mel'nikov Yuri I., 2006, P357; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; MUZAFFAR SB, 2006, WATERBIRDS, V29, P243, DOI DOI 10.1675/1524-4695(2006)29[243:AIAEAE]2.0.CO;2; Nolet BA, 2002, J ANIM ECOL, V71, P979, DOI 10.1046/j.1365-2656.2002.00662.x; *OIE, 2008, UPD HIGHL PATH AV IN; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Robinson Timothy P, 2007, Vet Ital, V43, P745; Sabirovic M, 2006, SITUATION ANAL OUTBR; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Syroechkovski EE, 2002, WATERBIRDS, V25, P100; Teifke JP, 2007, VET PATHOL, V44, P137, DOI 10.1354/vp.44-2-137; Terregino C, 2006, VET REC, V158, P491, DOI 10.1136/vr.158.14.491; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Whitworth D., 2007, WILD BIRDS AVIAN INF; Yasue M, 2006, BIOSCIENCE, V56, P923, DOI 10.1641/0006-3568(2006)56[923:TEOHAI]2.0.CO;2; 2006, SCIENCE, V312, P1451	34	37	42	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5729	10.1371/journal.pone.0005729	http://dx.doi.org/10.1371/journal.pone.0005729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479053	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415100018
J	Kulangara, C; Kajava, AV; Corradin, G; Felger, I				Kulangara, Caroline; Kajava, Andrey V.; Corradin, Giampietro; Felger, Ingrid			Sequence Conservation in Plasmodium falciparum alpha-Helical Coiled Coil Domains Proposed for Vaccine Development	PLOS ONE			English	Article								Background: The availability of the P. falciparum genome has led to novel ways to identify potential vaccine candidates. A new approach for antigen discovery based on the bioinformatic selection of heptad repeat motifs corresponding to alpha-helical coiled coil structures yielded promising results. To elucidate the question about the relationship between the coiled coil motifs and their sequence conservation, we have assessed the extent of polymorphism in putative alpha-helical coiled coil domains in culture strains, in natural populations and in the single nucleotide polymorphism data available at PlasmoDB. Methodology/Principal Findings: 14 alpha-helical coiled coil domains were selected based on preclinical experimental evaluation. They were tested by PCR amplification and sequencing of different P. falciparum culture strains and field isolates. We found that only 3 out of 14 alpha-helical coiled coils showed point mutations and/or length polymorphisms. Based on promising immunological results 5 of these peptides were selected for further analysis. Direct sequencing of field samples from Papua New Guinea and Tanzania showed that 3 out of these 5 peptides were completely conserved. An in silico analysis of polymorphism was performed for all 166 putative alpha-helical coiled coil domains originally identified in the P. falciparum genome. We found that 82% (137/166) of these peptides were conserved, and for one peptide only the detected SNPs decreased substantially the probability score for alpha-helical coiled coil formation. More SNPs were found in arrays of almost perfect tandem repeats. In summary, the coiled coil structure prediction was rarely modified by SNPs. The analysis revealed a number of peptides with strictly conserved alpha-helical coiled coil motifs. Conclusion/Significance: We conclude that the selection of alpha-helical coiled coil structural motifs is a valuable approach to identify potential vaccine targets showing a high degree of conservation.			Kulangara, C (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	ingrid.felger@unibas.ch	Kajava, Andrey V/E-1107-2014	Kajava, Andrey V/0000-0002-2342-6886; Felger, Ingrid/0000-0003-1255-2606				Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Corradin Giarnpietro, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P259, DOI 10.2174/187153007782794371; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Felger I, 1999, T ROY SOC TROP MED H, V93, pS3; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; Franks S, 2003, INFECT IMMUN, V71, P3485, DOI 10.1128/IAI.71.6.3485-3495.2003; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2008, EXPERT REV VACCINES, V7, P597, DOI 10.1586/14760584.7.5.597; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Irion A, 1998, TROP MED INT HEALTH, V3, P490, DOI 10.1046/j.1365-3156.1998.00253.x; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; Lamb D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-70; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Marfurt J, 2007, AM J TROP MED HYG, V77, P947, DOI 10.4269/ajtmh.2007.77.947; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Plebanski M, 1997, PARASITOLOGY, V115, pS55, DOI 10.1017/S0031182097002035; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Pouniotis D S, 2004, J Postgrad Med, V50, P30; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Tetteh KKA, 2005, INFECT IMMUN, V73, P5928, DOI 10.1128/IAI.73.9.5928-5935.2005; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Walshaw J, 2001, PROTEIN SCI, V10, P668, DOI 10.1110/ps.36901	38	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5419	10.1371/journal.pone.0005419	http://dx.doi.org/10.1371/journal.pone.0005419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19492090	Green Published, gold			2022-12-27	WOS:000266331700001
J	Yang, CS; Hoelzle, M; Disanza, A; Scita, G; Svitkina, T				Yang, Changsong; Hoelzle, Matthew; Disanza, Andrea; Scita, Giorgio; Svitkina, Tatyana			Coordination of Membrane and Actin Cytoskeleton Dynamics during Filopodia Protrusion	PLOS ONE			English	Article								Leading edge protrusion of migrating cells involves tightly coordinated changes in the plasma membrane and actin cytoskeleton. It remains unclear whether polymerizing actin filaments push and deform the membrane, or membrane deformation occurs independently and is subsequently stabilized by actin filaments. To address this question, we employed an ability of the membrane-binding I-BAR domain of IRSp53 to uncouple the membrane and actin dynamics and to induce filopodia in expressing cells. Using time-lapse imaging and electron microscopy of IRSp53-I-BAR-expressing B16F1 melanoma cells, we demonstrate that cells are not able to protrude or maintain durable long extensions without actin filaments in their interior, but I-BAR-dependent membrane deformation can create a small and transient space at filopodial tips that is subsequently filled with actin filaments. Moreover, the expressed I-BAR domain forms a submembranous coat that may structurally support these transient actin-free protrusions until they are further stabilized by the actin cytoskeleton. Actin filaments in the I-BAR-induced filopodia, in contrast to normal filopodia, do not have a uniform length, are less abundant, poorly bundled, and display erratic dynamics. Such unconventional structural organization and dynamics of actin in I-BAR-induced filopodia suggests that a typical bundle of parallel actin filaments is not necessary for generation and mechanical support of the highly asymmetric filopodial geometry. Together, our data suggest that actin filaments may not directly drive the protrusion, but only stabilize the space generated by the membrane deformation; yet, such stabilization is necessary for efficient protrusion.			Yang, CS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	svitkina@sas.upenn.edu	Scita, Giorgio/J-9670-2012	Scita, Giorgio/0000-0001-7984-1889; Disanza, Andrea/0000-0001-5101-2907	NCRR NIH HHS [RR 22482, S10 RR022482] Funding Source: Medline; NIGMS NIH HHS [GM 70898, R01 GM070898] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070898] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bereiter-Hahn J, 2005, MED ENG PHYS, V27, P743, DOI 10.1016/j.medengphy.2005.04.021; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Saarikangas J, 2008, J CELL SCI, V121, P1444, DOI 10.1242/jcs.027466; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Small J V, 1988, Electron Microsc Rev, V1, P155; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Svitkina T, 2007, METHOD CELL BIOL, V79, P295, DOI 10.1016/S0091-679X(06)79012-4; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; SVITKINA TM, 2006, CELL BIOL LAB HDB, V3, P277; Weiss SM, 2009, CELL HOST MICROBE, V5, P244, DOI 10.1016/j.chom.2009.02.003; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317	34	79	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5678	10.1371/journal.pone.0005678	http://dx.doi.org/10.1371/journal.pone.0005678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479071	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331700006
J	Granlund, I; Hall, M; Kieselbach, T; Schroder, WP				Granlund, Irene; Hall, Michael; Kieselbach, Thomas; Schroder, Wolfgang P.			Light Induced Changes in Protein Expression and Uniform Regulation of Transcription in the Thylakoid Lumen of Arabidopsis thaliana	PLOS ONE			English	Article								In plants oxygenic photosynthesis is performed by large protein complexes found in the thylakoid membranes of chloroplasts. The soluble thylakoid lumen space is a narrow and compressed region within the thylakoid membrane which contains 80-200 proteins. Because the thylakoid lumen proteins are in close proximity to the protein complexes of photosynthesis, it is reasonable to assume that the lumen proteins are highly influenced by the presence of light. To identify light regulated proteins in the thylakoid lumen of Arabidopsis thaliana we developed a faster thylakoid preparation and combined this with difference gel electrophoresis (DIGE) of dark-adapted and light-adapted lumen proteomes. The DIGE experiments revealed that 19 lumen proteins exhibit increased relative protein levels after eight hour light exposure. Among the proteins showing increased abundance were the PsbP and PsbQ subunits of Photosystem II, major plastocyanin and several other proteins of known or unknown function. In addition, co-expression analysis of publicly available transcriptomic data showed that the co-regulation of lumen protein expression is not limited to light but rather that lumen protein genes exhibit a high uniformity of expression. The large proportion of thylakoid lumen proteins displaying increased abundance in light-adapted plants, taken together with the observed uniform regulation of transcription, implies that the majority of thylakoid lumen proteins have functions that are related to photosynthetic activity. This is the first time that an analysis of the differences in protein level during a normal day/night cycle has been performed and it shows that even a normal cycle of light significantly influences the thylakoid lumen proteome. In this study we also show for the first time, using co-expression analysis, that the prevalent lumenal chloroplast proteins are very similarly regulated at the level of transcription.			Granlund, I (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden.	wolfgang.schroder@chem.umu.se	Kieselbach, Thomas/O-6023-2015	Kieselbach, Thomas/0000-0001-5577-2938; Schroder, Wolfgang/0000-0001-9831-1533				Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Fankhauser C, 2002, PLANTA, V216, P1, DOI 10.1007/s00425-002-0831-4; Fu A, 2007, P NATL ACAD SCI USA, V104, P15947, DOI 10.1073/pnas.0707851104; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hashimoto A, 1996, FEBS LETT, V391, P29; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Kieselbach T, 2003, PHOTOSYNTH RES, V78, P249, DOI 10.1023/B:PRES.0000006913.86689.f1; Kieselbach T, 1998, J BIOL CHEM, V273, P6710, DOI 10.1074/jbc.273.12.6710; Kovalenko IB, 2006, PHYS BIOL, V3, P121, DOI 10.1088/1478-3975/3/2/004; Lima A, 2006, P NATL ACAD SCI USA, V103, P12631, DOI 10.1073/pnas.0605452103; Lintala M, 2007, PLANT J, V49, P1041, DOI 10.1111/j.1365-313X.2006.03014.x; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Pesaresi P, 2009, MOL PLANT, V2, P236, DOI 10.1093/mp/ssn041; Pfannschmidt T, 2001, PHYSIOL PLANTARUM, V112, P1, DOI 10.1034/j.1399-3054.2001.1120101.x; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V972, P163; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Schutze K, 2008, PHYSIOL PLANTARUM, V133, P557, DOI 10.1111/j.1399-3054.2008.01118.x; Sirpio S, 2007, BIOCHEM J, V406, P415, DOI 10.1042/BJ20070460; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510; THOMPSON WF, 1991, ANNU REV PLANT PHYS, V42, P423, DOI 10.1146/annurev.pp.42.060191.002231; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; VORST O, 1993, PLANT J, V4, P933, DOI 10.1046/j.1365-313X.1993.04060933.x; Westermeier R, 2002, PROTEOMICS PRACTICE; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yi XP, 2006, J BIOL CHEM, V281, P26260, DOI 10.1074/jbc.M603582200; Yonekura-Sakakibara K, 2007, J BIOL CHEM, V282, P14932, DOI 10.1074/jbc.M611498200; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	40	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5649	10.1371/journal.pone.0005649	http://dx.doi.org/10.1371/journal.pone.0005649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19461964	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331000008
J	Xiao, ZJ; Ma, CQ; Xu, P; Lu, JR				Xiao, Zijun; Ma, Cuiqing; Xu, Ping; Lu, Jian R.			Acetoin Catabolism and Acetylbutanediol Formation by Bacillus pumilus in a Chemically Defined Medium	PLOS ONE			English	Article								Background: Most low molecular diols are highly water-soluble, hygroscopic, and reactive with many organic compounds. In the past decades, microbial research to produce diols, e. g. 1,3-propanediol and 2,3-butanediol, were considerably expanded due to their versatile usages especially in polymer synthesis and as possible alternatives to fossil based feedstocks from the bioconversion of renewable natural resources. This study aimed to provide a new way for bacterial production of an acetylated diol, i.e. acetylbutanediol (ABD, 3,4-dihydroxy-3-methylpentan-2-one), by acetoin metabolism. Methodology/Principal Findings: When Bacillus pumilus ATCC 14884 was aerobically cultured in a chemically defined medium with acetoin as the sole carbon and energy source, ABD was produced and identified by gas chromatography chemical ionization mass spectrometry and NMR spectroscopy. Conclusions/Significance: Although the key enzyme leading to ABD from acetoin has not been identified yet at this stage, this study proposed a new metabolic pathawy to produce ABD in vivo from using renewable resources - in this case acetoin, which could be reproduced from glucose in this study - making it the first facility in the world to prepare this new bio-based diol product.			Xiao, ZJ (corresponding author), China Univ Petr, Ctr Bioengn Biotechnol, Qingdao, Peoples R China.	pingxu@sjtu.edu.cn; j.lu@manchester.ac.uk	Lu, Jian/GRY-4556-2022	, zijun/0000-0003-1141-8149; Yu, Hai/0000-0002-6386-9761; Ma, Cuiqing/0000-0002-7468-1027				Berkout VD, 2001, J AM SOC MASS SPECTR, V12, P641, DOI 10.1016/S1044-0305(01)00250-1; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; *BRIT PHARM COMM, 2003, BRIT PHARM APP 14; *BRIT STAND I, 2000, 8664 BS EN BRIT STAN; *EUR PHARM COMM, 1997, EP272 EUR PHARM COMM; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Holt J., 1994, BERGEYS MANUAL DETER; JUNI E, 1956, J BACTERIOL, V71, P425, DOI 10.1128/JB.71.4.425-432.1956; MILLER PE, 1986, INT J MASS SPECTROM, V72, P223, DOI 10.1016/0168-1176(86)80021-0; Nagradova N, 2003, IUBMB LIFE, V55, P459, DOI 10.1080/15216540310001602805; OPPERMANN FB, 1991, J BACTERIOL, V173, P757, DOI 10.1128/jb.173.2.757-767.1991; SERGEANT TP, 1957, J BACTERIOL, V74, P728, DOI 10.1128/JB.74.6.728-736.1957; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; Ui S, 1998, J FERMENT BIOENG, V85, P79, DOI 10.1016/S0922-338X(97)80358-3; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; XU P, 2006, Patent No. 2006053480	18	25	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5627	10.1371/journal.pone.0005627	http://dx.doi.org/10.1371/journal.pone.0005627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461961	gold, Green Submitted, Green Published			2022-12-27	WOS:000266234700014
J	Yaragatti, M; Wen, Q				Yaragatti, Mahesh; Wen, Qi			Analysis of Functional Genomic Signals Using the XOR Gate	PLOS ONE			English	Article								Modeling gene regulatory networks requires recognition of active transcriptional sites in the genome. For this reason, we present a novel approach for inferring active transcriptional regulatory modules in a genome using an established systems model of bit encoded DNA sequences. Our analysis showed variations in several properties between random and functional sequences. Cross correlation within random and functional groups uncovered a wave pattern associated with functional sequences. Using the exclusive-OR (XOR) logic gate, we formulated a scheme to threshold signals that may correlate to putative active transcriptional modules from a population of random genomic fragments. It is our intent to use this as a basis for identifying novel regulatory sites in the genome.			Yaragatti, M (corresponding author), Univ Penn, Biotechnol Program, Philadelphia, PA 19104 USA.	myar@seas.upenn.edu	Wen, Qi/E-3864-2015					Bina M, 2009, GENOMICS, V93, P314, DOI 10.1016/j.ygeno.2008.11.008; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; DASGUPTA B, 2005, BIOINFORMATICS, V16, P3424; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Gingeras TR, 2007, GENOME RES, V17, P682, DOI 10.1101/gr.6525007; Gingeras TR, 2006, NAT GENET, V38, P608, DOI 10.1038/ng0606-608; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Voelcker NH, 2008, SMALL, V4, P427, DOI 10.1002/smll.200700113; Warmflash A, 2008, P NATL ACAD SCI USA, V105, P17262, DOI 10.1073/pnas.0809314105; Yaragatti M, 2009, BIOINFORMATICS, V25, P353, DOI 10.1093/bioinformatics/btn622	10	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5608	10.1371/journal.pone.0005608	http://dx.doi.org/10.1371/journal.pone.0005608			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440336	Green Published, Green Submitted, gold			2022-12-27	WOS:000266161200010
J	Chen, ZJ; Leskinen, H; Liimatta, E; Sormunen, RT; Miinalainen, IJ; Hassinen, IE; Hiltunen, JK				Chen, Zhijun; Leskinen, Hanna; Liimatta, Erkki; Sormunen, Raija T.; Miinalainen, Ilkka J.; Hassinen, Ilmo E.; Hiltunen, J. Kalervo			Myocardial Overexpression of Mecr, a Gene of Mitochondrial FAS II Leads to Cardiac Dysfunction in Mouse	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; 2-ENOYL THIOESTER REDUCTASE; TRANSGENIC MICE; SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; EXPRESSION; HEART; CLONING; HYPERPLASIA; PHYSIOLOGY	It has been recently recognized that mammalian mitochondria contain most, if not all, of the components of fatty acid synthesis type II (FAS II). Among the components identified is 2-enoyl thioester reductase/mitochondrial enoyl-CoA reductase (Etr1/Mecr), which catalyzes the NADPH-dependent reduction of trans-2-enoyl thioesters, generating saturated acyl-groups. Although the FAS type II pathway is highly conserved, its physiological role in fatty acid synthesis, which apparently occurs simultaneously with breakdown of fatty acids in the same subcellular compartment in mammals, has remained an enigma. To study the in vivo function of the mitochondrial FAS in mammals, with special reference to Mecr, we generated mice overexpressing Mecr under control of the mouse metallothionein-1 promoter. These Mecr transgenic mice developed cardiac abnormalities as demonstrated by echocardiography in vivo, heart perfusion ex vivo, and electron microscopy in situ. Moreover, the Mecr transgenic mice showed decreased performance in endurance exercise testing. Our results showed a ventricular dilatation behind impaired heart function upon Mecr overexpression, concurrent with appearance of dysmorphic mitochondria. Furthermore, the data suggested that inappropriate expression of genes of FAS II can result in the development of hereditary cardiomyopathy.			Chen, ZJ (corresponding author), Univ Oulu, Bioctr Oulu, Oulu, Finland.	kalervo.hiltunen@oulu.fi	Chen, Zhijun/V-3228-2019	Miinalainen, Ilkka/0000-0002-3922-3442; Hiltunen, Kalervo/0000-0002-3073-9602				Alhonen L, 1996, BIOCHEM J, V314, P405, DOI 10.1042/bj3140405; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Baggio L, 2000, J BIOL CHEM, V275, P34471, DOI 10.1074/jbc.M005119200; BEHRINGER RR, 1990, NATURE, V345, P167, DOI 10.1038/345167a0; Boluyt MO, 2005, AM J HYPERTENS, V18, P202, DOI 10.1016/j.amjhyper.2004.08.034; Borutaite V, 2003, FEBS LETT, V541, P1, DOI 10.1016/S0014-5793(03)00278-3; CHAIN EB, 1969, BIOCHEM J, V115, P537, DOI 10.1042/bj1150537; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Coats Andrew J. S., 2001, Cardiology Clinics, V19, P517, DOI 10.1016/S0733-8651(05)70233-2; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Fukuda T, 2005, MOL CELL BIOL, V25, P5270, DOI 10.1128/MCB.25.12.5270-5281.2005; GAWEHN K, 1970, METHODEN ENZYMATISCH, P2156; HASSINEN I, 1968, BIOCHEM BIOPH RES CO, V31, P895, DOI 10.1016/0006-291X(68)90536-6; Joshi AK, 2003, J BIOL CHEM, V278, P33142, DOI 10.1074/jbc.M305459200; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Lamprecht W., 1970, METHODEN ENZYMATISCH, P2024; Liang TJ, 1996, J CLIN INVEST, V97, P2872, DOI 10.1172/JCI118744; LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637; Massett MP, 2005, AM J PHYSIOL-REG I, V288, pR1006, DOI 10.1152/ajpregu.00476.2004; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; Morikawa T, 2001, FEBS LETT, V498, P16, DOI 10.1016/S0014-5793(01)02469-3; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Schlame M, 1999, J LIPID RES, V40, P1585; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; Schneider R, 1997, CURR GENET, V32, P384, DOI 10.1007/s002940050292; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Suppola S, 1999, BIOCHEM J, V338, P311, DOI 10.1042/0264-6021:3380311; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Williamson J R, 1979, Methods Enzymol, V55, P200; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200; Zhang WY, 2003, J BIOL CHEM, V278, P21459, DOI 10.1074/jbc.M301652200	40	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5589	10.1371/journal.pone.0005589	http://dx.doi.org/10.1371/journal.pone.0005589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440339	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107500017
J	Yang, L; Zhao, TJ; Shi, XL; Nakhaei, P; Wang, YL; Sun, Q; Hiscott, J; Lin, RT				Yang, Long; Zhao, Tiejun; Shi, Xiaoliu; Nakhaei, Peyman; Wang, Yunling; Sun, Qiang; Hiscott, John; Lin, Rongtuan			Functional Analysis of a Dominant Negative Mutation of Interferon Regulatory Factor 5	PLOS ONE			English	Article								Background: Interferon regulatory factor (IRF) family members have been implicated as critical transcription factors that function in immune response, hematopoietic differentiation and cell growth regulation. Activation of IRF-5 results in the production of pro-inflammatory cytokines such as TNF alpha, IL6 and IL12p40, as well as type I interferons. Methodology/Principal Findings: In this study, we identify a G202C (position relative to translation start codon) missense-mutation transcript of IRF-5 in transformed B and T cell lines, which were either infected or non-infected by viruses, and peripheral blood from ATL or CLL patients. The mutated transcript encodes a novel protein in which the sixty-eighth amino acid, Alanine, is substituted by Proline (IRF-5P68) in the DNA binding domain of IRF-5. IRF-5P68 phenotype results in a complete loss of its DNA-binding activity and functions as a dominant negative molecule through interacting with wild type IRF-5. Co-expression of IRF-5P68 inhibits MyD88-mediated IRF-5 transactivation. Moreover, Toll-like receptor (TLR)-dependent IL6 and IL12P40 production induced by lipopolysaccharide (LPS), R837 or CpG ODN 1826 was reduced in IRF-5 (P68) expressing cells as compared to the control cells. Conclusion: IRF-5P68 acts as a dominant negative regulator that interferes with IRF-5-mediated production of proinflammatory cytokines. The functional characterization of the novel IRF-5 mutant in transformed B and T cell lines and in ATL and CLL patients may lead to a better understanding of the role of these transcriptional regulators in hematopoietic malignancies.			Yang, L (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada.	rongtuan.lin@mcgill.ca	Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503; Shi, Xiaoliu/0000-0002-9759-2254				Abbott BL, 2006, CANCER INVEST, V24, P302, DOI 10.1080/07357900600620525; BALKHI MY, 2008, MOL CELL BIOL; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Decker T, 2000, BLOOD, V95, P999, DOI 10.1182/blood.V95.3.999.003k10_999_1006; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Mattick JS, 2008, TRENDS NEUROSCI, V31, P227, DOI 10.1016/j.tins.2008.02.003; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Spaner DE, 2006, LEUKEMIA, V20, P286, DOI 10.1038/sj.leu.2404061; Spaner DE, 2004, BRIT J HAEMATOL, V127, P531, DOI 10.1111/j.1365-2141.2004.05240.x; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	34	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5500	10.1371/journal.pone.0005500	http://dx.doi.org/10.1371/journal.pone.0005500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430534	Green Submitted, gold, Green Published			2022-12-27	WOS:000266009700006
J	Grip, O; Janciauskiene, S				Grip, Olof; Janciauskiene, Sabina			Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease	PLOS ONE			English	Article								Background: In Crohn's disease high tissue expression and serum levels of chemokines and their receptors are known to correlate with disease activity. Because statins can reduce chemokine expression in patients with coronary diseases, we wanted to test whether this can be achieved in patients with Crohn's disease. Methodology/Principal Findings: We investigated plasma levels of chemokines (CCL2, CCL4, CCL11, CCL13, CCL17, CCL22, CCL26, CXCL8, CXCL10) and endothelial cytokines (sP-selectin, sE-selectin, sICAM-3, thrombomodulin) in ten Crohn's disease patients before and after thirteen weeks' daily treatment with 80 mg atorvastatin. Of the 13 substances investigated, only CXCL10 was found to be significantly reduced (by 34%, p = 0.026) in all of the treated patients. Levels of CXCL10 correlated with C-reactive protein (r = 0.82, p<0.01). Conclusions/Significance: CXCL10 is a ligand for the CXCR3 receptor, the activation of which results in the recruitment of T lymphocytes and the perpetuation of mucosal inflammation. Hence the reduction of plasma CXCL10 levels by atorvastatin may represent a candidate for an approach to the treatment of Crohns disease in the future.			Grip, O (corresponding author), Lund Univ, Div Gastroenterol & Hepatol, Dept Clin Sci Malmo, Univ Hosp MAS, Malmo, Sweden.	olof.grip@med.lu.se						Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Andoh A, 2005, AM J GASTROENTEROL, V100, P2042, DOI 10.1111/j.1572-0241.2005.50381.x; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Barnes PJ, 1997, INT J BIOCHEM CELL B, V29, P867, DOI 10.1016/S1357-2725(96)00159-8; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Blanco-Colio LM, 2007, AM HEART J, V153, P881, DOI 10.1016/j.ahj.2007.02.029; Bolewski A, 2008, CARDIOLOGY, V111, P140, DOI 10.1159/000119702; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Chen W, 2001, SCAND J GASTROENTERO, V36, P515, DOI 10.1080/003655201750153377; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; Dwinell MB, 2001, GASTROENTEROLOGY, V120, P49, DOI 10.1053/gast.2001.20914; Garcia-Lopez MA, 2001, LAB INVEST, V81, P409, DOI 10.1038/labinvest.3780248; Gasperini S, 1999, J IMMUNOL, V162, P4928; Goke M, 1997, J GASTROENTEROL, V32, P480, DOI 10.1007/BF02934086; Grip O, 2004, INFLAMM BOWEL DIS, V10, P193, DOI 10.1097/00054725-200405000-00003; Grip O, 2008, BRIT J PHARMACOL, V155, P1085, DOI 10.1038/bjp.2008.369; Heystek HC, 2003, INT IMMUNOL, V15, P827, DOI 10.1093/intimm/dxg079; Hyun JG, 2005, INFLAMM BOWEL DIS, V11, P799, DOI 10.1097/01.MIB.0000178263.34099.89; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jugde F, 2001, EUR CYTOKINE NETW, V12, P468; KOBAYASHI T, 2008, GUT; Kushiya F, 2005, AM J HEMATOL, V78, P1, DOI 10.1002/ajh.20191; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Moser B, 2004, ANN RHEUM DIS, V63, P84, DOI 10.1136/ard.2004.028316; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rauch U, 2000, ATHEROSCLEROSIS, V153, P181, DOI 10.1016/S0021-9150(00)00397-X; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sanders DSA, 2005, J CLIN PATHOL, V58, P568, DOI 10.1136/jcp.2004.021840; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Singh UP, 2003, J IMMUNOL, V171, P1401, DOI 10.4049/jimmunol.171.3.1401; Solem CA, 2005, INFLAMM BOWEL DIS, V11, P707, DOI 10.1097/01.MIB.0000173271.18319.53; Takahashi HK, 2005, J LEUKOCYTE BIOL, V77, P400, DOI 10.1189/jlb.0904510; Uguccioni M, 1999, AM J PATHOL, V155, P331, DOI 10.1016/S0002-9440(10)65128-0; Waehre T, 2003, J AM COLL CARDIOL, V41, P1460, DOI 10.1016/S0735-1097(03)00263-8; Wagner AH, 2002, BRIT J PHARMACOL, V136, P143, DOI 10.1038/sj.bjp.0704678; Wong CK, 2007, IMMUNOL LETT, V112, P82, DOI 10.1016/j.imlet.2007.07.002; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhong W, 2008, FRONT BIOSCI-LANDMRK, V13, P1654, DOI 10.2741/2789	52	47	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5263	10.1371/journal.pone.0005263	http://dx.doi.org/10.1371/journal.pone.0005263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421322	gold, Green Published, Green Submitted			2022-12-27	WOS:000265836900001
J	Wognum, S; Lagoa, CE; Nagatomi, J; Sacks, MS; Vodovotz, Y				Wognum, Silvia; Lagoa, Claudio E.; Nagatomi, Jiro; Sacks, Michael S.; Vodovotz, Yoram			An Exploratory Pathways Analysis of Temporal Changes Induced by Spinal Cord Injury in the Rat Bladder Wall: Insights on Remodeling and Inflammation	PLOS ONE			English	Article								Background: Spinal cord injuries (SCI) can lead to severe bladder pathologies associated with inflammation, fibrosis, and increased susceptibility to urinary tract infections. We sought to characterize the complex pathways of remodeling, inflammation, and infection in the urinary bladder at the level of the transcriptome in a rat model of SCI, using pathways analysis bioinformatics. Methodology/Principal Findings: Experimental data were obtained from the study of Nagatomi et al. (Biochem Biophys Res Commun 334: 1159). In this study, bladders from rats subjected to surgical SCI were obtained at 3, 7 or 25 days post-surgery, and Affymetrix GeneChip (R) Rat Genome U34A arrays were used for cRNA hybridizations. In the present study, Ingenuity Pathways Analysis (Ingenuity (R) Systems, www.ingenuity.com) of differentially expressed genes was performed. Analysis of focus genes in networks, functional analysis, and canonical pathway analysis reinforced our previous findings related to the presence of up-regulated genes involved in tissue remodeling, such as lysyl oxidase, tropoelastin, TGF-beta 1, and IGF-1. This analysis also highlighted a central role for inflammation and infection, evidenced by networks containing genes such as CD74, S100A9, and THY1. Conclusions/Significance: Our findings suggest that tissue remodeling, infection, inflammation, and tissue damage/dysfunction all play a role in the urinary bladder, in the complex response to SCI.			Wognum, S (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu	Sacks, Michael s/F-3703-2011	Lagoa, Constantino/0000-0001-6871-3240	NICHD NIH HHS [P01 HD039768, P01-HD39768] Funding Source: Medline; NIDCD NIH HHS [R01-DC-008290, R01 DC008290] Funding Source: Medline; NIGMS NIH HHS [P50 GM053789, P50-GM-53789] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008290] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; BADESCH DB, 1989, BIOCHEM BIOPH RES CO, V160, P382, DOI 10.1016/0006-291X(89)91667-7; Bethea JR, 2000, PROG BRAIN RES, V128, P33; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; DAVIDSON JM, 1993, J CELL PHYSIOL, V155, P149, DOI 10.1002/jcp.1041550119; Deveaud CM, 1998, J UROLOGY, V160, P1518, DOI 10.1016/S0022-5347(01)62606-5; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fischer HP, 2005, BIOTECHNOL ANN REV, V11, P1, DOI 10.1016/S1387-2656(05)11001-1; Foell D, 2005, J IMMUNOL, V175, P3459, DOI 10.4049/jimmunol.175.6.3459; Gloeckner DC, 2002, J UROLOGY, V167, P2247, DOI 10.1016/S0022-5347(05)65137-3; Guzey M, 2004, J CELL BIOCHEM, V93, P271, DOI 10.1002/jcb.20182; HACKLER RH, 1989, J UROLOGY, V141, P1390, DOI 10.1016/S0022-5347(17)41319-X; Harlow CR, 2003, ENDOCRINOLOGY, V144, P154, DOI 10.1210/en.2002-220652; Hipp JD, 2007, BJU INT, V99, P418, DOI 10.1111/j.1464-410X.2007.06676.x; Ibarra A, 2007, SPINAL CORD, V45, P380, DOI 10.1038/sj.sc.3101972; IZUHARA Y, 2008, ARTERIOSCLER THROMB; Janzen J, 2001, SPINAL CORD, V39, P568, DOI 10.1038/sj.sc.3101218; Lagoa CE, 2006, SHOCK, V26, P592, DOI 10.1097/01.shk.0000232272.03602.0a; Lau YKI, 2006, ANN BIOMED ENG, V34, P1239, DOI 10.1007/s10439-006-9130-8; Leung YF, 2003, TRENDS GENET, V19, P649, DOI 10.1016/j.tig.2003.09.015; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; Makibayashi K, 2001, AM J PATHOL, V158, P1733, DOI 10.1016/S0002-9440(10)64129-6; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meyer-Siegler KL, 2005, J UROLOGY, V173, P615, DOI 10.1097/01.ju.0000143188.02802.f3; MIMATA H, 1993, UROL INT, V51, P89, DOI 10.1159/000282520; Nagatomi J, 2005, ANN BIOMED ENG, V33, P1078, DOI 10.1007/s10439-005-5776-x; Nagatomi J, 2005, BIOCHEM BIOPH RES CO, V334, P1159, DOI 10.1016/j.bbrc.2005.07.011; Nagatomi J, 2004, ANN BIOMED ENG, V32, P1409, DOI 10.1114/B:ABME.0000042228.89106.48; Nagatomi J, 2008, BIOMECH MODEL MECHAN, V7, P395, DOI 10.1007/s10237-007-0095-9; Noordewier MO, 2001, TRENDS BIOTECHNOL, V19, P412, DOI 10.1016/S0167-7799(01)01735-8; PAREKH A, 2009, J UROL IN PRESS; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Saban Ricardo, 2007, BMC Physiology, V7, P3, DOI 10.1186/1472-6793-7-3; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Toosi KK, 2008, ANN BIOMED ENG, V36, P1470, DOI 10.1007/s10439-008-9525-9; van Someren EP, 2002, PHARMACOGENOMICS, V3, P507, DOI 10.1517/14622416.3.4.507; Wang XX, 2007, CELL SIGNAL, V19, P1372, DOI 10.1016/j.cellsig.2007.03.013; Wang XQ, 1999, J CELL BIOL, V147, P389, DOI 10.1083/jcb.147.2.389; Watanabe T, 1996, UROL CLIN N AM, V23, P459, DOI 10.1016/S0094-0143(05)70325-6; Weld KJ, 2000, J UROLOGY, V163, P1228, DOI 10.1016/S0022-5347(05)67730-0; WOLFE BL, 1993, J BIOL CHEM, V268, P12418	52	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5852	10.1371/journal.pone.0005852	http://dx.doi.org/10.1371/journal.pone.0005852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513121	gold, Green Published, Green Submitted			2022-12-27	WOS:000267228800016
J	Yan, RHY; Bunning, M; Wahlsten, D; Hurd, PL				Yan, Reginia H. Y.; Bunning, Mark; Wahlsten, Douglas; Hurd, Peter L.			Digit Ratio (2D:4D) Differences between 20 Strains of Inbred Mice	PLOS ONE			English	Article							LENGTH RATIOS; SEXUAL-DIMORPHISM; FINGER-LENGTH; RELATIVE LENGTHS; 2D/4D; ORIENTATION; HORMONES; MALES; MEN	The second to fourth digit ratio (2D:4D) is sexually differentiated in a variety of species, including humans, rats, birds, and lizards. In humans, this ratio tends to be lower in males than in females. Lower digit ratios are believed to indicate increased prenatal testosterone exposure, and are associated with more masculinized behavior across a range of traits. The story seems more complicated in laboratory mice. We have previously shown that there is no sex difference in the digit ratios of inbred mice, but found behavioral evidence to suggest that higher 2D: 4D is associated with more masculinized behaviors. Work examining intrauterine position effects show that neighbouring males raise pup digit ratio, suggesting again that higher digit ratios are associated with increased developmental androgens. Other work has suggested that masculinization is associated with lower digit ratios in lab mice. Here, we examine the fore- and hindlimb digit ratios of 20 inbred mouse strains. We find large inter-strain differences, but no sexual dimorphism. Digit ratios also did not correlate with mice behavioral traits. This result calls into question the use of this trait as a broadly applicable indicator for prenatal androgen exposure. We suggest that the inbred mice model presents an opportunity for researchers to investigate the genetic, and gene-environmental influence on the development of digit ratios.			Yan, RHY (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	phurd@ualberta.ca	Hurd, Peter L/A-4342-2009	Hurd, Peter L/0000-0002-4389-0846	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012714] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], 2011, J SEX MED, DOI DOI 10.1111/j.1743-6109.2011.02449.x; Bailey AA, 2005, GENES BRAIN BEHAV, V4, P318, DOI 10.1111/j.1601-183X.2004.00110.x; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Brown WM, 2002, ANAT RECORD, V267, P231, DOI 10.1002/ar.10108; Burley NT, 2004, P ROY SOC B-BIOL SCI, V271, P239, DOI 10.1098/rspb.2003.2562; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLLAER ML, 1995, PSYCHOL BULL, V118, P55, DOI 10.1037/0033-2909.118.1.55; Csatho A, 2003, BIOL PSYCHOL, V62, P147, DOI 10.1016/S0301-0511(02)00127-8; Efron B, 1994, INTRO BOOTSTRAP; Forstmeier W, 2005, P R SOC B, V272, P2641, DOI 10.1098/rspb.2005.3264; Hurd PL, 2008, ARCH SEX BEHAV, V37, P9, DOI 10.1007/s10508-007-9259-z; Hurd PL, 2007, ARCH SEX BEHAV, V36, P139, DOI 10.1007/s10508-006-9149-9; Leoni B, 2005, ANAT REC PART A, V286A, P955, DOI 10.1002/ar.a.20226; Loehlin JC, 2006, ARCH SEX BEHAV, V35, P739, DOI 10.1007/s10508-006-9039-1; Manning JT, 2003, MED HYPOTHESES, V60, P340, DOI 10.1016/S0306-9877(02)00400-0; Manning JT., 2002, DIGIT RATIO POINTER; McFadden D, 2005, HORM BEHAV, V47, P99, DOI 10.1016/j.yhbeh.2004.08.013; McFadden D, 2002, HORM BEHAV, V42, P492, DOI 10.1006/hbeh.2002.1833; McFadden D, 2005, ARCH SEX BEHAV, V34, P341, DOI 10.1007/s10508-005-3123-9; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; Puts DA, 2008, ARCH SEX BEHAV, V37, P100, DOI 10.1007/s10508-007-9271-3; Putz DA, 2004, EVOL HUM BEHAV, V25, P182, DOI 10.1016/j.evolhumbehav.2004.03.005; Rammsayer TH, 2007, PERS INDIV DIFFER, V42, P911, DOI 10.1016/j.paid.2006.09.002; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, ANAT REC PART A, V288A, P491, DOI 10.1002/ar.a.20323; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; Saino N, 2007, NATURWISSENSCHAFTEN, V94, P207, DOI 10.1007/s00114-006-0188-9; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Voracek M, 2006, GENES BRAIN BEHAV, V5, P299, DOI 10.1111/j.1601-183x.2006.00217.x; WALSTEN D, 2007, NEUROBEHAVIORAL GENE, P149; Yan RHY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003216	31	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5801	10.1371/journal.pone.0005801	http://dx.doi.org/10.1371/journal.pone.0005801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	454XI	19495421	gold, Green Submitted, Green Published			2022-12-27	WOS:000266716900011
J	Gu, JJ; Orr, N; Park, SD; Katz, LM; Sulimova, G; MacHugh, DE; Hill, EW				Gu, Jingjing; Orr, Nick; Park, Stephen D.; Katz, Lisa M.; Sulimova, Galina; MacHugh, David E.; Hill, Emmeline W.			A Genome Scan for Positive Selection in Thoroughbred Horses	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; P85-ALPHA REGULATORY SUBUNIT; STANDARD-BRED TROTTERS; BROWN ADIPOSE-TISSUE; GENE-EXPRESSION; INSULIN-RESISTANCE; PHOSPHATIDYLINOSITOL 3-KINASE; GAMMA-HYDROXYBUTYRATE; DIABETES-MELLITUS; POPULATION DIFFERENTIATION	Thoroughbred horses have been selected for exceptional racing performance resulting in system-wide structural and functional adaptations contributing to elite athletic phenotypes. Because selection has been recent and intense in a closed population that stems from a small number of founder animals Thoroughbreds represent a unique population within which to identify genomic contributions to exercise-related traits. Employing a population genetics-based hitchhiking mapping approach we performed a genome scan using 394 autosomal and X chromosome microsatellite loci and identified positively selected loci in the extreme tail-ends of the empirical distributions for (1) deviations from expected heterozygosity (Ewens-Watterson test) in Thoroughbred (n = 112) and (2) global differentiation among four geographically diverse horse populations (F-ST). We found positively selected genomic regions in Thoroughbred enriched for phosphoinositide-mediated signalling (3.2-fold enrichment; P<0.01), insulin receptor signalling (5.0-fold enrichment; P<0.01) and lipid transport (2.2-fold enrichment; P<0.05) genes. We found a significant overrepresentation of sarcoglycan complex (11.1-fold enrichment; P<0.05) and focal adhesion pathway (1.9-fold enrichment; P<0.01) genes highlighting the role for muscle strength and integrity in the Thoroughbred athletic phenotype. We report for the first time candidate athletic-performance genes within regions targeted by selection in Thoroughbred horses that are principally responsible for fatty acid oxidation, increased insulin sensitivity and muscle strength: ACSS1 (acyl-CoA synthetase short-chain family member 1), ACTA1 (actin, alpha 1, skeletal muscle), ACTN2 (actinin, alpha 2), ADHFE1 (alcohol dehydrogenase, iron containing, 1), MTFR1 (mitochondrial fission regulator 1), PDK4 (pyruvate dehydrogenase kinase, isozyme 4) and TNC (tenascin C). Understanding the genetic basis for exercise adaptation will be crucial for the identification of genes within the complex molecular networks underlying obesity and its consequential pathologies, such as type 2 diabetes. Therefore, we propose Thoroughbred as a novel in vivo large animal model for understanding molecular protection against metabolic disease.			Gu, JJ (corresponding author), Univ Coll Dublin, Coll Life Sci, Sch Agr Food Sci & Vet Med, Anim Genom Lab, Dublin 2, Ireland.	Emmeline.Hill@ucd.ie		Katz, Lisa/0000-0001-5547-2089; MacHugh, David/0000-0002-8112-4704; Hill, Emmeline/0000-0002-1805-2250				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Andreelli F, 1999, DIABETOLOGIA, V42, P358, DOI 10.1007/s001250051163; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BELL RH, 1983, J SURG RES, V35, P433, DOI 10.1016/0022-4804(83)90034-3; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Bottcher Y, 2007, DIABETES METAB, V33, P277, DOI 10.1016/j.diabet.2007.02.005; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; Burgomaster KA, 2007, AM J PHYSIOL-REG I, V292, pR1970, DOI 10.1152/ajpregu.00503.2006; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chan S, 2008, AM J PHYSIOL-CELL PH, V295, pC897, DOI 10.1152/ajpcell.00179.2008; Clarke NF, 2007, ANN NEUROL, V61, P552, DOI 10.1002/ana.21112; CONSTANTINOPOL M, 1989, J APPL PHYSIOL, V67, P871, DOI 10.1152/jappl.1989.67.2.871; Cornuet JM, 1996, GENETICS, V144, P2001; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Durieux AC, 2007, BIOCHEM SOC T, V35, P1312, DOI 10.1042/BST0351312; EATON MD, 1995, EQUINE VET J S, V18, P353; ESSENGUSTAVSSON B, 1985, EQUINE VET J, V17, P434, DOI 10.1111/j.2042-3306.1985.tb02549.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frank N., 2006, Proceedings of the 52nd Annual Convention of the American Association of Equine Practitioners, San Antonio, Texas, USA, 2-6 December, 2006, P51; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; GAFFNEY B, 1988, NATURE, V332, P722, DOI 10.1038/332722a0; Galloway GP, 1997, ADDICTION, V92, P89, DOI 10.1111/j.1360-0443.1997.tb03640.x; Geor RJ, 2002, EQUINE VET J, V34, P22; Geor RJ, 2000, J APPL PHYSIOL, V89, P1086, DOI 10.1152/jappl.2000.89.3.1086; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grabowski M, 2003, EUR J HUM GENET, V11, P138, DOI 10.1038/sj.ejhg.5200938; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gunn H. M., 1987, EQUINE EXERCISE PHYS, V2, P253; GUNN HM, 1983, P 1 INT C EQ EX PHYS, P271; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Hinchcliff K. W., 2008, HORSE ATHLETE PHYSL, p[ix, 463]; Hoffman RM, 2003, J ANIM SCI, V81, P2333; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; HOUSTON ME, 2006, BIOCH PRIMER EXERCIS, pR11; Hyyppa S, 1997, AM J VET RES, V58, P162; Johnson PJ, 2002, VET CLIN N AM-EQUINE, V18, P271, DOI 10.1016/S0749-0739(02)00006-8; JONES JH, 1989, J APPL PHYSIOL, V67, P862, DOI 10.1152/jappl.1989.67.2.862; JONES JH, 1993, ANNU REV PHYSIOL, V55, P547, DOI 10.1146/annurev.physiol.55.1.547; KAPLAN NL, 1989, GENETICS, V123, P887; Kardon T, 2006, FEBS LETT, V580, P2347, DOI 10.1016/j.febslet.2006.02.082; Katz L. M., 2005, Equine and Comparative Exercise Physiology, V2, P229, DOI 10.1079/ECP200570; Kauer MO, 2003, GENETICS, V165, P1137; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kayser M, 2003, MOL BIOL EVOL, V20, P893, DOI 10.1093/molbev/msg092; Kearns CF, 2002, VET J, V164, P224, DOI 10.1053/tvjl.2001.0702; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kim JY, 2007, ARCH BIOCHEM BIOPHYS, V464, P100, DOI 10.1016/j.abb.2007.04.018; Kronfeld DS, 2000, AM J VET RES, V61, P144, DOI 10.2460/ajvr.2000.61.144; Kronfeld DS, 2005, J ANIM SCI, V83, P22, DOI DOI 10.2527/2005.8313_SUPPLE22X; Lebrun P, 2008, ACTA PHYSIOL, V192, P29, DOI 10.1111/j.1748-1716.2007.01782.x; Levine M., 1999, LATE PREHISTORIC EXP, P5; Liou AKF, 1997, EMBO J, V16, P4311, DOI 10.1093/emboj/16.14.4311; Llorca O, 2001, J STRUCT BIOL, V135, P205, DOI 10.1006/jsbi.2001.4359; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MARCO S, 1994, BIOPHYS J, V67, P364, DOI 10.1016/S0006-3495(94)80489-8; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mattiangeli V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r74; MICKELSON J, 2009, EVALUATION EQUINESNP; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; MIZUNO Y, 1994, MUSCLE NERVE, V17, P206, DOI 10.1002/mus.880170212; Monticone M, 2007, REPRODUCTION, V134, P483, DOI 10.1530/REP-07-0199; Mota MDS, 2005, J ANIM BREED GENET, V122, P393, DOI 10.1111/j.1439-0388.2005.00551.x; Muller B, 2002, AM J HUM GENET, V71, P1303, DOI 10.1086/344531; Myles S, 2008, ANN HUM GENET, V72, P99, DOI 10.1111/j.1469-1809.2007.00390.x; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Ochala J, 2008, J MOL MED-JMM, V86, P1197, DOI 10.1007/s00109-008-0380-9; OLDHAM SL, 1990, J EQUINE VET SCI, V10, P353, DOI 10.1016/S0737-0806(06)80096-1; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Payseur BA, 2002, MOL BIOL EVOL, V19, P1143, DOI 10.1093/oxfordjournals.molbev.a004172; Penedo MCT, 2005, CYTOGENET GENOME RES, V111, P5, DOI 10.1159/000085664; Pilegaard H, 2004, P NUTR SOC, V63, P221, DOI 10.1079/PNS2004345; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; POSO AR, 1993, EQUINE VET J, V25, P527, DOI 10.1111/j.2042-3306.1993.tb03007.x; Prior SJ, 2003, PHYSIOL GENOMICS, V15, P20, DOI 10.1152/physiolgenomics.00061.2003; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Roques M, 1999, J BIOL CHEM, V274, P34005, DOI 10.1074/jbc.274.48.34005; Rotmistrovsky K, 2004, NUCLEIC ACIDS RES, V32, pW108, DOI 10.1093/nar/gkh450; SAHLIN K, 2008, ACTA PHYSL OXF; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; SHIBASAKI F, 1994, BIOCHEM J, V302, P551, DOI 10.1042/bj3020551; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Swinbume JE, 2006, GENOMICS, V87, P1, DOI 10.1016/j.ygeno.2005.09.001; TAKAHARA J, 1977, J CLIN ENDOCR METAB, V44, P1014, DOI 10.1210/jcem-44-5-1014; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tonachini L, 2004, J CELL PHYSIOL, V201, P470, DOI 10.1002/jcp.20126; Tozaki T, 2007, MOL GENET GENOMICS, V277, P663, DOI 10.1007/s00438-007-0216-2; Treiber KH, 2005, J ANIM SCI, V83, P2357; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tsuchida H, 2002, PFLUG ARCH EUR J PHY, V445, P25, DOI 10.1007/s00424-002-0907-9; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wagner PD, 1995, J EQUINE VET SCI, V15, P398, DOI 10.1016/S0737-0806(07)80484-9; WATTERSON GA, 1978, GENETICS, V88, P171; Weatherby and Sons, 1791, INTR GEN STUD BOOK; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; *WHO, 2000, TECHNICAL REPORT SER, V895; Willett P., 1975, INTRO THOROUGHBRED; Williams H, 1998, IRISH MED J, V91, P56; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Young BL, 2002, EQUINE VET J, V34, P469, DOI 10.2746/042516402776117755; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005; Zuccarello D, 2008, HUM REPROD, V23, P1957, DOI 10.1093/humrep/den193	137	100	110	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5767	10.1371/journal.pone.0005767	http://dx.doi.org/10.1371/journal.pone.0005767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503617	Green Published, Green Submitted, gold			2022-12-27	WOS:000266587400010
J	Choi, S; Min, HJ; Kim, M; Hwang, ES; Lee, K				Choi, Sunghee; Min, Hyun Jung; Kim, Miyoung; Hwang, Eun Sook; Lee, Kyunglim			Proton Pump Inhibitors Exert Anti-Allergic Effects by Reducing TCTP Secretion	PLOS ONE			English	Article								Background: Extracellular translationally controlled tumor protein (TCTP) is known to play a role in human allergic responses. TCTP has been identified outside of macrophages, in activated mononuclear cells, and in biological fluids from allergic patients. Even TCTP devoid of signal sequences, is secreted to extracellular environment by an yet undefined mechanism. This study is aimed at understanding the mechanism of TCTP release and its regulation. A secondary goal is to see if inhibitors of TCTP release can serve as potential anti-allergic asthmatic drugs. Methodology/Principal Findings: Using Western blotting assay in HEK293 and U937 cells, we found that TCTP secretion is reduced by omeprazole and pantoprazole, both of which are proton pump inhibitors. We then transfected HEK293 cells with proton pump expression vectors to search for the effects of exogeneously overexpressed H+/ K+-ATPase on the TCTP secretion. Based on these in vitro data we checked the in vivo effects of pantoprazole in a murine model of ovalbumin-induced allergy. Omeprazole and pantoprazole reduced TCTP secretion from HEK293 and U937 cells in a concentration-dependent fashion and the secretion of TCTP from HEK293 cells increased when they over-expressed H+/K+-ATPase. In a murine model of ovalbumin-induced allergy, pretreatment with pantoprazole reduced infiltration of inflammatory cells, increased goblet cells, and increased TCTP secretion induced by OVA challenge. Conclusion: Since Omeprazole and pantoprazole decrease the secretion of TCTP which is associated with the development of allergic reaction, they may have the potential to serve as anti-allergic (asthmatic) drugs.			Choi, S (corresponding author), Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Coll Pharm, Seoul, South Korea.	klyoon@ewha.ac.kr	Min, Hyunjung/ABA-8709-2020					Agastya G, 2000, IMMUNOPHARM IMMUNOT, V22, P357, DOI 10.3109/08923970009016425; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; BELL NJV, 1992, GUT, V33, P118, DOI 10.1136/gut.33.1.118; Bheekha-Escura R, 2000, BLOOD, V96, P2191; Bommer UA, 2002, RNA, V8, P478, DOI 10.1017/S1355838202022586; de Oliveira RM, 2007, INFLAMM RES, V56, P105, DOI 10.1007/s00011-006-6127-6; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Grant RL, 1996, IN VITRO CELL DEV-AN, V32, P38, DOI 10.1007/BF02722992; Holm A, 1999, MED BIOL ENG COMPUT, V37, P410, DOI 10.1007/BF02513321; IM WB, 1985, J BIOL CHEM, V260, P9452; Jiang SP, 2002, ANTIMICROB AGENTS CH, V46, P2569, DOI 10.1128/AAC.46.8.2569-2574.2002; KUCHLER K, 1992, ENDOCR REV, V13, P499, DOI 10.1210/er.13.3.499; LICHTENSTEIN LM, 1988, J ALLERGY CLIN IMMUN, V81, P814, DOI 10.1016/0091-6749(88)90936-0; LIU MC, 1986, J IMMUNOL, V136, P2588; LORENTZON P, 1987, BIOCHIM BIOPHYS ACTA, V897, P41, DOI 10.1016/0005-2736(87)90313-0; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; Naseri E, 2006, EUR J PHARMACOL, V531, P226, DOI 10.1016/j.ejphar.2005.12.025; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nielsen HV, 1998, ALLERGY, V53, P642, DOI 10.1111/j.1398-9995.1998.tb03950.x; PASMANS SGMA, 1994, INT ARCH ALLERGY IMM, V103, P44, DOI 10.1159/000236604; Schroeder JT, 1997, J IMMUNOL, V159, P447; Suzuki M, 1999, J GASTROEN HEPATOL, V14, P27, DOI 10.1046/j.1440-1746.1999.01809.x; Teshima S, 1998, J IMMUNOL, V161, P6356; WANDALL JH, 1992, GUT, V33, P617, DOI 10.1136/gut.33.5.617; WARNER JA, 1986, J IMMUNOL, V136, P2583; YOON KL, 1994, J BIOL CHEM, V269, P28249; Yoshida N, 2000, ALIMENT PHARM THERAP, V14, P74, DOI 10.1046/j.1365-2036.2000.014s1074.x; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	30	9	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5732	10.1371/journal.pone.0005732	http://dx.doi.org/10.1371/journal.pone.0005732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484128	Green Submitted, Green Published, gold			2022-12-27	WOS:000266528200001
J	Gao, D; Yang, YK; Wang, RP; Zhou, X; Diao, FC; Li, MD; Zhai, ZH; Jiang, ZF; Chen, DY				Gao, Dong; Yang, Yong-Kang; Wang, Rui-Peng; Zhou, Xiang; Diao, Fei-Ci; Li, Min-Dian; Zhai, Zhong-He; Jiang, Zheng-Fan; Chen, Dan-Ying			REUL Is a Novel E3 Ubiquitin Ligase and Stimulator of Retinoic-Acid-Inducible Gene-I	PLOS ONE			English	Article								RIG-I and MDA5 are cytoplasmic sensors that recognize different species of viral RNAs, leads to activation of the transcription factors IRF3 and NF-kappa B, which collaborate to induce type I interferons. In this study, we identified REUL, a RING-finger protein, as a specific RIG-I-interacting protein. REUL was associated with RIG-I, but not MDA5, through its PRY and SPRY domains. Overexpression of REUL potently potentiated RIG-I-, but not MDA5-mediated downstream signalling and antiviral activity. In contrast, the RING domain deletion mutant of REUL suppressed Sendai virus (SV)-induced, but not cytoplasmic polyI:C-induced activation of IFN-beta promoter. Knockdown of endogenous REUL by RNAi inhibited SV-triggered IFN-beta expression, and also increased VSV replication. Full-length RIG-I, but not the CARD domain deletion mutant of RIG-I, underwent ubiquitination induced by REUL. The Lys 154, 164, and 172 residues of the RIG-I CARD domain were critical for efficient REUL-mediated ubiquitination, as well as the ability of RIG-I to induce activation of IFN-beta promoter. These findings suggest that REUL is an E3 ubiquitin ligase of RIG-I and specifically stimulates RIG-I-mediated innate antiviral activity.			Gao, D (corresponding author), Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.	dychen@pku.edu.cn	Wang, Ruipeng/I-1407-2013; Li, Min-Dian/F-1721-2015; YANG, YONGKANG/AEP-2772-2022	Wang, Ruipeng/0000-0002-1003-1420; Li, Min-Dian/0000-0002-3650-1507; YANG, YONGKANG/0000-0002-0333-7712; Gao, Dong/0000-0003-1821-2741				Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Douglas J, 2007, NAT GENET, V39, P963, DOI 10.1038/ng2083; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jenne DE, 2003, GENE CHROMOSOME CANC, V37, P111, DOI 10.1002/gcc.10206; Jenne DE, 2001, AM J HUM GENET, V69, P516, DOI 10.1086/323043; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; ORIMO A, 1995, J BIOL CHEM, V270, P24406, DOI 10.1074/jbc.270.41.24406; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200	26	97	104	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5760	10.1371/journal.pone.0005760	http://dx.doi.org/10.1371/journal.pone.0005760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484123	gold, Green Submitted, Green Published			2022-12-27	WOS:000266528200012
J	Karapetyan, YE; Saa, P; Mahal, SP; Sferrazza, GF; Sherman, A; Sales, N; Weissmann, C; Lasmezas, CI				Karapetyan, Yervand Eduard; Saa, Paula; Mahal, Sukhvir Paul; Sferrazza, Gian Franco; Sherman, Alexandra; Sales, Nicole; Weissmann, Charles; Lasmezas, Corinne Ida			Prion Strain Discrimination Based on Rapid In Vivo Amplification and Analysis by the Cell Panel Assay	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SINGLE AMINO-ACID; INCUBATION-TIME; NERVOUS-SYSTEM; PROTEIN; SCRAPIE; PRP; MICE; EXPRESSION; AGENT	Prion strain identification has been hitherto achieved using time-consuming incubation time determinations in one or more mouse lines and elaborate neuropathological assessment. In the present work, we make a detailed study of the properties of PrP-overproducing Tga20 mice. We show that in these mice the four prion strains examined are rapidly and faithfully amplified and can subsequently be discriminated by a cell-based procedure, the Cell Panel Assay.			Karapetyan, YE (corresponding author), Scripps Res Inst, Dept Infectol, Jupiter, FL USA.	lasmezas@scripps.edu	, Karapetyan/AAN-1433-2020; Saa, Paula/AAB-6607-2019	Saa, Paula/0000-0001-6077-4532	NINDS NIH HHS [R01 NS059543] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Brown KL, 2000, MICROSC RES TECHNIQ, V50, P40, DOI 10.1002/1097-0029(20000701)50:1<40::AID-JEMT7>3.0.CO;2-M; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; Cohen E, 2003, EMBO J, V22, P404, DOI 10.1093/emboj/cdg045; Couzin J, 2004, SCIENCE, V305, P589; CRONIER S, 2008, BIOCH J; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; DICKINSON AG, 1989, UNCONVENTIONAL VIRUS, P446; Dickinson AG., 1979, SLOW TRANSMISSIBLE D, P13; DOI S, 1988, J GEN VIROL, V69, P955, DOI 10.1099/0022-1317-69-4-955; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Haeberle AM, 2000, MICROSC RES TECHNIQ, V50, P66, DOI 10.1002/1097-0029(20000701)50:1<66::AID-JEMT10>3.0.CO;2-3; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Laine J, 2001, EUR J NEUROSCI, V14, P47, DOI 10.1046/j.0953-816x.2001.01621.x; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liu T, 2001, BRAIN RES, V896, P118, DOI 10.1016/S0006-8993(01)02050-9; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Manson JC, 1999, EMBO J, V18, P6855, DOI 10.1093/emboj/18.23.6855; Montrasio F, 2001, P NATL ACAD SCI USA, V98, P4034, DOI 10.1073/pnas.051609398; Owen JP, 2007, MOL BIOTECHNOL, V35, P161, DOI 10.1007/BF02686111; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; REED L. J., 1938, AMER JOUR HYG, V27, P493; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; SEGADE F, 1995, J IMMUNOL, V154, P2384; Sun R, 2008, VIRAL IMMUNOL, V21, P293, DOI 10.1089/vim.2008.0039; Thackray AM, 2003, J VIROL, V77, P7991, DOI 10.1128/JVI.77.14.7991-7998.2003; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998	50	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5730	10.1371/journal.pone.0005730	http://dx.doi.org/10.1371/journal.pone.0005730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478942	Green Published, gold, Green Submitted			2022-12-27	WOS:000266490000007
J	Ukkola, LT; Onkamo, P; Raijas, P; Karma, K; Jarvela, I				Ukkola, Liisa T.; Onkamo, Paivi; Raijas, Pirre; Karma, Kai; Jarvela, Irma			Musical Aptitude Is Associated with AVPR1A-Haplotypes	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; REGION 5-HTTLPR; PROMOTER REGION; RECEPTOR GENE; VASOPRESSIN; POLYMORPHISM; AVPR1A; BEHAVIOR; BRAIN; IDENTIFICATION	Artistic creativity forms the basis of music culture and music industry. Composing, improvising and arranging music are complex creative functions of the human brain, which biological value remains unknown. We hypothesized that practicing music is social communication that needs musical aptitude and even creativity in music. In order to understand the neurobiological basis of music in human evolution and communication we analyzed polymorphisms of the arginine vasopressin receptor 1A (AVPR1A), serotonin transporter (SLC6A4), catecol-O-methyltranferase (COMT), dopamin receptor D2 (DRD2) and tyrosine hydroxylase 1 (TPH1), genes associated with social bonding and cognitive functions in 19 Finnish families (n = 343 members) with professional musicians and/or active amateurs. All family members were tested for musical aptitude using the auditory structuring ability test (Karma Music test; KMT) and Carl Seashores tests for pitch (SP) and for time (ST). Data on creativity in music (composing, improvising and/or arranging music) was surveyed using a web-based questionnaire. Here we show for the first time that creative functions in music have a strong genetic component (h(2) = .84; composing h(2) = .40; arranging h(2) = .46; improvising h(2) = .62) in Finnish multigenerational families. We also show that high music test scores are significantly associated with creative functions in music (p <.0001). We discovered an overall haplotype association with AVPR1A gene (markers RS1 and RS3) and KMT (p = 0.0008; corrected p = 0.00002), SP (p = 0.0261; corrected p = 0.0072) and combined music test scores (COMB) (p = 0.0056; corrected p = 0.0006). AVPR1A haplotype AVR+RS1 further suggested a positive association with ST (p = 0.0038; corrected p = 0.00184) and COMB (p = 0.0083; corrected p = 0.0040) using haplotype-based association test HBAT. The results suggest that the neurobiology of music perception and production is likely to be related to the pathways affecting intrinsic attachment behavior.			Ukkola, LT (corresponding author), Univ Helsinki, Dept Med Genet, Helsinki, Finland.	irma.jarvela@kolumbus.fi	Jarvela, Irma E/L-5836-2013; Ukkola-Vuoti, Liisa/E-6564-2016	Jarvela, Irma E/0000-0002-1770-6187; Ukkola-Vuoti, Liisa/0000-0002-0770-361X				Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Aleman A, 2008, BIOL PSYCHOL, V79, P58, DOI 10.1016/j.biopsycho.2008.01.009; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bachner-Melman R., 2005, J INDIVID DIFFER, V26, P2, DOI DOI 10.1027/1614-0001.26.1.2; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Bondy B, 2006, MOL PSYCHIATR, V11, P336, DOI 10.1038/sj.mp.4001803; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; COKER J, 1986, IMPROVISING JAZZ; COOPER JR, 1961, J PHARMACOL EXP THER, V132, P265; CSIKSZENTMIHALY.M, 1990, FLOW PSYCHOL OPTIMAL, P33; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ekman A, 2007, EUR J EPIDEMIOL, V22, P293, DOI 10.1007/s10654-006-9091-0; Emanuele E, 2007, NEUROENDOCRINOL LETT, V28, P815; Fink S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-176; Gagne F, 1997, ROEPER REV, V20, P76; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gosso MF, 2008, EUR J HUM GENET, V16, P1075, DOI 10.1038/ejhg.2008.57; GRANDY DK, 1993, HUM MOL GENET, V2, P2197, DOI 10.1093/hmg/2.12.2197-a; Granota RY, 2007, EVOL HUM BEHAV, V28, P313, DOI 10.1016/j.evolhumbehav.2007.05.003; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; HASSLER M, 1992, PSYCHONEUROENDOCRINO, V17, P55, DOI 10.1016/0306-4530(92)90076-J; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Ijmker S, 2008, SCAND J WORK ENV HEA, V34, P113, DOI 10.5271/sjweh.1220; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Justus T, 2005, MUSIC PERCEPT, V23, P1, DOI 10.1525/mp.2005.23.1.1; Karma K., 1994, PSYCHOL MUSIC, V22, P20, DOI DOI 10.1177/0305735694221002; Karma K., 2007, PSYCHOMUSICOLOGY, V19, P79, DOI [10.1037/h0094033, DOI 10.1037/H0094033]; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; Kirsch P, 2006, NEUROSCI LETT, V405, P196, DOI 10.1016/j.neulet.2006.07.030; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kremer I, 2005, AM J PSYCHIAT, V162, P924, DOI 10.1176/appi.ajp.162.5.924; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lang UE, 2007, NEUROPSYCHOPHARMACOL, V32, P1950, DOI 10.1038/sj.npp.1301335; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Levitin DJ, 2005, ANN NY ACAD SCI, V1060, P325, DOI 10.1196/annals.1360.027; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; MARTINDALE C, 2006, HDB CREATIVITY, P137; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PALADE GE, 2001, ORIGINS CREATIVITY, P145; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; PIIRTO J, 2004, UNDERSTANDING CREATI, P360; Pulli K, 2008, J MED GENET, V45, P451, DOI 10.1136/jmg.2007.056366; Rasmussen HB, 2007, PSYCHIAT GENET, V17, P287, DOI 10.1097/YPG.0b013e328133f331; Rauceo S, 2008, BEHAV BRAIN RES, V187, P133, DOI 10.1016/j.bbr.2007.09.003; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; Reuter M, 2005, BEHAV BRAIN RES, V164, P93, DOI 10.1016/j.bbr.2005.06.002; Reuter M, 2005, AM J MED GENET B, V134B, P20, DOI 10.1002/ajmg.b.30153; Seashore CE., 1960, SEASHORE MEASURES MU; Shaw P, 2007, BIOESSAYS, V29, P962, DOI 10.1002/bies.20641; Sloboda JA., 2001, MUSIC EMOTION THEORY; Sternberg RJ, 2006, INTERNATIONAL HANDBOOK OF CREATIVITY, P1; Thibonnier M, 1996, GENOMICS, V31, P327, DOI 10.1006/geno.1996.0055; Thompson R, 2004, PSYCHONEUROENDOCRINO, V29, P35, DOI 10.1016/S0306-4530(02)00133-6; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; WEINSHILBOUM R, 1977, NEUROPHARMACOLOGY, V16, P703, DOI 10.1016/0028-3908(77)90124-1; Wichers M, 2008, NEUROPSYCHOPHARMACOL, V33, P3030, DOI 10.1038/sj.npp.1301520; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Winner E., 1996, GIFTED CHILDREN MYTH; Yirmiya N, 2006, MOL PSYCHIATR, V11, P488, DOI 10.1038/sj.mp.4001812; Yonan AL, 2006, PSYCHIAT GENET, V16, P31, DOI 10.1097/01.ypg.0000174393.79883.05; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588; Zatorre R, 2005, NATURE, V434, P312, DOI 10.1038/434312a; Zeki S, 2007, FEBS LETT, V581, P2575, DOI 10.1016/j.febslet.2007.03.094	70	74	79	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5534	10.1371/journal.pone.0005534	http://dx.doi.org/10.1371/journal.pone.0005534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448AY	19461995	Green Published, gold, Green Submitted			2022-12-27	WOS:000266234700001
J	Bodewes, R; Kreijtz, JHCM; Baas, C; Geelhoed-Mieras, MM; de Mutsert, G; van Amerongen, G; van den Brand, JMA; Fouchier, RAM; Osterhaus, ADME; Rimmelzwaan, GF				Bodewes, Rogier; Kreijtz, Joost H. C. M.; Baas, Chantal; Geelhoed-Mieras, Martina M.; de Mutsert, Gerrie; van Amerongen, Geert; van den Brand, Judith M. A.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.			Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus	PLOS ONE			English	Article								Annual vaccination against seasonal influenza viruses is recommended for certain individuals that have a high risk for complications resulting from infection with these viruses. Recently it was recommended in a number of countries including the USA to vaccinate all healthy children between 6 and 59 months of age as well. However, vaccination of immunologically naive subjects against seasonal influenza may prevent the induction of heterosubtypic immunity against potentially pandemic strains of an alternative subtype, otherwise induced by infection with the seasonal strains. Here we show in a mouse model that the induction of protective heterosubtypic immunity by infection with a human A/H3N2 influenza virus is prevented by effective vaccination against the A/H3N2 strain. Consequently, vaccinated mice were no longer protected against a lethal infection with an avian A/H5N1 influenza virus. As a result H3N2-vaccinated mice continued to loose body weight after A/H5N1 infection, had 100-fold higher lung virus titers on day 7 post infection and more severe histopathological changes than mice that were not protected by vaccination against A/H3N2 influenza. The lack of protection correlated with reduced virus-specific CD8+ T cell responses after A/H5N1 virus challenge infection. These findings may have implications for the general recommendation to vaccinate all healthy children against seasonal influenza in the light of the current pandemic threat caused by highly pathogenic avian A/H5N1 influenza viruses.			Bodewes, R (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	g.rimmelzwaan@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172; Bodewes, Rogier/0000-0002-0689-7889				Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Cassetti Maria Cristina, 2005, Vaccine, V23, P1529, DOI 10.1016/j.vaccine.2004.09.004; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; DOHERTY PC, 1978, J EXP MED, V148, P534, DOI 10.1084/jem.148.2.534; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Epstein SL, 1997, J IMMUNOL, V158, P1222; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; FRANK AL, 1980, J CLIN MICROBIOL, V12, P426, DOI 10.1128/JCM.12.3.426-432.1980; Girard MP, 2008, VACCINE, V26, P3969, DOI [10.1016/j.vaccine.2008.04.051, 10.1016/j.vaccine.2008.03.006]; GREBE KM, 2008, MICROBES INFECT; Haanen JBAG, 1999, EUR J IMMUNOL, V29, P1168, DOI 10.1002/(SICI)1521-4141(199904)29:04<1168::AID-IMMU1168>3.0.CO;2-J; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Heikkinen T, 2006, EUR J PEDIATR, V165, P223, DOI 10.1007/s00431-005-0040-9; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jameson J, 1999, J IMMUNOL, V162, P7578; Karber G, 1931, EXP PATHOL PHARM, V162, P480; Kohlmeier JE, 2007, J IMMUNOL, V178, P4721, DOI 10.4049/jimmunol.178.8.4721; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; LEE LY, 2008, J CLIN INVEST; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Luce BR, 2008, VACCINE, V26, P2841, DOI 10.1016/j.vaccine.2008.03.046; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Palmer DF, 1975, ADV LAB TECHNIQUES I, P25; Philippa J, 2007, VACCINE, V25, P3800, DOI 10.1016/j.vaccine.2007.01.121; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Salo H, 2006, VACCINE, V24, P4934, DOI 10.1016/j.vaccine.2006.03.057; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849; VESIKARI T, 2008, SS04 3 MF59T ADJUVAN; Voeten JTM, 1999, VACCINE, V17, P1942, DOI 10.1016/S0264-410X(98)00464-2; WEBSTER RG, 1980, EUR J IMMUNOL, V10, P396, DOI 10.1002/eji.1830100515; *WHO, 2008, CONF HUM CAS AV INFL; Williams MA, 2004, J IMMUNOL, V173, P6694, DOI 10.4049/jimmunol.173.11.6694; *WRIT COMM 2 WHO C, 2008, NEW ENGL J MED, P261; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6	50	83	84	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5538	10.1371/journal.pone.0005538	http://dx.doi.org/10.1371/journal.pone.0005538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19440239	gold, Green Published, Green Submitted			2022-12-27	WOS:000266107300005
J	Kalil, AC; Freifeld, AG; Lyden, ER; Stoner, JA				Kalil, Andre C.; Freifeld, Alison G.; Lyden, Elizabeth R.; Stoner, Julie A.			Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy	PLOS ONE			English	Article								Background: Several anti-viral drugs have demonstrated efficacy in preventing Cytomegalovirus (CMV) infections in solid organ transplant (SOT) patients. The recently approved valganciclovir is the most commonly used and most expensive drug for CMV prevention. The safety and efficacy data have been drawn from a single trial. We hypothesized that valganciclovir may not be as safe as nor more effective than other therapies for CMV prevention. Methods: All experimental and analytical studies that compared valganciclovir with other therapies for prevention of CMV infection after SOT were selected. Based on meta-analytic and multivariate regression methodologies we critically analyzed all available evidence. Findings: Nine studies were included (N = 1,831). In trials comparing valganciclovir with ganciclovir, the risk for CMV disease is 0.98 (95% Confidence Interval (95% CI) 0.67 to 1.43; P = 0.92; I-2 = 0%). Valganciclovir was significantly associated with the risk of absolute neutropenia (< 1,500/mm(3)) compared with all therapies (Odds Ratio (OR) 3.63 95% CI 1.75 to 7.53; P = 0.001; I-2 = 0%); with ganciclovir only (OR 2.88, 95%CI 1.27 to 6.53; P = 0.01; I-2 = 0%); or with non-ganciclovir therapies (OR 8.30, 95% CI 1.51 to 45.58; P = 0.01; I-2 = 10%). For a neutropenia cut-off of < 1,000/mm(3), the risk remained elevated (OR 1.97, 95% CI 1.03 to 3.67; P = 0.04; I-2 = 0%). For every 24 patients who receive valganciclovir prophylaxis, one more will develop neutropenia compared to other therapies. The risk of late-onset CMV disease with valganciclovir was similar to ganciclovir and higher than those with non-ganciclovir therapies [OR 8.95, 95% CI 1.07 to 74.83; P = 0.04; I-2 = 0%]. One more patient will develop late-onset CMV disease for every 25 who receive valganciclovir compared to treatment with non-ganciclovir therapies. The risk of CMV tissue-invasive disease in liver recipients receiving valganciclovir was 4.5 times the risk seen with ganciclovir [95% CI 1.00 to 20.14] (p = 0.04). All results remained consistent across different study designs, valganciclovir doses, and CMV serostatus. Conclusions: Valganciclovir shows no superior efficacy and significantly higher risk of absolute neutropenia, CMV late-onset disease, and CMV tissue-invasive disease compared to other standard therapies. Due to the availability of efficacious, safer, and lower cost drugs (high-dose acyclovir, valacyclovir, ganciclovir), our results do not favor the use of valganciclovir as a first-line agent for CMV preemptive or universal prophylaxis in SOT patients.			Kalil, AC (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Infect Dis, Omaha, NE USA.	akalil@unmc.edu						Aigner C, 2005, WIEN KLIN WOCHENSCHR, V117, P480, DOI 10.1007/s00508-005-0413-0; Akalin E, 2003, AM J TRANSPLANT, V3, P731, DOI 10.1034/j.1600-6143.2003.00140.x; Baliga RS, 2004, AM J TRANSPLANT, V4, P495; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Boivin G, 2004, J INFECT DIS, V189, P1615, DOI 10.1086/382753; Brennan DC, 1997, TRANSPLANTATION, V64, P1843, DOI 10.1097/00007890-199712270-00036; Bucher HC, 1999, JAMA-J AM MED ASSOC, V282, P771, DOI 10.1001/jama.282.8.771; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Couchoud C., 2000, COCHRANE DB SYST REV; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devyatko E, 2004, J HEART LUNG TRANSPL, V23, P1277, DOI 10.1016/j.healun.2003.08.034; Diaz-Pedroche C, 2006, TRANSPLANTATION, V82, P30, DOI 10.1097/01.tp.0000225830.76907.d0; Einsele H, 2006, BLOOD, V107, P3002, DOI 10.1182/blood-2005-09-3786; Fiddian P, 2002, J INFECT DIS, V186, pS110, DOI 10.1086/342965; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Freeman RB, 2004, TRANSPLANTATION, V78, P1765, DOI 10.1097/01.TP.0000142619.01510.A5; Gane E, 1997, LANCET, V350, P1729, DOI 10.1016/S0140-6736(97)05535-9; Gomberg-Maitland M, 2003, AM HEART J, V146, P398, DOI 10.1016/S0002-8703(03)00324-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humar A, 2005, AM J TRANSPLANT, V5, P1462, DOI 10.1111/j.1600-6143.2005.00866.x; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jain A, 2005, TRANSPLANT P, V37, P3182, DOI 10.1016/j.transproceed.2005.07.032; Jain A, 2006, LIVER TRANSPLANT, V12, P1020, DOI 10.1002/lt.20749; Kalil AC, 2005, ANN INTERN MED, V143, P870, DOI 10.7326/0003-4819-143-12-200512200-00005; Keven K, 2004, TRANSPL P, V36, P3107, DOI 10.1016/j.transproceed.2004.11.092; Khoury JA, 2006, AM J TRANSPLANT, V6, P2134, DOI 10.1111/j.1600-6143.2006.01413.x; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; LANGE WR, 2007, 2003 SAFETY ALERT VA; Levitsky J, 2007, AM J TRANSPLANT, V7, P197; Limaye AP, 2006, TRANSPLANTATION, V81, P1645, DOI 10.1097/01.tp.0000226071.12562.1a; Limaye AP, 2004, TRANSPLANTATION, V78, P1390, DOI 10.1097/01.TP.0000145989.22373.03; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Lopau K, 2007, CLIN TRANSPLANT, V21, P80, DOI 10.1111/j.1399-0012.2006.00586.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mattes FM, 2005, J INFECT DIS, V191, P89, DOI 10.1086/425905; MERIGAN TC, 1992, NEW ENGL J MED, V326, P1182, DOI 10.1056/NEJM199204303261803; MULROW CD, 1998, SYSTEMATIC REV SYNTH, P117; MUNOZ V, EPIDEMIOLOGY CITOMEG; *NAT CANC I, 2006, GUID TOOLS PROT DEV; Park JM, 2006, LIVER TRANSPLANT, V12, P112, DOI 10.1002/lt.20562; Paya C, 2004, AM J TRANSPLANT, V4, P611, DOI 10.1111/j.1600-6143.2004.00382.x; Pescovitz M D, 1999, Transpl Infect Dis, V1 Suppl 1, P31; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pocock SJ, 2003, FUND CLIN PHARMACOL, V17, P483, DOI 10.1046/j.1472-8206.2003.00162.x; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Said T, 2007, TRANSPL P, V39, P997, DOI 10.1016/j.transproceed.2007.03.046; Sia IG, 2000, CLIN MICROBIOL REV, V13, P83, DOI 10.1128/CMR.13.1.83-121.2000; Singh N, 2000, TRANSPLANTATION, V70, P717, DOI 10.1097/00007890-200009150-00002; Singh N, 2005, TRANSPLANTATION, V79, P85, DOI 10.1097/01.TP.0000146844.65273.62; Singh N, 2005, CLIN INFECT DIS, V40, P704, DOI 10.1086/427506; Small LN, 2006, CLIN INFECT DIS, V43, P869, DOI 10.1086/507337; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Strippoli GFM, 2006, TRANSPLANTATION, V81, P139, DOI 10.1097/01.tp.0000183970.71366.da; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Walker JK, 2007, TRANSPLANTATION, V83, P874, DOI 10.1097/01.tp.0000257923.69422.4d; Weng FL, 2007, TRANSPLANTATION, V83, P290, DOI 10.1097/01.tp.0000251371.34968.ca; Zamora MR, 2004, AM J TRANSPLANT, V4, P1635, DOI 10.1111/j.1600-6143.2004.00571.x	58	63	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5512	10.1371/journal.pone.0005512	http://dx.doi.org/10.1371/journal.pone.0005512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436751	Green Submitted, Green Published, gold			2022-12-27	WOS:000266009900005
J	Garthe, A; Behr, J; Kempermann, G				Garthe, Alexander; Behr, Joachim; Kempermann, Gerd			Adult-Generated Hippocampal Neurons Allow the Flexible Use of Spatially Precise Learning Strategies	PLOS ONE			English	Article							MORRIS WATER MAZE; SYNAPTIC PLASTICITY; DENTATE GYRUS; TRANSGENIC MICE; GRANULE CELLS; MUTANT MICE; NEUROGENESIS; MEMORY; ASTROCYTES; HYPOTHESIS	Despite enormous progress in the past few years the specific contribution of newly born granule cells to the function of the adult hippocampus is still not clear. We hypothesized that in order to solve this question particular attention has to be paid to the specific design, the analysis, and the interpretation of the learning test to be used. We thus designed a behavioral experiment along hypotheses derived from a computational model predicting that new neurons might be particularly relevant for learning conditions, in which novel aspects arise in familiar situations, thus putting high demands on the qualitative aspects of (re-)learning. In the reference memory version of the water maze task suppression of adult neurogenesis with temozolomide (TMZ) caused a highly specific learning deficit. Mice were tested in the hidden platform version of the Morris water maze (6 trials per day for 5 days with a reversal of the platform location on day 4). Testing was done at 4 weeks after the end of four cycles of treatment to minimize the number of potentially recruitable new neurons at the time of testing. The reduction of neurogenesis did not alter longterm potentiation in CA3 and the dentate gyrus but abolished the part of dentate gyrus LTP that is attributed to the new neurons. TMZ did not have any overt side effects at the time of testing, and both treated mice and controls learned to find the hidden platform. Qualitative analysis of search strategies, however, revealed that treated mice did not advance to spatially precise search strategies, in particular when learning a changed goal position ( reversal). New neurons in the dentate gyrus thus seem to be necessary for adding flexibility to some hippocampus-dependent qualitative parameters of learning. Our finding that a lack of adult-generated granule cells specifically results in the animal's inability to precisely locate a hidden goal is also in accordance with a specialized role of the dentate gyrus in generating a metric rather than just a configurational map of the environment. The discovery of highly specific behavioral deficits as consequence of a suppression of adult hippocampal neurogenesis thus allows to link cellular hippocampal plasticity to well-defined hypotheses from theoretical models.			Garthe, A (corresponding author), CRTD, Dresden, Germany.	gerd.kempermann@crt-dresden.de	Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061				Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Balschun D, 2003, J NEUROSCI, V23, P6304; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Chowdhury S, 1999, CANCER TREAT REV, V25, P259, DOI 10.1053/ctrv.1999.0138; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; *EMEA, 2005, EMEAHC0229; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kempermann G, 2002, DEV BRAIN RES, V134, P1, DOI 10.1016/S0165-3806(01)00224-3; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; LeMarec N, 1997, EXP BRAIN RES, V116, P131, DOI 10.1007/PL00005733; Mason WP, 2005, CAN J NEUROL SCI, V32, P18, DOI 10.1017/S0317167100016838; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Wolfer DP, 2000, EXP PHYSIOL, V85, P627, DOI 10.1017/S0958067000020959; Wolfer DP, 1998, EUR J NEUROSCI, V10, P708, DOI 10.1046/j.1460-9568.1998.00089.x; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; ZHANG CL, 2000, NATURE	42	430	437	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5464	10.1371/journal.pone.0005464	http://dx.doi.org/10.1371/journal.pone.0005464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	442JH	19421325	Green Submitted, Green Published, gold			2022-12-27	WOS:000265837000004
J	Mukherjee, P; Cao, TV; Winter, SL; Alexandrow, MG				Mukherjee, Piyali; Cao, Thinh V.; Winter, Sherry L.; Alexandrow, Mark G.			Mammalian MCM Loading in Late-G(1) Coincides with Rb Hyperphosphorylation and the Transition to Post-Transcriptional Control of Progression into S-Phase	PLOS ONE			English	Article								Background: Control of the onset of DNA synthesis in mammalian cells requires the coordinated assembly and activation of the pre-Replication Complex. In order to understand the regulatory events controlling preRC dynamics, we have investigated how the timing of preRC assembly relates temporally to other biochemical events governing progress into S-phase. Methodology/Principal Finding: In murine and Chinese hamster (CHO) cells released from quiescence, the loading of the replicative MCM helicase onto chromatin occurs in the final 3-4 hrs of G(1). Cdc45 and PCNA, both of which are required for G(1)-S transit, bind to chromatin at the G(1)-S transition or even earlier in G(1), when MCMs load. An RNA polymerase II inhibitor (DRB) was added to synchronized murine keratinocytes to show that they are no longer dependent on new mRNA synthesis 3-4 hrs prior to S-phase entry, which is also true for CHO and human cells. Further, CHO cells can progress into S-phase on time, and complete S-phase, under conditions where new mRNA synthesis is significantly compromised, and such mRNA suppression causes no adverse effects on preRC dynamics prior to, or during, S-phase progression. Even more intriguing, hyperphosphorylation of Rb coincides with the start of MCM loading and, paradoxically, with the time in late-G(1) when de novo mRNA synthesis is no longer rate limiting for progression into S-phase. Conclusions/Significance: MCM, Cdc45, and PCNA loading, and the subsequent transit through G(1)-S, do not depend on concurrent new mRNA synthesis. These results indicate that mammalian cells pass through a distinct transition in late-G(1) at which time Rb becomes hyperphosphorylated and MCM loading commences, but that after this transition the control of MCM, Cdc45, and PCNA loading and the onset of DNA replication are regulated at the post-transcriptional level.			Mukherjee, P (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL USA.	Mark.Alexandrow@Moffitt.org						ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Alexandrow MG, 2004, MOL CELL BIOL, V24, P1614, DOI 10.1128/MCB.24.4.1614-1627.2004; ALEXANDROW MG, 1995, CANCER RES, V55, P3928; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Botz J, 1996, MOL CELL BIOL, V16, P3401; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; CAMPISI J, 1984, MOL CELL BIOL, V4, P1807, DOI 10.1128/MCB.4.9.1807; Cayirlioglu P, 2003, MOL CELL BIOL, V23, P2123, DOI 10.1128/MCB.23.6.2123-2134.2003; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Chow KNB, 1996, MOL CELL BIOL, V16, P7173; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Geng Y, 1996, ONCOGENE, V12, P1173; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Harlow E., 1988, ANTIBODIES LAB MANUA; Harvey KJ, 2003, J BIOL CHEM, V278, P48524, DOI 10.1074/jbc.M307661200; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; KEDINGER C, 1974, J CELL BIOL, V63, P831, DOI 10.1083/jcb.63.3.831; Keenan SM, 2004, J BIOL CHEM, V279, P5387, DOI 10.1074/jbc.M310383200; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Leone G, 1999, P NATL ACAD SCI USA, V96, P6626, DOI 10.1073/pnas.96.12.6626; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MITTNACHT S, 1991, COLD SPRING HARB SYM, V56, P197; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Ohtsu M, 2008, DNA RES, V15, P241, DOI 10.1093/dnares/dsn015; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; PEI R, 1988, MOL CELL BIOL, V8, P2860, DOI 10.1128/MCB.8.7.2860; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; SEHGAL PB, 1976, CELL, V9, P473, DOI 10.1016/0092-8674(76)90092-1; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Stoeber K, 1998, EMBO J, V17, P7219, DOI 10.1093/emboj/17.24.7219; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; WELLS DJ, 1979, J CELL PHYSIOL, V100, P199, DOI 10.1002/jcp.1041000202; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wu JR, 1997, MOL CELL BIOL, V17, P4312, DOI 10.1128/MCB.17.8.4312; YAMAGUCHI M, 1995, J BIOL CHEM, V270, P25159, DOI 10.1074/jbc.270.42.25159; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; ZYLBER EA, 1971, P NATL ACAD SCI USA, V68, P2861, DOI 10.1073/pnas.68.11.2861	63	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5462	10.1371/journal.pone.0005462	http://dx.doi.org/10.1371/journal.pone.0005462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421323	gold, Green Published, Green Submitted			2022-12-27	WOS:000265837000003
J	Salari, R; Aksay, C; Karakoc, E; Unrau, PJ; Hajirasouliha, I; Sahinalp, SC				Salari, Raheleh; Aksay, Cagri; Karakoc, Emre; Unrau, Peter J.; Hajirasouliha, Iman; Sahinalp, S. Cenk			smyRNA: A Novel Ab Initio ncRNA Gene Finder	PLOS ONE			English	Article								Background: Non-coding RNAs (ncRNAs) have important functional roles in the cell: for example, they regulate gene expression by means of establishing stable joint structures with target mRNAs via complementary sequence motifs. Sequence motifs are also important determinants of the structure of ncRNAs. Although ncRNAs are abundant, discovering novel ncRNAs on genome sequences has proven to be a hard task; in particular past attempts for ab initio ncRNA search mostly failed with the exception of tools that can identify micro RNAs. Methodology/Principal Findings: We present a very general ab initio ncRNA gene finder that exploits differential distributions of sequence motifs between ncRNAs and background genome sequences. Conclusions/Significance: Our method, once trained on a set of ncRNAs from a given species, can be applied to a genome sequences of other organisms to find not only ncRNAs homologous to those in the training set but also others that potentially belong to novel (and perhaps unknown) ncRNA families. Availability: http://compbio.cs.sfu.ca/taverna/smyrna			Sahinalp, SC (corresponding author), Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada.	cenk@cs.sfu.ca	Sahinalp, Suleyman Cenk/X-7843-2018; Hajirasouliha, Iman/E-2984-2010	Sahinalp, Suleyman Cenk/0000-0002-5050-0682; 				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Coventry A, 2004, P NATL ACAD SCI USA, V101, P12102, DOI 10.1073/pnas.0404193101; di Bernardo D, 2003, BIOINFORMATICS, V19, P1606, DOI 10.1093/bioinformatics/btg229; Dieterich C, 2003, NUCLEIC ACIDS RES, V31, P55, DOI 10.1093/nar/gkg007; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; FONTAINE A, 2005, JOBIM; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEYER IM, 2007, BRIEF BIOINFORM; Meyer IM, 2007, PLOS COMPUT BIOL, V3, P1441, DOI 10.1371/journal.pcbi.0030149; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Rivas E, 2000, BIOINFORMATICS, V16, P583, DOI 10.1093/bioinformatics/16.7.583; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126	24	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5433	10.1371/journal.pone.0005433	http://dx.doi.org/10.1371/journal.pone.0005433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415115	Green Submitted, Green Published, gold			2022-12-27	WOS:000265836700006
J	Kasuga, T; Mannhaupt, G; Glass, NL				Kasuga, Takao; Mannhaupt, Gertrud; Glass, N. Louise			Relationship between Phylogenetic Distribution and Genomic Features in Neurospora crassa	PLOS ONE			English	Article								In the post-genome era, insufficient functional annotation of predicted genes greatly restricts the potential of mining genome data. We demonstrate that an evolutionary approach, which is independent of functional annotation, has great potential as a tool for genome analysis. We chose the genome of a model filamentous fungus Neurospora crassa as an example. Phylogenetic distribution of each predicted protein coding gene (PCG) in the N. crassa genome was used to classify genes into six mutually exclusive lineage specificity (LS) groups, i.e. Eukaryote/Prokaryote- core, Dikarya-core, Ascomycota-core, Pezizomycotina-specific, N. crassa-orphans and Others. Functional category analysis revealed that only similar to 23% of PCGs in the two most highly lineage-specific grouping, Pezizomycotina-specific and N. crassa-orphans, have functional annotation. In contrast, similar to 76% of PCGs in the remaining four LS groups have functional annotation. Analysis of chromosomal localization of N. crassa-orphan PCGs and genes encoding for secreted proteins showed enrichment in subtelomeric regions. The origin of N. crassa-orphans is not known. We found that 11% of N. crassa-orphans have paralogous N. crassa-orphan genes. Of the paralogous N. crassa-orphan gene pairs, 33% were tandemly located in the genome, implying a duplication origin of N. crassa-orphan PCGs in the past. LS grouping is thus a useful tool to explore and understand genome organization, evolution and gene function in fungi.			Kasuga, T (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	tkasuga@ucdavis.edu	Glass, N. Louise/ABA-7303-2021	Aramayo, Rodolfo/0000-0001-9702-6204	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM068087, GM068087] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Arnold R, 2005, BIOINFORMATICS, V21, P42, DOI 10.1093/bioinformatics/bti1107; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai JJ, 2006, J MOL EVOL, V63, P1, DOI 10.1007/s00239-004-0372-5; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dufayard JF, 2005, BIOINFORMATICS, V21, P2596, DOI 10.1093/bioinformatics/bti325; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Fan C, 2008, MOL PLANT, V1, P839, DOI 10.1093/mp/ssn050; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Kasuga T, 2008, EUKARYOT CELL, V7, P1549, DOI 10.1128/EC.00195-08; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Mannhaupt G, 2003, NUCLEIC ACIDS RES, V31, P1944, DOI 10.1093/nar/gkg293; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Margolin BS, 1998, GENETICS, V149, P1787; Nei M., 2000, MOL EVOLUTION PHYLOG; Ohno S., 1970, EVOLUTION GENE DUPLI; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Rattei T, 2006, NUCLEIC ACIDS RES, V34, pD252, DOI 10.1093/nar/gkj106; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Selker EU, 1997, TRENDS GENET, V13, P296, DOI 10.1016/S0168-9525(97)01201-8; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner BC, 2001, FUNGAL GENET BIOL, V32, P67, DOI 10.1006/fgbi.2001.1247; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Watters MK, 1999, GENETICS, V153, P705; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wortman JR, 2006, MED MYCOL, V44, pS3, DOI 10.1080/13693780600835799	39	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2009	4	4							e5286	10.1371/journal.pone.0005286	http://dx.doi.org/10.1371/journal.pone.0005286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437VA	19461939	Green Submitted, Green Published, gold			2022-12-27	WOS:000265513800017
J	Cook, C; Gass, J; Dunmore, J; Tong, JM; Taylor, J; Eriksen, J; McGowan, E; Lewis, J; Johnston, J; Petrucelli, L				Cook, Casey; Gass, Jennifer; Dunmore, Judith; Tong, Jimei; Taylor, Julie; Eriksen, Jason; McGowan, Eileen; Lewis, Jada; Johnston, Jennifer; Petrucelli, Leonard			Aging Is Not Associated with Proteasome Impairment in UPS Reporter Mice	PLOS ONE			English	Article								Background: Covalent linkage of ubiquitin regulates the function and, ultimately, the degradation of many proteins by the ubiquitin-proteasome system (UPS). Given its essential role in protein regulation, even slight perturbations in UPS activity can substantially impair cellular function. Methodology/Principal Findings: We have generated and characterized a novel transgenic mouse model which expresses a previously described reporter for UPS function. This UPS reporter contains a degron sequence attached to the C-terminus of green fluorescent protein, and is predominantly expressed in neurons throughout the brain of our transgenic model. We then demonstrated that this reporter system is sensitive to UPS inhibition in vivo. Conclusions/Significance: Given the obstacles associated with evaluating proteasomal function in the brain, our mouse model uniquely provides the capability to monitor UPS function in real time in individual neurons of a complex organism. Our novel mouse model now provides a useful resource with which to evaluate the impact of aging, as well as various genetic and/or pharmacological modifiers of neurodegenerative disease(s).			Cook, C (corresponding author), Mayo Clin, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu	Eriksen, Jason/A-8054-2008	Eriksen, Jason/0000-0003-1549-4165; Johnston, Jennifer/0000-0002-4867-9230	NIA NIH HHS [R01 AG026251, P01 AG017216, AG17216, R01-AG-026251-01] Funding Source: Medline; NINDS NIH HHS [R21 NS055698, R21 NS059363, NS55698, NS59363J1] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055698, R21NS059363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026251, P01AG017216] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adori C, 2005, NEUROBIOL DIS, V19, P427, DOI 10.1016/j.nbd.2005.01.015; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bedford L, 2008, BBA-MOL BASIS DIS, V1782, P683, DOI 10.1016/j.bbadis.2008.10.009; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005128; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; EMMANOUILIDOU E, 2008, NEUROBIOL AGING; Furukawa Y, 2002, ANN NEUROL, V51, P779, DOI 10.1002/ana.10207; Ge PF, 2007, STROKE, V38, P3230, DOI 10.1161/STROKEAHA.107.487108; Ghee M, 2000, J NEUROCHEM, V75, P2221, DOI 10.1046/j.1471-4159.2000.0752221.x; GRAY DA, 2003, SCI AGING KNOWLEDGE, pRE6; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kisselev AF, 1999, MOL CELL, V4, P395, DOI 10.1016/S1097-2765(00)80341-X; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Lindsten K, 2003, AGEING RES REV, V2, P433, DOI 10.1016/S1568-1637(03)00031-X; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; McNaught KSP, 2002, NEUROSCI LETT, V326, P155, DOI 10.1016/S0304-3940(02)00296-3; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Schwartz AL, 1999, ANNU REV MED, V50, P57; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; TSENG BP, 2007, NEUROBIOL AGING; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Zhang NY, 2008, J BIOL CHEM, V283, P20288, DOI 10.1074/jbc.M710560200	46	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5888	10.1371/journal.pone.0005888	http://dx.doi.org/10.1371/journal.pone.0005888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517018	Green Submitted, gold, Green Published			2022-12-27	WOS:000266873100016
J	Xing, Z; McFarland, CT; Sallenave, JM; Izzo, A; Wang, J; McMurray, DN				Xing, Zhou; McFarland, Christine T.; Sallenave, Jean-Michel; Izzo, Angelo; Wang, Jun; McMurray, David N.			Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis	PLOS ONE			English	Article								Background: Recombinant adenovirus-vectored ( Ad) tuberculosis ( TB) vaccine platform has demonstrated great potential to be used either as a stand-alone or a boost vaccine in murine models. However, Ad TB vaccine remains to be evaluated in a more relevant and sensitive guinea pig model of pulmonary TB. Many vaccine candidates shown to be effective in murine models have subsequently failed to pass the test in guinea pig models. Methods and Findings: Specific pathogen-free guinea pigs were immunized with BCG, AdAg85A intranasally (i.n), AdAg85A intramuscularly (i.m), BCG boosted with AdAg85A i.m, BCG boosted with AdAg85A i.m, or treated only with saline. The animals were then infected by a low-dose aerosol of M. tuberculosis (M.tb). At the specified times, the animals were sacrificed and the levels of infection in the lung and spleen were assessed. In separate studies, the long-term disease outcome of infected animals was monitored until the termination of this study. Immunization with Ad vaccine alone had minimal beneficial effects. Immunization with BCG alone and BCG prime-Ad vaccine boost regimens significantly reduced the level of M.tb infection in the tissues to a similar extent. However, while BCG alone prolonged the survival of infected guinea pigs, the majority of BCG-immunized animals succumbed by 53 weeks post-M.tb challenge. In contrast, intranasal or intramuscular Ad vaccine boosting of BCG-primed animals markedly improved the survival rate with 60% of BCG/Ad i.n- and 40% of BCG/Ad i.m-immunized guinea pigs still surviving by 74 weeks post-aerosol challenge. Conclusions: Boosting, particularly via the intranasal mucosal route, with AdAg85A vaccine is able to significantly enhance the long-term survival of BCG-primed guinea pigs following pulmonary M.tb challenge. Our results thus support further evaluation of this viral-vectored TB vaccine in clinical trials.			Xing, Z (corresponding author), McMaster Univ, Dept Pathol & Mol Med, MG DeGroote Inst Infect Dis Res, Ctr Gene Therapeut, Hamilton, ON, Canada.	xingz@mcmaster.ca	SALLENAVE, Jean-Michel/J-3746-2017; Izzo, Angelo A/F-1229-2017	SALLENAVE, Jean-Michel/0000-0002-8595-6970; Izzo, Angelo A/0000-0003-3208-2330	PHS HHS [HHSN 26620040091C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Basaraba RJ, 2006, VACCINE, V24, P280, DOI 10.1016/j.vaccine.2005.07.103; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Brennan MJ, 2007, PLOS MED, V4, P1299, DOI 10.1371/journal.pmed.0040252; Buddle BM, 2003, INFECT IMMUN, V71, P6411, DOI 10.1128/IAI.71.11.6411-6419.2003; Damjanovic Daniela, 2008, Genet Vaccines Ther, V6, P5, DOI 10.1186/1479-0556-6-5; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; Horwitz MA, 2005, INFECT IMMUN, V73, P4676, DOI 10.1128/IAI.73.8.4676-4683.2005; Ibango HB, 2006, LANCET INFECT DIS, V6, P522, DOI 10.1016/S1473-3099(06)70552-7; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Kugathasan K, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-48; Lei XF, 1998, CLIN EXP IMMUNOL, V113, P157; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Ly LH, 2008, EXPERT REV VACCINES, V7, P635, DOI 10.1586/14760584.7.5.635; Ly LH, 2008, AM J RESP CELL MOL, V38, P455, DOI 10.1165/rcmb.2007-0326OC; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; MU J, 2009, MOL THER        0324; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Santosuosso M, 2005, VIRAL IMMUNOL, V18, P283, DOI 10.1089/vim.2005.18.283; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Santosuosso M, 2007, J IMMUNOL, V178, P2387, DOI 10.4049/jimmunol.178.4.2387; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Vordermeier HM, 2006, INFECT IMMUN, V74, P1416, DOI 10.1128/IAI.74.2.1416-1418.2006; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Xing Z, 2005, CURR GENE THER, V5, P485, DOI 10.2174/156652305774329230; Xing Z, 2007, EXPERT REV VACCINES, V6, P539, DOI 10.1586/14760584.6.4.539; Yamamoto T, 2007, TUBERCULOSIS, V87, P155, DOI 10.1016/j.tube.2006.07.002; 2009, GENETIC ENG BIO 0319, V2, P33	30	86	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5856	10.1371/journal.pone.0005856	http://dx.doi.org/10.1371/journal.pone.0005856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516906	Green Published, Green Submitted, gold			2022-12-27	WOS:000266872900007
J	Lange, AW; Keiser, AR; Wells, JM; Zorn, AM; Whitsett, JA				Lange, Alexander W.; Keiser, Angela R.; Wells, James M.; Zorn, Aaron M.; Whitsett, Jeffrey A.			Sox17 Promotes Cell Cycle Progression and Inhibits TGF-beta/Smad3 Signaling to Initiate Progenitor Cell Behavior in the Respiratory Epithelium	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; BETA-CATENIN; BRANCHING MORPHOGENESIS; ENDODERM FORMATION; LUNG DEVELOPMENT; REDUNDANT ROLES; II CELLS; EXPRESSION; DIFFERENTIATION	The Sry-related high mobility group box transcription factor Sox17 is required for diverse developmental processes including endoderm formation, vascular development, and fetal hematopoietic stem cell maintenance. Expression of Sox17 in mature respiratory epithelial cells causes proliferation and lineage respecification, suggesting that Sox17 can alter adult lung progenitor cell fate. In this paper, we identify mechanisms by which Sox17 influences lung epithelial progenitor cell behavior and reprograms cell fate in the mature respiratory epithelium. Conditional expression of Sox17 in epithelial cells of the adult mouse lung demonstrated that cell cluster formation and respecification of alveolar progenitor cells toward proximal airway lineages were rapidly reversible processes. Prolonged expression of Sox17 caused the ectopic formation of bronchiolar-like structures with diverse respiratory epithelial cell characteristics in alveolar regions of lung. During initiation of progenitor cell behavior, Sox17 induced proliferation and increased the expression of the progenitor cell marker Sca-1 and genes involved in cell cycle progression. Notably, Sox17 enhanced cyclin D1 expression in vivo and activated cyclin D1 promoter activity in vitro. Sox17 decreased the expression of transforming growth factor-beta (TGF-beta)-responsive cell cycle inhibitors in the adult mouse lung, including p15, p21, and p57, and inhibited TGF-beta 1-mediated transcriptional responses in vitro. Further, Sox17 interacted with Smad3 and blocked Smad3 DNA binding and transcriptional activity. Together, these data show that a subset of mature respiratory epithelial cells retains remarkable phenotypic plasticity and that Sox17, a gene required for early endoderm formation, activates the cell cycle and reinitiates multipotent progenitor cell behavior in mature lung cells.			Lange, AW (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH USA.	Jeffrey.Whitsett@chmcc.org			NHLBI NIH HHS [T32 HL007752, R01 HL090156, HL007752, R01 HL095580, P01 HL061646, HL61646, HL090156] Funding Source: Medline; NIDDK NIH HHS [R01 DK070858] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL061646, T32HL007752, R01HL090156, R01HL095580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070858] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Besnard V, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1113, DOI 10.1016/B978-012370615-7/50077-9; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Blundell R, 2004, EXP LUNG RES, V30, P447, DOI 10.1080/01902140490476373; Buckley S, 1997, AM J PHYSIOL-LUNG C, V273, pL572, DOI 10.1152/ajplung.1997.273.3.L572; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Clements D, 2000, MECH DEVELOP, V99, P65, DOI 10.1016/S0925-4773(00)00476-7; Corroyer S, 1997, ENDOCRINOLOGY, V138, P3677, DOI 10.1210/en.138.9.3677; Donjerkovic D, 2000, CELL RES, V10, P179, DOI 10.1038/sj.cr.7290047; DUNN TL, 1995, GENE, V161, P223, DOI 10.1016/0378-1119(95)00280-J; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; HERBER B, 1994, ONCOGENE, V9, P1295; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Kanai Y, 1996, J CELL BIOL, V133, P667, DOI 10.1083/jcb.133.3.667; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kang Y, 2000, MOL CARCINOGEN, V29, P112, DOI 10.1002/1098-2744(200010)29:2<112::AID-MC8>3.0.CO;2-9; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kim CF, 2007, AM J PHYSIOL-LUNG C, V293, pL1092, DOI 10.1152/ajplung.00015.2007; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Latella L, 2001, MOL CELL BIOL, V21, P5631, DOI 10.1128/MCB.21.16.5631-5643.2001; Liu C, 2002, AM J PHYSIOL-LUNG C, V283, pL468, DOI 10.1152/ajplung.00044.2002; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Nabeyrat E, 2000, AM J PHYSIOL-LUNG C, V278, pL42, DOI 10.1152/ajplung.2000.278.1.L42; Otto WR, 2002, J PATHOL, V197, P527, DOI 10.1002/path.1160; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Park KS, 2006, DEV BIOL, V294, P192, DOI 10.1016/j.ydbio.2006.02.038; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Perl AKT, 2005, GENESIS, V41, P23, DOI 10.1002/gene.20093; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Rippon HJ, 2006, STEM CELLS, V24, P1389, DOI 10.1634/stemcells.2005-0465; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Weiss MA, 2001, MOL ENDOCRINOL, V15, P353, DOI 10.1210/me.15.3.353; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Winkler ME, 2008, CLONING STEM CELLS, V10, P49, DOI 10.1089/clo.2007.0075; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang FJ, 2004, AM J RESP CELL MOL, V31, P679, DOI 10.1165/rcmb.2004-0182OC; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	67	44	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5711	10.1371/journal.pone.0005711	http://dx.doi.org/10.1371/journal.pone.0005711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479035	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415000020
J	Parise, CV; Spence, C				Parise, Cesare Valerio; Spence, Charles			'When Birds of a Feather Flock Together': Synesthetic Correspondences Modulate Audiovisual Integration in Non-Synesthetes	PLOS ONE			English	Article							CROSS-MODAL SIMILARITY; VISION	Background: Synesthesia is a condition in which the stimulation of one sense elicits an additional experience, often in a different (i.e., unstimulated) sense. Although only a small proportion of the population is synesthetic, there is growing evidence to suggest that neurocognitively-normal individuals also experience some form of synesthetic association between the stimuli presented to different sensory modalities (i.e., between auditory pitch and visual size, where lower frequency tones are associated with large objects and higher frequency tones with small objects). While previous research has highlighted crossmodal interactions between synesthetically corresponding dimensions, the possible role of synesthetic associations in multisensory integration has not been considered previously. Methodology: Here we investigate the effects of synesthetic associations by presenting pairs of asynchronous or spatially discrepant visual and auditory stimuli that were either synesthetically matched or mismatched. In a series of three psychophysical experiments, participants reported the relative temporal order of presentation or the relative spatial locations of the two stimuli. Principal Findings: The reliability of non-synesthetic participants' estimates of both audiovisual temporal asynchrony and spatial discrepancy were lower for pairs of synesthetically matched as compared to synesthetically mismatched audiovisual stimuli. Conclusions: Recent studies of multisensory integration have shown that the reduced reliability of perceptual estimates regarding intersensory conflicts constitutes the marker of a stronger coupling between the unisensory signals. Our results therefore indicate a stronger coupling of synesthetically matched vs. mismatched stimuli and provide the first psychophysical evidence that synesthetic congruency can promote multisensory integration. Synesthetic crossmodal correspondences therefore appear to play a crucial (if unacknowledged) role in the multisensory integration of auditory and visual information.			Parise, CV (corresponding author), Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, S Parks Rd, Oxford OX1 3UD, England.	cesare.parise@psy.ox.ac.uk	Parise, Cesare/AAY-2913-2020					Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; BERNSTEIN IH, 1971, J EXP PSYCHOL, V87, P241, DOI 10.1037/h0030524; Bertelson P, 1998, PSYCHON B REV, V5, P482, DOI 10.3758/BF03208826; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; Burr D, 2009, P ROY SOC B-BIOL SCI, V276, P1761, DOI 10.1098/rspb.2008.1899; Calvert G., 2004, HDB MULTISENSORY PRO; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; DZN HD, 1954, J OPT SOC AM, V44, P380, DOI 10.1364/JOSA.44.000380; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Ernst MO, 2005, PERCEPTION HUMAN BOD, P105; Gallace A, 2006, PERCEPT PSYCHOPHYS, V68, P1191, DOI 10.3758/BF03193720; Helbig HB, 2007, PERCEPTION, V36, P1523, DOI 10.1068/p5851; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Kadosh RC, 2007, TRENDS COGN SCI, V11, P177, DOI 10.1016/j.tics.2007.01.003; King RB, 1997, HUM FACTORS, V39, P287, DOI 10.1518/001872097778543895; Marks L. E., 2004, HDB MULTISENSORY PRO, P85; MARKS LE, 1987, J EXP PSYCHOL HUMAN, V13, P384, DOI 10.1037/0096-1523.13.3.384; MARKS LE, 1989, J EXP PSYCHOL HUMAN, V15, P586, DOI 10.1037/0096-1523.15.3.586; Martino G, 2000, PERCEPTION, V29, P745, DOI 10.1068/p2984; Martino G, 2001, CURR DIR PSYCHOL SCI, V10, P61, DOI 10.1111/1467-8721.00116; MELARA RD, 1987, J EXP PSYCHOL GEN, V116, P323; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; OBOYLE MW, 1980, J PSYCHOLINGUIST RES, V9, P535, DOI 10.1007/BF01068115; Parise C, 2008, NEUROSCI LETT, V442, P257, DOI 10.1016/j.neulet.2008.07.010; ROBSON JG, 1966, J OPT SOC AM, V56, P1141, DOI 10.1364/JOSA.56.001141; Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Vatakis A, 2008, ACTA PSYCHOL, V127, P12, DOI 10.1016/j.actpsy.2006.12.002; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Vatakis A, 2008, J VISION, V8, DOI 10.1167/8.9.14; WALKER P, 1984, PERCEPTION, V13, P75, DOI 10.1068/p130075; WALKER P, 1985, PERCEPTION, V14, P729, DOI 10.1068/p140729; WATSON AB, 1990, PERCEPT PSYCHOPHYS, V47, P87, DOI 10.3758/BF03208169; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	38	179	181	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5664	10.1371/journal.pone.0005664	http://dx.doi.org/10.1371/journal.pone.0005664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	450QD	19471644	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415000004
J	Xanthopoulos, K; Polymenidou, M; Bellworthy, SJ; Benestad, SL; Sklaviadis, T				Xanthopoulos, Konstantinos; Polymenidou, Magdalini; Bellworthy, Sue J.; Benestad, Sylvie L.; Sklaviadis, Theodoros			Species and Strain Glycosylation Patterns of PrPSc	PLOS ONE			English	Article								Background: A key event in transmissible spongiform encephalopathies (TSEs) is the conversion of the soluble, protease-sensitive glycosylated prion protein (PrPC) to an abnormally structured, aggregated and partially protease-resistant isoform (PrPSc). Both PrP isoforms bear two potential glycosylation sites and thus in a typical western blot with an anti-PrP antibody three distinct bands appear, corresponding to the di-, mono- or unglycosylated forms of the protein. The relative intensity and electrophoretic mobility of the three bands are characteristic of each TSE strain and have been used to discriminate between them. Methodology/Principal Findings: In the present study we used lectin-based western blotting to evaluate possible variations in composition within sugar chains carried by PrPSc purified from subjects affected with different TSEs. Our findings indicate that in addition to the already well-documented differences in electrophoretic mobility and amounts of the glycosylated PrPSc forms, TSE strains also vary in the abundance of specific N-linked sugars of the PrPSc protein. Conclusions/Significance: These results imply that PrP glycosylation might fine-tune the conversion of PrPC to PrPSc and could play an accessory role in the appearance of some of the characteristic features of TSE strains. The differences in sugar composition could also be used as an additional tool for discrimination between the various TSEs.			Xanthopoulos, K (corresponding author), Aristotle Univ Thessaloniki, Pharmacol Lab, Dept Pharm, GR-54006 Thessaloniki, Greece.	sklaviad@auth.gr	Sklaviadis, Theoodoros/AGK-6763-2022; Dafou, Dimitra/N-6094-2015; Polymenidou, Magdalini/D-2254-2014	Dafou, Dimitra/0000-0003-4170-0612; Sklaviadis, Theodoros/0000-0002-0246-3100				Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Barret A, 2005, J BIOL CHEM, V280, P10516, DOI 10.1074/jbc.M412635200; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Booth S, 2004, BIOCHEM BIOPH RES CO, V325, P1339, DOI 10.1016/j.bbrc.2004.10.150; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; COLLINGE J, 1996, CJD NATURE, V383, P685; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Ermonval M, 2009, GLYCOCONJUGATE J, V26, P477, DOI 10.1007/s10719-008-9198-5; Goh AXH, 2007, J NEUROCHEM, V100, P841, DOI 10.1111/j.1471-4159.2006.04268.x; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; GUILLERMEBOSSEL.F, 2009, GLYCOBIOLOG IN PRESS; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; Harmeyer S, 1998, J GEN VIROL, V79, P937, DOI 10.1099/0022-1317-79-4-937; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Klingeborn M, 2006, J GEN VIROL, V87, P1751, DOI 10.1099/vir.0.81618-0; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Levavasseur E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002786; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; Nielsen D, 2004, BIOCHEM J, V380, P571, DOI 10.1042/BJ20040010; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2005, J CLIN MICROBIOL, V43, P1118, DOI 10.1128/JCM.43.3.1118-1126.2005; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; PIRO JR, 2009, J VIROL IN PRESS; Plaitakis A, 2001, ANN NEUROL, V50, P227, DOI 10.1002/ana.1285; Polymenidou M, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-23; Priola SA, 2001, EMBO J, V20, P6692, DOI 10.1093/emboj/20.23.6692; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; SKLAVIADIS T, 1986, P NATL ACAD SCI USA, V83, P6146, DOI 10.1073/pnas.83.16.6146; Somerville RA, 1999, J GEN VIROL, V80, P1865, DOI 10.1099/0022-1317-80-7-1865; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Triantaphyllidou IE, 2006, ANAL BIOCHEM, V359, P176, DOI 10.1016/j.ab.2006.10.002; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Vorberg I, 2002, J BIOL CHEM, V277, P36775, DOI 10.1074/jbc.M206865200; Yokoyama T, 2007, ARCH VIROL, V152, P603, DOI 10.1007/s00705-006-0858-0	51	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5633	10.1371/journal.pone.0005633	http://dx.doi.org/10.1371/journal.pone.0005633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461968	Green Submitted, gold, Green Published			2022-12-27	WOS:000266234700020
J	Franci, C; Gallen, M; Alameda, F; Baro, T; Iglesias, M; Virtanen, I; de Herreros, AG				Franci, Clara; Gallen, Manel; Alameda, Francesc; Baro, Teresa; Iglesias, Mar; Virtanen, Ismo; Garcia de Herreros, Antonio			Snail1 Protein in the Stroma as a New Putative Prognosis Marker for Colon Tumours	PLOS ONE			English	Article								Over-expression of Snail1 gene transcriptional repressor promotes an epithelial-to-mesenchymal transition in epithelial tumour cell lines. Expression of Snail1 RNA has been associated to the pathogenesis of a number of malignancies; however, the lack of good monoclonal antibodies against this protein has precluded a definitive analysis of Snail1 protein. In this study, we aimed to determine the expression of this transcriptional factor in colorectal tumours. Using a Snail1 well-characterized monoclonal antibody developed in our laboratories we have analyzed by immunohistochemistry a cohort of 162 human colorectal tumours. Ninety tumours (56%) showed nuclear expression in the tumoral tissue and the adjacent stroma; in 34 (21%), Snail1 was detected just in the stroma, whereas in only 4 the expression of Snail1 was detected in the tumoral tissue and the stroma was negative. No correlation was found between the presence of Snail1 in the tumour and tumour stage; however, a trend (p = 0.054) was detected when the expression of this factor in the stroma was considered. Snail1 immunoreactivity in this compartment was associated with presence of distant metastasis (p = 0.006). Moreover, expression of Snail1 in the tumor stroma correlated with lower specific survival of cancer patients (p = 0.011). Interestingly, this correlation was also detected in stage I and II tumors. Therefore, our results indicate that the presence of nuclear Snail1 immunoreactive cells in the stroma may be an informative indicator of prognosis of colon tumours especially useful in those corresponding to lower stages and identify a new marker suitable to label activated stroma in colon tumours.			Franci, C (corresponding author), IMIM Hosp Mar, Programa Recerca Canc, Barcelona, Spain.	agarcia@imim.es	de Herreros, A Garcia/H-3104-2014	de Herreros, A Garcia/0000-0001-5270-0808				Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Blechschmidt K, 2007, DIAGN MOL PATHOL, V16, P222, DOI 10.1097/PDM.0b013e31806219ae; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Locascio A, 2002, J BIOL CHEM, V277, P38803, DOI 10.1074/jbc.M205358200; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rosivatz E, 2006, VIRCHOWS ARCH, V448, P277, DOI 10.1007/s00428-005-0118-9; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; Sobin, 2009, UICC TNM CLASSIFICAT; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	25	85	86	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5595	10.1371/journal.pone.0005595	http://dx.doi.org/10.1371/journal.pone.0005595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440385	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107500022
J	Kobrinsky, E; Abrahimi, P; Duong, SQ; Thomas, S; Harry, JB; Patel, C; Lao, QZ; Soldatov, NM				Kobrinsky, Evgeny; Abrahimi, Parwiz; Duong, Son Q.; Thomas, Sam; Harry, Jo Beth; Patel, Chirag; Lao, Qi Zong; Soldatov, Nikolai M.			Effect of Ca-v beta Subunits on Structural Organization of Ca(v)1.2 Calcium Channels	PLOS ONE			English	Article							FLUORESCENT PROTEIN; MOLECULAR ARCHITECTURE; FUNCTIONAL EXPRESSION; SKELETAL-MUSCLE; RELEASE UNITS; FRET; MODULATION; INACTIVATION; CALMODULIN; MYOCYTES	Background: Voltage-gated Ca(v)1.2 calcium channels play a crucial role in Ca2+ signaling. The pore-forming alpha(1C) subunit is regulated by accessory Ca-v beta subunits, cytoplasmic proteins of various size encoded by four different genes (Ca-v beta(1) - beta(4)) and expressed in a tissue-specific manner. Methods and Results: Here we investigated the effect of three major Ca-v beta types, beta(1b), beta(2d) and beta(3), on the structure of Ca(v)1.2 in the plasma membrane of live cells. Total internal reflection fluorescence microscopy showed that the tendency of Ca(v)1.2 to form clusters depends on the type of the Ca-v beta subunit present. The highest density of Ca(v)1.2 clusters in the plasma membrane and the smallest cluster size were observed with neuronal/cardiac beta(1b) present. Ca(v)1.2 channels containing beta(3), the predominant Ca-v beta subunit of vascular smooth muscle cells, were organized in a significantly smaller number of larger clusters. The inter- and intramolecular distances between alpha(1C) and Ca-v beta in the plasma membrane of live cells were measured by three-color FRET microscopy. The results confirm that the proximity of Ca(v)1.2 channels in the plasma membrane depends on the Ca-v beta type. The presence of different Ca-v beta subunits does not result in significant differences in the intramolecular distance between the termini of alpha(1C), but significantly affects the distance between the termini of neighbor alpha(1C) subunits, which varies from 67 angstrom with beta(1b) to 79 A with beta(3). Conclusions: Thus, our results show that the structural organization of Ca(v)1.2 channels in the plasma membrane depends on the type of Ca-v beta subunits present.			Kobrinsky, E (corresponding author), NIA, NIH, Baltimore, MD 21224 USA.	soldatovN@grc.nia.nih.gov			Intramural NIH HHS [Z01 AG000294] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000294, ZIAAG000294] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chen-Izu Y, 2006, BIOPHYS J, V91, P1, DOI 10.1529/biophysj.105.077180; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; COLLIN T, 1994, EUR J BIOCHEM, V220, P257, DOI 10.1111/j.1432-1033.1994.tb18621.x; Di Biase V, 2005, J CELL BIOL, V171, P695, DOI 10.1083/jcb.200503077; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; FALLON JL, 2009, P NATL ACAD SCI USA, P1; Floyd R, 2007, CELL CALCIUM, V42, P467, DOI 10.1016/j.ceca.2007.05.011; Franzini-Armstrong C, 1998, ANN NY ACAD SCI, V853, P20, DOI 10.1111/j.1749-6632.1998.tb08253.x; Franzini-Armstrong C, 2005, ANN NY ACAD SCI, V1047, P76, DOI 10.1196/annals.1341.007; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Gathercole DV, 2000, J MOL CELL CARDIOL, V32, P1981, DOI 10.1006/jmcc.2000.1230; Harms GS, 2001, BIOPHYS J, V81, P2639, DOI 10.1016/S0006-3495(01)75907-3; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Inoue M, 2003, CIRC RES, V92, P532, DOI 10.1161/01.RES.0000064175.70693.EC; Kammermeier PJ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-1; Kepplinger KJF, 2000, FEBS LETT, V477, P161, DOI 10.1016/S0014-5793(00)01791-9; Kobrinsky E, 2005, J BIOL CHEM, V280, P12474, DOI 10.1074/jbc.M412140200; Kobrinsky E, 2004, BIOPHYS J, V87, P844, DOI 10.1529/biophysj.104.041152; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lao QZ, 2008, J BIOL CHEM, V283, P15577, DOI 10.1074/jbc.M802035200; LEE KL, 2005, NOVEL WAVELET STAT B, P7664; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; Mager DE, 2007, BIOPHYS J, V93, P2900, DOI 10.1529/biophysj.106.102582; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Murakami M, 2003, J BIOL CHEM, V278, P43261, DOI 10.1074/jbc.M211380200; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Papadopoulos A, 2008, COMPUT BIOL MED, V38, P1045, DOI 10.1016/j.compbiomed.2008.07.006; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Protasi F, 1996, DEV BIOL, V173, P265, DOI 10.1006/dbio.1996.0022; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Scriven DRL, 2002, ANN NY ACAD SCI, V976, P488; Shuai JW, 2003, P NATL ACAD SCI USA, V100, P506, DOI 10.1073/pnas.0236032100; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Takagishi Y, 2000, AM J PHYSIOL-CELL PH, V279, pC1963, DOI 10.1152/ajpcell.2000.279.6.C1963; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wiedenmann J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854680; Woo SH, 2003, J PHYSIOL-LONDON, V552, P437, DOI 10.1113/jphysiol.2003.048330; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang R, 2005, FASEB J, V19, P1153, DOI 10.1096/fj.04-3283fje; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	65	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5587	10.1371/journal.pone.0005587	http://dx.doi.org/10.1371/journal.pone.0005587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19492014	gold, Green Submitted, Green Published			2022-12-27	WOS:000266107500016
J	Liu, H; Buus, R; Clague, MJ; Urbe, S				Liu, Han; Buus, Richard; Clague, Michael J.; Urbe, Sylvie			Regulation of ErbB2 Receptor Status by the Proteasomal DUB POH1	PLOS ONE			English	Article							TYROSINE KINASES; DOWN-REGULATION; ENDOCYTOSIS; UBIQUITIN; DEGRADATION; MONOUBIQUITINATION; PHOSPHORYLATION; TRASTUZUMAB	Understanding the factors, which control ErbB2 and EGF receptor (EGFR) status in cells is likely to inform future therapeutic approaches directed at these potent oncogenes. ErbB2 is resistant to stimulus-induced degradation and high levels of overexpression can inhibit EGF receptor down-regulation. We now show that for HeLa cells expressing similar numbers of EGFR and ErbB2, EGFR down-regulation is efficient and insensitive to reduction of ErbB2 levels. Deubiquitinating enzymes (DUBs) may extend protein half-lives by rescuing ubiquitinated substrates from proteasomal degradation or from ubiquitin-dependent lysosomal sorting. Using a siRNA library directed at the full complement of human DUBs, we identified POH1 (also known as Rpn11 or PSMD14), a component of the proteasome lid, as a critical DUB controlling the apparent ErbB2 levels. Moreover, the effects on ErbB2 levels can be reproduced by administration of proteasomal inhibitors such as epoxomicin used at maximally tolerated doses. However, the extent of this apparent loss and specificity for ErbB2 versus EGFR could not be accounted for by changes in transcription or degradation rate. Further investigation revealed that cell surface ErbB2 levels are only mildly affected by POH1 knock-down and that the apparent loss can at least partially be explained by the accumulation of higher molecular weight ubiquitinated forms of ErbB2 that are detectable with an extracellular but not intracellular domain directed antibody. We propose that POH1 may deubiquitinate ErbB2 and that this activity is not necessarily coupled to proteasomal degradation.			Liu, H (corresponding author), Sch Biomed Sci, Physiol Lab, Liverpool, Merseyside, England.	clague@liv.ac.uk; urbe@liv.ac.uk	Urbe, Sylvie/S-1433-2018; Clague, Michael J/A-7199-2008	Urbe, Sylvie/0000-0003-4735-9814; Clague, Michael J/0000-0003-3355-9479; Liu, Han/0000-0002-0014-4675; Buus, Richard/0000-0002-3386-3465	Cancer Research UK [C20535/A6999] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Cardoso F, 2006, MOL CANCER THER, V5, P3042, DOI 10.1158/1535-7163.MCT-06-0104; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Daviet L, 2008, BIOCHIMIE, V90, P270, DOI 10.1016/j.biochi.2007.09.013; Finley D., 2004, CELL, V116, pS32; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haslekas C, 2005, MOL BIOL CELL, V16, P5832, DOI 10.1091/mbc.E05-05-0456; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Lerdrup M, 2006, J CELL SCI, V119, P85, DOI 10.1242/jcs.02707; Marx C, 2007, MOL PHARMACOL, V71, P1525, DOI 10.1124/mol.107.034090; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pedersen NM, 2008, MOL CANCER RES, V6, P491, DOI 10.1158/1541-7786.MCR-07-0191; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Shen F, 2008, CELL SIGNAL, V20, P779, DOI 10.1016/j.cellsig.2007.12.021; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	34	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5544	10.1371/journal.pone.0005544	http://dx.doi.org/10.1371/journal.pone.0005544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436748	gold, Green Published, Green Submitted			2022-12-27	WOS:000266107300009
J	Duval, L; Nerrienet, E; Rousset, D; Mba, SAS; Houze, S; Fourment, M; Le Bras, J; Robert, V; Ariey, F				Duval, Linda; Nerrienet, Eric; Rousset, Dominique; Mba, Serge Alain Sadeuh; Houze, Sandrine; Fourment, Mathieu; Le Bras, Jacques; Robert, Vincent; Ariey, Frederic			Chimpanzee Malaria Parasites Related to Plasmodium ovale in Africa	PLOS ONE			English	Article							RIBOSOMAL-RNA; RESERVOIRS; PHYLOGENY; EVOLUTION; MONKEYS; GENE	Since the 1970's, the diversity of Plasmodium parasites in African great apes has been neglected. Surprisingly, P. reichenowi, a chimpanzee parasite, is the only such parasite to have been molecularly characterized. This parasite is closely phylogenetically related to P. falciparum, the principal cause of the greatest malaria burden in humans. Studies of malaria parasites from anthropoid primates may provide relevant phylogenetic information, improving our understanding of the origin and evolutionary history of human malaria species. In this study, we screened 130 DNA samples from chimpanzees (Pan troglodytes) and gorillas (Gorilla gorilla) from Cameroon for Plasmodium infection, using cytochrome b molecular tools. Two chimpanzees from the subspecies Pan t. troglodytes presented single infections with Plasmodium strains molecularly related to the human malaria parasite P. ovale. These chimpanzee parasites and 13 human strains of P. ovale originated from a various sites in Africa and Asia were characterized using cytochrome b and cytochrome c oxidase 1 mitochondrial partial genes and nuclear ldh partial gene. Consistent with previous findings, two genetically distinct types of P. ovale, classical and variant, were observed in the human population from a variety of geographical locations. One chimpanzee Plasmodium strain was genetically identical, on all three markers tested, to variant P. ovale type. The other chimpanzee Plasmodium strain was different from P. ovale strains isolated from humans. This study provides the first evidence of possibility of natural cross-species exchange of P. ovale between humans and chimpanzees of the subspecies Pan t. troglodytes.	[Duval, Linda; Robert, Vincent] Museum Natl Hist Nat, USM 504, Lab Biol Fonct Protozoaires, F-75231 Paris, France; [Duval, Linda] Inst Pasteur, Lab Pathogen virale, Paris, France; [Nerrienet, Eric] Inst Pasteur Cambodge, Lab HIV Hepatites, Phnom Penh, Cambodia; [Rousset, Dominique; Mba, Serge Alain Sadeuh] Cte Pasteur Cameroun, Unite Virol, Yaounde, Cameroon; [Houze, Sandrine; Le Bras, Jacques] AP HP, Hop Bichat Claude Bernard, Ctr Natl Reference Paludisme, Paris, France; [Fourment, Mathieu] Inst Pasteur Cambodge, Unite Virol, Phnom Penh, Cambodia; [Fourment, Mathieu] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Robert, Vincent] Inst Rech Dev, Unite Rech Caracterisat controle popul vecteurs, UR 16, Montpellier, France; [Ariey, Frederic] Inst Pasteur Cambodge, Unite Epidemiol Mol, Phnom Penh, Cambodia	Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Macquarie University; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Duval, L (corresponding author), Museum Natl Hist Nat, USM 504, Lab Biol Fonct Protozoaires, F-75231 Paris, France.	lduval@pasteur.fr	Fourment, Mathieu/E-4665-2012; ariey, frederic/P-1185-2017; Rousset, Dominique/S-5400-2019; sandrine, houze/M-3260-2017	Fourment, Mathieu/0000-0001-8153-9822; ariey, frederic/0000-0002-0680-1090; Rousset, Dominique/0000-0002-1473-3147; SADEUH-MBA, Serge Alain/0000-0003-3377-8225; sandrine, houze/0000-0001-9016-3847; ROBERT, Vincent/0000-0003-1738-1842				BRAY RS, 1957, AM J TROP MED HYG, V6, P638, DOI 10.4269/ajtmh.1957.6.638; CADIGAN FC, 1969, T ROY SOC TROP MED H, V63, P681, DOI 10.1016/0035-9203(69)90194-1; Calattini S, 2006, J MED PRIMATOL, V35, P59, DOI 10.1111/j.1600-0684.2006.00149.x; COATNEY GR, 1971, PRIMATE MALARIAS; Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005; CONTACOS PG, 1970, AM J TROP MED HYG, V19, P190, DOI 10.4269/ajtmh.1970.19.190; Cornu M, 1986, Med Trop (Mars), V46, P131; Duval L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-157; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Fandeur T, 2000, PARASITOLOGY, V120, P11, DOI 10.1017/S0031182099005168; Faye FBK, 1998, T ROY SOC TROP MED H, V92, P522, DOI 10.1016/S0035-9203(98)90900-2; Garnham PCC., 1966, MALARIA PARASITES OT; GLEASON NN, 1970, B WORLD HEALTH ORGAN, V42, P399; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagner SC, 2007, PARASITOL RES, V101, P493, DOI 10.1007/s00436-007-0499-6; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Haydon DT, 2003, EMERG INFECT DIS, V9, P1495; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Incardona S, 2005, AM J TROP MED HYG, V72, P719, DOI 10.4269/ajtmh.2005.72.719; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; MACFIE TS, 2009, MOL BIOL EVOL   0130; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Ollomo B, 1997, AM J TROP MED HYG, V56, P440, DOI 10.4269/ajtmh.1997.56.440; Perkins SL, 2007, INFECT GENET EVOL, V7, P74, DOI 10.1016/j.meegid.2006.04.005; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020; Rodhain J., 1955, Annales de la Societe Belge de Medecine Tropicale, V35, P757; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Tachibana M, 2002, MOL BIOCHEM PARASIT, V122, P223, DOI 10.1016/S0166-6851(02)00101-9; Talman AM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-140; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Win TT, 2004, EMERG INFECT DIS, V10, P1235, DOI 10.3201/eid1007.030411; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	39	53	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5520	10.1371/journal.pone.0005520	http://dx.doi.org/10.1371/journal.pone.0005520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436742	Green Published, Green Submitted, gold			2022-12-27	WOS:000266009900013
J	Ardura, MI; Banchereau, R; Mejias, A; Di Pucchio, T; Glaser, C; Allantaz, F; Pascual, V; Banchereau, J; Chaussabel, D; Ramilo, O				Ardura, Monica I.; Banchereau, Romain; Mejias, Asuncion; Di Pucchio, Tiziana; Glaser, Casey; Allantaz, Florence; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien; Ramilo, Octavio			Enhanced Monocyte Response and Decreased Central Memory T Cells in Children with Invasive Staphylococcus aureus Infections	PLOS ONE			English	Article								Staphylococcus aureus has emerged as a significant pathogen causing severe invasive disease in otherwise healthy people. Despite considerable advances in understanding the epidemiology, resistance mechanisms, and virulence factors produced by the bacteria, there is limited knowledge of the in vivo host immune response to acute, invasive S. aureus infections. Herein, we report that peripheral blood mononuclear cells from patients with severe S. aureus infections demonstrate a distinctive and robust gene expression profile which is validated in a distinct group of patients and on a different microarray platform. Application of a systems-wide modular analysis framework reveals significant over-expression of innate immunity genes and under-expression of genes related to adaptive immunity. Simultaneous flow cytometry analyses demonstrated marked alterations in immune cell numbers, with decreased central memory CD4 and CD8 T cells and increased numbers of monocytes. CD14+ monocyte numbers significantly correlated with the gene expression levels of genes related to the innate immune response. These results demonstrate the value of applying a systems biology approach that reveals the significant alterations in the components of circulating blood lymphocytes and monocytes in invasive S. aureus infections.			Ardura, MI (corresponding author), Univ Texas SW Med Ctr Dallas, Div Pediat Infect Dis, Dept Pediat, Dallas, TX 75390 USA.	octavio.ramilo@utsouthwestern.edu	Chaussabel, Damien/AAX-1909-2020; Mejias, Asuncion/AAC-5998-2019; Pascual, Virginia/ABD-3099-2020; Mejias, Maria Asuncion/E-3659-2011; Ardura, Monica/AHA-7339-2022	Mejias, Asuncion/0000-0002-5983-8006; Ardura, Monica/0000-0002-2853-2581; Chaussabel, Damien/0000-0002-6131-7242	NCI NIH HHS [P01 CA084512, R01 CA078846] Funding Source: Medline; NCRR NIH HHS [KL2 RR024983, KL2RR024983, UL1 RR024982, UL1RR024982] Funding Source: Medline; NIAID NIH HHS [U19 AI057234] Funding Source: Medline; NIAMS NIH HHS [P50 AR054083, R01 AR050770-01, R01 AR050770] Funding Source: Medline; PHS HHS [R01 I068842, U19 AIO57234-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA084512, R01CA078846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982, KL2RR024983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054083, R01AR050770] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Baran Jaroslaw, 1999, Medycyna Doswiadczalna i Mikrobiologia, V51, P37; Barnes MG, 2004, RHEUMATOLOGY, V43, P973, DOI 10.1093/rheumatology/keh224; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Benoist C, 2006, IMMUNOL REV, V210, P229, DOI 10.1111/j.0105-2896.2006.00374.x; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bueno C, 2001, CYTOMETRY, V46, P33, DOI 10.1002/1097-0320(20010215)46:1<33::AID-CYTO1035>3.0.CO;2-S; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Hadley JS, 2005, INFECT IMMUN, V73, P7613, DOI 10.1128/IAI.73.11.7613-7619.2005; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Holub M, 2003, CLIN MICROBIOL INFEC, V9, P202, DOI 10.1046/j.1469-0691.2003.00518.x; Jeffrey Stefanie S, 2002, Mol Interv, V2, P101, DOI 10.1124/mi.2.2.101; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mobley JL, 2007, INFLAMMATION, V30, P189, DOI 10.1007/s10753-007-9036-0; Montet D, 2006, MICROBIAL BIOTECHNOLOGY IN HORTICULTURE, VOL 1, P309; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Sundstedt A, 1998, IMMUNOLOGY, V95, P76; Viau M, 2005, J IMMUNOL, V175, P7719, DOI 10.4049/jimmunol.175.11.7719; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yoh K, 2000, NEPHROL DIAL TRANSPL, V15, P1170, DOI 10.1093/ndt/15.8.1170; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	39	63	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5446	10.1371/journal.pone.0005446	http://dx.doi.org/10.1371/journal.pone.0005446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424507	gold, Green Published, Green Submitted			2022-12-27	WOS:000265933800009
J	Balasu, MC; Spiridon, LN; Miron, S; Craescu, CT; Scheidig, AJ; Petrescu, AJ; Szedlacsek, SE				Balasu, Mihaela C.; Spiridon, Laurentiu N.; Miron, Simona; Craescu, Constantin T.; Scheidig, Axel J.; Petrescu, Andrei-Jose; Szedlacsek, Stefan E.			Interface Analysis of the Complex between ERK2 and PTP-SL	PLOS ONE			English	Article								The activity of ERK2, an essential component of MAP-kinase pathway, is under the strict control of various effector proteins. Despite numerous efforts, no crystal structure of ERK2 complexed with such partners has been obtained so far. PTP-SL is a major regulator of ERK2 activity. To investigate the ERK2-PTP-SL complex we used a combined method based on cross-linking, MALDI-TOF analysis, isothermal titration calorimetry, molecular modeling and docking. Hence, new insights into the stoichiometry, thermodynamics and interacting regions of the complex are obtained and a structural model of ERK2-PTP-SL complex in a state consistent with PTP-SL phosphatase activity is developed incorporating all the experimental constraints available at hand to date. According to this model, part of the N-terminal region of PTP-SL has propensity for intrinsic disorder and becomes structured within the complex with ERK2. The proposed model accounts for the structural basis of several experimental findings such as the complex-dissociating effect of ATP, or PTP-SL blocking effect on the ERK2 export to the nucleus. A general observation emerging from this model is that regions involved in substrate binding in PTP-SL and ERK2, respectively are interacting within the interface of the complex.			Balasu, MC (corresponding author), Inst Biochem, Dept Enzymol, Bucharest, Romania.	stefan.szedlacsek@biochim.ro	Miron, Simona/M-9223-2018; Scheidig, Axel/C-9141-2011; Szedlacsek, Stefan Eugen/F-1830-2010; Petrescu, Andrei-Jose J/G-4576-2016; Spiridon, Laurentiu N/A-3352-2017	Szedlacsek, Stefan Eugen/0000-0002-3416-5036; Petrescu, Andrei-Jose J/0000-0002-4478-3946; Spiridon, Laurentiu N/0000-0003-3080-1610				Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buist P, 1999, BIOCHEMISTRY-US, V38, P914, DOI 10.1021/bi981936b; Bystroff Christopher, 2002, Bioinformatics, V18 Suppl 1, pS54; Camacho CJ, 2005, BIOINFORMATICS, V21, P2534, DOI 10.1093/bioinformatics/bti322; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chu FX, 2004, P NATL ACAD SCI USA, V101, P16454, DOI 10.1073/pnas.0407456101; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Eswaran J, 2006, BIOCHEM J, V395, P483, DOI 10.1042/BJ20051931; Fan H, 2005, P NATL ACAD SCI USA, V102, P6760, DOI 10.1073/pnas.0408857102; Farmer TB, 1998, J MASS SPECTROM, V33, P697, DOI 10.1002/(SICI)1096-9888(199808)33:8<697::AID-JMS711>3.0.CO;2-H; FERRERAS M, 1993, ANAL BIOCHEM, V213, P206, DOI 10.1006/abio.1993.1410; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Janin J, 2003, PROTEINS, V52, P1, DOI 10.1002/prot.10398; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim KL, 1999, BBA-PROTEIN STRUCT M, V1434, P275, DOI 10.1016/S0167-4838(99)00189-2; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mouradov D, 2006, PROTEIN ENG DES SEL, V19, P9, DOI 10.1093/protein/gzi070; Mouradov Dmitri, 2008, V426, P459, DOI 10.1007/978-1-60327-058-8_31; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; SHARMA E, 1995, J BIOL CHEM, V270, P49, DOI 10.1074/jbc.270.1.49; SHIOZUKA K, 1995, GENE, V162, P279, DOI 10.1016/0378-1119(95)00306-Q; Song HW, 2001, MOL CELL, V7, P615, DOI 10.1016/S1097-2765(01)00208-8; Szedlacsek SE, 2001, J MOL BIOL, V311, P557, DOI 10.1006/jmbi.2001.4890; Tarrega C, 2005, J BIOL CHEM, V280, P37885, DOI 10.1074/jbc.M504366200; Wang ZH, 2005, PRES VES P, V2, P307; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wefing S, 2006, ANAL CHEM, V78, P1235, DOI 10.1021/ac051634x; WEFING S, 2001, SEARCHXLINKS; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; ZHANG XD, 1994, IEEE PARALL DISTRIB, V2, P3; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5432	10.1371/journal.pone.0005432	http://dx.doi.org/10.1371/journal.pone.0005432			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424502	Green Published, Green Submitted, gold			2022-12-27	WOS:000265933800007
J	Piwko-Czuchra, A; Koegel, H; Meyer, H; Bauer, M; Werner, S; Brakebusch, C; Fassler, R				Piwko-Czuchra, Aleksandra; Koegel, Heidi; Meyer, Hannelore; Bauer, Martina; Werner, Sabine; Brakebusch, Cord; Faessler, Reinhard			beta 1 Integrin-Mediated Adhesion Signalling Is Essential for Epidermal Progenitor Cell Expansion	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; MESSENGER-RNA DECAY; BETA-1-INTEGRIN FUNCTION; GENE-MUTATIONS; MICE; EXPRESSION; DIFFERENTIATION; SKIN; KERATINOCYTES; MIGRATION	Background: There is a major discrepancy between the in vitro and in vivo results regarding the role of beta 1 integrins in the maintenance of epidermal stem/progenitor cells. Studies of mice with skin-specific ablation of beta 1 integrins suggested that epidermis can form and be maintained in their absence, while in vitro data have shown a fundamental role for these adhesion receptors in stem/progenitor cell expansion and differentiation. Methodology/Principal Findings: To elucidate this discrepancy we generated hypomorphic mice expressing reduced beta 1 integrin levels on keratinocytes that developed similar, but less severe defects than mice with beta 1-deficient keratinocytes. Surprisingly we found that upon aging these abnormalities attenuated due to a rapid expansion of cells, which escaped or compensated for the down-regulation of beta 1 integrin expression. A similar phenomenon was observed in aged mice with a complete, skin-specific ablation of the beta 1 integrin gene, where cells that escaped Cre-mediated recombination repopulated the mutant skin in a very short time period. The expansion of beta 1 integrin expressing keratinocytes was even further accelerated in situations of increased keratinocyte proliferation such as wound healing. Conclusions/Significance: These data demonstrate that expression of beta 1 integrins is critically important for the expansion of epidermal progenitor cells to maintain epidermal homeostasis.			Piwko-Czuchra, A (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18A, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de		Werner, Sabine/0000-0001-7397-8710; Brakebusch, Cord/0000-0002-9342-1634				Bouvard D, 2001, CIRC RES, V89, P211, DOI 10.1161/hh1501.094874; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Grose R, 2002, DEVELOPMENT, V129, P2303; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jensen UB, 1999, DEVELOPMENT, V126, P2409; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Romero MR, 1999, EXP DERMATOL, V8, P53, DOI 10.1111/j.1600-0625.1999.tb00348.x; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Wan H, 2003, J CELL SCI, V116, P4239, DOI 10.1242/jcs.00701; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639	37	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5488	10.1371/journal.pone.0005488	http://dx.doi.org/10.1371/journal.pone.0005488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424505	Green Published, Green Submitted, gold			2022-12-27	WOS:000265933800018
J	Sijbrands, EJG; Tornij, E; Homsma, SJ				Sijbrands, Eric J. G.; Tornij, Erik; Homsma, Sietske J.			Mortality Risk Prediction by an Insurance Company and Long-Term Follow-Up of 62,000 Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DIABETICS; ONSET	Background: Insurance companies use medical information to classify the mortality risk of applicants. Adding genetic tests to this assessment is currently being debated. This debate would be more meaningful, if results of present-day risk prediction were known. Therefore, we compared the predicted with the observed mortality of men who applied for life insurance, and determined the prognostic value of the risk assessment. Methods: Long-term follow-up was available for 62,334 male applicants whose mortality risk was predicted with medical evaluation and they were assigned to five groups with increasing risk from 1 to 5. We calculated all cause standardized mortality ratios relative to the Dutch population and compared groups with Cox's regression. We compared the discriminative ability of risk assessments as indicated by a concordance index (c). Results: In 844,815 person years we observed 3,433 deaths. The standardized mortality relative to the Dutch male population was 0.76 (95 percent confidence interval, 0.73 to 0.78). The standardized mortality ratios ranged from 0.54 in risk group 1 to 2.37 in group 5. A large number of risk factors and diseases were significantly associated with increased mortality. The algorithm of prediction was significantly, but only slightly better than summation of the number of disorders and risk factors (c-index, 0.64 versus 0.60, P<0.001). Conclusions: Men applying for insurance clearly had better survival relative to the general population. Readily available medical evaluation enabled accurate prediction of the mortality risk of large groups, but the deceased men could not have been identified with the applied prediction method.			Sijbrands, EJG (corresponding author), Erasmus MC, Div Pharmacol Vasc & Metab Dis, Dept Internal Med, Rotterdam, Netherlands.	e.sijbrands@erasmusmc.nl	Sijbrands, Eric/A-1065-2009	Sijbrands, Eric/0000-0001-8857-7389				[Anonymous], 1988, ARCH INTERN MED, V148, P1023; Asao K, 2003, DIABETES CARE, V26, P2037, DOI 10.2337/diacare.26.7.2037; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bourassa M G, 1985, Circulation, V72, pV71; Carragee EJ, 2005, NEW ENGL J MED, V352, P1891, DOI 10.1056/NEJMcp042054; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clayton EW, 2003, NEW ENGL J MED, V349, P562, DOI 10.1056/NEJMra012577; COLEMAN MP, 1989, PERSON YEARS PYRS FU; FULLER JH, 1983, DIABETOLOGIA, V24, P336; GLEESON RK, 2004, GENETICS LIFE INSURA, P73; HOES AW, 1993, EUR J EPIDEMIOL, V9, P285, DOI 10.1007/BF00146265; KENDAL DG, 1962, RANK CORRELATION MET; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; KLEINMAN JC, 1988, AM J EPIDEMIOL, V128, P389, DOI 10.1093/oxfordjournals.aje.a114979; KROLEWSKI AS, 1987, AM J CARDIOL, V59, P750, DOI 10.1016/0002-9149(87)91086-1; Mayor S, 2005, BRIT MED J, V330, P617, DOI 10.1136/bmj.330.7492.617; Morrison PJ, 2005, LANCET, V366, P877, DOI 10.1016/S0140-6736(05)67298-4; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; Ossa Diego F, 2004, Eur J Health Econ, V5, P116, DOI 10.1007/s10198-003-0213-2; Raithatha N, 2004, LANCET, V363, P395, DOI 10.1016/S0140-6736(04)15442-1; ROTHENBERG RB, 1994, EPIDEMIOLOGY, V5, P197, DOI 10.1097/00001648-199403000-00010; Sijbrands EJG, 2001, BMJ-BRIT MED J, V322, P1019, DOI 10.1136/bmj.322.7293.1019; SINGER RB, 1998, MED SELECTION LIFE R, P37; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; SYTKOWSKI PA, 1990, NEW ENGL J MED, V322, P1635, DOI 10.1056/NEJM199006073222304; TUNBRIDGE WMG, 1981, LANCET, V2, P569; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5457	10.1371/journal.pone.0005457	http://dx.doi.org/10.1371/journal.pone.0005457			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421319	Green Published, Green Submitted, gold			2022-12-27	WOS:000265836900013
J	Tcherepanova, I; Starr, A; Lackford, B; Adams, MD; Routy, JP; Boulassel, MR; Calderhead, D; Healey, D; Nicolette, C				Tcherepanova, Irina; Starr, Aijing; Lackford, Brad; Adams, Melissa D.; Routy, Jean-Pierre; Boulassel, Mohamed Rachid; Calderhead, David; Healey, Don; Nicolette, Charles			The Immunosuppressive Properties of the HIV Vpr Protein Are Linked to a Single Highly Conserved Residue, R90	PLOS ONE			English	Article								Background: A hallmark of AIDS progression is a switch of cytokines from Th1 to Th2 in the plasma of patients. IL-12, a critical Th1 cytokine secreted by antigen presenting cells (APCs) is suppressed by Vpr, implicating it as an important virulence factor. We hypothesize that Vpr protein packaged in the virion may be required for disabling APCs of the first infected mucosal tissues. Consistent with this idea are reports that defects in the C-terminus of Vpr are associated with long-term non-progression. Principal Findings: Vpr RNA amplified from various sources was electroporated into monocyte-derived DC and IL-12 levels in supernatants were analyzed. The analysis of previously reported C-terminal Vpr mutations demonstrate that they do not alleviate the block of IL-12 secretion. However, a novel single conservative amino acid substitution, R90K, reverses the IL-12 suppression. Analysis of 1226 Vpr protein sequences demonstrated arginine (R) present at position 90 in 98.8%, with other substitutions at low frequency. Furthermore, none of sequences report lysine (K) in position 90. Vpr clones harboring the reported substitutions in position 90 were studied for their ability to suppress IL-12. Our data demonstrates that none of tested substitutions other than K relieve IL-12 suppression. This suggests a natural selection for sequences which suppress IL-12 secretion by DC and against mutations which relieve such suppression. Further analyses demonstrated that the R90K, as well as deletion of the C-terminus, directs the Vpr protein for rapid degradation. Conclusion: This study supports Vpr as an HIV virulence factor during HIV infection and for the first time provides a link between evolutionary conservation of Vpr and its ability to suppress IL-12 secretion by DC. DC activated in the presence of Vpr would be defective in the production of IL-12, thus contributing to the prevailing Th2 cytokine profile associated with progressive HIV disease. These findings should be considered in the design of future immunotherapies that incorporate Vpr as an antigen.			Tcherepanova, I (corresponding author), Argos Therapeut Inc, Dept Res & Dev, Durham, NC USA.	itcherepanova@argostherapeutics.com						Addo MM, 2002, DNA CELL BIOL, V21, P671, DOI 10.1089/104454902760330219; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Badley AD, 2003, TRENDS PHARMACOL SCI, V24, P298, DOI 10.1016/S0165-6147(03)00125-1; Bourbigot S, 2005, BIOCHEM J, V387, P333, DOI 10.1042/BJ20041759; Brenner C, 2003, J CLIN INVEST, V111, P1455, DOI 10.1172/JCI200318609; Butterfield LH, 2008, J IMMUNOTHER, V31, P89, DOI 10.1097/CJI.0b013e318158fce0; Calderhead DM, 2008, J IMMUNOTHER, V31, P731, DOI 10.1097/CJI.0b013e318183db02; Caly L, 2005, AIDS RES HUM RETROV, V21, P728, DOI 10.1089/aid.2005.21.728; Caly L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-67; CHANG PS, 1990, CLIN BIOTECHNOL, V2, P23; CHEHIMI J, 1994, J EXP MED, V179, P1361, DOI 10.1084/jem.179.4.1361; CLERICI M, 1993, SCIENCE, V262, P1721, DOI 10.1126/science.7903123; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; DeBenedette MA, 2008, J IMMUNOL, V181, P5296, DOI 10.4049/jimmunol.181.8.5296; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Gulzar N, 2004, CURR HIV RES, V2, P23, DOI 10.2174/1570162043485077; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; MICHAEL NL, 1995, J VIROL, V69, P4228, DOI 10.1128/JVI.69.7.4228-4236.1995; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; Mologni D, 2006, AIDS, V20, P567, DOI 10.1097/01.aids.0000210611.60459.0e; Mortarini R, 2000, CANCER RES, V60, P3559; Muller B, 2000, J VIROL, V74, P9727, DOI 10.1128/JVI.74.20.9727-9731.2000; Muthumani K, 2002, J MED PRIMATOL, V31, P179, DOI 10.1034/j.1600-0684.2002.02004.x; Muthumani K, 2005, INT IMMUNOL, V17, P103, DOI 10.1093/intimm/dxh190; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; Schuler W, 1999, J MOL BIOL, V285, P2105, DOI 10.1006/jmbi.1998.2381; Singh SP, 2000, J VIROL, V74, P10650, DOI 10.1128/JVI.74.22.10650-10657.2000; Tcherepanova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001489; Tcherepanova IY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-90; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Wang B, 1996, VIROLOGY, V223, P224, DOI 10.1006/viro.1996.0471; Xu SW, 2003, J IMMUNOL, V171, P2251, DOI 10.4049/jimmunol.171.5.2251; Zhao YQ, 2002, VIRUS RES, V89, P103, DOI 10.1016/S0168-1702(02)00127-2	37	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5853	10.1371/journal.pone.0005853	http://dx.doi.org/10.1371/journal.pone.0005853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516896	Green Submitted, Green Published, gold			2022-12-27	WOS:000266872900004
J	Wittenberg, AHJ; van der Lee, TAJ; Ben M'Barek, S; Ware, SB; Goodwin, SB; Kilian, A; Visser, RGF; Kema, GHJ; Schouten, HJ				Wittenberg, Alexander H. J.; van der Lee, Theo A. J.; Ben M'Barek, Sarrah; Ware, Sarah B.; Goodwin, Stephen B.; Kilian, Andrzej; Visser, Richard G. F.; Kema, Gert H. J.; Schouten, Henk J.			Meiosis Drives Extraordinary Genome Plasticity in the Haploid Fungal Plant Pathogen Mycosphaerella graminicola	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; ARRAYS TECHNOLOGY DART; GENETIC-LINKAGE MAP; RICE BLAST FUNGUS; DIVERSITY ARRAYS; SUPERNUMERARY CHROMOSOME; MICROSATELLITE LOCI; MEIOTIC BEHAVIOR; BLOTCH PATHOGEN; DUPLICATION	Meiosis in the haploid plant-pathogenic fungus Mycosphaerella graminicola results in eight ascospores due to a mitotic division following the two meiotic divisions. The transient diploid phase allows for recombination among homologous chromosomes. However, some chromosomes of M. graminicola lack homologs and do not pair during meiosis. Because these chromosomes are not present universally in the genome of the organism they can be considered to be dispensable. To analyze the meiotic transmission of unequal chromosome numbers, two segregating populations were generated by crossing genetically unrelated parent isolates originating from Algeria and The Netherlands that had pathogenicity towards durum or bread wheat, respectively. Detailed genetic analyses of these progenies using high-density mapping (1793 DArT, 258 AFLP and 25 SSR markers) and graphical genotyping revealed that M. graminicola has up to eight dispensable chromosomes, the highest number reported in filamentous fungi. These chromosomes vary from 0.39 to 0.77 Mb in size, and represent up to 38% of the chromosomal complement. Chromosome numbers among progeny isolates varied widely, with some progeny missing up to three chromosomes, while other strains were disomic for one or more chromosomes. Between 15-20% of the progeny isolates lacked one or more chromosomes that were present in both parents. The two high-density maps showed no recombination of dispensable chromosomes and hence, their meiotic processing may require distributive disjunction, a phenomenon that is rarely observed in fungi. The maps also enabled the identification of individual twin isolates from a single ascus that shared the same missing or doubled chromosomes indicating that the chromosomal polymorphisms were mitotically stable and originated from nondisjunction during the second division and, less frequently, during the first division of fungal meiosis. High genome plasticity could be among the strategies enabling this versatile pathogen to quickly overcome adverse biotic and abiotic conditions in wheat fields.			Wittenberg, AHJ (corresponding author), Keygene NV, Wageningen, Netherlands.	gert.kema@wur.nl	Goodwin, Steve/ABB-1862-2021; Visser, Richard GF/B-3423-2012	Visser, Richard GF/0000-0002-0213-4016; Kema, Gerrit HJ/0000-0002-2732-6911; Goodwin, Stephen/0000-0001-5708-9729; Ben M'Barek, Sarrah/0000-0002-6719-0895; Kilian, Andrzej/0000-0002-2730-7462				Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; BAINBRIDGE BW, 1966, J GEN MICROBIOL, V42, P417, DOI 10.1099/00221287-42-3-417; Chen RS, 1996, GENETICS, V142, P1119; Chuma I, 2003, CURR GENET, V43, P191, DOI 10.1007/s00294-003-0390-7; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; CUTTER VM, 1951, ANNU REV MICROBIOL, V5, P17, DOI 10.1146/annurev.mi.05.100151.000313; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; FARMAN ML, 1995, GENETICS, V140, P479; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; Garmaroodi HS, 2007, MOL PLANT MICROBE IN, V20, P1495, DOI 10.1094/MPMI-20-12-1495; Geiser DM, 1996, MOL BIOL EVOL, V13, P809, DOI 10.1093/oxfordjournals.molbev.a025641; Goodwin S. B., 2004, Applied mycology and biotechnology. Volume 4: fungal genomics, P315; Goodwin SB, 2001, PHYTOPATHOLOGY, V91, P1181, DOI 10.1094/PHYTO.2001.91.12.1181; Goodwin SB, 2007, FUNGAL GENET BIOL, V44, P398, DOI 10.1016/j.fgb.2006.09.004; GUACCI V, 1991, GENETICS, V127, P475; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Han YN, 2001, PLANT J, V25, P305, DOI 10.1046/j.1365-313x.2001.00969.x; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hardham AR, 1998, FUNGAL GENET BIOL, V24, P252, DOI 10.1006/fgbi.1998.1055; Hatta R, 2002, GENETICS, V161, P59; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Kema GHJ, 1999, SEPTORIA ON CEREALS: A STUDY OF PATHOSYSTEMS, P161; Kema GHJ, 1996, CURR GENET, V30, P251, DOI 10.1007/s002940050129; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P200, DOI 10.1094/Phyto-86-200; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P213, DOI 10.1094/Phyto-86-213; Kema GHJ, 2002, GENETICS, V161, P1497; Kohn LM, 2005, ANNU REV PHYTOPATHOL, V43, P279, DOI 10.1146/annurev.phyto.43.040204.135958; Koszul R, 2006, GENETICS, V172, P2211, DOI 10.1534/genetics.105.048058; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Leclair S, 1996, CURR GENET, V30, P541, DOI 10.1007/s002940050167; Lengeler KB, 2001, INFECT IMMUN, V69, P115, DOI 10.1128/IAI.69.1.115-122.2001; LOIDL J, 1994, P NATL ACAD SCI US; MCDONALD BA, 1991, CURR GENET, V19, P265, DOI 10.1007/BF00355053; Mehrabi R, 2007, MYCOLOGIA, V99, P868, DOI 10.3852/mycologia.99.6.868; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Orbach MJ, 1996, MOL PLANT MICROBE IN, V9, P261, DOI 10.1094/MPMI-9-0261; Owen PG, 1998, MOL ECOL, V7, P1611, DOI 10.1046/j.1365-294X.1998.00499.x; Perkins DD, 2000, FUNGAL GENET BIOL, V31, P153, DOI 10.1006/fgbi.2000.1248; Perkins DD, 1997, ADV GENET, V36, P239, DOI 10.1016/S0065-2660(08)60311-9; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; SMITH DA, 1975, GENETICS, V80, P125; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stukenbrock EH, 2007, MOL BIOL EVOL, V24, P398; Swart K, 2001, FUNGAL GENET BIOL, V33, P25, DOI 10.1006/fgbi.2001.1266; TZENG TH, 1992, GENETICS, V130, P81; VANETTEN H, 1994, ANTON LEEUW INT J G, V65, P263, DOI 10.1007/BF00871955; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang CS, 2003, FEMS MICROBIOL LETT, V226, P373, DOI 10.1016/S0378-1097(03)00640-2; WARE SB, 2006, ASPECTS SEXUAL REPRO, P75; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wittenberg AHJ, 2005, MOL GENET GENOMICS, V274, P30, DOI 10.1007/s00438-005-1145-6; Zhan J, 2003, FUNGAL GENET BIOL, V38, P286, DOI 10.1016/S1087-1845(02)00538-8; ZOLAN ME, 1995, MICROBIOL REV, V59, P686, DOI 10.1128/MMBR.59.4.686-698.1995	56	105	106	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5863	10.1371/journal.pone.0005863	http://dx.doi.org/10.1371/journal.pone.0005863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516898	Green Submitted, Green Published, gold			2022-12-27	WOS:000266872900014
J	Kinch, LN; Yarbrough, ML; Orth, K; Grishin, NV				Kinch, Lisa N.; Yarbrough, Melanie L.; Orth, Kim; Grishin, Nick V.			Fido, a Novel AMPylation Domain Common to Fic, Doc, and AvrB	PLOS ONE			English	Article								Background: The Vibrio parahaemolyticus type III secreted effector VopS contains a fic domain that covalently modifies Rho GTPase threonine with AMP to inhibit downstream signaling events in host cells. The VopS fic domain includes a conserved sequence motif (HPFx[D/E]GN[G/K]R) that contributes to AMPylation. Fic domains are found in a variety of species, including bacteria, a few archaea, and metazoan eukaryotes. Methodology/Principal Findings: We show that the AMPylation activity extends to a eukaryotic fic domain in Drosophila melanogaster CG9523, and use sequence and structure based computational methods to identify related domains in doc toxins and the type III effector AvrB. The conserved sequence motif that contributes to AMPylation unites fic with doc. Although AvrB lacks this motif, its structure reveals a similar topology to the fic and doc folds. AvrB binds to a peptide fragment of its host virulence target in a similar manner as fic binds peptide substrate. AvrB also orients a phosphate group from a bound ADP ligand near the peptide-binding site and in a similar position as a bound fic phosphate. Conclusions/Significance: The demonstrated eukaryotic fic domain AMPylation activity suggests that the VopS effector has exploited a novel host posttranslational modification. Fic domain-related structures give insight to the AMPylation active site and to the VopS fic domain interaction with its host GTPase target. These results suggest that fic, doc, and AvrB stem from a common ancestor that has evolved to AMPylate protein substrates.			Kinch, LN (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	lkinch@chop.swmed.edu	Yarbrough, Melanie/T-4078-2019; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Yarbrough, Melanie/0000-0003-2166-7552; Kinch, Lisa/0000-0003-3041-2615	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067165] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01-AI056404, R01 AI056404] Funding Source: Medline; NIGMS NIH HHS [GM67165, R01 GM067165] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2004, PROTEINS, V56, P795, DOI 10.1002/prot.20140; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; CUFF ME, STRUCTURE C IN PRESS; CUFF ME, GENOMICS MC IN PRESS; Das D, 2009, PROTEINS, V75, P264, DOI 10.1002/prot.22338; Desveaux D, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030048; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Fueller F, 2008, PROTEIN SCI, V17, P1456, DOI 10.1110/ps.035386.108; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Ginalski K, 2004, NUCLEIC ACIDS RES, V32, pW576, DOI 10.1093/nar/gkh370; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; *JCSG, CRYSTAL STR IN PRESS; Kajan L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-304; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KAWAMUKAI M, 1988, J BACTERIOL, V170, P3864, DOI 10.1128/jb.170.9.3864-3869.1988; Kinch LN, 2005, PROTEIN SCI, V14, P360, DOI 10.1110/ps.041114805; KOMANO T, 1991, RES MICROBIOL, V142, P269, DOI 10.1016/0923-2508(91)90040-H; Lee CC, 2004, STRUCTURE, V12, P487, DOI 10.1016/j.str.2004.02.013; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Ong LE, 2006, MOL MICROBIOL, V60, P951, DOI 10.1111/j.1365-2958.2006.05162.x; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Sadreyev RI, 2007, NUCLEIC ACIDS RES, V35, pW653, DOI 10.1093/nar/gkm293; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	38	102	106	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5818	10.1371/journal.pone.0005818	http://dx.doi.org/10.1371/journal.pone.0005818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503829	gold, Green Submitted, Green Published			2022-12-27	WOS:000266717200014
J	Greene, CS; Penrod, NM; Williams, SM; Moore, JH				Greene, Casey S.; Penrod, Nadia M.; Williams, Scott M.; Moore, Jason H.			Failure to Replicate a Genetic Association May Provide Important Clues About Genetic Architecture	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E APOE; EPISTASIS; GENOTYPE; LOCI	Replication has become the gold standard for assessing statistical results from genome-wide association studies. Unfortunately this replication requirement may cause real genetic effects to be missed. A real result can fail to replicate for numerous reasons including inadequate sample size or variability in phenotype definitions across independent samples. In genome-wide association studies the allele frequencies of polymorphisms may differ due to sampling error or population differences. We hypothesize that some statistically significant independent genetic effects may fail to replicate in an independent dataset when allele frequencies differ and the functional polymorphism interacts with one or more other functional polymorphisms. To test this hypothesis, we designed a simulation study in which case-control status was determined by two interacting polymorphisms with heritabilities ranging from 0.025 to 0.4 with replication sample sizes ranging from 400 to 1600 individuals. We show that the power to replicate the statistically significant independent main effect of one polymorphism can drop dramatically with a change of allele frequency of less than 0.1 at a second interacting polymorphism. We also show that differences in allele frequency can result in a reversal of allelic effects where a protective allele becomes a risk factor in replication studies. These results suggest that failure to replicate an independent genetic effect may provide important clues about the complexity of the underlying genetic architecture. We recommend that polymorphisms that fail to replicate be checked for interactions with other polymorphisms, particularly when samples are collected from groups with distinct ethnic backgrounds or different geographic regions.			Greene, CS (corresponding author), Dartmouth Coll, Dept Genet, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Jason.H.Moore@dartmouth.edu	Moore, Jason H./AAV-9645-2021; Williams, Scott/Q-4812-2019; Greene, Casey/L-2057-2015; Williams, Scott/B-9491-2012	Moore, Jason H./0000-0002-5015-1099; Williams, Scott/0000-0002-4835-9544; Greene, Casey/0000-0001-8713-9213; 	NIAID NIH HHS [R01-AI59694, R01 AI059694] Funding Source: Medline; NICHD NIH HHS [R01-HD047447, R01 HD047447] Funding Source: Medline; NIEHS NIH HHS [R01-ES007373, P42 ES007373] Funding Source: Medline; NLM NIH HHS [R01 LM009012, R01-LM009012] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059694] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		ASKLAND K, 2009, HUMAN GENETICS; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bush WS, 2009, PAC S BIOC; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Kimmel SE, 2008, PHARMACOGENOMICS J, V8, P53, DOI 10.1038/sj.tpj.6500445; Kohnke H, 2005, EUR J CLIN PHARMACOL, V61, P381, DOI 10.1007/s00228-005-0936-3; Kohnke H, 2005, EUR J CLIN PHARMACOL, V61, P781, DOI 10.1007/s00228-005-0982-x; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McKusick V.A., 1998, MENDELIAN INHERITANC; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Saccone SF, 2008, BIOINFORMATICS, V24, P1805, DOI 10.1093/bioinformatics/btn315; Sconce EA, 2006, PHARMACOGENET GENOM, V16, P609, DOI 10.1097/01.fpc.0000220567.98089.b5; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Shriner D, 2007, SCIENCE, V316, P1840; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wilke R. A., 2008, Current Pharmacogenomics & Personalized Medicine, V6, P150; Williams SM, 2007, SCIENCE, V316, P1841	31	195	198	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5639	10.1371/journal.pone.0005639	http://dx.doi.org/10.1371/journal.pone.0005639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503614	Green Submitted, Green Published, gold			2022-12-27	WOS:000266587400001
J	Minor, JS; Tang, HY; Pereira, FA; Alford, RL				Minor, Jacob S.; Tang, Hsiao-Yuan; Pereira, Fred A.; Alford, Raye Lynn			DNA Sequence Analysis of SLC26A5, Encoding Prestin, in a Patient-Control Cohort: Identification of Fourteen Novel DNA Sequence Variations	PLOS ONE			English	Article								Background: Prestin, encoded by the gene SLC26A5, is a transmembrane protein of the cochlear outer hair cell (OHC). Prestin is required for the somatic electromotile activity of OHCs, which is absent in OHCs and causes severe hearing impairment in mice lacking prestin. In humans, the role of sequence variations in SLC26A5 in hearing loss is less clear. Although prestin is expected to be required for functional human OHCs, the clinical significance of reported putative mutant alleles in humans is uncertain. Methodology/Principal Findings: To explore the hypothesis that SLC26A5 may act as a modifier gene, affecting the severity of hearing loss caused by an independent etiology, a patient-control cohort was screened for DNA sequence variations in SLC26A5 using sequencing and allele specific methods. Patients in this study carried known pathogenic or controversial sequence variations in GJB2, encoding Connexin 26, or confirmed or suspected sequence variations in SLC26A5; controls included four ethnic populations. Twenty-three different DNA sequence variations in SLC26A5, 14 of which are novel, were observed: 4 novel sequence variations were found exclusively among patients; 7 novel sequence variations were found exclusively among controls; and, 12 sequence variations, 3 of which are novel, were found in both patients and controls. Twenty-one of the 23 DNA sequence variations were located in non-coding regions of SLC26A5. Two coding sequence variations, both novel, were observed only in patients and predict a silent change, p. S434S, and an amino acid substitution, p. I663V. In silico analysis of the p. I663V amino acid variation suggested this variant might be benign. Using Fisher's exact test, no statistically significant difference was observed between patients and controls in the frequency of the identified DNA sequence variations. Haplotype analysis using HaploView 4.0 software revealed the same predominant haplotype in patients and controls and derived haplotype blocks in the patient-control cohort similar to those generated from the International HapMap Project. Conclusions/Significance: Although these data fail to support a hypothesis that SLC26A5 acts as a modifier gene of GJB2-related hearing loss, the sample size is small and investigation of a larger population might be more informative. The 14 novel DNA sequence variations in SLC26A5 reported here will serve as useful research tools for future studies of prestin.			Minor, JS (corresponding author), Univ Colorado, Denver Hlth Sci Ctr, Dept Otolaryngol, Aurora, CO USA.	ralford@bcm.edu		Pereira, Fred/0000-0003-2100-0280	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008134, R01DC004585, R01DC000354, R01DC009622, F32DC000354] Funding Source: NIH RePORTER; NIDCD NIH HHS [R21 DC008134, R01 DC000354, F32 DC000354, R01 DC009622, DC008134-01, R01 DC004585, DC00354] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		*APPL BIOS YST, 2008, TAQMAN SNP GEN ASS; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CONNERS BW, 2002, MED PHYSL CELLULAR M, P325; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; DALLOS P, 1992, J NEUROSCI, V12, P4575; Dallos P, 2006, J PHYSIOL-LONDON, V576, P37, DOI 10.1113/jphysiol.2006.114652; Database of Single Nucleotide Polymorphisms, 2008, DATABASE SINGLE NUCL; Deak L, 2005, J PHYSIOL-LONDON, V563, P483, DOI 10.1113/jphysiol.2004.078857; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Ogino S, 2007, J MOL DIAGN, V9, P1, DOI 10.2353/jmoldx.2007.060081; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Tang HY, 2006, AM J MED GENET A, V140A, P2401, DOI 10.1002/ajmg.a.31525; Tang HY, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-30; Toth T, 2007, INT J MOL MED, V20, P545; VANCAMP G, 2008, HEREDITARY HEARING L; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2003, MAMM GENOME, V14, P87, DOI 10.1007/s00335-002-2227-y	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5762	10.1371/journal.pone.0005762	http://dx.doi.org/10.1371/journal.pone.0005762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19492055	Green Published, Green Submitted, gold			2022-12-27	WOS:000266587400005
J	Blum, R; Gupta, R; Burger, PE; Ontiveros, CS; Salm, SN; Xiong, XZ; Kamb, A; Wesche, H; Marshall, L; Cutler, G; Wang, XY; Zavadil, J; Moscatelli, D; Wilson, EL				Blum, Roy; Gupta, Rashmi; Burger, Patricia E.; Ontiveros, Christopher S.; Salm, Sarah N.; Xiong, Xiaozhong; Kamb, Alexander; Wesche, Holger; Marshall, Lisa; Cutler, Gene; Wang, Xiangyun; Zavadil, Jiri; Moscatelli, David; Wilson, E. Lynette			Molecular Signatures of Prostate Stem Cells Reveal Novel Signaling Pathways and Provide Insights into Prostate Cancer	PLOS ONE			English	Article							HEMATOPOIETIC STEM; GENE-EXPRESSION; PROXIMAL REGION; FUNCTIONAL-CHARACTERIZATION; COORDINATE REGULATION; TGF-BETA; IN-UTERO; RECEPTOR; PROTEIN; DIFFERENTIATION	Background: The global gene expression profiles of adult and fetal murine prostate stem cells were determined to define common and unique regulators whose misexpression might play a role in the development of prostate cancer. Methodology/Principal Findings: A distinctive core of transcriptional regulators common to both fetal and adult primitive prostate cells was identified as well as molecules that are exclusive to each population. Elements common to fetal and adult prostate stem cells include expression profiles of Wnt, Shh and other pathways identified in stem cells of other organs, signatures of the aryl-hydrocarbon receptor, and up-regulation of components of the aldehyde dehydrogenase/retinoic acid receptor axis. There is also a significant lipid metabolism signature, marked by overexpression of lipid metabolizing enzymes and the presence of the binding motif for Srebp1. The fetal stem cell population, characterized by more rapid proliferation and self-renewal, expresses regulators of the cell cycle, such as E2f, Nfy, Tead2 and Ap2, at elevated levels, while adult stem cells show a signature in which TGF-beta has a prominent role. Finally, comparison of the signatures of primitive prostate cells with previously described profiles of human prostate tumors identified stem cell molecules and pathways with deregulated expression in prostate tumors including chromatin modifiers and the oncogene, Erg. Conclusions/Significance: Our data indicate that adult prostate stem or progenitor cells may acquire characteristics of self-renewing primitive fetal prostate cells during oncogenesis and suggest that aberrant activation of components of prostate stem cell pathways may contribute to the development of prostate tumors.			Blum, R (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	Elaine.Wilson@nyumc.org	Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Moscatelli, David/0000-0002-4627-4213; Blum, Roy/0000-0002-3987-7198	NATIONAL CANCER INSTITUTE [R01CA132641, R01CA090593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK071468] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090593, R01 CA132641, R01 CA090593-04, CA132641, CA 90593] Funding Source: Medline; NIDDK NIH HHS [5F32DK071468, F32 DK071468] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Aparicio LMA, 2007, CLIN TRANSL ONCOL, V9, P66, DOI 10.1007/s12094-007-0015-6; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Clarke AR, 2006, ONCOGENE, V25, P7512, DOI 10.1038/sj.onc.1210065; Corti S, 2006, HUM MOL GENET, V15, P167, DOI 10.1093/hmg/ddi446; Cunha G R, 1987, Prog Clin Biol Res, V239, P273; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Fanayan S, 2000, J BIOL CHEM, V275, P39146, DOI 10.1074/jbc.M006964200; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Gipp J, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-19; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Habib FK, 2003, CLIN CANCER RES, V9, P1815; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hoei-Hansen CE, 2006, J PATHOL, V209, P25, DOI 10.1002/path.1948; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Honda M, 2005, BIOCHEM BIOPH RES CO, V333, P1334, DOI 10.1016/j.bbrc.2005.05.202; Huang L, 2003, J BIOL CHEM, V278, P51085, DOI 10.1074/jbc.M308321200; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaneko KJ, 2004, MOL CELL BIOL, V24, P1968, DOI 10.1128/MCB.24.5.1968-1982.2004; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Kues WA, 2005, BIOL REPROD, V72, P1020, DOI 10.1095/biolreprod.104.031229; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lin TM, 2003, TOXICOL SCI, V76, P171, DOI 10.1093/toxsci/kfg218; Lin TM, 2002, TOXICOL SCI, V68, P479, DOI 10.1093/toxsci/68.2.479; LOUGHRAN SJ, 2008, NAT IMMUNOL; Mehra R, 2008, CANCER RES, V68, P3584, DOI 10.1158/0008-5472.CAN-07-6154; Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murante FG, 2000, TOXICOL SCI, V54, P374, DOI 10.1093/toxsci/54.2.374; Nishimori T, 2006, PROTEOMICS, V6, P1011, DOI 10.1002/pmic.200500262; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Petkov PM, 2004, HEPATOLOGY, V39, P617, DOI 10.1002/hep.20088; Purton LE, 2007, PPAR RES, V2007, DOI 10.1155/2007/87934; Qian H, 2007, BLOOD, V110, P2399, DOI 10.1182/blood-2006-10-051276; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakai R, 2003, TOXICOL SCI, V72, P84, DOI 10.1093/toxsci/kfg002; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Seo J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-395; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shetty RS, 2005, MOL CELL NEUROSCI, V30, P583, DOI 10.1016/j.mcn.2005.06.003; Signoretti S, 2007, SEMIN CANCER BIOL, V17, P219, DOI 10.1016/j.semcancer.2006.04.004; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Szatmari I, 2007, BLOOD, V110, P3271, DOI 10.1182/blood-2007-06-096222; TAMIMI Y, 1993, CANCER RES, V53, P5512; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Traynor P, 2008, DIS MARKERS, V24, P157, DOI 10.1155/2008/918087; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Wenzel PL, 2007, GENE DEV, V21, P85, DOI 10.1101/gad.1485307; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Winkler S, 2007, CANCER GENET CYTOGEN, V177, P98, DOI 10.1016/j.cancergencyto.2007.06.008; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yamada K, 2006, CANCER SCI, V97, P106, DOI 10.1111/j.1349-7006.2006.00147.x; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102	79	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5722	10.1371/journal.pone.0005722	http://dx.doi.org/10.1371/journal.pone.0005722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478945	Green Published, gold			2022-12-27	WOS:000266490000004
J	Kawahara, AY; Mignault, AA; Regier, JC; Kitching, IJ; Mitter, C				Kawahara, Akito Y.; Mignault, Andre A.; Regier, Jerome C.; Kitching, Ian J.; Mitter, Charles			Phylogeny and Biogeography of Hawkmoths (Lepidoptera: Sphingidae): Evidence from Five Nuclear Genes	PLOS ONE			English	Article							COMPLEX LEPIDOPTERA; INITIAL EVIDENCE; SEQUENCE DATA; DEEP FLOWERS; EVOLUTION; MOTHS; PLANT; BIODIVERSITY; CONGRUENCE; UTILITY	Background: The 1400 species of hawkmoths (Lepidoptera: Sphingidae) comprise one of most conspicuous and well-studied groups of insects, and provide model systems for diverse biological disciplines. However, a robust phylogenetic framework for the family is currently lacking. Morphology is unable to confidently determine relationships among most groups. As a major step toward understanding relationships of this model group, we have undertaken the first large-scale molecular phylogenetic analysis of hawkmoths representing all subfamilies, tribes and subtribes. Methodology/Principal Findings: The data set consisted of 131 sphingid species and 6793 bp of sequence from five protein-coding nuclear genes. Maximum likelihood and parsimony analyses provided strong support for more than two-thirds of all nodes, including strong signal for or against nearly all of the fifteen current subfamily, tribal and sub-tribal groupings. Monophyly was strongly supported for some of these, including Macroglossinae, Sphinginae, Acherontiini, Ambulycini, Philampelini, Choerocampina, and Hemarina. Other groupings proved para-or polyphyletic, and will need significant redefinition; these include Smerinthinae, Smerinthini, Sphingini, Sphingulini, Dilophonotini, Dilophonotina, Macroglossini, and Macroglossina. The basal divergence, strongly supported, is between Macroglossinae and Smerinthinae+Sphinginae. All genes contribute significantly to the signal from the combined data set, and there is little conflict between genes. Ancestral state reconstruction reveals multiple separate origins of New World and Old World radiations. Conclusions/Significance: Our study provides the first comprehensive phylogeny of one of the most conspicuous and well-studied insects. The molecular phylogeny challenges current concepts of Sphingidae based on morphology, and provides a foundation for a new classification. While there are multiple independent origins of New World and Old World radiations, we conclude that broad-scale geographic distribution in hawkmoths is more phylogenetically conserved than previously postulated.			Kawahara, AY (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	kawahara@umd.edu						Agosta SJ, 2005, OIKOS, V108, P183, DOI 10.1111/j.0030-1299.2005.13504.x; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; BATRA SWT, 1983, J NEW YORK ENTOMOL S, V91, P304; Bazinet AL, 2007, FUTURE GENER COMP SY, V23, P517, DOI 10.1016/j.future.2006.07.009; BAZINET AL, DISTRIBUTED IN PRESS; Beck J, 2006, BIODIVERS CONSERV, V15, P465, DOI 10.1007/s10531-005-0306-6; Beck J, 2006, BIOL J LINN SOC, V89, P455, DOI 10.1111/j.1095-8312.2006.00686.x; BELL TRD, 1937, FAUNA BRIT INDIA, V5; BELLOTTI AC, 1992, FLA ENTOMOL, V75, P506, DOI 10.2307/3496132; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brower AVZ, 1998, INSECT MOL BIOL, V7, P73, DOI 10.1046/j.1365-2583.1998.71052.x; Caterino MS, 2001, SYST BIOL, V50, P106, DOI 10.1080/106351501750107530; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; DERZHAVETS YA, 1993, ENTOMOL OBOZR, V73, P648; Eaton JL, 1988, LEPIDOPTERAN ANATOMY; EATON JL, 1971, INT J INSECT MORPHOL, V3, P47; Fang QQ, 1997, SYST BIOL, V46, P269, DOI 10.2307/2413623; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Forbes William T. M., 1911, Annals of the Entomological Society of America, V4; Goloboff P., 1999, NONA NO NAME VERSION; GREGORY DAVID P., 1963, ALISO, V5, P357; GU X, 1995, MOL BIOL EVOL, V12, P546; HABER WA, 1989, BIOTROPICA, V21, P155, DOI 10.2307/2388706; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HARRIS P, 1972, CAN ENTOMOL, V104, P71, DOI 10.4039/Ent10471-1; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hennig W., 1950, GRUNDZUGE THEORIE PH; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; HODGES RW, 1971, MOTHS N AM N MEXICO, V21; Hundsdoerfer AK, 2005, ORG DIVERS EVOL, V5, P173, DOI 10.1016/j.ode.2004.11.012; Hundsdoerfer AK, 2005, MOL PHYLOGENET EVOL, V35, P442, DOI 10.1016/j.ympev.2005.02.004; JACKSON DM, 1990, FLA ENTOMOL, V73, P378, DOI 10.2307/3495456; JANSE AJT, 1932, MOTHS S AFRICA; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jindra M, 1997, INSECT MOL BIOL, V6, P41, DOI 10.1046/j.1365-2583.1997.00153.x; Jochova J, 1997, DEV GENET, V21, P249, DOI 10.1002/(SICI)1520-6408(1997)21:4<249::AID-DVG2>3.0.CO;2-7; KATOH K, 2008, MAFFT VER 6 611; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kessler A, 2002, ECOLOGY, V83, P2346, DOI 10.1890/0012-9658(2002)083[2346:MQSOOI]2.0.CO;2; Kitching I. J., 2000, HAWKMOTHS WORLD ANNO; Kitching IJ, 2003, SYST ENTOMOL, V28, P71, DOI 10.1046/j.1365-3113.2003.00199.x; Kitching IJ, 2002, ZOOL J LINN SOC-LOND, V135, P471, DOI 10.1046/j.1096-3642.2002.00021.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lemaire C., 1998, LEPIDOPTERA MOTHS BU, P321; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; Maddison W.P., 2008, MESQUITE MODULAR SYS; MINET J, 1991, ENTOMOL SCAND, V22, P69; MINET J, 1994, ENTOMOL SCAND, V25, P63, DOI 10.1163/187631294X00045; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; Nakamura M., 1977, New Entomologist Ueda, V26, P1; Nakamura M., 1976, YUGATO, V63, P19; NAKAMURA M, 1978, YUGATO, V74, P111; NILSSON LA, 1992, NATURE, V360, P666, DOI 10.1038/360666a0; NILSSON LA, 1985, BIOL J LINN SOC, V26, P1, DOI 10.1111/j.1095-8312.1985.tb01549.x; Nilsson LA, 1998, TRENDS ECOL EVOL, V13, P259, DOI 10.1016/S0169-5347(98)01359-7; Nixon K.C., 2002, WINCLADA VER 1 00 08; Osier TL, 1996, OIKOS, V77, P481, DOI 10.2307/3545937; Pielou E.C., 1979, BIOGEOGRAPHY; PITTAWAY A. R., 1997, SPHINGIDAE W PALAEAR; PITTAWAY AR, 2006, SPHINGIDAE E PALAEAR; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; *PROM CORP, 2004, Z3100 PROM CORP; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Regier JC, 2000, INSECT SYST EVOL, V31, P179, DOI 10.1163/187631200X00372; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Regier JC, 2001, MOL PHYLOGENET EVOL, V20, P311, DOI 10.1006/mpev.2001.0963; Regier JC, 2008, PROTOCOLS CONCEPTS R; Regier JC, 2008, SYST ENTOMOL, V33, P219, DOI 10.1111/j.1365-3113.2007.00416.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; ROBINSON GS, 2009, HOSTS DATABASE WORLD; ROE AD, 2009, GENETICS MOL BIOL LE; ROEDER KD, 1970, J INSECT PHYSIOL, V16, P1069, DOI 10.1016/0022-1910(70)90199-X; ROTHSCHILD LW, 1903, NOV ZOOL S, V9, P1; RUBINOFF D, 2009, J LEPIDOPTERISTS SOC; Rubinoff D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004035; SEVASTOPULO DG, 1949, EARLY STAGES E UNPUB; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; SOKAL RR, 1981, SYST ZOOL, V30, P309, DOI 10.2307/2413252; SORENSON MD, 1999, TREEROT VERSION 2; STADEN R, 1999, COMPUTER METHODS MOL, P115; Struck TH, 2006, SYST BIOL, V55, P1, DOI 10.1080/10635150500354910; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tuttle J. P., 2007, HAWK MOTHS N AM NATU; Udvardy M.D.F., 1975, CLASSIFICATION BIOGE; Wannenmacher G, 2003, J INSECT PHYSIOL, V49, P765, DOI 10.1016/S0022-1910(03)00113-6; Wasserthal LT, 1998, TRENDS ECOL EVOL, V13, P459, DOI 10.1016/S0169-5347(98)01496-7; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x; Willis Judith H., 1995, P1; WINDER JA, 1976, PANS, V22, P449; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; ZWICK A, 2008, SYSTEMATIC ENTOMOLOG, P190; Zwickl DJ., 2006, THESIS	98	75	80	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5719	10.1371/journal.pone.0005719	http://dx.doi.org/10.1371/journal.pone.0005719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19492095	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415100012
J	Jones, HP; Schmitz, OJ				Jones, Holly P.; Schmitz, Oswald J.			Rapid Recovery of Damaged Ecosystems	PLOS ONE			English	Article							SUSTAINABILITY SCIENCE; RESTORATION ECOLOGY; RESILIENCE; STABILITY; RESISTANCE; SYSTEMS	Background: Recent reports on the state of the global environment provide evidence that humankind is inflicting great damage to the very ecosystems that support human livelihoods. The reports further predict that ecosystems will take centuries to recover from damages if they recover at all. Accordingly, there is despair that we are passing on a legacy of irreparable damage to future generations which is entirely inconsistent with principles of sustainability. Methodology/Principal Findings: We tested the prediction of irreparable harm using a synthesis of recovery times compiled from 240 independent studies reported in the scientific literature. We provide startling evidence that most ecosystems globally can, given human will, recover from very major perturbations on timescales of decades to half-centuries. Significance/Conclusions: Accordingly, we find much hope that humankind can transition to more sustainable use of ecosystems.			Jones, HP (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	holly.jones@yale.edu		Jones, Holly/0000-0002-5512-9958	Direct For Biological Sciences [0816504] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		[Anonymous], 2005, EC HUM WELL BEING SY; Baumol W., 1996, ENVIRON DEV ECON, V3, P221, DOI 10.1017/S1355770X98240125; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Carpenter SR, 2000, ECOSYSTEMS, V3, P495, DOI 10.1007/s100210000043; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Dobson AP, 1997, SCIENCE, V277, P515, DOI 10.1126/science.277.5325.515; DUDZIK M, 1975, STABILITY INDICATORS; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris Jim A., 2006, P3; HARRISON GW, 1980, ECOL MODEL, V10, P227, DOI 10.1016/0304-3800(80)90061-7; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; HARWELL MA, 1977, ECOLOGY, V58, P660, DOI 10.2307/1939016; *HJ HEINZ CTR SCI, 2005, STAT NAT EC 2008; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; LEWONTIN RC, 1969, BROOKHAVEN SYM BIOL, P13; McLauchlan KK, 2007, P NATL ACAD SCI USA, V104, P7466, DOI 10.1073/pnas.0701779104; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377	24	214	217	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5653	10.1371/journal.pone.0005653	http://dx.doi.org/10.1371/journal.pone.0005653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19471645	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415000002
J	Bleeker, FE; Lamba, S; Zanon, C; van Tilborg, AA; Leenstra, S; Troost, D; Hulsebos, T; Vandertop, WP; Bardelli, A				Bleeker, Fonnet E.; Lamba, Simona; Zanon, Carlo; van Tilborg, Angela A.; Leenstra, Sieger; Troost, Dirk; Hulsebos, Theo; Vandertop, W. Peter; Bardelli, Alberto			Absence of AKT1 Mutations in Glioblastoma	PLOS ONE			English	Article								Background: Oncogenic activation of the PI3K signalling pathway plays a pivotal role in the development of glioblastoma multiforme (GBM). A central node in PI3K downstream signalling is controlled by the serine-threonine kinase AKT1. A somatic mutation affecting residue E17 of the AKT1 gene has recently been identified in breast and colon cancer. The E17K change results in constitutive AKT1 activation, induces leukaemia in mice, and accordingly, may be therapeutically exploited to target the PI3K pathway. Assessing whether AKT1 is activated by somatic mutations in GBM is relevant to establish its role in this aggressive disease. Methodology/Principal Findings: We performed a systematic mutational analysis of the complete coding sequence of the AKT1 gene in a panel of 109 tumor GBM samples and nine high grade astrocytoma cell lines. However, no somatic mutations were detected in the coding region of AKT1. Conclusions/Significance: Our data indicate that in GBM oncogenic deregulation of the PI3K pathway does not involve somatic mutations in the coding region of AKT1.			Bleeker, FE (corresponding author), Univ Amsterdam, Acad Med Ctr, Neurosurg Ctr Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	f.e.bleeker@amc.uva.nl	Vandertop, William P./K-9288-2018; van Tilborg, Angela/M-5704-2015; BARDELLI, Alberto/J-9721-2018	van Tilborg, Angela/0000-0003-3968-5345; BARDELLI, Alberto/0000-0003-1647-5070; Zanon, Carlo/0000-0003-2539-7238; Vandertop, William/0000-0001-5417-0265; Lamba, Simona Elena/0000-0003-3207-1594				Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Benvenuti S, 2008, HUM MUTAT, V29, P284, DOI 10.1002/humu.20648; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Hartmann C, 2005, ACTA NEUROPATHOL, V109, P639, DOI 10.1007/s00401-005-1000-1; Kim MS, 2008, BRIT J CANCER, V98, P1533, DOI 10.1038/sj.bjc.6604212; Kita D, 2007, ACTA NEUROPATHOL, V113, P295, DOI 10.1007/s00401-006-0186-1; Knobbe CB, 2005, NEUROPATH APPL NEURO, V31, P486, DOI 10.1111/j.1365-2990.2005.00660.x; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schuller U, 2008, ACTA NEUROPATHOL, V115, P367, DOI 10.1007/s00401-007-0334-2; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	22	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5638	10.1371/journal.pone.0005638	http://dx.doi.org/10.1371/journal.pone.0005638			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461960	Green Published, Green Submitted, gold			2022-12-27	WOS:000266234700024
J	Nevin, KP; Kim, BC; Glaven, RH; Johnson, JP; Woodard, TL; Methe, BA; DiDonato, RJ; Covalla, SF; Franks, AE; Liu, A; Lovley, DR				Nevin, Kelly P.; Kim, Byoung-Chan; Glaven, Richard H.; Johnson, Jessica P.; Woodard, Trevor L.; Methe, Barbara A.; DiDonato, Raymond J., Jr.; Covalla, Sean F.; Franks, Ashley E.; Liu, Anna; Lovley, Derek R.			Anode Biofilm Transcriptomics Reveals Outer Surface Components Essential for High Density Current Production in Geobacter sulfurreducens Fuel Cells	PLOS ONE			English	Article							FE(III) REDUCTION; ELECTRON-TRANSFER; GENETIC-CHARACTERIZATION; HARVESTING ELECTRICITY; DNA MICROARRAY; EXPRESSION; ENERGY; OMCB; CYTOCHROMES; EFFICIENCIES	The mechanisms by which Geobacter sulfurreducens transfers electrons through relatively thick (> 50 mu m) biofilms to electrodes acting as a sole electron acceptor were investigated. Biofilms of Geobacter sulfurreducens were grown either in flow-through systems with graphite anodes as the electron acceptor or on the same graphite surface, but with fumarate as the sole electron acceptor. Fumarate-grown biofilms were not immediately capable of significant current production, suggesting substantial physiological differences from current-producing biofilms. Microarray analysis revealed 13 genes in current-harvesting biofilms that had significantly higher transcript levels. The greatest increases were for pilA, the gene immediately downstream of pilA, and the genes for two outer c-type membrane cytochromes, OmcB and OmcZ. Down-regulated genes included the genes for the outer-membrane c-type cytochromes, OmcS and OmcT. Results of quantitative RT-PCR of gene transcript levels during biofilm growth were consistent with microarray results. OmcZ and the outer-surface c-type cytochrome, OmcE, were more abundant and OmcS was less abundant in current-harvesting cells. Strains in which pilA, the gene immediately downstream from pilA, omcB, omcS, omcE, or omcZ was deleted demonstrated that only deletion of pilA or omcZ severely inhibited current production and biofilm formation in current-harvesting mode. In contrast, these gene deletions had no impact on biofilm formation on graphite surfaces when fumarate served as the electron acceptor. These results suggest that biofilms grown harvesting current are specifically poised for electron transfer to electrodes and that, in addition to pili, OmcZ is a key component in electron transfer through differentiated G. sulfurreducens biofilms to electrodes.			Nevin, KP (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	knevin@microbio.umass.edu	Nevin, Kelly/AAA-4626-2019	Franks, Ashley/0000-0003-1664-6060; Johnson, Jessica/0000-0001-6367-4561				Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Butler JE, 2006, J BACTERIOL, V188, P450, DOI 10.1128/JB.188.2.450-455.2006; Coppi MV, 2007, MICROBIOL-SGM, V153, P3572, DOI 10.1099/mic.0.2007/006478-0; Coppi MV, 2001, APPL ENVIRON MICROB, V67, P3180, DOI 10.1128/AEM.67.7.3180-3187.2001; Debabov VG, 2008, MICROBIOLOGY+, V77, P123, DOI 10.1134/S002626170802001X; DiDonato LN, 2006, J BACTERIOL, V188, P8469, DOI 10.1128/JB.01278-06; Du ZW, 2007, BIOTECHNOL ADV, V25, P464, DOI 10.1016/j.biotechadv.2007.05.004; FRANCIS RT, 1984, ANAL BIOCHEM, V136, P509, DOI 10.1016/0003-2697(84)90253-7; Holmes DE, 2006, ENVIRON MICROBIOL, V8, P1805, DOI 10.1111/j.1462-2920.2006.01065.x; Holmes DE, 2004, MICROB ECOL, V48, P178, DOI 10.1007/s00248-003-0004-4; Ishii S, 2008, APPL ENVIRON MICROB, V74, P7348, DOI 10.1128/AEM.01639-08; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; Kim BC, 2006, J BACTERIOL, V188, P3138, DOI 10.1128/JB.188.8.3138-3142.2006; Kim BC, 2005, J BACTERIOL, V187, P4505, DOI 10.1128/JB.187.13.4505-4513.2005; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krushkal J, 2007, FUNCT INTEGR GENOMIC, V7, P229, DOI 10.1007/s10142-007-0048-5; Leang C, 2005, MICROBIOL-SGM, V151, P1761, DOI 10.1099/mic.0.27870-0; Leang C, 2003, J BACTERIOL, V185, P2096, DOI 10.1128/JB.185.7.2096-2103.2003; Leang C, 2005, J BACTERIOL, V187, P5918, DOI 10.1128/JB.187.17.5918-5926.2005; Lee HS, 2008, WATER RES, V42, P1501, DOI 10.1016/j.watres.2007.10.036; Liu Y, 2008, BIOSENS BIOELECTRON, V24, P1006, DOI 10.1016/j.bios.2008.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd JR, 2003, BIOCHEM J, V369, P153, DOI 10.1042/BJ20020597; Lovley D, 2006, SCIENTIST, V20, P46; Lovley DR, 2006, CURR OPIN BIOTECH, V17, P327, DOI 10.1016/j.copbio.2006.04.006; Lovley DR, 2006, NAT REV MICROBIOL, V4, P497, DOI 10.1038/nrmicro1442; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; Mehta T, 2005, APPL ENVIRON MICROB, V71, P8634, DOI 10.1128/AEM.71.12.8634-8641.2005; Methe BA, 2005, APPL ENVIRON MICROB, V71, P2530, DOI 10.1128/AEM.71.5.2530-2538.2005; Murphy KC, 2000, GENE, V246, P321, DOI 10.1016/S0378-1119(00)00071-8; Nevin KP, 2008, ENVIRON MICROBIOL, V10, P2505, DOI 10.1111/j.1462-2920.2008.01675.x; Nunez C, 2006, J BACTERIOL, V188, P2792, DOI 10.1128/JB.188.8.2792-2800.2006; ONEIL RA, 2008, INVESTIGATION UNPUB; Postier B, 2008, J MICROBIOL METH, V74, P26, DOI 10.1016/j.mimet.2007.07.004; Qian XL, 2007, FEMS MICROBIOL LETT, V277, P21, DOI 10.1111/j.1574-6968.2007.00915.x; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2007, J BACTERIOL, V189, P2125, DOI 10.1128/JB.01284-06; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Reyne JA, 2004, APPL ENVIRON MICROB, V70, P6181, DOI 10.1128/AEM.70.10.6181-6187.2004; RICHTER H, 2009, ENERGY ENV IN PRESS; Richter H, 2007, APPL ENVIRON MICROB, V73, P5347, DOI 10.1128/AEM.00804-07; Rozen S, 2000, Methods Mol Biol, V132, P365; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Srikanth S, 2008, BIOTECHNOL BIOENG, V99, P1065, DOI 10.1002/bit.21671; Strycharz SM, 2008, APPL ENVIRON MICROB, V74, P5943, DOI 10.1128/AEM.00961-08; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Torres CI, 2007, APPL MICROBIOL BIOT, V77, P689, DOI 10.1007/s00253-007-1198-z	52	292	302	8	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5628	10.1371/journal.pone.0005628	http://dx.doi.org/10.1371/journal.pone.0005628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461962	Green Published, gold			2022-12-27	WOS:000266234700015
J	Alvarez-Blasco, F; Martinez-Garcia, MA; Luque-Ramirez, M; Parraza, N; Millan, JLS; Escobar-Morreale, HF				Alvarez-Blasco, Francisco; Martinez-Garcia, Ma Angeles; Luque-Ramirez, Manuel; Parraza, Naiara; Millan, Jose L. San; Escobar-Morreale, Hector F.			Role of Haptoglobin in Polycystic Ovary Syndrome (PCOS), Obesity and Disorders of Glucose Tolerance in Premenopausal Women	PLOS ONE			English	Article								Background: Hp(2) alleles of the haptoglobin alpha-chain polymorphism reduce the anti-oxidant properties and increase the proinflammatory actions of this acute-phase protein in a gene-dosage fashion. We hypothesized that the haptoglobin polymorphism might contribute to the increased oxidative stress and low-grade chronic inflammation frequently associated with polycystic ovary syndrome, obesity, and abnormalities of glucose tolerance. Methodology/Principal Findings: Serum haptoglobin and the haptoglobin alpha-chain polymorphism were determined in 141 patients with polycystic ovary syndrome and 102 non-hyperandrogenic women. Of the whole group of 243 premenopausal women, 117 were obese and 51 showed abnormal glucose tolerance. Although serum haptoglobin concentrations were similar in PCOS patients and controls, the former presented with an increased frequency of Hp(2) alleles (62% vs. 52%, P = 0.023). Circulating haptoglobin levels increased with obesity (P<0.001), yet no association was found between obesity and haptoglobin genotypes. No differences were observed in haptoglobin levels or genotype frequencies depending on glucose tolerance. Fifty percent of the variation in serum haptoglobin concentrations was explained by the variability in serum C-reactive protein concentrations, BMI, insulin sensitivity and haptoglobin genotypes. Conclusions/Significance: Serum haptoglobin concentrations in premenopausal women are largely dependent on the haptoglobin polymorphism and on the presence of obesity, with insulin resistance and chronic inflammation possibly modulating this relationship. The association of polycystic ovary syndrome with Hp(2) alleles suggests that the anti-oxidant and anti-inflammatory properties of haptoglobin may be reduced in these patients.			Alvarez-Blasco, F (corresponding author), Hosp Univ Ramon & Cajal, Dept Endocrinol, Madrid, Spain.	hescobarm.hrc@salud.madrid.org	Ramírez, Manuel Luque/AAN-6775-2021; Luque-Ramírez, Manuel/AAG-4264-2019; San-Millán, José L./F-9944-2015; García, María Ángeles Martínez/B-9712-2014; Escobar-Morreale, Héctor F/G-5468-2010; Ramírez, Manuel Luque/G-5037-2015	Luque-Ramírez, Manuel/0000-0002-6002-4237; García, María Ángeles Martínez/0000-0002-8354-7284; Escobar-Morreale, Héctor F/0000-0002-6890-1644; Ramírez, Manuel Luque/0000-0002-6002-4237				Alvarez-Blasco F, 2006, ARCH INTERN MED, V166, P2081, DOI 10.1001/archinte.166.19.2081; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; AZZIZ R, 2008, FERTIL STERIL   1022; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Botella-Carretero JI, 2006, DIABETES CARE, V29, P2556, DOI 10.2337/dc06-1655; Bowman, 1993, HEPATIC PLASMA PROTE, P159; Chiellini C, 2004, J CLIN ENDOCR METAB, V89, P2678, DOI 10.1210/jc.2003-031965; Christian RC, 2003, J CLIN ENDOCR METAB, V88, P2562, DOI 10.1210/jc.2003-030334; Codner E, 2007, J CLIN ENDOCR METAB, V92, P1209, DOI 10.1210/jc.2006-2641; Conn JJ, 2000, CLIN ENDOCRINOL, V52, P81, DOI 10.1046/j.1365-2265.2000.00884.x; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; De Pergola G, 2007, J ENDOCRINOL INVEST, V30, P399, DOI 10.1007/BF03346317; Delanghe JR, 2002, ATHEROSCLEROSIS, V160, P471, DOI 10.1016/S0021-9150(01)00607-4; Escobar-Morreale HF, 2005, DIABETES CARE, V28, P2042, DOI 10.2337/diacare.28.8.2042; Escobar-Morreale HF, 2005, ENDOCR REV, V26, P251, DOI 10.1210/er.2004-0004; Escobar-Morreale HF, 2003, DIABETOLOGIA, V46, P625, DOI 10.1007/s00125-003-1090-z; Escobar-Morreale HF, 2000, J CLIN ENDOCR METAB, V85, P4182, DOI 10.1210/jc.85.11.4182; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; INSENSER M, 2008, DIFFERENTIAL EXPRESI; Kelly CCJ, 2001, J CLIN ENDOCR METAB, V86, P2453, DOI 10.1210/jc.86.6.2453; Koch W, 2002, CLIN CHEM, V48, P1377; Langlois MR, 2000, CLIN CHEM, V46, P1619; Langlois MR, 1996, CLIN CHEM, V42, P1589; Legro RS, 2003, ENDOCR REV, V24, P302, DOI 10.1210/er.2003-0004; Levy AP, 2007, ARTERIOSCL THROM VAS, V27, P134, DOI 10.1161/01.ATV.0000251020.24399.a2; Levy AP, 2000, NEW ENGL J MED, V343, P969, DOI 10.1056/NEJM200009283431313; Luque-Ramirez M, 2007, HUM REPROD, V22, P3197, DOI 10.1093/humrep/dem324; Luque-Ramirez M, 2007, DIABETES CARE, V30, P2309, DOI 10.2337/dc07-0642; Matharoo-Ball B, 2007, J PROTEOME RES, V6, P3321, DOI 10.1021/pr070124b; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Moirand R, 1997, ANN INTERN MED, V127, P105, DOI 10.7326/0003-4819-127-2-199707150-00002; Sabuncu T, 2001, CLIN BIOCHEM, V34, P407, DOI 10.1016/S0009-9120(01)00245-4; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	36	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5606	10.1371/journal.pone.0005606	http://dx.doi.org/10.1371/journal.pone.0005606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440331	gold, Green Published, Green Submitted			2022-12-27	WOS:000266161200009
J	Swoboda, KJ; Scott, CB; Reyna, SP; Prior, TW; LaSalle, B; Sorenson, SL; Wood, J; Acsadi, G; Crawford, TO; Kissel, JT; Krosschell, KJ; D'Anjou, G; Bromberg, MB; Schroth, MK; Chan, GM; Elsheikh, B; Simard, LR				Swoboda, Kathryn J.; Scott, Charles B.; Reyna, Sandra P.; Prior, Thomas W.; LaSalle, Bernard; Sorenson, Susan L.; Wood, Janine; Acsadi, Gyula; Crawford, Thomas O.; Kissel, John T.; Krosschell, Kristin J.; D'Anjou, Guy; Bromberg, Mark B.; Schroth, Mary K.; Chan, Gary M.; Elsheikh, Bakri; Simard, Louise R.			Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy	PLOS ONE			English	Article								Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit. We performed an open label trial of VPA in 42 subjects with SMA to assess safety and explore potential outcome measures to help guide design of future controlled clinical trials. Subjects included 2 SMA type I ages 2-3 years, 29 SMA type II ages 2-14 years and 11 type III ages 2-31 years, recruited from a natural history study. VPA was well-tolerated and without evident hepatotoxicity. Carnitine depletion was frequent and temporally associated with increased weakness in two subjects. Exploratory outcome measures included assessment of gross motor function via the modified Hammersmith Functional Motor Scale (MHFMS), electrophysiologic measures of innervation including maximum ulnar compound muscle action potential (CMAP) amplitudes and motor unit number estimation (MUNE), body composition and bone density via dual-energy X-ray absorptiometry (DEXA), and quantitative blood SMN mRNA levels. Clear decline in motor function occurred in several subjects in association with weight gain; mean fat mass increased without a corresponding increase in lean mass. We observed an increased mean score on the MHFMS scale in 27 subjects with SMA type II (p <= 0.001); however, significant improvement was almost entirely restricted to participants,5 years of age. Full length SMN levels were unchanged and Delta 7SMN levels were significantly reduced for 2 of 3 treatment visits. In contrast, bone mineral density (p <= 0.0036) and maximum ulnar CMAP scores (p <= 0.0001) increased significantly. Conclusions: While VPA appears safe and well-tolerated in this initial pilot trial, these data suggest that weight gain and carnitine depletion are likely to be significant confounding factors in clinical trials. This study highlights potential strengths and limitations of various candidate outcome measures and underscores the need for additional controlled clinical trials with VPA targeting more restricted cohorts of subjects.			Swoboda, KJ (corresponding author), Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA.	Swoboda@genetics.utah.edu	Crawford, Thomas/E-6307-2012	Krosschell, Kristin/0000-0003-2879-5055; Simard, Louise/0000-0003-0391-8821; Swoboda, Kathryn/0000-0002-4593-6342	NCRR NIH HHS [UL1-RR025764, UL1 RR025764, C06 RR011234] Funding Source: Medline; NICHD NIH HHS [R01 HD054599-05, R01 HD054599] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR011234, UL1RR025764] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Boluk A, 2004, PHARMACOL RES, V50, P93, DOI 10.1016/j.phrs.2003.11.011; Brahe C, 2005, EUR J HUM GENET, V13, P256, DOI 10.1038/sj.ejhg.5201320; Brahe C, 1996, J MOL MED-JMM, V74, P555, DOI 10.1007/s001090050059; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Brichta L, 2006, ANN NEUROL, V59, P970, DOI 10.1002/ana.20836; Bromberg MB, 2002, MUSCLE NERVE, V25, P445, DOI 10.1002/mus.10050; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; COULTER DL, 1984, LANCET, V1, P689; Crawford TO, 1999, ANN NEUROL, V45, P337, DOI 10.1002/1531-8249(199903)45:3<337::AID-ANA9>3.0.CO;2-U; CZEIZEL A, 1989, J MED GENET, V26, P761, DOI 10.1136/jmg.26.12.761; Ecevit CG, 2004, PEDIATR NEUROL, V31, P279, DOI 10.1016/j.pediatrneurol.2004.03.021; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; Kernochan LE, 2005, HUM MOL GENET, V14, P1171, DOI 10.1093/hmg/ddi130; Krosschell KJ, 2006, NEUROMUSCULAR DISORD, V16, P417, DOI 10.1016/j.nmd.2006.03.015; Kumandas S, 2006, J PEDIATR ENDOCR MET, V19, P529; Leet AI, 2006, J PEDIATR ORTHOPED, V26, P624, DOI 10.1097/01.bpo.0000235228.45539.c7; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; MELEGH B, 1994, J PEDIATR-US, V125, P317, DOI 10.1016/S0022-3476(94)70218-7; Mercuri E, 2006, NEUROMUSCULAR DISORD, V16, P93, DOI 10.1016/j.nmd.2005.11.010; MERLINI L, 1992, NEUROMUSCULAR DISORD, V2, P197, DOI 10.1016/0960-8966(92)90006-R; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; Simard LR, 2007, NEUROLOGY, V68, P451, DOI 10.1212/01.wnl.0000252934.70676.ab; Sugai F, 2004, EUR J NEUROSCI, V20, P3179, DOI 10.1111/j.1460-9568.2004.03765.x; Sumner CJ, 2006, NEUROLOGY, V66, P1067, DOI 10.1212/01.wnl.0000201929.56928.13; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; TEIN I, 1995, PEDIATR NEUROL, V12, P21, DOI 10.1016/0887-8994(94)00100-G; Tsai LK, 2007, EUR J NEUROL, V14, pE8, DOI 10.1111/j.1468-1331.2007.01992.x; Tsai LK, 2008, J MOL MED, V86, P1243, DOI 10.1007/s00109-008-0388-1; Tsai LK, 2006, NEUROBIOL DIS, V24, P286, DOI 10.1016/j.nbd.2006.07.004; van Bergeijk J, 2006, CHEM BIOL DRUG DES, V67, P244, DOI 10.1111/j.1747-0285.2006.00369.x; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Weihl CC, 2006, NEUROLOGY, V67, P500, DOI 10.1212/01.wnl.0000231139.26253.d0; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7	45	133	138	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5268	10.1371/journal.pone.0005268	http://dx.doi.org/10.1371/journal.pone.0005268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19440247	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107300001
J	Tanaka, M; Oikawa, K; Takanashi, M; Kudo, M; Ohyashiki, J; Ohyashiki, K; Kuroda, M				Tanaka, Masami; Oikawa, Kosuke; Takanashi, Masakatsu; Kudo, Motoshige; Ohyashiki, Junko; Ohyashiki, Kazuma; Kuroda, Masahiko			Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; LUNG CANCERS; MICRORNAS; EXPRESSION; EXOSOMES; MIR-17-92; ACCUMULATION; POLYCISTRON; MECHANISM; BEARING	Background: MicroRNAs are a family of 19- to 25-nucleotides noncoding small RNAs that primarily function as gene regulators. Aberrant microRNA expression has been described for several human malignancies, and this new class of small regulatory RNAs has both oncogenic and tumor suppressor functions. Despite this knowledge, there is little information regarding microRNAs in plasma especially because microRNAs in plasma, if exist, were thought to be digested by RNase. Recent studies, however, have revealed that microRNAs exist and escape digestion in plasma. Methodology/Principal Findings: We performed microRNA microaray to obtain insight into microRNA deregulation in the plasma of a leukemia patient. We have revealed that microRNA-638 (miR-638) is stably present in human plasmas, and microRNA-92a (miR-92a) dramatically decreased in the plasmas of acute leukemia patients. Especially, the ratio of miR-92a/miR-638 in plasma was very useful for distinguishing leukemia patients from healthy body. Conclusions/Significance: The ratio of miR-92a/miR-638 in plasma has strong potential for clinical application as a novel biomarker for detection of leukemia.			Tanaka, M (corresponding author), Tokyo Med & Dent Univ, Dept Pathol, Tokyo, Japan.	kuroda@tokyo-med.ac.jp						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128	32	221	248	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5532	10.1371/journal.pone.0005532	http://dx.doi.org/10.1371/journal.pone.0005532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19440243	gold, Green Submitted, Green Published			2022-12-27	WOS:000266107300002
J	DeVaney, SC; McNyset, KM; Williams, JB; Peterson, AT; Wiley, EO				DeVaney, Shannon C.; McNyset, Kristina M.; Williams, Justin B.; Peterson, A. Townsend; Wiley, Edward O.			A Tale of Four "Carp'': Invasion Potential and Ecological Niche Modeling	PLOS ONE			English	Article							BLACK CARP; GEOGRAPHIC DISTRIBUTIONS; SPECIES DISTRIBUTIONS; BIOLOGICAL INVASIONS; SAMPLE-SIZE; GRASS CARP; PREDICTION; RANGE; RISK; OCCURRENCES	Background: Invasive species are a serious problem in ecosystems, but are difficult to eradicate once established. Predictive methods can be key in determining which areas are of concern regarding invasion by such species to prevent establishment [1]. We assessed the geographic potential of four Eurasian cyprinid fishes (common carp, tench, grass carp, black carp) as invaders in North America via ecological niche modeling (ENM). These "carp'' represent four stages of invasion of the continent (a long-established invader with a wide distribution, a long-established invader with a limited distribution, a spreading invader whose distribution is expanding, and a newly introduced potential invader that is not yet established), and as such illustrate the progressive reduction of distributional disequilibrium over the history of species' invasions. Methodology/Principal Findings: We used ENM to estimate the potential distributional area for each species in North America using models based on native range distribution data. Environmental data layers for native and introduced ranges were imported from state, national, and international climate and environmental databases. Models were evaluated using independent validation data on native and invaded areas. We calculated omission error for the independent validation data for each species: all native range tests were highly successful (all omission values,7%); invaded-range predictions were predictive for common and grass carp (omission values 8.8 and 19.8%, respectively). Model omission was high for introduced tench populations (54.7%), but the model correctly identified some areas where the species has been successful; distributional predictions for black carp show that large portions of eastern North America are at risk. Conclusions/Significance: ENMs predicted potential ranges of carp species accurately even in regions where the species have not been present until recently. ENM can forecast species' potential geographic ranges with reasonable precision and within the short screening time required by proposed U. S. invasive species legislation.			DeVaney, SC (corresponding author), Nat Hist Museum Los Angeles Cty, Los Angeles, CA USA.	sdevaney@nhm.org	Peterson, A. Townsend/I-5697-2013	Peterson, A. Townsend/0000-0003-0243-2379				Allan JD., 2021, STREAM ECOLOGY STRUC, DOI [DOI 10.1007/978-3-030-61286-3, 10.1007/978-3-030-61286-3]; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Angermeier PL, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P519; [Anonymous], 1984, FISHES JAPANESE ARCH; [Anonymous], 1949, FRESHWATER FISHES US; BAIN MB, 1993, ENVIRON MANAGE, V107, P221; Banarescu P., 1964, PISCES OSTEICHTHYES; BAUGHMAN JL, 1947, J WILDLIFE MANAGE, V11, P197, DOI 10.2307/3796278; BELLRICHARD SJ, 1996, EFFECTS COMMON CARP; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; BIRO P, 1999, FRESHWATER FISHES EU; Bowden GJ, 2003, ECOLOGICAL INFORMATICS -BOOK, P215; BROENNIMANN O, 2007, ECOLOGY LETT; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; *CENTR INT AG, 1979, CHIN; Chick JH, 2003, SCIENCE, V300, P1876, DOI 10.1126/science.300.5627.1876; COURTENAY WR, 1993, INDIANA U PURDUE U; Courtenay WR, 2004, SNAKEHEADS PISCES CH; Cox GW, 1993, CONSERVATION ECOLOGY; Drake JA, 1989, BIOL INVASIONS GLOBA; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; EVTUSHENKO N. Y., 1994, HYDROBIOL J, V30, P1; Ferber D, 2001, SCIENCE, V292, P203, DOI 10.1126/science.292.5515.203; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; FROESE R, 2008, FISHBASE; Fuller PL, 1999, NONINDIGENOUS FISHES; Grinnell J., 1917, Auk Cambridge Mass, V34; GUILLORY V, 1978, T AM FISH SOC, V107, P105, DOI 10.1577/1548-8659(1978)107&lt;105:ZOTGCI&gt;2.0.CO;2; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; GUISAN A, 2000, ECOLOGICAL MODELLING, V135; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANSEN CM, 2003, GLOBAL PERCENT TREE; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iguchi K, 2004, T AM FISH SOC, V133, P845, DOI 10.1577/T03-172.1; IPCC, 2001, CLIM DAT ARCH; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Keith P., 2001, ATLAS POISSONS EAU D; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Lachner EA, 1970, SMITHSONIAN CONTRIB, V59, P1, DOI DOI 10.5479/SI.00810282.59; LAMBRECHT B, 2000, INVASION ASIAN CARP; LOBO JM, 2007, GLOBAL ECOLOGY BIOGE; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marchetti MP, 2004, ECOL APPL, V14, P1507, DOI 10.1890/03-5173; Marsh-Matthews E, 2000, ECOL FRESHW FISH, V9, P9, DOI 10.1034/j.1600-0633.2000.90103.x; McNyset KM, 2005, ECOL FRESHW FISH, V14, P243, DOI 10.1111/j.1600-0633.2005.00101.x; Mohamed KI, 2006, AMBIO, V35, P281, DOI 10.1579/05-R-051R.1; *NAS, 2002, PRED INV NON PLANTS; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; Nichols J.T., 1943, FRESHWATER FISHES CH; Nico L., 1996, RISK ASSESSMENT BLAC; NICO LG, 2001, CARP MYLOPHARYNGODON; Nyari A, 2006, J AVIAN BIOL, V37, P306, DOI 10.1111/j.2006.0908-8857.03686.x; Olden JD, 2002, FRESHWATER BIOL, V47, P1976, DOI 10.1046/j.1365-2427.2002.00945.x; PANETTA FD, 1987, J AUST I AGR SCI, V53, P11; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2005, CURR SCI INDIA, V89, P9; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; PETERSON AT, 2008, PLOS ONE; Pflieger W.L., 1975, FISHES MISSOURI CONS; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; SCACHETTIPEREIR.R, 2002, DESKTOP GARP VERSION; Scott WB, 1998, FRESHWATER FISHES CA; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; STANLEY JG, 1978, T AM FISH SOC, V107, P119, DOI 10.1577/1548-8659(1978)107&lt;119:RRALFN&gt;2.0.CO;2; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; TONN WM, 1990, T AM FISH SOC, V119, P337, DOI 10.1577/1548-8659(1990)119<0337:CCAFCA>2.3.CO;2; *U KANS, 2005, SPEC AN; *US GEOL SURV, 2008, NON AQ SPEC; *US NAT GEOSP INT, 2008, GEONET NAM SERV; *USGS, 2008, GEOGR NAM INF SYST; USGS, 2001, HYDRO1K EL DER DAT; Vander Zanden MJ, 2004, ECOL APPL, V14, P132; Venable DL, 2000, J WORLD AQUACULT SOC, V31, P158, DOI 10.1111/j.1749-7345.2000.tb00349.x; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Williams J., 2005, STATUS TRENDS NATION; Williamson M., 1996, BIOL INVASIONS; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Zambrano L, 2006, CAN J FISH AQUAT SCI, V63, P1903, DOI 10.1139/F06-088; 1999, FED REG, P6183	93	33	36	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5451	10.1371/journal.pone.0005451	http://dx.doi.org/10.1371/journal.pone.0005451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421314	Green Published, Green Submitted, gold			2022-12-27	WOS:000265836900009
J	Suzan, G; Marce, E; Giermakowski, JT; Mills, JN; Ceballos, G; Ostfeld, RS; Armien, B; Pascale, JM; Yates, TL				Suzan, Gerardo; Marce, Erika; Giermakowski, J. Tomasz; Mills, James N.; Ceballos, Gerardo; Ostfeld, Richard S.; Armien, Blas; Pascale, Juan M.; Yates, Terry L.			Experimental Evidence for Reduced Rodent Diversity Causing Increased Hantavirus Prevalence	PLOS ONE			English	Article								Emerging and re-emerging infectious diseases have become a major global environmental problem with important public health, economic, and political consequences. The etiologic agents of most emerging infectious diseases are zoonotic, and anthropogenic environmental changes that affect wildlife communities are increasingly implicated in disease emergence and spread. Although increased disease incidence has been correlated with biodiversity loss for several zoonoses, experimental tests in these systems are lacking. We manipulated small-mammal biodiversity by removing non-reservoir species in replicated field plots in Panama, where zoonotic hantaviruses are endemic. Both infection prevalence of hantaviruses in wild reservoir (rodent) populations and reservoir population density increased where small-mammal species diversity was reduced. Regardless of other variables that affect the prevalence of directly transmitted infections in natural communities, high biodiversity is important in reducing transmission of zoonotic pathogens among wildlife hosts. Our results have wide applications in both conservation biology and infectious disease management.			Suzan, G (corresponding author), Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Ciudad Univ, Mexico City 04510, DF, Mexico.	rostfeld@caryinstitute.org	Giermakowski, Jacek T/B-3689-2009	Giermakowski, Jacek T/0000-0002-6422-157X; Suzan, Gerardo/0000-0003-2508-6376; Ostfeld, Richard/0000-0002-3707-9301; Ceballos, Gerardo/0000-0001-8374-2656				Alam M, 2004, INFECT MED, V21, P327; Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], 2003, PATCH ANAL EXTENSION; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Begon Michael, 2008, P12; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Hall SR, 2009, ECOLOGY, V90, P791, DOI 10.1890/08-0838.1; Hjelle B, 1997, J CLIN MICROBIOL, V35, P600, DOI 10.1128/JCM.35.3.600-608.1997; Jackson LE, 2006, INT J EPIDEMIOL, V35, P315, DOI 10.1093/ije/dyi284; Johnson PTJ, 2008, ECOL LETT, V11, P1017, DOI 10.1111/j.1461-0248.2008.01212.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Lehmer EM, 2008, OECOLOGIA, V155, P429, DOI 10.1007/s00442-007-0922-9; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Peixoto ID, 2006, ECOLOGY, V87, P873, DOI 10.1890/0012-9658(2006)87[873:TEOBOT]2.0.CO;2; Roscher C, 2007, OECOLOGIA, V153, P173, DOI 10.1007/s00442-007-0713-3; Ruedas LA, 2004, J VECTOR ECOL, V29, P177; Suzan G, 2008, J MAMMAL, V89, P684, DOI 10.1644/07-MAMM-A-015R1.1; Suzan G, 2006, AM J TROP MED HYG, V74, P1103, DOI 10.4269/ajtmh.2006.74.1103; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Tersago K, 2008, VECTOR-BORNE ZOONOT, V8, P235, DOI 10.1089/vbz.2007.0160; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; YAMADA T, 1995, J VIROL, V69, P1939, DOI 10.1128/JVI.69.3.1939-1943.1995; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2	33	147	151	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5461	10.1371/journal.pone.0005461	http://dx.doi.org/10.1371/journal.pone.0005461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421313	Green Submitted, Green Published, gold			2022-12-27	WOS:000265836900016
J	Devantier, SL; Minda, JP; Goldszmidt, M; Haddara, W				Devantier, Sarah L.; Minda, John Paul; Goldszmidt, Mark; Haddara, Wael			Categorizing Patients in a Forced-Choice Triad Task: The Integration of Context in Patient Management	PLOS ONE			English	Article							EXPERTISE; REPRESENTATION; SIMILARITY; KNOWLEDGE; NOVICES	Background: Studies of experts' problem-solving abilities have shown that experts can attend to the deep structure of a problem whereas novices attend to the surface structure. Although this effect has been replicated in many domains, there has been little investigation into such effects in medicine in general or patient management in particular. Methodology/Principal Findings: We designed a 10-item forced-choice triad task in which subjects chose which one of two hypothetical patients best matched a target patient. The target and its potential matches were related in terms of surface features (e. g., two patients of a similar age and gender) and deep features (e. g., two diabetic patients with similar management strategies: a patient with arthritis and a blind patient would both have difficulty with self-injected insulin). We hypothesized that experts would have greater knowledge of management categories and would be more likely to choose deep matches. We contacted 130 novices (medical students), 11 intermediates (medical residents), and 159 experts (practicing endocrinologists) and 15, 11, and 8 subjects (respectively) completed the task. A linear mixed effects model indicated that novices were less likely to make deep matches than experts (t(68) = -3.63, p = .0006), while intermediates did not differ from experts (t(68) = -0.24, p = .81). We also found that the number of years in practice correlated with performance on diagnostic (r = .39, p = .02), but not management triads (r = .17, p = .34). Conclusions: We found that experts were more likely than novices to match patients based on deep features, and that this pattern held for both diagnostic and management triads. Further, management and diagnostic triads were equally salient for expert physicians suggesting that physicians recognize and may create management-oriented categories of patients.			Devantier, SL (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	sdevanti@uwo.ca	Goldszmidt, Mark/G-3297-2011; Haddara, Wael/C-8747-2014; Haddara, Wael/N-1990-2019; Minda, John Paul/O-9083-2017	Goldszmidt, Mark/0000-0002-5861-5222; Haddara, Wael/0000-0002-9817-5524; Minda, John Paul/0000-0002-4081-010X				BARSALOU LW, 1991, PSYCHOL LEARN MOTIV, V27, P1, DOI 10.1016/S0079-7421(08)60120-6; BARSALOU LW, 1983, MEM COGNITION, V11, P211, DOI 10.3758/BF03196968; BORDAGE G, 1994, ACAD MED, V69, P883, DOI 10.1097/00001888-199411000-00004; Bordage G, 1999, ACAD MED, V74, pS138, DOI 10.1097/00001888-199910000-00065; CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; Custers EJFM, 1998, COGNITION INSTRUCT, V16, P367, DOI 10.1207/s1532690xci1604_1; Eva KW, 2002, ACAD MED, V77, pS1, DOI 10.1097/00001888-200210001-00002; FREYHOF H, 1992, PSYCHOL RES-PSYCH FO, V54, P32, DOI 10.1007/BF01359221; Gobet F, 1996, PSYCHON B REV, V3, P159, DOI 10.3758/BF03212414; HARDIMAN PT, 1989, MEM COGNITION, V17, P55; Haynes R Brian, 2002, ACP J Club, V136, pA11; Higgins MP, 2005, MED EDUC, V39, P184, DOI 10.1111/j.1365-2929.2004.02056.x; Johnson KE, 1997, J EXP PSYCHOL GEN, V126, P248, DOI 10.1037/0096-3445.126.3.248; LARKIN J, 1980, SCIENCE, V208, P1335, DOI 10.1126/science.208.4450.1335; Lin EL, 2001, J EXP PSYCHOL GEN, V130, P3, DOI 10.1037/0096-3445.130.1.3; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Medin DL, 1997, COGNITIVE PSYCHOL, V32, P49, DOI 10.1006/cogp.1997.0645; Norman G, 2005, MED EDUC, V39, P418, DOI 10.1111/j.1365-2929.2005.02127.x; Norman G, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P339; Norman GR, 1997, ADV HEALTH SCI EDUC, V2, P173, DOI 10.1023/A:1009784330364; Proffitt JB, 2000, J EXP PSYCHOL LEARN, V26, P811, DOI 10.1037/0278-7393.26.4.811; Rabinowitz M., 2002, P 23 ANN C COGN SCI, P826; RIPS LJ, 1989, SIMILARITY AND ANALOGICAL REASONING, P21, DOI 10.1017/CBO9780511529863.004; Schmidt HG, 1993, EDUC PSYCHOL REV, V5, P205, DOI 10.1007/BF01323044; Shafto P, 2003, J EXP PSYCHOL LEARN, V29, P641, DOI 10.1037/0278-7393.29.4.641; SIMON HA, 1973, AM SCI, V61, P394; Verkoeijen PPJL, 2004, MED EDUC, V38, P617, DOI 10.1046/j.1365-2923.2004.01797.x	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5881	10.1371/journal.pone.0005881	http://dx.doi.org/10.1371/journal.pone.0005881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456TJ	19516910	Green Published, gold, Green Submitted			2022-12-27	WOS:000266873100013
J	Murtaza, M; Kisat, M; Daniel, H; Sonawalla, AB				Murtaza, Muhammed; Kisat, Mehreen; Daniel, Haroon; Sonawalla, Aziz B.			Classification and Clinical Features of Headache Disorders in Pakistan: A Retrospective Review of Clinical Data	PLOS ONE			English	Review								Background: Morbidity associated with primary headache disorders is a major public health problem with an overall prevalence of 46%. Tension-type headache and migraine are the two most prevalent causes. However, headache has not been sufficiently studied as a cause of morbidity in the developing world. Literature on prevalence and classification of these disorders in South Asia is scarce. The aim of this study is to describe the classification and clinical features of headache patients who seek medical advice in Pakistan. Methods and Results: Medical records of 255 consecutive patients who presented to a headache clinic at a tertiary care hospital were reviewed. Demographic details, onset and lifetime duration of illness, pattern of headache, associated features and family history were recorded. International Classification of Headache Disorders version 2 was applied. 66% of all patients were women and 81% of them were between 16 and 49 years of age. Migraine was the most common disorder (206 patients) followed by tension-type headache (58 patients), medication-overuse headache (6 patients) and cluster headache (4 patients). Chronic daily headache was seen in 99 patients. Patients with tension-type headache suffered from more frequent episodes of headache than patients with migraine (p < 0.001). Duration of each headache episode was higher in women with menstrually related migraine (p = 0.015). Median age at presentation and at onset was lower in patients with migraine who reported a first-degree family history of the disease (p = 0.003 and p < 0.001 respectively). Conclusions/Significance: Patients who seek medical advice for headache in Pakistan are usually in their most productive ages. Migraine and tension-type headache are the most common clinical presentations of headache. Onset of migraine is earlier in patients with first-degree family history. Menstrually related migraine affects women with headache episodes of longer duration than other patients and it warrants special therapeutic consideration. Follow-up studies to describe epidemiology and burden of headache in Pakistan are needed.			Murtaza, M (corresponding author), Aga Khan Univ Hosp, Coll Med, Karachi, Pakistan.	murtaza@consulnet.net	Murtaza, Muhammed/A-4188-2011	Murtaza, Muhammed/0000-0001-7557-2861				Ahmed A, 1999, ANN K EDWARD MED COL, V5, P315; Allais G, 2004, NEUROL SCI, V25, pS229, DOI 10.1007/s10072-004-0292-6; [Anonymous], 2004, CEPHALALGIA S1, V24, P9; BAIER WK, 1985, NEUROPEDIATRICS, V16, P84, DOI 10.1055/s-2008-1052549; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Chakravarty A, 2003, CEPHALALGIA, V23, P348, DOI 10.1046/j.1468-2982.2003.00514.x; Hussain R, 1998, J BIOSOC SCI, V30, P261, DOI 10.1017/S0021932098002612; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Mateen F, 2008, HEADACHE DISORDERS D; Rainero I, 2002, FUNCT NEUROL, V17, P193; RASMUSSEN BK, 1992, J EPIDEMIOL COMMUN H, V46, P443, DOI 10.1136/jech.46.4.443; Ravi G, 2007, J PAK PSYCH SOC, V4, P19; Silberstein SD, 2000, CURR OPIN NEUROL, V13, P277, DOI 10.1097/00019052-200006000-00008; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6	15	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5827	10.1371/journal.pone.0005827	http://dx.doi.org/10.1371/journal.pone.0005827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503794	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717400007
J	Romanel, EAC; Schrago, CG; Counago, RM; Russo, CAM; Alves-Ferreira, M				Romanel, Elisson A. C.; Schrago, Carlos G.; Counago, Rafael M.; Russo, Claudia A. M.; Alves-Ferreira, Marcio			Evolution of the B3 DNA Binding Superfamily: New Insights into REM Family Gene Diversification	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENOME REVEALS; FUS3 GENE; PROTEIN; DOMAIN; EXPRESSION; SEQUENCE; ALIGNMENT; LAND	Background: The B3 DNA binding domain includes five families: auxin response factor (ARF), abscisic acid-insensitive3 (ABI3), high level expression of sugar inducible (HSI), related to ABI3/VP1 (RAV) and reproductive meristem (REM). The release of the complete genomes of the angiosperm eudicots Arabidopsis thaliana and Populus trichocarpa, the monocot Orysa sativa, the bryophyte Physcomitrella patens, the green algae Chlamydomonas reinhardtii and Volvox carteri and the red algae Cyanidioschyzon melorae provided an exceptional opportunity to study the evolution of this superfamily. Methodology: In order to better understand the origin and the diversification of B3 domains in plants, we combined comparative phylogenetic analysis with exon/intron structure and duplication events. In addition, we investigated the conservation and divergence of the B3 domain during the origin and evolution of each family. Conclusions: Our data indicate that showed that the B3 containing genes have undergone extensive duplication events, and that the REM family B3 domain has a highly diverged DNA binding. Our results also indicate that the founding member of the B3 gene family is likely to be similar to the ABI3/HSI genes found in C. reinhardtii and V. carteri. Among the B3 families, ABI3, HSI, RAV and ARF are most structurally conserved, whereas the REM family has experienced a rapid divergence. These results are discussed in light of their functional and evolutionary roles in plant development.			Romanel, EAC (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	alvesfer@biologia.ufrj.br	Romanel, Elisson AC/F-1933-2013; Schrago, Carlos/E-4612-2012; Counago, Rafael/F-4418-2016; Couñago, Rafael/AAX-1577-2020; Romanel, Elisson AC/E-5888-2019; Counago, Rafael/F-7459-2011; Russo, Claudia A M/I-1217-2012; Alves-Ferreira, Marcio/C-5849-2009; de Moraes Russo, Claudia Augusta/N-6361-2019; Russo, Claudia/R-7432-2019; Russo, Claudia/N-8063-2019	Romanel, Elisson AC/0000-0002-4794-4215; Schrago, Carlos/0000-0001-6257-8906; Counago, Rafael/0000-0003-1847-5090; Couñago, Rafael/0000-0003-1847-5090; Romanel, Elisson AC/0000-0002-4794-4215; Russo, Claudia A M/0000-0002-1252-9206; Alves-Ferreira, Marcio/0000-0002-6107-3700; Russo, Claudia/0000-0002-1252-9206; 				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Alves-Ferreira M, 2007, PLANT PHYSIOL, V145, P747, DOI 10.1104/pp.107.104422; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BAUMLEIN H, 1994, PLANT J, V6, P379, DOI 10.1046/j.1365-313X.1994.06030379.x; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carranco RT, 2004, PLANT MOL BIOL, V55, P221, DOI 10.1007/s11103-004-0512-8; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; De Meutter J, 2005, MOL PLANT PATHOL, V6, P321, DOI 10.1111/j.1364-3703.2005.00283.x; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fischerova L, 2008, PLANT CELL REP, V27, P435, DOI 10.1007/s00299-007-0469-6; Franco-Zorrilla JM, 2002, PLANT PHYSIOL, V128, P418, DOI 10.1104/pp.010323; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Henikoff S, 1997, PROTEIN SCI, V6, P698; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; LOGSDON JM, 1995, P NATL ACAD SCI USA, V92, P8507, DOI 10.1073/pnas.92.18.8507; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Monke G, 2004, PLANTA, V219, P158, DOI 10.1007/s00425-004-1206-9; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; NICHOLAS HB, 1995, J MOL EVOL, V40, P482; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Reidt W, 2000, PLANT J, V21, P401, DOI 10.1046/j.1365-313x.2000.00686.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rensing SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-130; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schoof H, 2002, NUCLEIC ACIDS RES, V30, P91, DOI 10.1093/nar/30.1.91; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shrager J, 2003, PLANT PHYSIOL, V131, P401, DOI 10.1104/pp.016899; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrio R, 1998, P NATL ACAD SCI USA, V95, P1658, DOI 10.1073/pnas.95.4.1658; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukagoshi H, 2005, PLANT PHYSIOL, V138, P675, DOI 10.1104/pp.104.057752; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Yamasaki K, 2004, PLANT CELL, V16, P3448, DOI 10.1105/tpc.104.026112; Yamasaki K, 2008, PLANT PHYSIOL BIOCH, V46, P394, DOI 10.1016/j.plaphy.2007.12.015; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	87	90	101	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5791	10.1371/journal.pone.0005791	http://dx.doi.org/10.1371/journal.pone.0005791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503786	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717400001
J	Song, JW; Cavnar, SP; Walker, AC; Luker, KE; Gupta, M; Tung, YC; Luker, GD; Takayama, S				Song, Jonathan W.; Cavnar, Stephen P.; Walker, Ann C.; Luker, Kathryn E.; Gupta, Mudit; Tung, Yi-Chung; Luker, Gary D.; Takayama, Shuichi			Microfluidic Endothelium for Studying the Intravascular Adhesion of Metastatic Breast Cancer Cells	PLOS ONE			English	Article								Background: The ability to properly model intravascular steps in metastasis is essential in identifying key physical, cellular, and molecular determinants that can be targeted therapeutically to prevent metastatic disease. Research on the vascular microenvironment has been hindered by challenges in studying this compartment in metastasis under conditions that reproduce in vivo physiology while allowing facile experimental manipulation. Methodology/Principal Findings: We present a microfluidic vasculature system to model interactions between circulating breast cancer cells with microvascular endothelium at potential sites of metastasis. The microfluidic vasculature produces spatially-restricted stimulation from the basal side of the endothelium that models both organ-specific localization and polarization of chemokines and many other signaling molecules under variable flow conditions. We used this microfluidic system to produce site-specific stimulation of microvascular endothelium with CXCL12, a chemokine strongly implicated in metastasis. Conclusions/Significance: When added from the basal side, CXCL12 acts through receptor CXCR4 on endothelium to promote adhesion of circulating breast cancer cells, independent of CXCL12 receptors CXCR4 or CXCR7 on tumor cells. These studies suggest that targeting CXCL12-CXCR4 signaling in endothelium may limit metastases in breast and other cancers and highlight the unique capabilities of our microfluidic device to advance studies of the intravascular microenvironment in metastasis.			Song, JW (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Charlestown, MA USA.	gluker@med.umich.edu; takayama@umich.edu	Tung, Yi-Chung/A-1163-2007; Song, Jonathan W./C-1922-2013	Tung, Yi-Chung/0000-0002-6170-2992; Song, Jonathan W./0000-0002-6991-5298; Luker, Kathryn/0000-0001-8314-3370; luker, gary/0000-0001-6832-2581	NATIONAL CANCER INSTITUTE [R01CA136829, P50CA093990, R01CA136553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084370] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA093990, R01 CA136829, R01 CA136553, 1 R01 CA136553, 1 R01 CA136829] Funding Source: Medline; NHLBI NIH HHS [R01 HL084370, HL084370, R01 HL084370-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali S, 2007, CANCER METAST REV, V26, P401, DOI 10.1007/s10555-007-9073-z; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BEUTLER B, 1988, ENDOCR REV, V9, P57, DOI 10.1210/edrv-9-1-57; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Cardones AR, 2003, CANCER RES, V63, P6751; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55, DOI 10.1152/physiolgenomics.2001.7.1.55; Chiu JJ, 2003, BLOOD, V101, P2667, DOI 10.1182/blood-2002-08-2560; CHRISTOPHER MJ, 2009, BLOOD; Chueh BH, 2007, ANAL CHEM, V79, P3504, DOI 10.1021/ac062118p; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DESJARDINS C, 1990, AM J PHYSIOL, V258, pH647, DOI 10.1152/ajpheart.1990.258.3.H647; Dong C, 2005, FRONT BIOSCI-LANDMRK, V10, P379, DOI 10.2741/1535; Farokhzad OC, 2005, ANAL CHEM, V77, P5453, DOI 10.1021/ac050312q; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Garcia-Cardena G, 2001, P NATL ACAD SCI USA, V98, P4478, DOI 10.1073/pnas.071052598; Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9; Gomes N, 2003, BIORHEOLOGY, V40, P41; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; GROBER JS, 1993, J CLIN INVEST, V91, P2609, DOI 10.1172/JCI116500; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Heo YS, 2007, ANAL CHEM, V79, P1126, DOI 10.1021/ac061990v; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; JORNESKOG G, 1995, DIABETOLOGIA, V38, P474; Kanda S, 2003, J BIOL CHEM, V278, P257, DOI 10.1074/jbc.M204771200; Konstantopoulos K, 1998, ADV DRUG DELIVER REV, V33, P141, DOI 10.1016/S0169-409X(98)00024-6; Kryczek I, 2005, CANCER RES, V65, P465; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; Luker KE, 2001, CANCER RES, V61, P6540; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; MORZYCKI W, 1990, IMMUNOL LETT, V25, P331, DOI 10.1016/0165-2478(90)90204-4; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2002, CANCER RES, V62, P7328; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Rivera R, 2007, VIROLOGY, V363, P48, DOI 10.1016/j.virol.2007.01.033; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schrage A, 2008, HEPATOLOGY, V48, P1262, DOI 10.1002/hep.22443; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Ulbrich H, 2003, TRENDS PHARMACOL SCI, V24, P640, DOI 10.1016/j.tips.2003.10.004; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F	54	235	240	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5756	10.1371/journal.pone.0005756	http://dx.doi.org/10.1371/journal.pone.0005756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484126	Green Published, gold, Green Submitted			2022-12-27	WOS:000266528200009
J	Campbell, MS; Gottlieb, GS; Hawes, SE; Nickle, DC; Wong, KG; Deng, WJ; Lampinen, TM; Kiviat, NB; Mullins, JI				Campbell, Mary S.; Gottlieb, Geoffrey S.; Hawes, Stephen E.; Nickle, David C.; Wong, Kim G.; Deng, Wenjie; Lampinen, Thomas M.; Kiviat, Nancy B.; Mullins, James I.			HIV-1 Superinfection in the Antiretroviral Therapy Era: Are Seroconcordant Sexual Partners at Risk?	PLOS ONE			English	Article								Background: Acquisition of more than one strain of human immunodeficiency virus type 1 (HIV-1) has been reported to occur both during and after primary infection, but the risks and repercussions of dual and superinfection are incompletely understood. In this study, we evaluated a longitudinal cohort of chronically HIV-infected men who were sexual partners to determine if individuals acquired their partners' viral strains. Methodology: Our cohort of HIV-positive men consisted of 8 couples that identified themselves as long-term sexual partners. Viral sequences were isolated from each subject and analyzed using phylogenetic methods. In addition, strain-specific PCR allowed us to search for partners' viruses present at low levels. Finally, we used computational algorithms to evaluate for recombination between partners' viral strains. Principal Findings/Conclusions: All couples had at least one factor associated with increased risk for acquisition of new HIV strains during the study, including detectable plasma viral load, sexually transmitted infections, and unprotected sex. One subject was dually HIV-1 infected, but neither strain corresponded to that of his partner. Three couples' sequences formed monophyletic clusters at the entry visit, with phylogenetic analysis suggesting that one member of the couple had acquired an HIV strain from his identified partner or that both had acquired it from the same source outside their partnership. The 5 remaining couples initially displayed no evidence of dual infection, using phylogenetic analysis and strain-specific PCR. However, in 1 of these couples, further analysis revealed recombinant viral strains with segments of viral genomes in one subject that may have derived from the enrolled partner. Thus, chronically HIV-1 infected individuals may become superinfected with additional HIV strains from their seroconcordant sexual partners. In some cases, HIV-1 superinfection may become apparent when recombinant viral strains are detected.			Campbell, MS (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	msc6@u.washington.edu	Nickle, David/ABF-2727-2020	Gottlieb, Geoffrey/0000-0002-5749-481X	NCI NIH HHS [R01 CA055488, R01CA055488] Funding Source: Medline; NIAID NIH HHS [P01AI57005, T32 AI007044, K08 AI074424, R37AI047734, P30AI27757, T32AI007044, K08AI074424, R37 AI047734, P30 AI027757, P01 AI057005] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, K08AI074424, R37AI047734, P01AI057005, T32AI007044] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Anderson JP, 2003, MOL BIOL EVOL, V20, P1168, DOI 10.1093/molbev/msg128; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Becker-Pergola G, 2000, AIDS RES HUM RETROV, V16, P1099, DOI 10.1089/088922200414938; Brenner B, 2004, AIDS, V18, P1653, DOI 10.1097/01.aids.0000131377.28694.04; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Chakraborty B, 2004, AIDS, V18, P132, DOI 10.1097/01.aids.0000096893.73209.0e; Chohan B, 2005, J VIROL, V79, P10701, DOI 10.1128/JVI.79.16.10701-10708.2005; DIAZ RS, 1995, J VIROL, V69, P3272; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Fang WB, 2004, J GEOPHYS ENG, V1, P153, DOI 10.1088/1742-2132/1/2/008; Gerhardt M, 2005, J VIROL, V79, P8249, DOI 10.1128/JVI.79.13.8249-8261.2005; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Gonzales MJ, 2003, J INFECT DIS, V188, P397, DOI 10.1086/376534; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Gottlieb GS, 2007, CLIN INFECT DIS, V45, P501, DOI 10.1086/520024; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Janini LM, 1998, J INFECT DIS, V177, P227, DOI 10.1086/517360; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Koelsch KK, 2003, AIDS, V17, pF11, DOI 10.1097/00002030-200305020-00001; Kozaczynska K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-59; Lampinen TM, 2000, AIDS, V14, pF69, DOI 10.1097/00002030-200003310-00001; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Liu SL, 1997, J VIROL, V71, P4284, DOI 10.1128/JVI.71.6.4284-4295.1997; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; MADDISON WP, 2001, MACCLADE ANAL PHYLOG, P503; Manigart O, 2004, AIDS, V18, P1645, DOI 10.1097/01.aids.0000131333.30548.db; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; PIANTADOSI A, 2008, AIDS RES HUM RETROVI; Piantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177; Plantier JC, 2004, AIDS, V18, P2444; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; Smith DM, 2004, JAMA-J AM MED ASSOC, V292, P1177, DOI 10.1001/jama.292.10.1177; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsui R, 2004, J VIROL, V78, P94, DOI 10.1128/JVI.78.1.94-103.2004; van der Kuyl AC, 2005, NEW ENGL J MED, V352, P2557, DOI 10.1056/NEJM200506163522420; Vernazza P, 2008, B MED SUISSES, V89, P165; Willberg CB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000185; Yerly S, 2004, AIDS, V18, P1413, DOI 10.1097/01.aids.0000131330.28762.0c	50	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5690	10.1371/journal.pone.0005690	http://dx.doi.org/10.1371/journal.pone.0005690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479055	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415100004
J	Williams, R; Yao, HH; Dhillon, NK; Buch, SJ				Williams, Rachel; Yao, Honghong; Dhillon, Navneet K.; Buch, Shilpa J.			HIV-1 Tat Co-Operates with IFN-gamma and TNF-alpha to Increase CXCL10 in Human Astrocytes	PLOS ONE			English	Article								HIV-associated neurological disorders (HAND) are estimated to affect 60% of the HIV infected population. HIV-encephalitis (HIVE), the pathological correlate of the most severe form of HAND is often characterized by glial activation, cytokine/chemokine dysregulation, and neuronal damage and loss. However, the severity of HIVE correlates better with glial activation rather than viral load. One of the characteristic features of HIVE is the increased amount of the neurotoxic chemokine, CXCL10. This chemokine can be released from astroglia activated with the pro-inflammatory cytokines IFN-gamma and TNF-alpha, in conjunction with HIV-1 Tat, all of which are elevated in HIVE. In an effort to understand the pathogenesis of HAND, this study was aimed at exploring the regulation of CXCL10 by cellular and viral factors during astrocyte activation. Specifically, the data herein demonstrate that the combined actions of HIV-1 Tat and the pro-inflammatory cytokines, IFN-gamma and TNF-alpha, result in the induction of CXCL10 at both the RNA and protein level. Furthermore, CXCL10 induction was found to be regulated transcriptionally by the activation of the p38, Jnk, and Akt signaling pathways and their downstream transcription factors, NF-kappa B and STAT-1 alpha. Since CXCL10 levels are linked to disease severity, understanding its regulation could aid in the development of therapeutic intervention strategies for HAND.			Williams, R (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	sbuch@kumc.edu		Buch, Shilpa/0000-0002-3103-6685	NCRR NIH HHS [RR016443, P20 RR016443] Funding Source: Medline; NIDA NIH HHS [DA023397, DA020392, R01 DA020392, R21 DA023397, R01 DA024442, DA024442] Funding Source: Medline; NIMH NIH HHS [R01 MH068212, MH62969, MH068212] Funding Source: Medline; NINDS NIH HHS [F31NS062665, F31 NS062665] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, R03MH062969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS062665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020392, R21DA023397, R01DA024442] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; Andras IE, 2003, J NEUROSCI RES, V74, P255, DOI 10.1002/jnr.10762; Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Asensio VC, 2001, J VIROL, V75, P7067, DOI 10.1128/JVI.75.15.7067-7077.2001; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bonavia R, 2001, BIOCHEM BIOPH RES CO, V288, P301, DOI 10.1006/bbrc.2001.5743; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Conant K, 1996, J VIROL, V70, P1384, DOI 10.1128/JVI.70.3.1384-1389.1996; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Davis RL, 2004, NEUROSCI LETT, V362, P220, DOI 10.1016/j.neulet.2004.03.015; Davis RL, 2002, ALCOHOL CLIN EXP RES, V26, P1404, DOI 10.1097/01.ALC.0000030841.92766.80; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; Dhillon NK, 2007, AM J PHYSIOL-LUNG C, V292, pL1233, DOI 10.1152/ajplung.00293.2006; Dou HY, 2006, GLIA, V54, P81, DOI 10.1002/glia.20358; Gelbard HA, 1999, ANN NY ACAD SCI, V890, P312, DOI 10.1111/j.1749-6632.1999.tb08008.x; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Giunta B, 2006, BRAIN RES, V1123, P216, DOI 10.1016/j.brainres.2006.09.057; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; HURWITZ AA, 1995, J NEUROIMMUNOL, V57, P193, DOI 10.1016/0165-5728(95)00011-P; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kolb SA, 1999, J NEUROIMMUNOL, V93, P172, DOI 10.1016/S0165-5728(98)00223-9; Kolson DL, 2002, CLIN LAB MED, V22, P703, DOI 10.1016/S0272-2712(02)00009-4; Kutsch O, 2000, J VIROL, V74, P9214, DOI 10.1128/JVI.74.19.9214-9221.2000; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Majumder S, 1998, J IMMUNOL, V161, P4736; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; McArthur JC, 1999, SEMIN NEUROL, V19, P129, DOI 10.1055/s-2008-1040831; Means TK, 2000, J LEUKOCYTE BIOL, V67, P885, DOI 10.1002/jlb.67.6.885; Miller RJ, 1999, TRENDS NEUROSCI, V22, P471, DOI 10.1016/S0166-2236(99)01408-3; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603; OHMORI Y, 1995, J IMMUNOL, V154, P5235; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Oshima T, 2000, AIDS, V14, P475, DOI 10.1097/00002030-200003310-00002; Ozdener H, 2005, J BIOSCIENCES, V30, P391, DOI 10.1007/BF02703676; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Popik W, 1998, J VIROL, V72, P6406, DOI 10.1128/JVI.72.8.6406-6413.1998; Prendergast MA, 2002, BRAIN RES, V954, P300, DOI 10.1016/S0006-8993(02)03360-7; Saha RN, 2003, J NEUROCHEM, V86, P1057, DOI 10.1046/j.1471-4159.2003.01942.x; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Shapiro L, 1998, P NATL ACAD SCI USA, V95, P7422, DOI 10.1073/pnas.95.13.7422; Shapshak P, 2004, FRONT BIOSCI-LANDMRK, V9, P1073, DOI 10.2741/1271; Sheng WS, 2003, BIOCHEM PHARMACOL, V65, P9, DOI 10.1016/S0006-2952(02)01480-6; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Sui YJ, 2006, EUR J NEUROSCI, V23, P957, DOI 10.1111/j.1460-9568.2006.04631.x; Sui YJ, 2004, AM J PATHOL, V164, P1557, DOI 10.1016/S0002-9440(10)63714-5; Turchan-Cholewo J, 2009, ANTIOXID REDOX SIGN, V11, P193, DOI [10.1089/ars.2008.2097, 10.1089/ARS.2008.2097]; TYOR WR, 1992, ANN NEUROL, V31, P349, DOI 10.1002/ana.410310402; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; Van Wagoner NJ, 2000, J NEUROCHEM, V75, P563, DOI 10.1046/j.1471-4159.2000.0750563.x; Wang ZY, 2004, J NEUROVIROL, V10, P25, DOI 10.1080/13550280490270851; Wesselingh SL, 1997, J NEUROIMMUNOL, V74, P1, DOI 10.1016/S0165-5728(96)00160-9; WESSELINGH SL, 1993, ANN NEUROL, V33, P576, DOI 10.1002/ana.410330604; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WILLIAMS R, 2008, GLIA; Yan MJ, 2007, BRAIN RES, V1184, P28, DOI 10.1016/j.brainres.2007.09.082; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	67	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5709	10.1371/journal.pone.0005709	http://dx.doi.org/10.1371/journal.pone.0005709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19479051	Green Submitted, gold, Green Published			2022-12-27	WOS:000266415100009
J	Musini, VM; Wright, JM				Musini, Vijaya M.; Wright, James M.			Factors Affecting Blood Pressure Variability: Lessons Learned from Two Systematic Reviews of Randomized Controlled Trials	PLOS ONE			English	Article								Systematic reviews can often reveal much more than the original objective of the work. The objectives of this retrospective analysis were to answer three basic questions about blood pressure variability: 1) Does blood pressure entry criterion have an effect on baseline blood pressure variability? 2) Do thiazide diuretics have a significant effect on blood pressure variability? and 3) Does systolic blood pressure vary to the same degree as diastolic blood pressure? This analysis of blood pressure variability is based on resting standardized research setting BP readings from two systematic reviews evaluating blood pressure lowering efficacy of thiazide diuretics from double blind randomized controlled trials in 33,611 patients with primary hypertension. The standard deviation reported in trials was the focus of the research and the unit of analysis. When a threshold systolic or diastolic blood pressure value is used to determine entry into a trial, baseline variability is significantly decreased, systolic from 14.0 to 9.3 mmHg and diastolic from 8.4 to 5.3 mmHg. Thiazides do not change BP variability as the standard deviation and coefficient of variation of systolic blood pressure and diastolic blood pressure did not differ between thiazide and placebo groups at end of treatment. The coefficient of variation of systolic blood pressure was significantly greater than the coefficient of variation of diastolic blood pressure. Entry criterion decreases the baseline blood pressure variability. Treatment with a thiazide diuretic does not affect blood pressure variability. Systolic blood pressure varies to a greater degree than diastolic blood pressure.			Musini, VM (corresponding author), Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada.	vijaya@ti.ubc.ca		Musini, Vijaya/0000-0002-8096-6563				Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; Musini V, 2000, THESIS U BRIT COLUMB; MUSINI VM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003824; Parati G, 2005, J HYPERTENS, V23, pS19, DOI 10.1097/01.hjh.0000165624.79933.d3; Pierdomenico SD, 2006, AM J HYPERTENS, V19, P991, DOI 10.1016/j.amjhyper.2006.03.009; Wright J. M., 2009, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD001841, DOI 10.1002/14651858.CD001841]; Wright JM, 1999, CAN MED ASSOC J, V161, P25	9	46	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5673	10.1371/journal.pone.0005673	http://dx.doi.org/10.1371/journal.pone.0005673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19479061	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331200010
J	Wildgruber, M; Lee, H; Chudnovskiy, A; Yoon, TJ; Etzrodt, M; Pittet, MJ; Nahrendorf, M; Croce, K; Libby, P; Weissleder, R; Swirski, FK				Wildgruber, Moritz; Lee, Hakho; Chudnovskiy, Aleksey; Yoon, Tae-Jong; Etzrodt, Martin; Pittet, Mikael J.; Nahrendorf, Matthias; Croce, Kevin; Libby, Peter; Weissleder, Ralph; Swirski, Filip K.			Monocyte Subset Dynamics in Human Atherosclerosis Can Be Profiled with Magnetic Nano-Sensors	PLOS ONE			English	Article								Monocytes are circulating macrophage and dendritic cell precursors that populate healthy and diseased tissue. In humans, monocytes consist of at least two subsets whose proportions in the blood fluctuate in response to coronary artery disease, sepsis, and viral infection. Animal studies have shown that specific shifts in the monocyte subset repertoire either exacerbate or attenuate disease, suggesting a role for monocyte subsets as biomarkers and therapeutic targets. Assays are therefore needed that can selectively and rapidly enumerate monocytes and their subsets. This study shows that two major human monocyte subsets express similar levels of the receptor for macrophage colony stimulating factor (MCSFR) but differ in their phagocytic capacity. We exploit these properties and custom-engineer magnetic nanoparticles for ex vivo sensing of monocytes and their subsets. We present a two-dimensional enumerative mathematical model that simultaneously reports number and proportion of monocyte subsets in a small volume of human blood. Using a recently described diagnostic magnetic resonance (DMR) chip with 1 mu l sample size and high throughput capabilities, we then show that application of the model accurately quantifies subset fluctuations that occur in patients with atherosclerosis.			Wildgruber, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu; fswirski@mgh.harvard.edu	Pittet, Mikael/ABD-6300-2021; Libby, Peter/AAY-6404-2021; Etzrodt, Martin/P-3325-2015; Swirski, Filip/AAF-1340-2019	Libby, Peter/0000-0002-1502-502X; Etzrodt, Martin/0000-0003-1928-3904; Swirski, Filip/0000-0002-3163-9152; /0000-0003-0828-4143	NATIONAL CANCER INSTITUTE [P50CA086355, P01CA069246] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL086672, R01HL095629, R01HL096576, U01HL080731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004626] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA086355, P01 CA069246, R24 CA69246, P50 CA86355] Funding Source: Medline; NHLBI NIH HHS [U01 HL080731, K08 HL086672, R01 HL096576, R01 HL095629] Funding Source: Medline; NIBIB NIH HHS [R01-EB004626] Funding Source: Medline; PHS HHS [P01-A154904] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; AUFFRAY C, 2009, ANN REV IMMUNOL; Dragu R, 2008, ATHEROSCLEROSIS, V196, P405, DOI 10.1016/j.atherosclerosis.2006.11.022; Draude G, 1999, AM J PHYSIOL-HEART C, V276, pH1144, DOI 10.1152/ajpheart.1999.276.4.H1144; FINGERLE G, 1993, BLOOD, V82, P3170; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Josephson L, 2002, BIOCONJUGATE CHEM, V13, P554, DOI 10.1021/bc015555d; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2008, CIRCULATION, V117, P3168, DOI 10.1161/CIRCULATIONAHA.108.783068; Metz S, 2004, EUR RADIOL, V14, P1851, DOI 10.1007/s00330-004-2405-2; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Schinkel C, 1998, J TRAUMA, V44, P743, DOI 10.1097/00005373-199805000-00001; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Stroh A, 2006, NEUROIMAGE, V33, P886, DOI 10.1016/j.neuroimage.2006.07.009; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Ulrich C, 2006, NEPHROL DIAL TRANSPL, V21, P1596, DOI 10.1093/ndt/gfl008; Waldo SW, 2008, AM J PATHOL, V172, P1112, DOI 10.2353/ajpath.2008.070513; Waterhouse DF, 2008, VASC HEALTH RISK MAN, V4, P177, DOI 10.2147/vhrm.2008.04.01.177; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Wunderbaldinger P, 2002, ACAD RADIOL, V9, pS304, DOI 10.1016/S1076-6332(03)80210-6; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902	34	50	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5663	10.1371/journal.pone.0005663	http://dx.doi.org/10.1371/journal.pone.0005663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19461894	gold, Green Published, Green Submitted			2022-12-27	WOS:000266331200003
J	Lester, RT; Yao, XD; Ball, TB; McKinnon, LR; Omange, WR; Kaul, R; Wachihi, C; Jaoko, W; Rosenthal, KL; Plummer, FA				Lester, Richard T.; Yao, Xiao-Dan; Ball, T. Blake; McKinnon, Lyle R.; Omange, Were R.; Kaul, Rupert; Wachihi, Charles; Jaoko, Walter; Rosenthal, Kenneth L.; Plummer, Francis A.			HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers	PLOS ONE			English	Article							SINGLE-STRANDED RNA; IMMUNE ACTIVATION; MICROBIAL TRANSLOCATION; RECEPTOR LIGANDS; TOLERANCE; INFECTION; RECOGNITION; EXPRESSION; PATHOGENESIS; THERAPY	Background: Subclinical endotoxemia has been reported in HIV-1 infected persons and may drive systemic immune activation and pathogenesis. Proinflammatory responsiveness to endotoxin (LPS) is mediated by Toll-like receptor 4 (TLR4). We therefore examined the association between plasma LPS levels, HIV RNA, and TLR4 expression and cytokine responses in the blood of HIV infected and uninfected participants in a cohort of female sex-workers in Kenya. Methodology/Principal Findings: Ex vivo plasma and peripheral blood mononuclear cells (PBMC) were assessed for LPS and TLR mRNA, respectively. The effects of HIV single stranded RNA, a TLR8 ligand, on TLR4 and LPS signaling were further assessed in short term PBMC culture. Both HIV uninfected and infected subjects frequently had low detectable LPS levels in their plasmas. Significantly increased LPS levels were associated with chronic HIV-1 infection, both treated and untreated, but not with other acute or semi-chronic conditions reported. In HIV-uninfected subjects, TLR4 mRNA expression levels correlated inversely with plasma LPS levels, suggesting chronic endotoxin 'tolerance' in vivo. A similar effect of reduced TLR4 mRNA was seen in short term PBMC culture after stimulation with LPS. Interestingly, the apparent in vivo tolerance effect was diminished in subjects with HIV infection. Additionally, pre-stimulation of PBMC with LPS lead to proinflammatory (TNF-alpha) tolerance to subsequent LPS stimulation; however, pre-treatment of PBMC with HIV single-stranded RNA40, could enhance TLR4-mediated LPS responsiveness in vitro. Conclusions/Significance: Thus, dysregulation of endotoxin tolerance by HIV-1 RNA may exacerbate HIV chronic immune activation and pathogenesis.			Lester, RT (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.	rlester.id@gmail.com	Jaoko, Walter/AAN-5048-2020; Omange, Were/F-1454-2016	Jaoko, Walter/0000-0002-7134-6581; Kaul, Rupert/0000-0002-1586-4093; McKinnon, Lyle/0000-0002-7157-0700; Omange, Were/0000-0002-0421-110X				Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Bafica A, 2004, J LEUKOCYTE BIOL, V75, P460, DOI 10.1189/jlb.0803388; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Douek Daniel, 2007, Top HIV Med, V15, P114; Fonck K, 2001, SEX TRANSM INFECT, V77, P271, DOI 10.1136/sti.77.4.271; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; MEIER A, 2007, J VIROL; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Paiardini M, 2008, AIDS REV, V10, P36; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Parker LC, 2005, J LEUKOCYTE BIOL, V78, P1301, DOI 10.1189/jlb.0405236; Pearce CB, 2005, WORLD J GASTROENTERO, V11, P7142, DOI 10.3748/wjg.v11.i45.7142; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schmitz JE, 2001, BLOOD, V98, P3757, DOI 10.1182/blood.V98.13.3757; Walson JL, 2008, AIDS, V22, P1601, DOI 10.1097/QAD.0b013e32830a502e	32	54	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5644	10.1371/journal.pone.0005644	http://dx.doi.org/10.1371/journal.pone.0005644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19461969	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331000003
J	Bonett, RM; Chippindale, PT; Moler, PE; Van Devender, RW; Wake, DB				Bonett, Ronald M.; Chippindale, Paul T.; Moler, Paul E.; Van Devender, R. Wayne; Wake, David B.			Evolution of Gigantism in Amphiumid Salamanders	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; BODY-SIZE EVOLUTION; PHYLOGENETIC-RELATIONSHIPS; PLETHODONTID SALAMANDERS; AMBYSTOMATID SALAMANDER; MOLECULAR EVOLUTION; DIVERGENCE TIMES; ABSOLUTE RATES; RANGE SIZES; DIVERSIFICATION	The Amphiumidae contains three species of elongate, permanently aquatic salamanders with four diminutive limbs that append one, two, or three toes. Two of the species, Amphiuma means and A. tridactylum, are among the largest salamanders in the world, reaching lengths of more than one meter, whereas the third species (A. pholeter), extinct amphiumids, and closely related salamander families are relatively small. Amphiuma means and A. tridactylum are widespread species and live in a wide range of lowland aquatic habitats on the Coastal Plain of the southeastern United States, whereas A. pholeter is restricted to very specialized organic muck habitats and is syntopic with A. means. Here we present analyses of sequences of mitochondrial and nuclear loci from across the distribution of the three taxa to assess lineage diversity, relationships, and relative timing of divergence in amphiumid salamanders. In addition we analyze the evolution of gigantism in the clade. Our analyses indicate three lineages that have diverged since the late Miocene, that correspond to the three currently recognized species, but the two gigantic species are not each other's closest relatives. Given that the most closely related salamander families and fossil amphiumids from the Upper Cretaceous and Paleocene are relatively small, our results suggest at least two extreme changes in body size within the Amphuimidae. Gigantic body size either evolved once as the ancestral condition of modern amphiumas, with a subsequent strong size reduction in A. pholeter, or gigantism independently evolved twice in the modern species, A. means and A. tridactylum. These patterns are concordant with differences in habitat breadth and range size among lineages, and have implications for reproductive isolation and diversification of amphiumid salamanders.			Bonett, RM (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	ron-bonett@utulsa.edu						*AMPHIBIAWEB, 2009, AMPHIBIAWEB INFORM A; [Anonymous], 2010, SALAMANDERS US CANAD; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; BANCROFT GT, 1983, A835 US ARM ENG WAT; BEHLER JL, 1998, AUDUBON SOC FIELD GU; Blackburn TM, 1996, PHILOS T R SOC B, V351, P897, DOI 10.1098/rstb.1996.0083; BOUNDY J, 2005, AMPHIBIAN DECLINES C, P00646; Brandle M, 2002, EVOL ECOL RES, V4, P993; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chippindale PT, 2004, EVOLUTION, V58, P2809; CLARK JM, 1985, J HERPETOL, V19, P41, DOI 10.2307/1564418; CONANT R, 1998, FIELD GUIDE AMPHIBIA; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; Estes R., 1969, Breviora, VNo. 322, P1; Etienne RS, 2004, AM NAT, V163, P69, DOI 10.1086/380582; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontenot CL, 1999, J HERPETOL, V33, P100, DOI 10.2307/1565548; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Gardner JD, 2003, J VERTEBR PALEONTOL, V23, P769, DOI 10.1671/1828-4; GOOD DA, 1992, U CALIFORNIA PUBLICA, V126; Gould Gina C., 2004, Bulletin of the American Museum of Natural History, V285, P219, DOI 10.1206/0003-0090(2004)285<0219:C>2.0.CO;2; HILL IR, 1954, TULANE STUD ZOOL, V12, P191; Hoegg S, 2004, MOL BIOL EVOL, V21, P1188, DOI 10.1093/molbev/msh081; HOLMAN JA, 1977, HERPETOLOGICA, V33, P391; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; Johnson SA, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P642; Karlin A.A., 1993, AM MIDLAND NATURALIS, V132, P1; Kozak KH, 2005, EVOLUTION, V59, P2000; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; MACHOVINA BL, 1994, THESIS FLORIDA INT U; Maddison W.P., 2008, MESQUITE MODULAR SYS; McClain CR, 2006, J BIOGEOGR, V33, P1578, DOI 10.1111/j.1365-2699.2006.01545.x; MEANS DB, 2005, AMPHIBIAN DECLINES C, P645; MEANS DB, 1996, AMPHIUMA PHOLETER; Meiri S, 2007, GLOBAL ECOL BIOGEOGR, V16, P702, DOI 10.1111/j.1466-8238.2007.00327.x; Moen DS, 2009, EVOLUTION, V63, P195, DOI 10.1111/j.1558-5646.2008.00538.x; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; NAYLOR BG, 1993, CAN J EARTH SCI, V30, P814, DOI 10.1139/e93-067; Nylander JAA., 2004, BIOINFORMATICS; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; Pfennig DW, 2006, ECOLOGY, V87, P769, DOI 10.1890/05-0787; Pyron M, 1999, J BIOGEOGR, V26, P549, DOI 10.1046/j.1365-2699.1999.00303.x; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Samuels AK, 2005, GENE, V349, P43, DOI 10.1016/j.gene.2004.12.037; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; Swofford DL., 2001, PAUP PHYLOGENETIC AN; TIHEN JA, 1981, J HERPETOL, V15, P35, DOI 10.2307/1563644; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vieites DR, 2007, P NATL ACAD SCI USA, V104, P19903, DOI 10.1073/pnas.0705056104; Weisrock DW, 2005, SYST BIOL, V54, P758, DOI 10.1080/10635150500234641; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wirta H, 2008, MOL PHYLOGENET EVOL, V47, P1076, DOI 10.1016/j.ympev.2008.03.010	65	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5615	10.1371/journal.pone.0005615	http://dx.doi.org/10.1371/journal.pone.0005615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461997	Green Submitted, Green Published, gold			2022-12-27	WOS:000266234700008
J	Chechko, N; Wehrle, R; Erhardt, A; Holsboer, F; Czisch, M; Samann, PG				Chechko, Natalya; Wehrle, Renate; Erhardt, Angelika; Holsboer, Florian; Czisch, Michael; Saemann, Philipp G.			Unstable Prefrontal Response to Emotional Conflict and Activation of Lower Limbic Structures and Brainstem in Remitted Panic Disorder	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL MECHANISMS; COUNTING STROOP; FUNCTIONAL NEUROANATOMY; RESOLVE CONFLICT; ANXIETY DISORDER; FACIAL AFFECT; AMYGDALA; INFORMATION; FMRI	Background: The neural mechanisms of panic disorder (PD) are only incompletely understood. Higher sensitivity of patients to unspecific fear cues and similarities to conditioned fear suggest involvement of lower limbic and brainstem structures. We investigated if emotion perception is altered in remitted PD as a trait feature. Methodology/Principal Findings: We used blood oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) to study neural and behavioural responses of 18 remitted PD patients and 18 healthy subjects to the emotional conflict paradigm that is based on the presentation of emotionally congruent and incongruent face/word pairs. We observed that patients showed stronger behavioural interference and lower adaptation to interference conflict. Overall performance in patients was slower but not less accurate. In the context of preceding congruence, stronger dorsal anterior cingulate cortex (dACC) activation during conflict detection was found in patients. In the context of preceding incongruence, controls expanded dACC activity and succeeded in reducing behavioural interference. In contrast, patients demonstrated a dropout of dACC and dorsomedial prefrontal cortex (dmPFC) recruitment but activation of the lower limbic areas (including right amygdala) and brainstem. Conclusions/Significance: This study provides evidence that stimulus order in the presentation of emotional stimuli has a markedly larger influence on the brain's response in remitted PD than in controls, leading to abnormal responses of the dACC/dmPFC and lower limbic structures (including the amygdala) and brainstem. Processing of non-panic related emotional stimuli is disturbed in PD patients despite clinical remission.			Chechko, N (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	saemann@mpipsykl.mpg.de						American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Anderson IM, 2007, NEUROREPORT, V18, P1351, DOI 10.1097/WNR.0b013e3282742115; Arce E, 2008, PSYCHOPHARMACOLOGY, V196, P661, DOI 10.1007/s00213-007-1004-8; Asami T, 2008, PSYCHIAT CLIN NEUROS, V62, P322, DOI 10.1111/j.1440-1819.2008.01800.x; Bandelow B., 1999, PANIC AGORAPHOBIA SC; Battaglia M, 2005, NEUROSCI BIOBEHAV R, V29, P169, DOI 10.1016/j.neubiorev.2004.06.013; Beck A. T., 1961, ARCH GEN PSYCHIAT; BENKELFAT C, 1995, AM J PSYCHIAT, V152, P1180; Berkowitz RL, 2007, REV NEUROSCIENCE, V18, P191; Bienvenu OJ, 2006, BRIT J PSYCHIAT, V188, P432, DOI 10.1192/bjp.bp.105.010827; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bouton ME, 2001, PSYCHOL REV, V108, P4, DOI 10.1037//0033-295X.108.1.4; Browning M, 2007, J PSYCHOPHARMACOL, V21, P684, DOI 10.1177/0269881106074062; Bush G, 2006, NAT PROTOC, V1, P230, DOI 10.1038/nprot.2006.35; Bystritsky A, 2001, NEUROREPORT, V12, P3953, DOI 10.1097/00001756-200112210-00020; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; DECORT K, 2007, DEPRESS ANXIETY; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dieler AC, 2008, CURR PHARM DESIGN, V14, P3492, DOI 10.2174/138161208786848801; Drevets W. C., 1994, Society for Neuroscience Abstracts, V20, P368; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, J COGNITIVE NEUROSCI, V17, P1774, DOI 10.1162/089892905774589226; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Ekman P., 1976, PICTURES FACIAL AFFE; ESER D, 2007, HUM BRAIN MAPP; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hoehn-Saric R, 2004, PSYCHIAT RES-NEUROIM, V131, P11, DOI 10.1016/j.pscychresns.2004.02.003; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Laux L., 1981, STATE TRAIT ANGSTINV; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MARTIN M, 1991, BEHAV RES THER, V29, P147, DOI 10.1016/0005-7967(91)90043-3; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; MCNALLY RJ, 1994, BEHAV RES THER, V32, P119, DOI 10.1016/0005-7967(94)90092-2; Merens W, 2007, J AFFECT DISORDERS, V103, P43, DOI 10.1016/j.jad.2007.01.032; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Most SB, 2006, NEUROIMAGE, V31, P934, DOI 10.1016/j.neuroimage.2005.12.031; Nash JR, 2004, EUR NEUROPSYCHOPHARM, V14, pS322, DOI 10.1016/S0924-977X(04)80424-3; Neumeister A, 2004, J NEUROSCI, V24, P589, DOI 10.1523/JNEUROSCI.4921-03.2004; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; ONODA K, 2007, NEUROPSYCHOLOGIA; Paul MA, 2007, AVIAT SPACE ENVIR MD, V78, P693; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pfleiderer B, 2007, WORLD J BIOL PSYCHIA, V8, P269, DOI 10.1080/15622970701216673; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pillay SS, 2007, J ANXIETY DISORD, V21, P381, DOI 10.1016/j.janxdis.2006.04.001; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Protopopescu X, 2006, NEUROREPORT, V17, P361, DOI 10.1097/01.wnr.0000203354.80438.1; Rose EJ, 2006, PSYCHOPHARMACOLOGY, V185, P339, DOI 10.1007/s00213-006-0334-2; Roy-Byrne PP, 2006, LANCET, V368, P1023, DOI 10.1016/S0140-6736(06)69418-X; Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010; Schneider S, 2008, PSYCHOPATHOLOGY, V41, P179, DOI 10.1159/000120986; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Teachman BA, 2007, BEHAV RES THER, V45, P1791, DOI 10.1016/j.brat.2007.01.009; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Uchida RR, 2008, PSYCHIAT RES-NEUROIM, V163, P21, DOI 10.1016/j.pscychresns.2007.04.015; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P922, DOI 10.1001/archpsyc.62.8.922; Vaswani M, 2003, PROG NEURO-PSYCHOPH, V27, P85, DOI 10.1016/S0278-5846(02)00338-X; Wadsworth EJK, 2005, HUM PSYCHOPHARM CLIN, V20, P561, DOI 10.1002/hup.725; Wenzel Amy, 2006, Cognitive Behaviour Therapy, V35, P129, DOI 10.1080/16506070600583130; Whalen PJ, 2006, NAT PROTOC, V1, P293, DOI 10.1038/nprot.2006.45; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	79	62	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5537	10.1371/journal.pone.0005537	http://dx.doi.org/10.1371/journal.pone.0005537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	448AY	19462002	Green Published, Green Submitted, gold			2022-12-27	WOS:000266234700003
J	Baugh, LA; Marotta, JJ				Baugh, Lee A.; Marotta, Jonathan J.			When What's Left Is Right: Visuomotor Transformations in an Aged Population	PLOS ONE			English	Article							PRISM ADAPTATION; SENSORIMOTOR ADAPTATION; PARKINSONS-DISEASE; INTERNAL-MODELS; VISUAL FEEDBACK; CEREBRAL-CORTEX; SEX-DIFFERENCES; MOTOR-SEQUENCE; OLDER-ADULTS; PLASTICITY	Background: There has been little consensus as to whether age-related visuomotor adaptation effects are readily observable. Some studies have found slower adaptation, and/or reduced overall levels. In contrast, other methodologically similar studies have found no such evidence of aging effects on visuomotor adaptation. A crucial early step in successful adaptation is the ability to perform the necessary transformation to complete the task at hand. The present study describes the use of a viewing window paradigm to examine the effects of aging in a visuomotor transformation task. Methods: Two groups of participants, a young adult control group (age range 18-33 years old, mean age = 22) and an older adult group (age range 62-74, mean age = 68) completed a viewing window task that was controlled by the user via a computer touchscreen. Four visuomotor "flip" conditions were created by varying the relationship between the participant's movement, and the resultant on-screen movement of the viewing window: 1) No flip 2) X-Axis and Y-axis body movements resulted in the opposite direction of movement of the viewing window. In each of the 3) Flip-X and 4) Flip-Y conditions, the solitary X- or Y-axes were reversed. Response times and movement of the window were recorded. Conclusions: Older participants demonstrated impairments in performing a required visuomotor transformation, as evidenced by more complex scanning patterns and longer scanning times when compared to younger control participants. These results provide additional evidence that the mechanisms involved in visuomotor transformation are negatively affected by age.			Baugh, LA (corresponding author), Univ Manitoba, Dept Psychol, Percept & Act Lab, Winnipeg, MB R3T 2N2, Canada.	umbaughL@cc.umanitoba.ca		Baugh, Lee/0000-0001-6227-497X; Marotta, Jonathan/0000-0001-6635-4694				ABED F, 1991, J CROSS CULTURAL PSY, V22; Baugh LA, 2007, J NEUROSCI METH, V160, P128, DOI 10.1016/j.jneumeth.2006.09.002; Bennett PJ, 2001, ACTA PSYCHOL, V107, P249, DOI 10.1016/S0001-6918(01)00037-3; Bock O, 2002, NEUROSCI BIOBEHAV R, V26, P761, DOI 10.1016/S0149-7634(02)00063-5; BOUCHER JL, 1991, PERCEPT MOTOR SKILL, V72, P507, DOI 10.2466/PMS.72.2.507-512; Boyd LA, 2003, PHYS THER, V83, P976, DOI 10.1093/ptj/83.11.976; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CANAVAN AGM, 1990, NEUROPSYCHOLOGIA, V28, P969, DOI 10.1016/0028-3932(90)90112-2; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; DIAMOND MC, 1985, EXP NEUROL, V87, P309, DOI 10.1016/0014-4886(85)90221-3; FERCHMIN PA, 1986, DEV PSYCHOBIOL, V19, P511, DOI 10.1002/dev.420190604; Fernandez-Ruiz J, 2003, EUR J NEUROSCI, V18, P689, DOI 10.1046/j.1460-9568.2003.02785.x; Fernandez-Ruiz J, 2000, COGNITIVE BRAIN RES, V9, P223, DOI 10.1016/S0926-6410(99)00057-9; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gorbet DJ, 2007, EUR J NEUROSCI, V25, P1228, DOI 10.1111/j.1460-9568.2007.05358.x; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; HARRINGTON DL, 1992, PSYCHOL AGING, V7, P425, DOI 10.1037/0882-7974.7.3.425; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Kaas JH, 1999, NEURON, V22, P657, DOI 10.1016/S0896-6273(00)80725-4; KIM WS, 1987, IEEE T SYST MAN CYB, V17, P61, DOI 10.1109/TSMC.1987.289333; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Kucera H., 1967, COMPUTATIONAL ANAL P; Lehmbeck JT, 2006, NEUROREPORT, V17, P467, DOI 10.1097/01.wnr.0000209012.24341.7f; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Marotta JJ, 2005, J NEUROPHYSIOL, V93, P1104, DOI 10.1152/jn.00859.2004; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Newport R, 2006, CORTEX, V42, P720, DOI 10.1016/S0010-9452(08)70410-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PARSONS TD, 2007, AGING NEUROPSYCHOL C, V12, P78; Pohl PS, 2006, CLIN REHABIL, V20, P246, DOI 10.1191/0269215506cr916oa; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; ROBYBRAMI A, 1995, COGNITIVE BRAIN RES, V2, P229, DOI 10.1016/0926-6410(95)90014-4; Roller CA, 2002, NEUROBIOL AGING, V23, P117, DOI 10.1016/S0197-4580(01)00264-0; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Seidler RD, 2007, LEARN MEMORY, V14, P17, DOI 10.1101/lm.394707; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; Seidler-Dobrin RD, 1998, EXP BRAIN RES, V119, P467, DOI 10.1007/s002210050362; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Teulings HL, 2002, J NEUROL NEUROSUR PS, V72, P315, DOI 10.1136/jnnp.72.3.315; van den Dobbelsteen JJ, 2004, J NEUROPHYSIOL, V92, P416, DOI 10.1152/jn.00764.2003; Vetter P, 1999, J NEUROPHYSIOL, V81, P935, DOI 10.1152/jn.1999.81.2.935; VURPILLOT E, 1976, TRAVAIL HUMAIN, V39; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	47	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5484	10.1371/journal.pone.0005484	http://dx.doi.org/10.1371/journal.pone.0005484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	444WA	19436727	gold, Green Published, Green Submitted			2022-12-27	WOS:000266009900002
J	Nelis, M; Esko, T; Magi, R; Zimprich, F; Zimprich, A; Toncheva, D; Karachanak, S; Piskackova, T; Balascak, I; Peltonen, L; Jakkula, E; Rehnstrom, K; Lathrop, M; Heath, S; Galan, P; Schreiber, S; Meitinger, T; Pfeufer, A; Wichmann, HE; Melegh, B; Polgar, N; Toniolo, D; Gasparini, P; D'Adamo, P; Klovins, J; Nikitina-Zake, L; Kucinskas, V; Kasnauskiene, J; Lubinski, J; Debniak, T; Limborska, S; Khrunin, A; Estivill, X; Rabionet, R; Marsal, S; Julia, A; Antonarakis, SE; Deutsch, S; Borel, C; Attar, H; Gagnebin, M; Macek, M; Krawczak, M; Remm, M; Metspalu, A				Nelis, Mari; Esko, Tonu; Magi, Reedik; Zimprich, Fritz; Zimprich, Alexander; Toncheva, Draga; Karachanak, Sena; Piskackova, Tereza; Balascak, Ivan; Peltonen, Leena; Jakkula, Eveliina; Rehnstrom, Karola; Lathrop, Mark; Heath, Simon; Galan, Pilar; Schreiber, Stefan; Meitinger, Thomas; Pfeufer, Arne; Wichmann, H-Erich; Melegh, Bela; Polgar, Noemi; Toniolo, Daniela; Gasparini, Paolo; D'Adamo, Pio; Klovins, Janis; Nikitina-Zake, Liene; Kucinskas, Vaidutis; Kasnauskiene, Jurate; Lubinski, Jan; Debniak, Tadeusz; Limborska, Svetlana; Khrunin, Andrey; Estivill, Xavier; Rabionet, Raquel; Marsal, Sara; Julia, Antonio; Antonarakis, Stylianos E.; Deutsch, Samuel; Borel, Christelle; Attar, Homa; Gagnebin, Maryline; Macek, Milan; Krawczak, Michael; Remm, Maido; Metspalu, Andres			Genetic Structure of Europeans: A View from the North-East	PLOS ONE			English	Article								Using principal component (PC) analysis, we studied the genetic constitution of 3,112 individuals from Europe as portrayed by more than 270,000 single nucleotide polymorphisms (SNPs) genotyped with the Illumina Infinium platform. In cohorts where the sample size was >100, one hundred randomly chosen samples were used for analysis to minimize the sample size effect, resulting in a total of 1,564 samples. This analysis revealed that the genetic structure of the European population correlates closely with geography. The first two PCs highlight the genetic diversity corresponding to the northwest to southeast gradient and position the populations according to their approximate geographic origin. The resulting genetic map forms a triangular structure with a) Finland, b) the Baltic region, Poland and Western Russia, and c) Italy as its vertexes, and with d) Central- and Western Europe in its centre. Inter- and intra- population genetic differences were quantified by the inflation factor lambda (lambda) (ranging from 1.00 to 4.21), fixation index (F(st)) (ranging from 0.000 to 0.023), and by the number of markers exhibiting significant allele frequency differences in pair-wise population comparisons. The estimated lambda was used to assess the real diminishing impact to association statistics when two distinct populations are merged directly in an analysis. When the PC analysis was confined to the 1,019 Estonian individuals (0.1% of the Estonian population), a fine structure emerged that correlated with the geography of individual counties. With at least two cohorts available from several countries, genetic substructures were investigated in Czech, Finnish, German, Estonian and Italian populations. Together with previously published data, our results allow the creation of a comprehensive European genetic map that will greatly facilitate inter-population genetic studies including genome wide association studies (GWAS).			Nelis, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	andres@ebc.ee	borel, christelle/AAC-9645-2019; Antonarakis, Stylianos E/N-8866-2014; Klovins, Janis/C-5695-2011; Meitinger, Thomas/O-1318-2015; Karachanak-Yankova, Sena/AAL-2721-2021; Nelis, Mari/ABG-7775-2020; Estivill, Xavier/E-2957-2012; rabionet, raquel/A-7407-2009; Rabionet, Raquel/C-8379-2009; Remm, Maido/L-9072-2019; Wichmann, Heinz Erich/AAA-5695-2022; Limborska, Svetlana/S-2961-2019; Limborska, Svetlana/A-5633-2016; Gasparini, Paolo/B-6173-2014; Zimprich, Fritz/O-1406-2019; Estivill, Xavier/A-3125-2013; Krawczak, Michael/A-8964-2010; Polgar, Noemi/B-3948-2013; Zimprich, Alexander/A-5232-2017; Heath, Simon C/J-4138-2012; KUČINSKAS, Vaidutis/A-4798-2013; Toniolo, Daniela/AAE-2969-2019; Pfeufer, Arne/B-6634-2013; Mägi, Reedik/AAJ-9679-2021; Zimprich, Fritz/W-1738-2017; d'Adamo, Adamo Pio/G-4064-2011	Antonarakis, Stylianos E/0000-0001-8907-5823; Karachanak-Yankova, Sena/0000-0001-6441-629X; Nelis, Mari/0000-0001-9748-1020; rabionet, raquel/0000-0001-5006-8140; Rabionet, Raquel/0000-0001-5006-8140; Remm, Maido/0000-0003-3966-8422; Limborska, Svetlana/0000-0002-1697-6820; Zimprich, Fritz/0000-0002-6998-5480; Estivill, Xavier/0000-0002-0723-2256; Krawczak, Michael/0000-0003-2603-1502; Zimprich, Alexander/0000-0002-1668-5177; Heath, Simon C/0000-0002-9550-0897; Toniolo, Daniela/0000-0001-9545-6032; Zimprich, Fritz/0000-0002-6998-5480; d'Adamo, Adamo Pio/0000-0001-9367-4909; Magi, Reedik/0000-0002-2964-6011; Polgar, Noemi/0000-0002-8400-162X; Meitinger, Thomas/0000-0002-8838-8403; Julia Cano, Antonio/0000-0001-6064-3620; Gasparini, Paolo/0000-0002-0859-0856; Deutsch, Samuel/0000-0001-9456-7101; Venkatasubramanian, Siddharth/0000-0002-5860-0768; marsal, sara/0000-0001-5515-3854; Klovins, Janis/0000-0001-8362-5505; s, hema/0000-0002-3440-9475; Toncheva, Draga/0000-0002-7451-6363; Esko, Tonu/0000-0003-1982-6569; Lubinski, Jan/0000-0003-2931-3003				Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barbujani G, 2004, ANNU REV GENOM HUM G, V5, P119, DOI 10.1146/annurev.genom.5.061903.180021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	35	234	239	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5472	10.1371/journal.pone.0005472	http://dx.doi.org/10.1371/journal.pone.0005472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424496	Green Submitted, Green Published, gold			2022-12-27	WOS:000265933800011
J	Smith, CE; Tucker, KL; Scott, TM; Van Rompay, M; Mattei, J; Lai, CQ; Parnell, LD; Junyent, M; Lee, YC; Garcia-Bailo, B; Ordovas, JM				Smith, Caren E.; Tucker, Katherine L.; Scott, Tammy M.; Van Rompay, Maria; Mattei, Josiemer; Lai, Chao-Qiang; Parnell, Laurence D.; Junyent, Mireia; Lee, Yu-Chi; Garcia-Bailo, Bibiana; Ordovas, Jose M.			Apolipoprotein C3 Polymorphisms, Cognitive Function and Diabetes in Caribbean Origin Hispanics	PLOS ONE			English	Article								Background: Apolipoprotein C3 (APOC3) modulates triglyceride metabolism through inhibition of lipoprotein lipase, but is itself regulated by insulin, so that APOC3 represents a potential mechanism by which glucose metabolism may affect lipid metabolism. Unfavorable lipoprotein profiles and impaired glucose metabolism are linked to cognitive decline, and all three conditions may decrease lifespan. Associations between apolipoprotein C3 (APOC3) gene polymorphisms and impaired lipid and glucose metabolism are well-established, but potential connections between APOC3 polymorphisms, cognitive decline and diabetes deserve further attention. Methods: We examined whether APOC3 single nucleotide polymorphisms (SNPs) m482 (rs2854117) and 3u386 (rs5128) were related to cognitive measures, whether the associations between cognitive differences and genotype were related to metabolic differences, and how diabetes status affected these associations. Study subjects were Hispanics of Caribbean origin (n = 991, aged 45-74) living in the Boston metropolitan area. Results: Cognitive and metabolic measures differed substantially by type II diabetes status. In multivariate regression models, APOC3 m482 AA subjects with diabetes exhibited lower executive function (P = 0.009), Stroop color naming score (P = 0.014) and Stroop color-word score (P = 0.022) compared to AG/GG subjects. APOC3 m482 AA subjects with diabetes exhibited significantly higher glucose (P = 0.032) and total cholesterol (P = 0.028) compared to AG/GG subjects. APOC3 3u386 GC/GG subjects with diabetes exhibited significantly higher triglyceride (P = 0.004), total cholesterol (P = 0.003) and glucose (P = 0.016) compared to CC subjects. Conclusions: In summary, we identified significant associations between APOC3 polymorphisms, impaired cognition and metabolic dysregulation in Caribbean Hispanics with diabetes. Further research investigating these relationships in other populations is warranted.			Smith, CE (corresponding author), Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept, Boston, MA 02111 USA.	jose.ordovas@tufts.edu	Mattei, Josiemer/H-1800-2016; Tucker, Katherine L/A-4545-2010; Van Rompay, Maria/G-9452-2012; Ordovas, Jose/B-8727-2013	Mattei, Josiemer/0000-0001-5424-8245; Lai, Chao-Qiang/0000-0003-1107-8375; Tucker, Katherine/0000-0001-7640-662X; Parnell, Laurence/0000-0001-9718-1335; Ordovas, Jose/0000-0002-7581-5680	NHLBI NIH HHS [R01 HL054776, HL54776, T32 HL069772] Funding Source: Medline; NIA NIH HHS [5P01AG023394, P01 AG023394] Funding Source: Medline; NIDDK NIH HHS [DK075030, R01 DK075030, T32 DK007651-19, DK007651-19, T32 DK062032, T32 DK007651] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776, T32HL069772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062032, T32DK007651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG023394] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altomonte J, 2004, J CLIN INVEST, V114, P1493, DOI 10.1172/JCI200419992; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Atzmon G, 2002, J GERONTOL A-BIOL, V57, pM712, DOI 10.1093/gerona/57.11.M712; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65; Brown CM, 2006, J MOL MED, V84, P561, DOI 10.1007/s00109-005-0037-x; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Dallinga-Thie GM, 2001, J LIPID RES, V42, P1450; Falush D, 2003, GENETICS, V164, P1567; FU YX, 1993, GENETICS, V133, P693; Gervaise N, 2000, DIABETOLOGIA, V43, P703, DOI 10.1007/s001250051366; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Hallman DM, 2006, METABOLISM, V55, P1574, DOI 10.1016/j.metabol.2006.07.018; HAVILAND MB, 1991, AM J HUM GENET, V49, P350; Hong SH, 1997, CLIN CHEM, V43, P13; HOULDEN H, 1995, NEUROSCI LETT, V188, P202, DOI 10.1016/0304-3940(95)11422-S; Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253; Kawakami A, 2006, CIRCULATION, V114, P681, DOI 10.1161/CIRCULATIONAHA.106.622514; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Ko YL, 1997, HUM GENET, V100, P327, DOI 10.1007/s004390050511; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; MOSS SE, 1991, AM J PUBLIC HEALTH, V81, P1158, DOI 10.2105/AJPH.81.9.1158; Muendlein A, 2008, ATHEROSCLEROSIS, V199, P179, DOI 10.1016/j.atherosclerosis.2007.10.030; ORDOVAS JM, 1991, ATHEROSCLEROSIS, V87, P75, DOI 10.1016/0021-9150(91)90234-T; Paolisso G, 2001, EXP GERONTOL, V37, P149, DOI 10.1016/S0531-5565(01)00148-6; Perez-Jimenez F, 2002, DIABETOLOGIA, V45, P1196, DOI 10.1007/s00125-002-0884-8; Pollex RL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-80; Qi L, 2007, ATHEROSCLEROSIS, V192, P204, DOI 10.1016/j.atherosclerosis.2006.05.006; ROGERS RL, 1989, ANGIOLOGY, V40, P260, DOI 10.1177/000331978904000404; Schupf N, 2004, NEUROBIOL AGING, V25, P1231, DOI 10.1016/j.neurobiolaging.2003.11.010; Sun Y, 2005, NEUROSCI LETT, V380, P219, DOI 10.1016/j.neulet.2005.01.038; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Wang J, 2008, AM J HUM GENET, V83, P53, DOI 10.1016/j.ajhg.2008.06.010; Waterworth DM, 2001, DIABETOLOGIA, V44, P245, DOI 10.1007/s001250051607	38	15	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5465	10.1371/journal.pone.0005465	http://dx.doi.org/10.1371/journal.pone.0005465			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424489	Green Published, Green Submitted, gold			2022-12-27	WOS:000265933800003
J	Kashiwagi, T; Leung, BW; Deng, T; Chen, HL; Brownlee, GG				Kashiwagi, Takahito; Leung, Bo Wah; Deng, Tao; Chen, Hualan; Brownlee, George G.			The N-Terminal Region of the PA Subunit of the RNA Polymerase of Influenza A/HongKong/156/97 (H5N1) Influences Promoter Binding	PLOS ONE			English	Article							SINGLE AMINO-ACID; A VIRUS; HEMAGGLUTININ GENE; COMPLETE SEQUENCE; MESSENGER-RNA; CAP-BINDING; REPLICATION; PROTEIN; PB2; TRANSCRIPTION	Background: The RNA polymerase of influenza virus is a heterotrimeric complex of PB1, PB2 and PA subunits which cooperate in the transcription and replication of the viral genome. Previous research has shown that the N-terminal region of the PA subunit of influenza A/WSN/33 (H1N1) virus is involved in promoter binding. Methodology/Principal Findings: Here we extend our studies of the influenza RNA polymerase to that of influenza strains A/HongKong/156/97 (H5N1) and A/Vietnam/1194/04 (H5N1). Both H5N1 strains, originally isolated from patients in 1997 and 2004, showed significantly higher polymerase activity compared with two classical human strains, A/WSN/33 (H1N1) and A/NT/60/68 (H3N2) in vitro. This increased polymerase activity correlated with enhanced promoter binding. The N-terminal region of the PA subunit was the major determinant of this enhanced promoter activity. Conclusions/Significance: Overall we suggest that the N-terminal region of the PA subunit of two recent H5N1 strains can influence promoter binding and we speculate this may be a factor in their virulence.			Kashiwagi, T (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	george.brownlee@path.ox.ac.uk			MRC [G9523972] Funding Source: UKRI; Medical Research Council [G9523972, G9901312] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BISHOP DHL, 1982, VIROLOGY, V120, P481, DOI 10.1016/0042-6822(82)90049-6; BISHOP DHL, 1982, NUCLEIC ACIDS RES, V10, P1335, DOI 10.1093/nar/10.4.1335; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Brownlee GG, 2002, J VIROL, V76, P7103, DOI 10.1128/JVI.76.14.7103-7113.2002; Chan AY, 2006, VIROLOGY, V351, P210, DOI 10.1016/j.virol.2006.03.005; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; DE BK, 1988, NUCLEIC ACIDS RES, V16, P4181, DOI 10.1093/nar/16.9.4181; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Deng T, 2006, J GEN VIROL, V87, P3373, DOI 10.1099/vir.0.82199-0; DIAS A, 2009, NATURE IN PRESS; Fan SF, 2009, VIROLOGY, V384, P28, DOI 10.1016/j.virol.2008.11.044; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Fodor E, 2002, PERSP MED V, V7, P1; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hiromoto Y, 2000, VIROLOGY, V272, P429, DOI 10.1006/viro.2000.0371; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Ito T, 2000, J VIROL, V74, P9300, DOI 10.1128/JVI.74.19.9300-9305.2000; JONES KL, 1983, NUCLEIC ACIDS RES, V11, P1555, DOI 10.1093/nar/11.5.1555; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Li Y, 2006, ARCH VIROL, V151, P1615, DOI 10.1007/s00705-006-0738-7; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 2007, ANTIVIR THER, V12, P617; Ortin J, 2006, ANNU REV MICROBIOL, V60, P305, DOI 10.1146/annurev.micro.60.080805.142248; Palese P., 2007, FIELDS VIROLOGY, P1647; Perales B, 2000, J VIROL, V74, P1307, DOI 10.1128/JVI.74.3.1307-1312.2000; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; PLOTCH SJ, 1979, P NATL ACAD SCI USA, V76, P1618, DOI 10.1073/pnas.76.4.1618; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; TREANOR J, 1994, J VIROL, V68, P7684, DOI 10.1128/JVI.68.12.7684-7688.1994; Uyeki TM, 2008, RESPIROLOGY, V13, pS2, DOI 10.1111/j.1440-1843.2008.01246.x; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Webster RG, 2002, J VIROL, V76, P118, DOI 10.1128/JVI.76.1.118-126.2002; WOOD GW, 1993, ARCH VIROL, V130, P209, DOI 10.1007/BF01319010; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; YUAN P, 2009, NATURE IN PRESS	66	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5473	10.1371/journal.pone.0005473	http://dx.doi.org/10.1371/journal.pone.0005473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421324	Green Published, gold, Green Submitted			2022-12-27	WOS:000265837000008
J	Liu, TT; Lin, YH; Hung, CS; Liu, TJ; Chen, Y; Huang, YC; Tsai, TH; Wang, HH; Wang, DW; Wang, JK; Wang, YL; Lin, CH				Liu, Ting-Ting; Lin, You-Hsuan; Hung, Chia-Sui; Liu, Tian-Jiun; Chen, Yu; Huang, Yung-Ching; Tsai, Tsung-Heng; Wang, Huai-Hsien; Wang, Da-Wei; Wang, Juen-Kai; Wang, Yuh-Lin; Lin, Chi-Hung			A High Speed Detection Platform Based on Surface-Enhanced Raman Scattering for Monitoring Antibiotic-Induced Chemical Changes in Bacteria Cell Wall	PLOS ONE			English	Article							GROWTH-PHASE; SERS; DISCRIMINATION; NANOPARTICLES; SPECTRA	Rapid and accurate diagnosis for pathogens and their antibiotic susceptibility is critical for controlling bacterial infections. Conventional methods for determining bacterium's sensitivity to antibiotic depend mostly on measuring the change of microbial proliferation in response to the drug. Such "biological assay'' inevitably takes time, ranging from days for fast-growing bacteria to weeks for slow-growers. Here, a novel tool has been developed to detect the "chemical features'' of bacterial cell wall that enables rapid identification of drug resistant bacteria within hours. The surface-enhanced Raman scattering (SERS) technique based on our newly developed SERS-active substrate was applied to assess the fine structures of the bacterial cell wall. The SERS profiles recorded by such a platform are sensitive and stable, that could readily reflect different bacterial cell walls found in Gram-positive, Gram-negative, or mycobacteria groups. Moreover, characteristic changes in SERS profile were noticed in the drug-sensitive bacteria at the early period (i.e., similar to 1 hr) of antibiotic exposure, which could be used to differentiate them from the drug-resistant ones. The SERS-based diagnosis could be applied to a single bacterium. The high-speed SERS detection represents a novel approach for microbial diagnostics. The single-bacterium detection capability of SERS makes possible analyses directly on clinical specimen instead of pure cultured bacteria.			Liu, TT (corresponding author), Natl Yang Ming Univ, Div Res & Dev, Taipei 112, Taiwan.	jkwang@ntu.edu.tw; ylwnag@pub.iams.sinica.edu.tw; linch@ym.edu.tw	Wang, Juen-Kai/F-7932-2012; Wang, Yuh-Lin/F-7910-2012	Wang, Yuh-Lin/0000-0001-5920-3468; Tsai, Tsung-Heng/0000-0001-5211-2985				Efrima S, 1998, J PHYS CHEM B, V102, P5947, DOI 10.1021/jp9813903; Franklin T.J., 2005, BIOCH MOL BIOL ANTIM; GLASER L, 1977, J BACTERIOL, V130, P610, DOI 10.1128/JB.130.2.610-619.1977; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jarvis RM, 2006, FARADAY DISCUSS, V132, P281, DOI 10.1039/b506413a; Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c; Jiang W, 2004, LANGMUIR, V20, P11433, DOI 10.1021/la049043+; Kahraman M, 2007, APPL SPECTROSC, V61, P479, DOI 10.1366/000370207780807731; Kennedy BJ, 1999, J PHYS CHEM B, V103, P3640, DOI 10.1021/jp984454i; KNEIP K, 2006, PHYS APPL TOPICS APP, V103, P1; Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050; Naja G, 2007, ANALYST, V132, P679, DOI 10.1039/b701160a; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n; PREMASIRI WR, 2005, VIBRATIONAL FINGERPR; Rolain JM, 2004, J ANTIMICROB CHEMOTH, V54, P538, DOI 10.1093/jac/dkh324; Sengupta A, 2005, APPL SPECTROSC, V59, P1016, DOI 10.1366/0003702054615124; SFRIMA S, 2008, J RAMAN SPECTROSC, V40, P277; SHOCKMAN GD, 1958, J BIOL CHEM, V230, P961; Szeghalmi A, 2007, J PHYS CHEM B, V111, P12916, DOI 10.1021/jp075422a; Walker SL, 2005, APPL ENVIRON MICROB, V71, P3093, DOI 10.1128/AEM.71.6.3093-3099.2005; Wang HH, 2006, ADV MATER, V18, P491, DOI 10.1002/adma.200501875	22	143	151	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5470	10.1371/journal.pone.0005470	http://dx.doi.org/10.1371/journal.pone.0005470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421405	Green Published, gold, Green Submitted			2022-12-27	WOS:000265837000006
J	Ahmed, N				Ahmed, Niyaz			A Flood of Microbial Genomes-Do We Need More?	PLOS ONE			English	Editorial Material											Ahmed, N (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India.	ahmed.nizi@gmail.com	Ahmed, Niyaz/D-2589-2010	Ahmed, Niyaz/0000-0001-6425-7583				Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Alvi A, 2007, J CLIN MICROBIOL, V45, P4039, DOI 10.1128/JCM.01631-07; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Craddock T, 2008, NAT REV MICROBIOL, V6, P948, DOI 10.1038/nrmicro2031; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; Ge ZM, 1999, ANNU REV MICROBIOL, V53, P353, DOI 10.1146/annurev.micro.53.1.353; Green P, 2007, GENOME RES, V17, P1547, DOI 10.1101/gr.7050807; Hugenholtz P, 2002, GENOME BIOL, V3; Inda Marcia A, 2008, BMC Res Notes, V1, P63, DOI 10.1186/1756-0500-1-63; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Kohler J, 2006, BIOINFORMATICS, V22, P1383, DOI 10.1093/bioinformatics/btl081; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Prouzet-Mauleon V, 2005, J CLIN MICROBIOL, V43, P4237, DOI 10.1128/JCM.43.8.4237-4241.2005; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Suen G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000743; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; TSOLIS RM, 2009, PLOS ONE IN PRESS; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Yamaoka Y, 2008, J MED MICROBIOL, V57, P545, DOI 10.1099/jmm.0.2008/000570-0	29	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5831	10.1371/journal.pone.0005831	http://dx.doi.org/10.1371/journal.pone.0005831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513110	Green Submitted, gold, Green Published			2022-12-27	WOS:000267228800004
J	Cheung, JK; Awad, MM; McGowan, S; Rood, JI				Cheung, Jackie K.; Awad, Milena M.; McGowan, Sheena; Rood, Julian I.			Functional Analysis of the VirSR Phosphorelay from Clostridium perfringens	PLOS ONE			English	Article							EXTRACELLULAR TOXIN PRODUCTION; RESPONSE REGULATOR; ALPHA-TOXIN; ESCHERICHIA-COLI; PERFRINGOLYSIN-O; VIRR/VIRS SYSTEM; GENOME SEQUENCE; VIRULENCE GENES; THETA-TOXIN; DNA-BINDING	Toxin production in Clostridium perfringens is controlled by the VirSR two-component signal transduction system, which comprises the VirS sensor histidine kinase and the VirR response regulator. Other studies have concentrated on the elucidation of the genes controlled by this network; there is little information regarding the phosphorelay cascade that is the hallmark of such regulatory systems. In this study, we have examined each step in this cascade, beginning with autophosphorylation of VirS, followed by phosphotransfer from VirS to VirR. We also have studied the effects of gene dosage and phosphorylation in vivo. We have used random and site-directed mutagenesis to identify residues in VirS that are important for its function and have identified a region in the putative sensory domain of VirS that appeared to be essential for function. In vitro phosphorylation studies showed that VirSc, a truncated VirS protein that lacked the N-terminal sensory domain, was capable of autophosphorylation and could subsequently act as a phosphodonor for its cognate response regulator, VirR. Conserved residues of both VirS and VirR, including the D57 residue of VirR, were shown to be essential for this process. By use of Targetron technology, we were able to introduce a single copy of virR or virRD57N onto the chromosome of a virR mutant of C. perfringens. The results showed that in vivo, when virR was present in single copy, the production of wild-type levels of perfringolysin O was dependent on the presence of virS and an unaltered D57 residue in VirR. These results provide good evidence that phosphorylation is critical for VirR function.			Cheung, JK (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	julian.rood@med.monash.edu.au	McGowan, Sheena/C-4797-2014; Rood, Julian I/A-4858-2008	McGowan, Sheena/0000-0001-6863-1106; Rood, Julian I/0000-0003-2126-7209; Awad, Milena/0000-0002-9275-3979				AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Awad MM, 2001, INFECT IMMUN, V69, P7904, DOI 10.1128/IAI.69.12.7904-7910.2001; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; Banu S, 2000, MOL MICROBIOL, V35, P854, DOI 10.1046/j.1365-2958.2000.01760.x; BaThein W, 1996, J BACTERIOL, V178, P2514, DOI 10.1128/jb.178.9.2514-2520.1996; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; BOUCHER PE, 1995, J BACTERIOL, V177, P6486, DOI 10.1128/jb.177.22.6486-6491.1995; BOUCHER PE, 1994, J MOL BIOL, V241, P363, DOI 10.1006/jmbi.1994.1513; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Cheung Jackie K., 2005, P545, DOI 10.1201/9780203489819.pt4; Cheung JK, 2000, J BACTERIOL, V182, P57, DOI 10.1128/JB.182.1.57-66.2000; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; Cheung JK, 2000, MICROBIOL-UK, V146, P517, DOI 10.1099/00221287-146-2-517; Cho HS, 2001, CURR OPIN STRUC BIOL, V11, P679, DOI 10.1016/S0959-440X(01)00271-8; Czeczulin JR, 1996, INFECT IMMUN, V64, P3301, DOI 10.1128/IAI.64.8.3301-3309.1996; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; Da Re SS, 1999, FEBS LETT, V457, P323, DOI 10.1016/S0014-5793(99)01057-1; DARE S, 1994, NUCLEIC ACIDS RES, V22, P1555; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dutta R, 1996, J BIOL CHEM, V271, P1424, DOI 10.1074/jbc.271.3.1424; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Ellemor DM, 1999, INFECT IMMUN, V67, P4902, DOI 10.1128/IAI.67.9.4902-4907.1999; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; HIGASHI Y, 1973, BIKEN J, V16, P1; Hirschman A, 2001, BIOCHEMISTRY-US, V40, P13876, DOI 10.1021/bi0113622; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; IMAGAWA T, 1981, BIKEN J, V24, P13; IMAGAWA T, 1992, MICROBIOL IMMUNOL, V36, P523, DOI 10.1111/j.1348-0421.1992.tb02050.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kawsar HI, 2004, FEMS MICROBIOL LETT, V235, P289, DOI 10.1016/j.femsle.2004.04.047; Kim SB, 2001, FEMS MICROBIOL LETT, V195, P179, DOI 10.1111/j.1574-6968.2001.tb10518.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Mayover TL, 1999, BIOCHEMISTRY-US, V38, P2259, DOI 10.1021/bi981707p; McGowan S, 2002, J MOL BIOL, V322, P997, DOI 10.1016/S0022-2836(02)00850-1; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morelle G, 1989, FOCUS, V11, P7; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Ohtani K, 2000, MICROBIOL IMMUNOL, V44, P525, DOI 10.1111/j.1348-0421.2000.tb02528.x; Ohtani K, 2003, FEMS MICROBIOL LETT, V222, P137, DOI 10.1016/S0378-1097(03)00255-6; OHTANI K, 2009, J BACTERIOL     0410; Okumura K, 2005, FEMS MICROBIOL LETT, V242, P281, DOI 10.1016/j.femsle.2004.11.019; Okumura K, 2008, J BACTERIOL, V190, P7719, DOI 10.1128/JB.01573-07; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Qi Y, 1998, MOL MICROBIOL, V28, P1187, DOI 10.1046/j.1365-2958.1998.00882.x; ROBERTS I, 1986, APPL ENVIRON MICROB, V52, P197, DOI 10.1128/AEM.52.1.197-199.1986; ROOD JI, 1978, ANTIMICROB AGENTS CH, V13, P871, DOI 10.1128/AAC.13.5.871; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; ROOD JI, 1983, CAN J MICROBIOL, V29, P1241, DOI 10.1139/m83-193; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCOTT PT, 1989, GENE, V82, P327, DOI 10.1016/0378-1119(89)90059-0; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Shimizu T, 2002, J BACTERIOL, V184, P2587, DOI 10.1128/JB.184.10.2587-2594.2002; SHIMIZU T, 1994, J BACTERIOL, V176, P1616, DOI 10.1128/jb.176.6.1616-1623.1994; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; SLOAN J, 1992, PLASMID, V27, P207, DOI 10.1016/0147-619X(92)90023-4; Songer J. Glenn, 2005, P527; Stevens DL, 1997, J INFECT DIS, V176, P189, DOI 10.1086/514022; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wolanin PM, 2002, GENOME BIOL, V3; Zhang JH, 2003, BIOCHEMISTRY-US, V42, P2552, DOI 10.1021/bi0272205	68	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5849	10.1371/journal.pone.0005849	http://dx.doi.org/10.1371/journal.pone.0005849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513115	Green Submitted, gold, Green Published			2022-12-27	WOS:000267228800014
J	Rattinger, G; Bero, L				Rattinger, Gail; Bero, Lisa			Factors Associated with Results and Conclusions of Trials of Thiazolidinediones	PLOS ONE			English	Article								Background: When a sponsor funds a study of two competing drugs in a head-to-head comparison, the results and conclusions are likely to favor the sponsor's drug. Thiazolidinediones, oral medications used for the treatment of type 2 diabetes, are one of the most costly choices of oral anti-diabetic medications, yet they do not demonstrate clinically relevant differences in achieving lower glycosylated hemoglobin levels compared to other oral antidiabetic drugs. Our aim is to examine associations between research funding source, study design characteristics aimed at reducing bias, and other factors with the results and conclusions of randomized controlled trials (RCTs) of thiazolidinediones compared to other oral hypoglycemic agents. Methods and Findings: This is a cross-sectional study of 61 published RCTs comparing a thiazolidinedione (glitazone) to another anti-diabetic drug or placebo for treatment of type 2 diabetes. Data on study design characteristics, funding source, author's financial ties, results for primary outcomes, and author conclusions were extracted. Univariate logistic regression identified associations between independent variables and results and conclusions that favored the glitazone. Of the RCTs, 59% (36/61) were funded by industry, 39% (24/61) did not disclose any funding. Common study design weaknesses included inadequate blinding and lack of concealment of allocation. Trials that reported favorable glycemic control results for the glitazone were more likely to have adequate blinding (OR (95% CI) = 5.42 (1.46, 21.19), p = 0.008) and have a corresponding author with financial ties to the glitazone manufacturer (OR (95% CI) = 4.12 (1.05, 19.53); p = 0.04). Trials with conclusions favoring the glitazone were less likely to be funded by a comparator drug company than a glitazone company (OR (95% CI) = 0.026 (0, 0.40), p = 0.003) and less likely to be published in journals with higher impact factors (OR (95% CI) = 0.79 (0.62, 0.97), p = 0.011). One limitation of our study is that we categorized studies as funded by industry based on each article's disclosure which could underestimate the number of industry sponsored studies and personal ties of investigators. Additionally, our study did not include any head-to-head comparisons of one glitazone to another. Conclusions: Published RCT comparisons of glitazones with other anti-diabetic drugs or placebo are predominantly industry supported and this support, as well as the financial ties of study authors, appears to be associated with favorable findings.			Rattinger, G (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA.	berol@pharmacy.ucsf.edu		Boutron, Isabelle/0000-0002-5263-6241; Bero, Lisa/0000-0003-1893-6651				Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Buchkowsky SS, 2004, ANN PHARMACOTHER, V38, P579, DOI 10.1345/aph.1D267; *CDC, 2007, NAT DIAB SURV SYST; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1401, DOI 10.1001/jama.263.10.1401; CHALMERS TC, 1972, NEW ENGL J MED, V287, P75, DOI 10.1056/NEJM197207132870205; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Derosa G, 2005, J INT MED RES, V33, P284, DOI 10.1177/147323000503300303; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Hanefeld M, 2004, DIABETES CARE, V27, P141, DOI 10.2337/diacare.27.1.141; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; *HHS, 2007, REZ WITHDR MARK; Holmboe ES, 2002, JAMA-J AM MED ASSOC, V287, P373, DOI 10.1001/jama.287.3.373; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Ioannidis JPA, 1997, CONTROL CLIN TRIALS, V18, P431, DOI 10.1016/S0197-2456(97)00097-4; Ioannidis JPA, 2003, EUR J CANCER, V39, P2278, DOI 10.1016/S0959-8049(03)00571-9; Isa SHM, 2006, DIABETES RES CLIN PR, V72, P48, DOI 10.1016/j.diabres.2005.09.011; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Ko GTC, 2006, ADV THER, V23, P799, DOI 10.1007/BF02850321; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Lawrence JM, 2004, DIABETES CARE, V27, P41, DOI 10.2337/diacare.27.1.41; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Matthews DR, 2005, DIABETES-METAB RES, V21, P167, DOI 10.1002/dmrr.478; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; Nathan DM, 2002, NEW ENGL J MED, V347, P1342, DOI 10.1056/NEJMcp021106; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; Perriello G, 2006, DIABETIC MED, V23, P246, DOI 10.1111/j.1464-5491.2006.01801.x; Ramachandran A, 2004, J Assoc Physicians India, V52, P459; Richter B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006060.pub2; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063; Saad MF, 2004, DIABETES CARE, V27, P1324, DOI 10.2337/diacare.27.6.1324; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Umpierrez G, 2006, CURR MED RES OPIN, V22, P751, DOI 10.1185/030079906X104786; Yamanouchi T, 2005, DIABETIC MED, V22, P980, DOI 10.1111/j.1464-5491.2005.01656.x; Yu Dahong, 2006, Diab Vasc Dis Res, V3, P189, DOI 10.3132/dvdr.2006.029; 2008, PIOGLITAZONE FULL PR; 2007, ROSIGLITAZONE FULL P	44	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5826	10.1371/journal.pone.0005826	http://dx.doi.org/10.1371/journal.pone.0005826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503811	gold, Green Published, Green Submitted			2022-12-27	WOS:000266717400006
J	Cotterman, R; Knoepfler, PS				Cotterman, Rebecca; Knoepfler, Paul S.			N-Myc Regulates Expression of Pluripotency Genes in Neuroblastoma Including lif, klf2, klf4, and lin28b	PLOS ONE			English	Article							CELL SELF-RENEWAL; C-MYC; GENOMIC TARGETS; GROWTH; LETHALITY; REVEALS; SITES	myc genes are best known for causing tumors when overexpressed, but recent studies suggest endogenous myc regulates pluripotency and self-renewal of stem cells. For example, N-myc is associated with a number of tumors including neuroblastoma, but also plays a central role in the function of normal neural stem and precursor cells (NSC). Both c- and N-myc also enhance the production of induced pluripotent stem cells (iPSC) and are linked to neural tumor stem cells. The mechanisms by which myc regulates normal and neoplastic stem-related functions remain largely open questions. Here from a global, unbiased search for N-Myc bound genes using ChIP-chip assays in neuroblastoma, we found lif as a putative N-Myc bound gene with a number of strong N-Myc binding peaks in the promoter region enriched for E-boxes. Amongst putative N-Myc target genes in expression microarray studies in neuroblastoma we also found lif and three additional important embryonic stem cell (ESC)-related factors that are linked to production of iPSC: klf2, klf4, and lin28b. To examine the regulation of these genes by N-Myc, we measured their expression using neuroblastoma cells that contain a Tetregulatable N-myc transgene (TET21N) as well as NSC with a nestin-cre driven N-myc knockout. N-myc levels closely correlated with the expression of all of these genes in neuroblastoma and all but lif in NSC. Direct ChIP assays also indicate that N-Myc directly binds the lif promoter. N-Myc regulates trimethylation of lysine 4 of histone H3 in the promoter of lif and possibly in the promoters of several other stem-related genes. Together these findings indicate that N-Myc regulates overlapping stem-related gene expression programs in neuroblastoma and NSC, supporting a novel model by which amplification of the N-myc gene may drive formation of neuroblastoma. They also suggest mechanisms by which Myc proteins more generally contribute to maintenance of pluripotency and self-renewal of ESC as well as to iPSC formation.			Cotterman, R (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Shriners Hosp Children No Calif, Sacramento, CA 95817 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	NATIONAL CANCER INSTITUTE [K01CA114400] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA114400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; HANNA J, 2008, COLD SPRING HARB S Q; Hatton B, 2006, CANCER RES, V66, P1; Hatzi E, 2002, EUR J BIOCHEM, V269, P3732, DOI 10.1046/j.1432-1033.2002.03066.x; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lutz W, 1996, ONCOGENE, V13, P803; Martins RAP, 2008, GENE DEV, V22, P179, DOI 10.1101/gad.1608008; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Orian A, 2005, COLD SH Q B, V70, P299, DOI 10.1101/sqb.2005.70.019; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pitman M, 2004, MOL CELL NEUROSCI, V27, P255, DOI 10.1016/j.mcn.2004.07.004; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	40	64	66	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5799	10.1371/journal.pone.0005799	http://dx.doi.org/10.1371/journal.pone.0005799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495417	Green Submitted, Green Published, gold			2022-12-27	WOS:000266716900009
J	Hu, VW; Nguyen, A; Kim, KS; Steinberg, ME; Sarachana, T; Scully, MA; Soldin, SJ; Luu, T; Lee, NH				Hu, Valerie W.; Nguyen, AnhThu; Kim, Kyung Soon; Steinberg, Mara E.; Sarachana, Tewarit; Scully, Michele A.; Soldin, Steven J.; Luu, Truong; Lee, Norman H.			Gene Expression Profiling of Lymphoblasts from Autistic and Nonaffected Sib Pairs: Altered Pathways in Neuronal Development and Steroid Biosynthesis	PLOS ONE			English	Article							DOPAMINE-BETA-HYDROXYLASE; LEMLI-OPITZ-SYNDROME; CENTRAL-NERVOUS-SYSTEM; CHAIN FATTY-ACIDS; FACTOR-KAPPA-B; SPECTRUM DISORDERS; GASTROINTESTINAL SYMPTOMS; CELL-LINES; CYTOKINE PRODUCTION; FETAL TESTOSTERONE	Despite the identification of numerous autism susceptibility genes, the pathobiology of autism remains unknown. The present "case-control'' study takes a global approach to understanding the molecular basis of autism spectrum disorders based upon large-scale gene expression profiling. DNA microarray analyses were conducted on lymphoblastoid cell lines from over 20 sib pairs in which one sibling had a diagnosis of autism and the other was not affected in order to identify biochemical and signaling pathways which are differentially regulated in cells from autistic and nonautistic siblings. Bioinformatics and gene ontological analyses of the data implicate genes which are involved in nervous system development, inflammation, and cytoskeletal organization, in addition to genes which may be relevant to gastrointestinal or other physiological symptoms often associated with autism. Moreover, the data further suggests that these processes may be modulated by cholesterol/steroid metabolism, especially at the level of androgenic hormones. Elevation of male hormones, in turn, has been suggested as a possible factor influencing susceptibility to autism, which affects similar to 4 times as many males as females. Preliminary metabolic profiling of steroid hormones in lymphoblastoid cell lines from several pairs of siblings reveals higher levels of testosterone in the autistic sibling, which is consistent with the increased expression of two genes involved in the steroidogenesis pathway. Global gene expression profiling of cultured cells from ASD probands thus serves as a window to underlying metabolic and signaling deficits that may be relevant to the pathobiology of autism.			Hu, VW (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmvwh@gwumc.edu	Kim, Joanna/U-5556-2018	Kim, Joanna/0000-0001-7877-9446; Steinberg Lowe, Mara/0000-0002-3129-0755; Hu, Valerie/0000-0002-3357-0777	NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073393] Funding Source: NIH RePORTER; NIMH NIH HHS [R21 MH073393-01A2, R21 MH073393-02, R21 MH073393] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANTON ES, 1995, J NEUROSCI, V15, P584; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BANERJEE SA, 1995, MOL CELL NEUROSCI, V6, P462, DOI 10.1006/mcne.1995.1034; Baron CA, 2006, J AUTISM DEV DISORD, V36, P973, DOI 10.1007/s10803-006-0134-x; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; Chuan Y, 2005, INT J ANDROL, V28, P291, DOI 10.1111/j.1365-2605.2005.00552.x; Cohly HHP, 2005, INT REV NEUROBIOL, V71, P317, DOI 10.1016/S0074-7742(05)71013-8; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Corbett BA, 2006, PSYCHONEUROENDOCRINO, V31, P59, DOI 10.1016/j.psyneuen.2005.05.011; Croonenberghs J, 2002, NEUROPSYCHOBIOLOGY, V45, P1, DOI 10.1159/000048665; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ellis JA, 2001, CLIN EXP PHARMACOL P, V28, P1053, DOI 10.1046/j.1440-1681.2001.03579.x; Fatemi SH, 2001, J AUTISM DEV DISORD, V31, P529, DOI 10.1023/A:1013234708757; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Ford GD, 2008, BIOCHEM BIOPH RES CO, V377, P556, DOI 10.1016/j.bbrc.2008.10.033; Freeman SJ, 2005, DIABETES CARE, V28, P925, DOI 10.2337/diacare.28.4.925; GARNIER C, 1986, J AUTISM DEV DISORD, V16, P23, DOI 10.1007/BF01531575; Geier DA, 2007, NEUROENDOCRINOL LETT, V28, P565; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Guo TD, 2006, CLIN CHIM ACTA, V372, P76, DOI 10.1016/j.cca.2006.03.034; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Hallmayer J, 2002, AM J HUM GENET, V71, P941, DOI 10.1086/342990; Herbert MR, 2006, NEUROTOXICOLOGY, V27, P671, DOI 10.1016/j.neuro.2006.03.017; Hong SJ, 2008, NEUROCHEM RES, V33, P1821, DOI 10.1007/s11064-008-9639-3; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Horvath Karoly, 2002, Curr Gastroenterol Rep, V4, P251, DOI 10.1007/s11894-002-0071-6; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Iafusco D, 2006, DIABETES CARE, V29, P1985, DOI 10.2337/dc06-0842; Ingram JL, 2000, TERATOLOGY, V62, P393, DOI 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M; Ingudomnuku E, 2007, HORM BEHAV, V51, P597, DOI 10.1016/j.yhbeh.2007.02.001; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2002, MOL PSYCHIATR, V7, P302, DOI 10.1038/sj.mp.4000979; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Jones MB, 2004, AM J MED GENET B, V126B, P58, DOI 10.1002/ajmg.b.20172; Jyonouchi H, 2005, NEUROPSYCHOBIOLOGY, V51, P77, DOI 10.1159/000084164; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Kagawa T, 1997, J NEUROSCI RES, V50, P312, DOI 10.1002/(SICI)1097-4547(19971015)50:2<312::AID-JNR19>3.0.CO;2-9; KALIMI M, 1994, MOL CELL BIOCHEM, V131, P99, DOI 10.1007/BF00925945; Kelley R I, 2000, Adv Pediatr, V47, P1; Kimonides VG, 1999, NEUROSCIENCE, V89, P429, DOI 10.1016/S0306-4522(98)00347-9; Knickmeyer R, 2005, J CHILD PSYCHOL PSYC, V46, P198, DOI 10.1111/j.1469-7610.2004.00349.x; Knickmeyer R, 2006, HORM BEHAV, V50, P148, DOI 10.1016/j.yhbeh.2006.02.006; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lathe R., 2006, AUTISM BRAIN ENV; Lee Norman H, 2007, Methods Mol Biol, V353, P265; Levy SE, 2007, BIOL PSYCHIAT, V61, P492, DOI 10.1016/j.biopsych.2006.07.013; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; MacFabe D., 2008, AM J BIOCH BIOTECHNO, V4, P146, DOI 10.3844/ajbbsp.2008.146.166; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MacLusky NJ, 2006, NEUROSCIENCE, V138, P957, DOI 10.1016/j.neuroscience.2005.12.054; Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Noebels JL, 2002, NOVART FDN SYMP, V241, P109; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Robinson PD, 2001, AM J MED GENET, V100, P30, DOI 10.1002/ajmg.1187; Saemundsen E, 2007, EPILEPSIA, V48, P1724, DOI 10.1111/j.1528-1167.2007.01150.x; Santangelo SL, 2005, AM J PHARMACOGENOMIC, V5, P71, DOI 10.2165/00129785-200505020-00001; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shultz SR, 2008, NEUROPHARMACOLOGY, V54, P901, DOI 10.1016/j.neuropharm.2008.01.013; Sikora DM, 2006, AM J MED GENET A, V140A, P1511, DOI 10.1002/ajmg.a.31294; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; SPENCE SJ, 2009, PEDIAT RES IN PRESS; Strous RD, 2005, EUR NEUROPSYCHOPHARM, V15, P305, DOI 10.1016/j.euroneuro.2004.12.004; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Tierney E, 2000, MENT RETARD DEV D R, V6, P131, DOI 10.1002/1098-2779(2000)6:2<131::AID-MRDD7>3.0.CO;2-R; Tierney E, 2006, AM J MED GENET B, V141B, P666, DOI 10.1002/ajmg.b.30368; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valicenti-McDermott M, 2006, J DEV BEHAV PEDIATR, V27, pS128, DOI 10.1097/00004703-200604002-00011; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; VOLKMAR FR, 1994, AM J PSYCHIAT, V151, P1361; Waage-Baudet H, 2005, DEV NEUROSCI-BASEL, V27, P378, DOI 10.1159/000088453; Walker SJ, 2006, NEUROTOXICOLOGY, V27, P685, DOI 10.1016/j.neuro.2006.06.003; Wassink TH, 2001, AM J MED GENET, V105, P406, DOI 10.1002/ajmg.1401; Yonan AL, 2003, GENES BRAIN BEHAV, V2, P303, DOI 10.1034/j.1601-183X.2003.00041.x; Zamani MR, 2000, J NEUROPHYSIOL, V84, P1800, DOI 10.1152/jn.2000.84.4.1800; Zecavati N, 2009, CURR NEUROL NEUROSCI, V9, P129, DOI 10.1007/s11910-009-0021-x; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; 2003, GENOME BIOL, V4, pP3	103	116	119	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5775	10.1371/journal.pone.0005775	http://dx.doi.org/10.1371/journal.pone.0005775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492049	Green Published, gold, Green Submitted			2022-12-27	WOS:000266624300012
J	Liu, BL; Morse, D; Cappadocia, M				Liu, Bolin; Morse, David; Cappadocia, Mario			Compatible Pollinations in Solanum chacoense Decrease Both S-RNase and S-RNase mRNA	PLOS ONE			English	Article							F-BOX PROTEIN; GAMETOPHYTIC SELF-INCOMPATIBILITY; PRIMARY STRUCTURAL FEATURES; POLLEN REJECTION; NICOTIANA-ALATA; MOLECULAR ANALYSIS; PRUNUS-AVIUM; IDENTIFICATION; GENE; DEGRADATION	Gametophytic self-incompatibility (GSI) allows plants to block fertilization by haploid pollen whose S-allele constitution matches one of the two S-alleles in the diploid styles. GSI in Solanum chacoense requires a stylar S-RNase, first secreted from cells of the transmitting tract then imported into incompatible (self) pollen tubes. However, the molecular mechanisms allowing compatible pollen to evade S-RNase attack are less clear, as compatible pollen tubes also import S-RNase. Using styles of the same age and size in order to lower the degree of inter-style variability in S-RNase levels, we observe reduction of up to 30% of the total non-self stylar S-RNase in vivo during compatible crosses, whereas no degradation of self S-RNases is detected. This marked difference in stylar S-RNase levels dovetails with measurements of pollen-specific Lat52 mRNA, which decreases four-fold in incompatible compared to compatible crosses. Unexpectedly, we also find evidence for a reciprocal signaling mechanism from compatible pollen to the cells of the transmitting tract that results in a roughly threefold decrease in S-RNase transcript levels. These findings reveal a previously unsuspected feedback loop that may help reinforce the compatible reaction.			Liu, BL (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Dept Biol, Montreal, PQ H1X 2B2, Canada.	mario.cappadocia@umontreal.ca		Morse, David/0000-0003-4131-4367				Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cruz-Garcia F, 2005, PLANT J, V42, P295, DOI 10.1111/j.1365-313X.2005.02375.x; de Nettancourt D., 1977, INCOMPATIBILITY ANGI; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; Feng JR, 2006, MOL BIOL REP, V33, P215, DOI 10.1007/s11033-006-0011-x; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; GREEN PJ, 1994, ANNU REV PLANT PHYS, V45, P421, DOI 10.1146/annurev.pp.45.060194.002225; HERRERO M, 1979, J CELL SCI, V36, P1; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hua ZH, 2008, PLANT J, V54, P1094, DOI 10.1111/j.1365-313X.2008.03487.x; Hua ZH, 2007, PLANT CELL, V19, P3593, DOI 10.1105/tpc.107.055426; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; HUANG S, 1994, PLANT CELL, V6, P1021, DOI 10.1105/tpc.6.7.1021; Ikeda K, 2004, SEX PLANT REPROD, V16, P235, DOI 10.1007/s00497-003-0200-x; IOERGER TR, 1991, SEX PLANT REPROD, V4, P81; Ishimizu T, 1998, FEBS LETT, V440, P337, DOI 10.1016/S0014-5793(98)01470-7; Jan VV, 1997, PLANT CELL TISS ORG, V47, P9, DOI 10.1007/BF02318960; Kao TH, 2004, PLANT CELL, V16, pS72, DOI 10.1105/tpc.016154; Liu BL, 2008, J EXP BOT, V59, P545, DOI 10.1093/jxb/erm339; Luu DT, 2000, NATURE, V407, P649, DOI 10.1038/35036623; Luu DT, 2001, GENETICS, V159, P329; Matton DP, 1997, PLANT CELL, V9, P1757, DOI 10.1105/tpc.9.10.1757; Matton DP, 1999, PLANT CELL, V11, P2087, DOI 10.1105/tpc.11.11.2087; McClure B, 1999, P NATL ACAD SCI USA, V96, P13548, DOI 10.1073/pnas.96.23.13548; MCCLURE B, 2007, SCI STKE, pPE17; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McClure B, 2006, CURR OPIN PLANT BIOL, V9, P639, DOI 10.1016/j.pbi.2006.09.004; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; McCubbin AG, 2000, ANNU REV CELL DEV BI, V16, P333, DOI 10.1146/annurev.cellbio.16.1.333; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Brien M, 2002, PLANT J, V32, P985, DOI 10.1046/j.1365-313X.2002.01486.x; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Qiao H, 2004, PLANT CELL, V16, P2307, DOI 10.1105/tpc.104.024919; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Qin X, 2001, PLANT MOL BIOL, V45, P295, DOI 10.1023/A:1006445120648; Qin XK, 2006, J EXP BOT, V57, P2001, DOI 10.1093/jxb/erj147; Qin XK, 2005, PLANTA, V221, P531, DOI 10.1007/s00425-004-1470-8; RIVARD SR, 1989, THEOR APPL GENET, V78, P49, DOI 10.1007/BF00299752; Roalson EH, 2003, MOL PHYLOGENET EVOL, V29, P490, DOI 10.1016/S1055-7903(03)00195-7; ROYO J, 1994, P NATL ACAD SCI USA, V91, P6511, DOI 10.1073/pnas.91.14.6511; SABAELLEIL MK, 1994, PLANT MOL BIOL, V24, P571, DOI 10.1007/BF00023555; Sambrook J., 2001, MOL CLONING LAB MANU; SASSA H, 1993, MOL GEN GENET, V241, P17, DOI 10.1007/BF00280196; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sims TL, 2001, PLANT MOL BIOL, V47, P771, DOI 10.1023/A:1013639528858; SINGH A, 1992, PLANT PHYSIOL, V99, P38, DOI 10.1104/pp.99.1.38; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Steinbachs JE, 2002, MOL BIOL EVOL, V19, P825, DOI 10.1093/oxfordjournals.molbev.a004139; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Vaughan SP, 2006, THEOR APPL GENET, V112, P856, DOI 10.1007/s00122-005-0187-9; VISSER T, 1982, EUPHYTICA, V31, P305, DOI 10.1007/BF00021645; VISSER T, 1983, POLLEN BIOL IMPLICAT, P229; Wang H, 1996, PLANT J, V9, P715, DOI 10.1046/j.1365-313X.1996.9050715.x; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Xue YB, 1996, PLANT CELL, V8, P805, DOI 10.1105/tpc.8.5.805; Yamane H, 2003, THEOR APPL GENET, V107, P1357, DOI 10.1007/s00122-003-1389-7	58	16	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5774	10.1371/journal.pone.0005774	http://dx.doi.org/10.1371/journal.pone.0005774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492064	Green Published, gold, Green Submitted			2022-12-27	WOS:000266624300011
J	Cadotte, MW; Cavender-Bares, J; Tilman, D; Oakley, TH				Cadotte, Marc W.; Cavender-Bares, Jeannine; Tilman, David; Oakley, Todd H.			Using Phylogenetic, Functional and Trait Diversity to Understand Patterns of Plant Community Productivity	PLOS ONE			English	Article								Background: Two decades of research showing that increasing plant diversity results in greater community productivity has been predicated on greater functional diversity allowing access to more of the total available resources. Thus, understanding phenotypic attributes that allow species to partition resources is fundamentally important to explaining diversity-productivity relationships. Methodology/Principal Findings: Here we use data from a long-term experiment ( Cedar Creek, MN) and compare the extent to which productivity is explained by seven types of community metrics of functional variation: 1) species richness, 2) variation in 10 individual traits, 3) functional group richness, 4) a distance-based measure of functional diversity, 5) a hierarchical multivariate clustering method, 6) a nonmetric multidimensional scaling approach, and 7) a phylogenetic diversity measure, summing phylogenetic branch lengths connecting community members together and may be a surrogate for ecological differences. Although most of these diversity measures provided significant explanations of variation in productivity, the presence of a nitrogen fixer and phylogenetic diversity were the two best explanatory variables. Further, a statistical model that included the presence of a nitrogen fixer, seed weight and phylogenetic diversity was a better explanation of community productivity than other models. Conclusions: Evolutionary relationships among species appear to explain patterns of grassland productivity. Further, these results reveal that functional differences among species involve a complex suite of traits and that perhaps phylogenetic relationships provide a better measure of the diversity among species that contributes to productivity than individual or small groups of traits.			Cadotte, MW (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	cadotte@nceas.ucsb.edu	Cavender-Bares, Jeannine/K-5716-2013; Oakley, Todd/A-5419-2008; Tilman, David/ABD-5309-2021; Cadotte, Marc/AAG-8147-2020	Oakley, Todd/0000-0002-4478-915X; Cadotte, Marc/0000-0002-5816-7693; Cavender-Bares, Jeannine/0000-0003-3375-9630				Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2009, DIVERS DISTRIB, V15, P481, DOI 10.1111/j.1472-4642.2009.00560.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cavender-Bares J, 2003, ECOLOGY, V84, P592, DOI 10.1890/0012-9658(2003)084[0592:IMAMPI]2.0.CO;2; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; CAVENDERBARES J, 2009, ECOLOGY LET IN PRESS; Darwin C, 1859, ORIGIN SPECIES MEANS; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Flombaum P, 2008, P NATL ACAD SCI USA, V105, P6087, DOI 10.1073/pnas.0704801105; Fornara DA, 2008, J ECOL, V96, P314, DOI 10.1111/j.1365-2745.2007.01345.x; GIVNISH TJ, 1976, AM NAT, V110, P743, DOI 10.1086/283101; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haddad NM, 2002, ECOL LETT, V5, P110, DOI 10.1046/j.1461-0248.2002.00293.x; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kent M., 2012, VEGETATION DESCRIPTI, V2nd ed.; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Lanta V, 2006, ACTA OECOL, V29, P85, DOI 10.1016/j.actao.2005.08.003; Legendre P., 2012, NUMERICAL ECOLOGY; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Oakley TH, 2005, MOL BIOL EVOL, V22, P40, DOI 10.1093/molbev/msh257; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; Rasband W., 2006, IMAGEJ; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Suding KN, 2006, OECOLOGIA, V149, P141, DOI 10.1007/s00442-006-0421-4; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x	57	461	488	11	346	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5695	10.1371/journal.pone.0005695	http://dx.doi.org/10.1371/journal.pone.0005695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479086	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415000008
J	Knieke, K; Hoff, H; Maszyna, F; Kolar, P; Schrage, A; Hamann, A; Debes, GF; Brunner-Weinzierl, MC				Knieke, Karin; Hoff, Holger; Maszyna, Frank; Kolar, Paula; Schrage, Arnhild; Hamann, Alf; Debes, Gudrun F.; Brunner-Weinzierl, Monika C.			CD152 (CTLA-4) Determines CD4 T Cell Migration In Vitro and In Vivo	PLOS ONE			English	Article							HIGH ENDOTHELIAL VENULES; LYMPHOCYTE ANTIGEN-4; UP-REGULATION; PERIPHERAL-TISSUES; SIGNAL STRENGTH; DENDRITIC CELLS; CHEMOKINES; ACTIVATION; RESPONSES; LOCALIZATION	Background: Migration of antigen-experienced T cells to secondary lymphoid organs and the site of antigenic-challenge is a mandatory prerequisite for the precise functioning of adaptive immune responses. The surface molecule CD152 (CTLA-4) is mostly considered as a negative regulator of T cell activation during immune responses. It is currently unknown whether CD152 can also influence chemokine-driven T cell migration. Methodology/Principal Findings: We analyzed the consequences of CD152 signaling on Th cell migration using chemotaxis assays in vitro and radioactive cell tracking in vivo. We show here that the genetic and serological inactivation of CD152 in Th1 cells reduced migration towards CCL4, CXCL12 and CCL19, but not CXCL9, in a G-protein dependent manner. In addition, retroviral transduction of CD152 cDNA into CD152 negative cells restored Th1 cell migration. Crosslinking of CD152 together with CD3 and CD28 stimulation on activated Th1 cells increased expression of the chemokine receptors CCR5 and CCR7, which in turn enhanced cell migration. Using sensitive liposome technology, we show that mature dendritic cells but not activated B cells were potent at inducing surface CD152 expression and the CD152-mediated migration-enhancing signals. Importantly, migration of CD152 positive Th1 lymphocytes in in vivo experiments increased more than 200% as compared to CD152 negative counterparts showing that indeed CD152 orchestrates specific migration of selected Th1 cells to sites of inflammation and antigenic challenge in vivo. Conclusions/Significance: We show here, that CD152 signaling does not just silence cells, but selects individual ones for migration. This novel activity of CD152 adds to the already significant role of CD152 in controlling peripheral immune responses by allowing T cells to localize correctly during infection. It also suggests that interference with CD152 signaling provides a tool for altering the cellular composition at sites of inflammation and antigenic challenge.			Knieke, K (corresponding author), Otto Von Guericke Univ, Univ Kinderklin, Magdeburg, Germany.	monika.brunner-weinzierl@med.ovgu.de	Brunner-Weinzierl, Monika/AAB-8813-2019	Brunner-Weinzierl, Monika/0000-0002-6838-3568; Debes, Gudrun/0000-0003-4208-7362				Bleul CC, 1998, J EXP MED, V187, P753, DOI 10.1084/jem.187.5.753; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Brunner M, 1995, EUR J IMMUNOL, V25, P3285, DOI 10.1002/eji.1830251213; Brunner MC, 1999, J IMMUNOL, V162, P5813; Brunner-Weinzierl MC, 2004, ARTHRITIS RES THER, V6, P45, DOI 10.1186/ar1158; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Casares Sofia, 2001, Current Molecular Medicine (Hilversum), V1, P357; Chambers CA, 1998, EUR J IMMUNOL, V28, P3137, DOI 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.0.CO;2-X; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; Debes GF, 2002, J IMMUNOL, V168, P5441, DOI 10.4049/jimmunol.168.11.5441; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Doyle AM, 2001, J EXP MED, V194, P893, DOI 10.1084/jem.194.7.893; Dudda JC, 2005, EUR J IMMUNOL, V35, P1056, DOI 10.1002/eji.200425817; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fedyk ER, 1999, J LEUKOCYTE BIOL, V66, P667, DOI 10.1002/jlb.66.4.667; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Gimsa U, 2004, J MOL MED-JMM, V82, P364, DOI 10.1007/s00109-004-0531-6; Hamann A, 2005, LEUKOCYTE TRAFFICKING: MOLECULAR MECHANISMS, THERAPEUTIC TARGETS, AND METHODS, P1, DOI 10.1002/352760779X; Hjelmstrom P, 2000, AM J PATHOL, V156, P1133, DOI 10.1016/S0002-9440(10)64981-4; HOFF H, 2009, JI; Kirchhoff S, 2000, EUR J IMMUNOL, V30, P2765, DOI 10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W; Kolar P, 2009, ARTHRITIS RHEUM-US, V60, P123, DOI 10.1002/art.24181; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Maszyna F, 2003, J IMMUNOL, V171, P3459, DOI 10.4049/jimmunol.171.7.3459; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Mustelin T, 2006, SCIENCE, V313, P1902, DOI 10.1126/science.1133578; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; OLSSON T, 1995, IMMUNOL REV, V144, P245, DOI 10.1111/j.1600-065X.1995.tb00072.x; Pandiyan P, 2004, J EXP MED, V199, P831, DOI 10.1084/jem.20031058; POWRIE F, 1993, IMMUNOL TODAY, V14, P270, DOI 10.1016/0167-5699(93)90044-L; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; SCHEFFOLD A, 1995, IMMUNOTECHNOLOGY, V1, P127, DOI 10.1016/1380-2933(95)00014-3; Scheffold A, 2000, NAT MED, V6, P107, DOI 10.1038/71441; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Schneider H, 2002, J IMMUNOL, V169, P3475, DOI 10.4049/jimmunol.169.7.3475; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; SIMON AK, 1994, P NATL ACAD SCI USA, V91, P8562, DOI 10.1073/pnas.91.18.8562; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Warnock RA, 2000, J EXP MED, V191, P77, DOI 10.1084/jem.191.1.77; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638	55	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5702	10.1371/journal.pone.0005702	http://dx.doi.org/10.1371/journal.pone.0005702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479036	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415000014
J	Miller, AW; Reynolds, AC; Sobrino, C; Riedel, GF				Miller, A. Whitman; Reynolds, Amanda C.; Sobrino, Cristina; Riedel, Gerhardt F.			Shellfish Face Uncertain Future in High CO2 World: Influence of Acidification on Oyster Larvae Calcification and Growth in Estuaries	PLOS ONE			English	Article							CARBON-DIOXIDE; OCEAN ACIDIFICATION; CALCIUM-CARBONATE; ALKALINITY; SEAWATER; IMPACT; RIVERS; WATER	Background: Human activities have increased atmospheric concentrations of carbon dioxide by 36% during the past 200 years. One third of all anthropogenic CO2 has been absorbed by the oceans, reducing pH by about 0.1 of a unit and significantly altering their carbonate chemistry. There is widespread concern that these changes are altering marine habitats severely, but little or no attention has been given to the biota of estuarine and coastal settings, ecosystems that are less pH buffered because of naturally reduced alkalinity. Methodology/Principal Findings: To address CO2-induced changes to estuarine calcification, veliger larvae of two oyster species, the Eastern oyster (Crassostrea virginica), and the Suminoe oyster (Crassostrea ariakensis) were grown in estuarine water under four pCO(2) regimes, 280, 380, 560 and 800 mu atm, to simulate atmospheric conditions in the pre-industrial era, present, and projected future concentrations in 50 and 100 years respectively. CO2 manipulations were made using an automated negative feedback control system that allowed continuous and precise control over the pCO(2) in experimental aquaria. Larval growth was measured using image analysis, and calcification was measured by chemical analysis of calcium in their shells. C. virginica experienced a 16% decrease in shell area and a 42% reduction in calcium content when pre-industrial and end of 21(st) century pCO(2) treatments were compared. C. ariakensis showed no change to either growth or calcification. Both species demonstrated net calcification and growth, even when aragonite was undersaturated, a result that runs counter to previous expectations for invertebrate larvae that produce aragonite shells. Conclusions and Significance: Our results suggest that temperate estuarine and coastal ecosystems are vulnerable to the expected changes in water chemistry due to elevated atmospheric CO2 and that biological responses to acidification, especially calcifying biota, will be species-specific and therefore much more variable and complex than reported previously.			Miller, AW (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	millerw@si.edu	Sobrino, Cristina/J-3534-2012; Miller, Whitman/C-7811-2017	Sobrino, Cristina/0000-0003-0431-1220; Miller, Whitman/0000-0003-0484-182X				[Anonymous], [No title captured]; [Anonymous], 2007, CO2SYS XLS CALCULATO; Bijma J, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000388; BREESE WP, 1977, AQUACULTURE, V12, P123, DOI 10.1016/0044-8486(77)90178-8; Breitburg Denise L., 2005, P167; Burke K, 2008, J SHELLFISH RES, V27, P701, DOI 10.2983/0730-8000(2008)27[701:LQOANB]2.0.CO;2; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Cai WJ, 1999, LIMNOL OCEANOGR, V44, P639, DOI 10.4319/lo.1999.44.3.0639; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CARRIKER MR, 1979, P NATL SHELLFISH ASS, V69, P102; *CHES BAY PROGR, CHES BAY PROGR WAT Q; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; EDMOND JM, 1970, DEEP-SEA RES, V17, P737, DOI 10.1016/0011-7471(70)90038-0; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Green MA, 2004, LIMNOL OCEANOGR, V49, P727, DOI 10.4319/lo.2004.49.3.0727; HALLSPENCER JM, 2008, NATURE ONLINE, DOI DOI 10.1038/NATURE07051; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; John E., 2007, CRC HDB CHEM PHYS; Kennedy Victor S., 1996, P371; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Kleypas JA, 2006, WORKSH HELD 18 20 AP; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; Leggett J., 1992, CLIMATE CHANGE 1992, P69; MORGAN SG, 1996, ECOLOGY MARINE INVER, P279; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; *OSB, 2004, NONN OYST CHES BAY; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; *SCION CORP, SCION IM WIND REL AL; Smith SV, 1997, ECOL MONOGR, V67, P509, DOI 10.1890/0012-9615(1997)067[0509:ACAIVO]2.0.CO;2; The Royal Society, 2005, 1205 ROYAL SOC; Turley C., 2006, AVOIDING DANGEROUS C, V8, P65; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; WONG GTF, 1979, LIMNOL OCEANOGR, V24, P970, DOI 10.4319/lo.1979.24.5.0970	47	257	268	2	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5661	10.1371/journal.pone.0005661	http://dx.doi.org/10.1371/journal.pone.0005661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19478855	gold, Green Submitted, Green Published			2022-12-27	WOS:000266415000003
J	Fu, Y; Tian, W; Pratt, EB; Dirling, LB; Shyng, SL; Meshul, CK; Cohen, DM				Fu, Yi; Tian, Wei; Pratt, Emily B.; Dirling, Lisa B.; Shyng, Show-Ling; Meshul, Charles K.; Cohen, David M.			Down-Regulation of ZnT8 Expression in INS-1 Rat Pancreatic Beta Cells Reduces Insulin Content and Glucose-Inducible Insulin Secretion	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ZINC-TRANSPORTER; GENE-EXPRESSION; RISK LOCI; FLUORESCENT-PROBE; ALLELIC VARIATION; TYPE-2; POLYMORPHISMS; CDKAL1; COMMON	The SLC30A8 gene codes for a pancreatic beta-cell-expressed zinc transporter, ZnT8. A polymorphism in the SLC30A8 gene is associated with susceptibility to type 2 diabetes, although the molecular mechanism through which this phenotype is manifest is incompletely understood. Such polymorphisms may exert their effect via impacting expression level of the gene product. We used an shRNA-mediated approach to reproducibly downregulate ZnT8 mRNA expression by >90% in the INS-1 pancreatic beta cell line. The ZnT8-downregulated cells exhibited diminished uptake of exogenous zinc, as determined using the zinc-sensitive reporter dye, zinquin. ZnT8-downregulated cells showed reduced insulin content and decreased insulin secretion (expressed as percent of total insulin content) in response to hyperglycemic stimulus, as determined by insulin immunoassay. ZnT8-depleted cells also showed fewer dense-core vesicles via electron microscopy. These data indicate that reduced ZnT8 expression in cultured pancreatic beta cells gives rise to a reduced insulin response to hyperglycemia. In addition, although we provide no direct evidence, these data suggest that an SLC30A8 expression-level polymorphism could affect insulin secretion and the glycemic response in vivo.			Fu, Y (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97201 USA.	cohend@ohsu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK057699, R01 DK057699-09] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Buckland PR, 2006, BBA-MOL BASIS DIS, V1762, P17, DOI 10.1016/j.bbadis.2005.10.004; Buckland PR, 2004, HUM MOL GENET, V13, pR255, DOI 10.1093/hmg/ddh227; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; COYLE P, 1994, BIOCHEM J, V303, P781, DOI 10.1042/bj3030781; Frisk P, 2007, PANCREAS, V35, pE37, DOI 10.1097/mpa.0b013e3180986e84; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hudson TJ, 2003, NAT GENET, V33, P439, DOI 10.1038/ng0403-439; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Liu GH, 2004, MOL PHARMACOL, V65, P1269, DOI 10.1124/mol.65.5.1269; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; MacDonald PE, 2007, PHYSIOLOGY, V22, P113, DOI 10.1152/physiol.00047.2006; Min L, 2007, J BIOL CHEM, V282, P33530, DOI 10.1074/jbc.M703402200; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Omori S., 2008, Diabetes (New York), V57, P791, DOI 10.2337/db07-0979; PALMER ND, 2008, DIABETES; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; RAYNER MH, 1995, BIOMETALS, V8, P188; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Scott WJ, 2007, RES J BIOTECHNOL, V2, P5; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smidt K, 2007, MOL CELL ENDOCRINOL, V264, P68, DOI 10.1016/j.mce.2006.10.010; Sondergaard LG, 2005, HORM METAB RES, V37, P133, DOI 10.1055/s-2005-861290; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; NATURE, V447, P661	40	57	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5679	10.1371/journal.pone.0005679	http://dx.doi.org/10.1371/journal.pone.0005679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19479076	Green Submitted, gold, Green Published			2022-12-27	WOS:000266331700007
J	Peng, H; Dong, ZZ; Qi, J; Yang, YY; Liu, Y; Li, ZM; Xu, JK; Zhang, JT				Peng, Hui; Dong, Zizheng; Qi, Jing; Yang, Youyun; Liu, Yang; Li, Zhaomin; Xu, Junkang; Zhang, Jian-Ting			A Novel Two Mode-Acting Inhibitor of ABCG2-Mediated Multidrug Transport and Resistance in Cancer Chemotherapy	PLOS ONE			English	Article								Background: Multidrug resistance (MDR) is a major problem in successful treatment of cancers. Human ABCG2, a member of the ATP-binding cassette transporter superfamily, plays a key role in MDR and an important role in protecting cancer stem cells. Knockout of ABCG2 had no apparent adverse effect on the mice. Thus, ABCG2 is an ideal target for development of chemo-sensitizing agents for better treatment of drug resistant cancers and helping eradicate cancer stem cells. Methods/Preliminary Findings: Using rational screening of representatives from a chemical compound library, we found a novel inhibitor of ABCG2, PZ-39 (N-(4-chlorophenyl)-2-[(6-{[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]amino}-1,3-benzothiazol-2-yl) sulfanyl]acetamide), that has two modes of actions by inhibiting ABCG2 activity and by accelerating its lysosome-dependent degradation. PZ-39 has no effect on ABCB1 and ABCC1-mediated drug efflux, resistance, and their expression, indicating that it may be specific to ABCG2. Analyses of its analogue compounds showed that the pharmacophore of PZ-39 is benzothiazole linked to a triazine ring backbone. Conclusion/Significance: Unlike any previously known ABCG2 transporter inhibitors, PZ-39 has a novel two-mode action by inhibiting ABCG2 activity, an acute effect, and by accelerating lysosome-dependent degradation, a chronic effect. PZ-39 is potentially a valuable probe for structure-function studies of ABCG2 and a lead compound for developing therapeutics targeting ABCG2-mediated MDR in combinational cancer chemotherapy.			Peng, H (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China.	jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015		NCI NIH HHS [R01 CA113384, R01 CA120221] Funding Source: Medline; NHLBI NIH HHS [T32 HL007910, T32 HL07910] Funding Source: Medline; NIDDK NIH HHS [T32 DK007519, T32 DK07519] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA120221, R01CA113384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed-Belkacem A, 2005, CANCER RES, V65, P4852, DOI 10.1158/0008-5472.CAN-04-1817; Ahmed-Belkacem A, 2006, ANTI-CANCER DRUG, V17, P239, DOI 10.1097/00001813-200603000-00001; Allen JD, 2002, MOL CANCER THER, V1, P417; Chen Q, 2006, J BIOL CHEM, V281, P31152, DOI 10.1074/jbc.M603529200; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Henrich CJ, 2006, J BIOMOL SCREEN, V11, P176, DOI 10.1177/1087057105284576; Henrich CJ, 2007, MOL CANCER THER, V6, P3271, DOI 10.1158/1535-7163.MCT-07-0352; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Horton JK, 1998, CELL PHYSIOL BIOCHEM, V8, P246, DOI 10.1159/000016287; Imai Y, 2004, CANCER RES, V64, P4346, DOI 10.1158/0008-5472.CAN-04-0078; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Liu Y, 2005, MOL PHARMACOL, V68, P430, DOI 10.1124/mol.105.011015; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Rabindran SK, 1998, CANCER RES, V58, P5850; Rabindran SK, 2000, CANCER RES, V60, P47; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Whiteley CG, 2000, CELL BIOCHEM BIOPHYS, V33, P217, DOI 10.1385/CBB:33:3:217; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Xu JK, 2007, CURR MED CHEM, V14, P689, DOI 10.2174/092986707780059580; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zhang Jian-Ting, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P531; Zhang SZ, 2004, MOL PHARMACOL, V65, P1208, DOI 10.1124/mol.65.5.1208; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999	27	41	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2009	4	5							e5676	10.1371/journal.pone.0005676	http://dx.doi.org/10.1371/journal.pone.0005676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LH	19479068	gold, Green Published, Green Submitted			2022-12-27	WOS:000266331600001
J	Lamm, N; Ordan, E; Shponkin, R; Richler, C; Aker, M; Tzfati, Y				Lamm, Noa; Ordan, Elly; Shponkin, Rotem; Richler, Carmelit; Aker, Memet; Tzfati, Yehuda			Diminished Telomeric 3 ' Overhangs Are Associated with Telomere Dysfunction in Hoyeraal-Hreidarsson Syndrome	PLOS ONE			English	Article								Background: Eukaryotic chromosomes end with telomeres, which in most organisms are composed of tandem DNA repeats associated with telomeric proteins. These DNA repeats are synthesized by the enzyme telomerase, whose activity in most human tissues is tightly regulated, leading to gradual telomere shortening with cell divisions. Shortening beyond a critical length causes telomere uncapping, manifested by the activation of a DNA damage response (DDR) and consequently cell cycle arrest. Thus, telomere length limits the number of cell divisions and provides a tumor-suppressing mechanism. However, not only telomere shortening, but also damaged telomere structure, can cause telomere uncapping. Dyskeratosis Congenita (DC) and its severe form Hoyeraal-Hreidarsson Syndrome (HHS) are genetic disorders mainly characterized by telomerase deficiency, accelerated telomere shortening, impaired cell proliferation, bone marrow failure, and immunodeficiency. Methodology/Principal Findings: We studied the telomere phenotypes in a family affected with HHS, in which the genes implicated in other cases of DC and HHS have been excluded, and telomerase expression and activity appears to be normal. Telomeres in blood leukocytes derived from the patients were severely short, but in primary fibroblasts they were normal in length. Nevertheless, a significant fraction of telomeres in these fibroblasts activated DDR, an indication of their uncapped state. In addition, the telomeric 3' overhangs are diminished in blood cells and fibroblasts derived from the patients, consistent with a defect in telomere structure common to both cell types. Conclusions/Significance: Altogether, these results suggest that the primary defect in these patients lies in the telomere structure, rather than length. We postulate that this defect hinders the access of telomerase to telomeres, thus causing accelerated telomere shortening in blood cells that rely on telomerase to replenish their telomeres. In addition, it activates the DDR and impairs cell proliferation, even in cells with normal telomere length such as fibroblasts. This work demonstrates a telomere length-independent pathway that contributes to a telomere dysfunction disease.			Lamm, N (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	tzfati@cc.huji.ac.il		Tzfati, Yehuda/0000-0001-7720-435X				Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; DOKAL I, 1992, BLOOD, V80, P3090; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Gu BW, 2009, CELL CYCLE, V8, P6, DOI 10.4161/cc.8.1.7265; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Kataoka H, 1997, DIFFERENTIATION, V62, P203; Kedde M, 2006, J BIOL CHEM, V281, P40503, DOI 10.1074/jbc.M607676200; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Marrone A, 2007, BLOOD, V110, P4198, DOI 10.1182/blood-2006-12-062851; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Poon SSS, 2001, METHOD CELL BIOL, V64, P69; Rog O, 2008, CURR OPIN GENET DEV, V18, P212, DOI 10.1016/j.gde.2008.01.011; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Yaghmai R, 2000, J PEDIATR-US, V136, P390, DOI 10.1067/mpd.2000.104295; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	47	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2009	4	5							e5666	10.1371/journal.pone.0005666	http://dx.doi.org/10.1371/journal.pone.0005666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LD	19461895	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331200005
J	Li, OTW; Chan, MCW; Leung, CSW; Chan, RWY; Guan, Y; Nicholls, JM; Poon, LLM				Li, Olive T. W.; Chan, Michael C. W.; Leung, Cynthia S. W.; Chan, Renee W. Y.; Guan, Yi; Nicholls, John M.; Poon, Leo L. M.			Full Factorial Analysis of Mammalian and Avian Influenza Polymerase Subunits Suggests a Role of an Efficient Polymerase for Virus Adaptation	PLOS ONE			English	Article							DETERMINES HOST-RANGE; A H5N1 VIRUSES; RNA-POLYMERASE; HIGH VIRULENCE; PB1 PROTEIN; AMINO-ACID; COMPLEX-FORMATION; VIRAL POLYMERASE; GENES CONTRIBUTE; NUCLEAR IMPORT	Amongst all the internal gene segments (PB2, PB1, PA, NP, M and NS), the avian PB1 segment is the only one which was reassorted into the human H2N2 and H3N2 pandemic strains. This suggests that the reassortment of polymerase subunit genes between mammalian and avian influenza viruses might play roles for interspecies transmission. To test this hypothesis, we tested the compatibility between PB2, PB1, PA and NP derived from a H5N1 virus and a mammalian H1N1 virus. All 16 possible combinations of avian-mammalian chimeric viral ribonucleoproteins (vRNPs) were characterized. We showed that recombinant vRNPs with a mammalian PB2 and an avian PB1 had the strongest polymerase activities in human cells at all studied temperature. In addition, viruses with this specific PB2-PB1 combination could grow efficiently in cell cultures, especially at a high incubation temperature. These viruses were potent inducers of proinflammatory cytokines and chemokines in primary human macrophages and pneumocytes. Viruses with this specific PB2-PB1 combination were also found to be more capable to generate adaptive mutations under a new selection pressure. These results suggested that the viral polymerase activity might be relevant for the genesis of influenza viruses of human health concern.			Li, OTW (corresponding author), Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	llmpoon@hkucc.hku.hk	Chan, Renee/D-4799-2012; Poon, Leo Lit Man/C-4382-2009; Poon, Leo/AAP-6887-2020; Chan, Renee Wan Yi/AAA-6598-2020; Chan, Michael Chi Wai/C-4212-2009; Nicholls, John Malcolm/C-4375-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Chan, Renee Wan Yi/0000-0001-6485-0926; Chan, Michael Chi Wai/0000-0001-8174-8405; Nicholls, John Malcolm/0000-0001-7217-7444; Guan, Yi/0000-0001-6057-9243	NIAID NIH HHS [HHSN266200700005C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Aoki FY, 2007, ANTIVIR THER, V12, P603; BARCENA J, 1994, J VIROL, V68, P6900; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; Capua I, 2006, AVIAN PATHOL, V35, P189, DOI 10.1080/03079450600717174; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Chan AY, 2006, VIROLOGY, V351, P210, DOI 10.1016/j.virol.2006.03.005; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Cheung TKW, 2005, J GEN VIROL, V86, P1447, DOI 10.1099/vir.0.80727-0; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; DIGARD P, 1989, VIROLOGY, V171, P162, DOI 10.1016/0042-6822(89)90523-0; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; GIESENDORF B, 1986, VIRUS RES, V5, P27, DOI 10.1016/0168-1702(86)90063-8; Gomez-Puertas P, 1999, J GEN VIROL, V80, P1635, DOI 10.1099/0022-1317-80-7-1635; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Honda A, 2007, GENES CELLS, V12, P133, DOI 10.1111/j.1365-2443.2007.01047.x; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; IWATSUKIHORIMOT.K, 2008, VIRUS RES; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Keech M, 1998, OCCUP MED-OXFORD, V48, P85, DOI 10.1093/occmed/48.2.85; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Li CJ, 2008, J VIROL, V82, P11880, DOI 10.1128/JVI.01445-08; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Luo G, 1993, Virus Res, V29, P321; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Murphy B.R, 1996, FIELDS VIROLOGY, P1397; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; PEREZ DR, 1995, J VIROL, V69, P6932; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Poole EL, 2007, FEBS LETT, V581, P5300, DOI 10.1016/j.febslet.2007.10.025; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; STERN H, 1963, LANCET, V1, P1301; Stray SJ, 2001, VIRUS RES, V77, P3, DOI 10.1016/S0168-1702(01)00260-X; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Ueda M, 2008, VIRUS RES, V136, P91, DOI 10.1016/j.virusres.2008.04.028; Varich NL, 2008, ARCH VIROL, V153, P1149, DOI 10.1007/s00705-008-0070-5; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Webster RG, 1997, FEMS IMMUNOL MED MIC, V18, P275, DOI 10.1016/S0928-8244(97)00058-8; WHO, 2021, CUM NUMB CONF HUM CA; WOLFF T, 2008, BIOL CHEM; Yano T, 2008, MICROBIOL IMMUNOL, V52, P216, DOI 10.1111/j.1348-0421.2008.00034.x	87	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5658	10.1371/journal.pone.0005658	http://dx.doi.org/10.1371/journal.pone.0005658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19462010	gold, Green Published, Green Submitted			2022-12-27	WOS:000266331000016
J	Schleheck, D; Barraud, N; Klebensberger, J; Webb, JS; McDougald, D; Rice, SA; Kjelleberg, S				Schleheck, David; Barraud, Nicolas; Klebensberger, Janosch; Webb, Jeremy S.; McDougald, Diane; Rice, Scott A.; Kjelleberg, Staffan			Pseudomonas aeruginosa PAO1 Preferentially Grows as Aggregates in Liquid Batch Cultures and Disperses upon Starvation	PLOS ONE			English	Article								In both natural and artificial environments, bacteria predominantly grow in biofilms, and bacteria often disperse from biofilms as freely suspended single-cells. In the present study, the formation and dispersal of planktonic cellular aggregates, or 'suspended biofilms', by Pseudomonas aeruginosa in liquid batch cultures were closely examined, and compared to biofilm formation on a matrix of polyester (PE) fibers as solid surface in batch cultures. Plankton samples were analyzed by laser-diffraction particle-size scanning (LDA) and microscopy of aggregates. Interestingly, LDA indicated that up to 90% of the total planktonic biomass consisted of cellular aggregates in the size range of 10-400 mm in diameter during the growth phase, as opposed to individual cells. In cultures with PE surfaces, P. aeruginosa preferred to grow in biofilms, as opposed to planktonicly. However, upon carbon, nitrogen or oxygen limitation, the planktonic aggregates and PE-attached biofilms dispersed into single cells, resulting in an increase in optical density (OD) independent of cellular growth. During growth, planktonic aggregates and PE-attached biofilms contained densely packed viable cells and extracellular DNA (eDNA), and starvation resulted in a loss of viable cells, and an increase in dead cells and eDNA. Furthermore, a release of metabolites and infective bacteriophage into the culture supernatant, and a marked decrease in intracellular concentration of the second messenger cyclic di-GMP, was observed in dispersing cultures. Thus, what traditionally has been described as planktonic, individual cell cultures of P. aeruginosa, are in fact suspended biofilms, and such aggregates have behaviors and responses (e. g. dispersal) similar to surface associated biofilms. In addition, we suggest that this planktonic biofilm model system can provide the basis for a detailed analysis of the synchronized biofilm life cycle of P. aeruginosa.			Schleheck, D (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	s.kjelleberg@unsw.edu.au	Rice, Scott/A-6084-2019; Kjelleberg, Staffan/C-9229-2015; Barraud, Nicolas/D-1569-2010; McDougald, Diane/AAF-4799-2020; Kjelleberg, Staffan/AAB-4641-2020; McDougald, Diane/B-5564-2009	Rice, Scott/0000-0002-9486-2343; Kjelleberg, Staffan/0000-0003-4271-6413; Barraud, Nicolas/0000-0002-1807-7765; McDougald, Diane/0000-0001-5827-8441; Kjelleberg, Staffan/0000-0003-4271-6413; McDougald, Diane/0000-0001-5827-8441; Klebensberger, Janosch/0000-0003-2740-3769; Webb, Jeremy/0000-0003-2068-8589	BBSRC [BB/C520655/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C520655/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALLDREDGE AL, 1986, LIMNOL OCEANOGR, V31, P68, DOI 10.4319/lo.1986.31.1.0068; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; [Anonymous], 2007, BIOFILM PRIMER; APPLEGATE DH, 1991, BIOTECHNOL BIOENG, V37, P17, DOI 10.1002/bit.260370105; Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06; Biggs CA, 2000, WATER RES, V34, P2542, DOI 10.1016/S0043-1354(99)00431-5; BYNG GS, 1979, J BACTERIOL, V138, P846, DOI 10.1128/JB.138.3.846-852.1979; Chandrasekaran EV, 1980, METHODS CARBOHYDRATE, P89; Chayabutra C, 2001, BIOTECHNOL BIOENG, V72, P25, DOI 10.1002/1097-0290(20010105)72:1<25::AID-BIT4>3.0.CO;2-J; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; DELAQUIS PJ, 1989, MICROBIAL ECOL, V18, P199, DOI 10.1007/BF02075808; Fakhruddin ANM, 2007, BIODEGRADATION, V18, P189, DOI 10.1007/s10532-006-9054-x; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; GROSSART HP, 1993, LIMNOL OCEANOGR, V38, P532, DOI 10.4319/lo.1993.38.3.0532; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; KENNEDY SIT, 1968, BIOCHEM J, V107, P497, DOI 10.1042/bj1070497; KISAALITA WS, 1994, BIOTECHNOL TECH, V8, P747, DOI 10.1007/BF00151481; Kjelleberg S, 2007, BIOFILM MODE LIFE ME, P5; Kjelleberg S., 1993, STARVATION BACTERIA; Klebensberger J, 2006, ARCH MICROBIOL, V185, P417, DOI 10.1007/s00203-006-0111-y; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Mason C.A., 1993, STARVATION BACTERIA, P81, DOI DOI 10.1007/978-1-4899-2439-1_4; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Nielsen PH, 2004, WATER SCI TECHNOL, V49, P51, DOI 10.2166/wst.2004.0606; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Sawyer LK, 2000, WATER SCI TECHNOL, V41, P139, DOI 10.2166/wst.2000.0437; Schleheck D, 2004, INT J SYST EVOL MICR, V54, P1489, DOI 10.1099/ijs.0.03020-0; Schleheck D, 2004, APPL ENVIRON MICROB, V70, P4053, DOI 10.1128/AEM.70.7.4053-4063.2004; Schleheck D, 2000, APPL ENVIRON MICROB, V66, P1911, DOI 10.1128/AEM.66.5.1911-1916.2000; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Spormann AM, 2008, CURR TOP MICROBIOL, V322, P17; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Thormann KM, 2005, J BACTERIOL, V187, P1014, DOI 10.1128/JB.187.3.1014-1021.2005; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Tlemcani LL, 2008, ARCH MICROBIOL, V190, P141, DOI 10.1007/s00203-008-0380-8; Wagner M, 2002, ANTON LEEUW INT J G, V81, P665, DOI 10.1023/A:1020586312170; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003	42	138	146	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5513	10.1371/journal.pone.0005513	http://dx.doi.org/10.1371/journal.pone.0005513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436737	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000266009900006
J	Campo, CG; Sinagra, M; Verrier, D; Manzoni, OJ; Chavis, P				Campo, Cecilia Gonzalez; Sinagra, Melanie; Verrier, Daniele; Manzoni, Olivier J.; Chavis, Pascale			Reelin Secreted by GABAergic Neurons Regulates Glutamate Receptor Homeostasis	PLOS ONE			English	Article								Background: Reelin is a large secreted protein of the extracellular matrix that has been proposed to participate to the etiology of schizophrenia. During development, reelin is crucial for the correct cytoarchitecture of laminated brain structures and is produced by a subset of neurons named Cajal-Retzius. After birth, most of these cells degenerate and reelin expression persists in postnatal and adult brain. The phenotype of neurons that bind secreted reelin and whether the continuous secretion of reelin is required for physiological functions at postnatal stages remain unknown. Methodology/Principal Findings: Combining immunocytochemical and pharmacological approaches, we first report that two distinct patterns of reelin expression are present in cultured hippocampal neurons. We show that in hippocampal cultures, reelin is secreted by GABAergic neurons displaying an intense reelin immunoreactivity (IR). We demonstrate that secreted reelin binds to receptors of the lipoprotein family on neurons with a punctate reelin IR. Secondly, using calcium imaging techniques, we examined the physiological consequences of reelin secretion blockade. Blocking protein secretion rapidly and reversibly changes the subunit composition of N-methyl-D-aspartate glutamate receptors (NMDARs) to a predominance of NR2B-containing NMDARs. Addition of recombinant or endogenously secreted reelin rescues the effects of protein secretion blockade and reverts the fraction of NR2B-containing NMDARs to control levels. Therefore, the continuous secretion of reelin is necessary to control the subunit composition of NMDARs in hippocampal neurons. Conclusions/Significance: Our data show that the heterogeneity of reelin immunoreactivity correlates with distinct functional populations: neurons synthesizing and secreting reelin and/or neurons binding reelin. Furthermore, we show that continuous reelin secretion is a strict requirement to maintain the composition of NMDARs. We propose that reelin is a trans-neuronal messenger secreted by GABAergic neurons that regulates NMDARs homeostasis in postnatal hippocampus. Defects in reelin secretion could play a major role in the development of neuropsychiatric disorders, particularly those associated with deregulation of NMDARs such as schizophrenia.			Campo, CG (corresponding author), INSERM, Neuroctr Magendie Pathophysiol Synapt Plast, U862, Bordeaux, France.	pascale.chavis@inserm.fr	Chavis, Pascale/M-8312-2016; Manzoni, Olivier/M-7899-2016	Chavis, Pascale/0000-0002-3038-1014; Manzoni, Olivier/0000-0002-5579-6208				Alcantara S, 1998, J NEUROSCI, V18, P7779; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; De A, 2003, BRAIN RES, V981, P133, DOI 10.1016/S0006-8993(03)02997-4; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Drakew A, 1998, NEUROSCIENCE, V82, P1079; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Ikeda Y, 1997, DEV DYNAM, V210, P157, DOI 10.1002/(SICI)1097-0177(199710)210:2<157::AID-AJA8>3.0.CO;2-F; Ina A, 2007, EUR J NEUROSCI, V26, P615, DOI 10.1111/j.1460-9568.2007.05703.x; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Lacor PN, 2000, P NATL ACAD SCI USA, V97, P3556, DOI 10.1073/pnas.050589597; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Martinez-Cerdeno V, 2002, CEREB CORTEX, V12, P1298, DOI 10.1093/cercor/12.12.1298; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Qiu SF, 2006, J NEUROSCI, V26, P12943, DOI 10.1523/JNEUROSCI.2561-06.2006; Ramos-Moreno T, 2006, EUR J NEUROSCI, V23, P401, DOI 10.1111/j.1460-9568.2005.04567.x; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tovar KR, 1999, J NEUROSCI, V19, P4180; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069	41	69	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2009	4	5							e5505	10.1371/journal.pone.0005505	http://dx.doi.org/10.1371/journal.pone.0005505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444VY	19430527	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009700010
J	Whitehead, K; Pan, M; Masumura, K; Bonneau, R; Baliga, NS				Whitehead, Kenia; Pan, Min; Masumura, Ken-ichi; Bonneau, Richard; Baliga, Nitin S.			Diurnally Entrained Anticipatory Behavior in Archaea	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; HALOBACTERIUM-HALOBIUM; GENOME SEQUENCE; RHODOPSIN-II; GENE; MECHANISM; PHOTOSYNTHESIS; TRANSCRIPTS; TEMPERATURE; EXPRESSION	By sensing changes in one or few environmental factors biological systems can anticipate future changes in multiple factors over a wide range of time scales (daily to seasonal). This anticipatory behavior is important to the fitness of diverse species, and in context of the diurnal cycle it is overall typical of eukaryotes and some photoautotrophic bacteria but is yet to be observed in archaea. Here, we report the first observation of light-dark (LD)-entrained diurnal oscillatory transcription in up to 12% of all genes of a halophilic archaeon Halobacterium salinarum NRC-1. Significantly, the diurnally entrained transcription was observed under constant darkness after removal of the LD stimulus (free-running rhythms). The memory of diurnal entrainment was also associated with the synchronization of oxic and anoxic physiologies to the LD cycle. Our results suggest that under nutrient limited conditions halophilic archaea take advantage of the causal influence of sunlight (via temperature) on O-2 diffusivity in a closed hypersaline environment to streamline their physiology and operate oxically during nighttime and anoxically during daytime.			Whitehead, K (corresponding author), Inst Syst Biol, Seattle, WA USA.	nbaliga@systemsbiology.org	Bonneau, Richard/ABD-6737-2021; Bonneau, Richard/GZL-2900-2022; Masumura, Kenichi/J-7936-2019	Masumura, Kenichi/0000-0002-7907-164X; baliga, nitin/0000-0001-9157-5974	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077398, P50GM076547] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM077398-01A2, P50 GM076547, R01 GM077398, P50GM076547] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHTON PJ, 1983, HYDROBIOLOGIA, V99, P61, DOI 10.1007/BF00013718; Baliga NS, 2008, SCIENCE, V320, P1297, DOI 10.1126/science.1159485; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; Baliga NS, 2001, P NATL ACAD SCI USA, V98, P2521, DOI 10.1073/pnas.051632498; Bare JC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-456; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BETLACH MC, 1989, CAN J MICROBIOL, V35, P134, DOI 10.1139/m89-020; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; DasSarma S, 2001, PHOTOSYNTH RES, V70, P3, DOI 10.1023/A:1013879706863; DASSARMA S, 1999, HALOPHILES ENCY LIFE, P458; *DEP MET, DEP MET UOU ANN TEMP; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Han P, 1996, J PHYS CHEM-US, V100, P5597, DOI 10.1021/jp952903y; HARTMANN R, 1980, P NATL ACAD SCI-BIOL, V77, P3821, DOI 10.1073/pnas.77.7.3821; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; HORNE JH, 1986, ASTROPHYS J, V302, P757, DOI 10.1086/164037; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; KREBS MP, 1993, J BACTERIOL, V175, P1555, DOI 10.1128/JB.175.6.1555-1560.1993; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Moreno-Hagelsieb Gabriel, 2002, Bioinformatics, V18 Suppl 1, pS329; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Oren A, 2001, HYDROBIOLOGIA, V466, P61, DOI 10.1023/A:1014557116838; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; PINCKNEY J, 1995, J EXP MAR BIOL ECOL, V187, P223, DOI 10.1016/0022-0981(94)00185-G; Press W. H., 1992, ART SCI COMPUTING; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; Saenger Casey, 2006, Saline Syst, V2, P8, DOI 10.1186/1746-1448-2-8; SCARGLE JD, 1982, APJ, V263, P835, DOI DOI 10.1086/160554; Schmid AK, 2007, GENOME RES, V17, P1399, DOI 10.1101/gr.6728007; SHAND RF, 1991, J BACTERIOL, V173, P4692, DOI 10.1128/jb.173.15.4692-4699.1991; Shannon PT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-176; SPUDICH EN, 1989, P NATL ACAD SCI USA, V86, P7746, DOI 10.1073/pnas.86.20.7746; Spudich JL, 2002, CURR OPIN STRUC BIOL, V12, P540, DOI 10.1016/S0959-440X(02)00359-7; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; SPUDICH JL, 1993, J BACTERIOL, V175, P7755, DOI 10.1128/JB.175.24.7755-7761.1993; Stumm W., 1981, AQUAT CHEM, P780; SUMPER M, 1976, ANGEW CHEM INT EDIT, V15, P187, DOI 10.1002/anie.197601871; TAGKOPOULOS I, 2008, SCIENCE; Taniguchi Y, 2007, GENE DEV, V21, P60, DOI 10.1101/gad.1488107; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Twellmeyer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001064; Valdez-Holguin Jose, 1994, Ciencias Marinas, V20, P123; Vityazev VV, 1997, ASTR SOC P, V125, P166; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Wieland A, 2006, FEMS MICROBIOL ECOL, V55, P195, DOI 10.1111/j.1574-6941.2005.00031.x	55	39	41	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5485	10.1371/journal.pone.0005485	http://dx.doi.org/10.1371/journal.pone.0005485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424498	Green Submitted, gold, Green Published			2022-12-27	WOS:000265933800015
J	Tee, JM; van Rooijen, C; Boonen, R; Zivkovic, D				Tee, Jin-Ming; van Rooijen, Carina; Boonen, Rick; Zivkovic, Danica			Regulation of Slow and Fast Muscle Myofibrillogenesis by Wnt/beta-Catenin and Myostatin Signaling	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; MYOGENIC DIFFERENTIATION; PARAXIAL MESODERM; SKELETAL-MUSCLE; SONIC HEDGEHOG; BETA-CATENIN; STEM-CELLS; ZEBRAFISH; WNT; EXPRESSION	Deviation from proper muscle development or homeostasis results in various myopathic conditions. Employing genetic as well as chemical intervention, we provide evidence that a tight regulation of Wnt/beta-catenin signaling is essential for muscle fiber growth and maintenance. In zebrafish embryos, gain-of-Wnt/beta-catenin function results in unscheduled muscle progenitor proliferation, leading to slow and fast muscle hypertrophy accompanied by fast muscle degeneration. The effects of Wnt/beta-catenin signaling on fast muscle hypertrophy were rescued by misexpression of Myostatin or p21(CIP/WAF), establishing an in vivo regulation of myofibrillogenesis by Wnt/beta-catenin signaling and Myostatin. Epistatic analyses suggest a possible genetic interaction between Wnt/beta-catenin and Myostatin in regulation of slow and fast twitch muscle myofibrillogenesis.			Tee, JM (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands.	d.zivkovic@hubrecht.eu						Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bassett D, 2004, CLIN EXP PHARMACOL P, V31, P537, DOI 10.1111/j.1440-1681.2004.04030.x; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Biga PR, 2006, AM J PHYSIOL-REG I, V291, pR1327, DOI 10.1152/ajpregu.00905.2005; Borello U, 1999, DEVELOPMENT, V126, P4247; Brand-Saberi B, 2000, CURR TOP DEV BIOL, V48, P1; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Cinquin O, 2007, MECH DEVELOP, V124, P501, DOI 10.1016/j.mod.2007.06.004; Descamps S, 2008, CELL TISSUE RES, V332, P299, DOI 10.1007/s00441-008-0574-z; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Francis-West PH, 2003, J ANAT, V202, P69, DOI 10.1046/j.1469-7580.2003.00136.x; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Galli LM, 2004, DEV BIOL, V269, P489, DOI 10.1016/j.ydbio.2004.01.041; Geetha-Loganathan P, 2008, ANN ANAT, V190, P208, DOI 10.1016/j.aanat.2007.12.003; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Hammond CL, 2007, DEV BIOL, V302, P504, DOI 10.1016/j.ydbio.2006.10.009; Hayashi S, 2008, P JPN ACAD B-PHYS, V84, P354, DOI 10.2183/pjab.84.354; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Hirsinger E, 2004, DEV BIOL, V275, P143, DOI 10.1016/j.ydbio.2004.07.030; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Mansouri A, 1998, CRIT REV ONCOGENESIS, V9, P141, DOI 10.1615/CritRevOncog.v9.i2.40; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Matsakas A, 2006, EXP PHYSIOL, V91, P983, DOI 10.1113/expphysiol.2006.033571; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Schmidt M, 2000, DEVELOPMENT, V127, P4105; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Stack JH, 1997, DEVELOPMENT, V124, P3185; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Steffen LS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-79; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; van de Water S, 2001, DEVELOPMENT, V128, P3877; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8	55	31	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5880	10.1371/journal.pone.0005880	http://dx.doi.org/10.1371/journal.pone.0005880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517013	Green Submitted, Green Published, gold			2022-12-27	WOS:000266873100015
J	Khodarev, NN; Roach, P; Pitroda, SP; Golden, DW; Bhayani, M; Shao, MY; Darga, TE; Beveridge, MG; Sood, RF; Sutton, HG; Beckett, MA; Mauceri, HJ; Posner, MC; Weichselbaum, RR				Khodarev, Nikolai N.; Roach, Paul; Pitroda, Sean P.; Golden, Daniel W.; Bhayani, Mihir; Shao, Michael Y.; Darga, Thomas E.; Beveridge, Mara G.; Sood, Ravi F.; Sutton, Harold G.; Beckett, Michael A.; Mauceri, Helena J.; Posner, Mitchell C.; Weichselbaum, Ralph R.			STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy	PLOS ONE			English	Article								Background: Traditionally IFN/STAT1 signaling is connected with an anti-viral response and pro-apoptotic tumor-suppressor functions. Emerging functions of a constitutively activated IFN/STAT1 pathway suggest an association with an aggressive tumor phenotype. We hypothesized that tumor clones that constitutively overexpress this pathway are preferentially selected by the host microenvironment due to a resistance to STAT1-dependent cytotoxicity and demonstrate increased metastatic ability combined with increased resistance to genotoxic stress. Methodology/Principal Findings: Here we report that clones of B16F1 tumors grown in the lungs of syngeneic C57BL/6 mice demonstrate variable transcriptional levels of IFN/STAT1 pathway expression. Tumor cells that constitutively overexpress the IFN/STAT1 pathway (STAT1(H) genotype) are selected by the lung microenvironment. STAT1(H) tumor cells also demonstrate resistance to IFN-gamma (IFN gamma), ionizing radiation (IR), and doxorubicin relative to parental B16F1 and low expressors of the IFN/STAT1 pathway (STAT1(L) genotype). Stable knockdown of STAT1 reversed the aggressive phenotype and decreased both lung colonization and resistance to genotoxic stress. Conclusions: Our results identify a pathway activated by tumor-stromal interactions thereby selecting for pro-metastatic and therapy-resistant tumor clones. New therapies targeted against the IFN/STAT1 signaling pathway may provide an effective strategy to treat or sensitize aggressive tumor clones to conventional cancer therapies and potentially prevent distant organ colonization.			Khodarev, NN (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	rrw@radonc.uchicago.edu	Beveridge, Mara/W-5950-2019	Darga, Thomas/0000-0002-8968-6701; /0000-0002-2808-722X	NATIONAL CANCER INSTITUTE [R01CA111423] Funding Source: NIH RePORTER; NCI NIH HHS [CA111423, R01 CA111423] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhanoori M, 2003, ONCOGENE, V22, P117, DOI 10.1038/sj.onc.1206065; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; EFIMOVA EV, 2009, INT J RAD B IN PRESS; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; FIDLER IJ, 1978, ISRAEL J MED SCI, V14, P38; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Friedberg JW, 2004, LEUKEMIA RES, V28, P139, DOI 10.1016/S0145-2126(03)00213-3; Fryknas M, 2007, INT J CANCER, V120, P189, DOI 10.1002/ijc.22291; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; HALLAHAN DE, 1995, NAT MED, V1, P786, DOI 10.1038/nm0895-786; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Hui ZG, 2009, INT J RADIAT ONCOL, V73, P288, DOI 10.1016/j.ijrobp.2008.08.043; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Khodarev NN, 2004, INT J CANCER, V109, P214, DOI 10.1002/ijc.11728; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Kita K, 2003, RADIAT RES, V160, P302, DOI 10.1667/RR3039; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; MAUCERI HJ, 2008, CANC GENE THER; Meistey N, 2007, EUR J CANCER, V43, P1833, DOI 10.1016/j.ejca.2007.05.028; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Rickardson L, 2005, BRIT J CANCER, V93, P483, DOI 10.1038/sj.bjc.6602699; Ries L MD, 2008, SEER CANC STAT REV 1; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; TALMADGE JE, 1982, SCIENCE, V217, P361, DOI 10.1126/science.6953592; Thomas M, 2004, CANCER RES, V64, P8357, DOI 10.1158/0008-5472.CAN-04-1864; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Townsend PA, 2005, J CELL SCI, V118, P1629, DOI 10.1242/jcs.01728; Townsend PA, 2004, J BIOL CHEM, V279, P5811, DOI 10.1074/jbc.M302637200; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Zimmerer JM, 2008, CLIN CANCER RES, V14, P1438, DOI 10.1158/1078-0432.CCR-07-4178	62	94	95	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5821	10.1371/journal.pone.0005821	http://dx.doi.org/10.1371/journal.pone.0005821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503789	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717400002
J	Rakovski, CS; Stram, DO				Rakovski, Cyril S.; Stram, Daniel O.			A Kinship-Based Modification of the Armitage Trend Test to Address Hidden Population Structure and Small Differential Genotyping Errors	PLOS ONE			English	Article							ASSOCIATION; SUSCEPTIBILITY	Background/Aims: We propose a modification of the well-known Armitage trend test to address the problems associated with hidden population structure and hidden relatedness in genome-wide case-control association studies. Methods: The new test adopts beneficial traits from three existing testing strategies: the principal components, mixed model, and genomic control while avoiding some of their disadvantageous characteristics, such as the tendency of the principal components method to over-correct in certain situations or the failure of the genomic control approach to reorder the adjusted tests based on their degree of alignment with the underlying hidden structure. The new procedure is based on Gauss-Markov estimators derived from a straightforward linear model with an imposed variance structure proportional to an empirical relatedness matrix. Lastly, conceptual and analytical similarities to and distinctions from other approaches are emphasized throughout. Results: Our simulations show that the power performance of the proposed test is quite promising compared to the considered competing strategies. The power gains are especially large when small differential differences between cases and controls are present; a likely scenario when public controls are used in multiple studies. Conclusion: The proposed modified approach attains high power more consistently than that of the existing commonly implemented tests. Its performance improvement is most apparent when small but detectable systematic differences between cases and controls exist.			Rakovski, CS (corresponding author), Chapman Univ, Dept Math & Comp Sci, Orange, CA 92866 USA.	rakovski@chapman.edu			NATIONAL CANCER INSTITUTE [P01CA017054] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069890] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA17054-27A2, P01 CA017054] Funding Source: Medline; NHGRI NIH HHS [P50 HG002790-01A1, P50 HG002790] Funding Source: Medline; NHLBI NIH HHS [U01 HL084705-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM069890, R01 GM069890-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; DELVIN B, 1999, BIOMETRICS, V55, P997; Graybill F.A., 1976, THEORY APPL LINEAR M; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Tiwari HK, 2008, HUM HERED, V66, P67, DOI 10.1159/000119107; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004	18	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5825	10.1371/journal.pone.0005825	http://dx.doi.org/10.1371/journal.pone.0005825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503792	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717400005
J	Sarnataro, D; Caputo, A; Casanova, P; Puri, C; Paladino, S; Tivodar, SS; Campana, V; Tacchetti, C; Zurzolo, C				Sarnataro, Daniela; Caputo, Anna; Casanova, Philippe; Puri, Claudia; Paladino, Simona; Tivodar, Simona S.; Campana, Vincenza; Tacchetti, Carlo; Zurzolo, Chiara			Lipid Rafts and Clathrin Cooperate in the Internalization of PrPC in Epithelial FRT Cells	PLOS ONE			English	Article								Background: The cellular prion protein (PrPC) plays a key role in the pathogenesis of Transmissible Spongiform Encephalopathies in which the protein undergoes post-translational conversion to the infectious form (PrPSc). Although endocytosis appears to be required for this conversion, the mechanism of PrPC internalization is still debated, as caveolae/raft- and clathrin-dependent processes have all been reported to be involved. Methodology/Principal Findings: We have investigated the mechanism of PrPC endocytosis in Fischer Rat Thyroid (FRT) cells, which lack caveolin-1 (cav-1) and caveolae, and in FRT/cav-1 cells which form functional caveolae. We show that PrPC internalization requires activated Cdc-42 and is sensitive to cholesterol depletion but not to cav-1 expression suggesting a role for rafts but not for caveolae in PrPC endocytosis. PrPC internalization is also affected by knock down of clathrin and by the expression of dominant negative Eps15 and Dynamin 2 mutants, indicating the involvement of a clathrin-dependent pathway. Notably, PrPC co-immunoprecipitates with clathrin and remains associated with detergent-insoluble microdomains during internalization thus indicating that PrPC can enter the cell via multiple pathways and that rafts and clathrin cooperate in its internalization. Conclusions/Significance: These findings are of particular interest if we consider that the internalization route/s undertaken by PrPC can be crucial for the ability of different prion strains to infect and to replicate in different cell lines.			Sarnataro, D (corresponding author), Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy.	zurzolo@pasteur.fr	Sarnataro, Daniela/X-5629-2019; Zurzolo, Chiara/AAH-5225-2019; Paladino, Simona/ABH-7826-2020; Paladino, Simona/J-5383-2018	Sarnataro, Daniela/0000-0002-6094-8384; Paladino, Simona/0000-0001-5332-6774; ZURZOLO, Chiara/0000-0001-6048-6602; TACCHETTI, CARLO/0000-0003-4602-000X	Telethon [GGP04147] Funding Source: Medline	Telethon(Fondazione Telethon)		Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Brown CM, 1998, J CELL SCI, V111, P271; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deinhardt K, 2007, TRAFFIC, V8, P1736, DOI 10.1111/j.1600-0854.2007.00645.x; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; Galvan C, 2005, MOL CELL NEUROSCI, V30, P304, DOI 10.1016/j.mcn.2005.07.003; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; LAMAZE C, 1995, CURR OPIN CELL BIOL, V7, P573, DOI 10.1016/0955-0674(95)80015-8; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lipardi C, 1998, J CELL BIOL, V140, P617, DOI 10.1083/jcb.140.3.617; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; Prado MAM, 2004, J NEUROCHEM, V88, P769, DOI 10.1046/j.1471-4159.2003.02199.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Sarnataro D, 2004, MOL BIOL CELL, V15, P4031, DOI 10.1091/mbc.E03-05-0271; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; Schatzl HM, 1997, J VIROL, V71, P8821; Shogomori H, 2001, J BIOL CHEM, V276, P9182, DOI 10.1074/jbc.M009414200; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STEER CJ, 1984, J CELL BIOL, V99, P315, DOI 10.1083/jcb.99.1.315; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Torgersen ML, 2001, J CELL SCI, V114, P3737; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; ZURZOLO C, 1993, J CELL BIOL, V121, P1031, DOI 10.1083/jcb.121.5.1031; Zurzolo C., 1994, CELL BIOL LAB HDB, P185	83	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5829	10.1371/journal.pone.0005829	http://dx.doi.org/10.1371/journal.pone.0005829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503793	Green Published, gold			2022-12-27	WOS:000266717400009
J	Gispert, S; Ricciardi, F; Kurz, A; Azizov, M; Hoepken, HH; Becker, D; Voos, W; Leuner, K; Muller, WE; Kudin, AP; Kunz, WS; Zimmermann, A; Roeper, J; Wenzel, D; Jendrach, M; Garcia-Arencibia, M; Fernandez-Ruiz, J; Huber, L; Rohrer, H; Barrera, M; Reichert, AS; Rub, U; Chen, A; Nussbaum, RL; Auburger, G				Gispert, Suzana; Ricciardi, Filomena; Kurz, Alexander; Azizov, Mekhman; Hoepken, Hans-Hermann; Becker, Dorothea; Voos, Wolfgang; Leuner, Kristina; Mueller, Walter E.; Kudin, Alexei P.; Kunz, Wolfram S.; Zimmermann, Annabelle; Roeper, Jochen; Wenzel, Dirk; Jendrach, Marina; Garcia-Arencibia, Moises; Fernandez-Ruiz, Javier; Huber, Leslie; Rohrer, Hermann; Barrera, Miguel; Reichert, Andreas S.; Rueb, Udo; Chen, Amy; Nussbaum, Robert L.; Auburger, Georg			Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration	PLOS ONE			English	Article								Background: Parkinson's disease (PD) is an adult-onset movement disorder of largely unknown etiology. We have previously shown that loss-of-function mutations of the mitochondrial protein kinase PINK1 (PTEN induced putative kinase 1) cause the recessive PARK6 variant of PD. Methodology/Principal Findings: Now we generated a PINK1 deficient mouse and observed several novel phenotypes: A progressive reduction of weight and of locomotor activity selectively for spontaneous movements occurred at old age. As in PD, abnormal dopamine levels in the aged nigrostriatal projection accompanied the reduced movements. Possibly in line with the PARK6 syndrome but in contrast to sporadic PD, a reduced lifespan, dysfunction of brainstem and sympathetic nerves, visible aggregates of alpha-synuclein within Lewy bodies or nigrostriatal neurodegeneration were not present in aged PINK1-deficient mice. However, we demonstrate PINK1 mutant mice to exhibit a progressive reduction in mitochondrial preprotein import correlating with defects of core mitochondrial functions like ATP-generation and respiration. In contrast to the strong effect of PINK1 on mitochondrial dynamics in Drosophila melanogaster and in spite of reduced expression of fission factor Mtp18, we show reduced fission and increased aggregation of mitochondria only under stress in PINK1-deficient mouse neurons. Conclusion: Thus, aging Pink1(-/-) mice show increasing mitochondrial dysfunction resulting in impaired neural activity similar to PD, in absence of overt neuronal death.	Univ Bonn, Med Ctr, Dept Epileptol, Bonn, Germany	University of Bonn	Gispert, S (corresponding author), Univ Med Sch, Dept Neurol, Frankfurt, Germany.	auburger@em.uni-frankfurt.de	Reichert, Andreas/A-4090-2012; Garcia-Arencibia, Moises/K-9920-2013; Kunz, Wolfram/K-1232-2019; Garcia-Arencibia, Moises/B-5538-2012; Friedland, Kristina/G-4651-2015; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018	Garcia-Arencibia, Moises/0000-0002-1618-4487; Kunz, Wolfram/0000-0003-1113-3493; Reichert, Andreas/0000-0001-9340-3113; Friedland, Kristina/0000-0001-8603-5957; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604; Muller, Werner E.G./0000-0002-8223-3689; Roeper, Jochen/0000-0003-2145-8742				Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bentivoglio AR, 2001, MOVEMENT DISORD, V16, P999, DOI 10.1002/mds.10034; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Dagda R. K., 2009, J BIOL CHEM; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Hoepken HH, 2008, EXP NEUROL, V212, P307, DOI 10.1016/j.expneurol.2008.04.004; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Kahle PJ, 2008, ACTA NEUROPATHOL, V115, P87, DOI 10.1007/s00401-007-0302-x; Keil U, 2006, BRIT J PHARMACOL, V147, P199, DOI 10.1038/sj.bjp.0706459; KENNEDY WR, 1984, NEUROSCIENCE, V11, P741, DOI 10.1016/0306-4522(84)90057-5; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; KITADA T, 2007, P NATL ACAD SCI US; Krohn AJ, 1998, J NEUROSCI, V18, P8186; Kun E, 1979, Methods Enzymol, V55, P115; Lastres-Becker I, 2005, NEUROBIOL DIS, V19, P96, DOI 10.1016/j.nbd.2004.11.009; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; Martella G, 2009, EXP NEUROL, V215, P388, DOI 10.1016/j.expneurol.2008.11.001; Mattson MP, 2007, NEUROCHEM RES, V32, P707, DOI 10.1007/s11064-006-9170-3; McBride HM, 2008, J CELL BIOL, V183, P757, DOI 10.1083/jcb.200810184; Nakajima A, 2003, CANCER LETT, V201, P195, DOI 10.1016/S0304-3835(03)00443-9; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PICCOLI C, 2008, NEUROCHEM RES; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Schestatsky P, 2006, MOVEMENT DISORD, V21, P1744, DOI 10.1002/mds.21006; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stanke M, 2006, DEVELOPMENT, V133, P141, DOI 10.1242/dev.02189; Tondera D, 2005, J CELL SCI, V118, P3049, DOI 10.1242/jcs.02415; Tondera D, 2004, J BIOL CHEM, V279, P31544, DOI 10.1074/jbc.M404704200; Truscott KN, 1999, BIOL CHEM, V380, P1151, DOI 10.1515/BC.1999.146; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wang DL, 2006, P NATL ACAD SCI USA, V103, P13520, DOI 10.1073/pnas.0604661103; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	49	264	269	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5777	10.1371/journal.pone.0005777	http://dx.doi.org/10.1371/journal.pone.0005777			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492057	Green Submitted, gold, Green Published			2022-12-27	WOS:000266624300013
J	Glass, GE; Gardner-Santana, LC; Holt, RD; Chen, J; Shields, TM; Roy, M; Schachterle, S; Klein, SL				Glass, Gregory E.; Gardner-Santana, Lynne C.; Holt, Robert D.; Chen, Jessica; Shields, Timothy M.; Roy, Manojit; Schachterle, Stephen; Klein, Sabra L.			Trophic Garnishes: Cat-Rat Interactions in an Urban Environment	PLOS ONE			English	Article								Background: Community interactions can produce complex dynamics with counterintuitive responses. Synanthropic community members are of increasing practical interest for their effects on biodiversity and public health. Most studies incorporating introduced species have been performed on islands where they may pose a risk to the native fauna. Few have examined their interactions in urban environments where they represent the majority of species. We characterized house cat (Felis catus) predation on wild Norway rats (Rattus norvegicus), and its population effects in an urban area as a model system. Three aspects of predation likely to influence population dynamics were examined; the stratum of the prey population killed by predators, the intensity of the predation, and the size of the predator population. Methodology/Principal Findings: Predation pressure was estimated from the sizes of the rat and cat populations, and the characteristics of rats killed in 20 alleys. Short and long term responses of rat population to perturbations were examined by removal trapping. Perturbations removed an average of 56% of the rats/alley but had no negative long-term impact on the size of the rat population (49.6 +/- 12.5 rats/alley and 123.8 +/- 42.2 rats/alley over two years). The sizes of the cat population during two years (3.5 animals/alley and 2.7 animals/alley) also were unaffected by rat population perturbations. Predation by cats occurred in 9/20 alleys. Predated rats were predominantly juveniles and significantly smaller (144.6 g +/- 17.8 g) than the trapped rats (385.0 g +/- 135.6 g). Cats rarely preyed on the larger, older portion of the rat population. Conclusions/Significance: The rat population appears resilient to perturbation from even substantial population reduction using targeted removal. In this area there is a relatively low population density of cats and they only occasionally prey on the rat population. This occasional predation primarily removes the juvenile proportion of the rat population. The top predator in this urban ecosystem appears to have little impact on the size of the prey population, and similarly, reduction in rat populations doesn't impact the size of the cat population. However, the selected targeting of small rats may locally influence the size structure of the population which may have consequences for patterns of pathogen transmission.			Glass, GE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.	gglass@jhsph.edu	Chen, Jessica/AAG-5989-2020	Chen, Jessica/0000-0001-8290-1299				Bonnaud E, 2007, J MAMMAL, V88, P1074, DOI 10.1644/06-MAMM-A-031R2.1; Bowers RG, 1997, J THEOR BIOL, V187, P95, DOI 10.1006/jtbi.1997.0418; BROWN RZ, 1955, AM J HYG, V6, P89; Caughley G., 1977, ANAL VERTEBRATE POPU; CHILDS J E, 1991, Bulletin of the Society for Vector Ecology, V16, P245; CHILDS JE, 1986, J MAMMAL, V67, P196, DOI 10.2307/1381025; CHILDS JE, 1987, AM J TROP MED HYG, V37, P648, DOI 10.4269/ajtmh.1987.37.648; CHILDS JE, 1982, ECOLOGY PUBLIC HLTH, P302; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DAVIS DE, 1950, AM J HYG, V52, P143, DOI 10.1093/oxfordjournals.aje.a119414; DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296; Easterbrook JD, 2008, LAB ANIM-UK, V42, P92, DOI 10.1258/la.2007.06015e; EMLEN JT, 1948, ECOLOGY, V29, P133, DOI 10.2307/1932809; Glass G.E., 1989, Occasional Papers of the Museum of Natural History University of Kansas, VNo. 130, P1; GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; JACKSON WB, 1951, J MAMMAL, V32, P458, DOI 10.2307/1375794; Jaenike J, 2002, AM NAT, V160, pS23, DOI 10.1086/342137; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Klein SL, 2002, J MAMMAL, V83, P478, DOI 10.1644/1545-1542(2002)083&lt;0478:EAPFAW&gt;2.0.CO;2; Matias R, 2008, POLAR BIOL, V31, P609, DOI 10.1007/s00300-007-0396-6; Noether G. E., 1976, INTRO STAT NONPARAME; ORGAIN H, 1953, ECOLOGY, V34, P467, DOI 10.2307/1929719; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Rayner MJ, 2007, P NATL ACAD SCI USA, V104, P20862, DOI 10.1073/pnas.0707414105; Resto-Ruiz S, 2003, DNA CELL BIOL, V22, P431, DOI 10.1089/104454903767650694; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Roy M, 2008, THEOR POPUL BIOL, V73, P319, DOI 10.1016/j.tpb.2007.12.008; STOLZENBURG W, 2008, CONSERVATION MAGAZIN, V9, P20; TODD NB, 1978, THEOR APPL GENET, V52, P257, DOI 10.1007/BF00303502	39	20	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2009	4	6							e5794	10.1371/journal.pone.0005794	http://dx.doi.org/10.1371/journal.pone.0005794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453PV	19492061	Green Published, gold, Green Submitted			2022-12-27	WOS:000266624300022
J	Dyer, GA; Serratos-Hernandez, JA; Perales, HR; Gepts, P; Pineyro-Nelson, A; Chavez, A; Salinas-Arreortua, N; Yunez-Naude, A; Taylor, JE; Alvarez-Buylla, ER				Dyer, George A.; Antonio Serratos-Hernandez, J.; Perales, Hugo R.; Gepts, Paul; Pineyro-Nelson, Alma; Chavez, Angeles; Salinas-Arreortua, Noe; Yunez-Naude, Antonio; Taylor, J. Edward; Alvarez-Buylla, Elena R.			Dispersal of Transgenes through Maize Seed Systems in Mexico	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; CRY1AB PROTEIN; GENE FLOW; CROP; LANDRACES; DIVERSITY; OAXACA; CONSERVATION; POPULATIONS; ENVIRONMENT	Objectives: Current models of transgene dispersal focus on gene flow via pollen while neglecting seed, a vital vehicle for gene flow in centers of crop origin and diversity. We analyze the dispersal of maize transgenes via seeds in Mexico, the crop's cradle. Methods: We use immunoassays (ELISA) to screen for the activity of recombinant proteins in a nationwide sample of farmer seed stocks. We estimate critical parameters of seed population dynamics using household survey data and combine these estimates with analytical results to examine presumed sources and mechanisms of dispersal. Results: Recombinant proteins Cry1Ab/Ac and CP4/EPSPS were found in 3.1% and 1.8% of samples, respectively. They are most abundant in southeast Mexico but also present in the west-central region. Diffusion of seed and grain imported from the United States might explain the frequency and distribution of transgenes in west-central Mexico but not in the southeast. Conclusions: Understanding the potential for transgene survival and dispersal should help design methods to regulate the diffusion of germplasm into local seed stocks. Further research is needed on the interactions between formal and informal seed systems and grain markets in centers of crop origin and diversification.			Dyer, GA (corresponding author), Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA.	gdyer@primal.ucdavis.edu; eabuylla@gmail.com	Perales, Hugo/F-6193-2010; Piñeyro-Nelson, Alma/AAB-5587-2020; Gepts, Paul/B-4417-2009; Gepts, Paul/O-8229-2019	Perales, Hugo/0000-0003-3431-5759; Gepts, Paul/0000-0002-1056-4665; Gepts, Paul/0000-0002-1056-4665; Pineyro-Nelson, Alma/0000-0001-7349-0096; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473				ACATZI A, 2008, DETECTION QUANTIFICA; Akiyama H, 2008, J AGR FOOD CHEM, V56, P1977, DOI 10.1021/jf0727239; Anklam E, 2002, EUR FOOD RES TECHNOL, V214, P3, DOI 10.1007/s002170100415; Arnaud JF, 2003, P ROY SOC B-BIOL SCI, V270, P1565, DOI 10.1098/rspb.2003.2407; Beckie HJ, 2008, PLANT SCI, V175, P615, DOI 10.1016/j.plantsci.2008.05.021; Bellon M., 2005, IMPACT IMPROVED MAIZ; Bellon MR, 2004, PLANT PHYSIOL, V134, P883, DOI 10.1104/pp.103.038331; Bohorova N, 1999, THEOR APPL GENET, V99, P437, DOI 10.1007/s001220051255; CEC, 2004, MAIZ BIOD EFF TRANSG; Chilcutt CF, 2004, P NATL ACAD SCI USA, V101, P7526, DOI 10.1073/pnas.0400546101; Chiueh LC, 2001, J FOOD DRUG ANAL, V9, P50; Cleveland David A., 2005, Environmental Biosafety Research, V4, P197, DOI 10.1051/ebr:2006006; Dyer GA, 2008, P NATL ACAD SCI USA, V105, P470, DOI 10.1073/pnas.0706321105; Ermolli M, 2006, ACCREDIT QUAL ASSUR, V11, P55, DOI 10.1007/s00769-005-0027-2; Espinosa Calderon A., 1999, Agricultura Tecnica en Mexico, V25, P83; EZCURRA E, 2002, LMOS ENV, P289; *FAO SAGARPA, 2001, INF NAC PROGR KIL KI; Garnier A, 2006, ECOL MODEL, V197, P373, DOI 10.1016/j.ecolmodel.2006.03.031; Gepts P, 2002, CROP SCI, V42, P1780, DOI 10.2135/cropsci2002.1780; Gepts Paul, 2003, Environmental Biosafety Research, V2, P89, DOI 10.1051/ebr:2003009; Giauffret C, 2000, CROP SCI, V40, P1004, DOI 10.2135/cropsci2000.4041004x; Hansen M.H., 1993, SAMPLE SURVEY METHOD, V1; Iyer LM, 2000, PLANT MOL BIOL, V43, P323, DOI 10.1023/A:1006412318311; KISH L, 1993, SURVEY SAMPLING; Lavigne C, 2008, J APPL ECOL, V45, P1104, DOI 10.1111/j.1365-2664.2008.01504.x; Lee D, 2006, TRENDS BIOTECHNOL, V24, P109, DOI 10.1016/j.tibtech.2006.01.006; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Ma BL, 2005, J ENVIRON SCI HEAL B, V40, P633, DOI 10.1081/PFC-200061573; Marvier M, 2005, FRONT ECOL ENVIRON, V3, P99, DOI 10.2307/3868516; Monnerat R, 2006, APPL ENVIRON MICROB, V72, P7029, DOI 10.1128/AEM.01454-06; Morris M L, 1999, 9907 CIMMYT; Ortiz-Garcia S, 2005, P NATL ACAD SCI USA, V102, P12338, DOI 10.1073/pnas.0503356102; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, pE74, DOI 10.1073/pnas.0905971106; Raven PH, 2005, P NATL ACAD SCI USA, V102, P13003, DOI 10.1073/pnas.0506082102; Sanchez JJ, 2000, ECON BOT, V54, P43, DOI 10.1007/BF02866599; Serratos J. Antonio, 1997, GENE FLOW MAIZE LAND; Serratos-Hernandez JA, 2007, FRONT ECOL ENVIRON, V5, P247, DOI 10.1890/1540-9295(2007)5[247:TPIMIT]2.0.CO;2; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Spillane C, 2001, BROADENING GENETIC B, P25, DOI DOI 10.1079/9780851994116.0025; Thiele G, 1999, WORLD DEV, V27, P83, DOI 10.1016/S0305-750X(98)00128-4; Vermij P, 2006, NAT BIOTECHNOL, V24, P1301, DOI 10.1038/nbt1106-1301; Walschus U, 2002, FOOD AGR IMMUNOL, V14, P231, DOI [10.1080/0954010021000096382, 10.1080/0954010021000096382a]; Willcox M., 1997, Transgenic plants: Bacillus thuringiensis in Mesoamerican agriculture., P98; Zwahlen C, 2003, MOL ECOL, V12, P765, DOI 10.1046/j.1365-294X.2003.01767.x	49	51	57	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5734	10.1371/journal.pone.0005734	http://dx.doi.org/10.1371/journal.pone.0005734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19503610	gold, Green Published			2022-12-27	WOS:000266490000010
J	Faurie, C; Russell, AF; Lummaa, V				Faurie, Charlotte; Russell, Andrew F.; Lummaa, Virpi			Middleborns Disadvantaged? Testing Birth-Order Effects on Fitness in Pre-Industrial Finns	PLOS ONE			English	Article							PARENTAL INVESTMENT; REPRODUCTIVE SUCCESS; CHILDHOOD MORTALITY; FAMILY-SIZE; FOLLOW-UP; FERTILITY; LIFE; HEALTH; COMPETITION; FAVORITISM	Parental investment is a limited resource for which offspring compete in order to increase their own survival and reproductive success. However, parents might be selected to influence the outcome of sibling competition through differential investment. While evidence for this is widespread in egg-laying species, whether or not this may also be the case in viviparous species is more difficult to determine. We use pre-industrial Finns as our model system and an equal investment model as our null hypothesis, which predicts that (all else being equal) middleborns should be disadvantaged through competition. We found no overall evidence to suggest that middleborns in a family are disadvantaged in terms of their survival, age at first reproduction or lifetime reproductive success. However, when considering birth-order only among same-sexed siblings, first-, middle-and lastborn sons significantly differed in the number of offspring they were able to rear to adulthood, although there was no similar effect among females. Middleborn sons appeared to produce significantly less offspring than first-or lastborn sons, but they did not significantly differ from lastborn sons in the number of offspring reared to adulthood. Our results thus show that taking sex differences into account is important when modelling birth-order effects. We found clear evidence of firstborn sons being advantaged over other sons in the family, and over firstborn daughters. Therefore, our results suggest that parents invest differentially in their offspring in order to both preferentially favour particular offspring or reduce offspring inequalities arising from sibling competition.			Faurie, C (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	charlotte.faurie@univ-montp2.fr	Lummaa, Virpi/AHB-0181-2022					ALTUS WD, 1966, SCIENCE, V151, P44, DOI 10.1126/science.151.3706.44; BALLWEG JA, 1992, POPUL RES POLICY REV, V11, P73, DOI 10.1007/BF00136395; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; BEGON M, 1986, OIKOS, V47, P293, DOI 10.2307/3565440; Beise J., 2002, HIST FAMILY, V7, P515; BELMONT L, 1973, SCIENCE, V182, P1096, DOI 10.1126/science.182.4117.1096; BIERMANN GC, 1983, ANIM BEHAV, V31, P311, DOI 10.1016/S0003-3472(83)80206-1; BIJUR PE, 1988, SOC SCI MED, V26, P839, DOI 10.1016/0277-9536(88)90176-1; BOONE JL, 1986, AM ANTHROPOL, V88, P859; BORGERHOFFMULDE.M, 1998, HUM NATURE, V9, P119; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; BRITTAIN AW, 1992, SOC SCI MED, V35, P1259, DOI 10.1016/0277-9536(92)90179-T; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Draper P, 2000, HUM NATURE-INT BIOS, V11, P117, DOI 10.1007/s12110-000-1016-0; ELLIOTT BA, 1992, SOC SCI MED, V35, P443, DOI 10.1016/0277-9536(92)90337-P; Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001; Ghalambor CK, 2000, ANIM BEHAV, V60, P263, DOI 10.1006/anbe.2000.1472; Gillespie DOS, 2008, P ROY SOC B-BIOL SCI, V275, P713, DOI 10.1098/rspb.2007.1000; Gurven M, 2006, P ROY SOC B-BIOL SCI, V273, P835, DOI 10.1098/rspb.2005.3380; Hertwig R, 2002, PSYCHOL BULL, V128, P728, DOI 10.1037//0033-2909.128.5.728; HORTON S, 1988, ECON DEV CULT CHANGE, V36, P341, DOI 10.1086/451655; HRDY SB, 1993, HUM NATURE-INT BIOS, V4, P1, DOI 10.1007/BF02734088; Hrdy SB., 1999, ANIM BEHAV, DOI DOI 10.1006/ANBE.1999.1378; Jeon J, 2008, BEHAV ECOL, V19, P344, DOI 10.1093/beheco/arm136; JOHANSSON SR, 1987, POPUL DEV REV, V13, P439, DOI 10.2307/1973134; KAPLAN BA, 1992, J BIOSOC SCI, V24, P25, DOI 10.1017/S0021932000006775; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; Keister LA, 2003, DEMOGRAPHY, V40, P521, DOI 10.1353/dem.2003.0026; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Korpelainen H, 2000, P ROY SOC B-BIOL SCI, V267, P1765, DOI 10.1098/rspb.2000.1208; Korpelainen H, 2003, AM J PHYS ANTHROPOL, V120, P384, DOI 10.1002/ajpa.10191; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; LOW BS, 1991, ETHOL SOCIOBIOL, V12, P411, DOI 10.1016/0162-3095(91)90024-K; Lummaa V, 2003, AM J HUM BIOL, V15, P370, DOI 10.1002/ajhb.10155; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Luther G., 1993, SUOMEN TILASTOTOIMEN; Mace R, 1996, BEHAV ECOL SOCIOBIOL, V38, P75, DOI 10.1007/s002650050219; MAGNUS P, 1985, EARLY HUM DEV, V12, P49, DOI 10.1016/0378-3782(85)90136-7; MARJORIBANKS K, 1989, SOC BIOL, V36, P23; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Modin B, 2002, SOC SCI MED, V54, P1051, DOI 10.1016/S0277-9536(01)00080-6; Moring B, 2003, CONTINUITY CHANGE, V18, P77, DOI 10.1017/S0268416003004508; MORING B, 1993, J FAM HIST, V18, P395, DOI 10.1177/036319909301800407; Moring B, 1996, CONTINUITY CHANGE, V11, P91, DOI 10.1017/S0268416000003106; NOWAK RM, 2005, WALKERS MARSUPIALS W; Pavard S, 2005, J BIOSOC SCI, V37, P209, DOI 10.1017/S0021932004006571; PENNINGTON R, 1988, AM J PHYS ANTHROPOL, V77, P303, DOI 10.1002/ajpa.1330770304; Pettay JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000606; POWELL B, 1993, AM SOCIOL REV, V58, P367, DOI 10.2307/2095906; Rickard IJ, 2007, P ROY SOC B-BIOL SCI, V274, P2981, DOI 10.1098/rspb.2007.1051; RICKARD IJ, 2008, EVOLUTION H IN PRESS; Rohde PA, 2003, EVOL HUM BEHAV, V24, P261, DOI 10.1016/S1090-5138(03)00033-3; Russell AF, 2003, BEHAV ECOL, V14, P486, DOI 10.1093/beheco/arg022; Salmon C, 2003, HUM NATURE-INT BIOS, V14, P73, DOI 10.1007/s12110-003-1017-x; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Slagsvold T, 1997, ANIM BEHAV, V54, P1357, DOI 10.1006/anbe.1997.0530; Smiseth PT, 2007, EVOLUTION, V61, P2331, DOI 10.1111/j.1558-5646.2007.00192.x; Stearns S.C., 1992, pi; Steelman LC, 2002, ANNU REV SOCIOL, V28, P243, DOI 10.1146/annurev.soc.28.111301.093304; TRIVERS RL, 1974, AM ZOOL, V14, P249; Voland E, 1998, ANNU REV ANTHROPOL, V27, P347, DOI 10.1146/annurev.anthro.27.1.347; VOLAND E, 1995, HUM NATURE-INT BIOS, V6, P33, DOI 10.1007/BF02734134; VOLAND E, 1987, HUMAN REPRODUCTIVE B, P253	66	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5680	10.1371/journal.pone.0005680	http://dx.doi.org/10.1371/journal.pone.0005680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	449LI	19492096	Green Accepted, Green Published, gold			2022-12-27	WOS:000266331700008
J	Duda, TF; Lee, T				Duda, Thomas F., Jr.; Lee, Taehwan			Ecological Release and Venom Evolution of a Predatory Marine Snail at Easter Island	PLOS ONE			English	Article								Background: Ecological release is coupled with adaptive radiation and ecological diversification yet little is known about the molecular basis of phenotypic changes associated with this phenomenon. The venomous, predatory marine gastropod Conus miliaris has undergone ecological release and exhibits increased dietary breadth at Easter Island. Methodology/Principal Findings: We examined the extent of genetic differentiation of two genes expressed in the venom of C. miliaris among samples from Easter Island, American Samoa and Guam. The population from Easter Island exhibits unique frequencies of alleles that encode distinct peptides at both loci. Levels of divergence at these loci exceed observed levels of divergence observed at a mitochondrial gene region at Easter Island. Conclusions/Significance: Patterns of genetic variation at two genes expressed in the venom of this C. miliaris suggest that selection has operated at these genes and contributed to the divergence of venom composition at Easter Island. These results show that ecological release is associated with strong selection pressures that promote the evolution of new phenotypes.			Duda, TF (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	tfduda@umich.edu						Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Binford GJ, 2001, BIOL J LINN SOC, V74, P581, DOI 10.1111/j.1095-8312.2001.tb01415.x; BIRKY CW, 1983, GENETICS, V103, P513; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Creer S, 2003, J MOL EVOL, V56, P317, DOI 10.1007/s00239-002-2403-4; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Duda TF, 2008, MOL ECOL, V17, P3018, DOI 10.1111/j.1365-294X.2008.03804.x; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; DUDA TF, 2009, MARINE BIOL IN PRESS; Gibbs HL, 2008, J MOL EVOL, V66, P151, DOI 10.1007/s00239-008-9067-7; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; JUKES T H, 1969, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOHN AJ, 1978, ECOL MONOGR, V48, P323, DOI 10.2307/2937234; Kohn AJ, 2001, CORAL REEFS, V20, P25; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; LEWONTIN RC, 1973, GENETICS, V74, P175; Nosil P, 2005, BIOL J LINN SOC, V86, P297, DOI 10.1111/j.1095-8312.2005.00517.x; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rehder HA., 1980, SMITHSONIAN CONTRIB, V239, P1, DOI [10.5479/si.00810282.289, DOI 10.5479/SI.00810282.289]; Rockel D, 1995, MANUAL LIVING CONIDA; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHNEIDER S, 2000, ARLEQUIN VER 2 0 SOF; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TAYLOR MFJ, 1995, SCIENCE, V270, P1497, DOI 10.1126/science.270.5241.1497; TEMPLETON AR, 1992, GENETICS, V132, P619; Van VALEN LEIGH, 1965, AMER NATUR, V99, P377, DOI 10.1086/282379; Vermeij GJ, 2000, PALEOBIOLOGY, V26, P19, DOI 10.1666/0094-8373(2000)026<0019:TMGSRP>2.0.CO;2; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	37	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5558	10.1371/journal.pone.0005558	http://dx.doi.org/10.1371/journal.pone.0005558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19462001	Green Published, Green Submitted, gold			2022-12-27	WOS:000266234700006
J	Haridas, V; Nishimura, G; Xu, ZX; Connolly, F; Hanausek, M; Walaszek, Z; Zoltaszek, R; Gutterman, JU				Haridas, Valsala; Nishimura, Goshi; Xu, Zhi-Xiang; Connolly, Fiona; Hanausek, Margaret; Walaszek, Zbigniew; Zoltaszek, Robert; Gutterman, Jordan U.			Avicin D: A Protein Reactive Plant Isoprenoid Dephosphorylates Stat 3 by Regulating Both Kinase and Phosphatase Activities	PLOS ONE			English	Article							ACACIA-VICTORIAE BENTHAM; TRITERPENOID SAPONINS; SERINE PHOSPHORYLATION; JAK/STAT PATHWAY; NATURAL-PRODUCTS; VEGF EXPRESSION; ACTIVATION; TRANSCRIPTION; APOPTOSIS; CARCINOMA	Avicins, a class of electrophilic triterpenoids with pro-apoptotic, anti-inflammatory and antioxidant properties, have been shown to induce redox-dependant post-translational modification of cysteine residues to regulate protein function. Based on (a) the cross-talk that occurs between redox and phosphorylation processes, and (b) the role of Stat3 in the process of apoptosis and carcinogenesis, we chose to study the effects of avicins on the processes of phosphorylation/ dephosphorylation in Stat3. Avicins dephosphorylate Stat3 in a variety of human tumor cell lines, leading to a decrease in the transcriptional activity of Stat3. The expression of Stat3-regulated proteins such as c-myc, cyclin D1, Bcl2, survivin and VEGF were reduced in response to avicin treatment. Underlying avicin-induced dephosphorylation of Stat3 was dephosphorylation of JAKs, as well as activation of protein phosphatase-1. Downregulation of both Stat3 activity and expression of Stat 3-controlled pro-survival proteins, contributes to the induction of apoptosis in avicin treated tumor cells. Based on the role of Stat3 in inflammation and wounding, and the in vivo inhibition of VEGF by avicins in a mouse skin carcinogenesis model, it is likely that avicin-induced inhibition of Stat3 activity results in the suppression of the pro-inflammatory and pro-oxidant stromal environment of tumors. Activation of PP-1, which also acts as a cellular economizer, combined with the redox regulation by avicins, can aid in redirecting metabolism from growth promoting anabolic to energy sparing pathways.			Haridas, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	vharidas@mdanderson.org						Alvarez JV, 2004, CANCER BIOL THER, V3, P1045, DOI 10.4161/cbt.3.11.1172; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; Blackstone NW, 2005, P ROY SOC B-BIOL SCI, V272, P527, DOI 10.1098/rspb.2004.2981; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Caceres-Cortes JR, 2008, ANTI-CANCER AGENT ME, V8, P717, DOI 10.2174/187152008785914752; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; DePinho RA, 2003, J CLIN INVEST, V111, pS9; Drahl C, 2005, ANGEW CHEM INT EDIT, V44, P5788, DOI 10.1002/anie.200500900; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Frank DA, 1999, MOL MED, V5, P432; Fung MM, 2003, CELL SIGNAL, V15, P625, DOI 10.1016/S0898-6568(03)00003-2; Gaikwad A, 2005, CLIN CANCER RES, V11, P1953, DOI 10.1158/1078-0432.CCR-04-1704; Gibbons JA, 2005, J BIOL CHEM, V280, P15903, DOI 10.1074/jbc.M500871200; Hanausek M, 2001, P NATL ACAD SCI USA, V98, P11551, DOI 10.1073/pnas.191363198; Haridas V, 2005, P NATL ACAD SCI USA, V102, P10088, DOI 10.1073/pnas.0504430102; Haridas V, 2004, J CLIN INVEST, V113, P65, DOI 10.1172/JCI200418699; Haridas V, 2001, P NATL ACAD SCI USA, V98, P5821, DOI 10.1073/pnas.101619098; Haridas V, 2001, P NATL ACAD SCI USA, V98, P11557, DOI 10.1073/pnas.191363498; Haridas V, 2007, MITOCHONDRION, V7, P234, DOI 10.1016/j.mito.2006.12.005; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Jayatilake GS, 2003, J NAT PROD, V66, P779, DOI 10.1021/np020400v; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Lemeshko VV, 2006, ARCH BIOCHEM BIOPHYS, V454, P114, DOI 10.1016/j.abb.2006.08.008; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Masuda M, 2003, CLIN CANCER RES, V9, P3486; MITSIADES CS, 2004, BLOOD, V104, P2403; Mujoo K, 2001, CANCER RES, V61, P5486; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schultz JC, 2002, NATURE, V416, P267, DOI 10.1038/416267a; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; Walsh C., 2006, POSTTRANSLATIONAL MO; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Walsh CT, 2005, NAT CHEM BIOL, V1, P122, DOI 10.1038/nchembio0805-122; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Zhang CL, 2008, J INVEST DERMATOL, V128, P2728, DOI 10.1038/jid.2008.138; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607	65	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5578	10.1371/journal.pone.0005578	http://dx.doi.org/10.1371/journal.pone.0005578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440292	gold, Green Published, Green Submitted			2022-12-27	WOS:000266107500009
J	Peng, XN; Zeng, XM; Peng, SH; Deng, DF; Zhang, J				Peng, Xiaoning; Zeng, Xiaomin; Peng, Sihua; Deng, Defeng; Zhang, Jian			The Association Risk of Male Subfertility and Testicular Cancer: A Systematic Review	PLOS ONE			English	Review								Background: An association between male subfertility and an increased risk of testicular cancer has been proposed, but conflicting results of research on this topic have rendered this theory equivocal. To more precisely assess the association between subfertility and the risk of testicular cancer, we performed a systematic review of international epidemiologic evidence. Principal Findings: We searched the Medline database for records from January 1966 to March 2008 complemented with manual searches of the literature and then identified studies that met our inclusion criteria. Study design, sample size, exposure to subfertility and risk estimates of testicular cancer incidence were abstracted. Summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated using the DerSimonian and Laird model. All statistical tests were two-sided. We identified seven case-control studies and two cohort studies published between 1987 and 2005. Analysis of the seven case-control studies that included 4,954 participants revealed an overall statistically significant association between subfertility and increased risk of testicular cancer (summary RR = 1.68, 95% CI: 1.22 to 2.31), without heterogeneity between studies (Q = 8.46, P heterogeneity = 0.21, I(2) statistics = 0.29). The association between subfertility and testicular cancer was somewhat stronger in the United States (summary RR = 1.75, 95% CI: 1.01 to 3.02) than it was in Europe (summary RR = 1.53, 95% CI: 1.22 to 1.92). The source of the control subjects had a statistically significant effect on the magnitude of the association (population-based summary-RR = 2.15, 95% CI: 1.11 to 4.17; hospital-based summary-RR = 1.56, 95% CI: 0.93 to 2.61). After excluding possible cryptorchidism, an important confounding factor, we also found a positive association between subfertility and increased risk of testicular cancer (summary RR = 1.59, 95% CI: 1.28 to 1.98). These results were consistent between studies conducted in the United States and in Europe (Q = 0.20, P heterogeneity = 0.66). Of the two cohort studies that reported standardized incidence ratios, both reported a statistically significant positive association between subfertility and increased risk of testicular cancer. Conclusions: Our findings support a relationship between subfertility and increased risk of testicular cancer and apply to the management of men with subfertility, and prevention and diagnosis of testicular cancer.			Peng, XN (corresponding author), Hunan Normal Univ, Dept Internal Med, Coll Med, Changsha, Hunan, Peoples R China.	pxiaoning@hunnu.edu.cn; zhangjian@hunnu.edu.cn						Baker JA, 2005, CANCER CAUSE CONTROL, V16, P295, DOI 10.1007/s10552-004-4024-2; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BROWN LM, 1987, J EPIDEMIOL COMMUN H, V41, P349, DOI 10.1136/jech.41.4.349; Chow V, 2006, J REPROD MED, V51, P149; de Kretser DM, 2000, BRIT MED J, V321, P781, DOI 10.1136/bmj.321.7264.781; DEPUE RH, 1983, J NATL CANCER I, V71, P1151; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8; Doria-Rose VP, 2005, CANCER CAUSE CONTROL, V16, P651, DOI 10.1007/s10552-005-0169-x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Fossa SD, 2000, BRIT J CANCER, V82, P737, DOI 10.1054/bjoc.1999.0989; Garner MJ, 2005, INT J CANCER, V116, P331, DOI 10.1002/ijc.21032; Giwercman A, 2007, REPROD BIOMED ONLINE, V15, P633, DOI 10.1016/S1472-6483(10)60530-5; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HAUGHEY BP, 1989, AM J EPIDEMIOL, V130, P25, DOI 10.1093/oxfordjournals.aje.a115319; Heimdal K, 1996, BRIT J CANCER, V73, P970, DOI 10.1038/bjc.1996.174; HENDERSON BE, 1979, INT J CANCER, V23, P598, DOI 10.1002/ijc.2910230503; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoei-Hansen CE, 2005, ANN ONCOL, V16, P863, DOI 10.1093/annonc/mdi175; HORWITZ RI, 1979, AM J MED, V66, P556, DOI 10.1016/0002-9343(79)91164-1; Huyghe E, 2003, J UROLOGY, V170, P5, DOI 10.1097/01.ju.0000053866.68623.da; Jacobsen R, 2000, BMJ-BRIT MED J, V321, P789, DOI 10.1136/bmj.321.7264.789; Jacobsen R, 2000, HUM REPROD, V15, P1958, DOI 10.1093/humrep/15.9.1958; KAHN HA, 1989, EPIDEMIOLOGY BIOSTAT, V12, pE3; Mancini M, 2007, HUM REPROD, V22, P1042, DOI 10.1093/humrep/del500; Moller H, 1999, BMJ-BRIT MED J, V318, P559, DOI 10.1136/bmj.318.7183.559; Nathanson KL, 2005, AM J HUM GENET, V77, P1034, DOI 10.1086/498455; Olesen IA, 2007, INT J ANDROL, V30, P406, DOI 10.1111/j.1365-2605.2007.00798.x; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Raman JD, 2005, J UROLOGY, V174, P1819, DOI 10.1097/01.ju.0000177491.98461.aa; Richiardi L, 2004, J NATL CANCER I, V96, P145, DOI 10.1093/jnci/djh012; Skakkebaek NE, 2006, INT J ANDROL, V29, P2, DOI 10.1111/j.1365-2605.2005.00573.x; Snick HKA, 1997, HUM REPROD, V12, P1582, DOI 10.1093/humrep/12.7.1582; SWERDLOW AJ, 1989, INT J CANCER, V43, P549, DOI 10.1002/ijc.2910430403; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Walschaerts M, 2008, CANCER CAUSE CONTROL, V19, P155, DOI 10.1007/s10552-007-9081-x; Weir HK, 2000, INT J CANCER, V87, P438, DOI 10.1002/1097-0215(20000801)87:3<438::AID-IJC20>3.0.CO;2-1; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	41	42	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5591	10.1371/journal.pone.0005591	http://dx.doi.org/10.1371/journal.pone.0005591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440348	gold, Green Submitted, Green Published			2022-12-27	WOS:000266107500019
J	Vuilleumier, S; Chistoserdova, L; Lee, MC; Bringel, F; Lajus, A; Zhou, Y; Gourion, B; Barbe, V; Chang, J; Cruveiller, S; Dossat, C; Gillett, W; Gruffaz, C; Haugen, E; Hourcade, E; Levy, R; Mangenot, S; Muller, E; Nadalig, T; Pagni, M; Penny, C; Peyraud, R; Robinson, DG; Roche, D; Rouy, Z; Saenampechek, C; Salvignol, G; Vallenet, D; Wu, ZN; Marx, CJ; Vorholt, JA; Olson, MV; Kaul, R; Weissenbach, J; Medigue, C; Lidstrom, ME				Vuilleumier, Stephane; Chistoserdova, Ludmila; Lee, Ming-Chun; Bringel, Francoise; Lajus, Aurelie; Zhou, Yang; Gourion, Benjamin; Barbe, Valerie; Chang, Jean; Cruveiller, Stephane; Dossat, Carole; Gillett, Will; Gruffaz, Christelle; Haugen, Eric; Hourcade, Edith; Levy, Ruth; Mangenot, Sophie; Muller, Emilie; Nadalig, Thierry; Pagni, Marco; Penny, Christian; Peyraud, Remi; Robinson, David G.; Roche, David; Rouy, Zoe; Saenampechek, Channakhone; Salvignol, Gregory; Vallenet, David; Wu, Zaining; Marx, Christopher J.; Vorholt, Julia A.; Olson, Maynard V.; Kaul, Rajinder; Weissenbach, Jean; Medigue, Claudine; Lidstrom, Mary E.			Methylobacterium Genome Sequences: A Reference Blueprint to Investigate Microbial Metabolism of C1 Compounds from Natural and Industrial Sources	PLOS ONE			English	Article							ACETIC-ACID BACTERIUM; EXTORQUENS AM1; METHANOL DEHYDROGENASE; METHYLOTROPHIC BACTERIA; SP-NOV.; METHYLOBACILLUS-FLAGELLATUS; OBLIGATE METHYLOTROPHY; INSERTION SEQUENCES; UTILIZATION GENES; SERINE CYCLE	Background: Methylotrophy describes the ability of organisms to grow on reduced organic compounds without carbon-carbon bonds. The genomes of two pink-pigmented facultative methylotrophic bacteria of the Alpha-proteobacterial genus Methylobacterium, the reference species Methylobacterium extorquens strain AM1 and the dichloromethane-degrading strain DM4, were compared. Methodology/Principal Findings: The 6.88 Mb genome of strain AM1 comprises a 5.51 Mb chromosome, a 1.26 Mb megaplasmid and three plasmids, while the 6.12 Mb genome of strain DM4 features a 5.94 Mb chromosome and two plasmids. The chromosomes are highly syntenic and share a large majority of genes, while plasmids are mostly strain-specific, with the exception of a 130 kb region of the strain AM1 megaplasmid which is syntenic to a chromosomal region of strain DM4. Both genomes contain large sets of insertion elements, many of them strain-specific, suggesting an important potential for genomic plasticity. Most of the genomic determinants associated with methylotrophy are nearly identical, with two exceptions that illustrate the metabolic and genomic versatility of Methylobacterium. A 126 kb dichloromethane utilization (dcm) gene cluster is essential for the ability of strain DM4 to use DCM as the sole carbon and energy source for growth and is unique to strain DM4. The methylamine utilization (mau) gene cluster is only found in strain AM1, indicating that strain DM4 employs an alternative system for growth with methylamine. The dcm and mau clusters represent two of the chromosomal genomic islands (AM1: 28; DM4: 17) that were defined. The mau cluster is flanked by mobile elements, but the dcm cluster disrupts a gene annotated as chelatase and for which we propose the name "island integration determinant'' (iid). Conclusion/Significance: These two genome sequences provide a platform for intra- and interspecies genomic comparisons in the genus Methylobacterium, and for investigations of the adaptive mechanisms which allow bacterial lineages to acquire methylotrophic lifestyles.			Vuilleumier, S (corresponding author), Univ Strasbourg, Dept Microorganismes, CNRS, UMR7156, Strasbourg, France.	vuilleumier@unistra.fr; milachis@u.washington.edu	Peyraud, Rémi/G-5226-2010; Vuilleumier, Stéphane/D-2647-2012; Muller, Emilie/J-8727-2019; Vorholt, Julia/K-3514-2016; Bringel, Francoise/AAQ-6484-2021; Muller, emilie/B-3418-2015; Gourion, Benjamin/AAG-9063-2019; Chistoserdova, Ludmila/K-2364-2017	Peyraud, Rémi/0000-0002-7580-042X; Vuilleumier, Stéphane/0000-0003-2232-7023; Muller, Emilie/0000-0002-3750-2966; Vorholt, Julia/0000-0002-6011-4910; Bringel, Francoise/0000-0002-4529-5143; Muller, emilie/0000-0002-3750-2966; Gourion, Benjamin/0000-0001-5768-6961; Chistoserdova, Ludmila/0000-0002-5777-0263; Vallenet, David/0000-0001-6648-0332; Kaul, Rajinder/0000-0002-7895-9284; Pagni, Marco/0000-0001-9292-9463; Gruffaz, Christelle/0000-0001-5709-0527; Haugen, Eric/0000-0001-7444-8981	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058933] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 58933, R01 GM058933] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Afolabi PR, 2001, BIOCHEMISTRY-US, V40, P9799, DOI 10.1021/bi002932l; Anthony C., 1982, BIOCH METHYLOTROPHS; Bauer M, 2004, J MOL EVOL, V59, P571, DOI 10.1007/s00239-004-2643-6; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; Boyer F, 2005, BIOINFORMATICS, V21, P4209, DOI 10.1093/bioinformatics/bti711; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Cevallos MA, 2008, PLASMID, V60, P19, DOI 10.1016/j.plasmid.2008.03.001; Chandler M, 2002, MOBILE DNA, V2, P305; CHISTOSERDOV AY, 1994, J BACTERIOL, V176, P4052, DOI 10.1128/JB.176.13.4052-4065.1994; Chistoserdova L, 2005, ASM NEWS, V71, P521; Chistoserdova L, 2004, MOL BIOL EVOL, V21, P1234, DOI 10.1093/molbev/msh113; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chistoserdova L, 2000, MICROBIOL-SGM, V146, P233, DOI 10.1099/00221287-146-1-233; Chistoserdova L, 1997, MICROBIOL-UK, V143, P1729, DOI 10.1099/00221287-143-5-1729; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P9076, DOI 10.1128/JB.01229-07; Chistoserdova L, 2007, J BACTERIOL, V189, P4020, DOI 10.1128/JB.00045-07; CHISTOSERDOVA LV, 1994, J BACTERIOL, V176, P7398, DOI 10.1128/JB.176.23.7398-7404.1994; Crowther GJ, 2008, J BACTERIOL, V190, P5057, DOI 10.1128/JB.00228-08; Davidson VL, 2001, ADV PROTEIN CHEM, V58, P95; Denef VJ, 2005, J BACTERIOL, V187, P7996, DOI 10.1128/JB.187.23.7996-8005.2005; Doronina NV, 2000, SYST APPL MICROBIOL, V23, P210, DOI 10.1016/S0723-2020(00)80007-7; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Fukuda N, 2005, J MUSCLE RES CELL M, V26, P319, DOI 10.1007/s10974-005-9038-1; Galbally IE, 2002, J ATMOS CHEM, V43, P195, DOI 10.1023/A:1020684815474; GALLI R, 1985, CONSERV RECYCLING, V8, P91, DOI 10.1016/0361-3658(85)90028-1; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; Giovannoni SJ, 2008, ENVIRON MICROBIOL, V10, P1771, DOI 10.1111/j.1462-2920.2008.01598.x; Gisi D, 1999, ARCH TOXICOL, V73, P71, DOI 10.1007/s002040050589; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Greenberg DE, 2007, J BACTERIOL, V189, P8727, DOI 10.1128/JB.00793-07; Greenberg DE, 2006, INT J SYST EVOL MICR, V56, P2609, DOI 10.1099/ijs.0.64412-0; Guo XF, 2008, BIOTECHNOL BIOENG, V99, P929, DOI 10.1002/bit.21652; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Jourand P, 2004, INT J SYST EVOL MICR, V54, P2269, DOI 10.1099/ijs.0.02902-0; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kalyuzhnaya MG, 2008, J BACTERIOL, V190, P3817, DOI 10.1128/JB.00180-08; Kalyuzhnaya MG, 2006, INT J SYST EVOL MICR, V56, P2517, DOI 10.1099/ijs.0.64422-0; Kalyuzhnaya MG, 2005, J BACTERIOL, V187, P7511, DOI 10.1128/JB.187.21.7511-7517.2005; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Kato Y, 2005, J GEN APPL MICROBIOL, V51, P287, DOI 10.2323/jgam.51.287; Kayser MF, 2002, MICROBIOL-SGM, V148, P1915, DOI 10.1099/00221287-148-6-1915; Kayser MF, 2001, J BACTERIOL, V183, P5209, DOI 10.1128/JB.183.17.5209-5212.2001; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; Khalil MAK, 1999, J GEOPHYS RES-ATMOS, V104, P8333, DOI 10.1029/1998JD100079; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Lidstrom ME, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P618, DOI 10.1007/0-387-30742-7_20; Lidstrom ME, 2002, J BACTERIOL, V184, P1818, DOI 10.1128/JB.184.7.1818.2002; Marx Christopher J, 2008, BMC Res Notes, V1, P1, DOI 10.1186/1756-0500-1-1; Marx CJ, 2005, PLOS BIOL, V3, P244, DOI 10.1371/journal.pbio.0030016; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; Marx CJ, 2003, J BACTERIOL, V185, P7169, DOI 10.1128/JB.185.24.7169-7175.2003; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; Marx CJ, 2004, MICROBIOL-SGM, V150, P9, DOI 10.1099/mic.0.26587-0; Marx CJ, 2003, J BACTERIOL, V185, P669, DOI 10.1128/JB.185.2.669-673.2003; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; McCulloch A, 1999, J GEOPHYS RES-ATMOS, V104, P8417, DOI 10.1029/1999JD900011; McPherran M. L., 2002, BIOTECHNOLOGY ENV ST, V35, P105; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Necsulea A, 2007, MOL BIOL EVOL, V24, P2169, DOI 10.1093/molbev/msm148; Neff JC, 2002, BIOGEOCHEMISTRY, V57, P99, DOI 10.1023/A:1015791622742; NIETOPENALVER CG, 2006, J BACTERIOL, V188, P7321; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; PEEL D, 1961, BIOCHEM J, V81, P465, DOI 10.1042/bj0810465; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Pomper BK, 1999, EUR J BIOCHEM, V261, P475, DOI 10.1046/j.1432-1327.1999.00291.x; RAS J, 1995, J BACTERIOL, V177, P247, DOI 10.1128/jb.177.1.247-251.1995; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; SchmidAppert M, 1997, MICROBIOL-SGM, V143, P2557, DOI 10.1099/00221287-143-8-2557; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Starkenburg SR, 2008, APPL ENVIRON MICROB, V74, P2852, DOI 10.1128/AEM.02311-07; Starr TB, 2006, TOXICOL SCI, V91, P20, DOI 10.1093/toxsci/kfj145; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; TAYLOR IJ, 1976, J GEN MICROBIOL, V93, P259, DOI 10.1099/00221287-93-2-259; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Van Aken B, 2004, APPL ENVIRON MICROB, V70, P508, DOI 10.1128/AEM.70.1.508-517.2004; Van Dien SJ, 2003, MICROBIOL-SGM, V149, P601, DOI 10.1099/mic.0.25955-0; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Vorholt JA, 1998, J BACTERIOL, V180, P5351, DOI 10.1128/JB.180.20.5351-5356.1998; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Vuilleumier S, 2001, MICROBIOL-SGM, V147, P611, DOI 10.1099/00221287-147-3-611; Wagner A, 2007, NUCLEIC ACIDS RES, V35, P5284, DOI 10.1093/nar/gkm597; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Williams PA, 2005, ACTA CRYSTALLOGR D, V61, P75, DOI 10.1107/S0907444904026964; Wilson SM, 2008, MICROBIOL-SGM, V154, P296, DOI 10.1099/mic.0.2007/011346-0	93	168	249	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5584	10.1371/journal.pone.0005584	http://dx.doi.org/10.1371/journal.pone.0005584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440302	Green Published, gold			2022-12-27	WOS:000266107500013
J	Depaulis, F; Orlando, L; Hanni, C				Depaulis, Frantz; Orlando, Ludovic; Haenni, Catherine			Using Classical Population Genetics Tools with Heterochroneous Data: Time Matters!	PLOS ONE			English	Article							ANCIENT DNA EVIDENCE; BEAR URSUS-SPELAEUS; MITOCHONDRIAL-DNA; CAVE BEAR; LINKAGE DISEQUILIBRIUM; NEUTRALITY TESTS; SEGREGATING SITES; BROWN BEAR; RECOMBINATION; EVOLUTION	Background: New polymorphism datasets from heterochroneous data have arisen thanks to recent advances in experimental and microbial molecular evolution, and the sequencing of ancient DNA (aDNA). However, classical tools for population genetics analyses do not take into account heterochrony between subsets, despite potential bias on neutrality and population structure tests. Here, we characterize the extent of such possible biases using serial coalescent simulations. Methodology/Principal Findings: We first use a coalescent framework to generate datasets assuming no or different levels of heterochrony and contrast most classical population genetic statistics. We show that even weak levels of heterochrony (similar to 10% of the average depth of a standard population tree) affect the distribution of polymorphism substantially, leading to overestimate the level of polymorphism h, to star like trees, with an excess of rare mutations and a deficit of linkage disequilibrium, which are the hallmark of e. g. population expansion (possibly after a drastic bottleneck). Substantial departures of the tests are detected in the opposite direction for more heterochroneous and equilibrated datasets, with balanced trees mimicking in particular population contraction, balancing selection, and population differentiation. We therefore introduce simple corrections to classical estimators of polymorphism and of the genetic distance between populations, in order to remove heterochrony-driven bias. Finally, we show that these effects do occur on real aDNA datasets, taking advantage of the currently available sequence data for Cave Bears (Ursus spelaeus), for which large mtDNA haplotypes have been reported over a substantial time period (22-130 thousand years ago (KYA)). Conclusions/Significance: Considering serial sampling changed the conclusion of several tests, indicating that neglecting heterochrony could provide significant support for false past history of populations and inappropriate conservation decisions. We therefore argue for systematically considering heterochroneous models when analyzing heterochroneous samples covering a large time scale.			Depaulis, F (corresponding author), UPMC Paris Univ, CNRS, Ecol Lab, Ecole Normale Super,UMR 7625, Paris, France.	depaulis@ens.fr	Orlando, Ludovic/A-8932-2013	Orlando, Ludovic/0000-0003-3936-1850; Depaulis, Frantz/0000-0001-5761-2751				Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196; Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Axelsson E, 2008, MOL BIOL EVOL, V25, P2181, DOI 10.1093/molbev/msn163; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Baudry E, 2003, GENETICS, V165, P1619; Belle EMS, 2006, P NATL ACAD SCI USA, V103, P8012, DOI 10.1073/pnas.0509718103; Calvignac S, 2008, MOL ECOL, V17, P1962, DOI 10.1111/j.1365-294X.2008.03631.x; Chan YL, 2006, PLOS GENET, V2, P451, DOI 10.1371/journal.pgen.0020059; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Depaulis F, 2003, J MOL EVOL, V57, pS190, DOI 10.1007/s00239-003-0027-y; Depaulis F, 2005, MOL B INT U, P34, DOI 10.1007/0-387-27651-3_4; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2002, GENETICS, V161, P1307; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Fay JC, 2000, GENETICS, V155, P1405; Forsberg R, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-35; FU YX, 1993, GENETICS, V133, P693; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Hadly EA, 1998, P NATL ACAD SCI USA, V95, P6893, DOI 10.1073/pnas.95.12.6893; HANNI C, 1994, P NATL ACAD SCI USA, V91, P12336, DOI 10.1073/pnas.91.25.12336; Hansen AJ, 2006, GENETICS, V173, P1175, DOI 10.1534/genetics.106.057349; Hey J, 2000, TRENDS ECOL EVOL, V15, P181, DOI 10.1016/S0169-5347(00)01856-5; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, BIOL LETTERS, V3, P702, DOI 10.1098/rsbl.2007.0377; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Hofreiter M, 2004, CURR BIOL, V14, P40, DOI 10.1016/j.cub.2003.12.035; Hofreiter M, 2002, MOL BIOL EVOL, V19, P1244, DOI 10.1093/oxfordjournals.molbev.a004185; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P23; HUDSON RR, 1992, GENETICS, V132, P583; HUDSON RR, 1985, GENETICS, V111, P147; Innan H, 2002, MOL BIOL EVOL, V19, P1122, DOI 10.1093/oxfordjournals.molbev.a004170; Kelly JK, 1997, GENETICS, V146, P1197; Kivisild T, 2000, Science, V288, P1931; Kuhn R, 2001, ACTA THERIOL, V46, P61, DOI 10.1007/BF03192417; KURTEN B, 1976, CAVE BEAR STORY; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Lenski RE, 2003, J MOL EVOL, V56, P498, DOI 10.1007/s00239-002-2423-0; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Liu XM, 2008, THEOR POPUL BIOL, V74, P56, DOI 10.1016/j.tpb.2008.04.006; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Malmstrom H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-71; Mazza Paul, 1994, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V230, P1; McVean GAT, 2002, GENETICS, V162, P987; Meunier J, 2001, MOL BIOL EVOL, V18, P2132, DOI 10.1093/oxfordjournals.molbev.a003756; OHTA T, 1982, GENETICS, V101, P139; Orlando L, 2002, MOL BIOL EVOL, V19, P1920, DOI 10.1093/oxfordjournals.molbev.a004016; OTTE M, 1998, RECHERCHES GROTTES S, V2, P79; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Piganeau G, 2004, HEREDITY, V92, P282, DOI 10.1038/sj.hdy.6800413; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Ramakrishnan U, 2005, MOL ECOL, V14, P2915, DOI 10.1111/j.1365-294X.2005.02586.x; Raquin AL, 2008, GENETICS, V179, P2195, DOI 10.1534/genetics.107.071332; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Saccone C, 2002, GENE, V286, P3, DOI 10.1016/S0378-1119(01)00807-1; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Valdiosera C, 2006, BIOL LETT-UK, V2, P601, DOI 10.1098/rsbl.2006.0515; Valdiosera CE, 2008, P NATL ACAD SCI USA, V105, P5123, DOI 10.1073/pnas.0712223105; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; van Tuinen M, 2004, PHILOS T R SOC A, V362, P2795, DOI 10.1098/rsta.2004.1465; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Williamson EG, 1999, GENETICS, V152, P755; Wiuf C, 2001, GENETICS, V159, P749; Wright S, 1931, GENETICS, V16, P0097	74	35	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5541	10.1371/journal.pone.0005541	http://dx.doi.org/10.1371/journal.pone.0005541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19440242	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107300007
J	Vitalo, A; Fricchione, J; Casali, M; Berdichevsky, Y; Hoge, EA; Rauch, SL; Berthiaume, F; Yarmush, ML; Benson, H; Fricchione, GL; Levine, JB				Vitalo, Antonia; Fricchione, Jonathan; Casali, Monica; Berdichevsky, Yevgeny; Hoge, Elizabeth A.; Rauch, Scott L.; Berthiaume, Francois; Yarmush, Martin L.; Benson, Herbert; Fricchione, Gregory L.; Levine, John B.			Nest Making and Oxytocin Comparably Promote Wound Healing in Isolation Reared Rats	PLOS ONE			English	Article								Background: Environmental enrichment (EE) fosters attachment behavior through its effect on brain oxytocin levels in the hippocampus and other brain regions, which in turn modulate the hypothalamic-pituitary axis (HPA). Social isolation and other stressors negatively impact physical healing through their effect on the HPA. Therefore, we reasoned that: 1) provision of a rat EE (nest building with NestletsH) would improve wound healing in rats undergoing stress due to isolation rearing and 2) that oxytocin would have a similar beneficial effect on wound healing. Methodology/Principal Findings: In the first two experiments, we provided isolation reared rats with either EE or oxytocin and compared their wound healing to group reared rats and isolation reared rats that did not receive Nestlets or oxytocin. In the third experiment, we examined the effect of Nestlets on open field locomotion and immediate early gene (IEG) expression. We found that isolation reared rats treated with Nestlets a) healed significantly better than without Nestlets, 2) healed at a similar rate to rats treated with oxytocin, 3) had decreased hyperactivity in the open field test, and 4) had normalized IEG expression in brain hippocampus. Conclusions/Significance: This study shows that when an EE strategy or oxytocin is given to isolation reared rats, the peripheral stress response, as measured by burn injury healing, is decreased. The findings indicate an association between the effect of nest making on wound healing and administration of the pro-bonding hormone oxytocin. Further elucidation of this animal model should lead to improved understanding of how EE strategies can ameliorate poor wound healing and other symptoms that result from isolation stress.			Vitalo, A (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.	gfricchione@partners.org; jblevine@partners.org	Berthiaume, Francois/ABD-2139-2020; Hoge, Elizabeth A/H-5879-2012; Levine, John/G-6221-2015	Hoge, Elizabeth A/0000-0002-5513-2292; Berdichevsky, Yevgeny/0000-0001-7539-601X; Yarmush, Martin/0000-0003-4986-8444				Antonawich FJ, 1997, BRAIN RES, V764, P249, DOI 10.1016/S0006-8993(97)00488-5; Belz EE, 2003, PHARMACOL BIOCHEM BE, V76, P481, DOI 10.1016/j.pbb.2003.09.005; Bond TLY, 2002, PHYSIOL BEHAV, V75, P551, DOI 10.1016/S0031-9384(02)00659-5; Calamandrei Gemma, 2004, Ann Ist Super Sanita, V40, P195; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; DeVries AC, 2007, PSYCHONEUROENDOCRINO, V32, P587, DOI 10.1016/j.psyneuen.2007.04.007; Cui SS, 2001, J NEUROSCI, V21, P9867, DOI 10.1523/JNEUROSCI.21-24-09867.2001; De Kloet ER, 2004, ANN NY ACAD SCI, V1032, P14, DOI 10.1196/annals.1314.003; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DEKLOET ER, 1994, PSYCHONEUROENDOCRINO, V19, P121, DOI 10.1016/0306-4530(94)90002-7; Detillion CE, 2004, PSYCHONEUROENDOCRINO, V29, P1004, DOI 10.1016/j.psyneuen.2003.10.003; Diaz-Cabiale Z, 2004, J NEUROENDOCRINOL, V16, P183, DOI 10.1111/j.0953-8194.2004.01146.x; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; GALLITANOMENDEL A, 2007, NEUROSCIENCE; Glaser R, 1999, ARCH GEN PSYCHIAT, V56, P450, DOI 10.1001/archpsyc.56.5.450; Glasper ER, 2005, BRAIN BEHAV IMMUN, V19, P61, DOI 10.1016/j.bbi.2004.03.002; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Holst S, 2002, AUTON NEUROSCI-BASIC, V99, P85, DOI 10.1016/S1566-0702(02)00134-0; Iseri SO, 2008, BURNS, V34, P361, DOI 10.1016/j.burns.2007.03.022; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377; KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001; Kovacs GL, 1998, PSYCHONEUROENDOCRINO, V23, P945; Lapiz M D S, 2003, Neurosci Behav Physiol, V33, P13, DOI 10.1023/A:1021171129766; Levine JB, 2008, NEUROSCIENCE, V151, P589, DOI 10.1016/j.neuroscience.2007.10.014; Levine JB, 2007, NEUROSCIENCE, V145, P42, DOI 10.1016/j.neuroscience.2006.11.063; Li X, 2006, LIFE SCI, V78, P1933, DOI 10.1016/j.lfs.2005.08.002; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; Meaney MJ, 2000, J NEUROSCI, V20, P3926, DOI 10.1523/JNEUROSCI.20-10-03926.2000; Mercado AM, 2002, BRAIN BEHAV IMMUN, V16, P150, DOI 10.1006/brbi.2001.0623; Mercado AM, 2002, J NEUROIMMUNOL, V129, P74, DOI 10.1016/S0165-5728(02)00174-1; Moriceau S, 2005, DEV PSYCHOBIOL, V47, P230, DOI 10.1002/dev.20093; Padgett DA, 1998, BRAIN BEHAV IMMUN, V12, P64, DOI 10.1006/brbi.1997.0512; PETERSOHN D, 1995, J BIOL CHEM, V270, P24361, DOI 10.1074/jbc.270.41.24361; Petersson M, 1999, NEUROSCI LETT, V264, P41, DOI 10.1016/S0304-3940(99)00159-7; Petersson M, 1998, N-S ARCH PHARMACOL, V357, P701, DOI 10.1007/PL00005227; Petersson M, 2005, MATURITAS, V51, P426, DOI 10.1016/j.maturitas.2004.10.005; Petersson M, 2003, NEUROSCI LETT, V343, P97, DOI 10.1016/S0304-3940(03)00334-3; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tarrier N, 2005, BURNS, V31, P45, DOI 10.1016/j.burns.2004.06.010; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004	47	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5523	10.1371/journal.pone.0005523	http://dx.doi.org/10.1371/journal.pone.0005523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436750	Green Published, gold			2022-12-27	WOS:000266009900015
J	Takizawa, R; Tochigi, M; Kawakubo, Y; Marumo, K; Sasaki, T; Fukuda, M; Kasai, K				Takizawa, Ryu; Tochigi, Mamoru; Kawakubo, Yuki; Marumo, Kohei; Sasaki, Tsukasa; Fukuda, Masato; Kasai, Kiyoto			Association between Catechol-O-Methyltrasferase Val108/158Met Genotype and Prefrontal Hemodynamic Response in Schizophrenia	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; VAL(108/158) MET GENOTYPE; WORKING-MEMORY DEFICITS; FRONTAL-LOBE FUNCTION; VERBAL FLUENCY TASK; HUMAN BRAIN; BIPOLAR DISORDER; BLOOD-FLOW; COMT; METHYLTRANSFERASE	Background: "Imaging genetics'' studies have shown that brain function by neuroimaging is a sensitive intermediate phenotype that bridges the gap between genes and psychiatric conditions. Although the evidence of association between functional val108/158met polymorphism of the catechol-O-methyltransferase gene (COMT) and increasing risk for developing schizophrenia from genetic association studies remains to be elucidated, one of the most topical findings from imaging genetics studies is the association between COMT genotype and prefrontal function in schizophrenia. The next important step in the translational approach is to establish a useful neuroimaging tool in clinical settings that is sensitive to COMT variation, so that the clinician could use the index to predict clinical response such as improvement in cognitive dysfunction by medication. Here, we investigated spatiotemporal characteristics of the association between prefrontal hemodynamic activation and the COMT genotype using a noninvasive neuroimaging technique, near-infrared spectroscopy (NIRS). Methodology/Principal Findings: Study participants included 45 patients with schizophrenia and 60 healthy controls matched for age and gender. Signals that are assumed to reflect regional cerebral blood volume were monitored over prefrontal regions from 52-channel NIRS and compared between two COMT genotype subgroups (Met carriers and Val/Val individuals) matched for age, gender, premorbid IQ, and task performance. The [oxy-Hb] increase in the Met carriers during the verbal fluency task was significantly greater than that in the Val/Val individuals in the frontopolar prefrontal cortex of patients with schizophrenia, although neither medication nor clinical symptoms differed significantly between the two subgroups. These differences were not found to be significant in healthy controls. Conclusions/Significance: These data suggest that the prefrontal NIRS signals can noninvasively detect the impact of COMT variation in patients with schizophrenia. NIRS may be a promising candidate translational approach in psychiatric neuroimaging.			Takizawa, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.	takizawar-tky@umin.ac.jp		Kasai, Kiyoto/0000-0002-4443-4535				Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Bertolino A, 2004, AM J PSYCHIAT, V161, P1798, DOI 10.1176/appi.ajp.161.10.1798; Bertolino A, 2007, SCHIZOPHR RES, V95, P253, DOI 10.1016/j.schres.2007.06.014; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Brahmbhatt SB, 2006, SCHIZOPHR RES, V87, P191, DOI 10.1016/j.schres.2006.05.019; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; DESIMONE R, 1995, NATURE, V376, P549, DOI 10.1038/376549a0; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ehlis AC, 2007, NEUROPSYCHOPHARMACOL, V32, P162, DOI 10.1038/sj.npp.1301151; Elfgren CI, 1998, NEUROPSYCHOLOGIA, V36, P505, DOI 10.1016/S0028-3932(97)00146-2; First M. B., 1997, STRUCTURED CLIN INTE; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kuwabara H, 2006, BEHAV BRAIN RES, V172, P272, DOI 10.1016/j.bbr.2006.05.020; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001760; Lee SG, 2005, HUM GENET, V116, P319, DOI 10.1007/s00439-004-1239-y; Li T, 2000, MOL PSYCHIATR, V5, P452, DOI 10.1038/sj.mp.4000752; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Lu BY, 2007, BIOL PSYCHIAT, V62, P822, DOI 10.1016/j.biopsych.2006.11.030; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Matsuo K, 2003, PSYCHOPHYSIOLOGY, V40, P492, DOI 10.1111/1469-8986.00051; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Moore H, 1999, BIOL PSYCHIAT, V46, P40, DOI 10.1016/S0006-3223(99)00078-5; Munafo MR, 2005, MOL PSYCHIATR, V10, P765, DOI 10.1038/sj.mp.4001664; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ohnishi T, 2006, BRAIN, V129, P399, DOI 10.1093/brain/awh702; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Roffman JL, 2006, HARVARD REV PSYCHIAT, V14, P78, DOI 10.1080/10673220600642945; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Sesack SR, 1998, J NEUROSCI, V18, P2697; SHAM PC, 1994, BRIT J PSYCHIAT, V165, P466, DOI 10.1192/bjp.165.4.466; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Takizawa R, 2008, SCHIZOPHR RES, V99, P250, DOI 10.1016/j.schres.2007.10.025; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004; Weickert TW, 2004, BIOL PSYCHIAT, V56, P677, DOI 10.1016/j.biopsych.2004.08.012; Weinberger DR, 2001, BIOL PSYCHIAT, V50, P825, DOI 10.1016/S0006-3223(01)01252-5; Williams HJ, 2005, AM J PSYCHIAT, V162, P1736, DOI 10.1176/appi.ajp.162.9.1736; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Woodward ND, 2007, SCHIZOPHR RES, V90, P86, DOI 10.1016/j.schres.2006.10.002; Yamashita Y, 1996, OPT ENG, V35, P1046, DOI 10.1117/1.600721	67	33	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5495	10.1371/journal.pone.0005495	http://dx.doi.org/10.1371/journal.pone.0005495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	443TN	19424500	Green Submitted, Green Published, gold			2022-12-27	WOS:000265933800022
J	Chokejindachai, W; Conway, DJ				Chokejindachai, Watcharee; Conway, David J.			Case-Control Approach to Identify Plasmodium falciparum Polymorphisms Associated with Severe Malaria	PLOS ONE			English	Article								Background: Studies to identify phenotypically-associated polymorphisms in the Plasmodium falciparum 23 Mb genome will require a dense array of marker loci. It was considered promising to undertake initial allelic association studies to prospect for virulence polymorphisms in Thailand, as the low endemicity would allow higher levels of linkage disequilibrium (LD) than would exist in more highly endemic areas. Methodology/Principal Findings: Assessment of LD was first made with 11 microsatellite loci widely dispersed in the parasite genome, and 16 microsatellite loci covering a,140 kb region of chromosome 2 (an arbitrarily representative non-telomeric part of the genome), in a sample of 100 P. falciparum isolates. The dispersed loci showed minimal LD (Index of Association, I(A)(S) = 0.013, P = 0.10), while those on chromosome 2 showed significant LD values mostly between loci,5 kb apart. A disease association study was then performed comparing parasites in 113 severe malaria cases and 245 mild malaria controls. Genotyping was performed on almost all polymorphisms in the binding domains of three erythrocyte binding antigens (eba175, eba140 and eba181), and repeat sequence polymorphisms,2 kb apart in each of three reticulocyte binding homologues (Rh1, Rh2a/b, and Rh4). Differences between cases and controls were seen for (i) codons 388-90 in eba175, and (ii) a repeat sequence centred on Rh1 codon 667. Conclusions/Significance: Allelic association studies on P. falciparum require dense genotypic markers, even in a population of only moderate endemicity that has more extensive LD than highly endemic populations. Disease-associated polymorphisms in the eba175 and Rh1 genes encode differences in the middle of previously characterised erythrocyte binding domains, marking these for further investigation.			Chokejindachai, W (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	dconway@mrc.gm		Conway, David/0000-0002-8711-3037	Medical Research Council [MC_U190081987, G9803180] Funding Source: Medline; MRC [MC_U190081987] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amodu OK, 2008, ANN TROP MED PARASIT, V102, P95, DOI 10.1179/136485908X252340; Anderson Tim J. C., 2004, Current Drug Targets - Infectious Disorders, V4, P65, DOI 10.2174/1568005043480943; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338; Ariey F, 2001, J INFECT DIS, V184, P237, DOI 10.1086/322012; Baum J, 2003, GENETICS, V163, P1327; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CONSORTIUM M, 2008, NATURE, V456, P732; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cramer JP, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-11; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; ENGELBRECHT F, 1995, EXP PARASITOL, V81, P90, DOI 10.1006/expr.1995.1096; Faiz MA, 2005, LANCET, V366, P717; Gao XH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000104; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07; Kun JFJ, 1998, T ROY SOC TROP MED H, V92, P110, DOI 10.1016/S0035-9203(98)90979-8; Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004; Lobo CA, 2006, MOL BIOCHEM PARASIT, V149, P246, DOI 10.1016/j.molbiopara.2006.05.011; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Mayer DCG, 2004, P NATL ACAD SCI USA, V101, P2518, DOI 10.1073/pnas.0307318101; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; OTSUKI H, 2009, P NATL ACAD SCI US; PATTARADILOKRAT S, 2009, P NATL ACAD SCI US; Pearce R, 2005, MOL BIOL EVOL, V22, P1834, DOI 10.1093/molbev/msi177; Polley SD, 2003, GENETICS, V165, P555; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Razakandrainibe FG, 2005, P NATL ACAD SCI USA, V102, P17388, DOI 10.1073/pnas.0508871102; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sakihama N, 1999, GENE, V230, P47, DOI 10.1016/S0378-1119(99)00069-4; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Toure FS, 2006, CLIN MED RES, V4, P7, DOI 10.3121/cmr.4.1.7; Vannaphan Suparp, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P385; Verra F, 2006, MOL BIOCHEM PARASIT, V149, P182, DOI 10.1016/j.molbiopara.2006.05.010; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	52	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5454	10.1371/journal.pone.0005454	http://dx.doi.org/10.1371/journal.pone.0005454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421327	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000265836900010
J	Rauch, M; Tussiwand, R; Bosco, N; Rolink, AG				Rauch, Melanie; Tussiwand, Roxane; Bosco, Nabil; Rolink, Antonius G.			Crucial Role for BAFF-BAFF-R Signaling in the Survival and Maintenance of Mature B Cells	PLOS ONE			English	Article							NF-KAPPA-B; LYMPHOCYTE STIMULATOR; CUTTING EDGE; MONOCLONAL-ANTIBODY; AUTOIMMUNE-DISEASE; RECEPTOR; MICE; EXPRESSION; MATURATION; APOPTOSIS	Defects in the expression of either BAFF (B cell activating factor) or BAFF-R impairs B cell development beyond the immature, transitional type-1 stage and thus, prevents the formation of follicular and marginal zone B cells, whereas B-1 B cells remain unaffected. The expression of BAFF-R on all mature B cells might suggest a role for BAFF-R signaling also for their in vivo maintenance. Here, we show that, 14 days following a single injection of an anti-BAFF-R mAb that prevents BAFF binding, both follicular and marginal zone B cell numbers are drastically reduced, whereas B-1 cells are not affected. Injection of control, isotype-matched but non-blocking anti-BAFF-R mAbs does not result in B cell depletion. We also show that this depletion is neither due to antibody-dependent cellular cytotoxicity nor to complement-mediated lysis. Moreover, prevention of BAFF binding leads to a decrease in the size of the B cell follicles, an impairment of a T cell dependent humoral immune response and a reduction in the formation of memory B cells. Collectively, these results establish a central role for BAFF-BAFF-R signaling in the in vivo survival and maintenance of both follicular and marginal zone B cell pools.			Rauch, M (corresponding author), Univ Basel, Dept Biomed DBM, Basel, Switzerland.	antonius.rolink@unibas.ch	Bosco, Nabil/AAD-1579-2022	Tussiwand, Roxane/0000-0002-1712-868X				Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1992, J IMMUNOL, V149, P2533; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gerondakis S, 2003, SEMIN IMMUNOL, V15, P159, DOI 10.1016/S1044-5323(03)00036-8; Gorelik L, 2004, J IMMUNOL, V172, P762, DOI 10.4049/jimmunol.172.2.762; GORONZY J, 1986, J EXP MED, V164, P911, DOI 10.1084/jem.164.3.911; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; GROSS TM, 2000, DIABETES TECHNOL THE, V2, P19, DOI DOI 10.1089/15209150050214087; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Kalled SL, 2005, IMMUNOL REV, V204, P43, DOI 10.1111/j.0105-2896.2005.00219.x; Kern C, 2004, BLOOD, V103, P679, DOI 10.1182/blood-2003-02-0540; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lin WY, 2007, BLOOD, V110, P3959, DOI 10.1182/blood-2007-04-088088; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; Novak AJ, 2004, BLOOD, V103, P689, DOI 10.1182/blood-2003-06-2043; Novak AJ, 2002, BLOOD, V100, P2973, DOI 10.1182/blood-2002-02-0558; OSMOND DG, 1993, IMMUNOL TODAY, V14, P34, DOI 10.1016/0167-5699(93)90322-C; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; Otero DC, 2003, J IMMUNOL, V170, P73, DOI 10.4049/jimmunol.170.1.73; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tardivel A, 2004, EUR J IMMUNOL, V34, P509, DOI 10.1002/eji.200324692; WALLNY HJ, 1995, EUR J IMMUNOL, V25, P1262, DOI 10.1002/eji.1830250520; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	58	87	94	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5456	10.1371/journal.pone.0005456	http://dx.doi.org/10.1371/journal.pone.0005456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421318	Green Published, gold, Green Submitted			2022-12-27	WOS:000265836900012
J	Coulibaly, B; Zoungrana, A; Mockenhaupt, FP; Schirmer, RH; Klose, C; Mansmann, U; Meissner, PE; Muller, O				Coulibaly, Boubacar; Zoungrana, Augustin; Mockenhaupt, Frank P.; Schirmer, R. Heiner; Klose, Christina; Mansmann, Ulrich; Meissner, Peter E.; Mueller, Olaf			Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSMISSION; ARTESUNATE; PRIMAQUINE; SAFETY; RESISTANCE; REDUCTION; MORBIDITY; CHILDREN; STRAINS	Background: With the availability of new preventive and curative interventions, global malaria control has been strengthened significantly in recent years. Drugs effective in reducing malaria gametocytaemia might contribute to local elimination and possible long-term eradication. We here report on the effects of methylene blue (MB)-based malaria combination therapy on gametocytaemia during a randomised-controlled trial in Burkina Faso. Methods: An open-label randomised controlled phase II study in 180 children aged 6-10 years with uncomplicated falciparum malaria was conducted in Nouna, north-western Burkina Faso. Children were randomised to MB-artesunate (AS), MB-amodiaquine (AQ), and AS-AQ (local standard of care). Overall follow-up was for 28 days, follow-up for gametocytaemia was for 14 days. Findings: The treatment groups were similar in baseline characteristics and there was only one loss to follow-up. Compared to AS-AQ, both MB-containing regimens were associated with significantly reduced gametocyte carrier rates during follow-up days 3, 7, and 14. This effect was seen both in patients with and without P. falciparum gametocytaemia at baseline. Interpretation: MB reveals pronounced gametocytocidal activity which appears to act against both existing and developing P. falciparum gametocytes. MB-based combination therapy thus has the potential to reduce transmission of P. falciparum malaria in endemic regions, which has important implications for future elimination and eradication strategies.			Muller, O (corresponding author), Heidelberg Univ, Sch Med, Dept Trop Hyg & Publ Hlth, Heidelberg, Germany.	olaf.mueller@urz.uni-heidelberg.de	Mockenhaupt, Frank P/U-9824-2017	Mockenhaupt, Frank P/0000-0002-8117-5421				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Akoachere M, 2005, ANTIMICROB AGENTS CH, V49, P4592, DOI 10.1128/AAC.49.11.4592-4597.2005; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; ARNOLD J, 1955, J LAB CLIN MED, V46, P391; Barber MA, 1932, AM J HYG, V15, P601, DOI 10.1093/oxfordjournals.aje.a117835; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Duffy PE, 2005, LANCET, V366, P1908, DOI 10.1016/S0140-6736(05)67768-9; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Garner P, 2005, PLOS MED, V2, P287, DOI 10.1371/journal.pmed.0020105; Gogtay NJ, 1999, ANN TROP MED PARASIT, V93, P813, DOI 10.1080/00034989957808; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; GREENWOOD D, 1995, J ANTIMICROB CHEMOTH, V36, P857, DOI 10.1093/jac/36.5.857; Guttmann P., 1891, BERLIN KLIN WOCH, P953; HENDERSON L. H., 1934, Transactions of the Royal Society of Tropical Medicine and Hygiene, V28, P157, DOI 10.1016/S0035-9203(34)90137-1; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127; Lengeler C., 2004, COCHRANE LIB; Mandi G, 2005, TROP MED INT HEALTH, V10, P32, DOI 10.1111/j.1365-3156.2004.01356.x; Meissner PE, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-45; Meissner PE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-84; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Noedl H, 2007, TROP MED INT HEALTH, V12, P69; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; RIECKMANN KH, 1969, MIL MED, V134, P802; Sachs JD, 2005, NEW ENGL J MED, V352, P115, DOI 10.1056/NEJMp048319; Samarasekera U, 2008, LANCET, V371, P1403, DOI 10.1016/S0140-6736(08)60611-X; Schirmer RH, 2003, REDOX REP, V8, P272, DOI 10.1179/135100003225002899; Shekalaghe S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001023; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Tanner M, 2008, B WORLD HEALTH ORGAN, V86, P82, DOI 10.2471/BLT.07.050633; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; White NJ, 2006, NEW ENGL J MED, V355, P1956, DOI 10.1056/NEJMp068214; WHO, 2003, ASS MON ANT DRUG EFF; Zoungrana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001630; 1933, Q B HLTH ORG LEAGUE, V2, P181	40	91	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5318	10.1371/journal.pone.0005318	http://dx.doi.org/10.1371/journal.pone.0005318			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415120	gold, Green Published, Green Submitted			2022-12-27	WOS:000265836700002
J	Chang, FY; Lee, CC; Huang, CC; Hsu, KS				Chang, Fang-Yu; Lee, Cheng-Che; Huang, Chiung-Chun; Hsu, Kuei-Sen			Unconjugated Bilirubin Exposure Impairs Hippocampal Long-Term Synaptic Plasticity	PLOS ONE			English	Article								Background: Jaundice is one of the most common problems encountered in newborn infants, due to immaturity of hepatic conjugation and transport processes for bilirubin. Although the majority of neonatal jaundice is benign, some neonates with severe hyperbilirubinemia develop bilirubin encephalopathy or kernicterus. Accumulation of unconjugated bilirubin (UCB) in selected brain regions may result in temporary or permanent impairments of auditory, motor, or cognitive function; however, the molecular mechanisms by which UCB elicits such neurotoxicity are still poorly understood. The present study is undertaken to investigate whether prolonged exposure of rat organotypic hippocampal slice cultures to UCB alters the induction of long-term synaptic plasticity. Methodology/Principal Findings: Using electrophysiological recording techniques, we find that exposure of hippocampal slice cultures to clinically relevant concentrations of UCB for 24 or 48 h results in an impairment of CA1 long-term potentiation (LTP) and long-term depression (LTD) induction in a time-and concentration-dependent manner. Hippocampal slice cultures stimulated with UCB show no changes in the secretion profiles of the pro-inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, or the propidium ioide uptake. UCB treatment produced a significant decrease in the levels of NR1, NR2A and NR2B subunits of N-methyl-D-aspartate (NMDA) receptors through a calpain-mediated proteolytic cleavage mechanism. Pretreatment of the hippocampal slice cultures with NMDA receptor antagonist or calpain inhibitors effectively prevented the UCB-induced impairment of LTP and LTD. Conclusion/Significance: Our results indicate that the proteolytic cleavage of NMDA receptor subunits by calpain may play a critical role in mediating the UCB-induced impairment of long-term synaptic plasticity in the hippocampus. These observations provide new insights into the molecular mechanisms underlying UCB-induced impairment of hippocampal synaptic plasticity which, in turn, might provide opportunities for the development of novel therapeutic strategies that targets these pathways for treatment.			Chang, FY (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	richard@mail.ncku.edu.tw	Hsu, Kuei-Sen/AAV-8386-2021					AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Albensi BC, 2000, SYNAPSE, V35, P151; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; BERK PD, 1994, SEMIN LIVER DIS, V14, P325; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Bi RF, 1998, BRAIN RES, V797, P154, DOI 10.1016/S0006-8993(98)00433-8; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen SF, 2004, EPILEPSIA, V45, P322, DOI 10.1111/j.0013-9580.2004.37403.x; Dennery PA, 2001, NEW ENGL J MED, V344, P581, DOI 10.1056/NEJM200102223440807; Dobbing J, 1981, SCI F PAEDIATRICS, P744; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Falcao AS, 2005, NEUROBIOL DIS, V20, P199, DOI 10.1016/j.nbd.2005.03.001; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; Gourley G R, 1997, Adv Pediatr, V44, P173; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; Guttmann RP, 1998, J BIOL CHEM, V273, P13331, DOI 10.1074/jbc.273.21.13331; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; HAHM JS, 1992, J LIPID RES, V33, P1123; Hanko E, 2006, PEDIATR RES, V59, P72, DOI 10.1203/01.pdr.0000191135.63586.08; HANSEN TWR, 1988, PEDIATR RES, V23, P453; HANSEN TWR, 1988, PEDIATR RES, V23, P219, DOI 10.1203/00006450-198802000-00018; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hoffman DJ, 1996, PEDIATR RES, V40, P804, DOI 10.1203/00006450-199612000-00005; Holopainen IE, 2003, NEUROSCIENCE, V118, P967, DOI 10.1016/S0306-4522(03)00046-0; Huang CC, 1999, J NEUROSCI, V19, P9728; Huuskonen J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-25; Ip S, 2004, PEDIATRICS, V114, pE130, DOI 10.1542/peds.114.1.e130; JOHNSON L, 1974, PHOTOTHERAPY NEWBORN, P122; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Ku HY, 2008, NEUROPSYCHOPHARMACOL, V33, P2847, DOI 10.1038/npp.2008.36; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lynch MA, 1998, REV NEUROSCIENCE, V9, P169; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MCDONAGH AF, 1979, PORPHYRINS, P294; McDonald JW, 1998, EXP NEUROL, V150, P21, DOI 10.1006/exnr.1997.6762; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Newman TB, 2006, NEW ENGL J MED, V354, P1889, DOI 10.1056/NEJMoa054244; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Oktay R, 1996, TURKISH J PEDIATR, V38, P199; Ostrow JD, 2003, PEDIATR RES, V54, P98, DOI 10.1203/01.PDR.0000067486.79854.D5; Pickering C, 2006, BRAIN RES, V1099, P101, DOI 10.1016/j.brainres.2006.04.136; Rodrigues CMP, 2002, J LIPID RES, V43, P885; RUBIN RA, 1979, J PEDIATR-US, V94, P601, DOI 10.1016/S0022-3476(79)80022-0; Shapiro SM, 2003, PEDIATR NEUROL, V29, P410, DOI 10.1016/j.pediatrneurol.2003.09.011; Silva R, 1999, BIOCHEM BIOPH RES CO, V265, P67, DOI 10.1006/bbrc.1999.1646; Silva RFM, 2002, PEDIATR RES, V51, P535, DOI 10.1203/00006450-200204000-00022; Silva RFM, 2001, NEUROCHEM RES, V26, P793, DOI 10.1023/A:1011608017870; Simpkins KL, 2003, J NEUROSCI, V23, P11322; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Weisiger RA, 2001, J BIOL CHEM, V276, P29953, DOI 10.1074/jbc.M104628200; Zhang L, 2003, PEDIATR RES, V53, P939, DOI 10.1203/01.PDR.0000061563.63230.86; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	60	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5876	10.1371/journal.pone.0005876	http://dx.doi.org/10.1371/journal.pone.0005876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517010	Green Published, gold, Green Submitted			2022-12-27	WOS:000266873100009
J	Deveaux, V; Cadoudal, T; Ichigotani, Y; Teixeira-Clerc, F; Louvet, A; Manin, S; Tran-Van Nhieu, J; Belot, MP; Zimmer, A; Even, P; Cani, PD; Knauf, C; Burcelin, R; Bertola, A; Le Marchand-Brustel, Y; Gual, P; Mallat, A; Lotersztajn, S				Deveaux, Vanessa; Cadoudal, Thomas; Ichigotani, Yasukatsu; Teixeira-Clerc, Fatima; Louvet, Alexandre; Manin, Sylvie; Tran-Van Nhieu, Jeanne; Belot, Marie Pierre; Zimmer, Andreas; Even, Patrick; Cani, Patrice D.; Knauf, Claude; Burcelin, Remy; Bertola, Adeline; Le Marchand-Brustel, Yannick; Gual, Philippe; Mallat, Ariane; Lotersztajn, Sophie			Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis	PLOS ONE			English	Article								Background: Obesity-associated inflammation is of critical importance in the development of insulin resistance and nonalcoholic fatty liver disease. Since the cannabinoid receptor CB2 regulates innate immunity, the aim of the present study was to investigate its role in obesity-induced inflammation, insulin resistance and fatty liver. Methodology: Murine obesity models included genetically leptin-deficient ob/ob mice and wild type (WT) mice fed a high fat diet (HFD), that were compared to their lean counterparts. Animals were treated with pharmacological modulators of CB2 receptors. Experiments were also performed in mice knock-out for CB2 receptors (Cnr2 -/-). Principal Findings: In both HFD-fed WT mice and ob/ob mice, Cnr2 expression underwent a marked induction in the stromal vascular fraction of epididymal adipose tissue that correlated with increased fat inflammation. Treatment with the CB2 agonist JWH-133 potentiated adipose tissue inflammation in HFD-fed WT mice. Moreover, cultured fat pads isolated from ob/ob mice displayed increased Tnf and Ccl2 expression upon exposure to JWH-133. In keeping, genetic or pharmacological inactivation of CB2 receptors decreased adipose tissue macrophage infiltration associated with obesity, and reduced inductions of Tnf and Ccl2 expressions. In the liver of obese mice, Cnr2 mRNA was only weakly induced, and CB2 receptors moderately contributed to liver inflammation. HFD-induced insulin resistance increased in response to JWH-133 and reduced in Cnr2 -/- mice. Finally, HFD-induced hepatic steatosis was enhanced in WT mice treated with JWH-133 and blunted in Cnr2 -/- mice. Conclusion/Significance: These data unravel a previously unrecognized contribution of CB2 receptors to obesity-associated inflammation, insulin resistance and non-alcoholic fatty liver disease, and suggest that CB2 receptor antagonists may open a new therapeutic approach for the management of obesity-associated metabolic disorders.			Deveaux, V (corresponding author), Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France.	sophie.lotersztajn@inserm.fr	Teixeira-Clerc, Fatima/C-9884-2009; Louvet, Alexandre/S-4422-2018; burcelin, remy/M-6013-2014; Gual, Philippe/P-9833-2019; VAN NHIEU, Jeanne TRAN/R-5235-2018; Teixeira-Clerc, Fatima/AAB-5499-2021; D., Cani Patrice/M-8055-2016; Lotersztajn, Sophie/K-9160-2017; Zimmer, Andreas/B-8357-2009; Gual, Philippe/M-8787-2017	Louvet, Alexandre/0000-0002-5293-007X; Gual, Philippe/0000-0001-7393-8356; Teixeira-Clerc, Fatima/0000-0003-1098-9222; D., Cani Patrice/0000-0003-2040-2448; Gual, Philippe/0000-0001-7393-8356; Knauf, Claude/0000-0001-5213-5378; Bertola, Adeline/0000-0002-4885-8423; BELOT, Marie-Pierre/0000-0001-7502-0549; lotersztajn, Sophie/0000-0002-0053-7807; Even, Patrick/0000-0001-5733-3023				Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Bellocchio L, 2006, CURR OPIN PHARMACOL, V6, P586, DOI 10.1016/j.coph.2006.09.001; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; DEFER N, 2009, FASEB J; Derocq JM, 2000, J BIOL CHEM, V275, P15621, DOI 10.1074/jbc.275.21.15621; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; EVEN PC, 1991, PHYSIOL BEHAV, V49, P177, DOI 10.1016/0031-9384(91)90252-J; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hezode C, 2005, HEPATOLOGY, V42, P63, DOI 10.1002/hep.20733; Hezode C, 2008, GASTROENTEROLOGY, V134, P432, DOI 10.1053/j.gastro.2007.11.039; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Knauf C, 2005, J CLIN INVEST, V115, P3554, DOI 10.1172/JCI25764; Kunos G, 2008, AM J PHYSIOL-GASTR L, V294, pG1101, DOI 10.1152/ajpgi.00057.2008; Lotersztajn S, 2008, BRIT J PHARMACOL, V153, P286, DOI 10.1038/sj.bjp.0707511; Mallat A, 2008, AM J PHYSIOL-GASTR L, V294, pG9, DOI 10.1152/ajpgi.00467.2007; Mallat A, 2006, J Endocrinol Invest, V29, P58; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; PERTWEE R, 1995, LIFE SCI, V56, P1949, DOI 10.1016/0024-3205(95)00175-6; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	48	162	168	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5844	10.1371/journal.pone.0005844	http://dx.doi.org/10.1371/journal.pone.0005844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513120	Green Published, Green Submitted, gold			2022-12-27	WOS:000267228800010
J	Tsanov, M; Manahan-Vaughan, D				Tsanov, Marian; Manahan-Vaughan, Denise			Long-Term Plasticity Is Proportional to Theta-Activity	PLOS ONE			English	Article								Background: Theta rhythm in the hippocampal formation is a main feature of exploratory behaviour and is believed to enable the encoding of new spatial information and the modification of synaptic weights. Cyclic changes of dentate gyrus excitability during theta rhythm are related to its function, but whether theta epochs per se are able to alter network properties of dentate gyrus for long time-periods is still poorly understood. Methodology/Principal Findings: We used low-frequency stimulation protocols that amplify the power of endogenous theta oscillations, in order to estimate the plasticity effect of endogenous theta oscillations on a population level. We found that stimulation-induced augmentation of the theta rhythm is linked to a subsequent increase of neuronal excitability and decrease of the synaptic response. This EPSP-to-Spike uncoupling is related to an increased postsynaptic spiking on the positive phases of theta frequency oscillations. Parallel increase of the field EPSP slope and the population spike occurs only after concurrent pre- and postsynaptic activation. Furthermore, we observed that long-term potentiation (>24 h) occurs in the dentate gyrus of freely behaving adult rats after phasic activity of entorhinal afferents in the theta-frequency range. This plasticity is proportional to the field bursting activity of granule cells during the stimulation, and may comprise a key step in spatial information transfer. Long-term potentiation of the synaptic component occurs only when the afferent stimulus precedes the evoked population burst, and is input-specific. Conclusions/Significance: Our data confirm the role of the dentate gyrus in filtering information to the subsequent network during the activated state of the hippocampus.			Tsanov, M (corresponding author), Ruhr Univ Bochum, Fac Med, Dept Expt Neurophysiol, Bochum, Germany.	denise.manahan-vaughan@rub.de		Tsanov, Marian/0000-0002-4900-9597; Manahan-Vaughan, Denise/0000-0002-9283-9609				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bernard C, 1996, J PHYSIOL-LONDON, V495, P127, DOI 10.1113/jphysiol.1996.sp021579; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BLAND BH, 1984, BRAIN RES, V299, P121, DOI 10.1016/0006-8993(84)90794-7; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bragin A, 1997, J NEUROSCI, V17, P2567; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; BUZSAKI G, 1987, BRAIN RES, V435, P331, DOI 10.1016/0006-8993(87)91618-0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cain DP, 1997, PSYCHOPHARMACOLOGY, V130, P313, DOI 10.1007/s002130050245; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; DAVIES JM, 1992, PSYCHOANALYTIC DIALO, V2, P5, DOI DOI 10.1080/10481889209538920; DINGLEDINE R, 1986, J PHYSIOL-LONDON, V380, P175, DOI 10.1113/jphysiol.1986.sp016279; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hausser M, 2004, J NEUROSCI, V24, P9215, DOI 10.1523/JNEUROSCI.3375-04.2004; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Hyman JM, 2003, J NEUROSCI, V23, P11725; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Khaliq ZM, 2005, J NEUROSCI, V25, P454, DOI 10.1523/JNEUROSCI.3045-04.2005; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LARSON J, 1989, BRAIN RES, V489, P49, DOI 10.1016/0006-8993(89)90007-3; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Leutgeb JK, 2007, NEURON, V55, P176, DOI 10.1016/j.neuron.2007.07.002; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Manahan-Vaughan D, 1998, NEUROSCIENCE, V86, P709, DOI 10.1016/S0306-4522(98)00111-0; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCLAMB RL, 1990, PHARMACOL BIOCHEM BE, V37, P41, DOI 10.1016/0091-3057(90)90038-J; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser MB, 2000, NEURON, V26, P559, DOI 10.1016/S0896-6273(00)81192-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MULLER RU, 1987, J NEUROSCI, V7, P1935; NANRY KP, 1989, BEHAV BRAIN RES, V35, P45, DOI 10.1016/S0166-4328(89)80007-5; Noguchi K, 1998, BRAIN RES, V794, P151, DOI 10.1016/S0006-8993(98)00210-8; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Orr G, 2001, HIPPOCAMPUS, V11, P647, DOI 10.1002/hipo.1079; Otnaess MK, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-24-j0007.1999; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; PITLER TA, 1987, J NEUROPHYSIOL, V58, P866, DOI 10.1152/jn.1987.58.4.866; ROSE GM, 1986, NEUROSCI LETT, V69, P244, DOI 10.1016/0304-3940(86)90487-8; SAINSBURY RS, 1987, PHYSIOL BEHAV, V41, P489, DOI 10.1016/0031-9384(87)90085-0; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; STRINGER JL, 1989, J NEUROPHYSIOL, V62, P126, DOI 10.1152/jn.1989.62.1.126; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; TAUBE JS, 1988, J NEUROSCI, V8, P1632; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WILSON RC, 1981, J NEUROPHYSIOL, V46, P324, DOI 10.1152/jn.1981.46.2.324; Wohrl R, 2007, EUR J NEUROSCI, V26, P2873, DOI 10.1111/j.1460-9568.2007.05899.x; Xavier GF, 1999, HIPPOCAMPUS, V9, P668, DOI 10.1002/(SICI)1098-1063(1999)9:6<668::AID-HIPO8>3.0.CO;2-9; Yeckel MF, 1998, J NEUROSCI, V18, P438; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	78	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5850	10.1371/journal.pone.0005850	http://dx.doi.org/10.1371/journal.pone.0005850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513114	Green Submitted, Green Published, gold			2022-12-27	WOS:000267228800015
J	Ribeiro, CMP; Hurd, H; Wu, YC; Martino, MEB; Jones, L; Brighton, B; Boucher, RC; O'Neal, WK				Ribeiro, Carla Maria P.; Hurd, Harry; Wu, Yichao; Martino, Mary E. B.; Jones, Lisa; Brighton, Brian; Boucher, Richard C.; O'Neal, Wanda K.			Azithromycin Treatment Alters Gene Expression in Inflammatory, Lipid Metabolism, and Cell Cycle Pathways in Well-Differentiated Human Airway Epithelia	PLOS ONE			English	Article								Prolonged macrolide antibiotic therapy at low doses improves clinical outcome in patients affected with diffuse panbronchiolitis and cystic fibrosis. Consensus is building that the therapeutic effects are due to anti-inflammatory, rather than anti-microbial activities, but the mode of action is likely complex. To gain insights into how the macrolide azithromycin (AZT) modulates inflammatory responses in airways, well-differentiated primary cultures of human airway epithelia were exposed to AZT alone, an inflammatory stimulus consisting of soluble factors from cystic fibrosis airways, or AZT followed by the inflammatory stimulus. RNA microarrays were conducted to identify global and specific gene expression changes. Analysis of gene expression changes revealed that the AZT treatment alone altered the gene profile of the cells, primarily by significantly increasing the expression of lipid/cholesterol genes and decreasing the expression of cell cycle/mitosis genes. The increase in cholesterol biosynthetic genes was confirmed by increased filipin staining, an index of free cholesterol, after AZT treatment. AZT also affected genes with inflammatory annotations, but the effect was variable (both up- and down-regulation) and gene specific. AZT pretreatment prevented the up- regulation of some genes, such as MUC5AC and MMP9, triggered by the inflammatory stimulus, but the up- regulation of other inflammatory genes, e. g., cytokines and chemokines, such as interleukin-8, was not affected. On the other hand, HLA genes were increased by AZT. Notably, secreted IL-8 protein levels did not reflect mRNA levels, and were, in fact, higher after AZT pretreatment in cultures exposed to the inflammatory stimulus, suggesting that AZT can affect inflammatory pathways other than by altering gene expression. These findings suggest that the specific effects of AZT on inflamed and non-inflamed airway epithelia are likely relevant to its clinical activity, and their apparent complexity may help explain the diverse immunomodulatory roles of macrolides.			Ribeiro, CMP (corresponding author), N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	carla_ribeiro@med.unc.edu	Ribeiro, Carla Maria P/A-6955-2009					Abe S, 2000, AM J RESP CELL MOL, V22, P51, DOI 10.1165/ajrcmb.22.1.3400; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Askew DJ, 2008, J PERINATOL, V28, pS127, DOI 10.1038/jp.2008.150; Baronas ET, 2007, TOXICOL APPL PHARM, V218, P72, DOI 10.1016/j.taap.2006.10.015; Bengoechea-Alonso MT, 2005, P NATL ACAD SCI USA, V102, P11681, DOI 10.1073/pnas.0501494102; Chen SZ, 2005, CANCER CHEMOTH PHARM, V56, P212, DOI 10.1007/s00280-004-0960-5; Culic O, 2002, EUR J PHARMACOL, V450, P277, DOI 10.1016/S0014-2999(02)02042-3; D'Avila H, 2008, INT IMMUNOPHARMACOL, V8, P1308, DOI 10.1016/j.intimp.2008.01.035; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Fa N, 2007, BBA-BIOMEMBRANES, V1768, P1830, DOI 10.1016/j.bbamem.2007.04.013; Gaggar A, 2007, AM J PHYSIOL-LUNG C, V293, pL96, DOI 10.1152/ajplung.00492.2006; Hashimoto N, 2001, J LAB CLIN MED, V137, P176, DOI 10.1067/mlc.2001.112726; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; ICHIKAWA Y, 1992, AM REV RESPIR DIS, V146, P196, DOI 10.1164/ajrccm/146.1.196; Imamura Y, 2004, ANTIMICROB AGENTS CH, V48, P3457, DOI 10.1128/AAC.48.9.3457-3461.2004; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishimoto H, 2009, J ANTIMICROB CHEMOTH, V63, P109, DOI 10.1093/jac/dkn427; Jaffe A, 2001, PEDIATR PULM, V31, P464, DOI 10.1002/ppul.1076; Janowski BA, 2002, P NATL ACAD SCI USA, V99, P12675, DOI 10.1073/pnas.202471599; KADOTA J, 1993, AM REV RESPIR DIS, V147, P153, DOI 10.1164/ajrccm/147.1.153; Kanai KI, 2004, MEDIAT INFLAMM, V13, P313, DOI 10.1080/09629350400008810; Kauai K, 2004, EUR RESPIR J, V23, P671, DOI 10.1183/09031936.04.00057104; Kawasaki S, 1998, ANTIMICROB AGENTS CH, V42, P1499, DOI 10.1128/AAC.42.6.1499; Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P1157; KHAIR OA, 1995, EUR RESPIR J, V8, P1451; Koch CC, 2000, J ANTIMICROB CHEMOTH, V46, P19, DOI 10.1093/jac/46.1.19; Kurdowska A, 2001, J ANTIMICROB CHEMOTH, V47, P867, DOI 10.1093/jac/47.6.867; Liu K, 2008, INT IMMUNOPHARMACOL, V8, P126, DOI 10.1016/j.intimp.2007.10.002; Mankin AS, 2008, CURR OPIN MICROBIOL, V11, P414, DOI 10.1016/j.mib.2008.08.003; Matsumori N, 2006, J MED CHEM, V49, P3501, DOI 10.1021/jm051210v; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; ODA H, 1994, CHEST, V106, P1116, DOI 10.1378/chest.106.4.1116; Ogawa M, 2009, TRANSPL P, V41, P395, DOI 10.1016/j.transproceed.2008.10.057; Parnham MJ, 2005, EUR J PHARMACOL, V517, P132, DOI 10.1016/j.ejphar.2005.05.023; Pechere JC, 2001, INT J ANTIMICROB AG, V18, pS93, DOI 10.1016/S0924-8579(01)00393-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; Sagel SD, 2005, PEDIATR PULM, V39, P224, DOI 10.1002/ppul.20165; Sakito O, 1996, RESPIRATION, V63, P42; Shimizu T, 2003, AM J RESP CRIT CARE, V168, P581, DOI 10.1164/rccm.200212-1437OC; Shinkai M, 2006, ANTIMICROB AGENTS CH, V50, P1738, DOI 10.1128/AAC.50.5.1738-1744.2006; Shinkai M, 2006, AM J PHYSIOL-LUNG C, V290, pL75, DOI 10.1152/ajplung.00093.2005; Shinkai M, 2008, PHARMACOL THERAPEUT, V117, P393, DOI 10.1016/j.pharmthera.2007.11.001; Shinkai M, 2007, J ANTIMICROB CHEMOTH, V59, P1096, DOI 10.1093/jac/dkm084; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Takizawa H, 1997, AM J RESP CRIT CARE, V156, P266, DOI 10.1164/ajrccm.156.1.9612065; TAMAOKI J, 1995, ANTIMICROB AGENTS CH, V39, P1688, DOI 10.1128/AAC.39.8.1688; Tsai WC, 2004, AM J RESP CRIT CARE, V170, P1331, DOI 10.1164/rccm.200402-200OC; Tyteca D, 2003, J MEMBRANE BIOL, V192, P203, DOI 10.1007/s00232-002-1076-7; Van Bambeke F, 1998, J ANTIMICROB CHEMOTH, V42, P761, DOI 10.1093/jac/42.6.761; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Verleden GM, 2006, AM J RESP CRIT CARE, V174, P566, DOI 10.1164/rccm.200601-071OC; Wagner T, 2005, CHEST, V128, P912, DOI 10.1378/chest.128.2.912; White NM, 2004, AM J RESP CELL MOL, V31, P538, DOI 10.1165/rcmb.2004-0117OC; Wilms EB, 2006, THER DRUG MONIT, V28, P219, DOI 10.1097/01.ftd.0000195617.69721.a5; Yamasawa H, 2004, AM J RESP CELL MOL, V30, P569, DOI 10.1165/rcmb.2003-0105OC; Yu Q, 2000, GENE DEV, V14, P163	60	69	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5806	10.1371/journal.pone.0005806	http://dx.doi.org/10.1371/journal.pone.0005806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503797	Green Published, gold, Green Submitted			2022-12-27	WOS:000266717200003
J	Mintzes, B; Morgan, S; Wright, JM				Mintzes, Barbara; Morgan, Steve; Wright, James M.			Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale	PLOS ONE			English	Article							ADVERTISEMENTS; TELEVISION	Background: Direct-to-consumer advertising (DTCA) of prescription drugs is illegal in Canada as a health protection measure, but is permitted in the United States. However, in 2000, Canadian policy was changed to allow 'reminder' advertising of prescription drugs. This is a form of advertising that states the brand name without health claims. 'Reminder' advertising is prohibited in the US for drugs that have 'black box' warnings of serious risks. This study examines spending on DTCA in Canada from 1995 to 2006, 12 years spanning this policy shift. We ask how annual per capita spending compares to that in the US, and whether drugs with Canadian or US regulatory safety warnings are advertised to the Canadian public in reminder advertising. Methodology/Principal Findings: Prescription drug advertising spending data were extracted from a data set on health sector spending in Canada obtained from a market research company, TNS Media Inc. Spending was adjusted for inflation and compared with US spending. Inflation-adjusted spending on branded DTCA in Canada grew from under CAD$2 million per year before 1999 to over $22 million in 2006. The major growth was in broadcast advertising, accounting for 83% of spending in 2006. US annual per capita spending was on average 24 times Canadian levels. Celebrex (celecoxib), which has a US black box and was subject to three safety advisories in Canada, was the most heavily advertised drug on Canadian television in 2005 and 2006. Of 8 brands with >$500,000 spending, which together accounted for 59% of branded DTCA in all media, 6 were subject to Canadian safety advisories, and 4 had US black box warnings. Conclusions/Significance: Branded 'reminder' advertising has grown rapidly in Canada since 2000, mainly due to a growth in television advertising. Although DTCA spending per capita is much lower in Canada than in the US, there is no evidence of safer content or product choice; many heavily-advertised drugs in Canada have been subject to safety advisories. For governments searching for compromise solutions to industry pressure for expanded advertising, Canada's experience stands as a stark warning.			Mintzes, B (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.		Morgan, Steven/J-8814-2015; Mintzes, Barbara/AFK-6613-2022	Mintzes, Barbara/0000-0002-8671-915X; Morgan, Steven/0000-0002-7529-0028				Bell RA, 2000, J FAM PRACTICE, V49, P1092; Brownfield ED, 2004, J HEALTH COMMUN, V9, P491, DOI 10.1080/10810730490523115; Cotter J, 2005, CAN MED ASSOC J, V172, P1299, DOI 10.1503/cmaj.050456; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; FDA Alert, 2007, INF HEALTHC PROF ER; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Frosst Merck, 1996, DIRECT TO CONSUMER A; Gardner DM, 2003, CAN MED ASSOC J, V169, P425; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Health Canada, 2005, HLTH CAN HAS ASK PFI; *HLTH CAN, 2004, UPD SAF INF INCR CAR; *HLTH CAN, 2003, PUBL ADV DIAN 35 RIS; IMS Health, 2008, TOT US PROM SPEND TY; Institute of Medicine of the National Academies, 2006, FUT DRUG SAF PROM PR; Kallen A, 2007, HEALTH AFFAIR, V26, P1392, DOI 10.1377/hlthaff.26.5.1392; Kaphingst KA, 2005, J HEALTH COMMUN, V10, P609, DOI 10.1080/10810730500267647; Law MR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1055; *MARK HLTH PROD DI, 2002, IMP SAF CONC US DIAN; Mintzes B, 2005, CAN MED ASSOC J, V173, P1313, DOI 10.1503/cmaj.050567; Mintzes B, 2003, CAN MED ASSOC J, V169, P405; NICHOLS DM, 2005, DISTINCTION ADVERTIS; PhRMA, 2005, GUID PRINC DIR TO CO; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; ROWSELL LB, 2000, ADVERTISING CAMPAIGN; Standing Committee on Health, 2004, OP MED CAB 1 REP HLT; STUPAK B, 2008, DIRECT TO CONSUMER A; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; U. S. Food and Drug Administration, 2005, FDA UPD LAB ORTH EVR; *US GOV ACC OFF, 2006, PRESCR DRUGS IMPR NE; Woloshin S, 2001, LANCET, V358, P1141, DOI 10.1016/S0140-6736(01)06254-7; 2002, ADVISORY        0523; 2005, ADVISORY        0726; 2005, MED MARKETING M 0802	33	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5699	10.1371/journal.pone.0005699	http://dx.doi.org/10.1371/journal.pone.0005699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	450QD	19479084	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415000011
J	Venkatraman, P; Balakrishnan, S; Rao, S; Hooda, Y; Pol, S				Venkatraman, Prasanna; Balakrishnan, Satish; Rao, Shashidhar; Hooda, Yogesh; Pol, Suyog			A Sequence and Structure Based Method to Predict Putative Substrates, Functions and Regulatory Networks of Endo Proteases	PLOS ONE			English	Article							POSITIONAL-SCANNING LIBRARIES; MATRIX METALLOPROTEINASES; GRANZYME-B; PROTEIN; SPECIFICITY; MATRIPTASE; CLEAVAGE; TOOL; ACTIVATION; IDENTIFICATION	Background: Proteases play a central role in cellular homeostasis and are responsible for the spatio-temporal regulation of function. Many putative proteases have been recently identified through genomic approaches, leading to a surge in global profiling attempts to characterize their function. Through such efforts and others it has become evident that many proteases play non-traditional roles. Accordingly, the number and the variety of the substrate repertoire of proteases are expected to be much larger than previously assumed. In line with such global profiling attempts, we present here a method for the prediction of natural substrates of endo proteases (human proteases used as an example) by employing short peptide sequences as specificity determinants. Methodology/Principal Findings: Our method incorporates specificity determinants unique to individual enzymes and physiologically relevant dual filters namely, solvent accessible surface area-a parameter dependent on protein three-dimensional structure and subcellular localization. By incorporating such hitherto unused principles in prediction methods, a novel ligand docking strategy to mimic substrate binding at the active site of the enzyme, and GO functions, we identify and perform subjective validation on putative substrates of matriptase and highlight new functions of the enzyme. Using relative solvent accessibility to rank order we show how new protease regulatory networks and enzyme cascades can be created. Conclusion: We believe that our physiologically relevant computational approach would be a very useful complementary method in the current day attempts to profile proteases (endo proteases in particular) and their substrates. In addition, by using functional annotations, we have demonstrated how normal and unknown functions of a protease can be envisaged. We have developed a network which can be integrated to create a proteolytic world. This network can in turn be extended to integrate other regulatory networks to build a system wide knowledge of the proteome.			Venkatraman, P (corresponding author), Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India.	vprasanna@actrec.gov.in	Pol, Suyog/AAO-8804-2020	Hooda, Yogesh/0000-0002-7181-9254				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; CLARK ME, 1993, MOL CELL BIOL, V13, P1232, DOI 10.1128/MCB.13.2.1232; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; Edosada CY, 2006, J BIOL CHEM, V281, P7437, DOI 10.1074/jbc.M511112200; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Fonovic M, 2008, EXPERT REV PROTEOMIC, V5, P721, DOI 10.1586/14789450.5.5.721; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Garay-Malpartida HM, 2005, BIOINFORMATICS, V21, pI169, DOI 10.1093/bioinformatics/bti1034; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hockenbery DM, 2006, AM J PATHOL, V169, P1101, DOI 10.2353/ajpath.2006.060553; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Ju WJ, 2007, P NATL ACAD SCI USA, V104, P14294, DOI 10.1073/pnas.0702251104; Keller UAD, 2007, BIOL CHEM, V388, P1159, DOI 10.1515/BC.2007.146; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Nazif T, 2001, P NATL ACAD SCI USA, V98, P2967, DOI 10.1073/pnas.061028898; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Owen CA, 2008, INT J BIOCHEM CELL B, V40, P1246, DOI 10.1016/j.biocel.2008.01.020; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Porter AG, 1999, TRENDS CELL BIOL, V9, P394, DOI 10.1016/S0962-8924(99)01624-4; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Tobi D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-226; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476	53	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5700	10.1371/journal.pone.0005700	http://dx.doi.org/10.1371/journal.pone.0005700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492082	Green Submitted, Green Published, gold			2022-12-27	WOS:000266415000012
J	Di Santo, S; Yang, ZJ; von Ballmoos, MW; Voelzmann, J; Diehm, N; Baumgartner, I; Kalka, C				Di Santo, Stefano; Yang, Zijiang; von Ballmoos, Moritz Wyler; Voelzmann, Jan; Diehm, Nicolas; Baumgartner, Iris; Kalka, Christoph			Novel Cell-Free Strategy for Therapeutic Angiogenesis: In Vitro Generated Conditioned Medium Can Replace Progenitor Cell Transplantation	PLOS ONE			English	Article								Background: Current evidence suggests that endothelial progenitor cells (EPC) contribute to ischemic tissue repair by both secretion of paracrine factors and incorporation into developing vessels. We tested the hypothesis that cell-free administration of paracrine factors secreted by cultured EPC may achieve an angiogenic effect equivalent to cell therapy. Methodology/Principal Findings: EPC-derived conditioned medium (EPC-CM) was obtained from culture expanded EPC subjected to 72 hours of hypoxia. In vitro, EPC-CM significantly inhibited apoptosis of mature endothelial cells and promoted angiogenesis in a rat aortic ring assay. The therapeutic potential of EPC-CM as compared to EPC transplantation was evaluated in a rat model of chronic hindlimb ischemia. Serial intramuscular injections of EPC-CM and EPC both significantly increased hindlimb blood flow assessed by laser Doppler (81.2 +/- 2.9% and 83.7 +/- 3.0% vs. 53.5 +/- 2.4% of normal, P < 0.01) and improved muscle performance. A significantly increased capillary density (1.62 +/- 0.03 and 1.68 +/- 0.05/muscle fiber, P < 0.05), enhanced vascular maturation (8.6 +/- 0.3 and 8.1 +/- 0.4/HPF, P < 0.05) and muscle viability corroborated the findings of improved hindlimb perfusion and muscle function. Furthermore, EPC-CM transplantation stimulated the mobilization of bone marrow (BM)-derived EPC compared to control (678.7 +/- 44.1 vs. 340.0 +/- 29.1 CD34(+)/CD45(-) cells/1x10(5) mononuclear cells, P < 0.05) and their recruitment to the ischemic muscles (5.9 +/- 0.7 vs. 2.6 +/- 0.4CD34(+) cells/HPF, P < 0.001) 3 days after the last injection. Conclusions/Significance: Intramuscular injection of EPC-CM is as effective as cell transplantation for promoting tissue revascularization and functional recovery. Owing to the technical and practical limitations of cell therapy, cell free conditioned media may represent a potent alternative for therapeutic angiogenesis in ischemic cardiovascular diseases.			Di Santo, S (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Dept Vasc Med,Swiss Cardiovasc Ctr, Bern, Switzerland.	vascmed.unibe@gmail.com	Di Santo, Stefano/K-5739-2014; Yang, Zijiang/E-8837-2012; Reardon, Michael/ABF-8880-2021; Di Santo, Stefano/P-2433-2019	Di Santo, Stefano/0000-0002-4032-999X; Di Santo, Stefano/0000-0002-4032-999X				Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Aranguren XL, 2009, J MOL MED, V87, P3, DOI 10.1007/s00109-008-0394-3; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Asahara T, 1997, CIRCULATION, V96, pI; Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850; Bonheur JA, 2004, J SURG RES, V116, P55, DOI 10.1016/S0022-4804(03)00232-4; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Collinson DJ, 2004, EUR J VASC ENDOVASC, V28, P9, DOI 10.1016/j.ejvs.2004.03.021; Doyle B, 2008, STEM CELLS DEV, V17, P941, DOI 10.1089/scd.2007.0214; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; ISNER JM, 1994, LANCET, V344, P1653, DOI 10.1016/S0140-6736(94)90454-5; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; Korpisalo P, 2008, CIRC RES, V103, P1092, DOI 10.1161/CIRCRESAHA.108.182287; Kuhlmann MT, 2007, VASA-J VASCULAR DIS, V36, P253, DOI 10.1024/0301-1526.36.4.253; Lazarous DF, 2000, J AM COLL CARDIOL, V36, P1239, DOI 10.1016/S0735-1097(00)00882-2; LEONE AM, 2009, EUR HEART J IN PRESS; Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Nikol S, 2008, MOL THER, V16, P972, DOI 10.1038/mt.2008.33; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Post MJ, 2001, CARDIOVASC RES, V49, P522, DOI 10.1016/S0008-6363(00)00216-9; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; RUIZ DA, 2006, CELL, V124, P18; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; SCHEUBEL RJ, 2008, INT J CARDI IN PRESS; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371; Tse HF, 2007, EUR J HEART FAIL, V9, P747, DOI 10.1016/j.ejheart.2007.03.008; Unger EF, 2000, AM J CARDIOL, V85, P1414, DOI 10.1016/S0002-9149(00)00787-6; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005	53	176	183	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5643	10.1371/journal.pone.0005643	http://dx.doi.org/10.1371/journal.pone.0005643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19479066	Green Published, gold			2022-12-27	WOS:000266331000002
J	Romano, RA; Ortt, K; Birkaya, B; Smalley, K; Sinha, S				Romano, Rose-Anne; Ortt, Kori; Birkaya, Barbara; Smalley, Kirsten; Sinha, Satrajit			An Active Role of the Delta N Isoform of p63 in Regulating Basal Keratin Genes K5 and K14 and Directing Epidermal Cell Fate	PLOS ONE			English	Article								Background: One major defining characteristic of the basal keratinocytes of the stratified epithelium is the expression of the keratin genes K5 and K14. The temporal and spatial expression of these two genes is usually tightly and coordinately regulated at the transcriptional level. This ensures the obligate pairing of K5 and K14 proteins to generate an intermediate filament (IF) network that is essential for the structure and function of the proliferative keratinocytes. Our previous studies have shown that the basal-keratinocyte restricted transcription factor p63 is a direct regulator of K14 gene. Methodology/Principal Findings: Here we provide evidence that p63, specifically the Delta N isoform also regulates the expression of the K5 gene by binding to a conserved enhancer within the 59 upstream region. By using specific antibodies against Delta Np63, we show a concordance in the expression between basal keratins and Delta Np63 proteins but not the TAp63 isoforms during early embryonic skin development. We demonstrate, that contrary to a previous report, transgenic mice expressing Delta Np63 in lung epithelium exhibit squamous metaplasia with de novo induction of K5 and K14 as well as transdifferentiation to the epidermal cell lineage. Interestingly, the in vivo epidermal inductive properties of Delta Np63 do not require the C-terminal SAM domain. Finally, we show that Delta Np63 alone can restore the expression of the basal keratins and reinitiate the failed epidermal differentiation program in the skin of p63 null animals. Significance: Delta Np63 is a critical mediator of keratinocyte stratification program and directly regulates the basal keratin genes.			Romano, RA (corresponding author), SUNY Buffalo, Dept Biochem, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14214 USA.	ssinha2@buffalo.edu			NIAMS NIH HHS [R01 AR049238, R01AR049238] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049238] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Barbieri CE, 2005, CANCER RES, V65, P2314, DOI 10.1158/0008-5472.CAN-04-3449; Birkaya B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-43; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Cheng W, 2006, DEVELOPMENT, V133, P4783, DOI 10.1242/dev.02621; Chikh A, 2007, BIOCHEM BIOPH RES CO, V361, P1, DOI 10.1016/j.bbrc.2007.06.069; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Guttormsen J, 2008, DEV BIOL, V317, P187, DOI 10.1016/j.ydbio.2008.02.017; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Kaufman CK, 2002, MOL CELL BIOL, V22, P4293, DOI 10.1128/MCB.22.12.4293-4308.2002; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; King KE, 2007, MOL CARCINOGEN, V46, P716, DOI 10.1002/mc.20337; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2007, CELL CYCLE, V6, P269, DOI 10.4161/cc.6.3.3792; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2004, CELL CYCLE, V3, P411; Kurita T, 2005, MECH DEVELOP, V122, P1043, DOI 10.1016/j.mod.2005.04.008; Larouche D, 2008, FASEB J, V22, P1404, DOI 10.1096/fj.07-8109com; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Lu H, 2005, EUR J CELL BIOL, V84, P709, DOI 10.1016/j.ejcb.2005.04.001; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Mikaelian I, 2006, VET PATHOL, V43, P36, DOI 10.1354/vp.43-1-36; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nagarajan P, 2008, CRIT REV EUKAR GENE, V18, P57; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Ortt K, 2008, J CELL BIOCHEM, V104, P1204, DOI 10.1002/jcb.21700; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Romano RA, 2007, J INVEST DERMATOL, V127, P1175, DOI 10.1038/sj.jid.5700652; Romano RA, 2006, J INVEST DERMATOL, V126, P1469, DOI 10.1038/sj.jid.5700297; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sinha S, 2001, P NATL ACAD SCI USA, V98, P2455, DOI 10.1073/pnas.051633598; Sinha S, 2000, MOL CELL BIOL, V20, P2543, DOI 10.1128/MCB.20.7.2543-2555.2000; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tummala R, 2003, GENE, V321, P93, DOI 10.1016/S0378-1119(03)00840-0; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	54	125	129	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5623	10.1371/journal.pone.0005623	http://dx.doi.org/10.1371/journal.pone.0005623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19461998	gold, Green Published, Green Submitted			2022-12-27	WOS:000266234700010
J	Hayashi, S; Shimoda, T; Nakajima, M; Tsukada, Y; Sakumura, Y; Dale, JK; Maroto, M; Kohno, K; Matsui, T; Bessho, Y				Hayashi, Shinichi; Shimoda, Taiju; Nakajima, Masato; Tsukada, Yuki; Sakumura, Yuichi; Dale, J. Kim; Maroto, Miguel; Kohno, Kenji; Matsui, Takaaki; Bessho, Yasumasa			Sprouty4, an FGF Inhibitor, Displays Cyclic Gene Expression under the Control of the Notch Segmentation Clock in the Mouse PSM	PLOS ONE			English	Article								Background: During vertebrate embryogenesis, somites are generated at regular intervals, the temporal and spatial periodicity of which is governed by a gradient of fibroblast growth factor (FGF) and/or Wnt signaling activity in the presomitic mesoderm (PSM) in conjunction with oscillations of gene expression of components of the Notch, Wnt and FGF signaling pathways. Principal Findings: Here, we show that the expression of Sprouty4, which encodes an FGF inhibitor, oscillates in 2-h cycles in the mouse PSM in synchrony with other oscillating genes from the Notch signaling pathway, such as lunatic fringe. Sprouty4 does not oscillate in Hes7-null mutant mouse embryos, and Hes7 can inhibit FGF-induced transcriptional activity of the Sprouty4 promoter. Conclusions: Thus, periodic expression of Sprouty4 is controlled by the Notch segmentation clock and may work as a mediator that links the temporal periodicity of clock gene oscillations with the spatial periodicity of boundary formation which is regulated by the gradient of FGF/Wnt activity.			Hayashi, S (corresponding author), Nara Inst Sci & Technol, Lab Gene Regulat Res, Grad Sch Biol Sci, Ikoma, Japan.	ybessho@bs.naist.jp	Kohno, Kenji/AAZ-6573-2020; Dale, Kim J/A-4480-2016	Kohno, Kenji/0000-0002-3503-6551; Dale, Kim J/0000-0002-9294-947X	MRC [G120/989] Funding Source: UKRI; Medical Research Council [G120/989] Funding Source: Medline; Wellcome Trust [089357] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Dale JK, 2006, DEV CELL, V10, P355, DOI 10.1016/j.devcel.2006.02.011; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Ding W, 2004, AM J PHYSIOL-LUNG C, V287, pL52, DOI 10.1152/ajplung.00430.2003; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Elmasri H, 2004, GENE EXPR PATTERNS, V4, P553, DOI 10.1016/j.modgep.2004.02.003; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; IKEDA K, 1993, EUR J BIOCHEM, V218, P195, DOI 10.1111/j.1432-1033.1993.tb18365.x; Ishikawa A, 2004, MECH DEVELOP, V121, P1443, DOI 10.1016/j.mod.2004.08.003; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kawamura A, 2005, GENE DEV, V19, P1156, DOI 10.1101/gad.1291205; Klein T, 1998, DEVELOPMENT, V125, P2951; Maroto M, 2005, INT J DEV BIOL, V49, P309, DOI 10.1387/ijdb.041958mm; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Minowada G, 1999, DEVELOPMENT, V126, P4465; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2001, ANNU REV CELL DEV BI, V17, P311, DOI 10.1146/annurev.cellbio.17.1.311; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Prince VE, 2001, MECH DEVELOP, V105, P175, DOI 10.1016/S0925-4773(01)00398-7; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sawada A, 2001, DEVELOPMENT, V128, P4873; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	44	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5603	10.1371/journal.pone.0005603	http://dx.doi.org/10.1371/journal.pone.0005603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19440349	Green Published, gold, Green Submitted			2022-12-27	WOS:000266161200006
J	Rodriguez-Almazan, C; Zavala, LE; Munoz-Garay, C; Jimenez-Juarez, N; Pacheco, S; Masson, L; Soberon, M; Bravo, A				Rodriguez-Almazan, Claudia; Enrique Zavala, Luis; Munoz-Garay, Carlos; Jimenez-Juarez, Nuria; Pacheco, Sabino; Masson, Luke; Soberon, Mario; Bravo, Alejandra			Dominant Negative Mutants of Bacillus thuringiensis Cry1Ab Toxin Function as Anti-Toxins: Demonstration of the Role of Oligomerization in Toxicity	PLOS ONE			English	Article								Background: Bacillus thuringiensis Cry toxins, that are used worldwide in insect control, kill insects by a mechanism that depends on their ability to form oligomeric pores that insert into the insect-midgut cells. These toxins are being used worldwide in transgenic plants or spray to control insect pests in agriculture. However, a major concern has been the possible effects of these insecticidal proteins on non-target organisms mainly in ecosystems adjacent to agricultural fields. Methodology/Principal Findings: We isolated and characterized 11 non-toxic mutants of Cry1Ab toxin affected in different steps of the mechanism of action namely binding to receptors, oligomerization and pore-formation. These mutant toxins were analyzed for their capacity to block wild type toxin activity, presenting a dominant negative phenotype. The dominant negative phenotype was analyzed at two levels, in vivo by toxicity bioassays against susceptible Manduca sexta larvae and in vitro by pore formation activity in black lipid bilayers. We demonstrate that some mutations located in helix alpha-4 completely block the wild type toxin activity at sub-stoichiometric level confirming a dominant negative phenotype, thereby functioning as potent antitoxins. Conclusions/Significance: This is the first reported case of a Cry toxin dominant inhibitor. These data demonstrate that oligomerization is a fundamental step in Cry toxin action and represent a potential mechanism to protect special ecosystems from the possible effect of Cry toxins on non-target organisms.			Rodriguez-Almazan, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Morelos, Mexico.	bravo@ibt.unam.mx	Pacheco, Sabino/AFJ-9017-2022; de la Parra, Maria Alejandra Bravo/R-6740-2017	Munoz-Garay, Carlos/0000-0002-7218-4027; Pacheco, Sabino/0000-0002-0208-0046; Bravo, Alejandra/0000-0002-7573-7475	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI066014, 1R01 AI066014-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Bohn T, 2008, ARCH ENVIRON CON TOX, V55, P584, DOI 10.1007/s00244-008-9150-5; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Douville M, 2009, ECOTOX ENVIRON SAFE, V72, P17, DOI 10.1016/j.ecoenv.2008.02.006; Girard F, 2008, APPL ENVIRON MICROB, V74, P2565, DOI 10.1128/AEM.00094-08; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Kramarz PE, 2007, ENVIRON TOXICOL CHEM, V26, P73, DOI 10.1897/06-095R.1; Masson L, 1999, J BIOL CHEM, V274, P31996, DOI 10.1074/jbc.274.45.31996; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Rajamohan F, 1996, J BIOL CHEM, V271, P25220, DOI 10.1074/jbc.271.41.25220; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Rosi-Marshall EJ, 2007, P NATL ACAD SCI USA, V104, P16204, DOI 10.1073/pnas.0707177104; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Smedley DP, 1996, MICROBIOL-SGM, V142, P1617, DOI 10.1099/13500872-142-7-1617; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; THOMAS WE, 1983, J CELL SCI, V60, P181; Vachon V, 2004, APPL ENVIRON MICROB, V70, P6123, DOI 10.1128/AEM.70.10.6123-6130.2004; Vinion-Dubiel AD, 1999, J BIOL CHEM, V274, P37736, DOI 10.1074/jbc.274.53.37736; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; WU D, 1992, J BIOL CHEM, V267, P2311; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Yan M, 2003, MOL MED, V9, P46, DOI 10.1007/BF03402106; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200; Zwahlen C, 2003, MOL ECOL, V12, P1077, DOI 10.1046/j.1365-294X.2003.01799.x	36	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5545	10.1371/journal.pone.0005545	http://dx.doi.org/10.1371/journal.pone.0005545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19440244	Green Published, gold, Green Submitted			2022-12-27	WOS:000266107300010
J	Sonne, SB; Dalgaard, MD; Nielsen, JE; Hoei-Hansen, CE; Meyts, ERD; Gjerdrum, LM; Leffers, H				Sonne, Si Brask; Dalgaard, Marlene D.; Nielsen, John Erik; Hoei-Hansen, Christina E.; Meyts, Ewa Rajpert-De; Gjerdrum, Lise Mette; Leffers, Henrik			Optimizing Staining Protocols for Laser Microdissection of Specific Cell Types from the Testis Including Carcinoma In Situ	PLOS ONE			English	Article								Microarray and RT-PCR based methods are important tools for analysis of gene expression; however, in tissues containing many different cells types, such as the testis, characterization of gene expression in specific cell types can be severely hampered by noise from other cells. The laser microdissection technology allows for enrichment of specific cell types. However, when the cells are not morphologically distinguishable, it is necessary to use a specific staining method for the target cells. In this study we have tested different fixatives, storage conditions for frozen sections and staining protocols, and present two staining protocols for frozen sections, one for fast and specific staining of fetal germ cells, testicular carcinoma in situ cells, and other cells with embryonic stem cell-like properties that express the alkaline phosphatase, and one for specific staining of lipid droplet-containing cells, which is useful for isolation of the androgen-producing Leydig cells. Both protocols retain a morphology that is compatible with laser microdissection and yield RNA of a quality suitable for PCR and microarray analysis.			Sonne, SB (corresponding author), Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark.	si@bsonne.dk	Rajpert-De Meyts, Ewa/H-6526-2019; Sonne, Si Brask/A-4851-2012; Hoei-Hansen, Christina Engel/ABB-2281-2020	Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Sonne, Si Brask/0000-0003-3194-3805; Hoi-Hansen, Christina Engel/0000-0002-6191-694X; Gjerdrum, Lise Mette Rahbek/0000-0003-4377-3209				Abrahamsen HN, 2003, J MOL DIAGN, V5, P34, DOI 10.1016/S1525-1578(10)60449-7; Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Almstrup K, 2004, BIOL REPROD, V70, P1751, DOI 10.1095/biolreprod.103.026575; BERTHELSEN JG, 1981, SCAND J UROL NEPHROL, V15, P165, DOI 10.3109/00365598109179596; Buckanovich RJ, 2006, CANCER BIOL THER, V5, P635, DOI 10.4161/cbt.5.6.2676; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; Dabare AANPM, 1997, BRIT J UROL, V79, P455, DOI 10.1046/j.1464-410X.1997.03526.x; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Frank M, 2007, VIRCHOWS ARCH, V450, P699, DOI 10.1007/s00428-007-0412-9; Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104.028381; Ivell R, 2002, E SCHERING RES FDN W, P99; JACOBSEN GK, 1984, ACTA PATH MICRO IM A, V92, P323; Lillie RD, 1976, HISTOPATHOLOGIC TECH, V4th; Lindegaard MLS, 2005, J LIPID RES, V46, P439, DOI 10.1194/jlr.M400417-JLR200; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Metzdorff SB, 2007, TOXICOL SCI, V98, P87, DOI 10.1093/toxsci/kfm079; Mosselman S, 1996, P NATL ACAD SCI USA, V93, P2884, DOI 10.1073/pnas.93.7.2884; O'Connor MD, 2008, STEM CELLS, V26, P1109, DOI 10.1634/stemcells.2007-0801; Ottesen AM, 2003, GENE CHROMOSOME CANC, V38, P117, DOI 10.1002/gcc.10244; Plummer S, 2007, TOXICOL SCI, V97, P520, DOI 10.1093/toxsci/kfm062; Ravo M, 2008, LAB INVEST, V88, P430, DOI 10.1038/labinvest.2008.11; Schoor O, 2003, BIOTECHNIQUES, V35, P1192, DOI 10.2144/03356rr01; Sharpe RM, 2006, BEST PRACT RES CL EN, V20, P91, DOI 10.1016/j.beem.2005.09.005; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Sluka P, 2008, PROG HISTOCHEM CYTO, V42, P173, DOI 10.1016/j.proghi.2007.10.001; SONNE SB, 2009, CANC RES IN PRESS; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Szaniszlo P, 2004, CYTOM PART A, V59A, P191, DOI 10.1002/cyto.a.20055; Thompson KL, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-57; Vinggaard AM, 2005, TOXICOL SCI, V85, P886, DOI 10.1093/toxsci/kfi150	32	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2009	4	5							e5536	10.1371/journal.pone.0005536	http://dx.doi.org/10.1371/journal.pone.0005536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FX	19436754	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107300004
J	Datiko, DG; Lindtjorn, B				Datiko, Daniel G.; Lindtjorn, Bernt			Health Extension Workers Improve Tuberculosis Case Detection and Treatment Success in Southern Ethiopia: A Community Randomized Trial	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PREVALENCE; DISTRICT; SEASONALITY; STRATEGY	Background: One of the main strategies to control tuberculosis ( TB) is to find and treat people with active disease. Unfortunately, the case detection rates remain low in many countries. Thus, we need interventions to find and treat sufficient number of patients to control TB. We investigated whether involving health extension workers (HEWs: trained community health workers) in TB control improved smear-positive case detection and treatment success rates in southern Ethiopia. Methodology/Principal Finding: We carried out a community-randomized trial in southern Ethiopia from September 2006 to April 2008. Fifty-one kebeles (with a total population of 296, 811) were randomly allocated to intervention and control groups. We trained HEWs in the intervention kebeles on how to identify suspects, collect sputum, and provide directly observed treatment. The HEWs in the intervention kebeles advised people with productive cough of 2 weeks or more duration to attend the health posts. Two hundred and thirty smear-positive patients were identified from the intervention and 88 patients from the control kebeles. The mean case detection rate was higher in the intervention than in the control kebeles (122.2% vs 69.4%, p<0.001). In addition, more females patients were identified in the intervention kebeles (149.0 vs 91.6, p<0.001). The mean treatment success rate was higher in the intervention than in the control kebeles (89.3% vs 83.1%, p=0.012) and more for females patients (89.8% vs 81.3%, p=0.05). Conclusions/Significance: The involvement of HEWs in sputum collection and treatment improved smear-positive case detection and treatment success rate, possibly because of an improved service access. This could be applied in settings with low health service coverage and a shortage of health workers.			Datiko, DG (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	danieljohn42@yahoo.com	Datiko, Daniel G./AAE-6856-2020; Lindtjorn, Bernt/K-9465-2018; Datiko, Daniel/AAE-7019-2020	Lindtjorn, Bernt/0000-0002-6267-6984; Datiko, Daniel/0000-0002-8556-3069				Agboatwalla M, 2003, East Mediterr Health J, V9, P732; Ahsan Giasuddin, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P126; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Dye C, 2003, TUBERCULOSIS, V83, P35, DOI 10.1016/S1472-9792(02)00056-2; Dye C, 2007, B WORLD HEALTH ORGAN, V85, P364, DOI 10.2471/BLT.06.037580; Enarson DA, 2000, INT J TUBERC LUNG D, V4, pS219; *FED MIN HLTH ETH, 2008, TUB LEPR TB HIV PROT; Federal Ministry of Health of Ethiopia, 2005, ESS HLTH SERV PACK E; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Harries AD, 2004, TB HIV CLIN MANUAL; Kangangi JK, 2003, INT J TUBERC LUNG D, V7, pS5; Kivihya-Ndugga LEA, 2005, INT J TUBERC LUNG D, V9, P294; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; Murray CJL, 1998, INT J TUBERC LUNG D, V2, pS9; Omaswa F, 2003, INT J TUBERC LUNG D, V7, pS1; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Santha T, 2003, INT J TUBERC LUNG D, V7, P258; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Shargie EB, 2006, INT J TUBERC LUNG D, V10, P87; Singh AA, 2004, INT J TUBERC LUNG D, V8, P800; Subramani R, 2008, INT J TUBERC LUNG D, V12, P916; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI [DOI 10.3310/HTA3050, DOI 10.3310/hta3050]; Wahyuni CU, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-135; Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248; WHO, 2007, TRAIN MAN WHO PACK E, P1; *WHO, 2003, COMM TB CAR PRACT PO; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1	30	104	106	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5443	10.1371/journal.pone.0005443	http://dx.doi.org/10.1371/journal.pone.0005443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424460	gold, Green Published			2022-12-27	WOS:000265933800008
J	Shearer, GC; Pottala, JV; Spertus, JA; Harris, WS				Shearer, Gregory C.; Pottala, James V.; Spertus, John A.; Harris, William S.			Red Blood Cell Fatty Acid Patterns and Acute Coronary Syndrome	PLOS ONE			English	Article								Background: Assessment of coronary heart disease (CHD) risk is typically based on a weighted combination of standard risk factors. We sought to determine the extent to which a lipidomic approach based on red blood cell fatty acid (RBC-FA) profiles could discriminate acute coronary syndrome (ACS) cases from controls, and to compare RBC-FA discrimination with that based on standard risk factors. Methodology/Principal Findings: RBC-FA profiles were measured in 668 ACS cases and 680 age-, race- and gender-matched controls. Multivariable logistic regression models based on FA profiles ( FA) and standard risk factors (SRF) were developed on a random 2/3 rds derivation set and validated on the remaining 1/3 rd. The area under receiver operating characteristic (ROC) curves (c-statistics), misclassification rates, and model calibrations were used to evaluate the individual and combined models. The FA discriminated cases from controls better than the SRF (c = 0.85 vs. 0.77, p = 0.003) and the FA profile added significantly to the standard model (c = 0.88 vs. 0.77, p, 0.0001). Hosmer-Lemeshow calibration was poor for the FA model alone (p = 0.01), but acceptable for both the SRF (p = 0.30) and combined models (p = 0.22). Misclassification rates were 23%, 29% and 20% for FA, the SRF, and the combined models, respectively. Conclusions/Significance: RBC-FA profiles contribute significantly to the discrimination of ACS cases, especially when combined with standard risk factors. The utility of FA patterns in risk prediction warrants further investigation.			Shearer, GC (corresponding author), Sanford Res USD Cardiovasc Hlth Res Ctr, Sioux Falls, SD USA.	harrisw@sanfordhealth.org	Spertus, John/ABD-3075-2021; Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353				Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BLOCK RC, 2007, ATHEROSCLEROSIS; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Greenland P, 2008, STAT MED, V27, P188, DOI 10.1002/sim.2976; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harris WS, 2008, CURR CARDIOVASC RISK, V2, P161, DOI 10.1007/s12170-008-0029-9; Harris William S, 2006, Curr Atheroscler Rep, V8, P453, DOI 10.1007/s11883-006-0019-7; Harris WS, 2007, PHARMACOL RES, V55, P217, DOI 10.1016/j.phrs.2007.01.013; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Harris WS, 2004, CIRCULATION, V110, P1645, DOI 10.1161/01.CIR.0000142292.10048.B2; JURAND J, 1970, ATHEROSCLEROSIS, V11, P157, DOI 10.1016/0021-9150(70)90013-4; KARK JD, 1995, J CLIN EPIDEMIOL, V48, P889, DOI 10.1016/0895-4356(94)00218-F; Koshkin V, 1998, J BIOL CHEM, V273, P6046, DOI 10.1074/jbc.273.11.6046; LANDS WEM, 1995, AM J CLIN NUTR, V61, p721S, DOI 10.1093/ajcn/61.3.721S; Lemaitre RN, 2002, CIRCULATION, V105, P697, DOI 10.1161/hc0602.103583; LLOYDJONES DM, 2006, ANN INTERN MED; Ma DWL, 2004, J NUTR BIOCHEM, V15, P700, DOI 10.1016/j.jnutbio.2004.08.002; MAIDMENT CGH, 1988, ATHEROSCLEROSIS, V74, P9, DOI 10.1016/0021-9150(88)90185-2; MARCEL YL, 1968, BIOCHIM BIOPHYS ACTA, V164, P25, DOI 10.1016/0005-2760(68)90067-2; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Niu KJ, 2006, AM J CLIN NUTR, V84, P223, DOI 10.1093/ajcn/84.1.223; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pitt B, 2008, J AM COLL CARDIOL, V51, P1440, DOI [10.1016/j.jacc.2007.11.075, 10.1016/j.jacc.2007.11.015]; Ridker P. M., 2008, CIRCULATION; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Wang FW, 2006, LANDSLIDES, V3, P84, DOI 10.1007/s10346-005-0010-3; Willett WC, 2006, ATHEROSCLEROSIS SUPP, V7, P5, DOI 10.1016/j.atherosclerosissup.2006.04.002; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	42	48	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5444	10.1371/journal.pone.0005444	http://dx.doi.org/10.1371/journal.pone.0005444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421317	Green Submitted, gold, Green Published			2022-12-27	WOS:000265836900005
J	Cox, D; Fox, L; Tian, RY; Bardet, W; Skaley, M; Mojsilovic, D; Gumperz, J; Hildebrand, W				Cox, Daryl; Fox, Lisa; Tian, Runying; Bardet, Wilfried; Skaley, Matthew; Mojsilovic, Danijela; Gumperz, Jenny; Hildebrand, William			Determination of Cellular Lipids Bound to Human CD1d Molecules	PLOS ONE			English	Article								CD1 molecules are glycoproteins that present lipid antigens at the cell surface for immunological recognition by specialized populations of T lymphocytes. Prior experimental data suggest a wide variety of lipid species can bind to CD1 molecules, but little is known about the characteristics of cellular ligands that are selected for presentation. Here we have molecularly characterized lipids bound to the human CD1d isoform. Ligands were eluted from secreted CD1d molecules and separated by normal phase HPLC, then characterized by mass spectroscopy. A total of 177 lipid species were molecularly identified, comprising glycerophospholipids and sphingolipids. The glycerophospholipids included common diacylglycerol species, reduced forms known as plasmalogens, lyso-phospholipids (monoacyl species), and cardiolipins (tetraacyl species). The sphingolipids included sphingomyelins and glycosylated forms, such as the ganglioside GM3. These results demonstrate that human CD1d molecules bind a surprising diversity of lipid structures within the secretory pathway, including compounds that have been reported to play roles in cancer, autoimmune diseases, lipid signaling, and cell death.			Gumperz, J (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jegumperz@wisc.edu			NHLBI NIH HHS [R01 HL071590] Funding Source: Medline; NIAID NIH HHS [R01 AI074940, HHSN266200400027C] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074940] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Chen XX, 2007, J IMMUNOL, V178, P6181, DOI 10.4049/jimmunol.178.10.6181; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Giabbai B, 2005, J IMMUNOL, V175, P977, DOI 10.4049/jimmunol.175.2.977; Goff RD, 2004, J AM CHEM SOC, V126, P13602, DOI 10.1021/ja045385q; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2005.00364.x; HAX WMA, 1977, J CHROMATOGR, V142, P735, DOI 10.1016/S0021-9673(01)92081-3; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Hickman HD, 2000, HUM IMMUNOL, V61, P1339, DOI 10.1016/S0198-8859(00)00216-0; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P797, DOI 10.1016/S1044-0305(00)00151-3; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P1510, DOI 10.1016/j.jasms.2005.04.018; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P1, DOI 10.1016/j.jasms.2003.08.006; Hsu FF, 2003, J MASS SPECTROM, V38, P752, DOI 10.1002/jms.491; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P680, DOI 10.1016/S1044-0305(02)00362-8; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Hsu FF, 2006, J AM SOC MASS SPECTR, V17, P420, DOI 10.1016/j.jasms.2005.11.019; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P2065, DOI 10.1016/j.jasms.2007.08.019; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P783, DOI 10.1016/j.jasms.2006.12.012; Im JS, 2004, J BIOL CHEM, V279, P299, DOI 10.1074/jbc.M308803200; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Metelmann W, 2001, J MASS SPECTROM, V36, P21, DOI 10.1002/jms.100; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Park JE, 2008, IMMUNOLOGY, V123, P145, DOI 10.1111/j.1365-2567.2007.02760.x; Prilliman K, 1997, IMMUNOGENETICS, V45, P379, DOI 10.1007/s002510050219; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SHIMIZU Y, 1986, MOL CELL BIOL, V6, P1074, DOI 10.1128/MCB.6.4.1074; Sorensen LK, 2006, RAPID COMMUN MASS SP, V20, P3625, DOI 10.1002/rcm.2775; Tsuji M, 2006, CELL MOL LIFE SCI, V63, P1889, DOI 10.1007/s00018-006-6073-z; Vukelic Z, 2001, BIOL CHEM, V382, P259, DOI 10.1515/BC.2001.033; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2008, J MOL BIOL, V377, P1104, DOI 10.1016/j.jmb.2008.01.061; Zajonc DM, 2006, J IMMUNOL, V177, P4577, DOI 10.4049/jimmunol.177.7.4577; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	55	109	110	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5325	10.1371/journal.pone.0005325	http://dx.doi.org/10.1371/journal.pone.0005325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415116	gold, Green Submitted, Green Published			2022-12-27	WOS:000265836700003
J	Janic, B; Rad, AM; Jordan, EK; Iskander, ASM; Ali, MM; Varma, NRS; Frank, JA; Arbab, AS				Janic, Branislava; Rad, Ali M.; Jordan, Elaine K.; Iskander, A. S. M.; Ali, Md M.; Varma, N. Ravi S.; Frank, Joseph A.; Arbab, Ali S.			Optimization and Validation of FePro Cell Labeling Method	PLOS ONE			English	Article								Current method to magnetically label cells using ferumoxides (Fe)-protamine (Pro) sulfate (FePro) is based on generating FePro complexes in a serum free media that are then incubated overnight with cells for the efficient labeling. However, this labeling technique requires long (>12-16 hours) incubation time and uses relatively high dose of Pro (5-6 mu g/ml) that makes large extracellular FePro complexes. These complexes can be difficult to clean with simple cell washes and may create low signal intensity on T2* weighted MRI that is not desirable. The purpose of this study was to revise the current labeling method by using low dose of Pro and adding Fe and Pro directly to the cells before generating any FePro complexes. Human tumor glioma (U251) and human monocytic leukemia cell (THP-1) lines were used as model systems for attached and suspension cell types, respectively and dose dependent (Fe 25 to 100 mu g/ml and Pro 0.75 to 3 mu g/ml) and time dependent (2 to 48 h) labeling experiments were performed. Labeling efficiency and cell viability of these cells were assessed. Prussian blue staining revealed that more than 95% of cells were labeled. Intracellular iron concentration in U251 cells reached similar to 30-35 pg-iron/cell at 24 h when labeled with 100 mu g/ml of Fe and 3 mu g/ml of Pro. However, comparable labeling was observed after 4 h across the described FePro concentrations. Similarly, THP-1 cells achieved similar to 10 pg-iron/cell at 48 h when labeled with 100 mu g/ml of Fe and 3 mu g/ml of Pro. Again, comparable labeling was observed after 4 h for the described FePro concentrations. FePro labeling did not significantly affect cell viability. There was almost no extracellular FePro complexes observed after simple cell washes. To validate and to determine the effectiveness of the revised technique, human T-cells, human hematopoietic stem cells (hHSC), human bone marrow stromal cells (hMSC) and mouse neuronal stem cells (mNSC C17.2) were labeled. Labeling for 4 hours using 100 mu g/ml of Fe and 3 mu g/ml of Pro resulted in very efficient labeling of these cells, without impairing their viability and functional capability. The new technique with short incubation time using 100 mu g/ml of Fe and 3 mu g/ml of Pro is effective in labeling cells for cellular MRI.			Janic, B (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	bjanic@rad.hfh.edu	Arbab, Ali/AAS-1933-2020; Frank, Joseph/W-2021-2019		NATIONAL CANCER INSTITUTE [R01CA122031, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058589] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R21 CA 129801, R21 CA129801, R01 CA 122031, R01 CA122031] Funding Source: Medline; NINDS NIH HHS [R21 NS 058589, R21 NS058589] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abou-Montet K, 2005, MOL IMAGING, V4, P165; Ahrens ET, 2003, MAGN RESON MED, V49, P1006, DOI 10.1002/mrm.10465; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1; FERRUCCI JT, 1990, AM J ROENTGENOL, V155, P943, DOI 10.2214/ajr.155.5.2120963; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; Montet-Abou K, 2007, MOL IMAGING, V6, P1, DOI 10.2310/7290.2006.00028; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Pittet MJ, 2006, NAT PROTOC, V1, P73, DOI 10.1038/nprot.2006.11; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978; Reynolds F, 2005, BIOCONJUGATE CHEM, V16, P1240, DOI 10.1021/bc0501451; SOLTANIANZADEH H, 1992, IEEE T MED IMAGING, V11, P302, DOI 10.1109/42.158934	18	50	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2009	4	6							e5873	10.1371/journal.pone.0005873	http://dx.doi.org/10.1371/journal.pone.0005873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TJ	19517015	Green Published, Green Submitted, gold			2022-12-27	WOS:000266873100006
J	Chen, XQ; Zhang, J; Neumeyer, JL; Jin, GZ; Hu, GY; Zhang, A; Zhen, XC				Chen, Xue-Qin; Zhang, Jing; Neumeyer, John L.; Jin, Guo-Zhang; Hu, Guo-Yuan; Zhang, Ao; Zhen, Xuechu			Arylbenzazepines Are Potent Modulators for the Delayed Rectifier K+ Channel: A Potential Mechanism for Their Neuroprotective Effects	PLOS ONE			English	Article								(+/-) SKF83959, like many other arylbenzazepines, elicits powerful neuroprotection in vitro and in vivo. The neuroprotective action of the compound was found to partially depend on its D-1-like dopamine receptor agonistic activity. The precise mechanism for the (+/-) SKF83959-mediated neuroprotection remains elusive. We report here that (+/-) SKF83959 is a potent blocker for delayed rectifier K+ channel. (+/-) SKF83959 inhibited the delayed rectifier K+ current (I-K) dose-dependently in rat hippocampal neurons. The IC50 value for inhibition of I-K was 41.9 +/- 2.3 mu M (Hill coefficient = 1.81 +/- 0.13, n = 6), whereas that for inhibition of I-A was 307.9 +/- 38.5 mu M (Hill coefficient = 1.37 +/- 0.08, n = 6). Thus, (+/-) SKF83959 is 7.3-fold more potent in suppressing I-K than I-A. Moreover, the inhibition of I-K by (+/-) SKF83959 was voltage-dependent and not related to dopamine receptors. The rapidly onset of inhibition and recovery suggests that the inhibition resulted from a direct interaction of (+/-) SKF83959 with the K+ channel. The intracellular application of (+/-) SKF83959 had no effects of on I-K, indicating that the compound most likely acts at the outer mouth of the pore of K+ channel. We also tested the enantiomers of (+/-) SKF83959, R-(+) SKF83959 (MCL-201), and S-(-) SKF83959 (MCL-202), as well as SKF38393; all these compounds inhibited IK. However, (+/-) SKF83959, at either 0.1 or 1 mM, exhibited the strongest inhibition on the currents among all tested drug. The present findings not only revealed a new potent blocker of I-K, but also provided a novel mechanism for the neuroprotective action of arylbenzazepines such as (+/-) SKF83959.			Chen, XQ (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 2, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	aozhang@mail.shcnc.ac.cn; xczhen@mail.shcnc.ac.cn		zhen, xuechu/0000-0001-7458-2566; Neumeyer, John/0000-0003-2287-9864	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014251] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA014251, DA-14251] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Agnati LF, 2004, BRAIN RES BULL, V64, P155, DOI 10.1016/j.brainresbull.2004.06.003; Ahn HS, 2007, N-S ARCH PHARMACOL, V374, P305, DOI 10.1007/s00210-006-0118-6; Andringa G, 1999, PSYCHOPHARMACOLOGY, V146, P328, DOI 10.1007/s002130051124; ARNT J, 1992, EUR J PHARMACOL, V213, P259, DOI 10.1016/0014-2999(92)90690-6; Clifford JJ, 1999, NEUROSCIENCE, V93, P1483, DOI 10.1016/S0306-4522(99)00297-3; Cools AR, 2002, NEUROPHARMACOLOGY, V42, P237, DOI 10.1016/S0028-3908(01)00169-1; Delpon E, 1997, CARDIOVASC RES, V35, P341, DOI 10.1016/S0008-6363(97)00121-1; Desai RI, 2007, BEHAV PHARMACOL, V18, P745, DOI 10.1097/FBP.0b013e3282f14ee6; Desai RI, 2007, EUR J PHARMACOL, V558, P98, DOI 10.1016/j.ejphar.2006.11.042; DEVENEY AM, 1995, BRIT J PHARMACOL, V116, P2120, DOI 10.1111/j.1476-5381.1995.tb16420.x; Franciosi S, 2006, J NEUROSCI, V26, P11652, DOI 10.1523/JNEUROSCI.2490-06.2006; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P287, DOI 10.1007/BF02246103; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P275, DOI 10.1007/BF02246102; Hu GY, 2002, J NEUROPHYSIOL, V87, P2676, DOI 10.1152/jn.2002.87.6.2676; Huang H, 2001, NEUROSCI LETT, V305, P83, DOI 10.1016/S0304-3940(01)01821-3; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; la Cour CM, 2007, NEUROPHARMACOLOGY, V52, P1003, DOI 10.1016/j.neuropharm.2006.10.021; Neumeyer JL, 2003, EUR J PHARMACOL, V474, P137, DOI 10.1016/S0014-2999(03)02008-9; Nutt JG, 1997, MOVEMENT DISORD, V12, P285, DOI 10.1002/mds.870120304; Obeso JA, 2004, NEUROLOGY, V62, pS17, DOI 10.1212/WNL.62.1_suppl_1.S17; Pal S, 2003, J NEUROSCI, V23, P4798; Panchalingam S, 2001, NEUROPHARMACOLOGY, V40, P826, DOI 10.1016/S0028-3908(01)00011-9; Redman PT, 2006, NEUROSCIENCE, V143, P1, DOI 10.1016/j.neuroscience.2006.08.039; Shieh CC, 2000, PHARMACOL REV, V52, P557; Song MK, 2006, EUR J PHARMACOL, V531, P47, DOI 10.1016/j.ejphar.2005.12.029; Waddington JL, 2005, PSYCHOPHARMACOLOGY, V181, P611, DOI 10.1007/s00213-005-0058-8; Wei L, 2003, STROKE, V34, P1281, DOI 10.1161/01.STR.0000065828.18661.FE; Wickenden AD, 2002, PHARMACOL THERAPEUT, V94, P157, DOI 10.1016/S0163-7258(02)00201-2; Wirtshafter D, 2005, EUR J PHARMACOL, V528, P88, DOI 10.1016/j.ejphar.2005.11.003; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186; Yu Y, 2008, J NEUROCHEM, V104, P946, DOI 10.1111/j.1471-4159.2007.05062.x; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zhang H, 2007, NEUROPHARMACOLOGY, V53, P125, DOI 10.1016/j.neuropharm.2007.04.004; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016	35	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5811	10.1371/journal.pone.0005811	http://dx.doi.org/10.1371/journal.pone.0005811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503734	gold, Green Submitted, Green Published			2022-12-27	WOS:000266717200007
J	Ivanic, J; Yu, XP; Wallqvist, A; Reifman, J				Ivanic, Joseph; Yu, Xueping; Wallqvist, Anders; Reifman, Jaques			Influence of Protein Abundance on High-Throughput Protein-Protein Interaction Detection	PLOS ONE			English	Article								Experimental protein-protein interaction (PPI) networks are increasingly being exploited in diverse ways for biological discovery. Accordingly, it is vital to discern their underlying natures by identifying and classifying the various types of deterministic (specific) and probabilistic (nonspecific) interactions detected. To this end, we have analyzed PPI networks determined using a range of high-throughput experimental techniques with the aim of systematically quantifying any biases that arise from the varying cellular abundances of the proteins. We confirm that PPI networks determined using affinity purification methods for yeast and Eschericia coli incorporate a correlation between protein degree, or number of interactions, and cellular abundance. The observed correlations are small but statistically significant and occur in both unprocessed (raw) and processed (high-confidence) data sets. In contrast, the yeast two-hybrid system yields networks that contain no such relationship. While previously commented based on mRNA abundance, our more extensive analysis based on protein abundance confirms a systematic difference between PPI networks determined from the two technologies. We additionally demonstrate that the centrality-lethality rule, which implies that higher-degree proteins are more likely to be essential, may be misleading, as protein abundance measurements identify essential proteins to be more prevalent than nonessential proteins. In fact, we generally find that when there is a degree/abundance correlation, the degree distributions of nonessential and essential proteins are also disparate. Conversely, when there is no degree/abundance correlation, the degree distributions of nonessential and essential proteins are not different. However, we show that essentiality manifests itself as a biological property in all of the yeast PPI networks investigated here via enrichments of interactions between essential proteins. These findings provide valuable insights into the underlying natures of the various high-throughput technologies utilized to detect PPIs and should lead to more effective strategies for the inference and analysis of high-quality PPI data sets.			Ivanic, J (corresponding author), USA, Biotechnol HPC Software Applicat Inst, Telemed & Adv Technol Res Ctr, Med Res & Mat Command, Ft Detrick, MD USA.	jaques.reifman@us.army.mil	wallqvist, anders/W-2584-2019	wallqvist, anders/0000-0002-9775-7469				Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Bjorklund AK, 2008, PROTEOMICS, V8, P4657, DOI 10.1002/pmic.200800150; Bro C, 2003, J BIOL CHEM, V278, P32141, DOI 10.1074/jbc.M304478200; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Draghici S., 2003, DATA ANAL TOOLS DNA; Fields S, 2005, FEBS J, V272, P5391, DOI 10.1111/j.1742-4658.2005.04973.x; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fry RC, 2003, MECH AGEING DEV, V124, P839, DOI 10.1016/S0047-6374(03)00144-1; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ivanic J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000114; Ivanic J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-11; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lubovac Z, 2006, PROTEINS, V64, P948, DOI 10.1002/prot.21071; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; PRZULJ N, 2005, KNOWLEDGE DISCOVERY; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sen TZ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-355; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Sprinzak E, 2003, J MOL BIOL, V327, P919, DOI 10.1016/S0022-2836(03)00239-0; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang JS, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.48; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	58	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5815	10.1371/journal.pone.0005815	http://dx.doi.org/10.1371/journal.pone.0005815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503833	gold, Green Submitted, Green Published			2022-12-27	WOS:000266717200011
J	Sims, LM; Garvey, D; Ballantyne, J				Sims, Lynn M.; Garvey, Dennis; Ballantyne, Jack			Improved Resolution Haplogroup G Phylogeny in the Y Chromosome, Revealed by a Set of Newly Characterized SNPs	PLOS ONE			English	Article								Background: Y-SNP haplogroup G (hgG), defined by Y-SNP marker M201, is relatively uncommon in the United States general population, with only 8 additional sub-markers characterized. Many of the previously described eight sub-markers are either very rare (2-4%) or do not distinguish between major populations within this hg. In fact, prior to the current study, only 2% of our reference Caucasian population belonged to hgG and all of these individuals were in sub-haplogroup G2a, defined by P15. Additional Y-SNPs are needed in order to differentiate between individuals within this haplogroup. Principal Findings: In this work we have investigated whether we could differentiate between a population of 63 hgG individuals using previously uncharacterized Y-SNPs. We have designed assays to test these individuals using all known hgG SNPs (n = 9) and an additional 16 unreported/undefined Y-SNPS. Using a combination of DNA sequence and genetic genealogy databases, we have uncovered a total of 15 new hgG SNPs that had been previously reported but not phylogenetically characterized. Ten of the new Y-SNPs are phylogenetically equivalent to M201, one is equivalent to P15 and, interestingly, four create new, separate haplogroups. Three of the latter are more common than many of the previously defined Y-SNPs. Y-STR data from these individuals show that DYS385*12 is present in (70%) of G2a3b1-U13 individuals while only 4% of non-G2a3b1-U13 individuals posses the DYS385*12 allele. Conclusions: This study uncovered several previously undefined Y-SNPs by using data from several database sources. The new Y-SNPs revealed in this paper will be of importance to those with research interests in population biology and human evolution.			Sims, LM (corresponding author), Univ Cent Florida, Grad Program Chem, Orlando, FL 32816 USA.	jballant@mail.ucf.edu	Sims, Lynn M./T-8422-2019	Sims, Lynn/0000-0002-3126-1460				Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brion M, 2005, ELECTROPHORESIS, V26, P4411, DOI 10.1002/elps.200500293; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Daniels DL, 2004, J FORENSIC SCI, V49, P668; Ellis N, 2002, GENOME RES, V12, P339; Flores C, 2005, J HUM GENET, V50, P435, DOI 10.1007/s10038-005-0274-4; Hall A, 2003, ANAL BIOANAL CHEM, V376, P1234, DOI 10.1007/s00216-003-2039-2; HAMMER MF, 2005, FORENSIC SCI INT; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jobling MA, 2001, FORENSIC SCI INT, V118, P158, DOI 10.1016/S0379-0738(01)00385-1; JONES DA, 1972, J FORENSIC SCI SOC, V12, P355, DOI 10.1016/S0015-7368(72)70695-7; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; KIDD KK, 2005, FORENSIC SCI INT; Marjanovic D, 2005, ANN HUM GENET, V69, P757, DOI 10.1111/j.1529-8817.2005.00190.x; Nasidze I, 2004, ANN HUM GENET, V68, P588, DOI 10.1046/j.1529-8817.2004.00131.x; Nasidze I, 2004, ANN HUM GENET, V68, P205, DOI 10.1046/j.1529-8817.2004.00092.x; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez JJ, 2003, FORENSIC SCI INT, V137, P74, DOI 10.1016/S0379-0738(03)00299-8; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; SIMS LM, 2008, BIOCH GENET; Sims Lynn M, 2007, Hum Mutat, V28, P97, DOI 10.1002/humu.9469; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Vallone PM, 2004, J FORENSIC SCI, V49, P723; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040	27	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2009	4	6							e5792	10.1371/journal.pone.0005792	http://dx.doi.org/10.1371/journal.pone.0005792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XI	19495413	Green Published, gold, Green Submitted			2022-12-27	WOS:000266716900004
J	Mora, GN; Bramanti, P; Osculati, F; Chakir, A; Nicolato, E; Marzola, P; Sbarbati, A; Fabene, PF				Mora, Graciela Navarro; Bramanti, Placido; Osculati, Francesco; Chakir, Asmaa; Nicolato, Elena; Marzola, Pasquina; Sbarbati, Andrea; Fabene, Paolo Francesco			Does Pilocarpine-Induced Epilepsy in Adult Rats Require Status epilepticus?	PLOS ONE			English	Article								Pilocarpine-induced seizures in rats provide a widely animal model of temporal lobe epilepsy. Some evidences reported in the literature suggest that at least 1 h of status epilepticus (SE) is required to produce subsequent chronic phase, due to the SE-related acute neuronal damage. However, recent data seems to indicate that neuro-inflammation plays a crucial role in epileptogenesis, modulating secondarily a neuronal insult. For this reason, we decided to test the following hypotheses: a) whether pilocarpine-injected rats that did not develop SE can exhibit long-term chronic spontaneous recurrent seizures (SRS) and b) whether acute neurodegeneration is mandatory to obtain chronic epilepsy. Therefore, we compared animals injected with the same dose of pilocarpine that developed or did not SE, and saline treated rats. We used telemetric acquisition of EEG as long-term monitoring system to evaluate the occurrence of seizures in non-SE pilocarpineinjected animals. Furthermore, histology and MRI analysis were applied in order to detect neuronal injury and neuropathological signs. Our observations indicate that non-SE rats exhibit SRS almost 8 (+/22) months after pilocarpine-injection, independently to the absence of initial acute neuronal injury. This is the first time reported that pilocarpine injected rats without developing SE, can experience SRS after a long latency period resembling human pathology. Thus, we strongly emphasize the important meaning of including these animals to model human epileptogenesis in pilocarpine induced epilepsy.			Mora, GN (corresponding author), Univ Verona, Dept Morphol & Biomed Sci, Sect Anat & Histol, I-37100 Verona, Italy.	paolo.fabene@univr.it	Bramanti, Placido/K-5117-2016	MARZOLA, Pasquina/0000-0001-6936-8901; Fabene, Paolo/0000-0002-9644-4399				Arzimanoglou A, 2002, EPILEPTIC DISORD, V4, P173; Blanco MM, 2009, EPILEPSIA, V50, P824, DOI 10.1111/j.1528-1167.2008.01797.x; Brandt C, 2003, EPILEPSY RES, V55, P83, DOI 10.1016/S0920-1211(03)00114-1; Cassidy RM, 1998, J NEUROSCI, V18, P9002; Cavalheiro EA, 1996, EPILEPSIA, V37, P1015, DOI 10.1111/j.1528-1157.1996.tb00541.x; CAVALHEIRO EA, 1995, ITAL J NEUROL SCI, V16, P33, DOI 10.1007/BF02229072; Chakir A, 2006, BRAIN RES BULL, V71, P127, DOI 10.1016/j.brainresbull.2006.08.009; Chuang YC, 2004, EPILEPSIA, V45, P1202, DOI 10.1111/j.0013-9580.2004.18204.x; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; De-Mello N, 2005, BEHAV BRAIN RES, V158, P263, DOI 10.1016/j.bbr.2004.09.006; Dijkhuizen RM, 2003, J CEREBR BLOOD F MET, V23, P1383, DOI 10.1097/01.WCB.0000100341.78607.EB; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Fabene PF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001105; Fabene PF, 2004, CURR DRUG TARGETS, V5, P629, DOI 10.2174/1389450043345218; Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; Glien M, 2001, EPILEPSY RES, V46, P111, DOI 10.1016/S0920-1211(01)00272-8; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Hamani Clement, 2002, Thalamus & Related Systems, V2, P49, DOI 10.1017/S1472928802000298; HAUSER WA, 1990, NEUROLOGY, V40, P9; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Holtkamp M, 2005, NEUROBIOL DIS, V19, P162, DOI 10.1016/j.nbd.2004.12.002; Kwong KL, 2003, PEDIATR NEUROL, V29, P46, DOI 10.1016/S0887-8994(03)00028-6; Majores M, 2004, EPILEPSY RES, V60, P173, DOI 10.1016/j.eplepsyres.2004.07.002; Marchi N, 2007, EPILEPSIA, V48, P1934, DOI 10.1111/j.1528-1167.2007.01185.x; Meierkord H, 2007, EPILEPSIA, V48, P94, DOI 10.1111/j.1528-1167.2007.01362.x; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Priel MR, 1996, EPILEPSY RES, V26, P115, DOI 10.1016/S0920-1211(96)00047-2; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; Scorza FA, 1998, EPILEPSIA, V39, P1041, DOI 10.1111/j.1528-1157.1998.tb01288.x; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Uva L, 2008, NEUROSCIENCE, V151, P303, DOI 10.1016/j.neuroscience.2007.10.037; Zhang X, 2002, J NEUROSCI, V22, P6052	36	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2009	4	6							e5759	10.1371/journal.pone.0005759	http://dx.doi.org/10.1371/journal.pone.0005759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453CI	19503612	Green Published, gold, Green Submitted			2022-12-27	WOS:000266587400003
J	Lubin, M; Lubin, A				Lubin, Martin; Lubin, Adam			Selective Killing of Tumors Deficient in Methylthioadenosine Phosphorylase: A Novel Strategy	PLOS ONE			English	Article								Background: The gene for methylthioadenosine phosphorylase (MTAP) lies on 9p21, close to the gene CDKN2A that encodes the tumor suppressor proteins p16 and p14ARF. MTAP and CDKN2A are homozygously co-deleted, with a frequency of 35 to 70%, in lung and pancreatic cancer, glioblastoma, osteosarcoma, soft-tissue sarcoma, mesothelioma, and T-cell acute lymphoblastic leukemia. In normal cells, but not in tumor cells lacking MTAP, MTAP cleaves the natural substrate, 5'-deoxy-5-methylthioadenosine (MTA), to adenine and 5-methylthioribose-1-phosphate (MTR-1-P), which are then converted to adenine nucleotides and methionine. This distinct difference between normal MTAP-positive cells and tumor MTAP-negative cells led to several proposals for therapy. We offer a novel strategy in which both MTA and a toxic adenine analog, such as 2,6-diaminopurine (DAP), 6-methylpurine (MeP), or 2-fluoroadenine (F-Ade), are administered. In MTAP-positive cells, abundant adenine, generated from supplied MTA, competitively blocks the conversion of an analog, by adenine phosphoribosyltransferase (APRT), to its active nucleotide form. In MTAP-negative tumor cells, the supplied MTA cannot generate adenine; hence conversion of the analog is not blocked. Principal Findings: We show that this combination treatment - adenine analog plus MTA - kills MTAP-negative A549 lung tumor cells, while MTAP-positive human fibroblasts (HF) are protected. In co-cultures of the breast tumor cell line, MCF-7, and HF cells, MCF-7 is inhibited or killed, while HF cells proliferate robustly. 5-fluorouracil (5-FU) and 6-thioguanine (6-TG) may also be used with our strategy. Though neither analog is activated by APRT, in MTAP-positive cells, adenine produced from supplied MTA blocks conversion of 5-FU and 6-TG to their toxic nucleotide forms by competing for 5-phosphoribosyl-1-pyrophosphate (PRPP). The combination of MTA with 5-FU or 6-TG, in the treatment of MTAP-negative tumors, may produce a significantly improved therapeutic index. Conclusion: We describe a selective strategy to kill tumor cells lacking MTAP.			Lubin, M (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA.	martin.lubin@dartmouth.edu						Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Batova A, 2006, BLOOD, V107, P898, DOI 10.1182/blood-2005-06-2430; Batova A, 1996, BLOOD, V88, P3083, DOI 10.1182/blood.V88.8.3083.bloodjournal8883083; Behrmann I, 2003, AM J PATHOL, V163, P683, DOI 10.1016/S0002-9440(10)63695-4; BERTINO JR, 1993, J CLIN ONCOL, V11, P5, DOI 10.1200/JCO.1993.11.1.5; BURCHENAL JH, 1951, CANCER-AM CANCER SOC, V4, P549, DOI 10.1002/1097-0142(195105)4:3<549::AID-CNCR2820040308>3.0.CO;2-J; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; *CLINICALTRIALS GO, NCT00075894 CLINICAL; *CLINICALTRIALS GO, NCT00062283 CLINICAL; De Carvalho GSG, 2009, TETRAHEDRON LETT, V50, P463, DOI 10.1016/j.tetlet.2008.11.039; DELLARAGIONE F, 1995, ONCOGENE, V10, P827; Gadi VK, 2003, J PHARMACOL EXP THER, V304, P1280, DOI 10.1124/jpet.102.044743; Garcia-Castellano JM, 2002, CLIN CANCER RES, V8, P782; HASHIMOTO H, 1990, LEUKEMIA RES, V14, P1061, DOI 10.1016/0145-2126(90)90120-X; HEIMER R, 1983, BIOCHEM PHARMACOL, V32, P199, DOI 10.1016/0006-2952(83)90544-0; Ikeguchi Y, 2006, J BIOCHEM, V139, P1, DOI 10.1093/jb/mvj019; Illei PB, 2003, CLIN CANCER RES, V9, P2108; KAMATANI N, 1981, P NATL ACAD SCI-BIOL, V78, P1219, DOI 10.1073/pnas.78.2.1219; Karikari CA, 2005, MOL CANCER THER, V4, P1860, DOI 10.1158/1535-7163.MCT-05-0103; KINDLER HL, 2008, INVEST NEW DRUGS; Kung PP, 2005, BIOORG MED CHEM LETT, V15, P2829, DOI 10.1016/j.bmcl.2005.03.107; Li WW, 2004, ONCOL RES, V14, P373, DOI 10.3727/0965040041292332; LUBIN M, 2009, P AM ASS CANC RES S; MONTGOMERY JA, 1974, J MED CHEM, V17, P1197, DOI 10.1021/jm00257a014; Moratti EM, 1998, Patent No. 5753213; NOBORI T, 1991, CANCER RES, V51, P3193; NOBORI T, 1993, CANCER RES, V53, P1098; PEGG AE, 1969, BIOCHEM J, V115, P241, DOI 10.1042/bj1150241; PEGG AE, 1981, BIOCHEM J, V194, P79, DOI 10.1042/bj1940079; RISCOE MK, 1984, J BIOL CHEM, V259, P5465; Russo G L, 1988, Adv Exp Med Biol, V250, P229; SANTELLI G, 1980, J NATL CANCER I, V64, P69; SAVARESE TM, 1984, BIOCHEM PHARMACOL, V34, P361; Simile MM, 2001, J HEPATOL, V34, P386, DOI 10.1016/S0168-8278(00)00078-7; Sufrin JR, 2008, ANTIMICROB AGENTS CH, V52, P211, DOI 10.1128/AAC.00480-07; TISDALE MJ, 1983, BIOCHEM PHARMACOL, V32, P2915, DOI 10.1016/0006-2952(83)90396-9; TOOHEY JI, 1978, BIOCHEM BIOPH RES CO, V83, P27, DOI 10.1016/0006-291X(78)90393-5; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; WOLFORD RW, 1984, EXP HEMATOL, V12, P867; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Zhang Y, 2005, CURR TOP MED CHEM, V5, P1259, DOI 10.2174/156802605774463105	41	51	52	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2009	4	5							e5735	10.1371/journal.pone.0005735	http://dx.doi.org/10.1371/journal.pone.0005735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451SH	19478948	Green Published, Green Submitted, gold			2022-12-27	WOS:000266490000011
J	Chisamore, MJ; Cunningham, ME; Flores, O; Wilkinson, HA; Chen, JD				Chisamore, Michael J.; Cunningham, Michael E.; Flores, Osvaldo; Wilkinson, Hilary A.; Chen, J. Don			Characterization of a Novel Small Molecule Subtype Specific Estrogen-Related Receptor alpha Antagonist in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article								Background: The orphan nuclear receptor estrogen-related receptor alpha (ERR alpha) is a member of the nuclear receptor superfamily. It was identified through a search for genes encoding proteins related to estrogen receptor alpha (ER alpha). An endogenous ligand has not been found. Novel ERR alpha antagonists that are highly specific for binding to the ligand binding domain (LBD) of ERR alpha have been recently reported. Research suggests that ERR alpha may be a novel drug target to treat breast cancer and/or metabolic disorders and this has led to an effort to characterize the mechanisms of action of N-[(2Z)-3-(4,5-dihydro-1,3-thiazol-2- yl)-1,3-thiazolidin-2-ylidene]-5H dibenzo[a,d][7]annulen-5-amine, a novel ERR alpha specific antagonist. Methodology/Principal Findings: We demonstrate this ERR alpha ligand inhibits ERR alpha transcriptional activity in MCF-7 cells by luciferase assay but does not affect mRNA levels measured by real-time RT-PCR. Also, ER alpha (ESR1) mRNA levels were not affected upon treatment with the ERR alpha antagonist, but other ERR alpha (ESRRA) target genes such as pS2 (TFF1), osteopontin (SPP1), and aromatase (CYP19A1) mRNA levels decreased. In vitro, the ERR alpha antagonist prevents the constitutive interaction between ERR alpha and nuclear receptor coactivators. Furthermore, we use Western blots to demonstrate ERR alpha protein degradation via the ubiquitin proteasome pathway is increased by the ERR alpha-subtype specific antagonist. We demonstrate by chromatin immunoprecipitation (ChIP) that the interaction between ACADM, ESRRA, and TFF1 endogenous gene promoters and ERR alpha protein is decreased when cells are treated with the ligand. Knocking-down ERR alpha (shRNA) led to similar genomic effects seen when MCF-7 cells were treated with our ERR alpha antagonist. Conclusions/Significance: We report the mechanism of action of a novel ERR alpha specific antagonist that inhibits transcriptional activity of ERR alpha, disrupts the constitutive interaction between ERR alpha and nuclear coactivators, and induces proteasome-dependent ERR alpha protein degradation. Additionally, we confirmed that knocking-down ERR alpha lead to similar genomic effects demonstrated in vitro when treated with the ERR alpha specific antagonist.			Chisamore, MJ (corresponding author), Merck Res Labs, Dept Mol Endocrinol, West Point, PA USA.	michael_chisamore@merck.com			NIDDK NIH HHS [R01 DK052888, R01 DK52888] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052888] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		American Cancer Society, 2008, CANC FACTS FIG 2008; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Ariazi EA, 2002, CANCER RES, V62, P6510; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Bross PF, 2003, CLIN CANCER RES, V9, P4309; Busch BB, 2004, J MED CHEM, V47, P5593, DOI 10.1021/jm049334f; Chisamore MJ, 2008, DRUG DEVELOP RES, V69, P203, DOI 10.1002/ddr.20246; Chisarnore MJ, 2009, MOL CANCER THER, V8, P672, DOI 10.1158/1535-7163.MCT-08-1028; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Fan MY, 2003, MOL ENDOCRINOL, V17, P356, DOI 10.1210/me.2002-0323; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; HORWITZ KB, 1978, CANCER RES, V38, P2434; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Kallen J, 2007, J BIOL CHEM, V282, P23231, DOI 10.1074/jbc.M703337200; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kraus RJ, 2002, J BIOL CHEM, V277, P24826, DOI 10.1074/jbc.M202952200; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Liu DX, 2003, ENDOCRINOLOGY, V144, P4894, DOI 10.1210/en.2003-0432; Lu DS, 2001, CANCER RES, V61, P6755; MARSELOS M, 1992, EUR J CANCER, V28A, P1182, DOI 10.1016/0959-8049(92)90482-H; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Schaufele F, 2000, MOL ENDOCRINOL, V14, P2024, DOI 10.1210/me.14.12.2024; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Stein RA, 2006, ENDOCR-RELAT CANCER, V13, pS25, DOI 10.1677/erc.1.01292; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Tremblay GB, 2001, ENDOCRINOLOGY, V142, P4572, DOI 10.1210/en.142.10.4572; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wijayaratne AL, 1999, ENDOCRINOLOGY, V140, P5828, DOI 10.1210/en.140.12.5828; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yang C, 1998, CANCER RES, V58, P5695; Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795; Zhang ZP, 2000, J BIOL CHEM, V275, P20837, DOI 10.1074/jbc.M001880200	46	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2009	4	5							e5624	10.1371/journal.pone.0005624	http://dx.doi.org/10.1371/journal.pone.0005624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448AY	19462000	Green Published, gold, Green Submitted			2022-12-27	WOS:000266234700011
J	Batista, MD; Ferreira, S; Sauer, MM; Tomiyama, H; Giret, MTM; Pannuti, CS; Diaz, RS; Sabino, EC; Kallas, EG				Batista, Mariana Dias; Ferreira, Suzete; Sauer, Mariana M.; Tomiyama, Helena; Maidana Giret, Maria Teresa; Pannuti, Claudio S.; Diaz, Ricardo S.; Sabino, Ester C.; Kallas, Esper G.			High Human Herpesvirus 8 (HHV-8) Prevalence, Clinical Correlates and High Incidence among Recently HIV-1-Infected Subjects in Sao Paulo, Brazil	PLOS ONE			English	Article								Background: Human herpesvirus 8 (HHV-8) is the etiological agent for Kaposi Sarcoma, which occurs especially in HIV-infected subjects. HHV-8 infection and its clinical correlates have not been well characterized in recently HIV-1-infected subjects, especially men who have sex with men (MSM). Methodology/Principal Findings: We assessed the HHV-8 seroprevalence, clinical correlates, and incidence after one year of follow-up in a cohort of 228 recently HIV-1-infected individuals, of whom 83.6% were MSM, using indirect immunofluorescence assay. The prevalence of HHV-8 infection at the time of cohort enrollment was 25.9% (59/228). In the univariate model, there were significant associations with male gender, black ethnicity, MSM practice, and previous hepatitis B virus and syphilis infections. In the multivariate model we could still demonstrate association with MSM, hepatitis B, and black ethnicity. No differences in mean CD4+ cell counts or HIV viral load according to HHV-8 status were found. In terms of incidence, there were 23/127 (18.1%) seroconversions in the cohort after 1 year. Conclusions: HHV-8 is highly prevalent among recently HIV-1-infected subjects. Correlations with other sexually transmitted infections suggest common transmission routes.			Batista, MD (corresponding author), Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil.	esper.kallas@gmail.com	Sabino, Ester C/F-7750-2010; Diaz, Ricardo/K-3978-2012; Pannuti, Claudio/B-7649-2012; Ferreira, Suzete Cleusa/K-1626-2016; Kallas, Esper G/C-9539-2012	Sabino, Ester C/0000-0003-2623-5126; Ferreira, Suzete Cleusa/0000-0002-4190-0238; Kallas, Esper/0000-0003-2026-6925				Ait-Arkoub Z, 2003, AIDS, V17, P1394, DOI 10.1097/00002030-200306130-00016; Barbour JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001080; Bassichetto KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001423; Biggar RJ, 2003, J INFECT DIS, V187, P12, DOI 10.1086/345866; Cannon MJ, 2001, NEW ENGL J MED, V344, P637, DOI 10.1056/NEJM200103013440904; Caselli E, 2001, J GEN VIROL, V82, P1965, DOI 10.1099/0022-1317-82-8-1965; Caselli E, 2005, BLOOD, V106, P2790, DOI 10.1182/blood-2005-04-1390; Caselli E, 2003, J GEN VIROL, V84, P1123, DOI 10.1099/vir.0.18799-0; Casper C, 2002, J INFECT DIS, V185, P990, DOI 10.1086/339605; Casper C, 2007, J INFECT DIS, V195, P30, DOI 10.1086/509621; Caterino-De-Araujo A, 1999, J INFECT DIS, V179, P1591, DOI 10.1086/314789; Crum NF, 2003, SEX TRANSM DIS, V30, P713, DOI 10.1097/01.OLQ.0000078627.30743.4A; Diamond C, 2001, SEX TRANSM DIS, V28, P176, DOI 10.1097/00007435-200103000-00010; Dukers NHTM, 2000, AM J EPIDEMIOL, V151, P213, DOI 10.1093/oxfordjournals.aje.a010195; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Giuliani M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-143; Greene JT, 2001, ADV INV AN, V8, P183; Harris AH, 2002, SUPPORT CARE CANCER, V10, P486, DOI 10.1007/s00520-002-0363-2; Hyun TS, 2001, J VIROL, V75, P8761, DOI 10.1128/JVI.75.18.8761-8771.2001; Jacobson LP, 2000, J INFECT DIS, V181, P1940, DOI 10.1086/315503; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Lennette ET, 1996, LANCET, V348, P858, DOI 10.1016/S0140-6736(96)03240-0; Mercader M, 2000, AM J PATHOL, V156, P1961, DOI 10.1016/S0002-9440(10)65069-9; Nascimento MC, 2007, J CLIN MICROBIOL, V45, P715, DOI 10.1128/JCM.01264-06; Pierrotti LC, 2005, SEX TRANSM DIS, V32, P57, DOI 10.1097/01.olq.0000148300.33428.6e; Renwick N, 1998, AIDS, V12, P2481, DOI 10.1097/00002030-199818000-00018; Smith NA, 1999, J INFECT DIS, V180, P600, DOI 10.1086/314926; Strathdee S A, 1996, AIDS, V10 Suppl A, pS51, DOI 10.1097/00002030-199601001-00008; de Souza VAUF, 2007, J MED VIROL, V79, P1562, DOI 10.1002/jmv.20949; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; Zago A, 2000, SEX TRANSM DIS, V27, P468, DOI 10.1097/00007435-200009000-00009; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06	33	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2009	4	5							e5613	10.1371/journal.pone.0005613	http://dx.doi.org/10.1371/journal.pone.0005613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446ZK	19479040	Green Published, Green Submitted, gold			2022-12-27	WOS:000266161200014
J	Muzard, J; Sarda-Mantel, L; Loyau, S; Meulemans, A; Louedec, L; Bantsimba-Malanda, C; Hervatin, F; Marchal-Somme, J; Michel, JB; Le Guludec, D; Billiald, P; Jandrot-Perrus, M				Muzard, Julien; Sarda-Mantel, Laure; Loyau, Stephane; Meulemans, Alain; Louedec, Liliane; Bantsimba-Malanda, Claudie; Hervatin, Florence; Marchal-Somme, Joelle; Michel, Jean Baptiste; Le Guludec, Dominique; Billiald, Philippe; Jandrot-Perrus, Martine			Non-Invasive Molecular Imaging of Fibrosis Using a Collagen-Targeted Peptidomimetic of the Platelet Collagen Receptor Glycoprotein VI	PLOS ONE			English	Article							BINDING; IDENTIFICATION; EXPRESSION; PEPTIDES; EPITOPE; ALPHA; GPVI; MRI	Background: Fibrosis, which is characterized by the pathological accumulation of collagen, is recognized as an important feature of many chronic diseases, and as such, constitutes an enormous health burden. We need non-invasive specific methods for the early diagnosis and follow-up of fibrosis in various disorders. Collagen targeting molecules are therefore of interest for potential in vivo imaging of fibrosis. In this study, we developed a collagen-specific probe using a new approach that takes advantage of the inherent specificity of Glycoprotein VI (GPVI), the main platelet receptor for collagens I and III. Methodology/Principal Findings: An anti-GPVI antibody that neutralizes collagen-binding was used to screen a bacterial random peptide library. A cyclic motif was identified, and the corresponding peptide (designated collagelin) was synthesized. Solid-phase binding assays and histochemical analysis showed that collagelin specifically bound to collagen (Kd 10(-7) M) in vitro, and labelled collagen fibers ex vivo on sections of rat aorta and rat tail. Collagelin is therefore a new specific probe for collagen. The suitability of collagelin as an in vivo probe was tested in a rat model of healed myocardial infarctions (MI). Injecting Tc-99m-labelled collagelin and scintigraphic imaging showed that uptake of the probe occurred in the cardiac area of rats with MI, but not in controls. Post mortem autoradiography and histological analysis of heart sections showed that the labeled areas coincided with fibrosis. Scintigraphic molecular imaging with collagelin provides high resolution, and good contrast between the fibrotic scars and healthy tissues. The capacity of collagelin to image fibrosis in vivo was confirmed in a mouse model of lung fibrosis. Conclusion/Significance: Collagelin is a new collagen-targeting agent which may be useful for non-invasive detection of fibrosis in a broad spectrum of diseases.			Muzard, J (corresponding author), Hop Bichat Claude Bernard, INSERM, U698, F-75877 Paris, France.	martine.jandrot-perrus@inserm.fr	Sarda-Mantel, Laure/R-8223-2018; BILLIALD, Philippe/ABF-7417-2021; Jandrot-Perrus, Martine/GZM-1526-2022; Michel, Jean-Baptiste/AAH-9336-2020	Sarda-Mantel, Laure/0000-0003-2926-1717; BILLIALD, Philippe/0000-0001-8148-5297; JANDROT-PERRUS, Martine/0000-0002-8450-9247; Loyau, stephane/0000-0001-8748-501X				Aina OH, 2007, MOL PHARMACEUT, V4, P631, DOI 10.1021/mp700073y; Caravan P, 2007, ANGEW CHEM INT EDIT, V46, P8171, DOI 10.1002/anie.200700700; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; de Ledinghen V, 2007, J PEDIATR GASTR NUTR, V45, P443, DOI 10.1097/MPG.0b013e31812e56ff; Depraetere H, 1998, BLOOD, V92, P4207, DOI 10.1182/blood.V92.11.4207.423a02_4207_4211; Dilsizian V, 2007, J NUCL MED, V48, P182; Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907; FISHBEIN MC, 1978, AM J PATHOL, V90, P57; Gawaz M, 2005, THROMB HAEMOSTASIS, V93, P910, DOI 10.1160/TH04-10-0660; Helm PA, 2008, RADIOLOGY, V247, P788, DOI 10.1148/radiol.2473070975; Inoue O, 2006, BLOOD, V107, P1405, DOI 10.1182/blood-2005-06-2406; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Lagrue-Lak-Hal AH, 2001, J BIOL CHEM, V276, P15316, DOI 10.1074/jbc.M009117200; Lecut C, 2004, J BIOL CHEM, V279, P52293, DOI 10.1074/jbc.M406342200; Lecut C, 2003, J THROMB HAEMOST, V1, P2653, DOI 10.1111/j.1538-7836.2003.00495.x; Massberg S, 2003, FASEB J, V17, P397, DOI 10.1096/f.03-0464.fje; Megens RTA, 2007, MOL IMAGING, V6, P247, DOI 10.2310/7290.2007.00021; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nelson TJ, 2007, J BIOL CHEM, V282, P31238, DOI 10.1074/jbc.M705558200; OHLMANN P, 2008, J THROMB HAEMOST; Petegnief Y, 1998, PHYS MED BIOL, V43, P3629, DOI 10.1088/0031-9155/43/12/018; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; van den Borne SWM, 2009, JACC-CARDIOVASC IMAG, V2, P187, DOI 10.1016/j.jcmg.2008.11.011; van den Borne SWM, 2008, J AM COLL CARDIOL, V52, P2017, DOI 10.1016/j.jacc.2008.07.067; Vanhoorelbeke K, 2003, J BIOL CHEM, V278, P37815, DOI 10.1074/jbc.M304289200; Verjans JWH, 2008, JACC-CARDIOVASC IMAG, V1, P354, DOI 10.1016/j.jcmg.2007.11.007; Viaene A, 2001, J PARASITOL, V87, P619, DOI 10.1645/0022-3395(2001)087[0619:IOACBP]2.0.CO;2	32	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5585	10.1371/journal.pone.0005585	http://dx.doi.org/10.1371/journal.pone.0005585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440310	Green Published, Green Submitted, gold			2022-12-27	WOS:000266107500014
J	Lengyel, S; Gove, AD; Latimer, AM; Majer, JD; Dunn, RR				Lengyel, Szabolcs; Gove, Aaron D.; Latimer, Andrew M.; Majer, Jonathan D.; Dunn, Robert R.			Ants Sow the Seeds of Global Diversification in Flowering Plants	PLOS ONE			English	Article								Background: The extraordinary diversification of angiosperm plants in the Cretaceous and Tertiary periods has produced an estimated 250,000-300,000 living angiosperm species and has fundamentally altered terrestrial ecosystems. Interactions with animals as pollinators or seed dispersers have long been suspected as drivers of angiosperm diversification, yet empirical examples remain sparse or inconclusive. Seed dispersal by ants (myrmecochory) may drive diversification as it can reduce extinction by providing selective advantages to plants and can increase speciation by enhancing geographical isolation by extremely limited dispersal distances. Methodology/Principal Findings: Using the most comprehensive sister-group comparison to date, we tested the hypothesis that myrmecochory leads to higher diversification rates in angiosperm plants. As predicted, diversification rates were substantially higher in ant-dispersed plants than in their non-myrmecochorous relatives. Data from 101 angiosperm lineages in 241 genera from all continents except Antarctica revealed that ant-dispersed lineages contained on average more than twice as many species as did their non-myrmecochorous sister groups. Contrasts in species diversity between sister groups demonstrated that diversification rates did not depend on seed dispersal mode in the sister group and were higher in myrmecochorous lineages in most biogeographic regions. Conclusions/Significance: Myrmecochory, which has evolved independently at least 100 times in angiosperms and is estimated to be present in at least 77 families and 11 000 species, is a key evolutionary innovation and a globally important driver of plant diversity. Myrmecochory provides the best example to date for a consistent effect of any mutualism on large-scale diversification.			Lengyel, S (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	szabolcslengyel@yahoo.com	Lengyel, Szabolcs/A-3483-2011; Dunn, Robert/B-1360-2013	Lengyel, Szabolcs/0000-0002-7049-0100; Latimer, Andrew/0000-0001-8098-0448; Dunn, Robert/0000-0002-6030-4837				Barraclough TG, 2001, EVOLUTION, V55, P677, DOI 10.1554/0014-3820(2001)055[0677:ERASDI]2.0.CO;2; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; BENNINGTON CC, 1994, ECOLOGY, V75, P717, DOI 10.2307/1941729; BERG RY, 1975, AUST J BOT, V23, P475, DOI 10.1071/BT9750475; BOESEWINKEL FD, 1984, EMBRYOLOGY ANGIOSPER, P567, DOI DOI 10.1007/978-3-642-69302-1_12; Bolmgren K, 2005, OIKOS, V109, P255, DOI 10.1111/j.0030-1299.2005.12663.x; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; BOND WJ, 1983, S AFR J SCI, V79, P231; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Calvino-Cancela M, 2008, DIVERS DISTRIB, V14, P11, DOI 10.1111/j.1472-4642.2007.00402.x; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; CREPET WL, 1984, ANN MO BOT GARD, V71, P607, DOI 10.2307/2399041; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; de Queiroz A, 2002, SYST BIOL, V51, P917, DOI 10.1080/10635150290155980; Dodd ME, 1999, EVOLUTION, V53, P732, DOI [10.2307/2640713, 10.1111/j.1558-5646.1999.tb05367.x]; DUNN RR, 2008, INSETOS SOCIAIS BIOL, P323; Edwards W, 2006, J ECOL, V94, P687, DOI 10.1111/j.1365-2745.2006.01116.x; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Forest F, 2007, EVOLUTION, V61, P1675, DOI 10.1111/j.1558-5646.2007.00138.x; Frohlich MW, 2007, NATURE, V450, P1184, DOI 10.1038/nature06393; Giladi I, 2006, OIKOS, V112, P481, DOI 10.1111/j.0030-1299.2006.14258.x; Gomez C, 1998, J BIOGEOGR, V25, P573, DOI 10.1046/j.1365-2699.1998.2530573.x; Gorb, 2003, SEED DISPERSAL ANTS; Goudet J, 1999, AM NAT, V153, P549, DOI 10.1086/303190; HANDEL SN, 1981, B TORREY BOT CLUB, V108, P430, DOI 10.2307/2484443; HE TH, NEW PHYTOL, V181, P725; HERRERA CM, 1989, AM NAT, V133, P309, DOI 10.1086/284921; Hu SS, 2008, P NATL ACAD SCI USA, V105, P240, DOI 10.1073/pnas.0707989105; Jansson R, 2008, ECOL LETT, V11, P173, DOI 10.1111/j.1461-0248.2007.01138.x; Jensen JM, 2006, ENVIRON ENTOMOL, V35, P326, DOI 10.1603/0046-225X-35.2.326; Kalisz S, 1999, ECOLOGY, V80, P2620, DOI 10.1890/0012-9658(1999)080[2620:AMSDAP]2.0.CO;2; Kalisz S, 2001, EVOLUTION, V55, P1560, DOI 10.1111/j.0014-3820.2001.tb00675.x; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; LENGYEL S, PERSPECTIVE IN PRESS; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; McConway KJ, 2004, EVOLUTION, V58, P12; McPeek MA, 1996, ECOLOGY, V77, P1355, DOI 10.2307/2265533; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Nee Sean, 1996, P230; PEMBERTON RW, 1990, WEED SCI, V38, P615, DOI 10.1017/S0043174500051584; Pinheiro J, 2001, MIXED EFFECTS MODELS; Purvis Andy, 1996, P153; R Core Team, 2018, R LANG ENV STAT COMP; REGAL PJ, 1977, SCIENCE, V196, P622, DOI 10.1126/science.196.4290.622; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; RICKLEFS RE, 1994, EVOLUTION, V48, P1619, DOI 10.1111/j.1558-5646.1994.tb02200.x; RICOGRAY V, 2007, ECOLOGY EVOLUTION AN; Sanderson MJ, 1996, TRENDS ECOL EVOL, V11, P15, DOI 10.1016/0169-5347(96)81059-7; SLOWINSKI JB, 1993, AM NAT, V142, P1019, DOI 10.1086/285586; Smith JF, 2001, AM NAT, V157, P646, DOI 10.1086/320625; SOLTIS DE, 2008, YEAR EVOLUTIONARY BI, P3; Stanley S. M., 1979, MACROEVOLUTION PATTE; STEBBINS GL, 1981, BIOSCIENCE, V31, P573, DOI 10.2307/1308219; Stevens PF, 2008, ANGIOSPERM PHYLOGENY; TIFFNEY BH, 1995, EVOL ECOL, V9, P93, DOI 10.1007/BF01237700; TIFFNEY BH, 1984, ANN MO BOT GARD, V71, P551, DOI 10.2307/2399037; Vamosi SM, 2005, EVOL ECOL RES, V7, P567; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; Vellend M, 2006, ECOL LETT, V9, P316, DOI 10.1111/j.1461-0248.2005.00878.x; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, VI; WESTOBY M, 1990, ECOLOGY, V71, P1307, DOI 10.2307/1938268; Zhou HP, 2007, J HERED, V98, P317, DOI 10.1093/jhered/esm032	64	136	143	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5480	10.1371/journal.pone.0005480	http://dx.doi.org/10.1371/journal.pone.0005480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436714	Green Published, gold, Green Accepted			2022-12-27	WOS:000266009900001
J	Nitsch, D; Tranchevent, LC; Thienpont, B; Thorrez, L; Van Esch, H; Devriendt, K; Moreau, Y				Nitsch, Daniela; Tranchevent, Leon-Charles; Thienpont, Bernard; Thorrez, Lieven; Van Esch, Hilde; Devriendt, Koenraad; Moreau, Yves			Network Analysis of Differential Expression for the Identification of Disease-Causing Genes	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; GERM-CELLS; INTERACTOME; PRIORITIZATION; DATABASE; HOMOLOG; FAMILY; WOMEN; PIWI; VASA	Genetic studies (in particular linkage and association studies) identify chromosomal regions involved in a disease or phenotype of interest, but those regions often contain many candidate genes, only a few of which can be followed-up for biological validation. Recently, computational methods to identify (prioritize) the most promising candidates within a region have been proposed, but they are usually not applicable to cases where little is known about the phenotype (no or few confirmed disease genes, fragmentary understanding of the biological cascades involved). We seek to overcome this limitation by replacing knowledge about the biological process by experimental data on differential gene expression between affected and healthy individuals. Considering the problem from the perspective of a gene/protein network, we assess a candidate gene by considering the level of differential expression in its neighborhood under the assumption that strong candidates will tend to be surrounded by differentially expressed neighbors. We define a notion of soft neighborhood where each gene is given a contributing weight, which decreases with the distance from the candidate gene on the protein network. To account for multiple paths between genes, we define the distance using the Laplacian exponential diffusion kernel. We score candidates by aggregating the differential expression of neighbors weighted as a function of distance. Through a randomization procedure, we rank candidates by p-values. We illustrate our approach on four monogenic diseases and successfully prioritize the known disease causing genes.			Nitsch, D (corresponding author), Katholieke Univ Leuven, Dept Elect Engn, ESAT SCD, Louvain, Belgium.	Daniela.Nitsch@esat.kuleuven.be	Van+Esch, Hilde/AAU-5688-2020; Thorrez, Lieven/A-2583-2011; Thienpont, Bernard/AAG-5423-2019	Thorrez, Lieven/0000-0002-5896-6823; Van Esch, Hilde/0000-0002-9604-5726; Thienpont, Bernard/0000-0002-8772-6845; Moreau, Yves/0000-0002-4647-6560; Tranchevent, Leon-Charles/0000-0002-1257-4824				Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Bach F.R., 2005, P 22 INT C MACH LEAR, P33, DOI DOI 10.1145/1102351.1102356; Bach FR, 2002, J MACHINE LEARNING R, V3, P1; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BECKER P E, 1957, Acta Genet Stat Med, V7, P303; Bubendorf L, 2001, EUR UROL, V40, P231, DOI 10.1159/000049777; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Corton M, 2007, J CLIN ENDOCR METAB, V92, P328, DOI 10.1210/jc.2006-1665; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; DRAGHICI S, 2003, DATA ANAL TOOLS DNA, P345; Fine S, 2002, J MACH LEARN RES, V2, P243, DOI 10.1162/15324430260185619; Fouss F, 2006, IEEE DATA MINING, P863; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Franks S, 2006, FERTIL STERIL, V86, pS15, DOI 10.1016/j.fertnstert.2006.04.016; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Ina S, 2003, GENE EXPR PATTERNS, V3, P635, DOI 10.1016/S1567-133X(03)00111-X; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Jones MR, 2007, MOL HUM REPROD, V13, P237, DOI 10.1093/molehr/gal120; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kondor R. I., 2002, PROC 19 INT C MACH L, P315; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kyo K, 2001, J HUM GENET, V46, P5, DOI 10.1007/s100380170118; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Malmberg EK, 2006, AM J PHYSIOL-GASTR L, V291, pG203, DOI 10.1152/ajpgi.00491.2005; Moehle C, 2006, J MOL MED, V84, P1055, DOI 10.1007/s00109-006-0100-2; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Probst FJ, 2007, AM J MED GENET A, V143A, P1358, DOI 10.1002/ajmg.a.31781; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg EH, 2004, AM J HUM GENET, V75, P97, DOI 10.1086/422102; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Tanaka SS, 2000, GENE DEV, V14, P841; Urbanek M, 2005, J CLIN ENDOCR METAB, V90, P6623, DOI 10.1210/jc.2005-0622; Urbanek M, 2007, J CLIN ENDOCR METAB, V92, P4191, DOI 10.1210/jc.2007-0761; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wright JM, 2006, AM J RESP CELL MOL, V35, P327, DOI 10.1165/rcmb.2005-0359OC; Yao ZZ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-319; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22	44	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5526	10.1371/journal.pone.0005526	http://dx.doi.org/10.1371/journal.pone.0005526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436755	Green Published, Green Submitted, gold			2022-12-27	WOS:000266009900018
J	Stallings, CD				Stallings, Christopher D.			Fishery-Independent Data Reveal Negative Effect of Human Population Density on Caribbean Predatory Fish Communities	PLOS ONE			English	Article							CORAL-REEF FISH; NORTHERN LINE ISLANDS; MARINE FOOD WEBS; CLIMATE-CHANGE; PACIFIC; ATLANTIC; DECLINE; IMPACTS; BIODIVERSITY; ECOSYSTEMS	Background: Understanding the current status of predatory fish communities, and the effects fishing has on them, is vitally important information for management. However, data are often insufficient at region-wide scales to assess the effects of extraction in coral reef ecosystems of developing nations. Methodology/Principal Findings: Here, I overcome this difficulty by using a publicly accessible, fisheries-independent database to provide a broad scale, comprehensive analysis of human impacts on predatory reef fish communities across the greater Caribbean region. Specifically, this study analyzed presence and diversity of predatory reef fishes over a gradient of human population density. Across the region, as human population density increases, presence of large-bodied fishes declines, and fish communities become dominated by a few smaller-bodied species. Conclusions/Significance: Complete disappearance of several large-bodied fishes indicates ecological and local extinctions have occurred in some densely populated areas. These findings fill a fundamentally important gap in our knowledge of the ecosystem effects of artisanal fisheries in developing nations, and provide support for multiple approaches to data collection where they are commonly unavailable.			Stallings, CD (corresponding author), Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA.	stallings@bio.fsu.edu		Stallings, Christopher/0000-0002-3410-4540				Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Allen G.R, 1985, FAO SPECIES CATALOGU; [Anonymous], COASTAL RESOURCE MAN; Aronson RB, 2003, SCIENCE, V302, P1502; Bellwood DR, 2005, ECOL LETT, V8, P643, DOI 10.1111/j.1461-0248.2005.00763.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bouchon-Navaro Y, 2005, J EXP MAR BIOL ECOL, V315, P31, DOI 10.1016/j.jembe.2004.08.028; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; *CAR TOUR ORG, 2008, TOUR STOP ARR; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; *CENTR INT AG, 2008, WORLD FACTB; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Cohen JE, 1997, SCIENCE, V278, P1211; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; Dampier W, 1729, NEW VOYAGE WORLD, V7th; Dandonneau Y, 2004, DEEP-SEA RES PT II, V51, P303, DOI 10.1016/j.dsr2.2003.07.018; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; ELTON CS, 1958, ECOLOGY INVASIONS PL; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fogarty MJ, 1998, ECOL APPL, V8, pS6, DOI 10.2307/2641359; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Froese R, 2005, FISHBASE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Heemstra P.C., 1993, FAO SPECIES CATALOGU, V125; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humann P., 2002, REEF FISH IDENTIFICA; HUNTSMAN GR, 1999, GROUPERS SERRANIDAE; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Jennings S, 1999, CONSERV BIOL, V13, P1466, DOI 10.1046/j.1523-1739.1999.98324.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Leichter JJ, 2006, J MAR RES, V64, P563, DOI 10.1357/002224006778715711; Levin Phillip S., 2002, P377, DOI 10.1016/B978-012615185-5/50022-0; LEVIN PS, 2002, CORAL REEF FISHES DY; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; MAC ARTHUR ROBERT H., 1967; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Mather P. M., 1976, COMPUTATIONAL METHOD; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McCune B., 2011, PC ORD MULTIVARIATE; McLeod K.L., 2005, SCI CONSENSUS STATEM; Miller MW, 2002, BIOL CONSERV, V106, P37, DOI 10.1016/S0006-3207(01)00227-0; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munro JL., 1983, CARIBBEAN CORAL REEF, V2, P1; MUNRO JL, 1996, REEF FISHERIES, P1; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; PADDACK MJ, CURRENT BIOL; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; POLUNIN NVC, 1996, REEF FISHERIES CHAPM; Roberts CM, 1997, TRENDS ECOL EVOL, V12, P35, DOI 10.1016/S0169-5347(96)20109-0; Rogers C, 2009, P R SOC B, V276, P197, DOI 10.1098/rspb.2008.0606; Russ G.R., 1991, P601; Russ GR, 1996, ECOL APPL, V6, P947, DOI 10.2307/2269497; Ruttenberg BI, 2001, CONSERV BIOL, V15, P1691, DOI 10.1046/j.1523-1739.2001.99556.x; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmitt EF, 1996, B MAR SCI, V59, P404; Schmitt EF, 2002, CORAL REEFS, V21, P216, DOI 10.1007/s00338-002-0216-y; Spalding M. D., 2001, WORLD ATLAS CORAL RE; STALLINGS CD, MARINE ECOL IN PRESS; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; *UN, 2005, WORLD POPULATIONS PR; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; WATSON M, 1994, MAR ECOL PROG SER, V109, P115, DOI 10.3354/meps109115; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Wing SR, 2001, CORAL REEFS, V20, P1; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wormald C. L., 2007, THESIS U RHODE ISLAN	102	143	143	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5333	10.1371/journal.pone.0005333	http://dx.doi.org/10.1371/journal.pone.0005333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421312	Green Published, gold, Green Submitted			2022-12-27	WOS:000265836900002
J	Han, CS; Jablonski, PG				Han, Chang S.; Jablonski, Piotr G.			Female Genitalia Concealment Promotes Intimate Male Courtship in a Water Strider	PLOS ONE			English	Article								Violent coercive mating initiation is typical for animals with sexual conflict over mating. In these species, the coevolutionary arms-race between female defenses against coercive mating and male counter-adaptations for increased mating success leads to coevolutionary chases of male and female traits that influence the mating. It has been controversial whether one of the sexes can evolve traits that allow them to "win'' this arms race. Here, we use morphological analysis (traditional and scanning electron micrographs), laboratory experiments and comparative methods to show how females of a species characterized by typical coercive mating initiation appear to "win'' a particular stage of the sexual conflict by evolving morphology to hide their genitalia from direct, forceful access by males. In an apparent response to the female morphological adaptation, males of this species added to their typically violent coercive mounting of the female new post-mounting, pre-copulatory courtship signals produced by tapping the water's surface with the mid-legs. These courtship signals are intimate in the sense that they are aimed at the female, on whom the male is already mounted. Females respond to the signals by exposing their hidden genitalia for copulatory intromission. Our results indicate that the apparent victory of coevolutionary arms race by one sex in terms of morphology may trigger evolution of a behavioral phenotype in the opposite sex.			Han, CS (corresponding author), Seoul Natl Univ, Sch Biol Sci, Lab Behav Ecol & Evolut, Seoul, South Korea.	piotrjab@cbe-pan.pl	Jablonski, Piotr G/A-2753-2015; Jabłoński, Piotr/K-4231-2012; Han, Chang/AAI-1865-2020	Han, Chang/0000-0001-9261-4031; /0000-0002-8333-0106				ANDERSEN NM, 1992, CAN J ZOOL, V70, P753, DOI 10.1139/z92-110; ANDERSEN NM, 1993, CAN J ZOOL, V71, P2473, DOI 10.1139/z93-343; [Anonymous], [No title captured]; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; ARNQVIST G, 1989, ANIM BEHAV, V38, P749, DOI 10.1016/S0003-3472(89)80107-1; Arnqvist G, 2002, EVOLUTION, V56, P936; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; Arnqvist G, 1999, EVOLUTION, V53, P147, DOI [10.2307/2640927, 10.1111/j.1558-5646.1999.tb05340.x]; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Arnqvist Goran, 2005, pUnpaginated; Bertin A, 2005, J EVOLUTION BIOL, V18, P949, DOI 10.1111/j.1420-9101.2005.00913.x; Brennan PLR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000418; Brinkhurst R. O., 1960, Proceedings of the Zoological Society of London, V133, P531; Damgaard J, 2006, SYST ENTOMOL, V31, P93, DOI 10.1111/j.1365-3113.2005.00302.x; Damgaard J, 2001, SYST ENTOMOL, V26, P241, DOI 10.1046/j.1365-3113.2001.00141.x; Eberhard W, 2006, J EVOLUTION BIOL, V19, P657, DOI 10.1111/j.1420-9101.2005.01057.x; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard WG, 2004, EVOLUTION, V58, P1947; EBERHARD WG, 1994, EVOLUTION, V48, P711, DOI [10.2307/2410481, 10.1111/j.1558-5646.1994.tb01356.x]; Eberhard WG, 2002, REV BIOL TROP, V50, P485; FAIRBAIRN DJ, 1993, BEHAV ECOL, V4, P224, DOI 10.1093/beheco/4.3.224; Fairbairn DJ, 2003, CAN J ZOOL, V81, P400, DOI 10.1139/Z03-021; Han SE, 2008, J MATH IMAGING VIS, V31, P1, DOI 10.1007/s10851-007-0061-2; Harari AR, 1999, ANIM BEHAV, V58, P1191, DOI 10.1006/anbe.1999.1257; HAYASHI K, 1985, BEHAV ECOL SOCIOBIOL, V16, P301, DOI 10.1007/BF00295542; HEMINGVANBATTUM KF, 1986, J MORPHOL, V190, P121, DOI 10.1002/jmor.1051900202; HUNGERFORD HB, 1960, KEYS SUBFAMILIES TRI; Jablonski P, 1995, BEHAV ECOL, V6, P388, DOI 10.1093/beheco/6.4.388; Jablonski PG, 1996, ETHOLOGY, V102, P353; Maddison W.P., 2008, MESQUITE MODULAR SYS; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MARTINS EP, 2004, COMPARE VERSION 4 6; NUMMELIN M, 1987, ANN ENTOMOL FENN, V53, P17; NUMMELIN M, 1988, ANN ENTOMOL FENN, V54, P121; Parker G.A., 1979, P123; Preziosi RF, 1996, OECOLOGIA, V108, P424, DOI 10.1007/BF00333717; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Ronkainen K, 2005, J INSECT BEHAV, V18, P619, DOI 10.1007/s10905-005-7015-6; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; SATTLER W, 1956, ZOOMORPHOLOGY, V45, P411; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; SPENCE JR, 1986, BEHAV ECOL SOCIOBIOL, V19, P87, DOI 10.1007/BF00299943; SPENCE JR, 1994, ANNU REV ENTOMOL, V39, P101, DOI 10.1146/annurev.en.39.010194.000533; STICHEL W., 1955, ILLUSTRIERTE BESTIMM; VEPSALAINEN K, 1985, ANN ZOOL FENN, V22, P441; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101; WILCOX RS, 1986, BEHAV ECOL SOCIOBIOL, V19, P79, DOI 10.1007/BF00299942; WILCOX RS, 1991, J INSECT BEHAV, V4, P43, DOI 10.1007/BF01092550; WILCOX RS, 1980, BEHAV RES METH INSTR, V12, P361, DOI 10.3758/BF03201676; WILCOX RS, 1979, SCIENCE, V206, P1325, DOI 10.1126/science.206.4424.1325; Zar JH, 1999, BIOSTATISTICAL ANAL	54	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2009	4	6							e5793	10.1371/journal.pone.0005793	http://dx.doi.org/10.1371/journal.pone.0005793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456TI	19516886	Green Published, Green Submitted, gold			2022-12-27	WOS:000266872900001
J	Bowman, GR; Pande, VS				Bowman, Gregory R.; Pande, Vijay S.			The Roles of Entropy and Kinetics in Structure Prediction	PLOS ONE			English	Article								Background: Here we continue our efforts to use methods developed in the folding mechanism community to both better understand and improve structure prediction. Our previous work demonstrated that Rosetta's coarse-grained potentials may actually impede accurate structure prediction at full-atom resolution. Based on this work we postulated that it may be time to work completely at full-atom resolution but that doing so may require more careful attention to the kinetics of convergence. Methodology/Principal Findings: To explore the possibility of working entirely at full-atom resolution, we apply enhanced sampling algorithms and the free energy theory developed in the folding mechanism community to full-atom protein structure prediction with the prominent Rosetta package. We find that Rosetta's full-atom scoring function is indeed able to recognize diverse protein native states and that there is a strong correlation between score and Ca RMSD to the native state. However, we also show that there is a huge entropic barrier to folding under this potential and the kinetics of folding are extremely slow. We then exploit this new understanding to suggest ways to improve structure prediction. Conclusions/Significance: Based on this work we hypothesize that structure prediction may be improved by taking a more physical approach, i.e. considering the nature of the model thermodynamics and kinetics which result from structure prediction simulations.			Pande, VS (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.	pande@stanford.edu	Pande, Vijay/ABE-8145-2020		NIGMS NIH HHS [R01 GM062868, R01-GM062868] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062868] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Bowman GR, 2008, J AM CHEM SOC, V130, P9676, DOI 10.1021/ja8032857; Bowman GR, 2009, PROTEINS, V74, P777, DOI 10.1002/prot.22210; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Chiu TK, 2005, P NATL ACAD SCI USA, V102, P7517, DOI 10.1073/pnas.0502495102; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Haspel N, 2003, PROTEIN SCI, V12, P1177, DOI 10.1110/ps.0232903; Huang XH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2908251; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kifer I, 2008, PROTEINS, V73, P380, DOI 10.1002/prot.22073; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LYUBARTSEV AP, 1992, J CHEM PHYS, V96, P1776, DOI 10.1063/1.462133; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Mitsutake A, 2001, BIOPOLYMERS, V60, P96, DOI 10.1002/1097-0282(2001)60:2<96::AID-BIP1007>3.0.CO;2-F; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Neale C, 2008, CHEM PHYS LETT, V460, P375, DOI 10.1016/j.cplett.2008.05.099; Rao F, 2003, J CHEM PHYS, V119, P4035, DOI 10.1063/1.1591721; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; SHMYGELSKA A, 2009, P NATL ACAD SCI US; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sugita Y, 2000, J CHEM PHYS, V113, P6042, DOI 10.1063/1.1308516; Tsai CJ, 2000, P NATL ACAD SCI USA, V97, P12038, DOI 10.1073/pnas.97.22.12038	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5840	10.1371/journal.pone.0005840	http://dx.doi.org/10.1371/journal.pone.0005840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513117	gold, Green Published, Green Submitted			2022-12-27	WOS:000267228800006
J	Beckstead, WA; Ebbert, MTW; Rowe, MJ; McClellan, DA				Beckstead, Wesley A.; Ebbert, Mark T. W.; Rowe, Mark J.; McClellan, David A.			Evolutionary Pressure on Mitochondrial Cytochrome b Is Consistent with a Role of CytbI7T Affecting Longevity during Caloric Restriction	PLOS ONE			English	Article							AMINO-ACID PROPERTIES; BC(1) COMPLEX; LIFE-SPAN; ADAPTATION; MECHANISMS; RESOLUTION; STABILITY; SUBSTRATE; OXIDATION; SELECTION	Background: Metabolism of energy nutrients by the mitochondrial electron transport chain (ETC) is implicated in the aging process. Polymorphisms in core ETC proteins may have an effect on longevity. Here we investigate the cytochrome b (cytb) polymorphism at amino acid 7 (cytbI7T) that distinguishes human mitochondrial haplogroup H from haplogroup U. Principal Findings: We compared longevity of individuals in these two haplogroups during historical extremes of caloric intake. Haplogroup H exhibits significantly increased longevity during historical caloric restriction compared to haplogroup U (p = 0.02) while during caloric abundance they are not different. The historical effects of natural selection on the cytb protein were estimated with the software TreeSAAP using a phylogenetic reconstruction for 107 mammal taxa from all major mammalian lineages using 13 complete protein-coding mitochondrial gene sequences. With this framework, we compared the biochemical shifts produced by cytbI7T with historical evolutionary pressure on and near this polymorphic site throughout mammalian evolution to characterize the role cytbI7T had on the ETC during times of restricted caloric intake. Significance: Our results suggest the relationship between caloric restriction and increased longevity in human mitochondrial haplogroup H is determined by cytbI7T which likely enhances the ability of water to replenish the Q(i) binding site and decreases the time ubisemiquinone is at the Q(o) site, resulting in a decrease in the average production rate of radical oxygen species (ROS).			Beckstead, WA (corresponding author), Natl Canc Inst, Oncogenom Sect, Pediat Oncol Branch, Adv Technol Ctr, Gaithersburg, MD USA.	dmcclellan@bigelow.org		Ebbert, Mark/0000-0001-9158-4440; McClellan, David/0000-0002-2595-3620				Aguilaniu H, 2005, GENE DEV, V19, P2399, DOI 10.1101/gad.1366505; Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611; Chamala Srikar, 2007, Int J Bioinform Res Appl, V3, P504, DOI 10.1504/IJBRA.2007.015418; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Cutler R G, 1985, Basic Life Sci, V35, P15; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; Ebbert Mark T W, 2007, Int J Bioinform Res Appl, V3, P471, DOI 10.1504/IJBRA.2007.015415; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gromiha MM, 1999, J PROTEIN CHEM, V18, P565, DOI 10.1023/A:1020603401001; Gromiha MM, 1997, J BIOL PHYS, V23, P151, DOI 10.1023/A:1004981409616; GROMIHA MM, 1993, J THEOR BIOL, V165, P97; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Horner DS, 2003, PHILOS T ROY SOC B, V358, P37; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0; Kolling DRJ, 2003, J BIOL CHEM, V278, P39747, DOI 10.1074/jbc.M305913200; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lane N., 2005, POWER SEX SUICIDE MI; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Novotny M, 2007, ACTA CRYSTALLOGR D, V63, P270, DOI [10.1107/S0907444906044118, 10.1101/S0907444906044118]; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; Pearl R., 1928, RATE LIVING; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448	45	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2009	4	6							e5836	10.1371/journal.pone.0005836	http://dx.doi.org/10.1371/journal.pone.0005836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XN	19503808	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717400015
J	Byrnes, A; Jacks, A; Dahlman-Wright, K; Evengard, B; Wright, FA; Pedersen, NL; Sullivan, PF				Byrnes, Andrea; Jacks, Andreas; Dahlman-Wright, Karin; Evengard, Birgitta; Wright, Fred A.; Pedersen, Nancy L.; Sullivan, Patrick F.			Gene Expression in Peripheral Blood Leukocytes in Monozygotic Twins Discordant for Chronic Fatigue: No Evidence of a Biomarker	PLOS ONE			English	Article							FUNCTIONAL CATEGORIES; DISCOVERY; ENCEPHALOMYELITIS; IDENTIFICATION; MANAGEMENT; FRAMEWORK; GENOMICS; SUBTYPES	Background: Chronic fatiguing illness remains a poorly understood syndrome of unknown pathogenesis. We attempted to identify biomarkers for chronic fatiguing illness using microarrays to query the transcriptome in peripheral blood leukocytes. Methods: Cases were 44 individuals who were clinically evaluated and found to meet standard international criteria for chronic fatigue syndrome or idiopathic chronic fatigue, and controls were their monozygotic co-twins who were clinically evaluated and never had even one month of impairing fatigue. Biological sampling conditions were standardized and RNA stabilizing media were used. These methodological features provide rigorous control for bias resulting from case-control mismatched ancestry and experimental error. Individual gene expression profiles were assessed using Affymetrix Human Genome U133 Plus 2.0 arrays. Findings: There were no significant differences in gene expression for any transcript. Conclusions: Contrary to our expectations, we were unable to identify a biomarker for chronic fatiguing illness in the transcriptome of peripheral blood leukocytes suggesting that positive findings in prior studies may have resulted from experimental bias.			Byrnes, A (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	nancy.pedersen@ki.se; pfsulliv@med.unc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056014] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI056014] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Baker R, 2007, BMJ-BRIT MED J, V335, P446, DOI 10.1136/bmj.39302.509005.AE; Barry WT, 2008, ANN APPL STAT, V2, P286, DOI 10.1214/07-AOAS146; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Chen R, 2008, J INT MED RES, V36, P867, DOI 10.1177/147323000803600501; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cho HJ, 2006, CURR OPIN PSYCHIATR, V19, P67, DOI 10.1097/01.yco.0000194370.40062.b0; Coggill Penny, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0205s23; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Evengard B, 2005, PSYCHOL MED, V35, P1317, DOI 10.1017/S0033291705005052; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GENTLEMAN R, 2006, BIOCONDUCTOR; Grans H, 2005, J INTERN MED, V258, P388, DOI 10.1111/j.1365-2796.2005.01548.x; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kerr JR, 2007, J CLIN PATHOL, V60, P113, DOI 10.1136/jcp.2006.042374; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Klimas Nancy G, 2007, Curr Rheumatol Rep, V9, P482, DOI 10.1007/s11926-007-0078-y; Komaroff AL, 1998, ANNU REV MED, V49, P1; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Peppercorn J, 2008, CANCER INVEST, V26, P1, DOI 10.1080/07357900701784238; Powell R, 2003, CLIN EXP ALLERGY, V33, P1450, DOI 10.1046/j.1365-2222.2003.01745.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Sharpe M, 1996, PSYCHIAT CLIN N AM, V19, P549, DOI 10.1016/S0193-953X(05)70305-1; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Sullivan PF, 2005, PSYCHOL MED, V35, P1327, DOI 10.1017/S0033291705005222; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	39	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2009	4	6							e5805	10.1371/journal.pone.0005805	http://dx.doi.org/10.1371/journal.pone.0005805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454XL	19503787	Green Published, Green Submitted, gold			2022-12-27	WOS:000266717200002
J	Simeonov, A; Kulkarni, A; Dorjsuren, D; Jadhav, A; Shen, M; McNeill, DR; Austin, CP; Wilson, DM				Simeonov, Anton; Kulkarni, Avanti; Dorjsuren, Dorjbal; Jadhav, Ajit; Shen, Min; McNeill, Daniel R.; Austin, Christopher P.; Wilson, David M., III			Identification and Characterization of Inhibitors of Human Apurinic/apyrimidinic Endonuclease APE1	PLOS ONE			English	Article								APE1 is the major nuclease for excising abasic (AP) sites and particular 3'-obstructive termini from DNA, and is an integral participant in the base excision repair (BER) pathway. BER capacity plays a prominent role in dictating responsiveness to agents that generate oxidative or alkylation DNA damage, as well as certain chain-terminating nucleoside analogs and 5-fluorouracil. We describe within the development of a robust, 1536-well automated screening assay that employs a deoxyoligonucleotide substrate operating in the red-shifted fluorescence spectral region to identify APE1 endonuclease inhibitors. This AP site incision assay was used in a titration-based high-throughput screen of the Library of Pharmacologically Active Compounds (LOPAC(1280)), a collection of well-characterized, drug-like molecules representing all major target classes. Prioritized hits were authenticated and characterized via two high-throughput screening assays - a Thiazole Orange fluorophore-DNA displacement test and an E. coli endonuclease IV counterscreen - and a conventional, gel-based radiotracer incision assay. The top, validated compounds, i.e. 6-hydroxy-DL-DOPA, Reactive Blue 2 and myricetin, were shown to inhibit AP site cleavage activity of whole cell protein extracts from HEK 293T and HeLa cell lines, and to enhance the cytotoxic and genotoxic potency of the alkylating agent methylmethane sulfonate. The studies herein report on the identification of novel, small molecule APE1-targeted bioactive inhibitor probes, which represent initial chemotypes towards the development of potential pharmaceuticals.			Simeonov, A (corresponding author), NHGRI, NIH, Chem Genom Ctr, Bethesda, MD 20892 USA.	wilsonda@mail.nih.gov	Wilson, David M/AAK-5409-2021	Wilson, David M/0000-0002-8945-0395; Jadhav, Ajit/0000-0001-7955-1451	Intramural NIH HHS Funding Source: Medline; NIMH NIH HHS [1 R03 MH086444] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000750] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; BAPAT A, 2009, GOING APE APPROACH C; BENCHOKROUN Y, 1995, BIOCHEM PHARMACOL, V49, P305, DOI 10.1016/0006-2952(94)00465-X; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; BINASTEIN M, 1976, MOL PHARMACOL, V12, P191; BO XN, 1994, BRIT J PHARMACOL, V112, P1151, DOI 10.1111/j.1476-5381.1994.tb13204.x; Brown J, 2002, VASC PHARMACOL, V39, P309, DOI 10.1016/S1537-1891(03)00030-2; BURTON SJ, 1988, J CHROMATOGR, V435, P127, DOI 10.1016/S0021-9673(01)82168-3; Case D.A., 2002, AMBER, V7; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; DAS M, 1987, CANCER RES, V47, P767; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; DEWOLFF FA, 1995, BRIT MED J, V310, P1216, DOI 10.1136/bmj.310.6989.1216; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; GILBERTOGONZALEZ R, 1980, BIOCHEMISTRY-US, V19, P4299, DOI 10.1021/bi00559a023; Hakkinen SH, 1999, J AGR FOOD CHEM, V47, P2274, DOI 10.1021/jf9811065; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Horton JK, 2007, DNA REPAIR, V6, P530, DOI 10.1016/j.dnarep.2006.10.016; IMOTO M, 1993, J ANTIBIOT, V46, P1342, DOI 10.7164/antibiotics.46.1342; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; JONSSON G, 1973, BIOCHEM PHARMACOL, V22, P1709, DOI 10.1016/0006-2952(73)90384-5; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Lee KW, 2007, CARCINOGENESIS, V28, P1918, DOI 10.1093/carcin/bgm110; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; McNeill DR, 2007, MOL CANCER RES, V5, P61, DOI 10.1158/1541-7786.MCR-06-0329; McNeill DR, 2004, ENVIRON HEALTH PERSP, V112, P799, DOI 10.1289/ehp.7038; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Nakamura J, 1998, CANCER RES, V58, P222; Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1; Paz-Elizur T, 2007, DNA REPAIR, V6, P45, DOI 10.1016/j.dnarep.2006.08.003; Perez-Ruiz T, 2001, ELECTROPHORESIS, V22, P134, DOI 10.1002/1522-2683(200101)22:1<134::AID-ELPS134>3.3.CO;2-O; Seiple LA, 2008, MOL PHARMACOL, V73, P669, DOI 10.1124/mol.107.042622; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; Tse WC, 2004, ACCOUNTS CHEM RES, V37, P61, DOI 10.1021/ar030113y; UYETA M, 1981, MUTAT RES, V88, P233, DOI 10.1016/0165-1218(81)90035-5; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wilson DM, 2005, J MOL BIOL, V345, P1003, DOI 10.1016/j.jmb.2004.11.028; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Zaremba T, 2007, ANTI-CANCER AGENT ME, V7, P515, DOI 10.2174/187152007781668715; Zawahir Z, 2009, J MED CHEM, V52, P20, DOI 10.1021/jm800739m; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	55	83	90	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5740	10.1371/journal.pone.0005740	http://dx.doi.org/10.1371/journal.pone.0005740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484131	Green Submitted, Green Published, gold			2022-12-27	WOS:000266528200002
J	Stephens, CR; Heau, JG; Gonzalez, C; Ibarra-Cerdena, CN; Sanchez-Cordero, V; Gonzalez-Salazar, C				Stephens, Christopher R.; Gimenez Heau, Joaquin; Gonzalez, Camila; Ibarra-Cerdena, Carlos N.; Sanchez-Cordero, Victor; Gonzalez-Salazar, Constantino			Using Biotic Interaction Networks for Prediction in Biodiversity and Emerging Diseases	PLOS ONE			English	Article								Networks offer a powerful tool for understanding and visualizing inter-species ecological and evolutionary interactions. Previously considered examples, such as trophic networks, are just representations of experimentally observed direct interactions. However, species interactions are so rich and complex it is not feasible to directly observe more than a small fraction. In this paper, using data mining techniques, we show how potential interactions can be inferred from geographic data, rather than by direct observation. An important application area for this methodology is that of emerging diseases, where, often, little is known about inter-species interactions, such as between vectors and reservoirs. Here, we show how using geographic data, biotic interaction networks that model statistical dependencies between species distributions can be used to infer and understand inter-species interactions. Furthermore, we show how such networks can be used to build prediction models. For example, for predicting the most important reservoirs of a disease, or the degree of disease risk associated with a geographical area. We illustrate the general methodology by considering an important emerging disease - Leishmaniasis. This data mining methodology allows for the use of geographic data to construct inferential biotic interaction networks which can then be used to build prediction models with a wide range of applications in ecology, biodiversity and emerging diseases.			Stephens, CR (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad C3, Ciudad Mexico, Mexico City 04510, DF, Mexico.	stephens@nucleares.unam.mx	González, Camila/AAW-9144-2021; González-Salazar, Constantino/M-3913-2015	González-Salazar, Constantino/0000-0001-7347-714X; Ibarra-Cerdena, Carlos N./0000-0003-4980-4344; Gonzalez, Camila/0000-0001-8089-4056				[Anonymous], [No title captured]; BALASHOV YS, 1984, ANNU REV ENTOMOL, V29, P137, DOI 10.1146/annurev.en.29.010184.001033; BIAGI F, 1965, PRENSA MED MEX, V30, P276; Canto-Lara SB, 1999, MEM I OSWALDO CRUZ, V94, P305, DOI 10.1590/S0074-02761999000300005; Chaves LF, 2007, TRENDS PARASITOL, V23, P311, DOI 10.1016/j.pt.2007.05.003; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; *ER IV SOS BIB, 2004, DIAGN ID SUBG LEISHM; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guevara-Chumacero L. M., 2001, Acta Zoologica Mexicana Nueva Serie, P35; Hall E.R., 1981, MAMMALS N AM, V2; Hall E. R., 1981, MAMMALS N AM, V1; Ibanez-Bernal S, 2004, MEM I OSWALDO CRUZ, V99, P127, DOI 10.1590/S0074-02762004000200002; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; LIM BK, 2004, J BIODIV CONS, V11, P1237; Lomolino M. V., 2005, BIOGEOGRAPHY; LOSSOS J, 1996, ECOLOGY, V77, P1344; McCann K, 2007, NATURE, V446, P29, DOI 10.1038/446029a; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Ponder WF, 2001, CONSERV BIOL, V15, P648, DOI 10.1046/j.1523-1739.2001.015003648.x; RebollarTellez EA, 1996, MEM I OSWALDO CRUZ, V91, P555, DOI 10.1590/S0074-02761996000500004; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Van Wynsberghe NR, 2000, MEM I OSWALDO CRUZ, V95, P595, DOI 10.1590/S0074-02762000000500001; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775	29	57	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2009	4	5							e5725	10.1371/journal.pone.0005725	http://dx.doi.org/10.1371/journal.pone.0005725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QE	19478956	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415100016
J	Drecoll, E; Gaertner, FC; Miederer, M; Blechert, B; Vallon, M; Muller, JM; Alke, A; Seidl, C; Bruchertseifer, F; Morgenstern, A; Senekowitsch-Schmidtke, R; Essler, M				Drecoll, Enken; Gaertner, Florian C.; Miederer, Matthias; Blechert, Birgit; Vallon, Mario; Mueller, Jan M.; Alke, Andrea; Seidl, Christof; Bruchertseifer, Frank; Morgenstern, Alfred; Senekowitsch-Schmidtke, Reingard; Essler, Markus			Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide Bi-213-DTPA-[F3](2) into the Nucleus of Tumor Cells	PLOS ONE			English	Article							IN-VIVO; ENDOTHELIAL-CELLS; ALPHA-THERAPY; CANCER; RADIOIMMUNOTHERAPY; VASCULATURE; GENERATOR; AC-225; TH-229	Background: alpha-particle emitting isotopes are effective novel tools in cancer therapy, but targeted delivery into tumors is a prerequisite of their application to avoid toxic side effects. Peritoneal carcinomatosis is a widespread dissemination of tumors throughout the peritoneal cavity. As peritoneal carcinomatosis is fatal in most cases, novel therapies are needed. F3 is a tumor homing peptide which is internalized into the nucleus of tumor cells upon binding to nucleolin on the cell surface. Therefore, F3 may be an appropriate carrier for alpha-particle emitting isotopes facilitating selective tumor therapies. Principal Findings: A dimer of the vascular tumor homing peptide F3 was chemically coupled to the alpha-emitter Bi-213(Bi-213-DTPA-[F3](2)). We found Bi-213-DTPA-[F3](2) to accumulate in the nucleus of tumor cells in vitro and in intraperitoneally growing tumors in vivo. To study the anti-tumor activity of Bi-213-DTPA-[F3](2) we treated mice bearing intraperitoneally growing xenograft tumors with Bi-213-DTPA-[F3](2). In a tumor prevention study between the days 4-14 after inoculation of tumor cells 6x1.85 MBq (50 mu Ci) of Bi-213-DTPA-[F3](2) were injected. In a tumor reduction study between the days 16-26 after inoculation of tumor cells 6x1.85 MBq of Bi-213-DTPA-[F3](2) were injected. The survival time of the animals was increased from 51 to 93.5 days in the prevention study and from 57 days to 78 days in the tumor reduction study. No toxicity of the treatment was observed. In bio-distribution studies we found Bi-213-DTPA-[F3](2) to accumulate in tumors but only low activities were found in control organs except for the kidneys, where Bi-213-DTPA-[F3](2) is found due to renal excretion. Conclusions/Significance: In conclusion we report that Bi-213-DTPA-[F3](2) is a novel tool for the targeted delivery of alpha-emitters into the nucleus of tumor cells that effectively controls peritoneal carcinomatosis in preclinical models and may also be useful in oncology.			Drecoll, E (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-8000 Munich, Germany.	Markus.Essler@gmx.de	Miederer, Matthias/ABA-5988-2020; Miederer, Matthias/C-4405-2014	Miederer, Matthias/0000-0001-5075-5995; 				Akerman ME, 2002, P NATL ACAD SCI USA, V99, P12617, DOI 10.1073/pnas.152463399; Apostolidis C, 2005, ANAL CHEM, V77, P6288, DOI 10.1021/ac0580114; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Beck R, 2007, CANCER SCI, V98, P1215, DOI 10.1111/j.1349-7006.2007.00525.x; Beyer GJ, 2004, EUR J NUCL MED MOL I, V31, P547, DOI 10.1007/s00259-003-1413-9; Bloechl S, 2005, CLIN CANCER RES, V11, p7070S, DOI 10.1158/1078-0432.CCR-1004-0017; Borchardt PE, 2003, CANCER RES, V63, P5084; Buchhorn HM, 2007, EUR J NUCL MED MOL I, V34, P841, DOI 10.1007/s00259-006-0311-3; Cherukuri S, 2008, MOL BIOL CELL, V19, P1816, DOI 10.1091/mbc.E07-10-1018; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Glehen O, 2004, LANCET ONCOL, V5, P219, DOI 10.1016/S1470-2045(04)01425-1; Gunn AJ, 2007, EXPERT OPIN DRUG DEL, V4, P389, DOI 10.1517/17425247.4.4.389; Kinuya S, 2007, NUCL MED COMMUN, V28, P129, DOI 10.1097/MNM.0b013e328013e5a8; Koppe MJ, 2006, J NUCL MED, V47, P1867; McDevitt MR, 2001, SCIENCE, V294, P1537, DOI 10.1126/science.1064126; Miederer M, 2008, ADV DRUG DELIVER REV, V60, P1371, DOI 10.1016/j.addr.2008.04.009; Miederer M, 2008, CLIN CANCER RES, V14, P3555, DOI 10.1158/1078-0432.CCR-07-4647; Milenic D, 2004, CANCER BIOTHER RADIO, V19, P135, DOI 10.1089/108497804323071904; Nayak TK, 2007, NUCL MED BIOL, V34, P185, DOI 10.1016/j.nucmedbio.2006.11.006; Palm S, 2007, INT J RADIAT ONCOL, V69, P572, DOI 10.1016/j.ijrobp.2007.06.023; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Porkka K, 2002, P NATL ACAD SCI USA, V99, P7444, DOI 10.1073/pnas.062189599; Raja C, 2007, CANCER BIOL THER, V6, P846, DOI 10.4161/cbt.6.6.4089; Reubi JC, 2005, J NUCL MED, V46, p67S; Ruoslahti E, 2000, SEMIN CANCER BIOL, V10, P435, DOI 10.1006/scbi.2000.0334; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Stavila V, 2006, COORDIN CHEM REV, V250, P2782, DOI 10.1016/j.ccr.2006.02.032; Zielinska B, 2007, SOLVENT EXTR ION EXC, V25, P339, DOI 10.1080/07366290701285108	28	46	48	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5715	10.1371/journal.pone.0005715	http://dx.doi.org/10.1371/journal.pone.0005715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19479088	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415000022
J	Tariq, L; van den Berg, M; Hoogenveen, RT; van Baal, PHM				Tariq, Luqman; van den Berg, Matthijs; Hoogenveen, Rudolf T.; van Baal, Pieter H. M.			Cost-Effectiveness of an Opportunistic Screening Programme and Brief Intervention for Excessive Alcohol Use in Primary Care	PLOS ONE			English	Article							BRIEF PHYSICIAN ADVICE; RANDOMIZED CONTROLLED-TRIAL; IDENTIFICATION TEST AUDIT; AT-RISK DRINKING; DRINKERS; CONSUMPTION; BURDEN; PREVENTION; IMPACT	Background: Effective prevention of excessive alcohol use has the potential to reduce the public burden of disease considerably. We investigated the cost-effectiveness of Screening and Brief Intervention (SBI) for excessive alcohol use in primary care in the Netherlands, which is targeted at early detection and treatment of 'at-risk' drinkers. Methodology and Results: We compared a SBI scenario (opportunistic screening and brief intervention for 'at-risk' drinkers) in general practices with the current practice scenario (no SBI) in the Netherlands. We used the RIVM Chronic Disease Model (CDM) to extrapolate from decreased alcohol consumption to effects on health care costs and Quality Adjusted Life Years (QALYs) gained. Probabilistic sensitivity analysis was employed to study the effect of uncertainty in the model parameters. In total, 56,000 QALYs were gained at an additional cost of (sic)298,000,000 due to providing alcohol SBI in the target population, resulting in a cost- effectiveness ratio of (sic)5,400 per QALY gained. Conclusion: Prevention of excessive alcohol use by implementing SBI for excessive alcohol use in primary care settings appears to be cost- effective.			Tariq, L (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands.	luqman.tariq@rivm.nl		van Baal, Pieter/0000-0001-9913-2393				Anderson P., 2006, ALCOHOL EUROPE; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Babor TF, 2006, ALCOHOL ALCOHOLISM, V41, P624, DOI 10.1093/alcalc/agl078; BAUMBERG B, 2006, ALCOHOL EUROPE PUBLI; Beich A, 2003, BMJ-BRIT MED J, V327, P536, DOI 10.1136/bmj.327.7414.536; Bertholet N, 2005, ARCH INTERN MED, V165, P986, DOI 10.1001/archinte.165.9.986; Bradley KA, 1998, J GEN INTERN MED, V13, P379, DOI 10.1046/j.1525-1497.1998.00118.x; Bray JW, 2007, MED CARE, V45, P177, DOI 10.1097/01.mlr.0000252542.16255.fc; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; *CBS STATL, 2007 STAT NETH; Cnossen S, 2007, INT TAX PUBLIC FINAN, V14, P699, DOI 10.1007/s10797-007-9035-y; *COLL ZORG, 2005, RICHTL FARM OND EV A; de Hollander AEM, 2007, CARE HLTH 2006 DUTCH; Drummond MF, 2015, METHODS EC EVALUATIO; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FENWICK E, 2007, HEALTH ECON, V10, P779; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Fleming MF, 1999, J FAM PRACTICE, V48, P378; Fleming MF, 2000, MED CARE, V38, P7, DOI 10.1097/00005650-200001000-00003; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; Gold R, 1996, COST EFFECTIVENESS H; Holman CDJ, 1996, MED J AUSTRALIA, V164, P141, DOI 10.5694/j.1326-5377.1996.tb122011.x; Hoogenveen Rudolf T, 2008, Cost Eff Resour Alloc, V6, P1, DOI 10.1186/1478-7547-6-1; Jacobs-van der Bruggen MAM, 2007, DIABETES CARE, V30, P128, DOI 10.2337/dc06-0690; Jarl J, 2008, EUR J HEALTH ECON, V9, P351, DOI 10.1007/s10198-007-0082-1; Kaner E, 2003, PATIENT EDUC COUNS, V51, P277, DOI 10.1016/S0738-3991(02)00242-2; Kraemer Kevin L, 2007, Subst Abus, V28, P67, DOI 10.1300/J465v28n03_07; Kypri K, 2008, ARCH INTERN MED, V168, P530, DOI 10.1001/archinternmed.2007.109; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; Nilssen O, 2004, ALCOHOL ALCOHOLISM, V39, P548, DOI 10.1093/alcalc/agh095; OOSTENBRINK JB, 2004, STANDAARD KOSTPRIJZE; *POLS GEZ ARB, 2006, PERM OND LEEFS GEZ A; Rehm J, 2004, COMP QUANTIFICATION, P959; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHUTTEN M, 2004, LAAGDREMPELIGE SCREE; Senft RA, 1997, AM J PREV MED, V13, P464, DOI 10.1016/S0749-3797(18)30143-0; SLOBBE LCJ, 2003, COST OF ILLNESS NETH; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; Struijs JN, 2005, STROKE, V36, P1648, DOI 10.1161/01.STR.0000173221.37568.d2; van Baal PHM, 2008, VALUE HEALTH, V11, P1033, DOI 10.1111/j.1524-4733.2008.00328.x; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Van Baal PHM, 2007, HEALTH ECON, V16, P421, DOI 10.1002/hec.1181; van Baal Pieter H M, 2006, Popul Health Metr, V4, P1, DOI 10.1186/1478-7954-4-1; van den Berg M, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-36; Volk RJ, 1997, ADDICTION, V92, P197, DOI 10.1046/j.1360-0443.1997.9221978.x; Wutzke SE, 2002, ADDICTION, V97, P665, DOI 10.1046/j.1360-0443.2002.00080.x; Wutzke SE, 2001, SOC SCI MED, V52, P863, DOI 10.1016/S0277-9536(00)00189-1	49	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5696	10.1371/journal.pone.0005696	http://dx.doi.org/10.1371/journal.pone.0005696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	450QD	19479081	Green Published, gold, Green Submitted			2022-12-27	WOS:000266415000009
J	Zhang, CY; Kuspa, A				Zhang, Chenyu; Kuspa, Adam			Transcriptional Down-Regulation and rRNA Cleavage in Dictyostelium discoideum Mitochondria during Legionella pneumophila Infection	PLOS ONE			English	Article							II PROTEIN SECRETION; LEGIONNAIRES-DISEASE; INTRACELLULAR MULTIPLICATION; GROWTH; APOPTOSIS; PHAGOSOME; BACTERIUM; PATHOGEN; AMEBAS; MODEL	Bacterial pathogens employ a variety of survival strategies when they invade eukaryotic cells. The amoeba Dictyostelium discoideum is used as a model host to study the pathogenic mechanisms that Legionella pneumophila, the causative agent of Legionnaire's disease, uses to kill eukaryotic cells. Here we show that the infection of D. discoideum by L. pneumophila results in a decrease in mitochondrial messenger RNAs, beginning more than 8 hours prior to detectable host cell death. These changes can be mimicked by hydrogen peroxide treatment, but not by other cytotoxic agents. The mitochondrial large subunit ribosomal RNA (LSU rRNA) is also cleaved at three specific sites during the course of infection. Two LSU rRNA fragments appear first, followed by smaller fragments produced by additional cleavage events. The initial LSU rRNA cleavage site is predicted to be on the surface of the large subunit of the mitochondrial ribosome, while two secondary sites map to the predicted interface with the small subunit. No LSU rRNA cleavage was observed after exposure of D. discoideum to hydrogen peroxide, or other cytotoxic chemicals that kill cells in a variety of ways. Functional L. pneumophila type II and type IV secretion systems are required for the cleavage, establishing a correlation between the pathogenesis of L. pneumophila and D. discoideum LSU rRNA destruction. LSU rRNA cleavage was not observed in L. pneumophila infections of Acanthamoeba castellanii or human U937 cells, suggesting that L. pneumophila uses distinct mechanisms to interrupt metabolism in different hosts. Thus, L. pneumophila infection of D. discoideum results in dramatic decrease of mitochondrial RNAs, and in the specific cleavage of mitochondrial rRNA. The predicted location of the cleavage sites on the mitochondrial ribosome suggests that rRNA destruction is initiated by a specific sequence of events. These findings suggest that L. pneumophila specifically disrupts mitochondrial protein synthesis in D. discoideum during the course of infection.			Zhang, CY (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	akuspa@bcm.tmc.edu		Kuspa, Adam/0000-0002-9156-149X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052359] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD039691, HD39691] Funding Source: Medline; NIGMS NIH HHS [GM52359, R01 GM052359] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu Kwaik Y, 1998, APPL ENVIRON MICROB, V64, P3127; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Barth C, 2001, CURR GENET, V39, P355; BERGER KH, 1994, MOL MICROBIOL, V14, P809, DOI 10.1111/j.1365-2958.1994.tb01317.x; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; CHANDLER FW, 1977, NEW ENGL J MED, V297, P1218, DOI 10.1056/NEJM197712012972206; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Crawford DR, 1997, FREE RADICAL BIO MED, V22, P1295, DOI 10.1016/S0891-5849(96)00544-8; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; FEELEY JC, 1978, J CLIN MICROBIOL, V8, P320; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gao LY, 1999, INFECT IMMUN, V67, P862, DOI 10.1128/IAI.67.2.862-870.1999; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; Hales LM, 1999, INFECT IMMUN, V67, P3662, DOI 10.1128/IAI.67.7.3662-3666.1999; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hilbi H, 2001, MOL MICROBIOL, V42, P603, DOI 10.1046/j.1365-2958.2001.02645.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J CLIN INVEST, V71, P15, DOI 10.1172/JCI110744; HORWITZ MA, 1983, INT REV CYTOL, P307; HORWITZ MA, 1984, J CELL BIOL, V99, P1936, DOI 10.1083/jcb.99.6.1936; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Lammertyn E, 2004, FEMS MICROBIOL LETT, V238, P273, DOI 10.1016/j.femsle.2004.07.056; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; MATSUMOTO H, 1989, BIOCHEM BIOPH RES CO, V158, P105, DOI 10.1016/S0006-291X(89)80183-4; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Muller A, 1996, INFECT IMMUN, V64, P4900; Neumeister B, 2002, MICROBIOL-SGM, V148, P3639, DOI 10.1099/00221287-148-11-3639; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Ogawa S, 2000, MOL GEN GENET, V263, P514, DOI 10.1007/PL00008685; PEARLMAN E, 1988, MICROB PATHOGENESIS, V5, P87, DOI 10.1016/0882-4010(88)90011-3; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Rossier O, 2001, INFECT IMMUN, V69, P2092, DOI 10.1128/IAI.69.4.2092-2098.2001; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; SCANDALIOS JG, 1997, OXIDATIVE STRESS MOL, P1; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shuman HA, 1998, CURR TOP MICROBIOL, V225, P99; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; SUSSMAN R, 1971, ARCH BIOCHEM BIOPHYS, V144, P127, DOI 10.1016/0003-9861(71)90462-0; Tilney LG, 2001, J CELL SCI, V114, P4637; WADOWSKY RM, 1988, APPL ENVIRON MICROB, V54, P2677, DOI 10.1128/AEM.54.11.2677-2682.1988; Wilczynska Z, 1997, BIOCHEM BIOPH RES CO, V234, P39, DOI 10.1006/bbrc.1997.6574; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308	58	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5706	10.1371/journal.pone.0005706	http://dx.doi.org/10.1371/journal.pone.0005706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492077	gold, Green Published, Green Submitted			2022-12-27	WOS:000266415000016
J	Morrison, LJ; Tweedie, A; Black, A; Pinchbeck, GL; Christley, RM; Schoenefeld, A; Hertz-Fowler, C; MacLeod, A; Turner, CMR; Tait, A				Morrison, Liam J.; Tweedie, Alison; Black, Alana; Pinchbeck, Gina L.; Christley, Robert M.; Schoenefeld, Andreas; Hertz-Fowler, Christiane; MacLeod, Annette; Turner, C. Michael R.; Tait, Andy			Discovery of Mating in the Major African Livestock Pathogen Trypanosoma congolense	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC EXCHANGE; SLEEPING SICKNESS; BRUCEI-GAMBIENSE; AGENT; PLASMODIUM; CRUZI; AMPLIFICATION; PREVALENCE; EVOLUTION	The protozoan parasite, Trypanosoma congolense, is one of the most economically important pathogens of livestock in Africa and, through its impact on cattle health and productivity, has a significant effect on human health and well being. Despite the importance of this parasite our knowledge of some of the fundamental biological processes is limited. For example, it is unknown whether mating takes place. In this paper we have taken a population genetics based approach to address this question. The availability of genome sequence of the parasite allowed us to identify polymorphic microsatellite markers, which were used to genotype T. congolense isolates from livestock in a discrete geographical area of The Gambia. The data showed a high level of diversity with a large number of distinct genotypes, but a deficit in heterozygotes. Further analysis identified cryptic genetic subdivision into four sub-populations. In one of these, parasite genotypic diversity could only be explained by the occurrence of frequent mating in T. congolense. These data are completely inconsistent with previous suggestions that the parasite expands asexually in the absence of mating. The discovery of mating in this species of trypanosome has significant consequences for the spread of critical traits, such as drug resistance, as well as for fundamental aspects of the biology and epidemiology of this neglected but economically important pathogen.			Morrison, LJ (corresponding author), Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland.	lm78y@udcf.gla.ac.uk		Hamilton, Alana/0000-0001-5704-2293; Christley, Robert/0000-0001-9250-3032; Morrison, Liam/0000-0002-8304-9066; Hertz-Fowler, Christiane/0000-0002-0729-6479	Wellcome Trust [074732, 079703] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Balloux F, 2003, GENETICS, V164, P1635; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; de Meeus T, 2007, INFECT GENET EVOL, V7, P308, DOI 10.1016/j.meegid.2006.07.003; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faye D, 2001, VET PARASITOL, V101, P101, DOI 10.1016/S0304-4017(01)00503-9; GASHUMBA JK, 1988, PARASITOLOGY, V96, P475, DOI 10.1017/S0031182000080112; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Gibson W, 2006, BIOCHEM SOC T, V34, P557, DOI 10.1042/BST0340557; GIBSON W, 1992, MOL BIOCHEM PARASIT, V51, P189, DOI 10.1016/0166-6851(92)90069-V; Gibson W, 1997, MICROBIOL-UK, V143, P909, DOI 10.1099/00221287-143-3-909; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hedrick WP, 2005, GENETICS POPULATIONS; HOARE AC, 1972, ZOOLOGICAL MONOGRAPH; HOLMES PH, 2004, TRYPANOSOMIASES; Hope M, 1999, MOL BIOCHEM PARASIT, V104, P1, DOI 10.1016/S0166-6851(99)00103-6; Hughes AL, 2003, MOL BIOL EVOL, V20, P644, DOI 10.1093/molbev/msg062; Jamonneau V, 2003, INFECT GENET EVOL, V3, P143, DOI 10.1016/S1567-1348(03)00069-8; Koffi M, 2009, P NATL ACAD SCI USA, V106, P209, DOI 10.1073/pnas.0811080106; LEWICKA K, 1995, EXP PARASITOL, V81, P20, DOI 10.1006/expr.1995.1088; MacLeod A, 2000, P NATL ACAD SCI USA, V97, P13442, DOI 10.1073/pnas.230434097; MACLEOD A, 2007, TRYPANOSOMES GENOME; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; Morrison LJ, 2008, INFECT GENET EVOL, V8, P121, DOI 10.1016/j.meegid.2007.10.010; Morrison LJ, 2007, AM J TROP MED HYG, V76, P1132, DOI 10.4269/ajtmh.2007.76.1132; Morrison LJ, 2008, INFECT GENET EVOL, V8, P847, DOI 10.1016/j.meegid.2008.08.005; Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pinchbeck GL, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-7; Pritchard JK, 2000, GENETICS, V155, P945; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Razakandrainibe FG, 2005, P NATL ACAD SCI USA, V102, P17388, DOI 10.1073/pnas.0508871102; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Shaw APM, 2005, TRYPANOSOMIASES, P369, DOI 10.1079/9780851994758.0369; Stenberg P, 2003, MOL ECOL NOTES, V3, P329, DOI 10.1046/j.1471-8286.2003.00408.x; STERNBERG J, 1989, MOL BIOCHEM PARASIT, V34, P269, DOI 10.1016/0166-6851(89)90056-X; Stevens JR, 1999, PARASITOLOGY, V118, P107, DOI 10.1017/S0031182098003473; Stevens JR, 1996, PARASITOLOGY, V112, P481, DOI 10.1017/S0031182000076940; Tait A, 1996, MOL BIOCHEM PARASIT, V76, P31, DOI 10.1016/0166-6851(95)02528-6; TAIT A, 1980, NATURE, V287, P536, DOI 10.1038/287536a0; Tait A, 2007, MOL BIOCHEM PARASIT, V151, P133, DOI 10.1016/j.molbiopara.2006.10.009; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; TIBAYRENC M, 1986, P NATL ACAD SCI USA, V83, P115, DOI 10.1073/pnas.83.1.115; Weir W, 2007, MOL BIOCHEM PARASIT, V154, P170, DOI 10.1016/j.molbiopara.2007.04.015; YOUNG CJ, 1983, ANN TROP MED PARASIT, V77, P467, DOI 10.1080/00034983.1983.11811740	53	49	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5564	10.1371/journal.pone.0005564	http://dx.doi.org/10.1371/journal.pone.0005564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440370	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000266107400008
J	Suchindran, S; Brouwer, ES; Van Rie, A				Suchindran, Sujit; Brouwer, Emily S.; Van Rie, Annelies			Is HIV Infection a Risk Factor for Multi-Drug Resistant Tuberculosis? A Systematic Review	PLOS ONE			English	Review								Background: Tuberculosis ( TB) is an important cause of human suffering and death. Human immunodeficiency virus (HIV), multi-drug resistant TB (MDR-TB), and extensive drug resistant tuberculosis (XDR-TB) have emerged as threats to TB control. The association between MDR-TB and HIV infection has not yet been fully investigated. We conducted a systematic review and meta-analysis to summarize the evidence on the association between HIV infection and MDR-TB. Methods and Results: Original studies providing Mycobacterium tuberculosis resistance data stratified by HIV status were identified using MEDLINE and ISI Web of Science. Crude MDR-TB prevalence ratios were calculated and analyzed by type of TB (primary or acquired), region and study period. Heterogeneity across studies was assessed, and pooled prevalence ratios were generated if appropriate. No clear association was found between MDR-TB and HIV infection across time and geographic locations. MDR-TB prevalence ratios in the 32 eligible studies, comparing MDR-TB prevalence by HIV status, ranged from 0.21 to 41.45. Assessment by geographical region or study period did not reveal noticeable patterns. The summary prevalence ratios for acquired and primary MDR-TB were 1.17 (95% CI 0.86, 1.6) and 2.72 (95% CI 2.03, 3.66), respectively. Studies eligible for review were few considering the size of the epidemics. Most studies were not adjusted for confounders and the heterogeneity across studies precluded the calculation of a meaningful overall summary measure. Conclusions: We could not demonstrate an overall association between MDR-TB and HIV or acquired MDR-TB and HIV, but our results suggest that HIV infection is associated with primary MDR-TB. Future well-designed studies and surveillance in all regions of the world are needed to better clarify the relationship between HIV infection and MDR-TB.			Suchindran, S (corresponding author), Univ N Carolina, Sch Med, Sch Publ Hlth, Chapel Hill, NC 27515 USA.	vanrie@email.unc.edu	Van Rie, Annelies/C-2082-2017	Van Rie, Annelies/0000-0001-7666-3263; Brouwer, Emily/0000-0002-2894-8632	FOGARTY INTERNATIONAL CENTER [U2RTW007373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217] Funding Source: NIH RePORTER; FIC NIH HHS [U2R TW007373, 1 U2R-TW007373-01A1] Funding Source: Medline; NIAID NIH HHS [3 U19 AI053217-04SI R2C01, U19 AI053217] Funding Source: Medline; PHS HHS [U62/CCU422422] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Alberte-Castineiras A, 2006, INT J TUBERC LUNG D, V10, P554; Anastasis D, 1997, INT J TUBERC LUNG D, V1, P220; [Anonymous], 2003, STAT STAT SOFTW REL; Antunes ML, 2000, INT J TUBERC LUNG D, V4, P223; AUSINA V, 1995, EUR J CLIN MICROBIOL, V14, P105, DOI 10.1007/BF02111867; Balabanova Ia M, 2005, Probl Tuberk Bolezn Legk, P25; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; BRAUN MM, 1992, AIDS, V6, P1327, DOI 10.1097/00002030-199211000-00014; Campos PE, 2003, EMERG INFECT DIS, V9, P1571, DOI 10.3201/eid0912.020731; Chum HJ, 1996, AIDS, V10, P299, DOI 10.1097/00002030-199603000-00009; Cohn JA, 2002, INFECT DIS CLIN N AM, V16, P745, DOI 10.1016/S0891-5520(02)00012-0; Coker RJ, 2004, TROP MED INT HEALTH, V9, P25, DOI 10.1046/j.1365-3156.2003.01156.x; Conaty SJ, 2004, EPIDEMIOL INFECT, V132, P1099, DOI 10.1017/S0950268804002869; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Djuretic T, 2002, THORAX, V57, P477, DOI 10.1136/thorax.57.6.477; Drobniewski F, 2002, THORAX, V57, P810, DOI 10.1136/thorax.57.9.810; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Ferrazoli L, 2000, INT J TUBERC LUNG D, V4, P18; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; Fujiwara PI, 1997, ARCH INTERN MED, V157, P531, DOI 10.1001/archinte.157.5.531; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Girardi E, 1996, SCAND J INFECT DIS, V28, P487, DOI 10.3109/00365549609037945; Gordin FM, 1996, AM J RESP CRIT CARE, V154, P1478, DOI 10.1164/ajrccm.154.5.8912768; Irish C, 1999, BMJ-BRIT MED J, V318, P497, DOI 10.1136/bmj.318.7182.497; Joseph P, 2006, AIDS, V20, P415, DOI 10.1097/01.aids.0000206505.09159.9a; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; LEYPSHINA S, 2007, 38 WORLD C LUNG HLTH; Liberato Isabella Ramos de Oliveira, 2004, Rev. Soc. Bras. Med. Trop., V37, P46, DOI 10.1590/S0037-86822004000100012; Liu ZY, 1998, INT J EPIDEMIOL, V27, P121, DOI 10.1093/ije/27.1.121; Mac-Arthur A, 2001, INT J TUBERC LUNG D, V5, P894; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; Moore M, 1999, PUBLIC HEALTH REP, V114, P269, DOI 10.1093/phr/114.3.269; Murray J, 2000, S AFR MED J, V90, P381; Ormerod LP, 2005, BRIT MED BULL, V73-74, P17, DOI 10.1093/bmb/ldh047; PATEL KB, 1995, NEW ENGL J MED, V332, P336, DOI 10.1056/NEJM199502023320518; Pereira M, 2005, INDIAN J MED RES, V121, P235; Post FA, 1997, S AFR MED J, V87, P903; Punnotok J, 2000, INT J TUBERC LUNG D, V4, P537; Quy HT, 2006, INT J TUBERC LUNG D, V10, P160; Robert J, 2000, INT J TUBERC LUNG D, V4, P665; Schwoebel V, 1998, BRIT MED J, V317, P630, DOI 10.1136/bmj.317.7159.630; Taylor JP, 1999, AM J EPIDEMIOL, V149, P359, DOI 10.1093/oxfordjournals.aje.a009821; Telles MAS, 2005, INT J TUBERC LUNG D, V9, P970; VALWAY SE, 1994, J INFECT DIS, V170, P151, DOI 10.1093/infdis/170.1.151; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WEYER K, 2004, SURVEY TUBERCULOSIS; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; *WHO, 2002, 2 WHOIUATLD; *WHO, 1997, ANT DRUG RES WORLD W; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization (WHO), 2008, 4 WHOIUATLD; Yoshiyama T, 2001, INT J TUBERC LUNG D, V5, P32; 1991, MMWR MORB MORTAL WKL, V40, P585	58	129	131	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5561	10.1371/journal.pone.0005561	http://dx.doi.org/10.1371/journal.pone.0005561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440304	gold, Green Published, Green Submitted			2022-12-27	WOS:000266107400005
J	Kim, SM; Frank, LM				Kim, Steve M.; Frank, Loren M.			Hippocampal Lesions Impair Rapid Learning of a Continuous Spatial Alternation Task	PLOS ONE			English	Article								The hippocampus is essential for the formation of memories for events, but the specific features of hippocampal neural activity that support memory formation are not yet understood. The ideal experiment to explore this issue would be to monitor changes in hippocampal neural coding throughout the entire learning process, as subjects acquire and use new episodic memories to guide behavior. Unfortunately, it is not clear whether established hippocampally-dependent learning paradigms are suitable for this kind of experiment. The goal of this study was to determine whether learning of the W-track continuous alternation task depends on the hippocampal formation. We tested six rats with NMDA lesions of the hippocampal formation and four sham-operated controls. Compared to controls, rats with hippocampal lesions made a significantly higher proportion of errors and took significantly longer to reach learning criterion. The effect of hippocampal lesion was not due to a deficit in locomotion or motivation, because rats with hippocampal lesions ran well on a linear track for food reward. Rats with hippocampal lesions also exhibited a pattern of perseverative errors during early task experience suggestive of an inability to suppress behaviors learned during pretraining on a linear track. Our findings establish the W-track continuous alternation task as a hippocampally-dependent learning paradigm which may be useful for identifying changes in the neural representation of spatial sequences and reward contingencies as rats learn and apply new task rules.			Kim, SM (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu		Frank, Loren/0000-0002-1752-5677	NIMH NIH HHS [R01 MH080283, MH080283] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; Ainge JA, 2007, J NEUROSCI, V27, P9769, DOI 10.1523/JNEUROSCI.2011-07.2007; Amaral David G., 1995, P443; Anderson MI, 2006, HIPPOCAMPUS, V16, P730, DOI 10.1002/hipo.20206; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Brunner E, 2002, NONPARAMETRIC ANAL L; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Clark RE, 2000, J NEUROSCI, V20, P8853; DAVIDSON TL, 2008, HIPPOCAMPUS; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Faraji J, 2008, BEHAV BRAIN RES, V189, P17, DOI 10.1016/j.bbr.2007.12.002; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Flaherty CF, 1998, BEHAV BRAIN RES, V93, P1, DOI 10.1016/S0166-4328(97)00138-1; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Gluck MA, 2003, TRENDS COGN SCI, V7, P269, DOI 10.1016/S1364-6613(03)00105-0; Godsil BP, 2005, BEHAV NEUROSCI, V119, P1339, DOI 10.1037/0735-7044.119.5.1339; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Holland PEC, 1999, HIPPOCAMPUS, V9, P143, DOI 10.1002/(SICI)1098-1063(1999)9:2<143::AID-HIPO6>3.0.CO;2-Z; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Jarrard LE, 2004, HIPPOCAMPUS, V14, P434, DOI 10.1002/hipo.10194; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; Ji DY, 2008, J NEUROSCI, V28, P4679, DOI 10.1523/JNEUROSCI.4597-07.2008; Johnson A, 2005, NEURAL NETWORKS, V18, P1163, DOI 10.1016/j.neunet.2005.08.009; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kobayashi T, 1997, J NEUROPHYSIOL, V78, P597, DOI 10.1152/jn.1997.78.2.597; Kobayashi T, 2003, NEUROSCIENCE, V117, P1025, DOI 10.1016/S0306-4522(02)00700-5; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Lee I, 2006, NEURON, V51, P639, DOI 10.1016/j.neuron.2006.06.033; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lipton PA, 2007, J NEUROSCI, V27, P5787, DOI 10.1523/JNEUROSCI.1063-07.2007; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNish KA, 1997, J NEUROSCI, V17, P9353; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pouzet B, 1999, EUR J NEUROSCI, V11, P123, DOI 10.1046/j.1460-9568.1999.00413.x; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmelzeis MC, 1996, BEHAV NEUROSCI, V110, P1049; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Smith DM, 2006, HIPPOCAMPUS, V16, P716, DOI 10.1002/hipo.20208; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; Whishaw IQ, 1997, HIPPOCAMPUS, V7, P361, DOI 10.1002/(SICI)1098-1063(1997)7:4<361::AID-HIPO2>3.0.CO;2-M; Wiebe SP, 1999, J NEUROSCI, V19, P10562; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	73	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5494	10.1371/journal.pone.0005494	http://dx.doi.org/10.1371/journal.pone.0005494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424438	Green Submitted, gold, Green Published			2022-12-27	WOS:000265933800021
J	Krishnan, R; Park, CY; Lin, YC; Mead, J; Jaspers, RT; Trepat, X; Lenormand, G; Tambe, D; Smolensky, AV; Knoll, AH; Butler, JP; Fredberg, JJ				Krishnan, Ramaswamy; Park, Chan Young; Lin, Yu-Chun; Mead, Jere; Jaspers, Richard T.; Trepat, Xavier; Lenormand, Guillaume; Tambe, Dhananjay; Smolensky, Alexander V.; Knoll, Andrew H.; Butler, James P.; Fredberg, Jeffrey J.			Reinforcement versus Fluidization in Cytoskeletal Mechanoresponsiveness	PLOS ONE			English	Article								Every adherent eukaryotic cell exerts appreciable traction forces upon its substrate. Moreover, every resident cell within the heart, great vessels, bladder, gut or lung routinely experiences large periodic stretches. As an acute response to such stretches the cytoskeleton can stiffen, increase traction forces and reinforce, as reported by some, or can soften and fluidize, as reported more recently by our laboratory, but in any given circumstance it remains unknown which response might prevail or why. Using a novel nanotechnology, we show here that in loading conditions expected in most physiological circumstances the localized reinforcement response fails to scale up to the level of homogeneous cell stretch; fluidization trumps reinforcement. Whereas the reinforcement response is known to be mediated by upstream mechanosensing and downstream signaling, results presented here show the fluidization response to be altogether novel: it is a direct physical effect of mechanical force acting upon a structural lattice that is soft and fragile. Cytoskeletal softness and fragility, we argue, is consistent with early evolutionary adaptations of the eukaryotic cell to material properties of a soft inert microenvironment.			Krishnan, R (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, 665 Huntington Ave, Boston, MA 02115 USA.	jfredber@hsph.harvard.edu	Trepat, Xavier/I-3912-2015; Fredberg, Jeffrey/M-9877-2019; Tambe, Dhananjay/E-3511-2010	Trepat, Xavier/0000-0002-7621-5214; Jaspers, Richard/0000-0002-6951-0952; Lin, Yu-chun/0000-0002-6140-5656; Tambe, Dhananjay/0000-0002-6534-6577	NHLBI NIH HHS [R01 HL084224, R01 HL065960, R01 HL65960, R01 HL 084224] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065960, R01HL084224] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cannon W.B., 1963, WISDOM BODY; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; de Gennes P., 1996, FRAGILE OBJECTS SOFT; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Gunst SJ, 2003, J APPL PHYSIOL, V95, P413, DOI 10.1152/japplphysiol.00277.2003; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; KROY KGJ, 2007, NEW J PHYS, V9, P1; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Mijailovich SM, 2000, BIOPHYS J, V79, P2667, DOI 10.1016/S0006-3495(00)76505-2; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; PENDER N, 1991, J CELL SCI, V100, P187; PRATUSEVICH VR, 1995, J GEN PHYSIOL, V105, P73, DOI 10.1085/jgp.105.1.73; Semmrich C, 2007, P NATL ACAD SCI USA, V104, P20199, DOI 10.1073/pnas.0705513104; Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104; Stamenovic D, 2004, J APPL PHYSIOL, V96, P1600, DOI 10.1152/japplphysiol.00595.2003; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; von Wichert G, 2008, EUR J CELL BIOL, V87, P1, DOI 10.1016/j.ejcb.2007.07.008; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001	36	206	208	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5486	10.1371/journal.pone.0005486	http://dx.doi.org/10.1371/journal.pone.0005486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424501	Green Published, Green Submitted, gold			2022-12-27	WOS:000265933800016
J	Seth, M; Lamont, EA; Janagama, HK; Widdel, A; Vulchanova, L; Stabel, JR; Waters, WR; Palmer, MV; Sreevatsan, S				Seth, Meetu; Lamont, Elise A.; Janagama, Harish K.; Widdel, Andrea; Vulchanova, Lucy; Stabel, Judith R.; Waters, W. Ray; Palmer, Mitchell V.; Sreevatsan, Srinand			Biomarker Discovery in Subclinical Mycobacterial Infections of Cattle	PLOS ONE			English	Article								Background: Bovine tuberculosis is a highly prevalent infectious disease of cattle worldwide; however, infection in the United States is limited to 0.01% of dairy herds. Thus detection of bovine TB is confounded by high background infection with M. avium subsp. paratuberculosis. The present study addresses variations in the circulating peptidome based on the pathogenesis of two biologically similar mycobacterial diseases of cattle. Methodology/Principal Findings: We hypothesized that serum proteomes of animals in response to either M. bovis or M. paratuberculosis infection will display several commonalities and differences. Sera prospectively collected from animals experimentally infected with either M. bovis or M. paratuberculosis were analyzed using high-resolution proteomics approaches. iTRAQ, a liquid chromatography and tandem mass spectrometry approach, was used to simultaneously identify and quantify peptides from multiple infections and contemporaneous uninfected control groups. Four comparisons were performed: 1) M. bovis infection versus uninfected controls, 2) M. bovis versus M. paratuberculosis infection, 3) early, and 4) advanced M. paratuberculosis infection versus uninfected controls. One hundred and ten differentially elevated proteins (P <= 0.05) were identified. Vitamin D binding protein precursor (DBP), alpha-1 acid glycoprotein, alpha-1B glycoprotein, fetuin, and serine proteinase inhibitor were identified in both infections. Transthyretin, retinol binding proteins, and cathelicidin were identified exclusively in M. paratuberculosis infection, while the serum levels of alpha-1-microglobulin/bikunin precursor (AMBP) protein, alpha-1 acid glycoprotein, fetuin, and alpha-1B glycoprotein were elevated exclusively in M. bovis infected animals. Conclusions/Significance: The discovery of these biomarkers has significant impact on the elucidation of pathogenesis of two mycobacterial diseases at the cellular and the molecular level and can be applied in the development of mycobacterium-specific diagnostic tools for the monitoring progression of disease, response to therapy, and/or vaccine based interventions.			Seth, M (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.	sreev001@umn.edu	Palmer, Mitchell/R-7091-2018; Sreevatsan, Srinand/V-6808-2019	Palmer, Mitchell/0000-0002-5902-3333; Sreevatsan, Srinand/0000-0002-5162-2403; Lamont, Elise/0000-0001-7085-9740; Vulchanova, Lucy/0000-0002-6577-4467				Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Ceciliani F, 2007, VET IMMUNOL IMMUNOP, V116, P145, DOI 10.1016/j.vetimm.2007.01.006; Chang SJ, 2007, IET OPTOELECTRON, V1, P39, DOI 10.1049/iet-opt:20060025; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; CROWLE AJ, 1989, INFECT IMMUN, V57, P840, DOI 10.1128/IAI.57.3.840-844.1989; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; Desvergne B, 2007, NAT MED, V13, P671, DOI 10.1038/nm0607-671; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; GRANGE JM, 1984, TUBERCLE, V65, P23, DOI 10.1016/0041-3879(84)90027-8; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Kisker O, 2003, NEOPLASIA, V5, P32, DOI 10.1016/S1476-5586(03)80015-5; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liu PT, 2007, TRENDS MOL MED, V13, P117, DOI 10.1016/j.molmed.2007.01.006; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mackay C R, 1989, Int Immunol, V1, P540, DOI 10.1093/intimm/1.5.540; Munroe FA, 2000, PREV VET MED, V45, P247, DOI 10.1016/S0167-5877(00)00126-4; Nelsestuen GL, 2005, PROTEOMICS, V5, P4012, DOI 10.1002/pmic.200401234; Palmer MV, 2007, VET PATHOL, V44, P863, DOI 10.1354/vp.44-6-863; Palmer MV, 2006, CLIN VACCINE IMMUNOL, V13, P387, DOI 10.1128/CVI.13.3.387-394.2006; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; PETERSON PA, 1971, J BIOL CHEM, V246, P34; Shen Y, 2004, ANAL CHEM, V76, P144, DOI 10.1021/ac030096q; SONG X, 2008, J PROTEOME RES; STABEL JR, 2007, 9 INT C PAR TSUK JAP, P50; Thoen C., 2006, MYCOBACTERIUM BOVIS, P18; Trauger SA, 2004, ANAL CHEM, V76, P4484, DOI 10.1021/ac049657j; Wilkins MJ, 2008, EMERG INFECT DIS, V14, P657, DOI 10.3201/eid1404.070408; WONG CT, 1989, TROP GEOGR MED, V41, P218; Yamamoto N, 1996, J IMMUNOL, V157, P1744; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388; Zinsstag J., 2006, MYCOBACTERIUM BOVIS, P68, DOI DOI 10.1002/9780470344538.CH9	34	72	77	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5478	10.1371/journal.pone.0005478	http://dx.doi.org/10.1371/journal.pone.0005478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424492	Green Published, Green Submitted, gold			2022-12-27	WOS:000265933800012
J	Shimoni, Y; Altuvia, S; Margalit, H; Biham, O				Shimoni, Yishai; Altuvia, Shoshy; Margalit, Hanah; Biham, Ofer			Stochastic Analysis of the SOS Response in Escherichia coli	PLOS ONE			English	Article							BACTERIAL RECA PROTEIN; NETWORK MOTIFS; SIMULATION; CLEAVAGE; KINETICS; COMPLEX	Background: DNA damage in Escherichia coli evokes a response mechanism called the SOS response. The genetic circuit of this mechanism includes the genes recA and lexA, which regulate each other via a mixed feedback loop involving transcriptional regulation and protein-protein interaction. Under normal conditions, recA is transcriptionally repressed by LexA, which also functions as an auto-repressor. In presence of DNA damage, RecA proteins recognize stalled replication forks and participate in the DNA repair process. Under these conditions, RecA marks LexA for fast degradation. Generally, such mixed feedback loops are known to exhibit either bi-stability or a single steady state. However, when the dynamics of the SOS system following DNA damage was recently studied in single cells, ordered peaks were observed in the promoter activity of both genes (Friedman et al., 2005, PLoS Biol. 3(7):e238). This surprising phenomenon was masked in previous studies of cell populations. Previous attempts to explain these results harnessed additional genes to the system and deployed complex deterministic mathematical models that were only partially successful in explaining the results. Methodology/Principal Findings: Here we apply stochastic methods, which are better suited for dynamic simulations of single cells. We show that a simple model, involving only the basic components of the circuit, is sufficient to explain the peaks in the promoter activities of recA and lexA. Notably, deterministic simulations of the same model do not produce peaks in the promoter activities. Conclusion/Significance: We conclude that the double negative mixed feedback loop with auto-repression accounts for the experimentally observed peaks in the promoter activities. In addition to explaining the experimental results, this result shows that including additional regulations in a mixed feedback loop may dramatically change the dynamic functionality of this regulatory module. Furthermore, our results suggests that stochastic fluctuations strongly affect the qualitative behavior of important regulatory modules even under biologically relevant conditions, thus emphasizing the importance of stochastic analysis of regulatory circuits.			Shimoni, Y (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Mol Genet & Biotechnol, Jerusalem, Israel.	yshimoni@phys.huji.ac.il	Margalit, Hanah/H-1651-2013					Alon U., 2006, INTRO SYSTEMS BIOL D; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BRASH DE, 1985, J BIOL CHEM, V260, P1438; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Francois P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031908; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Henriksson-Peltola P, 2007, NUCLEIC ACIDS RES, V35, P3181, DOI 10.1093/nar/gkm172; INGRAHAM J, 1987, ESCHERICHIA COLI SAL, V1, pCH89; INGRAHAM J, 1987, ESCHERICHIA COLI SAL, V2, pCH89; Kozer N, 2004, J MOL BIOL, V336, P763, DOI 10.1016/j.jmb.2003.12.008; Krishna S, 2007, PLOS COMPUT BIOL, V3, P451, DOI 10.1371/journal.pcbi.0030041; Li DF, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011903; Lipshtat A, 2005, GENE, V347, P265, DOI 10.1016/j.gene.2004.12.016; LITTLE JW, 1983, J MOL BIOL, V167, P791, DOI 10.1016/S0022-2836(83)80111-9; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MCCLURE WR, 1980, P NATL ACAD SCI-BIOL, V77, P5634, DOI 10.1073/pnas.77.10.5634; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MILO R, 2007, BIONUMBERS; Ni M, 2007, BIOPHYS J, V93, P62, DOI 10.1529/biophysj.106.090712; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; TAKAHASHI M, 1994, ADV BIOPHYS, V30, P1, DOI 10.1016/0065-227X(94)90009-4; Thomas R., 1990, BIOL FEEDBACK; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101	33	38	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5363	10.1371/journal.pone.0005363	http://dx.doi.org/10.1371/journal.pone.0005363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424504	Green Published, Green Submitted, gold			2022-12-27	WOS:000265933800006
J	Yang, HC; Liang, YJ; Wu, YL; Chung, CM; Chiang, KM; Ho, HY; Ting, CT; Lin, TH; Sheu, SH; Tsai, WC; Chen, JH; Leu, HB; Yin, WH; Chiu, TY; Chen, CI; Fann, CSJ; Wu, JY; Lin, TN; Lin, SJ; Chen, YT; Chen, JW; Pan, WH				Yang, Hsin-Chou; Liang, Yu-Jen; Wu, Yi-Lin; Chung, Chia-Min; Chiang, Kuang-Mao; Ho, Hung-Yun; Ting, Chih-Tai; Lin, Tsung-Hsien; Sheu, Sheng-Hsiung; Tsai, Wei-Chuan; Chen, Jyh-Hong; Leu, Hsin-Bang; Yin, Wei-Hsian; Chiu, Ting-Yu; Chen, Chin-Iuan; Fann, Cathy S. J.; Wu, Jer-Yuarn; Lin, Teng-Nan; Lin, Shing-Jong; Chen, Yuan-Tsong; Chen, Jaw-Wen; Pan, Wen-Harn			Genome-Wide Association Study of Young-Onset Hypertension in the Han Chinese Population of Taiwan	PLOS ONE			English	Article							BLOOD-PRESSURE; PROTEOGLYCAN SYNTHESIS; GENE; PREVALENCE; EXPRESSION; CANDIDATE; EFFICIENT; PRODUCT; HEALTH; RISK	Young-onset hypertension has a stronger genetic component than late-onset counterpart; thus, the identification of genes related to its susceptibility is a critical issue for the prevention and management of this disease. We carried out a two-stage association scan to map young-onset hypertension susceptibility genes. The first-stage analysis, a genome-wide association study, analyzed 175 matched case-control pairs; the second-stage analysis, a confirmatory association study, verified the results at the first stage based on a total of 1,008 patients and 1,008 controls. Single-locus association tests, multilocus association tests and pair-wise gene-gene interaction tests were performed to identify young-onset hypertension susceptibility genes. After considering stringent adjustments of multiple testing, gene annotation and single-nucleotide polymorphism (SNP) quality, four SNPs from two SNP triplets with strong association signals (-log(10)(p) > 7) and 13 SNPs from 8 interactive SNP pairs with strong interactive signals (-log(10)(p) > 8) were carefully re-examined. The confirmatory study verified the association for a SNP quartet 219 kb and 495 kb downstream of LOC344371 ( a hypothetical gene) and RASGRP3 on chromosome 2p22.3, respectively. The latter has been implicated in the abnormal vascular responsiveness to endothelin-1 and angiotensin II in diabetic-hypertensive rats. Intrinsic synergy involving IMPG1 on chromosome 6q14.2-q15 was also verified. IMPG1 encodes interphotoreceptor matrix proteoglycan 1 which has cation binding capacity. The genes are novel hypertension targets identified in this first genome-wide hypertension association study of the Han Chinese population.			Yang, HC (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	jwchen@vghtpe.gov.tw; pan@ibms.sinica.edu.tw	Lin, Teng-nan/Q-4566-2018; Yang, Hsin-Chou/AAP-2547-2021; Fann, Cathy SJ/F-9410-2010; Wu, Jer-Yuarn/S-7010-2018; Pan, Wen-Harn/F-9972-2010	Lin, Teng-nan/0000-0002-4009-0798; Yang, Hsin-Chou/0000-0001-6853-7881; Fann, Cathy SJ/0000-0001-9025-2276; Pan, Wen-Harn/0000-0001-9136-0658; Chiang, Kuang-Mao/0000-0002-8745-2004; Lin, Tsung-Hsien/0000-0002-7226-8730				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; CHEN CH, 2005, ASSESSING POPULATION, pS16; Chen P, 2005, J BIOMED SCI, V12, P651, DOI 10.1007/s11373-005-7707-0; Chen P, 2009, HUM MUTAT, V30, P49, DOI 10.1002/humu.20812; Chen YH, 2008, NUCLEIC ACIDS RES, V36, pW336, DOI 10.1093/nar/gkn214; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Cox DR., 1989, ANAL BINARY DATA; Cox DR., 1970, ANAL BINARY DATA; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; EHRET GB, 2008, EUR J HUM GENET, V4, P1; Fan CT, 2008, PHARMACOGENOMICS, V9, P235, DOI 10.2217/14622416.9.2.235; Felbor U, 1998, CYTOGENET CELL GENET, V81, P12, DOI 10.1159/000015001; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Karram K, 2005, J ANAT, V207, P735, DOI 10.1111/j.1469-7580.2005.00461.x; Kuehn MH, 1999, MATRIX BIOL, V18, P509, DOI 10.1016/S0945-053X(99)00043-8; Lifton Richard P, 2004, Harvey Lect, V100, P71; Lifton RP, 2002, COLD SPRING HARB SYM, V67, P445, DOI 10.1101/sqb.2002.67.445; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Mehta C. R., 1992, J COMPUT GRAPH STAT, V1, P21; Mehta CR, 2000, J AM STAT ASSOC, V95, P99, DOI 10.2307/2669530; Morton NE, 2008, ADV GENET, V60, P727, DOI 10.1016/S0065-2660(07)00425-7; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Pan WH, 2001, J HUM HYPERTENS, V15, P793, DOI 10.1038/sj.jhh.1001268; Pan WH, 2000, HUM GENET, V107, P210, DOI 10.1007/s004390000365; Pritchard JK, 2000, GENETICS, V155, P945; Puddu P, 2007, ACTA CARDIOL, V62, P281, DOI 10.2143/AC.62.3.2020818; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rankinen T, 2001, HYPERTENSION, V38, P30, DOI 10.1161/01.HYP.38.1.30; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Survase S, 2005, VASC HEALTH RISK MAN, V1, P199; van Lith-Verhoeven JJC, 2004, INVEST OPHTH VIS SCI, V45, P30, DOI 10.1167/iovs.03-0392; Wang RY, 2008, HUM HERED, V65, P85, DOI 10.1159/000108940; Weir BS., 1996, GENETIC DATA ANAL; Wu XD, 2006, AM J HYPERTENS, V19, P122, DOI 10.1016/j.amjhyper.2005.07.010; Yang HC, 2006, J BIOMED SCI, V13, P489, DOI 10.1007/s11373-006-9077-7; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	47	55	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5459	10.1371/journal.pone.0005459	http://dx.doi.org/10.1371/journal.pone.0005459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421330	gold, Green Published			2022-12-27	WOS:000265837000002
J	Mok, E; Letellier, G; Cuisset, JM; Denjean, A; Gottrand, F; Alberti, C; Hankard, R				Mok, Elise; Letellier, Guy; Cuisset, Jean-Marie; Denjean, Andre; Gottrand, Frederic; Alberti, Corinne; Hankard, Regis			Lack of Functional Benefit with Glutamine versus Placebo in Duchenne Muscular Dystrophy: A Randomized Crossover Trial	PLOS ONE			English	Article							GREEN TEA EXTRACT; AMINO-ACID; BODY-COMPOSITION; MUSCLE NECROSIS; ORAL GLUTAMINE; MOUSE MODEL; MDX MICE; CHILDREN; SUPPLEMENTATION; METABOLISM	Background: Oral glutamine decreases whole body protein breakdown in Duchenne muscular dystrophy (DMD). We evaluated the functional benefit of 4 months oral glutamine in DMD. Methodology/Principal Findings: 30 ambulant DMD boys were included in this double-blind, randomized crossover trial with 2 intervention periods: glutamine (0.5 g/kg/d) and placebo, 4 months each, separated by a 1-month wash-out, at 3 outpatient clinical investigation centers in France. Functional benefit was tested by comparing glutamine versus placebo on change in walking speed at 4 months. Secondary outcome measures were: 2-minute walk test, work, power, muscle mass (urinary creatinine), markers of myofibrillar protein breakdown (urinary 3-methyl-histidine/creatinine), serum creatine phospho-kinase, body composition (fat free mass, fat mass percentage), safety and oral nutrient intake. There was no improvement in the primary end point (walking speed) or in secondary measures of muscle function (2-minute walk test, work, power) in the glutamine group compared with placebo. However, subjects receiving glutamine or placebo showed no deterioration in functional measures over the course of the 9-month trial. No differences in muscle mass, markers of protein breakdown or serum creatine phosho-kinase were observed, except for a blunted increase in fat free mass in the glutamine group which led to a greater increase in fat mass percentage. Glutamine was safe and well-tolerated. Conclusions: This trial did not identify additional benefit of 4 months oral glutamine over placebo on muscle mass or function in ambulatory DMD boys. Although apparently safe, current data cannot support routine supplementation in this population as a whole, until further research proves otherwise.			Mok, E (corresponding author), CHU Poitiers, INSERM, Ctr Invest Clin 802, Poitiers, France.	r.hankard@chu-poitiers.fr	HANKARD, Regis/A-8771-2009; gottrand, frederic F/G-7370-2015	gottrand, frederic F/0000-0002-5290-0436; HANKARD, Regis/0000-0001-8450-5839				ARCHER JD, 2006, FASEB J; BARTON ER, 2005, MUSCLE NERVE; Beenakker EAC, 2005, EUR J PAEDIATR NEURO, V9, P387, DOI 10.1016/j.ejpn.2005.06.004; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; BLAHD WH, 1967, NEW ENGL J MED, V276, P1349, DOI 10.1056/NEJM196706152762404; Bowen TR, 1999, J PEDIATR ORTHOPED, V19, P133, DOI 10.1097/00004694-199901000-00027; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; Buetler TM, 2002, AM J CLIN NUTR, V75, P749, DOI 10.1093/ajcn/75.4.749; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; Chazalette D, 2005, FEBS LETT, V579, P1079, DOI 10.1016/j.febslet.2004.12.081; Dorchies OM, 2006, AM J PHYSIOL-CELL PH, V290, pC616, DOI 10.1152/ajpcell.00425.2005; EDMONDS CJ, 1985, CLIN SCI, V68, P379, DOI 10.1042/cs0680379; ELIA M, 1981, BRIT MED J, V282, P351, DOI 10.1136/bmj.282.6261.351; Escolar DM, 2005, ANN NEUROL, V58, P151, DOI 10.1002/ana.20523; Granchelli JA, 2000, NEUROMUSCULAR DISORD, V10, P235, DOI 10.1016/S0960-8966(99)00126-1; GRIGGS RC, 1983, ANN NEUROL, V13, P125, DOI 10.1002/ana.410130204; GRIGGS RC, 1983, NEUROLOGY, V33, P158, DOI 10.1212/WNL.33.2.158; HANKARD R, 1994, PEDIATR RES, V36, P202, DOI 10.1203/00006450-199408000-00011; Hankard R, 1999, CLIN NUTR, V18, P365, DOI 10.1016/S0261-5614(99)80017-X; Hankard R, 1996, PEDIATR RES, V40, P29, DOI 10.1203/00006450-199607000-00006; HANKARD RG, 1995, AM J PHYSIOL-ENDOC M, V269, pE663, DOI 10.1152/ajpendo.1995.269.4.E663; Hankard RG, 1996, AM J PHYSIOL-ENDOC M, V271, pE748, DOI 10.1152/ajpendo.1996.271.4.E748; Hankard RG, 1998, PEDIATR RES, V43, P222, DOI 10.1203/00006450-199802000-00011; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; HICKSON RC, 1995, AM J PHYSIOL-ENDOC M, V268, pE730, DOI 10.1152/ajpendo.1995.268.4.E730; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Hubner C, 1996, PEDIATR RES, V40, P444, DOI 10.1203/00006450-199609000-00013; Mayhew JE, 2007, MUSCLE NERVE, V35, P36, DOI 10.1002/mus.20654; MENDELL JR, 1984, MUSCLE NERVE, V7, P535, DOI 10.1002/mus.880070704; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Mok E, 2006, AM J CLIN NUTR, V83, P823, DOI 10.1093/ajcn/83.4.823; Mok E, 2006, AM J CLIN NUTR, V83, P65; Mok E, 2008, PEDIATR RES, V63, P268, DOI 10.1203/PDR.0b013e318163a259; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; Passaquin AC, 2002, NEUROMUSCULAR DISORD, V12, P174, DOI 10.1016/S0960-8966(01)00273-5; Payne ET, 2006, MUSCLE NERVE, V33, P66, DOI 10.1002/mus.20436; RENNIE MJ, 1989, METABOLISM, V38, P47, DOI 10.1016/0026-0495(89)90140-6; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; Rossier P, 2001, ARCH PHYS MED REHAB, V82, P9, DOI 10.1053/apmr.2001.9396; Salehian B, 2006, METABOLISM, V55, P1239, DOI 10.1016/j.metabol.2006.05.009; Tarnopolsky MA, 2004, NEUROLOGY, V62, P1771, DOI 10.1212/01.WNL.0000125178.18862.9D; UPTON CJ, 1988, ARCH DIS CHILD, V63, P1444, DOI 10.1136/adc.63.12.1444; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Yoshida M, 2006, AM J PHYSIOL-REG I, V290, pR449, DOI 10.1152/ajpregu.00684.2004; ZDANOWICZ MM, 1995, J NUTR, V125, P1150	45	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2009	4	5							e5448	10.1371/journal.pone.0005448	http://dx.doi.org/10.1371/journal.pone.0005448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JG	19421321	Green Published, Green Submitted, gold			2022-12-27	WOS:000265836900007
J	Karathanasis, E; Chan, L; Karumbaiah, L; McNeeley, K; D'Orsi, CJ; Annapragada, AV; Sechopoulos, I; Bellamkonda, RV				Karathanasis, Efstathios; Chan, Leslie; Karumbaiah, Lohitash; McNeeley, Kathleen; D'Orsi, Carl J.; Annapragada, Ananth V.; Sechopoulos, Ioannis; Bellamkonda, Ravi V.			Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PRIMARY BREAST-CANCER; VEGF; CHEMOTHERAPY; DTPA; LOCALIZATION; LIPOSOMES; DELIVERY; RECEPTOR; AGENTS	Background: Vascular endothelial growth factor (VEGF) receptor-2 is the major mediator of the mitogenic, angiogenic, and vascular hyperpermeability effects of VEGF on breast tumors. Overexpression of VEGF and VEGF receptor-2 is associated with the degree of pathomorphosis of the tumor tissue and unfavorable prognosis. In this study, we demonstrate that non-invasive quantification of the degree of tumor vascular permeability to a nanoprobe correlates with the VEGF and its receptor levels and tumor growth. Methodology/Principal Findings: We designed an imaging nanoprobe and a methodology to detect the intratumoral deposition of a 100 nm-scale nanoprobe using mammography allowing measurement of the tumor vascular permeability in a rat MAT B III breast tumor model. The tumor vascular permeability varied widely among the animals. Notably, the VEGF and VEGF receptor-2 gene expression of the tumors as measured by qRT-PCR displayed a strong correlation to the imaging-based measurements of vascular permeability to the 100 nm-scale nanoprobe. This is in good agreement with the fact that tumors with high angiogenic activity are expected to have more permeable blood vessels resulting in high intratumoral deposition of a nanoscale agent. In addition, we show that higher intratumoral deposition of the nanoprobe as imaged with mammography correlated to a faster tumor growth rate. This data suggest that vascular permeability scales to the tumor growth and that tumor vascular permeability can be a measure of underlying VEGF and VEGF receptor-2 expression in individual tumors. Conclusions/Significance: This is the first demonstration, to our knowledge, that quantitative imaging of tumor vascular permeability to a nanoprobe represents a form of a surrogate, functional biomarker of underlying molecular markers of angiogenesis.			Karathanasis, E (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	ravi@gatech.edu	Annapragada, Ananth/GOK-1576-2022; Sechopoulos, Ioannis/B-4762-2016	Sechopoulos, Ioannis/0000-0001-9615-8205; Karathanasis, Efstathios/0000-0001-7484-7552; Chan, Leslie/0000-0002-0999-6890; Karumbaiah, Lohitash/0000-0001-7969-417X; Annapragada, Ananth/0000-0002-3156-9617				BRIX G, 1991, J COMPUT ASSIST TOMO, V15, P621, DOI 10.1097/00004728-199107000-00018; BROWN BW, 1984, J NATL CANCER I, V72, P31, DOI 10.1093/jnci/72.1.31; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chen K, 2009, MOL IMAGING BIOL, V11, P15, DOI 10.1007/s11307-008-0172-1; Chen K, 2008, EUR J NUCL MED MOL I, V35, P2235, DOI 10.1007/s00259-008-0860-8; Drevs J, 2006, J INTERN MED, V260, P517, DOI 10.1111/j.1365-2796.2006.01727.x; Drummond DC, 1999, PHARMACOL REV, V51, P691; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrara N, 2005, ROLE VEGF REGULATION, P209; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fox SB, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1796; Fox SB, 2001, LANCET ONCOL, V2, P278, DOI 10.1016/S1470-2045(00)00323-5; FUKUMURA D, 2007, MICROVASC RES; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Gasparini G, 2001, CRIT REV ONCOL HEMAT, V37, P97, DOI 10.1016/S1040-8428(00)00105-0; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Harrington KJ, 2001, CLIN CANCER RES, V7, P243; Heffelfinger SC, 2004, LAB INVEST, V84, P989, DOI 10.1038/labinvest.3700128; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hubbell J. H., 1996, TABLES XRAY MASS ATT; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Karathanasis E, 2008, BIOMATERIALS, V29, P4815, DOI 10.1016/j.biomaterials.2008.08.036; Karathanasis E, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/31/315101; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Kim EA, 2008, B EXP BIOL MED+, V145, P245, DOI 10.1007/s10517-008-0061-2; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; LARSSON HBW, 1990, MAGNET RESON MED, V16, P117, DOI 10.1002/mrm.1910160111; Lasic DD, 1995, STEALTH LIPOSOMES; Linderholm B, 1998, J CLIN ONCOL, V16, P3121, DOI 10.1200/JCO.1998.16.9.3121; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maeda H, 2001, ADV DRUG DELIVER REV, V46, P169, DOI 10.1016/S0169-409X(00)00134-4; McDonald DM, 2002, CANCER RES, V62, P5381; McNeeley KM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/38/385101; Miller JC, 2005, JNCI-J NATL CANCER I, V97, P172, DOI 10.1093/jnci/dji023; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Northfelt DW, 1996, J CLIN PHARMACOL, V36, P55, DOI 10.1002/j.1552-4604.1996.tb04152.x; Nunes FLS, 2002, MED PHYS, V29, P2925, DOI 10.1118/1.1521119; Park JW, 2002, CLIN CANCER RES, V8, P1172; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Raatschen HJ, 2008, RADIOLOGY, V247, P391, DOI 10.1148/radiol.2472070363; Relf M, 1997, CANCER RES, V57, P963; Saucier Jenifer M, 2007, J Oncol Pharm Pract, V13, P39, DOI 10.1177/1078155207077948; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Wagner KU, 2004, BREAST CANCER RES, V6, P31, DOI 10.1186/bcr723; Yamaji-Kegan K, 2006, AM J PHYSIOL-LUNG C, V291, pL1159, DOI 10.1152/ajplung.00168.2006; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	53	57	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2009	4	6							e5843	10.1371/journal.pone.0005843	http://dx.doi.org/10.1371/journal.pone.0005843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460YH	19513111	Green Published, gold, Green Submitted			2022-12-27	WOS:000267228800009
J	Achilli, A; Bonfiglio, S; Olivieri, A; Malusa, A; Pala, M; Kashani, BH; Perego, UA; Ajmone-Marsan, P; Liotta, L; Semino, O; Bandelt, HJ; Ferretti, L; Torroni, A				Achilli, Alessandro; Bonfiglio, Silvia; Olivieri, Anna; Malusa, Arianna; Pala, Maria; Kashani, Baharak Hooshiar; Perego, Ugo A.; Ajmone-Marsan, Paolo; Liotta, Luigi; Semino, Ornella; Bandelt, Hans-Juergen; Ferretti, Luca; Torroni, Antonio			The Multifaceted Origin of Taurine Cattle Reflected by the Mitochondrial Genome	PLOS ONE			English	Article								A Neolithic domestication of taurine cattle in the Fertile Crescent from local aurochsen (Bos primigenius) is generally accepted, but a genetic contribution from European aurochsen has been proposed. Here we performed a survey of a large number of taurine cattle mitochondrial DNA (mtDNA) control regions from numerous European breeds confirming the overall clustering within haplogroups (T1, T2 and T3) of Near Eastern ancestry, but also identifying eight mtDNAs (1.3%) that did not fit in haplogroup T. Sequencing of the entire mitochondrial genome showed that four mtDNAs formed a novel branch (haplogroup R) which, after the deep bifurcation that gave rise to the taurine and zebuine lineages, constitutes the earliest known split in the mtDNA phylogeny of B. primigenius. The remaining four mtDNAs were members of the recently discovered haplogroup Q. Phylogeographic data indicate that R mtDNAs were derived from female European aurochsen, possibly in the Italian Peninsula, and sporadically included in domestic herds. In contrast, the available data suggest that Q mtDNAs and T subclades were involved in the same Neolithic event of domestication in the Near East. Thus, the existence of novel (and rare) taurine haplogroups highlights a multifaceted genetic legacy from distinct B. primigenius populations. Taking into account that the maternally transmitted mtDNA tends to underestimate the extent of gene flow from European aurochsen, the detection of the R mtDNAs in autochthonous breeds, some of which are endangered, identifies an unexpected reservoir of genetic variation that should be carefully preserved.			Achilli, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	lucaf@ipvgen.unipv.it; torroni@ipvgen.unipv.it	Torroni, Antonio/E-1557-2011; OLIVIERI, ANNA/I-9235-2012; Perego, Ugo/AAG-9327-2019; Bonfiglio, Silvia/AAC-1988-2019; Ferretti, Luca/D-2337-2013; Achilli, Alessandro/I-9236-2012; Liotta, Luigi/P-6190-2015; AJMONE MARSAN, Paolo/M-2466-2018	Torroni, Antonio/0000-0002-4163-4478; OLIVIERI, ANNA/0000-0002-3941-8098; Achilli, Alessandro/0000-0001-6871-3451; Bonfiglio, Silvia/0000-0002-4422-1580; SEMINO, Ornella/0000-0002-9675-9403; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Ferretti, Luca/0000-0001-5044-8442; Pala, Maria/0000-0001-9202-8331; Liotta, Luigi/0000-0002-3242-1817				Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Anderung C, 2005, P NATL ACAD SCI USA, V102, P8431, DOI 10.1073/pnas.0503396102; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418; Bradley DG, 1998, EVOL ANTHROPOL, V6, P79, DOI 10.1002/(SICI)1520-6505(1998)6:3<79::AID-EVAN2>3.0.CO;2-R; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Carvajal-Carmona LG, 2003, GENETICS, V165, P1457; Cortes O, 2008, ANIM GENET, V39, P649, DOI 10.1111/j.1365-2052.2008.01782.x; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Lai SJ, 2006, MOL PHYLOGENET EVOL, V38, P146, DOI 10.1016/j.ympev.2005.06.013; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lei CZ, 2006, ANIM GENET, V37, P579, DOI 10.1111/j.1365-2052.2006.01524.x; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Schlumbaum A, 2006, ANIM GENET, V37, P373, DOI 10.1111/j.1365-2052.2006.01435.x; STOCK F, 2009, ANIM GENET IN PRESS; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088	27	136	139	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2009	4	6							e5753	10.1371/journal.pone.0005753	http://dx.doi.org/10.1371/journal.pone.0005753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	452GL	19484124	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000266528200006
J	Sandebring, A; Thomas, KJ; Beilina, A; van der Brug, M; Cleland, MM; Ahmad, R; Miller, DW; Zambrano, I; Cowburn, RF; Behbahani, H; Cedazo-Minguez, A; Cookson, MR				Sandebring, Anna; Thomas, Kelly Jean; Beilina, Alexandra; van der Brug, Marcel; Cleland, Megan M.; Ahmad, Rili; Miller, David W.; Zambrano, Ibardo; Cowburn, Richard F.; Behbahani, Homira; Cedazo-Minguez, Angel; Cookson, Mark R.			Mitochondrial Alterations in PINK1 Deficient Cells Are Influenced by Calcineurin-Dependent Dephosphorylation of Dynamin-Related Protein 1	PLOS ONE			English	Article								PTEN-induced novel kinase 1 (PINK1) mutations are associated with autosomal recessive parkinsonism. Previous studies have shown that PINK1 influences both mitochondrial function and morphology although it is not clearly established which of these are primary events and which are secondary. Here, we describe a novel mechanism linking mitochondrial dysfunction and alterations in mitochondrial morphology related to PINK1. Cell lines were generated by stably transducing human dopaminergic M17 cells with lentiviral constructs that increased or knocked down PINK1. As in previous studies, PINK1 deficient cells have lower mitochondrial membrane potential and are more sensitive to the toxic effects of mitochondrial complex I inhibitors. We also show that wild-type PINK1, but not recessive mutant or kinase dead versions, protects against rotenone-induced mitochondrial fragmentation whereas PINK1 deficient cells show lower mitochondrial connectivity. Expression of dynamin-related protein 1 (Drp1) exaggerates PINK1 deficiency phenotypes and Drp1 RNAi rescues them. We also show that Drp1 is dephosphorylated in PINK1 deficient cells due to activation of the calcium-dependent phosphatase calcineurin. Accordingly, the calcineurin inhibitor FK506 blocks both Drp1 dephosphorylation and loss of mitochondrial integrity in PINK1 deficient cells but does not fully rescue mitochondrial membrane potential. We propose that alterations in mitochondrial connectivity in this system are secondary to functional effects on mitochondrial membrane potential.			Sandebring, A (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.	Cookson@mail.nih.gov	Cedazo-Minguez, Angel/C-6707-2012; Cookson, Mark/AAW-2516-2021; Thomas Craig, Kelly Jean/ABE-6181-2021	Cedazo-Minguez, Angel/0000-0003-4626-4864; Cookson, Mark/0000-0002-1058-3831; Thomas Craig, Kelly Jean/0000-0002-9954-2795; Harwig, Megan/0000-0003-2140-5739; Matton, Anna/0000-0002-7819-0495	NATIONAL INSTITUTE ON AGING [ZIAAG000940, Z01AG000940] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Babcock DF, 1997, J CELL BIOL, V136, P833, DOI 10.1083/jcb.136.4.833; Baptista MJ, 2003, J NEUROCHEM, V85, P957, DOI 10.1046/j.1471-4159.2003.01742.x; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; BIEDLER JL, 1978, CANCER RES, V38, P3751; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; CRIBBS JT, 2007, EMBO REP; Dagda R. K., 2009, J BIOL CHEM; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004756; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HOEPKEN HH, 2006, NEUROBIOL DIS; Ichishita R, 2008, J BIOCHEM, V143, P449, DOI 10.1093/jb/mvm245; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004597; MARONGIU R, 2009, J NEUROCHEM; McBride HM, 2008, J CELL BIOL, V183, P757, DOI 10.1083/jcb.200810184; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; OHARE MMT, 1989, CANCER RES, V49, P7015; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; PARK J, 2008, BIOCH BIOPHYS RES CO; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plecita-Hlavata L, 2008, BBA-BIOENERGETICS, V1777, P834, DOI 10.1016/j.bbabio.2008.04.002; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; RAHMANROBLICK R, 2008, ONCOGENE; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; RETTIG WJ, 1987, CANCER RES, V47, P1383; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	67	157	157	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2009	4	5							e5701	10.1371/journal.pone.0005701	http://dx.doi.org/10.1371/journal.pone.0005701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	450QD	19492085	Green Published, Green Submitted, gold			2022-12-27	WOS:000266415000013
J	Miller, CMD; Smith, NC; Ikin, RJ; Boulter, NR; Dalton, JP; Donnelly, S				Miller, Catherine M. D.; Smith, Nicholas C.; Ikin, Rowan J.; Boulter, Nicola R.; Dalton, John P.; Donnelly, Sheila			Immunological Interactions between 2 Common Pathogens, Th1-Inducing Protozoan Toxoplasma gondii and the Th2-Inducing Helminth Fasciola hepatica	PLOS ONE			English	Article								Background: The nature of the immune response to infection is dependent on the type of infecting organism. Intracellular organisms such as Toxoplasma gondii stimulate a Th1-driven response associated with production of IL-12, IFN-gamma, nitric oxide and IgG2a antibodies and classical activation of macrophages. In contrast, extracellular helminths such as Fasciola hepatica induce Th2 responses characterised by the production of IL-4, IL-5, IL-10 and IgG1 antibodies and alternative activation of macrophages. As co-infections with these types of parasites commonly exist in the field it is relevant to examine how the various facets of the immune responses induced by each may influence or counter-regulate that of the other. Principal Findings: Regardless, of whether F. hepatica infection preceded or succeeded T. gondii infection, there was little impact on the production of the Th1 cytokines IL-12, IFN-gamma or on the development of classically-activated macrophages induced by T. gondii. By contrast, the production of helminth-specific Th2 cytokines, such as IL-4 and IL-5, was suppressed by infection with T. gondii. Additionally, the recruitment and alternative activation of macrophages by F. hepatica was blocked or reversed by subsequent infection with T. gondii. The clinical symptoms of toxoplasmosis and the survival rate of infected mice were not significantly altered by the helminth. Conclusions: Despite previous studies showing that F. hepatica suppressed the classical activation of macrophages and the Th1-driven responses of mice to bystander microbial infection, as well as reduced their ability to reject these, here we found that the potent immune responses to T. gondii were capable of suppressing the responses to helminth infection. Clearly, the outcome of particular infections in polyparasitoses depends on the means and potency by which each pathogen controls the immune response.			Miller, CMD (corresponding author), Univ Technol Sydney, Sydney, NSW 2007, Australia.	Catherine.Miller@uts.edu.au	Dalton, John/K-4457-2014; Miller, Catherine/G-9368-2011; Donnelly, Sheila/H-7733-2014	Miller, Catherine/0000-0001-6071-5102; Donnelly, Sheila/0000-0003-2005-3698; Smith, Nicholas/0000-0002-7467-1451				Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Araujo MI, 2001, INFECT IMMUN, V69, P1454, DOI 10.1128/IAI.69.3.1454-1462.2001; Boucher JL, 1999, CELL MOL LIFE SCI, V55, P1015, DOI 10.1007/s000180050352; Boyle JP, 2007, EXP PARASITOL, V116, P302, DOI 10.1016/j.exppara.2007.01.010; Brady MT, 1999, INFECT IMMUN, V67, P5372, DOI 10.1128/IAI.67.10.5372-5378.1999; Brunet LR, 2001, INT IMMUNOPHARMACOL, V1, P1457, DOI 10.1016/S1567-5769(01)00090-X; Chiu BC, 2002, PARASITE IMMUNOL, V24, P285, DOI 10.1046/j.1365-3024.2002.00466.x; De Nadai P, 2006, J IMMUNOL, V176, P6286, DOI 10.4049/jimmunol.176.10.6286; DEROUIN F, 2008, CLIN MICROBIOL  1115; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Fouts AE, 2007, INFECT IMMUN, V75, P634, DOI 10.1128/IAI.01228-06; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; Kodelja V, 1998, J IMMUNOL, V160, P1411; Liesenfeld O, 2004, INFECT IMMUN, V72, P3812, DOI 10.1128/IAI.72.7.3812-3822.2004; Loke P, 2000, EUR J IMMUNOL, V30, P1127, DOI 10.1002/(SICI)1521-4141(200004)30:4&lt;1127::AID-IMMU1127&gt;3.0.CO;2-#; Marshall AJ, 1999, J IMMUNOL, V163, P2089; Miller C, 2005, INT J PARASITOL, V35, P821, DOI 10.1016/j.ijpara.2005.03.006; Miller CMD, 2000, INT J PARASITOL, V30, P1467, DOI 10.1016/S0020-7519(00)00118-1; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mulcahy G, 1999, FASCIOLOSIS, P341; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Nguyen TD, 1998, INFECT IMMUN, V66, P2991, DOI 10.1128/IAI.66.6.2991-2995.1998; O'Neill SM, 2001, PARASITE IMMUNOL, V23, P541, DOI 10.1046/j.1365-3024.2001.00411.x; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; Piedrafita D, 2000, PARASITE IMMUNOL, V22, P287, DOI 10.1046/j.1365-3024.2000.00300.x; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Rodriguez-Sosa M, 2002, INFECT IMMUN, V70, P3656, DOI 10.1128/IAI.70.7.3656-3664.2002; Santiago HC, 1999, INFECT IMMUN, V67, P4939, DOI 10.1128/IAI.67.9.4939-4944.1999; Sasaki M, 2001, J MED MICROBIOL, V50, P952, DOI 10.1099/0022-1317-50-11-952; Stoicov C, 2004, J IMMUNOL, V173, P3329, DOI 10.4049/jimmunol.173.5.3329; VENKATESAN P, 1993, PARASITOL TODAY, V9, P228, DOI 10.1016/0169-4758(93)90020-G; Vulcano M, 2003, J IMMUNOL, V170, P3843, DOI 10.4049/jimmunol.170.7.3843	34	36	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2009	4	5							e5692	10.1371/journal.pone.0005692	http://dx.doi.org/10.1371/journal.pone.0005692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LI	19478853	Green Accepted, Green Published, gold			2022-12-27	WOS:000266331700017
J	Ahier, A; Rondard, P; Gouignard, N; Khayath, N; Huang, S; Trolet, J; Donoghue, DJ; Gauthier, M; Pin, JP; Dissous, C				Ahier, Arnaud; Rondard, Philippe; Gouignard, Nadege; Khayath, Naji; Huang, Siluo; Trolet, Jacques; Donoghue, Daniel J.; Gauthier, Monique; Pin, Jean-Philippe; Dissous, Colette			A New Family of Receptor Tyrosine Kinases with a Venus Flytrap Binding Domain in Insects and Other Invertebrates Activated by Aminoacids	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; AGONIST-BINDING; PROTEIN; TRANSDUCTION; REPERTOIRE; PREDICTION; MECHANISM; EVOLUTION	Background: Tyrosine kinase receptors (RTKs) comprise a large family of membrane receptors that regulate various cellular processes in cell biology of diverse organisms. We previously described an atypical RTK in the platyhelminth parasite Schistosoma mansoni, composed of an extracellular Venus flytrap module (VFT) linked through a single transmembrane domain to an intracellular tyrosine kinase domain similar to that of the insulin receptor. Methods and Findings: Here we show that this receptor is a member of a new family of RTKs found in invertebrates, and particularly in insects. Sixteen new members of this family, named Venus Kinase Receptor (VKR), were identified in many insects. Structural and phylogenetic studies performed on VFT and TK domains showed that VKR sequences formed monophyletic groups, the VFT group being close to that of GABA(B) receptors and the TK one being close to that of insulin receptors. We show that a recombinant VKR is able to autophosphorylate on tyrosine residues, and report that it can be activated by L-arginine. This is in agreement with the high degree of conservation of the alpha amino acid binding residues found in many amino acid binding VFTs. The presence of high levels of vkr transcripts in larval forms and in female gonads indicates a putative function of VKR in reproduction and/or development. Conclusion: The identification of RTKs specific for parasites and insect vectors raises new perspectives for the control of human parasitic and infectious diseases.			Ahier, A (corresponding author), Univ Lille 2, INSERM, Inst Pasteur, U547, Lille, France.	colette.dissous@pasteur-lille.fr	Rondard, Philippe/N-9720-2018; Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Gouignard, Nadege/0000-0001-8787-2503; Ahier, Arnaud/0000-0002-9999-3887; RONDARD, Philippe/0000-0003-1134-2738; Dissous, Colette/0000-0002-5003-8205				Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Catherinot V, 2004, BIOINFORMATICS, V20, P3694, DOI 10.1093/bioinformatics/bth429; Crossley C, 2007, NINETEEN CENT FR ST, V35, P491; Dalton R, 2009, NATURE, V457, P368, DOI 10.1038/457368a; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; GRAU Y, 2007, Patent No. 2007132090; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Kucharski R., 2007, Invertebrate Neuroscience, V7, P99, DOI 10.1007/s10158-007-0045-3; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lapraz F, 2006, DEV BIOL, V300, P132, DOI 10.1016/j.ydbio.2006.08.048; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Miller MA, 2000, DEV BIOL, V224, P286, DOI 10.1006/dbio.2000.9786; Mitri C, 2004, J BIOL CHEM, V279, P9313, DOI 10.1074/jbc.M310878200; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; Reidling JC, 2000, J BIOL CHEM, V275, P10323, DOI 10.1074/jbc.275.14.10323; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Rondard P, 2006, J BIOL CHEM, V281, P24653, DOI 10.1074/jbc.M602277200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAVARE JM, 1991, J BIOL CHEM, V266, P1390; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vicogne J, 2003, MOL BIOCHEM PARASIT, V126, P51, DOI 10.1016/S0166-6851(02)00249-9; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	49	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5651	10.1371/journal.pone.0005651	http://dx.doi.org/10.1371/journal.pone.0005651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19461966	Green Published, Green Submitted, gold			2022-12-27	WOS:000266331000010
J	Herbst, KJ; Allen, MD; Zhang, J				Herbst, Katie J.; Allen, Michael D.; Zhang, Jin			The cAMP-Dependent Protein Kinase Inhibitor H-89 Attenuates the Bioluminescence Signal Produced by Renilla Luciferase	PLOS ONE			English	Article							ASSAYS; BIOSENSORS; DYNAMICS; FAMILY	Background: Investigations into the regulation and functional roles of kinases such as cAMP-dependent protein kinase (PKA) increasingly rely on cellular assays. Currently, there are a number of bioluminescence-based assays, for example reporter gene assays, that allow the study of the regulation, activity, and functional effects of PKA in the cellular context. Additionally there are continuing efforts to engineer improved biosensors that are capable of detecting real-time PKA signaling dynamics in cells. These cell-based assays are often utilized to test the involvement of PKA-dependent processes by using H-89, a reversible competitive inhibitor of PKA. Principal Findings: We present here data to show that H-89, in addition to being a competitive PKA inhibitor, attenuates the bioluminescence signal produced by Renilla luciferase (RLuc) variants in a population of cells and also in single cells. Using 10 mM of luciferase substrate and 10 mM H-89, we observed that the signal from RLuc and RLuc8, an eight-point mutation variant of RLuc, in cells was reduced to 50% (+/- 15%) and 54% (+/- 14%) of controls exposed to the vehicle alone, respectively. In vitro, we showed that H-89 decreased the RLuc8 bioluminescence signal but did not compete with coelenterazine-h for the RLuc8 active site, and also did not affect the activity of Firefly luciferase. By contrast, another competitive inhibitor of PKA, KT5720, did not affect the activity of RLuc8. Significance: The identification and characterization of the adverse effect of H-89 on RLuc signal will help deconvolute data previously generated from RLuc-based assays looking at the functional effects of PKA signaling. In addition, for the current application and future development of bioluminscence assays, KT5720 is identified as a more suitable PKA inhibitor to be used in conjunction with RLuc-based assays. These principal findings also provide an important lesson to fully consider all of the potential effects of experimental conditions on a cell-based assay readout before drawing conclusions from the data.			Herbst, KJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	jzhang32@jhmi.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK073368] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Andorfer CA, 2000, DEV NEUROSCI-BASEL, V22, P303, DOI 10.1159/000017454; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bakhtiarova A, 2006, BIOCHEM BIOPH RES CO, V351, P481, DOI 10.1016/j.bbrc.2006.10.057; Brovko Lubov Y., 2007, Science Progress, V90, P129, DOI 10.3184/003685007X215986; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Costanzo V, 1999, CURR BIOL, V9, P903, DOI 10.1016/S0960-9822(99)80395-9; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Deroo BJ, 2002, J BIOL CHEM, V277, P20120, DOI 10.1074/jbc.C200173200; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; MATYAKHINA L, 2006, ANN NY ACAD SCI, V968, P148; MILLER WR, 2006, ANN NY ACAD SCI, V968, P37; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nesher R, 2002, DIABETES, V51, pS68, DOI 10.2337/diabetes.51.2007.S68; OKADA Y, 1995, J NEUROSCI, V15, P3053; Rocha S, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-9; ROSENBERG D, 2006, ANN NY ACAD SCI, V968, P65; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Woo JC, 2008, PROTEIN SCI, V17, P725, DOI 10.1110/ps.073355508; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2007, MOL BIOSYST, V3, P759, DOI 10.1039/b706628g; Zhang LM, 2007, NAT MED, V13, P1114, DOI 10.1038/nm1608	30	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2009	4	5							e5642	10.1371/journal.pone.0005642	http://dx.doi.org/10.1371/journal.pone.0005642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	449LB	19461967	Green Published, gold, Green Submitted			2022-12-27	WOS:000266331000001
J	Karaca, M; Castel, J; Tourrel-Cuzin, C; Brun, M; Geant, A; Dubois, M; Catesson, S; Rodriguez, M; Luquet, S; Cattan, P; Lockhart, B; Lang, JC; Ktorza, A; Magnan, C; Kargar, C				Karaca, Melis; Castel, Julien; Tourrel-Cuzin, Cecile; Brun, Manuel; Geant, Anne; Dubois, Mathilde; Catesson, Sandra; Rodriguez, Marianne; Luquet, Serge; Cattan, Pierre; Lockhart, Brian; Lang, Jochen; Ktorza, Alain; Magnan, Christophe; Kargar, Catherine			Exploring Functional beta-Cell Heterogeneity In Vivo Using PSA-NCAM as a Specific Marker	PLOS ONE			English	Article								Background: The mass of pancreatic beta-cells varies according to increases in insulin demand. It is hypothesized that functionally heterogeneous beta-cell subpopulations take part in this process. Here we characterized two functionally distinct groups of beta-cells and investigated their physiological relevance in increased insulin demand conditions in rats. Methods: Two rat beta-cell populations were sorted by FACS according to their PSA-NCAM surface expression, i.e. beta(high) and beta(low)-cells. Insulin release, Ca(2+) movements, ATP and cAMP contents in response to various secretagogues were analyzed. Gene expression profiles and exocytosis machinery were also investigated. In a second part, beta(high) and beta(low)-cell distribution and functionality were investigated in animal models with decreased or increased beta-cell function: the Zucker Diabetic Fatty rat and the 48 h glucose-infused rat. Results: We show that beta-cells are heterogeneous for PSA-NCAM in rat pancreas. Unlike beta(low)-cells, beta(high)-cells express functional beta-cell markers and are highly responsive to various insulin secretagogues. Whereas beta(low)-cells represent the main population in diabetic pancreas, an increase in beta(high)-cells is associated with gain of function that follows sustained glucose overload. Conclusion: Our data show that a functional heterogeneity of beta-cells, assessed by PSA-NCAM surface expression, exists in vivo. These findings pinpoint new target populations involved in endocrine pancreas plasticity and in beta-cell defects in type 2 diabetes.			Karaca, M (corresponding author), Univ Paris Diderot, Lab Physiopathol Nutr, CNRS, UMR 7059, Paris, France.	meliskaraca@gmail.com	Luquet, serge/AAT-1809-2021; Dubois, Mathilde/M-2971-2014; Lang, Jochen/B-1215-2010; magnan, christophe/AAJ-7622-2021; Lang, Jochen/F-5782-2014	Luquet, serge/0000-0001-8668-6645; Lang, Jochen/0000-0001-6847-5641; magnan, christophe/0000-0002-7044-2571; Lang, Jochen/0000-0001-6847-5641; CASTEL, JULIEN/0000-0003-4309-701X; Karaca, Melis/0000-0001-6951-3507; Tourrel-Cuzin, Cecile/0000-0002-5368-4018				Ahren B, 2003, J CLIN ENDOCR METAB, V88, P1264, DOI 10.1210/jc.2002-021547; Bernard C, 1998, DIABETES, V47, P1058, DOI 10.2337/diabetes.47.7.1058; Bernard-Kargar C, 2001, DIABETES, V50, pS125, DOI 10.2337/diabetes.50.2007.S125; Boal F, 2004, BIOCHEMISTRY-US, V43, P16212, DOI 10.1021/bi048612+; BOSCO D, 1991, ENDOCRINOLOGY, V129, P3157, DOI 10.1210/endo-129-6-3157; Bosco D, 2007, J ENDOCRINOL, V194, P21, DOI 10.1677/JOE-06-0169; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Dachicourt N, 1996, AM J PHYSIOL-ENDOC M, V271, pE725, DOI 10.1152/ajpendo.1996.271.4.E725; Dubois M, 2007, ENDOCRINOLOGY, V148, P1605, DOI 10.1210/en.2006-1022; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; HIRIART M, 1991, ENDOCRINOLOGY, V128, P3193, DOI 10.1210/endo-128-6-3193; HIRIART M, 1995, BIOCHEM MOL MED, V54, P133, DOI 10.1006/bmme.1995.1019; HOWELL SL, 1982, DIABETOLOGIA, V22, P301; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; KIEKENS R, 1992, J CLIN INVEST, V89, P117, DOI 10.1172/JCI115551; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Leibowitz G, 2001, DIABETES, V50, P1799, DOI 10.2337/diabetes.50.8.1799; Ling ZD, 2006, DIABETES, V55, P78, DOI 10.2337/diabetes.55.01.06.db05-0820; Matschinsky F.M., 2001, HDB PHYSL 7, P125; Meier JJ, 2008, DIABETOLOGIA, V51, P703, DOI 10.1007/s00125-008-0936-9; NIELSEN DA, 1982, DIABETES, V31, P299, DOI 10.2337/diabetes.31.4.299; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; PIPELEERS DG, 1992, DIABETES, V41, P777, DOI 10.2337/diabetes.41.7.777; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Quintens R, 2008, BIOCHEM SOC T, V36, P300, DOI 10.1042/BST0360300; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Theodosis DT, 1999, J NEUROSCI, V19, P10228; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Topp BG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1730, DOI 10.1152/ajpendo.00572.2007; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; VANSCHRAVENDIJK CFH, 1992, J BIOL CHEM, V267, P21344; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Yang JC, 2006, DIABETES, V55, P193, DOI 10.2337/diabetes.55.01.06.db05-0938	38	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2009	4	5							e5555	10.1371/journal.pone.0005555	http://dx.doi.org/10.1371/journal.pone.0005555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FZ	19440374	Green Submitted, gold, Green Published			2022-12-27	WOS:000266107500002
J	Denuc, A; Bosch-Comas, A; Gonzalez-Duarte, R; Marfany, G				Denuc, Amanda; Bosch-Comas, Anna; Gonzalez-Duarte, Roser; Marfany, Gemma			The UBA-UIM Domains of the USP25 Regulate the Enzyme Ubiquitination State and Modulate Substrate Recognition	PLOS ONE			English	Article								USP25m is the muscle isoform of the deubiquitinating (DUB) enzyme USP25. Similarly to most DUBs, data on USP25 regulation and substrate recognition is scarce. In silico analysis predicted three ubiquitin binding domains (UBDs) at the Nterminus: one ubiquitin-associated domain (UBA) and two ubiquitin-interacting motifs (UIMs), whereas no clear structural homology at the extended C-terminal region outside the catalytic domains were detected. In order to asses the contribution of the UBDs and the C-terminus to the regulation of USP25m catalytic activity, ubiquitination state and substrate interaction, serial and combinatorial deletions were generated. Our results showed that USP25m catalytic activity did not strictly depend on the UBDs, but required a coiled-coil stretch between amino acids 679 to 769. USP25 oligomerized but this interaction did not require either the UBDs or the C-terminus. Besides, USP25 was monoubiquitinated and able to autodeubiquitinate in a possible loop of autoregulation. UBDs favored the monoubiquitination of USP25m at the preferential site lysine 99 (K99). This residue had been previously shown to be a target for SUMO and this modification inhibited USP25 activity. We showed that mutation of K99 clearly diminished USP25-dependent rescue of the specific substrate MyBPC1 from proteasome degradation, thereby supporting a new mechanistic model, in which USP25m is regulated through alternative conjugation of ubiquitin (activating) or SUMO (inhibiting) to the same lysine residue (K99), which may promote the interaction with distinct intramolecular regulatory domains.			Denuc, A (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	gmarfany@ub.edu	Marfany, Gemma/I-5668-2015	Marfany, Gemma/0000-0001-7941-983X				Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bosch-Comas A, 2006, CELL MOL LIFE SCI, V63, P723, DOI 10.1007/s00018-005-5533-1; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groothuis TAM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-21; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Marfany G, 2008, BIOCHEM SOC T, V36, P833, DOI 10.1042/BST0360833; Meek DW, 2003, MOL CANCER RES, V1, P1017; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Mohideen F, 2008, MOL CELL, V30, P539, DOI 10.1016/j.molcel.2008.05.010; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Valero R, 1999, GENOMICS, V62, P395, DOI 10.1006/geno.1999.6025; VALERO R, 2001, GENOME BIOL, V2; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484	35	51	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2009	4	5							e5571	10.1371/journal.pone.0005571	http://dx.doi.org/10.1371/journal.pone.0005571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	446FY	19440361	Green Submitted, Green Published, gold			2022-12-27	WOS:000266107400014
J	Sun, S; Xu, JP				Sun, Sheng; Xu, Jianping			Chromosomal Rearrangements between Serotype A and D Strains in Cryptococcus neoformans	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; MATING-TYPE; REPRODUCTIVE ISOLATION; GENOME SEQUENCE; EVOLUTION; YEAST; DIVERSITY; RECOMBINATION; POLYMORPHISMS; HYBRIDIZATION	Cryptococcus neoformans is a major human pathogenic fungus that can cause meningoencephalitis in immunocompromised hosts. It contains two divergent varieties, var. grubii (serotype A) and var. neoformans (serotype D), as well as hybrids (serotype AD) between these two varieties. In this study, we investigated the extent of chromosomal rearrangements between the two varieties, estimated the effects of chromosomal rearrangements on recombination frequencies, and surveyed the potential polymorphisms of the rearrangements among natural strains of the three serotypes. Through the analyses of two sequenced genomes from strains H99 (representing var. grubii) and JEC21 (representing var. neoformans), we revealed a total of 32 unambiguous chromosome rearrangements, including five translocations, nine simple inversions, and 18 complex rearrangements. Our analyses identified that overall, rearranged regions had recombination frequencies about half of those around syntenic regions. Using a direct PCR screening strategy, we examined the potential polymorphisms of 11 rearrangements among 64 natural C. neoformans strains from five countries. We found no polymorphism within var. neoformans and very limited polymorphism within var. grubii. However, strains of serotype AD showed significant polymorphism, consistent with their hybrid origins coupled with differential loss of heterozygosity. We discuss the implications of these results on the genome structure, ecology, and evolution of C. neoformans.			Sun, S (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	suns6@mcmaster.ca						Armengol L, 2005, GENOMICS, V86, P692, DOI 10.1016/j.ygeno.2005.08.008; Boekhout T, 1997, CURR GENET, V32, P203, DOI 10.1007/s002940050267; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Depaulis F, 1999, GENETICS, V152, P1017; Fischer G, 2006, PLOS GENET, V2, P253, DOI 10.1371/journal.pgen.0020032; Forche A, 2000, FUNGAL GENET BIOL, V31, P189, DOI 10.1006/fgbi.2000.1240; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; Fries BC, 1996, J CLIN MICROBIOL, V34, P1531, DOI 10.1128/JCM.34.6.1531-1534.1996; Goodwin TJD, 2001, YEAST, V18, P865, DOI 10.1002/yea.733; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Hu GG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r41; Hughes D, 2000, GENOME BIOL, V1; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kavanaugh LA, 2006, MOL BIOL EVOL, V23, P1879, DOI 10.1093/molbev/msl070; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Klepser ME, 1998, J CLIN MICROBIOL, V36, P3653, DOI 10.1128/JCM.36.12.3653-3656.1998; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Lengeler KB, 2001, INFECT IMMUN, V69, P115, DOI 10.1128/IAI.69.1.115-122.2001; Lin XR, 2008, INFECT IMMUN, V76, P2923, DOI 10.1128/IAI.00168-08; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Marra RE, 2004, GENETICS, V167, P619, DOI 10.1534/genetics.103.023408; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Navarro A, 1997, GENETICS, V147, P931; Navarro A, 1997, GENETICS, V146, P695; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Rieseberg LH, 1999, GENETICS, V152, P713; RIESEBERG LH, 1995, GENETICS, V141, P1163; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rustchenko E, 2007, FEMS YEAST RES, V7, P2, DOI 10.1111/j.1567-1364.2006.00150.x; Sukroongreung S, 2001, J CLIN MICROBIOL, V39, P2060, DOI 10.1128/JCM.39.6.2060-2064.2001; Sun S, 2007, GENETICS, V177, P1475, DOI 10.1534/genetics.107.078923; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Xu JP, 2003, MICROBIOL-SGM, V149, P2147, DOI 10.1099/mic.0.26180-0; Xu JP, 2002, MICROBIOL-SGM, V148, P203, DOI 10.1099/00221287-148-1-203; Xu JP, 2001, ANTIMICROB AGENTS CH, V45, P420, DOI 10.1128/AAC.45.2.420-427.2001; Yang J, 2003, J MICROBIOL METH, V54, P423, DOI 10.1016/S0167-7012(03)00094-0; ZOLAN ME, 1995, MICROBIOL REV, V59, P686, DOI 10.1128/MMBR.59.4.686-698.1995	53	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2009	4	5							e5524	10.1371/journal.pone.0005524	http://dx.doi.org/10.1371/journal.pone.0005524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	444WA	19436753	Green Published, gold, Green Submitted			2022-12-27	WOS:000266009900016
J	Da Silva, M; Upton, C				Da Silva, Melissa; Upton, Chris			Vaccinia Virus G8R Protein: A Structural Ortholog of Proliferating Cell Nuclear Antigen (PCNA)	PLOS ONE			English	Article								Background: Eukaryotic DNA replication involves the synthesis of both a DNA leading and lagging strand, the latter requiring several additional proteins including flap endonuclease (FEN-1) and proliferating cell nuclear antigen (PCNA) in order to remove RNA primers used in the synthesis of Okazaki fragments. Poxviruses are complex viruses (dsDNA genomes) that infect eukaryotes, but surprisingly little is known about the process of DNA replication. Given our previous results that the vaccinia virus (VACV) G5R protein may be structurally similar to a FEN-1-like protein and a recent finding that poxviruses encode a primase function, we undertook a series of in silico analyses to identify whether VACV also encodes a PCNA-like protein. Results: An InterProScan of all VACV proteins using the JIPS software package was used to identify any PCNA-like proteins. The VACV G8R protein was identified as the only vaccinia protein that contained a PCNA-like sliding clamp motif. The VACV G8R protein plays a role in poxvirus late transcription and is known to interact with several other poxvirus proteins including itself. The secondary and tertiary structure of the VACV G8R protein was predicted and compared to the secondary and tertiary structure of both human and yeast PCNA proteins, and a high degree of similarity between all three proteins was noted. Conclusions: The structure of the VACV G8R protein is predicted to closely resemble the eukaryotic PCNA protein; it possesses several other features including a conserved ubiquitylation and SUMOylation site that suggest that, like its counterpart in T4 bacteriophage (gp45), it may function as a sliding clamp ushering transcription factors to RNA polymerase during late transcription.			Da Silva, M (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	cupton@uvic.ca		Upton, Chris/0000-0002-9019-8967	NIAID NIH HHS [HHSN266200400036C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afonso CL, 1999, J VIROL, V73, P533, DOI 10.1128/JVI.73.1.533-552.1999; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BEAUD G, 1995, J VIROL, V69, P1819, DOI 10.1128/JVI.69.3.1819-1826.1995; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Black EP, 1998, VIROLOGY, V245, P313, DOI 10.1006/viro.1998.9166; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Chivian D, 2005, PROTEINS, V61, P157, DOI 10.1002/prot.20733; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; De Silva FS, 2007, P NATL ACAD SCI USA, V104, P18724, DOI 10.1073/pnas.0709276104; Dellis S, 2004, VIROLOGY, V329, P328, DOI 10.1016/j.virol.2004.08.017; Dore AS, 2006, NUCLEIC ACIDS RES, V34, P4515, DOI 10.1093/nar/gkl623; Fu TJ, 1996, EMBO J, V15, P4414, DOI 10.1002/j.1460-2075.1996.tb00814.x; Ivanov I, 2006, NUCLEIC ACIDS RES, V34, P6023, DOI 10.1093/nar/gkl744; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; KELMAN Z, 1995, NUCLEIC ACIDS RES, V23, P3613, DOI 10.1093/nar/23.18.3613; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kovacs GR, 1996, J VIROL, V70, P6796, DOI 10.1128/JVI.70.10.6796-6802.1996; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Mayrose DR, 1996, PROTEIN SCI, V5, P1928, DOI 10.1002/pro.5560050920; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moss B, 2007, FIELDS VIROLOGY; Mulder Nicola, 2007, V396, P59; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nechaev S, 2008, J MOL BIOL, V379, P402, DOI 10.1016/j.jmb.2008.03.071; Negi SS, 2007, BIOINFORMATICS, V23, P3397, DOI 10.1093/bioinformatics/btm474; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POGO BGT, 1978, VIROLOGY, V84, P1, DOI 10.1016/0042-6822(78)90213-1; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schormann N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-45; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Silva MD, 2006, BIOINFORMATICS, V22, P2846, DOI 10.1093/bioinformatics/btl506; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; Syed A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-462; TinkerKulberg RL, 1996, EMBO J, V15, P5032, DOI 10.1002/j.1460-2075.1996.tb00883.x; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Trakselis MA, 2001, TRENDS BIOCHEM SCI, V26, P566, DOI 10.1016/S0968-0004(01)01929-6; Tsurimoto T, 1998, BBA-GENE STRUCT EXPR, V1443, P23, DOI 10.1016/S0167-4781(98)00204-8; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; WRIGHT CF, 1993, J VIROL, V67, P7264, DOI 10.1128/JVI.67.12.7264-7270.1993; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; ZHANG YF, 1992, J VIROL, V66, P6470, DOI 10.1128/JVI.66.11.6470-6479.1992	53	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2009	4	5							e5479	10.1371/journal.pone.0005479	http://dx.doi.org/10.1371/journal.pone.0005479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JH	19421403	Green Published, Green Submitted, gold			2022-12-27	WOS:000265837000012
J	Liu, HY; Kohane, IS				Liu, Hongye; Kohane, Issac S.			Tissue and Process Specific microRNA-mRNA Co-Expression in Mammalian Development and Malignancy	PLOS ONE			English	Article								An association between enrichment and depletion of microRNA (miRNA) binding sites, 3' UTR length, and mRNA expression has been demonstrated in various developing tissues and tissues from different mature organs; but functional, context-dependent miRNA regulations have yet to be elucidated. Towards that goal, we examined miRNA-mRNA interactions by measuring miRNA and mRNA in the same tissue during development and also in malignant conditions. We identified significant miRNA-mediated biological process categories in developing mouse cerebellum and lung using non-targeted mRNA expression as the negative control. Although miRNAs in general suppress target mRNA messages, many predicted miRNA targets demonstrate a significantly higher level of co-expression than non-target genes in developing cerebellum. This phenomenon is tissue specific since it is not observed in developing lungs. Comparison of mouse cerebellar development and medulloblastoma demonstrates a shared miRNA-mRNA co-expression program for brain-specific neurologic processes such as synaptic transmission and exocytosis, in which miRNA target expression increases with the accumulation of multiple miRNAs in developing cerebellum and decreases with the loss of these miRNAs in brain tumors. These findings demonstrate the context-dependence of miRNA-mRNA co-expression.			Liu, HY (corresponding author), Childrens Hosp, Informat Program, 300 Longwood Ave, Boston, MA 02115 USA.	hongye.liu@childrens.harvard.edu	Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828, P01NS047572] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH085143-01, R01 MH085143] Funding Source: Medline; NINDS NIH HHS [P01 NS047572-01A, P01 NS047572, P50 NS040828-08, P50 NS040828] Funding Source: Medline; NLM NIH HHS [5U54 LM008748-02, U54 LM008748] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cardoso WV, 2000, DEV DYNAM, V219, P121, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1053>3.3.CO;2-8; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Iwama H, 2007, FEBS LETT, V581, P1805, DOI 10.1016/j.febslet.2007.03.066; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PURVES GJ, 1997, NEUROSCIENCE; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; THOMSON JM, 2006, GENES DEV; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	48	56	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2009	4	5							e5436	10.1371/journal.pone.0005436	http://dx.doi.org/10.1371/journal.pone.0005436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442JE	19415117	Green Published, gold			2022-12-27	WOS:000265836700009
J	Zhang, C; Yang, N; Yang, CH; Ding, HS; Luo, C; Zhang, Y; Wu, MJ; Zhang, XW; Shen, X; Jiang, HL; Meng, LH; Ding, J				Zhang, Chao; Yang, Na; Yang, Chun-hao; Ding, Hua-sheng; Luo, Cheng; Zhang, Yu; Wu, Mao-jiang; Zhang, Xiong-wen; Shen, Xu; Jiang, Hua-Liang; Meng, Ling-hua; Ding, Jian			S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton	PLOS ONE			English	Article								Background: Deregulation of the phosphatidylinositol 3-kinases (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway plays a central role in tumor formation and progression, providing validated targets for cancer therapy. S9, a hybrid of alpha-methylene-gamma-lactone and 2-phenyl indole compound, possessed potent activity against this pathway. Methodology/Principal Findings: Effects of S9 on PI3K-Akt-mTOR pathway were determined by Western blot, immunofluorescence staining and in vitro kinas assay. The interactions between tubulin and S9 were investigated by polymerization assay, CD, and SPR assay. The potential binding modes between S9 and PI3K, mTOR or tubulin were analyzed by molecular modeling. Anti-tumor activity of S9 was evaluated in tumor cells and in nude mice bearing human cancer xenografts. S9 abrogated EGF-activated PI3K-Akt-mTOR signaling cascade and Akt translocation to cellular membrane in human tumor cells. S9 possessed inhibitory activity against both PI3K and mTOR with little effect on other tested 30 kinases. S9 also completely impeded hyper-phosphorylation of Akt as a feedback of inhibition of mTOR by rapamycin. S9 unexpectedly arrested cells in M phase other than G1 phase, which was distinct from compounds targeting PI3K-Akt-mTOR pathway. Further study revealed that S9 inhibited tubulin polymerization via binding to colchicine-binding site of tubulin and resulted in microtubule disturbance. Molecular modeling indicated that S9 could potentially bind to the kinase domains of PI3K p110 alpha subunit and mTOR, and shared similar hydrophobic interactions with colchicines in the complex with tubulin. Moreover, S9 induced rapid apoptosis in tumor cell, which might reflect a synergistic cooperation between blockade of both PI3-Akt-mTOR signaling and tubulin cytoskeleton. Finally, S9 displayed potent antiproliferative activity in a panel of tumor cells originated from different tissue types including drug-resistant cells and in nude mice bearing human tumor xenografts. Conclusions/Significance: Taken together, S9 targets both PI3K-Akt-mTOR signaling and microtubule cytoskeleton, which combinatorially contributes its antitumor activity and provides new clues for anticancer drug design and development.	[Zhang, Chao; Yang, Na; Zhang, Xiong-wen; Meng, Ling-hua; Ding, Jian] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China; [Yang, Chun-hao; Ding, Hua-sheng; Wu, Mao-jiang] Chinese Acad Sci, Shanghai Inst Mat Med, Div Organ Synthesis, Shanghai 200031, Peoples R China; [Luo, Cheng; Zhang, Yu; Shen, Xu; Jiang, Hua-Liang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Shen, Xu; Jiang, Hua-Liang] East China Univ Sci & Technol, Sch Pharm, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China University of Science & Technology	Zhang, C (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China.	lhmeng@mail.shcnc.ac.cn; jding@mail.shcnc.ac.cn	Zhang, Yu/J-5225-2014; meng, linghua/Y-8110-2019		Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-YW-R-25]; National Natural Science Foundation of China [30721005, 90713034]; Science and Technology Commission of Shanghai Municipality Pujiang Talent Program [08PJ14114, 07dz05906]	Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Pujiang Talent Program(Science & Technology Commission of Shanghai Municipality (STCSM))	Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R-25), National Natural Science Foundation of China (30721005, 90713034), Science and Technology Commission of Shanghai Municipality Pujiang Talent Program (08PJ14114), Grant 07dz05906. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Ding HS, 2005, BIOORG MED CHEM LETT, V15, P4799, DOI 10.1016/j.bmcl.2005.07.050; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gastpar R, 1998, J MED CHEM, V41, P4965, DOI 10.1021/jm980228l; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P1091; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Maira SM, 2008, EXPERT OPIN THER TAR, V12, P223, DOI 10.1517/14728222.12.2.223 ; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NOBES CD, 1995, J CELL SCI, V108, P225; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; PANDA HPM, RAPID TREADMILLING B; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Tong YG, 2006, MOL PHARMACOL, V69, P1226, DOI 10.1124/mol.105.020537; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wipf P, 2005, ORG BIOMOL CHEM, V3, P2053, DOI 10.1039/B504418a; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang C, 2006, BRIT J PHARMACOL, V148, P741, DOI 10.1038/sj.bjp.0706741; Zhang LH, 2006, CANCER RES, V66, P951, DOI 10.1158/0008-5472.CAN-05-2083	33	85	94	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2009	4	3							e4881	10.1371/journal.pone.0004881	http://dx.doi.org/10.1371/journal.pone.0004881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437OK	19293927	Green Published, gold, Green Submitted			2022-12-27	WOS:000265496600007
J	Ballhorn, DJ; Kautz, S; Heil, M; Hegeman, AD				Ballhorn, Daniel J.; Kautz, Stefanie; Heil, Martin; Hegeman, Adrian D.			Cyanogenesis of Wild Lima Bean (Phaseolus lunatus L.) Is an Efficient Direct Defence in Nature	PLOS ONE			English	Article							TRIFOLIUM-REPENS-L; INSECT HERBIVORY; PLANT DEFENSE; VOLATILES INDUCE; HOST PLANTS; POLYMORPHISM; RESPONSES; OVIPOSITION; EVOLUTION; SORGHUM	In natural systems plants face a plethora of antagonists and thus have evolved multiple defence strategies. Lima bean (Phaseolus lunatus L.) is a model plant for studies of inducible indirect anti-herbivore defences including the production of volatile organic compounds (VOCs) and extrafloral nectar (EFN). In contrast, studies on direct chemical defence mechanisms as crucial components of lima beans' defence syndrome under natural conditions are nonexistent. In this study, we focus on the cyanogenic potential (HCNp; concentration of cyanogenic glycosides) as a crucial parameter determining lima beans' cyanogenesis, i.e. the release of toxic hydrogen cyanide from preformed precursors. Quantitative variability of cyanogenesis in a natural population of wild lima bean in Mexico was significantly correlated with missing leaf area. Since existing correlations do not by necessity mean causal associations, the function of cyanogenesis as efficient plant defence was subsequently analysed in feeding trials. We used natural chrysomelid herbivores and clonal lima beans with known cyanogenic features produced from field-grown mother plants. We show that in addition to extensively investigated indirect defences, cyanogenesis has to be considered as an important direct defensive trait affecting lima beans' overall defence in nature. Our results indicate the general importance of analysing 'multiple defence syndromes' rather than single defence mechanisms in future functional analyses of plant defences.			Ballhorn, DJ (corresponding author), Univ Duisburg Essen, Dept Gen Bot Plant Ecol, Essen, Germany.	daniel.ballhorn@uni-due.de	Heil, Martin/T-3960-2019; Heil, Martin/AAC-2730-2022; Hegeman, Adrian/D-5984-2013	Heil, Martin/0000-0001-8036-8697; Hegeman, Adrian/0000-0003-1008-6066				Agrawal AA, 2008, ENTOMOL EXP APPL, V128, P126, DOI 10.1111/j.1570-7458.2008.00690.x; Agrawal AA, 2008, P NATL ACAD SCI USA, V105, P10057, DOI 10.1073/pnas.0802368105; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Ball JP, 2000, J APPL ECOL, V37, P247, DOI 10.1046/j.1365-2664.2000.00487.x; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2006, J CHEM ECOL, V32, P1861, DOI 10.1007/s10886-006-9114-z; Ballhorn DJ, 2006, J CHEM ECOL, V32, P261, DOI 10.1007/s10886-005-9001-z; Ballhorn DJ, 2005, J CHEM ECOL, V31, P1445, DOI 10.1007/s10886-005-5791-2; Becerra JX, 2001, AM ZOOL, V41, P865, DOI 10.1668/0003-1569(2001)041[0865:IBCAMD]2.0.CO;2; Bouwmeester HJ, 1999, PLANT PHYSIOL, V121, P173, DOI 10.1104/pp.121.1.173; BURGER JC, 1994, OECOLOGIA, V99, P79, DOI 10.1007/BF00317086; Busk PK, 2002, PLANT PHYSIOL, V129, P1222, DOI 10.1104/pp.000687; CAHN MG, 1976, HEREDITY, V37, P309, DOI 10.1038/hdy.1976.95; Choh Y, 2006, OECOLOGIA, V147, P455, DOI 10.1007/s00442-005-0289-8; Dicke M, 1999, ENTOMOL EXP APPL, V91, P131, DOI 10.1023/A:1003608019062; DIRZO R, 1982, J ECOL, V70, P119, DOI 10.2307/2259868; FLOSS HG, 1965, NATURE, V208, P1207, DOI 10.1038/2081207a0; Gleadow RM, 2000, AUST J PLANT PHYSIOL, V27, P693, DOI 10.1071/PP00004; Goodger JQD, 2002, BIOCHEM SYST ECOL, V30, P617, DOI 10.1016/S0305-1978(01)00141-7; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; Heil M, 2008, J CHEM ECOL, V34, P601, DOI 10.1007/s10886-008-9464-9; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Horiuchi J, 2003, APPL ENTOMOL ZOOL, V38, P109, DOI 10.1303/aez.2003.109; HUGHES MA, 1991, HEREDITY, V66, P105, DOI 10.1038/hdy.1991.13; Iason G, 2005, P NUTR SOC, V64, P123, DOI 10.1079/PNS2004415; Jenrich R, 2007, P NATL ACAD SCI USA, V104, P18848, DOI 10.1073/pnas.0709315104; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; JONES DA, 1962, NATURE, V193, P1109, DOI 10.1038/1931109a0; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; KOST C, 2005, BASIC APPL ECOL, V94, P619; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1457, DOI 10.1007/BF02035145; LOYD RC, 1970, AGRON J, V62, P394, DOI 10.2134/agronj1970.00021962006200030025x; Masumoto T, 2000, POPUL ECOL, V42, P145, DOI 10.1007/PL00011993; Meiners SJ, 2000, PLANT ECOL, V151, P161, DOI 10.1023/A:1026509529570; Mithofer A, 2004, J PLANT GROWTH REGUL, V23, P170, DOI 10.1007/s00344-004-0034-2; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; NAHRSTEDT A, 1985, PLANT SYST EVOL, V150, P35, DOI 10.1007/BF00985566; NOTTINGHAM SF, 1988, J INSECT PHYSIOL, V34, P227, DOI 10.1016/0022-1910(88)90053-4; Paul ND, 2000, TRENDS PLANT SCI, V5, P220, DOI 10.1016/S1360-1385(00)01603-4; Piotrowski M, 2001, J BIOL CHEM, V276, P2616, DOI 10.1074/jbc.M007890200; Rand TA, 1999, OECOLOGIA, V121, P39, DOI 10.1007/s004420050905; Rodriguez-Saona C, 2005, ECOL ENTOMOL, V30, P156, DOI 10.1111/j.0307-6946.2005.00682.x; Romeo JT, 1998, ECOSCIENCE, V5, P287, DOI 10.1080/11956860.1998.11682475; SHURE DJ, 1991, OECOLOGIA, V86, P325, DOI 10.1007/BF00317597; Skaloudova B, 2007, ANIM BEHAV, V74, P813, DOI 10.1016/j.anbehav.2007.02.005; Tentelier C, 2006, BEHAV ECOL, V17, P515, DOI 10.1093/beheco/arj062; Thomsen K, 1997, BOT J LINN SOC, V124, P273, DOI 10.1006/bojl.1997.0100; van der Meijden E, 2000, OIKOS, V89, P202, DOI 10.1034/j.1600-0706.2000.890123.x; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195	57	50	51	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2009	4	5							e5450	10.1371/journal.pone.0005450	http://dx.doi.org/10.1371/journal.pone.0005450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	443TN	19424497	gold, Green Published			2022-12-27	WOS:000265933800010
